PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Grassilli, E; Pisano, F; Cialdella, A; Bonomo, S; Missaglia, C; Cerrito, MG; Masiero, L; Ianzano, L; Giordano, F; Cicirelli, V; Narloch, R; D'Amato, F; Noli, B; Ferri, GL; Leone, BE; Stanta, G; Bonin, S; Helin, K; Giovannoni, R; Lavitrano, M				Grassilli, E.; Pisano, F.; Cialdella, A.; Bonomo, S.; Missaglia, C.; Cerrito, M. G.; Masiero, L.; Ianzano, L.; Giordano, F.; Cicirelli, V.; Narloch, R.; D'Amato, F.; Noli, B.; Ferri, G. L.; Leone, B. E.; Stanta, G.; Bonin, S.; Helin, K.; Giovannoni, R.; Lavitrano, M.			A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation	ONCOGENE			English	Article							BRUTONS TYROSINE KINASE; SIGNALING PATHWAYS; POINT MUTATION; HNRNP-K; TRANSLATION; ACTIVATION; INHIBITION; DEFICIENCY; REGION; GENE	Bruton's tyrosine kinase (BTK) is essential for B-cell proliferation/differentiation and it is generally believed that its expression and function are limited to bone marrow-derived cells. Here, we report the identification and characterization of p65BTK, a novel isoform abundantly expressed in colon carcinoma cell lines and tumour tissue samples. p65BTK protein is expressed, through heterogeneous nuclear ribonucleoprotein K (hnRNPK)-dependent and internal ribosome entry site-driven translation, from a transcript containing an alternative first exon in the 5'-untranslated region, and is post-transcriptionally regulated, via hnRNPK, by the mitogen-activated protein kinase (MAPK) pathway. p65BTK is endowed with strong transforming activity that depends on active signal-regulated protein kinases-1/2 (ERK1/2) and its inhibition abolishes RAS transforming activity. Accordingly, p65BTK overexpression in colon cancer tissues correlates with ERK1/2 activation. Moreover, p65BTK inhibition affects growth and survival of colon cancer cells. Our data reveal that BTK, via p65BTK expression, is a novel and powerful oncogene acting downstream of the RAS/MAPK pathway and suggest that its targeting may be a promising therapeutic approach.	[Grassilli, E.; Pisano, F.; Cialdella, A.; Bonomo, S.; Missaglia, C.; Cerrito, M. G.; Masiero, L.; Ianzano, L.; Giordano, F.; Cicirelli, V.; Narloch, R.; Leone, B. E.; Giovannoni, R.; Lavitrano, M.] Univ Milano Bicocca, Sch Med & Surg, Via Cadore 48, I-20900 Monza, MB, Italy; [Grassilli, E.; Pisano, F.; Cialdella, A.] BiOnSil Srl, Monza, Italy; [D'Amato, F.; Noli, B.; Ferri, G. L.] Univ Cagliari, Dept Biomed Sci, NEF Lab, Monserrato, Italy; [Stanta, G.; Bonin, S.] Univ Trieste, Cattinara Hosp, Dept Med Sci, Trieste, Italy; [Helin, K.] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Helin, K.] Univ Copenhagen, Ctr Epigenet, Copenhagen, Denmark; [Helin, K.] Univ Copenhagen, Danish Stem Cell Ctr Danstem, Copenhagen, Denmark	University of Milano-Bicocca; University of Cagliari; University of Trieste; University of Copenhagen; University of Copenhagen; University of Copenhagen	Grassilli, E; Lavitrano, M (corresponding author), Univ Milano Bicocca, Sch Med & Surg, Via Cadore 48, I-20900 Monza, MB, Italy.	emanuela.grassilli@unimib.it; marialuisa.lavitrano@unimib.it	Ferri, Luca Angelo/AAC-5890-2022; Bonin, Serena/C-9332-2015; Giovannoni, Roberto/A-1413-2009; grassilli, emanuela/ABB-7845-2020; Helin, Kristian/K-2526-2019; Grassilli, Emanuela/L-7296-2013; Helin, Kristian/HDM-8306-2022; Cerrito, Maria Grazia/AAA-1190-2019; LEONE, BIAGIO EUGENIO/J-8803-2018	Ferri, Luca Angelo/0000-0001-9031-6284; Bonin, Serena/0000-0002-7349-0296; Giovannoni, Roberto/0000-0002-7706-0672; grassilli, emanuela/0000-0001-5387-5925; Grassilli, Emanuela/0000-0001-5387-5925; Helin, Kristian/0000-0003-1975-6097; Cerrito, Maria Grazia/0000-0002-3347-5817; cicirelli, vincenzo/0000-0003-2792-8848; STANTA, GIORGIO/0000-0002-3261-4272; LEONE, BIAGIO EUGENIO/0000-0002-6978-2405; FERRI, Gian-Luca/0000-0003-2768-349X; Lavitrano, Marialuisa/0000-0003-4852-1318	MIUR [PON01_02782]; Ministry of Health [RF-2010-2305526]; University of Milano-Bicocca, FAR grants; Novo Nordisk Foundation Section for Basic Stem Cell Biology [Helin group NNF] Funding Source: researchfish	MIUR(Ministry of Education, Universities and Research (MIUR)); Ministry of Health; University of Milano-Bicocca, FAR grants; Novo Nordisk Foundation Section for Basic Stem Cell Biology	We thank BiOnSil, srl, spin-off of the University of Milano-Bicocca, for making available BN49 anti-p65BTK antibody in the frame of the Scientific agreement with the University of Cagliari, and Dr Elena Sacco and Dr Luca Mologni from the University of Milano-Bicocca for the gift of the RAS-DN and pS-shRAS plasmids. This work was funded by MIUR, PON01_02782, by Ministry of Health, RF-2010-2305526 and by University of Milano-Bicocca, FAR grants to ML.	Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Burger JA, 2014, CURR HEMATOL MALIG R, V9, P44, DOI 10.1007/s11899-013-0188-8; Carpenter B, 2006, BRIT J CANCER, V95, P921, DOI 10.1038/sj.bjc.6603349; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; Didiot MC, 2013, J BIOMOL SCREEN, V18, P407, DOI 10.1177/1087057112466698; Dingjan GM, 1998, EMBO J, V17, P5309, DOI 10.1093/emboj/17.18.5309; Eifert C, 2013, GENE CHROMOSOME CANC, V52, P961, DOI 10.1002/gcc.22091; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Feldhahn N, 2005, P NATL ACAD SCI USA, V102, P13266, DOI 10.1073/pnas.0505196102; Gao B, 2014, BIOCHIM BIOPHYS ACTA, V1849, P753; Guha M, 2014, NAT BIOTECHNOL, V32, P113, DOI 10.1038/nbt0214-113; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Kang SW, 2001, EMBO J, V20, P5692, DOI 10.1093/emboj/20.20.5692; Komar AA, 2012, GENE, V502, P75, DOI 10.1016/j.gene.2012.04.039; LI TJ, 1995, IMMUNITY, V2, P451, DOI 10.1016/1074-7613(95)90026-8; Liu WM, 2001, NAT IMMUNOL, V2, P939, DOI 10.1038/ni1001-939; Marash L, 2008, MOL CELL, V30, P447, DOI 10.1016/j.molcel.2008.03.018; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; Novero A, 2014, EXP HEMATOL ONCOL, V3, DOI 10.1186/2162-3619-3-4; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; POW DV, 1993, J NEUROSCI METH, V48, P51, DOI 10.1016/S0165-0270(05)80007-X; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; Salamov AA, 1998, BIOINFORMATICS, V14, P384, DOI 10.1093/bioinformatics/14.5.384; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Smith L, 2008, BIOCHEM SOC T, V36, P708, DOI 10.1042/BST0360708; Spatuzza C, 2008, NUCLEIC ACIDS RES, V36, P4402, DOI 10.1093/nar/gkn413; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0; Wurth L, 2015, BBA-GENE REGUL MECH, V1849, P881, DOI 10.1016/j.bbagrm.2014.10.001; YAO L, 1994, P NATL ACAD SCI USA, V91, P9175, DOI 10.1073/pnas.91.19.9175; Yu L, 2006, J BIOL CHEM, V281, P18201, DOI 10.1074/jbc.M603090200	37	41	41	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	33					4368	4378		10.1038/onc.2015.504	http://dx.doi.org/10.1038/onc.2015.504			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU3ZU	26804170	hybrid, Green Published			2022-12-26	WOS:000382152100008
J	Bishop, JH; Fox, JR; Maple, R; Loretan, C; Badger, GJ; Henry, SM; Vizzard, MA; Langevin, HM				Bishop, James H.; Fox, James R.; Maple, Rhonda; Loretan, Caitlin; Badger, Gary J.; Henry, Sharon M.; Vizzard, Margaret A.; Langevin, Helene M.			Ultrasound Evaluation of the Combined Effects of Thoracolumbar Fascia Injury and Movement Restriction in a Porcine Model	PLOS ONE			English	Article							LOW-BACK-PAIN; SENSORY INNERVATION; PIG; ANATOMY; SKIN; RATS	The persistence of back pain following acute back "sprains" is a serious public health problem with poorly understood pathophysiology. The recent finding that human subjects with chronic low back pain (LBP) have increased thickness and decreased mobility of the thoracolumbar fascia measured with ultrasound suggest that the fasciae of the back may be involved in LBP pathophysiology. This study used a porcine model to test the hypothesis that similar ultrasound findings can be produced experimentally in a porcine model by combining a local injury of fascia with movement restriction using a "hobble" device linking one foot to a chest harness for 8 weeks. Ultrasound measurements of thoracolumbar fascia thickness and shear plane mobility (shear strain) during passive hip flexion were made at the 8 week time point on the non-intervention side (injury and/or hobble). Injury alone caused both an increase in fascia thickness (p =.007) and a decrease in fascia shear strain on the non-injured side (p =.027). Movement restriction alone did not change fascia thickness but did decrease shear strain on the non-hobble side (p =.024). The combination of injury plus movement restriction had additive effects on reducing fascia mobility with a 52% reduction in shear strain compared with controls and a 28% reduction compared to movement restriction alone. These results suggest that a back injury involving fascia, even when healed, can affect the relative mobility of fascia layers away from the injured area, especially when movement is also restricted.	[Bishop, James H.; Fox, James R.; Maple, Rhonda; Loretan, Caitlin; Vizzard, Margaret A.; Langevin, Helene M.] Univ Vermont, Dept Neurol Sci, Burlington, VT USA; [Badger, Gary J.] Univ Vermont, Dept Med Biostat, Burlington, VT USA; [Henry, Sharon M.] Univ Vermont, Dept Rehabil & Movement Sci, Burlington, VT USA; [Langevin, Helene M.] Harvard Univ, Sch Med, Div Prevent Med, Brigham & Womens Hosp, Boston, MA 02115 USA	University of Vermont; University of Vermont; University of Vermont; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Langevin, HM (corresponding author), Univ Vermont, Dept Neurol Sci, Burlington, VT USA.; Langevin, HM (corresponding author), Harvard Univ, Sch Med, Div Prevent Med, Brigham & Womens Hosp, Boston, MA 02115 USA.	hlangevin@partners.org			National Center for Complementary and Alternative Medicine [RO1AT004400]; National Center for Complementary and Integrative Health [RO1 AT004400]; National Center for Complementary & Integrative Health [R01AT004400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051369, R01DK060481] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary and Integrative Health; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this work came from National Center for Complementary and Alternative Medicine RO1AT004400. The funding entity had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors thank Dr. Ruth Blauwiekel, Mr. Stephen Bell and the University of Vermont animal care staff for invaluable assistance with the care of the animals. This project was supported by Research Grants RO1 AT004400 from the National Center for Complementary and Integrative Health. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Complementary and Integrative Health, National Institutes of Health.	Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; Benetazzo L, 2011, SURG RADIOL ANAT, V33, P855, DOI 10.1007/s00276-010-0757-7; Corey SM, 2011, CELLS TISSUES ORGANS; Crick SJ, 1998, J ANAT, V193, P105, DOI 10.1046/j.1469-7580.1998.19310105.x; DOUGLAS WR, 1972, SPACE LIFE SCI, V3, P226, DOI 10.1007/BF00928167; Eakin CL, 2001, PHYSICIAN SPORTSMED, V29, P31, DOI 10.3810/psm.2001.03.668; Johanson E, 2011, EUR SPINE J, V20, P2152, DOI 10.1007/s00586-011-1825-3; KERRIGAN CL, 1986, LAB ANIM SCI, V36, P408; Langevin HM, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-203; Langevin HM, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-151; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Malanga GA, 2010, PHYS MED REH CLIN N, V21, P711, DOI 10.1016/j.pmr.2010.07.003; MARCARIAN HQ, 1966, AM J VET RES, V27, P765; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; MEYER W, 1981, ARCH DERMATOL RES, V270, P391, DOI 10.1007/BF00403783; Meyer W, 1978, Curr Probl Dermatol, V7, P39; Rose E H, 1978, Ann Plast Surg, V1, P252, DOI 10.1097/00000637-197805000-00002; Schilling Nadja, 2005, Pathophysiology, V12, P233, DOI 10.1016/j.pathophys.2005.09.005; Solomonow M, 2012, J ELECTROMYOGR KINES, V22, P155, DOI 10.1016/j.jelekin.2011.11.008; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Surnmerfield A, 2015, MOL IMMUNOL, V66, P14, DOI 10.1016/j.molimm.2014.10.023; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Taguchi T, 2008, PAIN, V138, P119, DOI 10.1016/j.pain.2007.11.015; Tesarz J, 2011, NEUROSCIENCE, V194, P302, DOI 10.1016/j.neuroscience.2011.07.066; Tillman L.J., 1992, DYNAMICS HUMAN BIOL; Vardaxis NJ, 1997, J ANAT, V190, P601, DOI 10.1046/j.1469-7580.1997.19040601.x; VLEEMING A, 1995, SPINE, V20, P753, DOI 10.1097/00007632-199504000-00001; Weinstein Stuart MHS, 2005, PHYS MED REHABILITAI; Willard FH, 2012, J ANAT, V221, P507, DOI 10.1111/j.1469-7580.2012.01511.x; YAHIA LH, 1992, ACTA ORTHOP SCAND, V63, P195, DOI 10.3109/17453679209154822	30	25	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147393	10.1371/journal.pone.0147393	http://dx.doi.org/10.1371/journal.pone.0147393			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820883	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528400023
J	de Kretser, DM; Bensley, JG; Phillips, DJ; Levvey, BJ; Snell, GI; Lin, E; Hedger, MP; O'Hehir, RE				de Kretser, David M.; Bensley, Jonathan G.; Phillips, David J.; Levvey, Bronwyn J.; Snell, Greg I.; Lin, Enjarn; Hedger, Mark P.; O'Hehir, Robyn E.			Substantial Increases Occur in Serum Activins and Follistatin during Lung Transplantation	PLOS ONE			English	Article							BINDING-PROTEIN; REPERFUSION INJURY; INFLAMMATION; ISCHEMIA; FIBROSIS; HEPARIN; KIDNEY; ACTIVATION; RELEASE; DEATH	Background Lung transplantation exposes the donated lung to a period of anoxia. Re-establishing the circulation after ischemia stimulates inflammation causing organ damage. Since our published data established that activin A is a key pro-inflammatory cytokine, we assessed the roles of activin A and B, and their binding protein, follistatin, in patients undergoing lung transplantation. Methods Sera from 46 patients participating in a published study of remote ischemia conditioning in lung transplantation were used. Serum activin A and B, follistatin and 11 other cytokines were measured in samples taken immediately after anaesthesia induction, after remote ischemia conditioning or sham treatment undertaken just prior to allograft reperfusion and during the subsequent 24 hours. Results Substantial increases in serum activin A, B and follistatin occurred after the baseline sample, taken before anaesthesia induction and peaked immediately after the remote ischemia conditioning/sham treatment. The levels remained elevated 15 minutes after lung transplantation declining thereafter reaching baseline 2 hours post-transplant. Activin B and follistatin concentrations were lower in patients receiving remote ischemia conditioning compared to sham treated patients but the magnitude of the decrease did not correlate with early transplant outcomes. Conclusions We propose that the increases in the serum activin A, B and follistatin result from a combination of factors; the acute phase response, the reperfusion response and the use of heparin- based anti-coagulants.	[de Kretser, David M.; Bensley, Jonathan G.] Monash Univ, Sch Biomed Sci, Dept Anat & Dev Biol, Clayton, Vic, Australia; [de Kretser, David M.; Phillips, David J.; Hedger, Mark P.] Hudson Inst Med Res, Clayton, Vic, Australia; [Levvey, Bronwyn J.; Snell, Greg I.; O'Hehir, Robyn E.] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia; [Levvey, Bronwyn J.; Snell, Greg I.; O'Hehir, Robyn E.] Alfred Hosp, Lung Transplant Serv, Melbourne, Vic, Australia; [Snell, Greg I.] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Lin, Enjarn] Alfred Hosp, Dept Anaesthesia & Perioperat Med, Melbourne, Vic, Australia; [Phillips, David J.] Epworth HealthCare, Epworth Res Inst, Richmond, Vic, Australia	Monash University; Hudson Institute of Medical Research; Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health; Monash University; Florey Institute of Neuroscience & Mental Health	de Kretser, DM (corresponding author), Monash Univ, Sch Biomed Sci, Dept Anat & Dev Biol, Clayton, Vic, Australia.; de Kretser, DM (corresponding author), Hudson Inst Med Res, Clayton, Vic, Australia.	david.de.kretser@monash.edu	Hedger, Mark P/C-3495-2008; O'Hehir, Robyn E/H-3627-2011	O'Hehir, Robyn E/0000-0002-3489-7595; Levvey, Bronwyn/0000-0002-1954-4249; Bensley, Jonathan/0000-0003-2926-1856; Hedger, Mark/0000-0003-0602-3724	National Health and Medical Research Council of Australia (NHMRC) [APP1048094]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	The study was supported in part by a grant (APP1048094) from the National Health and Medical Research Council of Australia (NHMRC) and by the Victorian Government's Operational Infrastructure Support Program.	Aoki F, 2007, ENDOCR J, V54, P849, DOI 10.1507/endocrj.KR07E-001; Chen Y, 2014, CYTOKINE, V69, P255, DOI 10.1016/j.cyto.2014.06.017; Chen Y, 2011, CYTOKINE, V54, P154, DOI 10.1016/j.cyto.2011.01.001; COLLETTI LM, 1990, J CLIN INVEST, V85, P1936, DOI 10.1172/JCI114656; Cypel M, 2011, NEW ENGL J MED, V364, P1431, DOI 10.1056/NEJMoa1014597; de Kretser DM, 2012, MOL CELL ENDOCRINOL, V359, P101, DOI 10.1016/j.mce.2011.10.009; de Kretser DM, 2013, CRIT CARE, V17, DOI 10.1186/cc13093; de Kretser DM, 1999, J ENDOCRINOL, V161, P195, DOI 10.1677/joe.0.1610195; de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO; de Vries DK, 2011, AM J TRANSPLANT, V11, P1064, DOI 10.1111/j.1600-6143.2011.03466.x; Dohi T, 2005, GASTROENTEROLOGY, V128, P411, DOI 10.1053/j.gastro.2004.11.063; Dorgan DJ, 2014, EXPERT REV RESP MED, V8, P315, DOI 10.1586/17476348.2014.899906; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Hardy CL, 2015, IMMUNOL CELL BIOL, V93, P567, DOI 10.1038/icb.2015.7; Hardy CL, 2006, CLIN EXP ALLERGY, V36, P941, DOI 10.1111/j.1365-2222.2006.02523.x; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Hedger MP, 2011, VITAM HORM, V85, P255, DOI 10.1016/B978-0-12-385961-7.00013-5; Hirche TO, 2014, PULM MED, V2014, DOI 10.1155/2014/621342; Jones KL, 2004, J ENDOCRINOL, V181, P307, DOI 10.1677/joe.0.1810307; Jones KL, 2007, P NATL ACAD SCI USA, V104, P16239, DOI 10.1073/pnas.0705971104; King RC, 2000, ANN THORAC SURG, V69, P1681, DOI 10.1016/S0003-4975(00)01425-9; Lerch TF, 2007, J BIOL CHEM, V282, P15930, DOI 10.1074/jbc.M700737200; Lin E, 2014, J HEART LUNG TRANSPL, V33, P1139, DOI 10.1016/j.healun.2014.04.022; Ludlow H, 2009, CLIN ENDOCRINOL, V71, P867, DOI 10.1111/j.1365-2265.2009.03567.x; Michel U, 2003, EUR J ENDOCRINOL, V148, P559, DOI 10.1530/eje.0.1480559; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Oto T, 2008, AM J TRANSPLANT, V8, P2132, DOI 10.1111/j.1600-6143.2008.02357.x; Patella S, 2001, J HEPATOL, V34, P576, DOI 10.1016/S0168-8278(00)00029-5; Patella S, 2006, AM J PHYSIOL-GASTR L, V290, pG137, DOI 10.1152/ajpgi.00080.2005; Phillips DJ, 2000, J CLIN ENDOCR METAB, V85, P2411, DOI 10.1210/jc.85.7.2411; Phillips DJ, 1996, J ENDOCRINOL, V151, P119, DOI 10.1677/joe.0.1510119; Russell CE, 1999, MOL CELL ENDOCRINOL, V148, P129, DOI 10.1016/S0303-7207(98)00226-3; SCHWALL RH, 1993, HEPATOLOGY, V18, P347, DOI 10.1016/0270-9139(93)90018-I; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yamashita S, 2004, J AM SOC NEPHROL, V15, P91, DOI 10.1097/01.ASN.0000103225.68136.E6; Zipori D, 2001, J LEUKOCYTE BIOL, V69, P867	37	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0140948	10.1371/journal.pone.0140948	http://dx.doi.org/10.1371/journal.pone.0140948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820896	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528400001
J	Pchelintsev, NA; Adams, PD; Nelson, DM				Pchelintsev, Nikolay A.; Adams, Peter D.; Nelson, David M.			Critical Parameters for Efficient Sonication and Improved Chromatin Immunoprecipitation of High Molecular Weight Proteins	PLOS ONE			English	Article							DNA INTERACTIONS INVIVO; CROSS-LINKING; FORMALDEHYDE	Solubilization of cross-linked cells followed by chromatin shearing is essential for successful chromatin immunoprecipitation (ChIP). However, this task, typically accomplished by ultrasound treatment, may often become a pitfall of the process, due to inconsistent results obtained between different experiments under seemingly identical conditions. To address this issue we systematically studied ultrasound-mediated cell lysis and chromatin shearing, identified critical parameters of the process and formulated a generic strategy for rational optimization of ultrasound treatment. We also demonstrated that whereas ultrasound treatment required to shear chromatin to within a range of 100-400 bp typically degrades large proteins, a combination of brief sonication and benzonase digestion allows for the generation of similarly sized chromatin fragments while preserving the integrity of associated proteins. This approach should drastically improve ChIP efficiency for this class of proteins.	[Pchelintsev, Nikolay A.; Adams, Peter D.; Nelson, David M.] Univ Glasgow, Inst Canc Sci, CR UK Beatson Labs, Glasgow, Lanark, Scotland; [Pchelintsev, Nikolay A.] Abcam Plc, 204 Cambridge Sci Pk, Cambridge, England	University of Glasgow	Pchelintsev, NA (corresponding author), Univ Glasgow, Inst Canc Sci, CR UK Beatson Labs, Glasgow, Lanark, Scotland.; Pchelintsev, NA (corresponding author), Abcam Plc, 204 Cambridge Sci Pk, Cambridge, England.	nikolay.pchelintsev@abcam.com		Adams, Peter/0000-0002-0684-1770	CR-UK program project [C10652/A10250]; program project NIA [AG031862-02]; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER; Cancer Research UK [16566] Funding Source: researchfish	CR-UK program project; program project NIA; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cancer Research UK(Cancer Research UK)	Work in the Adams laboratory was funded by CR-UK program project, C10652/A10250, and program project NIA AG031862-02.	ELSNER HI, 1989, DNA-J MOLEC CELL BIO, V8, P697, DOI 10.1089/dna.1989.8.697; GILMOUR DS, 1984, P NATL ACAD SCI-BIOL, V81, P4275, DOI 10.1073/pnas.81.14.4275; Ginsburg E, 1998, Adm Radiol J, V17, P17; Kurdistani SK, 2003, METHODS, V31, P90, DOI 10.1016/S1046-2023(03)00092-6; Pchelintsev NA, 2013, CELL REP, V3, P1012, DOI 10.1016/j.celrep.2013.03.026; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schmiedeberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004636; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297	10	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148023	10.1371/journal.pone.0148023	http://dx.doi.org/10.1371/journal.pone.0148023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821228	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000369528400059
J	Zhou, SF; Gopalakrishnan, S; Xu, YH; Yang, J; Lam, YW; Pang, SW				Zhou, Shu Fan; Gopalakrishnan, Singaram; Xu, Yuan Hao; Yang, Jie; Lam, Yun Wah; Pang, Stella W.			A Unidirectional Cell Switching Gate by Engineering Grating Length and Bending Angle	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; SUBSTRATE TOPOGRAPHY; SHEAR-STRESS; ENDOTHELIAL-CELLS; STEM-CELLS; IN-VITRO; MIGRATION; GUIDANCE; BEHAVIOR; MORPHOLOGY	On a microgrooved substrate, cells migrate along the pattern, and at random positions, reverse their directions. Here, we demonstrate that these reversals can be controlled by introducing discontinuities to the pattern. On "V-shaped grating patterns", mouse osteogenic progenitor MC3T3-E1 cells reversed predominately at the bends and the ends. The patterns were engineered in a way that the combined effects of angle-and length-dependence could be examined in addition to their individual effects. Results show that when the bend was placed closer to one end, migration behaviour of cells depends on their direction of approach. At an obtuse bend (135 degrees), more cells reversed when approaching from the long segment than from the short segment. But at an acute bend (45 degrees), this relationship was reversed. Based on this anisotropic behaviour, the designed patterns effectively allowed cells to move in one direction but blocked migrations in the opposing direction. This study demonstrates that by the strategic placement of bends and ends on grating patterns, we can engineer effective unidirectional switching gates that can control the movement of adherent cells. The knowledge developed in this study could be utilised in future cell sorting or filtering platforms without the need for chemotaxis or microfluidic control.	[Zhou, Shu Fan; Xu, Yuan Hao; Pang, Stella W.] City Univ Hong Kong, Dept Elect Engn, Kowloon, Hong Kong, Peoples R China; [Zhou, Shu Fan; Gopalakrishnan, Singaram; Xu, Yuan Hao; Yang, Jie; Lam, Yun Wah; Pang, Stella W.] City Univ Hong Kong, Ctr Biosyst Neurosci & Nanotechnol, Kowloon, Hong Kong, Peoples R China; [Gopalakrishnan, Singaram; Yang, Jie; Lam, Yun Wah] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China	City University of Hong Kong; City University of Hong Kong; City University of Hong Kong	Pang, SW (corresponding author), City Univ Hong Kong, Dept Elect Engn, Kowloon, Hong Kong, Peoples R China.; Lam, YW; Pang, SW (corresponding author), City Univ Hong Kong, Ctr Biosyst Neurosci & Nanotechnol, Kowloon, Hong Kong, Peoples R China.; Lam, YW (corresponding author), City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China.	yunwlam@cityu.edu.hk; pang@cityu.edu.hk	Gopalakrishnan, Singaram/AEB-6454-2022; Pang, Stella/A-7770-2012	Xu, Yuanhao/0000-0001-5529-5078; Pang, Stella/0000-0002-4330-0877; Lam, Yun Wah/0000-0001-8929-5965	Centre for Biosystems, Neuroscience, and Nanotechnology of City University of Hong Kong [9360148]; University Grants Council of Hong Kong [GRF 120413, 11210814]; City University of Hong Kong [9380062]	Centre for Biosystems, Neuroscience, and Nanotechnology of City University of Hong Kong; University Grants Council of Hong Kong; City University of Hong Kong(City University of Hong Kong)	This project received the financial support from the Centre for Biosystems, Neuroscience, and Nanotechnology of City University of Hong Kong under project number 9360148, the University Grants Council of Hong Kong (GRF 120413 and 11210814) and grant from the City University of Hong Kong (9380062).	Ankam S, 2013, ACTA BIOMATER, V9, P4535, DOI 10.1016/j.actbio.2012.08.018; Beuneu H, 2009, BLOOD, V114, P3227, DOI 10.1182/blood-2009-06-228759; Boneschansker L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5787; Cardozo BL, 2008, J VAC SCI TECHNOL B, V26, P2578, DOI 10.1116/1.2991859; Chen P, 2008, FRONT BIOSCI-LANDMRK, V13, P2464, DOI 10.2741/2859; Chen P, 2010, ANAL CHIM ACTA, V663, P1, DOI 10.1016/j.aca.2010.01.046; Choi MJ, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/4/045006; Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033; CLARK P, 1991, J CELL SCI, V99, P73; Crouch AS, 2009, BIOMATERIALS, V30, P1560, DOI 10.1016/j.biomaterials.2008.11.041; Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0; DAVIES PF, 1984, J CLIN INVEST, V73, P1121, DOI 10.1172/JCI111298; de la Vega M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1243; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; Diao JP, 2006, LAB CHIP, V6, P381, DOI 10.1039/b511958h; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dukkipati VR, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/46/465102; Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9; Frey MT, 2006, BIOPHYS J, V90, P3774, DOI 10.1529/biophysj.105.074526; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gaharwar AK, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015001; Ghibaudo M, 2009, BIOPHYS J, V97, P357, DOI 10.1016/j.bpj.2009.04.024; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Guo AH, 2010, J INVEST DERMATOL, V130, P2320, DOI 10.1038/jid.2010.96; Guvakova MA, 2007, INT J BIOCHEM CELL B, V39, P890, DOI 10.1016/j.biocel.2006.10.013; Hamilton DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015129; Hu W, 2005, J VAC SCI TECHNOL B, V23, P2984, DOI 10.1116/1.2121729; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Jana S, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035012; Jeffries EM, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035015; Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102; Kemkemer R, 2006, BIOPHYS J, V90, P4701, DOI 10.1529/biophysj.105.067967; Kidoaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078067; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; Kolind K, 2012, BIOMATERIALS, V33, P6626, DOI 10.1016/j.biomaterials.2012.05.070; Koufaki N, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/4/045004; Kumar G, 2007, ADV MATER, V19, P1084, DOI 10.1002/adma.200601629; Kurosaka Satoshi, 2008, Birth Defects Research, V84, P102, DOI 10.1002/bdrc.20125; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lawrence BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050190; Li JY, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035003; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Mandal K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6749; McKee CT, 2012, BIOPHYS J, V102, P1224, DOI 10.1016/j.bpj.2012.01.053; Mitchel JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024316; Ozkucur N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006131; Palm D, 2005, SEMIN CANCER BIOL, V15, P396, DOI 10.1016/j.semcancer.2005.06.008; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Raghavan V, 2014, P NATL ACAD SCI USA, V111, P8506, DOI 10.1073/pnas.1402195111; Saadi W, 2006, BIOMED MICRODEVICES, V8, P109, DOI 10.1007/s10544-006-7706-6; Song S, 2015, LAB CHIP, V15, P1250, DOI 10.1039/c4lc01417k; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Tang QY, 2015, J BIOMED MATER RES A, V103, P2383, DOI 10.1002/jbm.a.35378; Tang QY, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/1/015011; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Veith M, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035001; Ventre M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0687; Walboomers X F, 2001, Odontology, V89, P2, DOI 10.1007/s10266-001-8178-z; Wang L, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035013; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058; Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	66	45	46	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147801	10.1371/journal.pone.0147801	http://dx.doi.org/10.1371/journal.pone.0147801			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821058	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528400046
J	Markey, KL; Abdo, DA; Evans, SN; Bosserelle, C				Markey, Kathryn L.; Abdo, Dave A.; Evans, Scott N.; Bosserelle, Cyprien			Keeping It Local: Dispersal Limitations of Coral Larvae to the High Latitude Coral Reefs of the Houtman Abrolhos Islands	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SCLERACTINIAN CORALS; COMPETENCE PERIODS; SURVIVAL DYNAMICS; GENETIC DIVERSITY; SETTLEMENT; REPRODUCTION; CONNECTIVITY; SURVIVORSHIP; RECRUITMENT	In 2011 the first recorded bleaching event for the high latitude Houtman Abrolhos Islands (HAI) coral communities was documented. This bleaching event highlighted the question of whether a supply of `heat tolerant' coral recruits from the tropical north would be sufficient to provide a level of resistance for these reefs to future warming events. Using Lagrangian modelling we showed that due to its regional isolation, large-scale larval input from potential tropical northern source populations to the HAI is unlikely, despite the southward flowing Leeuwin current. Successful recruitment to artificial substrates was recorded following the bleaching event. However, this was negligible (0.4 +/- 0.1 recruits per tile) compared to 2013 post impact recruitment (128.8 +/- 15.8 recruits per tile). Our data therefore provides preliminary evidence suggesting that the connectivity of the HAI with coral communities in the north is limited, and population maintenance and recovery is likely driven primarily by self-recruitment. Given the low thermal tolerance of the HAI coral communities, the dominance of Acropora, and the apparent reliance on self-recruitment, an increased frequency of thermally anomalous conditions at the HAI (such as experienced in 2011) has the potential to reduce the long-term stability of the HAI coral populations and species that depend upon them.	[Markey, Kathryn L.; Abdo, Dave A.; Evans, Scott N.] Govt Western Australia, Dept Fisheries, Biodivers & Biosecur Branch, Marine Ecol & Monitoring Sect, POB 20, North Beach, WA 6920, Australia; [Bosserelle, Cyprien] Secretariat Pacific Commun, Geosci Div, Private Mail Bag, Suva, Fiji	Government of Western Australia	Abdo, DA (corresponding author), Govt Western Australia, Dept Fisheries, Biodivers & Biosecur Branch, Marine Ecol & Monitoring Sect, POB 20, North Beach, WA 6920, Australia.	dave.abdo@fish.wa.gov.au		Markey, Kathryn/0000-0002-2556-3366	Department of Fisheries, Government of Western Australia	Department of Fisheries, Government of Western Australia	Funding was provided by the Department of Fisheries, Government of Western Australia. The authors would like to thank Tyrone Ridgway for helpful discussions and editing earlier versions of this manuscript and Joshua Dornan and Nick Konzewistch for field and laboratory assistance.; Funding for this study was provided by the Department of Fisheries, Government of Western Australia.	Abdo DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043878; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Andutta FP, 2012, ESTUAR COAST SHELF S, V101, P54, DOI 10.1016/j.ecss.2012.02.013; Babcock RC, 2003, ZOOL STUD, V42, P211; BABCOCK RC, 1984, CORAL REEFS, V2, P187; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baird AH, 2001, ECOLOGY CORAL LARVAE; Baird Andrew H., 2004, Journal and Proceedings of the Royal Society of New South Wales, V137, P43; Ben-David-Zaslow R, 1998, MAR ECOL PROG SER, V163, P235, DOI 10.3354/meps163235; Ben-David-Zaslow R., 1996, J EXP MAR BIOL ECOL, V206, P55, DOI DOI 10.1016/S0022-0981(96)02618-4; BLACK KP, 1991, MAR ECOL PROG SER, V74, P1, DOI 10.3354/meps074001; BLACK KP, 1990, CORAL REEFS, V9, P105, DOI 10.1007/BF00258221; Celliers L, 2002, MAR POLLUT BULL, V44, P1380, DOI 10.1016/S0025-326X(02)00302-8; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; Cooper TF, 2012, SCIENCE, V335, P593, DOI 10.1126/science.1214570; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Dahan M, 1998, INVERTEBR BIOL, V117, P271, DOI 10.2307/3227029; Depczynski M, 2013, CORAL REEFS, V32, P233, DOI 10.1007/s00338-012-0974-0; Dullo WC, 2005, FACIES, V51, P33, DOI 10.1007/s10347-005-0060-y; English S., 1997, SURVEY MANUAL TROPIC; Figueiredo J, 2014, NAT CLIM CHANGE, V4, P498, DOI 10.1038/NCLIMATE2210; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Gilmour JP, 2009, MAR BIOL, V156, P1297, DOI 10.1007/s00227-009-1171-8; Glassom D, 2004, MAR BIOL, V144, P641, DOI 10.1007/s00227-003-1243-0; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Greenstein BJ, 2008, GLOBAL CHANGE BIOL, V14, P513, DOI 10.1111/j.1365-2486.2007.01506.x; Harii S, 2002, MAR BIOL, V141, P39, DOI 10.1007/s00227-002-0812-y; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; Harrison PL, 2011, CORAL REEFS, V30, P775, DOI 10.1007/s00338-011-0778-7; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Ho MJ, 2014, ZOOL STUD, V53, DOI 10.1186/1810-522X-53-5; Hoey AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025824; Hughes TP, 2007, TRENDS ECOL EVOL, V22, P1, DOI 10.1016/j.tree.2006.10.009; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Hughes TP, 2002, ECOLOGY, V83, P436, DOI 10.2307/2680026; Lough JM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034634; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; Miller K, 2003, CORAL REEFS, V22, P99, DOI 10.1007/s00338-003-0290-9; Miller KJ, 2008, CONSERV BIOL, V22, P1245, DOI 10.1111/j.1523-1739.2008.00985.x; Nishikawa A, 2005, ZOOL SCI, V22, P391, DOI 10.2108/zsj.22.391; Nishikawa A, 2003, MAR ECOL PROG SER, V256, P87, DOI 10.3354/meps256087; Noreen AME, 2009, P ROY SOC B-BIOL SCI, V276, P3927, DOI 10.1098/rspb.2009.1050; Nozawa Y, 2000, P 9 INT COR REEF S B; Nozawa Y, 2008, MAR BIOL, V155, P347, DOI 10.1007/s00227-008-1034-8; Nozawa Y, 2011, BIOL BULL-US, V220, P15, DOI 10.1086/BBLv220n1p15; Oliver J. K., 2009, V205, P21; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2002, CORAL REEFS, V21, P13, DOI 10.1007/s00338-001-0204-7; Pearce AF, 2013, J MARINE SYST, V111, P139, DOI 10.1016/j.jmarsys.2012.10.009; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; Ross C, 2013, CORAL REEFS, V32, P71, DOI 10.1007/s00338-012-0956-2; Rosser NL, 2008, CORAL REEFS, V27, P345, DOI 10.1007/s00338-007-0335-6; Rosser NL, 2013, CORAL REEFS, V32, P455, DOI 10.1007/s00338-012-0986-9; SAMMARCO PW, 1991, PALAEOGEOGR PALAEOCL, V88, P1, DOI 10.1016/0031-0182(91)90011-F; Shedrawi G, 2013, W AUSTR MARINE MONIT, P63; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; SMITH SV, 1981, LIMNOL OCEANOGR, V26, P612, DOI 10.4319/lo.1981.26.4.0612; Sudek M, 2012, CORAL REEFS, V31, P351, DOI 10.1007/s00338-011-0844-1; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Tay YC, 2011, J EXP MAR BIOL ECOL, V409, P324, DOI 10.1016/j.jembe.2011.09.013; Thomas L, 2015, P ROY SOC B-BIOL SCI, V282, P50, DOI 10.1098/rspb.2015.1217; Underwood JN, 2013, J NAT CONSERV, V21, P163, DOI 10.1016/j.jnc.2012.12.001; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Veron JEN, 1988, RECORDS W AUSTR S29; Viikmae B, 2013, OCEAN DYNAM, V63, P589, DOI 10.1007/s10236-013-0615-3; WALLACE CC, 1985, MAR BIOL, V88, P217, DOI 10.1007/BF00392585; Watch NCR, 2014, NOAA COR REEF WATCH; Wells F, 1997, MARINE FLORA FAUNA H; Whitaker K, 2006, MAR ECOL PROG SER, V306, P115, DOI 10.3354/meps306115; Wijeratne EMS, 2014, AUSTR COAST OC MOD O; Wijeratne EMS, 2012, MODELLING MESOSCALE; Wilson JR, 1998, MAR BIOL, V131, P339, DOI 10.1007/s002270050327; Woolsey ES, 2013, MAR ECOL PROG SER, V493, P179, DOI 10.3354/meps10499	75	14	14	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147628	10.1371/journal.pone.0147628	http://dx.doi.org/10.1371/journal.pone.0147628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812259	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528000045
J	Streit, MR; Weiss, CS; Meyer, S; Ochs, MM; Hagenmueller, M; Riffel, JH; Buss, SJ; Heger, T; Katus, HA; Hardt, SE				Streit, Marcus R.; Weiss, Celine S.; Meyer, Soeren; Ochs, Marco M.; Hagenmueller, Marco; Riffel, Johannes H.; Buss, Sebastian J.; Heger, Thomas; Katus, Hugo A.; Hardt, Stefan E.			Cardiac Effects of Attenuating Gs alpha - Dependent Signaling	PLOS ONE			English	Article							HEART-FAILURE; PROTEIN; DISRUPTION; MICE; OVEREXPRESSION; CARDIOMYOPATHY; CARVEDILOL; MORTALITY; MYOCYTES	Aims Inhibition of beta-adrenergic signalling plays a key role in treatment of heart failure. Gs alpha is essential for beta-adrenergic signal transduction. In order to reduce side-effects of beta-adrenergic inhibition diminishing beta-adrenergic signalling in the heart at the level of Gsa is a promising option. Methods and Results We analyzed the influence of Gsa on regulation of myocardial function and development of cardiac hypertrophy, using a transgenic mouse model (C57BL6/J mice) overexpressing a dominant negative Gs alpha-mutant under control of the alpha-MHC-promotor. Cardiac phenotype was characterized in vivo and in vitro and under acute and chronic beta-adrenergic stimulation. At rest, Gs alpha-DN-mice showed bradycardia (602 +/- 13 vs. 660 +/- 17 bpm, p<0.05) and decreased dp/dt(max) (5037 +/- 546- vs. 6835 +/- 505 mmHg/s, p = 0.02). No significant differences were found regarding ejection fraction, heart weight and cardiomyocyte size. beta-blockade by propranolol revealed no baseline differences of hemodynamic parameters between wildtype and Gsa-DN-mice. Acute adrenergic stimulation resulted in decreased beta-adrenergic responsiveness in Gsa-DN-mice. Under chronic adrenergic stimulation, wildtype mice developed myocardial hypertrophy associated with increase of LV/BW-ratio by 23% (4.4 +/- 0.2 vs. 3.5 +/- 0.1 mg/g, p<0.01) and cardiac myocyte size by 24% (14927 +/- 442 px vs. 12013 +/- 583 px, p<0.001). In contrast, both parameters were unchanged in Gsa-DN-mice after chronic isoproterenol stimulation. Conclusion Overexpression of a dominant negative mutant of Gsa leads to decreased beta-adrenergic responsiveness and is protective against isoproterenol-induced hypertrophy. Thus, Gs alpha-DN-mice provide novel insights into beta-adrenergic signal transduction and its modulation in myocardial overload and failure.	[Streit, Marcus R.; Weiss, Celine S.; Meyer, Soeren; Ochs, Marco M.; Hagenmueller, Marco; Riffel, Johannes H.; Buss, Sebastian J.; Heger, Thomas; Katus, Hugo A.; Hardt, Stefan E.] Univ Heidelberg Hosp, Dept Cardiol, Neuenheimer Feld 410, D-69120 Heidelberg, Germany; [Streit, Marcus R.] Univ Heidelberg Hosp, Ctr Orthoped Trauma Surg & Spinal Cord Injury, Clin Orthoped & Trauma Surg, Schlierbacher Landstr 200a, D-69118 Heidelberg, Germany; [Hardt, Stefan E.] Ctr Cardiac & Circulatory Dis, Hoheneggerstr 9, D-76646 Bruchsal, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Hardt, SE (corresponding author), Univ Heidelberg Hosp, Dept Cardiol, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.; Hardt, SE (corresponding author), Ctr Cardiac & Circulatory Dis, Hoheneggerstr 9, D-76646 Bruchsal, Germany.	stefanhardt@outlook.com			Deutsche Forschungsgemeinschaft [HA 2959/2-2, HA 2959/3-1, DFG-Forschergruppe 1036]; Ernst-und-Berta-Grimmke foundation; Deutsche Herzstiftung e.V	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ernst-und-Berta-Grimmke foundation; Deutsche Herzstiftung e.V	The work presented herein was in part supported by the Deutsche Forschungsgemeinschaft (HA 2959/2-2, and HA 2959/3-1 within the DFG-Forschergruppe 1036), by a research grant from the Ernst-und-Berta-Grimmke foundation (SEH), and by a research grant of the Deutsche Herzstiftung e.V (CSW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai K, 1999, J CLIN INVEST, V104, P551, DOI 10.1172/JCI7418; El-Armouche A, 2008, CARDIOVASC RES, V80, P396, DOI 10.1093/cvr/cvn208; El-Armouche A, 2009, HEART FAIL REV, V14, P225, DOI 10.1007/s10741-008-9132-8; Eschenhagen T, 2008, NAT MED, V14, P485, DOI 10.1038/nm0508-485; GAUDIN C, 1995, J CLIN INVEST, V95, P1676, DOI 10.1172/JCI117843; Geng YJ, 1999, CIRC RES, V84, P34; Hardt SE, 2002, CIRCULATION, V105, P614, DOI 10.1161/hc0502.103012; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Hjalmarson A, 1999, LANCET, V353, P2001; Ho D, 2010, HEART FAIL REV, V15, P495, DOI 10.1007/s10741-010-9183-5; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Iiri T, 1999, P NATL ACAD SCI USA, V96, P499, DOI 10.1073/pnas.96.2.499; Iwase M, 1997, AM J PHYSIOL-HEART C, V272, pH585, DOI 10.1152/ajpheart.1997.272.1.H585; Iwase M, 1996, CIRC RES, V78, P517, DOI 10.1161/01.RES.78.4.517; Kim SJ, 1999, J CLIN INVEST, V103, P1089, DOI 10.1172/JCI4848; Krum H, 2003, JAMA-J AM MED ASSOC, V289, P712, DOI 10.1001/jama.289.6.712; Lechat P, 1999, LANCET, V353, P9; Lee S, 2008, PFLUG ARCH EUR J PHY, V455, P767, DOI 10.1007/s00424-007-0324-1; LONGABAUGH JP, 1988, J CLIN INVEST, V81, P420, DOI 10.1172/JCI113335; LUSTIG KD, 1993, J BIOL CHEM, V268, P13900; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Okumura S, 2003, P NATL ACAD SCI USA, V100, P9986, DOI 10.1073/pnas.1733772100; Okumura S, 2003, CIRC RES, V93, P364, DOI 10.1161/01.RES.0000086986.35568.63; Okumura S, 2007, CIRCULATION, V116, P1776, DOI 10.1161/CIRCULATIONAHA.107.698662; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Tilley DG, 2011, CIRC RES, V109, P217, DOI 10.1161/CIRCRESAHA.110.231225; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	29	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146988	10.1371/journal.pone.0146988	http://dx.doi.org/10.1371/journal.pone.0146988			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811901	gold, Green Published			2022-12-26	WOS:000369528000018
J	Tuong, ZK; Lau, P; Du, XM; Condon, ND; Goode, JM; Oh, TG; Yeo, JC; Muscat, GEO; Stow, JL				Tuong, Zewen Kelvin; Lau, Patrick; Du, Ximing; Condon, Nicholas D.; Goode, Joel M.; Oh, Tae Gyu; Yeo, Jeremy C.; Muscat, George E. O.; Stow, Jennifer L.			ROR alpha and 25-Hydroxycholesterol Crosstalk Regulates Lipid Droplet Homeostasis in Macrophages	PLOS ONE			English	Article							ORPHAN RECEPTOR-ALPHA; NUCLEAR RECEPTOR; ROR-ALPHA(SG/SG) MICE; VLDL RECEPTOR; CHOLESTEROL; EXPRESSION; PROTEIN; MOUSE; IDENTIFICATION; LOCALIZATION	Nuclear hormone receptors have important roles in the regulation of metabolic and inflammatory pathways. The retinoid-related orphan receptor alpha (Ror alpha)-deficient staggerer (sg/sg) mice display several phenotypes indicative of aberrant lipid metabolism, including dyslipidemia, and increased susceptibility to atherosclerosis. In this study we demonstrate that macrophages from sg/sg mice have increased ability to accumulate lipids and accordingly exhibit larger lipid droplets (LD). We have previously shown that BMMs from sg/sg mice have significantly decreased expression of cholesterol 25-hydroxylase (Ch25h) mRNA, the enzyme that produces the oxysterol, 25-hydroxycholesterol (25HC), and now confirm this at the protein level. 25HC functions as an inverse agonist for ROR alpha. siRNA knockdown of Ch25h in macrophages up-regulates Vldlr mRNA expression and causes increased accumulation of LDs. Treatment with physiological concentrations of 25HC in sg/sg macrophages restored lipid accumulation back to normal levels. Thus, 25HC and ROR alpha signify a new pathway involved in the regulation of lipid homeostasis in macrophages, potentially via increased uptake of lipid which is suggested by mRNA expression changes in Vldlr and other related genes.	[Tuong, Zewen Kelvin; Lau, Patrick; Condon, Nicholas D.; Goode, Joel M.; Oh, Tae Gyu; Yeo, Jeremy C.; Muscat, George E. O.; Stow, Jennifer L.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Du, Ximing] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	University of Queensland; University of New South Wales Sydney	Muscat, GEO; Stow, JL (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	g.muscat@imb.uq.edu; j.stow@imb.uq.edu.au	Tuong, Zewen Kelvin/E-4419-2017; Muscat, George/A-6401-2017; Stow, Jennifer/I-4723-2013	Tuong, Zewen Kelvin/0000-0002-6735-6808; Lau, Patrick/0000-0002-9693-390X; OH, TAE GYU/0000-0003-3971-6789; Muscat, George/0000-0002-5829-5695; Stow, Jennifer/0000-0002-5409-9101; Oh, Tae Gyu/0000-0002-2756-3546	Australian Research Council, Australia, Research Project [DP140101461]; National Health and Medical Research Council, Australia, Fellowships; Australian Cancer Research Foundation Cancer Biology Imaging Facility at Institute for Molecular Bioscience, UQ, Australia; UQ International RHD Scholarship	Australian Research Council, Australia, Research Project(Australian Research Council); National Health and Medical Research Council, Australia, Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation Cancer Biology Imaging Facility at Institute for Molecular Bioscience, UQ, Australia; UQ International RHD Scholarship	This work was supported by the Australian Research Council, Australia, Research Project Grant DP140101461 and National Health and Medical Research Council, Australia, Fellowships to J.L.S. and G.E.O.M. Imaging was performed in the Australian Cancer Research Foundation Cancer Biology Imaging Facility at Institute for Molecular Bioscience, UQ, Australia. Z.K. Tuong is a recipient of a UQ International RHD Scholarship.	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Bitsch F, 2003, ANAL BIOCHEM, V323, P139, DOI 10.1016/j.ab.2003.08.029; Bjorkhem I, 2000, TRENDS ENDOCRIN MET, V11, P180, DOI 10.1016/S1043-2760(00)00255-1; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2012, J BIOL CHEM, V287, P2273, DOI 10.1074/jbc.R111.309088; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; Du XM, 2004, J BIOL CHEM, V279, P47010, DOI 10.1074/jbc.M408690200; Fitzsimmons RL, 2012, J STEROID BIOCHEM, V130, P159, DOI 10.1016/j.jsbmb.2011.06.009; Fujimoto T, 2004, SEIKAGAKU, V76, P578; Hiltunen TP, 1998, CIRCULATION, V97, P1079, DOI 10.1161/01.CIR.97.11.1079; Huang YL, 2014, J BIOL CHEM, V289, P3001, DOI 10.1074/jbc.M113.524587; HUME DA, 1983, J CELL PHYSIOL, V117, P189, DOI 10.1002/jcp.1041170209; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; Lau P, 2008, J BIOL CHEM, V283, P18411, DOI 10.1074/jbc.M710526200; Listenberger LL, 2007, CURR PROTOC CELL BIO; Mamontova A, 1998, CIRCULATION, V98, P2738, DOI 10.1161/01.CIR.98.24.2738; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; McDonald JG, 2010, J LEUKOCYTE BIOL, V88, P1071, DOI 10.1189/jlb.0710418; Perman JC, 2011, J CLIN INVEST, V121, P2625, DOI 10.1172/JCI43068; Prieur X, 2010, BBA-MOL CELL BIOL L, V1801, P327, DOI 10.1016/j.bbalip.2009.09.017; Raichur S, 2010, NUCLEIC ACIDS RES, V38, P4296, DOI 10.1093/nar/gkq180; Ramirez DMO, 2008, J COMP NEUROL, V507, P1676, DOI 10.1002/cne.21605; Shurety W, 2000, J INTERF CYTOK RES, V20, P427, DOI 10.1089/107999000312379; Silva AR, 2009, BBA-MOL CELL BIOL L, V1791, P1066, DOI 10.1016/j.bbalip.2009.06.004; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Stapleton CM, 2005, AM J PHYSIOL-LUNG C, V289, pL144, DOI 10.1152/ajplung.00348.2004; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tuong ZK, 2013, ENDOCRINOLOGY, V154, P140, DOI 10.1210/en.2012-1889; Van Eck M, 2005, ATHEROSCLEROSIS, V183, P230, DOI 10.1016/j.atherosclerosis.2005.03.045; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; Yang HY, 2012, CURR OPIN CELL BIOL, V24, P509, DOI 10.1016/j.ceb.2012.05.012	35	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147179	10.1371/journal.pone.0147179	http://dx.doi.org/10.1371/journal.pone.0147179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812621	gold, Green Submitted, Green Published			2022-12-26	WOS:000369528000024
J	DeSouza, O; Araujo, APA; Florencio, DF; Rosa, CS; Marins, A; Costa, DA; Rodrigues, VB; Cristaldo, PF				DeSouza, Og; Albano Araujo, Ana Paula; Florencio, Daniela Faria; Rosa, Cassiano Sousa; Marins, Alessandra; Costa, Diogo Andrade; Rodrigues, Vinicius Barros; Cristaldo, Paulo Fellipe			Allometric Scaling of Patrolling Rate and Nest Volume in Constrictotermes cyphergaster Termites: Hints on the Settlement of Inquilines	PLOS ONE			English	Article							COLONY SIZE; ANT; DEFENSE; ISOPTERA; CAATINGA; BEHAVIOR; INSECTS; ECOLOGY; GROWTH; STAGE	Structural and functional traits of organisms are known to be related to the size of individuals and to the size of their colonies when they belong to one. Among such traits, propensity to inquilinism in termites is known to relate positively to colony size. Larger termitaria hold larger diversity of facultative inquilines than smaller nests, whereas obligate inquilines seem unable to settle in nests smaller than a threshold volume. Respective underlying mechanisms, however, remain hypothetical. Here we test one of such hypotheses, namely, that nest defence correlates negatively to nest volume in Constrictotermes cyphergaster termites (Termitidae: Nasutitermitinae). As a surrogate to defence, we used 'patrolling rate', i.e., the number of termite individuals attending per unit time an experimentally damaged spot on the outer wall of their termitaria. We found that patrolling rate decayed allometrically with increasing nest size. Conspicuously higher patrolling rates occurred in smaller nests, while conspicuously lower rates occurred in larger nests presenting volumes in the vicinity of the threshold value for the establishment of inquilinism. This could be proven adaptive for the host and guest. At younger nest age, host colonies are smaller and presumably more vulnerable and unstable. Enhanced defence rates may, hence, prevent eventual risks to hosts from inquilinism at the same time that it prevents inquilines to settle in a still unstable nest. Conversely, when colonies grow and maturate enough to stand threats, they would invest in priorities other than active defence, opening an opportunity for inquilines to settle in nests which are more suitable or less risky. Under this two-fold process, cohabitation between host and inquiline could readily stabilize.	[DeSouza, Og; Marins, Alessandra; Costa, Diogo Andrade; Rodrigues, Vinicius Barros] Univ Fed Vicosa, Dept Entomol, Lab Termitol, Vicosa, MG, Brazil; [Albano Araujo, Ana Paula; Cristaldo, Paulo Fellipe] Univ Fed Sergipe, Dept Ecol, Lab Interacoes Ecol, Sao Cristovao, SE, Brazil; [Florencio, Daniela Faria] Univ Fed Rural Semi Arido, Dept Agrotecnol & Ciencias Sociais, Mossoro, RN, Brazil; [Rosa, Cassiano Sousa] Univ Fed Triangulo Mineiro, Iturama, MG, Brazil; [Costa, Diogo Andrade] Univ Estado Mato Grosso, Dept Ciencias Biol, Tangara Da Serra, MT, Brazil	Universidade Federal de Vicosa; Universidade Federal de Sergipe; Universidade Federal Rural do Semi-Arido (UFERSA); Universidade Federal do Triangulo Mineiro; Universidade do Estado de Mato Grosso	Cristaldo, PF (corresponding author), Univ Fed Sergipe, Dept Ecol, Lab Interacoes Ecol, Sao Cristovao, SE, Brazil.	pfellipec@gmail.com	DeSouza, Og/A-7140-2008; Cristaldo, Paulo/A-1247-2013; Rosa, Cassiano S/A-1780-2011; Rodrigues, Vinícius Barros/G-1317-2014	DeSouza, Og/0000-0002-7108-0242; Cristaldo, Paulo/0000-0003-4939-0487; Rosa, Cassiano S/0000-0003-3294-5677; Rodrigues, Vinícius Barros/0000-0003-4196-8088; Albano Araujo, Ana P./0000-0001-7853-8001	National Council for Scientific and Technological Development (CNPq-Brazil); Coordination for the Improvement of High Education Personnel (CAPES-Brazil) [PVE 0148/2012]; Minas Gerais Foundation for Research Support (FAPEMIG-Brazil) [APQ 01519-11, APQ 00811-15]; CNPq [PDJ 502940/2014-7, PQ 305736/2013-2]; CNPq/FAPITEC [DCR 302246/2014, DCR 303326/2014-0]; CAPES [142551/2008-2]	National Council for Scientific and Technological Development (CNPq-Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of High Education Personnel (CAPES-Brazil); Minas Gerais Foundation for Research Support (FAPEMIG-Brazil); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/FAPITEC; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was funded by the National Council for Scientific and Technological Development (CNPq-Brazil, http://www.cnpq.br), Coordination for the Improvement of High Education Personnel (CAPES-Brazil PVE 0148/2012, http://www.capes.gov.br) and Minas Gerais Foundation for Research Support (FAPEMIG-Brazil, APQ 01519-11 and APQ 00811-15, http://www.fapemig.br). Post-doctoral grants are held by AM (CNPq PDJ 502940/2014-7), PFC (CNPq/FAPITEC DCR 302246/2014), DFF (CNPq/FAPITEC DCR 303326/2014-0) and CSR (CAPES 142551/2008-2). A CAPES doctoral grant supports VBR. ODS holds a Research Fellowship from CNPq (PQ 305736/2013-2).	Agritempo, 2018, AGR; Anderson C, 1999, AM NAT, V154, P521, DOI 10.1086/303255; [Anonymous], 2014, R LANG ENV STAT COMP; Ballesteros FJ, 2014, ARXIV14073659; Bourguignon T, 2011, ECOL ENTOMOL, V36, P261, DOI 10.1111/j.1365-2311.2011.01265.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cristaldo PF, 2012, INSECT SOC, V59, P541, DOI 10.1007/s00040-012-0249-3; Cristaldo PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085315; da Cunha HF, 2003, SOCIOBIOLOGY, V42, P761; Dahlsjo CAL, 2015, ACTA OECOL, V63, P16, DOI 10.1016/j.actao.2015.01.003; Dial KP, 2008, TRENDS ECOL EVOL, V23, P394, DOI 10.1016/j.tree.2008.03.005; Domingos, 1983, CIENC CULT, V35, P783; EMERSON ALFRED E., 1938, ECOL MONOGR, V8, P247, DOI 10.2307/1943251; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Evans TA, 2006, INSECT SOC, V53, P56, DOI 10.1007/s00040-005-0835-8; Florencio DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066535; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GORDON DM, 1991, AM NAT, V138, P379, DOI 10.1086/285223; Hou C, 2010, P NATL ACAD SCI USA, V107, P3634, DOI 10.1073/pnas.0908071107; INMET, 2015, BANC DAT MET ENS PES; JEANNE RL, 1986, BEHAV ECOL SOCIOBIOL, V19, P333, DOI 10.1007/BF00295706; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Lailvaux SP, 2004, P ROY SOC B-BIOL SCI, V271, P2501, DOI 10.1098/rspb.2004.2891; Lavine L, 2015, ANNU REV ENTOMOL, V60, P453, DOI 10.1146/annurev-ento-010814-021045; Pequeno PACL, 2013, ECOL ENTOMOL, V38, P515, DOI 10.1111/een.12044; London KB, 2003, BEHAV ECOL SOCIOBIOL, V54, P539, DOI 10.1007/s00265-003-0662-8; Mailleux AC, 2003, INSECT SOC, V50, P24, DOI 10.1007/s000400300004; Mathews A. G. A., 1977, STUDIES TERMITES MAT; Moura FMS, 2006, INSECT SOC, V53, P472, DOI 10.1007/s00040-005-0899-0; Muradian R, 1999, PHYSIOL BEHAV, V66, P731, DOI 10.1016/S0031-9384(99)00011-6; Noirot C, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P121; Oster G.F., 1978, Monographs in Population Biology, pi; Pohl S, 2013, INSECT SOC, V60, P293, DOI 10.1007/s00040-013-0293-7; Porter EE, 2001, AM NAT, V157, P97, DOI 10.1086/317006; Riveros AJ, 2011, J INSECT PHYSIOL, V57, P688, DOI 10.1016/j.jinsphys.2011.01.011; Satoh T, 2005, ENTOMOL SCI, V8, P277, DOI 10.1111/j.1479-8298.2005.00126.x; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; Sibly R. M., 2012, METABOLIC ECOLOGY SC; STUART AM, 1967, SCIENCE, V156, P1123, DOI 10.1126/science.156.3778.1123; Szczuka A, 1997, ACTA NEUROBIOL EXP, V57, P135; Valverde S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066106; Vasconcellos A, 2007, NEOTROP ENTOMOL, V36, P693, DOI 10.1590/S1519-566X2007000500009; WEDDERBURN RWM, 1974, BIOMETRIKA, V61, P439, DOI 10.2307/2334725; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Wiernasz DC, 2014, INSECT SOC, V61, P273, DOI 10.1007/s00040-014-0352-8	46	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147594	10.1371/journal.pone.0147594	http://dx.doi.org/10.1371/journal.pone.0147594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808197	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800145
J	Gogoi, P; Sepehri, S; Zhou, Y; Gorin, MA; Paolillo, C; Capoluongo, E; Gleason, K; Payne, A; Boniface, B; Cristofanilli, M; Morgan, TM; Fortina, P; Pienta, KJ; Handique, K; Wang, YX				Gogoi, Priya; Sepehri, Saedeh; Zhou, Yi; Gorin, Michael A.; Paolillo, Carmela; Capoluongo, Ettore; Gleason, Kyle; Payne, Austin; Boniface, Brian; Cristofanilli, Massimo; Morgan, Todd M.; Fortina, Paolo; Pienta, Kenneth J.; Handique, Kalyan; Wang, Yixin			Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples	PLOS ONE			English	Article							PERIPHERAL-BLOOD; CANCER-PATIENTS; PROSTATE-CANCER; BREAST-CANCER; PROGRESSION; SURVIVAL	Current analysis of circulating tumor cells (CTCs) is hindered by sub-optimal sensitivity and specificity of devices or assays as well as lack of capability of characterization of CTCs with clinical biomarkers. Here, we validate a novel technology to enrich and characterize CTCs from blood samples of patients with metastatic breast, prostate and colorectal cancers using a microfluidic chip which is processed by using an automated staining and scanning system from sample preparation to image processing. The Celsee system allowed for the detection of CTCs with apparent high sensitivity and specificity (94% sensitivity and 100% specificity). Moreover, the system facilitated rapid capture of CTCs from blood samples and also allowed for downstream characterization of the captured cells by immunohistochemistry, DNA and mRNA fluorescence in-situ hybridization (FISH). In a subset of patients with prostate cancer we compared the technology with a FDA-approved CTC device, CellSearch and found a higher degree of sensitivity with the Celsee instrument. In conclusion, the integrated Celsee system represents a promising CTC technology for enumeration and molecular characterization.	[Gogoi, Priya; Sepehri, Saedeh; Zhou, Yi; Gleason, Kyle; Payne, Austin; Boniface, Brian; Handique, Kalyan; Wang, Yixin] Celsee Diagnost, 46701 Commerce Ctr Dr, Plymouth, MI USA; [Gorin, Michael A.; Pienta, Kenneth J.] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA; [Gorin, Michael A.; Pienta, Kenneth J.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA; [Paolillo, Carmela; Fortina, Paolo] Thomas Jefferson Univ, Dept Canc Biol, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Paolillo, Carmela; Capoluongo, Ettore] Univ Hosp A Gemelli, Dept Lab Med, Mol Biol Lab, Rome, Italy; [Cristofanilli, Massimo] Northwestern Univ, Robert Lurie Canc Ctr, Div Hematol Oncol, Chicago, IL 60611 USA; [Morgan, Todd M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Fortina, Paolo] Univ Roma La Sapienza, Dept Mol Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy	Johns Hopkins University; Johns Hopkins University; Jefferson University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; University of Michigan System; University of Michigan; Sapienza University Rome	Wang, YX (corresponding author), Celsee Diagnost, 46701 Commerce Ctr Dr, Plymouth, MI USA.	ywang@celsee.com	Paolillo, Carmela/AAK-2578-2020; Fortina, Paolo/ABE-8350-2020; Gorin, M.D., Michael A./GZM-6377-2022	Paolillo, Carmela/0000-0003-2677-5747; Gorin, M.D., Michael A./0000-0002-8315-6603; CAPOLUONGO, Ettore Domenico/0000-0003-4402-8403; Fortina, Paolo/0000-0002-5898-2081; Morgan, Todd/0000-0002-1140-0603	Celsee Diagnostics; NIH/NCI Cancer Center Core grant [P30 CA056036]; Department of Defense Physician Research Training Award [W81XWH-14-1-0287]; PCF Young Investigator Award; A. Alfred Taubman Medical Research Institute at the University of Michigan; NATIONAL CANCER INSTITUTE [P30CA056036, P30CA060553] Funding Source: NIH RePORTER	Celsee Diagnostics; NIH/NCI Cancer Center Core grant; Department of Defense Physician Research Training Award(United States Department of Defense); PCF Young Investigator Award; A. Alfred Taubman Medical Research Institute at the University of Michigan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was in part funded by Celsee Diagnostics and by NIH/NCI Cancer Center Core grant (P30 CA056036) to PF of Thomas Jefferson University, a Department of Defense Physician Research Training Award (W81XWH-14-1-0287) (TMM), PCF Young Investigator Award (TMM), and by the A. Alfred Taubman Medical Research Institute (TMM) at the University of Michigan. The funding provided support in the form of salaries for the authors PG, SS, YZ, KG, AP, BB, KH and YW, but did not have any additional role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The roles of these authors are specifically articulated in the Author Contributions section.	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; [Anonymous], [US Patent Application, Celsee Diagnostics], Patent No. [US 2013/ 0190212 A1, 20130190212]; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; He W, 2007, P NATL ACAD SCI USA, V104, P11760, DOI 10.1073/pnas.0703875104; Hou HW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01259; Khoo BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099409; Li P, 2013, LAB CHIP, V13, P602, DOI 10.1039/c2lc90148j; Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002; Majid EW, 2013, LAB CHIP; Morgan TM, 2009, CLIN CANCER RES, V15, P677, DOI 10.1158/1078-0432.CCR-08-1754; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Pantel K, 2010, TRENDS MOL MED, V16, P398, DOI 10.1016/j.molmed.2010.07.001; Paris PL, 2009, CANCER LETT, V277, P164, DOI 10.1016/j.canlet.2008.12.007; Powell AA, 2012, PLOS ONE, V2012; Punnoose EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012517; Riahi R, 2014, INT J ONCOL, V44, P1870, DOI 10.3892/ijo.2014.2353; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Ring AE, 2005, BRIT J CANCER, V92, P906, DOI 10.1038/sj.bjc.6602418; Saliba AE, 2010, P NATL ACAD SCI USA, V107, P14524, DOI 10.1073/pnas.1001515107; Scher HI, 2009, LANCET ONCOL, V10, P233, DOI 10.1016/S1470-2045(08)70340-1; Sieuwerts AM, 2009, J NATL CANCER I, V101, P61, DOI 10.1093/jnci/djn419; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Tan SJ, 2010, BIOSENS BIOELECTRON, V26, P1701, DOI 10.1016/j.bios.2010.07.054; Warkiani ME, 2014, LAB CHIP, V14, P128, DOI 10.1039/c3lc50617g; Zheng SY, 2011, BIOMED MICRODEVICES, V13, P203, DOI 10.1007/s10544-010-9485-3	27	61	62	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147400	10.1371/journal.pone.0147400	http://dx.doi.org/10.1371/journal.pone.0147400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808060	Green Published, gold			2022-12-26	WOS:000369527800088
J	Greenwald, R; Hayat, MJ; Barton, J; Lopukhin, A				Greenwald, Roby; Hayat, Matthew J.; Barton, Jerusha; Lopukhin, Anastasia			A Novel Method for Quantifying the Inhaled Dose of Air Pollutants Based on Heart Rate, Breathing Rate and Forced Vital Capacity	PLOS ONE			English	Article							POLLUTION; EXPOSURE; ASSOCIATION; VENTILATION; PEDESTRIANS; EXERCISE	To better understand the interaction of physical activity and air pollution exposure, it is important to quantify the change in ventilation rate incurred by activity. In this paper, we describe a method for estimating ventilation using easily-measured variables such as heart rate (HR), breathing rate (f(B)), and forced vital capacity (FVC). We recruited healthy adolescents to use a treadmill while we continuously measured HR, fB, and the tidal volume (V-T) of each breath. Participants began at rest then walked and ran at increasing speed until HR was 160-180 beats per minute followed by a cool down period. The novel feature of this method is that minute ventilation ((V) over dot(E)) was normalized by FVC. We used general linear mixed models with a random effect for subject and identified nine potential predictor variables that influence either (V) over dot(E) or FVC. We assessed predictive performance with a five-fold cross-validation procedure. We used a brute force selection process to identify the best performing models based on cross-validation percent error, the Akaike Information Criterion and the p-value of parameter estimates. We found a two-predictor model including HR and fB to have the best predictive performance ((V) over dot(E)/FVC=-4.247+0.0595HR+0.226fB, mean percent error = 8.1 +/- 29%); however, given the ubiquity of HR measurements, a one-predictor model including HR may also be useful ((V) over dot(E)/FVC = -3.859+0.101HR, mean percent error = 11.3+/-36%).	[Greenwald, Roby] Georgia State Univ, Div Environm Hlth, Sch Publ Hlth, Atlanta, GA 30303 USA; [Greenwald, Roby; Barton, Jerusha; Lopukhin, Anastasia] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Hayat, Matthew J.] Georgia State Univ, Div Epidemiol & Biostat, Sch Publ Hlth, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; Emory University; Rollins School Public Health; University System of Georgia; Georgia State University	Greenwald, R (corresponding author), Georgia State Univ, Div Environm Hlth, Sch Publ Hlth, Atlanta, GA 30303 USA.; Greenwald, R (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA.	rgreenwald@gsu.edu			NIEHS [K25ES020355]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K25ES020355] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding for this work came from NIEHS grant number K25ES020355. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babb TG, 2013, EXERC SPORT SCI REV, V41, P11, DOI 10.1097/JES.0b013e318267c0d2; Beals JAJ, 1996, ENVIRON HEALTH PERSP, V104, P974, DOI 10.2307/3433145; Bernmark E, 2006, ERGONOMICS, V49, P1486, DOI 10.1080/00140130600708206; Brook RD, 2008, CLIN SCI, V115, P175, DOI 10.1042/CS20070444; Cozza IC, 2015, SCI TOTAL ENVIRON, V520, P160, DOI 10.1016/j.scitotenv.2015.03.049; Luke C, 2006, ENVIRON INT, V32, P815, DOI 10.1016/j.envint.2006.03.012; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dockery D W, 1993, N Engl J Med, V329, P1753, DOI 10.1056/NEJM199312093292401; Dockery DW, 2001, ENVIRON HEALTH PERSP, V109, P483, DOI 10.2307/3454657; Faria M, 2014, TRANSP RES PROC, V3, P780, DOI 10.1016/j.trpro.2014.10.057; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hupin D, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094306; Hyatt RE, 2014, INTERPRETATION PULMO; Jakes RW, 2002, AM J EPIDEMIOL, V156, P139, DOI 10.1093/aje/kwf021; Liu ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134804; MacAuley D, 1999, IRISH J MED SCI, V168, P119, DOI 10.1007/BF02946480; MERMIER CM, 1993, ARCH ENVIRON HEALTH, V48, P263, DOI 10.1080/00039896.1993.9940371; Mirowsky J, 2015, J EXPO SCI ENV EPID, V25, P354, DOI 10.1038/jes.2014.93; Morton AR, 1999, PEDIAT RESP MED, P111; Nayor M, 2015, CURRENT OPINION CARD, V30; Peters A, 2001, CIRCULATION, V103, P2810; Ramos CA, 2015, SCI TOTAL ENVIRON, V527, P111, DOI 10.1016/j.scitotenv.2015.04.120; Samet JM, 1993, HLTH EFFECTS I, P59; Stewart RAH, 2015, CURR OPIN CARDIOL, V30, P551, DOI 10.1097/HCO.0000000000000207; Teychenne M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1843-x; VANWIJNEN JH, 1995, INT ARCH OCC ENV HEA, V67, P187, DOI 10.1007/BF00626351; Zuurbier M, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-48	28	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147578	10.1371/journal.pone.0147578	http://dx.doi.org/10.1371/journal.pone.0147578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809066	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800139
J	Kuan, CS; Too, WCS; Few, LL				Kuan, Chee Sian; Too, Wei Cun See; Few, Ling Ling			Sp1 and Sp3 Are the Transcription Activators of Human ek1 Promoter in TSA-Treated Human Colon Carcinoma Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; REAL-TIME PCR; REFERENCE GENES; ETHANOLAMINE; EXPRESSION; DNA; PHOSPHORYLATION; KINASE; CANCER; ALPHA	Background Ethanolamine kinase (EK) catalyzes the phosphorylation of ethanolamine, the first step in the CDP-ethanolamine pathway for the biosynthesis of phosphatidylethanolamine (PE). Human EK exists as EK1, EK2 alpha and EK2 beta isoforms, encoded by two separate genes, named ek1 and ek2. EK activity is stimulated by carcinogens and oncogenes, suggesting the involvement of EK in carcinogenesis. Currently, little is known about EK transcriptional regulation by endogenous or exogenous signals, and the ek gene promoter has never been studied. Methodology/Principal Findings In this report, we mapped the important regulatory regions in the human ek1 promoter. 5' deletion analysis and site-directed mutagenesis identified a Sp site at position (-40/-31) that was essential for the basal transcription of this gene. Treatment of HCT116 cells with trichostatin A (TSA), a histone deacetylase inhibitor, significantly upregulated the ek1 promoter activity through the Sp(-40/-31) site and increased the endogenous expression of ek1. Chromatin immunoprecipitation assay revealed that TSA increased the binding of Sp1, Sp3 and RNA polymerase II to the ek1 promoter in HCT116 cells. The effect of TSA on ek1 promoter activity was cell-line specific as TSA treatment did not affect ek1 promoter activity in HepG2 cells. Conclusion/Significance In conclusion, we showed that Sp1 and Sp3 are not only essential for the basal transcription of the ek1 gene, their accessibility to the target site on the ek1 promoter is regulated by histone protein modification in a cell line dependent manner.	[Kuan, Chee Sian; Too, Wei Cun See; Few, Ling Ling] Univ Sains Malaysia, Sch Hlth Sci, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia	Universiti Sains Malaysia	Few, LL (corresponding author), Univ Sains Malaysia, Sch Hlth Sci, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia.	fewling@usm.my	Few, Ling Ling/E-1964-2012; See Too, Wei Cun/C-9382-2016	Few, Ling Ling/0000-0001-8296-8135; See Too, Wei Cun/0000-0003-1933-3107	Universiti Sains Malaysia Research University Grant [1001/PPSK/815101]; Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia [203/PPSK/6171171]	Universiti Sains Malaysia Research University Grant(Universiti Sains Malaysia); Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia	This work is supported by Universiti Sains Malaysia Research University Grant (1001/PPSK/815101) (http://www.research.usm.my/default.asp?tag=23) to WCST, and Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia (203/PPSK/6171171) (https://jpt.mohe.gov.my/menupenyelidik.php), to LLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MR, 2007, AM J PHYSIOL-GASTR L, V293, pG374, DOI 10.1152/ajpgi.00128.2007; Ammanamanchi S, 2003, J BIOL CHEM, V278, P35775, DOI 10.1074/jbc.M305961200; Banchio C, 2006, J BIOL CHEM, V281, P10010, DOI 10.1074/jbc.M513503200; Block KL, 1996, BLOOD, V88, P2071, DOI 10.1182/blood.V88.6.2071.bloodjournal8862071; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Chua SL, 2011, CYTOTECHNOLOGY, V63, P645, DOI 10.1007/s10616-011-9383-4; COLGAN J, 1995, P NATL ACAD SCI USA, V92, P1955, DOI 10.1073/pnas.92.6.1955; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Fu J, 2009, ANAL SCI, V25, P675, DOI 10.2116/analsci.25.675; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; HAGEN G, 1995, J BIOL CHEM, V270, P24989, DOI 10.1074/jbc.270.42.24989; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Jung HH, 2005, FEBS LETT, V579, P3941, DOI 10.1016/j.febslet.2005.06.011; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; Kiss Z, 1997, EUR J BIOCHEM, V250, P395, DOI 10.1111/j.1432-1033.1997.0395a.x; Kiss Z, 1999, CELL SIGNAL, V11, P149, DOI 10.1016/S0898-6568(98)00057-6; KISS Z, 1995, FEBS LETT, V357, P279, DOI 10.1016/0014-5793(94)01371-7; KISS Z, 1993, FEBS LETT, V336, P115, DOI 10.1016/0014-5793(93)81622-7; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lykidis A, 2001, J BIOL CHEM, V276, P2174, DOI 10.1074/jbc.M008794200; Malewicz B, 1998, EUR J BIOCHEM, V253, P10, DOI 10.1046/j.1432-1327.1998.2530010.x; Mazzella N, 2004, J LIPID RES, V45, P1355, DOI 10.1194/jlr.D300040-JLR200; Ni PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050502; Nunes MJ, 2010, J NEUROCHEM, V113, P418, DOI 10.1111/j.1471-4159.2010.06612.x; Pan QH, 2010, BIOCHEM BIOPH RES CO, V401, P306, DOI 10.1016/j.bbrc.2010.09.058; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Setiadi AF, 2008, CANCER RES, V68, P9601, DOI 10.1158/0008-5472.CAN-07-5270; Sharma P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-178; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Takai Daiya, 2003, In Silico Biology, V3, P235; Tsukiyama T, 1997, CURR OPIN GENET DEV, V7, P182, DOI 10.1016/S0959-437X(97)80127-X; Ward CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062610; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; ZENZIEGREGORY B, 1993, MOL CELL BIOL, V13, P3841, DOI 10.1128/MCB.13.7.3841; Zhang Y, 2002, J BIOL CHEM, V277, P33431, DOI 10.1074/jbc.M204417200	42	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147886	10.1371/journal.pone.0147886	http://dx.doi.org/10.1371/journal.pone.0147886			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807725	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800239
J	Mercy, C; Ize, B; Salcedo, SP; de Bentzmann, S; Bigot, S				Mercy, Chryslene; Ize, Berengere; Salcedo, Suzana P.; de Bentzmann, Sophie; Bigot, Sarah			Functional Characterization of Pseudomonas Contact Dependent Growth Inhibition (CDI) Systems	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; ESCHERICHIA-COLI; AERUGINOSA; BACTERIA; SECRETION; VIRULENCE; PROTEINS; IMMUNITY; TOXIN; IDENTIFICATION	Contact-dependent inhibition (CDI) toxins, delivered into the cytoplasm of target bacterial cells, confer to host strain a significant competitive advantage. Upon cell contact, the toxic C-terminal region of surface-exposed CdiA protein (CdiA-CT) inhibits the growth of CDI- bacteria. CDI+ cells express a specific immunity protein, CdiI, which protects from autoinhibition by blocking the activity of cognate CdiA-CT. CdiA-CT are separated from the rest of the protein by conserved peptide motifs falling into two distinct classes, the "E. coli"- and "Burkholderia-type". CDI systems have been described in numerous species except in Pseudomonadaceae. In this study, we identified functional toxin/immunity genes linked to CDI systems in the Pseudomonas genus, which extend beyond the conventional CDI classes by the variability of the peptide motif that delimits the polymorphic CdiA-CT domain. Using P. aeruginosa PAO1 as a model, we identified the translational repressor RsmA as a negative regulator of CDI systems. Our data further suggest that under conditions of expression, P. aeruginosa CDI systems are implicated in adhesion and biofilm formation and provide an advantage in competition assays. All together our data imply that CDI systems could play an important role in niche adaptation of Pseudomonadaceae.	[Mercy, Chryslene; Ize, Berengere; de Bentzmann, Sophie; Bigot, Sarah] Univ Aix Marseille, CNRS, Lab Ingn Syst Macromol, UMR7255, Marseille, France; [Mercy, Chryslene; Salcedo, Suzana P.; Bigot, Sarah] Univ Lyon 1, CNRS, Bases Mol & Struct Syst Infect, UMR 5086,Inst Biol & Chim Prot, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Bigot, S (corresponding author), Univ Aix Marseille, CNRS, Lab Ingn Syst Macromol, UMR7255, Marseille, France.; Bigot, S (corresponding author), Univ Lyon 1, CNRS, Bases Mol & Struct Syst Infect, UMR 5086,Inst Biol & Chim Prot, F-69365 Lyon, France.	sarah.bigot@ibcp.fr	Salcedo, Suzana P/C-2853-2014; salcedo, suzana/P-9830-2019; IZE, Bérengère/GLQ-7207-2022	Salcedo, Suzana P/0000-0001-5149-7756; salcedo, suzana/0000-0001-5149-7756; IZE, Bérengère/0000-0001-9106-9254	CNRS, Aix-Marseille University; French cystic fibrosis foundation [RF20120600719]; FINOVI grant	CNRS, Aix-Marseille University; French cystic fibrosis foundation; FINOVI grant	This work was supported by the CNRS, Aix-Marseille University, by a grant from the French cystic fibrosis foundation (http://www.vaincrelamuco.org/) -SB- grant number: RF20120600719 and a FINOVI grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai G, 2003, MOL MICROBIOL, V47, P61, DOI 10.1046/j.1365-2958.2003.03283.x; Anderson MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004076; Anderson MS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002877; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2010, NATURE, V468, P439, DOI 10.1038/nature09490; Beck CM, 2014, STRUCTURE, V22, P707, DOI 10.1016/j.str.2014.02.012; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Faure LM, 2013, MICROBIOL-SGM, V159, P1315, DOI 10.1099/mic.0.067645-0; Garcia EC, 2013, MOL MICROBIOL, V89, P1213, DOI 10.1111/mmi.12339; Ghequire MGK, 2014, FEMS MICROBIOL REV, V38, P523, DOI 10.1111/1574-6976.12079; HARTLEY RW, 1989, TRENDS BIOCHEM SCI, V14, P450, DOI 10.1016/0968-0004(89)90104-7; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Jamet A, 2015, MBIO, V6, DOI 10.1128/mBio.00285-15; Jamet A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004592; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Koskiniemi S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004255; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Li KW, 2013, MBIO, V4, DOI 10.1128/mBio.00419-13; Mazar J, 2007, TRENDS MICROBIOL, V15, P508, DOI 10.1016/j.tim.2007.10.005; Morse RP, 2012, P NATL ACAD SCI USA, V109, P21480, DOI 10.1073/pnas.1216238110; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; Nikolakakis K, 2012, MOL MICROBIOL, V84, P516, DOI 10.1111/j.1365-2958.2012.08039.x; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Perler FB, 1998, CELL, V92, P1, DOI 10.1016/S0092-8674(00)80892-2; Poole SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002217; Ruhe ZC, 2015, MOL MICROBIOL, V98, P175, DOI 10.1111/mmi.13114; Toyofuku M, 2012, J PROTEOME RES, V11, P4906, DOI 10.1021/pr300395j; Vakulskas CA, 2015, MICROBIOL MOL BIOL R, V79, P193, DOI 10.1128/MMBR.00052-14; Wei X, 2013, J BACTERIOL, V195, P3387, DOI 10.1128/JB.00214-13; Williams D, 2015, AM J RESP CRIT CARE, V191, P775, DOI 10.1164/rccm.201409-1646OC; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18; Zhang DP, 2011, NUCLEIC ACIDS RES, V39, P4532, DOI 10.1093/nar/gkr036	38	36	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147435	10.1371/journal.pone.0147435	http://dx.doi.org/10.1371/journal.pone.0147435			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808644	Green Published, gold			2022-12-26	WOS:000369527800094
J	Rodriguez, M; Salmeron, MD; Martin-Malo, A; Barbieri, C; Mari, F; Molina, RI; Costa, P; Aljama, P				Rodriguez, Mariano; Dolores Salmeron, M.; Martin-Malo, Alejandro; Barbieri, Carlo; Mari, Flavio; Molina, Rafael I.; Costa, Pedro; Aljama, Pedro			A New Data Analysis System to Quantify Associations between Biochemical Parameters of Chronic Kidney Disease-Mineral Bone Disease	PLOS ONE			English	Article							SECONDARY HYPERPARATHYROIDISM; SURVIVAL PREDICTABILITY; PARATHYROID-HORMONE; CKD-MBD; METABOLISM; DISORDER; MORTALITY; PHOSPHATE; CALCIUM; RISK	Background In hemodialysis patients, deviations from KDIGO recommended values of individual parameters, phosphate, calcium or parathyroid hormone (PTH), are associated with increased mortality. However, it is widely accepted that these parameters are not regulated independently of each other and that therapy aimed to correct one parameter often modifies the others. The aim of the present study is to quantify the degree of association between parameters of chronic kidney disease and mineral bone disease (CKD-MBD). Methods Data was extracted from a cohort of 1758 adult HD patients between January 2000 and June 2013 obtaining a total of 46.141 records (10 year follow-up). We used an advanced data analysis system called Random Forest (RF) which is based on self-learning procedure with similar axioms to those utilized for the development of artificial intelligence. This new approach is particularly useful when the variables analyzed are closely dependent to each other. Results The analysis revealed a strong association between PTH and phosphate that was superior to that of PTH and Calcium. The classical linear regression analysis between PTH and phosphate shows a correlation coefficient is 0.27, p<0.001, the possibility to predict PTH changes from phosphate modification is marginal. Alternatively, RF assumes that changes in phosphate will cause modifications in other associated variables (calcium and others) that may also affect PTH values. Using RF the correlation coefficient between changes in serum PTH and phosphate is 0.77, p<0.001; thus, the power of prediction is markedly increased. The effect of therapy on biochemical variables was also analyzed using this RF. Conclusion Our results suggest that the analysis of the complex interactions between mineral metabolism parameters in CKD-MBD may demand a more advanced data analysis system such as RF.	[Rodriguez, Mariano; Dolores Salmeron, M.; Martin-Malo, Alejandro; Molina, Rafael I.; Aljama, Pedro] Univ Cordoba, IMIBIC, Hosp Reina Sofia, Serv Nephrol, Cordoba, Spain; [Barbieri, Carlo; Mari, Flavio] Fresenius Med Care, Bad Homburg, Germany; [Costa, Pedro] Fresenius Med Care, Madrid, Spain	Universidad de Cordoba	Martin-Malo, A (corresponding author), Univ Cordoba, IMIBIC, Hosp Reina Sofia, Serv Nephrol, Cordoba, Spain.	alejandro.martin.sspa@juntadeandalucia.es		Rodriguez, Mariano/0000-0002-9380-6614	Nephrologic Foundation of Cordoba (Junta de Andalucia) [PI-0311-2014]; Fresenius Medical Care	Nephrologic Foundation of Cordoba (Junta de Andalucia)(Junta de Andalucia); Fresenius Medical Care	This work was supported by a restricted grant from Nephrologic Foundation of Cordoba (PI-0311-2014 Junta de Andalucia). Fresenius Medical Care provided support in the form of salaries for authors [CB, FM and PC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al Aly Z, 2004, AM J NEPHROL, V24, P422, DOI 10.1159/000080087; Almaden Y, 1998, J AM SOC NEPHROL, V9, P1845; Berdud I, 1996, NEPHROL DIAL TRANSPL, V11, P1292; Bhan I, 2010, J GEN INTERN MED, V25, P710, DOI 10.1007/s11606-010-1316-y; Block GA, 2004, NEW ENGL J MED, V350, P1516, DOI 10.1056/NEJMoa031633; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Block GA, 2013, CLIN J AM SOC NEPHRO, V8, P2132, DOI 10.2215/CJN.04260413; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Cleophas TJ, 2014, SPRINGERBRIEF STAT, P1, DOI 10.1007/978-3-319-04181-0; Cozzolino M, 2014, NEPHROL DIAL TRANSPL, V29, P1815, DOI 10.1093/ndt/gft514; Danese MD, 2008, CLIN J AM SOC NEPHRO, V3, P1423, DOI 10.2215/CJN.01060308; Eknoyan G, 2003, AM J KIDNEY DIS, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3; Evenepoel P, 2014, SEMIN NEPHROL, V34, P151, DOI 10.1016/j.semnephrol.2014.02.007; Felsenfeld AJ, 1999, J AM SOC NEPHROL, V10, P878; Floege J, 2011, NEPHROL DIAL TRANSPL, V26, P1948, DOI 10.1093/ndt/gfq219; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Jamal SA, 2013, LANCET, V382, P1268, DOI 10.1016/S0140-6736(13)60897-1; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Ketteler M, 2015, KID INT; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Lertdumrongluk P, 2013, NEPHROL DIAL TRANSPL, V28, P2535, DOI 10.1093/ndt/gft290; Leung RKK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-162; Lorenzo V, 2001, AM J KIDNEY DIS, V37, P1260, DOI 10.1053/ajkd.2001.24532; Mas VR, 2007, MOL MED, V13, P315, DOI 10.2119/2007-00017.Mas; Palmer SC, 2009, COCHRANE DATABASE SY; Palomares I, 2013, BLOOD PURIFICAT, V36, P122, DOI 10.1159/000353418; Savage N., 2012, COMMUN ACM, V55, P1719; Scian MJ, 2012, TRANSPLANTATION, V94, P851, DOI 10.1097/TP.0b013e318263702b; Tentori F, 2014, AM J KIDNEY DIS, V63, P851, DOI 10.1053/j.ajkd.2014.02.003; Torregrosa JV, 2011, NEFROLOGIA, V31, P3, DOI 10.3265/Nefrologia.pre2011.Jan.10816; Vervloet MG, 2014, LANCET DIABETES ENDO, V2, P427, DOI 10.1016/S2213-8587(14)70059-2; Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x	33	15	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146801	10.1371/journal.pone.0146801	http://dx.doi.org/10.1371/journal.pone.0146801			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808154	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800033
J	Sina, M; Wood, RC; Saldarriaga, E; Lawler, J; Zunt, J; Garcia, P; Carcamo, C				Sina, Mariella; Wood, Rachel C.; Saldarriaga, Enrique; Lawler, Joshua; Zunt, Joseph; Garcia, Patricia; Carcamo, Cesar			Understanding Perceptions of Climate Change, Priorities, and Decision-Making among Municipalities in Lima, Peru to Better Inform Adaptation and Mitigation Planning	PLOS ONE			English	Article							EL-NINO; HEALTH; IMPACT; CHALLENGES; LEVEL	Climate change poses multiple risks to the population of Lima, the largest city and capital of Peru, located on the Pacific coast in a desert ecosystem. These risks include increased water scarcity, increased heat, and the introduction and emergence of vector-borne and other climate sensitive diseases. To respond to these threats, it is necessary for the government, at every level, to adopt more mitigation and adaptation strategies. Here, focus groups were conducted with representatives from five Lima municipalities to determine priorities, perception of climate change, and decision-making processes for implementing projects within each municipality. These factors can affect the ability and desire of a community to implement climate change adaptation and mitigation strategies. The results show that climate change and other environmental factors are of relatively low priority, whereas public safety and water and sanitation services are of highest concern. Perhaps most importantly, climate change is not well understood among the municipalities. Participants had trouble distinguishing climate change from other environmental issues and did not fully understand its causes and effects. Greater understanding of what climate change is and why it is important is necessary for it to become a priority for the municipalities. Different aspects of increased climate change awareness seem to be connected to having experienced extreme weather events, whether related or not to climate change, and to higher socioeconomic status.	[Sina, Mariella; Saldarriaga, Enrique; Garcia, Patricia; Carcamo, Cesar] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru; [Wood, Rachel C.; Zunt, Joseph] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Lawler, Joshua] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA	Universidad Peruana Cayetano Heredia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wood, RC (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	woodr8@uw.edu	Zunt, Joseph/ABD-2886-2021	Saldarriaga, Enrique M/0000-0001-8879-6354; Sina, Mariella/0000-0001-9056-5969	National Institutes of Health Research Training Grant [5D43TW009375-02]; FOGARTY INTERNATIONAL CENTER [D43TW009375] Funding Source: NIH RePORTER	National Institutes of Health Research Training Grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the National Institutes of Health Research Training Grant 5D43TW009375-02 awarded to Kuskaya: An Interdisciplinary Training Program for Innovation in Global Health from the Fogarty International Center, United States National Institutes of Health (http://www.fic.nih.gov/). The funders had no role in study design, data collection, and analysis, decision to publish, or preparing the manuscript.	APEIM. [Socioeconomic Levels in Lima and Callao], 2005, SOC LEV LIM CALL; Baraer M, 2012, J GLACIOL, V58, P134, DOI 10.3189/2012JoG11J186; Bayer AM, 2014, DISASTERS, V38, P351, DOI 10.1111/disa.12046; Baylis M, 2013, ANIM HEALTH RES REV, V14, P143, DOI 10.1017/S1466252313000145; Begum RA, 2015, MITIG ADAPT STRAT GL, V20, P361, DOI 10.1007/s11027-013-9495-6; Bijma J, 2013, MAR POLLUT BULL, V74, P495, DOI 10.1016/j.marpolbul.2013.07.022; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Cardwell FS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-208; Debela N, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1012-9; Detchon R, 2014, NATURE, V508, P309, DOI 10.1038/508309a; Diaz H.F., 2000, EL NINO SO OSCILLATI; Doyle J., 2011, ENVIRON SOCIOL; Funari E, 2012, ANN I SUPER SANITA, V48, P473, DOI 10.4415/ANN_12_04_13; Garcia RA, 2014, SCIENCE, V344, P486, DOI 10.1126/science.1247579; Grimm P., 2010, WILEY INT ENCY MARKE, DOI 10.1002/9781444316568.wiem02057; Hamilton LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138208; Dang HL, 2014, ENVIRON MANAGE, V54, P331, DOI 10.1007/s00267-014-0299-6; INEI, 2012, PER EST PROYECC POBL; Ipsos APOYO, 2012, 211 IPS APOYO; Ipsos Peru, 2014, PERF ZON LIM METR 20; Laukkonen J, 2009, HABITAT INT, V33, P287, DOI 10.1016/j.habitatint.2008.10.003; Lennox E, 2014, ECOSYST SERV, V10, P155, DOI 10.1016/j.ecoser.2014.08.007; Lundgren K, 2013, IND HEALTH, V51, P3, DOI 10.2486/indhealth.2012-0089; Measham TG, 2011, MITIG ADAPT STRAT GL, V16, P889, DOI 10.1007/s11027-011-9301-2; MEF MINAM GIZ, 2013, MAP PEL ESC CLIM; Mimura N, 2013, P JPN ACAD B-PHYS, V89, P281, DOI 10.2183/pjab.89.281; Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556; Nuttall N, 2014, LIMA CALL CLIMATE AC; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Penuelas J, 2013, GLOBAL CHANGE BIOL, V19, P2303, DOI 10.1111/gcb.12143; Poortinga W, 2011, GLOBAL ENVIRON CHANG, V21, P1015, DOI 10.1016/j.gloenvcha.2011.03.001; Raymond CM, 2013, J ENVIRON MANAGE, V115, P69, DOI 10.1016/j.jenvman.2012.11.003; Ripoll J, 2014, J EXP BOT, V65, P4097, DOI 10.1093/jxb/eru197; SENAMHI, 2009, ESC CLIM PER AN 2030; Takahashi Bruno, 2013, Public Underst Sci, V22, P427, DOI 10.1177/0963662511431204; Taylor A, 2014, RISK ANAL, V34, P1995, DOI 10.1111/risa.12234; Tirado MC, 2013, FOOD NUTR BULL, V34, P533, DOI 10.1177/156482651303400415; UCL, 2013, TRANSF PLANN ENV JUS; UNFCCC MINAM, LIM COP20 CMP 10; Villacorta S, 2015, EVALUACION GEOLOGICA; Wei JN, 2014, ENVIRON RES, V134, P301, DOI 10.1016/j.envres.2014.08.006; Whitmarsh L, 2008, J RISK RES, V11, P351, DOI 10.1080/13669870701552235	42	5	5	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147201	10.1371/journal.pone.0147201	http://dx.doi.org/10.1371/journal.pone.0147201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808087	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800060
J	Xu, F; Wang, F; Wang, ZH; Lv, WS; Wang, W; Wang, YG				Xu, Feng; Wang, Fang; Wang, Zhenhong; Lv, Wenshan; Wang, Wei; Wang, Yangang			Glucose Uptake Activities of Bis (2, 3-Dibromo-4, 5-Dihydroxybenzyl) Ether, a Novel Marine Natural Product from Red Alga Odonthaliacorymbifera with Protein Tyrosine Phosphatase 1B Inhibition, In Vitro and In Vivo	PLOS ONE			English	Article							INSULIN SENSITIVITY; BROMOPHENOLS; RESISTANCE; PTP1B	Background and Aims Protein tyrosine phosphatase 1B (PTP1B) is a novel therapeutic target for type-2 diabetes, which negatively regulates the insulin signaling transduction. Bis (2, 3-dibromo-4, 5-dihydroxybenzyl) ether (BDDE), a novel bromophenol isolated from the Red Alga, is a novel PTP1B inhibitor. But the anti-diabetic effects are not clear. In the present study, we evaluated the in vitro and in vivo antidiabetic effects of BDDE. Methods The insulin-resistant HepG2 cells were used to evaluate the in vitro antidiabetic effects of BDDE. MTT assay was used to determine the safety concentrations in HepG2 cells. Glucose assay kit was used to check glucose uptake after treated with BDDE. Western blotting assay was used to explore the potent mechanisms. The db/db mice were used to evaluate the in vivo antidiabetic effects of BDDE. Body weight, blood glucose, Glycated hemoglobin (HbA1c), lipid profile, and insulin level were checked at the respective time points. Gastrocnemii were dissected and used to analyze the PTP1B and insulin receptor beta (IR beta) expression. Results BDDE increased the insulin-resisted glucose uptake in HepG2 cells. BDDE also decreased the expression of PTP1B and activated the substrates and downstream signals in insulin signal pathway, such as IR beta, insulin receptor substrate-1/2 (IRS1/2), phosphoinositide 3-kinase (PI3K), and protein kinase B (PKB/Akt). In the db/db mice model, BDDE significantly decreased the blood glucose, HbA1c and triglyceride (TG) levels. BDDE also decreased the expression of PTP1B and activated the phosphorylation of IR beta in gastrocnemii. Moreover, BDDE at high doses downregulated the body weight without affecting food and water intake. Conclusion Our results suggest that BDDE as a new PTP1B inhibitor improves glucose metabolism by stimulating the insulin signaling and could be used in the treatment of type-2 diabetes mellitus.	[Xu, Feng] Qingdao Univ, Affiliated Hosp, Res & Educ Dept, Qingdao 266071, Peoples R China; [Wang, Fang; Lv, Wenshan; Wang, Yangang] Qingdao Univ, Affiliated Hosp, Dept Endocrinol, Qingdao 266071, Peoples R China; [Wang, Zhenhong] Qingdao Univ, Affiliated Hosp, Dept Continued Educ, Qingdao 266071, Peoples R China; [Wang, Wei] Qingdao Univ, Affiliated Hosp, Dept Hematol, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University; Qingdao University; Qingdao University	Wang, YG (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Endocrinol, Qingdao 266071, Peoples R China.	wangyg1966@126.com			Natural Science Foundation of Shandong Province, China [2014ZRB01809]	Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province)	This work was financially supported by the Natural Science Foundation of Shandong Province, China (#2014ZRB01809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, HOME HEALTHCARE NOW, V33, P311; Byon JCH, 1998, MOL CELL BIOCHEM, V182, P101, DOI 10.1023/A:1006868409841; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fukuda S, 2010, DIABETES OBES METAB, V12, P299, DOI 10.1111/j.1463-1326.2009.01162.x; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; Hu X, 2014, INT J MOL SCI, V15, P10446, DOI 10.3390/ijms150610446; Kennedy BP, 2000, BIOCHEM PHARMACOL, V60, P877, DOI 10.1016/S0006-2952(00)00305-1; Kim KY, 2008, PHYTOCHEMISTRY, V69, P2820, DOI 10.1016/j.phytochem.2008.09.007; Kim KY, 2010, J FOOD SCI, V75, pH145, DOI 10.1111/j.1750-3841.2010.01629.x; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kurihara H, 1999, J NAT PROD, V62, P882, DOI 10.1021/np980324p; Kurihara H, 1999, FISHERIES SCI, V65, P300, DOI 10.2331/fishsci.65.300; Nader NS, 2008, CURR DIABETES REP, V8, P383, DOI 10.1007/s11892-008-0066-2; Nagao M, 2015, ENDOCR J, V62, P561, DOI 10.1507/endocrj.EJ15-0055; Ramachandran C, 2003, CURR TOP MED CHEM, V3, P749, DOI 10.2174/1568026033452276; Shi DY, 2008, CHINESE SCI BULL, V53, P2476, DOI 10.1007/s11434-008-0353-y; Shi DY, 2013, MAR DRUGS, V11, P350, DOI 10.3390/md11020350; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199	19	19	19	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147748	10.1371/journal.pone.0147748	http://dx.doi.org/10.1371/journal.pone.0147748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808535	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800204
J	Yang, JM; Sung, MS; Heo, H; Park, SW				Yang, Jee Myung; Sung, Mi Sun; Heo, Hwan; Park, Sang Woo			The Effect of Laser Trabeculoplasty on Posture-Induced Intraocular Pressure Changes in Patients with Open Angle Glaucoma	PLOS ONE			English	Article							LATERAL DECUBITUS POSITION; NORMAL-TENSION GLAUCOMA; VISUAL-FIELD LOSS; GOLDMANN APPLANATION TONOMETER; EPISCLERAL VENOUS-PRESSURE; HEALTHY-YOUNG SUBJECTS; BODY POSITION; OCULAR HYPERTENSION; EYES; FLUCTUATION	Purpose To investigate the effect of argon laser trabeculoplasty (ALT) on posture-induced intraocular pressure (IOP) changes in patients with open angle glaucoma (OAG). Methods Thirty eyes of 30 consecutive patients with OAG who underwent ALT were prospectively analyzed. The IOP was measured using Icare PRO in the sitting position, supine position, and dependent lateral decubitus position (DLDP) before ALT and at 1 week, 1 month, 2 months, and 3 months after ALT. Results Compared to the baseline values, the IOP in each position was significantly decreased after ALT (all P < 0.001). During follow-up, the mean percentage of IOP reduction was similar in the sitting and supine positions, but was significantly lower in DLDP than in the sitting or supine positions (all P < 0.05). In terms of postural IOP changes, the IOP in the supine position and DLDP was significantly higher than that in the sitting position at the same time points during the follow-up period (all P < 0.001). The difference between the IOP in the supine position and DLDP during follow-up was significant (all P < 0.001). The extent of IOP differences between any positions did not show significant changes during the follow-up period (all P > 0.05). Conclusions ALT appears to be effective in lowering the IOP in various body positions, but the degree of this effect was significantly lower in DLDP. In addition, ALT seemed to have limited effects on posture-induced IOP changes.	[Yang, Jee Myung; Sung, Mi Sun; Heo, Hwan; Park, Sang Woo] Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Gwang Ju, South Korea; [Park, Sang Woo] Chonnam Natl Univ, Ctr Creat Biomed Sci, Gwang Ju, South Korea	Chonnam National University; Chonnam National University	Park, SW (corresponding author), Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Gwang Ju, South Korea.; Park, SW (corresponding author), Chonnam Natl Univ, Ctr Creat Biomed Sci, Gwang Ju, South Korea.	exo70@naver.com		Yang, Jee Myung/0000-0001-5729-2233	Cheil-Nammyung Foundation Research Fund	Cheil-Nammyung Foundation Research Fund	This study was supported by the 2012 Cheil-Nammyung Foundation Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ED, 2011, CLIN OPHTHALMOL, V5, P933, DOI 10.2147/OPTH.S21759; ARMALY MF, 1963, ARCH OPHTHALMOL-CHIC, V70, P603; BABIZHAYEV MA, 1990, GRAEF ARCH CLIN EXP, V228, P90, DOI 10.1007/BF02764299; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Buys YM, 2010, OPHTHALMOLOGY, V117, P1348, DOI 10.1016/j.ophtha.2009.11.015; BYLSMA SS, 1988, ARCH OPHTHALMOL-CHIC, V106, P544; Caprioli J, 2008, OPHTHALMOLOGY, V115, P1123, DOI 10.1016/j.ophtha.2007.10.031; Caprioli J, 2007, ARCH OPHTHALMOL-CHIC, V125, P1124, DOI 10.1001/archopht.125.8.1124; Cook JA, 2012, OPHTHALMOLOGY, V119, P1552, DOI 10.1016/j.ophtha.2012.02.030; FRIBERG TR, 1987, AM J OPHTHALMOL, V103, P523, DOI 10.1016/S0002-9394(14)74275-8; GREENIDGE KC, 1983, OPHTHALMOLOGY, V90, P800; Guzey M, 1999, OPHTHALMOLOGICA, V213, P214, DOI 10.1159/000027424; Heijl A, 2011, AM J OPHTHALMOL, V152, P842, DOI 10.1016/j.ajo.2011.04.036; HETLANDE.J, 1966, ACTA OPHTHALMOL, V44, P515; Hirooka K, 2003, J GLAUCOMA, V12, P379, DOI 10.1097/00061198-200308000-00015; Hirooka K, 2009, J GLAUCOMA, V18, P689, DOI 10.1097/IJG.0b013e31819c49f4; Hong S, 2007, ARCH OPHTHALMOL-CHIC, V125, P1010, DOI 10.1001/archopht.125.8.1010; Iliev ME, 2006, BRIT J OPHTHALMOL, V90, P833, DOI 10.1136/bjo.2005.089870; Juzych MS, 2004, OPHTHALMOLOGY, V111, P1853, DOI 10.1016/j.ophtha.2004.04.030; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kim KN, 2014, AM J OPHTHALMOL, V157, P739, DOI 10.1016/j.ajo.2013.12.016; Kim KN, 2013, OPHTHALMOLOGY, V120, P731, DOI 10.1016/j.ophtha.2012.09.021; Kita Y, 2011, JPN J OPHTHALMOL, V55, P228, DOI 10.1007/s10384-011-0017-3; Kiuchi T, 2007, AM J OPHTHALMOL, V143, P693, DOI 10.1016/j.ajo.2006.11.020; Kiuchi T, 2006, OPHTHALMOLOGY, V113, P2150, DOI 10.1016/j.ophtha.2006.06.014; KRIEGLSTEIN GK, 1975, OPHTHALMOLOGICA, V171, P132, DOI 10.1159/000307479; KRIEGLSTEIN GK, 1978, A GRAEF ARCH KLIN EX, V206, P99, DOI 10.1007/BF00414618; KRUG J, 1995, AM J OPHTHALMOL, V120, P718; Lee AC, 2007, OPHTHALMOLOGY, V114, P666, DOI 10.1016/j.ophtha.2006.07.058; Lee HS, 2005, J KOREAN OPHTHALMOL, V46, P2004; Lee JWY, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000238; Lee JY, 2013, AM J OPHTHALMOL, V155, P329, DOI 10.1016/j.ajo.2012.08.003; Lee JY, 2012, ACTA OPHTHALMOL, V90, pE68, DOI 10.1111/j.1755-3768.2011.02208.x; Lee TE, 2013, OPHTHALMOLOGY, V120, P1565, DOI 10.1016/j.ophtha.2013.01.011; Lee TE, 2015, AM J OPHTHALMOL, DOI [10.1016/j.ajo.2015.07.030, DOI 10.1016/J.AJ0.2015.07.030]; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Malihi M, 2012, OPHTHALMOLOGY, V119, P987, DOI 10.1016/j.ophtha.2011.11.024; Mizokami J, 2011, GRAEF ARCH CLIN EXP, V249, P879, DOI 10.1007/s00417-010-1565-9; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; PARSLEY J, 1987, BRIT J OPHTHALMOL, V71, P494, DOI 10.1136/bjo.71.7.494; Sahin A, 2007, CLIN EXP OPHTHALMOL, V35, P335, DOI 10.1111/j.1442-9071.2007.01451.x; Sawada A, 2014, INVEST OPHTH VIS SCI, V55, P446, DOI 10.1167/iovs.13-13030; Sawada A, 2012, INVEST OPHTH VIS SCI, V53, P7631, DOI 10.1167/iovs.12-10454; Sawada A, 2012, GRAEF ARCH CLIN EXP, V250, P1361, DOI 10.1007/s00417-012-1942-7; SHINGLETON BJ, 1993, OPHTHALMOLOGY, V100, P1324; SINGH M, 1992, INT OPHTHALMOL, V16, P163, DOI 10.1007/BF00916436; SMITH TJ, 1985, AM J OPHTHALMOL, V99, P617, DOI 10.1016/S0002-9394(14)77989-9; SOMMER A, 1989, AM J OPHTHALMOL, V107, P186, DOI 10.1016/0002-9394(89)90221-3; Sultan M, 2003, J GLAUCOMA, V12, P370, DOI 10.1097/00061198-200308000-00013; Sung MS, 2013, J GLAUCOMA; TSUKAHARA S, 1984, BRIT J OPHTHALMOL, V68, P389, DOI 10.1136/bjo.68.6.389; VANBUSKIRK EM, 1984, OPHTHALMOLOGY, V91, P1005; WISE JB, 1979, ARCH OPHTHALMOL-CHIC, V97, P319, DOI 10.1001/archopht.1979.01020010165017; YAMABAYASHI S, 1991, BRIT J OPHTHALMOL, V75, P652, DOI 10.1136/bjo.75.11.652; Yang YX, 2014, J GLAUCOMA, V23, P19, DOI 10.1097/IJG.0b013e31825afc9d; 1996, OPHTHALMOLOGY, V103, P1706	56	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147963	10.1371/journal.pone.0147963	http://dx.doi.org/10.1371/journal.pone.0147963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807852	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800254
J	Zhuang, JG; Gao, P; Pollock, Z; Harrod, KS; Xu, FD				Zhuang, Jianguo; Gao, Peng; Pollock, Zemmie; Harrod, Kevin S.; Xu, Fadi			Depressed Hypoxic and Hypercapnic Ventilatory Responses at Early Stage of Lethal Avian Influenza A Virus Infection in Mice	PLOS ONE			English	Article							PULMONARY; INDONESIA; NEURONS; HUMANS; APNEA; VIRULENCE; INJECTION; PATHWAYS; FEATURES; LACKING	H5N1 virus infection results in similar to 60% mortality in patients primarily due to respiratory failure, but the underlying causes of mortality are unclear. The goal of this study is to reveal respiratory disorders occurring at the early stage of infection that may be responsible for subsequent respiratory failure and death. BALB/c mice were intranasally infected with one of two H5N1 virus strains: HK483 (lethal) or HK486 (non-lethal) virus. Pulmonary ventilation and the responses to hypoxia (HVR; 7% O-2 for 3 min) and hypercapnia (HCVR; 7% CO2 for 5 min) were measured daily at 2 days prior and 1, 2, and 3 days postinfection (dpi) and compared to mortality typically by 8 dpi. At 1, 2, and 3 dpi, immunoreactivities (IR) of substance P (SP-IR) in the nodose ganglion or tyrosine hydroxylase (TH-IR) in the carotid body coupled with the nucleoprotein of influenza A (NP-IR) was examined in some mice, while arterial blood was collected in others. Our results showed that at 2 and 3 dpi: 1) both viral infections failed to alter body temperature and weight, V (V) over dot (CO2), or induce viremia while producing similarly high lung viral titers; 2) HK483, but not HK486, virus induced tachypnea and depressed HVR and HCVR without changes in arterial blood pH and gases; and 3) only HK483 virus led to NP-IR in vagal SP-IR neurons, but not in the carotid body, and increased density of vagal SP-IR neurons. In addition, all HK483, rather than HK486, mice died at 6 to 8 dpi and the earlier death was correlated with more severe depression of HVR and HCVR. Our data suggest that tachypnea and depressed HVR/HCVR occur at the early stage of lethal H5N1 viral infection associated with viral replication and increased SP-IR density in vagal neurons, which may contribute to the respiratory failure and death.	[Zhuang, Jianguo; Gao, Peng; Pollock, Zemmie; Harrod, Kevin S.; Xu, Fadi] Lovelace Resp Res Inst, Pathophysiol Program, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA	Lovelace Respiratory Research Institute	Xu, FD (corresponding author), Lovelace Resp Res Inst, Pathophysiol Program, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA.	fxu@lrri.org		Harrod, Kevin/0000-0003-0780-9470	 [HL119683];  [HL 107462];  [AI111457]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119683, R01HL107462] Funding Source: NIH RePORTER	; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The studies were supported by HL119683 and HL 107462 (Fadi Xu) and AI111457 (Kevin Harrod). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Bauman NM, 2000, ANN OTO RHINOL LARYN, V109, P1150, DOI 10.1177/000348940010901213; Boychuk CR, BEHAV BRAIN RES; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V46, P1245; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1204; COLERIDGE HM, 1994, ANNU REV PHYSIOL, V56, P69, DOI 10.1146/annurev.ph.56.030194.000441; De Vleeschauwer A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006662; Gao P, 1999, J VIROL, V73, P3184, DOI 10.1128/JVI.73.4.3184-3189.1999; Gozal D, 1996, AM J RESP CRIT CARE, V153, P761, DOI 10.1164/ajrccm.153.2.8564130; Hatta Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001139; Horie Y, 1999, AM J RESP CRIT CARE, V159, pA786; Ilyushina NA, 2008, ANTIMICROB AGENTS CH, V52, P3889, DOI 10.1128/AAC.01579-07; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Kim HM, 2015, ARCH VIROL, V160, P305, DOI 10.1007/s00705-014-2284-z; Kubin L, 2006, J APPL PHYSIOL, V101, P618, DOI 10.1152/japplphysiol.00252.2006; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Moreira TS, 2007, J NEUROPHYSIOL, V98, P3627, DOI 10.1152/jn.00675.2007; Morishima Tsuneo, 2004, Rinsho Shinkeigaku, V44, P965; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Nishimura H, 2000, J GEN VIROL, V81, P2503, DOI 10.1099/0022-1317-81-10-2503; Okumura A, 2013, J CLIN VIROL, V56, P25, DOI 10.1016/j.jcv.2012.10.007; Oner AF, 2006, NEW ENGL J MED, V355, P2179, DOI 10.1056/NEJMoa060601; Paton JFR, 1997, J PHYSIOL-LONDON, V502, P623, DOI 10.1111/j.1469-7793.1997.623bj.x; Paton JFR, 1998, J NEUROPHYSIOL, V79, P2365, DOI 10.1152/jn.1998.79.5.2365; Paton JFR, 2001, NEUROSCIENCE, V105, P231, DOI 10.1016/S0306-4522(01)00106-3; Pendlebury JD, 2008, AM J RESP CRIT CARE, V177, P1255, DOI 10.1164/rccm.200711-1739OC; Perrone LA, 2010, J INFECT DIS, V202, P1161, DOI 10.1086/656365; Plourde JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046605; Quintana A, 2012, J CLIN INVEST, V122, P2359, DOI 10.1172/JCI62923; Robinson DM, 2002, J PHYSIOL-LONDON, V538, P957, DOI 10.1113/jphysiol.2001.012705; Sapru HN, 1996, ADV EXP MED BIOL, V410, P357; Schuen JN, 1997, RESP PHYSIOL, V109, P231, DOI 10.1016/S0034-5687(97)00052-2; Sedyaningsih ER, 2007, J INFECT DIS, V196, P522, DOI 10.1086/519692; SHEA SA, 1993, J PHYSIOL-LONDON, V468, P623, DOI 10.1113/jphysiol.1993.sp019792; Smart JA, 2000, BRIT J ANAESTH, V84, P735, DOI 10.1093/oxfordjournals.bja.a013584; Soepandi PZ, 2010, CHEST, V138, P665, DOI 10.1378/chest.09-2644; Takakura ACT, 2006, J PHYSIOL-LONDON, V572, P503, DOI 10.1113/jphysiol.2005.103788; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; Uchimura T, 2012, J INFECT CHEMOTHER, V18, P59, DOI 10.1007/s10156-011-0284-4; UGOLINI G, 1992, J COMP NEUROL, V326, P527, DOI 10.1002/cne.903260404; WHO, 2021, CUM NUMB CONF HUM CA; Xu F, 2007, RESP PHYSIOL NEUROBI, V158, P5, DOI 10.1016/j.resp.2007.04.004; Xu F, 2003, J APPL PHYSIOL, V94, P1446, DOI 10.1152/japplphysiol.00767.2002; Xu FD, 2005, FASEB J, V19, pA656; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhuang J, 2008, FASEB J, V22, P1172; Zhuang J, 2014, PHYSL REP, V2, P1	51	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147522	10.1371/journal.pone.0147522	http://dx.doi.org/10.1371/journal.pone.0147522			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808681	Green Submitted, gold, Green Published			2022-12-26	WOS:000369527800120
J	Ballottari, M; Truong, TB; De Re, E; Erickson, E; Stella, GR; Fleming, GR; Bassi, R; Niyogi, KK				Ballottari, Matteo; Truong, Thuy B.; De Re, Eleonora; Erickson, Erika; Stella, Giulio R.; Fleming, Graham R.; Bassi, Roberto; Niyogi, Krishna K.			Identification of pH-sensing Sites in the Light Harvesting Complex Stress-related 3 Protein Essential for Triggering Non-photochemical Quenching in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOPROTECTIVE ENERGY-DISSIPATION; PHOTOSYSTEM-II; CHLOROPHYLL FLUORESCENCE; XANTHOPHYLL CYCLE; CHLOROPLAST MEMBRANES; THERMAL DISSIPATION; CATION FORMATION; IN-VIVO; STATE; PSBS	Light harvesting complex stress-related 3 (LHCSR3) is the protein essential for photoprotective excess energy dissipation (non-photochemical quenching, NPQ) in the model green alga Chlamydomonas reinhardtii. Activation of NPQ requires low pH in the thylakoid lumen, which is induced in excess light conditions and sensed by lumen-exposed acidic residues. In this work we have used site-specific mutagenesis in vivo and in vitro for identification of the residues in LHCSR3 that are responsible for sensing lumen pH. Lumen-exposed protonatable residues, aspartate and glutamate, were mutated to asparagine and glutamine, respectively. By expression in a mutant lacking all LHCSR isoforms, residues Asp(117), Glu(221), and Glu(224) were shown to be essential for LHCSR3-dependent NPQ induction in C. reinhardtii. Analysis of recombinant proteins carrying the same mutations refolded in vitro with pigments showed that the capacity of responding to low pH by decreasing the fluorescence life time, present in the wild-type protein, was lost. Consistent with a role in pH sensing, the mutations led to a substantial reduction in binding the NPQ inhibitor dicyclohexylcarbodiimide.	[Ballottari, Matteo; Stella, Giulio R.; Bassi, Roberto] Univ Verona, Dept Biotechnol, Str Le Grazie, I-37134 Verona, Italy; [Truong, Thuy B.; Erickson, Erika; Niyogi, Krishna K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Fleming, Graham R.] Univ Calif Berkeley, Dept Chem, Hildebrand B77, Berkeley, CA 94720 USA; [Stella, Giulio R.] Univ Paris 06, Sorbonne Univ, CNRS, Lab Biol Computat & Quantitat,UMR 7238, 15 Rue Ecole Med, F-75006 Paris, France; [De Re, Eleonora; Erickson, Erika; Fleming, Graham R.; Niyogi, Krishna K.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [De Re, Eleonora; Fleming, Graham R.] Univ Calif Berkeley, Grad Grp Appl Sci & Technol, Berkeley, CA 94720 USA; [Truong, Thuy B.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	University of Verona; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Donald Danforth Plant Science Center	Bassi, R (corresponding author), Univ Verona, Dept Biotechnol, Str Le Grazie, I-37134 Verona, Italy.; Niyogi, KK (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	roberto.bassi@univr.it; niyogi@berkeley.edu	Ballottari, Matteo/N-1916-2019	Ballottari, Matteo/0000-0001-8410-3397; Erickson, Erika/0000-0001-7806-9348; bassi, roberto/0000-0002-4140-8446	U.S. Department of Energy, Office of Science, Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division [449B]; Italian Ministry of Education, University and Research through PRIN ("Progetti di Ricerca di Interesse Nazionale") [2012XSAWYM]; National Science Foundation; Marie Curie Actions Initial Training Networks ACCLIPHOT [PITN-GA-2012-316427]	U.S. Department of Energy, Office of Science, Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division(United States Department of Energy (DOE)); Italian Ministry of Education, University and Research through PRIN ("Progetti di Ricerca di Interesse Nazionale"); National Science Foundation(National Science Foundation (NSF)); Marie Curie Actions Initial Training Networks ACCLIPHOT	This work was supported in part by the U.S. Department of Energy, Office of Science, Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division under field work proposal 449B. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the Italian Ministry of Education, University and Research through PRIN ("Progetti di Ricerca di Interesse Nazionale") project 2012XSAWYM.r Supported by a National Science Foundation Graduate Research Fellowship.r Supported by Marie Curie Actions Initial Training Networks ACCLIPHOT Grant PITN-GA-2012-316427.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Alboresi A, 2010, P NATL ACAD SCI USA, V107, P11128, DOI 10.1073/pnas.1002873107; Amarnath K, 2012, P NATL ACAD SCI USA, V109, P8405, DOI 10.1073/pnas.1205303109; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Ballottari M, 2004, EUR J BIOCHEM, V271, P4659, DOI 10.1111/j.1432-1033.2004.04426.x; Ballottari M, 2013, J PHYS CHEM B, V117, P11337, DOI 10.1021/jp402977y; Ballottari M, 2012, BBA-BIOENERGETICS, V1817, P143, DOI 10.1016/j.bbabio.2011.06.005; Ballottari M, 2010, J BIOL CHEM, V285, P28309, DOI 10.1074/jbc.M110.124115; Ballottari M, 2009, J BIOL CHEM, V284, P8103, DOI 10.1074/jbc.M808326200; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; Belgio E, 2013, PHYS CHEM CHEM PHYS, V15, P12253, DOI 10.1039/c3cp51925b; Bonente G, 2008, J BIOL CHEM, V283, P8434, DOI 10.1074/jbc.M708291200; Bonente G, 2012, J BIOL CHEM, V287, P5833, DOI 10.1074/jbc.M111.304279; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Bonente G, 2008, PHOTOCHEM PHOTOBIOL, V84, P1359, DOI 10.1111/j.1751-1097.2008.00456.x; Cellini B, 2006, BIOCHEMISTRY-US, V45, P14140, DOI 10.1021/bi061496l; Cruz JA, 2005, PHOTOSYNTH RES, V85, P221, DOI 10.1007/s11120-005-4731-x; Dall'Osto L, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0221; de Bianchi S, 2010, BIOCHEM SOC T, V38, P651, DOI 10.1042/BST0380651; DEMMIG B, 1987, PLANT PHYSIOL, V84, P218, DOI 10.1104/pp.84.2.218; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Fan MR, 2015, NAT STRUCT MOL BIOL, V22, P729, DOI 10.1038/nsmb.3068; Ferrante P, 2012, J BIOL CHEM, V287, P16276, DOI 10.1074/jbc.M111.316729; Finazzi G, 1998, BIOCHEMISTRY-US, V37, P9999, DOI 10.1021/bi980320j; Gerotto C, 2011, PLANT CELL ENVIRON, V34, P922, DOI 10.1111/j.1365-3040.2011.02294.x; Ginsberg NS, 2011, P NATL ACAD SCI USA, V108, P3848, DOI 10.1073/pnas.1012054108; Giuffra E, 1996, EUR J BIOCHEM, V238, P112, DOI 10.1111/j.1432-1033.1996.0112q.x; Gwizdala M, 2013, BBA-BIOENERGETICS, V1827, P348, DOI 10.1016/j.bbabio.2012.11.001; Holleboom CP, 2015, PHOTOSYNTH RES, V124, P171, DOI 10.1007/s11120-015-0113-1; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; HORTON P, 1994, PLANT PHYSIOL, V106, P415, DOI 10.1104/pp.106.2.415; Johnson MP, 2012, PLANTA, V235, P193, DOI 10.1007/s00425-011-1502-0; Kirilovsky D, 2013, PHOTOCH PHOTOBIO SCI, V12, P1135, DOI 10.1039/c3pp25406b; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lepetit B, 2013, PLANT PHYSIOL, V161, P853, DOI 10.1104/pp.112.207811; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liguori N, 2013, J AM CHEM SOC, V135, P18339, DOI 10.1021/ja4107463; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; Mou SL, 2012, EXTREMOPHILES, V16, P193, DOI 10.1007/s00792-011-0419-7; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Muller MG, 2010, CHEMPHYSCHEM, V11, P1289, DOI 10.1002/cphc.200900852; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Pan XW, 2011, NAT STRUCT MOL BIOL, V18, P309, DOI 10.1038/nsmb.2008; Pandit A, 2013, BBA-BIOENERGETICS, V1827, P738, DOI 10.1016/j.bbabio.2013.02.015; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Pesaresi P, 1997, FEBS LETT, V402, P151, DOI 10.1016/S0014-5793(96)01518-9; Petrou K, 2014, BBA-BIOENERGETICS, V1837, P1533, DOI 10.1016/j.bbabio.2013.11.018; Pinnola A, 2015, J BIOL CHEM, V290, P24340, DOI 10.1074/jbc.M115.668798; Pinnola A, 2013, PLANT CELL, V25, P3519, DOI 10.1105/tpc.113.114538; REES D, 1992, PHOTOSYNTH RES, V31, P11, DOI 10.1007/BF00049532; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Ruban AV, 1999, PLANT PHYSIOL, V119, P531, DOI 10.1104/pp.119.2.531; Ruban AV, 1996, BIOCHEMISTRY-US, V35, P674, DOI 10.1021/bi9524878; RUBAN AV, 1992, FEBS LETT, V309, P175, DOI 10.1016/0014-5793(92)81089-5; RUBAN AV, 1993, PLANT PHYSIOL, V102, P741, DOI 10.1104/pp.102.3.741; SUELTEMEYER DF, 1986, PLANT PHYSIOL, V81, P372, DOI 10.1104/pp.81.2.372; Tokutsu R, 2004, PLANT CELL PHYSIOL, V45, P138, DOI 10.1093/pcp/pch013; Tokutsu R, 2013, P NATL ACAD SCI USA, V110, P10016, DOI 10.1073/pnas.1222606110; Truong T. N, 2011, THESIS; van Oort B, 2007, FEBS LETT, V581, P3528, DOI 10.1016/j.febslet.2007.06.070; Walters RG, 1996, P NATL ACAD SCI USA, V93, P14204, DOI 10.1073/pnas.93.24.14204; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003	73	66	68	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7334	7346		10.1074/jbc.M115.704601	http://dx.doi.org/10.1074/jbc.M115.704601			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26817847	Green Published, hybrid			2022-12-26	WOS:000383447600011
J	Lahaie, N; Kralikova, M; Prezeau, L; Blahos, J; Bouvier, M				Lahaie, Nicolas; Kralikova, Michaela; Prezeau, Laurent; Blahos, Jaroslav; Bouvier, Michel			Post-endocytotic Deubiquitination and Degradation of the Metabotropic -Aminobutyric Acid Receptor by the Ubiquitin-specific Protease 14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioluminescence resonance energy transfer (BRET); biosensor; deubiquitylation (deubiquitination); G protein-coupled receptor (GPCR); GABA receptor; protein degradation; receptor endocytosis; ubiquitylation (ubiquitination)	RESONANCE ENERGY-TRANSFER; GABA(B) RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; ENZYME USP14; B RECEPTORS; MEDIATES UBIQUITINATION; LYSOSOMAL DEGRADATION; PROTEINS ACTIVATE; DOWN-REGULATION; PHOSPHORYLATION	Mechanisms controlling the metabotropic -aminobutyric acid receptor (GABA(B)) cell surface stability are still poorly understood. In contrast with many other G protein-coupled receptors (GPCR), it is not subject to agonist-promoted internalization, but is constitutively internalized and rapidly down-regulated. In search of novel interacting proteins regulating receptor fate, we report that the ubiquitin-specific protease 14 (USP14) interacts with the GABA(B(1b)) subunit's second intracellular loop. Probing the receptor for ubiquitination using bioluminescence resonance energy transfer (BRET), we detected a constitutive and phorbol 12-myristate 13-acetate (PMA)-induced ubiquitination of the receptor at the cell surface. PMA also increased internalization and accelerated receptor degradation. Overexpression of USP14 decreased ubiquitination while treatment with a small molecule inhibitor of the deubiquitinase (IU1) increased receptor ubiquitination. Treatment with the internalization inhibitor Dynasore blunted both USP14 and IU1 effects on the receptor ubiquitination state, suggesting a post-endocytic site of action. Overexpression of USP14 also led to an accelerated degradation of GABA(B) in a catalytically independent fashion. We thus propose a model whereby cell surface ubiquitination precedes endocytosis, after which USP14 acts as an ubiquitin-binding protein that targets the ubiquitinated receptor to lysosomal degradation and promotes its deubiquitination.	[Lahaie, Nicolas; Bouvier, Michel] Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada; [Lahaie, Nicolas; Bouvier, Michel] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3T 1J4, Canada; [Kralikova, Michaela; Blahos, Jaroslav] Acad Sci Czech Republic, Inst Mol Genet, Videnska 1083, CR-14220 Prague 4, Czech Republic; [Prezeau, Laurent] Univ Montpellier I, Inst Genom Fonct, F-34090 Montpellier, France; [Prezeau, Laurent] Univ Montpellier 2, F-34090 Montpellier, France	Universite de Montreal; Universite de Montreal; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Universite de Montpellier; Universite de Montpellier	Blahos, J (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Videnska 1083, CR-14220 Prague 4, Czech Republic.; Bouvier, M (corresponding author), Univ Montreal, IRIC, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	blahos@img.cas.cz; michel.bouvier@umontreal.ca	Bouvier, Michel/H-2758-2014; Kralikova, Michaela/H-2588-2014; Blahos, Jaroslav/G-8325-2017	Bouvier, Michel/0000-0003-1128-0100; Blahos, Jaroslav/0000-0003-3355-1469; Blahos, Jaroslav/0000-0001-9803-0061	Canadian Institutes of Health Research (CIHR) [MOP 10501]; Czech Science Foundation [GACR P303/12/2408]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Czech Science Foundation(Grant Agency of the Czech Republic)	These studies were supported by the Canadian Institutes of Health Research (CIHR) (MOP 10501) and the Czech Science Foundation (GACR P303/12/2408). The authors declare that they have no conflicts of interest with the contents of this article.	Berlin I, 2010, J BIOL CHEM, V285, P37895, DOI 10.1074/jbc.M110.129411; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Bhattacharyya BJ, 2012, AM J PHYSIOL-CELL PH, V302, pC698, DOI 10.1152/ajpcell.00326.2010; Breton B, 2010, FASEB J, V24, P4733, DOI 10.1096/fj.10-164061; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; DUTAR P, 1988, NEURON, V1, P585, DOI 10.1016/0896-6273(88)90108-0; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Guetg N, 2010, P NATL ACAD SCI USA, V107, P13924, DOI 10.1073/pnas.1000909107; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Kanaide M, 2007, J CELL PHYSIOL, V210, P237, DOI 10.1002/jcp.20863; Kuramoto N, 2007, NEURON, V53, P233, DOI 10.1016/j.neuron.2006.12.015; Kuramoto N, 2013, NEUROCHEM INT, V62, P137, DOI 10.1016/j.neuint.2012.12.003; Lappe-Siefke C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000631; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Li SS, 2013, MOL PHARMACOL, V84, P139, DOI 10.1124/mol.113.086769; Luttrell LM, 2002, J CELL SCI, V115, P455; Maier PJ, 2010, J BIOL CHEM, V285, P35606, DOI 10.1074/jbc.M110.142406; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Mines MA, 2009, J BIOL CHEM, V284, P5742, DOI 10.1074/jbc.M808507200; Mukherjee RS, 2006, MOL PHARMACOL, V70, P1406, DOI 10.1124/mol.106.024463; Na CH, 2012, J PROTEOME RES, V11, P4722, DOI 10.1021/pr300536k; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Nagai A, 2009, BIOCHEM BIOPH RES CO, V379, P995, DOI 10.1016/j.bbrc.2008.12.182; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Pontier SM, 2006, EMBO J, V25, P2698, DOI 10.1038/sj.emboj.7601157; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; Sarker Subhodeep, 2011, Commun Integr Biol, V4, P528, DOI 10.4161/cib.4.5.16458; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Terunuma M, 2010, P NATL ACAD SCI USA, V107, P13918, DOI 10.1073/pnas.1000853107; Vargas KJ, 2008, J BIOL CHEM, V283, P24641, DOI 10.1074/jbc.M802419200; Villemure JF, 2005, BIOCHEM J, V388, P47, DOI 10.1042/BJ20041435; Walters BJ, 2014, J PHYSIOL-LONDON, V592, P571, DOI 10.1113/jphysiol.2013.266015; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008; Zemoura K, 2014, J BIOL CHEM, V289, P7738, DOI 10.1074/jbc.M113.541987; Zemoura K, 2013, J BIOL CHEM, V288, P34897, DOI 10.1074/jbc.M113.514745	54	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7156	7170		10.1074/jbc.M115.686907	http://dx.doi.org/10.1074/jbc.M115.686907			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26817839	Green Published, hybrid			2022-12-26	WOS:000373299700048
J	Kuhne, M; Knecht, S; Muhl, A; Reichlin, T; Pavlovic, N; Kessel-Schaefer, A; Kaufmann, BA; Schaer, B; Sticherling, C; Osswald, S				Kuehne, Michael; Knecht, Sven; Muehl, Aline; Reichlin, Tobias; Pavlovic, Nikola; Kessel-Schaefer, Arnheid; Kaufmann, Beat A.; Schaer, Beat; Sticherling, Christian; Osswald, Stefan			Fluoroscopy-Free Pulmonary Vein Isolation in Patients with Atrial Fibrillation and a Patent Foramen Ovale Using Solely an Electroanatomic Mapping System	PLOS ONE			English	Article							CATHETER ABLATION PROCEDURES; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; FOLLOW-UP; RISK; MANAGEMENT	Introduction The advent of electroanatomical mapping (EAM) systems for pulmonary vein isolation (PVI) has dramatically decreased radiation exposure. However, the need for some fluoroscopy remains for obtaining left atrial (LA) access. The aim was to test the feasibility of fluoroscopy-free PVI in patients with atrial fibrillation (AF) and a patent for a men ovale (PFO) guided solely by an EAM system. Methods Consecutive patients with AF undergoing PVI and documented PFO were studied. An EAM-guided approach without fluoroscopy and ultrasound was used. After completing the map of the right atrium, the superior vena cava and the coronary sinus, a catheter pull-down to the PFO was performed allowing LA access. The map of the LA and subsequent PVI was also performed without fluoroscopy. Results 30 patients [age 61 +/- 12 years, 73% male, ejection fraction 0.64 (0.53-0.65), LA size in parasternal long axis 38 +/- 7 mm] undergoing PVI were included. The time required for right atrial mapping including transseptal crossing was 9 +/- 4 minutes. Total procedure time was 127 +/- 37 minutes. Fluoroscopy-free PVI was feasible in 26/30 (87%) patients. In four patients, fluoroscopy was needed to access (n = 3) or to re-access (n = 1) the LA. In these four patients, total fluoroscopy time was 5 +/- 3 min and the DAP was 14.9 +/- 13.4 Gy*cm(2). Single-procedure success rate was 80% (24/30) after a median follow-up of 12 months. Conclusion In patients with a documented PFO, completely fluoroscopy-free PVI is feasible in the vast majority of cases.	[Kuehne, Michael; Knecht, Sven; Muehl, Aline; Reichlin, Tobias; Kessel-Schaefer, Arnheid; Kaufmann, Beat A.; Schaer, Beat; Sticherling, Christian; Osswald, Stefan] Univ Basel Hosp, Cardiol Electrophysiol, CH-4031 Basel, Switzerland; [Pavlovic, Nikola] Univ Hosp Ctr Sisters Mercy, Zagreb, Croatia	University of Basel	Kuhne, M (corresponding author), Univ Basel Hosp, Cardiol Electrophysiol, CH-4031 Basel, Switzerland.	michael.kuehne@usb.ch	Knecht, Sven/AAP-6941-2020; Sticherling, Christian/AAY-4435-2021; Kühne, Michael/AAB-5202-2022; Kaufmann, Beat/AAB-7805-2022; Osswald, Stefan/A-6904-2018	Sticherling, Christian/0000-0001-8428-7050; Kühne, Michael/0000-0002-2937-3711; Osswald, Stefan/0000-0002-9240-6731; Knecht, Sven/0000-0001-7122-021X; Pavlovic, Nikola/0000-0001-9187-7681; Kaufmann, Beat/0000-0001-6295-3630				Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Fernandez-Gomez JM, 2014, J CARDIOVASC ELECTR, V25, P638, DOI 10.1111/jce.12385; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; Klein LW, 2009, HEART RHYTHM, V6, P439, DOI 10.1016/j.hrthm.2009.01.030; Knecht S, 2015, EUROPACE, V17, P1694, DOI 10.1093/europace/euv006; Kuhne M, 2013, J INTERV CARD ELECTR, V36, P47, DOI 10.1007/s10840-012-9740-z; Kuhl HP, 1999, J AM COLL CARDIOL, V34, P1823, DOI 10.1016/S0735-1097(99)00412-X; Lehrmann H, 2014, J CARDIOVASC ELECTR, V25, P479, DOI 10.1111/jce.12356; Lickfett L, 2004, CIRCULATION, V110, P3003, DOI 10.1161/01.CIR.0000146952.49223.11; Macias R, 2014, PACE, V37, P1029, DOI 10.1111/pace.12376; Meissner I, 1999, MAYO CLIN PROC, V74, P862, DOI 10.4065/74.9.862; Pavlovic N, 2014, J INTERV CARD ELECTR, V41, P261, DOI 10.1007/s10840-014-9952-5; Perisinakis K, 2001, CIRCULATION, V104, P58, DOI 10.1161/hc2601.091710; Sorgente A, 2012, AM J CARDIOL, V109, P1179, DOI 10.1016/j.amjcard.2011.11.058	15	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148059	10.1371/journal.pone.0148059	http://dx.doi.org/10.1371/journal.pone.0148059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820309	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528400062
J	Rodriguez-Escudero, M; Cid, VJ; Molina, M; Schulze-Luehrmann, J; Luhrmann, A; Rodriguez-Escudero, I				Rodriguez-Escudero, Maria; Cid, Victor J.; Molina, Maria; Schulze-Luehrmann, Jan; Luehrmann, Anja; Rodriguez-Escudero, Isabel			Studying Coxiella burnetii Type IV Substrates in the Yeast Saccharomyces cerevisiae: Focus on Subcellular Localization and Protein Aggregation	PLOS ONE			English	Article							INTRACELLULAR REPLICATION; EFFECTOR PROTEIN; APOPTOSIS; PATHWAY; SYSTEM; IDENTIFICATION; EXPRESSION; SECRETION; ANKYRIN; KINASE	Coxiella burnetii is a Gram-negative obligate parasitic bacterium that causes the disease Q-fever in humans. To establish its intracellular niche, it utilizes the Icm/Dot type IVB secretion system (T4BSS) to inject protein effectors into the host cell cytoplasm. The host targets of most cognate and candidate T4BSS-translocated effectors remain obscure. We used the yeast Saccharomyces cerevisiae as a model to express and study six C. burnetii effectors, namely AnkA, AnkB, AnkF, CBU0077, CaeA and CaeB, in search for clues about their role in C. burnetii virulence. When ectopically expressed in HeLa cells, these effectors displayed distinct subcellular localizations. Accordingly, GFP fusions of these proteins produced in yeast also decorated distinct compartments, and most of them altered cell growth. CaeA was ubiquitinated both in yeast and mammalian cells and, in S. cerevisiae, accumulated at juxtanuclear quality-control compartments (JUNQs) and insoluble protein deposits (IPODs), characteristic of aggregative or misfolded proteins. AnkA, which was not ubiquitinated, accumulated exclusively at the IPOD. CaeA, but not AnkA or the other effectors, caused oxidative damage in yeast. We discuss that CaeA and AnkA behavior in yeast may rather reflect misfolding than recognition of conserved targets in the heterologous system. In contrast, CBU0077 accumulated at vacuolar membranes and abnormal ER extensions, suggesting that it interferes with vesicular traffic, whereas AnkB associated with the yeast nucleolus. Both effectors shared common localization features in HeLa and yeast cells. Our results support the idea that C. burnetii T4BSS effectors manipulate multiple host cell targets, which can be conserved in higher and lower eukaryotic cells. However, the behavior of CaeA and AnkA prompt us to conclude that heterologous protein aggregation and proteostatic stress can be a limitation to be considered when using the yeast model to assess the function of bacterial effectors.	[Rodriguez-Escudero, Maria; Cid, Victor J.; Molina, Maria; Rodriguez-Escudero, Isabel] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain; [Rodriguez-Escudero, Maria; Cid, Victor J.; Molina, Maria; Rodriguez-Escudero, Isabel] IRyCIS, Madrid, Spain; [Schulze-Luehrmann, Jan; Luehrmann, Anja] Univ Erlangen Nurnberg, Mikrobiol Inst Klin Mikrobiol Immunol & Hyg, Univ Klinikum Erlangen, D-91054 Erlangen, Germany	Complutense University of Madrid; University of Erlangen Nuremberg	Cid, VJ (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain.; Cid, VJ (corresponding author), IRyCIS, Madrid, Spain.	vicjcid@ucm.es	Molina, Maria/ABE-7186-2021; CID, VICTOR JIMENEZ/I-1240-2015; Rodríguez, Isabel/I-5955-2017; JIMENEZ CID, VICTOR/ABC-4858-2021	Molina, Maria/0000-0003-0074-3309; CID, VICTOR JIMENEZ/0000-0002-3933-2016; Rodríguez, Isabel/0000-0002-1792-1143; JIMENEZ CID, VICTOR/0000-0002-3933-2016	ERA-NET Pathogenomics "CellPath" Project; Ministerio de Ciencia e Innovacion (Spain) [PIM2010EPA-00664]; ERA-NET PathoGenoMics "Cellpath" Project [0315903]	ERA-NET Pathogenomics "CellPath" Project; Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ERA-NET PathoGenoMics "Cellpath" Project	This work was supported by the ERA-NET Pathogenomics "CellPath" Project, grant PIM2010EPA-00664 from Ministerio de Ciencia e Innovacion (Spain) to IRE, and ERA-NET PathoGenoMics "Cellpath" Project, grant 0315903, to AL.	Aleman A, 2005, CELL MICROBIOL, V7, P1432, DOI 10.1111/j.1462-5822.2005.00568.x; Beare PA, 2012, ADV EXP MED BIOL, V984, P249, DOI 10.1007/978-94-007-4315-1_13; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; Berens C, 2015, JOVE-J VIS EXP, DOI 10.3791/52903; Berger AB, 2008, NAT METHODS, V5, P1031, DOI 10.1038/nmeth.1266; Buttner S, 2011, EMBO J, V30, P2779, DOI 10.1038/emboj.2011.197; Carey KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002056; Greenwood MT, 2010, CELL DEATH DIFFER, V17, P737, DOI 10.1038/cdd.2009.177; Heath VL, 2004, EUKARYOT CELL, V3, P695, DOI 10.1128/EC.3.3.695-704.2004; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Klingenbeck L, 2013, CELL MICROBIOL, V15, P675, DOI 10.1111/cmi.12066; Lifshitz Z, 2014, INFECT IMMUN, V82, P3740, DOI 10.1128/IAI.01729-14; Luhrmann A, 2010, P NATL ACAD SCI USA, V107, P18997, DOI 10.1073/pnas.1004380107; Madariaga MG, 2003, LANCET INFECT DIS, V3, P709, DOI 10.1016/S1473-3099(03)00804-1; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Campoy EM, 2011, INFECT IMMUN, V79, P402, DOI 10.1128/IAI.00688-10; Martin H, 1997, MOL MICROBIOL, V23, P431, DOI 10.1046/j.1365-2958.1997.d01-1870.x; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Miller SBM, 2015, J MOL BIOL, V427, P1564, DOI 10.1016/j.jmb.2015.02.006; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Nagarajan L, 1997, J BIOL CHEM, V272, P4444, DOI 10.1074/jbc.272.7.4444; Newton HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054566; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Park J, 2004, CELL MICROBIOL, V6, P743, DOI 10.1111/j.1462-5822.2004.00400.x; Rennoll-Bankert KE, 2015, CELL MICROBIOL, V17, P1640, DOI 10.1111/cmi.12461; Rodiguez-Escudero I, 2006, MICROBIOL-SGM, V152, P3437, DOI 10.1099/mic.0.29186-0; Rodriguez-Escudero I, 2011, MOL MICROBIOL, V80, P1220, DOI 10.1111/j.1365-2958.2011.07639.x; Rodriguez-Escudero I, 2009, J BIOL CHEM, V284, P13373, DOI 10.1074/jbc.M807867200; ROMAN MJ, 1991, ACTA VIROL, V35, P503; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Spokoini R, 2012, CELL REP, V2, P738, DOI 10.1016/j.celrep.2012.08.024; Valdivia RH, 2004, EUKARYOT CELL, V3, P827, DOI 10.1128/EC.3.4.827-834.2004; van Schaik EJ, 2013, NAT REV MICROBIOL, V11, P561, DOI 10.1038/nrmicro3049; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Voth DE, 2007, CELL MICROBIOL, V9, P829, DOI 10.1111/j.1462-5822.2007.00901.x; Voth DE, 2009, J BACTERIOL, V191, P4232, DOI 10.1128/JB.01656-08; Voth DE, 2009, CURR OPIN MICROBIOL, V12, P74, DOI 10.1016/j.mib.2008.11.005; Weber MM, 2013, J BACTERIOL, V195, P3914, DOI 10.1128/JB.00071-13; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973	42	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148032	10.1371/journal.pone.0148032	http://dx.doi.org/10.1371/journal.pone.0148032			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821324	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000369528400060
J	Xi, QY; Liu, ZH; Zhao, ZH; Luo, Q; Huang, ZW				Xi, Qunying; Liu, Zhihong; Zhao, Zhihui; Luo, Qin; Huang, Zhiwei			High Frequency of Pulmonary Hypertension-Causing Gene Mutation in Chinese Patients with Chronic Thromboembolic Pulmonary Hypertension	PLOS ONE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; ARTERIAL-HYPERTENSION; EMBOLISM; LESIONS; LYSIS	The pathogenesis of chronic thromboembolic pulmonary hypertension (CTEPH) is unknown. Histopathologic studies revealed that pulmonary vasculature lesions similar to idiopathic pulmonary arterial hypertension (PAH) existed in CTEPH patients as well. It's well-known that genetic predisposition plays an important role in the mechanism of PAH. So we hypothesized that PAH-causing gene mutation might exist in some CTEPH patients and act as a background to facilitate the development of CTEPH. In this study, we analyzed 7 PAH-causing genes including BMPR2, ACVRL1, ENG, SMAD9, CAV1, KCNK3, and CBLN2 in 49 CTEPH patients and 17 patients recovered from pulmonary embolism (PE) but without pulmonary hypertension(PH). The results showed that the nonsynonymous mutation rate in CTEPH patients is significantly higher than that in PE without PH patients (25 out of 49 (51%) CTEPH patients vs. 3 out of 17 PE without PH patients (18%); p = 0.022). Four CTEPH patients had the same point mutation in ACVRL1 exon 10 (c. 1450C>G), a mutation approved to be associated with PH in a previous study. In addition, we identified two CTEPH associated SNPs (rs3739817 and rs55805125). Our results suggest that PAH-causing gene mutation might play an important role in the development of CTEPH.	[Xi, Qunying; Huang, Zhiwei] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp, Beijing 100730, Peoples R China; [Xi, Qunying; Liu, Zhihong; Zhao, Zhihui; Luo, Qin; Huang, Zhiwei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xi, Qunying; Liu, Zhihong; Zhao, Zhihui; Luo, Qin; Huang, Zhiwei] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Ctr Pulm Vasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Liu, ZH (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.; Liu, ZH (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Ctr Pulm Vasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China.	fuwaipumc@163.com	Xi, Qunying/GWR-3728-2022	Liu, Zhihong/0000-0001-8639-6306; Huang, Zhiwei/0000-0002-6312-7434	National Key Technology R&D Program in the 12th Five year Plan of China [2011BA11B17]	National Key Technology R&D Program in the 12th Five year Plan of China(National Key Technology R&D Program)	This study was supported by a grant from National Key Technology R&D Program in the 12th Five year Plan of China (2011BA11B17). ZHL recieved the funding.	Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888; Becattini C, 2006, CHEST, V130, P172, DOI 10.1378/chest.130.1.172; Chaouat A, 2004, THORAX, V59, P446, DOI 10.1136/thx.2003.11890; Delcroix M, 2013, EUR RESPIR J, V41, P224, DOI 10.1183/09031936.00047712; Germain M, 2013, NAT GENET, V45, P518, DOI 10.1038/ng.2581; Gurney AM, 2003, CIRC RES, V93, P957, DOI 10.1161/01.RES.0000099883.68414.61; Haythe J, 2012, PROG CARDIOVASC DIS, V55, P134, DOI 10.1016/j.pcad.2012.07.005; Huang Z, 2009, HUM MOL GENET, V18, P2791, DOI 10.1093/hmg/ddp214; Lang I, 2010, BRIT J HAEMATOL, V149, P478, DOI 10.1111/j.1365-2141.2010.08142.x; Lang IM, 2013, EUR RESPIR J, V41, P462, DOI 10.1183/09031936.00049312; Ma LJ, 2014, HUM GENET, V133, P471, DOI 10.1007/s00439-014-1419-3; Ma L, 2013, NEW ENGL J MED, V369, P351, DOI 10.1056/NEJMoa1211097; Mathew R, 2004, CIRCULATION, V110, P1499, DOI 10.1161/01.CIR.0000141576.39579.23; Miniati M, 2010, AM J RESP CRIT CARE, V181, P992, DOI 10.1164/rccm.200907-1135OC; Morris TA, 2006, AM J RESP CRIT CARE, V173, P1270, DOI 10.1164/rccm.200506-916OC; MOSER KM, 1993, CHEST, V103, P685, DOI 10.1378/chest.103.3.685; Nijkeuter M, 2006, CHEST, V129, P192, DOI 10.1378/chest.129.1.192; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Ribeiro A, 1999, CIRCULATION, V99, P1325, DOI 10.1161/01.CIR.99.10.1325; Soubrier F, 2013, J AM COLL CARDIOL, V62, pD13, DOI 10.1016/j.jacc.2013.10.035; Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503; Tuder RM, 2013, J AM COLL CARDIOL, V62, pD4, DOI 10.1016/j.jacc.2013.10.025; Yi ES, 2000, AM J RESP CRIT CARE, V162, P1577, DOI 10.1164/ajrccm.162.4.9912131	23	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147396	10.1371/journal.pone.0147396	http://dx.doi.org/10.1371/journal.pone.0147396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820968	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528400024
J	Aymerich, IF; Oliva, M; Giralt, S; Martin-Herrero, J				Aymerich, Ismael F.; Oliva, Marc; Giralt, Santiago; Martin-Herrero, Julio			Detection of Tephra Layers in Antarctic Sediment Cores with Hyperspectral Imaging	PLOS ONE			English	Article							SOUTH-SHETLAND-ISLANDS; LIVINGSTON-ISLAND; ANISOTROPIC DIFFUSION; BYERS PENINSULA; LAKE; ICE; ERUPTION; ICELAND; QUALITY; RECORD	Tephrochronology uses recognizable volcanic ash layers (from airborne pyroclastic deposits, or tephras) in geological strata to set unique time references for paleoenvironmental events across wide geographic areas. This involves the detection of tephra layers which sometimes are not evident to the naked eye, including the so-called cryptotephras. Tests that are expensive, time-consuming, and/or destructive are often required. Destructive testing for tephra layers of cores from difficult regions, such as Antarctica, which are useful sources of other kinds of information beyond tephras, is always undesirable. Here we propose hyperspectral imaging of cores, Self-Organizing Map (SOM) clustering of the preprocessed spectral signatures, and spatial analysis of the classified images as a convenient, fast, non-destructive method for tephra detection. We test the method in five sediment cores from three Antarctic lakes, and show its potential for detection of tephras and cryptotephras.	[Aymerich, Ismael F.; Martin-Herrero, Julio] Univ Vigo, AtlantTIC, Vigo 36310, Spain; [Oliva, Marc] Univ Lisbon, Ctr Geog Studies IGOT, P-1699 Lisbon, Portugal; [Giralt, Santiago] Inst Earth Sci Jaume Almera CSIC, Barcelona, Spain	Universidade de Vigo; atlanTTic; Universidade de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Geociencias Barcelona (GEO3BCN)	Aymerich, IF (corresponding author), Univ Vigo, AtlantTIC, Vigo 36310, Spain.	ismael.aymerich@gmail.com	Giralt, Santiago/G-4823-2011; Martin-Herrero, Julio/D-3827-2009; Oliva, Marc/K-5423-2014; Giralt, Santiago/AAA-8585-2020	Giralt, Santiago/0000-0001-8570-7838; Oliva, Marc/0000-0001-6521-6388; Giralt, Santiago/0000-0001-8570-7838; Martin-Herrero, Julio/0000-0003-1109-6338	Portuguese Science Foundation through the HOLOANTAR (Holocene environmental change in the Maritime Antarctic: Interactions Between permafrost and the lacustrine environment) project; Portuguese Polar Program (PROPOLAR); AXA Research Fund	Portuguese Science Foundation through the HOLOANTAR (Holocene environmental change in the Maritime Antarctic: Interactions Between permafrost and the lacustrine environment) project; Portuguese Polar Program (PROPOLAR); AXA Research Fund(AXA Research Fund)	Core extraction and analyses were funded by the Portuguese Science Foundation through the HOLOANTAR (Holocene environmental change in the Maritime Antarctic: Interactions Between permafrost and the lacustrine environment) project and the Portuguese Polar Program (PROPOLAR). The AXA Research Fund sponsored M. Oliva's research activities in Antarctica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro P, 2010, J IBER GEOL, V36, P21; Andrews JT, 2006, HOLOCENE, V16, P1035, DOI 10.1177/0959683606069384; Aymerich IF, 2009, APPL SPECTROSC, V63, P716, DOI 10.1366/000370209788559683; Bartolini S, 2014, J VOLCANOL GEOTH RES, V285, P150, DOI 10.1016/j.jvolgeores.2014.08.009; BJORCK S, 1991, ANTARCT SCI, V3, P61, DOI 10.1017/S095410209100010X; Bjorck S, 1996, LIVINGSTON ISLAND BA, P49; Blockley SPE, 2005, QUATERNARY SCI REV, V24, P1952, DOI 10.1016/j.quascirev.2004.12.008; Calvino-Cancela M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102381; Caseldine C, 1999, HOLOCENE, V9, P635, DOI 10.1191/095968399666026772; Chen QQ, 2013, POLAR RES, V32, DOI 10.3402/polar.v32i0.19932; Cioni R, 2014, EARTH PLANET SC LETT, V394, P111, DOI 10.1016/j.epsl.2014.02.051; DEPERSIA AT, 1995, P SOC PHOTO-OPT INS, V2496, P159, DOI 10.1117/12.211312; Ferreiro-Arman M, 2006, LECT NOTES COMPUT SC, V4142, P730; Gehrels MJ, 2008, QUATERN INT, V178, P68, DOI 10.1016/j.quaint.2006.10.014; Giardino C, 2007, REMOTE SENS ENVIRON, V109, P183, DOI 10.1016/j.rse.2006.12.017; Grahn H. F., 2007, TECHNIQUES APPL HYPE; Grosjean M., 2014, Past Global Changes Magazine, V22, P10; Gudmundsdottir ER, 2011, J QUATERNARY SCI, V26, P589, DOI 10.1002/jqs.1474; Himberg J, 2001, PATTERN RECOGN, P38; Hodgson DA, 1998, ANTARCT SCI, V10, P13, DOI 10.1017/S0954102098000030; Huang H, 2014, SENSORS-BASEL, V14, P7248, DOI 10.3390/s140407248; Hunt JB, 2001, J QUATERNARY SCI, V16, P105, DOI 10.1002/jqs.571; Kim MS, 2001, T ASAE, V44, P721; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Kohonen T., 1989, SELF ORG ASS MEMORY; Kohonen T, 1997, SELF ORGANIZING MAPS; Kruse FA, 1998, P 9 AUSTR REM SENS C; Kylander ME, 2012, HOLOCENE, V22, P371, DOI 10.1177/0959683611423688; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee YI, 2007, QUATERNARY SCI REV, V26, P3167, DOI 10.1016/j.quascirev.2007.09.007; Levy J, 2014, ANTARCT SCI, V26, P565, DOI 10.1017/S0954102013000977; Liu EJ, 2015, SEDIMENTARY IN PRESS, DOI [10.1016/j.sedgeo.2015.08.002, DOI 10.1016/J.SEDGEO.2015.08.002]; Majewski W, 2012, MAR GEOL, V326, P67, DOI 10.1016/j.margeo.2012.08.009; MARTI J., 2013, B VOLCANOL, V75, P1; Martin-Herrero J, 2004, INT C PATT RECOG, P301, DOI 10.1109/ICPR.2004.1333763; Martin-Herrero J, 2004, LECT NOTES COMPUT SC, V3212, P323; Martin-Herrero J., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P2820, DOI 10.1109/ICPR.2010.691; Martin-Herrero J, 2007, IEEE T GEOSCI REMOTE, V45, P1386, DOI 10.1109/TGRS.2007.894569; Mehl PM, 2004, J FOOD ENG, V61, P67, DOI 10.1016/S0260-8774(03)00188-2; Mendez-Rial R, 2012, IEEE T IMAGE PROCESS, V21, P2389, DOI 10.1109/TIP.2011.2179059; Narcisi B, 2005, EARTH PLANET SC LETT, V239, P253, DOI 10.1016/j.epsl.2005.09.005; Narcisi B, 2012, QUATERNARY SCI REV, V49, P52, DOI 10.1016/j.quascirev.2012.06.011; NICODEMU.FE, 1965, APPL OPTICS, V4, P767, DOI 10.1364/AO.4.000767; Oladottir BA, 2008, B VOLCANOL, V70, P475, DOI 10.1007/s00445-007-0150-5; Pallas R, 2001, HOLOCENE, V11, P149, DOI 10.1191/095968301669281809; Parton E, 2013, SPIE PROFESSIONAL, V8; Pedrazzi D, 2014, J GEOL SOC LONDON, V171, P765, DOI 10.1144/jgs2014-015; Ponomareva V, 2004, J VOLCANOL GEOTH RES, V136, P199, DOI 10.1016/j.jvolgeores.2004.05.013; Ponomareva V, 2013, INT J EARTH SCI, V102, P1673, DOI 10.1007/s00531-013-0898-0; Reguera-Salgado J, 2012, IEEE T GEOSCI REMOTE, V50, P4409, DOI 10.1109/TGRS.2012.2192938; SERRA J, 1986, COMPUT VISION GRAPH, V35, P283, DOI 10.1016/0734-189X(86)90002-2; Severi M, 2012, CLIM PAST, V8, P509, DOI 10.5194/cp-8-509-2012; Shannon CE, 1998, P IEEE, V86, P447, DOI 10.1109/JPROC.1998.659497; Shippert P, 2004, PHOTOGRAMM ENG REM S, V70, P377; Smellie JL, 1999, GLOBAL PLANET CHANGE, V21, P51, DOI 10.1016/S0921-8181(99)00007-7; Sorg BS, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003369; Stokman H., 1999, BMVC99. Proceedings of the 10th British Machine Vision Conference, P643; Thorarinsson S, 1967, ERUPTIONS HEKLA HIST; THORNorarinsson S, 1939, GEOGR ANN, V21, P216; Toro M, 2013, ANTARCT SCI, V25, P198, DOI 10.1017/S0954102012000788; ULTSCH A, 1990, INTERNATIONAL NEURAL NETWORK CONFERENCE, VOLS 1 AND 2, P305; Winter EM, 2004, INT GEOSCI REMOTE SE, P1597	63	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146578	10.1371/journal.pone.0146578	http://dx.doi.org/10.1371/journal.pone.0146578			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815202	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528200017
J	Teixeira, MBCG; Martins, GM; Miranda-Rodrigues, M; De Araujo, IF; Oliveira, R; Brum, PC; Gouveia, CHA				Cruz Grecco Teixeira, Marilia Bianca; Martins, Gisele Miyamura; Miranda-Rodrigues, Manuela; De Araujo, Iasmin Ferreira; Oliveira, Ricardo; Brum, Patricia Chakur; Azevedo Gouveia, Cecilia Helena			Lack of alpha(2C)-Adrenoceptor Results in Contrasting Phenotypes of Long Bones and Vertebra and Prevents the Thyrotoxicosis-Induced Osteopenia	PLOS ONE			English	Article							ALPHA(2)-ADRENERGIC RECEPTOR SUBTYPES; SYMPATHETIC-NERVOUS-SYSTEM; THYROID-HORMONE; TRABECULAR BONE; L-THYROXINE; LEPTIN; HYPERTHYROIDISM; MASS; METABOLISM; RELEASE	A series of studies have demonstrated that activation of the sympathetic nervous system (SNS) causes osteopenia via beta(2)-adrenoceptor (beta(2)-AR) signaling. However, in a recent study, we found an unexpected and generalized phenotype of high bone mass in female mice with chronic sympathetic hyperactivity, due to double gene inactivation of adrenoceptors that negatively regulate norepinephrine release, alpha(2A)-and alpha(2C)-AR (alpha(2A/2C)-AR(-/-)). These findings suggest that beta(2)-AR is not the single adrenoceptor involved in bone turnover regulation and show that alpha(2)-AR signaling may also mediate the SNS actions in the skeleton. In addition, we found that alpha(2A/2C)-AR(-/-) animals are resistant to the thyrotoxicosis-induced osteopenia, suggesting that thyroid hormone (TH), when in supraphysiological levels, interacts with the SNS to control bone mass and structure, and that this interaction may also involve alpha(2)-AR signaling. In the present study, to further investigate these hypotheses and to discriminate the roles of alpha(2)-AR subtypes, we have evaluated the bone phenotype of mice with the single gene inactivation of alpha(2C)-AR subtype, which mRNA expression was previously shown to be down regulated by triiodothyronine (T3). A cohort of 30 day-old female alpha(2C)AR(-/-) mice and their wild-type (WT) controls were treated with a supraphysiological dose of T3 for 30 or 90 days, which induced a thyrotoxic state in both mouse lineages. The microcomputed tomographic (mu CT) analysis showed that alpha(2C)-AR(-/-) mice present lower trabecular bone volume (BV/TV) and number (Tb.N), and increased trabecular separation (Tb.Sp) in the femur compared with WT mice; which was accompanied by decreased bone strength (determined by the three-point bending test) in the femur and tibia. The opposite was observed in the vertebra, where alpha(2C)-AR(-/-) mice show increased BV/TV, Tb.N and trabecular thickness (Tb.Th), and decreased Tb.Sp, compared with WT animals. In spite of the contrasting bone phenotypes of the femur and L5, thyrotoxicosis negatively regulated most of the micro architectural features of the trabecular bone in both skeletal sites of WT, but not of alpha(2C)-AR-/- mice. T3 treatment also decreased biomechanical properties (maximum load and ultimate load) in the femur and tibia of WT, but not of knockout mice. The mRNA expression of osteocalcin, a marker of mature osteoblasts, and tartrate-resistant acid phosphatase, which is expressed by osteoclasts and is involved in collagen degradation, was increased by T3 treatment only in WT, and not in alpha(2C)-AR(-/-) mice. Altogether, these findings suggest that alpha(2C)-AR subtype mediates the effects of the SNS in the bone in a skeletal site-dependent manner, and that thyrotoxicosis depends on alpha(2C)-AR signaling to promote bone loss, which sustains the hypothesis of a TH-SNS interaction to modulate bone remodeling and structure.	[Cruz Grecco Teixeira, Marilia Bianca; Martins, Gisele Miyamura; Miranda-Rodrigues, Manuela; De Araujo, Iasmin Ferreira; Azevedo Gouveia, Cecilia Helena] Univ Sao Paulo, Dept Anat, Inst Biomed Sci, Sao Paulo, Brazil; [Oliveira, Ricardo] RDODiagnost Med, Sao Paulo, Brazil; [Brum, Patricia Chakur] Univ Sao Paulo, Dept Biodinam Human Body Moviment, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Martins, Gisele Miyamura] Univ Fed Juiz de Fora, Hlth Basic Dept, Juiz De Fora, MG, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Juiz de Fora	Gouveia, CHA (corresponding author), Univ Sao Paulo, Dept Anat, Inst Biomed Sci, Sao Paulo, Brazil.	cgouveia@usp.br	Gouveia, Cecilia H A/E-3444-2012; Brum, Patricia C/E-6605-2011; Oliveira, Ricardo/GVS-4393-2022	Gouveia, Cecilia H A/0000-0001-8662-943X; Brum, Patricia C/0000-0002-4750-6506; 	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2010/06409-0, 2010/50068-2]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) Grants: 2010/06409-0 and 2010/50068-2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1997, J CLIN INVEST, V99, P391, DOI 10.1172/JCI119172; Bassett JHD, 2007, MOL ENDOCRINOL, V21, P1095, DOI 10.1210/me.2007-0033; Bassett JHD, 2003, TRENDS ENDOCRIN MET, V14, P356, DOI 10.1016/S1043-2760(03)00144-90; Beber EH, 2009, CALCIFIED TISSUE INT, V84, P324, DOI 10.1007/s00223-009-9230-1; BEYLOT M, 1982, NOUV PRESSE MED, V11, P989; BJURHOLM A, 1988, J AUTONOM NERV SYST, V25, P119, DOI 10.1016/0165-1838(88)90016-1; Bonnet N, 2005, MED SCI SPORT EXER, V37, P1493, DOI 10.1249/01.mss.0000177592.82507.95; Bonnet N., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P94; Bonnet N, 2007, J BONE MINER RES, V22, P578, DOI 10.1359/JBMR.070117; Brede M, 2002, CIRCULATION, V106, P2491, DOI 10.1161/01.CIR.0000036600.39600.66; Brede M, 2004, BIOL CELL, V96, P343, DOI 10.1016/j.biolcel.2004.03.006; Bucheler MM, 2002, NEUROSCIENCE, V109, P819, DOI 10.1016/S0306-4522(01)00531-0; Burguera B, 2001, ENDOCRINOLOGY, V142, P3546, DOI 10.1210/en.142.8.3546; COINDRE JM, 1986, ARCH INTERN MED, V146, P48, DOI 10.1001/archinte.146.1.48; Cray JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069067; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Elefteriou F, 2014, CALCIFIED TISSUE INT, V94, P140, DOI 10.1007/s00223-013-9752-4; ERIKSEN EF, 1985, BONE, V6, P421, DOI 10.1016/8756-3282(85)90218-2; Fonseca TL, 2014, AM J PHYSIOL-ENDOC M, V307, pE408, DOI 10.1152/ajpendo.00643.2013; Fonseca TL, 2011, J BONE MINER RES, V26, P591, DOI 10.1002/jbmr.243; FOX KM, 1995, ANAT RECORD, V241, P284, DOI 10.1002/ar.1092410215; GARNERO P, 1994, J CLIN ENDOCR METAB, V78, P955, DOI 10.1210/jc.78.4.955; Gorka J, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/638727; Gouveia CHA, 1997, J BONE MINER RES, V12, P2098, DOI 10.1359/jbmr.1997.12.12.2098; Gribble FM, 2010, NEW ENGL J MED, V362, P361, DOI 10.1056/NEJMcibr0911499; Hamrick MW, 2004, J BONE MINER RES, V19, P1607, DOI 10.1359/JBMR.040712; Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667; Hein L, 2006, CELL TISSUE RES, V326, P541, DOI 10.1007/s00441-006-0285-2; Kanbur Nuray O, 2002, Int J Adolesc Med Health, V14, P235; Kondo A, 2013, INT J MOL MED, V31, P1457, DOI 10.3892/ijmm.2013.1349; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; KRAGSTRUP J, 1981, METAB BONE DIS RELAT, V3, P181, DOI 10.1016/0221-8747(81)90006-0; KRANE SM, 1956, J CLIN INVEST, V35, P874, DOI 10.1172/JCI103340; Livak K, 1997, SEQUENCE DETECTION S; LU PW, 1994, BONE, V15, P199, DOI 10.1016/8756-3282(94)90708-0; MELSEN F, 1977, ACTA PATH MICRO IM A, V85, P141; Mlakar V, 2015, J CELL MOL MED; MOSEKILDE L, 1977, ACTA ENDOCRINOL-COP, V85, P515, DOI 10.1530/acta.0.0850515; MOSEKILDE L, 1978, ACTA PATH MICRO IM A, V86, P56; OPPENHEIMER JH, 1991, J CLIN INVEST, V87, P125, DOI 10.1172/JCI114961; Philbin KE, 2010, BRAIN RES, V1347, P65, DOI 10.1016/j.brainres.2010.06.001; Philipp M, 2004, PHARMACOL THERAPEUT, V101, P65, DOI 10.1016/j.pharmthera.2003.10.004; Rozanski A, 2013, MOL ENDOCRINOL, V27, P2055, DOI 10.1210/me.2013-1018; RUDE RK, 1976, NEW ENGL J MED, V294, P431, DOI 10.1056/NEJM197602192940807; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Scheibner J, 2001, BRIT J PHARMACOL, V132, P925, DOI 10.1038/sj.bjp.0703882; Senese R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00475; Suwanwalaikorn S, 1996, EUR J ENDOCRINOL, V134, P655, DOI 10.1530/eje.0.1340655; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; TOH SH, 1985, ARCH INTERN MED, V145, P883, DOI 10.1001/archinte.145.5.883; Trost Z, 2010, BONE, V46, P72, DOI 10.1016/j.bone.2009.09.015; Warren JT, 2015, J CELL BIOCH; Waung JA, 2012, TRENDS ENDOCRIN MET, V23, P155, DOI 10.1016/j.tem.2011.11.002; Williams GR, 2014, ENDOCRINOLOGY, V155, P2747, DOI 10.1210/en.2014-1527; Williams GR, 2013, EUR THYROID J, V2, P3, DOI 10.1159/000345548	55	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146795	10.1371/journal.pone.0146795	http://dx.doi.org/10.1371/journal.pone.0146795			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815679	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528200020
J	Wong, SM; Liu, FH; Lee, YL; Huang, HM				Wong, Shuit-Mun; Liu, Fu-Hwa; Lee, Yueh-Lun; Huang, Huei-Mei			MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; CYCLE PROGRESSION; CANCER-CELLS; K562 CELLS; MESYLATE; KINASE; BCL-2; PHOSPHORYLATION; INDUCTION; ARREST	Chronic myeloid leukemia (CML) is a clonal disorder of hematopoietic stem/progenitor cells that is caused by the Bcr-Abl oncoprotein. Clinical resistance to the Bcr-Abl inhibitor imatinib is a critical problem in treating CML. This study investigated the antitumor effect and mechanism of MPT0B169, a new antitubulin agent, in K562 CML cells and their derived imatinib-resistant cells, IMR2 and IMR3. IMR2 and IMR3 cells showed complete resistance to imatinib-induced growth inhibition and apoptosis. Resistance involved ERK1/2 overactivation and MDR1 overexpression. MPT0B169 inhibited the growth of K562, IMR2, and IMR3 cells in a dose-and time-dependent manner. MPT0B169 substantially inhibited the mRNA and protein levels of Bcr-Abl, followed by its downstream pathways including Akt, ERK1/2, and STAT3 in these cells. MPT0B169 treatment resulted in a decrease in the polymer form of tubulin according to Western blot analysis. It triggered cell cycle arrest at the G2/M phase before apoptosis, which was related to the upregulation of the mitotic marker MPM2 and the cyclin B1 level, and a change in the phosphorylation of Cdk1. MPT0B169 induced apoptosis in nonresistant and imatinib-resistant cells via a mitochondrion-mediated caspase pathway. Further study showed that the agent led to a decrease in the antiapoptotic proteins Bcl-2, Bcl-xL, and Mcl-1 and an increase in the apoptotic protein Bax. Taken together, our results suggest that MPT0B169 might be a promising agent for overcoming imatinib resistance in CML cells.	[Wong, Shuit-Mun; Huang, Huei-Mei] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Liu, Fu-Hwa] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Lee, Yueh-Lun] Taipei Med Univ, Coll Med, Dept Microbiol & Immunol, Taipei, Taiwan	Taipei Medical University; Academia Sinica - Taiwan; Taipei Medical University	Huang, HM (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	cmbhhm@tmu.edu.tw			Ministry of Science and Technology, Taiwan, ROC [MOST 104-2320-B-038-028]	Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Ministry of Science and Technology (MOST 104-2320-B-038-028), Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves-Luquero CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006124; Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Baccarani M, 2015, ANN HEMATOL, V94, pS141, DOI 10.1007/s00277-015-2322-2; Bonhoure E, 2008, LEUKEMIA, V22, P971, DOI 10.1038/leu.2008.95; Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; Chen JG, 2002, CANCER RES, V62, P1935; Chu R, 2012, BIOCHEM PHARMACOL, V83, P199, DOI 10.1016/j.bcp.2011.10.008; CLARKE PR, 1991, J CELL SCI, V100, P409; Cory S, 2005, CANCER CELL, V8, P5, DOI 10.1016/j.ccr.2005.06.012; Dai Y, 2004, J BIOL CHEM, V279, P34227, DOI 10.1074/jbc.M402290200; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Fava C, 2015, ANN HEMATOL, V94, pS123, DOI 10.1007/s00277-015-2321-3; Goldman JM, 2008, ACTA HAEMATOL-BASEL, V119, P212, DOI 10.1159/000140633; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Handa H, 1997, LEUKEMIA RES, V21, P479, DOI 10.1016/S0145-2126(97)00006-4; Holyoake TL, 2001, BRIT J HAEMATOL, V113, P11, DOI 10.1046/j.1365-2141.2001.02558.x; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Huang HM, 2004, BIOCHEM BIOPH RES CO, V320, P1247, DOI 10.1016/j.bbrc.2004.06.083; Hutchins JRA, 2004, CELL CYCLE, V3, P41; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kang CD, 2000, LEUKEMIA RES, V24, P527, DOI 10.1016/S0145-2126(00)00010-2; Kimura S, 2014, INT J CLIN ONCOL, V19, P3, DOI 10.1007/s10147-013-0641-7; KING KL, 1995, J CELL BIOCHEM, V58, P175, DOI 10.1002/jcb.240580206; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; Lee J, 2013, BIOMED PHARMACOTHER, V67, P157, DOI 10.1016/j.biopha.2012.10.017; Lee WH, 2014, AM J PHYSIOL-CELL PH, V306, pC407, DOI 10.1152/ajpcell.00312.2013; Lee WH, 2013, PHARMACOLOGY, V92, P90, DOI 10.1159/000351852; Lee YL, 2013, PLOS ONE, V17; Mahon FX, 2003, BLOOD, V101, P2368, DOI 10.1182/blood.V101.6.2368; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Roy MJ, 2014, BRIT J PHARMACOL, V171, P1973, DOI 10.1111/bph.12431; Savitskaya MA, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1393, DOI 10.1134/S0006297915110012; Scatena CD, 1998, J BIOL CHEM, V273, P30777, DOI 10.1074/jbc.273.46.30777; Shi XP, 2009, CLIN CANCER RES, V15, P1686, DOI 10.1158/1078-0432.CCR-08-2141; Smaili SS, 2001, CELL DEATH DIFFER, V8, P909, DOI 10.1038/sj.cdd.4400889; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Wei GQ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-47	43	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0148093	10.1371/journal.pone.0148093	http://dx.doi.org/10.1371/journal.pone.0148093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815740	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528200073
J	Solomon, SS; Srikrishnan, AK; McFall, AM; Kumar, MS; Saravanan, S; Balakrishnan, P; Solomon, S; Thomas, DL; Sulkowski, MS; Mehta, SH				Solomon, Sunil S.; Srikrishnan, Aylur K.; McFall, Allison M.; Kumar, M. Suresh; Saravanan, Shanmugam; Balakrishnan, Pachamuthu; Solomon, Suniti; Thomas, David L.; Sulkowski, Mark S.; Mehta, Shruti H.			Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India	PLOS ONE			English	Article							HEPATITIS-C VIRUS; TRANSIENT ELASTOGRAPHY; NATURAL-HISTORY; RISK BEHAVIORS; INSULIN-RESISTANCE; B-VIRUS; INFECTION; FIBROSIS; PREVALENCE; USERS	Background and Objective We characterize the burden of liver disease in a cohort of PWID in Chennai, India, with a high prevalence of HCV. Materials and Methods 1,042 PWID were sampled through community outreach in Chennai. Participants underwent fasting blood draw, questionnaire and an examination that included liver stiffness assessment using transient elastography (Fibroscan) and assessment of steatosis via ultrasound. Results The median age was 39 years, all were male, 14.8% were HIV infected and 35.6% were HCV antibody positive, of whom 78.9% were chronically infected (HCV RNA positive). Median liver stiffness was 6.2 kPA; 72.9% had no evidence of or mild stiffness, 14.5% had moderate stiffness, and 12.6% had evidence of severe stiffness/cirrhosis. Prevalence of severe stiffness/cirrhosis was significantly higher among persons who were older, had a longer duration of injecting drugs, higher body mass index, higher prevalence of insulin resistance, higher prevalence of steatosis, higher HCV RNA levels and evidence of alcohol dependence. An estimated 42.1% of severe stiffness/cirrhosis in this sample was attributable to HCV. 529 (53.0%) had some evidence of steatosis. Prevalence of steatosis was higher among those who had larger waist circumference, insulin resistance, higher HDL cholesterol and a history of antiretroviral therapy. Conclusions We observed a high burden of liver disease in this relatively young cohort that was primarily driven by chronic HCV infection, metabolic factors (insulin resistance and steatosis) and heavy alcohol use. Interventions to improve access to HCV treatment and reduce alcohol use are needed to prevent further progression of liver disease.	[Solomon, Sunil S.; Thomas, David L.; Sulkowski, Mark S.] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; [Solomon, Sunil S.; McFall, Allison M.; Mehta, Shruti H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Solomon, Sunil S.; Srikrishnan, Aylur K.; Kumar, M. Suresh; Saravanan, Shanmugam; Balakrishnan, Pachamuthu; Solomon, Suniti] YR Gaitonde Ctr AIDS Res & Educ, Madras, Tamil Nadu, India	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Mehta, SH (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	smehta@jhu.edu	Balakrishnan, Pachamuthu/ABV-6282-2022; Saravanan, Shanmugam/GOG-9024-2022; Solomon, Sunil Suhas/P-6907-2019	Balakrishnan, Pachamuthu/0000-0002-1710-9155; Saravanan, Shanmugam/0000-0002-5991-8022; 	National Institute on Drug Abuse [R01 DA026727];  [P30 AI094189]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026727, K24DA034621] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by R01 DA026727 (http://www.drugabuse.gov/), National Institute on Drug Abuse (to SHM); and P30 AI094189 (http://hopkinscfar.org/funding-opportunities/faculty-development-awards/), Johns Hopkins Center for AIDS Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004; Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Baden R, 2014, J INFECT DIS, V209, pS81, DOI 10.1093/infdis/jiu057; BENVEGNU L, 1994, CANCER, V74, P2442, DOI 10.1002/1097-0142(19941101)74:9<2442::AID-CNCR2820740909>3.0.CO;2-#; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chu CJ, 2008, J GASTROEN HEPATOL, V23, P512, DOI 10.1111/j.1440-1746.2008.05384.x; Das K, 2012, HEPATOLOGY, V55, P584, DOI 10.1002/hep.24694; Goyal R, 2013, J GASTROEN HEPATOL, V28, P1738, DOI 10.1111/jgh.12318; Guy Jennifer, 2013, Gastroenterol Hepatol (N Y), V9, P633; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Jayasekera CR, 2014, NEW ENGL J MED, V370, P1869, DOI 10.1056/NEJMp1400160; Kirk GD, 2013, ANN INTERN MED, V158, P658, DOI 10.7326/0003-4819-158-9-201305070-00604; Kirk GD, 2009, CLIN INFECT DIS, V48, P963, DOI 10.1086/597350; Liu CJ, 2014, WORLD J GASTROENTERO, V20, P2955, DOI 10.3748/wjg.v20.i11.2955; Lucas GM, 2016, AIDS, V30, P619, DOI [10.1097/QAD.0000000000000949, 10.1097/QAD.0000000000000592]; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Mehta SH, 2012, ANTIVIR THER, V17, P813, DOI 10.3851/IMP2085; Mohan V, 2009, DIABETES RES CLIN PR, V84, P84, DOI 10.1016/j.diabres.2008.11.039; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Panda S, 1997, DRUG ALCOHOL REV, V16, P17, DOI 10.1080/09595239700186291; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Sagnelli E, 2000, HEPATOLOGY, V32, P1106, DOI 10.1053/jhep.2000.19288; Sagnelli E, 2002, HEPATOLOGY, V36, P1285, DOI 10.1053/jhep.2002.36509; Saludes V, 2014, WORLD J GASTROENTERO, V20, P3431, DOI 10.3748/wjg.v20.i13.3431; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; SATO S, 1994, J HEPATOL, V21, P159, DOI 10.1016/S0168-8278(05)80389-7; SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13; Shaheen AAM, 2007, AM J GASTROENTEROL, V102, P2589, DOI 10.1111/j.1572-0241.2007.01466.x; Sharma P, 2014, INDIAN J GASTROENTER, V33, P445, DOI 10.1007/s12664-014-0491-x; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Sirli R, 2009, J GASTROINTEST LIVER, V18, P57; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Solomon SS, 2008, JAIDS-J ACQ IMM DEF, V49, P327, DOI 10.1097/QAI.0b013e3181831e85; Solomon SS, 2010, SUBST USE MISUSE, V45, P354, DOI 10.3109/10826080903452447; Solomon SS, 2009, AIDS, V23, P997, DOI 10.1097/QAD.0b013e32832a594e; Solomon SS, 2015, LANCET INFECT DIS, V15, P36, DOI 10.1016/S1473-3099(14)71045-X; Solomon SS, 2014, CLIN INFECT DIS, V59, P589, DOI 10.1093/cid/ciu324; Solomon SS, 2010, AM J EPIDEMIOL, V172, P1259, DOI 10.1093/aje/kwq288; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; United Nations Office on Drugs and Crime, 2008 WORLD DRUG REP; WELTMAN MD, 1995, J VIRAL HEPATITIS, V2, P39, DOI 10.1111/j.1365-2893.1995.tb00070.x; Yu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139015; Zarski JP, 1998, J HEPATOL, V28, P27, DOI 10.1016/S0168-8278(98)80198-0	47	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147879	10.1371/journal.pone.0147879	http://dx.doi.org/10.1371/journal.pone.0147879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812065	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528000059
J	Lima, VBD; Dourado, LRB; Machado, LP; Biagiotti, D; de Lima, SBP; Ferreira, GJBD; Farias, LA; de Sousa, FA; Acacio, RM; Silva, DRSE				de Sousa Lima, Vania Batista; Barros Dourado, Leilane Rocha; Machado, Luciana Pereira; Biagiotti, Daniel; Pinheiro de Lima, Stelio Bezerra; Bolzani de Campos Ferreira, Guilherme Jose; Farias, Leonardo Atta; de Sousa, Francinete Alves; Acacio, Raian Malta; Silva e Silva, Danilo Rodrigo			Cottonseed Oil in Diets for Broilers in the Pre-Starter and Starter Phases	PLOS ONE			English	Article							LIPID SOURCES; PERFORMANCE; IRON; MEAL; YIELD	The objective of this study was to evaluate the effect of different levels of crude cottonseed oil in isoenergetic diets, with or without supplementation of ferrous sulfate, on performance variables, relative weight of organs, and blood parameters of broilers, and on the economic viability of diets in the periods from 1 to 7 and 1 to 21 days of age. A total of 600 male birds of the Ross line were distributed in a completely randomized design in a (4x2) factorial arrangement with eight treatments (0, 2, 4, and 6% cottonseed oil with and without ferrous sulfate), and five replicates. The following variables were studied: feed intake, weight gain, feed conversion, weight of organs, blood parameters, and yield of carcass and cuts at 21 days. No effects of the levels of cottonseed oil were found on the performance of animals aged 1 to 7 days, or on the relative weights of the organs. In this same period, the weight gain, and the relative weights of heart, liver, and intestine of the animals that received ferrous sulfate were decreased, and feed conversion was worsened. In the period from 1 to 21 days, weight gain increased linearly with the increase in the levels of cottonseed oil. Blood parameters were not influenced by the diets. Crude cottonseed oil can be utilized in diets for broilers in the periods from 1 to 7 and 1 to 21 days of age at up to 6% of inclusion, and supplementation with ferrous sulfate is unnecessary if the differences in metabolization of the cottonseed oil are considered, with and without, it during the diet formulation process.	[de Sousa Lima, Vania Batista] Univ Fed Piaui, Anim Nutr Lab, Teresina, Piaui, Brazil; [Barros Dourado, Leilane Rocha; Pinheiro de Lima, Stelio Bezerra; Farias, Leonardo Atta] Univ Fed Piaui, Dept Anim Sci, Bom Jesus, Piaui, Brazil; [Machado, Luciana Pereira] Fed Univ Fronteira Sul, Dept Vet Sci, Realeza, Parana, Brazil; [Biagiotti, Daniel] Univ Fed Piaui, Tech Coll, Bom Jesus, Piaui, Brazil; [Bolzani de Campos Ferreira, Guilherme Jose] Univ Fed Piaui, Dept Vet Sci, Bom Jesus, Piaui, Brazil; [de Sousa, Francinete Alves; Acacio, Raian Malta; Silva e Silva, Danilo Rodrigo] Univ Fed Piaui, Bom Jesus, Piaui, Brazil	Universidade Federal do Piaui; Universidade Federal do Piaui; Universidade Federal da Fronteira Sul; Universidade Federal do Piaui; Universidade Federal do Piaui; Universidade Federal do Piaui	Lima, VBD (corresponding author), Univ Fed Piaui, Anim Nutr Lab, Teresina, Piaui, Brazil.; Dourado, LRB (corresponding author), Univ Fed Piaui, Dept Anim Sci, Bom Jesus, Piaui, Brazil.	vania_vet06@hotmail.com; leilane@ufpi.edu.br		, Danilo/0000-0001-7929-7254				Adams N.R., 1989, TOXICANTS PLANT ORIG, V4, P25; Alexander J., 2008, EFSA J, V908, P1; Baião NC, 2005, Rev. Bras. Cienc. Avic., V7, P129, DOI 10.1590/S1516-635X2005000300001; BERTECHINI A.G., 2013, NUTR MONOGASTRICOS, V2; Collier HB, 1944, CAN MED ASS J, V50; Duarte FD, 2010, ARQ BRAS MED VET ZOO, V62, P439, DOI 10.1590/S0102-09352010000200025; FORBES GB, 1972, J NUTR, V102, P647, DOI 10.1093/jn/102.5.647; Freire RM, 2006, REV EMBRAPA ALGODAO; Gamboa DA, 2001, POULTRY SCI, V80, P789, DOI 10.1093/ps/80.6.789; GOLDENFARB PB, 1971, AM J CLIN PATHOL, V56, P35; Kakani R., 2010, OPEN TOXICOLOGY J, V4, P26; KLEBANOFF SJ, 1989, J BIOL CHEM, V264, P19765; Lara LJC, 2006, ARQ BRAS MED VET ZOO, V58, P108, DOI 10.1590/S0102-09352006000100016; Lara LJC, 2005, ARQ BRAS MED VET ZOO, V57, P792; Menten JFM, 2000, REV BRASILEIRA CIENC, V2, P219; Moreira I, 2006, REV BRAS ZOOTECN, P35; Murakami AE, 2009, REV BRAS ZOOTECN, V38, P1256, DOI 10.1590/S1516-35982009000700014; Nagalakshmi Devanaboyina, 2007, Journal of Poultry Science, V44, P119, DOI 10.2141/jpsa.44.119; NRC, 1994, NUTR REQ POULTR; OBrien RD, 2005, BAILEYS IND OIL FAT; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Porto Graça, 2012, J Port Gastrenterol., V19, P26; Ramadan N. A., 2010, International Journal of Poultry Science, V9, P842; Rostagno H.S., 2011, COMPOSICAO ALIMENTOS, V2, P186; Sakomura NK, 2004, REV BRAS ZOOTECN, V33, P1758, DOI 10.1590/S1516-35982004000700014; Sakomura NK, 2016, METODOS PESQUISA ANI; Santos M. do S. V. dos, 2009, Revista Brasileira de Saude e Producao Animal, V10, P654; Siah Chiang W, 2006, Clin Biochem Rev, V27, P5; SKUTCHES CL, 1973, J NUTR, V103, P851, DOI 10.1093/jn/103.6.851; Soares KR, 2005, CIENC AGROTEC, V29, P238, DOI 10.1590/S1413-70542005000100030; VAHL HA, 1987, BRIT POULTRY SCI, V28, P567, DOI 10.1080/00071668708416992; VANDERKRAAIJ AMM, 1988, CIRCULATION, V78, P442, DOI 10.1161/01.CIR.78.2.442; Wintrobe M.M., 1934, FOLIA HAEMATOL, V51, P32, DOI DOI 10.1111/J.1365-2141.1991.TB08590.X; Yang XJ, 2011, J APPL POULTRY RES, V20, P263, DOI 10.3382/japr.2010-00204	34	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147695	10.1371/journal.pone.0147695	http://dx.doi.org/10.1371/journal.pone.0147695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807917	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800185
J	He, WT; Zheng, XM; Zhang, YH; Gao, YG; Song, AX; van der Goot, FG; Hu, HY				He, Wen-Tian; Zheng, Xue-Ming; Zhang, Yu-Hang; Gao, Yong-Guang; Song, Ai-Xin; van der Goot, Francoise Gisou; Hu, Hong-Yu			Cytoplasmic Ubiquitin-Specific Protease 19 (USP19) Modulates Aggregation of Polyglutamine-Expanded Ataxin-3 and Huntingtin through the HSP90 Chaperone	PLOS ONE			English	Article							MOLECULAR CHAPERONES; DEUBIQUITINATING ENZYMES; TETRATRICOPEPTIDE REPEAT; QUALITY-CONTROL; PROTEINS; DISEASES; PROTEOSTASIS; DEGRADATION; CLEARANCE; SYSTEM	Ubiquitin-specific protease 19 (USP19) is one of the deubiquitinating enzymes (DUBs) involved in regulating the ubiquitination status of substrate proteins. There are two major isoforms of USP19 with distinct C-termini; the USP19_a isoform has a transmembrane domain for anchoring to the endoplasmic reticulum, while USP19_b contains an EEVD motif. Here, we report that the cytoplasmic isoform USP19_b up-regulates the protein levels of the polyglutamine (polyQ)-containing proteins, ataxin-3 (Atx3) and huntingtin (Htt), and thus promotes aggregation of their polyQ-expanded species in cell models. Our data demonstrate that USP19_b may orchestrate the stability, aggregation and degradation of the polyQ-expanded proteins through the heat shock protein 90 (HSP90) chaperone system. USP19_b directly interacts with HSP90 through its N-terminal CS (CHORD and SGT1)/P23 domains. In conjunction with HSP90, the cytoplasmic USP19 may play a key role in triage decision for the disease-related polyQ-expanded substrates, suggesting a function of USP19 in quality control of misfolded proteins by regulating their protein levels.	[He, Wen-Tian; Zheng, Xue-Ming; Zhang, Yu-Hang; Gao, Yong-Guang; Song, Ai-Xin; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [van der Goot, Francoise Gisou] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland; [Zheng, Xue-Ming] Jiangsu Univ, Sch Med Technol, Dept Biochem & Mol Biol, Zhenjiang 212013, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Jiangsu University	Hu, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	hyhu@sibcb.ac.cn	Hu, Hong-Yu/AAQ-2633-2020; Gao, Yongguang/B-8546-2012; van der Goot, Gisou/B-2279-2012	Gao, Yongguang/0000-0002-9359-4252; van der Goot, Gisou/0000-0002-8522-274X	National Basic Research Program of China [2012CB911003]; National Natural Science Foundation of China [31270773, 31470758]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the National Basic Research Program of China (2012CB911003) and the National Natural Science Foundation of China (31270773, 31470758).	Altun M, 2012, J BIOL CHEM, V287, P1962, DOI 10.1074/jbc.M111.305615; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Baldo B, 2012, J BIOL CHEM, V287, P1406, DOI 10.1074/jbc.M111.294801; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Che MX, 2011, FASEB J, V25, P2344, DOI 10.1096/fj.10-174482; Combaret L, 2005, AM J PHYSIOL-ENDOC M, V288, pE693, DOI 10.1152/ajpendo.00281.2004; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Gao XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019763; Gao XC, 2008, ACTA BIOCH BIOPH SIN, V40, P612, DOI 10.1111/j.1745-7270.2008.00441.x; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Herbst M, 2007, NEURODEGENER DIS, V4, P254, DOI 10.1159/000101849; Jiang YJ, 2011, J BIOL CHEM, V286, P25236, DOI 10.1074/jbc.M110.216333; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kubota H, 2009, J BIOCHEM, V146, P609, DOI 10.1093/jb/mvp139; Lee JG, 2014, J BIOL CHEM, V289, P3510, DOI 10.1074/jbc.M113.538934; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Mei YD, 2011, J BIOL CHEM, V286, P35380, DOI 10.1074/jbc.M111.282020; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Nagai Y, 2008, CURR PHARM DESIGN, V14, P3267, DOI 10.2174/138161208786404164; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Song AX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013202; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Wiles B, 2015, MOL BIOL CELL, V26, P913, DOI 10.1091/mbc.E14-06-1129; Williams AJ, 2009, NEUROBIOL DIS, V33, P342, DOI 10.1016/j.nbd.2008.10.016; Zhang MH, 2008, EMBO J, V27, P2789, DOI 10.1038/emboj.2008.190; Zhang Y, 2011, INT J EMERGING ELECT, V48, P1, DOI [10.1007/s13225-011-0117-x, DOI 10.1371/J0URNAL.P0NE.0029362]; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	41	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147515	10.1371/journal.pone.0147515	http://dx.doi.org/10.1371/journal.pone.0147515			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808260	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800117
J	Horton, RE; Yadid, M; McCain, ML; Sheehy, SP; Pasqualini, FS; Park, SJ; Cho, A; Campbell, P; Parker, KK				Horton, Renita E.; Yadid, Moran; McCain, Megan L.; Sheehy, Sean P.; Pasqualini, Francesco S.; Park, Sung-Jin; Cho, Alexander; Campbell, Patrick; Parker, Kevin Kit			Angiotensin II Induced Cardiac Dysfunction on a Chip	PLOS ONE			English	Article							HEART-FAILURE; VENTRICULAR MYOCYTES; GENE-EXPRESSION; EARLY AFTERDEPOLARIZATIONS; IN-VIVO; TRANSCRIPTIONAL REGULATION; CA2+ CHANNELS; RAT HEARTS; HYPERTROPHY; MYOCARDIUM	In vitro disease models offer the ability to study specific systemic features in isolation to better understand underlying mechanisms that lead to dysfunction. Here, we present a cardiac dysfunction model using angiotensin II (ANG II) to elicit pathological responses in a hearton-a-chip platform that recapitulates native laminar cardiac tissue structure. Our platform, composed of arrays of muscular thin films (MTF), allows for functional comparisons of healthy and diseased tissues by tracking film deflections resulting from contracting tissues. To test our model, we measured gene expression profiles, morphological remodeling, calcium transients, and contractile stress generation in response to ANG II exposure and compared against previous experimental and clinical results. We found that ANG II induced pathological gene expression profiles including over-expression of natriuretic peptide B, Rho GTPase 1, and T-type calcium channels. ANG II exposure also increased proarrhythmic early after depolarization events and significantly reduced peak systolic stresses. Although ANG II has been shown to induce structural remodeling, we control tissue architecture via microcontact printing, and show pathological genetic profiles and functional impairment precede significant morphological changes. We assert that our in vitro model is a useful tool for evaluating tissue health and can serve as a platform for studying disease mechanisms and identifying novel therapeutics.	[Horton, Renita E.; Yadid, Moran; McCain, Megan L.; Sheehy, Sean P.; Pasqualini, Francesco S.; Park, Sung-Jin; Cho, Alexander; Campbell, Patrick; Parker, Kevin Kit] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Wyss Inst Biol Inspired Engn, Dis Biophys Grp, Cambridge, MA 02138 USA; [Horton, Renita E.] Mississippi State Univ, Coll Agr & Life Sci, James Worth Bagley Coll Engn, Dept Agr & Biol Engn, Starkville, MS USA; [McCain, Megan L.] Univ So Calif, Dept Biomed Engn, Viterbi Sch Engn, Los Angeles, CA 90089 USA	Harvard University; Mississippi State University; University of Southern California	Parker, KK (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Wyss Inst Biol Inspired Engn, Dis Biophys Grp, Cambridge, MA 02138 USA.	kkparker@seas.harvard.edu	Pasqualini, Francesco/AAQ-5928-2021	Pasqualini, Francesco/0000-0001-7038-3121; Horton, Renita/0000-0001-7589-9485	National Institutes of Health [1 UH2TR000522-01, 4 UH3TR000522-03]; National Science Foundation Division of Materials Research [DMR-1420570]; Harvard School of Engineering and Applied Sciences; Harvard Materials Research Science and Engineering Center (MRSEC); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000522, UH3TR000522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Division of Materials Research(National Science Foundation (NSF)); Harvard School of Engineering and Applied Sciences; Harvard Materials Research Science and Engineering Center (MRSEC)(National Science Foundation (NSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded by the National Institutes of Health (www.nih.gov) Grants 1 UH2 TR000522-01, 4 UH3TR000522-03, the Harvard Materials Research Science and Engineering Center (MRSEC) as supported by National Science Foundation (www.nsf.gov) Division of Materials Research Grant DMR-1420570, and the Harvard School of Engineering and Applied Sciences. The funding institutions had no role in the study design, data collection and analysis, manuscript preparation, or the decision to publish.	Adams WJ, 2007, J COMPUT-AIDED MATER, V14, P19, DOI 10.1007/s10820-006-9045-6; Agarwal A, 2013, LAB CHIP, V13, P3599, DOI 10.1039/c3lc50350j; Aikawa R, 2000, MOL CELL BIOCHEM, V212, P177, DOI 10.1023/A:1007185711745; ALLEN IS, 1988, CIRC RES, V62, P524, DOI 10.1161/01.RES.62.3.524; Aoki H, 1998, CIRC RES, V82, P666, DOI 10.1161/01.RES.82.6.666; Arnolds DE, 2012, J CLIN INVEST, V122, P2509, DOI 10.1172/JCI62617; Balke CW, 1998, CARDIOVASC RES, V37, P290, DOI 10.1016/S0008-6363(97)00272-1; Baurand A, 2007, CIRC RES, V100, P1353, DOI 10.1161/01.RES.0000266605.63681.5a; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; BOLUYT MO, 1994, CIRC RES, V75, P23, DOI 10.1161/01.RES.75.1.23; BOULAY G, 1994, ENDOCRINOLOGY, V135, P2130, DOI 10.1210/en.135.5.2130; Bray MA, 2008, CELL MOTIL CYTOSKEL, V65, P641, DOI 10.1002/cm.20290; Byrne JA, 2003, CIRC RES, V93, P802, DOI 10.1161/01.RES.0000099504.30207.F5; CAPASSO JM, 1993, AM J PHYSIOL, V264, pH2056, DOI 10.1152/ajpheart.1993.264.6.H2056; CONRAD CH, 1995, CIRCULATION, V91, P161, DOI 10.1161/01.CIR.91.1.161; De Mello WC, 2000, HYPERTENSION, V35, P1183, DOI 10.1161/01.HYP.35.6.1183; DEFERRARI GM, 1995, CIRCULATION, V91, P2510, DOI 10.1161/01.CIR.91.10.2510; DZAU VJ, 1987, AM J CARDIOL, V59, pA59, DOI 10.1016/0002-9149(87)90178-0; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; Feinberg AW, 2012, BIOMATERIALS, V33, P5732, DOI 10.1016/j.biomaterials.2012.04.043; Ferrario CM, 2006, J RENIN-ANGIO-ALDO S, V7, P3, DOI 10.3317/jraas.2006.003; Ferron L, 2003, CIRC RES, V93, P1241, DOI 10.1161/01.RES.0000106134.69300.B7; Finckenberg P, 2003, AM J PATHOL, V163, P355, DOI 10.1016/S0002-9440(10)63659-0; Fischer R, 2007, AM J PHYSIOL-HEART C, V293, pH1242, DOI 10.1152/ajpheart.01400.2006; Foldes G, 2011, J MOL CELL CARDIOL, V50, P367, DOI 10.1016/j.yjmcc.2010.10.029; Gerdes AM, 2002, J CARD FAIL, V8, pS264, DOI 10.1054/jcaf.2002.129280; GRADY EF, 1991, J CLIN INVEST, V88, P921, DOI 10.1172/JCI115395; Gray MO, 1998, CARDIOVASC RES, V40, P352, DOI 10.1016/S0008-6363(98)00121-7; Grosberg A, 2011, LAB CHIP, V11, P4165, DOI 10.1039/c1lc20557a; Harada K, 1998, CIRCULATION, V97, P315; Hein S, 2000, CARDIOVASC RES, V45, P273, DOI 10.1016/S0008-6363(99)00268-0; Huang BY, 2000, CARDIOVASC RES, V46, P442, DOI 10.1016/S0008-6363(00)00017-1; Huffaker R, 2004, HEART RHYTHM, V1, P441, DOI 10.1016/j.hrthm.2004.06.005; Huggins CE, 2003, J RENIN-ANGIO-ALDO S, V4, P186, DOI 10.3317/jraas.2003.030; ISHIHATA A, 1993, BRIT J PHARMACOL, V108, P999, DOI 10.1111/j.1476-5381.1993.tb13497.x; Izumiya Y, 2012, INT J VASC MED, V2012, P9; Jane-Lise S, 2000, Heart Fail Rev, V5, P239; KIM NN, 1995, AM J PHYSIOL-ENDOC M, V269, pE426, DOI 10.1152/ajpendo.1995.269.3.E426; Kuwahara K, 2012, J PHARMACOL SCI, V119, P198, DOI 10.1254/jphs.12R04CP; Lefroy DC, 1996, AM J PHYSIOL-HEART C, V270, pH2060, DOI 10.1152/ajpheart.1996.270.6.H2060; Liu Y, 1998, CIRC RES, V82, P1145, DOI 10.1161/01.RES.82.11.1145; Majalahti T, 2007, MOL CELL ENDOCRINOL, V273, P59, DOI 10.1016/j.mce.2007.05.003; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; Martinez ML, 1999, J MOL CELL CARDIOL, V31, P1617, DOI 10.1006/jmcc.1999.0998; McCain ML, 2014, AM J PHYSIOL-HEART C, V306, pH1525, DOI 10.1152/ajpheart.00799.2013; McCain ML, 2013, P NATL ACAD SCI USA, V110, P9770, DOI 10.1073/pnas.1304913110; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Meissner A, 1998, J MOL CELL CARDIOL, V30, P2507, DOI 10.1006/jmcc.1998.0813; MORAVEC CS, 1990, CIRCULATION, V82, P1973, DOI 10.1161/01.CIR.82.6.1973; Moskowitz IPG, 2007, CELL, V129, P1365, DOI 10.1016/j.cell.2007.04.036; Onodera T, 1998, HYPERTENSION, V32, P753, DOI 10.1161/01.HYP.32.4.753; Palomeque J, 2006, AM J PHYSIOL-HEART C, V290, pH96, DOI 10.1152/ajpheart.00324.2005; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Pasqualini FS, 2015, STEM CELL REP, V4, P340, DOI 10.1016/j.stemcr.2015.01.020; Petroff MGV, 2000, J PHYSIOL-LONDON, V529, P189, DOI 10.1111/j.1469-7793.2000.00189.x; Remme CA, 2013, J PHYSIOL-LONDON, V591, P4099, DOI 10.1113/jphysiol.2013.256461; ROGERS TB, 1986, J PHARMACOL EXP THER, V236, P438; Ruiz-Ortega M, 2001, HYPERTENSION, V38, P1382, DOI 10.1161/hy1201.100589; Sakurai K, 2002, LIFE SCI, V70, P1173, DOI 10.1016/S0024-3205(01)01497-7; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selvetella G, 2004, CARDIOVASC RES, V63, P373, DOI 10.1016/j.cardiores.2004.04.031; SEN L, 1994, CIRC RES, V75, P149, DOI 10.1161/01.RES.75.1.149; Shang LL, 2008, AM J PHYSIOL-CELL PH, V294, pC372, DOI 10.1152/ajpcell.00186.2007; Sheehy SP, 2014, STEM CELL REP, V2, P282, DOI 10.1016/j.stemcr.2014.01.015; Sheehy SP, 2009, CIRC-CARDIOVASC GENE, V2, P116, DOI 10.1161/CIRCGENETICS.108.806935; Takeishi Y, 1998, J CLIN INVEST, V102, P72, DOI 10.1172/JCI2709; Tfelt-Hansen J, 2010, J CARDIOVASC ELECTR, V21, P107, DOI 10.1111/j.1540-8167.2009.01633.x; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Tian XL, 2004, CARDIOVASC RES, V61, P256, DOI 10.1016/j.cardiores.2003.11.007; vanKesteren CAM, 1997, J MOL CELL CARDIOL, V29, P2147, DOI 10.1006/jmcc.1997.0448; von Lewinski D, 2008, EUR J HEART FAIL, V10, P1172, DOI 10.1016/j.ejheart.2008.09.014; Weiss JN, 2010, HEART RHYTHM, V7, P1891, DOI 10.1016/j.hrthm.2010.09.017; ZENG JL, 1995, BIOPHYS J, V68, P949, DOI 10.1016/S0006-3495(95)80271-7; Zhao ZH, 2011, J MOL CELL CARDIOL, V50, P128, DOI 10.1016/j.yjmcc.2010.11.001	75	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146415	10.1371/journal.pone.0146415	http://dx.doi.org/10.1371/journal.pone.0146415			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808388	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800021
J	Lancaster, KE; Powers, KA; Lungu, T; Mmodzi, P; Hosseinipour, MC; Chadwick, K; Go, VF; Pence, BW; Hoffman, IF; Miller, WC				Lancaster, Kathryn Elizabeth; Powers, Kimberly A.; Lungu, Thandie; Mmodzi, Pearson; Hosseinipour, Mina C.; Chadwick, Katy; Go, Vivian F.; Pence, Brian W.; Hoffman, Irving F.; Miller, William C.			The HIV Care Continuum among Female Sex Workers: A Key Population in Lilongwe, Malawi	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; DRIED BLOOD SPOTS; ANTIRETROVIRAL TREATMENT; RISK BEHAVIORS; RESPONDENT-DRIVEN; PREVENTION; TRANSMISSION; PREVALENCE; INFECTION; MEN	Objective The HIV care continuum among female sex workers (FSW), a key population, has not been well characterized, especially within the generalized epidemics of sub-Saharan Africa. This was the first study to characterize the HIV care continuum among FSW in Lilongwe, Malawi. Methods From July through September 2014, we used venue-based sampling to enroll 200 adult FSW in Lilongwe, Malawi into a cross-sectional evaluation assessing HIV care continuum outcomes. Seropositive FSW, identified using HIV rapid testing, received rapid CD4 counts in addition to viral loads using dried blood spots. We calculated proportions of HIV-infected FSW who had history of care, were on ART, and had suppressed viral load and we used Poisson regression to estimate the associations of demographic characteristics and transmission risk behaviors with each outcome. Results HIV seroprevalence was 69% (n = 138). Among all FSW the median age was 24 years (IQR: 22-28). Among the 20% who were newly diagnosed and reported previously testing negative, the median time since last HIV test was 11 months (interquartile range: 3-17). The majority (69%) of HIV-infected FSW had a history of HIV care, 52% reported current ART use, and 45% were virally suppressed. Of the FSW who reported current ART use, 86% were virally suppressed. Transmission risk behaviors were not associated with continuum outcomes. Conclusions FSW in Lilongwe were predominately young and have a high HIV prevalence. Only half of HIV-infected FSW reported current ART use, but the majority of those on ART were virally suppressed. To reduce ongoing transmission and improve health outcomes, increased HIV testing, care engagement, and ART coverage is urgently needed among FSW. Universal testing and treatment strategies for all FSWin Malawi must be strongly considered.	[Lancaster, Kathryn Elizabeth; Powers, Kimberly A.; Pence, Brian W.; Miller, William C.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Lungu, Thandie; Mmodzi, Pearson; Hosseinipour, Mina C.; Hoffman, Irving F.] Univ N Carolina, UNC Project Malawi, Lilongwe, Malawi; [Lancaster, Kathryn Elizabeth; Hosseinipour, Mina C.; Hoffman, Irving F.; Miller, William C.] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA; [Chadwick, Katy] Theatre Change, Lilongwe, Malawi; [Go, Vivian F.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Lancaster, KE (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA.; Lancaster, KE (corresponding author), Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA.	klancaster@unc.edu	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827; Lancaster, Kathryn/0000-0003-2389-6973	NIH - Fogarty International Center [R25 TW009340]; NIH Office of the Director Office of AIDS Research; ORWH; NCI; NHLBI; NIAID [T32 AI0700]; University of North Carolina Center for AIDS Research; NIH [P30 AI50410]; National Institutes of Health [KL2 TR001109]; FOGARTY INTERNATIONAL CENTER [R25TW009340] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000700, T32AI007001, P30AI050410] Funding Source: NIH RePORTER	NIH - Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH Office of the Director Office of AIDS Research; ORWH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of North Carolina Center for AIDS Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIH Research Training Grant [http://www.fic.nih.gov/] (grant number: R25 TW009340) funded by the Fogarty International Center, the NIH Office of the Director Office of AIDS Research, ORWH, NCI, and NHLBI, the NIAID T32 training grant (grant number: T32 AI0700 [KEL]), the University of North Carolina Center for AIDS Research, an NIH funded program [www.unccfar.org](grant number: P30 AI50410 [KEL]), and the National Institutes of Health (grant number: KL2 TR001109 [KAP]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alary M, 2004, AIDS, V18, P945, DOI 10.1097/00002030-200404090-00013; Arredondo M, 2012, J CLIN MICROBIOL, V50, P569, DOI 10.1128/JCM.00418-11; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baral S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115465; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Batona G, 2015, JAIDS-J ACQ IMM DEF, V68, pS206, DOI 10.1097/QAI.0000000000000452; Bekker LG, 2015, LANCET, V385, P72, DOI 10.1016/S0140-6736(14)60974-0; Braunstein SL, 2011, JAIDS-J ACQ IMM DEF, V57, pE70, DOI 10.1097/QAI.0b013e3182170fd3; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Chersich MF, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17980; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Chimbwandria F, 2013, MMWR-MORBID MORTAL W, V62, P148; Chohan V, 2009, SEX TRANSM INFECT, V85, P489, DOI 10.1136/sti.2009.036103; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cowan FM, 2014, 20 INT AIDS C MELB A; Cowan FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077080; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Delva W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001258; Dhana A, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-46; Donastorg Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088157; Family Planning Association of Malawi, 2011, COUNT UNC REP SIT AN; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Fiscus SA, 2006, PLOS MED, V3, P1743, DOI 10.1371/journal.pmed.0030417; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Genberg BL, 2015, LANCET HIV, V2, pE20, DOI 10.1016/S2352-3018(14)00034-4; Goldenberg SM, 2016, AIDS BEHAV, V20, P977, DOI 10.1007/s10461-015-1102-2; Greenberg AE, 2009, HEALTH AFFAIR, V28, P1677, DOI 10.1377/hlthaff.28.6.1677; Herce ME, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1065-y; Holland CE, 2015, JAIDS-J ACQ IMM DEF, V68, pS232, DOI 10.1097/QAI.0000000000000443; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Johannessen A, 2009, CLIN INFECT DIS, V49, P976, DOI 10.1086/605502; Johnston LG, 2006, J URBAN HEALTH, V83, pI16, DOI 10.1007/s11524-006-9099-5; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Matovu JKB, 2012, INT J STD AIDS, V23, P267, DOI 10.1258/ijsa.2011.011313; McGrath N, 2013, AIDS, V27, P2461, DOI 10.1097/01.aids.0000432473.69250.19; Metsch LR, 2008, CLIN INFECT DIS, V47, P577, DOI 10.1086/590153; Mountain E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105645; National Statistical Office, 2011, MAL DEM HLTH SURV 20; Organization. WH, 2012, PREV TREATM HIV OTH; Peitzmeier S, 2014, INT J STD AIDS, V25, P244, DOI 10.1177/0956462413498858; Powers KA, 2007, AIDS, V21, P2237, DOI 10.1097/QAD.0b013e3282f08b4d; Risher K, 2015, CURR OPIN HIV AIDS, V10, P420, DOI 10.1097/COH.0000000000000200; Rottinghaus E, ANTIVIR THER, P15; Rutstein SE, 2014, J CLIN VIROL, V60, P392, DOI 10.1016/j.jcv.2014.05.005; Schwartz S, 2015, 8 IAS C HIV PATH TRE; Schwartz S, 2014, 20 INT AIDS C MELB A; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; Skov T, 1998, INT J EPIDEMIOL, V27, P91, DOI 10.1093/ije/27.1.91; Stueve A, 2001, AM J PUBLIC HEALTH, V91, P922, DOI 10.2105/AJPH.91.6.922; Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2; Van Beckhoven D, 2014, J INT AIDS SOC, V17, P30, DOI 10.7448/IAS.17.4.19534; Vuylsteke B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032627; Weir SS, 2012, SEX TRANSM INFECT, V88, pI95, DOI 10.1136/sextrans-2012-050638; WHO, 2012, CONS GUID US ANT DRU; Wirtz AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088047; World Health Organization, 2021, ANT DRUGS TREAT PREG; Zachariah R, 2003, INT J STD AIDS, V14, P185, DOI 10.1258/095646203762869197; Zulliger R, 2015, JAIDS-J ACQ IMM DEF, V69, P216, DOI 10.1097/QAI.0000000000000590; Zulliger R, 2015, AIDS BEHAV, V19, P715, DOI 10.1007/s10461-014-0979-5	62	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147662	10.1371/journal.pone.0147662	http://dx.doi.org/10.1371/journal.pone.0147662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808043	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800172
J	Lu, W; Sun, JH; Yoon, JS; Zhang, Y; Zheng, LX; Murphy, E; Mattson, MP; Lenardo, MJ				Lu, Wei; Sun, Junhui; Yoon, Jeong Seon; Zhang, Yan; Zheng, Lixin; Murphy, Elizabeth; Mattson, Mark P.; Lenardo, Michael J.			Mitochondrial Protein PGAM5 Regulates Mitophagic Protection against Cell Necroptosis	PLOS ONE			English	Article							RECEPTOR-INTERACTING PROTEIN; MIXED LINEAGE KINASE; PROGRAMMED NECROSIS; DEATH; PHOSPHATASE; RIP3; PHOSPHORYLATION; APOPTOSIS; TRIGGERS; DYNAMICS	Necroptosis as a molecular program, rather than simply incidental cell death, was established by elucidating the roles of receptor interacting protein (RIP) kinases 1 and 3, along with their downstream partner, mixed lineage kinase/like domain protein (MLKL). Previous studies suggested that phosphoglycerate mutase family member 5 (PGAM5), a mitochondrial protein that associates with RIP1/RIP3/MLKL complex, promotes necroptosis. We have generated mice deficient in the pgam5 gene and surprisingly found PGAM5-deficiency exacerbated rather than reduced necroptosis in response to multiple in vitro and in vivo necroptotic stimuli, including ischemic reperfusion injury (I/R) in the heart and brain. Electron microscopy, biochemical, and confocal analysis revealed that PGAM5 is indispensable for the process of PINK1 dependent mitophagy which antagonizes necroptosis. The loss of PGAM5/PINK1 mediated mitophagy causes the accumulation of abnormal mitochondria, leading to the overproduction of reactive oxygen species (ROS) that worsen necroptosis. Our results revise the former proposal that PGAM5 acts downstream of RIP1/RIP3 to mediate necroptosis. Instead, PGAM5 protects cells from necroptosis by independently promoting mitophagy. PGAM5 promotion of mitophagy may represent a therapeutic target for stroke, myocardial infarction and other diseases caused by oxidative damage and necroptosis.	[Lu, Wei; Zheng, Lixin; Lenardo, Michael J.] NIAID, Mol Dev Immune Syst Sect, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Sun, Junhui; Murphy, Elizabeth] NHLBI, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Yoon, Jeong Seon; Mattson, Mark P.] NIA, Cellular & Mol Neurosci Sect, Lab Neurosci, NIH, Baltimore, MD 21224 USA; [Zhang, Yan] NCI, Mol Mech Apoptosis Sect, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lenardo, MJ (corresponding author), NIAID, Mol Dev Immune Syst Sect, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	lenardo@nih.gov			Intramural Research Programs of the National Institute of Allergy and Infectious Diseases, National Heart Lung and Blood Institute; National Institute on Aging, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000566, ZIAAI000718] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institute of Allergy and Infectious Diseases, National Heart Lung and Blood Institute; National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Intramural Research Programs of the National Institute of Allergy and Infectious Diseases, National Heart Lung and Blood Institute and the National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billia F, 2011, P NATL ACAD SCI USA, V108, P9572, DOI 10.1073/pnas.1106291108; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chan FKM, 2012, CELL, V148, P17, DOI 10.1016/j.cell.2011.12.020; Chen G, 2014, MOL CELL, V54, P362, DOI 10.1016/j.molcel.2014.02.034; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Galluzzi L, 2009, J MOL CELL BIOL, V1, P8, DOI 10.1093/jmcb/mjp007; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; Imai Y, 2011, CURR OPIN NEUROBIOL, V21, P935, DOI 10.1016/j.conb.2011.10.016; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Lu W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5930; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Myeku N, 2011, J BIOL CHEM, V286, P22426, DOI 10.1074/jbc.M110.149252; Perier C, 2012, ANTIOXID REDOX SIGN, V16, P883, DOI 10.1089/ars.2011.4074; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shimamura N, 2006, J NEUROSCI METH, V156, P161, DOI 10.1016/j.jneumeth.2006.02.017; Sun JH, 2010, AM J PHYSIOL-HEART C, V299, pH1309, DOI 10.1152/ajpheart.00373.2010; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; SWANSON RA, 1994, J CEREBR BLOOD F MET, V14, P697, DOI 10.1038/jcbfm.1994.88; Takeda K, 2009, P NATL ACAD SCI USA, V106, P12301, DOI 10.1073/pnas.0901823106; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Wu H, 2014, AUTOPHAGY, V10, P1712, DOI 10.4161/auto.29568; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang DW, 2011, CELL RES, V21, P368, DOI 10.1038/cr.2011.3; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang WG, 1999, CANCER LETT, V138, P189, DOI 10.1016/S0304-3835(99)00013-0; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006	46	87	93	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147792	10.1371/journal.pone.0147792	http://dx.doi.org/10.1371/journal.pone.0147792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807733	gold, Green Submitted, Green Published			2022-12-26	WOS:000369527800211
J	Maina, D; Omuse, G; Revathi, G; Adam, RD				Maina, Daniel; Omuse, Geoffrey; Revathi, Gunturu; Adam, Rodney D.			Spectrum of Microbial Diseases and Resistance Patterns at a Private Teaching Hospital in Kenya: Implications for Clinical Practice	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; EPIDEMIOLOGY; CRYPTOCOCCOSIS; SURVEILLANCE; DEFINITIONS; BACTEREMIA; AFRICA; BURDEN; CARE	Background Accurate local prevalence of microbial diseases and microbial resistance data are vital for optimal treatment of patients. However, there are few reports of these data from developing countries, especially from sub-Saharan Africa. The status of Aga Khan University Hospital Nairobi as an internationally accredited hospital and a laboratory with an electronic medical record system has made it possible to analyze local prevalence and antimicrobial susceptibility data and compare it with other published data. Methods We have analyzed the spectrum of microbial agents and resistance patterns seen at a 300 bed tertiary private teaching hospital in Kenya using microbial identity and susceptibility data captured in hospital and laboratory electronic records between 2010 and 2014. Results For blood isolates, we used culture collection within the first three days of hospitalization as a surrogate for community onset, and within that group, Escherichia coli was the most common, followed by Staphylococcus aureus. In contrast, Candida spp. and Klebsiella pneumoniae were the most common hospital onset causes of bloodstream infection. Antimicrobial resistance rates for the most commonly isolated Gram negative organisms was higher than many recent reports from Europe and North America. In contrast, Gram positive resistance rates were quite low, with 94% of S. aureus being susceptible to oxacillin and only rare isolates of vancomycin-resistant enterococci. Conclusions The current report demonstrates high rates of antimicrobial resistance in Gram negative organisms, even in outpatients with urinary tract infections. On the other hand, rates of resistance in Gram positive organisms, notably S. aureus, are remarkably low. A better understanding of the reasons for these trends may contribute to ongoing efforts to combat antimicrobial resistance globally.	[Maina, Daniel; Omuse, Geoffrey; Revathi, Gunturu; Adam, Rodney D.] Aga Khan Univ Hosp, Dept Pathol, Nairobi, Kenya; [Adam, Rodney D.] Aga Khan Univ Hosp, Dept Med, Nairobi, Kenya		Adam, RD (corresponding author), Aga Khan Univ Hosp, Dept Pathol, Nairobi, Kenya.; Adam, RD (corresponding author), Aga Khan Univ Hosp, Dept Med, Nairobi, Kenya.	rodney.adam@aku.edu	OMUSE, GEOFFREY/EVF-7884-2022; Maina, Daniel/AAK-2944-2021	Maina, Daniel/0000-0002-6282-9311; OMUSE, GEOFFREY/0000-0002-3866-5118				Anderson DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091713; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bigogo G, 2010, INT J INFECT DIS, V14, pE967, DOI 10.1016/j.ijid.2010.05.016; Biondi E, 2013, PEDIATRICS, V132, P990, DOI 10.1542/peds.2013-1759; Deen J, 2012, LANCET INFECT DIS, V12, P480, DOI 10.1016/S1473-3099(12)70028-2; Dromer F, 2004, AIDS, V18, P555, DOI 10.1097/00002030-200402200-00024; Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hch093; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Goncalves-Pereira J, 2013, CLIN MICROBIOL INFEC, V19, P242, DOI 10.1111/j.1469-0691.2012.03776.x; Hampton T, 2015, JAMA-J AM MED ASSOC, V313, P2411, DOI 10.1001/jama.2015.4738; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hoenigl M, 2014, PLOS ONE, V9, DOI DOI 10.1371/journal.pone.0104702; Kibet E, 2014, AM J CLIN PATHOL, V141, P188, DOI 10.1309/AJCPV8A9MRWHGXEF; Kohli R, 2010, East Afr Med J, V87, P74; Laupland Kevin B, 2015, BMC Res Notes, V8, P123, DOI 10.1186/s13104-015-1051-x; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Leopold SJ, 2014, J ANTIMICROB CHEMOTH, V69, P2337, DOI 10.1093/jac/dku176; Lyytikainen O, 2002, CLIN INFECT DIS, V35, pE14, DOI 10.1086/340981; Manyahi Joel, 2014, BMC Res Notes, V7, P500, DOI 10.1186/1756-0500-7-500; Mirza SA, 2003, CLIN INFECT DIS, V36, P789, DOI 10.1086/368091; Onyango D, 2008, J INFECT DEV COUNTR, V2, P106, DOI 10.3855/T2.2.106; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Planche T, 2008, LANCET INFECT DIS, V8, P777, DOI 10.1016/S1473-3099(08)70233-0; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P934, DOI 10.1128/AAC.01247-10; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Rodriguez-Bano J, 2010, CLIN MICROBIOL INFEC, V16, P1408, DOI [10.1111/j.1469-0691.2010.03089.x, 10.1111/j.1469-0691.2009.03089.x]; Sader HS, 2014, DIAGN MICR INFEC DIS, V78, P443, DOI 10.1016/j.diagmicrobio.2013.11.025; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Simonsen KA, 2014, CLIN MICROBIOL REV, V27, P21, DOI 10.1128/CMR.00031-13; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; System NINS, 1997, SURV HOSP ACQ BACT E	31	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147659	10.1371/journal.pone.0147659	http://dx.doi.org/10.1371/journal.pone.0147659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807811	gold, Green Submitted, Green Published			2022-12-26	WOS:000369527800170
J	Munyua, PM; Murithi, RM; Ithondeka, P; Hightower, A; Thumbi, SM; Anyangu, SA; Kiplimo, J; Bett, B; Vrieling, A; Breiman, RF; Njenga, MK				Munyua, Peninah M.; Murithi, R. Mbabu; Ithondeka, Peter; Hightower, Allen; Thumbi, Samuel M.; Anyangu, Samuel A.; Kiplimo, Jusper; Bett, Bernard; Vrieling, Anton; Breiman, Robert F.; Njenga, M. Kariuki			Predictive Factors and Risk Mapping for Rift Valley Fever Epidemics in Kenya	PLOS ONE			English	Article							OUTBREAK; LIVESTOCK; TANZANIA; LINEAGES	Background To-date, Rift Valley fever (RVF) outbreaks have occurred in 38 of the 69 administrative districts in Kenya. Using surveillance records collected between 1951 and 2007, we determined the risk of exposure and outcome of an RVF outbreak, examined the ecological and climatic factors associated with the outbreaks, and used these data to develop an RVF risk map for Kenya. Methods Exposure to RVF was evaluated as the proportion of the total outbreak years that each district was involved in prior epizootics, whereas risk of outcome was assessed as severity of observed disease in humans and animals for each district. A probability-impact weighted score (1 to 9) of the combined exposure and outcome risks was used to classify a district as high (score >= 5) or medium (score >= 2 - <5) risk, a classification that was subsequently subjected to expert group analysis for final risk level determination at the division levels (total = 391 divisions). Divisions that never reported RVF disease (score <2) were classified as low risk. Using data from the 2006/07 RVF outbreak, the predictive risk factors for an RVF outbreak were identified. The predictive probabilities from the model were further used to develop an RVF risk map for Kenya. Results The final output was a RVF risk map that classified 101 of 391 divisions (26%) located in 21 districts as high risk, and 100 of 391 divisions (26%) located in 35 districts as medium risk and 190 divisions (48%) as low risk, including all 97 divisions in Nyanza and Western provinces. The risk of RVF was positively associated with Normalized Difference Vegetation Index (NDVI), low altitude below 1000m and high precipitation in areas with solonertz, luvisols and vertisols soil types (p <0.05). Conclusion RVF risk map serves as an important tool for developing and deploying prevention and control measures against the disease.	[Munyua, Peninah M.; Breiman, Robert F.; Njenga, M. Kariuki] US Ctr Dis Control & Prevent Kenya, Global Dis Detect Div, Nairobi, Kenya; [Murithi, R. Mbabu; Ithondeka, Peter] Minist Agr Livestock & Fisheries, Nairobi, Kenya; [Hightower, Allen] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA; [Thumbi, Samuel M.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Anyangu, Samuel A.] Minist Hlth, Nairobi, Kenya; [Kiplimo, Jusper; Bett, Bernard] Int Livestock Res Inst, Nairobi, Kenya; [Vrieling, Anton] Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, POB 217, NL-7500 AE Enschede, Netherlands; [Njenga, M. Kariuki] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; Washington State University; CGIAR; International Livestock Research Institute (ILRI); University of Twente; Kenya Medical Research Institute	Njenga, MK (corresponding author), US Ctr Dis Control & Prevent Kenya, Global Dis Detect Div, Nairobi, Kenya.; Njenga, MK (corresponding author), Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya.	Knjenga@kemri.org	Munyua, Peninah/AAA-5922-2021; Vrieling, Anton/B-2639-2012; Mwangi, Thumbi/L-2216-2019	Vrieling, Anton/0000-0002-7979-1540; Mwangi, Thumbi/0000-0002-5754-0556; Ronoh, Jusper/0000-0001-6575-0281	Biosecurity Engagement Program of United States Department of State; U.S. Centers for Disease Control and Prevention	Biosecurity Engagement Program of United States Department of State; U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding was provided by the Biosecurity Engagement Program of United States Department of State and the U.S. Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank the team of expert from the Kenya Ministry of Livestock Development and Kenya Ministry of Public Health and Sanitation for their valuable input, and Norah Nanjala and Triza Shigoli for administrative support. The Biosecurity Engagement Program of United States Department of State and the U.S. Centers for Disease Control and Prevention provided the financial support for this study. The findings and conclusions in this manuscript are by the authors and should not be construed to represent CDC's determination or policy	Abdo-Salem S, 2006, ANN NY ACAD SCI, V1081, P240, DOI 10.1196/annals.1373.028; Al-Hazmi M, 2003, CLIN INFECT DIS, V36, P245, DOI 10.1086/345671; Andriamandimby SF, 2010, EMERG INFECT DIS, V16, P963, DOI 10.3201/eid1606.091266; Anyamba A, 2001, Cad Saude Publica, V17 Suppl, P133, DOI 10.1590/S0102-311X2001000700022; Anyamba A, 2009, P NATL ACAD SCI USA, V106, P955, DOI 10.1073/pnas.0806490106; Bird BH, 2008, J VIROL, V82, P11152, DOI 10.1128/JVI.01519-08; Centre ECJR, 2003, GLOB LAND COV 2000 D; Chen J, 2004, REMOTE SENS ENVIRON, V91, P332, DOI 10.1016/j.rse.2004.03.014; FAO/IIASA/ISRIC/ISSCAS/JRC, 2012, HARM WORLD SOIL DAT; Hightower A, 2012, AM J TROP MED HYG, V86, P373, DOI 10.4269/ajtmh.2012.11-0450; Jost CC, 2010, AM J TROP MED HYG, V83, P65, DOI 10.4269/ajtmh.2010.09-0290; Meegan J. M., 1981, Rift Valley fever. Proceedings of a Workshop on Rift Valley fever, Herzlia, Israel, March 18-21, 1980., P100; Mohamed M, 2010, AM J TROP MED HYG, V83, P22, DOI 10.4269/ajtmh.2010.09-0318; Munyua P, 2010, AM J TROP MED HYG, V83, P58, DOI 10.4269/ajtmh.2010.09-0292; Murithi RM, 2011, EPIDEMIOL INFECT, V139, P372, DOI 10.1017/S0950268810001020; Nderitu L, 2011, J INFECT DIS, V203, P655, DOI 10.1093/infdis/jiq004; Nguku PM, 2010, AM J TROP MED HYG, V83, P5, DOI 10.4269/ajtmh.2010.09-0288; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; RVF Decision Support, 2010, AM J TROP MED HYG, V83, P75, DOI 10.4269/ajtmh.2010.83s2a03; SALUZZO JF, 1987, LANCET, V1, P504	20	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0144570	10.1371/journal.pone.0144570	http://dx.doi.org/10.1371/journal.pone.0144570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808021	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800004
J	Sweet, DE; Altice, FL; Cohen, CJ; Vandewalle, B				Sweet, Donna E.; Altice, Frederick L.; Cohen, Calvin J.; Vandewalle, Bjoern			Cost-Effectiveness of Single-Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United States	PLOS ONE			English	Article							EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE; ANTIRETROVIRAL THERAPY; DOUBLE-BLIND; INITIAL TREATMENT; EXPERIENCED PATIENTS; DRUG-RESISTANCE; TENOFOVIR DF; EFFICACY; SAFETY; COMBINATION	Background The possibility of incorporating generics into combination antiretroviral therapy and breaking apart once-daily single-tablet regimens (STRs), may result in less efficacious medications and/or more complex regimens with the expectation of marked monetary savings. A modeling approach that assesses the merits of such policies in terms of lifelong costs and health outcomes using adherence and effectiveness data from real-world U.S. settings. Methods A comprehensive computer-based microsimulation model was developed to assess the lifetime health (life expectancy and quality adjusted life-years-QALYs) and economic outcomes in HIV-1 infected patients initiating STRs compared with multiple-table regimens including generic medications where possible (gMTRs). The STRs considered included tenofovir disoproxil fumarate/emtricitabine and efavirenz or rilpivirine or elvitegravir/cobicistat. gMTRs substitutions included each counterpart to STRs, including generic lamivudine for emtricitabine and generic versus branded efavirenz. Results Life expectancy is estimated to be 1.301 years higher (discounted 0.619 QALY gain) in HIV-1 patients initiating a single-tablet regimen in comparison to a generic-based multiple-table regimen. STRs were associated with an average increment of $26,547.43 per patient in medication and $1,824.09 in other medical costs due to longer survival which were partially offset by higher inpatients costs ($12,035.61) with gMTRs treatment. Overall, STRs presented incremental lifetime costs of $16,335.91 compared with gMTRs, resulting in an incremental cost-effectiveness ratio of $26,383.82 per QALY gained. Conclusions STRs continue to represent good value for money under contemporary cost-effectiveness thresholds despite substantial price reductions of generic medications in the U.S.	[Sweet, Donna E.] Univ Kansas, Sch Med, Internal Med, Wichita, KS 67214 USA; [Altice, Frederick L.] Yale Univ, Sch Med, Infect Dis Sect, New Haven, CT USA; [Cohen, Calvin J.] CRI New England, Boston, MA USA; [Vandewalle, Bjoern] Exigo Consultores, Lisbon, Portugal; [Cohen, Calvin J.] Gilead Sci, Foster City, CA USA	University of Kansas; University of Kansas Medical Center; Yale University; Gilead Sciences	Vandewalle, B (corresponding author), Exigo Consultores, Lisbon, Portugal.	bjorn.vandewalle@exigoconsultores.com		Altice, Frederick/0000-0002-7860-693X	Gilead Sciences, Foster City, CA	Gilead Sciences, Foster City, CA(Gilead Sciences)	This work was supported by Gilead Sciences, Foster City, CA. DES, FLA, CJC and BV (prior to January 2015) are employees of independent academic institutions, research organizations or consulting firms and maintained independent scientific control over the study, including data analysis and interpretation of final results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries (after January 2015) for CJC. Gilead contracted with Exigo Consultores for the development of the model. Exigo Consultores provided support in the form of salaries for BV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arasteh K, 2009, ANTIVIR THER, V14, P859, DOI 10.3851/IMP1301; Barnett PG, 2011, MED CARE, V49, P848, DOI 10.1097/MLR.0b013e31821b34c0; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Cassetti I, 2007, HIV CLIN TRIALS, V8, P164, DOI 10.1310/hct0803-164; Castagna A, 2014, J INFECT DIS, V210, P354, DOI 10.1093/infdis/jiu051; CDC, 2014, NATL VITAL STAT REPO, V63; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; Cohen C, 2014, AIDS, V28, P989, DOI 10.1097/QAD.0000000000000169; Cohen CJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003028; Colombo GL, 2014, THER CLIN RISK MANAG, V10, P9, DOI 10.2147/TCRM.S49428; Colombo GL, 2013, CLINICOECONOMIC OUTC, V5, P59, DOI 10.2147/CEOR.S38977; Colombo GL, 2011, CLINICOECONOMIC OUTC, V3, P197, DOI 10.2147/CEOR.S24130; Cook J, 1999, AIDS RES HUM RETROV, V15, P499, DOI 10.1089/088922299311024; DHHS, 2015, GUIDELINES USE ANTIR; FDA, 2011, EMTR RILP TEN DIS FU; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gardner EM, 2010, AIDS, V24, P395, DOI 10.1097/QAD.0b013e328335cd8a; Gazzard B, 2012, CLINICOECONOMIC OUTC, V4, P193, DOI 10.2147/CEOR.S12496; Gebo KA, 2010, AIDS, V24, P2705, DOI 10.1097/QAD.0b013e32833f3c14; Gilead, 2013, MARKET SHARE DATA Q; Guria J, 2005, ENVIRON RESOUR ECON, V32, P113, DOI 10.1007/s10640-005-6030-6; Haubrich R, 2007, AIDS, V21, pF11, DOI 10.1097/QAD.0b013e3280b07b47; Hill AM, 2011, AIDS REV, V13, P41; Hosseinipour MC, 2013, J INFECT DIS, V207, pS49, DOI 10.1093/infdis/jit107; Janssen, 2015, POWER 1 2 96 WEEK PO; Johnson M, 2006, AIDS, V20, P711, DOI 10.1097/01.aids.0000216371.76689.63; Johnson M, 2005, AIDS, V19, P153, DOI 10.1097/00002030-200501280-00007; Katlama C, 2007, AIDS, V21, P395, DOI 10.1097/QAD.0b013e328013d9d7; Kauf TL, 2008, VALUE HEALTH, V11, P1144, DOI 10.1111/j.1524-4733.2008.00326.x; Lee FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097482; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Maggiolo F, 2015, PATIENT-RELAT OUTCOM, V6, P53, DOI 10.2147/PROM.S63586; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nachega JB, 2014, CLIN INFECT DIS, V58, P1297, DOI 10.1093/cid/ciu046; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; O'Hagan A, 2006, RELIAB ENG SYST SAFE, V91, P1290, DOI 10.1016/j.ress.2005.11.025; Porter DP, 2014, JAIDS-J ACQ IMM DEF, V65, P318, DOI 10.1097/QAI.0000000000000017; Pozniak A, 2013, 20 C RETR OPP INF; Ramiro MA, 2014, ENFERM INFEC MICR CL, V32, P598, DOI 10.1016/j.eimc.2013.06.008; Rao G, 2013, IMPACT HAART REGIMEN; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Rousseau FS, 2003, J INFECT DIS, V188, P1652, DOI 10.1086/379667; Sabin CA, 2000, J ACQ IMMUN DEF SYND, V23, P172; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Sax PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113031; Sax PE, 2012, LANCET, V379, P2439, DOI 10.1016/S0140-6736(12)60917-9; Sax PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031591; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Schackman BR, 2015, MED CARE, V53, P293, DOI 10.1097/MLR.0000000000000308; Sloan CE, 2012, AIDS, V26, P45, DOI 10.1097/QAD.0b013e32834dce6e; Solem CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098152; Sweet D, 2014, 20 INT AIDS C MELB A; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Trottier B, 2005, JAIDS-J ACQ IMM DEF, V40, P413, DOI 10.1097/01.qai.0000185313.48933.2c; Walensky RP, 2013, ANN INTERN MED, V158, P84, DOI 10.7326/0003-4819-158-2-201301150-00002; WHO, 2012, PHARM EQ CLIN INT GE; Wohl DA, 2014, JAIDS-J ACQ IMM DEF, V65, pE118, DOI 10.1097/QAI.0000000000000057; Zolopa A, 2013, JAIDS-J ACQ IMM DEF, V63, P96, DOI 10.1097/QAI.0b013e318289545c	59	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147821	10.1371/journal.pone.0147821	http://dx.doi.org/10.1371/journal.pone.0147821			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808503	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800217
J	Ullah, I; Javaid, A; Tahir, Z; Ullah, O; Shah, AA; Hasan, F; Ayub, N				Ullah, Irfan; Javaid, Arshad; Tahir, Zarfishan; Ullah, Obaid; Shah, Aamer Ali; Hasan, Fariha; Ayub, Najma			Pattern of Drug Resistance and Risk Factors Associated with Development of Drug Resistant Mycobacterium tuberculosis in Pakistan	PLOS ONE			English	Article							ANTITUBERCULOSIS DRUGS; NATIONAL-SURVEY; PREVALENCE; SURVEILLANCE	Background Drug resistant tuberculosis (DR-TB) is a major public health problem in developing countries such as Pakistan. Objective The current study was conducted to assess the frequency of drug resistant tuberculosis including multi drug resistance (MDR-TB) as well as risk factors for development of DR-TB, in Punjab, Pakistan. Methodology Drug susceptibility testing (DST) was performed, using proportion method, for 2367 culture positive Mycobacterium tuberculosis (MTB) cases that were enrolled from January 2012 to December 2013 in the province of Punjab, Pakistan, against first-line anti-tuberculosis drugs. The data was analyzed using statistical software; SPSS version 18. Results Out of 2367 isolates, 273 (11.5%) were resistant to at least one anti-TB drug, while 221 (9.3%) showed MDR-TB. Risk factors for development of MDR-TB were early age (ranges between 10-25 years) and previously treated TB patients. Conclusion DR-TB is a considerable problem in Pakistan. Major risk factors are previous history of TB treatment and younger age group. It emphasizes the need for effective TB control Program in the country.	[Ullah, Irfan; Shah, Aamer Ali; Hasan, Fariha; Ayub, Najma] Quaid I Azam Univ, Fac Biol Sci, Dept Microbiol, Islamabad, Pakistan; [Ullah, Irfan; Javaid, Arshad] Lady Reading Hosp, Programmat Management Drug Resistant TB Pulmonol, Peshawar, Pakistan; [Tahir, Zarfishan; Ullah, Obaid] Inst Publ Hlth, Dept Bacteriol, Jail Rd Lahore, Lahore, Pakistan	Quaid I Azam University	Ullah, I (corresponding author), Quaid I Azam Univ, Fac Biol Sci, Dept Microbiol, Islamabad, Pakistan.; Ullah, I (corresponding author), Lady Reading Hosp, Programmat Management Drug Resistant TB Pulmonol, Peshawar, Pakistan.	irfan_btn@hotmail.com	Ullah, Irfan/L-5150-2017	Ullah, Irfan/0000-0001-6992-6723; Shah, Aamer/0000-0001-7454-4105				Abbas A, 2007, BASIC PATHOLOGY, V8th; Bengisun JS, 2000, SCAND J INFECT DIS, V32, P507, DOI 10.1080/003655400458785; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Chacon L, 2009, INT J TUBERC LUNG D, V13, P62; Chonde TM, 2010, INT J TUBERC LUNG D, V14, P967; Cohn DL, 1997, CLIN INFECT DIS, V24, pS121, DOI 10.1093/clinids/24.Supplement_1.S121; den Boon S, 2007, EMERG INFECT DIS, V13, P1189, DOI 10.3201/eid1308.051327; Micheletti VCD, 2014, J BRAS PNEUMOL, V40, P155, DOI 10.1590/S1806-37132014000200009; Ejaz M, 2010, T ROY SOC TROP MED H, V104, P511, DOI 10.1016/j.trstmh.2010.03.005; Flora M S, 2013, Bangladesh Med Res Counc Bull, V39, P34; Gomes M., 2014, J TUBERCULOSIS RES, V2, P111, DOI DOI 10.4236/JTR.2014.23014; Hussain Rabia, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P257; India T, 2009, RNTCP STAT REP; Irfan Ullah, 2014, Global Veterinaria, V13, P1002; Javaid A, 2008, INT J TUBERC LUNG D, V12, P326; Javaid A, 2011, J POSTGRADUATE MED I, V24; Karamat K. A., 1999, JPMA (Journal of the Pakistan Medical Association), V49, P262; Law WS, 2008, INT J TUBERC LUNG D, V12, P1065; Li X, 2012, INT J TUBERC LUNG D, V16, P612, DOI 10.5588/ijtld.11.0507; Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68; Mor Z, 2014, INT J TUBERC LUNG D, V18, P1195, DOI 10.5588/ijtld.14.0192; Paramasivan CN, 2002, INT J TUBERC LUNG D, V6, P479; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; Vincent V, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P573; WHO, 2014, GLOB TUB REP 2014 WH; World Health Organization, 2013, WHO GLOB TUB REP 201; World Health Organization, 2021, 10 THREATS GLOB HLTH; Yang Y, 2014, INT J INFECT DIS, V22, P83, DOI 10.1016/j.ijid.2013.12.015; Yasmin M, 2014, INFECT GENET EVOL, V27, P6, DOI 10.1016/j.meegid.2014.06.017; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	30	43	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147529	10.1371/journal.pone.0147529	http://dx.doi.org/10.1371/journal.pone.0147529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809127	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800123
J	Wouters, H; Van Dijk, L; Geers, HCJ; Winters, NA; Van Geffen, ECG; Stiggelbout, AM; Bouvy, ML				Wouters, Hans; Van Dijk, Liset; Geers, Harm C. J.; Winters, Nina A.; Van Geffen, Erica C. G.; Stiggelbout, Anne M.; Bouvy, Marcel L.			Understanding Statin Non-Adherence: Knowing Which Perceptions and Experiences Matter to Different Patients	PLOS ONE			English	Article							ADJUVANT ENDOCRINE THERAPY; BREAST-CANCER; MEDICATION-ADHERENCE; SELF-EFFICACY; OLDER WOMEN; PREDICTORS; TAMOXIFEN; BELIEFS; DISCONTINUATION; ANTIDEPRESSANTS	Background Non-adherence to statins is substantial and is associated with numerous perceptions and experiences. However, time limits in clinical practice constrain in depth explorations of these perceptions and experiences. Objectives To propose and examine a strategy aimed at an efficient assessment of a wide array of perceptions and experiences regarding the efficacy, side effects, and practical problems of statins. Furthermore, to assess associations between this wide array of experiences and perceptions and non-adherence and to examine whether patients' 'perceived self-efficacy' moderated these associations. Methods Patients were recruited through community pharmacies. A wide array of specific patient perceptions and experiences was efficiently assessed using the electronic Tailored Medicine Inventory that allows people to skip irrelevant questions. Adherence was measured through self-report and pharmacy refill data. Results Of the two-hundred twenty-nine patients who participated (mean age 63.9, standard deviation 10.2), 40%-70% doubted the necessity of or lacked knowledge about the efficacy of statins, 20%-35% of the patients were worried about joint and muscle side effects or had experienced these, and 23% had encountered practical problems regarding information about statins, intake of tablets, the package, or the blister. Experiencing more practical problems was associated with increased unintentional non-adherence (Odds ratio 1.54, 95% CI: 1.13-2.10, P < 0.01), whereas worrying about side effects was associated with increased intentional non-adherence (Odds ratio 1.90, 95% CI: 1.17-3.08, P < 0.01). Higher perceived self-efficacy' did not moderate these associations. Conclusions Insight into patients' specific barriers with regard to appropriate statin use may reveal personal reasons for being non-adherent. The Tailored Medicine Inventory is a promising tool to devise individualized intervention strategies aimed at improving adherence by the clinician-patient alliance.	[Wouters, Hans] Univ Groningen, Fac Math & Nat Sci, Groningen Res Inst Pharm, Dept Pharm,Unit Pharmacotherapy & Pharmaceut Care, Groningen, Netherlands; [Van Dijk, Liset] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands; [Geers, Harm C. J.; Winters, Nina A.; Van Geffen, Erica C. G.; Bouvy, Marcel L.] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Stiggelbout, Anne M.] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands	University of Groningen; Netherlands Institute for Health Services Research; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Wouters, H (corresponding author), Univ Groningen, Fac Math & Nat Sci, Groningen Res Inst Pharm, Dept Pharm,Unit Pharmacotherapy & Pharmaceut Care, Groningen, Netherlands.	h.wouters@rug.nl	Stiggelbout, Anne M/D-2293-2018; Bouvy, Marcel/M-4233-2016	Stiggelbout, Anne M/0000-0002-6293-4509; Bouvy, Marcel/0000-0002-4596-0684	Netherlands Organisation for Health Research and Development (ZonMw) [152002028]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	Funding was provided by the Netherlands Organisation for Health Research and Development (ZonMw), http://www.zonmw.nl/en/, grant number 152002028. ZonMw had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PROD SUMM CHAR; Bates TR, 2009, EXPERT OPIN PHARMACO, V10, P2973, DOI 10.1517/14656560903376186; Brook OH, 2006, J CLIN PSYCHOPHARM, V26, P643, DOI 10.1097/01.jcp.0000246217.34024.53; Cameron KA, 2010, PATIENT EDUC COUNS, V80, P372, DOI 10.1016/j.pec.2010.06.029; Carpenter DM, 2010, PATIENT EDUC COUNS, V81, P169, DOI 10.1016/j.pec.2009.11.006; Casebeer L, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-48; Chlebowski RT, 2006, ONCOLOGY-BASEL, V71, P1, DOI 10.1159/000100444; Colivicchi F, 2007, STROKE, V38, P2652, DOI 10.1161/STROKEAHA.107.487017; Demissie S, 2001, J CLIN ONCOL, V19, P322, DOI 10.1200/JCO.2001.19.2.322; Ellis JJ, 2004, J GEN INTERN MED, V19, P638, DOI 10.1111/j.1525-1497.2004.30516.x; Fink AK, 2004, J CLIN ONCOL, V22, P3309, DOI 10.1200/JCO.2004.11.064; Gardarsdottir H, 2010, J CLIN EPIDEMIOL, V63, P422, DOI 10.1016/j.jclinepi.2009.07.001; Grunfeld EA, 2005, PATIENT EDUC COUNS, V59, P97, DOI 10.1016/j.pec.2004.10.005; Guth U, 2008, BRIT J CANCER, V99, P428, DOI 10.1038/sj.bjc.6604525; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Khanderia U, 2008, ANN PHARMACOTHER, V42, P192, DOI 10.1345/aph.1K497; Maddox TM, 2009, CURR OPIN CARDIOL, V24, P468, DOI 10.1097/HCO.0b013e32832ed62d; Mann DM, 2007, CARDIOVASC DRUG THER, V21, P311, DOI 10.1007/s10557-007-6040-4; Masand PS, 2003, CLIN THER, V25, P2289, DOI 10.1016/S0149-2918(03)80220-5; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Silliman RA, 2002, J CLIN ONCOL, V20, P2680, DOI 10.1200/JCO.2002.08.137; Sirey JA, 2001, PSYCHIAT SERV, V52, P1615, DOI 10.1176/appi.ps.52.12.1615; Uher R, 2009, BRIT J PSYCHIAT, V195, P202, DOI 10.1192/bjp.bp.108.061960; van Geffen ECG, 2010, ANN PHARMACOTHER, V44, P1104, DOI 10.1345/aph.1P052; Villeneuve J, 2010, CAN MED ASSOC J, V182, P447, DOI 10.1503/cmaj.090533; Wouters H, 2014, CLIN BREAST CANCER, V14, P460, DOI 10.1016/j.clbc.2014.04.005; Wouters H, 2014, PATIENT PREFER ADHER, V8, P179, DOI 10.2147/PPA.S53748; Wu JR, 2008, HEART LUNG, V37, P334, DOI 10.1016/j.hrtlng.2007.10.001; Ziller V, 2009, ANN ONCOL, V20, P431, DOI 10.1093/annonc/mdn646	30	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146272	10.1371/journal.pone.0146272	http://dx.doi.org/10.1371/journal.pone.0146272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808151	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800019
J	Wu, Q; Ren, JA; Wang, GF; Li, GW; Gu, GS; Wu, XW; Li, Y; Chen, J; Zhao, YZ; Li, JS				Wu, Qin; Ren, Jianan; Wang, Gefei; Li, Guanwei; Gu, Guosheng; Wu, Xiuwen; Li, Yuan; Chen, Jun; Zhao, Yunzhao; Li, Jieshou			The Incidence, Clinical Outcomes, and Risk Factors of Thrombocytopenia in Intra-Abdominal Infection Patients: A Retrospective Cohort Study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; PLATELET TRANSFUSION; CARE; THERAPY; COUNTS	Background Studies on the incidence and risk factors of thrombocytopenia among intra-abdominal infection patients remain absent, hindering efficacy assessments regarding thrombocytopenia prevention strategies. Methods We retrospectively studied 267 consecutively enrolled patients with intra-abdominal infections. Occurrence of thrombocytopenia was scanned for all patients. All-cause 28-day mortality was recorded. Variables from univariate analyses that were associated with occurrence of hospital-acquired thrombocytopenia were included in a multivariable logistic regression analysis to determine thrombocytopenia predictors. Results Median APACHE II score and SOFA score of the whole cohort was 12 and 3 respectively. The overall ICU mortality was 7.87% and the 28-day mortality was 8.98%. The incidence of thrombocytopenia among intra-abdominal infection patients was 21.73%. Regardless of preexisting or hospital-acquired one, thrombocytopenia is associated with an increased ICU mortality and 28-day mortality as well as length of ICU or hospital stay. A higher SOFA and ISTH score at admission were significant hospital-acquired thrombocytopenia risk factors. Conclusions This is the first study to identify a high incidence of thrombocytopenia in patients with intraabdominal infections. Our findings suggest that the inflammatory milieu of intra-abdominal infections may uniquely predispose those patients to thrombocytopenia. More effective thrombocytopenia prevention strategies are necessary in intra-abdominal infection patients.	[Wu, Qin; Ren, Jianan; Wang, Gefei; Li, Guanwei; Gu, Guosheng; Wu, Xiuwen; Li, Yuan; Chen, Jun; Zhao, Yunzhao; Li, Jieshou] Nanjing Univ, Sch Med, Jinling Hosp, Dept Gen Surg, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Ren, JA (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Gen Surg, Nanjing 210008, Jiangsu, Peoples R China.	JiananR@gmail.com	ZHAO, YUAN/HCI-5831-2022; Wu, Qin/AFJ-8752-2022; 吴, 秀文/AEO-0814-2022; zhao, YZ/GXH-6401-2022; Wu, Qin/AAF-5707-2022; Li, jie/GXG-4583-2022	Wu, Qin/0000-0002-7470-8429; Wu, Qin/0000-0002-7470-8429; Wu, Xiuwen/0000-0002-3813-3867	National Natural Science Foundation of China [81270478]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by grants from the National Natural Science Foundation of China (81270478) received by JR. The funder had a role in data collection and analysis.	Akca S, 2002, CRIT CARE MED, V30, P753, DOI 10.1097/00003246-200204000-00005; Alonso S, 2015, EJSO-EUR J SURG ONC, V41, P208, DOI 10.1016/j.ejso.2014.10.052; Chaari A, 2011, TRENDS ANAESTH CRIT, V1, P199, DOI 10.1016/j.tacc.2011.05.003; Crowther MA, 2005, J CRIT CARE, V20, P348, DOI 10.1016/j.jcrc.2005.09.008; Friedrich AKU, 2014, J INTENSIVE CARE MED, V29, P247, DOI 10.1177/0885066613476465; IBERTI TJ, 1986, ANN SURG, V204, P341, DOI 10.1097/00000658-198610000-00001; Lieberman L, 2014, BLOOD, V123, P280, DOI [10.1182/ blood- 2013- 02- 435693, DOI 10.1182/BL00D-2013-02-435693]; Lieberman L, 2014, BLOOD, V123, P1146, DOI 10.1182/blood-2013-02-435693; Lim SY, 2012, J KOREAN MED SCI, V27, P1418, DOI 10.3346/jkms.2012.27.11.1418; Radia D, 2013, THROMBOCYTOPENIA MED, V41, P225, DOI [10.1016/j.mpmed.2013.01.017, DOI 10.1016/J.MPMED.2013.01.017]; Riccio LM, 2014, SURG INFECT, V15, P417, DOI 10.1089/sur.2012.077; Sawyer RG, 2015, NEW ENGL J MED, V372, P1996, DOI 10.1056/NEJMoa1411162; Stanworth SJ, 2013, TRANSFUSION, V53, P1050, DOI 10.1111/j.1537-2995.2012.03866.x; Stephan F, 1999, CHEST, V115, P1363, DOI 10.1378/chest.115.5.1363; Williamson DR, 2013, CHEST, V144, P1207, DOI 10.1378/chest.13-0121; Williamson DR, 2013, CAN J ANESTH, V60, P641, DOI 10.1007/s12630-013-9933-7; Wu Q, 2017, CLIN APPL THROMB-HEM, V23, P84, DOI 10.1177/1076029615588785; Wu Q, 2014, J CRIT CARE, V29, P362, DOI 10.1016/j.jcrc.2013.11.023	18	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147482	10.1371/journal.pone.0147482	http://dx.doi.org/10.1371/journal.pone.0147482			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808492	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800105
J	Xiao, CW; Wood, CM; Swist, E; Nagasaka, R; Sarafin, K; Gagnon, C; Fernandez, L; Faucher, S; Wu, HX; Kenney, L; Ratnayake, WMN				Xiao, Chao-Wu; Wood, Carla M.; Swist, Eleonora; Nagasaka, Reiko; Sarafin, Kurtis; Gagnon, Claude; Fernandez, Lois; Faucher, Sylvie; Wu, Hong-Xing; Kenney, Laura; Ratnayake, Walisundera M. N.			Cardio-Metabolic Disease Risks and Their Associations with Circulating 25-Hydroxyvitamin D and Omega-3 Levels in South Asian and White Canadians	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MULTILAYER FILM ELEMENTS; GROWTH-FACTOR 23; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; ADHESION MOLECULES; INSULIN-RESISTANCE; CARDIOMETABOLIC DISEASE; CLINICAL ANALYSIS; E-SELECTIN	Objectives This study compared cardio-metabolic disease risk factors and their associations with serum vitamin D and omega-3 status in South Asian (SAC) and White Canadians (WC) living in Canada's capital region. Methods Fasting blood samples were taken from 235 SAC and 279 WC aged 20 to 79 years in Ottawa, and 22 risk factors were measured. Results SAC men and women had significantly higher fasting glucose, insulin, homeostasis model assessment for insulin resistance (HOMA-IR), apolipoprotein B (ApoB), ratios of total (TC) to HDL cholesterol (HDLC) and ApoB to ApoA1, leptin, E-selectin, P-selectin, ICAM-1 and omega-3 (p < 0.05), but lower HDLC, ApoA1, vitamin D levels than WC (p < 0.05). SAC women had higher CRP and VEGF than WC women. Adequate (50-74.9 nmol/L) or optimal (>= 75 nmol/L) levels of 25(OH) D were associated with lower BMI, glucose, insulin, HOMA-IR, TG, TC, low density lipoprotein cholesterol (LDLC), ApoB/ApoA1 ratio, CRP, leptin, and higher HDLC, ApoA1, omega-3 index, L-selectin levels in WC, but not in SAC. Intermediate (>4%-<8%) or high (>= 8%) levels of omega-3 indices were related to lower E-selectin, P-selectin, ICAM-1 and higher HDLC, 25(OH) D levels in WC, but not in SAC. The BMIs of <= 25 kg/m(2) were related to lower LDLC, ApoB, VEGF, creatinine and higher 25(OH) D in WC, but not in SAC. Conclusions The associations of vitamin D, omega-3 status, BMI and risk factors were more profound in the WC than SAC. Compared to WC, vitamin D status and omega-3 index may not be good predictive risk factors for the prevalence of CVD and diabetes in SAC.	[Xiao, Chao-Wu; Wood, Carla M.; Swist, Eleonora; Nagasaka, Reiko; Sarafin, Kurtis; Gagnon, Claude; Fernandez, Lois; Kenney, Laura; Ratnayake, Walisundera M. N.] Hlth Canada, Bur Nutr Sci, Nutr Res Div, Ottawa, ON K1A 0L2, Canada; [Nagasaka, Reiko] Grad Sch Marine Sci & Technol, Dept Food Sci & Technol, Food Chem & Funct Nutr, Minato Ku, 5-7 Konan 4, Tokyo, Japan; [Faucher, Sylvie] Hlth Canada, Ctr Biol Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0L2, Canada; [Xiao, Chao-Wu] Carleton Univ, Dept Chem, Food & Nutr Sci Program, Ottawa, ON K1S 5B6, Canada; [Wu, Hong-Xing] Hlth Canada, Bur Food Surveillance & Sci Integrat, Biostat & Modelling Div, Ottawa, ON K1A 0L2, Canada	Health Canada; Health Canada; Carleton University; Health Canada	Xiao, CW (corresponding author), Hlth Canada, Bur Nutr Sci, Nutr Res Div, Ottawa, ON K1A 0L2, Canada.; Xiao, CW (corresponding author), Carleton Univ, Dept Chem, Food & Nutr Sci Program, Ottawa, ON K1S 5B6, Canada.	Chaowu.xiao@hc-sc.gc.ca	NAGASAKA, Reiko/O-1985-2014	NAGASAKA, Reiko/0000-0001-6157-9384	Health Canada	Health Canada	This study was funded by Health Canada.	Adamska A, 2014, ENDOCRINE, V45, P422, DOI 10.1007/s12020-013-0025-9; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; Anand S S, 2000, Indian Heart J, V52, pS35; Bharmal N, 2015, J IMMIGR MINOR HEALT, V17, P781, DOI 10.1007/s10903-013-9973-7; Blann AD, 1998, BLOOD COAGUL FIBRIN, V9, P297, DOI 10.1097/00001721-199806000-00001; Celis-Morales CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082568; Chiu M, 2010, CAN MED ASSOC J, V182, P1334, DOI 10.1503/cmaj.110-2098; Cotran RS, 1998, PATHOL BIOL, V46, P164; CURME HG, 1978, CLIN CHEM, V24, P1335; Dalal M, 2011, EUR J ENDOCRINOL, V165, P797, DOI 10.1530/EJE-11-0577; Demerath E, 2001, ANN HUM BIOL, V28, P664, DOI 10.1080/03014460110048530; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Deurenberg-Yap M, 2000, INT J OBESITY, V24, P1011, DOI 10.1038/sj.ijo.0801353; FAO, 2010, FATS FATT AC HUM NUT; Garcia-Bailo B, 2013, J AM COLL NUTR, V32, P296, DOI 10.1080/07315724.2013.826112; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Ghouri N, 2013, DIABETOLOGIA, V56, P2238, DOI 10.1007/s00125-013-2969-y; Glowinska B, 2005, METABOLISM, V54, P1020, DOI 10.1016/j.metabol.2005.03.004; Goyal A, 2006, INDIAN J MED RES, V124, P235; Gray LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026464; Gupta M, 2006, CAN J CARDIOL, V22, P193, DOI 10.1016/S0828-282X(06)70895-9; Gupta M, 2002, CAN MED ASSOC J, V166, P717; Gutierrez OM, 2011, CLIN J AM SOC NEPHRO, V6, P2871, DOI 10.2215/CJN.02740311; Hanley DA, 2010, CAN MED ASSOC J, V182, pE610, DOI 10.1503/cmaj.080663; Harris WS, 2007, PHARMACOL RES, V55, P217, DOI 10.1016/j.phrs.2007.01.013; Harris WS, 2008, CURR ATHEROSCLER REP, V10, P503, DOI 10.1007/s11883-008-0078-z; Harris WS, 2008, PROSTAG LEUKOTR ESS, V79, P169, DOI 10.1016/j.plefa.2008.09.005; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hillis GS, 1998, HEART, V79, P429, DOI 10.1136/hrt.79.5.429; Hoffman M, 2004, ATHEROSCLEROSIS, V172, P1, DOI 10.1016/S0021-9150(03)00164-3; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Hunt BJ, 1998, BRIT MED J, V316, P1328, DOI 10.1136/bmj.316.7141.1328; Institute of Medicine, 2011, DIETARY REFERENCE IN; Kraushaar LE, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-64; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Lear SA, 2012, OBESITY, V20, P1293, DOI 10.1038/oby.2011.395; Leenen FHH, 2008, CAN MED ASSOC J, V178, P1441, DOI 10.1503/cmaj.071340; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Pan WH, 2004, AM J CLIN NUTR, V79, P31; Pottala JV, 2012, LIPIDS, V47, P835, DOI 10.1007/s11745-012-3693-y; Raiten DJ, 2004, AM J CLIN NUTR, V80, p1673S, DOI 10.1093/ajcn/80.6.1673S; Rambihar VS, 2010, AM HEART J, V159, P1, DOI 10.1016/j.ahj.2009.10.020; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; RUDENSKI AS, 1991, METABOLISM, V40, P908, DOI 10.1016/0026-0495(91)90065-5; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; Shai I, 2006, DIABETES CARE, V29, P1585, DOI 10.2337/dc06-0057; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; Skeaff CM, 2009, ANN NUTR METAB, V55, P173, DOI 10.1159/000229002; Sokup Alina, 2005, Przegl Lek, V62, P234; SPAYD RW, 1978, CLIN CHEM, V24, P1343; Statistics Canada, 2012, CENS 2012; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802	56	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147648	10.1371/journal.pone.0147648	http://dx.doi.org/10.1371/journal.pone.0147648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809065	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800167
J	Grun, D; Adhikary, G; Eckert, RL				Grun, D.; Adhikary, G.; Eckert, R. L.			VEGF-A acts via neuropilin-1 to enhance epidermal cancer stem cell survival and formation of aggressive and highly vascularized tumors	ONCOGENE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RECEPTOR NEUROPILIN-1; SKIN-CANCER; ANGIOGENESIS; EXPRESSION; OVEREXPRESSION; PROMOTE; PROGRESSION; ACTIVATION; INDUCTION	We identify a limited subpopulation of epidermal cancer stem cells (ECS cells), in squamous cell carcinoma, that form rapidly growing, invasive and highly vascularized tumors, as compared with non-stem cancer cells. These ECS cells grow as non-attached spheroids, and display enhanced migration and invasion. We show that ECS cell-produced vascular endothelial growth factor (VEGF)-A is required for the maintenance of this phenotype, as knockdown of VEGF-A gene expression or treatment with VEGF-A-inactivating antibody reduces these responses. In addition, treatment with bevacizumab reduces tumor vascularity and growth. Surprisingly, the classical mechanism of VEGF-A action via interaction with VEGF receptors does not mediate these events, as these cells lack VEGFR1 and VEGFR2. Instead, VEGF-A acts via the neuropilin-1 (NRP-1) co-receptor. Knockdown of NRP-1 inhibits ECS cell spheroid formation, invasion and migration, and attenuates tumor formation. These studies suggest that VEGF-A acts via interaction with NRP-1 to trigger intracellular events leading to ECS cell survival and formation of aggressive, invasive and highly vascularized tumors.	[Grun, D.; Adhikary, G.; Eckert, R. L.] Univ Maryland, Sch Med, Dept Biochem, Baltimore, MD 21201 USA; [Grun, D.; Adhikary, G.; Eckert, R. L.] Univ Maryland, Sch Med, Dept Mol Biol, Baltimore, MD 21201 USA; [Eckert, R. L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Eckert, R. L.] Univ Maryland, Sch Med, Dept Reprod Biol, Baltimore, MD 21201 USA; [Eckert, R. L.] Univ Maryland, Sch Med, Dept Marlene, Baltimore, MD 21201 USA; [Eckert, R. L.] Univ Maryland, Sch Med, Dept Stewart Greenebaum Canc, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Eckert, RL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 North Greene St,Rm 103, Baltimore, MD 21201 USA.	reckert@umaryland.edu		Grun, Daniel/0000-0003-4261-7765	Maryland Stem Cell Research Foundation; National Institutes of Health [CA131074, CA184027]; pilot grant from Greenebaum Cancer Center [P30 CA134274]; NATIONAL CANCER INSTITUTE [P30CA134274, R01CA131074, R01CA211909, R01CA184027] Funding Source: NIH RePORTER	Maryland Stem Cell Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); pilot grant from Greenebaum Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Maryland Stem Cell Research Foundation (RLE) and the National Institutes of Health (RLE - CA131074, CA184027) and a pilot grant from the Greenebaum Cancer Center (P30 CA134274).	Adhikary G, 2015, CARCINOGENESIS, V36, P800, DOI 10.1093/carcin/bgv064; Adhikary G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084324; Akagi M, 2003, BRIT J CANCER, V88, P796, DOI 10.1038/sj.bjc.6600811; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Bachelder RE, 2001, CANCER RES, V61, P5736; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Bickers DR, 2006, J AM ACAD DERMATOL, V55, P490, DOI 10.1016/j.jaad.2006.05.048; Borriello L, 2014, CANCER LETT, V349, P120, DOI 10.1016/j.canlet.2014.04.004; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; Cao Y, 2012, CANCER RES, V72, P3912, DOI 10.1158/0008-5472.CAN-11-4058; Casanova ML, 2002, CANCER RES, V62, P3402; Chew YC, 2013, J BIOL CHEM, V288, P17759, DOI 10.1074/jbc.M113.477133; Chun YS, 2002, J KOREAN MED SCI, V17, P581, DOI 10.3346/jkms.2002.17.5.581; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Djordjevic S, 2013, DRUG DISCOV TODAY, V18, P447, DOI 10.1016/j.drudis.2012.11.013; Eckert RL, 2013, BBA-GEN SUBJECTS, V1830, P2427, DOI 10.1016/j.bbagen.2012.07.002; Folkman J, 1992, Semin Cancer Biol, V3, P65; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Gray MJ, 2005, CANCER RES, V65, P3664, DOI 10.1158/0008-5472.CAN-04-2229; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Jarvis A, 2010, J MED CHEM, V53, P2215, DOI 10.1021/jm901755g; Jia H, 2010, BRIT J CANCER, V102, P541, DOI 10.1038/sj.bjc.6605539; Johnson KE, 2012, J SKIN CANCER, V2012, DOI 10.1155/2012/483439; Kawakami T, 2002, CANCER, V95, P2196, DOI 10.1002/cncr.10936; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Lampropoulou A, 2014, BIOCHEM SOC T, V42, P1623, DOI 10.1042/BST20140244; Larcher F, 1998, ONCOGENE, V17, P303, DOI 10.1038/sj.onc.1201928; Li M, 2004, CANCER-AM CANCER SOC, V101, P2341, DOI 10.1002/cncr.20634; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Linde N, 2012, J PATHOL, V227, P17, DOI 10.1002/path.3989; Mamluk R, 2002, J BIOL CHEM, V277, P24818, DOI 10.1074/jbc.M200730200; Man XY, 2006, MOL MED, V12, P127, DOI 10.2119/2006-00024.Man; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Miao HQ, 2000, FASEB J, V14, P2532, DOI 10.1096/fj.00-0250com; Migdal M, 1998, J BIOL CHEM, V273, P22272, DOI 10.1074/jbc.273.35.22272; Mueller MM, 2002, DIFFERENTIATION, V70, P486, DOI 10.1046/j.1432-0436.2002.700903.x; Nissen JC, 2013, J NEUROCHEM, V127, P394, DOI 10.1111/jnc.12404; Parikh AA, 2004, AM J PATHOL, V164, P2139, DOI 10.1016/S0002-9440(10)63772-8; Parikh AA, 2003, CANCER, V98, P720, DOI 10.1002/cncr.11560; Pincelli C, 2010, J CELL PHYSIOL, V225, P310, DOI 10.1002/jcp.22275; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Streit M, 1999, AM J PATHOL, V155, P441, DOI 10.1016/S0002-9440(10)65140-1; Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899; Tosetti F, 2002, FASEB J, V16, P2, DOI 10.1096/fj.01-0300rev; Vanveldhuizen PJ, 2003, ONCOL REP, V10, P1067; Wilgus TA, 2005, AM J PATHOL, V167, P1257, DOI 10.1016/S0002-9440(10)61213-8; Yang XH, 2006, BIOCHEM BIOPH RES CO, V349, P31, DOI 10.1016/j.bbrc.2006.07.213; Zhao Y, 2011, INT J DEV BIOL, V55, P477, DOI 10.1387/ijdb.103225yz; Zhu JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055463; Zhu JW, 2012, INT J BIOCHEM CELL B, V44, P246, DOI 10.1016/j.biocel.2011.10.022	56	52	55	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	33					4379	4387		10.1038/onc.2015.507	http://dx.doi.org/10.1038/onc.2015.507			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU3ZU	26804163	Green Accepted			2022-12-26	WOS:000382152100009
J	Kawatsuki, A; Yasunaga, J; Mitobe, Y; Green, PL; Matsuoka, M				Kawatsuki, A.; Yasunaga, J-i; Mitobe, Y.; Green, P. L.; Matsuoka, M.			HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4(+) T cells	ONCOGENE			English	Article							RETINOBLASTOMA PROTEIN; MOLECULAR-MECHANISMS; TAX; P53; DEGRADATION; GENE; RNA; HBZ; E2F; REPLICATION	Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic retrovirus that induces a fatal T-cell malignancy, adult T-cell leukemia (ATL). Among several regulatory/accessory genes in HTLV-1, HTLV-1 bZIP factor (HBZ) is the only viral gene constitutively expressed in infected cells. Our previous study showed that HBZ functions in two different molecular forms, HBZ protein and HBZ RNA. In this study, we show that HBZ protein targets retinoblastoma protein (Rb), which is a critical tumor suppressor in many types of cancers. HBZ protein interacts with the Rb/E2F-1 complex and activates the transcription of E2F-target genes associated with cell cycle progression and apoptosis. Mouse primary CD4(+) T cells transduced with HBZ show accelerated G1/S transition and apoptosis, and importantly, T cells from HBZ transgenic (HBZ-Tg) mice also demonstrate enhanced cell proliferation and apoptosis. To evaluate the functions of HBZ protein alone in vivo, we generated a new transgenic mouse strain that expresses HBZ mRNA altered by silent mutations but encoding intact protein. In these mice, the numbers of effector/memory and Foxp3(+) T cells were increased, and genes associated with proliferation and apoptosis were upregulated. This study shows that HBZ protein promotes cell proliferation and apoptosis in primary CD4(+) T cells through activation of the Rb/E2F pathway, and that HBZ protein also confers onto CD4(+) T-cell immunophenotype similar to those of ATL cells, suggesting that HBZ protein has important roles in dysregulation of CD4(+) T cells infected with HTLV-1.	[Kawatsuki, A.; Yasunaga, J-i; Mitobe, Y.; Matsuoka, M.] Kyoto Univ, Inst Virus Res, Lab Virus Control, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan; [Green, P. L.] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Green, P. L.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Green, P. L.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	Kyoto University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Yasunaga, J (corresponding author), Kyoto Univ, Inst Virus Res, Lab Virus Control, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	jyasunag@virus.kyoto-u.ac.jp		Matsuoka, Masao/0000-0002-0473-754X; Mitobe, Yuichi/0000-0001-5200-5362	Ministry of Education, Science, Sports and Culture of Japan [22114003, 26460554]; Takeda Science Foundation; National Institutes of Health [CA100730]; JSPS Core-to-Core Program A, Advanced Research Networks; NATIONAL CANCER INSTITUTE [P01CA100730] Funding Source: NIH RePORTER	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS Core-to-Core Program A, Advanced Research Networks(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Linda Kingsbury and Kathleen Hayes-Ozello for editorial comments and proofreading. This study was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan to MM (22114003) and JY (26460554) and a grant from the Takeda Science Foundation (JY) and a grant from the National Institutes of Health (CA100730) to PLG. This study was performed as a research program of the Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan (AK), and also supported in part by the JSPS Core-to-Core Program A, Advanced Research Networks.	Arnold J, 2008, BLOOD, V112, P3788, DOI 10.1182/blood-2008-04-154286; Arpin-Andre C, 2014, PLASMID, V74, P45, DOI 10.1016/j.plasmid.2014.06.001; Borchert S, 2014, J VIROL, V88, P3144, DOI 10.1128/JVI.02916-13; Bosco EE, 2004, NUCLEIC ACIDS RES, V32, P25, DOI 10.1093/nar/gkg919; Boyer SN, 1996, CANCER RES, V56, P4620; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Davidson W, 2008, CELL CYCLE, V7, P1224, DOI 10.4161/cc.7.9.5786; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fan J, 2010, J VIROL, V84, P7278, DOI 10.1128/JVI.02239-09; Gaudray G, 2002, J VIROL, V76, P12813, DOI 10.1128/JVI.76.24.12813-12822.2002; Gillet NA, 2011, BLOOD, V117, P3113, DOI 10.1182/blood-2010-10-312926; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; KATOH T, 1986, INT J CANCER, V38, P265, DOI 10.1002/ijc.2910380218; Kehn K, 2005, ONCOGENE, V24, P525, DOI 10.1038/sj.onc.1208105; Knight JS, 2005, P NATL ACAD SCI USA, V102, P18562, DOI 10.1073/pnas.0503886102; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Matsuoka M, 2013, CURR OPIN VIROL, V3, P684, DOI 10.1016/j.coviro.2013.08.010; Melamed A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003271; Mitobe Y, 2015, CANCER RES, V75, P4143, DOI 10.1158/0008-5472.CAN-15-0942; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; Peloponese JM, 2009, J VIROL, V83, P3238, DOI 10.1128/JVI.01824-08; Philip S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004040; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Satou Y, 2006, P NATL ACAD SCI USA, V103, P720, DOI 10.1073/pnas.0507631103; Satou Yorifumi, 2012, Leuk Res Treatment, V2012, P213653, DOI 10.1155/2012/213653; Satou Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001274; Sawada S, 1998, J EXP MED, V187, P1439, DOI 10.1084/jem.187.9.1439; Swaims AY, 2010, BLOOD, V116, P2994, DOI 10.1182/blood-2009-07-231050; Takeda S, 2004, INT J CANCER, V109, P559, DOI 10.1002/ijc.20007; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Vernin C, 2014, CANCER RES, V74, P6082, DOI 10.1158/0008-5472.CAN-13-3564; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Yamamoto-Taguchi N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003630; Yasunaga J, 2011, INT J HEMATOL, V94, P435, DOI 10.1007/s12185-011-0937-1; Yoshida M, 2008, J VIROL, V82, P9359, DOI 10.1128/JVI.00242-08; Zhao TJ, 2011, BLOOD, V118, P1865, DOI 10.1182/blood-2010-12-326199; Zhao T, 2009, BLOOD, V113, P2755, DOI 10.1182/blood-2008-06-161729	40	18	19	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	34					4509	4517		10.1038/onc.2015.510	http://dx.doi.org/10.1038/onc.2015.510			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU4AC	26804169	Green Accepted			2022-12-26	WOS:000382153100008
J	Ramirez-Escudero, M; Gimeno-Perez, M; Gonzalez, B; Linde, D; Merdzo, Z; Fernandez-Lobato, M; Sanz-Aparicio, J				Ramirez-Escudero, Mercedes; Gimeno-Perez, Maria; Gonzalez, Beatriz; Linde, Dolores; Merdzo, Zoran; Fernandez-Lobato, Maria; Sanz-Aparicio, Julia			Structural Analysis of -Fructofuranosidase from Xanthophyllomyces dendrorhous Reveals Unique Features and the Crucial Role of N-Glycosylation in Oligomerization and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; enzyme structure; glycoside hydrolase; glycosylation; kinetics; oligomerization; X-ray crystallography	CELL-WALL INVERTASE; BETA-FRUCTOFURANOSIDASE; CRYSTAL-STRUCTURE; SCHWANNIOMYCES-OCCIDENTALIS; SUBSTRATE; COMPLEX; ENZYME; DOMAIN; SITE; TRISACCHARIDE	Xanthophyllomyces dendrorhous -fructofuranosidase (XdINV)is a highly glycosylated dimeric enzyme that hydrolyzes sucrose and releases fructose from various fructooligosaccharides (FOS) and fructans. It also catalyzes the synthesis of FOS, prebiotics that stimulate the growth of beneficial bacteria in human gut. In contrast to most fructosylating enzymes, XdINV produces neo-FOS, which makes it an interesting biotechnology target. We present here its three-dimensional structure, which shows the expected bimodular arrangement and also a long extension of its C terminus that together with an N-linked glycan mediate the formation of an unusual dimer. The two active sites of the dimer are connected by a long crevice, which might indicate its potential ability to accommodate branched fructans. This arrangement could be representative of a group of GH32 yeast enzymes having the traits observed in XdINV. The inactive D80A mutant was used to obtain complexes with relevant substrates and products, with their crystals structures showing at least four binding subsites at each active site. Moreover, two different positions are observed from subsite +2 depending on the substrate, and thus, a flexible loop (Glu-334-His-343) is essential in binding sucrose and (2-1)-linked oligosaccharides. Conversely, (2-6) and neo-type substrates are accommodated mainly by stacking to Trp-105, explaining the production of neokestose and the efficient fructosylating activity of XdINV on -glucosides. The role of relevant residues has been investigated by mutagenesis and kinetics measurements, and a model for the transfructosylating reaction has been proposed. The plasticity of its active site makes XdINV a valuable and flexible biocatalyst to produce novel bioconjugates.	[Ramirez-Escudero, Mercedes; Gonzalez, Beatriz; Sanz-Aparicio, Julia] CSIC, Inst Phys Chem Rocasolano, Dept Crystallog & Struct Biol, Serrano 119, E-28006 Madrid, Spain; [Gimeno-Perez, Maria; Linde, Dolores; Merdzo, Zoran; Fernandez-Lobato, Maria] Univ Autonoma Madrid, CSIC, Ctr Mol Biol Severo Ochoa, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Sanz-Aparicio, J (corresponding author), CSIC, Inst Phys Chem Rocasolano, Dept Crystallog & Struct Biol, Serrano 119, E-28006 Madrid, Spain.; Fernandez-Lobato, M (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Mol Biol Severo Ochoa, E-28049 Madrid, Spain.	mfernandez@cbm.csic.es; xjulia@iqfr.csic.es	ESCUDERO, MERCEDES RAMIREZ/Q-3965-2018; Lobato, Maria Fernandez/F-1338-2016; Sanz-Aparicio, Julia/F-6201-2013; Escudero, Mercedes Ramirez/O-1690-2019; Gonzalez, Beatriz/M-1219-2014; Gimeno, Maria/AAN-1908-2020	ESCUDERO, MERCEDES RAMIREZ/0000-0001-7253-9572; Lobato, Maria Fernandez/0000-0003-0778-7443; Sanz-Aparicio, Julia/0000-0002-6849-8621; Escudero, Mercedes Ramirez/0000-0001-7253-9572; Gonzalez, Beatriz/0000-0002-0710-0202; Linde, Dolores/0000-0002-0359-0566; Gimeno-Perez, Maria/0000-0002-2663-7339	Spanish Ministry of Economy and Competitiveness [BIO2010-20508-C04-03/-04, BIO2013-48779-C4-3/-4]; European Community; Fundacion Ramon Areces institutional grant; Ministry of Education, Culture and Sports	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Community(European Commission); Fundacion Ramon Areces institutional grant; Ministry of Education, Culture and Sports	This work was supported in part by Spanish Ministry of Economy and Competitiveness Grants BIO2010-20508-C04-03/-04 and BIO2013-48779-C4-3/-4, BioStruct-X Program from the European Community's Seventh Framework Programme Grant FP7/2007-2013, and a Fundacion Ramon Areces institutional grant (to the Centro de Biologia Molecular "Severo Ochoa"). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Spanish doctoral fellowship from the Ministry of Education, Culture and Sports.	Alberto F, 2006, BIOCHEM J, V395, P457, DOI [10.1042/BJ20051936, 10.1042/Bj20051936]; Alvaro-Benito M, 2007, J BIOTECHNOL, V132, P75, DOI 10.1016/j.jbiotec.2007.07.939; Alvaro-Benito M, 2012, J BIOL CHEM, V287, P19674, DOI 10.1074/jbc.M112.355503; Alvaro-Benito M, 2010, J BIOL CHEM, V285, P13930, DOI 10.1074/jbc.M109.095430; Sainz-Polo MA, 2013, J BIOL CHEM, V288, P9755, DOI 10.1074/jbc.M112.446435; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bujacz A, 2011, FEBS J, V278, P1728, DOI 10.1111/j.1742-4658.2011.08098.x; Chuankhayan P, 2010, J BIOL CHEM, V285, P23249, DOI 10.1074/jbc.M110.113027; Cimini S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00089; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Rodriguez-Alegria ME, 2010, BIOCATAL BIOTRANSFOR, V28, P51, DOI 10.3109/10242420903388819; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franco-Robles Elena, 2015, ScientificWorldJournal, V2015, P289267, DOI 10.1155/2015/289267; Gimeno-Perez M, 2014, PROCESS BIOCHEM, V49, P423, DOI 10.1016/j.procbio.2013.12.018; Gimeno-Perez M, 2015, APPL MICROBIOL BIOT, V99, P3459, DOI 10.1007/s00253-014-6145-1; Henrissat B, 2008, CURR OPIN STRUC BIOL, V18, P527, DOI 10.1016/j.sbi.2008.09.003; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kilian S, 2002, WORLD J MICROB BIOT, V18, P637, DOI 10.1023/A:1016808015630; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Lammens W, 2008, J MOL BIOL, V377, P378, DOI 10.1016/j.jmb.2007.12.074; Lammens W, 2012, PLANT J, V70, P205, DOI 10.1111/j.1365-313X.2011.04858.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Roy K, 2007, PLANT PHYSIOL, V145, P616, DOI 10.1104/pp.107.105049; Lim JS, 2007, EUR FOOD RES TECHNOL, V225, P457, DOI 10.1007/s00217-006-0440-8; Linde D, 2012, BIORESOURCE TECHNOL, V109, P123, DOI 10.1016/j.biortech.2012.01.023; Linde D, 2009, APPL ENVIRON MICROB, V75, P1065, DOI 10.1128/AEM.02061-08; Lopez MG, 2003, J AGR FOOD CHEM, V51, P7835, DOI 10.1021/jf030383v; Marx SP, 2000, FEMS MICROBIOL LETT, V182, P163, DOI 10.1016/S0378-1097(99)00584-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagem RAP, 2004, J MOL BIOL, V344, P471, DOI 10.1016/j.jmb.2004.09.024; Polo A, 2010, ACTA CRYSTALLOGR F, V66, P1441, DOI [10.1107/S1744309110029192, 10.1107/S17443091100291]; Pons T, 2004, PROTEINS, V54, P424, DOI 10.1002/prot.10604; Pouyez J, 2012, BIOCHIMIE, V94, P2423, DOI 10.1016/j.biochi.2012.06.020; Ritsema T, 2003, CURR OPIN PLANT BIOL, V6, P223, DOI 10.1016/S1369-5266(03)00034-7; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tian F, 2012, J MOL CATAL B-ENZYM, V82, P71, DOI 10.1016/j.molcatb.2012.06.005; Trollope KM, 2015, FEBS J, V282, P4782, DOI 10.1111/febs.13536; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Velazquez-Hernandez ML, 2009, J APPL MICROBIOL, V106, P1763, DOI 10.1111/j.1365-2672.2008.04120.x; Verhaest M, 2007, NEW PHYTOL, V174, P90, DOI 10.1111/j.1469-8137.2007.01988.x; Verhaest M, 2006, ACTA CRYSTALLOGR D, V62, P1555, DOI 10.1107/S0907444906044489; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	45	31	31	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6843	6857		10.1074/jbc.M115.708495	http://dx.doi.org/10.1074/jbc.M115.708495			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26823463	Green Published, hybrid			2022-12-26	WOS:000373299700023
J	Bitto, D; Halldorsson, S; Caputo, A; Huiskonen, JT				Bitto, David; Halldorsson, Steinar; Caputo, Alessandro; Huiskonen, Juha T.			Low pH and Anionic Lipid-dependent Fusion of Uukuniemi Phlebovirus to Liposomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electron tomography; membrane; membrane fusion; virus entry; virus structure; bis(monoacylglycero)phosphate; bunyavirus; phlebovirus	SEMLIKI-FOREST-VIRUS; BORNE ENCEPHALITIS-VIRUS; MEMBRANE-FUSION; ELECTRON CRYOTOMOGRAPHY; SPONTANEOUS CURVATURE; SINDBIS VIRUS; FEVER; CHOLESTEROL; GLYCOPROTEIN; PROTEIN	Many phleboviruses (family Bunyaviridae) are emerging as medically important viruses. These viruses enter target cells by endocytosis and low pH-dependent membrane fusion in late endosomes. However, the necessary and sufficient factors for fusion have not been fully characterized. We have studied the minimal fusion requirements of a prototypic phlebovirus, Uukuniemi virus, in an in vitro virus-liposome assay. We show that efficient lipid mixing between viral and liposome membranes requires close to physiological temperatures and phospholipids with negatively charged headgroups, such as the late endosomal phospholipid bis(monoacylglycero)phosphate. We further demonstrate that bis(monoacylglycero)phosphate increases Uukuniemi virus fusion beyond the lipid mixing stage. By using electron cryotomography of viral particles in the presence or absence of liposomes, we observed that the conformation of phlebovirus glycoprotein capsomers changes from the native conformation toward a more elongated conformation at a fusion permissive pH. Our results suggest a rationale for phlebovirus entry in late endosomes.	[Bitto, David; Halldorsson, Steinar; Caputo, Alessandro; Huiskonen, Juha T.] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England; [Caputo, Alessandro] Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Huiskonen, JT (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England.	juha@strubi.ox.ac.uk	Caputo, Alessandro/AFM-4954-2022; Huiskonen, Juha T/C-3043-2008	Caputo, Alessandro/0000-0001-5007-6896; Huiskonen, Juha T/0000-0002-0348-7323; Bitto, David/0000-0003-3530-4947; Halldorsson, Steinar/0000-0003-1810-6607	Wellcome Trust JIF [060208/Z/00/Z]	Wellcome Trust JIF	We thank A. Siebert for electron microscopy support, K. Grunewald for helpful suggestions, and T. Bowden for critically reading the manuscript. Oxford Particle Imaging Centre electron microscopy facility was founded by a Wellcome Trust JIF award 060208/Z/00/Z.	Alley SH, 2008, CHEM PHYS LIPIDS, V154, P64, DOI 10.1016/j.chemphyslip.2008.03.007; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Bowden TA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003374; BRATT MA, 1969, P NATL ACAD SCI USA, V64, P536, DOI 10.1073/pnas.64.2.536; BRON R, 1993, EMBO J, V12, P693, DOI 10.1002/j.1460-2075.1993.tb05703.x; Cao S, 2013, P NATL ACAD SCI USA, V110, P13362, DOI 10.1073/pnas.1301911110; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; CORVER J, 1995, J VIROL, V69, P3220, DOI 10.1128/JVI.69.5.3220-3223.1995; Corver J, 2000, VIROLOGY, V269, P37, DOI 10.1006/viro.1999.0172; CYRKLAFF M, 1994, J MICROSC-OXFORD, V175, P135, DOI 10.1111/j.1365-2818.1994.tb03476.x; de Boer SM, 2012, J VIROL, V86, P13642, DOI 10.1128/JVI.01973-12; Dessau M, 2013, P NATL ACAD SCI USA, V110, P1696, DOI 10.1073/pnas.1217780110; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Floyd DL, 2008, P NATL ACAD SCI USA, V105, P15382, DOI 10.1073/pnas.0807771105; Freiberg AN, 2008, J VIROL, V82, P10341, DOI 10.1128/JVI.01191-08; Fuller N, 2003, BIOPHYS J, V85, P1667, DOI 10.1016/S0006-3495(03)74596-2; Gallala HD, 2011, NEUROCHEM RES, V36, P1594, DOI 10.1007/s11064-010-0337-6; Garigliany MM, 2012, ANTIVIR RES, V95, P82, DOI 10.1016/j.antiviral.2012.05.014; Harmon B, 2012, J VIROL, V86, P12954, DOI 10.1128/JVI.02242-12; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; Huiskonen JT, 2014, JOVE-J VIS EXP, DOI 10.3791/51714; Huiskonen JT, 2010, J VIROL, V84, P4889, DOI 10.1128/JVI.00057-10; Huiskonen JT, 2009, J VIROL, V83, P3762, DOI 10.1128/JVI.02483-08; Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; KUISMANEN E, 1982, MOL CELL BIOL, V2, P1444, DOI 10.1128/MCB.2.11.1444; Kyoung M, 2011, P NATL ACAD SCI USA, V108, pE304, DOI 10.1073/pnas.1107900108; Lee KK, 2010, EMBO J, V29, P1299, DOI 10.1038/emboj.2010.13; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; Lozach PY, 2011, CELL HOST MICROBE, V10, P75, DOI 10.1016/j.chom.2011.06.007; Lozach PY, 2010, CELL HOST MICROBE, V7, P488, DOI 10.1016/j.chom.2010.05.007; MARSH M, 1980, J MOL BIOL, V142, P439, DOI 10.1016/0022-2836(80)90281-8; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mobius W, 2003, TRAFFIC, V4, P222; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; NIEVA JL, 1994, EMBO J, V13, P2797, DOI 10.1002/j.1460-2075.1994.tb06573.x; Overby AK, 2008, P NATL ACAD SCI USA, V105, P2375, DOI 10.1073/pnas.0708738105; PAL R, 1988, BIOCHEMISTRY-US, V27, P30, DOI 10.1021/bi00401a006; Prins M, 1998, TRENDS MICROBIOL, V6, P31, DOI 10.1016/S0966-842X(97)01173-6; RENKONEN O, 1972, VIROLOGY, V50, P899, DOI 10.1016/0042-6822(72)90443-6; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Sherman MB, 2009, VIROLOGY, V387, P11, DOI 10.1016/j.virol.2009.02.038; Smit JM, 1999, J VIROL, V73, P8476, DOI 10.1128/JVI.73.10.8476-8484.1999; Umashankar M, 2008, J VIROL, V82, P9245, DOI 10.1128/JVI.00975-08; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Waarts BL, 2005, J VIROL, V79, P7942, DOI 10.1128/JVI.79.12.7942-7948.2005; WAHLBERG JM, 1992, J VIROL, V66, P7309, DOI 10.1128/JVI.66.12.7309-7318.1992; Walter CT, 2011, J GEN VIROL, V92, P2467, DOI 10.1099/vir.0.035105-0; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131	60	24	24	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6412	6422		10.1074/jbc.M115.691113	http://dx.doi.org/10.1074/jbc.M115.691113			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26811337	Green Published, hybrid			2022-12-26	WOS:000372894200029
J	Ash, GI; Kostek, MA; Lee, H; Angelopoulos, TJ; Clarkson, PM; Gordon, PM; Moyna, NM; Visich, PS; Zoeller, RF; Price, TB; Devaney, JM; Gordish-Dressman, H; Thompson, PD; Hoffman, EP; Pescatello, LS				Ash, Garrett I.; Kostek, Matthew A.; Lee, Harold; Angelopoulos, Theodore J.; Clarkson, Priscilla M.; Gordon, Paul M.; Moyna, Niall M.; Visich, Paul S.; Zoeller, Robert F.; Price, Thomas B.; Devaney, Joseph M.; Gordish-Dressman, Heather; Thompson, Paul D.; Hoffman, Eric P.; Pescatello, Linda S.			Glucocorticoid Receptor (NR3C1) Variants Associate with the Muscle Strength and Size Response to Resistance Training	PLOS ONE			English	Article							IN-VIVO; CARDIOVASCULAR-DISEASE; MAJOR DEPRESSION; N363S VARIANT; 1ST EXONS; GENE; POLYMORPHISM; SENSITIVITY; CORTISOL; WOMEN	Glucocorticoid receptor (NR3C1) polymorphisms associate with obesity, muscle strength, and cortisol sensitivity. We examined associations among four NR3C1 polymorphisms and the muscle response to resistance training (RT). European-American adults (n = 602, 23.8 +/- 0.4yr) completed a 12 week unilateral arm RT program. Maximum voluntary contraction (MVC) assessed isometric strength (kg) and MRI assessed biceps size (cm(2)) pre-and post-resistance training. Subjects were genotyped for NR3C1 -2722G> A, -1887G> A, -1017T>C, and +363A>G. Men carrying the -2722G allele gained less relative MVC (17.3 +/- 1.2vs33.5 +/- 6.1%) (p = 0.010) than AA homozygotes; men with -1887GG gained greater relative MVC than A allele carriers (19.6 +/- 1.4vs13.2 +/- 2.3%) (p = 0.016). Women carrying the -1017T allele gained greater relative size (18.7 +/- 0.5 vs 16.1 +/- 0.9%) (p = 0.016) than CC homozygotes. We found sex-specific NR3C1 associations with the muscle strength and size response to RT. Future studies should investigate whether these associations are partially explained by cortisol's actions in muscle tissue as they interact with sex differences in cortisol production.	[Ash, Garrett I.; Kostek, Matthew A.; Pescatello, Linda S.] Univ Connecticut, Dept Kinesiol, Storrs, CT USA; [Ash, Garrett I.; Kostek, Matthew A.; Pescatello, Linda S.] Univ Connecticut, Human Performance Lab, Storrs, CT USA; [Lee, Harold] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA; [Angelopoulos, Theodore J.] Emory & Henry Coll, Sch Hlth Sci, Emory, VA USA; [Clarkson, Priscilla M.] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA; [Gordon, Paul M.] Baylor Univ, Dept Hlth Human Performance & Recreat, Waco, TX 76798 USA; [Moyna, Niall M.] Dublin City Univ, Sch Hlth & Human Performance, Dublin 9, Ireland; [Visich, Paul S.] Univ New England, Exercise & Sport Performance Dept, Biddeford, ME USA; [Zoeller, Robert F.] Florida Atlantic Univ, Dept Exercise Sci & Hlth Promot, Boca Raton, FL 33431 USA; [Price, Thomas B.] Univ Bridgeport, Dept Hlth Sci, Bridgeport, CT USA; [Devaney, Joseph M.; Gordish-Dressman, Heather; Hoffman, Eric P.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Thompson, Paul D.] Hartford Hosp, Henry Low Heart Ctr, Div Cardiol, Hartford, CT 06115 USA; [Pescatello, Linda S.] Univ Connecticut, Inst Syst Genom, Storrs, CT USA	University of Connecticut; University of Connecticut; Brown University; University of Massachusetts System; University of Massachusetts Amherst; Baylor University; Dublin City University; University of New England - Maine; State University System of Florida; Florida Atlantic University; University of Bridgeport; Children's National Health System; Hartford Hospital; University of Connecticut	Ash, GI (corresponding author), Univ Connecticut, Dept Kinesiol, Storrs, CT USA.; Ash, GI (corresponding author), Univ Connecticut, Human Performance Lab, Storrs, CT USA.	garrett.ash@uconn.edu	Ash, Garrett I./H-2874-2019	Ash, Garrett I./0000-0002-8655-7525; Hoffman, Eric/0000-0001-6470-5139; Lee, Harold/0000-0001-5778-3227	National Institutes of Health National Institute of Neurological Disorders and Stroke [R01 NS40606-02]; University of Connecticut Center for Health, Intervention, and Prevention; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040606] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Connecticut Center for Health, Intervention, and Prevention; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by National Institutes of Health National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov/) R01 NS40606-02 and the University of Connecticut Center for Health, Intervention, and Prevention (http://www.chip.uconn.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clarkson PM, 2005, J APPL PHYSIOL, V99, P154, DOI 10.1152/japplphysiol.01139.2004; Hoffman EP, 2013, MED SCI SPORT EXER, V45, P1060, DOI 10.1249/MSS.0b013e31828093c1; Hubal MJ, 2005, MED SCI SPORT EXER, V37, P964, DOI 10.1249/01.mss.0000170469.90461.5f; Huizenga NATM, 1998, J CLIN ENDOCR METAB, V83, P144, DOI 10.1210/jc.83.1.144; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; Larsson CA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-16; Lin RCY, 2003, OBES RES, V11, P802, DOI 10.1038/oby.2003.111; Lin RCY, 2003, HYPERTENSION, V41, P404, DOI 10.1161/01.HYP.0000055342.40301.DC; Marti A, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-50; PAFFENBARGER RS, 1993, MED SCI SPORT EXER, V25, P60, DOI 10.1249/00005768-199301000-00010; Peeters GMEE, 2008, CLIN ENDOCRINOL, V69, P673, DOI 10.1111/j.1365-2265.2008.03212.x; Pescatello LS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/643575; Pistilli EE, 2008, CYTOKINE, V43, P45, DOI 10.1016/j.cyto.2008.04.008; Presul E, 2007, J MOL ENDOCRINOL, V38, P79, DOI 10.1677/jme.1.02183; Rosmond R, 2001, BRIT MED J, V322, P652, DOI 10.1136/bmj.322.7287.652; Schatzberg AF, 2014, MOL PSYCHIATR, V19, P220, DOI 10.1038/mp.2013.129; Sinclair D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031720; Spijker AT, 2009, ANN NY ACAD SCI, V1179, P199, DOI 10.1111/j.1749-6632.2009.04985.x; STARON RS, 1994, J APPL PHYSIOL, V76, P1247, DOI 10.1152/jappl.1994.76.3.1247; Thompson PD, 2004, MED SCI SPORT EXER, V36, P1132, DOI 10.1249/01.MSS.0000132274.26612.23; Turner JD, 2005, J MOL ENDOCRINOL, V35, P283, DOI 10.1677/jme.1.01822; van den Akker ELT, 2008, ARCH INTERN MED, V168, P33, DOI 10.1001/archinternmed.2007.41; van Raalte DH, 2012, DIABETIC MED, V29, pE211, DOI 10.1111/j.1464-5491.2012.03690.x; van Rossum EFC, 2002, DIABETES, V51, P3128, DOI 10.2337/diabetes.51.10.3128; van Rossum EFC, 2004, J CLIN ENDOCR METAB, V89, P4004, DOI 10.1210/jc.2003-031422; van Rossum EFC, 2003, CLIN ENDOCRINOL, V59, P585, DOI 10.1046/j.1365-2265.2003.01888.x; VIAU V, 1991, ENDOCRINOLOGY, V129, P2503, DOI 10.1210/endo-129-5-2503; Viau V, 1996, J NEUROSCI, V16, P1866; Walker BR, 2007, EUR J ENDOCRINOL, V157, P545, DOI 10.1530/EJE-07-0455; Zhang T, 2004, GENOME RES, V14, P79, DOI 10.1101/gr.1225204	30	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148112	10.1371/journal.pone.0148112	http://dx.doi.org/10.1371/journal.pone.0148112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821164	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528400068
J	Catry, B; Dewulf, J; Maes, D; Pardon, B; Callens, B; Vanrobaeys, M; Opsomer, G; de Kruif, A; Haesebrouck, F				Catry, Boudewijn; Dewulf, Jeroen; Maes, Dominiek; Pardon, Bart; Callens, Benedicte; Vanrobaeys, Mia; Opsomer, Geert; de Kruif, Aart; Haesebrouck, Freddy			Effect of Antimicrobial Consumption and Production Type on Antibacterial Resistance in the Bovine Respiratory and Digestive Tract	PLOS ONE			English	Article							FECAL ESCHERICHIA-COLI; VEAL CALVES; ANTIBIOTIC-RESISTANCE; FATTENING PIGS; DAIRY CALVES; DRUG-USE; FARMS; SUSCEPTIBILITY; BACTERIA; PASTEURELLA	The aim of this study was to investigate the relationship between antimicrobial use and the occurrence of antimicrobial resistance in the digestive and respiratory tract in three different production systems of food producing animals. A longitudinal study was set up in 25 Belgian bovine herds (10 dairy, 10 beef, and 5 veal herds) for a 2 year monitoring of antimicrobial susceptibilities in E. coli and Pasteurellaceae retrieved from the rectum and the nasal cavity, respectively. During the first year of observation, the antimicrobial use was prospectively recorded on 15 of these farms (5 of each production type) and transformed into the treatment incidences according to the (animal) defined daily dose (TIADD) and (actually) used daily dose (TIUDD). Antimicrobial resistance rates of 4,174 E. coli (all herds) and 474 Pasteurellaceae (beef and veal herds only) isolates for 12 antimicrobial agents demonstrated large differences between intensively reared veal calves (abundant and inconstant) and more extensively reared dairy and beef cattle (sparse and relatively stable). Using linear mixed effect models, a strong relation was found between antimicrobial treatment incidences and resistance profiles of 1,639 E. coli strains (p< 0.0001) and 309 Pasteurellaceae (p <= 0.012). These results indicate that a high antimicrobial selection pressure, here found to be represented by low dosages of oral prophylactic and therapeutic group medication, converts not only the commensal microbiota from the digestive tract but also the opportunistic pathogenic bacteria in the respiratory tract into reservoirs of multi-resistance.	[Catry, Boudewijn] Sci Inst Publ Hlth WIV ISP, Healthcare Associated Infect & Antimicrobial Resi, Brussels, Belgium; [Catry, Boudewijn; Dewulf, Jeroen; Maes, Dominiek; Pardon, Bart; Callens, Benedicte; Opsomer, Geert; de Kruif, Aart; Haesebrouck, Freddy] Univ Ghent, Fac Vet Med, Merelbeke, Belgium; [Vanrobaeys, Mia] Anim Hlth Care Flanders DGZ, Torhout, Belgium	Ghent University	Catry, B (corresponding author), Sci Inst Publ Hlth WIV ISP, Healthcare Associated Infect & Antimicrobial Resi, Brussels, Belgium.; Catry, B (corresponding author), Univ Ghent, Fac Vet Med, Merelbeke, Belgium.	Boudewijn.Catry@wiv-isp.be	Haesebrouck, Freddy/M-3857-2014; Dewulf, jeroen/AAJ-1580-2020	Haesebrouck, Freddy/0000-0002-1709-933X; Dewulf, jeroen/0000-0001-9843-5990; Pardon, Bart/0000-0003-1026-8433	Belgian Federal Public Service of Public Health, Food Chain Security and Environment [S-6166]	Belgian Federal Public Service of Public Health, Food Chain Security and Environment	This study was supported by the Belgian Federal Public Service of Public Health, Food Chain Security and Environment (Grant S-6166).	Berge ACB, 2006, APPL ENVIRON MICROB, V72, P3872, DOI 10.1128/AEM.02239-05; Busato A, 1997, DEUT TIERARZTL WOCH, V104, P131; Bywater R, 2004, J ANTIMICROB CHEMOTH, V54, P744, DOI 10.1093/jac/dkh422; Catry B, 2005, MICROB DRUG RESIST, V11, P387, DOI 10.1089/mdr.2005.11.387; Catry B, 2007, ANTIMICROBIAL USE RE; Catry B, 2007, MICROB DRUG RESIST, V13, P204, DOI 10.1089/mdr.2007.721; Catry B, 2007, MICROB DRUG RESIST, V13, P147, DOI 10.1089/mdr.2007.744; Checkley SL, 2010, CAN VET J, V51, P853; *DANMAP, 2005, US ANT AG OCC ANT RE; Dewulf J, 2007, PREV VET MED, V78, P339, DOI 10.1016/j.prevetmed.2006.11.001; Di Labio E, 2007, ZOONOSES PUBLIC HLTH, V54, P344, DOI 10.1111/j.1863-2378.2007.01071.x; Donaldson SC, 2006, APPL ENVIRON MICROB, V72, P3940, DOI 10.1128/AEM.02770-05; Gould CV, 2006, INFECT CONT HOSP EP, V27, P920, DOI 10.1086/507280; Heuer OE, 2002, MICROB DRUG RESIST, V8, P355, DOI 10.1089/10766290260469624; HINTON M, 1985, J APPL BACTERIOL, V58, P131, DOI 10.1111/j.1365-2672.1985.tb01439.x; HINTON M, 1985, J HYG-CAMBRIDGE, V95, P595, DOI 10.1017/S0022172400060691; Hoyle DV, 2004, APPL ENVIRON MICROB, V70, P6927, DOI 10.1128/AEM.70.11.6927-6930.2004; Jensen VF, 2004, PREV VET MED, V64, P201, DOI 10.1016/j.prevetmed.2004.04.001; Jordan D, 2005, AUST VET J, V83, P688, DOI 10.1111/j.1751-0813.2005.tb13051.x; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V51, P69, DOI 10.1093/jac/dkg028; Khachatryan AR, 2006, APPL ENVIRON MICROB, V72, P4583, DOI 10.1128/AEM.02584-05; Kolkman I, 2007, REPROD DOMEST ANIM, V42, P583, DOI 10.1111/j.1439-0531.2006.00825.x; Malhotra-Kumar S, 2007, LANCET, V369, P482, DOI 10.1016/S0140-6736(07)60235-9; MARAN, 2005, MON ANT RES ANT US A; MEEK AH, 1986, CAN J VET RES, V50, P7; Nicholls T, 2001, REV SCI TECH OIE, V20, P841, DOI 10.20506/rst.20.3.1317; Pardon B, 2012, J ANTIMICROB CHEMOTH, V67, P1027, DOI 10.1093/jac/dkr570; SARGEANT JM, 1994, CAN J VET RES, V58, P189; Sawant AA, 2007, APPL ENVIRON MICROB, V73, P156, DOI 10.1128/AEM.01551-06; Timmerman T, 2006, PREV VET MED, V74, P251, DOI 10.1016/j.prevetmed.2005.10.003; Walk ST, 2007, APPL ENVIRON MICROB, V73, P5982, DOI 10.1128/AEM.00709-07; WHOCC, 2020, GUID AN THER CHEM AT; World Health Organization, 2002, GUID ATCVET CLASS DD; Zhang L, 2013, ANTIMICROB AGENTS CH, V57, P3659, DOI 10.1128/AAC.00670-13	34	63	63	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0146488	10.1371/journal.pone.0146488	http://dx.doi.org/10.1371/journal.pone.0146488			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820134	Green Published, gold			2022-12-26	WOS:000369528400006
J	Devadas, K; Biswas, S; Haleyurgirisetty, M; Wood, O; Ragupathy, V; Lee, S; Hewlett, I				Devadas, Krishnakumar; Biswas, Santanu; Haleyurgirisetty, Mohan; Wood, Owen; Ragupathy, Viswanath; Lee, Sherwin; Hewlett, Indira			Analysis of Host Gene Expression Profile in HIV-1 and HIV-2 Infected T-Cells	PLOS ONE			English	Article							VIRUS TYPE-1 INFECTION; CD4+T CELLS; VIRAL LOAD; JURKAT CELLS; IDENTIFICATION; CANCER; REPLICATION; METABOLISM; CD4(+); DIFFERENTIATION	HIV replication is closely regulated by a complex pathway of host factors, many of them being determinants of cell tropism and host susceptibility to HIV infection. These host factors are known to exert a positive or negative influence on the replication of the two major types of HIV, HIV-1 and HIV-2, thereby modulating virus infectivity, host response to infection and ultimately disease progression profiles characteristic of these two types. Understanding the differential regulation of host cellular factors in response to HIV-1 and HIV-2 infections will help us to understand the apparent differences in rates of disease progression and pathogenesis. This knowledge would aid in the discovery of new biomarkers that may serve as novel targets for therapy and diagnosis. The objective of this study was to determine the differential expression of host genes in response to HIV-1/HIV-2 infection. To achieve this, we analyzed the effects of HIV-1 (MN) and HIV-2 (ROD) infection on the expression of host factors in PBMC at the RNA level using the Agilent Whole Human Genome Oligo Microarray. Differentially expressed genes were identified and their biological functions determined. Host gene expression profiles were significantly changed. Gene expression profiling analysis identified a subset of differentially expressed genes in HIV-1 and HIV-2 infected cells. Genes involved in cellular metabolism, apoptosis, immune cell proliferation and activation, cytokines, chemokines, and transcription factors were differentially expressed in HIV-1 infected cells. Relatively few genes were differentially expressed in cells infected with HIV-2.	[Devadas, Krishnakumar; Biswas, Santanu; Haleyurgirisetty, Mohan; Wood, Owen; Ragupathy, Viswanath; Lee, Sherwin; Hewlett, Indira] US FDA, Mol Virol Lab, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Devadas, K; Hewlett, I (corresponding author), US FDA, Mol Virol Lab, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	Krishnakumar.devadas@fda.hhs.gov; Indira.hewlett@fda.hhs.gov	Ragupathy, Viswanath/ABA-3444-2021	Biswas, Santanu/0000-0003-4056-4305	Intramural CBER Modernizing Grant; Food and Drug Administration	Intramural CBER Modernizing Grant; Food and Drug Administration(United States Department of Health & Human Services)	This work was funded by an Intramural CBER Modernizing Grant and the Food and Drug Administration.	Alimonti JB, 2003, J GEN VIROL, V84, P1649, DOI 10.1099/vir.0.19110-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosinger SE, 2004, J IMMUNOL, V173, P6858, DOI 10.4049/jimmunol.173.11.6858; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; GILLIS S, 1980, J IMMUNOL, V125, P2570; HILFINGER JM, 1993, J VIROL, V67, P4448, DOI 10.1128/JVI.67.7.4448-4453.1993; Hollenbaugh JA, 2011, VIROLOGY, V415, P153, DOI 10.1016/j.virol.2011.04.007; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017291; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Imbeault M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002861; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Jones NP, 2012, DRUG DISCOV TODAY, V17, P232, DOI 10.1016/j.drudis.2011.12.017; Kameoka M, 2007, BIOCHEM BIOPH RES CO, V359, P729, DOI 10.1016/j.bbrc.2007.05.173; Koblavi-Deme S, 2004, AIDS, V18, P413, DOI 10.1097/01.aids.0000104327.15729.cb; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lee YS, 2015, CANCER GENOM PROTEOM, V12, P153; Machuca A, 2004, AIDS RES HUM RETROV, V20, P507, DOI 10.1089/088922204323087750; Molina L, 2007, PROTEOMICS, V7, P3116, DOI 10.1002/pmic.200700306; Ockenhouse CF, 2005, J INFECT DIS, V191, P2064, DOI 10.1086/430321; Palmer CS, 2014, AIDS, V28, P297, DOI 10.1097/QAD.0000000000000128; Pincini A, 2013, CELL CYCLE, V12, P2409, DOI 10.4161/cc.25415; Popper SJ, 2000, J VIROL, V74, P1554, DOI 10.1128/JVI.74.3.1554-1557.2000; Popper SJ, 1999, J INFECT DIS, V180, P1116, DOI 10.1086/315010; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Rhoads MP, 2011, JAIDS-J ACQ IMM DEF, V57, P404, DOI 10.1097/QAI.0b013e31821d33be; Salgado M, 2011, VIROLOGY, V411, P103, DOI 10.1016/j.virol.2010.12.037; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sievers M, 2009, J INFECT DIS, V200, P252, DOI 10.1086/599986; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596; Tan JY, 2013, J CELL PHYSIOL, V228, P2305, DOI 10.1002/jcp.24397; van't Wout AB, 2003, J VIROL, V77, P1392, DOI 10.1128/JVI.77.2.1392-1402.2003; van 't Wout AB, 2005, J VIROL, V79, P10053, DOI 10.1128/JVI.79.15.10053-10058.2005; Wang X, 2012, CELL SIGNAL, V24, P1414, DOI 10.1016/j.cellsig.2012.02.016; Wang X, 2010, MOL CELL BIOCHEM, V337, P175, DOI 10.1007/s11010-009-0297-9; Wang X, 2009, MOL CELL BIOCHEM, V330, P23, DOI 10.1007/s11010-009-0096-3; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Xu WW, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-15; Ye YF, 2013, BIOCHEM BIOPH RES CO, V436, P19, DOI 10.1016/j.bbrc.2013.05.008	42	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147421	10.1371/journal.pone.0147421	http://dx.doi.org/10.1371/journal.pone.0147421			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821323	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528400027
J	Hasegawa, J; Toyokawa, S; Ikenoue, T; Asano, Y; Satoh, S; Ikeda, T; Ichizuka, K; Tamiya, N; Nakai, A; Fujimori, K; Maeda, T; Masuzaki, H; Suzuki, H; Ueda, S				Hasegawa, Junichi; Toyokawa, Satoshi; Ikenoue, Tsuyomu; Asano, Yuri; Satoh, Shoji; Ikeda, Tomoaki; Ichizuka, Kiyotake; Tamiya, Nanako; Nakai, Akihito; Fujimori, Keiya; Maeda, Tsugio; Masuzaki, Hideaki; Suzuki, Hideaki; Ueda, Shigeru		Prevention Recurrence Committee; Japan Obstet Compensation System	Relevant Obstetric Factors for Cerebral Palsy: From the Nationwide Obstetric Compensation System in Japan	PLOS ONE			English	Article							UMBILICAL-CORD PROLAPSE; PRETERM BIRTH; RISK-FACTORS; INTRAUTERINE GROWTH; PLACENTAL ABRUPTION; BREECH PRESENTATION; PERINATAL OUTCOMES; CASE-COHORT; TERM; PREGNANCIES	Objective The aim of this study was to identify the relevant obstetric factors for cerebral palsy (CP) after 33 weeks' gestation in Japan. Study design This retrospective case cohort study (1: 100 cases and controls) used a Japanese national CP registry. Obstetric characteristics and clinical course were compared between CP cases in the Japan Obstetric Compensation System for Cerebral Palsy database and controls in the perinatal database of the Japan Society of Obstetrics and Gynecology born as live singleton infants between 2009 and 2011 with a birth weight >= 2,000 g and gestation >= 33 weeks. Results One hundred and seventy-five CP cases and 17,475 controls were assessed. Major relevant single factors for CP were placental abnormalities (31%), umbilical cord abnormalities (15%), maternal complications (10%), and neonatal complications (1%). A multivariate regression model demonstrated that obstetric variables associated with CP were acute delivery due to non-reassuring fetal status (relative risk [RR]: 37.182, 95% confidence interval [CI]: 20.028-69.032), uterine rupture (RR: 24.770, 95% CI: 6.006-102.160), placental abruption (RR: 20.891, 95% CI: 11.817-36.934), and preterm labor (RR: 3.153, 95% CI: 2.024-4.911), whereas protective factors were head presentation (RR: 0.199, 95% CI: 0.088-0.450) and elective cesarean section (RR: 0.236, 95% CI: 0.067-0.828). Conclusion CP after 33 weeks' gestation in the recently reported cases in Japan was strongly associated with acute delivery due to non-reassuring fetal status, uterine rupture, and placental abruption.	[Hasegawa, Junichi] St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Kanagawa, Japan; [Toyokawa, Satoshi] Univ Tokyo, Dept Publ Hlth, Tokyo, Japan; [Ikenoue, Tsuyomu] Miyazaki Univ, Miyazaki, Japan; [Asano, Yuri; Suzuki, Hideaki; Ueda, Shigeru] Japan Council Qual Hlth Care, Dept Japan Obstetr Compensat Syst Cerebral Palsy, Publ Interest Inc Fdn, Tokyo, Japan; [Satoh, Shoji] Oita Prefectural Hosp, Maternal & Perinatal Care Ctr, Oita, Japan; [Ikeda, Tomoaki] Mie Univ, Sch Med, Dept Obstet & Gynecol, Tsu, Mie, Japan; [Ichizuka, Kiyotake] Showa Univ, Northern Yokohama Hosp, Kanagawa, Japan; [Tamiya, Nanako] Univ Tsukuba, Fac Med, Dept Hlth Serv Res, Ibaraki, Japan; [Nakai, Akihito] Nippon Med Sch, Dept Obstet & Gynecol, 1-1-5 Sendagi, Tokyo 113, Japan; [Fujimori, Keiya] Fukushima Med Univ, Dept Obstet & Gynecol, Fukushima, Japan; [Fujimori, Keiya] Inc Assoc Anzu Kai, Maeda Clin, Shizuoka, Japan; [Masuzaki, Hideaki] Nagasaki Univ, Dept Obstet & Gynecol, Nagasaki 852, Japan	Saint Marianna University; University of Tokyo; University of Miyazaki; Mie University; Showa University; University of Tsukuba; Nippon Medical School; Fukushima Medical University; Nagasaki University	Hasegawa, J (corresponding author), St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Kanagawa, Japan.	hasejun@oak.dti.ne.jp	Hasegawa, Junichi/AAO-5291-2020	Hasegawa, Junichi/0000-0002-5789-1022				Andersen GL, 2009, DEV MED CHILD NEUROL, V51, P860, DOI 10.1111/j.1469-8749.2009.03338.x; EDDLEMAN KA, 1992, AM J PERINAT, V9, P123, DOI 10.1055/s-2007-994684; Hasegawa J, ARCH GYNECO IN PRESS; Hasegawa J, J MATERN FE IN PRESS; Hasegawa J, J PERINATAL MED; Hasegawa J, 2016, J MATERN-FETAL NEO M, V29, P1652, DOI 10.3109/14767058.2015.1058772; Hayashi M, 2012, FERTIL STERIL, V98, P922, DOI 10.1016/j.fertnstert.2012.05.049; Heinonen S, 1996, OBSTET GYNECOL, V87, P112, DOI 10.1016/0029-7844(95)00339-8; Holbrook BD, 2013, OBSTET GYN CLIN N AM, V40, P1, DOI 10.1016/j.ogc.2012.11.002; Jacobsson B, 2004, BEST PRACT RES CL OB, V18, P425, DOI 10.1016/j.bpobgyn.2004.02.011; Jarvis S, 2003, LANCET, V362, P1106, DOI 10.1016/S0140-6736(03)14466-2; Jarvis S, 2006, CLIN PERINATOL, V33, P285, DOI 10.1016/j.clp.2006.03.009; Kahana B, 2004, INT J GYNECOL OBSTET, V84, P127, DOI 10.1016/S0020-7292(03)00333-3; KATZ Z, 1982, AM J OBSTET GYNECOL, V142, P239, DOI 10.1016/S0002-9378(16)32344-4; KOONINGS PP, 1990, J REPROD MED, V35, P690; Krebs L, 1999, BRIT J OBSTET GYNAEC, V106, P943, DOI 10.1111/j.1471-0528.1999.tb08434.x; MacLennan AH, 2002, MED J AUSTRALIA, V176, P425, DOI 10.5694/j.1326-5377.2002.tb04484.x; Mann JR, 2011, PAEDIATR PERINAT EP, V25, P100, DOI 10.1111/j.1365-3016.2010.01157.x; Matsuda Y, 2011, J OBSTET GYNAECOL RE, V37, P538, DOI 10.1111/j.1447-0756.2010.01408.x; McIntyre S, 2013, OBSTET GYNECOL, V122, P869, DOI 10.1097/AOG.0b013e3182a265ab; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; MURPHY DJ, 1995, BRIT J OBSTET GYNAEC, V102, P826, DOI 10.1111/j.1471-0528.1995.tb10850.x; Nelson KB, 2015, NEW ENGL J MED, V373, P946, DOI 10.1056/NEJMra1505261; O'Callaghan M, 2013, OBSTET GYNECOL, V122, P1169, DOI 10.1097/AOG.0000000000000020; O'Callaghan ME, 2011, OBSTET GYNECOL, V118, P576, DOI 10.1097/AOG.0b013e31822ad2dc; Oyelese Y, 2006, OBSTET GYNECOL, V108, P1005, DOI 10.1097/01.AOG.0000239439.04364.9a; Parkes J, 2001, PAEDIATR PERINAT EP, V15, P278, DOI 10.1046/j.1365-3016.2001.00349.x; Ray JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102275; Redline RW, 2004, HUM PATHOL, V35, P1494, DOI 10.1016/j.humpath.2004.08.003; Reid SM, 2011, DEV MED CHILD NEUROL, V53, P907, DOI 10.1111/j.1469-8749.2011.04039.x; Sameshima H, 2004, AM J OBSTET GYNECOL, V190, P118, DOI 10.1016/j.ajog.2003.07.014; Shiozaki A, 2011, J OBSTET GYNAECOL RE, V37, P1447, DOI 10.1111/j.1447-0756.2011.01565.x; Streja E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126743; Sukhov A, 2012, J MATERN-FETAL NEO M, V25, P53, DOI 10.3109/14767058.2011.564689; Thorngren-Jerneck K, 2006, OBSTET GYNECOL, V108, P1499, DOI 10.1097/01.AOG.0000247174.27979.6b; Tronnes H, 2014, DEV MED CHILD NEUROL, V56, P779, DOI 10.1111/dmcn.12430; Yamada T, 2013, J OBSTET GYNAECOL RE, V39, P1159, DOI 10.1111/jog.12036; Yamada T, 2012, EARLY HUM DEV, V88, P861, DOI 10.1016/j.earlhumdev.2012.06.008; Yang YT, 2009, MED CARE, V47, P234, DOI 10.1097/MLR.0b013e31818475de	39	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148122	10.1371/journal.pone.0148122	http://dx.doi.org/10.1371/journal.pone.0148122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821386	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528400071
J	Zhou, TT; Tao, Y; Jin, H; Song, B; Jing, T; Luo, D; Zhou, YS; Zhou, YK; Lee, YI; Mei, SR				Zhou, Tingting; Tao, Yun; Jin, Hua; Song, Bin; Jing, Tao; Luo, Dan; Zhou, Yusun; Zhou, Yikai; Lee, Yong-Ill; Mei, Surong			Fabrication of a Selective and Sensitive Sensor Based on Molecularly Imprinted Polymer/Acetylene Black for the Determination of Azithromycin in Pharmaceuticals and Biological Samples	PLOS ONE			English	Article							CARBON-PASTE ELECTRODE; ELECTROCHEMICAL SENSOR; COMPOSITE FILM; WATER SAMPLES; HUMAN PLASMA; POLYMER; NANOPARTICLES; GRAPHENE; ASSAY; TETRABROMOBISPHENOL	A new selective and sensitive sensor based on molecularly imprinted polymer/acetylene black (MIP/AB) was developed for the determination of azithromycin (AZM) in pharmaceuticals and biological samples. The MIP of AZM was synthesized by precipitation polymerization. MIP and AB were then respectively introduced as selective and sensitive elements for the preparation of MIP/AB-modified carbon paste (MIP/ABP) electrode. The performance of the obtained sensor was estimated by cyclic voltammetry (CV) and differential pulse voltammetry (DPV) techniques. Compared with non-molecularly imprinted polymer (NIP) electrodes, NIP/ABP electrodes, and MIP-modified carbon paste electrodes, MIP/ABP electrode exhibited excellent current response toward AZM. The prepared sensor also exhibited good selectivity for AZM in comparison with structurally similar compounds. The effect of electrode composition, extraction parameters, and electrolyte conditions on the current response of the sensor was investigated. Under the optimized conditions, the prepared sensor showed two dynamic linear ranges of 1.0 x 10(-7) mol L-1 to 2.0 x 10(-6) mol L-1 and 2.0 x 10(-6) mol L-1 to 2.0 x 10(-5) mol L-1, with a limit of detection of 1.1 x 10(-8) mol L-1. These predominant properties ensured that the sensor exhibits excellent reliability for detecting AZM in pharmaceuticals and biological fluids without the assistance of any separation techniques. The results were validated by the high-performance liquid chromatography-tandem mass spectrometry method.	[Zhou, Tingting; Tao, Yun; Song, Bin; Jing, Tao; Luo, Dan; Zhou, Yusun; Zhou, Yikai; Mei, Surong] Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubat,Key Lab Envir, Minist Educ,Key Lab Environm & Hlth Wuhan, Minist Environm Protect,Sch Publ Hlth,Tongji Med, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China; [Jin, Hua; Lee, Yong-Ill] Changwon Natl Univ, Dept Chem, Chang Won 641773, South Korea; [Jin, Hua] Yanbian Univ Hosp, Cent Lab, Yanji 133000, Jilin, Peoples R China	Huazhong University of Science & Technology; Changwon National University; Yanbian University	Mei, SR (corresponding author), Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubat,Key Lab Envir, Minist Educ,Key Lab Environm & Hlth Wuhan, Minist Environm Protect,Sch Publ Hlth,Tongji Med, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China.	surongmei@hust.edu.cn	Tao, Jing/H-3931-2014; Zhou, Tingting/AIA-2242-2022	Tao, Jing/0000-0002-1755-9578; Lee, Yong-Ill/0000-0001-5383-9801	National Basic Research Grant (973) of China [2015CB352100]; National Natural Science Foundation of China [21577043]	National Basic Research Grant (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Grant (973) of China (Grant No. 2015CB352100), and the National Natural Science Foundation of China (No. 21577043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh T, 2011, J ELECTROANAL CHEM, V657, P98, DOI 10.1016/j.jelechem.2011.03.029; Alreja Gaurav, 2012, J Cardiovasc Dis Res, V3, P319, DOI 10.4103/0975-3583.102720; Arvand M, 2013, SENSOR ACTUAT B-CHEM, V188, P797, DOI 10.1016/j.snb.2013.07.092; Ashour S, 2012, SPECTROCHIM ACTA A, V99, P74, DOI 10.1016/j.saa.2012.08.024; Bahrami BG, 2005, J CHROMATOGR B, V820, P277, DOI 10.1016/j.jchromb.2005.03.042; Breier AR, 2002, J PHARMACEUT BIOMED, V29, P957, DOI 10.1016/S0731-7085(02)00213-3; Chen HJ, 2013, ANALYST, V138, P2769, DOI 10.1039/c3an00146f; Chen LY, 2007, J CHROMATOGR B, V855, P255, DOI 10.1016/j.jchromb.2007.05.016; Ensafi AA, 2013, COLLOID SURFACE B, V103, P468, DOI 10.1016/j.colsurfb.2012.11.021; Filist M, 2014, J PHARMACEUT BIOMED, V100, P184, DOI 10.1016/j.jpba.2014.07.015; Gandhi R, 2000, J PHARMACEUT BIOMED, V23, P1073, DOI 10.1016/S0731-7085(00)00406-4; Gholivand MB, 2011, TALANTA, V84, P905, DOI 10.1016/j.talanta.2011.02.022; Hu XZ, 2010, COLLOID SURFACE B, V81, P27, DOI 10.1016/j.colsurfb.2010.06.018; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Li M, 2012, SENSOR ACTUAT B-CHEM, V168, P329, DOI 10.1016/j.snb.2012.04.030; Lin FY, 2001, J CHROMATOGR A, V912, P281, DOI 10.1016/S0021-9673(01)00584-2; Liu B, 2013, ANAL BIOCHEM, V440, P220, DOI 10.1016/j.ab.2013.05.030; Mandic Z, 2003, J PHARMACEUT BIOMED, V33, P647, DOI 10.1016/S0731-7085(03)00315-7; Mazloum-Ardakani M, 2014, ANAL BIOCHEM, V455, P60, DOI 10.1016/j.ab.2014.03.006; Miguel L, 2003, J PHARMACEUT BIOMED, V33, P211, DOI 10.1016/S0731-7085(03)00258-9; Muniz FWMG, 2013, EUR J PHARMACOL, V705, P135, DOI 10.1016/j.ejphar.2013.02.044; Nichols DP, 2013, J SURG RES, V183, P767, DOI 10.1016/j.jss.2013.02.003; Nigovic B, 2003, J PHARMACEUT BIOMED, V32, P197, DOI 10.1016/S0731-7085(03)00060-8; Parnham MJ, 2014, PHARMACOL THERAPEUT, V143, P225, DOI 10.1016/j.pharmthera.2014.03.003; Peng JY, 2011, TALANTA, V86, P227, DOI 10.1016/j.talanta.2011.09.005; Rafique S, 2015, BIOELECTROCHEMISTRY, V101, P75, DOI 10.1016/j.bioelechem.2014.08.001; Song B, 2014, MICROCHEM J, V116, P183, DOI 10.1016/j.microc.2014.05.010; Tong YJ, 2013, BIOSENS BIOELECTRON, V47, P553, DOI 10.1016/j.bios.2013.03.072; Turcinov T, 1998, J PHARMACEUT BIOMED, V17, P903, DOI 10.1016/S0731-7085(97)00275-6; Wan K, 2015, APPL CATAL B-ENVIRON, V165, P566, DOI 10.1016/j.apcatb.2014.10.054; Wang XJ, 2008, J MEMBRANE SCI, V313, P97, DOI 10.1016/j.memsci.2007.12.067; Wu NQ, 2005, NANOTECHNOLOGY, V16, P2878, DOI 10.1088/0957-4484/16/12/024; Xu W, 2013, MICROCHIM ACTA, V180, P1005, DOI 10.1007/s00604-013-1020-9; Yin YM, 2012, J CHROMATOGR A, V1220, P7, DOI 10.1016/j.chroma.2011.11.065; Yuan BQ, 2013, ELECTROCHIM ACTA, V88, P708, DOI 10.1016/j.electacta.2012.10.102; Zhang HJ, 2011, COLLOID SURFACE B, V87, P378, DOI 10.1016/j.colsurfb.2011.05.045; Zhang KX, 2013, ANAL CHIM ACTA, V787, P50, DOI 10.1016/j.aca.2013.05.037; Zhang XY, 2014, SENSOR ACTUAT B-CHEM, V200, P69, DOI 10.1016/j.snb.2014.04.028; Zhang YY, 2013, COLLOID SURFACE B, V103, P94, DOI 10.1016/j.colsurfb.2012.10.015; Zhang ZA, 2015, J POWER SOURCES, V284, P95, DOI 10.1016/j.jpowsour.2015.03.019; Zubata P, 2002, J PHARMACEUT BIOMED, V27, P833, DOI 10.1016/S0731-7085(01)00554-4	41	18	18	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147002	10.1371/journal.pone.0147002	http://dx.doi.org/10.1371/journal.pone.0147002			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820753	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528400011
J	Li, FR; Gao, B; Xu, W; Chen, L; Xiong, SD				Li, Furong; Gao, Bo; Xu, Wei; Chen, Ling; Xiong, Sidong			The Defect in Autophagy Induction by Clinical Isolates of Mycobacterium Tuberculosis Is Correlated with Poor Tuberculosis Outcomes	PLOS ONE			English	Article							GENETIC DIVERSITY; MACROPHAGES; SURVIVAL; DEFENSE; CELLS; FLUX	Background Tuberculosis (TB) represents a major global health problem. The prognosis of clinically active tuberculosis depends on the complex interactions between Mycobacterium tuberculosis (Mtb) and its host. In recent years, autophagy receives particular attention for its role in host defense against intracellular pathogens, including Mtb. In present study, we aim to investigate the relationship of autophagy induction by clinical isolates of Mtb with the clinical outcomes in patients with TB. Methodology/Principal Findings We collected 185 clinical isolates of Mtb, and determined the effect of these Mtb isolates on autophagy induction in macrophages. It was found that most of clinical isolates of Mtb were able to induce autophagosome formation in macrophages, however, the autophagy-inducing ability varied significantly among different isolates. Of importance, our results revealed that patients infected by Mtb with poor autophagy-inducing ability displayed more severe radiographic extent of disease (p<0.001), and were more likely to have unfavorable treatment outcomes (p<0.001). No significant association was observed between the extent of Mtb-induced autophagy with some socio-demographic characteristics (such as gender, age and tobacco consumption), and some laboratory tests (such as hemoglobin, leukocyte count and erythrocyte sedimentation rate). Furthermore, results from logistic regression analysis demonstrated that the defect in autophagy induction by clinical isolates of Mtb was an independent risk factor for far-advanced radiographic disease (aOR 4.710 [1.93-11.50]) and unfavorable treatment outcomes (aOR 8.309 [2.22-28.97]) in TB. Conclusion/Significance These data indicated that the defect in autophagy induction by Mtb isolates increased the risk of poor clinical outcomes in TB patients, and detection of clinical isolates-induced autophagosome formation might help evaluate the TB outcomes.	[Li, Furong; Gao, Bo; Xiong, Sidong] Fudan Univ, Shanghai Med Coll, Dept Immunol, Inst Immunobiol, Shanghai 200032, Peoples R China; [Xu, Wei; Xiong, Sidong] Soochow Univ, Inst Biol, Jiangsu Key Lab Infect & Immun, Suzhou 215006, Peoples R China; [Xu, Wei; Xiong, Sidong] Soochow Univ, Inst Med Sci, Suzhou 215006, Peoples R China; [Chen, Ling] Zunyi Med Coll, Affiliated Hosp, Dept Resp Med, Zunyi 563000, Peoples R China	Fudan University; Soochow University - China; Soochow University - China; Zunyi Medical University	Gao, B; Xiong, SD (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Immunol, Inst Immunobiol, Shanghai 200032, Peoples R China.; Xiong, SD (corresponding author), Soochow Univ, Inst Biol, Jiangsu Key Lab Infect & Immun, Suzhou 215006, Peoples R China.; Xiong, SD (corresponding author), Soochow Univ, Inst Med Sci, Suzhou 215006, Peoples R China.	gaobo@fudan.edu.cn; sdxiongfd@126.com			National Science & Technology Key Projects during the Twelfth Five-Year Plan Period of China [2013ZX10003007]; Major State Basic Research Development Program of China [2013CB530501, 2013CB531502]; National Natural Science Foundation of China [31470839, 81072428]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Provincial Innovative Research Team; Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China [PCSIRT-IRT1075]	National Science & Technology Key Projects during the Twelfth Five-Year Plan Period of China; Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Provincial Innovative Research Team; Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China	This work was supported by grants from the National Science & Technology Key Projects during the Twelfth Five-Year Plan Period of China (2013ZX10003007), Major State Basic Research Development Program of China (2013CB530501, 2013CB531502), the National Natural Science Foundation of China (31470839, 81072428), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Jiangsu Provincial Innovative Research Team, and the Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China (PCSIRT-IRT1075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bento CF, 2015, DNA CELL BIOL, V34, P228, DOI 10.1089/dna.2014.2745; Bruns H, 2014, FUTURE MICROBIOL, V9, P327, DOI 10.2217/fmb.13.164; Chakraborty P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062966; Chen L, 2012, J CLIN MICROBIOL, V50, P1043, DOI 10.1128/JCM.06095-11; Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; FALK AJ, 1969, CLASSIFICATION PULMO; Gao B, 2013, J IMMUNOL, V191, P464, DOI 10.4049/jimmunol.1203533; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harding CV, 2003, CURR OPIN IMMUNOL, V15, P112, DOI 10.1016/S0952-7915(02)00008-0; Kim JJ, 2012, CELL HOST MICROBE, V11, P457, DOI 10.1016/j.chom.2012.03.008; Krishnan N, 2013, TUBERCULOSIS, V93, P538, DOI 10.1016/j.tube.2013.05.002; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073563, 10.1371/journal.pone.0053163, 10.1371/journal.pone.0081438]; Miotto P, 2015, CHEST, V147, P1135, DOI 10.1378/chest.14-1286; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Petruccioli E, 2012, J INFECT DIS, V205, P1425, DOI 10.1093/infdis/jis226; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Romero Melissa R., 2012, Journal of Marine Biology, P1; Rubin EJ, 2014, NEW ENGL J MED, V370, P375, DOI 10.1056/NEJMe1312301; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Songane M, 2012, TUBERCULOSIS, V92, P388, DOI 10.1016/j.tube.2012.05.004; Srilohasin P, 2014, J CLIN MICROBIOL, V52, P4267, DOI 10.1128/JCM.01467-14; Vrba-Pech A, 2014, TUBERCULOSIS, V94, P383, DOI 10.1016/j.tube.2014.04.003; Wang J, 2015, NAT IMMUNOL, V16, P237, DOI 10.1038/ni.3096; WHO, 2014, GLOB TUB REP 2014; WHO, 2009, TREATM TUB GUID NAT; World Health Organisation, 2015, GUID MAN LAT TUB INF; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016; Zumla A, 2013, LANCET, V382, P1765, DOI 10.1016/S0140-6736(13)62078-4	31	48	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147810	10.1371/journal.pone.0147810	http://dx.doi.org/10.1371/journal.pone.0147810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815035	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528200054
J	Tan, XY; Xu, XB; Zeisberg, M; Zeisberg, EM				Tan, Xiaoying; Xu, Xingbo; Zeisberg, Michael; Zeisberg, Elisabeth M.			DNMT1 and HDAC2 Cooperate to Facilitate Aberrant Promoter Methylation in Inorganic Phosphate-Induced Endothelial-Mesenchymal Transition	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIAC FIBROSIS; KLOTHO GENE; CELLS; TARGET; SNAIL; PROGRESSION; ACTIVATION; PHOSPHORUS; PRESSURE	While phosphorus in the form of inorganic or organic phosphate is critically involved in most cellular functions, high plasma levels of inorganic phosphate levels have emerged as independent risk factor for cardiac fibrosis, cardiovascular morbidity and decreased life-expectancy. While the link of high phosphate and cardiovascular disease is commonly explained by direct cellular effects of phospho-regulatory hormones, we here explored the possibility of inorganic phosphate directly eliciting biological responses in cells. We demonstrate that human coronary endothelial cells (HCAEC) undergo an endothelial-mesenchymal transition (EndMT) when exposed to high phosphate. We further demonstrate that such EndMT is initiated by recruitment of aberrantly phosphorylated DNMT1 to the RASAL1 CpG island promoter by HDAC2, causing aberrant promoter methylation and transcriptional suppression, ultimately leading to increased Ras-GTP activity and activation of common EndMT regulators Twist and Snail. Our studies provide a novel aspect for known adverse effects of high phosphate levels, as eukaryotic cells are commonly believed to have lost phosphate-sensing mechanisms of prokaryotes during evolution, rendering them insensitive to extracellular inorganic orthophosphate. In addition, our studies provide novel insights into the mechanisms underlying specific targeting of select genes in context of fibrogenesis.	[Tan, Xiaoying; Xu, Xingbo; Zeisberg, Elisabeth M.] Univ Gottingen, Gottingen Univ Med Ctr, Dept Cardiol & Pneumol, D-37073 Gottingen, Germany; [Tan, Xiaoying; Zeisberg, Michael] Univ Gottingen, Gottingen Univ Med Ctr, Dept Nephrol & Rheumatol, D-37073 Gottingen, Germany; [Zeisberg, Michael; Zeisberg, Elisabeth M.] German Ctr Cardiovasc Res DZHK, Gottingen, Germany	University of Gottingen; University of Gottingen; German Centre for Cardiovascular Research	Zeisberg, EM (corresponding author), Univ Gottingen, Gottingen Univ Med Ctr, Dept Cardiol & Pneumol, D-37073 Gottingen, Germany.; Zeisberg, EM (corresponding author), German Ctr Cardiovasc Res DZHK, Gottingen, Germany.	elisabeth.zeisberg@med.uni-goettingen.de	Zeisberg, Elisabeth/ABG-4970-2021	Xu, Xingbo/0000-0002-8249-5507	DFG [SFB1002/C01, ZE523/4-1]; University of Gottingen Medical Center (UMG); "seed funding research program" of the Faculty of Medicine; Georg August University Gottingen	DFG(German Research Foundation (DFG)); University of Gottingen Medical Center (UMG); "seed funding research program" of the Faculty of Medicine; Georg August University Gottingen	This work was supported by DFG grants SFB1002/C01 (to EZ) and ZE523/4-1 (to MZ) and funds from the University of Gottingen Medical Center (UMG) to EZ and MZ. XX was supported by the "seed funding research program" of the Faculty of Medicine, Georg August University Gottingen.	Arking DE, 2005, CIRC RES, V96, P412, DOI 10.1161/01.RES.0000157171.04054.30; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1; Blaine J, 2015, CLIN J AM SOC NEPHRO, V10, P1257, DOI 10.2215/CJN.09750913; Chang ACY, 2011, DEV CELL, V21, P288, DOI 10.1016/j.devcel.2011.06.022; Charytan DM, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0029-6; Charytan DM, 2014, INT J CARDIOL, V176, P99, DOI 10.1016/j.ijcard.2014.06.062; Chavkin NW, 2015, EXP CELL RES, V333, P39, DOI 10.1016/j.yexcr.2015.02.002; Chen PY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005504; Czubryt MP, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-19; Damiani LA, 2008, CANCER RES, V68, P9005, DOI 10.1158/0008-5472.CAN-08-1276; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Ghosh AK, 2012, CELL SIGNAL, V24, P1031, DOI 10.1016/j.cellsig.2011.12.024; Hu MC, 2015, J AM SOC NEPHROL, V26, P1290, DOI 10.1681/ASN.2014050465; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Kuro-O M, 2011, KIDNEY INT S, V3, P420, DOI DOI 10.1038/KISUP.2013.88; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lavoie G, 2011, BIOCHEM BIOPH RES CO, V409, P187, DOI 10.1016/j.bbrc.2011.04.115; Lee SW, 2013, MOL THER, V21, P1767, DOI 10.1038/mt.2013.146; Liu Y, 2015, BBA-MOL BASIS DIS, V1852, P2456, DOI 10.1016/j.bbadis.2015.08.013; Ma KL, 2013, INT J MED SCI, V10, P420, DOI 10.7150/ijms.5723; Maeshima Y, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-13; Medici D, 2011, BIOCHEM J, V437, P515, DOI 10.1042/BJ20101500; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Saito S, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0024-y; Schaper W, 2009, BASIC RES CARDIOL, V104, P5, DOI 10.1007/s00395-008-0760-x; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shobeiri N, 2014, BRIT J CLIN PHARMACO, V77, P39, DOI 10.1111/bcp.12117; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; Stubbs JR, 2007, J AM SOC NEPHROL, V18, P2116, DOI 10.1681/ASN.2006121385; Tampe B, 2015, EBIOMEDICINE, V2, P19, DOI 10.1016/j.ebiom.2014.11.005; Tang RN, 2013, INT J CARDIOL, V162, P92, DOI 10.1016/j.ijcard.2011.06.052; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Xu XB, 2015, J BIOL CHEM, V290, P16653, DOI 10.1074/jbc.M115.636944; Xu XB, 2015, CIRC RES, V116, P857, DOI 10.1161/CIRCRESAHA.116.305629; Xu XB, 2015, CARDIOVASC RES, V105, P279, DOI 10.1093/cvr/cvv015; Yu HY, 2009, ACTA DERM-VENEREOL, V89, P351, DOI 10.2340/00015555-0634; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeng LF, 2013, J BIOL CHEM, V288, P31853, DOI 10.1074/jbc.M113.463745	44	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147816	10.1371/journal.pone.0147816	http://dx.doi.org/10.1371/journal.pone.0147816			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815200	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528200055
J	Zhao, PS; Zhang, JW; Zhao, X; Chen, GX; Ma, XF				Zhao, Pengshan; Zhang, Jiwei; Zhao, Xin; Chen, Guoxiong; Ma, Xiao-Fei			Different Sets of Post-Embryonic Development Genes Are Conserved or Lost in Two Caryophyllales Species (Reaumuria soongorica and Agriophyllum squarrosum)	PLOS ONE			English	Article							DESICCATION TOLERANCE; ARABIDOPSIS-THALIANA; ABSCISIC-ACID; MOLECULAR EVOLUTION; LEAFY PETIOLE; RESPONSES; STRESS; DEHYDRATION; GENOME; IDENTIFICATION	Reaumuria soongorica and sand rice (Agriophyllum squarrosum) belong to the clade of Caryophyllales and are widely distributed in the desert regions of north China. Both plants have evolved many specific traits and adaptation strategies to cope with recurring environmental threats. However, the genetic basis that underpins their unique traits and adaptation remains unknown. In this study, the transcriptome data of R. soongorica and sand rice were compared with three other species with previously sequenced genomes (Arabidopsis thaliana, Oryza sativa, and Beta vulgaris). Four different gene sets were identified, namely, the genes conserved in both species, those lost in both species, those conserved in R. soongorica only, and those conserved in sand rice only. Gene ontology showed that post-embryonic development genes (PEDGs) were enriched in all gene sets, and different sets of PEDGs were conserved or lost in both the R. soongorica and sand rice genomes. Expression profiles of Arabidopsis orthologs further provided some clues to the function of the species-specific conserved PEDGs. Such orthologs included LEAFY PETIOLE, which could be a candidate gene involved in the development of branch priority in sand rice.	[Zhao, Pengshan; Zhang, Jiwei; Zhao, Xin; Chen, Guoxiong; Ma, Xiao-Fei] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Stress Physiol & Ecol Cold & Arid Reg, Lanzhou, Gansu, Peoples R China; [Zhao, Pengshan; Zhang, Jiwei; Zhao, Xin; Chen, Guoxiong; Ma, Xiao-Fei] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Shapotou Desert Res & Expt Stn, Lanzhou, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Zhao, PS (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Stress Physiol & Ecol Cold & Arid Reg, Lanzhou, Gansu, Peoples R China.; Zhao, PS (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Shapotou Desert Res & Expt Stn, Lanzhou, Peoples R China.	zhaopengshan@lzb.ac.cn	Ma, Xiaofei/ABB-5302-2022	Ma, Xiaofei/0000-0001-9456-0065; zhang, ji wei/0000-0001-7402-4089	National Basic Research Program of China [2013CB429904]; National Natural Science Foundation of China [41201048]; Innovation Research Group Fund of Gansu Province, China [1308RJIA002]; "One Hundred Talents" Project of the Chinese Academy of Sciences [29Y127E71]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Research Group Fund of Gansu Province, China; "One Hundred Talents" Project of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China (973 Program, 2013CB429904), by National Natural Science Foundation of China (No. 41201048), by Innovation Research Group Fund (1308RJIA002) of Gansu Province, China, and by Grant 29Y127E71 from the "One Hundred Talents" Project of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors R, 2004, PLANT CELL, V16, P1925, DOI 10.1105/tpc.021832; Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Carretero-Paulet L, 2015, GENOME BIOL EVOL, V7, P444, DOI 10.1093/gbe/evu288; Catala R, 2007, PLANT CELL, V19, P2952, DOI 10.1105/tpc.106.049981; Chen GX, 2014, GENET RESOUR CROP EV, V61, P669, DOI 10.1007/s10722-014-0083-8; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; Davidson RM, 2012, PLANT J, V71, P492, DOI 10.1111/j.1365-313X.2012.05005.x; Dinakar C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00482; Dohm JC, 2014, NATURE, V505, P546, DOI 10.1038/nature12817; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Gaff DF, 2013, FUNCT PLANT BIOL, V40, P315, DOI 10.1071/FP12321; Gechev TS, 2013, CELL MOL LIFE SCI, V70, P689, DOI 10.1007/s00018-012-1155-6; Golicz AA, 2015, J EXP BOT, V66, P1489, DOI 10.1093/jxb/eru510; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Harmon F, 2008, PLANT J, V55, P568, DOI 10.1111/j.1365-313X.2008.03527.x; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Leprince O, 2010, PLANT SCI, V179, P554, DOI 10.1016/j.plantsci.2010.02.011; Li SF, 2009, PLANT CELL, V21, P72, DOI 10.1105/tpc.108.063503; Liu YB, 2007, J ARID ENVIRON, V70, P183, DOI 10.1016/j.jaridenv.2006.12.020; Liu YB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094277; Ma T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3797; Maia J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029123; Miura K, 2005, P NATL ACAD SCI USA, V102, P7760, DOI 10.1073/pnas.0500778102; Miura K, 2009, P NATL ACAD SCI USA, V106, P5418, DOI 10.1073/pnas.0811088106; Moon J, 2007, PLANT PHYSIOL, V143, P684, DOI 10.1104/pp.106.091439; Oliver MJ, 2011, PLANT CELL, V23, P1231, DOI 10.1105/tpc.110.082800; Oliver MJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-89; Parent JS, 2015, PLANT J, V81, P223, DOI 10.1111/tpj.12720; Rodriguez MCS, 2010, PLANT J, V63, P212, DOI 10.1111/j.1365-313X.2010.04243.x; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063993; Smarda P, 2014, P NATL ACAD SCI USA, V111, pE4096, DOI 10.1073/pnas.1321152111; Teotia S, 2009, PLANT PHYSIOL, V151, P180, DOI 10.1104/pp.109.142786; Vainonen JP, 2012, BIOCHEM J, V442, P573, DOI 10.1042/BJ20111739; van der Graaff E, 2000, DEVELOPMENT, V127, P4971; Vigeland MD, 2013, NEW PHYTOL, V199, P1060, DOI 10.1111/nph.12337; Wang XH, 2011, PLANT CELL REP, V30, P955, DOI 10.1007/s00299-011-1020-3; Ward JM, 2006, PLANT CELL, V18, P29, DOI 10.1105/tpc.105.036707; Xiao LH, 2015, P NATL ACAD SCI USA, V112, P5833, DOI 10.1073/pnas.1505811112; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yang Y, 2015, MOL BIOL EVOL, V32, P2001, DOI 10.1093/molbev/msv081; Yin HX, 2015, SCI REP-UK, V5, DOI 10.1038/srep15823; Zhang Y, 2008, PLANT PHYSIOL, V148, P2121, DOI 10.1104/pp.108.126912; Zhao PS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-872; Zhao Y, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0345-x	46	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0148034	10.1371/journal.pone.0148034	http://dx.doi.org/10.1371/journal.pone.0148034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815143	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528200068
J	Getino, M; Fernandez-Lopez, R; Palencia-Gandara, C; Campos-Gomez, J; Sanchez-Lopez, JM; Martinez, M; Fernandez, A; de la Cruz, F				Getino, Maria; Fernandez-Lopez, Raul; Palencia-Gandara, Carolina; Campos-Gomez, Javier; Sanchez-Lopez, Jose M.; Martinez, Marta; Fernandez, Antonio; de la Cruz, Fernando			Tanzawaic Acids, a Chemically Novel Set of Bacterial Conjugation Inhibitors	PLOS ONE			English	Article							RAPID COLORIMETRIC ASSAY; 2-ALKYNOIC FATTY-ACIDS; TUMOR-CELL-LINE; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; PENICILLIUM-CITRINUM; PLASMIDS; GROWTH; RELAXASE; SURVIVAL	Bacterial conjugation is the main mechanism for the dissemination of multiple antibiotic resistance in human pathogens. This dissemination could be controlled by molecules that interfere with the conjugation process. A search for conjugation inhibitors among a collection of 1,632 natural compounds, identified tanzawaic acids A and B as best hits. They specially inhibited IncW and IncFII conjugative systems, including plasmids mobilized by them. Plasmids belonging to IncFI, IncI, IncL/M, IncX and IncH incompatibility groups were targeted to a lesser extent, whereas IncN and IncP plasmids were unaffected. Tanzawaic acids showed reduced toxicity in bacterial, fungal or human cells, when compared to synthetic conjugation inhibitors, opening the possibility of their deployment in complex environments, including natural settings relevant for antibiotic resistance dissemination.	[Getino, Maria; Fernandez-Lopez, Raul; Palencia-Gandara, Carolina; Campos-Gomez, Javier; de la Cruz, Fernando] Univ Cantabria Consejo Super Invest Cient, Inst Biomed & Biotecnol Cantabria, Santander, Cantabria, Spain; [Sanchez-Lopez, Jose M.; Martinez, Marta; Fernandez, Antonio] Biomar Microbial Technol, Leon, Spain; [Campos-Gomez, Javier] So Res Inst, Drug Discovery Div, Dept Mol Biol & Biochem, Birmingham, AL 35255 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	de la Cruz, F (corresponding author), Univ Cantabria Consejo Super Invest Cient, Inst Biomed & Biotecnol Cantabria, Santander, Cantabria, Spain.	delacruz@unican.es	Palencia-Gándara, Carolina/AAT-9910-2021; de la Cruz, Fernando/L-2812-2014; Fernandez-Lopez, Raul/AAB-5928-2019; Getino, Maria/L-8541-2019	de la Cruz, Fernando/0000-0003-4758-6857; Fernandez-Lopez, Raul/0000-0002-9624-9059; Getino, Maria/0000-0002-2937-3420; Palencia-Gandara, Carolina/0000-0002-1421-8698; Campos-Gomez, Javier/0000-0002-2693-0885	Spanish Ministry of Economy and Competitiveness [BFU2014-55534-C2-1-P]; European Seventh Framework Programme [612146/FP7-ICT-2013-10, 282004/FP7-HEALTH-2011-2.3.1-2, 282004/FP7-HEALTH-2011-2.3.12]; University of Cantabria; European Molecular Biology Organization [402-2010]; Biomar Microbial Technologies	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Seventh Framework Programme(European Commission); University of Cantabria; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Biomar Microbial Technologies	Work in the FDLC group was supported by grants BFU2014-55534-C2-1-P from the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es) and 612146/FP7-ICT-2013-10 and 282004/FP7-HEALTH-2011-2.3.1-2 from the European Seventh Framework Programme (https://ec.europa.eu/research/fp7). MG was supported by a PhD fellowship from the University of Cantabria (http://www.unican.es). JCG was supported by a postdoctoral fellowship ASTF 402-2010 from the European Molecular Biology Organization (http://www.embo.org). Biomar Microbial Technologies was supported by grant 282004/FP7-HEALTH-2011-2.3.12 from the European Seventh Framework Programme (https://ec.europa.eu/research/fp7). Biomar Microbial Technologies provided support in the form of salaries for authors JMSL, MM, and AF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Baquero F, 2011, ANTIMICROB AGENTS CH, V55, P3649, DOI 10.1128/AAC.00013-11; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Carballeira NM, 2006, LIPIDS, V41, P507, DOI 10.1007/s11745-006-5124-4; Carballeira NM, 2012, BIOORG MED CHEM LETT, V22, P6185, DOI 10.1016/j.bmcl.2012.08.019; Cardoso-Martinez F, 2015, ORG BIOMOL CHEM, V13, P7248, DOI 10.1039/c5ob00773a; Christie PJ, 2014, BBA-MOL CELL RES, V1843, P1578, DOI 10.1016/j.bbamcr.2013.12.019; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Di Vaio C, 2013, J SCI FOOD AGR, V93, P1134, DOI 10.1002/jsfa.5863; Fernandez-Lopez R, 2005, MICROBIOL-SGM, V151, P3517, DOI 10.1099/mic.0.28216-0; Fernandez-Lopez R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004171; Garcillan-Barcia MP, 2007, MOL MICROBIOL, V63, P404, DOI 10.1111/j.1365-2958.2006.05523.x; GERSHON H, 1978, CAN J MICROBIOL, V24, P593, DOI 10.1139/m78-096; Getino M, 2015, MBIO, V6, DOI 10.1128/mBio.01032-15; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; GUSSONI M, 1994, MAGN RESON IMAGING, V12, P477, DOI 10.1016/0730-725X(94)92542-9; Halary S, 2010, P NATL ACAD SCI USA, V107, P127, DOI 10.1073/pnas.0908978107; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; KONTHIKAMEE W, 1982, ANTIMICROB AGENTS CH, V22, P805, DOI 10.1128/AAC.22.5.805; Kuramoto M, 1997, CHEM LETT, P885, DOI 10.1246/cl.1997.885; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Lin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019991; Lujan SA, 2007, P NATL ACAD SCI USA, V104, P12282, DOI 10.1073/pnas.0702760104; Malmstrom J, 2000, PHYTOCHEMISTRY, V54, P301, DOI 10.1016/S0031-9422(00)00106-0; MILLER JH, 1970, J BACTERIOL, V104, P1273, DOI 10.1128/JB.104.3.1273-1279.1970; Morbidoni HR, 2006, CHEM BIOL, V13, P297, DOI 10.1016/j.chembiol.2006.01.005; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nash RP, 2012, BIOCHEM BIOPH RES CO, V424, P697, DOI 10.1016/j.bbrc.2012.07.012; Niki E, 2005, BIOCHEM BIOPH RES CO, V338, P668, DOI 10.1016/j.bbrc.2005.08.072; Norman A, 2009, PHILOS T R SOC B, V364, P2275, DOI 10.1098/rstb.2009.0037; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; RESKEKUNZ AB, 1984, SCAND J IMMUNOL, V20, P97, DOI 10.1111/j.1365-3083.1984.tb00982.x; Sanabria-Rios DJ, 2014, CHEM PHYS LIPIDS, V178, P84, DOI 10.1016/j.chemphyslip.2013.12.006; Sandjo LP, 2014, BEILSTEIN J ORG CHEM, V10, P251, DOI 10.3762/bjoc.10.20; STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tasdemir D, 2010, BIOORGAN MED CHEM, V18, P7475, DOI 10.1016/j.bmc.2010.08.055; Taylor DE, 2004, PLASMID BIOLOGY, P473; TAYLOR DE, 1980, J GEN MICROBIOL, V116, P475; Quang TH, 2014, BIOORG MED CHEM LETT, V24, P5787, DOI 10.1016/j.bmcl.2014.10.035; Verovski VN, 1996, BRIT J CANCER, V73, P596, DOI 10.1038/bjc.1996.103; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521	43	32	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0148098	10.1371/journal.pone.0148098	http://dx.doi.org/10.1371/journal.pone.0148098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812051	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528000075
J	Leone, L; Mazzetta, F; Martinelli, D; Valente, S; Alimandi, M; Raffa, S; Santino, I				Leone, Laura; Mazzetta, Francesca; Martinelli, Daniela; Valente, Sabatino; Alimandi, Maurizio; Raffa, Salvatore; Santino, Iolanda			Klebsiella pneumoniae Is Able to Trigger Epithelial-Mesenchymal Transition Process in Cultured Airway Epithelial Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; EXPRESSION; INDUCTION; INFECTION; HYPOXIA; RESVERATROL; ACTIVATION; DEATH; EMT	The ability of some bacterial pathogens to activate Epithelial-Mesenchymal Transition normally is a consequence of the persistence of a local chronic inflammatory response or depends on a direct interaction of the pathogens with the host epithelial cells. In this study we monitored the abilities of the K. pneumoniae to activate the expression of genes related to EMT-like processes and the occurrence of phenotypic changes in airway epithelial cells during the early steps of cell infection. We describe changes in the production of intracellular reactive oxygen species and increased HIF-1 alpha mRNA expression in cells exposed to K. pneumoniae infection. We also describe the upregulation of a set of transcription factors implicated in the EMT processes, such as Twist, Snail and ZEB, indicating that the morphological changes of epithelial cells already appreciable after few hours from the K. pneumoniae infection are tightly regulated by the activation of transcriptional pathways, driving epithelial cells to EMT. These effects appear to be effectively counteracted by resveratrol, an antioxidant that is able to exert a sustained scavenging of the intracellular ROS. This is the first report indicating that strains of K. pneumoniae may promote EMT-like programs through direct interaction with epithelial cells without the involvement of inflammatory cells.	[Leone, Laura; Mazzetta, Francesca; Valente, Sabatino; Alimandi, Maurizio; Raffa, Salvatore; Santino, Iolanda] Univ Roma La Sapienza, Dept Clin & Mol Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Martinelli, Daniela; Santino, Iolanda] Azienda Osped St Andrea, Microbiol Unit, Rome, Italy; [Raffa, Salvatore] Azienda Osped St Andrea, Cellular Diagnost Unit, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Santino, I (corresponding author), Univ Roma La Sapienza, Dept Clin & Mol Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy.; Santino, I (corresponding author), Azienda Osped St Andrea, Microbiol Unit, Rome, Italy.	iolanda.santino@uniroma1.it	Raffa, Salvatore/GPX-5723-2022; Raffa, Salvatore/AAW-7060-2020; Alimandi, Maurizio/AAG-9246-2019; RAFFA, SALVATORE/AAL-5514-2020; Mazzetta, Francesca/AAU-7981-2020; Valente, Sabatino/D-9213-2017	Raffa, Salvatore/0000-0001-9501-7638; Alimandi, Maurizio/0000-0002-1409-6803; Valente, Sabatino/0000-0002-9614-3270				Barbara M, 2012, OTOL NEUROTOL, V33, P988, DOI 10.1097/MAO.0b013e318259b8a0; Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Borthwick LA, 2011, EUR RESPIR J, V37, P1237, DOI 10.1183/09031936.00088410; Candelario-Jalil E, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-25; Cane G, 2010, CELL MICROBIOL, V12, P640, DOI 10.1111/j.1462-5822.2009.01422.x; Cano V, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-156; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandrakesan P, 2014, ONCOGENE, V33, P2639, DOI 10.1038/onc.2013.210; De Majumdar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004627; Ding SZ, 2007, INFECT IMMUN, V75, P4030, DOI 10.1128/IAI.00172-07; Falagas ME, 2014, EMERG INFECT DIS, V20, P1170, DOI 10.3201/eid2007.121004; Franco AA, 1999, FREE RADICAL BIO MED, V27, P1122, DOI 10.1016/S0891-5849(99)00166-5; Garcia-Fernandez A, 2012, ANTIMICROB AGENTS CH, V56, P2143, DOI 10.1128/AAC.05308-11; Hofman P, 2012, GUT MICROBES, V3, P176, DOI 10.4161/gmic.20288; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim HY, 2007, EXP CELL RES, V313, P1866, DOI 10.1016/j.yexcr.2007.03.009; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kondo Y, 2012, AM J PHYSIOL-LUNG C, V303, pL1057, DOI 10.1152/ajplung.00096.2012; Kovacs D, 2009, J DERMATOL SCI, V54, P106, DOI 10.1016/j.jdermsci.2009.01.005; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Leonard SS, 2003, BIOCHEM BIOPH RES CO, V309, P1017, DOI 10.1016/j.bbrc.2003.08.105; Leone L, 2015, FUTURE MICROBIOL, V10, P743, DOI [10.2217/fmb.14.145, 10.2217/FMB.14.145]; Lin JC, 2004, MICROBES INFECT, V6, P1191, DOI 10.1016/j.micinf.2004.06.003; Markogiannakis A, 2013, FUTURE MICROBIOL, V8, P1147, DOI 10.2217/fmb.13.71; Martinez J, 2000, BIOCHEM PHARMACOL, V59, P865, DOI 10.1016/S0006-2952(99)00380-9; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nishi K, 2008, ANTIOXID REDOX SIGN, V10, P983, DOI 10.1089/ars.2007.1825; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Oh YT, 2008, NEUROSCI LETT, V431, P155, DOI 10.1016/j.neulet.2007.11.033; Passariello C, 2011, INT J MED MICROBIOL, V301, P97, DOI 10.1016/j.ijmm.2010.06.008; Pilpilidis I, 2011, J SURG RES, V166, P255, DOI 10.1016/j.jss.2010.02.012; Ranieri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057659; Saito Y, 2010, J EXP MED, V207, P2157, DOI 10.1084/jem.20100602; Santino I, 2013, INT J IMMUNOPATH PH, V26, P785, DOI 10.1177/039463201302600325; Strickertsson JAB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063147; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wright MS, 2015, ANTIMICROB AGENTS CH, V59, P536, DOI 10.1128/AAC.04037-14; Yang MH, 2008, CELL CYCLE, V7, P2090, DOI 10.4161/cc.7.14.6324; Yin YF, 2010, GUT, V59, P1037, DOI 10.1136/gut.2009.199794	39	13	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146365	10.1371/journal.pone.0146365	http://dx.doi.org/10.1371/journal.pone.0146365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812644	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528000008
J	Wang, DP; Yu, JM; Dorosky, RJ; Pierson, LS; Pierson, EA				Wang, Dongping; Yu, Jun Myoung; Dorosky, Robert J.; Pierson, Leland S., III; Pierson, Elizabeth A.			The Phenazine 2-Hydroxy-Phenazine-1-Carboxylic Acid Promotes Extracellular DNA Release and Has Broad Transcriptomic Consequences in Pseudomonas chlororaphis 30-84	PLOS ONE			English	Article							AUREOFACIENS STRAIN 30-84; BIOFILM FORMATION; FLUORESCENT PSEUDOMONADS; ANTIBIOTIC BIOSYNTHESIS; BIOLOGICAL-CONTROL; AERUGINOSA; EXPRESSION; SYSTEM; PUTIDA; GENES	Enhanced production of 2-hydroxy-phenazine-1-carboxylic acid (2-OH-PCA) by the biological control strain Pseudomonas chlororaphis 30-84 derivative 30-84O* was shown previously to promote cell adhesion and alter the three-dimensional structure of surface-attached biofilms compared to the wild type. The current study demonstrates that production of 2-OH-PCA promotes the release of extracellular DNA, which is correlated with the production of structured biofilm matrix. Moreover, the essential role of the extracellular DNA in maintaining the mass and structure of the 30-84 biofilm matrix is demonstrated. To better understand the role of different phenazines in biofilm matrix production and gene expression, transcriptomic analyses were conducted comparing gene expression patterns of populations of wild type, 30-84O* and a derivative of 30-84 producing only PCA (30-84PCA) to a phenazine defective mutant (30-84ZN) when grown in static cultures. RNA-Seq analyses identified a group of 802 genes that were differentially expressed by the phenazine producing derivatives compared to 30-84ZN, including 240 genes shared by the two 2-OH-PCA producing derivatives, the wild type and 30-84O*. A gene cluster encoding a bacteriophage-derived pyocin and its lysis cassette was upregulated in 2-OH-PCA producing derivatives. A holin encoded in this gene cluster was found to contribute to the release of eDNA in 30-84 biofilm matrices, demonstrating that the influence of 2-OH-PCA on eDNA production is due in part to cell autolysis as a result of pyocin production and release. The results expand the current understanding of the functions different phenazines play in the survival of bacteria in biofilm-forming communities.	[Wang, Dongping] Los Alamos Natl Lab, Earth & Environm Sci, POB 1663, Los Alamos, NM 87544 USA; [Yu, Jun Myoung; Dorosky, Robert J.; Pierson, Leland S., III; Pierson, Elizabeth A.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Pierson, Elizabeth A.] Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Pierson, EA (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA.; Pierson, EA (corresponding author), Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA.	eapierson@tamu.edu		Pierson, Elizabeth/0000-0001-8867-0743; Yu, Jun Myoung/0000-0003-1654-3053	National Science Foundation [0545804]; USDA NIFA [2008-35319-04490]; Director's Postdoctoral Fellowship at Los Alamos National Laboratory	National Science Foundation(National Science Foundation (NSF)); USDA NIFA(United States Department of Agriculture (USDA)); Director's Postdoctoral Fellowship at Los Alamos National Laboratory	This project was supported by the National Science Foundation, grant no. 0545804, and USDA NIFA award no. 2008-35319-04490. D. Wang was supported by a Director's Postdoctoral Fellowship at Los Alamos National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhede M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027943; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Chiang P, 2003, J BACTERIOL, V185, P2374, DOI 10.1128/JB.185.7.2374-2378.2003; Das T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08398; Das T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058299; Das T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046718; Delaney SM, 2001, J BACTERIOL, V183, P318, DOI 10.1128/JB.183.1.318-327.2001; Dotsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031092; Evans K, 1998, J BACTERIOL, V180, P5443, DOI 10.1128/JB.180.20.5443-5447.1998; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hishinuma S, 2008, FEMS MICROBIOL LETT, V289, P138, DOI 10.1111/j.1574-6968.2008.01374.x; Hishinuma S, 2006, ENVIRON MICROBIOL, V8, P2115, DOI 10.1111/j.1462-2920.2006.01088.x; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Kohler T, 1997, MOL MICROBIOL, V23, P345, DOI 10.1046/j.1365-2958.1997.2281594.x; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Maddula VSRK, 2008, J BACTERIOL, V190, P2759, DOI 10.1128/JB.01587-07; Maddula VSRK, 2006, MICROB ECOL, V52, P289, DOI 10.1007/s00248-006-9064-6; Martinez-Bueno MA, 2002, ENVIRON MICROBIOL, V4, P842, DOI 10.1046/j.1462-2920.2002.00371.x; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; MAZZOLA M, 1992, APPL ENVIRON MICROB, V58, P2616, DOI 10.1128/AEM.58.8.2616-2624.1992; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Morales DK, 2010, MOL MICROBIOL, V78, P1379, DOI 10.1111/j.1365-2958.2010.07414.x; Nakayama K, 2000, MOL MICROBIOL, V38, P213, DOI 10.1046/j.1365-2958.2000.02135.x; Petrova OE, 2012, J BACTERIOL, V194, P2413, DOI 10.1128/JB.00003-12; Pierson E. A., 2013, MICROBIAL PHENAZINES, P141, DOI [10.1007/978-3-642-40573-0_7, DOI 10.1007/978-3-642-40573-0_7]; PIERSON LS, 1992, MOL PLANT MICROBE IN, V5, P330, DOI 10.1094/MPMI-5-330; PIERSON LS, 1995, FEMS MICROBIOL LETT, V134, P299, DOI 10.1111/j.1574-6968.1995.tb07954.x; PIERSON LS, 1994, J BACTERIOL, V176, P3966, DOI 10.1128/JB.176.13.3966-3974.1994; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sonnleitner E, 2011, MOL MICROBIOL, V80, P868, DOI 10.1111/j.1365-2958.2011.07620.x; Wang DP, 2015, APPL ENVIRON MICROB, V81, P890, DOI 10.1128/AEM.02617-14; Wang DP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-618; Wang DP, 2013, MICROBIOLOGYOPEN, V2, P505, DOI 10.1002/mbo3.90; Wang DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045038; Wang DP, 2012, MICROBIOL-SGM, V158, P1745, DOI 10.1099/mic.0.059352-0; Wang DP, 2012, MOL PLANT MICROBE IN, V25, P6, DOI 10.1094/MPMI-08-11-0207; Wang DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025293; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; Wood DW, 1996, GENE, V168, P49, DOI 10.1016/0378-1119(95)00754-7; Zhang ZG, 2001, APPL ENVIRON MICROB, V67, P4305, DOI 10.1128/AEM.67.9.4305-4315.2001	47	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0148003	10.1371/journal.pone.0148003	http://dx.doi.org/10.1371/journal.pone.0148003			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812402	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528000070
J	Azizi, S; Nematollahi, MA; Amiri, BM; Velez, EJ; Lutfi, E; Navarro, I; Capilla, E; Gutierrez, J				Azizi, Sheida; Nematollahi, Mohammad Ali; Amiri, Bagher Mojazi; Velez, Emilio J.; Lutfi, Esmail; Navarro, Isabel; Capilla, Encarnacion; Gutierrez, Joaquim			Lysine and Leucine Deficiencies Affect Myocytes Development and IGF Signaling in Gilthead Sea Bream (Sparus aurata)	PLOS ONE			English	Article							MUSCLE-CELL DIFFERENTIATION; MYOGENIC REGULATORY FACTORS; HEPATIC GENE-EXPRESSION; IN-VITRO ASSESSMENT; RAINBOW-TROUT; SKELETAL-MUSCLE; GROWTH-PERFORMANCE; ATLANTIC SALMON; COMPENSATORY GROWTH; RECEPTOR EXPRESSION	Optimizing aquaculture production requires better knowledge of growth regulation and improvement in diet formulation. A great effort has been made to replace fish meal for plant protein sources in aquafeeds, making necessary the supplementation of such diets with crystalline amino acids (AA) to cover the nutritional requirements of each species. Lysine and Leucine are limiting essential AA in fish, and it has been demonstrated that supplementation with them improves growth in different species. However, the specific effects of AA deficiencies in myogenesis are completely unknown and have only been studied at the level of hepatic metabolism. It is well-known that the TOR pathway integrates the nutritional and hormonal signals to regulate protein synthesis and cell proliferation, to finally control muscle growth, a process also coordinated by the expression of myogenic regulatory factors (MRFs). This study aimed to provide new information on the impact of Lysine and Leucine deficiencies in gilthead sea bream cultured myocytes examining their development and the response of insulin-like growth factors (IGFs), MRFs, as well as key molecules involved in muscle growth regulation like TOR. Leucine deficiency did not cause significant differences in most of the molecules analyzed, whereas Lysine deficiency appeared crucial in IGFs regulation, decreasing significantly IGF-I, IGF-II and IGF-IRb mRNA levels. This treatment also down-regulated the gene expression of different MRFs, including Myf5, Myogenin and MyoD2. These changes were also corroborated by a significant decrease in proliferation and differentiation markers in the Lysine-deficient treatment. Moreover, both Lysine and Leucine limitation induced a significant down-regulation in FOXO3 gene expression, which deserves further investigation. We believe that these results will be relevant for the production of a species as appreciated for human consumption as it is gilthead sea bream and demonstrates the importance of an adequate level of Lysine in fishmeal diet formulation for optimum growth.	[Azizi, Sheida; Nematollahi, Mohammad Ali; Amiri, Bagher Mojazi] Univ Tehran, Fac Nat Resources, Dept Fisheries Sci, Karaj, Iran; [Azizi, Sheida; Velez, Emilio J.; Lutfi, Esmail; Navarro, Isabel; Capilla, Encarnacion; Gutierrez, Joaquim] Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona 08028, Spain	University of Tehran; University of Barcelona	Nematollahi, MA (corresponding author), Univ Tehran, Fac Nat Resources, Dept Fisheries Sci, Karaj, Iran.; Gutierrez, J (corresponding author), Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona 08028, Spain.	malahi@ut.ac.ir; jgutierrez@ub.edu	Lutfi, Esmail/J-3529-2017; Gutierrez, Joaquim/H-2836-2015; Vélez, Emilio J/M-7661-2015; Capilla, Encarnación/L-6143-2014; Amiri, Bagher Mojazi/AAP-3899-2021; Azizi, Sheida/F-2085-2017; NAVARRO ALVAREZ, ISABEL/L-9318-2014	Lutfi, Esmail/0000-0002-0208-9075; Gutierrez, Joaquim/0000-0002-3126-2236; Vélez, Emilio J/0000-0002-6363-0697; Capilla, Encarnación/0000-0002-0863-9728; Amiri, Bagher Mojazi/0000-0002-3862-3460; NAVARRO ALVAREZ, ISABEL/0000-0002-2641-0361	"Ministerio de Ciencia e Innovacion" (MICINN) [AGL2009-12427, AGL2012-39768]; "Xarxa de Referencia d'R+D+I en Aquicultura"; "Generalitat de Catalunya" [2009SGR-00402, 2014SGR-01371]	"Ministerio de Ciencia e Innovacion" (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); "Xarxa de Referencia d'R+D+I en Aquicultura"; "Generalitat de Catalunya"(Generalitat de Catalunya)	E.J.V. is supported by a predoctoral fellowship from the "Ministerio de Ciencia e Innovacion" (MICINN). This study was supported by the projects from the MICINN AGL2009-12427 and AGL2012-39768 to J.G., and the "Xarxa de Referencia d'R+D+I en Aquicultura" and the 2009SGR-00402 and 2014SGR-01371 from the "Generalitat de Catalunya". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GR, 2002, J APPL PHYSIOL, V93, P1159, DOI 10.1152/japplphysiol.01264.2001; Alami-Durante H, 2010, COMP BIOCHEM PHYS A, V156, P561, DOI 10.1016/j.cbpa.2010.04.015; Anthony JC, 2002, DIABETES, V51, P928, DOI 10.2337/diabetes.51.4.928; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Averous J, 2012, EXP CELL RES, V318, P217, DOI 10.1016/j.yexcr.2011.10.015; Azizi S, 2016, GEN COMP ENDOCR, V232, P7, DOI 10.1016/j.ygcen.2015.11.011; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Belghit I, 2014, BRIT J NUTR, V112, P493, DOI 10.1017/S0007114514001226; Benedito-Palos L, 2008, BRIT J NUTR, V100, P992, DOI 10.1017/S0007114508966071; Benedito-Palos L, 2007, AQUACULTURE, V267, P199, DOI 10.1016/j.aquaculture.2007.01.011; Bower NI, 2012, J BIOL CHEM, V287, P43936, DOI 10.1074/jbc.M112.361311; Bower NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011100; Bower NI, 2010, AM J PHYSIOL-REG I, V298, pR1615, DOI 10.1152/ajpregu.00114.2010; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Capilla E, 2011, GEN COMP ENDOCR, V172, P107, DOI 10.1016/j.ygcen.2011.03.020; Castillo J, 2004, AM J PHYSIOL-REG I, V286, pR935, DOI 10.1152/ajpregu.00459.2003; Castillo J, 2002, AM J PHYSIOL-REG I, V283, pR647, DOI 10.1152/ajpregu.00121.2002; Chauvigne F, 2003, GEN COMP ENDOCR, V132, P209, DOI 10.1016/S0016-6480(03)00081-9; CHOO PS, 1991, J NUTR, V121, P1932, DOI 10.1093/jn/121.12.1932; Codina M, 2008, GEN COMP ENDOCR, V157, P116, DOI 10.1016/j.ygcen.2008.04.009; Davies SJ, 1997, AQUAC RES, V28, P65, DOI 10.1111/j.1365-2109.1997.tb01316.x; Davies SJ, 1997, AQUAC RES, V28, P317; de Celis SVR, 2004, COMP BIOCHEM PHYS A, V138, P533, DOI 10.1016/j.cbpb.2004.06.007; de la Serrana DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074295; Deng DF, 2010, AQUACULTURE, V308, P44, DOI 10.1016/j.aquaculture.2010.07.041; Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; Du M, 2007, J ANIM SCI, V85, P919, DOI 10.2527/jas.2006-342; Duan CM, 1997, AM ZOOL, V37, P491; Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022; Duan CM, 2010, GEN COMP ENDOCR, V167, P344, DOI 10.1016/j.ygcen.2010.04.009; DUGUAY SJ, 1994, J MOL ENDOCRINOL, V12, P25, DOI 10.1677/jme.0.0120025; Duguay SJ, 1996, J MOL ENDOCRINOL, V16, P123, DOI 10.1677/jme.0.0160123; Gabillard JC, 2003, GEN COMP ENDOCR, V133, P233, DOI 10.1016/S0016-6480(03)00167-9; de la Serrana DG, 2014, COMP BIOCHEM PHYS A, V167, P90, DOI 10.1016/j.cbpa.2013.10.020; Gaylord TG, 2009, AQUACULTURE, V287, P180, DOI 10.1016/j.aquaculture.2008.10.037; GONG SS, 1991, MOL CELL BIOL, V11, P6059, DOI 10.1128/MCB.11.12.6059; Hevroy EM, 2007, GEN COMP ENDOCR, V152, P39, DOI 10.1016/j.ygcen.2007.02.015; Hevroy EM, 2008, COMP BIOCHEM PHYS A, V151, P621, DOI 10.1016/j.cbpa.2008.07.026; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; JAMES PL, 1993, J BIOL CHEM, V268, P22305; Jash S, 2014, MOL CELL BIOL, V34, P3594, DOI 10.1128/MCB.00742-14; Jimenez-Amilburu V, 2013, GEN COMP ENDOCR, V188, P151, DOI 10.1016/j.ygcen.2013.02.033; Jobling M., 2012, AQUACULT INT, V20, P601, DOI [DOI 10.1007/S10499-011-9480-6, 10.1007/s10499-011-9480-6]; Kim E, 2009, NUTR RES PRACT, V3, P64, DOI 10.4162/nrp.2009.3.1.64; Kwasek K, 2012, REV FISH BIOL FISHER, V22, P797, DOI 10.1007/s11160-012-9266-6; Lansard M, 2010, AMINO ACIDS, V39, P801, DOI 10.1007/s00726-010-0533-3; Le Bail PY, 1998, ANN NY ACAD SCI, V839, P157; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Meijer AJ, 2003, J NUTR, V133, p2057S, DOI 10.1093/jn/133.6.2057S; Mommsen Thomas W., 2001, Fish Physiology, V18, P251; Montserrat N, 2007, CELL TISSUE RES, V330, P503, DOI 10.1007/s00441-007-0507-2; Montserrat N, 2007, GEN COMP ENDOCR, V150, P462, DOI 10.1016/j.ygcen.2006.11.009; Montserrat Nuria, 2012, Front Endocrinol (Lausanne), V3, P55, DOI 10.3389/fendo.2012.00055; Moriyama S, 2000, BIOSCI BIOTECH BIOCH, V64, P1553, DOI 10.1271/bbb.64.1553; Picha ME, 2008, J ENDOCRINOL, V199, P81, DOI 10.1677/JOE-07-0649; Planas JV, 2000, AM ZOOL, V40, P223, DOI 10.1668/0003-1569(2000)040[0223:FIIIAI]2.0.CO;2; Pozios KC, 2001, AM J PHYSIOL-REG I, V280, pR1230, DOI 10.1152/ajpregu.2001.280.4.R1230; Ren HX, 2008, J CELL BIOL, V182, P979, DOI 10.1083/jcb.200712110; Rius-Francino M, 2011, GEN COMP ENDOCR, V172, P44, DOI 10.1016/j.ygcen.2011.03.024; Rolland M, 2015, COMP BIOCHEM PHYS B, V181, P33, DOI 10.1016/j.cbpb.2014.11.009; ROSENTHAL SM, 1991, J CLIN INVEST, V87, P1212, DOI 10.1172/JCI115121; ROTWEIN P, 1995, MOL ENDOCRINOL, V9, P913, DOI 10.1210/me.9.7.913; Salmeron C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075349; Seiliez I, 2008, AM J PHYSIOL-REG I, V295, pR329, DOI 10.1152/ajpregu.00146.2008; Seiliez I, 2012, AUTOPHAGY, V8, P364, DOI 10.4161/auto.18863; Seiliez I, 2010, COMP BIOCHEM PHYS B, V157, P258, DOI 10.1016/j.cbpb.2010.06.011; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Siwicki AK, 2003, J APPL ICHTHYOL, V19, P44, DOI 10.1046/j.1439-0426.2003.00348.x; Snyder GS, 2012, AQUACULTURE, V338, P72, DOI 10.1016/j.aquaculture.2011.12.042; Nguyen MV, 2014, AQUACULT NUTR, V20, P25, DOI 10.1111/anu.12043; Velez EJ, 2014, GEN COMP ENDOCR, V205, P296, DOI 10.1016/j.ygcen.2014.05.024; Wacyk J, 2012, AQUACULTURE, V356, P223, DOI 10.1016/j.aquaculture.2012.05.013; Yabu T, 2012, MAR BIOTECHNOL, V14, P491, DOI 10.1007/s10126-012-9432-9; Yang SD, 2011, AQUACULTURE, V312, P102, DOI 10.1016/j.aquaculture.2010.12.011; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	76	30	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147618	10.1371/journal.pone.0147618	http://dx.doi.org/10.1371/journal.pone.0147618			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808650	Green Submitted, gold, Green Published			2022-12-26	WOS:000369527800150
J	Chaudhari, MR; Fallavollita, JA; Farkas, GA				Chaudhari, Milind R.; Fallavollita, James A.; Farkas, Gaspar A.			The Effects of Experimental Sleep Apnea on Cardiac and Respiratory Functions in 6 and 18 Month Old Dystrophic (mdx) Mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; CHRONIC INTERMITTENT HYPOXIA; OBESE ZUCKER RATS; VOLUNTARY EXERCISE; ANESTHETIZED MICE; DIAPHRAGM MUSCLE; OXIDATIVE STRESS; NOCTURNAL ANGINA; GENE-EXPRESSION; HEART-FAILURE	Duchenne muscular dystrophy (DMD) is a fatal disease where over 90% of patients succumb to respiratory or cardiac failure. Sleep apnea and sleep disordered breathing (SDB) are noted in a plurality of DMD patients, and the resulting nocturnal episodic hypoxia (EH) cannot be ruled out as a contributing factor to cardiac and respiratory dysfunction. In this study, we investigated the impact of long-term episodic hypoxia, which mimics the cyclic hypoxia seen in sleep apnea, on cardiac and respiratory function in a murine model of DMD (mdx mice). Since the severity and prevalence of sleep apnea in DMD increases with age, we studied the impact of EH on young (6-month) and on older (18-month) mdx mice. Mice were either exposed for 12 weeks to EH (8 hours/day, 5 days/week) or to room air. We noted a significant increase in left ventricular (LV) dilatation (transthoracic echocardiography) on EH exposure in both age groups, but reduced LV contractility was seen only in 6-month old mice. With EH exposure, an increased fibrosis (hydroxyproline) was noted in both cardiac and diaphragm muscle in 18-month but not 6-month old mice. No significant change in relative diaphragm strength (in-vitro) was noted on EH exposure in 18-month old mice. In contrast, EH exposed 6-month old mice showed a significant increase in relative diaphragm strength. EH exposure did not result in any significant change in ventilatory parameters (barometric plethysmography) in awake 6-month old mdx mice. In contrast, 18-month old mdx mice showed considerable ventilatory dysfunction, consistent with reduced ventilatory reserve. Our findings highlight that sleep apnea impacts respiratory and cardiac function in muscular dystrophy, and that EH can have divergent effects on both systems. To our knowledge, this is the first comprehensive study to investigate the impact of EH on cardiac and respiratory function in mdx mice.	[Chaudhari, Milind R.; Farkas, Gaspar A.] SUNY Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA; [Chaudhari, Milind R.; Fallavollita, James A.] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA; [Chaudhari, Milind R.] SUNY Buffalo, Dept Epidemiol & Environm Hlth, Buffalo, NY 14260 USA; [Fallavollita, James A.] SUNY Buffalo, Ctr Res Cardiovasc Med, Buffalo, NY 14260 USA; [Fallavollita, James A.] VA Western New York Healthcare Syst Buffalo, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Farkas, GA (corresponding author), SUNY Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA.	farkas@buffalo.edu			National Institutes of Health [R21AR53901]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR053901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health R21AR53901 - (NIH.Gov) GAF.	AMBROSIO G, 1991, J CLIN INVEST, V87, P2056, DOI 10.1172/JCI115236; Ameen Venus, 2010, Open Cardiovasc Med J, V4, P265, DOI 10.2174/1874192401004010265; [Anonymous], 2004, REV MALADIES RESP 2, V21, p7S5; Au CG, 2011, INT J EXP PATHOL, V92, P57, DOI 10.1111/j.1365-2613.2010.00750.x; BARBE F, 1994, EUR RESPIR J, V7, P1403, DOI 10.1183/09031936.94.07081403; BARTLETT D, 1970, RESP PHYSIOL, V10, P384, DOI 10.1016/0034-5687(70)90056-3; Bia BL, 1999, J MOL CELL CARDIOL, V31, P1857, DOI 10.1006/jmcc.1999.1018; Bockhold KJ, 1998, MUSCLE NERVE, V21, P173, DOI 10.1002/(SICI)1097-4598(199802)21:2<173::AID-MUS4>3.0.CO;2-8; Bostick B, 2008, CIRC RES, V102, P121, DOI 10.1161/CIRCRESAHA.107.162982; Bradley TD, 2003, CIRCULATION, V107, P1671, DOI 10.1161/01.CIR.0000061757.12581.15; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Brussee V, 1997, NEUROMUSCULAR DISORD, V7, P487, DOI 10.1016/S0960-8966(97)00115-6; Campen MJ, 2005, J APPL PHYSIOL, V99, P2028, DOI 10.1152/japplphysiol.00411.2005; CHAN HS, 1991, CHEST, V99, P1023, DOI 10.1378/chest.99.4.1023; Chen L, 2008, J APPL PHYSIOL, V104, P218, DOI 10.1152/japplphysiol.00301.2007; CLOSE RI, 1972, PHYSIOL REV, V52, P129, DOI 10.1152/physrev.1972.52.1.129; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; Danialou G, 2001, FASEB J, V15, P1655, DOI 10.1096/fj.01-0030fje; Dematteis M, 2008, AM J RESP CRIT CARE, V177, P227, DOI 10.1164/rccm.200702-238OC; DRORBAUGH JE, 1955, PEDIATRICS, V16, P81; DUPONTVERSTEEGDEN EE, 1994, J APPL PHYSIOL, V77, P1736, DOI 10.1152/jappl.1994.77.4.1736; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Fan CH, 2005, PHYSIOL GENOMICS, V22, P292, DOI 10.1152/physiolgenomics.00217.2004; FARKAS GA, 1994, J APPL PHYSIOL, V77, P2250, DOI 10.1152/jappl.1994.77.5.2250; Farkas GA, 2007, MUSCLE NERVE, V36, P708, DOI 10.1002/mus.20858; Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446; FRANKLIN KA, 1995, LANCET, V345, P1085, DOI 10.1016/S0140-6736(95)90820-X; Gayraud J, 2007, J MUSCLE RES CELL M, V28, P29, DOI 10.1007/s10974-007-9101-1; GOSSELIN LE, 1994, AM J RESP CRIT CARE, V150, P174, DOI 10.1164/ajrccm.150.1.8025746; Gosselin LE, 2004, MUSCLE NERVE, V30, P645, DOI 10.1002/mus.20150; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Hayashi T, 2011, AM J PHYSIOL-HEART C, V301, pH1062, DOI 10.1152/ajpheart.00150.2011; Hayes A, 1996, J APPL PHYSIOL, V80, P670, DOI 10.1152/jappl.1996.80.2.670; Heslop L, 2000, J CELL SCI, V113, P2299; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Jearawiriyapaisarn N, 2010, CARDIOVASC RES, V85, P444, DOI 10.1093/cvr/cvp335; Joyeux-Faure M, 2005, J APPL PHYSIOL, V98, P1691, DOI 10.1152/japplphysiol.01146.2004; Labanowski M, 1996, NEUROLOGY, V47, P1173, DOI 10.1212/WNL.47.5.1173; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee SD, 2000, AM J RESP CRIT CARE, V162, P1009, DOI 10.1164/ajrccm.162.3.9909058; Lin M, 2007, AM J PHYSIOL-HEART C, V293, pH997, DOI 10.1152/ajpheart.01124.2006; Maddika S, 2009, CAN J PHYSIOL PHARM, V87, P120, DOI 10.1139/Y08-105; Markham LW, 2006, J AM SOC ECHOCARDIOG, V19, P865, DOI 10.1016/j.echo.2006.02.003; Matecki S, 2004, AM J PHYSIOL-REG I, V287, pR961, DOI 10.1152/ajpregu.00146.2004; Matsumoto C, 2009, HYPERTENSION, V54, P164, DOI 10.1161/HYPERTENSIONAHA.109.131391; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McGuire M, 1999, RESP PHYSIOL, V117, P53, DOI 10.1016/S0034-5687(99)00047-X; Mosqueira M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069567; MYERS ML, 1985, CIRCULATION, V72, P915, DOI 10.1161/01.CIR.72.4.915; Naghshin J, 2009, J APPL PHYSIOL, V107, P787, DOI 10.1152/japplphysiol.91256.2008; NIGRO G, 1990, INT J CARDIOL, V26, P271, DOI 10.1016/0167-5273(90)90082-G; Peled N, 1999, J AM COLL CARDIOL, V34, P1744, DOI 10.1016/S0735-1097(99)00407-6; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; PROCKOP DJ, 1960, ANAL BIOCHEM, V1, P228, DOI 10.1016/0003-2697(60)90050-6; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Rosa CM, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-152; Roth DM, 2002, AM J PHYSIOL-HEART C, V282, pH2134, DOI 10.1152/ajpheart.00845.2001; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; SMITH PEM, 1988, AM REV RESPIR DIS, V137, P884, DOI 10.1164/ajrccm/137.4.884; Spencer MJ, 2000, NEUROMUSCULAR DISORD, V10, P612, DOI 10.1016/S0960-8966(00)00160-7; Spurney CF, 2011, J CARDIOVASC PHARM T, V16, P87, DOI 10.1177/1074248410381757; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; SWITZER BR, 1971, ANAL BIOCHEM, V39, P487, DOI 10.1016/0003-2697(71)90438-6; Tan TP, 2003, J CARDIOVASC PHARM, V42, P182, DOI 10.1097/00005344-200308000-00005; TOLEP K, 1995, AM J RESP CRIT CARE, V152, P677, DOI 10.1164/ajrccm.152.2.7633725; TURNER PR, 1991, J CELL BIOL, V115, P1701, DOI 10.1083/jcb.115.6.1701; Van Erp C, 2010, MUSCLE NERVE, V42, P504, DOI 10.1002/mus.21716; Vilquin JT, 1998, MUSCLE NERVE, V21, P567, DOI 10.1002/(SICI)1097-4598(199805)21:5<567::AID-MUS2>3.0.CO;2-6; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Wehling-Henricks M, 2005, HUM MOL GENET, V14, P1921, DOI 10.1093/hmg/ddi197; Whitehead NP, 2006, CLIN EXP PHARMACOL P, V33, P657, DOI 10.1111/j.1440-1681.2006.04394.x; Wineinger MA, 1998, AM J PHYS MED REHAB, V77, P20, DOI 10.1097/00002060-199801000-00004; Wolk R, 2003, CIRCULATION, V108, P9, DOI 10.1161/01.CIR.0000072346.56728.E4; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Zhang W, 2008, J MOL CELL CARDIOL, V45, P754, DOI 10.1016/j.yjmcc.2008.09.125	76	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147640	10.1371/journal.pone.0147640	http://dx.doi.org/10.1371/journal.pone.0147640			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808526	gold, Green Submitted, Green Published			2022-12-26	WOS:000369527800162
J	Gil, DPI; Clayton, C				Gil, Diana P. Inchaustegui; Clayton, Christine			Purification of Messenger Ribonucleoprotein Particles via a Tagged Nascent Polypeptide	PLOS ONE			English	Article							RNA-BINDING PROTEINS; 3 UNTRANSLATED REGION; TRYPANOSOMA-BRUCEI; AFFINITY PURIFICATION; POLYPYRIMIDINE TRACT; IN-VIVO; EXPRESSION; POLYSOMES; IDENTIFICATION; COMPLEXES	The cytoplasmic fates of mRNAs are influenced by interactions between RNA-binding proteins and cis regulatory motifs. In the cytoplasm, mRNAs are present as messenger ribonucleoprotein particles, which include not only proteins that bind directly to the mRNA, but also additional proteins that are recruited via protein-protein interactions. Many labs have sought to purify such particles from cells, with limited success. We here describe a simple two-step procedure to purify actively translated mRNAs, with their associated proteins, from polysomes. We use a reporter mRNA that encodes a protein with three streptavidin binding peptides at the N-terminus. The polysomal reporter mRNA, with associated proteins, is purified via binding to a streptavidin matrix. The method takes four days, and can be applied in any cell that can be genetically manipulated. Using Trypanosoma brucei as a model system, we routinely purified 8% of the input reporter mRNA, with roughly 22-fold enrichment relative to un-tagged mRNAs, a final reporter-mRNA: total-mRNA ratio of about 1: 10, and a protein purification factor of slightly over 1000-fold. Although the overall reporter mRNP composition is masked by the presence of proteins that are associated with many polysomal mRNAs, our method can be used to detect association of an RNA-binding protein that binds to specifically to a reporter mRNA.	[Gil, Diana P. Inchaustegui; Clayton, Christine] Zentrum Mol Biol Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Heidelberg, Germany; [Gil, Diana P. Inchaustegui] Dieselstr 1A,Wohnung 10, D-63225 Langen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Clayton, C (corresponding author), Zentrum Mol Biol Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Heidelberg, Germany.	cclayton@zmbh.uni-heidelberg.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busby M, 2010, BIOPHYS CHEM, V152, P170, DOI 10.1016/j.bpc.2010.09.005; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; CORDINGLEY JS, 1980, MOL BIOCHEM PARASIT, V1, P129, DOI 10.1016/0166-6851(80)90011-0; De Gaudenzi JG, 2003, J BIOL CHEM, V278, P18884, DOI 10.1074/jbc.M301756200; Droll D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003286; Estevez AM, 2008, NUCLEIC ACIDS RES, V36, P4573, DOI 10.1093/nar/gkn406; Fadda A, 2014, MOL MICROBIOL, V94, P307, DOI 10.1111/mmi.12764; Furger A, 1997, MOL CELL BIOL, V17, P4372, DOI 10.1128/MCB.17.8.4372; GELVIN S, 1977, P NATL ACAD SCI USA, V74, P3193, DOI 10.1073/pnas.74.8.3193; GRONER B, 1977, J BIOL CHEM, V252, P6666; Haanstra JR, 2008, J BIOL CHEM, V283, P2495, DOI 10.1074/jbc.M705782200; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hartmann C, 2007, EUKARYOT CELL, V6, P1964, DOI 10.1128/EC.00279-07; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; HEHL A, 1994, P NATL ACAD SCI USA, V91, P370, DOI 10.1073/pnas.91.1.370; Hotz HR, 1997, NUCLEIC ACIDS RES, V25, P3017, DOI 10.1093/nar/25.15.3017; Klein C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135973; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Leppek K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt956; LHEUREUX M, 1979, NUCLEIC ACIDS RES, V7, P595, DOI 10.1093/nar/7.3.595; Li ZH, 2012, J BIOL CHEM; MACGILLIVRAY RTA, 1980, P NATL ACAD SCI-BIOL, V77, P5153, DOI 10.1073/pnas.77.9.5153; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; PALFI Z, 1991, P NATL ACAD SCI USA, V88, P9097, DOI 10.1073/pnas.88.20.9097; Pena AC, 2014, MOL MICROBIOL, V93, P645, DOI 10.1111/mmi.12677; SCHUTZ G, 1977, NUCLEIC ACIDS RES, V4, P71, DOI 10.1093/nar/4.1.71; Singh A, 2014, NUCLEIC ACIDS RES, V42, P4652, DOI 10.1093/nar/gkt1416; Slobodin B, 2010, RNA, V16, P2277, DOI 10.1261/rna.2091710; Stern MZ, 2009, RNA, V15, P648, DOI 10.1261/rna.1230209; Walker Scott C., 2008, V488, P23, DOI 10.1007/978-1-60327-475-3_3; Wurst M, 2012, MOL MICROBIOL, V83, P1048, DOI 10.1111/j.1365-2958.2012.07988.x; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0148131	10.1371/journal.pone.0148131	http://dx.doi.org/10.1371/journal.pone.0148131			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808308	gold, Green Submitted, Green Published			2022-12-26	WOS:000369527800272
J	Jalowiecki, L; Chojniak, JM; Dorgeloh, E; Hegedusova, B; Ejhed, H; Magner, J; Plaza, GA				Jalowiecki, Lukasz; Chojniak, Joanna Malgorzata; Dorgeloh, Elmar; Hegedusova, Berta; Ejhed, Helene; Magner, Jorgen; Plaza, Grazyna Anna			Microbial Community Profiles in Wastewaters from Onsite Wastewater Treatment Systems Technology	PLOS ONE			English	Article							LEVEL PHYSIOLOGICAL PROFILES; BIOLOGICAL CHARACTERISTICS; BACTERIAL COMMUNITIES; FUNCTIONAL DIVERSITY; PERFORMANCE; SITE; PLANT	The aim of the study was to determine the potential of community-level physiological profiles (CLPPs) methodology as an assay for characterization of the metabolic diversity of wastewater samples and to link the metabolic diversity patterns to efficiency of select onsite biological wastewater facilities. Metabolic fingerprints obtained from the selected samples were used to understand functional diversity implied by the carbon substrate shifts. Three different biological facilities of onsite wastewater treatment were evaluated: fixed bed reactor (technology A), trickling filter/biofilter system (technology B), and aerated filter system (the fluidized bed reactor, technology C). High similarities of the microbial community functional structures were found among the samples from the three onsite wastewater treatment plants (WWTPs), as shown by the diversity indices. Principal components analysis (PCA) showed that the diversity and CLPPs of microbial communities depended on the working efficiency of the wastewater treatment technologies. This study provided an overall picture of microbial community functional structures of investigated samples in WWTPs and discerned the linkages between microbial communities and technologies of onsite WWTPs used. The results obtained confirmed that metabolic profiles could be used to monitor treatment processes as valuable biological indicators of onsite wastewater treatment technologies efficiency. This is the first step toward understanding relations of technology types with microbial community patterns in raw and treated wastewaters.	[Jalowiecki, Lukasz; Chojniak, Joanna Malgorzata; Plaza, Grazyna Anna] Inst Ecol Ind Areas, Dept Environm Microbiol, Katowice, Poland; [Dorgeloh, Elmar; Hegedusova, Berta] Rhein Westfal TH Aachen, Dev & Assessment Inst Waste Water Technol, Aachen, Germany; [Ejhed, Helene; Magner, Jorgen] IVL Swedish Environm Res Inst, Nat Resources & Environm Effects, Stockholm, Sweden	Institute for Ecology of Industrial Areas; RWTH Aachen University; IVL Swedish Environmental Research Institute	Plaza, GA (corresponding author), Inst Ecol Ind Areas, Dept Environm Microbiol, Katowice, Poland.	pla@ietu.katowice.pl		Chojniak-Gronek, Joanna/0000-0002-9288-8953; Plaza, Grazyna/0000-0001-5862-0905; Jalowiecki, Lukasz/0000-0002-1468-6811	BONUS EEIG [2112932-1]	BONUS EEIG	Optimization of small wastewater treatment facilities (OPTITREAT)" no. 2112932-1 financed by BONUS EEIG.	Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Bradley RL, 2006, SOIL BIOL BIOCHEM, V38, P629, DOI 10.1016/j.soilbio.2005.07.002; Cicek N, 2001, WATER SCI TECHNOL, V43, P43, DOI 10.2166/wst.2001.0665; EPA, 2002, 821R02012 EPA US; Garcia SN, 2013, CHEMOSPHERE, V92, P38, DOI 10.1016/j.chemosphere.2013.03.007; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Gomez E, 2004, APPL SOIL ECOL, V26, P21, DOI 10.1016/j.apsoil.2003.10.007; Hench KR, 2004, WATER ENVIRON RES, V76, P468, DOI 10.2175/106143004X151554; Kapley A, 2007, RES MICROBIOL, V158, P494, DOI 10.1016/j.resmic.2007.04.004; Kapley A, 2007, BIORESOURCE TECHNOL, V98, P2479, DOI 10.1016/j.biortech.2006.09.012; Kenarova A, 2014, ECOTOX ENVIRON SAFE, V100, P226, DOI 10.1016/j.ecoenv.2013.11.012; Kirk JL, 2004, J MICROBIOL METH, V58, P169, DOI 10.1016/j.mimet.2004.04.006; Li JM, 2010, CAN J MICROBIOL, V56, P352, DOI [10.1139/w10-009, 10.1139/W10-009]; Liu Y, 2005, BIORESOURCE TECHNOL, V96, P1205, DOI 10.1016/j.biortech.2004.11.003; Manefield M, 2005, ENVIRON MICROBIOL, V7, P715, DOI 10.1111/j.1462-2920.2004.00746.x; Massoud MA, 2009, J ENVIRON MANAGE, V90, P652, DOI 10.1016/j.jenvman.2008.07.001; Nakajima J, 1999, WATER SCI TECHNOL, V39, P85, DOI 10.1016/S0273-1223(99)00189-4; Osem Y, 2007, ECOL ENG, V29, P133, DOI 10.1016/j.ecoleng.2006.06.003; Paul D, 2006, FEMS MICROBIOL ECOL, V57, P116, DOI 10.1111/j.1574-6941.2006.00103.x; Preston-Mafham J, 2002, FEMS MICROBIOL ECOL, V42, P1, DOI 10.1111/j.1574-6941.2002.tb00990.x; Rani A, 2008, BIORESOURCE TECHNOL, V99, P7098, DOI 10.1016/j.biortech.2008.01.003; Stefanis C, 2013, FOLIA MICROBIOL, V58, P61, DOI 10.1007/s12223-012-0179-5; Tiquia SM, 2010, ENVIRON POLLUT, V158, P1435, DOI 10.1016/j.envpol.2009.12.035; US Environmental Protection Agency, 2002, EPA652R00008 OFF WAT; US Environmental Protection Agency, 2005, 832B05001 EPA OFF WA; van Heerden J, 2002, WATER SA, V28, P29; van Heerden J, 2001, WATER SCI TECHNOL, V43, P83, DOI 10.2166/wst.2001.0020; Victorio L, 1996, WATER RES, V30, P1077, DOI 10.1016/0043-1354(95)00269-3; Wang S, 2014, J ENVIRON MANAGE, V136, P68, DOI 10.1016/j.jenvman.2014.01.038; Weber KP, 2007, J MICROBIOL METH, V69, P461, DOI 10.1016/j.mimet.2007.02.013; Weber KP, 2009, J MICROBIOL METH, V79, P55, DOI 10.1016/j.mimet.2009.07.020; Widmer F, 2001, SOIL BIOL BIOCHEM, V33, P1029, DOI 10.1016/S0038-0717(01)00006-2; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; ZAK JC, 1994, SOIL BIOL BIOCHEM, V26, P1101, DOI 10.1016/0038-0717(94)90131-7; Zhang CB, 2010, ECOL ENG, V36, P62, DOI 10.1016/j.ecoleng.2009.09.010	35	28	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147725	10.1371/journal.pone.0147725	http://dx.doi.org/10.1371/journal.pone.0147725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807728	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800197
J	van den Berg, SM; Seijkens, TTP; Kusters, PJH; Beckers, L; den Toom, M; Smeets, E; Levels, J; de Winther, MPJ; Lutgens, E				van den Berg, Susan M.; Seijkens, Tom T. P.; Kusters, Pascal J. H.; Beckers, Linda; den Toom, Myrthe; Smeets, Esther; Levels, Johannes; de Winther, Menno P. J.; Lutgens, Esther			Diet-induced obesity in mice diminishes hematopoietic stem and progenitor cells in the bone marrow	FASEB JOURNAL			English	Article						cBMT; flow cytometry; immune system	HIGH-FAT DIET; PROMOTES MYELOPOIESIS; NEGATIVE REGULATORS; INTERFERON-GAMMA; GENE-EXPRESSION; MONOCYTOSIS; HOMEOSTASIS; INHIBITORS; SUPPRESS; DORMANT	Obesity is associated with chronic low-grade inflammation, characterized by leukocytosis and inflammation in the adipose tissue. Continuous activation of the immune system is a stressor for hematopoietic stem and progenitor cells (HSPCs) in the bone marrow (BM). Here we studied how diet-induced obesity (DIO) affects HSPC population dynamics in the BM. Eight groups of age-matched C57B1/6 mice received a high-fat diet (45% kilocalories from fat) ranging from 1 d up to 18 wk. The obesogenic diet caused decreased proliferation of lineage(-)Sca-1(+) c-Kit(+) (LSK) cells in the BM and a general suppression of progenitor cell populations including common lymphoid progenitors and common myeloid progenitors. Within the LSK population, DIO induced a shift in stem cells that are capable of self-renewal toward maturing multipotent progenitor cells. The higher differentiation potential resulted in increased lymphoid and myeloid ex vivo colony-forming capacity. Ina competitive BM transplantation, BM from obese animals showed impaired multilineage reconstitution when transplanted into chow-fed mice. Our data demonstrate that obesity stimulates the differentiation and reduces proliferation of HSPCs in the BM, leading to a decreased HSPC population. This implies that the effects of obesity on HSPCs hampers proper functioning of the immune system.-Van den Berg, S. M., Seijkens, T. T. P., Kusters, P. J. H., Beckers, L., denToom, M., Smeets, E., Levels, J., de Winther, M. P. J., Lutgens, E. Diet-induced obesity in mice diminishes hematopoietic stem and progenitor cells in the bone marrow.	[van den Berg, Susan M.; Seijkens, Tom T. P.; Kusters, Pascal J. H.; Beckers, Linda; den Toom, Myrthe; Smeets, Esther; de Winther, Menno P. J.; Lutgens, Esther] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Subdiv Expt Vasc Biol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands; [Levels, Johannes] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Lutgens, Esther] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; University of Munich	Lutgens, E (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Subdiv Expt Vasc Biol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	e.lutgens@amc.uva.nl			Netherlands Organization for Scientific Research (NWO); Rembrandt Foundation; Netherlands Heart Foundation; Netherlands Cardio Vascular Research Initiative (CVON); Deutsche Forschungsgemeinschaft (DFG) [SFB1054-B04, SFB1123-A5]; Netherlands Organization for Scientific Research (Vici grant)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Rembrandt Foundation; Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Cardio Vascular Research Initiative (CVON); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Netherlands Organization for Scientific Research (Vici grant)(Netherlands Organization for Scientific Research (NWO))	The authors acknowledge the support from the Netherlands Organization for Scientific Research (NWO; Vici grant to E.L.), the Rembrandt Foundation (to S.B., M.W., and E.L.), the Netherlands Heart Foundation (Dr. E. Dekker programme grant to T.S.), the Netherlands Cardio Vascular Research Initiative (CVON2011-19), and the Deutsche Forschungsgemeinschaft (DFG; SFB1054-B04 to E.L., and SFB1123-A5 to E.L.). The authors declare no conflicts of interest.	Adler BJ, 2014, NAT REV ENDOCRINOL, V10, P737, DOI 10.1038/nrendo.2014.169; ANDO K, 1993, P NATL ACAD SCI USA, V90, P9571, DOI 10.1073/pnas.90.20.9571; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Bredella MA, 2011, OBESITY, V19, P49, DOI 10.1038/oby.2010.106; BURGER C, 1994, J CELL SCI, V107, P2047; Cortez M, 2013, INFLAMMATION, V36, P379, DOI 10.1007/s10753-012-9557-z; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Feng YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047286; Ferrante AW, 2013, DIABETES OBES METAB, V15, P34, DOI 10.1111/dom.12154; Huttunen R, 2013, INT J OBESITY, V37, P333, DOI 10.1038/ijo.2012.62; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Mirantes C, 2014, EXP CELL RES, V329, P248, DOI 10.1016/j.yexcr.2014.08.017; Moldenhauer A, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-56; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Quinton LJ, 2002, J INFECT DIS, V185, P1476, DOI 10.1086/340504; Rodriguez S, 2009, BLOOD, V114, P4064, DOI 10.1182/blood-2009-04-214916; Seijkens T, 2014, FASEB J, V28, P2202, DOI 10.1096/fj.13-243105; SELLERI C, 1995, J CELL PHYSIOL, V165, P538, DOI 10.1002/jcp.1041650312; Shahbazian LM, 2004, CRIT CARE MED, V32, P1740, DOI 10.1097/01.CCM.0000132900.84627.90; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Singer K, 2014, MOL METAB, V3, P664, DOI 10.1016/j.molmet.2014.06.005; Strandberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007605; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zeng WH, 2006, BLOOD, V107, P167, DOI 10.1182/blood-2005-05-1884	37	53	53	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1779	1788		10.1096/fj.201500175	http://dx.doi.org/10.1096/fj.201500175			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26813974				2022-12-26	WOS:000374879400009
J	Kataoka, H; Ariyama, Y; Deushi, M; Osaka, M; Nitta, K; Yoshida, M				Kataoka, Hiroshi; Ariyama, Yuno; Deushi, Michiyo; Osaka, Mizuko; Nitta, Kosaku; Yoshida, Masayuki			Inhibitory Effect of Serotonin Antagonist on Leukocyte-Endothelial Interactions In Vivo and In Vitro	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INTERCELLULAR-ADHESION MOLECULE-1; 5-HYDROXYTRYPTAMINE 2A RECEPTOR; SMOOTH-MUSCLE-CELLS; 5-HT2A RECEPTOR; COUPLED RECEPTORS; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; VASCULAR ENDOTHELIUM; INSULIN-RESISTANCE	Background Although 5-HT2A serotonergic antagonists have been used to treat vascular disease in patients with diabetes mellitus or obesity, their effects on leukocyte-endothelial interactions have not been fully investigated. In this study, we assessed the effects of sarpogrelate hydrochloride (SRPO), a 5-HT2A receptor inverse agonist, on leukocyte-endothelial cell interactions in obesity both in vivo and in vitro. Methods and Findings In the in vivo experiment, C57BL/6 mice were fed a high-fat high-fructose diet (HFFD), comprising 20% fat and 30% fructose, with or without intraperitoneal injection of 5 mg/kg/day SRPO for 4 weeks. The body weight, visceral fat weight, and serum monocyte chemoattractant protein-1 levels in the mice increased significantly with the HFFD, but these effects were prevented by chronic injections of SRPO. Intravital microscopy of the femoral artery detected significant leukocyte-endothelial interactions after treatment with HFFD, but these leukocyte-endothelial interactions were reduced in the mice injected with SRPO. In the in vitro experiment, pre-incubation of activated human umbilical vein endothelial cells (HUVECs) with platelet-rich plasma (PRP) induced THP-1 cell adhesion under physiological flow conditions, but the adhesion was reduced by pretreatment of PRP with SRPO. A fluorescent immunobinding assay showed that PRP induced significant upregulation of E-selectin in HUVECs, but this upregulation was reduced by pretreatment of PRP with SRPO. In other in vitro conditions, pre-incubation of THP-1 cells with phorbol 12-myristate 13-acetate increased the adhesion of THP-1 cells to activated HUVECs under rotational conditions, but this adhesion was reduced by pretreatment with SRPO. Western blotting analysis showed that protein kinase C alpha activation in THP-1 cells was inhibited by SRPO. Conclusion Our findings indicated that SRPO inhibits vascular inflammation in obesity via inactivation of platelets and leukocytes, and improvement of obese.	[Kataoka, Hiroshi; Nitta, Kosaku] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Tokyo, Japan; [Ariyama, Yuno; Deushi, Michiyo; Osaka, Mizuko; Yoshida, Masayuki] Tokyo Med & Dent Univ, Dept Life Sci & Bioeth, Grad Sch Med & Dent Sci, Tokyo, Japan	Tokyo Women's Medical University; Tokyo Medical & Dental University (TMDU)	Yoshida, M (corresponding author), Tokyo Med & Dent Univ, Dept Life Sci & Bioeth, Grad Sch Med & Dent Sci, Tokyo, Japan.	masa.vasc@tmd.ac.jp	Kataoka, Hiroshi/AAD-1531-2019	Kataoka, Hiroshi/0000-0001-9543-7608				Abul Muntasir H, 2007, J PHARMACOL SCI, V104, P274, DOI 10.1254/jphs.SC0060241; Angelico F, 2006, DIABETOLOGIA, V49, P1169, DOI 10.1007/s00125-006-0222-7; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; CONSIDINE RV, 1995, J CLIN INVEST, V95, P2938, DOI 10.1172/JCI118001; Durk T, 2005, INT IMMUNOL, V17, P599, DOI 10.1093/intimm/dxh242; Ferri C, 1999, HYPERTENSION, V34, P568, DOI 10.1161/01.HYP.34.4.568; Gawaz M, 1998, CIRCULATION, V98, P1164, DOI 10.1161/01.CIR.98.12.1164; Giri S, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-31; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Grewal JS, 1999, AM J PHYSIOL-RENAL, V276, pF922, DOI 10.1152/ajprenal.1999.276.6.F922; Gustafson B, 2010, J ATHEROSCLER THROMB, V17, P332, DOI 10.5551/jat.3939; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Inoue M, 2011, INT IMMUNOPHARMACOL, V11, P67, DOI 10.1016/j.intimp.2010.10.007; Inoue Y, 2004, J IMMUNOL, V172, P2147, DOI 10.4049/jimmunol.172.4.2147; Ito T, 2000, CIRCULATION, V102, P2522, DOI 10.1161/01.CIR.102.20.2522; Kajiwara I, 2011, THROMB RES, V128, P547, DOI 10.1016/j.thromres.2011.06.001; Kinoshita M, 2010, MOL ENDOCRINOL, V24, P1978, DOI 10.1210/me.2010-0054; Kojima C, 2007, J PHARMACOL EXP THER, V323, P855, DOI 10.1124/jpet.107.127944; Kuckleburg CJ, 2011, CARDIOVASC RES, V91, P134, DOI 10.1093/cvr/cvr040; Latek D, 2012, ACTA BIOCHIM POL, V59, P515; Lin OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087026; Machida T, 2011, EUR J PHARMACOL, V656, P19, DOI 10.1016/j.ejphar.2010.12.044; Missiou A, 2010, THROMB HAEMOSTASIS, V103, P788, DOI 10.1160/TH09-07-0463; Muntasir HA, 2006, J PHARMACOL SCI, V102, P189, DOI 10.1254/jphs.FP0060610; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; Nishihira K, 2008, J THROMB HAEMOST, V6, P1207, DOI 10.1111/j.1538-7836.2008.02996.x; Nomura S, 2005, BLOOD COAGUL FIBRIN, V16, P423, DOI 10.1097/01.mbc.0000176197.48134.08; Nonogaki K, 2006, BIOCHEM BIOPH RES CO, V351, P1078, DOI 10.1016/j.bbrc.2006.10.173; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Ogawa S, 2008, CLIN J AM SOC NEPHRO, V3, P362, DOI 10.2215/CJN.03450807; Osaka M, 2007, AM J PHYSIOL-HEART C, V292, pH1876, DOI 10.1152/ajpheart.00708.2006; Poggi M, 2009, DIABETOLOGIA, V52, P1152, DOI 10.1007/s00125-009-1267-1; Proenca-Ferreira R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089012; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Roebuck KA, 1999, J LEUKOCYTE BIOL, V65, P291, DOI 10.1002/jlb.65.3.291; Santilli F, 2012, OBES REV, V13, P27, DOI 10.1111/j.1467-789X.2011.00930.x; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Selbie LA, 1998, TRENDS PHARMACOL SCI, V19, P87, DOI 10.1016/S0165-6147(97)01166-8; Shen KP, 2009, J PHARM PHARMACOL, V61, P517, DOI 10.1211/jpp/61.04.0015; Suguro T, 2006, ATHEROSCLEROSIS, V186, P275, DOI 10.1016/j.atherosclerosis.2005.08.007; Takishita E, 2004, J CARDIOVASC PHARM, V43, P266, DOI 10.1097/00005344-200402000-00015; Tossidou I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010185; Uchida-Kitajima S, 2008, FEBS LETT, V582, P3037, DOI 10.1016/j.febslet.2008.07.044; Uchitomi Y, 2002, BIOL PSYCHIAT, V52, P1159, DOI 10.1016/S0006-3223(02)01420-8; Werry TD, 2003, BIOCHEM J, V374, P281, DOI 10.1042/BJ20030312; Xu YJ, 2012, J CELL MOL MED, V16, P2394, DOI 10.1111/j.1582-4934.2012.01554.x; Yan JC, 2003, ACTA PHARMACOL SIN, V24, P687; Yoshida M, 1996, J CELL BIOL, V133, P445, DOI 10.1083/jcb.133.2.445; Yoshida M, 2001, ARTERIOSCL THROM VAS, V21, P1165, DOI 10.1161/hq0701.092143; Yu RN, 2006, OBESITY, V14, P1353, DOI 10.1038/oby.2006.153; Zhang HR, 2010, WORLD J CARDIOL, V2, P370, DOI 10.4330/wjc.v2.i11.370	52	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147929	10.1371/journal.pone.0147929	http://dx.doi.org/10.1371/journal.pone.0147929			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824242	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600074
J	Phu, VD; Wertheim, HFL; Larsson, M; Nadjm, B; Dinh, QD; Nilsson, LE; Rydell, U; Le, TTD; Trinh, SH; Pham, HM; Tran, CT; Doan, HTH; Tran, NT; Le, ND; Van Huynh, N; Tran, TP; Tran, BD; Nguyen, ST; Pham, TTN; Dang, TQ; Nguyen, CVV; Lam, YM; Thwaites, G; Van Nguyen, K; Hanberger, H				Vu Dinh Phu; Wertheim, Heiman F. L.; Larsson, Mattias; Nadjm, Behzad; Quynh-Dao Dinh; Nilsson, Lennart E.; Rydell, Ulf; Tuyet Thi Diem Le; Son Hong Trinh; Hung Minh Pham; Cang Thanh Tran; Hanh Thi Hong Doan; Nguyen Thua Tran; Nhan Duc Le; Nhuan Van Huynh; Thao Phuong Tran; Bao Duc Tran; Son Truong Nguyen; Thao Thi Ngoc Pham; Tam Quang Dang; Chau Van Vinh Nguyen; Yen Minh Lam; Guy Thwaites; Kinh Van Nguyen; Hanberger, Hakan			Burden of Hospital Acquired Infections and Antimicrobial Use in Vietnamese Adult Intensive Care Units	PLOS ONE			English	Article							NOSOCOMIAL INFECTIONS; POINT-PREVALENCE; INICC REPORT; SURVEILLANCE; RESISTANCE; COUNTRIES; TURKEY; NEED	Background Vietnam is a lower middle-income country with no national surveillance system for hospital-acquired infections (HAIs). We assessed the prevalence of hospital-acquired infections and antimicrobial use in adult intensive care units (ICUs) across Vietnam. Methods Monthly repeated point prevalence surveys were systematically conducted to assess HAI prevalence and antimicrobial use in 15 adult ICUs across Vietnam. Adults admitted to participating ICUs before 08: 00 a.m. on the survey day were included. Results Among 3287 patients enrolled, the HAI prevalence was 29.5% (965/3266 patients, 21 missing). Pneumonia accounted for 79.4% (804/1012) of HAIs Most HAIs (84.5% [855/1012]) were acquired in the survey hospital with 42.5% (363/855) acquired prior to ICU admission and 57.5% (492/855) developed during ICU admission. In multivariate analysis, the strongest risk factors for HAI acquired in ICU were: intubation (OR 2.76), urinary catheter (OR 2.12), no involvement of a family member in patient care (OR 1.94), and surgery after admission (OR 1.66). 726 bacterial isolates were cultured from 622/1012 HAIs, most frequently Acinetobacter baumannii (177/726 [24.4%]), Pseudomonas aeruginosa (100/726 [13.8%]), and Klebsiella pneumoniae (84/726 [11.6%]), with carbapenem resistance rates of 89.2%, 55.7%, and 14.9% respectively. Antimicrobials were prescribed for 84.8% (2787/ 3287) patients, with 73.7% of patients receiving two or more. The most common antimicrobial groups were third generation cephalosporins, fluoroquinolones, and carbapenems (20.1%, 19.4%, and 14.1% of total antimicrobials, respectively). Conclusion A high prevalence of HAIs was observed, mainly caused by Gram-negative bacteria with high carbapenem resistance rates. This in combination with a high rate of antimicrobial use illustrates the urgent need to improve rational antimicrobial use and infection control efforts.	[Vu Dinh Phu] Natl Hosp Trop Dis, Intens Care Unit, Hanoi, Vietnam; [Wertheim, Heiman F. L.; Nadjm, Behzad; Quynh-Dao Dinh] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hanoi, Vietnam; [Wertheim, Heiman F. L.; Nadjm, Behzad; Guy Thwaites] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX1 2JD, England; [Larsson, Mattias] Karolinska Inst, Global Hlth IHCAR, Stockholm, Sweden; [Nilsson, Lennart E.] Linkoping Univ, Dept Clin & Expt Med, Clin Microbiol, Linkoping, Sweden; [Rydell, Ulf; Hanberger, Hakan] Linkoping Univ, Dept Clin & Expt Med, Infect Dis, Linkoping, Sweden; [Tuyet Thi Diem Le] Bach Mai Hosp, Intens Care Unit, Hanoi, Vietnam; [Son Hong Trinh] Viet Duc Hosp, Board Directors, Hanoi, Vietnam; [Hung Minh Pham] St Paul Hosp, Pharm, Hanoi, Vietnam; [Cang Thanh Tran] Viet Tiep Hosp, Intens Care, Hai Phong, Vietnam; [Hanh Thi Hong Doan] Vietnam Sweden Uong Bi Hosp, Board Directors, Quang Ninh, Vietnam; [Nguyen Thua Tran] Hue Cent Gen Hosp, Dept Gen Internal Med & Geriatr, Hue, Vietnam; [Nhan Duc Le] Da Nang Hosp, Board Directors, Da Nang, Vietnam; [Nhuan Van Huynh] Binh Dinh Hosp, Infect Dept, Binh Dinh, Vietnam; [Thao Phuong Tran] Khanh Hoa Hosp, Intens Care Unit, Khanh Hoa, Vietnam; [Bao Duc Tran] Dak Lak Hosp, Planning Dept, Dak Lak, Vietnam; [Son Truong Nguyen; Thao Thi Ngoc Pham] Cho Ray Hosp, Board Directors, Ho Chi Minh City, Vietnam; [Tam Quang Dang] Can Tho Cent Gen Hosptial, Board Directors, Can Tho, Vietnam; [Chau Van Vinh Nguyen; Yen Minh Lam] Hosp Trop Dis, Board Directors, Ho Chi Minh City, Vietnam; [Guy Thwaites] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Kinh Van Nguyen] Natl Hosp Trop Dis, Board Directors, Hanoi, Vietnam	National Hospital of Tropical Diseases; University of Oxford; University of Oxford; Karolinska Institutet; Linkoping University; Linkoping University; University of Oxford; National Hospital of Tropical Diseases	Phu, VD (corresponding author), Natl Hosp Trop Dis, Intens Care Unit, Hanoi, Vietnam.; Wertheim, HFL (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hanoi, Vietnam.; Wertheim, HFL (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX1 2JD, England.	vudinhphu07@gmail.com; Heiman.wertheim@gmail.com	Thwaites, Guy E/R-4993-2019; Wertheim, Heiman FL/F-3338-2016; Larsson, Mattias/C-6434-2017	Thwaites, Guy E/0000-0002-2858-2087; Wertheim, Heiman FL/0000-0002-5003-5565; Larsson, Mattias/0000-0002-0514-7445; Nadjm, Behzad/0000-0002-7704-3629	The British Council [172698142] Funding Source: researchfish	The British Council		Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; [Anonymous], 2004, INS MALPR FIN REP HO; Barrera L, 2011, AM J INFECT CONTROL, V39, P633, DOI 10.1016/j.ajic.2010.11.004; Behnke M, 2012, INFECT CONT HOSP EP, V33, P618, DOI 10.1086/665729; Bouadma L, 2012, CURR OPIN INFECT DIS, V25, P395, DOI 10.1097/QCO.0b013e328355a835; Dogru A, 2010, JPN J INFECT DIS, V63, P95; ECDC, 2012, HELICSWIN NET HWN; Erdem H, 2014, J INFECTION, V68, P131, DOI 10.1016/j.jinf.2013.11.001; European Center for Disease Control (ECDC), 2012, POINT PREV SURV HEAL; Hugonnet S, 2007, AM J EPIDEMIOL, V165, P1321, DOI 10.1093/aje/kwm041; Johansson M, 2011, TROP MED INT HEALTH, V16, P737, DOI 10.1111/j.1365-3156.2011.02753.x; Van Nguyen K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1158; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V63, P243, DOI 10.1093/jac/dkn511; Magill SS, 2014, JAMA-J AM MED ASSOC, V312, P1438, DOI 10.1001/jama.2014.12923; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Nguyen HS, 2008, J CLIN MED, P63; Oostdijk EAN, 2012, J ANTIMICROB CHEMOTH, V67, P2250, DOI 10.1093/jac/dks187; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020; Rosenthal VD, 2014, AM J INFECT CONTROL, V42, P942, DOI 10.1016/j.ajic.2014.05.029; Susan Hopkins KS, 2012, ENGLISH NATL POINT P; Van TD, 2014, J GLOB ANTIMICROB RE, V2, P318, DOI 10.1016/j.jgar.2014.05.003; Thu TA, 2011, INFECT CONT HOSP EP, V32, P1039, DOI 10.1086/661915; Truong AT, 2008, J CLIN MED, P51; Truong AT, 2008, J CLIN MED, P57; Vietnam Ministry of Health, 2012, PROJ DECR OV HOSP; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vu VG, 2008, J CLIN MED, P46; Vu VG, 2008, J CLIN MED, P39; Wertheim HFL, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001429; WHO, 2014, VIET NAM HLTH PROF; WHO, 2011, WHO LIB CAT PUBL DAT	32	68	75	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147544	10.1371/journal.pone.0147544	http://dx.doi.org/10.1371/journal.pone.0147544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824228	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528600034
J	Silva, JL; Peruchetti, DB; Moraes-Santos, F; Landgraf, SS; Silva, LS; Sirtoli, GM; Zamith-Miranda, D; Takiya, CM; Pinheiro, AAS; Diaz, BL; Caruso-Neves, C				Silva-Filho, Joao Luiz; Peruchetti, Diogo Barros; Moraes-Santos, Felipe; Landgraf, Sharon Schilling; Silva, Leandro Souza; Sirtoli, Gabriela Modenesi; Zamith-Miranda, Daniel; Takiya, Christina Maeda; Sa Pinheiro, Ana Acacia; Diaz, Bruno Lourenco; Caruso-Neves, Celso			Group V Secretory Phospholipase A(2) Is Involved in Tubular Integrity and Sodium Handling in the Kidney	PLOS ONE			English	Article							ARACHIDONIC-ACID RELEASE; REGULATORY T-CELLS; GROUP-II; EICOSANOID GENERATION; MAST-CELLS; GROUP-X; EXPRESSION; INDUCTION; CYCLOOXYGENASE-2; ENZYMES	Group V (GV) phospholipase A(2) (PLA(2)) is a member of the family of secreted PLA(2) (sPLA2) enzymes. This enzyme has been identified in several organs, including the kidney. However, the physiologic role of GV sPLA(2) in the maintenance of renal function remains unclear. We used mice lacking the gene encoding GV sPLA(2) (Pla2g5(-/-)) and wild- type breeding pairs in the experiments. Mice were individually housed in metabolic cages and 48-h urine was collected for biochemical assays. Kidney samples were evaluated for glomerular morphology, renal fibrosis, and expression/activity of the (Na+ + K+)-ATPase a1 subunit. We observed that plasma creatinine levels were increased in PLA2g5(-/-) mice following by a decrease in creatinine clearance. The levels of urinary protein were higher in PLA2g5(-/-) mice than in the control group. Markers of tubular integrity and function such as gamma-glutamyl transpeptidase, lactate dehydrogenase, and sodium excretion fraction (FENa+) were also increased in PLA(2)g5(-/-) mice. The increased FENa+ observed in PLA(2)g5(-/-) mice was correlated to alterations in cortical (Na+ + K+) ATPase activity/expression. In addition, the kidney from PLA2g5(-/-) mice showed accumulation of matrix in corticomedullary glomeruli and tubulointerstitial fibrosis. These data suggest GV sPLA(2) is involved in the maintenance of tubular cell function and integrity, promoting sodium retention through increased cortical (Na+ + K+)-ATPase expression and activity.	[Silva-Filho, Joao Luiz; Peruchetti, Diogo Barros; Moraes-Santos, Felipe; Landgraf, Sharon Schilling; Silva, Leandro Souza; Sirtoli, Gabriela Modenesi; Zamith-Miranda, Daniel; Sa Pinheiro, Ana Acacia; Diaz, Bruno Lourenco; Caruso-Neves, Celso] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, RJ, Brazil; [Landgraf, Sharon Schilling] Inst Fed Educ Ciencia & Tecnol, Rio De Janeiro, RJ, Brazil; [Takiya, Christina Maeda] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, RJ, Brazil; [Sa Pinheiro, Ana Acacia] Conselho Nacl Desenvolvimento Cient & Tecnol MCT, Inst Nacl Pesquisa Translac Saude & Ambiente Reg, Rio De Janeiro, RJ, Brazil; [Caruso-Neves, Celso] Inst Nacl Ciencia & Tecnol Biol & Bioimagem, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Instituto Federal do Rio de Janeiro (IFRJ); Instituto Federal do Sertao Pernambucano; Universidade Federal do Rio de Janeiro	Caruso-Neves, C (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, RJ, Brazil.; Caruso-Neves, C (corresponding author), Inst Nacl Ciencia & Tecnol Biol & Bioimagem, Rio De Janeiro, RJ, Brazil.	caruso@biof.ufrj.br	Silva-Filho, João Luiz/I-5704-2016; Diaz, Bruno L./A-5673-2009; Takiya, Christina/AAU-5959-2021; Peruchetti, Diogo B/L-3706-2017; Sila, Leandro/B-1381-2018; Caruso-Neves, Celso/C-4014-2013; Zamith-Miranda, Daniel/E-8877-2013	Silva-Filho, João Luiz/0000-0003-4762-2205; Diaz, Bruno L./0000-0001-8393-3823; Takiya, Christina/0000-0002-8019-628X; Peruchetti, Diogo B/0000-0002-7572-9731; Sila, Leandro/0000-0001-8720-0088; Caruso-Neves, Celso/0000-0002-2415-7753; Zamith-Miranda, Daniel/0000-0001-7532-2432	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [57.3695/2008-3 AASP, 57.3767/2008-4 CCN, 471771/2013-9 CCN, 456997/2014-8 AASP]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/110.551/2010 CCN, 111681/2013 CCN, E-26/102.170/2013 AASP, E-26/201.197/2014 CCN]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br): 1. 57.3695/2008-3 AASP, 2. 57.3767/2008-4 CCN, 3. 471771/2013-9 CCN, 4. 456997/2014-8 AASP, and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (www.faperj.br): 1. E-26/110.551/2010 CCN, 2. 111681/2013 CCN, 3. E-26/102.170/2013 AASP, 4. E-26/201.197/2014 CCN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balestrieri B, 2006, J BIOL CHEM, V281, P6691, DOI 10.1074/jbc.M508314200; Balestrieri B, 2006, BBA-MOL CELL BIOL L, V1761, P1280, DOI 10.1016/j.bbalip.2006.07.008; Balsinde J, 1999, J BIOL CHEM, V274, P25967, DOI 10.1074/jbc.274.37.25967; Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Belizario JE, 2012, J APPL GENET, V53, P295, DOI 10.1007/s13353-012-0096-y; Berrut G, 1997, CLIN NEPHROL, V48, P92; Boyanovsky BB, 2005, J BIOL CHEM, V280, P32746, DOI 10.1074/jbc.M502067200; Boyanoysky BB, 2012, AM J PATHOL, V181, P1088, DOI 10.1016/j.ajpath.2012.05.037; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; CHEN J, 1994, BBA-LIPID LIPID MET, V1215, P115, DOI 10.1016/0005-2760(94)90099-X; Cho W, 2000, BBA-MOL CELL BIOL L, V1488, P48, DOI 10.1016/S1388-1981(00)00109-8; Choi K, 2013, ISPRS ANN PHOTO REM, VII-3/W2, P1; Chung ES, 2015, J IMMUNOL, V195, P4853, DOI 10.4049/jimmunol.1500386; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Diaz BL, 2006, BBA-MOL CELL BIOL L, V1761, P1489, DOI 10.1016/j.bbalip.2006.09.009; Enomoto A, 2000, BIOCHEM BIOPH RES CO, V276, P667, DOI 10.1006/bbrc.2000.3468; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gotfried J, 2012, CLEV CLIN J MED, V79, P121, DOI 10.3949/ccjm.79a.11030; Han WK, 2003, J BIOL CHEM, V278, P24153, DOI 10.1074/jbc.M300424200; Harris Raymond C, 2013, Trans Am Clin Climatol Assoc, V124, P139; Herman MB, 2010, AM J PHYSIOL-RENAL, V298, pF1222, DOI 10.1152/ajprenal.00467.2009; Kalyvas A, 2009, BRAIN, V132, P1221, DOI 10.1093/brain/awp002; Kikawada E, 2007, BLOOD, V110, P561, DOI 10.1182/blood-2006-10-052258; Kim H, 2015, KIDNEY INT, V88, P550, DOI 10.1038/ki.2015.147; Kim KP, 2001, J BIOL CHEM, V276, P11126, DOI 10.1074/jbc.M004604200; Kim YJ, 2002, J BIOL CHEM, V277, P9358, DOI 10.1074/jbc.M110987200; Kinsey GR, 2009, J AM SOC NEPHROL, V20, P1744, DOI 10.1681/ASN.2008111160; Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200; Kvirkvelia N, 2013, AM J PHYSIOL-RENAL, V304, pF463, DOI 10.1152/ajprenal.00575.2012; Landgraf SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107549; Lee H, 2010, KIDNEY INT, V78, P1100, DOI 10.1038/ki.2010.139; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Gorriz JL, 2012, TRANSPLANT REV-ORLAN, V26, P3, DOI 10.1016/j.trre.2011.10.002; MARTINO G, 1978, Bollettino Societa Italiana Biologia Sperimentale, V54, P2577; Masuda S, 2005, BBA-MOL CELL BIOL L, V1736, P200, DOI 10.1016/j.bbalip.2005.08.014; Meliton AY, 2013, AM J PHYSIOL-LUNG C, V304, pL689, DOI 10.1152/ajplung.00047.2013; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Mukhopadhyay A, 1995, ARCH BIOCHEM BIOPHYS, V324, P78, DOI 10.1006/abbi.1995.9926; Murakami M, 2000, BBA-MOL CELL BIOL L, V1488, P159, DOI 10.1016/S1388-1981(00)00118-9; Murakami M, 1999, J BIOL CHEM, V274, P31435, DOI 10.1074/jbc.274.44.31435; Murakami M, 1999, J BIOL CHEM, V274, P29927, DOI 10.1074/jbc.274.42.29927; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123; Ohta S, 2013, J IMMUNOL, V190, P5927, DOI 10.4049/jimmunol.1203202; Ooi JD, 2011, KIDNEY INT, V79, P977, DOI 10.1038/ki.2010.541; Peruchetti DB, 2011, J BIOL CHEM, V286, P45041, DOI 10.1074/jbc.M111.260737; Pinhal CS, 2013, NEPHROL DIAL TRANSPL, V28, P2464, DOI 10.1093/ndt/gft304; Poschke A, 2012, AM J PHYSIOL-RENAL, V303, pF1435, DOI 10.1152/ajprenal.00512.2011; Portella VG, 2013, CRIT CARE MED, V41, P1056, DOI 10.1097/CCM.0b013e3182746696; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Santos C, 2010, TRANSPL P, V42, P3639, DOI 10.1016/j.transproceed.2010.06.024; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Sato H, 2014, CELL METAB, V20, P119, DOI 10.1016/j.cmet.2014.05.002; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Valentin E, 1999, J BIOL CHEM, V274, P31195, DOI 10.1074/jbc.274.44.31195; van der Helm HA, 2001, BBA-MOL CELL BIOL L, V1530, P86, DOI 10.1016/S1388-1981(00)00171-2; VIEYRA A, 1986, J BIOL CHEM, V261, P4247	59	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147785	10.1371/journal.pone.0147785	http://dx.doi.org/10.1371/journal.pone.0147785			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820468	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000369528400041
J	Yi, L; Lin, GG; Zhang, K; Wang, LN; Zhang, R; Xie, JH; Li, JM				Yi, Lang; Lin, Guigao; Zhang, Kuo; Wang, Lunan; Zhang, Rui; Xie, Jiehong; Li, Jinming			Molecular Genetics External Quality Assessment Pilot Scheme for Irinotecan-Related UGT1A1 Genotyping in China	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; PREANALYTICAL PHASE; RACIAL VARIABILITY; GILBERTS-SYNDROME; POLYMORPHISMS; UGT1A1-ASTERISK-28; CHEMOTHERAPY; PROMOTER; THERAPY; DNA	Irinotecan is widely used in the treatment of solid tumors, especially in colorectal cancer and lung cancer. Molecular testing for UGT1A1 genotyping is increasingly required in China for optimum irinotecan administration. In order to determine the performance of laboratories with regard to the whole testing process for UGT1A1 to ensure the consistency and accuracy of the test results, the National Center for Clinical Laboratories conducted an external quality assessment program for UGT1A1*28 genotyping in 2015. The panel, which comprised of four known mutational samples and six wild-type samples, was distributed to 45 laboratories that test for the presence of UGT1A1*28 polymorphisms. Participating laboratories were allowed to perform polymorphism analysis by using their routine methods. The accuracy of the genotyping and reporting of results was analyzed. Other information from the individual laboratories, including the number of samples tested each month, accreditation/ certification status, and test methodology, was reviewed. Forty-four of the 45 participants reported the correct results for all samples. There was only one genotyping error, with a corresponding analytical sensitivity of 99.44% (179/180 challenges; 95% confidence interval: 96.94-99.99%) and an analytical specificity of 100% (270/270 challenges; 95% confidence interval: 98.64-100%). Both commercial kits and laboratory development tests were commonly used by the laboratories, and pyrosequencing was the main methodology used (n = 26, 57.8%). The style of the written reports showed large variation, and many reports showed a shortage of information. In summary, the first UGT1A1 genotyping external quality assessment result demonstrated that UGT1A1 genotype analysis of good quality was performed in the majority of pharmacogenetic testing centers that were investigated. However, greater education on the reporting of UGT1A1 genetic testing results is needed.	[Yi, Lang; Lin, Guigao; Zhang, Kuo; Wang, Lunan; Zhang, Rui; Xie, Jiehong; Li, Jinming] Beijing Hosp, Natl Ctr Clin Labs, Beijing 100730, Peoples R China; [Yi, Lang; Li, Jinming] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China	Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, JM (corresponding author), Beijing Hosp, Natl Ctr Clin Labs, Beijing 100730, Peoples R China.; Li, JM (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China.	jmli@nccl.org.cn	Wang, Lunan/AAS-9785-2021	Wang, Lunan/0000-0003-3163-7891	Beijing Municipal Public Health Bureau [2011-4011-02]; National Population and Family Planning Commission of the P R China [201402018]	Beijing Municipal Public Health Bureau; National Population and Family Planning Commission of the P R China	This work was supported by the capital development fund from the Beijing Municipal Public Health Bureau (No. 2011-4011-02)(JL) and the Special Fund for Healthscientific Research in the Public Interest from National Population and Family Planning Commission of the P R China (No. 201402018)(JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, PHARMACOGENOMICS, V6, P671; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Etienne-Grimaldi MC, 2015, FUND CLIN PHARMACOL, V29, P219, DOI 10.1111/fcp.12117; Farrar JS, 2011, CLIN CHEM, V57, P1303, DOI 10.1373/clinchem.2011.166306; Fesenko EE, 2013, CLIN CHEM LAB MED, V51, P1177, DOI 10.1515/cclm-2012-0656; Hu ZY, 2010, CLIN CANCER RES, V16, P3832, DOI 10.1158/1078-0432.CCR-10-1122; Inoue K, 2013, TOHOKU J EXP MED, V229, P107, DOI 10.1620/tjem.229.107; International Organization for Standardization (ISO), 2012, ISO15189 TC MED LAB; Kaniwa N, 2005, DRUG METAB DISPOS, V33, P458, DOI 10.1124/dmd.104.001800; Kaya AO, 2012, J CHEMOTHERAPY, V24, P217, DOI 10.1179/1973947812Y.0000000020; Lara PN, 2009, J CLIN ONCOL, V27, P2530, DOI 10.1200/JCO.2008.20.1061; Liu X, 2014, PHARMACOGENOMICS, V15, P1171, DOI [10.2217/pgs.14.78, 10.2217/PGS.14.78]; Malentacchi F, 2013, CLIN CHIM ACTA, V424, P274, DOI 10.1016/j.cca.2013.05.012; Marcuello E, 2004, BRIT J CANCER, V91, P678, DOI 10.1038/sj.bjc.6602042; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Minami H, 2007, PHARMACOGENET GENOM, V17, P497, DOI 10.1097/FPC.0b013e328014341f; Monaghan G, 1996, LANCET, V347, P578, DOI 10.1016/S0140-6736(96)91273-8; Orlando C, 2007, CLIN CHEM, V53, P1349, DOI 10.1373/clinchem.2006.084004; Pazzagli M, 2013, METHODS, V59, P20, DOI 10.1016/j.ymeth.2012.10.007; Pizzolato JF, 2003, LANCET, V361, P2235, DOI 10.1016/S0140-6736(03)13780-4; Pratt VM, 2010, J MOL DIAGN, V12, P835, DOI 10.2353/jmoldx.2010.100090; Saeki M, 2003, CLIN CHEM, V49, P1182, DOI 10.1373/49.7.1182; Shen N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121485; Shulman K, 2011, CANCER-AM CANCER SOC, V117, P3156, DOI 10.1002/cncr.25735; Sunakawa Y, 2011, CANCER CHEMOTH PHARM, V68, P279, DOI 10.1007/s00280-010-1485-8; Swen JJ, 2011, CLIN PHARMACOL THER, V89, P662, DOI 10.1038/clpt.2011.34; Takano M, 2009, ONCOLOGY-BASEL, V76, P315, DOI 10.1159/000209335; Wong FL, 2007, J CLIN LAB ANAL, V21, P167, DOI 10.1002/jcla.20177; Wu AHB, 2013, ARCH PATHOL LAB MED, V137, P1232, DOI 10.5858/arpa.2012-0261-CP; Xu JM, 2013, WORLD J GASTROENTERO, V19, P3899, DOI 10.3748/wjg.v19.i24.3899; Yong WP, 2006, BRIT J CLIN PHARMACO, V62, P35, DOI 10.1111/j.1365-2125.2006.02591.x; Zhang A, 2007, PHARMACOGENOMICS J, V7, P333, DOI 10.1038/sj.tpj.6500424	33	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148081	10.1371/journal.pone.0148081	http://dx.doi.org/10.1371/journal.pone.0148081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820647	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528400064
J	Chiva-Blanch, G; Suades, R; Crespo, J; Pena, E; Padro, T; Jimenez-Xarrie, E; Marti-Fabregas, J; Badimon, L				Chiva-Blanch, Gemma; Suades, Rosa; Crespo, Javier; Pena, Esther; Padro, Teresa; Jimenez-Xarrie, Elena; Marti-Fabregas, Joan; Badimon, Lina			Microparticle Shedding from Neural Progenitor Cells and Vascular Compartment Cells Is Increased in Ischemic Stroke	PLOS ONE			English	Article							CIRCULATING ENDOTHELIAL MICROPARTICLES; ACTIVE TISSUE FACTOR; SMOOTH-MUSCLE-CELLS; MARKER; BRAIN	Purpose Ischemic stroke has shown to induce platelet and endothelial microparticle shedding, but whether stroke induces microparticle shedding from additional blood and vascular compartment cells is unclear. Neural precursor cells have been shown to replace dying neurons at sites of brain injury; however, if neural precursor cell activation is associated to microparticle shedding, and whether this activation is maintained at long term and associates to stroke type and severity remains unknown. We analyzed neural precursor cells and blood and vascular compartment cells microparticle shedding after an acute ischemic stroke. Methods Forty-four patients were included in the study within the first 48h after the onset of stroke. The cerebral lesion size was evaluated at 3-7 days of the stroke. Circulating microparticles from neural precursor cells and blood and vascular compartment cells (platelets, endothelial cells, erythrocytes, leukocytes, lymphocytes, monocytes and smooth muscle cells) were analyzed by flow cytometry at the onset of stroke and at 7 and 90 days. Forty-four age-matched high cardiovascular risk subjects without documented vascular disease were used as controls. Results Compared to high cardiovascular risk controls, patients showed higher number of neural precursor cell-and all blood and vascular compartment cell-derived microparticles at the onset of stroke, and after 7 and 90 days. At 90 days, neural precursor cell-derived microparticles decreased and smooth muscle cell-derived microparticles increased compared to levels at the onset of stroke, but only in those patients with the highest stroke-induced cerebral lesions. Conclusions Stroke increases blood and vascular compartment cell and neural precursor cell microparticle shedding, an effect that is chronically maintained up to 90 days after the ischemic event. These results show that stroke induces a generalized blood and vascular cell activation and the initiation of neuronal cell repair process after stroke. Larger cerebral lesions associate with deeper vessel injury affecting vascular smooth muscle cells.	[Chiva-Blanch, Gemma; Suades, Rosa; Crespo, Javier; Pena, Esther; Padro, Teresa; Badimon, Lina] Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain; [Chiva-Blanch, Gemma; Suades, Rosa; Crespo, Javier; Pena, Esther; Padro, Teresa; Jimenez-Xarrie, Elena; Marti-Fabregas, Joan; Badimon, Lina] Biomed Res Inst St Pau IIB St Pau, Barcelona, Spain; [Jimenez-Xarrie, Elena; Marti-Fabregas, Joan] Hosp Santa Creu & Sant Pau, Dept Neurol, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau	Badimon, L (corresponding author), Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain.; Badimon, L (corresponding author), Biomed Res Inst St Pau IIB St Pau, Barcelona, Spain.	lbadimon@csic-iccc.org	Soler, Rosa Suades/N-9330-2019; Chiva-Blanch, Gemma/O-8072-2018; Martí-Fàbregas, Joan/I-5933-2019; Peña, Esther/AAB-8217-2019; BADIMON, LINA/S-2950-2019; Badimon, Lina/O-4711-2014	Soler, Rosa Suades/0000-0002-0193-3115; Chiva-Blanch, Gemma/0000-0001-6093-0160; Martí-Fàbregas, Joan/0000-0001-9229-8649; Badimon, Lina/0000-0002-9162-2459; Padro, Teresa/0000-0003-1921-954X; Crespo, Javier/0000-0001-8248-0172; Pena, Esther/0000-0003-2750-0614	Instituto de Salud Carlos III [CD13/00023]; Spanish Ministry of Economy and Competitiveness [PNS-SAF2013-42962-R]; RETICS of Instituto Carlos III (RIC); RETICS of Instituto Carlos III (TERCEL); RETICS (FEDER) [INVICTUS-RD12/014/0002, FIS PI071062]; FEDER	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); RETICS of Instituto Carlos III (RIC); RETICS of Instituto Carlos III (TERCEL); RETICS (FEDER); FEDER(European Commission)	GC-B is a Sara Borrell Postdoctoral Fellow (CD13/00023) from Instituto de Salud Carlos III and received the ImmunoTools special Award 2014. This work has been possible thanks to funding received from Spanish Ministry of Economy and Competitiveness (PNS-SAF2013-42962-R, to LB) and from RETICS of Instituto Carlos III (RIC and TERCEL to LB, and RETICS (INVICTUS-RD12/014/0002 and FEDER and FIS PI071062 to JM-F). None of the funders played any role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alonso R, 2014, J AM COLL CARDIOL, V63, P1983, DOI 10.1016/j.jacc.2014.01.063; Amabile N, 2005, J AM SOC NEPHROL, V16, P3381, DOI 10.1681/ASN.2005050535; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Brisset AC, 2003, THROMB HAEMOSTASIS, V90, P511, DOI 10.1160/TH02-12-0291; Cherian P, 2003, STROKE, V34, P2132, DOI 10.1161/01.STR.0000086466.32421.F4; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Hussein MNA, 2003, J THROMB HAEMOST, V1, P2434; Jung KH, 2009, ANN NEUROL, V66, P191, DOI 10.1002/ana.21681; Koga H, 2005, J AM COLL CARDIOL, V45, P1622, DOI 10.1016/j.jacc.2005.02.047; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Lackner P, 2010, STROKE, V41, P2353, DOI 10.1161/STROKEAHA.110.584995; Latham SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16314; Leroyer AS, 2007, J AM COLL CARDIOL, V49, P772, DOI 10.1016/j.jacc.2006.10.053; Li PP, 2015, THROMB RES, V135, P375, DOI 10.1016/j.thromres.2014.12.006; Lindsberg PJ, 1996, CIRCULATION, V94, P939, DOI 10.1161/01.CIR.94.5.939; Loyer X, 2014, CIRC RES, V114, P345, DOI 10.1161/CIRCRESAHA.113.300858; Marti-Fabregas J, 2010, NEUROLOGY, V74, P357, DOI 10.1212/WNL.0b013e3181cbccec; Morel O, 2011, ARTERIOSCL THROM VAS, V31, P15, DOI 10.1161/ATVBAHA.109.200956; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Poittevin M, 2014, TRANSL STROKE RES, V5, P377, DOI 10.1007/s12975-013-0306-x; Preston RA, 2003, HYPERTENSION, V41, P211, DOI 10.1161/01.HYP.0000049760.15764.2D; Schecter AD, 2000, CIRC RES, V87, P126, DOI 10.1161/01.RES.87.2.126; Simak J, 2006, J THROMB HAEMOST, V4, P1296, DOI 10.1111/j.1538-7836.2006.01911.x; Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313; Sinning JM, 2011, EUR HEART J, V32, P2034, DOI 10.1093/eurheartj/ehq478; Starke RM, 2014, TRANSL STROKE RES, V5, P338, DOI 10.1007/s12975-013-0290-1; Suades R, 2014, THROMB HAEMOSTASIS, V111, P111, DOI 10.1160/TH13-07-0612; Suades R, 2012, THROMB HAEMOSTASIS, V108, P1208, DOI 10.1160/TH12-07-0486; Switonska M, 2015, EUR J NEUROL, V22, P395, DOI 10.1111/ene.12591; Viera AJ, 2012, J AM SOC HYPERTENS, V6, P243, DOI 10.1016/j.jash.2012.06.003; WANG PY, 1993, STROKE, V24, P236, DOI 10.1161/01.STR.24.2.236	32	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0148176	10.1371/journal.pone.0148176	http://dx.doi.org/10.1371/journal.pone.0148176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815842	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528200074
J	Flegr, J				Flegr, Jaroslav			Heterozygote Advantage Probably Maintains Rhesus Factor Blood Group Polymorphism: Ecological Regression Study	PLOS ONE			English	Article							RHD MOLECULE; TOXOPLASMOSIS; PROTEINS; WOMEN	Rhesus factor polymorphism has been an evolutionary enigma since its discovery in 1939. Carriers of the rarer allele should be eliminated by selection against Rhesus positive children born to Rhesus negative mothers. Here I used an ecologic regression study to test the hypothesis that Rhesus factor polymorphism is stabilized by heterozygote advantage. The study was performed in 65 countries for which the frequencies of RhD phenotypes and specific disease burden data were available. I performed multiple multivariate covariance analysis with five potential confounding variables: GDP, latitude (distance from the equator), humidity, medical care expenditure per capita and frequencies of smokers. The results showed that the burden associated with many diseases correlated with the frequencies of particular Rhesus genotypes in a country and that the direction of the relation was nearly always the opposite for the frequency of Rhesus negative homozygotes and that of Rhesus positive heterozygotes. On the population level, a Rhesus-negativity-associated burden could be compensated for by the heterozygote advantage, but for Rhesus negative subjects this burden represents a serious problem.	[Flegr, Jaroslav] Charles Univ Prague, Fac Sci, Div Biol, Prague, Czech Republic	Charles University Prague	Flegr, J (corresponding author), Charles Univ Prague, Fac Sci, Div Biol, Prague, Czech Republic.	flegr@cesnet.cz	Flegr, Jaroslav/A-1564-2008; Flegr, Jaroslav/AAG-7568-2021	Flegr, Jaroslav/0000-0002-0822-0126; Flegr, Jaroslav/0000-0002-0822-0126	Czech Science Foundation [P303/11/1398]	Czech Science Foundation(Grant Agency of the Czech Republic)	Funded by Czech Science Foundation P303/11/1398.	ALLISON AC, 1954, T ROY SOC TROP MED H, V48, P312, DOI 10.1016/0035-9203(54)90101-7; Anstee DJ, 2010, BLOOD, V115, P4635, DOI 10.1182/blood-2010-01-261859; FELDMAN MW, 1969, AM J HUM GENET, V21, P171; Fisher RA, 1944, NATURE, V153, P106, DOI 10.1038/153106b0; Flegel WA, 2011, TRANSFUS APHER SCI, V44, P81, DOI 10.1016/j.transci.2010.12.013; FLEGR J, 2014, PLOS ONE, V0009; Flegr J, 2013, PLOS ONE, V8; Flegr J, 2008, NEUROENDOCRINOL LETT, V29, P475; Flegr J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141362; Flegr J, 2014, FOLIA PARASIT, V61, P485, DOI 10.14411/fp.2014.061; Flegr J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049478; Flegr J, 2010, FOLIA PARASIT, V57, P143, DOI 10.14411/fp.2010.018; Flegr J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-72; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Guthrie KA, 2001, J ROY STAT SOC A STA, V164, P141, DOI 10.1111/1467-985X.00193; Haldane JBS, 1942, EUGENICS, V11, P333; Hogben L, 1943, NATURE, V152, P721, DOI 10.1038/152721c0; Kankova S, 2010, PARASITOLOGY, V137, P1773, DOI 10.1017/S0031182010000661; Kustu S, 2006, TRANSFUS CLIN BIOL, V13, P103, DOI 10.1016/j.tracli.2006.03.001; Le Van Kim C, 2006, BLOOD REV, V20, P93, DOI 10.1016/j.blre.2005.04.002; LI CC, 1953, AM NAT, V87, P257, DOI 10.1086/281782; MOURANT A. E, 1954, DISTRIBUTION HUMAN B; Novotna M, 2008, PARASITOLOGY, V135, P1253, DOI 10.1017/S003118200800485X; Wagner FF, 2000, BLOOD, V95, P3662; Wakefield J, 2001, J R STAT SOC A STAT, V164, P119, DOI 10.1111/1467-985X.00191; World Health Organization, 2008, GLOB BURD DIS 2004 U	26	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147955	10.1371/journal.pone.0147955	http://dx.doi.org/10.1371/journal.pone.0147955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811928	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528000066
J	Bucher, HC; Achermann, R; Stohler, N; Meier, CR				Bucher, Heiner C.; Achermann, Rita; Stohler, Nadja; Meier, Christoph R.			Surveillance of Physicians Causing Potential Drug-Drug Interactions in Ambulatory Care: A Pilot Study in Switzerland	PLOS ONE			English	Article							PATIENT SAFETY; HEALTH-CARE; PHARMACIES; SUPPORT; RATES	Objectives We analysed potential drug-drug interactions (DDI) in ambulatory care in Switzerland based on claims data from three large health insurers in 2010 to identify physicians with peculiar prescription behaviour differing from peers of the same specialty. Methods We analysed contraindicated or potentially contraindicated DDI from the national drug formulary and calculated for each physician the ratios of the number of patients with a potential DDI divided by the number of patients at risk and used a zero inflated binomial distribution to correct for the inflated number of observations with no DDI. We then calculated the probability that the number of caused potential DDI of physicians was unlikely (p-value < 0.05 and >= 0.01) and very unlikely (p-value <0.01) to be due to chance. Results Of 1'607'233 females and 1'525'307 males 1.3% and 1.2% were exposed to at least one potential DDI during 12 months. When analysing the 40 most common DDI, 598 and 416 of 18,297 physicians (3.3% and 2.3%) were causing potential DDI in a frequency unlikely (p<0.05 and p >= 0.01) and very unlikely (p<0.01) to be explained by chance. Patients cared by general practitioners and cardiologists had the lowest probability (0.20 and 0.26) for not being exposed to DDI. Conclusions Contraindicated or potentially contraindicated DDI are frequent in ambulatory care in Switzerland, with a small proportion of physicians causing potential DDI in a frequency that is very unlikely to be explained by chance when compared to peers of the same specialty.	[Bucher, Heiner C.; Achermann, Rita] Univ Basel Hosp, Dept Clin Res, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Stohler, Nadja; Meier, Christoph R.] Univ Basel, Dept Pharmaceut Sci, Inst Clin Pharm & Epidemiol, Basel, Switzerland; [Stohler, Nadja; Meier, Christoph R.] Univ Basel Hosp, Hosp Pharm, CH-4031 Basel, Switzerland	University of Basel; University of Basel; University of Basel	Bucher, HC (corresponding author), Univ Basel Hosp, Dept Clin Res, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland.	heiner.bucher@usb.ch			Swiss Medical Association (FMH); Santesuisse; Gottfried and Julia Bangerter-Rhyner-Foundation	Swiss Medical Association (FMH); Santesuisse; Gottfried and Julia Bangerter-Rhyner-Foundation	This study was supported by a grant from the Swiss Medical Association (FMH) and Santesuisse. The Basel Institute for Clinical Epidemiology has been supported by unrestricted research grants by Santesuisse and the Gottfried and Julia Bangerter-Rhyner-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the Swiss Medical Association (FMH) and Santesuisse. The Basel Institute for Clinical Epidemiology has been supported by unrestricted research grants by Santesuisse and the Gottfried and Julia Bangerter-Rhyner-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann R., 2006, ABRECHNUNGSEFFEKTE B; Becker ML, 2007, PHARMACOEPIDEM DR S, V16, P641, DOI 10.1002/pds.1351; Bjerrum L, 2003, SCAND J PRIM HEALTH, V21, P153, DOI 10.1080/02813430310001806; Hammerlein A, 2007, ANN PHARMACOTHER, V41, P1825, DOI 10.1345/aph.1K207; HANLON JT, 1992, J CLIN EPIDEMIOL, V45, P1045, DOI 10.1016/0895-4356(92)90144-C; Johnell K, 2008, SCAND J PRIM HEALTH, V26, P86, DOI 10.1080/02813430802022196; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Merlo J, 2001, BRIT MED J, V323, P427, DOI 10.1136/bmj.323.7310.427; Solberg LI, 2004, AM J MANAG CARE, V10, P753; Spinewine A, 2007, LANCET, V370, P173, DOI 10.1016/S0140-6736(07)61091-5; Steele AW, 2005, PLOS MED, V2, P864, DOI 10.1371/journal.pmed.0020255; Suzuki Y, 2015, BIOL PHARM BULL, V38, P680, DOI 10.1248/bpb.b14-00191; Tamblyn R, 2003, CAN MED ASSOC J, V169, P549; Tanskanen A, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0140-z; VGAM: Vector Generalized Linear and Additive Models, 2014, VGAM VECTOR GEN LINE; Vonbach P., 2007, THESIS U BASEL; Weingart SN, 2009, ARCH INTERN MED, V169, P1465, DOI 10.1001/archinternmed.2009.252; Wolfstadt JI, 2008, J GEN INTERN MED, V23, P451, DOI 10.1007/s11606-008-0504-5	18	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147606	10.1371/journal.pone.0147606	http://dx.doi.org/10.1371/journal.pone.0147606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808430	Green Submitted, gold, Green Published			2022-12-26	WOS:000369527800147
J	Chung, HK; Han, YK; Oh, S; Kim, SH				Chung, Ho Kyung; Han, Young Keun; Oh, Sohee; Kim, Seok Hwan			Comparison of Optical Coherence Tomography Measurement Reproducibility between Children and Adults	PLOS ONE			English	Article							NERVE-FIBER LAYER; THICKNESS	Purpose To compare the reproducibility of SD-OCT (spectral-domain optical coherence tomography) measurements of RNFL (retinal nerve fiber layer) and macular thickness between children and adults. Methods Seventy-one eyes of 71 children and 71 eyes of 71 adults were prospectively enrolled. RNFL and macular thicknesses were measured by one operator, with a brief rest between measurements. The two measurements were obtained using the eye tracking and retest function of Spectralis SD-OCT. Reproducibility was evaluated with reference to COVs (coefficients of variation) and ICCs (intraclass correlation coefficients). The ICC values of the RNFL and macular thicknesses were compared, respectively between the two groups, by Fisher's z-test. Results The RNFL and macular thicknesses did not differ between the two groups. The COVs of the RNFL measurements ranged from 0.945 to 4.531% in the children group and from 0.496 to 1.391% in the adults group. In most of the RNFL sectors, the ICCs of the children group (range: 0.731-0.987) were significantly lower than those of the adults group (range: 0.986-0.993). The COVs of themacular measurements ranged from 0.496 to 1.157% in the children group and from 0.275 to 0.656% in the adults group. The ICCs (range: 0.860-0.974) in the children group, significantly lower than for the adults (range: 0.989-0.995), in all of themacular sectors. Conclusions The reproducibility of SD-OCT RNFL and macular measurements for children was excellent, albeit statistically lower than that for adults.	[Chung, Ho Kyung; Han, Young Keun; Kim, Seok Hwan] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Chung, Ho Kyung; Han, Young Keun; Kim, Seok Hwan] Seoul Natl Univ, Boramae Hosp, Dept Ophthalmol, Seoul, South Korea; [Oh, Sohee] Seoul Natl Univ, Boramae Hosp, Dept Biostat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.; Kim, SH (corresponding author), Seoul Natl Univ, Boramae Hosp, Dept Ophthalmol, Seoul, South Korea.	xcski@hanmail.net	Kim, Seok-Hwan/AAV-3518-2021; Kim, Seok-Hwan/G-9981-2015	Kim, Seok-Hwan/0000-0003-0209-0444; Kim, Seok-Hwan/0000-0003-0209-0444	SK Telecom Research Fund [16-2013-6]	SK Telecom Research Fund	This work was supported by grant no. 16-2013-6 from the SK Telecom Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Haddad CE, 2011, BRIT J OPHTHALMOL, V95, P1696, DOI 10.1136/bjo.2010.195081; Altemir I, 2013, AM J OPHTHALMOL, V155, P171, DOI 10.1016/j.ajo.2012.06.012; Baker PS, 2010, OPHTHAL SURG LAS IM, V41, P201, DOI 10.3928/15428877-20100303-08; Bambo MP, 2014, BRIT J OPHTHALMOL, V98, P52, DOI 10.1136/bjophthalmol-2013-303752; Chang L, 2010, J AAPOS, V14, P511, DOI 10.1016/j.jaapos.2010.08.014; Donner A, 2002, J ROY STAT SOC D-STA, V51, P367, DOI 10.1111/1467-9884.00324; Drexler W, 2008, PROG RETIN EYE RES, V27, P45, DOI 10.1016/j.preteyeres.2007.07.005; El-Dairi MA, 2009, BRIT J OPHTHALMOL, V93, P1325, DOI 10.1136/bjo.2008.142562; Gabriele ML, 2011, INVEST OPHTH VIS SCI, V52, P2425, DOI 10.1167/iovs.10-6312; Ghasia FF, 2015, J GLAUCOMA, V24, P55, DOI 10.1097/IJG.0b013e31829521db; HEE MR, 1995, ARCH OPHTHALMOL-CHIC, V113, P325, DOI 10.1001/archopht.1995.01100030081025; Hess DB, 2005, AM J OPHTHALMOL, V139, P509, DOI 10.1016/j.ajo.2004.10.047; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jeoung JW, 2014, J GLAUCOMA, V23, P299, DOI 10.1097/IJG.0b013e3182741cc4; Kumar Vinod, 2010, Ophthalmic Surg Lasers Imaging, V41 Online, pe1, DOI 10.3928/15428877-20101223-06; Lange Alex P, 2012, ISRN Ophthalmol, V2012, P860819, DOI 10.5402/2012/860819; Langenegger SJ, 2011, INVEST OPHTH VIS SCI, V52, P3338, DOI 10.1167/iovs.10-6611; Liu H, 2010, J PEDIAT OPHTH STRAB, V47, P17, DOI [10.3928/01913913-20091019-06, 10.3928/01913913-20100101-16]; Pang Y, 2011, INVEST OPHTH VIS SCI, V52, P2444, DOI 10.1167/iovs.10-5550; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Pierro L, 2010, AM J OPHTHALMOL, V150, P199, DOI 10.1016/j.ajo.2010.03.015; Sakamoto A, 2008, OPHTHALMOLOGY, V115, P1071, DOI 10.1016/j.ophtha.2007.09.001; Sander B, 2005, BRIT J OPHTHALMOL, V89, P207, DOI 10.1136/bjo.2004.045989; Serbecic N, 2011, BRIT J OPHTHALMOL, V95, P804, DOI 10.1136/bjo.2010.186221; Wu HJ, 2011, J GLAUCOMA, V20, P470, DOI 10.1097/IJG.0b013e3181f3eb64; Youm Dong Ju, 2012, Korean J Ophthalmol, V26, P104, DOI 10.3341/kjo.2012.26.2.104	26	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147448	10.1371/journal.pone.0147448	http://dx.doi.org/10.1371/journal.pone.0147448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808961	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800096
J	Hane, FT; Hayes, R; Lee, BY; Leonenko, Z				Hane, Francis T.; Hayes, Reid; Lee, Brenda Y.; Leonenko, Zoya			Effect of Copper and Zinc on the Single Molecule Self-Affinity of Alzheimer's Amyloid-beta Peptides	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; A-BETA; PROTEIN OLIGOMERS; OXIDATIVE STRESS; DISEASE; BINDING; AGGREGATION; TOXICITY; SPECTROSCOPY; KINETICS	The presence of trace concentrations of metallic ions, such as copper and zinc, has previously been shown to drastically increase the aggregation rate and neurotoxicity of amyloid-beta (A beta), the peptide implicated in Alzheimer's disease (AD). The mechanism of why copper and zinc accelerate A beta aggregation is poorly understood. In this work, we use single molecule force spectroscopy (SMFS) to probe the kinetic and thermodynamic parameters (dissociation constant, K-d, kinetic dissociation rate, k(off), and free energy, Delta G) of the dissociation of an A beta dimer, the amyloid species which initiates the amyloid cascade. Our results show that nanomolar concentrations of copper do not change the single molecule affinity of A beta to another A beta peptide in a statistically significant way, while nanomolar concentrations of zinc decrease the affinity of A beta-A beta by an order of magnitude. This suggests that the binding of zinc ion to A beta may interfere with the binding of A beta-A beta, leading to a lower self-affinity.	[Hane, Francis T.; Lee, Brenda Y.; Leonenko, Zoya] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Hayes, Reid; Leonenko, Zoya] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Leonenko, Z (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.; Leonenko, Z (corresponding author), Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada.	zleonenk@uwaterloo.ca		Lee, Brenda/0000-0003-4086-7082	Canadian Foundation for Innovation (CFI); Ontario Research Fund (ORF); Natural Science and Engineering Research Council of Canada (NSERC); University of Waterloo	Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Research Fund (ORF); Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Waterloo	This research was supported by Canadian Foundation for Innovation (CFI), Ontario Research Fund (ORF), Natural Science and Engineering Research Council of Canada (NSERC) and University of Waterloo.	Alies B, 2011, J BIOL INORG CHEM, V16, P333, DOI 10.1007/s00775-010-0729-8; AnnaRita B, 2012, DYNAMIC FORCE SPECTR, P247; Azimi Samira, 2011, Int J Alzheimers Dis, V2011, P539762, DOI 10.4061/2011/539762; Bin YN, 2013, J INORG BIOCHEM, V119, P21, DOI 10.1016/j.jinorgbio.2012.10.013; Bisswanger H., 2008, ENZYME KINETICS PRIN; Buell AK, 2012, ANGEW CHEM INT EDIT, V51, P5247, DOI 10.1002/anie.201108040; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; Cuajungco MP, 2000, J BIOL CHEM, V275, P19439, DOI 10.1074/jbc.C000165200; Cuajungco MP, 1997, BRAIN RES REV, V23, P219, DOI 10.1016/S0165-0173(97)00002-7; Drolle E, 2014, DRUG METAB REV, V46, P207, DOI 10.3109/03602532.2014.882354; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Eskici G, 2012, BIOCHEMISTRY-US, V51, P6289, DOI 10.1021/bi3006169; Friddle RW, 2012, P NATL ACAD SCI USA, V109, P13573, DOI 10.1073/pnas.1202946109; Furlan S, 2010, J PHYS CHEM B, V114, P15119, DOI 10.1021/jp102928h; Gabdoulline RR, 2001, J MOL BIOL, V306, P1139, DOI 10.1006/jmbi.2000.4404; Garai K, 2007, BIOCHEMISTRY-US, V46, P10655, DOI 10.1021/bi700798b; Greenough MA, 2013, NEUROCHEM INT, V62, P540, DOI 10.1016/j.neuint.2012.08.014; Han DX, 2008, BIOMETALS, V21, P189, DOI 10.1007/s10534-007-9107-6; Hane F, 2013, SINGLE MOL FORCE SPE; Hane FT, 2014, SOFT MATTER, V10, P1924, DOI 10.1039/c3sm52257a; Hane F, 2014, BIOMOLECULES, V4, P101, DOI 10.3390/biom4010101; Hane F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059005; Hane FT, 2014, BIOSENS BIOELECTRON, V54, P492, DOI 10.1016/j.bios.2013.10.060; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Huang XD, 2004, J BIOL INORG CHEM, V9, P954, DOI 10.1007/s00775-004-0602-8; Hummer G, 2003, BIOPHYS J, V85, P5, DOI 10.1016/S0006-3495(03)74449-X; Innocenti M, 2010, J ALZHEIMERS DIS, V19, P1323, DOI 10.3233/JAD-2010-1338; Karacsony O, 2011, LANGMUIR, V27, P11287, DOI 10.1021/la202530j; Ma BY, 2012, J MOL BIOL, V421, P172, DOI 10.1016/j.jmb.2011.11.023; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Nair NG, 2010, J ALZHEIMERS DIS, V20, P57, DOI 10.3233/JAD-2010-1346; Nasica-Labouze J, 2015, CHEM REV, V115, P3518, DOI 10.1021/cr500638n; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Pedersen JT, 2011, J BIOL CHEM, V286, P26952, DOI 10.1074/jbc.M111.220863; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Rauk A, 2009, CHEM SOC REV, V38, P2698, DOI 10.1039/b807980n; Rozga M, 2010, CHEM RES TOXICOL, V23, P336, DOI 10.1021/tx900344n; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Sarell CJ, 2009, BIOCHEMISTRY-US, V48, P4388, DOI 10.1021/bi900254n; Suwalsky M, 2009, J ALZHEIMERS DIS, V17, P81, DOI 10.3233/JAD-2009-1032; Tougu V, 2011, METALLOMICS, V3, P250, DOI 10.1039/c0mt00073f; Zhang Yong, 2012, Yaoxue Xuebao, V47, P399	46	27	27	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147488	10.1371/journal.pone.0147488	http://dx.doi.org/10.1371/journal.pone.0147488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808970	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800110
J	Hu, JG; Zhou, J; Zhou, GM; Luo, YQ; Xu, XJ; Li, PH; Liang, JY				Hu, Junguo; Zhou, Jian; Zhou, Guomo; Luo, Yiqi; Xu, Xiaojun; Li, Pingheng; Liang, Junyi			Improving Estimations of Spatial Distribution of Soil Respiration Using the Bayesian Maximum Entropy Algorithm and Soil Temperature as Auxiliary Data	PLOS ONE			English	Article							CO2 EFFLUX; PARTICULATE MATTER; INTERPOLATION; VARIABILITY; AREA; HETEROGENEITY; DEPENDENCE; EMISSION; CARBON; SPACE	Soil respiration inherently shows strong spatial variability. It is difficult to obtain an accurate characterization of soil respiration with an insufficient number of monitoring points. However, it is expensive and cumbersome to deploy many sensors. To solve this problem, we proposed employing the Bayesian Maximum Entropy (BME) algorithm, using soil temperature as auxiliary information, to study the spatial distribution of soil respiration. The BME algorithm used the soft data (auxiliary information) effectively to improve the estimation accuracy of the spatiotemporal distribution of soil respiration. Based on the functional relationship between soil temperature and soil respiration, the BME algorithm satisfactorily integrated soil temperature data into said spatial distribution. As a means of comparison, we also applied the Ordinary Kriging (OK) and Co-Kriging (Co-OK) methods. The results indicated that the root mean squared errors (RMSEs) and absolute values of bias for both Day 1 and Day 2 were the lowest for the BME method, thus demonstrating its higher estimation accuracy. Further, we compared the performance of the BME algorithm coupled with auxiliary information, namely soil temperature data, and the OK method without auxiliary information in the same study area for 9, 21, and 37 sampled points. The results showed that the RMSEs for the BME algorithm (0.972 and 1.193) were less than those for the OK method (1.146 and 1.539) when the number of sampled points was 9 and 37, respectively. This indicates that the former method using auxiliary information could reduce the required number of sampling points for studying spatial distribution of soil respiration. Thus, the BME algorithm, coupled with soil temperature data, can not only improve the accuracy of soil respiration spatial interpolation but can also reduce the number of sampling points.	[Hu, Junguo; Zhou, Jian; Zhou, Guomo] Zhejiang A&F Univ, Informat Engn Coll, Linan, Peoples R China; [Hu, Junguo; Xu, Xiaojun; Li, Pingheng] Zhejiang Prov Key Lab Forestry Intelligent Monito, Linan, Peoples R China; [Luo, Yiqi; Liang, Junyi] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA	Zhejiang A&F University; University of Oklahoma System; University of Oklahoma - Norman	Zhou, GM (corresponding author), Zhejiang A&F Univ, Informat Engn Coll, Linan, Peoples R China.	zhougm@zafu.edu.cn	Liang, Junyi/H-3203-2016	Liang, Junyi/0000-0001-8252-5502; Zhou, Jian/0000-0001-9276-6086	NSF China Programs [31300539, 31500527, 31570629]; Public Welfare Technology Application Research Program of Zhejiang province [2015C31004]	NSF China Programs; Public Welfare Technology Application Research Program of Zhejiang province	This work was supported by the NSF China Programs (Grant No. 31300539 and 31500527), http://www.nsfc.gov.cn/; it was also supported by the Public Welfare Technology Application Research Program of Zhejiang province (Grant No. 2015C31004), http://www.zjkjt.gov.cn/.; This study was supported by the NSF China Programs (Grant No. 31300539 and 31570629) and the Public Welfare Technology Application Research Program of Zhejiang province (Grant No. 2015C31004).	Akita Y, 2012, J EXPO SCI ENV EPID, V22, P496, DOI 10.1038/jes.2012.57; [Anonymous], 2011, STAT SPATIOTEMPORAL; Bayat B, 2013, THEOR APPL CLIMATOL, V113, P429, DOI 10.1007/s00704-012-0795-7; Bogaert P, 2002, SOIL SCI SOC AM J, V66, P1492, DOI 10.2136/sssaj2002.1492; Bonavito N. L., 1994, Telematics and Informatics, V11, P295, DOI 10.1016/0736-5853(94)90021-3; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Boyer DG, 1996, SOIL SCI, V161, P278, DOI 10.1097/00010694-199605000-00003; Brus DJ, 2008, EUR J SOIL SCI, V59, P166, DOI 10.1111/j.1365-2389.2007.00981.x; Chen ST, 2015, APPL SOIL ECOL, V86, P148, DOI 10.1016/j.apsoil.2014.10.013; CHRISTAKOS G, 1990, MATH GEOL, V22, P763, DOI 10.1007/BF00890661; Christakos G, 2000, ATMOS ENVIRON, V34, P3393, DOI 10.1016/S1352-2310(00)00080-7; Christakos G, 1998, MATH GEOL, V30, P435, DOI 10.1023/A:1021748324917; Christakos G, 2001, J GEOPHYS RES-ATMOS, V106, P9717, DOI 10.1029/2000JD900780; Christakos G, 2002, TEMPORAL GIS CD ROM; Clayton V, 1998, TECHNOMETRICS; D'Or D, 2001, STOCH ENV RES RISK A, V15, P87, DOI 10.1007/s004770000057; Dore S, 2014, FOREST ECOL MANAG, V319, P150, DOI 10.1016/j.foreco.2014.02.012; Douaik A, 2005, GEODERMA, V128, P234, DOI 10.1016/j.geoderma.2005.04.006; Douaik A, 2004, STOCH ENV RES RISK A, V18, P219, DOI 10.1007/s00477-004-0177-5; Elbasiouny H, 2014, CATENA, V113, P70, DOI 10.1016/j.catena.2013.09.008; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Friedel MJ, 2013, ENVIRON MODELL SOFTW, V43, P60, DOI 10.1016/j.envsoft.2013.01.009; Gamma Design Software, 2008, GS GEOST ENV SCI VER; Gao SG, 2014, INT J APPL EARTH OBS, V32, P54, DOI 10.1016/j.jag.2014.03.003; Gomez-Casanovas N, 2013, GLOBAL CHANGE BIOL, V19, P1941, DOI 10.1111/gcb.12127; Guo PT, 2015, GEODERMA, V237, P49, DOI 10.1016/j.geoderma.2014.08.009; Hengl T., 2007, PRACTICAL GUIDE GEOS; Hu JG, 2013, ECOL MODEL, V266, P86, DOI 10.1016/j.ecolmodel.2013.06.027; Huang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105150; Jordan A, 2009, BIOGEOSCI DISCUSS, V6, P9977; Jurasinski G, 2012, FOREST ECOL MANAG, V263, P101, DOI 10.1016/j.foreco.2011.09.025; Kumar S, 2012, GEODERMA, V189, P627, DOI 10.1016/j.geoderma.2012.05.022; Lee SJ, 2010, STOCH ENV RES RISK A, V24, P283, DOI 10.1007/s00477-009-0317-z; Li AH, 2013, REMOTE SENS ENVIRON, V135, P52, DOI 10.1016/j.rse.2013.03.021; Li AH, 2013, INT J REMOTE SENS, V34, P227, DOI 10.1080/01431161.2012.712234; Li J., 2008, REV SPATIAL INTERPOL; Li J, 2010, GEOSCIENCE; Li J, 2014, ENVIRON MODELL SOFTW, V53, P173, DOI 10.1016/j.envsoft.2013.12.008; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Ngao J, 2012, AGR FOREST METEOROL, V154, P136, DOI 10.1016/j.agrformet.2011.11.003; Orton TG, 2009, STOCH ENV RES RISK A, V23, P319, DOI 10.1007/s00477-008-0217-7; Pang W, 2010, ENVIRONMETRICS, V21, P305, DOI 10.1002/env.1007; Puangthongthub S, 2007, ATMOS ENVIRON, V41, P7788, DOI 10.1016/j.atmosenv.2007.06.051; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Savelieva E, 2005, GEODERMA, V128, P312, DOI 10.1016/j.geoderma.2005.04.011; Stoyan H, 2000, PLANT SOIL, V222, P203, DOI 10.1023/A:1004757405147; Strebel K, 2013, ENVIRON MODELL SOFTW, V41, P151, DOI 10.1016/j.envsoft.2012.12.001; Teixeira DD, 2013, SCI AGR, V70, P195, DOI 10.1590/S0103-90162013000300008; Teixeira DD, 2011, PLANT SOIL, V345, P187, DOI 10.1007/s11104-011-0770-6; Wood TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080965; Xiao WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101890; [徐林 Xu Lin], 2013, [林业科学, Scientia Silvae Sinicae], V49, P122; Yari G, 2012, COMPUT IND ENG, V63, P338, DOI 10.1016/j.cie.2012.03.010; Younger M.S., 1985, 1 COURSE LINEAR REGR; Yu HL, 2013, ENVIRON SCI TECHNOL, V47, P1416, DOI 10.1021/es302539f; Yu HL, 2009, ENVIRON HEALTH PERSP, V117, P537, DOI 10.1289/ehp.0800089; Yu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117490; Zhang Bei, 2011, Acta Pedologica Sinica, V48, P831; Zhang SW, 2013, J INTEGR AGR, V12, P1673, DOI 10.1016/S2095-3119(13)60395-0; Zhou WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092531	60	11	12	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146589	10.1371/journal.pone.0146589	http://dx.doi.org/10.1371/journal.pone.0146589			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807579	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800028
J	Magombedze, G; Eda, S; Koets, A				Magombedze, Gesham; Eda, Shigetoshi; Koets, Ad			Can Immune Response Mechanisms Explain the Fecal Shedding Patterns of Cattle Infected with Mycobacterium avium Subspecies paratuberculosis?	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; GAMMA-INTERFERON; JOHNES-DISEASE; MACROPHAGES; INTERLEUKIN-10; EXPRESSION; SURVIVAL; CULTURE; CALVES	Johne's disease (JD) is a chronic disease in ruminants and is caused by infection with Mycobacterium avium subspecies paratuberculosis (MAP). At late stages of the disease, MAP bacilli are shed via feces excretion and in turn create the potential for oral-fecal transmission. The role of the host immune response in MAP bacteria shedding patterns at different stages of JD is still unclear. We employed mathematical modeling to predict if the variation in MAP shedding could be correlated to the immune response in infected animals. We used a novel inverse modeling approach that assumed biological interactions among the antigen-specific lymphocyte proliferation response (cell-mediated response), antibody/humoral immune responses, and MAP bacteria. The modeling framework was used to predict and test possible biological interactions between the measured variables and returns only the essential interactions that are relevant in explaining the observed cattle MAP experimental infection data. Through confronting the models with data, we predicted observed effects (enhancement or suppression) and extents of interactions among the three variables. This analysis enabled classification of the infected cattle into three different groups that correspond to the unique predicted immune responses that are essential to explain the data from cattle within these groups. Our analysis highlights the strong and weak points of the modeling approach, as well as the key immune mechanisms predicted to be expressed in all animals and those that were different between animals, hence giving insight into how animals exhibit different disease dynamics and bacteria shedding patterns.	[Magombedze, Gesham] Univ Tennessee, Natl Inst Math & Biol Synth NIMBioS, Knoxville, TN USA; [Magombedze, Gesham] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England; [Eda, Shigetoshi] Univ Tennessee, Dept Forestry Wildlife & Fisheries, Ctr Wildlife Hlth, Knoxville, TN USA; [Koets, Ad] Wageningen Univ & Res Ctr, Cent Vet Inst, Dept Bacteriol & Epidemiol, Lelystad, Netherlands; [Koets, Ad] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands	University of Tennessee System; University of Tennessee Knoxville; Imperial College London; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Wageningen University & Research; Utrecht University	Magombedze, G (corresponding author), Univ Tennessee, Natl Inst Math & Biol Synth NIMBioS, Knoxville, TN USA.; Magombedze, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England.	gmagombedze@nimbios.org		Magombedze, Gesham/0000-0003-2745-3475	National Institute for Mathematical and Biological Synthesis (NIMBioS); National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF [EF-0832858]; University of Tennessee, Knoxville	National Institute for Mathematical and Biological Synthesis (NIMBioS)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF(National Science Foundation (NSF)); University of Tennessee, Knoxville	The authors acknowledge the support of the National Institute for Mathematical and Biological Synthesis (NIMBioS), an Institute sponsored by the National Science Foundation, the U.S. Department of Homeland Security, and the U.S. Department of Agriculture through NSF Award #EF-0832858, with additional support from The University of Tennessee, Knoxville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank valuable comments on our models from members of NIMBioS working group, Within-host modeling of MAP infections.; The authors acknowledge the support of the National Institute for Mathematical and Biological Synthesis (NIMBioS), an Institute sponsored by the National Science Foundation, the U.S. Department of Homeland Security, and the U.S. Department of Agriculture through NSF Award #EF-0832858, with additional support from The University of Tennessee, Knoxville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank the members of the NIMBioS working group for their valuable comments regarding our within-host modeling of MAP infections.	Bannantine JP, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-2; Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Begg DJ, 2011, IMMUNOBIOLOGY, V216, P840, DOI 10.1016/j.imbio.2010.12.004; Buza JJ, 2004, INFECT IMMUN, V72, P2425, DOI 10.1128/IAI.72.4.2425-2428.2004; Coussens PM, 2004, INFECT IMMUN, V72, P3089, DOI 10.1128/IAI.72.6.3089-3096.2004; Coussens PM, 2004, INFECT IMMUN, V72, P1409, DOI 10.1128/IAI.72.3.1409-1422.2004; de Silva K, 2013, PREV VET MED, V112, P203, DOI 10.1016/j.prevetmed.2013.08.006; de Silva K, 2011, VET IMMUNOL IMMUNOP, V139, P10, DOI 10.1016/j.vetimm.2010.07.022; GILMOUR NJL, 1965, J COMP PATHOL THERAP, V75, P281, DOI 10.1016/0021-9975(65)90033-2; Gollnick NS, 2007, VET IMMUNOL IMMUNOP, V120, P93, DOI 10.1016/j.vetimm.2007.07.017; JORGENSEN JB, 1982, ACTA VET SCAND, V23, P325; Koets AP, 1999, VET IMMUNOL IMMUNOP, V70, P105, DOI 10.1016/S0165-2427(99)00062-8; Koets AP, 2001, INFECT IMMUN, V69, P1492, DOI 10.1128/IAI.69.3.1492-1498.2001; Kuehnel MP, 2001, CELL MICROBIOL, V3, P551, DOI 10.1046/j.1462-5822.2001.00139.x; Langelaar MFM, 2005, THESIS UTRECHT U; Magombedze G, 2013, FRONT PHYSIOL, P4; Magombedze G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076636; Magombedze G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003414; Nielsen SS, 2008, VET MICROBIOL, V129, P217, DOI 10.1016/j.vetmic.2007.12.011; Olsen I, 2002, VET QUART, V24, P12, DOI 10.1080/01652176.2002.9695120; Salem M, 2013, TROP ANIM HEALTH PRO, V45, P351, DOI 10.1007/s11250-012-0274-2; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i03; Stabel JR, 2011, CLIN VACCINE IMMUNOL, V18, P393, DOI 10.1128/CVI.00359-10; Stabel JR, 1996, J VET DIAGN INVEST, V8, P345, DOI 10.1177/104063879600800311; Stabel JR, 2000, VET MICROBIOL, V77, P465, DOI 10.1016/S0378-1135(00)00331-X; Subharat S, 2012, VET IMMUNOL IMMUNOP, V149, P225, DOI 10.1016/j.vetimm.2012.07.005; VARY PH, 1990, J CLIN MICROBIOL, V28, P933, DOI 10.1128/JCM.28.5.933-937.1990; Verna AE, 2007, ZOONOSES PUBLIC HLTH, V54, P243, DOI 10.1111/j.1863-2378.2007.01058.x; Weiss DJ, 2005, AM J VET RES, V66, P721, DOI 10.2460/ajvr.2005.66.721; Whitlock RH, 1996, VET CLIN N AM-FOOD A, V12, P345, DOI 10.1016/S0749-0720(15)30410-2; Whittington RJ, 2001, AUST VET J, V79, P267, DOI 10.1111/j.1751-0813.2001.tb11980.x	31	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146844	10.1371/journal.pone.0146844	http://dx.doi.org/10.1371/journal.pone.0146844			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808389	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800035
J	Nemescu, D; Ursu, RG; Nemescu, ER; Negura, L				Nemescu, Dragos; Ursu, Ramona Gabriela; Nemescu, Elena Roxana; Negura, Lucian			Heterogeneous Distribution of Fetal Microchimerism in Local Breast Cancer Environment	PLOS ONE			English	Article							CELLS; WOMEN; QUANTIFICATION; CHIMERISM; DNA	Fetal cells enter maternal circulation during pregnancy and persist in the woman's body for decades, achieving a form of physiological microchimerism. These cells were also evidenced in tumors. We investigated the frequency and concentration of fetal microchimerism in the local breast cancer environment. From 19 patients with confirmed breast neoplasia, after breast surgical resection, we collected three fresh specimens from the tumor core, breast tissue at tumor periphery, and adjacent normal breast tissue. The presence of male DNA was analyzed with a quantitative PCR assay for the sex determining region gene (SRY) gene. In the group of women who had given birth to at least one son, we detected fetal microchimerism in 100% of samples from tumors and their periphery and in 64% (9 of 14) of those from normal breast tissue. The tissues from the tumor and its periphery carry a significantly increased number of SRY copies compared to its neighboring common breast tissue (p = 0.005). The median of the normalized SRY-signal was about 77 (range, 3.2-21467) and 14-fold (range, 1.3-2690) greater in the tumor and respectively in the periphery than in the normal breast tissue. In addition, the relative expression of the SRY gene had a median 5.5 times larger in the tumor than in its periphery (range, 1.1-389.4). We found a heterogeneous distribution of fetal microchimerism in breast cancer environment. In women with sons, breast neoplasia harbors male cells at significantly higher levels than in peripheral and normal breast tissue.	[Nemescu, Dragos] Univ Med & Pharm Gr T Popa, Dept Obstet & Gynecol, Iasi, Romania; [Nemescu, Dragos] Cuza Voda Obstet & Gynecol Hosp, Iasi, Romania; [Ursu, Ramona Gabriela] Univ Med & Pharm Gr T Popa, Dept Microbiol, Iasi, Romania; [Nemescu, Elena Roxana] Univ Med & Pharm Gr T Popa, Dept Infect Dis, Iasi, Romania; [Negura, Lucian] Univ Med & Pharm Gr T Popa, Dept Immunol & Oncogenet, Iasi, Romania	Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy	Ursu, RG (corresponding author), Univ Med & Pharm Gr T Popa, Dept Microbiol, Iasi, Romania.	ramonagabrielaursu@yahoo.com	Ursu, Ramona Gabriela/U-6053-2017; Nemescu, Dragos/AAC-7813-2019; Negura, Lucian/A-9652-2011	Nemescu, Dragos/0000-0003-2345-1077; Ursu, Ramona Gabriela/0000-0002-1811-7923	Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii Young Research Teams research grantl [PN-II-RU-TE-2014-4-2257]; UEFISCDI Young Research Teams research grant [PN-II-RU-TE-2014-4-2257]	Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii Young Research Teams research grantl(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); UEFISCDI Young Research Teams research grant(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This work was partially supported by Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii Young Research Teams research grant PN-II-RU-TE-2014-4-2257. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper was supported partially by UEFISCDI Young Research Teams research grant PN-II-RU-TE-2014-4-2257. We would like to thank Dr S. Musca, Dr D. Scripcaru and Dr C. Terinte of the pathology unit for their assistance in probe collection and pathological evaluation.	Barbisin M, 2011, J FORENSIC RES, V2, P2; Barbisin M, 2009, J FORENSIC SCI, V54, P305, DOI 10.1111/j.1556-4029.2008.00951.x; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Cha D, 2003, OBSTET GYNECOL, V102, P774, DOI 10.1016/S0029-7844(03)00615-X; Dhimolea E, 2013, INT J CANCER, V133, P835, DOI 10.1002/ijc.28077; Dubernard G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1860; Eun JK, 2013, SCI REP-UK, V3, DOI 10.1038/srep02192; Fugazzola L, 2011, NAT REV ENDOCRINOL, V7, P89, DOI 10.1038/nrendo.2010.216; Gadi VK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001706; Gadi VK, 2007, CANCER RES, V67, P9035, DOI 10.1158/0008-5472.CAN-06-4209; Gadi VK, 2010, BREAST CANCER RES TR, V121, P241, DOI 10.1007/s10549-009-0548-1; Gadi VK, 2009, CANCER LETT, V276, P8, DOI 10.1016/j.canlet.2008.07.025; Huu SN, 2007, P NATL ACAD SCI USA, V104, P1871, DOI 10.1073/pnas.0606490104; Kamper-Jorgensen M, 2014, INT J EPIDEMIOL, V43, P168, DOI 10.1093/ije/dyt230; Kamper-Jorgensen Mads, 2012, Chimerism, V3, P72, DOI 10.4161/chim.22770; Kamper-Jorgensen M, 2012, EUR J CANCER, V48, P2227, DOI 10.1016/j.ejca.2012.02.006; Khosrotehrani K, 2004, JAMA-J AM MED ASSOC, V292, P75, DOI 10.1001/jama.292.1.75; Klonisch T, 2009, TRENDS MOL MED, V15, P510, DOI 10.1016/j.molmed.2009.09.002; Koopmans M, 2008, J REPROD IMMUNOL, V78, P68, DOI 10.1016/j.jri.2008.01.002; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Nemescu D, 2008, GINECO RO, V4, P212; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Russo J, 2005, BREAST CANCER RES, V7, P131, DOI 10.1186/bcr1029; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875	24	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147675	10.1371/journal.pone.0147675	http://dx.doi.org/10.1371/journal.pone.0147675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808509	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800176
J	Yu, G; Li, H; Yang, SH; Wen, JG; Niu, JQ; Zu, YL				Yu, Ge; Li, Huan; Yang, Shuanghui; Wen, Jianguo; Niu, Junqi; Zu, Youli			ssDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 Cells	PLOS ONE			English	Article							DISCOVERY	Hepatocellular carcinoma (HCC) is the third leading cause of death due to cancer worldwide with over 500,000 people affected annually. Although chemotherapy has been widely used to treat patients with HCC, alternate modalities to specifically deliver therapeutic cargos to cancer cells have been sought in recent years due to the severe side effects of chemotherapy. In this respect, aptamer-based tumor targeted drug delivery has emerged as a promising approach to increase the efficacy of chemotherapy and reduce or eliminate drug toxicity. In this study, we developed a new HepG2-specific aptamer (HCA#3) by a procedure known as systematic evolution of ligands by exponential enrichment (SELEX) and exploited its role as a targeting ligand to deliver doxorubicin (Dox) to HepG2 cells in vitro. The selected 76-base nucleotide aptamer preferentially bound to HepG2 hepatocellular carcinoma cells but not to control cells. The aptamer HCA#3 was modified with paired CG repeats at the 5'-end to carry and deliver a high payload of intercalated Dox molecules at the CG sites. Four Dox molecules (mol/mol) were fully intercalated in each conjugate aptamer-Dox (ApDC) molecule. Biostability analysis showed that the ApDC molecules are stable in serum. Functional analysis showed that ApDC specifically targeted and released Dox within HepG2 cells but not in control cells, and treatment with HCA#3 ApDC induced HepG2 cell apoptosis but had minimal effect on control cells. Our study demonstrated that HCA#3 ApDC is a promising aptamer-targeted therapeutic that can specifically deliver and release a high doxorubicin payload in HCC cells.	[Yu, Ge; Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun 130023, Jilin Province, Peoples R China; [Yu, Ge; Li, Huan; Yang, Shuanghui; Wen, Jianguo; Zu, Youli] Houston Methodist Hosp, Dept Pathol & Genom Med, Houston, TX USA; [Li, Huan; Yang, Shuanghui] Cent South Univ, Xiangya Hosp, Changsha 410083, Hunan, Peoples R China	Jilin University; The Methodist Hospital System; The Methodist Hospital - Houston; Central South University	Niu, JQ (corresponding author), Jilin Univ, Hosp 1, Dept Hepatol, Changchun 130023, Jilin Province, Peoples R China.; Wen, JG; Zu, YL (corresponding author), Houston Methodist Hosp, Dept Pathol & Genom Med, Houston, TX USA.	jwen@HoustonMethodist.org; junqiniu@aliyun.com; yzu@HoustonMethodist.org			National Instiutes of Health [R01CA151955, R33CA173382]; Cancer Prevention Research Institute of Texas [RP140315]; National Science and Technology Major Project [2014ZX10002002, 2013ZX10002008]; National Natural Science Foundation of China [81373057]; NATIONAL CANCER INSTITUTE [R01CA151955, R33CA173382] Funding Source: NIH RePORTER	National Instiutes of Health; Cancer Prevention Research Institute of Texas; National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by R01CA151955, http://www.nih.gov/, National Instiutes of Health to YLZ; R33CA173382, http://www.nih.gov/, National Instiutes of Health to YLZ; RP140315, http://www.cprit.state.tx.us/, Cancer Prevention Research Institute of Texas to YLZ; 2014ZX10002002, http://www.most.gov.cn/eng/programmes1/200610/t20061008_36200.htm, National Science and Technology Major Project to JQN; 2013ZX10002008, http://www.most.gov.cn/eng/programmes1/200610/t20061008_36200.htm, National Science and Technology Major Project to JQN; and 81373057, http://www.nsfc.gov.cn/, National Natural Science Foundation of China to JQN.	Akitomi J, 2011, BIOINFORMATION, V7, P38; Bagalkot V, 2006, ANGEW CHEM INT EDIT, V45, P8149, DOI 10.1002/anie.200602251; Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gish RG, 2012, EXPERT REV GASTROENT, V6, P173, DOI [10.1586/egh.11.105, 10.1586/EGH.11.105]; Gross S, 2006, CURR OPIN CHEM BIOL, V10, P334, DOI 10.1016/j.cbpa.2006.06.028; HEFFELFINGER SC, 1992, IN VITRO CELL DEV-AN, V28A, P136; Hong H, 2011, CURR MED CHEM, V18, P4195, DOI 10.2174/092986711797189691; Hu Y, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/728342; Ireson CR, 2006, MOL CANCER THER, V5, P2957, DOI 10.1158/1535-7163.MCT-06-0172; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Lencioni Riccardo, 2013, Recent Results Cancer Res, V190, P181, DOI 10.1007/978-3-642-16037-0_12; Lencioni R, 2012, SEMIN ONCOL, V39, P503, DOI 10.1053/j.seminoncol.2012.05.004; Lencioni R, 2010, HEPATOLOGY, V52, P762, DOI 10.1002/hep.23725; Liu Z, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-148; Llovet JM, 2005, J GASTROENTEROL, V40, P225, DOI 10.1007/s00535-005-1566-3; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet Josep M, 2004, Curr Treat Options Gastroenterol, V7, P431, DOI 10.1007/s11938-004-0002-8; Marrero JA, 2010, ONCOLOGIST, V15, P23, DOI 10.1634/theoncologist.2010-S4-23; Meng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033434; Parekh P, 2013, BIOMATERIALS, V34, P8909, DOI 10.1016/j.biomaterials.2013.07.099; Parekh P, 2010, ANAL CHEM, V82, P8642, DOI 10.1021/ac101801j; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Porciani D, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.9; Sefah K, 2010, NAT PROTOC, V5, P1169, DOI 10.1038/nprot.2010.66; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; Soontornworajit B, 2011, ANAL BIOANAL CHEM, V399, P1591, DOI 10.1007/s00216-010-4559-x; Subramanian N, 2012, MOL VIS, V18, P2783; Sun HG, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.32; Sundaram P, 2013, EUR J PHARM SCI, V48, P259, DOI 10.1016/j.ejps.2012.10.014; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wen J, 2015, LEUKEMIA; Xing H, 2013, J MATER CHEM B, V1, P5288, DOI 10.1039/c3tb20412j; Zuker M, 2000, CURR OPIN STRUC BIOL, V10, P303, DOI 10.1016/S0959-440X(00)00088-9; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	38	9	9	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147674	10.1371/journal.pone.0147674	http://dx.doi.org/10.1371/journal.pone.0147674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808385	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800175
J	Krick, S; Wang, JJ; St-Pierre, M; Gonzalez, C; Dahl, G; Salathe, M				Krick, Stefanie; Wang, Junjie; St-Pierre, Melissa; Gonzalez, Carlos; Dahl, Gerhard; Salathe, Matthias			Dual Oxidase 2 (Duox2) Regulates Pannexin 1-mediated ATP Release in Primary Human Airway Epithelial Cells via Changes in Intracellular pH and Not H2O2 Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acidosis; ATP; epithelial cell; hydrogen peroxide; pannexin; dual oxidase 2	GAP-JUNCTION HEMICHANNELS; CILIARY BEAT FREQUENCY; CYSTIC-FIBROSIS; CHRONIC-BRONCHITIS; CHLORIDE CURRENTS; LARGE-CONDUCTANCE; INTERFERON-GAMMA; XENOPUS OOCYTES; UP-REGULATION; CHANNELS	Human airway epithelial cells express pannexin 1 (Panx1) channels to release ATP, which regulates mucociliary clearance. Airway inflammation causes mucociliary dysfunction. Exposure of primary human airway epithelial cell cultures to IFN- for 48 h did not alter Panx1 protein expression but significantly decreased ATP release in response to hypotonic stress. The IFN--induced functional down-regulation of Panx1 was due to the up-regulation of dual oxidase 2 (Duox2). Duox2 suppression by siRNA led to an increase in ATP release in control cells and restoration of ATP release in cells treated with IFN-. Both effects were reduced by the pannexin inhibitor probenecid. Duox2 up-regulation stoichiometrically increases H2O2 and proton production. H2O2 inhibited Panx1 function temporarily by formation of disulfide bonds at the thiol group of its terminal cysteine. Long-term exposure to H2O2, however, had no inhibitory effect. To assess the role of cellular acidification upon IFN- treatment, fully differentiated airway epithelial cells were exposed to ammonium chloride to alkalinize the cytosol. This led to a 2-fold increase in ATP release in cells treated with IFN- that was also inhibited by probenecid. Duox2 knockdown also partially corrected IFN--mediated acidification. The direct correlation between intracellular pH and Panx1 open probability was shown in oocytes. Therefore, airway epithelial cells release less ATP in response to hypotonic stress in an inflammatory environment (IFN- exposure). Decreased Panx1 function is a response to cell acidification mediated by IFN--induced up-regulation of Duox2, representing a novel mechanism for mucociliary dysfunction in inflammatory airway diseases.	[Krick, Stefanie; St-Pierre, Melissa; Salathe, Matthias] Univ Miami, Div Pulm Allergy Crit Care & Sleep Med, Miami, FL 33136 USA; [Wang, Junjie; Dahl, Gerhard] Univ Miami, Dept Physiol & Biophys, Miami, FL 33136 USA; [Gonzalez, Carlos] Univ Valparaiso, Interdisciplinary Ctr Neurosci Valparaiso, Valparaiso 2362735, Chile	University of Miami; University of Miami; Universidad de Valparaiso	Salathe, M (corresponding author), Univ Miami, Miller Sch Med, Div Pulm Allergy Crit Care & Sleep Med, 1600 NW 10th Ave,RMSB 7061 R-47, Miami, FL 33136 USA.	msalathe@med.miami.edu	Gonzalez, Carlos/V-7628-2019	Salathe, Matthias/0000-0001-9092-4861	National Institutes of Health [R01 HL-89399, R01 HL-60644]; Flight Attendant Medical Research Institute [CIA103027, CIA13033]; Cystic Fibrosis Foundation [SALATH14G0]; Chilean [1120802, ACT1104]; Millennium Initiative [P09-022-F]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089399, R01HL060644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Chilean; Millennium Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 HL-89399 and R01 HL-60644, the Flight Attendant Medical Research Institute (CIA103027 and CIA13033), the Cystic Fibrosis Foundation (SALATH14G0; to M. S.), and Chilean Grants 1120802 and ACT1104 and Millennium Initiative P09-022-F (to C. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson WH, 2015, AM J RESP CRIT CARE, V192, P182, DOI 10.1164/rccm.201412-2230OC; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Beckel JM, 2014, GLIA, V62, P1486, DOI 10.1002/glia.22695; Bienert GP, 2014, BBA-GEN SUBJECTS, V1840, P1596, DOI 10.1016/j.bbagen.2013.09.017; Braiman A, 2001, CELL CALCIUM, V30, P361, DOI 10.1054/ceca.2001.0245; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Button B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003755; Conner GE, 2013, AM J RESP CELL MOL, V49, P672, DOI 10.1165/rcmb.2013-0156OC; DAVIS CW, 1992, AM J PHYSIOL, V262, pC1313, DOI 10.1152/ajpcell.1992.262.5.C1313; Duffy HS, 2004, CIRC RES, V94, P215, DOI 10.1161/01.RES.0000113924.06926.11; Fragoso MA, 2004, J PHYSIOL-LONDON, V561, P183, DOI 10.1113/jphysiol.2004.071548; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Gattas MV, 2009, FREE RADICAL BIO MED, V47, P1450, DOI 10.1016/j.freeradbiomed.2009.08.017; GEARY CA, 1995, AM J PHYSIOL-LUNG C, V268, pL1021, DOI 10.1152/ajplung.1995.268.6.L1021; Gonzalez-Nieto D, 2008, P NATL ACAD SCI USA, V105, P17169, DOI 10.1073/pnas.0804189105; Harper RW, 2005, FEBS LETT, V579, P4911, DOI 10.1016/j.febslet.2005.08.002; Hua DP, 2012, PLANT CELL, V24, P2546, DOI 10.1105/tpc.112.100107; Isakson BE, 2014, CHANNELS, V8, P118, DOI 10.4161/chan.27978; Kim DY, 1999, J BIOL CHEM, V274, P5581, DOI 10.1074/jbc.274.9.5581; Kumar Rakesh K., 2006, Inflammation & Allergy Drug Targets, V5, P253, DOI 10.2174/187152806779010909; Kumar Rakesh K., 2012, Inflammation & Allergy Drug Targets, V11, P292; LETHEM MI, 1993, AM J RESP CELL MOL, V9, P315, DOI 10.1165/ajrcmb/9.3.315; Li A, 1998, J NEUROSCI, V18, P6740; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; Manzanares D, 2015, J BIOL CHEM, V290, P25710, DOI 10.1074/jbc.M115.670885; Manzanares D, 2014, AM J PHYSIOL-LUNG C, V306, pL453, DOI 10.1152/ajplung.00247.2013; Manzanares D, 2011, J BIOL CHEM, V286, P19830, DOI 10.1074/jbc.M110.185074; MASON SJ, 1991, BRIT J PHARMACOL, V103, P1649, DOI 10.1111/j.1476-5381.1991.tb09842.x; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; Murali S, 2014, J PHYSIOL-LONDON, V592, P4747, DOI 10.1113/jphysiol.2014.279299; Nagai K, 2008, ANTIOXID REDOX SIGN, V10, P705, DOI 10.1089/ars.2007.1941; Negoro H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106269; Nlend MC, 2007, FEBS LETT, V581, P3241, DOI 10.1016/j.febslet.2007.06.015; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Panzner P, 2003, CHEST, V124, P1909, DOI 10.1378/chest.124.5.1909; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Pfahnl A, 1998, BIOPHYS J, V75, P2323, DOI 10.1016/S0006-3495(98)77676-3; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Ransford GA, 2009, AM J RESP CELL MOL, V41, P525, DOI 10.1165/rcmb.2008-0367OC; SCHLIEF T, 1995, J PHYSIOL-LONDON, V486, P123, DOI 10.1113/jphysiol.1995.sp020796; Schmid A, 2011, SUBCELL BIOCHEM, V55, P95, DOI 10.1007/978-94-007-1217-1_5; Schwarzer C, 2004, J BIOL CHEM, V279, P36454, DOI 10.1074/jbc.M404983200; Seminario-Vidal L, 2011, J BIOL CHEM, V286, P26277, DOI 10.1074/jbc.M111.260562; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Sutto Z, 2004, J PHYSIOL-LONDON, V560, P519, DOI 10.1113/jphysiol.2004.068171; Tarran R, 1998, AM J PHYSIOL-CELL PH, V274, pC904, DOI 10.1152/ajpcell.1998.274.4.C904; Thimm J, 2005, J BIOL CHEM, V280, P10646, DOI 10.1074/jbc.M412749200; Trexler EB, 1999, J GEN PHYSIOL, V113, P721; Wang JJ, 2010, J GEN PHYSIOL, V136, P515, DOI 10.1085/jgp.201010440	53	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6423	6432		10.1074/jbc.M115.664854	http://dx.doi.org/10.1074/jbc.M115.664854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26823467	hybrid, Green Published			2022-12-26	WOS:000372894200030
J	Sethna, S; Chamakkala, T; Gu, XW; Thompson, TC; Cao, GW; Elliott, MH; Finnemann, SC				Sethna, Saumil; Chamakkala, Tess; Gu, Xiaowu; Thompson, Timothy C.; Cao, Guangwen; Elliott, Michael H.; Finnemann, Silvia C.			Regulation of Phagolysosomal Digestion by Caveolin-1 of the Retinal Pigment Epithelium Is Essential for Vision	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caveolin; lysosomal acidification; lysosome; phagocytosis; retina; clearance; digestion; retinal pigment epithelium	AGE-RELATED-CHANGES; OUTER SEGMENTS; PHAGOSOME MATURATION; VISUAL CYCLE; RPE CELLS; PHAGOCYTOSIS; DEGRADATION; RHODOPSIN; RECEPTOR; PROTEIN	Caveolin-1 associates with the endo/lysosomal machinery of cells in culture, suggesting that it functions at these organelles independently of its contribution to cell surface caveolae. Here we explored mice lacking caveolin-1 specifically in the retinal pigment epithelium (RPE). The RPE supports neighboring photoreceptors via diurnal phagocytosis of spent photoreceptor outer segment fragments. Like mice lacking caveolin-1 globally, (RPE)CAV1(-/-) mice developed a normal RPE and neural retina but showed reduced rod photoreceptor light responses, indicating that lack of caveolin-1 affects photoreceptor function in a non-cell-autonomous manner. (RPE)CAV1(-/-) RPE in situ showed normal particle engulfment but delayed phagosome clearance and reversed diurnal profiles of levels and activities of lysosomal enzymes. Therefore, eliminating caveolin-1 specifically impairs phagolysosomal degradation by the RPE in vivo. Endogenous caveolin-1 was recruited to maturing phagolysosomes in RPE cells in culture. Consistent with these in vivo data, a moderate increase (to approximate to 2.5-fold) or decrease (by half) of caveolin-1 protein levels in RPE cells in culture was sufficient to accelerate or impair phagolysosomal digestion, respectively. A mutant form of caveolin-1 that fails to reach the cell surface augmented degradation like wild-type caveolin-1. Acidic lysosomal pH and increased protease activity are essential for digestion. We show that halving caveolin-1 protein levels significantly alkalinized lysosomal pH and decreased lysosomal enzyme activities. Taken together, our results reveal a novel role for intracellular caveolin-1 in modulating phagolysosomal function. Moreover, they show, for the first time, that organellar caveolin-1 significantly affects tissue functionality in vivo.	[Sethna, Saumil; Chamakkala, Tess; Finnemann, Silvia C.] Fordham Univ, Dept Biol Sci, Ctr Canc Genet Dis & Gene Regulat, 441 East Fordham Rd, Bronx, NY 10458 USA; [Gu, Xiaowu; Elliott, Michael H.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Thompson, Timothy C.; Cao, Guangwen] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Cao, Guangwen] Second Mil Med Univ, Dept Epidemiol, Shanghai 200433, Peoples R China	Fordham University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Texas System; UTMD Anderson Cancer Center; Naval Medical University	Finnemann, SC (corresponding author), Fordham Univ, Dept Biol Sci, Ctr Canc Genet Dis & Gene Regulat, 441 East Fordham Rd, Bronx, NY 10458 USA.; Elliott, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dean McGee Eye Inst, Dept Ophthalmol, 608 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	michael-elliott@ouhsc.edu; finnemann@fordham.edu		GU, XIAOWU/0000-0003-2266-5516; Cao, Guangwen/0000-0002-8094-1278	National Institutes of Health [R01EY013295, R01 EY019494, P3OEY021725]; Research to Prevent Blindness, Inc.; Fordham Graduate School of Arts and Sciences; NATIONAL EYE INSTITUTE [R01EY013295, R01EY019494, P30EY021725] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Fordham Graduate School of Arts and Sciences; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Institutes of Health Grants R01EY013295 (to S. C. F.) and R01 EY019494 (to M. H. E.) and Core Grant P3OEY021725 and by an unrestricted grant from Research to Prevent Blindness, Inc. (to the Department of Ophthalmology, University of Oklahoma Health Science Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Fordham Graduate School of Arts and Sciences alumni dissertation fellowship.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; BOSCH E, 1993, J HISTOCHEM CYTOCHEM, V41, P253, DOI 10.1177/41.2.8419462; Boscher C, 2012, ADV EXP MED BIOL, V729, P29, DOI 10.1007/978-1-4614-1222-9_3; Bulloj A, 2013, EXP EYE RES, V113, P9, DOI 10.1016/j.exer.2013.05.002; Cao GW, 2003, AM J PATHOL, V162, P1241, DOI 10.1016/S0002-9440(10)63920-X; Chang YG, 2007, J CELL SCI, V120, P3053, DOI 10.1242/jcs.006361; Chucair-Elliott AJ, 2012, J BIOL CHEM, V287, P24092, DOI 10.1074/jbc.M112.378240; Cingle KA, 1996, CURR EYE RES, V15, P433, DOI 10.3109/02713689608995834; Damek-Poprawa M, 2009, J BIOL CHEM, V284, P10877, DOI 10.1074/jbc.M808857200; DEGUCHI J, 1994, INVEST OPHTH VIS SCI, V35, P568; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Esteve-Rudd J, 2014, ADV EXP MED BIOL, V801, P85, DOI 10.1007/978-1-4614-3209-8_11; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Finnemann SC, 1999, J EXP MED, V190, P861, DOI 10.1084/jem.190.6.861; Fridolfsson HN, 2014, FASEB J, V28, P3823, DOI 10.1096/fj.14-252320; Gu XW, 2014, ADV EXP MED BIOL, V801, P15, DOI 10.1007/978-1-4614-3209-8_3; Gu XW, 2014, AM J PATHOL, V184, P541, DOI 10.1016/j.ajpath.2013.10.022; Guha S, 2014, EXP EYE RES, V126, P68, DOI 10.1016/j.exer.2014.05.013; He KM, 2015, CELL RES, V25, P738, DOI 10.1038/cr.2015.60; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; KURZCHALIA TV, 1994, FEBS LETT, V346, P88, DOI 10.1016/0014-5793(94)00466-8; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Laniosz V, 2008, J VIROL, V82, P6288, DOI 10.1128/JVI.00569-08; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Le YZ, 2008, INVEST OPHTH VIS SCI, V49, P1248, DOI 10.1167/iovs.07-1105; Li JW, 2005, CELL CYCLE, V4, P1599, DOI 10.4161/cc.4.11.2117; Li XM, 2012, J BIOL CHEM, V287, P16424, DOI 10.1074/jbc.M112.353763; Mandal MNA, 2011, J BIOL CHEM, V286, P32491, DOI 10.1074/jbc.M111.255877; Mao Yingyu, 2013, Methods Mol Biol, V935, P285, DOI 10.1007/978-1-62703-080-9_20; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Matsui T, 2014, METHOD ENZYMOL, V534, P195, DOI 10.1016/B978-0-12-397926-1.00011-1; Matsui T, 2011, TRAFFIC, V12, P1432, DOI 10.1111/j.1600-0854.2011.01240.x; Mora RC, 2006, AM J PHYSIOL-CELL PH, V290, pC832, DOI 10.1152/ajpcell.00405.2005; Mundy DI, 2012, MOL BIOL CELL, V23, P864, DOI 10.1091/mbc.E11-07-0598; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; Parinot C, 2014, JOVE-J VIS EXP, DOI 10.3791/52100; PLANTNER JJ, 1991, EXP EYE RES, V53, P269, DOI 10.1016/0014-4835(91)90083-Q; Querbes W, 2006, J VIROL, V80, P9402, DOI 10.1128/JVI.01086-06; Rakoczy PE, 1997, BIOCHEM J, V324, P935, DOI 10.1042/bj3240935; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; Reagan A, 2016, ADV EXP MED BIOL, V854, P411, DOI 10.1007/978-3-319-17121-0_54; REGAN CM, 1980, EXP EYE RES, V30, P183, DOI 10.1016/0014-4835(80)90112-8; Sethna Saumil, 2013, Methods Mol Biol, V935, P245, DOI 10.1007/978-1-62703-080-9_17; Shelby SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053964; Shi Y, 2015, AUTOPHAGY, V11, P769, DOI 10.1080/15548627.2015.1034411; Shiroto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087871; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strick DJ, 2009, INVEST OPHTH VIS SCI, V50, P2427, DOI 10.1167/iovs.08-3058; Valapala M, 2014, AUTOPHAGY, V10, P480, DOI 10.4161/auto.27292; Wavre-Shapton ST, 2014, J CELL SCI, V127, P3852, DOI 10.1242/jcs.154757; Yao JY, 2014, INVEST OPHTH VIS SCI, V55, P3237, DOI 10.1167/iovs.13-13336; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392	55	30	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6494	6506		10.1074/jbc.M115.687004	http://dx.doi.org/10.1074/jbc.M115.687004			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26814131	Green Published, hybrid			2022-12-26	WOS:000372894200036
J	Bienhold, C; Zinger, L; Boetius, A; Ramette, A				Bienhold, Christina; Zinger, Lucie; Boetius, Antje; Ramette, Alban			Diversity and Biogeography of Bathyal and Abyssal Seafloor Bacteria	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; DEEP-SEA; MICROBIAL ECOLOGY; BETA-DIVERSITY; PHYLOGENETIC DIVERSITY; SURFACE SEDIMENTS; PACIFIC-OCEAN; COMMUNITIES; ABUNDANCE; PATTERNS	The deep ocean floor covers more than 60% of the Earth's surface, and hosts diverse bacterial communities with important functions in carbon and nutrient cycles. The identification of key bacterial members remains a challenge and their patterns of distribution in seafloor sediment yet remain poorly described. Previous studies were either regionally restricted or included few deep-sea sediments, and did not specifically test biogeographic patterns across the vast oligotrophic bathyal and abyssal seafloor. Here we define the composition of this deep seafloor microbiome by describing those bacterial operational taxonomic units (OTU) that are specifically associated with deep-sea surface sediments at water depths ranging from 1000-5300 m. We show that the microbiome of the surface seafloor is distinct from the subsurface seafloor. The cosmopolitan bacterial OTU were affiliated with the clades JTB255 (class Gammaproteobacteria, order Xanthomonadales) and OM1 (Actinobacteria, order Acidimicrobiales), comprising 21% and 7% of their respective clades, and about 1% of all sequences in the study. Overall, few sequence-abundant bacterial types were globally dispersed and displayed positive range-abundance relationships. Most bacterial populations were rare and exhibited a high degree of endemism, explaining the substantial differences in community composition observed over large spatial scales. Despite the relative physicochemical uniformity of deep-sea sediments, we identified indicators of productivity regimes, especially sediment organic matter content, as factors significantly associated with changes in bacterial community structure across the globe.	[Bienhold, Christina] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, HGF MPG Grp Deep Sea Ecol & Technol, Bremerhaven, Germany; [Bienhold, Christina] Max Planck Inst Marine Microbiol, Bremen, Germany; [Zinger, Lucie] Univ Toulouse 3, CNRS, ENFA, UMR EDB 5174, Toulouse, France; [Ramette, Alban] Univ Bern, ISPM, Bern, Switzerland	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); University of Bern	Bienhold, C (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, HGF MPG Grp Deep Sea Ecol & Technol, Bremerhaven, Germany.; Bienhold, C (corresponding author), Max Planck Inst Marine Microbiol, Bremen, Germany.	cbienhol@mpi-bremen.de	Boetius, Antje/D-5459-2013; Zinger, Lucie/D-2527-2010; Ramette, Alban/E-9197-2016	Boetius, Antje/0000-0003-2117-4176; Zinger, Lucie/0000-0002-3400-5825; Ramette, Alban/0000-0002-3437-4639; Bienhold, Christina/0000-0003-2269-9468	European Research Council Advanced Investigator Grant [294757]; EU 7th FP HERMIONE project [226354]; Leibniz programme of the DFG; Census of Marine Life project International Census of Marine Microbes (ICoMM); Deep Carbon Observatory's Census of Deep Life; Helmholtz Association; Max Planck Society	European Research Council Advanced Investigator Grant(European Research Council (ERC)); EU 7th FP HERMIONE project; Leibniz programme of the DFG(German Research Foundation (DFG)); Census of Marine Life project International Census of Marine Microbes (ICoMM); Deep Carbon Observatory's Census of Deep Life; Helmholtz Association(Helmholtz Association); Max Planck Society(Max Planck Society)	This study contributes to the project ABYSS funded by the European Research Council Advanced Investigator Grant 294757 to AB. Additional resources for this study were provided by the EU 7th FP HERMIONE project (226354), the Leibniz programme of the DFG to AB, the Census of Marine Life project International Census of Marine Microbes (ICoMM) to AB and AR (Alfred P. Sloan Foundation); and the Deep Carbon Observatory's Census of Deep Life (Alfred P. Sloan Foundation) to AB and AR, the Helmholtz Association and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral-Zetter LA, 2010, LIFE WORLDS OCEANS D; Amend AS, 2013, J BIOGEOGR, V40, P800, DOI 10.1111/jbi.12034; Barberan A, 2014, ECOL LETT, V17, P794, DOI 10.1111/ele.12282; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Bell T, 2010, ISME J, V4, P1357, DOI 10.1038/ismej.2010.77; Bienhold C, 2012, ISME J, V6, P724, DOI 10.1038/ismej.2011.140; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Boetius A, 1998, DEEP-SEA RES PT I, V45, P239, DOI 10.1016/S0967-0637(97)00052-6; Boetius A, 2015, NAT REV MICROBIOL, V13, P677, DOI 10.1038/nrmicro3522; Boetius A, 2013, NAT GEOSCI, V6, P725, DOI [10.1038/ngeo1926, 10.1038/NGEO1926]; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Costello MJ, 2010, ENVIRON SCI TECHNOL, V44, P8821, DOI 10.1021/es1012752; Dang HY, 2009, WORLD J MICROB BIOT, V25, P179, DOI 10.1007/s11274-008-9877-1; Dyksma S, 2015, ISME J; Ebbe Brigitte, 2010, P139, DOI 10.1002/9781444325508.ch8; Fry JC, 2008, FEMS MICROBIOL ECOL, V66, P181, DOI 10.1111/j.1574-6941.2008.00566.x; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Fulthorpe RR, 2008, ISME J, V2, P901, DOI 10.1038/ismej.2008.55; Galand PE, 2010, ISME J, V4, P564, DOI 10.1038/ismej.2009.134; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Gaston KJ, 1996, OIKOS, V76, P211, DOI 10.2307/3546192; Gaston KJ, 1997, J ANIM ECOL, V66, P579, DOI 10.2307/5951; Ghiglione JF, 2012, P NATL ACAD SCI USA, V109, P17633, DOI 10.1073/pnas.1208160109; Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Giovannoni SJ, 2012, SCIENCE, V335, P671, DOI 10.1126/science.1198078; Glover AG, 2003, ENVIRON CONSERV, V30, P219, DOI 10.1017/S0376892903000225; Gobet A, 2014, ENVIRON MICROBIOL, V16, P2672, DOI 10.1111/1462-2920.12308; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Gobet A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq545; Grahn N, 2003, FEMS MICROBIOL LETT, V219, P87, DOI 10.1016/S0378-1097(02)01190-4; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Hamdan LJ, 2013, ISME J, V7, P685, DOI 10.1038/ismej.2012.143; Heijs SK, 2008, FEMS MICROBIOL ECOL, V64, P362, DOI 10.1111/j.1574-6941.2008.00463.x; Hilario A, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00006; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P14164, DOI 10.1073/pnas.0606083103; Jacob M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072779; Jansson JK, 2014, NAT REV MICROBIOL, V12, P414, DOI 10.1038/nrmicro3262; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Kimes NE, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00050; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Kouridaki I, 2010, INT MICROBIOL, V13, P143, DOI 10.2436/20.1501.01.119; Kulakov LA, 2002, APPL ENVIRON MICROB, V68, P1548, DOI 10.1128/AEM.68.4.1548-1555.2002; Ladau J, 2013, ISME J, V7, P1669, DOI 10.1038/ismej.2013.37; Laurence M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097876; Legendre L., 1998, NUMERICAL ECOLOGY; Legendre P, 2008, J PLANT ECOL, V1, P3, DOI 10.1093/jpe/rtm001; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Li HR, 2009, EXTREMOPHILES, V13, P233, DOI 10.1007/s00792-009-0225-7; Li KR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068157, 10.1371/journal.pone.0084171, 10.1371/journal.pone.0058057, 10.1371/journal.pone.0067018, 10.1371/journal.pone.0063139]; Li LN, 1999, BIODIVERS CONSERV, V8, P659, DOI 10.1023/A:1008848203739; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; Magnusson A, 2010, GMT INTERFACE GMT MA; MANTEL N, 1967, CANCER RES, V27, P209; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; Mason OU, 2014, ISME J, V8, P1464, DOI 10.1038/ismej.2013.254; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; MEADOWS A, 1994, J GEOL SOC LONDON, V151, P361, DOI 10.1144/gsjgs.151.2.0361; Muller AL, 2014, ISME J, V8, P1153, DOI 10.1038/ismej.2013.225; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Ostman O, 2010, ECOL LETT, V13, P118, DOI 10.1111/j.1461-0248.2009.01413.x; Pante E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073051; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ranjard L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2431; Rappe MS, 1997, LIMNOL OCEANOGR, V42, P811, DOI 10.4319/lo.1997.42.5.0811; Rex M.A., 2010, BIOSCIENCE; Ristova PP, 2015, ISME J, V9, P1306, DOI 10.1038/ismej.2014.217; Roesch LF, 2007, APPL ENVIRON MICROB, V75, P5111; Ruff SE, 2015, P NATL ACAD SCI USA, V112, P4015, DOI 10.1073/pnas.1421865112; Salter S, 2014, REAGENT CONTAMINATIO; Schauer R, 2010, ISME J, V4, P159, DOI 10.1038/ismej.2009.106; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seiter K, 2004, DEEP-SEA RES PT I, V51, P2001, DOI 10.1016/j.dsr.2004.06.014; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; SMITH CR, 1992, NATO ADV SCI I C-MAT, V360, P375; Smith CR, 2003, ECOSYSTEMS WORLD, P28; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; Smith Craig R., 2008, P334, DOI 10.1017/CBO9780511751790.030; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Soininen J, 2007, ECOLOGY, V88, P2830, DOI 10.1890/06-1730.1; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Sul WJ, 2013, P NATL ACAD SCI USA, V110, P2342, DOI 10.1073/pnas.1212424110; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Tamames J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-85; Teske AP, 2006, GEOMICROBIOL J, V23, P357, DOI 10.1080/01490450600875613; Tian F, 2009, POLAR BIOL, V32, P93, DOI 10.1007/s00300-008-0509-x; van Etten J., 2014, PACKAGE GDISTANCE VE; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Walsh EA, 2016, ISME J, V10, P979, DOI 10.1038/ismej.2015.175; WARNES GR, 2010, GPLOTS VARIOUS R PRO; Webster G, 2006, FEMS MICROBIOL ECOL, V58, P65, DOI 10.1111/j.1574-6941.2006.00147.x; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zinger L, 2014, MOL ECOL, V23, P954, DOI 10.1111/mec.12640; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	105	78	80	6	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0148016	10.1371/journal.pone.0148016	http://dx.doi.org/10.1371/journal.pone.0148016			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814838	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528200066
J	Carlin, DA; Caster, RW; Wang, XK; Betzenderfer, SA; Chen, CX; Duong, VM; Ryklansky, CV; Alpekin, A; Beaumont, N; Kapoor, H; Kim, N; Mohabbot, H; Pang, BY; Teel, R; Whithaus, L; Tagkopoulos, I; Siegel, JB				Carlin, Dylan Alexander; Caster, Ryan W.; Wang, Xiaokang; Betzenderfer, Stephanie A.; Chen, Claire X.; Duong, Veasna M.; Ryklansky, Carolina V.; Alpekin, Alp; Beaumont, Nathan; Kapoor, Harshul; Kim, Nicole; Mohabbot, Hosna; Pang, Boyu; Teel, Rachel; Whithaus, Lillian; Tagkopoulos, Ilias; Siegel, Justin B.			Kinetic Characterization of 100 Glycoside Hydrolase Mutants Enables the Discovery of Structural Features Correlated with Kinetic Constants	PLOS ONE			English	Article							COMPUTATIONAL PROTEIN DESIGN; ENZYMES; HYDROLYSIS; MECHANISMS; COMPLEXES; PATHWAY	The use of computational modeling algorithms to guide the design of novel enzyme catalysts is a rapidly growing field. Force-field based methods have now been used to engineer both enzyme specificity and activity. However, the proportion of designed mutants with the intended function is often less than ten percent. One potential reason for this is that current force-field based approaches are trained on indirect measures of function rather than direct correlation to experimentally-determined functional effects of mutations. We hypothesize that this is partially due to the lack of data sets for which a large panel of enzyme variants has been produced, purified, and kinetically characterized. Here we report the k(cat) and K-M values of 100 purified mutants of a glycoside hydrolase enzyme. We demonstrate the utility of this data set by using machine learning to train a new algorithm that enables prediction of each kinetic parameter based on readily-modeled structural features. The generated dataset and analyses carried out in this study not only provide insight into how this enzyme functions, they also provide a clear path forward for the improvement of computational enzyme redesign algorithms.	[Carlin, Dylan Alexander] Univ Calif Davis, Biophys Grad Grp, Davis, CA 95616 USA; [Caster, Ryan W.; Betzenderfer, Stephanie A.; Chen, Claire X.; Duong, Veasna M.; Ryklansky, Carolina V.; Alpekin, Alp; Beaumont, Nathan; Kapoor, Harshul; Kim, Nicole; Mohabbot, Hosna; Pang, Boyu; Teel, Rachel; Whithaus, Lillian; Tagkopoulos, Ilias; Siegel, Justin B.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Siegel, Justin B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Siegel, Justin B.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Wang, Xiaokang] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Tagkopoulos, Ilias] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Siegel, JB (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.; Siegel, JB (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.; Siegel, JB (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA.	jbsiegel@ucdavis.edu		Kim, Nicole/0000-0002-4560-8808; Beaumont, Nathan/0000-0002-1135-5785	Army Research Office [201121557]; National Science Foundation [1254205]; Alfred P. Sloan Foundation [BR2014-012]; University of California Davis Startup Funds	Army Research Office; National Science Foundation(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); University of California Davis Startup Funds	This work was supported by Army Research Office #201121557 and National Science Foundation #1254205 (IT) and Alfred P. Sloan Foundation #BR2014-012 and University of California Davis Startup Funds (JBS).	Damborsky J, 2014, CURR OPIN CHEM BIOL, V19, P8, DOI 10.1016/j.cbpa.2013.12.003; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gordon SR, 2012, J AM CHEM SOC, V134, P20513, DOI 10.1021/ja3094795; Govindarajan S, 2015, ACS SYNTH BIOL, V4, P221, DOI 10.1021/sb500242x; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Isorna P, 2007, J MOL BIOL, V371, P1204, DOI 10.1016/j.jmb.2007.05.082; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Khare SD, 2012, NAT CHEM BIOL, V8, P294, DOI [10.1038/NCHEMBIO.777, 10.1038/nchembio.777]; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Liao J, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-16; Mak WS, 2014, CURR OPIN STRUC BIOL, V27, P87, DOI 10.1016/j.sbi.2014.05.010; Marcheschi RJ, 2012, ACS CHEM BIOL, V7, P689, DOI 10.1021/cb200313e; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Mesecar AD, 1997, SCIENCE, V277, P202, DOI 10.1126/science.277.5323.202; Minshull J, 2005, CURR OPIN CHEM BIOL, V9, P202, DOI 10.1016/j.cbpa.2005.02.003; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; Romero PA, 2015, P NATL ACAD SCI; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Siegel JB, 2015, P NATL ACAD SCI USA, V112, P3704, DOI 10.1073/pnas.1500545112; Stiffler MA, 2015, CELL, V160, P882, DOI 10.1016/j.cell.2015.01.035; Sunden F, 2015, ELIFE, V4; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; Wu SJ, 2011, J BIOL CHEM, V286, P32586, DOI 10.1074/jbc.M111.251041	26	27	27	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147596	10.1371/journal.pone.0147596	http://dx.doi.org/10.1371/journal.pone.0147596			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815142	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528200041
J	Einarsson, EJ; Patel, M; Petersen, H; Wiebe, T; Magnusson, M; Moell, C; Fransson, PA				Einarsson, Einar-Jon; Patel, Mitesh; Petersen, Hannes; Wiebe, Thomas; Magnusson, Mans; Moell, Christian; Fransson, Per-Anders			Oculomotor Deficits after Chemotherapy in Childhood	PLOS ONE			English	Article							PURSUIT EYE-MOVEMENTS; TERM-FOLLOW-UP; SMOOTH-PURSUIT; PARKINSONS-DISEASE; BLOOD-ALCOHOL; VINCRISTINE; CHILDREN; SACCADES; CANCER; PERFORMANCE	Advances in the diagnosis and treatment of pediatric malignancies have substantially increased the number of childhood cancer survivors. However, reports suggest that some of the chemotherapy agents used for treatment can cross the blood brain barrier which may lead to a host of neurological symptoms including oculomotor dysfunction. Whether chemotherapy at young age causes oculomotor dysfunction later in life is unknown. Oculomotor performance was assessed with traditional and novel methods in 23 adults (mean age 25.3 years, treatment age 10.2 years) treated with chemotherapy for a solid malignant tumor not affecting the central nervous system. Their results were compared to those from 25 healthy, age-matched controls (mean age 25.1 years). Correlation analysis was performed between the subjective symptoms reported by the chemotherapy treated subjects (CTS) and oculomotor performance. In CTS, the temporal control of the smooth pursuit velocity (velocity accuracy) was markedly poorer (p<0.001) and the saccades had disproportionally shorter amplitude than normal for the associated saccade peak velocity (main sequence) (p = 0.004), whereas smooth pursuit and saccade onset times were shorter (p = 0.004) in CTS compared with controls. The CTS treated before 12 years of age manifested more severe oculomotor deficits. CTS frequently reported subjective symptoms of visual disturbances (70%), unsteadiness, light-headedness and that things around them were spinning or moving (87%). Several subjective symptoms were significantly related to deficits in oculomotor performance. To conclude, chemotherapy in childhood or adolescence can result in severe oculomotor dysfunctions in adulthood. The revealed oculomotor dysfunctions were significantly related to the subjects' self-perception of visual disturbances, dizziness, light-headedness and sensing unsteadiness. Assessments of oculomotor function may, thus, offer an objective method to track and rate the level of neurological complications following chemotherapy.	[Einarsson, Einar-Jon; Magnusson, Mans; Fransson, Per-Anders] Lund Univ, Dept Clin Sci, Lund, Sweden; [Einarsson, Einar-Jon; Petersen, Hannes] Univ Iceland, Fac Med, Reykjavik, Iceland; [Patel, Mitesh] Univ E London, Sch Biosci, London E15 4LZ, England; [Patel, Mitesh] Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, London, England; [Petersen, Hannes] Landspitali Univ Hosp, Dept Otorhinolaryngol, Reykjavik, Iceland; [Wiebe, Thomas; Moell, Christian] Skane Univ Hosp, Dept Paediat, Lund, Sweden; [Magnusson, Mans] Skane Univ Hosp, Dept Otorhinolaryngol, Lund, Sweden	Lund University; University of Iceland; University of East London; Imperial College London; Landspitali National University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Fransson, PA (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.	Per-Anders.Fransson@med.lu.se		Patel, Mitesh/0000-0001-6926-941X; Magnusson, Mans/0000-0002-4266-1996; Fransson, Per-Anders/0000-0002-9789-1748; Patel, Mitesh/0000-0002-3594-5448; Wiebe, Thomas/0000-0002-7567-9076; Petersen, Hannes/0000-0002-2327-523X				Bahill T., 1975, MATH BIOSCI, V24, P191; Bertolini P, 2004, J PEDIAT HEMATOL ONC, V26, P649, DOI 10.1097/01.mph.0000141348.62532.73; BITTENCOURT P, 1980, LANCET, V2, P981; Blohm G, 2010, J NEUROPHYSIOL, V104, P2103, DOI 10.1152/jn.00728.2009; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Chambers JM, 2010, NEUROPSYCHOLOGIA, V48, P887, DOI 10.1016/j.neuropsychologia.2009.11.006; Dietrich Joerg, 2006, J Biol, V5, P22, DOI 10.1186/jbiol50; Duman O, 2005, J PEDIAT HEMATOL ONC, V27, P241; Erkelens CJ, 2006, VISION RES, V46, P163, DOI 10.1016/j.visres.2005.06.027; Fransson PA, 2010, CLIN NEUROPHYSIOL, V121, P2134, DOI 10.1016/j.clinph.2010.05.003; Han Ruolan, 2008, J Biol, V7, P12, DOI 10.1186/jbiol69; Hartman A, 2006, CANCER, V106, P1395, DOI 10.1002/cncr.21706; Jacobson G P, 1991, J Am Acad Audiol, V2, P253; Kowler E., 2011, VISION RES, DOI [10.1016/j, DOI 10.1016/J]; Krauzlis RJ, 2002, NEURON, V35, P355, DOI 10.1016/S0896-6273(02)00756-0; Lacour M, 2009, ANN NY ACAD SCI, V1164, P268, DOI 10.1111/j.1749-6632.2008.03731.x; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Meyers Christina A, 2008, J Biol, V7, P11, DOI 10.1186/jbiol73; MOSKOWITZ H, 1973, PERCEPT MOTOR SKILL, V36, P801, DOI 10.2466/pms.1973.36.3.801; Muller L, 2004, PEDIATR BLOOD CANCER, V42, P287, DOI 10.1002/pbc.10301; Nicolao P, 2003, ONCOLOGY-BASEL, V65, P11, DOI 10.1159/000073352; Nilsson MH, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-33; Pierrot-Deseilligny C, 2002, ANN NY ACAD SCI, V956, P216, DOI 10.1111/j.1749-6632.2002.tb02821.x; PierrotDeseilligny C, 1997, J NEUROL, V244, P65, DOI 10.1007/s004150050051; Taylor A, 2004, PEDIATR BLOOD CANCER, V42, P161, DOI 10.1002/pbc.10482; Taylor N, 2010, EUR J CANCER, V46, P1069, DOI 10.1016/j.ejca.2010.01.022; TUXEN MK, 1994, CANCER TREAT REV, V20, P191, DOI 10.1016/0305-7372(94)90027-2; Vainionpaa L, 1995, PEDIATR NEUROL, V13, P314, DOI 10.1016/0887-8994(95)00191-3; Verstappen CCP, 2005, NEUROLOGY, V64, P1076, DOI 10.1212/01.WNL.0000154642.45474.28; YARDLEY L, 1992, J PSYCHOSOM RES, V36, P731, DOI 10.1016/0022-3999(92)90131-K; Zee D S, 1983, Neurol Clin, V1, P909	31	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147703	10.1371/journal.pone.0147703	http://dx.doi.org/10.1371/journal.pone.0147703			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815789	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000369528200046
J	McManus, C; Barcellos, JOJ; Formenton, BK; Hermuche, PM; Carvalho, OA; Guimaraes, R; Gianezini, M; Dias, EA; Lampert, VD; Zago, D; Neto, JB				McManus, Concepta; Jardim Barcellos, Julio Otavio; Formenton, Bruna Krummenauer; Hermuche, Potira Meirelles; de Carvalho, Osmar Abilio, Jr.; Guimaraes, RenatoFontes; Gianezini, Miguelangelo; Dias, Eduardo Antunes; Lampert, Vinicius do Nascimento; Zago, Daniele; Neto, Jose Braccini			Dynamics of Cattle Production in Brazil	PLOS ONE			English	Article							SHEEP PRODUCTION; BEEF	Movement of livestock production within a country or region has implications for genetics, adaptation, well-being, nutrition, and production logistics, particularly in continental-sized countries, such as Brazil. Cattle production in Brazil from 1977 to 2011 was spatialized, and the annual midpoint of production was calculated. Changes in the relative production and acceleration of production were calculated and spatialized using ARCGIS (R). Cluster and canonical discriminant analyses were performed to further highlight differences between regions in terms of cattle production. The mean production point has moved from the Center of Minas Gerais State (in the southeast region) to the North of Goias State (in the Midwest region). This reflects changes in environmental factors, such as pasture type, temperature and humidity. Acceleration in production in the northern region of Brazil has remained strong over the years. More recently, "traditional" cattle-rearing regions, such as the south and southeast, showed a reduction in growth rates as well as a reduction in herd size or internal migration over the period studied. These maps showed that this movement tends to be gradual, with few regions showing high acceleration or deceleration rates.	[McManus, Concepta] Univ Brasilia, INCT Pecuaria, Brasilia, DF, Brazil; [Jardim Barcellos, Julio Otavio; Formenton, Bruna Krummenauer; Gianezini, Miguelangelo; Dias, Eduardo Antunes; Zago, Daniele; Neto, Jose Braccini] Univ Fed Rio Grande UFRGS, Dept Zootecnia, NESPRO, Porto Alegre, RS, Brazil; [Hermuche, Potira Meirelles; de Carvalho, Osmar Abilio, Jr.; Guimaraes, RenatoFontes] Univ Brasilia, Brasilia, DF, Brazil; [Lampert, Vinicius do Nascimento] Empresa Brasileira Pesquisa Agropecuaria, Bage, RS, Brazil; [Lampert, Vinicius do Nascimento] EMBRAPA CPPSUL, Curitiba, Parana, Brazil	Universidade de Brasilia; Universidade Federal do Rio Grande do Sul; Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Barcellos, JOJ (corresponding author), Univ Fed Rio Grande UFRGS, Dept Zootecnia, NESPRO, Porto Alegre, RS, Brazil.	Julio.barcellos@ufrgs.br	McManus, Concepta M/I-4356-2012; Dias, Eduardo Antunes/AAY-5058-2020; McManus, Connie/GRS-6152-2022; Barcellos, Julio/A-9209-2013; McManus, Concepta/AAF-4679-2020; De+Carvalho+Júnior, Osmar/AAK-4880-2021; Neto, José Braccini/J-4369-2012; Guimaraes, Renato/C-4601-2013	McManus, Concepta M/0000-0002-1106-8962; Barcellos, Julio/0000-0001-9858-1728; De+Carvalho+Júnior, Osmar/0000-0002-0346-1684; Neto, José Braccini/0000-0003-2881-0235; Guimaraes, Renato/0000-0002-9555-043X; Zago, Daniele/0000-0003-3444-4323; Meirelles Hermuche, Potira/0000-0003-3059-5001				[Anonymous], AGR EC; ANUALPEC, 2013, ANUALPEC AN PEC BRAS; Barcellos J. O. J., 2011, REV BRAS ZOOTECN, V40, P189; Barcellos JOJ, 2013, P CD 8 JORN NESPRO 1; Bowman MS, 2012, LAND USE POLICY, V29, P558, DOI 10.1016/j.landusepol.2011.09.009; De Arruda ZJ, 1994, REGIONALIZACAO PECUA; Hermuche P, 2013, APPL GEOGR, V44, P172, DOI 10.1016/j.apgeog.2013.07.016; Hermuche PM, 2013, ISPRS INT J GEO-INF, V2, P665, DOI 10.3390/ijgi2030665; IBGE-Brazilian Institute of Geography and Statistics, 2011, 2006 AGR CENS; MAPA, 2011, AGR BRAS NUM PEC EV; Marques PR, 2011, AGR SYST, V104, P689, DOI 10.1016/j.agsy.2011.08.002; Martha GB, 2012, AGR SYST, V110, P173, DOI 10.1016/j.agsy.2012.03.001; McAlpine CA, 2009, GLOBAL ENVIRON CHANG, V19, P21, DOI 10.1016/j.gloenvcha.2008.10.008; McManus C.M., 2014, BRAZILIAN J SCI TECH, V1, P3, DOI [DOI 10.1093/BIOINFORMATICS/BTY633, 10.1186/2196-288X-1-3, DOI 10.1186/2196-288X-1-3]; Naas IA, 2010, SCI AGR, P67; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Procopio D. P., 2011, Revista de Politica Agricola, V20, P40; Rada N, 2013, FOOD POLICY, V38, P146, DOI 10.1016/j.foodpol.2012.11.002; Carvalho LFR, 2012, PREV VET MED, V103, P74, DOI 10.1016/j.prevetmed.2011.08.006; Ruviaro CF, 2014, LAND USE POLICY, V38, P104, DOI 10.1016/j.landusepol.2013.08.019; Sparovek G, 2009, MITIG ADAPT STRAT GL, V14, P285, DOI 10.1007/s11027-008-9164-3; Valentim J., 2009, AMAZONIA CI DESENV, V4, P9; Walker R, 2009, GEOPHYS MONOGR SER, V186, P61, DOI 10.1029/2008GM000735; Walker R, 2009, GEOFORUM, V40, P732, DOI 10.1016/j.geoforum.2008.10.009	24	56	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147138	10.1371/journal.pone.0147138	http://dx.doi.org/10.1371/journal.pone.0147138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814797	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528200026
J	Ndaimani, H; Tagwireyi, P; Sebele, L; Madzikanda, H				Ndaimani, Henry; Tagwireyi, Paradzayi; Sebele, Lovelater; Madzikanda, Hillary			An Ecological Paradox: The African Wild Dog (Lycaon Pictus) Is Not Attracted to Water Points When Water Is Scarce in Hwange National Park, Zimbabwe	PLOS ONE			English	Article							ELEPHANT LOXODONTA-AFRICANA; LARGE HERBIVORE RESPONSES; SPATIAL-DISTRIBUTION; SURFACE-WATER; DISTRIBUTION PATTERNS; PREY RELATIONSHIPS; FOOD-CONSUMPTION; SABLE ANTELOPE; LAND-USE; DESERT	In dry biomes, spatio-temporal variation in surface water resource stocks is pervasive, with unknown effects on the ranging behaviour of large predators. This study assessed the effect of spatial variation in surface water resources on the ranging behaviour of the African wild dog (Lycaon pictus). We analyzed data for 1992 (dry year with 20 water points) and 2000 (wet year with 30 water points) against presence-only data for five packs of L. pictus in a part of Hwange National Park and adjacent smallholder communal farming areas in western Zimbabwe. Modelling the potential habitat for L. pictus using Maxent with distance from water points (D-w) and Normalized Difference Vegetation Index (NDVI) as predictor variables was successful for 2000 (AUC = 0.793) but not successful for 1992 (AUC = 0.423), with L. pictus probability of occurrence near water points being more for year 2000 than for year 1992. The predicted L. pictus range was wider in 1992 (similar to 13888.1 km(2)) than in 2000 (similar to 958.4 km(2)) (Test of Proportions, chi(2) = 124.52, df = 1, P = 0.00). Using the 2nd order Multitype Nearest Neighbour Distance Function (Gcross), we also observed significant attraction between L. pictus and water points within only similar to 1km radius for 1992 but up to similar to 8km radius for 2000. Our study reinforced the notion that surface water resources attract wild dogs in the savannahs but paradoxically less so when water resources are scarce. In particular, our study furthers current understanding of the effects of changing water availability regimes on the endangered L. pictus, providing evidence that the endangered predator's home range encroaches into potential ecological traps (i.e., smallholder communal farming areas) when water resources are scarce.	[Ndaimani, Henry; Tagwireyi, Paradzayi] Univ Zimbabwe, Dept Geog & Environm Sci, Geoinformat & Earth Observat Ctr, Mt Pleasant, Harare, Zimbabwe; [Sebele, Lovelater] Zimbabwe Pk & Wildlife Management Author, Causeway, Harare, Zimbabwe; [Madzikanda, Hillary] Hwange Natl Pk, Painted Dog Conservat, Dete, Zimbabwe	University of Zimbabwe	Tagwireyi, P (corresponding author), Univ Zimbabwe, Dept Geog & Environm Sci, Geoinformat & Earth Observat Ctr, Mt Pleasant, Harare, Zimbabwe.	tagwireyi.1@buckeyemail.osu.edu	Ndaimani, Henry/AAE-4942-2021	Sebele, Lovelater/0000-0001-9355-048X				Abade L, 2014, BIOL CONSERV, V180, P241, DOI 10.1016/j.biocon.2014.10.005; Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Allen BL, 2012, AUST MAMMAL, V34, P251, DOI 10.1071/AM12012; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1988, ADV ECOL RES; Arjo WM, 2007, WEST N AM NATURALIST, V67, P389, DOI 10.3398/1527-0904(2007)67[389:CIKFRI]2.0.CO;2; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Bean WT, 2014, J APPL ECOL, V51, P1116, DOI 10.1111/1365-2664.12281; Bennitt E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101346; Bleich VC, 2009, CALIF FISH GAME, V95, P153; Cain JW, 2012, J ZOOL, V286, P58, DOI 10.1111/j.1469-7998.2011.00848.x; Cain JW, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2007-209; Chamaille-Jammes S, 2009, AFR J ECOL, V47, P804, DOI 10.1111/j.1365-2028.2009.01077.x; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; Creel S, 1996, CONSERV BIOL, V10, P526, DOI 10.1046/j.1523-1739.1996.10020526.x; Creel S., 2002, AFRICAN WILD DOG BEH; Creel S, 2003, AFRICAN WILD DOG BEH; Crosmary WG, 2012, ANIM BEHAV, V83, P1367, DOI 10.1016/j.anbehav.2012.03.004; Darnell AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098846; de Boer WF, 2010, J MAMMAL, V91, P1280, DOI 10.1644/09-MAMM-A-392.1; de Leeuw J, 2001, BIOL CONSERV, V100, P297, DOI 10.1016/S0006-3207(01)00034-9; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; Duncan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051490; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; FULLER TK, 1990, AFR J ECOL, V28, P330, DOI 10.1111/j.1365-2028.1990.tb01168.x; Gaylard A., 2003, KRUGER EXPERIENCE EC, P171; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Green DM, 1966, SIGNAL DETECTION THE; Groom R, 2010, AFR J ECOL, V48, P159, DOI 10.1111/j.1365-2028.2009.01097.x; Hall LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067800; Hayward MW, 2006, J MAMMAL, V87, P1122, DOI 10.1644/05-MAMM-A-304R2.1; Hayward MW, 2012, S AFR J WILDL RES, V42, P117, DOI 10.3957/056.042.0209; Hayward MW, 2008, S AFR J WILDL RES, V38, P93, DOI 10.3957/0379-4369-38.2.93; Hensman MC, 2014, AFR J ECOL, V52, P237, DOI 10.1111/aje.12111; Herrmann SM, 2005, GLOBAL ENVIRON CHANG, V15, P394, DOI 10.1016/j.gloenvcha.2005.08.004; Jackson CR, 2012, WILDLIFE RES, V39, P31, DOI 10.1071/WR11070; Latham ADM, 2013, ECOGRAPHY, V36, P1276, DOI 10.1111/j.1600-0587.2013.00035.x; Loveridge AJ, 2006, J ZOOL, V270, P523, DOI 10.1111/j.1469-7998.2006.00181.x; Maloiy GMO, 2008, COMP BIOCHEM PHYS A, V151, P185, DOI 10.1016/j.cbpa.2008.06.019; Marnewick K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086265; Martin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118461; Matawa F, 2012, ECOL MODEL, V242, P189, DOI 10.1016/j.ecolmodel.2012.05.010; Mbizah MM, 2014, BIODIVERS CONSERV, V23, P1441, DOI 10.1007/s10531-014-0675-9; Mbizah MM, 2012, S AFR J WILDL RES, V42, P94, DOI 10.3957/056.042.0213; Mills MGL, 1997, CONSERV BIOL, V11, P1397, DOI 10.1046/j.1523-1739.1997.96252.x; Morgart JR, 2005, WILDLIFE SOC B, V33, P51, DOI 10.2193/0091-7648(2005)33[51:SPUOAA]2.0.CO;2; Torres MEM, 2015, BEHAV PROCESS, V113, P163, DOI 10.1016/j.beproc.2015.02.006; Mponzi BP, 2014, HUM-WILDL INTERACT, V8, P218; MYNENI RB, 1994, REMOTE SENS ENVIRON, V49, P200, DOI 10.1016/0034-4257(94)90016-7; Newsome TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063931; O'Brien CS, 2006, WILDLIFE SOC B, V34, P582, DOI 10.2193/0091-7648(2006)34[582:WUOWCI]2.0.CO;2; Ogutu JO, 2014, BIODIVERS CONSERV, V23, P573, DOI 10.1007/s10531-013-0617-y; Ogutu JO, 2012, BIODIVERS CONSERV, V21, P1033, DOI 10.1007/s10531-012-0239-9; Ogutu JO, 2010, ECOL MONOGR, V80, P241, DOI 10.1890/09-0439.1; Ostrowski S, 2002, J MAMMAL, V83, P665, DOI 10.1644/1545-1542(2002)083<0665:WIAFCO>2.0.CO;2; Perry GLW, 2006, PLANT ECOL, V187, P59, DOI 10.1007/s11258-006-9133-4; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pole A, 2004, J ZOOL, V262, P207, DOI 10.1017/S0952836903004576; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Rasmussen GSA, 2012, J ZOOL, V286, P232, DOI 10.1111/j.1469-7998.2011.00874.x; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Rogers CML, 1993, WOODY VEGETATION SUR; Rosenstock SS, 1999, J RANGE MANAGE, V52, P302, DOI 10.2307/4003538; Schmidt-Nielsen K., 1964, DESERT ANIMALS PHYSL; Smit IPJ, 2007, BIOL CONSERV, V136, P85, DOI 10.1016/j.biocon.2006.11.009; Spackman KA, 1989, P 6 INT WORKSH MACH; Tilman D, 1984, Q REV BIOL, V59, P199, DOI [10.1086/413856, DOI 10.1086/413856]; Valeix M, 2007, J TROP ECOL, V23, P87, DOI 10.1017/S0266467406003609; Valeix M, 2011, BIOL CONSERV, V144, P902, DOI 10.1016/j.biocon.2010.10.029; van der Meer E, 2011, BEHAV ECOL, V22, P985, DOI 10.1093/beheco/arr079; van der Meer E, 2014, ORYX, V48, P285, DOI 10.1017/S0030605312001366; van der Meer E, 2014, AFR J ECOL, V52, P69, DOI 10.1111/aje.12092; Webster H, 2012, ETHOLOGY, V118, P147, DOI 10.1111/j.1439-0310.2011.01992.x; Western D., 1975, E AFR WILDL J, V13, P265, DOI DOI 10.1111/J.1365-2028.1975.TB00139.X; WHITTAKER RH, 1967, BIOL REV, V42, P207, DOI 10.1111/j.1469-185X.1967.tb01419.x; Whittington-Jones BM, 2014, S AFR J WILDL RES, V44, P135, DOI 10.3957/056.044.0201; Williams JB, 2001, J EXP BIOL, V204, P2301; Wilmshurst JF, 1999, CAN J ZOOL, V77, P1223, DOI 10.1139/cjz-77-8-1223; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Winterbach HEK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100202; Woodroffe R, 1999, ORYX, V33, P132, DOI 10.1017/S0030605300030398; Woodroffe R, 2011, J MAMMAL, V92, P305, DOI 10.1644/10-MAMM-A-157.1; Yravedra J, 2014, ARCHAEOL ANTHROP SCI, V6, P113, DOI 10.1007/s12520-013-0164-1	84	12	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146263	10.1371/journal.pone.0146263	http://dx.doi.org/10.1371/journal.pone.0146263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816321	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528200011
J	Li, XY; Liu, Y; Jiang, WD; Jiang, J; Wu, P; Zhao, J; Kuang, SY; Tang, L; Tang, WN; Zhang, YA; Zhou, XQ; Feng, L				Li, Xue-Yin; Liu, Yang; Jiang, Wei-Dan; Jiang, Jun; Wu, Pei; Zhao, Juan; Kuang, Sheng-Yao; Tang, Ling; Tang, Wu-Neng; Zhang, Yong-An; Zhou, Xiao-Qiu; Feng, Lin			Co- and Post-Treatment with Lysine Protects Primary Fish Enterocytes against Cu-Induced Oxidative Damage	PLOS ONE			English	Article							ANTIOXIDANT DEFENSES; GENE-EXPRESSION; GROWTH-PERFORMANCE; ATLANTIC SALMON; DIETARY LYSINE; RAINBOW-TROUT; JUVENILE JIAN; ASCORBIC-ACID; AMINO-ACIDS; VITAMIN-E	The aim of the work was primarily to explore the protective activity pathways of lysine against oxidative damage in fish in vivo and in enterocytes in vitro. First, grass carp were fed diets containing six graded levels of lysine (7.1-19.6 g kg(-1) diet) for 56 days. Second, the enterocytes were treated with different concentrations of lysine (0-300 mg/L in media) prior to (pre-treatment), along with (co-treatment) or following (post-treatment) with 6 mg/L of Cu for 24 h. The results indicated that lysine improved grass carp growth performance. Meanwhile, lysine ameliorated lipid and protein oxidation by elevating the gene expression and activity of antioxidant enzymes (superoxide dismutase (SOD), glutathioneperoxidase (GPx), glutathione-S-transferase (GST) and reductase (GR)), and nuclear factor erythroid 2-related factor 2 (Nrf2) mRNA levels in fish intestine. The in vitro studies showed that co- and post-treatment with lysine conferred significant protection against Cu-induced oxidative damage in fish primary enterocytes as measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) OD values, along with alkaline phosphatase (ALP) and lactate dehydrogenase activities, and the depletion of protein carbonyl (PC), malondialdehyde (MDA) and 8-hydroxydeoxyguanosine contents. Moreover, lysine co-treatment decreased the activities and mRNA level of cellular SOD, GPx, GST and GR compared with the Cu- only exposed group. Gene expression of the signalling molecule Nrf2 showed the same pattern as that of SOD activity, whereas Kelch-like ECH-associated protein 1b (Keap1b) followed the opposite trend, indicating that co-treatment with lysine induced antioxidant enzymes that protected against oxidative stress through Nrf2 pathway. In addition, posttreatment with lysine increased proteasomal activity and blocked the Cu-stimulated increase in mRNA levels of GST and associated catalase (CAT) and GST activities (P<0.01 and P<0.001). GR activity and gene expression, and glutathione (GSH) content followed an opposite trend to GST activity (P<0.05). Thus, post-treatment of lysine elevated protein and DNA repair abilities and ameliorated the cellular redox state of enterocytes. The overall results suggest that lysine plays a significant role in the protection of fish intestine in vivo and in vitro through the induction of key antioxidant protection.	[Li, Xue-Yin; Liu, Yang; Jiang, Wei-Dan; Jiang, Jun; Wu, Pei; Zhao, Juan; Zhou, Xiao-Qiu; Feng, Lin] Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China; [Li, Xue-Yin; Liu, Yang; Jiang, Wei-Dan; Jiang, Jun; Wu, Pei; Zhao, Juan; Zhou, Xiao-Qiu; Feng, Lin] Sichuan Agr Univ, Fish Nutr & Safety Prod Univ Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Liu, Yang; Jiang, Wei-Dan; Jiang, Jun; Wu, Pei; Zhao, Juan; Zhou, Xiao-Qiu; Feng, Lin] Sichuan Agr Univ, Key Lab Anim Disease Resistance Nutr China, Minist Educ, Chengdu, Sichuan, Peoples R China; [Kuang, Sheng-Yao; Tang, Ling; Tang, Wu-Neng] Sichuan Acad Anim Sci, Inst Anim Nutr, Chengdu 610066, Sichuan, Peoples R China; [Zhang, Yong-An] Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Zhou, XQ; Feng, L (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China.; Zhou, XQ; Feng, L (corresponding author), Sichuan Agr Univ, Fish Nutr & Safety Prod Univ Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China.; Zhou, XQ; Feng, L (corresponding author), Sichuan Agr Univ, Key Lab Anim Disease Resistance Nutr China, Minist Educ, Chengdu, Sichuan, Peoples R China.	zhouxq@sicau.edu.cn; fenglin@sicau.edu.cn	liu, yang/HHY-8583-2022; jiang, jun/GWC-9329-2022; Jun, Jiang/CAE-8962-2022	Zhang, Yong-An/0000-0002-9956-3879	National Basic Research Program of China [2014CB138600]; National Department Public Benefit Research Foundation (Agriculture) of China [201003020]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20135103110001]; Science and Technology Support Program of Sichuan Province of China [2014NZ0003]; Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China [2012NC0007, 2013NC0045]; Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China [2015CC0011]; Natural Science Foundation for Young Scientists of Sichuan Province [2014JQ0007]; Sichuan Province Research Foundation for Basic Research [2013JY0082]	National Basic Research Program of China(National Basic Research Program of China); National Department Public Benefit Research Foundation (Agriculture) of China; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science and Technology Support Program of Sichuan Province of China; Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China; Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China; Natural Science Foundation for Young Scientists of Sichuan Province; Sichuan Province Research Foundation for Basic Research	This research was financially supported by the National Basic Research Program of China (973 Program) (2014CB138600), National Department Public Benefit Research Foundation (Agriculture) of China (201003020), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20135103110001), Science and Technology Support Program of Sichuan Province of China (2014NZ0003), Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China (2012NC0007; 2013NC0045), the Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China (2015CC0011), Natural Science Foundation for Young Scientists of Sichuan Province (2014JQ0007), and Sichuan Province Research Foundation for Basic Research (2013JY0082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboudi T, 2006, AQUACULTURE, V261, P369, DOI 10.1016/j.aquaculture.2006.07.041; Aebi H, 1984, Methods Enzymol, V105, P121; Aggarwal S, 2011, BIOCHEM J, V433, P51, DOI 10.1042/BJ20100249; Agnoletto MH, 2007, CLIN BIOCHEM, V40, P1252, DOI 10.1016/j.clinbiochem.2007.08.017; Akrami R, 2013, FISH SHELLFISH IMMUN, V35, P1235, DOI 10.1016/j.fsi.2013.07.039; Armenteros M, 2009, MEAT SCI, V83, P104, DOI 10.1016/j.meatsci.2009.04.007; Barrera D, 2003, LIFE SCI, V73, P3027, DOI 10.1016/j.lfs.2003.06.002; Ben Salah-Abbes J, 2008, J PHARM PHARMACOL, V60, P761, DOI 10.1211/jpp.60.6.0012; Bicudo AJA, 2009, AQUACULTURE, V297, P151, DOI 10.1016/j.aquaculture.2009.09.031; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burk RF, 2008, FREE RADICAL BIO MED, V44, P1617, DOI 10.1016/j.freeradbiomed.2008.01.016; Chen DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037709; Chen J, 2009, AQUACULTURE, V288, P285, DOI 10.1016/j.aquaculture.2008.10.053; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Circu ML, 2012, SEMIN CELL DEV BIOL, V23, P729, DOI 10.1016/j.semcdb.2012.03.014; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; Deng DF, 2010, AQUACULTURE, V308, P44, DOI 10.1016/j.aquaculture.2010.07.041; Deng YP, 2014, AQUACULTURE, V434, P66, DOI 10.1016/j.aquaculture.2014.07.026; Dinu D, 2010, ARCH ENVIRON CON TOX, V58, P757, DOI 10.1007/s00244-009-9401-0; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; FARLEY JR, 1983, SCIENCE, V222, P330; Feng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069974; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gan L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115129; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Hevroy EM, 2007, GEN COMP ENDOCR, V152, P39, DOI 10.1016/j.ygcen.2007.02.015; Higgins AD, 2005, FISH PHYSIOL BIOCHEM, V31, P33, DOI 10.1007/s10695-005-4587-1; Jiang J, 2009, AQUACULT NUTR, V15, P409, DOI 10.1111/j.1365-2095.2008.00605.x; Jiang WD, 2013, AQUAT TOXICOL, V132, P100, DOI 10.1016/j.aquatox.2013.02.005; Jiang WD, 2011, AQUAT TOXICOL, V105, P543, DOI 10.1016/j.aquatox.2011.08.012; Katayama S, 2007, J AGR FOOD CHEM, V55, P8458, DOI 10.1021/jf070866p; Kim Go-Woon, 2010, Int J Cell Biol, V2010, P632739, DOI 10.1155/2010/632739; Lambertucci RH, 2007, MECH AGEING DEV, V128, P267, DOI 10.1016/j.mad.2006.12.006; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100685; Li XY, 2014, FISH PHYSIOL BIOCHEM, V40, P659, DOI 10.1007/s10695-013-9874-7; Lin YH, 2007, AQUACULTURE, V267, P38, DOI 10.1016/j.aquaculture.2006.12.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LIVINGSTONE DR, 1990, FUNCT ECOL, V4, P415, DOI 10.2307/2389604; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Lora J, 2004, EUR J BIOCHEM, V271, P4298, DOI 10.1111/j.1432-1033.2004.04370.x; Lushchak V I, 2001, Am J Physiol Regul Integr Comp Physiol, V280, pR100; Manabe E, 2008, J CELL BIOCHEM, V103, P1925, DOI 10.1002/jcb.21583; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; Merrifield DL, 2009, J FISH DIS, V32, P755, DOI 10.1111/j.1365-2761.2009.01052.x; Morris JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095486; Nandi D, 2005, TOXICOLOGY, V211, P26, DOI 10.1016/j.tox.2005.02.013; NRC, 2011, NUTR REQ FISH SHRIMP, DOI DOI 10.17226/13039; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Oh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045870; Padayatty SJ, 2003, J AM COLL NUTR, V22, P18, DOI 10.1080/07315724.2003.10719272; Pearce SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070215; Radak Z, 2008, FREE RADICAL BIO MED, V44, P153, DOI 10.1016/j.freeradbiomed.2007.01.029; Rau MA, 2004, COMP BIOCHEM PHYS C, V137, P335, DOI 10.1016/j.cca.2004.03.001; SADLER PJ, 1994, EUR J BIOCHEM, V220, P193, DOI 10.1111/j.1432-1033.1994.tb18614.x; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Schafer FQ, 2000, CELL MOL BIOL, V46, P657; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Selvakannan PR, 2003, LANGMUIR, V19, P3545, DOI 10.1021/la026906v; Shpyleva S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113712; Siems Werner, 2003, Molecular Aspects of Medicine, V24, P167, DOI 10.1016/S0098-2997(03)00011-6; Sies H., 1994, EJB REV 1993, V1993, P101; Singh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095855; Stockert JC, 2012, ACTA HISTOCHEM, V114, P785, DOI 10.1016/j.acthis.2012.01.006; Stoll B, 1998, J NUTR, V128, P606, DOI 10.1093/jn/128.3.606; Tian LX, 2004, N AM J AQUACULT, V66, P141, DOI 10.1577/A03-040.1; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Uchida K, 2003, AMINO ACIDS, V25, P249, DOI 10.1007/s00726-003-0015-y; Vardi N, 2008, FOOD CHEM TOXICOL, V46, P3015, DOI 10.1016/j.fct.2008.05.039; Vijayavel K, 2006, SCI TOTAL ENVIRON, V372, P157, DOI 10.1016/j.scitotenv.2006.09.027; Wang X, 2010, J ETHNOPHARMACOL, V127, P424, DOI 10.1016/j.jep.2009.10.022; Wang XJ, 2010, CHEM BIOL, V17, P75, DOI 10.1016/j.chembiol.2009.12.013; Wu P, 2014, FISH SHELLFISH IMMUN, V38, P374, DOI 10.1016/j.fsi.2014.03.032; Yang T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107670; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	78	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147408	10.1371/journal.pone.0147408	http://dx.doi.org/10.1371/journal.pone.0147408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812682	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528000033
J	Low, LL; Tong, SF; Low, WY				Low, Lee Lan; Tong, Seng Fah; Low, Wah Yun			Selection of Treatment Strategies among Patients with Type 2 Diabetes Mellitus in Malaysia: A Grounded Theory Approach	PLOS ONE			English	Article							SEEKING BEHAVIOR; HEALTH-CARE; ILLNESS; PEOPLE	Background Diabetes Mellitus is a multifaceted chronic illness and its life-long treatment process requires patients to continuously engage with the healthcare system. The understanding of how patients manoeuvre through the healthcare system for treatment is crucial in assisting them to optimise their disease management. This study aims to explore issues determining patients' treatment strategies and the process of patients manoeuvring through the current healthcare system in selecting their choice of treatment for T2DM. Methods The Grounded Theory methodology was used. Twelve patients with Type 2 Diabetes Mellitus, nine family members and five healthcare providers from the primary care clinics were interviewed using a semi-structured interview guide. Three focus group discussions were conducted among thirteen healthcare providers from public primary care clinics. Both purposive and theoretical samplings were used for data collection. The interviews were audio-taped and transcribed verbatim, followed by line-by-line coding and constant comparison to identify the categories and core category. Results The concept of "experimentation" was observed in patients' help-seeking behaviour. The "experimentation" process required triggers, followed by information seeking related to treatment characteristics from trusted family members, friends and healthcare providers to enable decisions to be made on the choice of treatment modalities. The whole process was dynamic and iterative through interaction with the healthcare system. The decision-making process in choosing the types of treatment was complex with an element of trial-and-error. The anchor of this process was the desire to fulfil the patient's expected outcome. Conclusion Patients with Type 2 Diabetes Mellitus continuously used "experimentation" in their treatment strategies and help-seeking process. The "experimentation" process was experiential, with continuous evaluation, information seeking and decision-making tinged with the element of trial-and-error. The theoretical model generated from this study is abstract, is believed to have a broad applicability to other diseases, may be applied at varying stages of disease development and is non-context specific.	[Low, Lee Lan] Univ Malaya, Fac Med, Med Educ & Res Dev Unit, Kuala Lumpur, Malaysia; [Low, Lee Lan] Minist Hlth Malaysia, Inst Hlth Syst Res, Shah Alam, Selangor, Malaysia; [Tong, Seng Fah] Univ Kebangsaan Malaysia, Fac Med, Dept Family Med, Kuala Lumpur, Malaysia; [Low, Wah Yun] Univ Malaya, Fac Med, Res & Management Ctr, Kuala Lumpur, Malaysia	Universiti Malaya; Kementerian Kesihatan Malaysia; Universiti Kebangsaan Malaysia; Universiti Malaya	Low, LL (corresponding author), Univ Malaya, Fac Med, Med Educ & Res Dev Unit, Kuala Lumpur, Malaysia.; Low, LL (corresponding author), Minist Hlth Malaysia, Inst Hlth Syst Res, Shah Alam, Selangor, Malaysia.	lowleelan@yahoo.com	Low, Wah-Yun/B-1775-2009	Low, Wah-Yun/0000-0003-4409-1509	University of Malaya research grant [PV108/2012A]; Fogarty International Centre, National Institutes of Health [D43TW008332]; FOGARTY INTERNATIONAL CENTER [D43TW008332] Funding Source: NIH RePORTER	University of Malaya research grant; Fogarty International Centre, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by a University of Malaya research grant (grant number PV108/2012A). LLL is supported by the Fogarty International Centre, National Institutes of Health, under Award Number: D43TW008332 (ASCEND Research Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, 14 DCPP; Atwine F, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.76.5497; Bowen ME, 2010, J MULTIDISCIP HEALTH, V3, P113; Broadbent E, 2011, DIABETES CARE, V34, P338, DOI 10.2337/dc10-1779; Burt RS, 2005, BROKERAGE CLOSURE IN; Charmaz, 2007, SAGE HDB GROUNDED TH, P97; CHARMAZ K, 1990, SOC SCI MED, V30, P1161, DOI 10.1016/0277-9536(90)90256-R; Debono Miguel, 2007, Psychol Health Med, V12, P545, DOI 10.1080/13548500701235740; Elliott Naomi, 2005, Aust J Adv Nurs, V22, P48; Hale NL, 2010, J COMMUN HEALTH, V35, P365, DOI 10.1007/s10900-010-9259-0; Hjelm K, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-11; Ibrahim W.N., 2010, MALAYSIAN J PUBLIC H, V10, P68; Institute for Public Health Malaysia, 2011, NAT HLTH MORB SURV 2, VII; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Kolling M, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-8; KROEGER A, 1983, SOC SCI MED, V17, P147, DOI 10.1016/0277-9536(83)90248-4; letchuman G. R., 2010, Medical Journal of Malaysia, V65, P173; Low Lee Lan, 2014, Coll Antropol, V38, P11; MacKian S, 2004, HEALTH POLICY PLANN, V19, P137, DOI 10.1093/heapol/czh017; MacKian S., 2003, REV HLTH SEEKING BEH; Mazura M, 2011, RES HIGHLIGHT MUCH D; Men CR, 2007, I WISH I HAD AIDS QU; Nguma LK, 2010, HLTH SEEKING HLTH RE; Polonsky WH, 2000, DIABETES SPECTRUM, V13, P36; Purintrapiban J, 2008, NATURAL PRODUCT RES, V25, P1379; Raaijmakers LGM, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-114; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Shaw C, 2008, INT J NURS STUD, V45, P1516, DOI 10.1016/j.ijnurstu.2007.11.005; Shaw C, 2001, J CLIN NURS, V10, P15, DOI 10.1046/j.1365-2702.2001.00443.x; Sheleaswani Inche ZA, 2014, ADV EPIDEMIOLOGY; Shenton A.K., 2004, ED INF, V22, P63, DOI DOI 10.3233/EFI-2004-22201; Unger-Saldana K, 2011, SOC SCI MED, V72, P1096, DOI 10.1016/j.socscimed.2011.01.022; WHO, 2000, WORLD HLTH REP HLTH; Wilde MH, 2007, J ADV NURS, V57, P339, DOI 10.1111/j.1365-2648.2006.04089.x; World Health Organization, 2001, LEG STAT TRAD MED CO; Worswick J, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-26	36	21	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147127	10.1371/journal.pone.0147127	http://dx.doi.org/10.1371/journal.pone.0147127			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GB	26812053	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528000019
J	Fichter, AM; Ritschl, LM; Borgmann, A; Humbs, M; Luppa, PB; Wolff, KD; Muke, T				Fichter, Andreas M.; Ritschl, Lucas M.; Borgmann, Anna; Humbs, Martin; Luppa, Peter B.; Wolff, Klaus-Dietrich; Mueke, Thomas			Development of an Extracorporeal Perfusion Device for Small Animal Free Flaps	PLOS ONE			English	Article							VIVO NORMOTHERMIC PERFUSION; MICROSURGICAL FREE FLAPS; RENAL-TRANSPLANTATION; MUSCLE FLAPS; EPIGASTRIC FLAPS; VITAL STORAGE; PORCINE MODEL; RATS; ISCHEMIA; TISSUE	Background Extracorporeal perfusion (ECP) might prolong the vital storage capabilities of composite free flaps, potentially opening a wide range of clinical applications. Aim of the study was the development a validated low-cost extracorporeal perfusion model for further research in small animal free flaps. Methods After establishing optimal perfusion settings, a specially designed extracorporeal perfusion system was evaluated during 8-hour perfusion of rat epigastric flaps followed by microvascular free flap transfer. Controls comprised sham-operation, ischemia and in vivo perfusion. Flaps and perfusate (diluted blood) were closely monitored by blood gas analysis, combined laser Doppler flowmetry and remission spectroscopy and Indocyanine-Green angiography. Evaluations were complemented by assessment of necrotic area and light microscopy at day 7. Results ECP was established and maintained for 8 hours with constant potassium and pH levels. Subsequent flap transfer was successful. Notably, the rate of necrosis of extracorporeally perfused flaps (27%) was even lower than after in vivo perfusion (49%), although not statistically significant (P = 0,083). After sham-operation, only 6% of the total flap area became necrotic, while 8-hour ischemia led to total flap loss (98%). Angiographic and histological findings confirmed these observations. Conclusions Vital storage capabilities of microvascular flaps can be prolonged by temporary ECP. Our study provides important insights on the pathophysiological processes during extracorporeal tissue perfusion and provides a validated small animal perfusion model for further studies.	[Fichter, Andreas M.; Ritschl, Lucas M.; Borgmann, Anna; Humbs, Martin; Wolff, Klaus-Dietrich; Mueke, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Dept Oral & Maxillofacial Surg, D-80290 Munich, Germany; [Luppa, Peter B.] Tech Univ Munich, Klinikum Rechts Isar, Inst Clin Chem & Pathobiochem, D-80290 Munich, Germany	Technical University of Munich; Technical University of Munich	Fichter, AM (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Oral & Maxillofacial Surg, D-80290 Munich, Germany.	andreas.fichter@tum.de	Mücke, Thomas/K-7106-2015	Mücke, Thomas/0000-0003-3561-1277	Deutsche Forschungsgemeinschaft [WO 507/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (WO 507/4-1), http://www.dfg.de.	Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Boehm O, 2007, BIOL CHEM, V388, P547, DOI 10.1515/BC.2007.061; CARREL ALEXIS, 1935, SCIENCE, V81-201, P621, DOI 10.1126/science.81.2112.621; Charles, 1984, BASELINE HEMATOLOGY; Constantinescu MA, 2011, J SURG RES, V171, P291, DOI 10.1016/j.jss.2010.01.040; COOLEY B C, 1990, Journal of Reconstructive Microsurgery, V6, P49, DOI 10.1055/s-2007-1006802; DOMINGOPECH J, 1991, INT ORTHOP, V15, P289; Dragu A, 2012, PLAST RECONSTR SURG, V130, p265E, DOI 10.1097/PRS.0b013e3182589c2d; Dragu A, 2012, ARCH ORTHOP TRAUM SU, V132, P655, DOI 10.1007/s00402-011-1458-3; Dragu A, 2011, ARCH ORTHOP TRAUM SU, V131, P849, DOI 10.1007/s00402-010-1251-8; Fichter AM, 2014, BRIT J ORAL MAX SURG, V52, P432, DOI 10.1016/j.bjoms.2014.02.013; Fowler JD, 1999, MICROSURG, V19, P135, DOI 10.1002/(SICI)1098-2752(1999)19:3<135::AID-MICR3>3.0.CO;2-Y; Greaney PJ, 2010, J RECONSTR MICROSURG, V26, P517, DOI 10.1055/s-0030-1262951; Hassanein WH, 1998, J THORAC CARDIOV SUR, V116, P821, DOI 10.1016/S0022-5223(98)00452-8; Holzle F, 2010, INT J ORAL MAX SURG, V39, P21, DOI 10.1016/j.ijom.2009.10.012; Holzle F, 2006, J CRANIO MAXILL SURG, V34, P25, DOI 10.1016/j.jcms.2005.07.010; Hosgood SA, 2014, AM J TRANSPLANT, V14, P1690, DOI 10.1111/ajt.12766; Hosgood SA, 2011, TRANSPLANTATION, V92, P735, DOI 10.1097/TP.0b013e31822d4e04; LI XL, 1993, J HAND SURG-AM, V18A, P629, DOI 10.1016/0363-5023(93)90306-N; MAEDA M, 1993, PLAST RECONSTR SURG, V91, P113, DOI 10.1097/00006534-199301000-00017; Maeda M, 1993, PLAST RECONSTR SURG, V91, P25; MAYER B, 1993, OTOLARYNG HEAD NECK, V109, P690, DOI 10.1177/019459989310900409; Mayer B, 1996, LARYNGO RHINO OTOL, V75, P175, DOI 10.1055/s-2007-997558; Mayer B, 2002, LARYNGO RHINO OTOL, V81, P640, DOI 10.1055/s-2002-34452; MAYER B, 1994, OTO RHINO LARYN NOVA, V4, P190; Mayer B, 1992, OTORHINOLARYNGOL NOV, V2, P212, DOI [10.1159/000312849, DOI 10.1159/000312849]; Mayer B, 1998, TIERSCHUTZBEAUFTRAGT, V1, P67; McBride C M, 1970, Arch Chir Neerl, V22, P91; Mucke T, 2013, BRIT J ORAL MAX SURG, V51, P555, DOI 10.1016/j.bjoms.2012.09.007; Mucke T, 2011, MICROSURG, V31, P472, DOI 10.1002/micr.20892; Muller S, 2013, J SURG RES, V181, P170, DOI 10.1016/j.jss.2012.05.088; Nicholson ML, 2013, AM J TRANSPLANT, V13, P1246, DOI 10.1111/ajt.12179; Rasband WS, 1997, INVENTORIMAGEJ1997 2; Ritschl LM, 2015, J RECONSTR MICROSURG, V31, P343, DOI 10.1055/s-0035-1546291; Sekine H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2406; STRAUCH B, 1967, PLAST RECONSTR SURG, V40, P325, DOI 10.1097/00006534-196710000-00002; Taeger CD, 2015, SCI REP-UK, V5, DOI 10.1038/srep11956; Taeger CD, 2014, J CELL MOL MED, V18, P885, DOI 10.1111/jcmm.12238; Tee R, 2012, TISSUE ENG PT A, V18, P1992, DOI [10.1089/ten.tea.2012.0151, 10.1089/ten.TEA.2012.0151]; USUI M, 1985, J BONE JOINT SURG BR, V67, P473, DOI 10.1302/0301-620X.67B3.3997959; Van Ginkel R J, 1999, Sarcoma, V3, P89, DOI 10.1080/13577149977703; Wesibroth, 1979, LAB RAT BIOL DIS; Wolfensohn S, 2003, HDB LAB ANIMAL MANAG; Wolff KD, 2014, J CRANIO MAXILL SURG, V42, P1423, DOI 10.1016/j.jcms.2014.04.004; Wolff KD, 2009, J SURG ONCOL, V99, P123, DOI 10.1002/jso.21205; Worner M, 2014, ARTIF ORGANS, V38, P352, DOI 10.1111/aor.12155; YABE Y, 1994, J RECONSTR MICROSURG, V10, P185, DOI 10.1055/s-2007-1006586	47	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147755	10.1371/journal.pone.0147755	http://dx.doi.org/10.1371/journal.pone.0147755			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808996	Green Published, gold			2022-12-26	WOS:000369527800207
J	Johnston, JD; Tuttle, SC; Nelson, MC; Bradshaw, RK; Hoybjerg, TG; Johnson, JB; Kruman, BA; Orton, TS; Cook, RB; Eggett, DL; Weber, KS				Johnston, James D.; Tuttle, Steven C.; Nelson, Morgan C.; Bradshaw, Rebecca K.; Hoybjerg, Taylor G.; Johnson, Julene B.; Kruman, Bryce A.; Orton, Taylor S.; Cook, Ryan B.; Eggett, Dennis L.; Weber, K. Scott			Evaporative Cooler Use Influences Temporal Indoor Relative Humidity but Not Dust Mite Allergen Levels in Homes in a Semi-Arid Climate	PLOS ONE			English	Article							DERMATOPHAGOIDES-PTERONYSSINUS; WATER-BALANCE; HOUSE; ASTHMA; EXPOSURE; PYROGLYPHIDAE; PREVALENCE; ACARI; SENSITIZATION; REQUIREMENTS	Concerns about energy consumption and climate change make residential evaporative coolers a popular alternative to central air conditioning in arid and semi-arid climates. However, evaporative coolers have been shown to significantly increase indoor relative humidity and dust mite allergen levels in some studies, while showing no association in other studies. Improved measurement of temporal fluctuations in indoor relative humidity may help identify factors that promote mite growth in homes in dry climates. Dust samples and continuous indoor relative humidity measurements were collected from homes with central air conditioning and homes with evaporative coolers in Utah. Samples were collected over two seasons, winter/spring (Jan-Apr) and summer (July-Sept), 2014. Dust samples were analyzed for Der p 1 and Der f 1 using a two-site monoclonal antibody-based enzyme-linked immuno-sorbent assay (ELISA) analysis. Housing characteristics including age of home, occupant density, and age of mattresses, furniture, and carpeting were also measured. Positive Der p 1 or Der f 1 samples were found in 25.0% of the homes and there was no difference in mean allergen levels by type of air conditioning. Indoor relative humidity was significantly higher in homes with evaporative coolers compared to those with central air conditioning during the summer. Homes with evaporative coolers also spent significantly more time during summer above 55.0% and 65.0% relative humidity compared to central air homes, but not above 75.0%. Findings from this study suggest that increased humidity from evaporative coolers may not be sufficient to exceed the critical equilibrium humidity or maintain humidity excursions for sufficient duration in relatively larger single-family homes in semi-arid climates to support mite growth and reproduction.	[Johnston, James D.; Tuttle, Steven C.; Bradshaw, Rebecca K.; Kruman, Bryce A.] Brigham Young Univ, Dept Hlth Sci, Provo, UT 84602 USA; [Nelson, Morgan C.; Hoybjerg, Taylor G.; Johnson, Julene B.; Orton, Taylor S.; Cook, Ryan B.; Weber, K. Scott] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA; [Eggett, Dennis L.] Brigham Young Univ, Dept Stat, Provo, UT 84602 USA	Brigham Young University; Brigham Young University; Brigham Young University	Johnston, JD (corresponding author), Brigham Young Univ, Dept Hlth Sci, Provo, UT 84602 USA.	scott_weber@byu.edu	Weber, Scott/O-1022-2014	Weber, Scott/0000-0003-3688-2191; Johnston, James/0000-0002-6009-7241				Arlian Larry G, 2002, Curr Allergy Asthma Rep, V2, P401, DOI 10.1007/s11882-002-0074-2; ARLIAN LG, 1992, EXP APPL ACAROL, V16, P15, DOI 10.1007/BF01201490; ARLIAN LG, 1992, J ALLERGY CLIN IMMUN, V90, P292, DOI 10.1016/S0091-6749(05)80006-5; Arlian LG, 1998, J MED ENTOMOL, V35, P46, DOI 10.1093/jmedent/35.1.46; ARLIAN LG, 1981, J MED ENTOMOL, V18, P351, DOI 10.1093/jmedent/18.4.351; Arlian LG, 2001, J ALLERGY CLIN IMMUN, V107, pS406, DOI 10.1067/mai.2001.113670; Committee on the Assessment of Asthma and Indoor Air-Institute of Medicine (US), 2000, CLEAR AIR ASTHM IND; Dai YJ, 2002, APPL THERM ENG, V22, P1417, DOI 10.1016/S1359-4311(02)00069-8; De Boer R, 1998, J MED ENTOMOL, V35, P905, DOI 10.1093/jmedent/35.6.905; ELLINGSON AR, 1995, J ALLERGY CLIN IMMUN, V96, P473, DOI 10.1016/S0091-6749(95)70289-X; Johnston JD, 2015, J OCCUP ENVIRON HYG, V12, P785, DOI 10.1080/15459624.2015.1047024; KUEHR J, 1994, J ALLERGY CLIN IMMUN, V94, P44, DOI 10.1016/0091-6749(94)90070-1; Lodge CJ, 2011, J ALLERGY CLIN IMMUN, V128, P782, DOI 10.1016/j.jaci.2011.06.038; MATHEWS EH, 1994, BUILD ENVIRON, V29, P197, DOI 10.1016/0360-1323(94)90070-1; MOYER DB, 1985, ANN ALLERGY, V55, P680; NELSON HS, 1995, ANN ALLERG ASTHMA IM, V75, P337; Pate AD, 2005, J ALLERGY CLIN IMMUN, V116, P844, DOI 10.1016/j.jaci.2005.06.016; PLATTSMILLS TAE, 1992, J ALLERGY CLIN IMMUN, V89, P1046, DOI 10.1016/0091-6749(92)90228-T; Portnoy J, 2013, ANN ALLERG ASTHMA IM, V111, P465, DOI 10.1016/j.anai.2013.09.018; Prasad C, 2009, ALLERGY ASTHMA PROC, V30, P624, DOI 10.2500/aap.2009.30.3290; SEARS MR, 1989, CLIN EXP ALLERGY, V19, P419, DOI 10.1111/j.1365-2222.1989.tb02408.x; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Teplitsky V, 2008, INT J DERMATOL, V47, P790, DOI 10.1111/j.1365-4632.2008.03657.x; Tovey E. R., 1997, Journal of Allergy and Clinical Immunology, V99, pS163; Tunnicliffe WS, 1999, EUR RESPIR J, V13, P654, DOI 10.1183/09031936.99.13365499; Vanlaar CH, 2001, ALLERGY, V56, P1211, DOI 10.1034/j.1398-9995.2001.00085.x; Watt J., 2012, EVAPORATIVE AIR COND; Wu JM, 2009, APPL THERM ENG, V29, P980, DOI 10.1016/j.applthermaleng.2008.05.016	28	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147105	10.1371/journal.pone.0147105	http://dx.doi.org/10.1371/journal.pone.0147105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808528	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800050
J	Liao, JQ; Yu, SC; Yang, F; Yang, M; Hu, YH; Zhang, JY				Liao, Jiaqiang; Yu, Shicheng; Yang, Fang; Yang, Min; Hu, Yuehua; Zhang, Juying			Short-Term Effects of Climatic Variables on Hand, Foot, and Mouth Disease in Mainland China, 2008-2013: A Multilevel Spatial Poisson Regression Model Accounting for Overdispersion	PLOS ONE			English	Article							ENTEROVIRUS-71; TEMPERATURE; EPIDEMIC; OUTBREAK; LEVEL	Background Hand, Foot, and Mouth Disease (HFMD) is a worldwide infectious disease. In China, many provinces have reported HFMD cases, especially the south and southwest provinces. Many studies have found a strong association between the incidence of HFMD and climatic factors such as temperature, rainfall, and relative humidity. However, few studies have analyzed cluster effects between various geographical units. Methods The nonlinear relationships and lag effects between weekly HFMD cases and climatic variables were estimated for the period of 2008-2013 using a polynomial distributed lag model. The extra-Poisson multilevel spatial polynomial model was used to model the exact relationship between weekly HFMD incidence and climatic variables after considering cluster effects, provincial correlated structure of HFMD incidence and overdispersion. The smoothing spline methods were used to detect threshold effects between climatic factors and HFMD incidence. Results The HFMD incidence spatial heterogeneity distributed among provinces, and the scale measurement of overdispersion was 548.077. After controlling for long-term trends, spatial heterogeneity and overdispersion, temperature was highly associated with HFMD incidence. Weekly average temperature and weekly temperature difference approximate inverse "V" shape and "V" shape relationships associated with HFMD incidence. The lag effects for weekly average temperature and weekly temperature difference were 3 weeks and 2 weeks. High spatial correlated HFMD incidence were detected in northern, central and southern province. Temperature can be used to explain most of variation of HFMD incidence in southern and northeastern provinces. After adjustment for temperature, eastern and Northern provinces still had high variation HFMD incidence. Conclusion We found a relatively strong association between weekly HFMD incidence and weekly average temperature. The association between the HFMD incidence and climatic variables spatial heterogeneity distributed across provinces. Future research should explore the risk factors that cause spatial correlated structure or high variation of HFMD incidence which can be explained by temperature. When analyzing association between HFMD incidence and climatic variables, spatial heterogeneity among provinces should be evaluated. Moreover, the extra-Poisson multilevel model was capable of modeling the association between overdispersion of HFMD incidence and climatic variables.	[Liao, Jiaqiang; Yang, Fang; Yang, Min; Zhang, Juying] Sichuan Univ, West China Sch Publ Hlth, Chengdu 610064, Sichuan Provinc, Peoples R China; [Yu, Shicheng; Hu, Yuehua] Chinese Ctr Dis Prevent & Control, Off Epidemiol, Beijing, Peoples R China	Sichuan University; Chinese Center for Disease Control & Prevention	Zhang, JY (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu 610064, Sichuan Provinc, Peoples R China.	Juying109@163.com	Hu, Yue/HGE-1673-2022; Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	 [2012LCLB02]		Funding for HFMD cases diagnose and data analysis was supported by NO.2012LCLB02 (http://bjs.lclxbx.zdsys.zhaolizhi.cn/).	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; [Anonymous], 2008, GUID PREP CONTR MEAS, P146; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chan KP, 2003, EMERG INFECT DIS, V9, P78; COOPER JP, 1972, AM STAT, V26, P32, DOI 10.2307/2682864; COX DR, 1983, BIOMETRIKA, V70, P269, DOI 10.1093/biomet/70.1.269; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Hinde J, 1998, COMPUT STAT DATA AN, V27, P151, DOI 10.1016/S0167-9473(98)00007-3; Huang Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-134; Li L, 2013, CHINESE GEN PRACTICE, V3, P326; Lianmei Y, 2003, ACTA GEOGRAPHICA SIN, V4, P012; Liu L, 2015, EPIDEMIOL INFECT, V143, P831, DOI 10.1017/S0950268814001587; Liu SL, 2015, REV MED VIROL, V25, P115, DOI 10.1002/rmv.1827; LIU Y, 2007, DIS SURVEILLANCE, P22; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; SALO RJ, 1976, ARCH VIROL, V52, P269, DOI 10.1007/BF01315616; TAGAYA I, 1981, JPN J MED SCI BIOL, V34, P191, DOI 10.7883/yoken1952.34.191; Toida M, 2003, J CLIN LASER MED SUR, V21, P363, DOI 10.1089/104454703322650176; Urashima M, 2003, JPN J INFECT DIS, V56, P48; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8; Xie YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085440, 10.1371/journal.pone.0088065]; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu YiLing, 2010, Journal of Tropical Medicine (Guangzhou), V10, P1237; Yu SC, 2012, BIOMED ENVIRON SCI, V25, P645, DOI 10.3967/0895-3988.2012.06.006; Yu Shicheng, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P271; Zhang SY, 2015, EXP THER MED, V9, P811, DOI 10.3892/etm.2015.2207; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhengrong L, 2012, CHIN J INFECT DIS, P201; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005	32	15	19	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147054	10.1371/journal.pone.0147054	http://dx.doi.org/10.1371/journal.pone.0147054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808311	gold, Green Submitted, Green Published			2022-12-26	WOS:000369527800048
J	Norazmi-Lokman, NH; Purser, GJ; Patil, JG				Norazmi-Lokman, Nor Hakim; Purser, G. J.; Patil, Jawahar G.			Gravid Spot Predicts Developmental Progress and Reproductive Output in a Livebearing Fish, Gambusia holbrooki	PLOS ONE			English	Article							GUPPY POECILIA-RETICULATA; SOUTH-EASTERN AUSTRALIA; MEDAKA ORYZIAS LATIPES; NUPTIAL COLORATION; INTRODUCED MOSQUITOFISH; SEXUAL CHARACTERISTICS; METHYL TESTOSTERONE; PLAGUE MINNOW; AFFINIS; BIOLOGY	In most livebearing fish, the gravid spot is an excellent marker to identify brooding females, however its use to predict progress of embryonic development, brood size, timing of parturition and overall reproductive potential of populations remain unexplored. Therefore, to understand these relationships, this study quantified visual attributes (intensity and size) of the gravid spot in relation to key internal development in Gambusia holbrooki. Observations show that the colour of the gravid spot arises from progressive melanisation on the surface of the ovarian sac at its hind margin, rather than melanisation of the developing embryos or the skin of the brooding mother. More importantly, the gravid spot intensity and size were closely linked with both developmental stages and clutch size, suggesting their reliable use as external surrogates of key internal developmental in the species. Using predictive consistency of the gravid spot, we also determined the effect of rearing temperature (23 degrees C and 25 degrees C) on gestation period and parturition behaviour. The results show that gestation period was significantly reduced (F = 364.58; df = 1,48; P>0.05) at 25 degrees C. However there was no significant difference in average number of fry parturated in the two temperature groups (P<0.05), reaffirming that gravid spot intensity is a reliable predictor of reproductive output. The parturition in the species occurred predominantly in the morning and in contrast to earlier reports, tails of the fry emerged first with a few exceptions of head-first, twin and premature births. This study demonstrates utility of the gravid spot for downstream reproductive investigations in a live-bearing fish both in the field and laboratory. The reproducibility of the relationships (intensity with both developmental stage and clutch size), imply that they are also relevant to wild populations that experience varying temperature climes and stressors, significant deviations of which may serve as indicators of environmental health and climate variability.	[Norazmi-Lokman, Nor Hakim; Purser, G. J.] Univ Tasmania, Inst Marine & Antarctic Studies, Fisheries & Aquaculture Ctr, Launceston, Tas, Australia; [Patil, Jawahar G.] Univ Tasmania, Inst Marine & Antarctic Studies, Fisheries & Aquaculture Ctr, Hobart, Tas, Australia; [Patil, Jawahar G.] Inland Fisheries Serv, New Norfolk, Tas, Australia; [Norazmi-Lokman, Nor Hakim] Univ Malaysia Terengganu, Sch Fisheries & Aquaculture Sci, Kuala Terengganu, Terengganu, Malaysia	University of Tasmania; University of Tasmania; Universiti Malaysia Terengganu	Patil, JG (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Fisheries & Aquaculture Ctr, Hobart, Tas, Australia.; Patil, JG (corresponding author), Inland Fisheries Serv, New Norfolk, Tas, Australia.	Jawahar.Patil@utas.edu.au	Norazmi, Lokman Nor Hakim/AAD-2229-2020; Patil, Jawahar G/B-9527-2012	Norazmi, Lokman Nor Hakim/0000-0002-1927-6846; Patil, Jawahar G/0000-0002-2154-4627	Australian Research Council; Inland Fisheries Service; Ministry of Higher Education, Malaysia	Australian Research Council(Australian Research Council); Inland Fisheries Service; Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	The project was funded by the Australian Research Council and Inland Fisheries Service. NHNL received an academic staff training scholarship Ministry of Higher Education, Malaysia.	Agrillo C, 2008, ETHOLOGY, V114, P479, DOI 10.1111/j.1439-0310.2008.01493.x; Arthur J, 2013, PREGNANCY FEMALE LIV; Bone Q., 2007, BIOL FISHES; CHAMBOLLE P, 1970, Bulletin Biologique de la France et de la Belgique, V104, P443; Chandra G, 2008, INDIAN J MED RES, V127, P13; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Constantz G.D., 1989, P33; Deaton R, 2008, J FISH BIOL, V72, P1607, DOI 10.1111/j.1095-8649.2008.01827.x; Dzikowski R, 2001, AQUACULTURE, V199, P323, DOI 10.1016/S0044-8486(01)00561-0; Edwards TM, 2007, AQUAT TOXICOL, V85, P40, DOI 10.1016/j.aquatox.2007.07.014; Emmens CW, 2013, KEEPING BREEDING AQU; Rautenberg GE, 2015, ECOL INDIC, V48, P706, DOI 10.1016/j.ecolind.2014.09.025; Fujii Ryozo, 1993, P535; Goodsell JA, 1999, CONSERV BIOL, V13, P921, DOI 10.1046/j.1523-1739.1999.98237.x; Greven H., 2005, VIVIPAROUS FISHES, P146; Hamer AJ, 2002, OECOLOGIA, V132, P445, DOI 10.1007/s00442-002-0968-7; Howard AFV, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-199; HOWELL WM, 1980, COPEIA, P676; HUBBS C, 1959, EVOLUTION, V13, P236, DOI 10.1111/j.1558-5646.1959.tb03008.x; Ishii S, 1963, J FS U TOKYO SECT, V4, P181; Ivantsoff W, 1999, MAR FRESHWATER RES, V50, P467, DOI 10.1071/MF98106; Jobling M., 1995, ENVIRON BIOL FISH; Keane JP, 2004, NEW ZEAL J MAR FRESH, V38, P857, DOI 10.1080/00288330.2004.9517285; Keller K, 2008, J FISH BIOL, V73, P1714, DOI 10.1111/j.1095-8649.2008.02045.x; Kouba A, 2013, J APPL ICHTHYOL, V29, P193, DOI 10.1111/jai.12010; Koya Y, 2000, FISHERIES SCI, V66, P63, DOI 10.1046/j.1444-2906.2000.00009.x; Kwan L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0267; Langerhans R. Brian, 2011, P228; Ling N, 2004, NEW ZEAL J MAR FRESH, V38, P473, DOI 10.1080/00288330.2004.9517254; Macdonald JI, 2012, MAR FRESHWATER RES, V63, P659, DOI 10.1071/MF12019; Morgan DL, 2004, NEW ZEAL J MAR FRESH, V38, P511, DOI 10.1080/00288330.2004.9517257; NIWA HS, 1965, EMBRYOLOGIA, V8, P299, DOI 10.1111/j.1440-169X.1965.tb00204.x; NIWA HS, 1965, EMBRYOLOGIA, V8, P289, DOI 10.1111/j.1440-169X.1965.tb00203.x; Nordeide JT, 2002, CAN J ZOOL, V80, P1344, DOI 10.1139/Z02-116; Patil J. G., 2012, ADAPTIVE MANAGEMENT; PEDEN AE, 1973, COPEIA, P250, DOI 10.2307/1442963; PEDEN AE, 1973, COPEIA, P210; Pyke GH, 2005, REV FISH BIOL FISHER, V15, P339, DOI 10.1007/s11160-006-6394-x; Pyke GH, 2008, ANNU REV ECOL EVOL S, V39, P171, DOI 10.1146/annurev.ecolsys.39.110707.173451; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reznick D, 1996, AM ZOOL, V36, P147; Reznick D.N., 1989, ECOLOGY EVOLUTION LI, P373; Rombought P. J, 1997, GLOBAL WARMING IMPLI, P177, DOI DOI 10.1007/BF02523274; ROSEN DE, 1961, COPEIA, P201, DOI 10.2307/1439999; ROSENTHAL HAROLD L., 1955, COPEIA, V1955, P52, DOI 10.2307/1439454; ROSENTHAL HL, 1951, COPEIA, P304; Rowe DK, 2008, REV IMPACTS GAMBUSIA; Scrimshaw Nevin S., 1944, COPEIA, V1944, P180, DOI 10.2307/1437814; SCRIMSHAW NS, 1945, BIOL BULL, V88, P233, DOI 10.2307/1538312; Senior AM, 2013, INDIVIDUAL POPULATIO; Skold HN, 2008, HORM BEHAV, V54, P549, DOI 10.1016/j.yhbeh.2008.05.018; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Svensson PA, 2011, SKIN BIOPSY PERSPECT, P336; Thresher RE, 2013, ECOL APPL, V23, P801, DOI 10.1890/12-1324.1; Tiwari V, 2007, J ENV RES DEV, V1, P241; Toft G, 2003, ECOTOX ENVIRON SAFE, V56, P228, DOI 10.1016/S0147-6513(02)00138-0; Toft G, 2001, ECOTOX ENVIRON SAFE, V48, P76, DOI 10.1006/eesa.2000.1985; Urban J, 2012, J APPL ICHTHYOL, P1; Yasir I, 2009, J WORLD AQUACULT SOC, V40, P337, DOI 10.1111/j.1749-7345.2009.00254.x	59	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147711	10.1371/journal.pone.0147711	http://dx.doi.org/10.1371/journal.pone.0147711			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808521	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800190
J	Rasheed, H; McKinney, C; Stamp, LK; Dalbeth, N; Topless, RK; Day, R; Kannangara, D; Williams, K; Smith, M; Janssen, M; Jansen, TL; Joosten, LA; Radstake, TR; Riches, PL; Tausche, AK; Liote, F; Lu, L; Stahl, EA; Choi, HK; So, A; Merriman, TR				Rasheed, Humaira; McKinney, Cushla; Stamp, Lisa K.; Dalbeth, Nicola; Topless, Ruth K.; Day, Richard; Kannangara, Diluk; Williams, Kenneth; Smith, Malcolm; Janssen, Matthijs; Jansen, Tim L.; Joosten, Leo A.; Radstake, Timothy R.; Riches, Philip L.; Tausche, Anne-Kathrin; Liote, Frederic; Lu, Leo; Stahl, Eli A.; Choi, Hyon K.; So, Alexander; Merriman, Tony R.			The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets	PLOS ONE			English	Article							ASSOCIATION; DISEASE; SUSCEPTIBILITY; POLYMORPHISMS; ARTHRITIS; GENE	Deposition of crystallized monosodium urate (MSU) in joints as a result of hyperuricemia is a central risk factor for gout. However other factors must exist that control the progression from hyperuricaemia to gout. A previous genetic association study has implicated the toll-like receptor 4 (TLR4) which activates the NLRP3 inflammasome via the nuclear factor-kappa B signaling pathway upon stimulation by MSU crystals. The T-allele of single nucleotide polymorphism rs2149356 in TLR4 is a risk factor associated with gout in a Chinese study. Our aim was to replicate this observation in participants of European and New Zealand Polynesian (Maori and Pacific) ancestry. A total of 2250 clinically-ascertained prevalent gout cases and 13925 controls were used. Non-clinically-ascertained incident gout cases and controls from the Health Professional Follow-up (HPFS) and Nurses Health Studies (NHS) were also used. Genotypes were derived from genome-wide genotype data or directly obtained using Taqman. Logistic regression analysis was done including age, sex, diuretic exposure and ancestry as covariates as appropriate. The T-allele increased the risk of gout in the clinically-ascertained European samples (OR = 1.12, P = 0.012) and decreased the risk of gout in Polynesians (OR = 0.80, P = 0.011). There was no evidence for association in the HPFS or NHS sample sets. In conclusion TLR4 SNP rs2143956 associates with gout risk in prevalent clinically-ascertained gout in Europeans, in a direction consistent with previously published results in Han Chinese. However, with an opposite direction of association in Polynesians and no evidence for association in a non-clinically-ascertained incident gout cohort this variant should be analysed in other international gout genetic data sets to determine if there is genuine evidence for association.	[Rasheed, Humaira; McKinney, Cushla; Topless, Ruth K.; Merriman, Tony R.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Rasheed, Humaira] Univ Engn & Technol, Lahore, Pakistan; [Stamp, Lisa K.] Univ Otago, Dept Med, Christchurch, New Zealand; [Dalbeth, Nicola] Univ Auckland, Dept Med, Auckland 1, New Zealand; [Day, Richard; Kannangara, Diluk; Williams, Kenneth] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Day, Richard; Kannangara, Diluk; Williams, Kenneth] St Vincents Hosp, Dept Clin Pharmacol & Toxicol, Sydney, NSW 2010, Australia; [Smith, Malcolm] Flinders Med Ctr, Dept Med, Adelaide, SA, Australia; [Smith, Malcolm] Repatriat Gen Hosp, Adelaide, SA, Australia; [Janssen, Matthijs] Rijnstate Hosp, Dept Rheumatol, Arnhem, Netherlands; [Jansen, Tim L.] VieCuri Med Ctr, Dept IQ HealthCare, Venlo, Netherlands; [Joosten, Leo A.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Joosten, Leo A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Radstake, Timothy R.] Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Riches, Philip L.] Univ Edinburgh, Inst Genet & Mol Med, Rheumat Dis Unit, Edinburgh, Midlothian, Scotland; [Tausche, Anne-Kathrin] Univ Clin Carl Gustav Carus, Dept Rheumatol, Dresden, Germany; [Liote, Frederic] Hosp Lariboisiere, INSERM, UMR S 1132, Paris, France; [Liote, Frederic] Univ Paris Diderot, Sorbonne Paris Cite, UFR Med, Paris, France; [Lu, Leo; Choi, Hyon K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA USA; [Stahl, Eli A.] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [So, Alexander] Univ Lausanne, Lab Rheumatol, Serv Rheumatol, DAL,CHUV, Lausanne, Switzerland	University of Otago; University of Engineering & Technology Lahore; University of Otago; University of Auckland; University of New South Wales Sydney; St Vincents Hospital Sydney; Flinders Medical Centre; Flinders University South Australia; Rijnstate Hospital; VieCuri Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; University of Edinburgh; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Harvard Medical School; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Merriman, TR (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.		Liote, Frederic/AAD-6926-2020; Janssen, Matthijs/AAZ-2784-2020; Day, Richard/D-8699-2011; Jansen, Tim/ABE-8812-2020; McKinney, Cushla/A-7407-2012; Joosten, Leo AB/H-3138-2015	Day, Richard/0000-0002-6045-6937; McKinney, Cushla/0000-0002-7051-6876; Joosten, Leo AB/0000-0001-6166-9830; Liote, Frederic/0000-0003-4419-0726; Janssen, Matthijs/0000-0003-3752-7837	Health Research Council of New Zealand [11/1075, 14/527]; Arthritis New Zealand; New Zealand Lottery Health; University of Otago and Arthritis Australia; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C, UL1RR025005]; NIH Roadmap for Medical Research; National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University;  [N01-HC-55015];  [N01-HC-55016];  [N01-HC-55018];  [N01-HC-55019];  [N01-HC55020];  [N01-HC-55021];  [N01-HC-55022];  [R01HL087641];  [R01HL59367];  [R01HL086694]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055016, N01HC055019, N01HC055021, N01HC055020, N01HC055022, N01HC055018, N01HC055015] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086694, R01HL059367, R01HL087641] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR065968] Funding Source: NIH RePORTER	Health Research Council of New Zealand(Health Research Council of New Zealand); Arthritis New Zealand; New Zealand Lottery Health; University of Otago and Arthritis Australia; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; ; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Health Research Council of New Zealand (11/1075, 14/527), Arthritis New Zealand, New Zealand Lottery Health, the University of Otago and Arthritis Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Atherosclerosis Risk in Communities study is supported by contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. The Framingham Heart Study and the Framingham SHARe project are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University.	Bao Y, 2015, ANN RHEUM DIS, V74, P1394, DOI 10.1136/annrheumdis-2014-206534; Batt C, 2014, ANN RHEUM DIS, V73, P2101, DOI 10.1136/annrheumdis-2013-203600; Brand S, 2005, INFLAMM BOWEL DIS, V11, P645, DOI 10.1097/01.MIB.0000168372.94907.d2; Busso N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2952; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Hajishengallis G, 2011, NAT REV IMMUNOL, V11, P187, DOI 10.1038/nri2918; Hamajima N, 2012, GENE, V503, P131, DOI 10.1016/j.gene.2012.04.064; Hollis-Moffatt JE, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3816; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Liote F, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4348; Liu-Bryan R., 2011, GOUT OTHER CRYST ART, V2011, P59; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Merriman TR, 2014, RHEUM DIS CLIN N AM, V40, P279, DOI 10.1016/j.rdc.2014.01.009; Noreen M, 2012, INFLAMM RES, V61, P177, DOI 10.1007/s00011-011-0427-1; Phipps-Green AJ, 2016, ANN RHEUM DIS, V75, P124, DOI 10.1136/annrheumdis-2014-205877; Qing YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064845; Radstake TRDJ, 2004, ARTHRITIS RHEUM, V50, P999, DOI 10.1002/art.20114; Ragnarsdottir B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010734; Rasheed H, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4366; Urano W, 2013, J RHEUMATOL, V40, P1374, DOI 10.3899/jrheum.121244; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320	24	21	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147939	10.1371/journal.pone.0147939	http://dx.doi.org/10.1371/journal.pone.0147939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808548	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800247
J	Sae-Lee, C; Moolsuwan, K; Chan, L; Poungvarin, N				Sae-Lee, Chanachai; Moolsuwan, Kanya; Chan, Lawrence; Poungvarin, Naravat			ChREBP Regulates Itself and Metabolic Genes Implicated in Lipid Accumulation in beta-Cell Line	PLOS ONE			English	Article							CARBOHYDRATE RESPONSE ELEMENT; PYRUVATE-KINASE GENE; FATTY-ACID-SYNTHASE; THIOREDOXIN-INTERACTING PROTEIN; TRANSCRIPTION FACTOR; BINDING PROTEIN; GLUCOSE REGULATION; RAT HEPATOCYTES; S-14 GENE; EXPRESSION	Carbohydrate response element binding protein (ChREBP) is an important transcription factor that regulates a variety of glucose-responsive genes in hepatocytes. To date, only two natural isoforms, Chrebpa and Chrebp beta, have been identified. Although ChREBP is known to be expressed in pancreatic beta cells, most of the glucose-responsive genes have never been verified as ChREBP targets in this organ. We aimed to explore the impact of ChREBP expression on regulating genes linked to accumulation of lipid droplets, a typical feature of beta-cell glucotoxicity. We assessed gene expression in 832/13 cells overexpressing constitutively active ChREBP (caChREBP), truncated ChREBP with nearly identical amino acid sequence to Chrebp beta, or dominant negative ChREBP (dnChREBP). Among multiple ChREBP-controlled genes, ChREBP was sufficient and necessary for regulation of Eno1, Pklr, Mdh1, Me1, Pdha1, Acly, Acaca, Fasn, Elovl6, Gpd1, Cpt1a, Rgs16, Mid1ip1, Txnip, and Chrebp beta. Expression of Chrebpa and Srebp1c were not changed by caChREBP or dnChREBP. We identified functional ChREBP binding sequences that were located on the promoters of Chrebp beta and Rgs16. We also showed that Rgs16 overexpression lead to increased considerable amounts of lipids in 832/13 cells. This phenotype was accompanied by reduction of Cpt1a expression and slight induction of Fasn and Pklr gene in these cells. In summary, we conclude that Chrebp beta modulates its own expression, not that of Chrebpa; it also regulates the expression of several metabolic genes in beta-cells without affecting SREBP-1c dependent regulation. We also demonstrate that Rgs16 is one of the ChREBP-controlled genes that potentiate accumulation of lipid droplets in beta-cells.	[Sae-Lee, Chanachai; Moolsuwan, Kanya; Poungvarin, Naravat] Mahidol Univ, Fac Med, Siriraj Hosp, Clin Mol Pathol Lab,Dept Clin Pathol, Bangkok 10700, Thailand; [Moolsuwan, Kanya] Mahidol Univ, Fac Sci, Multidisciplinary Unit, Program Mol Med, Bangkok 10400, Thailand; [Chan, Lawrence] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Mahidol University; Mahidol University; Baylor College of Medicine	Poungvarin, N (corresponding author), Mahidol Univ, Fac Med, Siriraj Hosp, Clin Mol Pathol Lab,Dept Clin Pathol, Bangkok 10700, Thailand.	naravat@gmail.com		Sae-Lee, Chanachai/0000-0001-7758-7653	Siriraj research fund from Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand [R015433020]; National Science and Technology Development Agency (NSTDA), Thailand; National Institutes of Health [HL051586/DK105527, P30DK079638]; Rutherford Chair in Diabetes research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER	Siriraj research fund from Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand; National Science and Technology Development Agency (NSTDA), Thailand; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutherford Chair in Diabetes research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Siriraj research fund (R015433020) from Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand (NP) and Discovery-based Development Grant (DD Grant) from National Science and Technology Development Agency (NSTDA), Thailand (NP). It was supported in part by National Institutes of Health grants HL051586/DK105527 and P30DK079638 and the Rutherford Chair in Diabetes research to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aipoalani DL, 2010, ENDOCRINOLOGY, V151, P2071, DOI 10.1210/en.2009-1058; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; BERGOT MO, 1992, NUCLEIC ACIDS RES, V20, P1871, DOI 10.1093/nar/20.8.1871; da Silva XG, 2006, J LIPID RES, V47, P2482, DOI DOI 10.1194/JLR.M600289-JLR200; Das AT, 2004, J BIOL CHEM, V279, P18776, DOI 10.1074/jbc.M313895200; DECAUX JF, 1989, J BIOL CHEM, V264, P11584; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Hanke N, 2011, BBA-MOL CELL RES, V1813, P377, DOI 10.1016/j.bbamcr.2010.12.021; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2013, ENDOCR J, V60, P473; Iizuka K, 2011, BIOCHEM BIOPH RES CO, V412, P638, DOI 10.1016/j.bbrc.2011.08.016; Iizuka K, 2009, FEBS LETT, V583, P2882, DOI 10.1016/j.febslet.2009.07.053; Iizuka K, 2009, BIOCHEM BIOPH RES CO, V379, P499, DOI 10.1016/j.bbrc.2008.12.100; Iizuka K, 2008, BIOCHEM BIOPH RES CO, V374, P95, DOI 10.1016/j.bbrc.2008.06.101; Jeong YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022544; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Koo SH, 2000, J BIOL CHEM, V275, P5200, DOI 10.1074/jbc.275.7.5200; Li MV, 2008, MOL ENDOCRINOL, V22, P1658, DOI 10.1210/me.2007-0560; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; LIU ZR, 1993, J BIOL CHEM, V268, P12787; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Metukuri MR, 2012, DIABETES, V61, P2004, DOI 10.2337/db11-0802; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Mourrieras F, 1997, BIOCHEM J, V326, P345, DOI 10.1042/bj3260345; Myburgh R, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.58; O'Callaghan BL, 2001, J BIOL CHEM, V276, P16033, DOI 10.1074/jbc.M101557200; Park MJ, 2014, J HEPATOL, V61, P1151, DOI 10.1016/j.jhep.2014.06.032; Pashkov V, 2011, J BIOL CHEM, V286, P15116, DOI 10.1074/jbc.M110.216234; Pedersen KB, 2007, AM J PHYSIOL-ENDOC M, V292, pE788, DOI 10.1152/ajpendo.00510.2006; Pedersen KB, 2010, BIOCHEM J, V426, P159, DOI 10.1042/BJ20091266; Poungvarin N, 2012, DIABETOLOGIA, V55, P1783, DOI 10.1007/s00125-012-2506-4; Poungvarin N, 2015, ENDOCRINOLOGY, V156, P1982, DOI 10.1210/en.2014-1666; PRIPBUUS C, 1995, EUR J BIOCHEM, V230, P309, DOI 10.1111/j.1432-1033.1995.tb20564.x; Roche E, 1998, DIABETES, V47, P1086, DOI 10.2337/diabetes.47.7.1086; Rufo C, 2001, J BIOL CHEM, V276, P21969, DOI 10.1074/jbc.M100461200; SHIH HM, 1995, J BIOL CHEM, V270, P21991, DOI 10.1074/jbc.270.37.21991; SHIH HM, 1994, J BIOL CHEM, V269, P9380; Tsatsos NG, 2006, BIOCHEM BIOPH RES CO, V340, P449, DOI 10.1016/j.bbrc.2005.12.029; Tsatsos NG, 2008, ENDOCRINOLOGY, V149, P5155, DOI 10.1210/en.2008-0215; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Villasenor A, 2010, DIS MODEL MECH, V3, P567, DOI 10.1242/dmm.003210; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wang HY, 2003, J BIOL CHEM, V278, P16622, DOI 10.1074/jbc.M212488200; Wutthisathapornchai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102730; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Zhang P, 2015, DIABETES	48	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147411	10.1371/journal.pone.0147411	http://dx.doi.org/10.1371/journal.pone.0147411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808438	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800091
J	Wang, DM; Meng, MC; Guo, Y				Wang, De-Ming; Meng, Mei-Cen; Guo, Yun			Pollen Organ Telangiopsis sp of Late Devonian Seed Plant and Associated Vegetative Frond	PLOS ONE			English	Article							SP NOV.; RECONSTRUCTION; PTERIDOSPERM; AFFINITIES; CUPULATE; GEN.	Pollen organ Telangiopsis sp., associated with but not attached to vegetative fronds, has been collected from the Upper Devonian (Famennian) Wutong Formation, Dongzhi County, Anhui Province, China. Fertile axes with terminal pollen organs are dichotomous for 2-4 times and may be proximally attached by fragmentary pinnules. Pollen organs are synangiate and borne on the top of a short stalk. Synangia are radial in symmetry and each consists of 4-8 elongate microsporangia fused at base. Microsporangia have a longitudinal dehiscence line and show a tapered apex. The associated stem is spiny and bears a vegetative frond which bifurcates once at the basalmost part. Frond rachises possess one order of pinna arranged alternately. Pinnules are borne alternately, planate, highly dissected, and equally dichotomous for 2-3 times. Comparisons among Late Devonian seed plants recognize several branching patterns in the fertile fronds/axes bearing terminal pollen organs. Telangiopsis sp. reinforces that the Late Devonian pollen organs are synangiate usually with basally fused microsporangia. It is suggested that the evolutionary divergence of radial and bilateral symmetries of pollen organs may have occurred in the Famennian, when the earliest seed plants evolved planate and sometimes laminate pinnules.	[Wang, De-Ming] Peking Univ, Key Lab Orogen Belts & Crustal Evolut, Dept Geol, Beijing 100871, Peoples R China; [Meng, Mei-Cen] China Sci Publishing & Media Ltd, Sci Press, 16 Donghuangchenggen North St, Beijing 100717, Peoples R China; [Guo, Yun] Yunnan Univ, Dept Geol, Sch Resource Environm & Earth Sci, Kunming 650091, Yunnan Province, Peoples R China	Peking University; Yunnan University	Wang, DM (corresponding author), Peking Univ, Key Lab Orogen Belts & Crustal Evolut, Dept Geol, Beijing 100871, Peoples R China.	dmwang@pku.edu.cn			National Basic Research Program of China of the Ministry of Science and Technology of China [2012CB821900]; National Natural Science Foundation of China [41402023, 41302014]	National Basic Research Program of China of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Basic Research Program of China of the Ministry of Science and Technology of China (http://www.973.gov.cn/Default_3.aspx, no. 2012CB821900), and the National Natural Science Foundation of China (http://www.nsfc.gov.cn/, no. 41402023 and no. 41302014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, ORIGIN EVOLUTION GYM; [Anonymous], [No title captured]; Cressler WL, 2010, INT J COAL GEOL, V83, P91, DOI 10.1016/j.coal.2009.10.002; EGGERT DA, 1971, BOT GAZ, V132, P30, DOI 10.1086/336559; Galtier J, 1998, T ROY SOC EDIN-EARTH, V88, P197; Guo Y, 2009, ACTA GEOL SIN-ENGL, V83, P479, DOI 10.1111/j.1755-6724.2009.00069.x; Hilton J, 1999, BOT J LINN SOC, V129, P1; Hilton J, 2006, REV PALAEOBOT PALYNO, V142, P137, DOI 10.1016/j.revpalbo.2006.03.022; JENNINGS JR, 1976, AM J BOT, V63, P1119, DOI 10.2307/2441657; Klavins SD, 1996, REV PALAEOBOT PALYNO, V93, P253, DOI 10.1016/0034-6667(95)00129-8; Li X.X., 1984, BULLETION CHINESE AC, P119; Matten Lawrence C., 1994, Palaeontographica Abteilung B Palaeophytologie, V232, P15; Meyer-Berthaud B., 1989, PALAEONTOGR ABT B, V211, P87; MEYERBERTHAUD B, 1986, REV PALAEOBOT PALYNO, V48, P181, DOI 10.1016/0034-6667(86)90058-8; MILLAY MA, 1979, BOT REV, V45, P301, DOI 10.1007/BF02860858; Orlova OA, 2009, PALEONTOL J+, V43, P1316, DOI 10.1134/S003103010910013X; Ouyang S., 2000, J STRATIGR, V3, P230; Prestianni C, 2013, INT J PLANT SCI, V174, P832, DOI 10.1086/670235; Rothwell G. W, 1988, ORIGIN EVOLUTION GYM, P85; ROWE NP, 1988, BOT J LINN SOC, V97, P125, DOI 10.1111/j.1095-8339.1988.tb02457.x; SERBET R, 1992, INT J PLANT SCI, V153, P602, DOI 10.1086/297083; Shadle Gary L, 1975, Am J Bot, V62, P67, DOI 10.1002/j.1537-2197.1975.tb12339.x; SKOG JE, 1980, AM J BOT, V67, P440, DOI 10.2307/2442283; Taylor T.N., 1988, ORIGIN EVOLUTION GYM, P177; TAYLOR TN, 1982, BIOSCIENCE, V32, P23, DOI 10.2307/1308750; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P1; TAYLOR TN, 1981, REV PALAEOBOT PALYNO, V32, P27, DOI 10.1016/0034-6667(81)90074-9; Wang DM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1613; Wang DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep10736; Wang DM, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0292-6; Wang DM, 2014, NATURWISSENSCHAFTEN, V101, P615, DOI 10.1007/s00114-014-1187-x; Wang Y, 2000, ACTA PALAEONTOL SIN, V39, P42	32	16	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147984	10.1371/journal.pone.0147984	http://dx.doi.org/10.1371/journal.pone.0147984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808271	gold, Green Submitted, Green Published			2022-12-26	WOS:000369527800257
J	Yang, L; He, CQ; Pang, MYC				Yang, Lei; He, Chengqi; Pang, Marco Yiu Chung			Reliability and Validity of Dual-Task Mobility Assessments in People with Chronic Stroke	PLOS ONE			English	Article							COGNITIVE-MOTOR INTERFERENCE; TEST-RETEST RELIABILITY; PREDICTING FALLS; OLDER-ADULTS; WALKING; GAIT; BALANCE; PERFORMANCE; INDIVIDUALS; IMPAIRMENT	Background The ability to perform a cognitive task while walking simultaneously (dual-tasking) is important in real life. However, the psychometric properties of dual-task walking tests have not been well established in stroke. Objective To assess the test-retest reliability, concurrent and known-groups validity of various dual-task walking tests in people with chronic stroke. Design Observational measurement study with a test-retest design. Methods Eighty-eight individuals with chronic stroke participated. The testing protocol involved four walking tasks (walking forward at self-selected and maximal speed, walking backward at self-selected speed, and crossing over obstacles) performed simultaneously with each of the three attention-demanding tasks (verbal fluency, serial 3 subtractions or carrying a cup of water). For each dual-task condition, the time taken to complete the walking task, the correct response rate (CRR) of the cognitive task, and the dual-task effect (DTE) for the walking time and CRR were calculated. Forty-six of the participants were tested twice within 3-4 days to establish test-retest reliability. Results The walking time in various dual-task assessments demonstrated good to excellent reliability [Intraclass correlation coefficient (ICC2,1) = 0.70-0.93; relative minimal detectable change at 95% confidence level (MDC95%) = 29%-45%]. The reliability of the CRR (ICC2,1 = 0.58-0.81) and the DTE in walking time (ICC2,1 = 0.11-0.80) was more varied. The reliability of the DTE in CRR (ICC2,1 = -0.31-0.40) was poor to fair. The walking time and CRR obtained in various dual-task walking tests were moderately to strongly correlated with those of the dual-task Timed-up-and-Go test, thus demonstrating good concurrent validity. None of the tests could discriminate fallers (those who had sustained at least one fall in the past year) from non-fallers. Limitation The results are generalizable to community-dwelling individuals with chronic stroke only. Conclusions The walking time derived from the various dual-task assessments generally demonstrated good to excellent reliability, making them potentially useful in clinical practice and future research endeavors. However, the usefulness of these measurements in predicting falls needs to be further explored. Relatively low reliability was shown in the cognitive outcomes and DTE, which may not be preferred measurements for assessing dual-task performance.	[Yang, Lei; He, Chengqi] Sichuan Univ, West China Hosp, Dept Rehabil Med, Chengdu 610064, Sichuan Provinc, Peoples R China; [Yang, Lei] Hong Kong Polytech Univ, Sichuan Univ, Inst Disaster Management & Reconstruct, Chengdu, Sichuan, Peoples R China; [Yang, Lei; Pang, Marco Yiu Chung] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China	Sichuan University; Hong Kong Polytechnic University; Sichuan University; Hong Kong Polytechnic University	Pang, MYC (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China.	Marco.Pang@polyu.edu.hk		Pang, Marco Yiu Chung/0000-0003-1652-8945	Institute of Disaster Management and Reconstruction, Sichuan University; Hong Kong Polytechnic University, Chengdu, Sichuan, China [RTHV]	Institute of Disaster Management and Reconstruction, Sichuan University; Hong Kong Polytechnic University, Chengdu, Sichuan, China	This work was funded by Institute of Disaster Management and Reconstruction, Sichuan University - The Hong Kong Polytechnic University, Chengdu, Sichuan, China (Grant number: RTHV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Andersson AG, 2006, J REHABIL MED, V38, P186, DOI 10.1080/16501970500478023; Beauchet O, 2008, J AM GERIATR SOC, V56, P1265, DOI 10.1111/j.1532-5415.2008.01766.x; Beauchet O, 2007, AGE AGEING, V36, P418, DOI 10.1093/ageing/afm011; Berger L, 2011, GAIT POSTURE, V33, P300, DOI 10.1016/j.gaitpost.2010.10.082; Cho KH, 2015, DISABIL REHABIL, V37, P512, DOI 10.3109/09638288.2014.932445; Divani AA, 2009, STROKE, V40, P3286, DOI 10.1161/STROKEAHA.109.559195; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; FLEISS JL, 1981, APPL PSYCH MEAS, V5, P105, DOI 10.1177/014662168100500115; Fuller RL, 2013, PARKINSONISM RELAT D, V19, P325, DOI 10.1016/j.parkreldis.2012.11.011; GOWLAND C, 1993, STROKE, V24, P58, DOI 10.1161/01.STR.24.1.58; Harley C, 2006, J NEUROL NEUROSUR PS, V77, P674, DOI 10.1136/jnnp.2005.074138; Harris JE, 2005, PHYS THER, V85, P150, DOI 10.1093/ptj/85.2.150; Hars M, 2013, GAIT POSTURE, V38, P1010, DOI 10.1016/j.gaitpost.2013.05.015; Hofheinz M, 2010, CLIN REHABIL, V24, P831, DOI 10.1177/0269215510367993; Hollman JH, 2010, GAIT POSTURE, V32, P23, DOI 10.1016/j.gaitpost.2010.02.017; Hsu PC, 2006, DISABIL REHABIL, V28, P1287, DOI 10.1080/09638280600638414; Hyndman D, 2006, DISABIL REHABIL, V28, P849, DOI 10.1080/09638280500534994; Hyndman D, 2004, J NEUROL NEUROSUR PS, V75, P994, DOI 10.1136/jnnp.2003.016014; Jorgensen L, 2002, STROKE, V33, P542, DOI 10.1161/hs0202.102375; Kelly VE, 2010, EXP BRAIN RES, V207, P65, DOI 10.1007/s00221-010-2429-6; Mak MK, 2007, ARCH PHYS MED REHAB, V88, P496, DOI 10.1016/j.apmr.2007.01.018; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; McCulloch KL, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932010-00002; Muhaidat J, 2014, ARCH PHYS MED REHAB, V95, P58, DOI 10.1016/j.apmr.2013.07.027; Muhaidat J, 2013, GAIT POSTURE, V38, P43, DOI 10.1016/j.gaitpost.2012.10.011; Nordin E, 2010, GAIT POSTURE, V32, P92, DOI 10.1016/j.gaitpost.2010.03.012; Patel P, 2014, NEUROSCIENCE, V260, P140, DOI 10.1016/j.neuroscience.2013.12.016; Patel P, 2014, TOP STROKE REHABIL, V21, P347, DOI 10.1310/tsr2104-347; Plummer P, 2013, ARCH PHYS MED REHAB, V94, P2565, DOI 10.1016/j.apmr.2013.08.002; Plummer-D'Amato P, 2008, GAIT POSTURE, V27, P683, DOI 10.1016/j.gaitpost.2007.09.001; Plummer-D'Amato P, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-129; Remaud A, 2013, EXP BRAIN RES, V231, P219, DOI 10.1007/s00221-013-3684-0; Said CM, 2013, PHYS THER, V93, P334, DOI 10.2522/ptj.20120200; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; Takatori Katsuhiko, 2012, Physiotherapy Theory and Practice, V28, P292, DOI 10.3109/09593985.2011.600424; Tang PF, 2015, GERIATR GERONTOL INT, V15, P204, DOI 10.1111/ggi.12258; Tsang CSL, 2013, PHYS THER, V93, P1102, DOI 10.2522/ptj.20120454; Verghese J, 2002, J AM GERIATR SOC, V50, P1572, DOI 10.1046/j.1532-5415.2002.50415.x; Wong A, 2009, DEMENT GERIATR COGN, V28, P81, DOI 10.1159/000232589; Wong MTP, 2002, INT J GERIATR PSYCH, V17, P459, DOI 10.1002/gps.633; Yang L, 2015, MATURITAS, V80, P359, DOI 10.1016/j.maturitas.2015.01.001	44	74	79	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147833	10.1371/journal.pone.0147833	http://dx.doi.org/10.1371/journal.pone.0147833			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808662	gold, Green Submitted, Green Published			2022-12-26	WOS:000369527800220
J	Tumiati, M; Munne, PM; Edgren, H; Eldfors, S; Hemmes, A; Kuznetsov, SG				Tumiati, M.; Munne, P. M.; Edgren, H.; Eldfors, S.; Hemmes, A.; Kuznetsov, S. G.			Rad51c- and Trp53-double-mutant mouse model reveals common features of homologous recombination-deficient breast cancers	ONCOGENE			English	Article							MAMMARY-TUMORS; P53; GENE; BRCA1; REPAIR; CELLS; IDENTIFICATION; TUMORIGENESIS; RESISTANCE; SYNERGIZES	Almost half of all hereditary breast cancers (BCs) are associated with germ-line mutations in homologous recombination (HR) genes. However, the tumor phenotypes associated with different HR genes vary, making it difficult to define the role of HR in BC predisposition. To distinguish between HR-dependent and -independent features of BCs, we generated a mouse model in which an essential HR gene, Rad51c, is knocked-out specifically in epidermal tissues. Rad51c is one of the key mediators of HR and a well-known BC predisposition gene. Here, we demonstrate that deletion of Rad51c invariably requires inactivation of the Trp53 tumor suppressor (TP53 in humans) to produce mammary carcinomas in 63% of female mice. Nonetheless, loss of Rad51c shortens the latency of Trp53-deficient mouse tumors from 11 to 6 months. Remarkably, the histopathological features of Rad51c-deficient mammary carcinomas, such as expression of hormone receptors and luminal epithelial markers, faithfully recapitulate the histopathology of human RAD51C-mutated BCs. Similar to other BC models, Rad51c/p53 double-mutant mouse mammary tumors also reveal a propensity for genomic instability, but lack the focal amplification of the Met locus or distinct mutational signatures reported for other HR genes. Using the human mammary epithelial cell line MCF10A, we show that deletion of TP53 can rescue RAD51C-deficient cells from radiation-induced cellular senescence, whereas it exacerbates their centrosome amplification and nuclear abnormalities. Altogether, our data indicate that a trend for genomic instability and inactivation of Trp53 are common features of HR-mediated BCs, whereas histopathology and somatic mutation patterns are specific for different HR genes.	[Tumiati, M.; Munne, P. M.; Edgren, H.; Eldfors, S.; Hemmes, A.; Kuznetsov, S. G.] Univ Helsinki, Inst Mol Med Finland FIMM, Biomed Helsinki 2U,Room E303b,Tukholmankatu 8, FIN-00290 Helsinki, Finland; [Edgren, H.] MediSapiens Ltd, Erottajankatu 19B, Helsinki, Finland	University of Helsinki	Kuznetsov, SG (corresponding author), Univ Helsinki, Inst Mol Med Finland FIMM, Biomed Helsinki 2U,Room E303b,Tukholmankatu 8, FIN-00290 Helsinki, Finland.	sergey.kuznetsov@helsinki.fi	Munne, Pauliina/M-8629-2015; Eldfors, Samuli/AAB-3029-2019	Munne, Pauliina/0000-0002-9720-9964; Eldfors, Samuli/0000-0001-5056-4750; Kuznetsov, Sergey/0000-0002-5662-9700; Tumiati, Manuela/0000-0003-4889-3445	Academy of Finland; Finnish Medical Foundation; Sigrid Juselius Foundation; Cancer Society of Finland; Biocenter Finland; Helsinki Doctoral Program in Biomedicine (DPBM)	Academy of Finland(Academy of Finland); Finnish Medical Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland; Biocenter Finland; Helsinki Doctoral Program in Biomedicine (DPBM)	We thank Pekka Ellonen, Maija Lepisto, Sonja Lagstrom, and the rest of the FIMM sequencing unit for advice and sequencing of tumor samples, the pathology unit of the Haartman Institute for histology services, Sami Blom and Dr Johan Lundin for scanning histological slides. We are grateful to Dr Shyam Sharan and Dr Madalena Tarsounas for providing critical comments on the manuscript. Financial support for the project was provided to SGK by the Academy of Finland, Finnish Medical Foundation, Sigrid Juselius Foundation, Cancer Society of Finland, and Biocenter Finland. MT was supported by a fellowship from the Helsinki Doctoral Program in Biomedicine (DPBM), and the Academy of Finland.	Arnes JB, 2005, CLIN CANCER RES, V11, P4003, DOI 10.1158/1078-0432.CCR-04-2064; Badie S, 2010, NAT STRUCT MOL BIOL, V17, P1461, DOI 10.1038/nsmb.1943; Badie S, 2009, J CELL BIOL, V185, P587, DOI 10.1083/jcb.200811079; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Bowman-Colin C, 2013, P NATL ACAD SCI USA, V110, P8632, DOI 10.1073/pnas.1305362110; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Chun J, 2013, MOL CELL BIOL, V33, P387, DOI 10.1128/MCB.00465-12; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dosanjh MK, 1998, NUCLEIC ACIDS RES, V26, P1179, DOI 10.1093/nar/26.5.1179; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Foulkes WD, 2004, J MED GENET, V41, P1, DOI 10.1136/jmg.2003.013805; Francis JC, 2015, J PATHOL, V236, P186, DOI 10.1002/path.4517; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Gevensleben H, 2014, VIRCHOWS ARCH, V465, P365, DOI 10.1007/s00428-014-1619-1; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jaspers JE, 2013, CANCER DISCOV, V3, P68, DOI 10.1158/2159-8290.CD-12-0049; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Katsura M, 2009, NUCLEIC ACIDS RES, V37, P3959, DOI 10.1093/nar/gkp262; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Knight JF, 2013, P NATL ACAD SCI USA, V110, pE1301, DOI 10.1073/pnas.1210353110; Kuznetsov S, 2007, J CELL BIOL, V176, P581, DOI 10.1083/jcb.200608130; Kuznetsov SG, 2009, CANCER RES, V69, P863, DOI 10.1158/0008-5472.CAN-08-3057; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; Lindh AR, 2007, CYTOGENET GENOME RES, V116, P38, DOI 10.1159/000097416; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Milner J, 1997, NATURE, V386, P772, DOI 10.1038/386772a0; Munne PM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04663; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Olivares-Illana V, 2010, ONCOGENE, V29, P5113, DOI 10.1038/onc.2010.266; Olopade OI, 2008, CLIN CANCER RES, V14, P7988, DOI 10.1158/1078-0432.CCR-08-1211; Oplustilova L, 2012, CELL CYCLE, V11, P3837, DOI 10.4161/cc.22026; Osorio A, 2012, HUM MOL GENET, V21, P2889, DOI 10.1093/hmg/dds115; Rodrigue A, 2013, J CELL SCI, V126, P348, DOI 10.1242/jcs.114595; Smolen GA, 2006, CANCER RES, V66, P3452, DOI 10.1158/0008-5472.CAN-05-4181; Somyajit K, 2012, J BIOL CHEM, V287, P3366, DOI 10.1074/jbc.M111.311241; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Tacconi EMC, 2015, CHROMOSOMA, V124, P119, DOI 10.1007/s00412-014-0497-2; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Tumiati M, 2015, J PATHOL, V235, P136, DOI 10.1002/path.4455; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018	49	4	4	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 1	2016	35	35					4601	4610		10.1038/onc.2015.528	http://dx.doi.org/10.1038/onc.2015.528			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU6PE	26820992				2022-12-26	WOS:000382336300006
J	Yoon, PO; Park, JW; Lee, CM; Kim, SH; Kim, HN; Ko, Y; Bae, SJ; Yun, S; Park, JH; Kwon, T; Kim, WS; Lee, J; Lu, Q; Kang, HR; Cho, WK; Elias, JA; Yang, JS; Park, HO; Lee, K; Lee, CG				Yoon, Pyoung Oh; Park, Jin Wook; Lee, Chang-Min; Kim, Sung Hwan; Kim, Han-Na; Ko, Youngho; Bae, Seon Joo; Yun, Sungil; Park, Jun Hong; Kwon, Taewoo; Kim, Woo Seok; Lee, Jiyoung; Lu, Qing; Kang, Hye-Ryun; Cho, Won-Kyung; Elias, Jack A.; Yang, Joo-Sung; Park, Han-Oh; Lee, Kyuhong; Lee, Chun Geun			Self-assembled Micelle Interfering RNA for Effective and Safe Targeting of Dysregulated Genes in Pulmonary Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						connective tissue growth factor (CTGF); cytokine; fibrosis; pulmonary fibrosis; siRNA; amphiregulin	GROWTH-FACTOR-BETA; IN-VIVO; SIRNA DELIVERY; LUNG FIBROSIS; EPITHELIAL-CELLS; FACTOR RECEPTOR; TGF-BETA; RAT; THERAPEUTICS; NANOPARTICLES	The siRNA silencing approach has long been used as a method to regulate the expression of specific target genes in vitro and in vivo. However, the effectiveness of delivery and the nonspecific immune-stimulatory function of siRNA are the limiting factors for therapeutic applications of siRNAs. To overcome these limitations, we developed self-assembled micelle inhibitory RNA (SAMiRNA) nanoparticles made of individually biconjugated siRNAs with a hydrophilic polymer and lipid on their ends and characterized their stability, immune-stimulatory function, and in vivo silencing efficacy. SAMiRNAs form very stable nanoparticles with no significant degradation in size distribution and polydispersity index over 1 year. Overnight incubation of SAMiRNAs (3 m) on murine peripheral blood mononuclear cells did not cause any significant elaboration of innate immune cytokines such as TNF-, IL-12, or IL-6, whereas unmodified siRNAs or liposomes or liposome complexes significantly stimulated the expression of these cytokines. Last, the in vivo silencing efficacy of SAMiRNAs was evaluated by targeting amphiregulin and connective tissue growth factor in bleomycin or TGF- transgenic animal models of pulmonary fibrosis. Intratracheal or intravenous delivery two or three times of amphiregulin or connective tissue growth factor SAMiRNAs significantly reduced the bleomycin- or TGF--stimulated collagen accumulation in the lung and substantially restored the lung function of TGF- transgenic mice. This study demonstrates that SAMiRNA nanoparticle is a less toxic, stable siRNA silencing platform for efficient in vivo targeting of genes implicated in the pathogenesis of pulmonary fibrosis.	[Yoon, Pyoung Oh; Kim, Han-Na; Ko, Youngho; Bae, Seon Joo; Yun, Sungil; Park, Jun Hong; Kwon, Taewoo; Kim, Woo Seok; Lee, Jiyoung; Yang, Joo-Sung; Park, Han-Oh] Bioneer Corp, Daejeon 306220, South Korea; [Park, Jin Wook; Lee, Chang-Min; Elias, Jack A.; Lee, Chun Geun] Brown Univ, Alpert Med Sch, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; [Lu, Qing; Cho, Won-Kyung] Brown Univ, Alpert Med Sch, Dept Med, Providence, RI 02912 USA; [Kim, Sung Hwan; Lee, Kyuhong] Korea Inst Toxicol, Inhalat Toxicol Ctr, Jeongeup Campus, Jeollabuk Do 580185, South Korea; [Kang, Hye-Ryun] Seoul Natl Univ Hosp, Dept Internal Med, Div Allergy & Clin Immunol, Seoul 110744, South Korea	Brown University; Brown University; Korea Institute of Toxicology; Seoul National University (SNU); Seoul National University Hospital	Lee, CG (corresponding author), Brown Univ, Alpert Med Sch, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA.; Lee, K (corresponding author), Korea Inst Toxicol, Inhalat Toxicol Ctr, Jeongeup Campus, Jeollabuk Do 580185, South Korea.	khlee@kitox.re.kr; chun_lee@brown.edu	Lee, Chun Geun/AAC-2838-2021	Lee, Chun Geun/0000-0002-9514-3658; Cho, Won-Kyung/0000-0003-1540-545X	National Institutes of Health [RO1-HL115813, PO1-HL114501]; Korea Drug Development Fund - Ministry of Science, ICT and Future Planning, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare Republic of Korea [201312-11]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130230, R01HL115813, P01HL114501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Drug Development Fund - Ministry of Science, ICT and Future Planning, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare Republic of Korea; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants RO1-HL115813 (to C. G. L.) and PO1-HL114501 (to J. A. E.) and Korea Drug Development Fund Grant 201312-11 funded by the Ministry of Science, ICT and Future Planning, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare Republic of Korea (to P. O. Y. and C. G. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barik S, 2005, J MOL MED, V83, P764, DOI 10.1007/s00109-005-0690-0; Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; BOTTEGA R, 1992, BIOCHEMISTRY-US, V31, P9025, DOI 10.1021/bi00152a045; BUNDSCHUH DS, 1995, IN VITRO CELL DEV-AN, V31, P684; Falsini S, 2014, J MED CHEM, V57, P1138, DOI 10.1021/jm400791q; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Gunther M, 2011, EUR J PHARM BIOPHARM, V77, P438, DOI 10.1016/j.ejpb.2010.11.007; Huang YY, 2011, MOL THER, V19, P381, DOI 10.1038/mt.2010.266; Izumi S, 2014, NEW ENGL J MED, V371, P781, DOI 10.1056/NEJMc1407776; Jeong JH, 2003, J CONTROL RELEASE, V93, P183, DOI 10.1016/j.jconrel.2003.07.002; Jeong JH, 2009, BIOCONJUGATE CHEM, V20, P5, DOI 10.1021/bc800278e; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kang HR, 2007, J EXP MED, V204, P1083, DOI 10.1084/jem.20061273; Kang Hye-Ryun, 2008, Expert Rev Clin Pharmacol, V1, P547, DOI 10.1586/17512433.1.4.547; Kelly M, 2003, CURR PHARM DESIGN, V9, P39, DOI 10.2174/1381612033392341; Kesharwani P, 2012, BIOMATERIALS, V33, P7138, DOI 10.1016/j.biomaterials.2012.06.068; Khalil N, 1996, AM J RESP CELL MOL, V14, P131, DOI 10.1165/ajrcmb.14.2.8630262; Khalil N, 2001, THORAX, V56, P907, DOI 10.1136/thorax.56.12.907; Kim JS, 2010, LAB ANIM-UK, V44, P20, DOI 10.1258/la.2009.009003; Kim SN, 2010, TOX RESEARCH, V26, P217, DOI 10.5487/TR.2010.26.3.217; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Krein PM, 2002, CHEST, V122, p289S, DOI 10.1378/chest.122.6_suppl.289S; Layzer JM, 2004, RNA, V10, P766, DOI 10.1261/rna.5239604; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Lee H, 2012, NAT NANOTECHNOL, V7, P389, DOI [10.1038/nnano.2012.73, 10.1038/NNANO.2012.73]; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Maeda H, 2010, BIOCONJUGATE CHEM, V21, P797, DOI 10.1021/bc100070g; Maurer N, 2001, BIOPHYS J, V80, P2310, DOI 10.1016/S0006-3495(01)76202-9; Nakao A, 1999, J CLIN INVEST, V104, P5, DOI 10.1172/JCI6094; Nguyen DN, 2012, P NATL ACAD SCI USA, V109, pE797, DOI 10.1073/pnas.1121423109; Opalinska JB, 2002, NAT REV DRUG DISCOV, V1, P503, DOI 10.1038/nrd837; Ponticos M, 2009, ARTHRITIS RHEUM-US, V60, P2142, DOI 10.1002/art.24620; Raghu G., 1998, FISHMANS PULMONARY D, P1037; Rayego-Mateos S, 2013, J MOL CELL BIOL, V5, P323, DOI 10.1093/jmcb/mjt030; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Robbins M, 2009, OLIGONUCLEOTIDES, V19, P89, DOI 10.1089/oli.2009.0180; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Sohn MH, 2010, AM J RESP CRIT CARE, V182, P918, DOI 10.1164/rccm.200912-1793OC; Viel T, 2008, OLIGONUCLEOTIDES, V18, P201, DOI 10.1089/oli.2008.0133; Wang QJ, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-4; Watts JK, 2008, DRUG DISCOV TODAY, V13, P842, DOI 10.1016/j.drudis.2008.05.007; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Xu YD, 2003, AM J PHYSIOL-LUNG C, V285, pL527, DOI 10.1152/ajplung.00298.2002; Yehualaeshet T, 2000, AM J RESP CELL MOL, V23, P204, DOI 10.1165/ajrcmb.23.2.4089; Zhang SB, 2012, J DRUG TARGET, V20, P724, DOI 10.3109/1061186X.2012.719232; Zhou Y, 2012, J BIOL CHEM, V287, P41991, DOI 10.1074/jbc.M112.356824	48	29	30	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6433	6446		10.1074/jbc.M115.693671	http://dx.doi.org/10.1074/jbc.M115.693671			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26817844	hybrid, Green Published			2022-12-26	WOS:000372894200031
J	Lien, RY; Yu, MH; Hsu, KH; Liao, PJ; Chen, YP; Lai, CC; Wu, WC				Lien, Reyin; Yu, Mu-Hsien; Hsu, Kuang-Hung; Liao, Pei-Ju; Chen, Yen-Po; Lai, Chi-Chun; Wu, Wei-Chi			Neurodevelopmental Outcomes in Infants with Retinopathy of Prematurity and Bevacizumab Treatment	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROLIFERATIVE DIABETIC-RETINOPATHY; MACULAR EDEMA SECONDARY; RETINAL VEIN OCCLUSION; INTRAVITREAL BEVACIZUMAB; VITREOUS HEMORRHAGE; AVASTIN; INJECTION; THERAPY; TRIAL	Purpose The current study aims to investigate the neurodevelopment of premature infants after intravitreal injections of bevacizumab (IVB) for the treatment of retinopathy of prematurity (ROP) up to the age of 2 years. Methods The study design was retrospective observational case series conducted at an institutional referral center. Infants with type 1 ROP were classified into 3 groups: laser only, IVB only, and a combination of IVB and laser treatment. Main Outcome Measures were neurodevelopmental outcomes of the patients after treatment were assessed by Bayley Scales for Infant Development. Results Sixty-one patients who finished the neurodevelopmental survey were included. No detrimental effects on neurodevelopment were found in IVB group compared with the patients who received laser treatment only. The patients in the IVB + laser group had a higher incidence of significant mental (p = 0.028) and psychomotor (p = 0.002) impairment at 24 months than the patients in the laser group. The odds ratio of having severe psychomotor defects in the IVB + laser group was 5.3 compared with the laser group (p = 0.041). The causal source for the differences that were detected remained unknown due to lack of randomization in the study and accompanying bias in patient selection. Conclusions Two years after laser and/or intravitreal injections of bevacizumab for infants with retinopathy of prematurity, no difference on neurodevelopment for those who received only bevacizumab versus only laser treatment were found. Those infants who required rescue therapy with laser or bevacizumab injection after initial, unsuccessful treatment showed some detrimental, neurodevelopmental effects.	[Lien, Reyin; Yu, Mu-Hsien] Chang Gung Mem Hosp, Dept Pediat, Div Neonatol, Taoyuan, Taiwan; [Lien, Reyin; Chen, Yen-Po; Lai, Chi-Chun; Wu, Wei-Chi] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Hsu, Kuang-Hung; Liao, Pei-Ju] Chang Gung Univ, Dept Hlth Care Management, Lab Epidemiol, Taoyuan, Taiwan; [Liao, Pei-Ju] Oriental Inst Technol, Dept Hlth Care Adm, New Taipei, Taiwan; [Liao, Pei-Ju] Natl Taiwan Univ, Dept Business Adm, Taipei 10764, Taiwan; [Chen, Yen-Po; Lai, Chi-Chun; Wu, Wei-Chi] Chang Gung Mem Hosp, Dept Ophthalmol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Asia Eastern University of Science & Technology; National Taiwan University; Chang Gung Memorial Hospital	Wu, WC (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Wu, WC (corresponding author), Chang Gung Mem Hosp, Dept Ophthalmol, Taoyuan, Taiwan.	weichi666@gmail.com		Hsu, Kuang-Hung/0000-0003-2642-7689; Lai, Chi-Chun/0000-0001-9547-7212	Ministry of Science and Technology, Taipei, Taiwan [NSC101-2314-B-182A-055-MY3, MOST104-2314-B-182A-100-MY2]; Chang Gung Memorial Hospital, Taoyuan, Taiwan [CMRPG3D0251, CMRPG3D0522]	Ministry of Science and Technology, Taipei, Taiwan; Chang Gung Memorial Hospital, Taoyuan, Taiwan(Chang Gung Memorial Hospital)	This study was supported by grants from the Ministry of Science and Technology, Taipei, Taiwan (NSC101-2314-B-182A-055-MY3 and MOST104-2314-B-182A-100-MY2) and Chang Gung Memorial Hospital, Taoyuan, Taiwan (CMRPG3D0251 and CMRPG3D0522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Avery RL, 2006, OPHTHALMOLOGY, V113, P1695, DOI 10.1016/j.ophtha.2006.05.064; Bakri SJ, 2007, OPHTHALMOLOGY, V114, P855, DOI 10.1016/j.ophtha.2007.01.017; Banach MJ, 2000, OPHTHALMOLOGY, V107, P324, DOI 10.1016/S0161-6420(99)00042-1; Bashshur ZF, 2009, AM J OPHTHALMOL, V148, P59, DOI 10.1016/j.ajo.2009.02.006; BREIER G, 1992, DEVELOPMENT, V114, P521; GLASCOE FP, 1993, CLIN PEDIATR, V32, P203; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Iliev ME, 2006, AM J OPHTHALMOL, V142, P1054, DOI 10.1016/j.ajo.2006.06.066; Jaissle GB, 2009, GRAEF ARCH CLIN EXP, V247, P27, DOI 10.1007/s00417-008-0916-2; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Jonas JB, 2008, ACTA OPHTHALMOL, V86, P585, DOI 10.1111/j.1600-0420.2007.01107.x; Kriechbaum K, 2008, BRIT J OPHTHALMOL, V92, P518, DOI 10.1136/bjo.2007.127282; Malik S, 2013, J NEUROSCI, V33, P411, DOI 10.1523/JNEUROSCI.4445-12.2013; Martinez-Castellanos MA, 2013, RETINA-J RET VIT DIS, V33, P329, DOI 10.1097/IAE.0b013e318275394a; Mason JO, 2006, AM J OPHTHALMOL, V142, P685, DOI 10.1016/j.ajo.2006.04.058; Micieli JA, 2009, AM J OPHTHALMOL, V148, P536, DOI 10.1016/j.ajo.2009.05.031; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Prager F, 2009, BRIT J OPHTHALMOL, V93, P452, DOI 10.1136/bjo.2008.141085; Provost Beth, 2004, Pediatr Phys Ther, V16, P149, DOI 10.1097/01.PEP.0000136005.41585.FE; Robinson GS, 2001, FASEB J, V15, P1215, DOI 10.1096/fj.00-0598fje; Ruiz-Moreno JM, 2008, ACTA OPHTHALMOL, V86, P231, DOI 10.1111/j.1600-0420.2007.01021.x; Sato T, 2012, AM J OPHTHALMOL, V153, P327, DOI 10.1016/j.ajo.2011.07.005; Sato T, 2009, OPHTHALMOLOGY, V116, P2165, DOI 10.1016/j.ophtha.2009.04.026; Sato T, 2009, OPHTHALMOLOGY, V116, P1599, DOI 10.1016/j.ophtha.2008.12.023; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P383, DOI 10.1097/00006982-200604000-00001; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P275, DOI 10.1097/00006982-200603000-00004; Wu WC, 2015, JAMA OPHTHALMOL, V133, P391, DOI 10.1001/jamaophthalmol.2014.5373; Wu WC, 2013, AM J OPHTHALMOL, V155, P150, DOI 10.1016/j.ajo.2012.06.010; Wu WC, 2011, OPHTHALMOLOGY, V118, P176, DOI 10.1016/j.ophtha.2010.04.018; Wu WC, 2010, INVEST OPHTH VIS SCI, V51, P3701, DOI 10.1167/iovs.09-4425	33	99	100	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0148019	10.1371/journal.pone.0148019	http://dx.doi.org/10.1371/journal.pone.0148019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815000	gold, Green Submitted, Green Published			2022-12-26	WOS:000369528200067
J	Zhang, Y; Wu, SJ; Luo, D; Zhou, JF; Li, DJ				Zhang, Ye; Wu, SiJing; Luo, Dan; Zhou, JianFeng; Li, DengJu			Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia	PLOS ONE			English	Article							TRANS-RETINOIC ACID; REMISSION INDUCTION; PROGNOSTIC-FACTORS; RAR-ALPHA; THERAPY; COAGULOPATHY; PML; CHEMOTHERAPY; PATHOGENESIS; MULTICENTER	Aim All-trans retinoic acid combined to anthracycline-based chemotherapy is the standard regimen of acute promyelocytic leukemia. The advent of arsenic trioxide has contributed to improve the anti-leukemic efficacy in acute promyelocytic leukemia. The objectives of the current study were to evaluate if dual induction by all-trans retinoic acid and arsenic trioxide could accelerate the recovery of abnormality of coagulation and fibrinolysis in patients with acute promyelocytic leukemia. Methods Retrospective analysis was performed in 103 newly-diagnosed patients with acute promyelocytic leukemia. Hemostatic variables and the consumption of component blood were comparably analyzed among patients treated by different induction regimen with or without arsenic trioxide. Results Compared to patients with other subtypes of de novo acute myeloid leukemia, patients with acute promyelocytic leukemia had lower platelet counts and fibrinogen levels, significantly prolonged prothrombin time and elevated D-dimers (P<0.001). Acute promyelocytic leukemia patients with high or intermediate risk prognostic stratification presented lower initial fibrinogen level than that of low-risk group (P<0.05). After induction treatment, abnormal coagulation and fibrinolysis of patients with acute promyelocytic leukemia was significantly improved before day 10. The recovery of abnormal hemostatic variables (platelet, prothrombin time, fibrinogen and D-dimer) was not significantly accelerated after adding arsenic trioxide in induction regimens; and the consumption of transfused component blood (platelet and plasma) did not dramatically change either. Acute promyelocytic leukemia patients with high or intermediate risk prognostic stratification had higher platelet transfusion demands than that of low-risk group (P<0.05). Conclusions Unexpectedly, adding arsenic trioxide could not accelerate the recovery of abnormality of coagulation and fibrinolysis in acute promyelocytic leukemia patients who received all-trans retinoic acid combining chemotherapy.	[Zhang, Ye; Wu, SiJing; Luo, Dan; Zhou, JianFeng; Li, DengJu] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Hematol, Tongji Hosp, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Li, DJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Hematol, Tongji Hosp, Wuhan 430074, Hubei, Peoples R China.	lidengju@163.com			Natural Science Foundation of Hubei Province of China [2013CFB075]; National Natural Science Foundation of China [81200353]	Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of Hubei Province of China (No. 2013CFB075) (http://www.hbstd.gov.cn/) and National Natural Science Foundation of China (No. 81200353). DJL received the funding.	Aribi A, 2007, CANCER, V109, P1355, DOI 10.1002/cncr.22524; Asou N, 2007, BLOOD, V110, P59, DOI 10.1182/blood-2006-08-043992; Bercovitz RS, 2012, HEMATOL-AM SOC HEMAT, P157, DOI 10.1182/asheducation-2012.1.157; BIONDI A, 1995, LEUKEMIA, V9, P1461; Breen KA, 2012, BRIT J HAEMATOL, V156, P24, DOI 10.1111/j.1365-2141.2011.08922.x; Candoni A, 2003, EUR J HAEMATOL, V71, P1, DOI 10.1034/j.1600-0609.2003.00084.x; Dally N, 2005, THROMB RES, V116, P109, DOI 10.1016/j.thromres.2004.11.001; de la Serna J, 2008, BLOOD, V111, P3395, DOI 10.1182/blood-2007-07-100669; DOMBRET H, 1993, LEUKEMIA, V7, P2; Estey E, 2006, BLOOD, V107, P3469, DOI 10.1182/blood-2005-10-4006; Falanga A, 2003, BEST PRACT RES CL HA, V16, P463, DOI 10.1016/S1521-6926(03)00059-8; Federici AB, 1996, BRIT J HAEMATOL, V92, P733, DOI 10.1046/j.1365-2141.1996.401939.x; Hu J, 2009, P NATL ACAD SCI USA, V106, P3342, DOI 10.1073/pnas.0813280106; Iland HJ, 2012, BLOOD, V120, P1570, DOI 10.1182/blood-2012-02-410746; Jing YK, 2001, BLOOD, V97, P264, DOI 10.1182/blood.V97.1.264; Kwaan HC, 2014, BEST PRACT RES CL HA, V27, P11, DOI 10.1016/j.beha.2014.04.005; Kwaan Hau C, 2014, Semin Thromb Hemost, V40, P332, DOI 10.1055/s-0034-1370792; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lehmann S, 2011, LEUKEMIA, V25, P1128, DOI 10.1038/leu.2011.78; Lengfelder E, 2012, LEUKEMIA, V26, P433, DOI 10.1038/leu.2011.245; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Powell BL, 2010, BLOOD, V116, P3751, DOI 10.1182/blood-2010-02-269621; Raelson JV, 1996, BLOOD, V88, P2826, DOI 10.1182/blood.V88.8.2826.bloodjournal8882826; ROVELLI A, 1992, J CLIN ONCOL, V10, P1413, DOI 10.1200/JCO.1992.10.9.1413; Sanz MA, 2004, BLOOD, V103, P1237, DOI 10.1182/blood-2003-07-2462; Sanz MA, 2014, BEST PRACT RES CL HA, V27, P33, DOI 10.1016/j.beha.2014.04.004; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Stein E, 2009, BEST PRACT RES CL HA, V22, P153, DOI 10.1016/j.beha.2008.12.007; TALLMAN MS, 1992, BLOOD, V79, P543; Tallman MS, 2002, BLOOD, V100, P4298, DOI 10.1182/blood-2002-02-0632; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Wandt H, 2012, LANCET, V380, P1309, DOI 10.1016/S0140-6736(12)60689-8; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147545	10.1371/journal.pone.0147545	http://dx.doi.org/10.1371/journal.pone.0147545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812490	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528000039
J	Chung, J; An, SH; Kang, SW; Kwon, K				Chung, Jihwa; An, Shung Hyun; Kang, Sang Won; Kwon, Kihwan			Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting RAGE Signaling in Diabetic Atherosclerosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; FACTOR-KAPPA-B; ADVANCED GLYCATION; OXIDATIVE STRESS; INDUCED APOPTOSIS; CARDIOVASCULAR-DISEASE; GENE-EXPRESSION; ER STRESS; ACTIVATION	A naturally occurring bile acid, ursodeoxycholic acid (UDCA), is known to alleviate endoplasmic reticulum (ER) stress at the cellular level. However, the detailed action mechanisms of UDCA in atherosclerosis are not fully understood. In this study, we demonstrated whether UDCA exerts anti-atherogenic activity in diabetic atherosclerosis by targeting ER stress and "receptor for advanced glycation endproduct" (RAGE) signaling. UDCA markedly reduced ER stress, RAGE expression, and pro-inflammatory responses [including NF-kappa B activation and reactive oxygen species (ROS) production] induced in endothelial cells (ECs) by high glucose (HG). In particular, UDCA inhibited HG-induced ROS production by increasing the Nrf2 level. In macrophages, UDCA also blocked HG-induced RAGE and pro-inflammatory cytokine expression and inhibited foam cell formation via upregulation of the ATP-binding cassette (ABC) transporters, ABCA1 and ABCG1. In the diabetic mouse model, UDCA inhibited atheromatous plaque formation by decreasing ER stress, and the levels of RAGE and adhesion molecules. In conclusion, UDCA exerts an anti-atherogenic activity in diabetic atherosclerosis by targeting both ER stress and RAGE signaling. Our work implicates UDCA as a potential therapeutic agent for prevention or treatment of diabetic atherosclerosis.	[Chung, Jihwa; An, Shung Hyun; Kwon, Kihwan] Ewha Womans Univ, Sch Med, Med Res Inst, Seoul, South Korea; [Kwon, Kihwan] Ewha Womans Univ, Sch Med, Div Cardiol, Dept Internal Med, Seoul, South Korea; [Kwon, Kihwan] Ewha Womans Univ, Sch Med, GT5 Program, Seoul, South Korea; [Kang, Sang Won] Ewha Womans Univ, Ctr Cell Signaling Res, Seoul, South Korea; [Kang, Sang Won] Ewha Womans Univ, Div Mol Life Sci, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University; Ewha Womans University; Ewha Womans University	Kwon, K (corresponding author), Ewha Womans Univ, Sch Med, Med Res Inst, Seoul, South Korea.; Kwon, K (corresponding author), Ewha Womans Univ, Sch Med, Div Cardiol, Dept Internal Med, Seoul, South Korea.; Kwon, K (corresponding author), Ewha Womans Univ, Sch Med, GT5 Program, Seoul, South Korea.	kankadin@ewha.ac.kr			Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MEST) [NRF-2011-0019695]; Daewoong Pharmaceutical Co. Ltd	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MEST); Daewoong Pharmaceutical Co. Ltd	This study was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST) (NRF-2011-0019695) and Daewoong Pharmaceutical Co. Ltd. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Basta G, 2002, CIRCULATION, V105, P816, DOI 10.1161/hc0702.104183; Beuers U, 1998, HEPATOLOGY, V28, P1449, DOI 10.1002/hep.510280601; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Bucciarelli LG, 2002, CIRCULATION, V106, P2827, DOI 10.1161/01.CIR.0000039325.03698.36; Ceriello A, 2003, DIABETES CARE, V26, P1589, DOI 10.2337/diacare.26.5.1589; CIRILLO NW, 1994, AM J GASTROENTEROL, V89, P1447; Civelek M, 2009, CIRC RES, V105, P453, DOI 10.1161/CIRCRESAHA.109.203711; Crampton Steve P, 2007, J Vis Exp, P183, DOI 10.3791/183; Daffu G, 2015, DIABETES, V64, P4046, DOI 10.2337/db15-0575; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Gao X, 2008, AM J PHYSIOL-HEART C, V295, pH491, DOI 10.1152/ajpheart.00464.2008; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Ha CH, 2013, INT J CARDIOL, V168, P4168, DOI 10.1016/j.ijcard.2013.07.112; Ha CH, 2013, INT J MOL MED, V32, P373, DOI 10.3892/ijmm.2013.1393; Han SH, 2011, MOL CELLS, V31, P91, DOI 10.1007/s10059-011-0030-x; Ho FM, 2000, CIRCULATION, V101, P2618, DOI 10.1161/01.CIR.101.22.2618; Kaneko M, 2003, BIOL PHARM BULL, V26, P931, DOI 10.1248/bpb.26.931; Khan MI, 2009, ANTIOXID REDOX SIGN, V11, P2289, DOI [10.1089/ars.2009.2569, 10.1089/ARS.2009.2569]; Kim SY, 2011, CARDIOVASC RES, V92, P307, DOI 10.1093/cvr/cvr219; Kumar P, 2013, METABOLISM, V62, P1149, DOI 10.1016/j.metabol.2013.02.006; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Laakso M, 1999, DIABETES, V48, P937, DOI 10.2337/diabetes.48.5.937; Lee DJ, 2013, CANCER RES, V73, P4744, DOI 10.1158/0008-5472.CAN-12-4226; Liu WL, 2000, AM J PHYSIOL-ENDOC M, V279, pE782, DOI 10.1152/ajpendo.2000.279.4.E782; Ma J, 2004, EUR J PHARMACOL, V505, P67, DOI 10.1016/j.ejphar.2004.10.042; Maiese K, 2007, CURR NEUROVASC RES, V4, P63, DOI 10.2174/156720207779940653; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Mauldin JP, 2006, J BIOL CHEM, V281, P21216, DOI 10.1074/jbc.M510952200; McGinn S, 2003, AM J PHYSIOL-ENDOC M, V285, pE708, DOI 10.1152/ajpendo.00572.2002; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Patel DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022142; Piperi C, 2012, J CLIN ENDOCR METAB, V97, P2231, DOI 10.1210/jc.2011-3408; Schiekofer S, 2003, DIABETES, V52, P621, DOI 10.2337/diabetes.52.3.621; Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246; Scull CM, 2011, ARTERIOSCL THROM VAS, V31, P2792, DOI 10.1161/ATVBAHA.111.224881; Soro-Paavonen A, 2008, DIABETES, V57, P2461, DOI 10.2337/db07-1808; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Werstruck GH, 2006, DIABETES, V55, P93, DOI 10.2337/diabetes.55.01.06.db05-0633; Win MTT, 2012, EXP DIABETES RES, DOI 10.1155/2012/894605; Yan SF, 2009, J MOL MED, V87, P235, DOI 10.1007/s00109-009-0439-2; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	48	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147839	10.1371/journal.pone.0147839	http://dx.doi.org/10.1371/journal.pone.0147839			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807573	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800224
J	Fei, XF; Lou, ZH; Christakos, G; Liu, QM; Ren, YJ; Wu, JP				Fei, Xufeng; Lou, Zhaohan; Christakos, George; Liu, Qingmin; Ren, Yanjun; Wu, Jiaping			A Geographic Analysis about the Spatiotemporal Pattern of Breast Cancer in Hangzhou from 2008 to 2012	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; WOMEN; RISK; MORTALITY; STAGE; DISPARITIES; DIAGNOSIS; DISEASE; CHINA; RACE	Background Breast cancer (BC) is the most common female malignant tumor. Previous studies have suggested a big incidence disparity among different cities in China. The present work selected a typical city, Hangzhou, to study BC incidence disparity within the city. Methods Totally, 8784 female breast cancer cases were obtained from the Hangzhou Center for Disease Control and Prevention during the period 2008-2012. Analysis of Variance and Poisson Regression were the statistical tools implemented to compare incidence disparity in the space-time domain (reference group: township residents during 2008, area: subdistrict, town, and township, time frame: 2008-2012), space-time scan statistics was employed to detect significant spatiotemporal clusters of BC compared to the null hypothesis that the probability of cases diagnosed at a particular location was equal to the probability of cases diagnosed in the whole study area. Geographical Information System (GIS) was used to generate BC spatial distribution and cluster maps at the township level. Results The subdistrict populations were found to have the highest and most stable BC incidence. Although town and township populations had a relatively low incidence, it displayed a significant increasing trend from 2008 to 2012. The BC incidence distribution was spatially heterogeneous and clustered with a trend-surface from the southwest low area to the northeast high area. High clusters were located in the northeastern Hangzhou area, whereas low clusters were observed in the southwestern area during the time considered. Conclusions Better healthcare service and lifestyle changes may be responsible for the increasing BC incidence observed in towns and townships. One high incidence cluster (Linping subdistrict) and two low incidence clusters (middle Hangzhou) were detected. The low clusters may be attributable mainly to developmental level disparity, whereas the high cluster could be associated with other risk factors, such as environmental pollution.	[Fei, Xufeng] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Lou, Zhaohan; Christakos, George; Wu, Jiaping] Zhejiang Univ, Inst Isl & Coastal Ecosyst, Zhoushan, Peoples R China; [Liu, Qingmin; Ren, Yanjun] Hangzhou Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wu, JP (corresponding author), Zhejiang Univ, Inst Isl & Coastal Ecosyst, Zhoushan, Peoples R China.	jw67@zju.edu.cn	Wu, Jiaping/AAD-8800-2022; 刘庆敏, Liu qingmin/AAQ-9255-2020		Department of Science and Technology, Zhejiang Province [2013C03045-2]; Commission of Science and Technology, Hangzhou City [20120533Q01]	Department of Science and Technology, Zhejiang Province(Department of Science & Technology (India)); Commission of Science and Technology, Hangzhou City	This work was supported partially by the Department of Science and Technology, Zhejiang Province (2013C03045-2) and by the Commission of Science and Technology, Hangzhou City (20120533Q01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, BRIT MED J, V329, P142, DOI 10.1136/bmj.38114.679387.AE; Bollaerts K, 2014, THYROID, V24, P906, DOI 10.1089/thy.2013.0227; Brody JG, 2007, CANCER-AM CANCER SOC, V109, P2667, DOI 10.1002/cncr.22655; Cheraghi Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051446; Chia KS, 2005, INT J CANCER, V113, P302, DOI 10.1002/ijc.20561; Christakos G, 1997, SOC SCI MED, V45, P1503, DOI 10.1016/S0277-9536(97)00080-4; Dalzell LP, 2015, CANCER CAUSE CONTROL, V26, P699, DOI 10.1007/s10552-015-0571-y; DAVIS DL, 1993, ENVIRON HEALTH PERSP, V101, P372, DOI 10.2307/3431889; Eriksen KT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100815; ESRI E, 2008, ARCMAP 9 3, V9, P1999; Esteve J, 1994, STAT METHODS CANC RE, VIV; Fei XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117572; Fei XF, 2014, STOCH ENV RES RISK A, V28, P1075, DOI 10.1007/s00477-014-0876-5; Ferlay J., 2004, GLOBOCAN 2002 CANC I; Ferlay J, 2001, GLOBOCAN 2000 CANC I; Goss PE, 2014, LANCET ONCOL, V15, P489, DOI 10.1016/S1470-2045(14)70029-4; Hampton T, 2008, JAMA-J AM MED ASSOC, V300, P1641, DOI 10.1001/jama.300.14.1641; Hao J, 2008, CHINESE CANC REGISTR; Harper S, 2009, CANCER EPIDEM BIOMAR, V18, P121, DOI 10.1158/1055-9965.EPI-08-0679; Hsieh JCF, 2016, STOCH ENV RES RISK A, V30, P155, DOI 10.1007/s00477-015-1050-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JOHN EM, 1993, EPIDEMIOL REV, V15, P157, DOI 10.1093/oxfordjournals.epirev.a036099; KEY T, 1994, BMJ-BRIT MED J, V308, P1520, DOI 10.1136/bmj.308.6943.1520; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lipkus IM, 1999, CANCER EPIDEM BIOMAR, V8, P533; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; O'Malley MS, 2001, AM J PUBLIC HEALTH, V91, P49; Pezzotti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005356; Pollan M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-78; Pudrovska T, 2012, J AGING HEALTH, V24, P323, DOI 10.1177/0898264311422744; Roetzheim RG, 1999, J NATL CANCER I, V91, P1409, DOI 10.1093/jnci/91.16.1409; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Terry PD, 2002, CANCER EPIDEM BIOMAR, V11, P953; VANLOON AJM, 1994, INT J EPIDEMIOL, V23, P899, DOI 10.1093/ije/23.5.899; Wang FH, 2012, APPL GEOGR, V35, P1, DOI 10.1016/j.apgeog.2012.04.005; Yang Richard C, 2006, Asian Pac J Cancer Prev, V7, P79; Zhang ZH, 2013, APPL GEOGR, V45, P193, DOI 10.1016/j.apgeog.2013.09.013	39	6	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147866	10.1371/journal.pone.0147866	http://dx.doi.org/10.1371/journal.pone.0147866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808895	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800235
J	Park, CH; Kim, EH; Kang, JH; Chung, H; Park, JC; Shin, SK; Lee, SK; Lee, YC				Park, Chan Hyuk; Kim, Eun Hye; Kang, Jung Hyun; Chung, Hyunsoo; Park, Jun Chul; Shin, Sung Kwan; Lee, Sang Kil; Lee, Yong Chan			Low Incidence of Synchronous or Metachronous Tumors after Endoscopic Submucosal Dissection for Early Gastric Cancer with Undifferentiated Histology	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; ATROPHIC GASTRITIS; CONFOCAL ENDOMICROSCOPY; RESECTION; OUTCOMES; SURVEILLANCE; NEOPLASIA; BIOPSIES; CRITERIA; STOMACH	Background Gastric cancer with undifferentiated histology has different clinicopathologic characteristics compared to differentiated type gastric cancer. We aimed to compare the risk of synchronous or metachronous tumors after curative resection of early gastric cancer (EGC) via endoscopic submucosal dissection (ESD), according to the histologic differentiation of the primary lesion. Methods Clinicopathological data of patients with initial-onset EGC curatively resected via ESD between January 2007 and November 2014 in a single institution were reviewed. We analyzed the incidence of synchronous or metachronous tumors after ESD with special reference to the differentiation status of the primary lesion. Results Of 1,560 patients with EGC who underwent curative resection via ESD, 1,447 had differentiated type cancers, and 113 had undifferentiated type cancers. The cumulative incidence of metachronous or synchronous tumor after ESD was higher in the differentiated cancer group than in the undifferentiated cancer group (P = 0.008). Incidence of metachronous or synchronous tumor was 4.8% and 1.2% per person-year in the differentiated and undifferentiated cancer groups, respectively. The Cox proportional hazard model revealed that undifferentiated cancers were associated with a low risk of synchronous or metachronous tumors after adjusting for confounding variables (hazard ratio [95% confidence interval] = 0.287 [0.090-0.918]). Conclusions The rate of synchronous or metachronous tumors after curative ESD was significantly lower for undifferentiated cancers compare to differentiated cancers. These findings suggest that ESD should be actively considered as a possible treatment for undifferentiated type EGCs.	[Park, Chan Hyuk] Hanyang Univ, Coll Med, Guri Hosp, Dept Internal Med, Guri, South Korea; [Kim, Eun Hye; Kang, Jung Hyun; Chung, Hyunsoo; Park, Jun Chul; Shin, Sung Kwan; Lee, Sang Kil; Lee, Yong Chan] Yonsei Univ, Coll Med, Inst Gastroenterol, Div Gastroenterol,Dept Internal,Med Severance Hos, Seoul, South Korea	Hanyang University; Yonsei University; Yonsei University Health System	Lee, YC (corresponding author), Yonsei Univ, Coll Med, Inst Gastroenterol, Div Gastroenterol,Dept Internal,Med Severance Hos, Seoul, South Korea.	leeyc@yuhs.ac	Park, Jun Chul/H-7218-2019; Park, Chan Hyuk/I-1794-2016; Chung, Hyunsoo/AAD-3634-2020	Park, Jun Chul/0000-0001-8018-0010; Park, Chan Hyuk/0000-0003-3824-3481; Chung, Hyunsoo/0000-0001-5159-357X; Shin, Sung Kwan/0000-0001-5466-1400; Lee, Yong Chan/0000-0001-8800-6906; Lee, Sang Kil/0000-0002-0721-0364				Adamu MA, 2010, EUR J EPIDEMIOL, V25, P439, DOI 10.1007/s10654-010-9482-0; Bok GH, 2013, GASTROINTEST ENDOSC, V77, P899, DOI 10.1016/j.gie.2013.01.018; Capelle LG, 2010, GASTROINTEST ENDOSC, V71, P1150, DOI 10.1016/j.gie.2009.12.029; CORREA P, 1988, CANCER RES, V48, P3554; Eguchi T, 1999, J AM COLL SURGEONS, V188, P22, DOI 10.1016/S1072-7515(98)00268-3; Gotoda T, 2007, GASTRIC CANCER, V10, P1, DOI 10.1007/s10120-006-0408-1; Gotoda Takuji, 2000, Gastric Cancer, V3, P219, DOI 10.1007/PL00011720; Hosokawa O, 2002, ENDOSCOPY, V34, P469, DOI 10.1055/s-2002-32007; Iseki K, 1998, GUT, V42, P20, DOI 10.1136/gut.42.1.20; Isomoto H, 2009, GUT, V58, P331, DOI 10.1136/gut.2008.165381; Ito S, 1996, GUT, V39, P800, DOI 10.1136/gut.39.6.800; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jeon SR, 2011, GASTROINTEST ENDOSC, V74, P772, DOI 10.1016/j.gie.2011.05.005; Kim JH, 2014, SURG ENDOSC, V28, P2627, DOI 10.1007/s00464-014-3514-x; Lee H, 2011, SURG ENDOSC, V25, P1985, DOI 10.1007/s00464-010-1499-7; Liu Y, 2005, J GASTROENTEROL, V40, P123, DOI 10.1007/s00535-004-1511-x; Mizuno S, 2010, DIGEST DIS SCI, V55, P3132, DOI 10.1007/s10620-010-1154-0; Nagahama T, 2011, GASTROINTEST ENDOSC, V74, P1259, DOI 10.1016/j.gie.2011.09.005; Nagata N, 2011, GASTROENTEROL RES, V4, P203, DOI 10.4021/gr357w; Nakajima Takeshi, 2006, Gastric Cancer, V9, P93, DOI 10.1007/s10120-006-0372-9; Ohata H, 2004, INT J CANCER, V109, P138, DOI 10.1002/ijc.11680; Oka S, 2014, SURG ENDOSC, V28, P639, DOI 10.1007/s00464-013-3222-y; Park CH, 2014, GASTROINTEST ENDOSC, V80, P599, DOI 10.1016/j.gie.2014.04.042; Park CH, 2014, SURG ENDOSC, V28, P1307, DOI 10.1007/s00464-013-3327-3; Park CH, 2013, DIGEST LIVER DIS, V45, P651, DOI 10.1016/j.dld.2013.01.014; Rugge M, 2008, DIGEST LIVER DIS, V40, P650, DOI 10.1016/j.dld.2008.02.030; Satoh K, 1996, AM J GASTROENTEROL, V91, P963; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Shim CN, 2014, WORLD J GASTROENTERO, V20, P3938, DOI 10.3748/wjg.v20.i14.3938; Takeda J, 1998, HEPATO-GASTROENTEROL, V45, P1907; Vieth M, 2006, WORLD J GASTROENTERO, V12, P6109, DOI 10.3748/wjg.v12.i38.6109; Yamaguchi N, 2009, DIGESTION, V80, P173, DOI 10.1159/000215388; Yamamoto Y., 2015, DIG ENDOSC	33	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147874	10.1371/journal.pone.0147874	http://dx.doi.org/10.1371/journal.pone.0147874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809013	Green Submitted, gold, Green Published			2022-12-26	WOS:000369527800236
J	Penedo, FJ; Yanez, B; Castaneda, SF; Gallo, L; Wortman, K; Gouskova, N; Simon, M; Arguelles, W; Llabre, M; Sanchez-Johnsen, L; Brintz, C; Gonzalez, P; Van Horn, L; Rademaker, AW; Ramirez, AG				Penedo, Frank J.; Yanez, Betina; Castaneda, Sheila F.; Gallo, Linda; Wortman, Katy; Gouskova, Natalia; Simon, Melissa; Arguelles, William; Llabre, Maria; Sanchez-Johnsen, Lisa; Brintz, Carrie; Gonzalez, Patricia; Van Horn, Linda; Rademaker, Alfred W.; Ramirez, Amelie G.			Self-Reported Cancer Prevalence among Hispanics in the US: Results from the Hispanic Community Health Study/Study of Latinos	PLOS ONE			English	Article							RISK-FACTORS; PUERTO-RICANS; STATISTICS; BREAST; PREDICTORS; MEXICANS; CUBANS	Cancer has surpassed heart disease as the leading cause of death among Hispanics in the U.S., yet data on cancer prevalence and risk factors in Hispanics in regard to ancestry remain scarce. This study sought to describe (a) the prevalence of cancer among Hispanics from four major U.S. metropolitan areas, (b) cancer prevalence across Hispanic ancestry, and (c) identify correlates of self-reported cancer prevalence. Participants were 16,415 individuals from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), who self-identified as Cuban, Dominican, Mexican, Puerto Rican, Central or South American. All data were collected at a single time point during the HCHS/SOL baseline clinic visit. The overall self-reported prevalence rate of cancer for the population was 4%. The rates varied by Hispanic ancestry group, with individuals of Cuban and Puerto Rican ancestry reporting the highest cancer prevalence. For the entire population, older age (OR = 1.47, p <.001, 95% CI, 1.26-1.71) and having health insurance (OR = 1.93, p <.001, 95% CI, 1.42-2.62) were all significantly associated with greater prevalence, whereas male sex was associated with lower prevalence (OR = 0.56, p <.01, 95% CI,.40-.79). Associations between study covariates and cancer prevalence also varied by Hispanic ancestry. Findings underscore the importance of sociodemographic factors and health insurance in relation to cancer prevalence for Hispanics and highlight variations in cancer prevalence across Hispanic ancestry groups. Characterizing differences in cancer prevalence rates and their correlates is critical to the development and implementation of effective prevention strategies across distinct Hispanic ancestry groups.	[Penedo, Frank J.; Yanez, Betina; Wortman, Katy] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Castaneda, Sheila F.; Gonzalez, Patricia] San Diego State Univ, Inst Behav & Community Hlth, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Gallo, Linda] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Gouskova, Natalia] Univ N Carolina, Dept Biostat, Gillings Sch Publ Hlth, Chapel Hill, NC USA; [Simon, Melissa] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA; [Arguelles, William; Llabre, Maria; Brintz, Carrie] Univ Miami, Dept Psychol, Coral Gables, FL 33124 USA; [Sanchez-Johnsen, Lisa] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Van Horn, Linda; Rademaker, Alfred W.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Ramirez, Amelie G.] Univ Texas Hlth Sci Ctr San Antonio, Inst Hlth Promot, San Antonio, TX 78229 USA	Northwestern University; Feinberg School of Medicine; California State University System; San Diego State University; California State University System; San Diego State University; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University; Feinberg School of Medicine; University of Miami; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Health San Antonio	Penedo, FJ (corresponding author), Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA.	Fpenedo@northwestern.edu	Castaneda, Sheila F./AAK-3025-2020; Bedjeti, Katy/GZM-2902-2022; Castaneda, Sheila/I-4132-2014	Castaneda, Sheila/0000-0002-1975-0544; Gallo, Linda C./0000-0002-3678-5888	National Heart, Lung, and Blood Institute (NHLBI) [N01-HC65233]; University of Miami [N01-HC65234]; Albert Einstein College of Medicine [N01-HC65235]; Northwestern University [N01HC65236]; San Diego State University [N01HC65237]; National Center on Minority Health and Health Disparities; National Institute on Deafness and Other Communications Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Neurological Disorders and Stroke; Office of Dietary Supplements; NIH/NHLBI [1 RC2 HL101649]; Redes En Accin; National Latino Cancer Research Network; National Cancer Institute (NCI) Center to Reduce Cancer Health Disparities grant; University of Texas Health Science Center at San Antonio Health [U01 CA114657-05, U54 CA153511]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC065233] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U54CA202995, P30CA060553, U54CA153511, U01CA114657, U54CA202997] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101649] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Miami; Albert Einstein College of Medicine; Northwestern University; San Diego State University; National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Deafness and Other Communications Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Redes En Accin; National Latino Cancer Research Network; National Cancer Institute (NCI) Center to Reduce Cancer Health Disparities grant; University of Texas Health Science Center at San Antonio Health; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Hispanic Community Health Study/Study of Latinos was carried out as a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), Northwestern University (N01HC65236), and San Diego State University (N01HC65237). The following institutes, centers, or offices contribute to the HCHS/SOL through a transfer of funds to the NHLBI: National Center on Minority Health and Health Disparities, the National Institute on Deafness and Other Communications Disorders, the National Institute of Dental and Craniofacial Research, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Neurological Disorders and Stroke, and the Office of Dietary Supplements. The authors thank the staff and participants of HCHS/SOL for their important contributions. A complete list of staff and investigators was published in Ann Epidemiol. 2010; 20:642-649 and is also available on the study website, http://www.cscc.unc.edu/hchs/. The HCHS/SOL Sociocultural Ancillary Study was supported by grant 1 RC2 HL101649 from the NIH/NHLBI (Gallo/Penedo MPIs). The authors thank the staff and participants of HCHS/SOL and the HCHS/SOL Sociocultural Ancillary Study for their important contributions. This research was also made possible by grants from Redes En Accion: The National Latino Cancer Research Network. This research was supported by a National Cancer Institute (NCI) Center to Reduce Cancer Health Disparities grant awarded to the University of Texas Health Science Center at San Antonio Health (Ramirez, PI; Penedo Midwest Region Co-PI/Research Project PI; U01 CA114657-05 and U54 CA153511).	American Cancer Society, 2012, CANC FACTS FIG HISP; American Cancer Society, 2014, CANC FACTS FIG 2014; Amir E, 2010, JNCI-J NATL CANCER I, V102, P680, DOI 10.1093/jnci/djq088; [Anonymous], 2014, THE BURDEN OF CANC; [Anonymous], 2011, PROFILE AM FACTS FEA; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P969; Brown A., 2014, STAT PORTRAIT HISPAN; Chiuve SE, 2012, J NUTR; Cokkinides VE, 2012, CA-CANCER J CLIN, V62, P353, DOI 10.3322/caac.21155; Coups EJ, 2005, PREV MED, V40, P702, DOI 10.1016/j.ypmed.2004.09.011; Daviglus ML, 2012, JAMA-J AM MED ASSOC, V308, P1775, DOI 10.1001/jama.2012.14517; Diaz JA, 2008, CANCER EPIDEM BIOMAR, V17, P2169, DOI 10.1158/1055-9965.EPI-07-2692; Howe HL, 2006, CANCER-AM CANCER SOC, V107, P1711, DOI 10.1002/cncr.22193; Johnson-Kozlow M, 2010, J IMMIGR MINOR HEALT, V12, P454, DOI 10.1007/s10903-009-9236-9; Kaplan RC, 2014, AM J PREV MED, V46, P496, DOI 10.1016/j.amepre.2014.01.014; Lee K, 2008, OBESITY, V16, P834, DOI 10.1038/oby.2007.109; MARIN G, 1987, HISPANIC J BEHAV SCI, V9, P183, DOI 10.1177/07399863870092005; Martinez-Tyson D, 2009, J IMMIGR MINOR HEALT, V11, P249, DOI 10.1007/s10903-008-9152-4; O'Brien K, 2003, CA-CANCER J CLIN, V53, P208, DOI 10.3322/canjclin.53.4.208; Pinheiro PS, 2009, CANCER EPIDEM BIOMAR, V18, P2162, DOI 10.1158/1055-9965.EPI-09-0329; Ramirez AG, 2000, AM J HEALTH PROMOT, V14, P292, DOI 10.4278/0890-1171-14.5.292; Ramirez AG, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-84; Selvin E, 2003, AM J PUBLIC HEALTH, V93, P618, DOI 10.2105/AJPH.93.4.618; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siegel R, 2012, CA-CANCER J CLIN, V62, DOI 10.3322/caac.21153; Sorlie PD, 2010, ANN EPIDEMIOL, V20, P629, DOI 10.1016/j.annepidem.2010.03.015; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Ward E, 2008, CA-CANCER J CLIN, V58, P9, DOI 10.3322/CA.2007.0011	28	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146268	10.1371/journal.pone.0146268	http://dx.doi.org/10.1371/journal.pone.0146268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808047	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800018
J	Takeuchi, Y; Hori, M; Tada, S; Oda, Y				Takeuchi, Yuichi; Hori, Michio; Tada, Shinya; Oda, Yoichi			Acquisition of Lateralized Predation Behavior Associated with Development of Mouth Asymmetry in a Lake Tanganyika Scale-Eating Cichlid Fish	PLOS ONE			English	Article							PERISSODUS-MICROLEPIS; MORPHOLOGICAL ASYMMETRY; DISRUPTIVE SELECTION; INTRASPECIFIC COMPETITION; MUSCLE WEIGHT; PATTERNS; MAUTHNER; DIMORPHISM; HANDEDNESS; EVOLUTION	The scale-eating cichlid Perissodus microlepis with asymmetric mouth is an attractive model of behavioral laterality: each adult tears off scales from prey fishes' left or right flanks according to the direction in which its mouth is skewed. To investigate the development of behavioral laterality and mouth asymmetry, we analyzed stomach contents and lower jawbone asymmetry of various-sized P. microlepis (22 <= SL < 115mm) sampled in Lake Tanganyika. The shapes of the pored scales found in each specimen's stomach indicated its attack side preference. Early-juvenile specimens (SL< 45mm) feeding mainly on zooplankton exhibited slight but significant mouth asymmetry. As the fish acquired scale-eating (45mm <= SL), attack side preference was gradually strengthened, as was mouth asymmetry. Among size-matched individuals, those with more skewed mouths ate more scales. These findings show that behavioral laterality in scale-eating P. microlepis is established in association with development of mouth asymmetry which precedes the behavioral acquisition, and that this synergistic interaction between physical and behavioral literalities may contribute to efficient scale-eating.	[Takeuchi, Yuichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Anat, Toyama 930, Japan; [Takeuchi, Yuichi; Oda, Yoichi] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi, Japan; [Hori, Michio] Kyoto Univ, Dept Biol Sci, Kyoto, Japan; [Tada, Shinya] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 790, Japan	University of Toyama; Nagoya University; Kyoto University; Ehime University	Takeuchi, Y (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Anat, Toyama 930, Japan.; Takeuchi, Y (corresponding author), Nagoya Univ, Grad Sch Sci, Nagoya, Aichi, Japan.	takeuchi@med.u-toyama.ac.jp	Takeuchi, Yuichi/G-6201-2013	Takeuchi, Yuichi/0000-0002-7096-3086	Japan Society for the Promotion of Science [22.7689]; JSPS KAKENHI [25890006, 26830009, 24405001]; Sumitomo Foundation [120890]; Brain Science Foundation; Narishige Zoological Science Award; Sasagawa Grants for Science Fellows [26-522]; Grant for the Biodiversity Research of the 21st Century COE [A14]; Global Centre of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research [15H05230] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sumitomo Foundation; Brain Science Foundation; Narishige Zoological Science Award; Sasagawa Grants for Science Fellows; Grant for the Biodiversity Research of the 21st Century COE; Global Centre of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Research Fellowship of the Japan Society for the Promotion of Science (22.7689 to Y.T.), JSPS KAKENHI (25890006, 26830009 to Y.T., and 24405001 to Y.O.), a Grant for Basic Science Research Projects from The Sumitomo Foundation (120890 to Y.T.), the Brain Science Foundation (Y.T.), a Narishige Zoological Science Award (Y.T.), Sasagawa Grants for Science Fellows (26-522), a Grant for the Biodiversity Research of the 21st Century COE (A14), and the Global Centre of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem", from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	ALOIA JF, 1978, METABOLISM, V27, P1793, DOI 10.1016/0026-0495(78)90265-2; Andrew RJ, 2009, PHILOS T R SOC B, V364, P983, DOI 10.1098/rstb.2008.0241; ANNETT M, 1970, BRIT J PSYCHOL, V61, P545, DOI 10.1111/j.2044-8295.1970.tb01274.x; ANNETT M, 1967, Q J EXP PSYCHOL, V19, P327, DOI 10.1080/14640746708400109; BENKMAN CW, 1991, NATURE, V349, P519, DOI 10.1038/349519a0; Bisazza A, 2005, P ROY SOC B-BIOL SCI, V272, P1677, DOI 10.1098/rspb.2005.3145; Bolnick DI, 2004, EVOLUTION, V58, P608, DOI 10.1111/j.0014-3820.2004.tb01683.x; Brandler WM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003751; Budaev S, 2009, BEHAV BRAIN RES, V200, P91, DOI 10.1016/j.bbr.2008.12.030; CANFIELD JG, 1993, J COMP PHYSIOL A, V172, P611, DOI 10.1007/BF00213683; CHHIBBER SR, 1972, ACTA ANAT, V81, P462; CHHIBBER SR, 1970, J ANAT, V106, P553; EATON RC, 1981, J COMP PHYSIOL, V144, P521, DOI 10.1007/BF01326837; Farrell AP, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1; Frasnelli E, 2012, NEUROSCI BIOBEHAV R, V36, P1273, DOI 10.1016/j.neubiorev.2012.02.006; FRYER G, 1972, CICHLID FISHES GREAT, P642; Ghirlanda S, 2009, PHILOS T R SOC B, V364, P861, DOI 10.1098/rstb.2008.0227; Gunturkun O, 2000, CURR BIOL, V10, P1079, DOI 10.1016/S0960-9822(00)00671-0; Hata H, 2013, ECOL EVOL, V3, P4641, DOI 10.1002/ece3.849; Hendry AP, 2009, P ROY SOC B-BIOL SCI, V276, P753, DOI 10.1098/rspb.2008.1321; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; HORI M, 1993, SCIENCE, V260, P216, DOI 10.1126/science.260.5105.216; Hori M., 1991, INTECOL B, V19, P89; Hori M, 2007, ZOOL SCI, V24, P486, DOI 10.2108/zsj.24.486; HUDDLESTON AL, 1980, JAMA-J AM MED ASSOC, V244, P1107, DOI 10.1001/jama.244.10.1107; HYNES HBN, 1950, J ANIM ECOL, V19, P36, DOI 10.2307/1570; Koblmueller Stephan, 2007, Molecular Phylogenetics and Evolution, V44, P1295, DOI 10.1016/j.ympev.2007.02.010; Kohashi T, 2008, J NEUROSCI, V28, P10641, DOI 10.1523/JNEUROSCI.1435-08.2008; Kusche H, 2012, P ROY SOC B-BIOL SCI, V279, P4715, DOI 10.1098/rspb.2012.2082; Lee HJ, 2010, J FISH BIOL, V76, P1940, DOI 10.1111/j.1095-8649.2010.02620.x; Lee HJ, 2015, ECOL EVOL, V5, P4277, DOI 10.1002/ece3.1691; Lee HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044670; LIEM K F, 1976, Bulletin of the Museum of Comparative Zoology, V147, P319; Magat M, 2009, P ROY SOC B-BIOL SCI, V276, P4155, DOI 10.1098/rspb.2009.1397; MARLER P, 1990, PHILOS T ROY SOC B, V329, P109, DOI 10.1098/rstb.1990.0155; McManus C, 1991, INHERITANCE LEFT HAN; MEYER A, 1987, EVOLUTION, V41, P1357, DOI 10.1111/j.1558-5646.1987.tb02473.x; Michel GF, 2002, DEV INFANT HANDEDNES, P165; Nakajima M, 2007, ZOOL SCI, P855; NILSSON BE, 1971, CLIN ORTHOP RELAT R, P179; NSHOMBO M, 1985, JPN J ICHTHYOL, V32, P66; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Rogers L.J., 2013, DIVIDED BRAINS BIOL; Rogers LJ, 2002, COMP VERTEBRATE LATE; Roy EA, 2003, BRAIN COGNITION, V53, P315, DOI 10.1016/S0278-2626(03)00133-7; Rueffler C, 2006, TRENDS ECOL EVOL, V21, P238, DOI 10.1016/j.tree.2006.03.003; Stewart TA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-8; Takahashi R, 2007, J FISH BIOL, V70, P1458, DOI 10.1111/j.1095-8649.2007.01423.x; Takeuchi Y, 2008, ANIM BEHAV, V75, P1359, DOI 10.1016/j.anbehav.2007.09.008; Takeuchi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029272; Takeuchi Y, 2010, BEHAV BRAIN RES, V208, P106, DOI 10.1016/j.bbr.2009.11.021; Van Dooren TJM, 2010, EVOLUTION, V64, P2159, DOI 10.1111/j.1558-5646.2010.00977.x; WIMBERGER PH, 1991, EVOLUTION, V45, P1545, DOI 10.1111/j.1558-5646.1991.tb02662.x; Yasugi M, 2011, ZOOL SCI, V28, P869, DOI 10.2108/zsj.28.869; ZOTTOLI SJ, 1977, J EXP BIOL, V66, P243	55	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147476	10.1371/journal.pone.0147476	http://dx.doi.org/10.1371/journal.pone.0147476			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808293	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800103
J	Urtasun, R; Elizalde, M; Azkona, M; Latasa, MU; Garcia-Irigoyen, O; Uriarte, I; Fernandez-Barrena, MG; Vicent, S; Alonso, MM; Muntane, J; Prieto, J; Avila, MA; Berasain, C				Urtasun, R.; Elizalde, M.; Azkona, M.; Latasa, M. U.; Garcia-Irigoyen, O.; Uriarte, I.; Fernandez-Barrena, M. G.; Vicent, S.; Alonso, M. M.; Muntane, J.; Prieto, J.; Avila, M. A.; Berasain, C.			Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression	ONCOGENE			English	Article							MICRORNA CLUSTER; CYCLE ARREST; AUTOPHAGY; MYC; APOPTOSIS; GROWTH; ROLES; AMPHIREGULIN; INHIBITION; METABOLISM	Resisting death is a central hallmark of cancer cells. Tumors rely on a number of genetic mechanisms to avoid apoptosis, and alterations in mRNA alternative splicing are increasingly recognized to have a role in tumorigenesis. In this study, we identify the splicing regulator SLU7 as an essential factor for the preservation of hepatocellular carcinoma (HCC) cells viability. Compared with hepatocytes, SLU7 expression is reduced in HCC cells; however, further SLU7 depletion triggered autophagy-related cellular apoptosis in association with the overproduction of reactive oxygen species. Remarkably, these responses were not observed in primary human hepatocytes or in the well-differentiated HepaRG cell line. Mechanistically, we demonstrate that SLU7 binds the C13orf25 primary transcript in which the polycistronic oncomir miR-17-92 cluster is encompassed, and is necessary for its processing and expression. SLU7 knockdown altered the splicing of the C13orf25 primary transcript, and markedly reduced the expression of its miR-17, miR-20 and miR-92a constituents. This led to the upregulation of CDKN1A (P21) and BCL2L11 (BIM) expression, two bona fide targets of the miR-17-92 cluster and recognized mediators of its pro-survival and tumorigenic activity. Interestingly, altered splicing of miR-17-92 and downregulation of miR-17 and miR-20 were not observed upon SLU7 knockdown in non-transformed hepatocytes, but was found in other (HeLa, H358) but not in all (Caco2) non-hepatic tumor cells. The functional relevance of miR-17-92 dysregulation upon SLU7 knockdown was established when oxidative stress, autophagy and apoptosis were reversed by co-transfection of HCC cells with a miR-17 mimic. Together, these findings indicate that SLU7 is co-opted by HCC cells and other tumor cell types to maintain survival, and identify this splicing regulator as a new determinant for the expression of the oncogenic miR-17-92 cluster. This novel mechanism may be exploited for the development of antitumoral strategies in cancers displaying such SLU7-miR-17-92 crosstalk.	[Urtasun, R.; Elizalde, M.; Azkona, M.; Latasa, M. U.; Garcia-Irigoyen, O.; Fernandez-Barrena, M. G.; Prieto, J.; Avila, M. A.; Berasain, C.] Univ Navarra, CIMA, Div Hepatol, Avda Pio 12,N55, Pamplona 31008, Spain; [Urtasun, R.; Latasa, M. U.; Fernandez-Barrena, M. G.; Vicent, S.; Alonso, M. M.; Avila, M. A.; Berasain, C.] Navarra Inst Hlth Res, IDISNA, Pamplona, Spain; [Uriarte, I.; Muntane, J.; Prieto, J.; Avila, M. A.; Berasain, C.] Inst Salud Carlos III, CIBERehd, Madrid, Spain; [Vicent, S.; Alonso, M. M.] Univ Navarra, CIMA, Div Oncol, Pamplona, Spain; [Alonso, M. M.] Univ Navarra Clin, Div Oncol, Pamplona, Spain; [Muntane, J.] Univ Seville, Dept Gen Surg, Virgen del Rocio Virgen Macarena Univ Hosp, IBiS,CSIC, Seville, Spain	University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; University of Navarra; University of Navarra; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS)	Avila, MA; Berasain, C (corresponding author), Univ Navarra, CIMA, Div Hepatol, Avda Pio 12,N55, Pamplona 31008, Spain.	maavila@unav.es; cberasain@unav.es	Sharma, Ashwani/AAK-3879-2020; Garcia-Irigoyen, Oihane/HDM-3461-2022; Uriarte, Iker/AFP-1513-2022; Avila, Matias A/Y-6342-2019; Vicent, Silvestre/K-4261-2017; Uriarte, Iker/AFP-1514-2022; Berasain, Carmen/E-4139-2016; Azkona, Maria/Z-2273-2019; Fernandez-Barrena, Maite G/J-8040-2014; URIARTE, IKER/Z-2161-2019; URTASUN, RAQUEL/AAD-1590-2021; M., Elizalde/Z-2691-2019; Alonso, Marta M/AAI-9457-2020; Latasa, Maria Ujue/Z-2178-2019	Sharma, Ashwani/0000-0001-9835-1973; Garcia-Irigoyen, Oihane/0000-0002-9964-3940; Avila, Matias A/0000-0001-6570-3557; Vicent, Silvestre/0000-0002-9457-6881; Berasain, Carmen/0000-0001-7075-2476; Azkona, Maria/0000-0003-4044-8427; Fernandez-Barrena, Maite G/0000-0003-0375-6236; URIARTE, IKER/0000-0001-5237-7799; M., Elizalde/0000-0002-7636-1836; Alonso, Marta M/0000-0002-7520-7351; Latasa, Maria Ujue/0000-0002-0878-1337; Prieto, Jesus/0000-0002-1091-9593; URTASUN, RAQUEL/0000-0003-2332-5361	Instituto de Salud Carlos III (ISCIII) - 'Fondo Europeo de Desarrollo Regional' (FEDER) 'Una manera de hacer Europa' [FIS PI10/02642, PI13/00359, PI10/00038, PI13/00385]; PFIS fellowship from ISCIII; FPU fellowship from Ministerio de Educacion, Cultura y Deporte; Gobierno de Navarra; Ministerio de Educacion; Fundaciones Mario Losantos, MTorres, Eugenio Rodriguez Pascual; Agustina Damboriena Support	Instituto de Salud Carlos III (ISCIII) - 'Fondo Europeo de Desarrollo Regional' (FEDER) 'Una manera de hacer Europa'; PFIS fellowship from ISCIII; FPU fellowship from Ministerio de Educacion, Cultura y Deporte; Gobierno de Navarra; Ministerio de Educacion; Fundaciones Mario Losantos, MTorres, Eugenio Rodriguez Pascual; Agustina Damboriena Support	FIMA and the 'UTE project CIMA'; RTICC-RD06 00200061; CIBERehd; Grant numbers: FIS PI10/02642, PI13/00359, PI10/00038, PI13/00385 from Instituto de Salud Carlos III (ISCIII) co-financed by 'Fondo Europeo de Desarrollo Regional' (FEDER) 'Una manera de hacer Europa'; Gobierno de Navarra; 'Torres Quevedo' and 'Ramon y Cajal' contracts from Ministerio de Educacion; PFIS fellowship from ISCIII; FPU fellowship from Ministerio de Educacion, Cultura y Deporte; Fundaciones Mario Losantos, MTorres, Eugenio Rodriguez Pascual; Agustina Damboriena Support.	Alberstein M, 2007, RNA, V13, P1988, DOI 10.1261/rna.492907; Bellot GL, 2013, MITOCHONDRION, V13, P155, DOI 10.1016/j.mito.2012.06.007; Berasain C, 2005, J BIOL CHEM, V280, P19012, DOI 10.1074/jbc.M413344200; Berasain C, 2014, HEPAT ONCOL, V1, P241, DOI [10.2217/hep.13.17, 10.2217/HEP.13.17]; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Castillo J, 2006, CANCER RES, V66, P6129, DOI 10.1158/0008-5472.CAN-06-0404; Castillo J, 2009, GASTROENTEROLOGY, V137, P1805, DOI 10.1053/j.gastro.2009.07.065; Chen J, 2015, ONCOGENE, V34, P1, DOI 10.1038/onc.2013.570; Chettouh H, 2013, CANCER RES, V73, P3974, DOI 10.1158/0008-5472.CAN-12-3824; Comincini S, 2013, CANCER BIOL THER, V14, P574, DOI 10.4161/cbt.24597; Concepcion CP, 2012, CANCER J, V18, P262, DOI 10.1097/PPO.0b013e318258b60a; Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063; Das S, 2014, MOL CANCER RES, V12, P1195, DOI 10.1158/1541-7786.MCR-14-0131; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Ebi H, 2009, ONCOGENE, V28, P3371, DOI 10.1038/onc.2009.201; Elizalde M, 2014, J CLIN INVEST, V124, P2909, DOI 10.1172/JCI74382; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Ghigna C, 1998, CANCER RES, V58, P5818; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907; Janas MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002330; Ji M, 2011, AM J PATHOL, V179, P1645, DOI 10.1016/j.ajpath.2011.06.008; Jiang XJ, 2015, J CLIN INVEST, V125, P47, DOI 10.1172/JCI73942; Kiyono K, 2009, CANCER RES, V69, P8844, DOI 10.1158/0008-5472.CAN-08-4401; Koh CM, 2015, NATURE, V523, P96, DOI 10.1038/nature14351; Kurokawa K, 2014, ONCOGENE, V33, P1407, DOI 10.1038/onc.2013.86; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Li YL, 2014, CANCER CELL, V26, P262, DOI 10.1016/j.ccr.2014.06.014; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Olive V, 2013, IMMUNOL REV, V253, P158, DOI 10.1111/imr.12054; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Oltean S, 2014, ONCOGENE, V33, P5311, DOI 10.1038/onc.2013.533; Osada H, 2011, CANCER SCI, V102, P9, DOI 10.1111/j.1349-7006.2010.01707.x; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Paglin S, 2001, CANCER RES, V61, P439; Perugorria MJ, 2009, CANCER RES, V69, P1358, DOI 10.1158/0008-5472.CAN-08-2545; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pichard Lydiane, 2006, Methods Mol Biol, V320, P283; Shomron N, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/594678; Singh RK, 2012, TRENDS MOL MED, V18, P472, DOI 10.1016/j.molmed.2012.06.006; Tan WQ, 2014, WORLD J GASTROENTERO, V20, P5962, DOI 10.3748/wjg.v20.i20.5962; Thomas M, 2013, INT J MOL SCI, V14, P12273, DOI 10.3390/ijms140612273; Urtasun R, 2011, HEPATOLOGY, V54, P2149, DOI 10.1002/hep.24587; Yang H, 2015, BRIT J CANCER, V112, P112, DOI 10.1038/bjc.2014.547; Ying SY, 2006, J BIOMED SCI, V13, P5, DOI 10.1007/s11373-005-9036-8; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhu HQ, 2014, AM J PATHOL, V184, P2828, DOI 10.1016/j.ajpath.2014.06.024	56	17	18	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 8	2016	35	36					4719	4729		10.1038/onc.2015.517	http://dx.doi.org/10.1038/onc.2015.517			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0IS	26804174				2022-12-26	WOS:000383324700005
J	Green, BR; Gajewiak, J; Chhabra, S; Skalicky, JJ; Zhang, MM; Rivier, JE; Bulaj, G; Olivera, BM; Yoshikami, D; Norton, RS				Green, Brad R.; Gajewiak, Joanna; Chhabra, Sandeep; Skalicky, Jack J.; Zhang, Min-Min; Rivier, Jean E.; Bulaj, Grzegorz; Olivera, Baldomero M.; Yoshikami, Doju; Norton, Raymond S.			Structural Basis for the Inhibition of Voltage-gated Sodium Channels by Conotoxin O-GVIIJ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						disulfide; high performance liquid chromatography (HPLC); nuclear magnetic resonance (NMR); peptide chemical synthesis; sodium channel; conotoxin; cysteine; structure-activity relationship studies; two-electrode voltage clamp electrophysiology	NMR CHEMICAL-SHIFTS; MU-CONOTOXIN; CYSTINE KNOT; PROTEIN STRUCTURES; TETRODOTOXIN; POLYPEPTIDES; IDENTIFY; PROGRAM; PEPTIDE; TOXINS	Cone snail toxins are well known blockers of voltage-gated sodium channels, a property that is of broad interest in biology and therapeutically in treating neuropathic pain and neurological disorders. Although most conotoxin channel blockers function by direct binding to a channel and disrupting its normal ion movement, conotoxin O -GVIIJ channel blocking is unique, using both favorable binding interactions with the channel and a direct tether via an intermolecular disulfide bond. Disulfide exchange is possible because conotoxin O -GVIIJ contains an S-cysteinylated Cys-24 residue that is capable of exchanging with a free cysteine thiol on the channel surface. Here, we present the solution structure of an analog of O -GVIIJ (GVIIJ[C24S]) and the results of structure-activity studies with synthetic O -GVIIJ variants. GVIIJ[C24S] adopts an inhibitor cystine knot structure, with two antiparallel -strands stabilized by three disulfide bridges. The loop region linking the -strands (loop 4) presents residue 24 in a configuration where it could bind to the proposed free cysteine of the channel (Cys-910, rat Na(V)1.2 numbering; at site 8). The structure-activity study shows that three residues (Lys-12, Arg-14, and Tyr-16) located in loop 2 and spatially close to residue 24 were also important for functional activity. We propose that the interaction of O -GVIIJ with the channel depends on not only disulfide tethering via Cys-24 to a free cysteine at site 8 on the channel but also the participation of key residues of O -GVIIJ on a distinct surface of the peptide.	[Green, Brad R.; Chhabra, Sandeep; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia; [Green, Brad R.; Gajewiak, Joanna; Zhang, Min-Min; Olivera, Baldomero M.; Yoshikami, Doju] Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA; [Skalicky, Jack J.] Univ Utah, Coll Pharm, Dept Biochem, Salt Lake City, UT 84108 USA; [Bulaj, Grzegorz] Univ Utah, Coll Pharm, Dept Med Chem, Salt Lake City, UT 84108 USA; [Rivier, Jean E.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Monash University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Salk Institute	Yoshikami, D (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.; Norton, RS (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	yoshikami@bioscience.utah.edu; ray.norton@monash.edu	Chhabra, Sandeep/T-5468-2018; chhabra, sandeep/R-9942-2017	Chhabra, Sandeep/0000-0002-5225-1333; Olivera, Baldomero/0000-0003-4556-1410; Norton, Raymond/0000-0001-8893-0584	National Institutes of Health [GM 048677]; Janssen Research and Development, LLC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janssen Research and Development, LLC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM 048677. Syntheses of GVIIJ analogs were also supported in part by funds from Janssen Research and Development, LLC. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BECKER S, 1992, BIOCHEMISTRY-US, V31, P8229, DOI 10.1021/bi00150a016; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Chahine M, 2008, CNS NEUROL DISORD-DR, V7, P144, DOI 10.2174/187152708784083830; Chen CL, 2012, J BIOL CHEM, V287, P39061, DOI 10.1074/jbc.M112.397646; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; Fiedler B, 2008, BIOCHEM PHARMACOL, V75, P2334, DOI 10.1016/j.bcp.2008.03.019; Gajewiak J, 2014, P NATL ACAD SCI USA, V111, P2758, DOI 10.1073/pnas.1324189111; Gilchrist J, 2013, P NATL ACAD SCI USA, V110, pE5016, DOI 10.1073/pnas.1314557110; Gracy J, 2008, NUCLEIC ACIDS RES, V36, pD314, DOI 10.1093/nar/gkm939; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leipold E, 2007, CHANNELS, V1, P253, DOI 10.4161/chan.4847; McArthur JR, 2011, BIOCHEMISTRY-US, V50, P116, DOI 10.1021/bi101316y; MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466; Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Robinson SD, 2014, MAR DRUGS, V12, P6058, DOI 10.3390/md12126058; SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shon KJ, 1998, J NEUROSCI, V18, P4473; SIBANDA BL, 1989, J MOL BIOL, V206, P759, DOI 10.1016/0022-2836(89)90583-4; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Waxman SG, 2002, J REHABIL RES DEV, V39, P233; West PJ, 2002, BIOCHEMISTRY-US, V41, P15388, DOI 10.1021/bi0265628; WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9; Wilson MJ, 2011, P NATL ACAD SCI USA, V108, P10302, DOI 10.1073/pnas.1107027108; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Zhang MM, 2007, J BIOL CHEM, V282, P30699, DOI 10.1074/jbc.M704616200; Zhang MM, 2015, BIOCHEMISTRY-US, V54, P3911, DOI 10.1021/acs.biochem.5b00390; Zhang MM, 2010, J NEUROPHYSIOL, V104, P88, DOI 10.1152/jn.00145.2010; Zhang MM, 2010, BIOCHEMISTRY-US, V49, P4804, DOI 10.1021/bi100207k; Zhang MM, 2009, CHANNELS, V3, P32, DOI 10.4161/chan.3.1.7500	37	4	6	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7205	7220		10.1074/jbc.M115.697672	http://dx.doi.org/10.1074/jbc.M115.697672			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26817840	Green Published, hybrid			2022-12-26	WOS:000373299700052
J	Li, Y; Burclaff, J; Anderson, JT				Li, Yan; Burclaff, Joseph; Anderson, James T.			Mutations in Mtr4 Structural Domains Reveal Their Important Role in Regulating tRNA(i)(Met) Turnover in Saccharomyces cerevisiae and Mtr4p Enzymatic Activities In Vitro	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; RIBOSOMAL-RNA; NUCLEAR-RNA; BOX PROTEIN; ARCH DOMAIN; EXOSOME; POLYADENYLATION; DEGRADATION; COMPLEX; BINDING	RNA processing and turnover play important roles in the maturation, metabolism and quality control of a large variety of RNAs thereby contributing to gene expression and cellular health. The TRAMP complex, composed of Air2p, Trf4p and Mtr4p, stimulates nuclear exosome-dependent RNA processing and degradation in Saccharomyces cerevisiae. The Mtr4 protein structure is composed of a helicase core and a novel so-called arch domain, which protrudes from the core. The helicase core contains highly conserved helicase domains RecA-1 and 2, and two structural domains of unclear functions, winged helix domain (WH) and ratchet domain. How the structural domains (arch, WH and ratchet domain) coordinate with the helicase domains and what roles they are playing in regulating Mtr4p helicase activity are unknown. We created a library of Mtr4p structural domain mutants for the first time and screened for those defective in the turnover of TRAMP and exosome substrate, hypo-modified tRNA(i)(Met). We found these domains regulate Mtr4p enzymatic activities differently through characterizing the arch domain mutants K700N and P731S, WH mutant K904N, and ratchet domain mutant R1030G. Arch domain mutants greatly reduced Mtr4p RNA binding, which surprisingly did not lead to significant defects on either in vivo tRNA(i)(Met) turnover, or in vitro unwinding activities. WH mutant K904N and Ratchet domain mutant R1030G showed decreased tRNA(i)(Met) turnover in vivo, as well as reduced RNA binding, ATPase and unwinding activities of Mtr4p in vitro. Particularly, K904 was found to be very important for steady protein levels in vivo. Overall, we conclude that arch domain plays a role in RNA binding but is largely dispensable for Mtr4p enzymatic activities, however the structural domains in the helicase core significantly contribute to Mtr4p ATPase and unwinding activities.	[Anderson, James T.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA; [Li, Yan] Agr Univ Hebei, Coll Vet Med, Baoding 071001, Hebei, Peoples R China; [Burclaff, Joseph] Washington Univ, Div Biol & Biomed Sci, St Louis, MO 63110 USA	Marquette University; Hebei Agricultural University; Washington University (WUSTL)	Anderson, JT (corresponding author), Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA.	james.anderson@marquette.edu		Burclaff, Joseph/0000-0002-0325-5039	National Institutes of Health National Institute of General Medical Sciences [1R15GM100445]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM100445] Funding Source: NIH RePORTER	National Institutes of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health National Institute of General Medical Sciences, grant number 1R15GM100445 funding to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; ANDERSON JT, 1993, MOL CELL BIOL, V13, P2730, DOI 10.1128/MCB.13.5.2730; Bernstein J, 2008, J BIOL CHEM, V283, P4930, DOI 10.1074/jbc.M706677200; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; CADWELL RC, 1994, PCR METH APPL, V3, pS136; Cristodero M, 2007, NUCLEIC ACIDS RES, V35, P7023, DOI 10.1093/nar/gkm736; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Domdey H, ANONYMOUS METHODS EN, P398; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; Falk S, 2014, MOL CELL; Fasken MB, 2011, J BIOL CHEM, V286, P37429, DOI 10.1074/jbc.M111.271494; Halbach F, 2013, CELL, V154, P814, DOI 10.1016/j.cell.2013.07.017; Halbach F, 2012, RNA, V18, P124, DOI 10.1261/rna.029553.111; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Holub P, 2012, NUCLEIC ACIDS RES, V40, P5679, DOI 10.1093/nar/gks223; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Inoue K, 2000, J BIOL CHEM, V275, P32793, DOI 10.1074/jbc.M004560200; Jackson RN, 2010, EMBO J, V29, P2205, DOI 10.1038/emboj.2010.107; Jia HJ, 2012, P NATL ACAD SCI USA, V109, P7292, DOI 10.1073/pnas.1201085109; Jia HJ, 2011, CELL, V145, P890, DOI 10.1016/j.cell.2011.05.010; Johnson SJ, 2013, RNA BIOL, V10, P33, DOI 10.4161/rna.22101; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; KADOWAKI T, 1994, J CELL BIOL, V126, P649, DOI 10.1083/jcb.126.3.649; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Liang S, 1996, MOL CELL BIOL, V16, P5139; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Philips AV, 2000, CELL MOL LIFE SCI, V57, P235, DOI 10.1007/PL00000687; Richards JD, 2008, J BIOL CHEM, V283, P5118, DOI 10.1074/jbc.M707548200; Shcherbik N, 2010, EMBO REP, V11, P106, DOI 10.1038/embor.2009.271; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taylor LL, 2014, NUCLEIC ACIDS RES, V42, P13861, DOI 10.1093/nar/gku1208; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104; Wang XY, 2008, RNA, V14, P107, DOI 10.1261/rna.808608; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107; Woodman IL, 2011, BIOCHEM SOC T, V39, P140, DOI 10.1042/BST0390140; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946	43	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148090	10.1371/journal.pone.0148090	http://dx.doi.org/10.1371/journal.pone.0148090			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820724	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528400065
J	Bigdeli, M; Jacobs, B; Men, CR; Nilsen, K; Van Damme, W; Dujardin, B				Bigdeli, Maryam; Jacobs, Bart; Men, Chean Rithy; Nilsen, Kristine; Van Damme, Wim; Dujardin, Bruno			Access to Treatment for Diabetes and Hypertension in Rural Cambodia: Performance of Existing Social Health Protection Schemes	PLOS ONE			English	Article							CHRONIC DISEASES; LOW-INCOME; NONCOMMUNICABLE DISEASES; ESSENTIAL MEDICINES; HOUSEHOLD SURVEYS; DETERMINANTS; EXPENDITURE; POOR; CARE; EXPLORATION	Background Non-communicable diseases (NCD) pose challenges to Cambodia's health system. Medicines for NCD are on the National Essential Medicines List but no clinical guidelines support their utilization. Two social health protection schemes aimed at the informal sector population exist (Health Equity Funds and Insurance) together with two disease-specific interventions (a Peer Educator Network and Chronic Diseases Clinics) targeted at NCD patients. This study examines performance of these various schemes in relation to NCD. Methods Cross-sectional household survey among 709 individuals self-reporting diabetes and/or hypertension in three geographical locations in rural Cambodia using a structured questionnaire investigating diagnostic and treatment pathways, health seeking behaviour, health expenditures, and financial coping mechanisms. Results Two third of respondents with NCD were female and 55% did not belong to any scheme. The majority (59%) were diagnosed in the private sector and only 56% were on allopathic treatment that was mainly sought in the private sector (49%). Outpatient treatment cost was higher in the private sector and when using multiple providers of care. The majority were indebted, 11% due to health-related expenses. Contrary to social health protection schemes, disease-specific interventions offered better access to allopathic treatment and provided medicines in accordance with NEML. Conclusion The benefit packages of existing social health protection schemes and services in the public health sector should be adjusted to cater for the needs of people living with NCD in rural Cambodia. Initiatives that offer active disease management strategies and promote patients and community participation appear more successful in increasing treatment adherence and decreasing the risk of financial hardship.	[Bigdeli, Maryam] World Hlth Org, Alliance Hlth Policy & Syst Res, Geneva, Switzerland; [Jacobs, Bart] Deutsch Gesell Int Zusammenarbeit GIZ, Phnom Penh, Cambodia; [Men, Chean Rithy] Chean & Jaco Consulting Co, Phnom Penh, Cambodia; [Nilsen, Kristine] Univ Southampton, Dept Social Stat & Demog, Southampton, Hants, England; [Van Damme, Wim] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Dujardin, Bruno] Univ Libre Bruxelles, Sch Publ Hlth, Sante Int, Ctr Rech Polit & Syst Sante, Brussels, Belgium	World Health Organization; University of Southampton; Institute of Tropical Medicine (ITM); Universite Libre de Bruxelles	Bigdeli, M (corresponding author), World Hlth Org, Alliance Hlth Policy & Syst Res, Geneva, Switzerland.	bigdelim@who.int	Albertin, Paloma C/X-1093-2018; Jacobs, Bart/AAF-2370-2019; Van Damme, Wim/F-7404-2011	Van Damme, Wim/0000-0002-6344-3007; Nilsen, Kristine/0000-0003-2009-4019	Alliance for Health Policy and Systems Research; Economic and Social Research Council [1226572] Funding Source: researchfish	Alliance for Health Policy and Systems Research; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Chean and Jaco Consulting Company is a not-for profit small research company founded by CM and BJ. None of them is salaried by the company. Chean and Jaco Consulting Company received funding from the Alliance for Health Policy and Systems Research to conduct this study, following a competitive bidding process. As principal and co-investigators of the concerned research, both CM and BJ were involved in the study design, data collection, analysis, decision to publish and preparation of the manuscript. However, this involvement was free of any conflict of interest. CM and BJ's respective contributions are stated in the "authors contributions" section.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Abegunde DO, 2008, SOC SCI MED, V66, P2296, DOI 10.1016/j.socscimed.2008.01.041; Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; Albanese E, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-153; [Anonymous], 2012, MOPOTSYO ANN REP 201; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Beaglehole R, 2003, LANCET, V362, P903, DOI 10.1016/S0140-6736(03)14335-8; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bhojani U, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-306; Bhojani U, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-990; Bigdeli M, 2013, HEALTH POLICY PLANN, V28, P692, DOI 10.1093/heapol/czs108; Brinda EM, 2012, INT PSYCHOGERIATR, V24, P1664, DOI 10.1017/S104161021200083X; Dalis P, 2014, CDRI WORKING PAPER S, V92; Eggermont N, 2011, EVALUATION PEER ED P; Gilson L, 2012, ED HLTH POLICY SYSTE; Minh HV, 2013, GLOBAL HEALTH ACTION, V6, P16, DOI 10.3402/gha.v5i0.18892; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; Ir P, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-383; Jacobs B, 2006, HEALTH POLICY PLANN, V21, P27, DOI 10.1093/heapol/czj001; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Jiang CH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-988; Jing SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053062; King H, 2005, LANCET, V366, P1633, DOI 10.1016/S0140-6736(05)67662-3; Mannava P, ASIA PACIFI IN PRESS; Meessen B, 2003, TROP MED INT HEALTH, V8, P581, DOI 10.1046/j.1365-3156.2003.01081.x; Meessen B, 2011, HEALTH POLICY PLANN, V26, pi30, DOI 10.1093/heapol/czr026; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Ministry of Health, 2009, ESS MED LIST; Ministry of Health, 2006, NAT GUID COMPL PACK; Ministry of Health, 2013, NAT STRAT PREV CONTR; Ministry of Health, 2012, STAND BEN PACK PROV; Ministry of Health, 2006, GUID IMPL COMM BAS H; Ministry of Health, 1996, NAT CHART HLTH FIN K; Ministry of Health, 2013, ANN HLTH FIN REP 201; Ministry of Health, 2006, GUID MIN PACK ACT HL; Ministry of Health, 2012, OUT OF POCK EXP HLTH; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; National Institute of Statistics, 2010, CAMB DEM HLTH SURV 2; Otgontuya D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-254; Ovesen J., 2010, CAMBODIANS THEIR DOC; Ozawa S, 2011, HEALTH POLICY PLANN, V26, pi20, DOI 10.1093/heapol/czr045; Peters D, 2012, NATURE, V487, P163, DOI 10.1038/487163a; Peters DH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6753; Porter T, 2009, J INT DEV, V21, P271, DOI 10.1002/jid.1552; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Raguenaud ME, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-33; Rahman Abdul Rashid Abdul, 2015, Asia Pac Fam Med, V14, P2, DOI 10.1186/s12930-015-0018-3; Rahman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056873; Sarayani A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005859; Shahrawat R, 2012, HEALTH POLICY PLANN, V27, P213, DOI 10.1093/heapol/czr029; Smith-Spangler CM, 2012, DIABETES CARE, V35, P319, DOI 10.2337/dc11-1770; Trankell I-B, 2007, MED IDENTITIES HLTH; Van Damme W, 2004, TROP MED INT HEALTH, V9, P273, DOI 10.1046/j.1365-3156.2003.01194.x; Van Pelt M., 2011, PEER ED NETWORKS PEO; Vialle-Valentin CE, 2015, HEALTH POLICY PLANN, V30, P1044, DOI 10.1093/heapol/czu107; Wagner AK, 2011, HEALTH POLICY, V100, P151, DOI 10.1016/j.healthpol.2010.08.004; Wang Q, 2015, HEALTH POLICY PLANN, V30, P242, DOI 10.1093/heapol/czu004; World Bank, 2013, CAMB RUR HLTH MARK; World Food Programme, 2015, CAMB FOOD PRIC WAG B; You X, 2011, APPL HEALTH ECON HEA, V9, P39, DOI 10.2165/11530730-000000000-00000	60	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146147	10.1371/journal.pone.0146147	http://dx.doi.org/10.1371/journal.pone.0146147			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GD	26815916	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000369528200008
J	Matza, D; Badou, A; Klemic, KG; Stein, J; Govindarajulu, U; Nadler, MJ; Kinet, JP; Peled, A; Shapira, OM; Kaczmarek, LK; Flavell, RA				Matza, Didi; Badou, Abdallah; Klemic, Kathryn G.; Stein, Judith; Govindarajulu, Usha; Nadler, Monica J.; Kinet, Jean-Pierre; Peled, Amnon; Shapira, Oz M.; Kaczmarek, Leonard K.; Flavell, Richard A.			T Cell Receptor Mediated Calcium Entry Requires Alternatively Spliced Ca(v)1.1 Channels	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; INTRACELLULAR CALCIUM; MICE LACKING; CA2+; ACTIVATION; LYMPHOCYTES; MEMBRANE; PROTEIN; INFLUX; STIM1	The process of calcium entry in T cells is a multichannel and multi-step process. We have studied the requirement for L-type calcium channels (Ca(v)1.1) alpha 1S subunits during calcium entry after TCR stimulation. High expression levels of Ca(v)1.1 channels were detected in activated T cells. Sequencing and cloning of Ca(v)1.1 channel cDNA from T cells revealed that a single splice variant is expressed. This variant lacks exon 29, which encodes the linker region adjacent to the voltage sensor, but contains five new N-terminal exons that substitute for exons 1 and 2, which are found in the Ca(v)1.1 muscle counterpart. Overexpression studies using cloned T cell Ca(v)1.1 in 293HEK cells (that lack TCR) suggest that the gating of these channels was altered. Knockdown of Ca(v)1.1 channels in T cells abrogated calcium entry after TCR stimulation, suggesting that Ca(v)1.1 channels are controlled by TCR signaling.	[Matza, Didi] Open Univ Israel, Dept Nat Sci, 1 Univ Rd, IL-4353701 Raanana, Israel; [Badou, Abdallah] Hassan II Univ, Casablanca Sch Med & Pharm, Genet & Mol Pathol Lab, Casablanca, Morocco; [Klemic, Kathryn G.] Virginia Tech Appl Res Corp, 900 North Glebe Rd, Arlington, VA 22203 USA; [Stein, Judith; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St, New Haven, CT 06520 USA; [Stein, Judith; Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Govindarajulu, Usha] Yale Univ, Sch Med, Yale Ctr Clin Invest, New Haven, CT 06520 USA; [Nadler, Monica J.; Kinet, Jean-Pierre] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Peled, Amnon] Hadassah Univ Hosp, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel; [Shapira, Oz M.] Hadassah Univ Hosp, Dept Cardiothorac Surg, IL-91120 Jerusalem, Israel; [Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Open University Israel; Hassan II University of Casablanca; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Harvard University; Beth Israel Deaconess Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Yale University; Yale University	Matza, D (corresponding author), Open Univ Israel, Dept Nat Sci, 1 Univ Rd, IL-4353701 Raanana, Israel.	didima@openu.ac.il		Govindarajulu, Usha/0000-0001-5864-7403; Badou, Abdallah/0000-0003-4849-9085	FP7-PEOPLE-RG - Acronym:Cav in Immune System and Cancer Research Institute postdoctoral fellowship [268263]; Arthritis National Research Foundation; Aaron Beare Foundation, South Africa;  [5R01AI075129]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075129] Funding Source: NIH RePORTER	FP7-PEOPLE-RG - Acronym:Cav in Immune System and Cancer Research Institute postdoctoral fellowship; Arthritis National Research Foundation(National Research Foundation of Korea); Aaron Beare Foundation, South Africa; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by (D.M.) - FP7-PEOPLE-2010-RG Proposal No 268263 - Acronym:Cav in Immune System and Cancer Research Institute postdoctoral fellowship, (A.B.) - Arthritis National Research Foundation. J.P.K. and M.J.N. were supported by 5R01AI075129 grant. R.A.F. is an investigator of the Howard Hughes Medical Institute.; The authors thank F. Manzo for assistance with the manuscript preparation. Dr. R. Babai for helpful discussions. D. M. also thank Michal Gropp and Etti Ben Shushan for their technical support. A.B. was supported by the Arthritis National Research Foundation. D. M was consecutively supported by Cancer Research Institute postdoctoral fellowship then by the European Council Marie Curie FP-7-PEOPLE-2010-RG (proposal number 268263) and The Aaron Beare Foundation, South Africa. J.P.K. and M.J.N. were supported by 5R01AI075129 grant. R. A. F. is an investigator of the Howard Hughes Medical Institute.	Badou A, 1997, J BIOL CHEM, V272, P32411, DOI 10.1074/jbc.272.51.32411; Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; Badou A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00243; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; Bertin S, 2014, NAT IMMUNOL, V15, P1055, DOI 10.1038/ni.3009; BILBREY GL, 1973, J CLIN INVEST, V52, P3011, DOI 10.1172/JCI107499; Cantrell DA, 1996, CANCER SURV, V27, P165; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chemin J, 2000, FEBS LETT, V478, P166, DOI 10.1016/S0014-5793(00)01832-9; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Findeisen F, 2010, CHANNELS, V4, P459, DOI 10.4161/chan.4.6.12867; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; GELFAND EW, 1986, EUR J IMMUNOL, V16, P907, DOI 10.1002/eji.1830160806; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Jha MK, 2009, NAT IMMUNOL, V10, P1275, DOI 10.1038/ni.1793; Komuro A, 2004, P NATL ACAD SCI USA, V101, P4053, DOI 10.1073/pnas.0308619101; Kotturi MF, 2006, TRENDS PHARMACOL SCI, V27, P360, DOI 10.1016/j.tips.2006.05.007; Kotturi MF, 2005, MOL IMMUNOL, V42, P1461, DOI 10.1016/j.molimm.2005.01.014; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Luo DL, 2000, GEN PHARMACOL-VASC S, V34, P211, DOI 10.1016/S0306-3623(00)00064-1; MASON MJ, 1993, AM J PHYSIOL, V264, pC654, DOI 10.1152/ajpcell.1993.264.3.C654; Matza D, 2008, IMMUNITY, V28, P64, DOI 10.1016/j.immuni.2007.11.020; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Omilusik K, 2011, IMMUNITY, V35, P349, DOI 10.1016/j.immuni.2011.07.011; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; RINK TJ, 1980, BIOCHIM BIOPHYS ACTA, V595, P15, DOI 10.1016/0005-2736(80)90243-6; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Savignac M, 2004, J IMMUNOL, V172, P5206, DOI 10.4049/jimmunol.172.9.5206; Savignac M, 2001, FASEB J, V15, P1577, DOI 10.1096/fj.00-0733fje; Stokes L, 2004, J BIOL CHEM, V279, P19566, DOI 10.1074/jbc.M401481200; Tang ZZ, 2012, HUM MOL GENET, V21, P1312, DOI 10.1093/hmg/ddr568; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Tuluc P, 2009, BIOPHYS J, V96, P35, DOI 10.1016/j.bpj.2008.09.027; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5; Wissenbach U, 2007, CELL CALCIUM, V42, P439, DOI 10.1016/j.ceca.2007.05.014; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	46	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147379	10.1371/journal.pone.0147379	http://dx.doi.org/10.1371/journal.pone.0147379			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815481	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528200031
J	Panek, J; Frac, M; Bilinska-Wielgus, N				Panek, Jacek; Frac, Magdalena; Bilinska-Wielgus, Nina			Comparison of Chemical Sensitivity of Fresh and Long-Stored Heat Resistant Neosartorya fischeri Environmental Isolates Using BIOLOG Phenotype MicroArray System	PLOS ONE			English	Article							CARBONIC-ANHYDRASE INHIBITORS; ANTIFUNGAL PROTEIN NFAP; BYSSOCHLAMYS-FULVA; ZARAGOZIC ACIDS; ISOZYME-II; DERIVATIVES; FUNGI; ASCOSPORES; SELENIUM; DNA	Spoilage of heat processed food and beverage by heat resistant fungi (HRF) is a major problem for food industry in many countries. Neosartorya fischeri is the leading source of spoilage in thermally processed products. Its resistance to heat processing and toxigenicity makes studies about Neosartorya fischeri metabolism and chemical sensitivity essential. In this study chemical sensitivity of two environmental Neosartorya fischeri isolates were compared. One was isolated from canned apples in 1923 (DSM3700), the other from thermal processed strawberry product in 2012 (KC179765), used as long-stored and fresh isolate, respectively. The study was conducted using Biolog Phenotype MicroArray platforms of chemical sensitivity panel and traditional hole-plate method. The study allowed for obtaining data about Neosartorya fischeri growth inhibitors. The fresh isolate appeared to be much more resistant to chemical agents than the long-stored isolate. Based on phenotype microarray assay nitrogen compounds, toxic cations and membrane function compounds were the most effective in growth inhibition of N. fischeri isolates. According to the study zaragozic acid A, thallium(I) acetate and sodium selenate were potent and promising N. fischeri oriented fungicides which was confirmed by both chemical sensitivity microplates panel and traditional hole-plate methods.	[Panek, Jacek; Frac, Magdalena; Bilinska-Wielgus, Nina] Polish Acad Sci, Dept Plant & Soil Syst, Lab Mol & Environm Microbiol, Inst Agrophys, Doswiadczalna 4, PL-20290 Lublin, Poland	Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences	Frac, M (corresponding author), Polish Acad Sci, Dept Plant & Soil Syst, Lab Mol & Environm Microbiol, Inst Agrophys, Doswiadczalna 4, PL-20290 Lublin, Poland.	m.frac@ipan.lublin.pl	Panek, Jacek/W-3379-2019	Panek, Jacek/0000-0002-9217-5902; Frac, Magdalena/0000-0001-9437-3139; Bilinska-Wielgus, Nina/0000-0002-6312-6167	National Science Centre (Poland) [DEC-2012/07/D/NZ9/03357]	National Science Centre (Poland)	This research was supported by National Science Centre (Poland), project No.: DEC-2012/07/D/NZ9/03357, https://www.ncn.gov.pl/?language=en. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Mejdad N.M.J.A., 2013, EUR J EXP BIOL, V3, P535; Bartizal KF, 1991, Novel anti-fungal compounds, Patent No. [US5053425 A, 5053425]; BERGSTROM JD, 1993, P NATL ACAD SCI USA, V90, P80, DOI 10.1073/pnas.90.1.80; BERGSTROM JD, 1995, ANNU REV MICROBIOL, V49, P607, DOI 10.1146/annurev.mi.49.100195.003135; Beuchat L. R., 2001, COMPENDIUM METHODS M, P217; BEUCHAT LR, 1986, J FOOD SCI, V51, P1506, DOI 10.1111/j.1365-2621.1986.tb13846.x; Bochner BR, 2003, NAT REV GENET, V4, P309, DOI 10.1038/nrg1046; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BRENNAN MB, 1980, J MOL BIOL, V136, P333, DOI 10.1016/0022-2836(80)90377-0; Bromley MJ, 2014, J GLOB ANTIMICROB RE, V2, P276, DOI 10.1016/j.jgar.2014.05.004; Brzozowski Z, 2010, EUR J MED CHEM, V45, P2396, DOI 10.1016/j.ejmech.2010.02.020; Chipley Jr, 2005, FOOD SCI, V143, P11; Conerly O, 2009, 7440280 CAS US EPA; Dabrah TT, 1995, Inhibitor of squalene synthase, Patent No. [US 5430055 A, 5430055]; David ER, 1959, Thiourea fungicides, Patent No. [US3006808 A, 3006808]; Delgado DA, 2012, FOOD CONTROL, V23, P165, DOI 10.1016/j.foodcont.2011.07.004; dos Santos L, 2008, BIOORGAN MED CHEM, V16, P8526, DOI 10.1016/j.bmc.2008.08.019; Faidallah HM, 2011, J FLUORINE CHEM, V132, P870, DOI 10.1016/j.jfluchem.2011.06.014; Frac M, SEQUENCE HEAT RESIST; Frac M, 2015, ADV AGRON, V132, P161, DOI 10.1016/bs.agron.2015.02.003; Gabrielson J, 2002, J MICROBIOL METH, V50, P63, DOI 10.1016/S0167-7012(02)00011-8; Gadad AK, 2000, EUR J MED CHEM, V35, P853, DOI 10.1016/S0223-5234(00)00166-5; Galgoczy L, 2013, MICROBIOL-SGM, V159, P411, DOI 10.1099/mic.0.061119-0; Galli A, 1996, MUTAT RES-GENET TOX, V370, P209, DOI 10.1016/S0165-1218(96)00078-X; Garaj V, 2005, BIOORG MED CHEM LETT, V15, P3102, DOI 10.1016/j.bmcl.2005.04.056; Hambuckers A, 2010, COMMUN SOIL SCI PLAN, V41, P1283, DOI 10.1080/00103621003759296; Hardy WB, 1957, Fungicide, Patent No. [US2953491 A, 2953491]; HARTMANN M, 1985, POLYM BULL, V13, P195; Johnson G. F., 1935, AGR HIST, V9, P67; Joung JK, 2000, P NATL ACAD SCI USA, V97, P7382, DOI 10.1073/pnas.110149297; JUKES T. H., 1963, Economic Botany, V17, P238, DOI 10.1007/BF02859441; Kaifuchi S, 2015, J ANTIBIOT, V68, P403, DOI 10.1038/ja.2014.167; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Kotowicz N. K., 2014, Journal of Animal and Plant Sciences (JAPS), V21, P3326; Kotzekidou P, 1997, J FOOD SCI, V62, P410, DOI 10.1111/j.1365-2621.1997.tb04014.x; Kovacic P, 2011, MED HYPOTHESES, V76, P24, DOI 10.1016/j.mehy.2010.08.023; Kovacs L, 2011, PEPTIDES, V32, P1724, DOI 10.1016/j.peptides.2011.06.022; Li SS, 2013, P NATL ACAD SCI USA, V110, P19018, DOI 10.1073/pnas.1310439110; Li SS, 2012, BIOORG MED CHEM LETT, V22, P3317, DOI 10.1016/j.bmcl.2012.03.006; Liebelt EL, 2007, BIRTH DEFECTS RES B, V80, P259, DOI 10.1002/bdrb.20123; Ostby DJ, 1991, Water soluble fungicide in matrix between two layers of hydrophilic paper; railroad ties, Patent No. [US5043225 A, 5043225]; Parry KE, 1958, ANN APPL BIOL, V46, P446, DOI 10.1111/j.1744-7348.1958.tb02225.x; Pieckova E, 1997, INT J FOOD MICROBIOL, V36, P227, DOI 10.1016/S0168-1605(97)01239-7; Rajashekhara E, 1998, J FOOD PROTECT, V61, P1358, DOI 10.4315/0362-028X-61.10.1358; Raper KB, 1965, GENUS ASPERGILLUS GE; Renzi G, 2000, BIOORG MED CHEM LETT, V10, P673, DOI 10.1016/S0960-894X(00)00075-5; Rodriguez-Mercado JJ, 2015, ENVIRON TOXICOL, V30, P572, DOI 10.1002/tox.21934; Saczewski F, 2008, BIOORGAN MED CHEM, V16, P3933, DOI 10.1016/j.bmc.2008.01.034; Salama SM, 2001, ANTIMICROB AGENTS CH, V45, P2420, DOI 10.1128/AAC.45.9.2420-2426.2001; Salomao BCM, 2007, LWT-FOOD SCI TECHNOL, V40, P676, DOI 10.1016/j.lwt.2006.03.008; SAMSON RA, 1990, NATO ADV SCI I A-LIF, V185, P455; Sant'Ana AS, 2009, J APPL MICROBIOL, V107, P197, DOI 10.1111/j.1365-2672.2009.04195.x; SCHIESTL RH, 1989, NATURE, V337, P285, DOI 10.1038/337285a0; Schrauzer GN, 2001, J AM COLL NUTR, V20, P1; Sharma BK, 2008, J ENZYM INHIB MED CH, V23, P168, DOI [10.1080/14756360701450301, 10.1080/14756360701450301 ]; Sturino J, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1227; Suresha GP, 2011, EUR J MED CHEM, V46, P2530, DOI 10.1016/j.ejmech.2011.03.041; TRESHOW M, 1965, MYCOLOGIA, V57, P216, DOI 10.2307/3756824; Tripathi K, 2012, FRONT MICROBIOL, P3; Turkkan M, 2014, PLANT PROTECT SCI, V50, P19, DOI 10.17221/9/2013-PPS; Ueda M, 2003, FEMS MICROBIOL LETT, V219, P93, DOI 10.1016/S0378-1097(02)01201-6; Vaas LAI, 2013, BIOINFORMATICS, V29, P1823, DOI 10.1093/bioinformatics/btt291; Vaas LAI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034846; Vandeputte Patrick, 2012, Int J Microbiol, V2012, P713687, DOI 10.1155/2012/713687; Venkatachalam TK, 2004, BIOORGAN MED CHEM, V12, P4275, DOI 10.1016/j.bmc.2004.04.050; Viragh M, 2014, PROTEIN EXPRES PURIF, V94, P79, DOI 10.1016/j.pep.2013.11.003; WILBER CG, 1980, CLIN TOXICOL, V17, P171, DOI 10.3109/15563658008985076; Wollinsky Beate, 2012, Methods Mol Biol, V944, P111, DOI 10.1007/978-1-62703-122-6_7; Xu W, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004427; Yavuz S, 2013, J CHEM, V2013, P1; Zani F, 1998, ARCH PHARM, V331, P219, DOI 10.1002/(SICI)1521-4184(199806)331:6&lt;219::AID-ARDP219&gt;3.0.CO;2-U; Ziegler-Skylakakis K, 2003, THIOUREA CONCISE INT	72	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147605	10.1371/journal.pone.0147605	http://dx.doi.org/10.1371/journal.pone.0147605			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815302	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528200042
J	Peterson, JR; Blieden, LS; Chuang, AZ; Baker, LA; Rigi, M; Feldman, RM; Bell, NP				Peterson, Jeffrey R.; Blieden, Lauren S.; Chuang, Alice Z.; Baker, Laura A.; Rigi, Mohammed; Feldman, Robert M.; Bell, Nicholas P.			Establishing Age-Adjusted Reference Ranges for Iris-Related Parameters in Open Angle Eyes with Anterior Segment Optical Coherence Tomography	PLOS ONE			English	Article							VOLUME; PREVALENCE; MYDRIASIS; GLAUCOMA; ADULTS; WIDTH	Purpose Define criteria for iris-related parameters in an adult open angle population as measured with swept source Fourier domain anterior segment optical coherence tomography (ASOCT). Methods Ninety-eight eyes of 98 participants with open angles were included and stratified into 5 age groups (18-35, 36-45, 46-55, 56-65, and 66-79 years). ASOCT scans with 3D mode angle analysis were taken with the CASIA SS-1000 (Tomey Corporation, Nagoya, Japan) and analyzed using the Anterior Chamber Analysis and Interpretation software. Anterior iris surface length (AISL), length of scleral spur landmark (SSL) to pupillary margin (SSL-to-PM), iris contour ratio (ICR = AISL/SSL-to-PM), pupil radius, radius of iris centroid (RICe), and iris volume were measured. Outcome variables were summarized for all eyes and age groups, and mean values among age groups were compared using one-way analysis of variance. Stepwise regression analysis was used to investigate demographic and ocular characteristic factors that affected each iris-related parameter. Results Mean (+/- SD) values were 2.24 mm (+/- 0.46), 4.06 mm (+/- 0.27), 3.65 mm (+/- 0.48), 4.16 mm (+/- 0.47), 1.14 (+/- 0.04), 1.51 mm(2) (+/- 0.23), and 38.42 mu L (+/- 4.91) for pupillary radius, RICe, SSL-to-PM, AISL, ICR, iris cross-sectional area, and iris volume, respectively. Both pupillary radius (P = 0.002) and RICe (P = 0.027) decreased with age, while SSL-to-PM (P = 0.002) and AISL increased with age (P = 0.001). ICR (P = 0.54) and iris volume (P = 0.49) were not affected by age.	[Peterson, Jeffrey R.; Blieden, Lauren S.; Chuang, Alice Z.; Feldman, Robert M.; Bell, Nicholas P.] Univ Texas Hlth Sci Ctr Houston, UTHlth McGovern Med Sch, Ruiz Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA; [Peterson, Jeffrey R.; Blieden, Lauren S.; Baker, Laura A.; Rigi, Mohammed; Feldman, Robert M.; Bell, Nicholas P.] Robert Cizik Eye Clin, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Bell, NP (corresponding author), Univ Texas Hlth Sci Ctr Houston, UTHlth McGovern Med Sch, Ruiz Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA.; Bell, NP (corresponding author), Robert Cizik Eye Clin, Houston, TX USA.	nbell@cizikeye.org		Feldman, Robert/0000-0001-8586-6345	National Eye Institute Vision Core Grant [P30EY010608]; Research to Prevent Blindness; Hermann Eye Fund; NATIONAL EYE INSTITUTE [P30EY010608] Funding Source: NIH RePORTER	National Eye Institute Vision Core Grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Hermann Eye Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Eye Institute Vision Core Grant P30EY010608, a Challenge Grant to The University of Texas Health Science Center at Houston (UTHealth) McGovern Medical School from Research to Prevent Blindness, and the Hermann Eye Fund. The funders had no role in study design; collection, analysis, or interpretation of data; manuscript	Aptel F, 2010, OPHTHALMOLOGY, V117, pc, DOI 10.1016/j.ophtha.2009.10.030; Blieden LS, 2015, INVEST OPHTH VIS SCI, V56, P2842, DOI 10.1167/iovs.14-15883; Chan FM, 2015, LARYNGOSCOPE; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Cumba RJ, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/487309; Dorairaj Syril, 2007, Trans Am Ophthalmol Soc, V105, P99; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Invernizzi A, 2015, INVEST OPHTH VIS SCI, V56, P4796, DOI 10.1167/iovs.15-16483; Lee RY, 2015, AM J OPHTHALMOL, V160, P506, DOI 10.1016/j.ajo.2015.06.002; Matsuki T, 2015, J GLAUCOMA, V24, P144, DOI 10.1097/IJG.0000000000000090; Mayama C, 2015, INVEST OPHTH VIS SCI, V56, P5681, DOI 10.1167/iovs.15-17208; Narayanaswamy A, 2013, INVEST OPHTH VIS SCI, V54, P708, DOI 10.1167/iovs.12-10844; Quigley HA, 2009, J GLAUCOMA, V18, P173, DOI 10.1097/IJG.0b013e31818624ce; Rigi M, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/590978; Seager FE, 2014, INVEST OPHTH VIS SCI, V55, P1672, DOI 10.1167/iovs.13-13641; Sharma R, 2015, J CLIN DIAGN RES, V9, DOI 10.7860/JCDR/2015/12764.6181; Spaeth G L, 1995, Trans Am Ophthalmol Soc, V93, P337; Spaeth G L, 1971, Trans Ophthalmol Soc U K, V91, P709; Tun TA, 2014, GRAEF ARCH CLIN EXP, V252, P1127, DOI 10.1007/s00417-014-2636-0; Wang YE, 2013, INVEST OPHTH VIS SCI, V54, P7717, DOI 10.1167/iovs.13-12850; WINN B, 1994, INVEST OPHTH VIS SCI, V35, P1132; Yun SC, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/581719; Zhang Y, 2014, INVEST OPHTH VIS SCI, V55, P4405, DOI 10.1167/iovs.13-13782	23	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147760	10.1371/journal.pone.0147760	http://dx.doi.org/10.1371/journal.pone.0147760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815917	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528200047
J	Boni, L; Ruhs, PA; Windhab, EJ; Fischer, P; Kuster, S				Boeni, Lukas; Ruehs, Patrick A.; Windhab, Erich J.; Fischer, Peter; Kuster, Simon			Gelation of Soy Milk with Hagfish Exudate Creates a Flocculated and Fibrous Emulsion- and Particle Gel	PLOS ONE			English	Article							SLIME GLAND; PROTEIN; FIBERS; BIOLOGY; SALIVA	Hagfish slime is an ultra dilute, elastic and cohesive hydrogel that deploys within milliseconds in cold seawater from a glandularly secreted exudate. The slime is made of long keratin-like fibers and mucin-like glycoproteins that span a network which entraps water and acts as a defense mechanism against predators. Unlike other hydrogels, the slime only confines water physically and is very susceptible to mechanical stress, which makes it unsuitable for many processing operations and potential applications. Despite its huge potential, little work has been done to improve and functionalize the properties of this hydrogel. To address this shortcoming, hagfish exudate was mixed with a soy protein isolate suspension (4% w/v) and with a soy emulsion (commercial soy milk) to form a more stable structure and combine the functionalities of a suspension and emulsion with those of the hydrogel. Hagfish exudate interacted strongly with the soy systems, showing a markedly increased visco-elasticity and water retention. Hagfish mucin was found to induce a depletion and bridging mechanism, which caused the emulsion and suspension to flocculate, making "soy slime", a cohesive and cold-set emulsion-and particle gel. The flocculation network increases viscoelasticity and substantially contributes to liquid retention by entrapping liquid in the additional confinements between aggregated particles and protein fibers. Because the mucin-induced flocculation resembles the salt- or acid-induced flocculation in tofu curd production, the soy slime was cooked for comparison. The cooked soy slime was similar to conventional cooked tofu, but possessed a long-range cohesiveness from the fibers. The fibrous, cold-set, and curd-like structure of the soy slime represents a novel way for a cold coagulation and fiber incorporation into a suspension or emulsion. This mechanism could be used to efficiently gel functionalized emulsions or produce novel tofu-like structured food products.	[Boeni, Lukas; Windhab, Erich J.; Fischer, Peter; Kuster, Simon] ETH, Inst Food Nutr & Hlth, Food Proc Engn Grp, CH-8092 Zurich, Switzerland; [Ruehs, Patrick A.] ETH, Dept Mat, Complex Mat Grp, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Boni, L (corresponding author), ETH, Inst Food Nutr & Hlth, Food Proc Engn Grp, CH-8092 Zurich, Switzerland.	lukas.boeni@hest.ethz.ch	Fischer, Peter/A-8740-2011; Kuster, Simon/B-6140-2014; Windhab, Erich J/C-3381-2016; Boni, Lukas/B-2690-2015	Fischer, Peter/0000-0002-2992-5037; Kuster, Simon/0000-0003-2771-9667; Boni, Lukas/0000-0003-4958-0037	Walter Hochstrasser Stiftung; ETH Research Grant [ETH-19 14-1]	Walter Hochstrasser Stiftung; ETH Research Grant	The study was funded by the ETH Research Grant ETH-19 14-1.; The authors thank the curator Rune Veiseth and the whole team of the Atlanterhavsparken Aquarium in angstrom lesund for kindly providing the hagfish. We also express our thanks to Moreforsking angstrom lesund for the opportunity to use their facilities and Snorre Bakke for supervising the sampling of the hagfish according to the ethical guidelines (FOTS ID 6912). We thank Stephane Isabettini for his help with the Zetasizer measurements and Ruben Zurfluh for his support with the mucin dry weight measurements. We also thank the Walter Hochstrasser Stiftung that kindly provided funding in the initial project phase. This work was supported by ETH Research Grant ETH-19 14-1.	[Anonymous], 2012, LECTINS PROPERTIES F; Bocker L, 2016, ACS BIOMATERIALS SCI; Dickinson E, 2013, ADV COLLOID INTERFAC, V199, P114, DOI 10.1016/j.cis.2013.07.002; Dickinson E, 2012, FOOD HYDROCOLLOID, V28, P224, DOI 10.1016/j.foodhyd.2011.12.017; DOWNING SW, 1981, SCIENCE, V214, P1143, DOI 10.1126/science.7302586; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Ellis JE, 2015, FISH RES, V161, P24, DOI 10.1016/j.fishres.2014.06.011; ETZLER ME, 1985, ANNU REV PLANT PHYS, V36, P209, DOI 10.1146/annurev.pp.36.060185.001233; Everett D. H., 1988, RSC PAPERBACKS; Ferry JD, 1941, J BIOL CHEM, V138, P263; Fu J, 2015, BIOMACROMOLECULES, V16, P2327, DOI 10.1021/acs.biomac.5b00552; Fudge DS, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P504; Fudge DS, 2005, J EXP BIOL, V208, P4613, DOI 10.1242/jeb.01963; Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3; FUKUSHIMA D, 1981, J AM OIL CHEM SOC, V58, P346, DOI 10.1007/BF02582376; Gabor F, 2004, ADV DRUG DELIVER REV, V56, P459, DOI 10.1016/j.addr.2003.10.015; HEALY TW, 1964, J COLL SCI IMP U TOK, V19, P323, DOI 10.1016/0095-8522(64)90034-0; Herr JE, 2010, J EXP BIOL, V213, P1092, DOI 10.1242/jeb.038992; HISAYASU S, 1992, J NUTR, V122, P1190, DOI 10.1093/jn/122.5.1190; Hyun K, 2011, PROG POLYM SCI, V36, P1697, DOI 10.1016/j.progpolymsci.2011.02.002; KINSELLA JE, 1979, J AM OIL CHEM SOC, V56, P242, DOI 10.1007/BF02671468; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; Lim J, 2006, J EXP BIOL, V209, P702, DOI 10.1242/jeb.02067; LUSAS EW, 1995, J NUTR, V125, pS573, DOI 10.1093/jn/125.3_Suppl.573S; Malhotra A, 2004, FOOD HYDROCOLLOID, V18, P101, DOI 10.1016/S0268-005X(03)00047-X; Maltais A, 2008, FOOD HYDROCOLLOID, V22, P550, DOI 10.1016/j.foodhyd.2007.01.026; Maltais A, 2009, FOOD HYDROCOLLOID, V23, P1647, DOI 10.1016/j.foodhyd.2008.12.006; McGuckin MA, 2012, METHODS MOL BIOL, V842, P1, DOI 10.1007/978-1-61779-513-8; Miserez A, 2013, CHEM SOC REV, V42, P1973, DOI 10.1039/c2cs35294j; NAGANO T, 1994, BIOPOLYMERS, V34, P1303, DOI 10.1002/bip.360341003; Negishi A, 2012, BIOMACROMOLECULES, V13, P3475, DOI 10.1021/bm3011837; Nishinari K, 2014, FOOD HYDROCOLLOID, V39, P301, DOI 10.1016/j.foodhyd.2014.01.013; Pinto N, 2014, BIOMACROMOLECULES, V15, P574, DOI 10.1021/bm401600a; Radford SJ, 2004, COLLOID SURFACE A, V238, P71, DOI 10.1016/j.colsurfa.2004.02.020; Raynal BDE, 2003, J BIOL CHEM, V278, P28703, DOI 10.1074/jbc.M304632200; SALO WL, 1983, PREP BIOCHEM, V13, P103, DOI 10.1080/00327488308068743; Schaffeld M, 2006, EXP CELL RES, V312, P1447, DOI 10.1016/j.yexcr.2006.01.005; Shurtleff W, 2000, TOFU SOYMILK PRODUCT; Silletti E, 2007, FOOD HYDROCOLLOID, V21, P596, DOI 10.1016/j.foodhyd.2006.07.004; Vingerhoeds MH, 2005, FOOD HYDROCOLLOID, V19, P915, DOI 10.1016/j.foodhyd.2004.12.005; Winegard TM, 2010, J EXP BIOL, V213, P1235, DOI 10.1242/jeb.038075	41	13	13	8	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147022	10.1371/journal.pone.0147022	http://dx.doi.org/10.1371/journal.pone.0147022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808048	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800046
J	Kempf, F; Slugocki, C; Blum, SE; Leitner, G; Germon, P				Kempf, Florent; Slugocki, Cindy; Blum, Shlomo E.; Leitner, Gabriel; Germon, Pierre			Genomic Comparative Study of Bovine Mastitis Escherichia coli	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; VIRULENCE FACTORS; CLINICAL MASTITIS; INNATE IMMUNITY; SEQUENCE; IDENTIFICATION; SEROTYPES; COMMENSAL; SUSCEPTIBILITY; ALGORITHM	Escherichia coli, one of the main causative agents of bovine mastitis, is responsible for significant losses on dairy farms. In order to better understand the pathogenicity of E. coli mastitis, an accurate characterization of E. coli strains isolated from mastitis cases is required. By using phylogenetic analyses and whole genome comparison of 5 currently available mastitis E. coli genome sequences, we searched for genotypic traits specific for mastitis isolates. Our data confirm that there is a bias in the distribution of mastitis isolates in the different phylogenetic groups of the E. coli species, with the majority of strains belonging to phylogenetic groups A and B1. An interesting feature is that clustering of strains based on their accessory genome is very similar to that obtained using the core genome. This finding illustrates the fact that phenotypic properties of strains from different phylogroups are likely to be different. As a consequence, it is possible that different strategies could be used by mastitis isolates of different phylogroups to trigger mastitis. Our results indicate that mastitis E. coli isolates analyzed in this study carry very few of the virulence genes described in other pathogenic E. coli strains. A more detailed analysis of the presence/absence of genes involved in LPS synthesis, iron acquisition and type 6 secretion systems did not uncover specific properties of mastitis isolates. Altogether, these results indicate that mastitis E. coli isolates are rather characterized by a lack of bona fide currently described virulence genes.	[Kempf, Florent; Slugocki, Cindy] INRA, UMR Infectiol & Sante Publ 1282, CIRM Bacteries Pathogenes, F-37380 Nouzilly, France; [Germon, Pierre] INRA, UMR Infectiol & Sante Publ 1282, Immunite & Infect Mammaires, F-37380 Nouzilly, France; [Kempf, Florent; Slugocki, Cindy; Germon, Pierre] Univ Tours, UMR Infectiol & Sante Publ 1282, F-37000 Tours, France; [Blum, Shlomo E.; Leitner, Gabriel] Kimron Vet Inst, Div Bacteriol, Natl Mastitis Ctr, POB 12, IL-50250 Bet Dagan, Israel	INRAE; INRAE; Universite de Tours; Kimron Veterinary Institute	Germon, P (corresponding author), INRA, UMR Infectiol & Sante Publ 1282, Immunite & Infect Mammaires, F-37380 Nouzilly, France.; Germon, P (corresponding author), Univ Tours, UMR Infectiol & Sante Publ 1282, F-37000 Tours, France.	pierre.germon@tours.inra.fr	GERMON, Pierre/M-5264-2019; GERMON, Pierre/AAC-9111-2019	GERMON, Pierre/0000-0003-3078-876X; 	French National Institute for Agricultural Research (INRA AIP "Bio-Ressources")	French National Institute for Agricultural Research (INRA AIP "Bio-Ressources")	This work was supported by the French National Institute for Agricultural Research (INRA AIP "Bio-Ressources"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blum S, 2008, VET MICROBIOL, V132, P135, DOI 10.1016/j.vetmic.2008.05.012; Blum S, 2012, J BACTERIOL, V194, P3732, DOI 10.1128/JB.00535-12; Blum SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136387; Blum SE, 2014, VET J, V201, P72, DOI 10.1016/j.tvjl.2014.04.008; Blum SE, 2013, VET MICROBIOL, V163, P305, DOI 10.1016/j.vetmic.2012.12.037; Bojer MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015467; Bouchard L, 1999, J DAIRY SCI, V82, P2574, DOI 10.3168/jds.S0022-0302(99)75512-8; Boulanger V, 2001, J DAIRY SCI, V84, P1430, DOI 10.3168/jds.S0022-0302(01)70175-0; BRAMLEY AJ, 1976, J DAIRY RES, V43, P205, DOI 10.1017/S0022029900015752; Braun V, 2011, CURR OPIN CHEM BIOL, V15, P328, DOI 10.1016/j.cbpa.2011.01.005; Bryson K, 2006, NUCLEIC ACIDS RES, V34, P3533, DOI 10.1093/nar/gkl471; Burvenich C, 2003, VET RES, V34, P521, DOI 10.1051/vetres:2003023; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Chaudhuri RR, 2012, INFECT GENET EVOL, V12, P214, DOI 10.1016/j.meegid.2012.01.005; Clermont O, 2011, INFECT GENET EVOL, V11, P654, DOI 10.1016/j.meegid.2011.02.005; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dogan B, 2006, VET MICROBIOL, V116, P270, DOI 10.1016/j.vetmic.2006.04.023; Dogan B, 2012, VET MICROBIOL, V159, P163, DOI 10.1016/j.vetmic.2012.03.033; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Fernandes JBC, 2011, J VET DIAGN INVEST, V23, P1146, DOI 10.1177/1040638711425581; Garenaux A, 2011, VET MICROBIOL, V153, P89, DOI 10.1016/j.vetmic.2011.05.023; Ghanbarpour R, 2010, RES VET SCI, V88, P6, DOI 10.1016/j.rvsc.2009.06.003; Gunther J, 2011, INFECT IMMUN, V79, P695, DOI 10.1128/IAI.01071-10; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hazen TH, 2013, P NATL ACAD SCI USA, V110, P12810, DOI 10.1073/pnas.1306836110; Heinrichs DE, 1998, MOL MICROBIOL, V30, P221, DOI 10.1046/j.1365-2958.1998.01063.x; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Hickey WJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00125; HOGAN JS, 1989, J DAIRY SCI, V72, P1893, DOI 10.3168/jds.S0022-0302(89)79308-5; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550; Kaipainen T, 2002, VET MICROBIOL, V85, P37, DOI 10.1016/S0378-1135(01)00483-7; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kempf F, 2015, GENOME ANNOUNCEMENTS, V3, DOI [10.1128/genomeA.00259-15, DOI 10.1128/GEN0MEA.00259-15]; Kohler CD, 2011, INT J MED MICROBIOL, V301, P642, DOI 10.1016/j.ijmm.2011.09.006; Koli P, 2011, MBIO, V2, DOI [10.1128/mBio.00182-11, DOI 10.1128/MBI0.00182-11]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lehtolainen T, 2003, ACTA VET SCAND, V44, P203, DOI 10.1186/1751-0147-44-203; Li J, 2015, ENVIRON MICROBIOL, V17, P2196, DOI 10.1111/1462-2920.12794; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LINTON AH, 1979, J APPL BACTERIOL, V46, P585, DOI 10.1111/j.1365-2672.1979.tb00859.x; LIPMAN LJA, 1995, VET MICROBIOL, V47, P1, DOI 10.1016/0378-1135(95)00108-M; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Munson GP, 2013, IMMUNOL RES, V57, P229, DOI 10.1007/s12026-013-8453-4; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Oshima K, 2008, DNA RES, V15, P375, DOI 10.1093/dnares/dsn026; PEAKER M, 1975, NATURE, V253, P464, DOI 10.1038/253464a0; Porcherie A, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-14; Porter ME, 2004, MOL MICROBIOL, V54, P1117, DOI 10.1111/j.1365-2958.2004.04333.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rainard P, 2006, VET RES, V37, P369, DOI 10.1051/vetres:2006007; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Reiland HA, 2014, ADV MICROBIOL, V4, P390, DOI DOI 10.4236/aim.2014.47046; Richards VP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119799; Riekerink RGMO, 2008, J DAIRY SCI, V91, P1366, DOI 10.3168/jds.2007-0757; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SELANDER RK, 1987, ESCHERICHIA COLI SAL, P1625; Shpigel NY, 2008, CURR OPIN MICROBIOL, V11, P60, DOI 10.1016/j.mib.2008.01.004; Spears KJ, 2006, FEMS MICROBIOL LETT, V255, P187, DOI 10.1111/j.1574-6968.2006.00119.x; Suojala L, 2011, VET MICROBIOL; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Urban CF, 2006, CELL MICROBIOL, V8, P1687, DOI 10.1111/j.1462-5822.2006.00792.x; Waage S, 1999, J DAIRY SCI, V82, P712, DOI 10.3168/jds.S0022-0302(99)75288-4; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wendel AM, 2009, CLIN INFECT DIS, V48, P1079, DOI 10.1086/597399; Wenz JR, 2006, J DAIRY SCI, V89, P3408, DOI 10.3168/jds.S0022-0302(06)72377-3; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zhao HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065466	82	42	44	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147954	10.1371/journal.pone.0147954	http://dx.doi.org/10.1371/journal.pone.0147954			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809117	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800251
J	Leite, F; Lima, M; Marino, F; Cosentino, M; Ribeiro, L				Leite, Fernanda; Lima, Margarida; Marino, Franca; Cosentino, Marco; Ribeiro, Laura			Dopaminergic Receptors and Tyrosine Hydroxylase Expression in Peripheral Blood Mononuclear Cells: A Distinct Pattern in Central Obesity	PLOS ONE			English	Article							ENDOGENOUS CATECHOLAMINES; INTERFERON-BETA; MESSENGER-RNA; T-CELLS; LYMPHOCYTES; D2; INSULIN; POLYMORPHISMS; ADDICTION; WEIGHT	Background Dopamine (DA) may be involved in central obesity (CO), an inflammatory condition, through its role in the central nervous system and in periphery, where it may affect immune cell function through five different DA receptors (DR). Whether dopaminergic pathways in peripheral immune cells are implicated in the inflammatory condition linked to CO is however unknown. Methods In a cohort of blood donors with and without CO, categorized by waist circumference (WC) (CO: WC >= 0.80 m in women and >= 0.94 m in men), we studied the expression of DR and tyrosine hydroxylase (TH), the rate-limiting enzyme in the synthesis of DA, in peripheral blood mononuclear cells (PBMCs) and their relation with anthropometric and metabolic/endocrine and inflammatory parameters. DR D1-5 and TH expression was assessed by semi quantitative real-time PCR. As inflammatory markers we investigated the immunophenotype of monocyte subsets by flow cytometry, staining for CD14, CD16, CD11b and CD36. Results qCO individuals showed higher plasma levels of leptin and higher inflammatory pattern of monocytes compared with non-CO. PBMC expression of DR D2, DRD4 and DR D5 as well as of TH were lower in CO in comparison with non-CO. DR D2, and DR D5 expression correlated with lower WC and weight, and with lower inflammatory pattern of monocytes, and TH expression correlated with lower WC. DR D-4 expression correlated with lower plasma levels of glycosylated hemoglobin, and DR D-2 expression correlated with lower CO. Conclusions Results show that CO is associated with peripheral inflammation and downregulation of dopaminergic pathways in PBMCs, possibly suggesting DR expressed on immune cells as pharmacological targets in obesity for better metabolic outcome.	[Leite, Fernanda; Ribeiro, Laura] Univ Porto, Fac Med, Dept Biochem, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Leite, Fernanda; Lima, Margarida] Ctr Hosp Porto, Dept Clin Haematol, Oporto, Portugal; [Leite, Fernanda; Lima, Margarida] Univ Porto, UMIB, ICBAS, Unit Multidisciplinary Res Biomed,Abel Salazar In, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Marino, Franca; Cosentino, Marco] Univ Insubria, Ctr Res Med Pharmacol, Varese, Italy; [Ribeiro, Laura] Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Ribeiro, Laura] Univ Porto, Dept Med Educ & Simulat, Fac Med, Rua Campo Alegre 823, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; University of Insubria; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto	Ribeiro, L (corresponding author), Univ Porto, Fac Med, Dept Biochem, Rua Campo Alegre 823, P-4100 Oporto, Portugal.; Ribeiro, L (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal.; Ribeiro, L (corresponding author), Univ Porto, Dept Med Educ & Simulat, Fac Med, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	lribeiro@med.up.pt	Leite, Fernanda/AAY-7771-2021; Leite, Fernanda/K-1470-2015; Cosentino, Marco/A-3848-2010; Leite, Fernanda/N-6357-2019; Lima, Margarida/S-7466-2016	Leite, Fernanda/0000-0002-7930-6066; Cosentino, Marco/0000-0002-6978-7775; Leite, Fernanda/0000-0002-7930-6066; Lima, Margarida/0000-0001-9702-5260; Ribeiro, Laura/0000-0003-1181-9217; Reis, AlessanRSS/0000-0001-8486-7469	FCT [UID/BIM/04293/2013, Pest-OE/SAU/UI0215/2014]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by FCT funding UID/BIM/04293/2013-Instituto de Investigacao e Inovacao em Saude (I3S), University of Porto, Porto, Portugal and Pest-OE/SAU/UI0215/2014-Unidade Multidisciplinar de Investigacao Biomedica-UMIB/ICBAS/UP.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Araki KY, 2007, BRAIN RES, V1156, P31, DOI 10.1016/j.brainres.2007.04.043; Baik JH, 2013, BMB REP, V46, P519, DOI 10.5483/BMBRep.2013.46.11.207; Basu S, 2000, J NEUROIMMUNOL, V102, P113, DOI 10.1016/S0165-5728(99)00176-9; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; BERGQUIST J, 1994, P NATL ACAD SCI USA, V91, P12912, DOI 10.1073/pnas.91.26.12912; Besser MJ, 2005, J NEUROIMMUNOL, V169, P161, DOI 10.1016/j.jneuroim.2005.07.013; Blum K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00919; Carlin J, 2013, OBESITY, V21, P2513, DOI 10.1002/oby.20374; Cosentino M, 1999, LIFE SCI, V64, P975, DOI 10.1016/S0024-3205(99)00023-5; Cosentino M, 2007, BLOOD, V109, P632, DOI 10.1182/blood-2006-01-028423; Cosentino M, 2014, J NEUROIMMUNOL, V277, P193, DOI 10.1016/j.jneuroim.2014.10.009; Cosentino M, 2013, J NEUROIMMUNE PHARM, V8, P163, DOI 10.1007/s11481-012-9410-z; Deng C, 2013, ENDOCRIN METAB CLIN, V42, P545, DOI 10.1016/j.ecl.2013.05.006; Eisenhofer G, 1997, J CLIN ENDOCR METAB, V82, P3864, DOI 10.1210/jc.82.11.3864; Giorelli M, 2005, J INTERF CYTOK RES, V25, P395, DOI 10.1089/jir.2005.25.395; Jafari M, 2013, IMMUNOBIOLOGY, V218, P979, DOI 10.1016/j.imbio.2012.11.002; Jiang XL, 2014, HYPERTENSION, V63, pE74, DOI 10.1161/HYPERTENSIONAHA.113.02569; Kaczmarczyk MM, 2013, PSYCHONEUROENDOCRINO, V38, P1553, DOI 10.1016/j.psyneuen.2013.01.004; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kenny PJ, 2013, CURR OPIN NEUROBIOL, V23, P535, DOI 10.1016/j.conb.2013.04.012; Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632; Levite M, 2012, NERVE-DRIVEN IMMUNITY: NEUROTRANSMITTERS AND NEUROPEPTIDES IN THE IMMUNE SYSTEM, P1, DOI 10.1007/978-3-7091-0888-8_1; Lima M, 2004, AM J PATHOL, V165, P1117, DOI 10.1016/S0002-9440(10)63373-1; Magro F, 2006, DIGEST DIS SCI, V51, P2039, DOI 10.1007/s10620-006-9168-3; McMurray RW, 2001, SEMIN ARTHRITIS RHEU, V31, P21, DOI 10.1053/sarh.2001.25482; Meijer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017154; Mobini M, 2011, IRAN RED CRESCENT ME, V13, P749; Oliver P, 2013, PFLUG ARCH EUR J PHY, V465, P459, DOI 10.1007/s00424-013-1246-8; PEARSE AGE, 1969, J HISTOCHEM CYTOCHEM, V17, P303, DOI 10.1177/17.5.303; Perez-Cornago A, 2014, PSYCHONEUROENDOCRINO, V47, P98, DOI 10.1016/j.psyneuen.2014.05.003; Rubi B, 2005, J BIOL CHEM, V280, P36824, DOI 10.1074/jbc.M505560200; Rubi B, 2010, ENDOCRINOLOGY, V151, P5570, DOI 10.1210/en.2010-0745; Sarkar C, 2010, BRAIN BEHAV IMMUN, V24, P525, DOI 10.1016/j.bbi.2009.10.015; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vincent S, 2004, CIRCULATION, V109, P3202, DOI 10.1161/01.CIR.0000130847.18666.39; Visvikis-Siest S, 2007, CLIN CHEM LAB MED, V45, P1154, DOI 10.1515/CCLM.2007.255; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Yu CQ, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-97; Zaffaroni M, 2008, EXP NEUROL, V214, P315, DOI 10.1016/j.expneurol.2008.08.015	40	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147483	10.1371/journal.pone.0147483	http://dx.doi.org/10.1371/journal.pone.0147483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808524	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800106
J	Nash, EE; Peters, BM; Lilly, EA; Noverr, MC; Fidel, PL				Nash, Evelyn E.; Peters, Brian M.; Lilly, Elizabeth A.; Noverr, Mairi C.; Fidel, Paul L., Jr.			A Murine Model of Candida glabrata Vaginitis Shows No Evidence of an Inflammatory Immunopathogenic Response	PLOS ONE			English	Article							VULVO-VAGINAL CANDIDIASIS; IN-VITRO; BIOFILM FORMATION; ALBICANS; COLONIZATION; EPIDEMIOLOGY; PATHOGENESIS; SUSCEPTIBILITY; INFECTIONS; EPITHELIUM	Candida glabrata is the second most common organism isolated from women with vulvovaginal candidiasis (VVC), particularly in women with uncontrolled diabetes mellitus. However, mechanisms involved in the pathogenesis of C. glabrata-associated VVC are unknown and have not been studied at any depth in animal models. The objective of this study was to evaluate host responses to infection following efforts to optimize a murine model of C. glabrata VVC. For this, various designs were evaluated for consistent experimental vaginal colonization (i.e., type 1 and type 2 diabetic mice, exogenous estrogen, varying inocula, and co-infection with C. albicans). Upon model optimization, vaginal fungal burden and polymorphonuclear neutrophil (PMN) recruitment were assessed longitudinally over 21 days post-inoculation, together with vaginal concentrations of IL-1 beta, S100A8 alarmin, lactate dehydrogenase (LDH), and in vivo biofilm formation. Consistent and sustained vaginal colonization with C. glabrata was achieved in estrogenized streptozotocin-induced type 1 diabetic mice. Vaginal PMN infiltration was consistently low, with IL-1 beta, S100A8, and LDH concentrations similar to uninoculated mice. Biofilm formation was not detected in vivo, and co-infection with C. albicans did not induce synergistic immunopathogenic effects. This data suggests that experimental vaginal colonization of C. glabrata is not associated with an inflammatory immunopathogenic response or biofilm formation.	[Nash, Evelyn E.; Noverr, Mairi C.; Fidel, Paul L., Jr.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, Sch Med, New Orleans, LA USA; [Peters, Brian M.; Lilly, Elizabeth A.; Noverr, Mairi C.; Fidel, Paul L., Jr.] Louisiana State Univ, Hlth Sci Ctr, Dept Oral & Craniofacial Biol, Sch Dent, New Orleans, LA USA; [Noverr, Mairi C.] Louisiana State Univ, Hlth Sci Ctr, Sch Dent, Prosthodont, New Orleans, LA USA; [Nash, Evelyn E.] Ctr Dis Control, Div STD Prevent, Atlanta, GA 30333 USA; [Peters, Brian M.] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Memphis, TN 38163 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Centers for Disease Control & Prevention - USA; University of Tennessee System; University of Tennessee Health Science Center	Fidel, PL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, Sch Med, New Orleans, LA USA.; Fidel, PL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Oral & Craniofacial Biol, Sch Dent, New Orleans, LA USA.	pfidel@lsuhsc.edu		Noverr, Mairi/0000-0002-8812-1450	Louisiana State University Health Sciences Center (LSUHSC) Foundation	Louisiana State University Health Sciences Center (LSUHSC) Foundation	This work was supported by the Louisiana State University Health Sciences Center (LSUHSC) Foundation (www.lsuhealthfoundation.org) (P.L.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CT, 2014, J INFECTION, V69, P396, DOI 10.1016/j.jinf.2014.06.002; Azoulay E, 2006, CHEST, V129, P110, DOI 10.1378/chest.129.1.110; Black CA, 1999, LAB ANIM SCI, V49, P668; Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; Brunke S, 2013, CELL MICROBIOL, V15, P701, DOI 10.1111/cmi.12091; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Corsello S, 2003, EUR J OBSTET GYN R B, V110, P66, DOI 10.1016/S0301-2115(03)00096-4; de Leon EM, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-1; Diaz PI, 2012, INFECT IMMUN, V80, P620, DOI 10.1128/IAI.05896-11; Dongari-Bagtzoglou A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007967; Fidel PL, 2004, INFECT IMMUN, V72, P2939, DOI 10.1128/IAI.72.5.2939-2946.2004; Fidel PL, 1996, CLIN MICROBIOL REV, V9, P335, DOI 10.1128/CMR.9.3.335; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; FIDEL PL, 1995, INFECT IMMUN, V63, P4191, DOI 10.1128/IAI.63.10.4191-4194.1995; Fidel PL, 1996, J INFECT DIS, V173, P425, DOI 10.1093/infdis/173.2.425; Gonzalez GM, 2011, MYCOSES, V54, P119, DOI 10.1111/j.1439-0507.2009.01775.x; Harriott MM, 2010, MICROBIOL-SGM, V156, P3635, DOI 10.1099/mic.0.039354-0; HAWSER SP, 1994, INFECT IMMUN, V62, P915, DOI 10.1128/IAI.62.3.915-921.1994; Holland J, 2003, SEX TRANSM INFECT, V79, P249, DOI 10.1136/sti.79.3.249; Kasper L, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov042; Kucharikova S, 2011, J MED MICROBIOL, V60, P1261, DOI 10.1099/jmm.0.032037-0; LEVISON ME, 1987, J INFECT DIS, V155, P841, DOI 10.1093/infdis/155.5.841; LYNCH ME, 1994, J MED VET MYCOL, V32, P267; Mahmoudi Rad Mahnaz, 2012, Infect Dis Obstet Gynecol, V2012, P872169, DOI 10.1155/2012/872169; Nett J, 2006, CURR OPIN MICROBIOL, V9, P340, DOI 10.1016/j.mib.2006.06.007; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nyirjesy P, 2013, POSTGRAD MED, V125, DOI 10.3810/pgm.2013.05.2650; Peters BM, 2014, INFECT IMMUN, V82, P532, DOI 10.1128/IAI.01417-13; Peters BM, 2013, INFECT IMMUN, V81, P2178, DOI 10.1128/IAI.00265-13; Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x; Richter SS, 2005, J CLIN MICROBIOL, V43, P2155, DOI 10.1128/JCM.43.5.2155-2162.2005; Saavedra M, 1999, INFECT IMMUN, V67, P5820, DOI 10.1128/IAI.67.11.5820-5826.1999; Seneviratne CJ, 2009, ARCH ORAL BIOL, V54, P1052, DOI 10.1016/j.archoralbio.2009.08.002; Silva S, 2011, J ORAL PATHOL MED, V40, P421, DOI 10.1111/j.1600-0714.2010.00981.x; Silva S, 2009, MED MYCOL, V47, P681, DOI 10.3109/13693780802549594; Sobel JD, 1997, NEW ENGL J MED, V337, P1896, DOI 10.1056/NEJM199712253372607; SOBEL JD, 1985, AM J OBSTET GYNECOL, V152, P924, DOI 10.1016/S0002-9378(85)80003-X; SOBEL JD, 1992, CLIN INFECT DIS, V14, pS148, DOI 10.1093/clinids/14.Supplement_1.S148; Sweet RL, 2009, INFECT DIS FEMALE GE, P199; Yano J, 2012, CYTOKINE, V58, P118, DOI 10.1016/j.cyto.2011.11.021; Yano J, 2010, INFECT IMMUN, V78, P5126, DOI 10.1128/IAI.00388-10	41	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147969	10.1371/journal.pone.0147969	http://dx.doi.org/10.1371/journal.pone.0147969			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807975	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800255
J	Real, FG; Barrionuevo, LP; Franklin, K; Bertelsen, RJ; Benediktsdottir, B; Forsberg, B; Gislason, T; Jogi, R; Johannessen, A; Omenaas, E; Saure, E; Schlunssen, V; Skorge, TD; Toren, K; Saavedra, AP; Svanes, O; Astrom, AN; Janson, C; Svanes, C				Real, Francisco Gomez; Barrionuevo, Laura Perez; Franklin, Karl; Bertelsen, Randi Jacobsen; Benediktsdottir, Bryndis; Forsberg, Bertil; Gislason, Thorarinn; Jogi, Rain; Johannessen, Ane; Omenaas, Ernst; Saure, Eirunn; Schlunssen, Vivi; Skorge, Trude Duelien; Toren, Kjell; Perez Saavedra, Antonio; Svanes, Oistein; Astrom, Anne Nordrehaug; Janson, Christer; Svanes, Cecilie			The Association of Gum Bleeding with Respiratory Health in a Population Based Study from Northern Europe	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PERIODONTAL-DISEASE; ORAL-HEALTH; GASTROESOPHAGEAL-REFLUX; ALZHEIMERS-DISEASE; AIRWAY-OBSTRUCTION; SALIVARY FLOW; ASTHMA; PATHOGENS; CARIES	Background There is little knowledge about how oral and respiratory health is interrelated even though the mucosa of the oral cavity and airways constitutes a continuum and the exposures to these are partly similar. Aims To investigate whether gum bleeding is related to asthma, respiratory symptoms and self-reported COPD. Methods A postal questionnaire including questions about respiratory and oral health was sent to general population samples in seven Northern European centres. In 13,409 responders, gum bleeding when brushing teeth was reported always/often by 4% and sometimes by 20%. Logistic regressions accounted for age, smoking, educational level, centre and gender. Effects of BMI, cardio-metabolic diseases, early life factors, gastro-oesophageal reflux, dental hygiene, nasal congestion, and asthma medication were addressed. Results Gum bleeding always/often was significantly associated with >= 3 asthma symptoms (OR 2.58, 95% CI 2.10-3.18), asthma (1.62 [1.23-2.14]) and self-reported COPD (2.02 [1.283.18]). There was a dose-response relationship between respiratory outcomes and gum bleeding frequency (>= 3 symptoms: gum bleeding sometimes 1.42 [1.25-1.60], often/always 2.58 [2.10-3.18]), and there was no heterogeneity between centres (p(heterogeneity) = 0.49). None of the investigated risk factors explained the associations. The observed associations were significantly stronger among current smokers (p(interaction) = 0.004). Conclusions A consistent link between gum bleeding and obstructive airways disease was observed, not explained by common risk factors or metabolic factors. We speculate that oral pathogens might have unfavourable impact on the airways, and that the direct continuity of the mucosa of the oral cavity and the airways reflects a pathway that might provide novel opportunities for interventions.	[Real, Francisco Gomez; Barrionuevo, Laura Perez; Bertelsen, Randi Jacobsen; Johannessen, Ane; Saure, Eirunn; Skorge, Trude Duelien; Svanes, Oistein; Svanes, Cecilie] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Real, Francisco Gomez] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [Franklin, Karl] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Bertelsen, Randi Jacobsen; Janson, Christer] Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden; [Benediktsdottir, Bryndis; Gislason, Thorarinn] Univ Iceland, Fac Med, Reykjavik, Iceland; [Forsberg, Bertil] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Jogi, Rain] Tartu Univ Clin, Lung Clin, Tartu, Estonia; [Johannessen, Ane; Omenaas, Ernst] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway; [Schlunssen, Vivi] Aarhus Univ, Dept Publ Hlth, Sect Environm Occupat & Hlth, Aarhus, Denmark; [Toren, Kjell] Sahlgrens Univ Hosp, Dept Occupat & Environm Med, Gothenburg, Sweden; [Perez Saavedra, Antonio] Clin Dent Perez Saveedra, Malaga, Spain; [Svanes, Oistein; Svanes, Cecilie] Haukeland Hosp, Dept Occupat Med, N-5021 Bergen, Norway; [Astrom, Anne Nordrehaug] Univ Bergen, Dept Clin Dent, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; Umea University; University of Iceland; Umea University; University of Tartu; University of Bergen; Haukeland University Hospital; Aarhus University; Sahlgrenska University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen	Real, FG (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.; Real, FG (corresponding author), Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway.	francisco.real@uib.no	Bertelsen, Randi J/N-6917-2017; Svanes, Cecilie/N-7556-2017	Bertelsen, Randi J/0000-0001-5319-525X; Svanes, Cecilie/0000-0001-8512-5192; Johannessen, Ane/0000-0003-3269-8354; Franklin, Karl/0000-0002-5306-1697; Gomez Real, Francisco/0000-0001-5407-3270; Schlunssen, Vivi/0000-0003-4915-1734	Norwegian Research Council [214123]; Bergen Medical Research Foundation; Western Norwegian Regional Health Authorities [911 892, 911 631]; Norwegian Labour Inspection; Norwegian Asthma and Allergy Association; Faculty of Health of Aarhus University [240008]; Wood Dust Foundation [444508795]; Danish Lung Association; Swedish Heart and Lung Foundation; Vardal Foundation for Health Care Science and Allergy Research; Swedish Council for Working Life and Social Research; Bror Hjerpstedt Foundation; Swedish Asthma and Allergy Association; Icelandic Research Council, Landspitali University; Estonian Science Foundation [4350]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Bergen Medical Research Foundation; Western Norwegian Regional Health Authorities; Norwegian Labour Inspection; Norwegian Asthma and Allergy Association; Faculty of Health of Aarhus University; Wood Dust Foundation; Danish Lung Association; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Vardal Foundation for Health Care Science and Allergy Research; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Bror Hjerpstedt Foundation; Swedish Asthma and Allergy Association; Icelandic Research Council, Landspitali University; Estonian Science Foundation	The RHINE III was supported financially by the Norwegian Research Council (Grant No. 214123), the Bergen Medical Research Foundation, the Western Norwegian Regional Health Authorities (Grant No. 911 892 and 911 631), the Norwegian Labour Inspection, the Norwegian Asthma and Allergy Association, the Faculty of Health of Aarhus University, (Project No. 240008), The Wood Dust Foundation (Project No. 444508795), the Danish Lung Association, the Swedish Heart and Lung Foundation, the Vardal Foundation for Health Care Science and Allergy Research, the Swedish Council for Working Life and Social Research, the Bror Hjerpstedt Foundation, the Swedish Asthma and Allergy Association, the Icelandic Research Council, Landspitali University Hospital Research Fund, and the Estonian Science Foundation (Grant No. 4350). None of the study sponsors/funders had any role on study design, data collection, data analysis, data interpretation or writing of the report. The corresponding author had full access to all the data in the study and had full responsibility for the decision to submit for publication.	AINAMO J, 1982, INT DENT J, V32, P281; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Bagaitkar J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027386; Bagaitkar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009323; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Costalonga M, 2014, IMMUNOL LETT, V162, P22, DOI 10.1016/j.imlet.2014.08.017; D'Aiuto F, 2005, Int J Immunopathol Pharmacol, V18, P1; Dasanayake Ananda P, 2009, J Evid Based Dent Pract, V9, P21, DOI 10.1016/j.jebdp.2008.12.010; Deo Vikas, 2009, Indian J Dent Res, V20, P466, DOI 10.4103/0970-9290.59456; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ercan E, 2013, ACTA ODONTOL SCAND, V71, P553, DOI 10.3109/00016357.2012.697576; Ersin NK, 2006, PEDIATR INT, V48, P549, DOI 10.1111/j.1442-200X.2006.02281.x; Gomes-Filho Isaac S, 2010, J Oral Microbiol, V2, DOI 10.3402/jom.v2i0.5811; Gomes IS, 2011, J PERIODONTOL, V82, P969, DOI 10.1902/jop.2010.100511; Goodson JM, 2009, J DENT RES, V88, P519, DOI 10.1177/0022034509338353; GREENSTEIN G, 1984, J PERIODONTOL, V55, P684, DOI 10.1902/jop.1984.55.12.684; Gunnbjomsdottir MI, 2004, EUR RESPIR J, V24, P116, DOI 10.1183/09031936.04.00042603; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; HYYPPA T, 1984, J CLIN PERIODONTOL, V11, P132, DOI 10.1111/j.1600-051X.1984.tb00841.x; Johannessen A, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-63; Katancik JA, 2005, J PERIODONTOL, V76, P2161, DOI 10.1902/jop.2005.76.11-S.2161; Katz J, 2009, J DENT RES, V88, P575, DOI 10.1177/0022034509338032; Laurikainen K, 1998, ALLERGY, V53, P316, DOI 10.1111/j.1398-9995.1998.tb03894.x; Leuckfeld I, 2008, RESP MED, V102, P488, DOI 10.1016/j.rmed.2007.12.001; Lindenmeyer A, 2013, FAM PRACT, V30, P113, DOI 10.1093/fampra/cms034; Lintula T, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-155; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Madianos PN, 2013, J CLIN PERIODONTOL, V40, pS170, DOI [10.1902/jop.2013.1340015, 10.1111/jcpe.12082]; Moutsopoulos NM, 2006, ANN NY ACAD SCI, V1088, P251, DOI 10.1196/annals.1366.032; Pekkanen J, 2005, EUR RESPIR J, V26, P28, DOI 10.1183/09031936.05.00120104; Petersen PE, 2013, ORAL HLTH SURVEYS BA, V5th; Petersen PE, 2012, PERIODONTOL 2000, V60, P15, DOI 10.1111/j.1600-0757.2011.00425.x; Rath SK, 2014, INDIAN J PATHOL MICR, V57, P259, DOI 10.4103/0377-4929.134704; Santos NC, 2012, ALLERGOL IMMUNOPATH, V40, P220, DOI 10.1016/j.aller.2011.04.005; Scannapieco FA, 2001, J PERIODONTOL, V72, P50, DOI 10.1902/jop.2001.72.1.50; Si Y, 2012, J PERIODONTOL, V83, P1288, DOI 10.1902/jop.2012.110472; Song JY, 2014, GUT LIVER, V8, P35, DOI 10.5009/gnl.2014.8.1.35; Stein PS, 2012, ALZHEIMERS DEMENT, V8, P196, DOI 10.1016/j.jalz.2011.04.006; Stensson M, 2010, CARIES RES, V44, P540, DOI 10.1159/000321566; Stensson M, 2011, ACTA ODONTOL SCAND, V69, P158, DOI 10.3109/00016357.2010.547516; Straka M, 2012, NEUROENDOCRINOL LETT, V33, P16; Swati P, 2012, ARCH GYNECOL OBSTET, V285, P613, DOI 10.1007/s00404-011-2012-9; Uppoor AS, 2013, GERODONTOLOGY, V30, P239, DOI 10.1111/j.1741-2358.2012.00660.x; Vargas MH, 2015, J ASTHMA, V52, P376, DOI 10.3109/02770903.2014.974816; Warburton David, 2006, Proc Am Thorac Soc, V3, P668, DOI 10.1513/pats.200605-122SF; Zeller I, 2014, J PERIODONTOL, V85, P837, DOI 10.1902/jop.2013.130336; Zhang LL, 2014, WIEN KLIN WOCHENSCHR, V126, P515, DOI 10.1007/s00508-014-0568-7; Zhou X, 2014, J CLIN PERIODONTOL, V41, P564, DOI 10.1111/jcpe.12247	48	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147518	10.1371/journal.pone.0147518	http://dx.doi.org/10.1371/journal.pone.0147518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808490	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800119
J	Sun, SL; Fu, HN; Wang, ZY; Duan, CX; Zong, XX; Zhu, ZD				Sun, Suli; Fu, Haining; Wang, Zhongyi; Duan, Canxing; Zong, Xuxiao; Zhu, Zhendong			Discovery of a Novel er1 Allele Conferring Powdery Mildew Resistance in Chinese Pea (Pisum sativum L.) Landraces	PLOS ONE			English	Article							ERYSIPHE-PISI; SCAR MARKERS; GENE; IDENTIFICATION; POLYMORPHISM; RAPD; TRIFOLII; ER-1; MAP; DC	Pea powdery mildew, caused by Erysiphe pisi D.C., is an important disease worldwide. Deployment of resistant varieties is the main way to control this disease. This study aimed to screen Chinese pea (Pisum sativum L.) landraces resistant to E. pisi, and to characterize the resistance gene(s) at the er1 locus in the resistant landraces, and to develop functional marker(s) specific to the novel er1 allele. The 322 landraces showed different resistance levels. Among them, 12 (3.73%), 4 (1.24%) and 17 (5.28%) landraces showed immunity, high resistance and resistance to E. pisi, respectively. The other landraces appeared susceptible or highly susceptible to E. pisi. Most of the immune and highly resistant landraces were collected from Yunnan province. To characterize the resistance gene at the er1 locus, cDNA sequences of PsMLO1 gene were determined in 12 immune and four highly resistant accessions. The cDNAs of PsMLO1 from the immune landrace G0005576 produced three distinct transcripts, characterized by a 129-bp deletion, and 155-bp and 220-bp insertions, which were consistent with those of er1-2 allele. The PsMLO1 cDNAs in the other 15 resistant landraces produced identical transcripts, which had a new point mutation (T -> C) at position 1121 of PsMLO1, indicating a novel er1 allele, designated as er1-6. This mutation caused a leucine to proline change in the amino acid sequence. Subsequently, the resistance allele er1-6 in landrace G0001778 was confirmed by resistance inheritance analysis and genetic mapping on the region of the er1 locus using populations derived from G0001778 x Bawan 6. Finally, a functional marker specific to er1-6, SNP1121, was developed using the high-resolution melting technique, which could be used in pea breeding via marker-assisted selection. The results described here provide valuable genetic information for Chinese pea landraces and a powerful tool for pea breeders.	[Sun, Suli; Fu, Haining; Wang, Zhongyi; Duan, Canxing; Zong, Xuxiao; Zhu, Zhendong] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhu, ZD (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	zhuzhendong@caas.cn			Modern Agro-industry Technology Research System (CARS-09); Crop Germplasm Conservation and Utilization Program from the Ministry of Agriculture of China [2014NWB030-14]; Agricultural Science and Technology Program for Innovation Team from Chinese Academy of Agricultural Sciences (CAAS); Public Welfare Special Fund from the Institute of Crop Science, CAAS [610092015002-01]	Modern Agro-industry Technology Research System (CARS-09); Crop Germplasm Conservation and Utilization Program from the Ministry of Agriculture of China; Agricultural Science and Technology Program for Innovation Team from Chinese Academy of Agricultural Sciences (CAAS); Public Welfare Special Fund from the Institute of Crop Science, CAAS	This research was supported by the Modern Agro-industry Technology Research System (CARS-09), the Crop Germplasm Conservation and Utilization Program (2014NWB030-14) from the Ministry of Agriculture of China, the Agricultural Science and Technology Program for Innovation Team from Chinese Academy of Agricultural Sciences (CAAS), and the Public Welfare Special Fund (1610092015002-01) from the Institute of Crop Science, CAAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Modern Agro-industry Technology Research System (CARS-09), the Crop Germplasm Conservation and Utilization Program (2014NWB030-14) from the Ministry of Agriculture of China, the Agricultural Science and Technology Program for Innovation Team from Chinese Academy of Agricultural Sciences (CAAS), and the Public Welfare Special Fund (1610092015002-01) from the Institute of Crop Science, CAAS.	Attanayake RN, 2010, PLANT PATHOL, V59, P712, DOI 10.1111/j.1365-3059.2010.02306.x; Bordat A, 2011, G3-GENES GENOM GENET, V1, P93, DOI 10.1534/g3.111.000349; [程建刚 CHENG Jiangang], 2009, [地理科学进展, Progress in Geography], V28, P18; COUSIN R, 1965, ANN AMELIOR PLANT, V15, P93; DIRLEWANGER E, 1994, THEOR APPL GENET, V88, P17, DOI 10.1007/BF00222388; Ek M, 2005, HEREDITAS, V142, P86, DOI 10.1111/j.1601-5223.2005.01906.x; Fondevilla S, 2008, MOL BREEDING, V22, P193, DOI 10.1007/s11032-008-9166-6; Fondevilla S, 2007, PLANT BREEDING, V126, P113, DOI 10.1111/j.1439-0523.2006.01312.x; Fondevilla S, 2006, EUR J PLANT PATHOL, V115, P309, DOI 10.1007/s10658-006-9015-6; Fondevilla S, 2013, EUR J PLANT PATHOL, V136, P557, DOI 10.1007/s10658-013-0187-6; Fondevilla S, 2011, PLANT BREEDING, V130, P281, DOI 10.1111/j.1439-0523.2010.01769.x; Fondevilla S, 2007, BREEDING SCI, V57, P181, DOI 10.1270/jsbbs.57.181; Fondevilla S, 2012, AGRON SUSTAIN DEV, V32, P401, DOI 10.1007/s13593-011-0033-1; [付海宁 Fu Haining], 2014, [植物遗传资源学报, Journal of Plant Genetic Resources], V15, P1028; Ghafoor A, 2012, EUPHYTICA, V186, P593, DOI 10.1007/s10681-011-0596-6; GRITTON ET, 1975, J AM SOC HORTIC SCI, V100, P137; HARLAND SC, 1948, HEREDITY, V2, P263, DOI 10.1038/hdy.1948.15; HERINGA RJ, 1969, EUPHYTICA, V18, P163, DOI 10.1007/BF00035687; Humphry M, 2011, MOL PLANT PATHOL, V12, P866, DOI [10.1111/J.1364-3703.2011.00718.X, 10.1111/j.1364-3703.2011.00718.x]; Huo ZG, 2001, ACTA ECOLOGICA SINIC, V22, P1873; Janila P, 2004, PLANT BREEDING, V123, P271, DOI 10.1111/j.1439-0523.2004.00963.x; Katoch V, 2010, MOL BREEDING, V25, P229, DOI 10.1007/s11032-009-9322-7; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kristensen LS, 2008, CANCER EPIDEM BIOMAR, V17, P1240, DOI 10.1158/1055-9965.EPI-07-2531; LANDER ES, 1993, CONSTRUCTING GENETIC; Lang LJ, 1988, WORLD CROPS COOL SEA, P1135; Lehmensiek A, 2008, THEOR APPL GENET, V117, P721, DOI 10.1007/s00122-008-0813-4; Li L, 2013, GENET RESOUR CROP EV, V60, P1801, DOI 10.1007/s10722-013-9955-6; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu SM, 2003, AUST J EXP AGR, V43, P373, DOI 10.1071/EA01142; Loridon K, 2005, THEOR APPL GENET, V111, P1022, DOI 10.1007/s00122-005-0014-3; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Munjal R.L., 1963, INDIAN PHYTOPATHO, V19, P260; Neumann P, 2003, PLANT MOL BIOL, V53, P399, DOI 10.1023/B:PLAN.0000006945.77043.ce; Ondrej Michal, 2006, Plant Protection Science, V42, P95; Pavan S, 2013, MOL BREEDING, V31, P247, DOI 10.1007/s11032-012-9781-0; Pavan S, 2011, THEOR APPL GENET, V123, P1425, DOI 10.1007/s00122-011-1677-6; Peng H.X., 1991, J SW AGR U, V13, P384; Pereira G, 2010, EUPHYTICA, V171, P327, DOI 10.1007/s10681-009-0003-8; Rana JC, 2013, EUPHYTICA, V189, P271, DOI 10.1007/s10681-012-0798-6; RUBIALES D, 1993, EUPHYTICA, V67, P215, DOI 10.1007/BF00040623; Santo T, 2013, MOL BREEDING, V32, P723, DOI 10.1007/s11032-013-9889-x; SARALA K., 1993, THESIS INDIAN AGR RE; Sharma B., 2003, Pisum Genetics, V35, P22; Sharma B., 2003, Pisum Genetics, V35, P30; SHURE M, 1983, CELL, V35, P225, DOI 10.1016/0092-8674(83)90225-8; Smith PH, 1996, PLANT PATHOL, V45, P302, DOI 10.1046/j.1365-3059.1996.d01-111.x; Srivastava RK, 2012, EUPHYTICA, V186, P855, DOI 10.1007/s10681-012-0650-z; Studer B, 2009, MOL BREEDING, V24, P191, DOI 10.1007/s11032-009-9291-x; Sun S, 2015, CROP J, V3, P489, DOI 10.1016/j.cj.2015.07.006; TIMMERMAN GM, 1994, THEOR APPL GENET, V88, P1050, DOI 10.1007/BF00220815; Tiwari KR, 1997, CAN J PLANT SCI, V77, P307, DOI 10.4141/P96-157; Tiwari KR, 1998, GENOME, V41, P440, DOI 10.1139/gen-41-3-440; Tonguc M., 2010, J PLANT MOL BIOL BIO, V1, P1; Vaid A, 1997, EUPHYTICA, V96, P203, DOI 10.1023/A:1002953129003; Wang X., 2007, IDENTIFICATION CONTR; Wang ZhongYi, 2015, Acta Agronomica Sinica, V41, P515; Wang ZhongYi, 2013, Acta Agronomica Sinica, V39, P1030, DOI 10.3724/SP.J.1006.2013.01030; Warkentin TD, 1996, CAN J PLANT SCI, V76, P933, DOI 10.4141/cjps96-156; Wu SB, 2008, THEOR APPL GENET, V118, P1, DOI 10.1007/s00122-008-0870-8; Zeng L., 2012, GRASS TURF, V32, P35; Zong XuXiao, 2008, Acta Agronomica Sinica, V34, P1330, DOI 10.1016/S1875-2780(08)60045-0	62	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147624	10.1371/journal.pone.0147624	http://dx.doi.org/10.1371/journal.pone.0147624			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809053	gold, Green Submitted, Green Published			2022-12-26	WOS:000369527800153
J	Zhao, Q; Wen, YJ; Jiang, Y; Zhang, C; Li, Y; Zhang, GY; Zhang, L; Qiu, MF				Zhao, Qi; Wen, Yujie; Jiang, Yan; Zhang, Chen; Li, Yang; Zhang, Guiyun; Zhang, Lei; Qiu, Maofeng			Next Generation Sequencing-Based Investigation of Potential Patient-to-Patient Hepatitis C Virus Transmission during Hemodialytic Treatment	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC ANALYSIS; RISK; UNIT; HIV	We investigated potential patient-to-patient transmission of hepatitis C virus (HCV) in two hemodialysis centers in Beijing, China. Approximately 8.25%(32/388) hemodialysis patients were HCV antibody positive, and 4.90% (19/388) were HCV RNA-positive, which consisted of 2a genotype (1/19) and 1b genotypes (18/19). Using next generation sequencing (NGS) approach, MiSeq platform, we sequenced HCV, targeting hypervariable region 1 (263 base-pairs) of genotype 1b specimens and obtained 18 to 243 unique HCV variants. Analysis of phylogenetic tree, viral epidemiology signature pattern (VESP) and Shannon entropy indicated no obvious HCV similarity for most HCV infections but limited HCV variants from Patient 31 (P31) were closer with respect to evolutionary relationship with Patient 24 (P24). However, it was unlikely that HCV was transmitted directly from P24 to P31 in the hemodialysis center. Otherwise, their genetic distance (3.92%-8.92%), would have been much less. Moreover, P31 was infected less than two years before specimen collection, and other external high risk factors existed for these two patients. Thus, our data indicated no evidence of patient-to-patient transmission of HCV in the two hemodialysis centers, suggesting that current HCV infection control measures are effective.	[Zhao, Qi; Wen, Yujie; Jiang, Yan; Zhang, Guiyun; Qiu, Maofeng] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Natl AIDS Reference Lab, Beijing, Peoples R China; [Zhang, Chen; Li, Yang] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Lei] Tsinghua Univ, Res Ctr Publ Hlth, Sch Med, Beijing 100084, Peoples R China; [Zhang, Lei] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Zhang, Lei] Monash Univ, Cent Clin Sch, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Tsinghua University; Monash University	Qiu, MF (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Natl AIDS Reference Lab, Beijing, Peoples R China.; Zhang, L (corresponding author), Tsinghua Univ, Res Ctr Publ Hlth, Sch Med, Beijing 100084, Peoples R China.; Zhang, L (corresponding author), Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.; Zhang, L (corresponding author), Monash Univ, Cent Clin Sch, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia.	lzhang20@mail.tsinghua.edu.cn; qiumaofeng@hotmail.com	Zhang, Lei/D-4039-2011	Zhang, Lei/0000-0003-2343-084X; li, yang/0000-0001-8771-7044	National Funding for Hepatitis C Virus Control and Prevention	National Funding for Hepatitis C Virus Control and Prevention	This work was supported by the National Funding for Hepatitis C Virus Control and Prevention 2015.	[Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P189; Busch MP, 2003, JAMA-J AM MED ASSOC, V289, P959, DOI 10.1001/jama.289.8.959; Campo DS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S5-S4; Carobene M, 2014, J MED VIROL, V86, P64, DOI 10.1002/jmv.23805; Chen Yuan-sheng, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P888; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Escobar-Gutierrez A, 2012, J CLIN MICROBIOL, V50, P1461, DOI 10.1128/JCM.00005-12; Esteban JI, 1996, NEW ENGL J MED, V334, P555, DOI 10.1056/NEJM199602293340902; Girou E, 2008, CLIN INFECT DIS, V47, P627, DOI 10.1086/590564; Gonzalez-Candelas F, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-76; INCHAUSPE G, 1991, P NATL ACAD SCI USA, V88, P10292, DOI 10.1073/pnas.88.22.10292; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Nan R, 2011, ZHONGGUO GAN RAN KON, V10, P412; OU CY, 1992, SCIENCE, V256, P1165, DOI 10.1126/science.256.5060.1165; Ramachandran S, 2008, J VIROL METHODS, V151, P217, DOI 10.1016/j.jviromet.2008.05.005; Ross RS, 2009, J MED VIROL, V81, P249, DOI 10.1002/jmv.21394; Saludes V, 2013, J CLIN VIROL, V57, P263, DOI 10.1016/j.jcv.2013.03.007; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Su YY, 2013, J MED VIROL, V85, P425, DOI 10.1002/jmv.23486; Toda T, 2009, J MED VIROL, V81, P1363, DOI 10.1002/jmv.21537	20	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147566	10.1371/journal.pone.0147566	http://dx.doi.org/10.1371/journal.pone.0147566			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808659	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800136
J	Teng, Y; Pi, W; Wang, Y; Cowell, JK				Teng, Y.; Pi, W.; Wang, Y.; Cowell, J. K.			WASF3 provides the conduit to facilitate invasion and metastasis in breast cancer cells through HER2/HER3 signaling	ONCOGENE			English	Article							RECEPTOR TYROSINE KINASES; LAMELLIPODIA FORMATION; PROMOTING PROTEIN; TARGETED THERAPY; GENE; ACTIVATION; EXPRESSION; MIGRATION; WAVE3; HER2	The WASF3 gene is overexpressed in high-grade breast cancer and promotes invasion and metastasis, but does not affect proliferation. The HER2/ERBB2/NEU gene is also frequently overexpressed in breast cancer, and has been shown to promote invasion and metastasis in these tumors. Here, we show that WASF3 is present in the HER2 immunocomplex and suppression of WASF3 function leads to suppression of invasion even in the presence of HER2 expression. Overexpression of both HER2 and WASF3 in non-metastatic MCF7 breast cancer cells promotes invasion and metastasis more significantly than either gene alone. HER2 forms homodimers as well as heterodimers with other HER family members and we now show that the ability of WASF3 to promote invasion is highly dependent on the HER2/HER3 heterodimer. The engagement of WASF3 with the HER2/HER3 complex facilitates its phospho-activation and transcriptional upregulation, which is facilitated by HER2/HER3 activation of JAK/STAT signaling. In breast cancer cells overexpressing HER2, therefore, WASF3 is specifically required to facilitate the invasion/metastasis response. Targeting WASF3, therefore, could be a potential therapeutic approach to suppress metastasis of HER2-overexpressing breast tumors.	[Teng, Y.; Wang, Y.; Cowell, J. K.] Georgia Regents Univ, Ctr Canc, Augusta, GA USA; [Teng, Y.; Pi, W.] Georgia Regents Univ, Dept Biochem & Mol Biol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Teng, Y (corresponding author), Georgia Regents Univ, 1120 15th St, Augusta, GA 30912 USA.	yteng@gru.edu	Teng, Yong/AAK-4160-2020	Teng, Yong/0000-0002-1856-7289	National Institutes of Health [CA120510]; NATIONAL CANCER INSTITUTE [R01CA120510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grant CA120510 from the National Institutes of Health. We would like to thank Yun Mei and Hao Zhang for the technical assistance.	Atalay G, 2003, ANN ONCOL, V14, P1346, DOI 10.1093/annonc/mdg365; Barok M, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3621; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Basso AD, 2002, ONCOGENE, V21, P1159, DOI 10.1038/sj.onc.1205184; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; Cai Z, 2008, ONCOGENE, V27, P3870, DOI 10.1038/onc.2008.13; Freudenberg JA, 2009, EXP MOL PATHOL, V87, P1, DOI 10.1016/j.yexmp.2009.05.001; Ghoshal P, 2012, INT J CANCER, V131, pE905, DOI 10.1002/ijc.27631; Gomez-Martin C, 2014, CANCER LETT, V351, P30, DOI 10.1016/j.canlet.2014.05.019; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Johnson E, 2010, J BIOL CHEM, V285, P29491, DOI 10.1074/jbc.M110.136770; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Liu JB, 2002, AM J RESP CELL MOL, V27, P306, DOI 10.1165/rcmb.4850; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Modi S, 2011, CLIN CANCER RES, V17, P5132, DOI 10.1158/1078-0432.CCR-11-0072; Muller-Tidow C, 2005, CANCER RES, V65, P1778, DOI 10.1158/0008-5472.CAN-04-3388; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Pellikainen JM, 2004, CLIN CANCER RES, V10, P7621, DOI 10.1158/1078-0432.CCR-04-1061; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Roses RE, 2009, CANCER EPIDEM BIOMAR, V18, P1386, DOI 10.1158/1055-9965.EPI-08-1101; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Shankaran H, 2006, BIOPHYS J, V90, P3993, DOI 10.1529/biophysj.105.080580; Sossey-Alaoui K, 2005, J BIOL CHEM, V280, P21748, DOI 10.1074/jbc.M500503200; Sossey-Alaoui K, 2002, ONCOGENE, V21, P5967, DOI 10.1038/sj.onc.1205734; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Sossey-Alaoui K, 2013, SEMIN CELL DEV BIOL, V24, P287, DOI 10.1016/j.semcdb.2012.10.006; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Taylor MA, 2013, BREAST CANCER RES TR, V142, P341, DOI 10.1007/s10549-013-2753-1; Teng Y, 2016, ONCOGENE, V35, P333, DOI 10.1038/onc.2015.86; Teng Y, 2014, ONCOGENE, V33, P203, DOI 10.1038/onc.2012.565; Teng Y, 2010, BRIT J CANCER, V103, P1066, DOI 10.1038/sj.bjc.6605850; Teng Y, 2015, CANC RES; Teng Yong, 2014, JAKSTAT, V3, pe28086, DOI 10.4161/jkst.28086; Teng Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-453; Teng Y, 2013, CARCINOGENESIS, V34, P1994, DOI 10.1093/carcin/bgt167; Teng Y, 2012, J BIOL CHEM, V287, P10051, DOI 10.1074/jbc.M111.335000; Teng Y, 2011, INT J CANCER, V129, P2825, DOI 10.1002/ijc.25964; Tsujioka H, 2010, ANTICANCER RES, V30, P3107; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; VANDEVIJVER MJ, 1988, NEW ENGL J MED, V319, P1239, DOI 10.1056/NEJM198811103191902; Vaught DB, 2012, CANCER RES, V72, P2672, DOI 10.1158/0008-5472.CAN-11-3594; Zhang J, 2013, GYNECOL ONCOL, V130, P354, DOI 10.1016/j.ygyno.2013.05.005	43	18	18	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 1	2016	35	35					4633	4640		10.1038/onc.2015.527	http://dx.doi.org/10.1038/onc.2015.527			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU6PE	26804171	Green Accepted			2022-12-26	WOS:000382336300009
J	Albarran, L; Lopez, JJ; Woodard, GE; Salido, GM; Rosado, JA				Albarran, Letizia; Lopez, Jose J.; Woodard, Geoffrey E.; Salido, Gines M.; Rosado, Juan A.			Store-operated Ca2+ Entry-associated Regulatory factor (SARAF) Plays an Important Role in the Regulation of Arachidonate-regulated Ca2+ (ARC) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arachidonic acid (AA) (ARA); calcium channel; calcium release-activated calcium channel protein 1 (ORAI1); protein-protein interaction; stromal interaction molecule 1 (STIM1); ARC channels; SARAF	MEDIATED CALCIUM-ENTRY; ACTIN CYTOSKELETON; HUMAN PLATELETS; RETINOIC ACID; STIM1; ACTIVATION; APOPTOSIS; DEPLETION; SURVIVAL; DEATH	The store-operated Ca2+ entry-associated regulatory factor (SARAF) has recently been identified as a STIM1 regulatory protein that facilitates slow Ca2+-dependent inactivation of store-operated Ca2+ entry (SOCE). Both the store-operated channels and the store-independent arachidonate-regulated Ca2+ (ARC) channels are regulated by STIM1. In the present study, we show that, in addition to its location in the endoplasmic reticulum, SARAF is constitutively expressed in the plasma membrane, where it can interact with plasma membrane (PM)-resident ARC forming subunits in the neuroblastoma cell line SH-SY5Y. Using siRNA-based and overexpression approaches we report that SARAF negatively regulates store-independent Ca2+ entry via the ARC channels. Arachidonic acid (AA) increases the association of PM-resident SARAF with Orai1. Finally, our results indicate that SARAF modulates the ability of AA to promote cell survival in neuroblastoma cells. In addition to revealing new insight into the biology of ARC channels in neuroblastoma cells, these findings provide evidence for an unprecedented location of SARAF in the plasma membrane.	[Albarran, Letizia; Lopez, Jose J.; Salido, Gines M.; Rosado, Juan A.] Univ Extremadura, Dept Physiol, Cellular Physiol Res Grp, Caceres 10003, Spain; [Woodard, Geoffrey E.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA	Universidad de Extremadura; Uniformed Services University of the Health Sciences - USA	Rosado, JA (corresponding author), Univ Extremadura, Dept Physiol, Caceres 10071, Spain.	jarosado@unex.es	Lopez, Jose J/F-4602-2016; Salido, Gines M/A-4292-2009; Rosado, Juan A/H-3488-2015	Lopez, Jose J/0000-0002-5234-1478; Salido, Gines M/0000-0002-8687-2445; Rosado, Juan A/0000-0002-9749-2325	MINECO (Ministerio de Economia y Competitividad) [BFU2013-45564-C2-1-P]; Junta de Extremadura-FEDER [GR15029]; MINECO [BES-2011-043356]; Juan de la Cierva Program	MINECO (Ministerio de Economia y Competitividad)(Spanish Government); Junta de Extremadura-FEDER(European Commission); MINECO(Spanish Government); Juan de la Cierva Program	This work was supported by MINECO (Ministerio de Economia y Competitividad) (Grant BFU2013-45564-C2-1-P) and Junta de Extremadura-FEDER (GR15029). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by MINECO Fellowship BES-2011-043356.; Supported by the Juan de la Cierva Program.	Albarran L, 2014, BBA-MOL CELL RES, V1843, P789, DOI 10.1016/j.bbamcr.2014.01.014; Bell E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068859; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; Csutora P, 2008, J BIOL CHEM, V283, P14524, DOI 10.1074/jbc.M709575200; Fisher JN, 2015, ONCOTARGET, V6, P13176, DOI 10.18632/oncotarget.3759; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Jha A, 2013, J CELL BIOL, V202, P71, DOI 10.1083/jcb.201301148; Kerper LE, 1997, TOXICOL APPL PHARM, V146, P127, DOI 10.1006/taap.1997.8234; Lopez E, 2015, THROMB HAEMOSTASIS, V114, P969, DOI 10.1160/TH14-09-0727; Lovat PE, 2003, J CELL BIOCHEM, V89, P698, DOI 10.1002/jcb.10551; Luo DL, 2001, J BIOL CHEM, V276, P20186, DOI 10.1074/jbc.M100327200; Mignen O, 2000, J BIOL CHEM, V275, P9114, DOI 10.1074/jbc.275.13.9114; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; Mignen O, 2009, J PHYSIOL-LONDON, V587, P4181, DOI 10.1113/jphysiol.2009.174193; Noy N, 2010, ANNU REV NUTR, V30, P201, DOI 10.1146/annurev.nutr.28.061807.155509; Palty R, 2012, CELL, V149, P425, DOI 10.1016/j.cell.2012.01.055; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Redondo PC, 2005, CELL SIGNAL, V17, P1011, DOI 10.1016/j.cellsig.2004.11.019; Romanuik TL, 2009, AM J PATHOL, V175, P2264, DOI 10.2353/ajpath.2009.080868; Rosado JA, 2000, J PHYSIOL-LONDON, V526, P221, DOI 10.1111/j.1469-7793.2000.t01-2-00221.x; Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527; Shuttleworth TJ, 2004, PHYSIOLOGY, V19, P355, DOI 10.1152/physiol.00018.2004; Shuttleworth TJ, 1996, J BIOL CHEM, V271, P21720, DOI 10.1074/jbc.271.36.21720; Thompson JL, 2015, J PHYSIOL-LONDON, V593, P559, DOI 10.1113/jphysiol.2014.284182; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0; Zhang XX, 2014, J GEN PHYSIOL, V143, P345, DOI 10.1085/jgp.201311084	26	26	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6982	6988		10.1074/jbc.M115.704940	http://dx.doi.org/10.1074/jbc.M115.704940			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26817842	Green Published, hybrid			2022-12-26	WOS:000373299700034
J	He, XH; Kong, QL; Patfield, S; Skinner, C; Rasooly, R				He, Xiaohua; Kong, Qiulian; Patfield, Stephanie; Skinner, Craig; Rasooly, Reuven			A New Immunoassay for Detecting All Subtypes of Shiga Toxins Produced by Shiga Toxin-Producing E. coli in Ground Beef	PLOS ONE			English	Article							ESCHERICHIA-COLI; UNITED-STATES; HEMORRHAGIC COLITIS; VARIANT; ENVIRONMENT; PATHOGENS; STRAINS; ILLNESS; FOOD	Background Shiga toxin (Stx) is a common virulence factor of all Shiga toxin producing E. coli (STEC) that cause a wide spectrum of disease, including hemorrhagic colitis and hemolytic uremic syndrome (HUS). Although several commercial kits are available for detection of Stx produced by STEC, none of them are capable of recognizing all subtypes of Stxs, which include three subtypes of Stx1 and seven subtypes of Stx2. Methods and Findings New monoclonal and polyclonal antibodies against Stx1 and Stx2 were developed. A universal sandwich ELISA capable of detecting all known subtypes of Stx1 and Stx2 was established using a pool of newly developed antibodies. To precisely monitor the sensitivity of the assay for each subtype of Stxs, recombinant toxoids were created and used as standards in ELISAs. Because of the high affinity of the antibodies incorporated, the ELISA assay is highly sensitive with a limit of detection for the different subtypes of Stx1a and Stx2a between 10 and 50 pg/mL in phosphate buffered saline (PBS). The assay was also able to identify STEC based on the production of Stxs using the supernatants of culture fluids or even single colonies on agar plates without lengthy enrichment in liquid medium. When applied to ground beef samples, this newly developed ELISA was capable of distinguishing beef samples spiked with a single bacterial cell. Conclusions A highly sensitive and universal assay for all subtypes of Stx1 and Stx2 was developed. It has significantly improved upon the current technologies by avoiding false negative results due to the narrow detection range of the assay. The assay developed in this study can be useful for prompt detection of new and emerging serotypes and screening ground beef samples for contamination of STEC at an early stage in the food supply chain, thus avoiding the need for possible recall.	[He, Xiaohua; Patfield, Stephanie; Skinner, Craig; Rasooly, Reuven] Agr Res Serv, Western Reg Res Ctr, US Dept Agr, Albany, CA USA; [Kong, Qiulian] Shanghai Shuneng Irradiat Technol Co Ltd, Shanghai Acad Agr Sci, Shanghai, Peoples R China	United States Department of Agriculture (USDA); Shanghai Academy of Agricultural Sciences	He, XH (corresponding author), Agr Res Serv, Western Reg Res Ctr, US Dept Agr, Albany, CA USA.	xiaohua.he@ars.usda.gov			USDA-ARS CRIS project [5325-42000-048-00D]; Shanghai Shuneng Irradiation Technology Co., Ltd.	USDA-ARS CRIS project(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Shanghai Shuneng Irradiation Technology Co., Ltd.	This work was supported by USDA-ARS CRIS project 5325-42000-048-00D and Shanghai Shuneng Irradiation Technology Co., Ltd. Both funders provided support in the form of salaries for authors [XH, QK, SP, CS, RR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We would like to thank Andrew Gehring, Pina Fratamico, Robert Mandrell, Michael Cooley, and Anna Bates for providing STEC strains. This work was supported by USDA-ARS CRIS project 5325-42000-048-00D and Shanghai Shuneng Irradiation Technology Co., Ltd. The funders provided support in the form of salaries for authors [XH, QK, SP, CS, RR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Beutin L, 2008, APPL ENVIRON MICROB, V74, P4806, DOI 10.1128/AEM.00623-08; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Fremaux B, 2008, VET MICROBIOL, V132, P1, DOI 10.1016/j.vetmic.2008.05.015; He XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076368; He XH, 2013, J IMMUNOL METHODS, V389, P18, DOI 10.1016/j.jim.2012.12.005; He XH, 2012, TOXINS, V4, P487, DOI 10.3390/toxins4070487; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; Klein S, 2013, RISKY MEAT CSPI FIEL; Manning SD, 2007, EMERG INFECT DIS, V13, P318, DOI 10.3201/eid1302.060813; MARCH SB, 1986, J CLIN MICROBIOL, V23, P869, DOI 10.1128/JCM.23.5.869-872.1986; Mead PS, 1999, EMERG INFECT DIS, V5, P841, DOI 10.3201/eid0506.990625; OBRIEN AD, 1983, LANCET, V1, P702; OJEDA A, 1995, J CLIN MICROBIOL, V33, P2199, DOI 10.1128/JCM.33.8.2199-2201.1995; Park CH, 2003, J CLIN MICROBIOL, V41, P2650, DOI 10.1128/JCM.41.6.2650-2653.2003; Pierard D, 1998, J CLIN MICROBIOL, V36, P3317; Scheutz F., 2012, EXTERNAL QUALITY ASS; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Schmidt H, 2000, APPL ENVIRON MICROB, V66, P1205, DOI 10.1128/AEM.66.3.1205-1208.2000; Skinner C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132419; Skinner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099854; Skinner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076563; Skinner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059760; Vallieres E, 2013, J CLIN MICROBIOL, V51, P481, DOI 10.1128/JCM.02219-12; WEINSTEIN DL, 1988, J BACTERIOL, V170, P4223, DOI 10.1128/jb.170.9.4223-4230.1988; Willford J, 2009, J FOOD PROTECT, V72, P741, DOI 10.4315/0362-028X-72.4.741	25	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148092	10.1371/journal.pone.0148092	http://dx.doi.org/10.1371/journal.pone.0148092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824247	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600098
J	Lazzaro, SC; Rutledge, RB; Burghart, DR; Glimcher, PW				Lazzaro, Stephanie C.; Rutledge, Robb B.; Burghart, Daniel R.; Glimcher, Paul W.			The Impact of Menstrual Cycle Phase on Economic Choice and Rationality	PLOS ONE			English	Article							WOMENS PREFERENCES; GENDER-DIFFERENCES; ESTROGEN ACTIONS; DECISION-MAKING; OVULATORY CYCLE; PROSPECT-THEORY; LUTEAL PHASES; LOSS AVERSION; BEHAVIOR; RISK	It is well known that hormones affect both brain and behavior, but less is known about the extent to which hormones affect economic decision-making. Numerous studies demonstrate gender differences in attitudes to risk and loss in financial decision-making, often finding that women are more loss and risk averse than men. It is unclear what drives these effects and whether cyclically varying hormonal differences between men and women contribute to differences in economic preferences. We focus here on how economic rationality and preferences change as a function of menstrual cycle phase in women. We tested adherence to the Generalized Axiom of Revealed Preference (GARP), the standard test of economic rationality. If choices satisfy GARP then there exists a well-behaved utility function that the subject's decisions maximize. We also examined whether risk attitudes and loss aversion change as a function of cycle phase. We found that, despite large fluctuations in hormone levels, women are as technically rational in their choice behavior as their male counterparts at all phases of the menstrual cycle. However, women are more likely to choose risky options that can lead to potential losses while ovulating; during ovulation women are less loss averse than men and therefore more economically rational than men in this regard. These findings may have market-level implications: ovulating women more effectively maximize expected value than do other groups.	[Lazzaro, Stephanie C.] UCL, Inst Cognit Neurosci, London, England; [Rutledge, Robb B.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Rutledge, Robb B.] Max Planck UCL Ctr Computat Psychiat & Ageing Res, London, England; [Burghart, Daniel R.] Calif State Univ Sacramento, Inst Cognit Neurosci, Sacramento, CA 95819 USA; [Glimcher, Paul W.] NYU, Ctr Neural Sci, New York, NY 10003 USA	University of London; University College London; University of London; University College London; California State University System; California State University Sacramento; New York University	Lazzaro, SC (corresponding author), UCL, Inst Cognit Neurosci, London, England.	s.lazzaro@ucl.ac.uk		Rutledge, Robb/0000-0001-7337-5039	National Institutes of Health [5R01NS054775]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (grant number 5R01NS054775) to PWG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afriat S.N, 1967, INT ECON REV, V8, P67, DOI [DOI 10.2307/2525382, 10.2307/2525382]; Ball A, 2013, BIOL PSYCHOL, V93, P52, DOI 10.1016/j.biopsycho.2013.01.005; Burghart DR, 2013, J RISK UNCERTAINTY, V46, P215, DOI 10.1007/s11166-013-9167-7; Buser T, 2012, J ECON BEHAV ORGAN, V83, P1, DOI 10.1016/j.jebo.2011.06.006; Camille N, 2011, J NEUROSCI, V31, P7527, DOI 10.1523/JNEUROSCI.6527-10.2011; Chen Y, 2007, J ECON THEORY, V136, P513, DOI 10.1016/j.jet.2006.09.012; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Dreher JC, 2007, P NATL ACAD SCI USA, V104, P2465, DOI 10.1073/pnas.0605569104; Durante KM, 2014, J MARKETING RES, V51, P27, DOI 10.1509/jmr.11.0327; Durante KM, 2011, J CONSUM RES, V37, P921, DOI 10.1086/656575; Eckel CC., 2008, HDB EXPT EC RESULTS, DOI 10.1016/S1574-0722(07)00113-8; Evans SM, 2002, PSYCHOPHARMACOLOGY, V159, P397, DOI 10.1007/s00213-001-0944-7; FerreiraPoblete A, 1997, ADV CONTRACEPT, V13, P83, DOI 10.1023/A:1006527232605; Gangestad SW, 2008, P ROY SOC B-BIOL SCI, V275, P991, DOI 10.1098/rspb.2007.1425; Gangestad SW, 2007, J PERS SOC PSYCHOL, V92, P151, DOI 10.1037/0022-3514.92.1.151; Gangestad SW, 1998, P ROY SOC B-BIOL SCI, V265, P927, DOI 10.1098/rspb.1998.0380; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; HAMPSON E, 1992, P357; Harbaugh WT, 2001, AM ECON REV, V91, P1539, DOI 10.1257/aer.91.5.1539; Harris CR, 2013, SEX ROLES, V69, P507, DOI 10.1007/s11199-012-0229-0; Hill SE, 2009, PERS SOC PSYCHOL B, V35, P1592, DOI 10.1177/0146167209346303; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Houthakker HS, 1950, ECONOMICA-NEW SER, V17, P159, DOI 10.2307/2549382; Johnston VS, 2001, EVOL HUM BEHAV, V22, P251, DOI 10.1016/S1090-5138(01)00066-6; Justice AJH, 1999, PSYCHOPHARMACOLOGY, V145, P67, DOI 10.1007/s002130051033; KAHNEMAN D, 1990, J POLIT ECON, V98, P1325, DOI 10.1086/261737; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Mani S, 2008, ENDOCRINOLOGY, V149, P2750, DOI 10.1210/en.2008-0097; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; Niederle M, 2011, ANNU REV ECON, V3, P601, DOI 10.1146/annurev-economics-111809-125122; Pearson M, 2013, GAME ECON BEHAV, V78, P1, DOI 10.1016/j.geb.2012.10.008; Penton-Voak IS, 2000, EVOL HUM BEHAV, V21, P39, DOI 10.1016/S1090-5138(99)00033-1; Protopopescu X, 2005, P NATL ACAD SCI USA, V102, P16060, DOI 10.1073/pnas.0502818102; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; Saad G, 2012, J CONSUM PSYCHOL, V22, P102, DOI 10.1016/j.jcps.2011.10.001; Samuelson PA, 1938, ECONOMICA-NEW SER, V5, P61, DOI 10.2307/2548836; SHERWIN BB, 1985, PSYCHONEUROENDOCRINO, V10, P325, DOI 10.1016/0306-4530(85)90009-5; Shughrue PJ, 1998, ENDOCRINOLOGY, V139, P5267, DOI 10.1210/en.139.12.5267; Sokol-Hessner P, 2009, P NATL ACAD SCI USA, V106, P5035, DOI 10.1073/pnas.0806761106; Speroff L, 2005, SPEROFFS CLIN GYNECO, P573; Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Tymula A, 2013, P NATL ACAD SCI USA, V110, P17143, DOI 10.1073/pnas.1309909110; Varian H. R., 1991, WORKING PAPER; WILCOX AJ, 1995, NEW ENGL J MED, V333, P1517, DOI 10.1056/NEJM199512073332301; Wozniak D, 2014, J LABOR ECON, V32, P161, DOI 10.1086/673324	48	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0144080	10.1371/journal.pone.0144080	http://dx.doi.org/10.1371/journal.pone.0144080			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824245	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528600002
J	Manifacier, I; Milan, JL; Jeanneau, C; Chmilewsky, F; Chabrand, P; About, I				Manifacier, Ian; Milan, Jean-Louis; Jeanneau, Charlotte; Chmilewsky, Fanny; Chabrand, Patrick; About, Imad			Computational Tension Mapping of Adherent Cells Based on Actin Imaging	PLOS ONE			English	Article							STRESS FIBERS; MODEL; ADHESION; MECHANICS; FORCE; MECHANOTRANSDUCTION; PRESTRESS; STIFFNESS	Forces transiting through the cytoskeleton are known to play a role in adherent cell activity. Up to now few approaches haves been able to determine theses intracellular forces. We thus developed a computational mechanical model based on a reconstruction of the cytoskeleton of an adherent cell from fluorescence staining of the actin network and focal adhesions ( FA). Our custom made algorithm converted the 2D image of an actin network into a map of contractile interactions inside a 2D node grid, each node representing a group of pixels. We assumed that actin filaments observed under fluorescence microscopy, appear brighter when thicker, we thus presumed that nodes corresponding to pixels with higher actin density were linked by stiffer interactions. This enabled us to create a system of heterogeneous interactions which represent the spatial organization of the contractile actin network. The contractility of this interaction system was then adapted to match the level of force the cell truly exerted on focal adhesions; forces on focal adhesions were estimated from their vinculin expressed size. This enabled the model to compute consistent mechanical forces transiting throughout the cell. After computation, we applied a graphical approach on the original actin image, which enabled us to calculate tension forces throughout the cell, or in a particular region or even in single stress fibers. It also enabled us to study different scenarios which may indicate the mechanical role of other cytoskeletal components such as microtubules. For instance, our results stated that the ratio between intra and extra cellular compression is inversely proportional to intracellular tension.	[Manifacier, Ian; Milan, Jean-Louis; Jeanneau, Charlotte; Chmilewsky, Fanny; Chabrand, Patrick; About, Imad] Aix Marseille Univ, ISM, CNRS, UMR 7287, Marseille, France; [Manifacier, Ian; Milan, Jean-Louis; Chabrand, Patrick] St Marguerite Hosp, Inst Locomot, APHM, F-13009 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Manifacier, I (corresponding author), Aix Marseille Univ, ISM, CNRS, UMR 7287, Marseille, France.; Manifacier, I (corresponding author), St Marguerite Hosp, Inst Locomot, APHM, F-13009 Marseille, France.	ian.manifacier@univ-amu.fr	Milan, Jean-Louis/I-5067-2016	Milan, Jean-Louis/0000-0001-5191-3094	 [ANR_12_BSV5_0010_04]		This study was supported by ANR_12_BSV5_0010_04 issued on December 18th, 2012 (www.agence-nationale-recherche.fr).	Abdul-Kadir MR, 2008, J BIOMECH, V41, P587, DOI 10.1016/j.jbiomech.2007.10.009; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Besser A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/425; Chong DYR, 2011, J BIOMECH, V44, P948, DOI 10.1016/j.jbiomech.2010.11.026; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Colombelli J, 2009, J CELL SCI, V122, P1928, DOI 10.1242/jcs.054577; Deguchi S, 2006, J BIOMECH, V39, P2603, DOI 10.1016/j.jbiomech.2005.08.026; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Dokukina IV, 2010, BIOPHYS J, V98, P2794, DOI 10.1016/j.bpj.2010.03.026; Enomoto T, 1996, CELL STRUCT FUNCT, V21, P317, DOI 10.1247/csf.21.317; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Han SJ, 2012, BIOPHYS J, V103, P640, DOI 10.1016/j.bpj.2012.07.023; Han SJ, 2011, COMPUT METHOD BIOMEC, V14, P459, DOI 10.1080/10255842.2011.554412; Herrera A, 2012, WORLD J ORTHOP, V3, P25, DOI 10.5312/wjo.v3.i4.25; Hersen P, 2011, NATURE; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hu SH, 2004, FRONT BIOSCI-LANDMRK, V9, P2177, DOI 10.2741/1352; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Itano N, 2003, P NATL ACAD SCI USA, V100, P5181, DOI 10.1073/pnas.0531397100; Ketene AN, 2012, INTEGR BIOL-UK, V4, P540, DOI 10.1039/c2ib00168c; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Maurin B, 2008, J BIOMECH, V41, P2036, DOI 10.1016/j.jbiomech.2008.03.011; Metcalf DJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50579; Milan JL, 2007, BIOMECH MODEL MECHAN, V6, P373, DOI 10.1007/s10237-006-0057-7; Milan JL, 2013, EUR CELLS MATER, V25, P97, DOI 10.22203/eCM.v025a07; Pathak A, 2012, J APPL MECH-T ASME, V79, DOI 10.1115/1.4006452; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Soine JRD, 2015, PLOS COMPUTATIONAL B, V11, DOI [10.1371/journal.pcbi.1004076, DOI 10.1371/J0URNAL.PCBI.1004076]; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; van Hoorn H, 2014, NANO LETT, V14, P4257, DOI 10.1021/nl5008773; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]; Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/nmat3889, 10.1038/NMAT3889]	38	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146863	10.1371/journal.pone.0146863	http://dx.doi.org/10.1371/journal.pone.0146863			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812601	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528000016
J	Tsao, CC; Tsao, PN; Chen, YG; Chuang, YH				Tsao, Cheng-Chiu; Tsao, Po-Nien; Chen, Yi-Guang; Chuang, Ya-Hui			Repeated Activation of Lung Invariant NKT Cells Results in Chronic Obstructive Pulmonary Disease-Like Symptoms	PLOS ONE			English	Article							SMOKE-INDUCED EMPHYSEMA; INNATE IMMUNE-RESPONSE; KILLER T-CELLS; CIGARETTE-SMOKE; AIRWAY HYPERREACTIVITY; INDUCED SPUTUM; COPD; ASTHMA; GLYCOSPHINGOLIPIDS; PATHOGENESIS	Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway inflammation, mucus hypersecretion, and emphysema, which lead to reduced lung function and breathlessness. The pathologies of COPD are due to an abnormal immune response. Invariant natural killer T (iNKT) cells are an important population of innate lymphocytes and have been implicated in the regulation of immune responses associated with a broad range of diseases including COPD. We have here analyzed the role of iNKT cells in a model of COPD induced by repeated intranasal administration of iNKT cell agonist alpha-galactosylceramide (alpha-GalCer). Our results demonstrated that mice that received repeated intranasal administration of alpha-GalCer had molecular and inflammatory features of COPD including airway inflammation with significant increases in infiltration of macrophages and lymphocytes, CD8(+) T cells, as well as proinflammatory cytokines IL-6 and TNF-alpha. In particular, these mice also showed the presence of pulmonary emphysema, mucus production, and pulmonary fibrosis. Furthermore, neutralization of IL-4 reduced alpha-GalCer induced emphysema. This study indicates the importance of iNKT cells in the pathogenesis of COPD by an IL-4 dependent mechanism.	[Tsao, Cheng-Chiu; Chuang, Ya-Hui] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Tsao, Po-Nien] Natl Taiwan Univ, Coll Med, Dept Pediat, Taipei, Taiwan; [Tsao, Po-Nien] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Chen, Yi-Guang] Med Coll Wisconsin, Dept Pediat, Max McGee Natl Res Ctr Juvenile Diabet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Chen, Yi-Guang] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA	National Taiwan University; National Taiwan University; National Taiwan University; Medical College of Wisconsin; Medical College of Wisconsin	Chuang, YH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.	yahuichuang@ntu.edu.tw		TSAO, PO-NIEN/0000-0002-6114-1769; CHUANG, YA-HUI/0000-0003-0857-0035	Ministry of Science and Technology, Taiwan [NSC 97-2320-B-002-017-MY3, NSC 100-2320-B-002086]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Ministry of Science and Technology, Taiwan, NSC 97-2320-B-002-017-MY3 and NSC 100-2320-B-002086-(YHC).	Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Atkinson JJ, 2011, AM J RESP CRIT CARE, V183, P876, DOI 10.1164/rccm.201005-0718OC; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Bartalesi B, 2005, EUR RESPIR J, V25, P15, DOI 10.1183/09031936.04.00067204; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Chang CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121320; Chuang YH, 2011, J IMMUNOL, V186, P4687, DOI 10.4049/jimmunol.1003659; Demedts IK, 2006, THORAX, V61, P196, DOI 10.1136/thx.2005.042432; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Jeffery PK, 1999, CLIN EXP ALLERGY, V29, P14, DOI 10.1046/j.1365-2222.1999.00004.x-i2; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Lin PY, 2015, IMMUNOLOGY, V144, P668, DOI 10.1111/imm.12419; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Meyer EH, 2006, P NATL ACAD SCI USA, V103, P2782, DOI 10.1073/pnas.0510282103; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Pichavant M, 2014, MUCOSAL IMMUNOL, V7, P568, DOI 10.1038/mi.2013.75; Provinciali M, 2011, CURR OPIN PULM MED, V17, pS3, DOI 10.1097/01.mcp.0000410742.90463.1f; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P752; Turato G, 2001, RESPIRATION, V68, P117, DOI 10.1159/000050478; Tyznik AJ, 2008, J IMMUNOL, V181, P4452, DOI 10.4049/jimmunol.181.7.4452; Urbanowicz RA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-76; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Wu LH, 2000, BIOCHEM BIOPH RES CO, V269, P808, DOI 10.1006/bbrc.2000.2368; Xie SP, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-148; Young HWJ, 2007, AM J RESP CELL MOL, V37, P273, DOI 10.1165/rcmb.2005-0460OC	35	9	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147710	10.1371/journal.pone.0147710	http://dx.doi.org/10.1371/journal.pone.0147710			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811900	gold, Green Published			2022-12-26	WOS:000369528000050
J	Abusara, Z; Von Kossel, M; Herzog, W				Abusara, Ziad; Von Kossel, Markus; Herzog, Walter			In Vivo Dynamic Deformation of Articular Cartilage in Intact Joints Loaded by Controlled Muscular Contractions	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; CHONDROCYTE; COMPRESSION; EXERCISE; CELL; INDENTATION; BEHAVIOR	When synovial joints are loaded, the articular cartilage and the cells residing in it deform. Cartilage deformation has been related to structural tissue damage, and cell deformation has been associated with cell signalling and corresponding anabolic and catabolic responses. Despite the acknowledged importance of cartilage and cell deformation, there are no dynamic data on these measures from joints of live animals using muscular load application. Research in this area has typically been done using confined and unconfined loading configurations and indentation testing. These loading conditions can be well controlled and allow for accurate measurements of cartilage and cell deformations, but they have little to do with the contact mechanics occurring in a joint where non-congruent cartilage surfaces with different material and functional properties are pressed against each other by muscular forces. The aim of this study was to measure in vivo, real time articular cartilage deformations for precisely controlled static and dynamic muscular loading conditions in the knees of mice. Fifty and 80% of the maximal knee extensor muscular force (equivalent to approximately 0.4N and 0.6N) produced average peak articular cartilage strains of 10.5+/-1.0% and 18.3+/-1.3% (Mean+/-SD), respectively, during 8s contractions. A sequence of 15 repeat, isometric muscular contractions (0.5s on, 3.5s off) of 50% and 80% of maximal muscular force produced cartilage strains of 3.0+/-1.1% and 9.6+/-1.5% (Mean +/- SD) on the femoral condyles of the mouse knee. Cartilage thickness recovery following mechanical compression was highly viscoelastic and took almost 50s following force removal in the static tests.	[Abusara, Ziad; Von Kossel, Markus; Herzog, Walter] Univ Calgary, Human Performance Lab, Fac Kinesiol, Calgary, AB T2N 1N4, Canada	University of Calgary	Abusara, Z (corresponding author), Univ Calgary, Human Performance Lab, Fac Kinesiol, Calgary, AB T2N 1N4, Canada.	zabusara@ucalgary.ca	Herzog, Walter/AAG-7188-2020; Von Kossel, Markus/AFK-6691-2022	Herzog, Walter/0000-0002-5341-0033; 	Alberta Innovates-Health Solutions; Canadian Institutes of Health research; Alberta Innovates Health Solutions	Alberta Innovates-Health Solutions; Canadian Institutes of Health research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions	Alberta Innovates-Health Solutions Fellowship and Team Grant on Osteoarthritis. The Canada Research Chair Program, the Canadian Institutes of Health Research, the Killam Foundation; This work was supported by Canadian Institutes of Health research (WH), Alberta Innovates Health Solutions (ZA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusara Z, 2013, J BIOMECH, V46, P1225, DOI 10.1016/j.jbiomech.2013.02.027; Abusara Z, 2011, J BIOMECH, V44, P930, DOI 10.1016/j.jbiomech.2010.11.031; ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304; Buschmann MD, 1996, J CELL SCI, V109, P499; Choi JB, 2007, J BIOMECH, V40, P2596, DOI 10.1016/j.jbiomech.2007.01.009; Cotofana S, 2011, EUR RADIOL, V21, P1127, DOI 10.1007/s00330-011-2057-y; Eckstein F, 1999, ANAT EMBRYOL, V200, P419, DOI 10.1007/s004290050291; Eckstein F, 2006, J ANAT, V208, P491, DOI 10.1111/j.1469-7580.2006.00546.x; Eckstein F, 2005, ANN RHEUM DIS, V64, P291, DOI 10.1136/ard.2004.022400; Eckstein F, 2000, J BIOMECH, V33, P819, DOI 10.1016/S0021-9290(00)00034-8; Federico S, 2005, J BIOMECH, V38, P2008, DOI 10.1016/j.jbiomech.2004.09.020; GRAY ML, 1988, J ORTHOPAED RES, V6, P777, DOI 10.1002/jor.1100060602; Guilak F, 1995, J BIOMECH, V28, P1529, DOI 10.1016/0021-9290(95)00100-X; GUILAK F, 1995, J ORTHOP RES, V13, P410, DOI 10.1002/jor.1100130315; Guilak F, 2000, BIORHEOLOGY, V37, P27; Han SK, 2012, J BIOMECH, V45, P2450, DOI 10.1016/j.jbiomech.2012.06.028; Han SK, 2012, J ORTHOP RES, V30, P475, DOI 10.1002/jor.21536; Han SK, 2009, MED ENG PHYS, V31, P1038, DOI 10.1016/j.medengphy.2009.05.013; HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3; Herberhold C, 1999, J BIOMECH, V32, P1287, DOI 10.1016/S0021-9290(99)00130-X; Herzog W, 1997, J BIOMECH, V30, P865, DOI 10.1016/S0021-9290(97)00046-8; Hosseini A, 2010, OSTEOARTHR CARTILAGE, V18, P909, DOI 10.1016/j.joca.2010.04.011; KIM YJ, 1994, ARCH BIOCHEM BIOPHYS, V311, P1, DOI 10.1006/abbi.1994.1201; Knight MM, 1998, MED ENG PHYS, V20, P684, DOI 10.1016/S1350-4533(98)00080-0; Li G, 2008, J BIOMECH, V41, P128, DOI 10.1016/j.jbiomech.2007.07.006; Li LP, 2005, MED ENG PHYS, V27, P51, DOI 10.1016/j.medengphy.2004.08.009; Moo EK, 2013, J BIOMECH, V46, P2024, DOI 10.1016/j.jbiomech.2013.06.007; Moskowitz RW, 1984, OSTEOARTHRITIS DIAGN, P213; MOW VC, 1989, J BIOMECH, V22, P853, DOI 10.1016/0021-9290(89)90069-9; MOW VC, 1984, J BIOMECH, V17, P377, DOI 10.1016/0021-9290(84)90031-9; MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5; Neu CP, 2003, J BIOMECH ENG-T ASME, V125, P180, DOI 10.1115/1.1560141; SAH RLY, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P373; Shrive N. G., 1999, BIOMECHANICS MUSCULO, P86; Sibole SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037538; Sutter EG, 2015, AM J SPORT MED, V43, P370, DOI 10.1177/0363546514559821; URBAN JPG, 1994, BRIT J RHEUMATOL, V33, P901; Urban JPG, 2000, BIORHEOLOGY, V37, P185; Van Ginckel A, 2013, PHYS THER, V93, P1049, DOI 10.2522/ptj.20120491	39	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147547	10.1371/journal.pone.0147547	http://dx.doi.org/10.1371/journal.pone.0147547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807930	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800129
J	Bier, G; Bongers, MN; Ditt, H; Bender, B; Ernemann, U; Horger, M				Bier, Georg; Bongers, Malte N.; Ditt, Hendrik; Bender, Benjamin; Ernemann, Ulrike; Horger, Marius			Accuracy of Non-Enhanced CT in Detecting Early Ischemic Edema Using Frequency Selective Non-Linear Blending	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; ALBERTA STROKE; HEMORRHAGIC TRANSFORMATION; THROMBECTOMY; REPERFUSION; OCCLUSION; SCORE; RECANALIZATION; INFARCTION; EVENTS	Purpose Ischemic brain edema is subtle and hard to detect by computed tomography within the first hours of stroke onset. We hypothesize that non-enhanced CT (NECT) post-processing with frequency-selective non-linear blending ("best contrast"/BC) increases its accuracy in detecting edema and irreversible tissue damage (infarction). Methods We retrospectively analyzed the NECT scans of 76 consecutive patients with ischemic stroke (exclusively middle cerebral artery territory-MCA) before and after post-processing with BC both at baseline before reperfusion therapy and at follow-up (5.73 +/- 12.74 days after stroke onset) using the Alberta Stroke Program Early CT Score (ASPECTS). We assessed the differences in ASPECTS between unprocessed and post-processed images and calculated sensitivity, specificity, and predictive values of baseline NECT using follow-up CT serving as reference standard for brain infarction. Results NECT detected brain tissue hypoattenuation in 35 of 76 patients (46.1%). This number increased to 71 patients (93.4%) after post-processing with BC. Follow-up NECT confirmed brain infarctions in 65 patients (85.5%; p = 0.012). Post-processing increased the sensitivity of NECT for brain infarction from 35/65 (54%) to 65/65 (100%), decreased its specificity from 11/11 (100%) to 7/11 (64%), its positive predictive value (PPV) from 35/35 (100%) to 65/69 (94%) and increased its accuracy 46/76 (61%) to 72/76 (95%). Conclusions This post-hoc analysis suggests that post-processing of NECT with BC may increase its sensitivity for ischemic brain damage significantly.	[Bier, Georg; Bongers, Malte N.; Horger, Marius] Univ Tubingen, Dept Diagnost & Intervent Radiol, D-72076 Tubingen, Germany; [Ditt, Hendrik] Siemens AG Healthcare, Imaging & Therapy Syst Computed Tomog & Radiat On, Siemensstr 1, D-91301 Forchheim, Germany; [Bender, Benjamin; Ernemann, Ulrike] Univ Tubingen, Dept Neuroradiol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Siemens AG; Eberhard Karls University of Tubingen	Bier, G (corresponding author), Univ Tubingen, Dept Diagnost & Intervent Radiol, D-72076 Tubingen, Germany.	georghomann@web.de		Bender, Benjamin/0000-0002-3205-4631	Siemens AG	Siemens AG(Siemens AG)	One of the authors (H.D.) is employed by a commercial company (Siemens AG Healthcare Sector). Since the manuscript is based on the application of a new software, the co-author gave technical support, but he and his organization did not play a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. Siemens AG gave financial support in the form of H.D.'s salaries only.	Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Coutts SB, 2012, STROKE, V43, P3018, DOI 10.1161/STROKEAHA.112.665141; Demchuk AM, 2005, NEUROIMAG CLIN N AM, V15, P409, DOI 10.1016/j.nic.2005.06.008; Demchuk AM, 2005, STROKE, V36, P2110, DOI 10.1161/01.STR.0000181116.15426.58; Dzialowski I, 2004, J NEUROIMAGING, V14, P42, DOI 10.1177/1051228403258135; Dzialowski I, 2007, RADIOLOGY, V243, P720, DOI 10.1148/radiol.2432060137; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fischer U, 2010, STROKE, V41, P661, DOI 10.1161/STROKEAHA.109.572883; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Hesselmann V, 2012, AM J NEURORADIOL, V33, P336, DOI 10.3174/ajnr.A2746; Higashida RT, 2003, STROKE, V34, pE109, DOI 10.1161/01.STR.0000082721.62796.09; Hirano T, 2012, J STROKE CEREBROVASC, V21, P898, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.018; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Na DG, 1998, RADIOLOGY, V207, P113, DOI 10.1148/radiology.207.1.9530306; Nambiar V, 2014, AM J NEURORADIOL, V35, P884, DOI 10.3174/ajnr.A3817; Paciaroni M, 2008, STROKE, V39, P2249, DOI 10.1161/STROKEAHA.107.510321; PESSIN MS, 1991, AM J NEURORADIOL, V12, P1123; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Srinivasan A, 2006, RADIOGRAPHICS, V26, pS75, DOI 10.1148/rg.26si065501; Tan S, 2014, J NEUROL, V261, P905, DOI 10.1007/s00415-014-7297-8; von Kummer R, 2015, STROKE, V46, P2981, DOI 10.1161/STROKEAHA.115.010049; vonKummer R, 1997, RADIOLOGY, V205, P327, DOI 10.1148/radiology.205.2.9356611	24	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147378	10.1371/journal.pone.0147378	http://dx.doi.org/10.1371/journal.pone.0147378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809010	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800082
J	Campos, LC; Rocha, MVV; Willers, DMC; Silva, DR				Campos, Leandro Cruz; Vieira Rocha, Marcos Vinicius; Cunha Willers, Denise Maria; Silva, Denise Rossato			Characteristics of Patients with Smear-Negative Pulmonary Tuberculosis (TB) in a Region with High TB and HIV Prevalence	PLOS ONE			English	Article							DIAGNOSIS; TRANSMISSION; COHORT; AREA; MORTALITY; SETTINGS; PROGRAM; ADULTS	Introduction Smear-negative pulmonary TB (SNPT) represents 30-60% of all pulmonary TB cases. The mortality of these patients can reach 25% in populations with high prevalence of HIV infection, and 10-20% of TB transmission at the population level are attributable to SNPT cases. Methods We conducted a retrospective study to evaluate epidemiological, clinical, and radiological characteristics of patients with SNPT and to compare these with patients who were diagnosed as having smear-positive pulmonary TB (SPPT). All adult patients (>= 18 years old) with a positive culture for Mycobacterium tuberculosis, and a diagnosis of pulmonary TB were included in the study. Results 198 patients met the inclusion criteria (positive culture for Mycobacterium tuberculosis) and were included in the analysis. Of these patients, 69 (34.8%) were smear positive (SPPT) and 129 (65.2%) were smear negative (SNPT). In univariate analysis, cough, dyspnea, and hemoptysis were less frequent in SNPT patients in comparison with SPPT patients. In a multivariate model, having no cough and no radiographic pattern typical of TB were the characteristics independently associated with a diagnosis of SNPT. Conclusions We found a very high prevalence of SNPT among patients with TB in a setting with high TB and HIV prevalence. The absence of cough in the presence of other symptoms suggestive of TB, and having no radiographic pattern typical of TB where independent predictors of SNPT.	[Campos, Leandro Cruz; Silva, Denise Rossato] Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Pneumol, Porto Alegre, RS, Brazil; [Vieira Rocha, Marcos Vinicius; Silva, Denise Rossato] Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil; [Cunha Willers, Denise Maria; Silva, Denise Rossato] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Silva, DR (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Pneumol, Porto Alegre, RS, Brazil.; Silva, DR (corresponding author), Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil.; Silva, DR (corresponding author), Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.	denise.rossato@terra.com.br		Rossato Silva, Denise/0000-0003-0230-2734	FIPE-HCPA (Fundo de Incentivo a Pesquisa - Hospital de Clinicas de Porto Alegre)	FIPE-HCPA (Fundo de Incentivo a Pesquisa - Hospital de Clinicas de Porto Alegre)	This work was supported by FIPE-HCPA (Fundo de Incentivo a Pesquisa - Hospital de Clinicas de Porto Alegre).	Affolabi D, 2011, INT J TUBERC LUNG D, V15, P67; Apers L, 2004, INT J TUBERC LUNG D, V8, P945; Basinga P, 2007, MED DECIS MAKING, V27, P53, DOI 10.1177/0272989X06297104; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011; Dimairo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011849; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; ELLIOTT AM, 1993, TUBERCLE LUNG DIS, V74, P191, DOI 10.1016/0962-8479(93)90010-U; Foulds J, 1998, INT J TUBERC LUNG D, V2, P778; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P113; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Harries AD, 1998, B WORLD HEALTH ORGAN, V76, P651; Harries AD, 1999, T ROY SOC TROP MED H, V93, P443, DOI 10.1016/S0035-9203(99)90153-0; Harries AD, 1997, ANN TROP MED PARASIT, V91, P771, DOI 10.1080/00034989760527; Henegar C, 2012, INT J TUBERC LUNG D, V16, P1199, DOI 10.5588/ijtld.11.0613; Hernandez-Garduno E, 2004, THORAX, V59, P286, DOI 10.1136/thx.2003.011759; Kanaya AM, 2001, CHEST, V120, P349, DOI 10.1378/chest.120.2.349; Kassu Afework, 2007, Journal of Microbiology Immunology and Infection, V40, P116; Loh L C, 2005, Med J Malaysia, V60, P62; LONG R, 1991, AM J PUBLIC HEALTH, V81, P1326, DOI 10.2105/AJPH.81.10.1326; MacPherson P, 2011, INT J TUBERC LUNG D, V15, P1390, DOI 10.5588/ijtld.11.0056; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; Mello FCD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-43; Ministerio da Saude, 2011, PROGR NAC CONTR TUB; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Palmieri F, 2002, INFECTION, V30, P68, DOI 10.1007/s15010-002-2062-9; Raviglione M C, 1997, AIDS, V11 Suppl B, pS115; Secretaria de Vigilancia em Saude-Ministerio da Saude, 2015, MIN SAUD B EP; Selwyn PA, 1998, AIDS, V12, P885, DOI 10.1097/00002030-199808000-00011; Shah NS, 2012, INT J TUBERC LUNG D, V16, P1234, DOI 10.5588/ijtld.11.0794; Soto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018486; Tostmann A, 2008, CLIN INFECT DIS, V47, P1135, DOI 10.1086/591974; Tozkoparan E, 2005, ARCH MED RES, V36, P166, DOI 10.1016/j.arcmed.2004.12.010; WHO, 2007, IMPR DIAGN TREATM SM; World Health Organization, 1998, GUID CONTR MON TOB E; World Health Organization, 2011, GLOB TUB CONTR WHO R	39	32	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147933	10.1371/journal.pone.0147933	http://dx.doi.org/10.1371/journal.pone.0147933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808299	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800244
J	Eckerdal, P; Kollia, N; Lofblad, J; Hellgren, C; Karlsson, L; Hogberg, U; Wikstrom, AK; Skalkidou, A				Eckerdal, Patricia; Kollia, Natasa; Lofblad, Johanna; Hellgren, Charlotte; Karlsson, Linnea; Hogberg, Ulf; Wikstrom, Anna-Karin; Skalkidou, Alkistis			Delineating the Association between Heavy Postpartum Haemorrhage and Postpartum Depression	PLOS ONE			English	Article							POSTNATAL-DEPRESSION; RISK-FACTORS; PREVALENCE; WOMEN; ANEMIA; PREGNANCY; DELIVERY; COHORT; VALIDATION; PREDICTORS	Objectives To explore the association between postpartum haemorrhage (PPH) and postpartum depression (PPD), taking into account the role of postpartum anaemia, delivery experience and psychiatric history. Methods A nested cohort study (n = 446), based on two population-based cohorts in Uppsala, Sweden. Exposed individuals were defined as having a bleeding of >= 1000ml (n = 196) at delivery, and non-exposed individuals as having bleeding of <650ml (n = 250). Logistic regression models with PPD symptoms (Edinburgh Postnatal Depression scale (EPDS) score >= 12) as the outcome variable and PPH, anaemia, experience of delivery, mood during pregnancy and other confounders as exposure variables were undertaken. Path analysis using Structural Equation Modeling was also conducted. Results There was no association between PPH and PPD symptoms. A positive association was shown between anaemia at discharge from the maternity ward and the development of PPD symptoms, even after controlling for plausible confounders (OR = 2.29, 95% CI = 1.15-4.58). Path analysis revealed significant roles for anaemia at discharge, negative self-reported delivery experience, depressed mood during pregnancy and postpartum stressors in increasing the risk for PPD. Conclusion This study proposes important roles for postpartum anaemia, negative experience of delivery and mood during pregnancy in explaining the development of depressive symptoms after PPH.	[Eckerdal, Patricia; Lofblad, Johanna; Hellgren, Charlotte; Hogberg, Ulf; Wikstrom, Anna-Karin; Skalkidou, Alkistis] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Kollia, Natasa] Harokopio Univ, Dept Biostat, Athens, Greece; [Karlsson, Linnea] Turku Univ Hosp, Dept Child Psychiat, FIN-20520 Turku, Finland; [Karlsson, Linnea] Univ Turku, Inst Clin Med, Turku Brain & Mind Ctr, Turku, Finland	Uppsala University; Harokopio University Athens; University of Turku; University of Turku	Eckerdal, P (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	patricia.eckerdal@kbh.uu.se	Skalkidou, Alkistis/C-1521-2015; Karlsson, Linnea/AAI-5959-2020	Skalkidou, Alkistis/0000-0002-4935-7532; Karlsson, Linnea/0000-0002-4725-0176	Gillbergska Foundation [464250651]; Marianne and Marcus Wallenberg Foundation [521-2013-2339]; Uppsala University Hospital [2012-Skalkidou]; Swedish Medical Society [SLS-250581]	Gillbergska Foundation; Marianne and Marcus Wallenberg Foundation; Uppsala University Hospital; Swedish Medical Society	This work was supported by the Gillbergska Foundation (grant number 464250651), the Marianne and Marcus Wallenberg Foundation (grant number: 521-2013-2339), the Uppsala University Hospital (grant number: 2012-Skalkidou), and the Swedish Medical Society (grant number SLS-250581). The funders had no role in study design, data Collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Kadir R, 2014, TRANSFUSION, V54, P1756, DOI 10.1111/trf.12550; Adams SS, 2012, BJOG-INT J OBSTET GY, V119, P298, DOI 10.1111/j.1471-0528.2011.03188.x; Albacar G, 2011, J AFFECT DISORDERS, V131, P136, DOI 10.1016/j.jad.2010.11.006; Alharbi AA, 2014, NEUROPSYCH DIS TREAT, V10, P311, DOI 10.2147/NDT.S57556; Almond P, 2009, PERSPECT PUBLIC HEAL, V129, P221, DOI 10.1177/1757913909343882; Andersen LB, 2012, ACTA OBSTET GYN SCAN, V91, P1261, DOI 10.1111/j.1600-0412.2012.01476.x; [Anonymous], 2008, WORLDW PREV AN 1993; Armony-Sivan R, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/521431; Bansil P, 2010, J WOMENS HEALTH, V19, P329, DOI 10.1089/jwh.2009.1387; Barroso F, 2011, EUR J OBSTET GYN R B, V159, P99, DOI 10.1016/j.ejogrb.2011.07.041; Beard JL, 2005, J NUTR, V135, P267, DOI 10.1093/jn/135.2.267; Bergmann RL, 2010, EUR J OBSTET GYN R B, V150, P126, DOI 10.1016/j.ejogrb.2010.02.030; Bloch M, 2006, GEN HOSP PSYCHIAT, V28, P3, DOI 10.1016/j.genhosppsych.2005.08.006; Bodnar LM, 2001, AM J OBSTET GYNECOL, V185, P438, DOI 10.1067/mob.2001.115996; Corwin EJ, 2005, JOGNN-J OBST GYN NEO, V34, P577, DOI 10.1177/0884217505279997; Corwin EJ, 2003, J NUTR, V133, P4139, DOI 10.1093/jn/133.12.4139; Corwin EJ, 2007, MCN-AM J MATERN-CHIL, V32, P215, DOI 10.1097/01.NMC.0000281959.71454.e5; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dahlke JD, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.023; Dorheim SK, 2009, SLEEP, V32, P847, DOI 10.1093/sleep/32.7.847; Ekselius L., 2012, DIAGNOSTIK UPPFOLJNI; Esscher A, 2014, SUICIDES PREGN UNPUB, P1980; Figueiredo B, 2013, J PEDIAT-BRAZIL, V89, P332, DOI 10.1016/j.jped.2012.12.002; Furuta M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-133; Gausia K, 2012, J HEALTH POPUL NUTR, V30, P172, DOI 10.3329/jhpn.v30i2.11310; Green L., 2015, BLOOD TRANSFUSION OB; Hofmeyr GJ, 2001, BEST PRACT RES CL OB, V15, P645, DOI 10.1053/beog.2001.0205; Iliadis SI, 2015, ARCH WOMEN MENT HLTH, V18, P539, DOI 10.1007/s00737-014-0478-8; Johnstone SJ, 2001, AUST NZ J PSYCHIAT, V35, P69, DOI 10.1046/j.1440-1614.2001.00862.x; Kassebaum N.J, 2014, LANCET; Katon W, 2014, J WOMENS HEALTH, V23, P753, DOI 10.1089/jwh.2014.4824; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; KLEINBAUM DG, 2007, APPL REGRESSION ANAL; Kline R.B., 2011, PRINCIPLES PRACTICE; Likis FE, 2015, MANAGEMENT POSTPARTU; Lindahl V, 2005, ARCH WOMEN MENT HLTH, V8, P77, DOI 10.1007/s00737-005-0080-1; Lukose A, 2014, MATERN CHILD HLTH J, V18, P161, DOI 10.1007/s10995-013-1249-2; Markova V, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010861.pub2; McLintock C, 2011, J THROMB HAEMOST, V9, P1441, DOI 10.1111/j.1538-7836.2011.04398.x; Milman N, 2011, ANN HEMATOL, V90, P1247, DOI 10.1007/s00277-011-1279-z; Mohammad KI, 2011, MIDWIFERY, V27, pE238, DOI 10.1016/j.midw.2010.10.008; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Oberg AS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4984; Olde E, 2006, CLIN PSYCHOL REV, V26, P1, DOI 10.1016/j.cpr.2005.07.002; Park EM, 2013, ARCH WOMEN MENT HLTH, V16, P539, DOI 10.1007/s00737-013-0356-9; Patel M, 2012, J HEALTH CARE POOR U, V23, P534, DOI 10.1353/hpu.2012.0037; Petersson K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-364; Rath WH, 2011, ACTA OBSTET GYN SCAN, V90, P421, DOI 10.1111/j.1600-0412.2011.01107.x; Richard Berkowitz R, 2012, MAN OBST HEM AM C OB; Rubertsson C, 2011, NORD J PSYCHIAT, V65, P414, DOI 10.3109/08039488.2011.590606; Sentilhes L, 2011, ACTA OBSTET GYN SCAN, V90, P615, DOI 10.1111/j.1600-0412.2011.01119.x; Sword W, 2011, BJOG-INT J OBSTET GY, V118, P966, DOI 10.1111/j.1471-0528.2011.02950.x; Sylven SM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.022; Sylven SM, 2011, ARCH WOMEN MENT HLTH, V14, P195, DOI 10.1007/s00737-011-0211-9; Thompson JF, 2011, AUST NZ J OBSTET GYN, V51, P365, DOI 10.1111/j.1479-828X.2011.01317.x; Tuohy Alan, 2008, Psychol Health Med, V13, P43, DOI 10.1080/13548500701294531; Vigod SN, 2010, BJOG-INT J OBSTET GY, V117, P540, DOI 10.1111/j.1471-0528.2009.02493.x; Weisman O, 2010, ARCH WOMEN MENT HLTH, V13, P505, DOI 10.1007/s00737-010-0169-z; Wickberg B, 1996, ACTA PSYCHIAT SCAND, V94, P181, DOI 10.1111/j.1600-0447.1996.tb09845.x; Wickberg B, 1996, J AFFECT DISORDERS, V39, P209, DOI 10.1016/0165-0327(96)00034-1; Wilkie GL, 2014, OBSTET GYNECOL, V123, p82S, DOI 10.1097/01.AOG.0000447410.24175.c4	61	38	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0144274	10.1371/journal.pone.0144274	http://dx.doi.org/10.1371/journal.pone.0144274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807799	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800002
J	Hao, HJ; Liang, JR; Duan, R; Chen, YH; Liu, C; Xiao, YC; Li, X; Su, MM; Jing, HQ; Wang, X				Hao, Huijing; Liang, Junrong; Duan, Ran; Chen, Yuhuang; Liu, Chang; Xiao, Yuchun; Li, Xu; Su, Mingming; Jing, Huaiqi; Wang, Xin			Yersinia spp. Identification Using Copy Diversity in the Chromosomal 16S rRNA Gene Sequence	PLOS ONE			English	Article							PSEUDOTUBERCULOSIS COMPLEX; DISTINCT TYPES; SP-NOV; ENTEROCOLITICA; FREDERIKSENII; WAUTERSII; STRAINS; GENOMES; OPERON; PESTIS	API 20E strip test, the standard for Enterobacteriaceae identification, is not sufficient to discriminate some Yersinia species for some unstable biochemical reactions and the same biochemical profile presented in some species, e.g. Yersinia ferderiksenii and Yersinia intermedia, which need a variety of molecular biology methods as auxiliaries for identification. The 16S rRNA gene is considered a valuable tool for assigning bacterial strains to species. However, the resolution of the 16S rRNA gene may be insufficient for discrimination because of the high similarity of sequences between some species and heterogeneity within copies at the intra-genomic level. In this study, for each strain we randomly selected five 16S rRNA gene clones from 768 Yersinia strains, and collected 3,840 sequences of the 16S rRNA gene from 10 species, which were divided into 439 patterns. The similarity among the five clones of 16S rRNA gene is over 99% for most strains. Identical sequences were found in strains of different species. A phylogenetic tree was constructed using the five 16S rRNA gene sequences for each strain where the phylogenetic classifications are consistent with biochemical tests; and species that are difficult to identify by biochemical phenotype can be differentiated. Most Yersinia strains form distinct groups within each species. However Yersinia kristensenii, a heterogeneous species, clusters with some Yersinia enterocolitica and Yersinia ferderiksenii/intermedia strains, while not affecting the overall efficiency of this species classification. In conclusion, through analysis derived from integrated information from multiple 16S rRNA gene sequences, the discrimination ability of Yersinia species is improved using our method.	[Hao, Huijing; Liang, Junrong; Duan, Ran; Chen, Yuhuang; Liu, Chang; Xiao, Yuchun; Li, Xu; Jing, Huaiqi; Wang, Xin] Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Liu, Chang] Jiangsu Univ, Sch Med Sci, Dept Pathogen Biol, Zhenjiang, Jiangsu, Peoples R China; [Su, Mingming] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Jiangsu University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Wang, X (corresponding author), Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.	wangxin@icdc.cn			National Natural Science Foundation of China [81470092]; NationalSci-Tech Key Project [2012ZX10004201, 2013ZX10004203-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NationalSci-Tech Key Project	The National Natural Science Foundation of China (General Project, no. 81470092); the NationalSci-Tech Key Project (2012ZX10004201, 2013ZX10004203-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Batzilla J, 2011, J BACTERIOL, V193, P2067, DOI 10.1128/JB.01484-10; BOTTONE EJ, 1977, CRC CR REV MICROBIOL, V5, P211, DOI 10.3109/10408417709102312; CLAYTON RA, 1995, INT J SYST BACTERIOL, V45, P595, DOI 10.1099/00207713-45-3-595; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; IBRAHIM A, 1993, FEMS MICROBIOL LETT, V114, P173, DOI 10.1016/0378-1097(93)90515-4; Jan Ursing DJB, 1980, CURRENT MICROBIOLOGY, V4, P213; Jaspers E, 2004, APPL ENVIRON MICROB, V70, P4831, DOI 10.1128/AEM.70.8.4831-4839.2004; Kim W, 2003, ANTON LEEUW INT J G, V83, P125, DOI 10.1023/A:1023301924932; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Liang JR, 2012, APPL ENVIRON MICROB, V78, P2949, DOI 10.1128/AEM.07893-11; Linde HJ, 1999, J CLIN MICROBIOL, V37, P211, DOI 10.1128/JCM.37.1.211-214.1999; Mittal S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-25; Moreno C, 2002, MICROBIOL-SGM, V148, P1233, DOI 10.1099/00221287-148-4-1233; Neubauer H, 2000, INT J MED MICROBIOL, V290, P61; Neubauer H, 1998, J CLIN MICROBIOL, V36, P3366, DOI 10.1128/JCM.36.11.3366-3368.1998; Neubauer H, 2015, INT J SYST EVOL MICR, V65, P732, DOI 10.1099/ijs.0.070383-0; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Savin C, 2014, INT J MED MICROBIOL, V304, P452, DOI 10.1016/j.ijmm.2014.02.002; Sihvonen LM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-208; Souza RA, 2013, INT J SYST EVOL MICR, V63, P3124, DOI 10.1099/ijs.0.047175-0; Sprague LD, 2005, INT J SYST EVOL MICR, V55, P831, DOI 10.1099/ijs.0.63220-0; Sprague LD, 2008, INT J SYST EVOL MICR, V58, P952, DOI 10.1099/ijs.0.65417-0; Sulakvelidze A, 2000, MICROBES INFECT, V2, P497, DOI 10.1016/S1286-4579(00)00311-7; Sun DL, 2013, APPL ENVIRON MICROB, V79, P5962, DOI 10.1128/AEM.01282-13; Wang X, 2009, EUR J CLIN MICROBIOL, V28, P1237, DOI 10.1007/s10096-009-0773-x; Wang Y, 1997, J BACTERIOL, V179, P3270, DOI 10.1128/jb.179.10.3270-3276.1997; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Woo PCY, 2003, J CLIN MICROBIOL, V41, P1996, DOI 10.1128/JCM.41.5.1996-2001.2003; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999	30	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147639	10.1371/journal.pone.0147639	http://dx.doi.org/10.1371/journal.pone.0147639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808495	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800161
J	Lithanatudom, P; Wipasa, J; Inti, P; Chawansuntati, K; Svasti, S; Fucharoen, S; Kangwanpong, D; Kampuansai, J				Lithanatudom, Pathrapol; Wipasa, Jiraprapa; Inti, Pitsinee; Chawansuntati, Kriangkrai; Svasti, Saovaros; Fucharoen, Suthat; Kangwanpong, Daoroong; Kampuansai, Jatupol			Hemoglobin E Prevalence among Ethnic Groups Residing in Malaria-Endemic Areas of Northern Thailand and Its Lack of Association with Plasmodium falciparum Invasion In Vitro	PLOS ONE			English	Article							E TRAIT; GENETIC-STRUCTURE; POPULATIONS; THALASSEMIA; HEMOZOIN; DNA	Hemoglobin E (HbE) is one of the most common hemoglobin variants caused by a mutation in the beta-globin gene, and found at high frequencies in various Southeast Asian groups. We surveyed HbE prevalence among 8 ethnic groups residing in 5 villages selected for their high period malaria endemicity, and 5 for low endemicity in northern Thailand, in order to uncover factors which may affect genetic persistence of HbE in these groups. We found the overall HbE prevalence 6.7%, with differing frequencies from 0% in the Pwo Karen, the Lawa, and the Skaw Karen to 24% in the Mon. All HbE genes were heterozygous (AE). Differences in HbE prevalence among the studied ethnic groups indirectly documents that ancestries and evolutionary forces, such as drift and admixture, are the important factors in the persistence of HbE distribution in northern Thailand. Furthermore, the presence of HbE in groups of northern Thailand had no effect on the in vitro infectivity and proliferation of Plasmodium falciparum, nor the production of hemozoin, a heme crystal produced by malaria parasites, when compared to normal red-blood-cell controls. Our data may contribute to a better understanding on the persistence of HbE among ethnic groups and its association with malaria.	[Lithanatudom, Pathrapol; Inti, Pitsinee; Kangwanpong, Daoroong; Kampuansai, Jatupol] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand; [Wipasa, Jiraprapa; Chawansuntati, Kriangkrai] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Svasti, Saovaros; Fucharoen, Suthat] Mahidol Univ, Inst Mol Biosci, Thalassemia Res Ctr, Nakhon Pathom, Thailand	Chiang Mai University; Chiang Mai University; Mahidol University	Kampuansai, J (corresponding author), Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand.	Jatupol.K@cmu.ac.th	Svasti, Saovaros/AAH-6111-2020; LITHANATUDOM, PATHRAPOL/AAQ-1131-2021		National Research Council of Thailand [83447]	National Research Council of Thailand(National Research Council of Thailand (NRCT))	This work was supported by the National Research Council of Thailand (http://en.nrct.go.th) Grant no. 83447 to JK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN AE, 1990, EUR J HAEMATOL, V45, P120; Bureau of Epidemiology, 2007, EP SURV REP; Chong SS, 2000, BLOOD, V95, P360; Chotivanich K, 2002, BLOOD, V100, P1172, DOI 10.1182/blood.V100.4.1172.h81602001172_1172_1176; Coronado LM, 2014, BBA-GEN SUBJECTS, V1840, P2032, DOI 10.1016/j.bbagen.2014.02.009; Fabry M, 2009, DISORDERS HEMOGLOBIN; Fucharoen Suthat, 2011, Indian J Med Res, V134, P498; Fucharoen S, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P417; Glushakova S, 2014, J INFECT DIS, V210, P1100, DOI 10.1093/infdis/jiu203; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; Hutagalung R, 1999, J INFECT DIS, V179, P283, DOI 10.1086/314561; Hutagalung R, 2000, J INFECT DIS, V181, P1513, DOI 10.1086/315373; Kampuansai Jatupol, 2007, ScienceAsia, V33, P443, DOI 10.2306/scienceasia1513-1874.2007.33.443; Kuesap J, 2015, KOREAN J PARASITOL, V53, P265, DOI 10.3347/kjp.2015.53.3.265; Kutanan W, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-56; Kutanan W, 2011, CHIANG MAI J SCI, V38, P295; Langlois S, 2008, J OBSTET GYNAECOL CA, V30, P950, DOI 10.1016/S1701-2163(16)32975-9; Martiney JA, 1996, MOL MED, V2, P236, DOI 10.1007/BF03401620; Naka I, 2008, BIOCHEM GENET, V46, P708, DOI 10.1007/s10528-008-9185-3; ORKIN SH, 1982, NATURE, V300, P768, DOI 10.1038/300768a0; Penth H, 2000, BRIEF HIST L N N CIV; Rangan A, 2009, INDIAN J PEDIATR, V76, P615, DOI 10.1007/s12098-009-0082-5; Schliesinger J, 2000, ETHNIC GROUPS THAILA; Schliesinger J, 2001, INTRO OVERVIEW TAI G; Shannon KL, 2015, AM J TROP MED HYG, V93, P281, DOI 10.4269/ajtmh.14-0623; TAN IK, 1969, CLIN CHEM, V15, P467; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; Tienthavorn V., 2006, THAI HEMATOL TRANSF, V16, P307; Men TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-272; Tripathi AK, 2004, ANAL BIOCHEM, V325, P85, DOI 10.1016/j.ab.2003.10.016; Venkatesan M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-41; Win N, 2005, ACTA MED OKAYAMA, V59, P63; Wipasa J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001281	33	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0148079	10.1371/journal.pone.0148079	http://dx.doi.org/10.1371/journal.pone.0148079			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808200	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800271
J	Minakhina, S; Naryshkina, T; Changela, N; Tan, W; Steward, R				Minakhina, Svetlana; Naryshkina, Tatyana; Changela, Neha; Tan, William; Steward, Ruth			Zfrp8/PDCD2 Interacts with RpS2 Connecting Ribosome Maturation and Gene-Specific Translation	PLOS ONE			English	Article							STEM-CELLS; FLUORESCENT PROTEIN; SELF-RENEWAL; DROSOPHILA; PDCD2; INITIATION; SUBUNITS; HOMOLOG; REVEALS; ENCODES	Zfrp8/PDCD2 is a highly conserved protein essential for stem cell maintenance in both flies and mammals. It is also required in fast proliferating cells such as cancer cells. Our previous studies suggested that Zfrp8 functions in the formation of mRNP (mRNA ribonucleoprotein) complexes and also controls RNA of select Transposable Elements (TEs). Here we show that in Zfrp8/PDCD2 knock down (KD) ovaries, specific mRNAs and TE transcripts show increased nuclear accumulation. We also show that Zfrp8/PDCD2 interacts with the (40S) small ribosomal subunit through direct interaction with RpS2 (uS5). By studying the distribution of endogenous and transgenic fluorescently tagged ribosomal proteins we demonstrate that Zfrp8/PDCD2 regulates the cytoplasmic levels of components of the small (40S) ribosomal subunit, but does not control nuclear/nucleolar localization of ribosomal proteins. Our results suggest that Zfrp8/PDCD2 functions at late stages of ribosome assembly and may regulate the binding of specific mRNA-RNPs to the small ribosomal subunit ultimately controlling their cytoplasmic localization and translation.	[Minakhina, Svetlana; Naryshkina, Tatyana; Changela, Neha; Tan, William; Steward, Ruth] Rutgers State Univ, Waksman Inst, Piscataway, NJ USA; [Minakhina, Svetlana] Rutgers State Univ, Dept Med, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Minakhina, S; Steward, R (corresponding author), Rutgers State Univ, Waksman Inst, Piscataway, NJ USA.; Minakhina, S (corresponding author), Rutgers State Univ, Dept Med, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA.	svetam@rutgers.edu; steward@waksman.rutgers.edu			National Insitutes of Health (NIH) [RO1GM089992]; W. Horace Goldsmith Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089992] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Insitutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. Horace Goldsmith Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a grant from the National Insitutes of Health, (NIH RO1GM089992) and by the W. Horace Goldsmith Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jubran K, 2013, RNA, V19, P1669, DOI 10.1261/rna.038356.113; ALLROBYN JA, 1990, MOL CELL BIOL, V10, P6544, DOI 10.1128/MCB.10.12.6544; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Barboza N, 2013, CANCER BIOL THER, V14, P546, DOI 10.4161/cbt.24484; Bardoni B, 2003, EXP CELL RES, V289, P95, DOI 10.1016/S0014-4827(03)00222-2; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Brogna S, 2002, MOL CELL, V10, P93, DOI 10.1016/S1097-2765(02)00565-8; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Burroughs AM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00424; Chan HYE, 2001, MOL BIOL CELL, V12, P1409, DOI 10.1091/mbc.12.5.1409; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Chen E, 2014, MOL CELL, V54, P407, DOI 10.1016/j.molcel.2014.03.023; CRAMTON SE, 1994, GENETICS, V137, P1039; Daftuar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068667; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fichelson P, 2009, NAT CELL BIOL, V11, P685, DOI 10.1038/ncb1874; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Granier CJ, 2014, BIOL OPEN, V3, P821, DOI 10.1242/bio.20148326; Gross CT, 1996, EMBO J, V15, P1961, DOI 10.1002/j.1460-2075.1996.tb00547.x; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Huttlin E, 2010, BIOGRID; Klenov MS, 2011, P NATL ACAD SCI USA, V108, P18760, DOI 10.1073/pnas.1106676108; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Kramer J, 2013, STEM CELLS DEV, V22, P58, DOI 10.1089/scd.2012.0074; Kyriakakis P, 2008, FLY, V2, P229, DOI 10.4161/fly.6669; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Lecuyer Eric, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5019; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; McLeod T, 2014, BIOCHEM SOC T, V42, P1224, DOI 10.1042/BST20140062; Minakhina S, 2007, DEVELOPMENT, V134, P2387, DOI 10.1242/dev.003616; Minakhina S, 2014, DEVELOPMENT, V141, P259, DOI 10.1242/dev.101410; Minakhina S, 2010, DEVELOPMENT, V137, P27, DOI 10.1242/dev.043943; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Mu W, 2010, DEV BIOL, V347, P279, DOI 10.1016/j.ydbio.2010.08.026; Munn K, 2000, GENETICS, V156, P245; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Pare C, 2000, J CELL SCI, V113, P2119; Perreault A, 2008, NUCLEIC ACIDS RES, V36, P6132, DOI 10.1093/nar/gkn625; Perreault A, 2009, J BIOL CHEM, V284, P15026, DOI 10.1074/jbc.M109.004812; PHILLIPS WF, 1976, J BIOL CHEM, V251, P2876; Quinones-Coello AT, 2007, GENETICS, V175, P1089, DOI 10.1534/genetics.106.065995; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Rugjee KN, 2013, PEERJ, V1, DOI 10.7717/peerj.15; Scarr RB, 2002, ONCOGENE, V21, P5245, DOI 10.1038/sj.onc.1205647; Shpiz S, 2007, MOL BIOL EVOL, V24, P2535, DOI 10.1093/molbev/msm205; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Soudet J, 2010, EMBO J, V29, P80, DOI 10.1038/emboj.2009.307; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Strunk BS, 2012, CELL, V150, P111, DOI 10.1016/j.cell.2012.04.044; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Sugimura K, 2003, J NEUROSCI, V23, P3752; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Swiercz R, 2007, J BIOL CHEM, V282, P16917, DOI 10.1074/jbc.M609778200; Sytnikova YA, 2014, GENOME RES, V24, P1977, DOI 10.1101/gr.178129.114; Szakmary A, 2009, J CELL BIOL, V185, P613, DOI 10.1083/jcb.200903034; Tan W, 2015, ZFRP8 FORMS CO UNPUB; TAUTZ D, 1988, MOL BIOL EVOL, V5, P366; Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Wilk R, 2013, G3-GENES GENOM GENET, V3, P1177, DOI 10.1534/g3.113.006023; Zalfa F, 2006, CURR OPIN NEUROBIOL, V16, P265, DOI 10.1016/j.conb.2006.05.010	70	9	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147631	10.1371/journal.pone.0147631	http://dx.doi.org/10.1371/journal.pone.0147631			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807849	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800156
J	Seike, S; Miyamoto, K; Kobayashi, K; Takehara, M; Nagahama, M				Seike, Soshi; Miyamoto, Kazuaki; Kobayashi, Keiko; Takehara, Masaya; Nagahama, Masahiro			Clostridium perfringens Delta-Toxin Induces Rapid Cell Necrosis	PLOS ONE			English	Article							PORE-FORMING TOXINS; BIOLOGICAL-ACTIVITIES; ALPHA-TOXIN; MEMBRANE; MECHANISM; COMPLEX; IDENTIFICATION; BINDING	Clostridium perfringens delta-toxin is a beta-pore-forming toxin and a putative pathogenic agent of C. perfringens types B and C. However, the mechanism of cytotoxicity of delta-toxin remains unclear. Here, we investigated the mechanisms of cell death induced by delta-toxin in five cell lines (A549, A431, MDCK, Vero, and Caco-2). All cell lines were susceptible to delta-toxin. The toxin caused rapid ATP depletion and swelling of the cells. Delta-toxin bound and formed oligomers predominantly in plasma membrane lipid rafts. Destruction of the lipid rafts with methyl beta-cyclodextrin inhibited delta-toxin-induced cytotoxicity and ATP depletion. Delta-toxin caused the release of carboxyfluorescein from sphingomyelin-cholesterol liposomes and formed oligomers; toxin binding to the liposomes declined with decreasing cholesterol content in the liposomes. Flow cytometric assays with annexin V and propidium iodide revealed that delta-toxin treatment induced an elevation in the population of annexin V-negative and propidium iodide-positive cells. Delta-toxin did not cause the fragmentation of DNA or caspase-3 activation. Furthermore, delta-toxin caused damage to mitochondrial membrane permeability and cytochrome c release. In the present study, we demonstrate that delta-toxin produces cytotoxic activity through necrosis.	[Seike, Soshi; Miyamoto, Kazuaki; Kobayashi, Keiko; Takehara, Masaya; Nagahama, Masahiro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Yamashiro Cho, Tokushima 7708514, Japan	Tokushima Bunri University	Nagahama, M (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Yamashiro Cho, Tokushima 7708514, Japan.	nagahama@ph.bunri-u.ac.jp		Alsayeh, Abdulaziz/0000-0003-2677-8841; Seike, Soshi/0000-0001-9029-0715	KAKENHI, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [2546052]	KAKENHI, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grants-in-Aid for Scientific Research, KAKENHI, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (https://www.jsps.go.jp/english/index.html), 2015, Grant number: 2546052. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1996, GENE DEV, V17, P2481; Alonso A, 2000, BIOCHEMISTRY-US, V39, P14019, DOI 10.1021/bi001739o; ALOUF JE, 1981, INFECT IMMUN, V31, P536, DOI 10.1128/IAI.31.2.536-546.1981; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; Bischofberger M, 2009, CURR OPIN CELL BIOL, V21, P589, DOI 10.1016/j.ceb.2009.04.003; CAVAILLON JM, 1986, J LEUKOCYTE BIOL, V40, P65, DOI 10.1002/jlb.40.1.65; DuMont AL, 2014, TRENDS MICROBIOL, V22, P21, DOI 10.1016/j.tim.2013.10.004; Feng XY, 2009, AM J PHYSIOL-RENAL, V296, pF1514, DOI 10.1152/ajprenal.00068.2009; FORTI S, 1989, EUR J BIOCHEM, V181, P767, DOI 10.1111/j.1432-1033.1989.tb14790.x; Husmann M, 2009, FEBS LETT, V583, P337, DOI 10.1016/j.febslet.2008.12.028; Huyet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066673; JOLIVETREYNAUD C, 1982, INFECT IMMUN, V38, P860, DOI 10.1128/IAI.38.3.860-864.1982; JOLIVETREYNAUD C, 1989, TOXICON, V27, P1113, DOI 10.1016/0041-0101(89)90005-6; Manich M, 2008, PLOS ONE, V3, pe3764, DOI [10.1371/journal.pone.0003764, DOI 10.1371/J0URNAL.P0NE.0003764]; Nagahama M, 2006, BIOCHEMISTRY-US, V45, P296, DOI 10.1021/bi051805s; Nagahama M, 2003, J BIOL CHEM, V278, P36934, DOI 10.1074/jbc.M306562200; Nagahama M, 1996, BBA-BIOMEMBRANES, V1280, P120, DOI 10.1016/0005-2736(95)00288-X; Nagahama M, 2015, TOXINS, V7, P396, DOI 10.3390/toxins7020396; Nagahama M, 2011, INFECT IMMUN, V79, P4353, DOI 10.1128/IAI.05677-11; NIILO L, 1988, CAN VET J, V29, P658; NIILO L, 1987, CAN J VET RES, V51, P224; Popoff MR, 2014, ANAEROBE, V30, P220, DOI 10.1016/j.anaerobe.2014.05.014; Popoff MR, 2009, FUTURE MICROBIOL, V4, P1021, DOI 10.2217/FMB.09.72; SAKURAI J, 1995, MICROBIOL IMMUNOL, V39, P249, DOI 10.1111/j.1348-0421.1995.tb02197.x; Savva CG, 2013, J BIOL CHEM, V288, P3512, DOI 10.1074/jbc.M112.430223; Sellman BR, 1997, MOL MICROBIOL, V23, P551, DOI 10.1046/j.1365-2958.1997.d01-1876.x; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Smedley JG, 2007, INFECT IMMUN, V75, P2381, DOI 10.1128/IAI.01737-06; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; Valeva A, 2006, J BIOL CHEM, V281, P26014, DOI 10.1074/jbc.M601960200; YAMAGISHI T, 1987, MICROBIOL IMMUNOL, V31, P859, DOI 10.1111/j.1348-0421.1987.tb03147.x; Yamasaki E, 2006, J BIOL CHEM, V281, P11250, DOI 10.1074/jbc.M509404200; Yan XX, 2013, MBIO, V4, DOI 10.1128/mBio.00019-13; Zeng R, 2012, ACTA PHARMACOL SIN, V33, P91, DOI 10.1038/aps.2011.143	34	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147957	10.1371/journal.pone.0147957	http://dx.doi.org/10.1371/journal.pone.0147957			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807591	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800252
J	Conway, JM; Pierce, WS; Le, JH; Harper, GW; Wright, JH; Tucker, AL; Zurawski, JV; Lee, LL; Blumer-Schuette, SE; Kelly, RM				Conway, Jonathan M.; Pierce, William S.; Le, Jaycee H.; Harper, George W.; Wright, John H.; Tucker, Allyson L.; Zurawski, Jeffrey V.; Lee, Laura L.; Blumer-Schuette, Sara E.; Kelly, Robert M.			Multidomain, Surface Layer-associated Glycoside Hydrolases Contribute to Plant Polysaccharide Degradation by Caldicellulosiruptor Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biofuel; cell surface; cell surface enzyme; enzyme; glycoside hydrolase; plant cell wall; Caldicellulosiruptor; S-layer; lignocellulose	THERMOANAEROBACTERIUM-THERMOSULFURIGENES EM1; HIGH-MOLECULAR-WEIGHT; S-LAYER; CELL-WALL; CLOSTRIDIUM-THERMOCELLUM; DOMAIN PROTEINS; GENOME SEQUENCE; XYLANASE; GENE; CLONING	The genome of the extremely thermophilic bacterium Caldicellulosiruptor kronotskyensis encodes 19 surface layer (S-layer) homology (SLH) domain-containing proteins, the most in any Caldicellulosiruptor species genome sequenced to date. These SLH proteins include five glycoside hydrolases (GHs) and one polysaccharide lyase, the genes for which were transcribed at high levels during growth on plant biomass. The largest GH identified so far in this genus, Calkro_0111 (2,435 amino acids), is completely unique to C. kronotskyensis and contains SLH domains. Calkro_0111 was produced recombinantly in Escherichia coli as two pieces, containing the GH16 and GH55 domains, respectively, as well as putative binding and spacer domains. These displayed endo- and exoglucanase activity on the -1,3-1,6-glucan laminarin. A series of additional truncation mutants of Calkro_0111 revealed the essential architectural features required for catalytic function. Calkro_0402, another of the SLH domain GHs in C. kronotskyensis, when produced in E. coli, was active on a variety of xylans and -glucans. Unlike Calkro_0111, Calkro_0402 is highly conserved in the genus Caldicellulosiruptor and among other biomass-degrading Firmicutes but missing from Caldicellulosiruptor bescii. As such, the gene encoding Calkro_0402 was inserted into the C. bescii genome, creating a mutant strain with its S-layer extensively decorated with Calkro_0402. This strain consequently degraded xylans more extensively than wild-type C. bescii. The results here provide new insights into the architecture and role of SLH domain GHs and demonstrate that hemicellulose degradation can be enhanced through non-native SLH domain GHs engineered into the genomes of Caldicellulosiruptor species.	[Conway, Jonathan M.; Pierce, William S.; Le, Jaycee H.; Harper, George W.; Wright, John H.; Tucker, Allyson L.; Zurawski, Jeffrey V.; Lee, Laura L.; Blumer-Schuette, Sara E.; Kelly, Robert M.] N Carolina State Univ, Dept Chem & Biomol Engn, EB-1,911 Partners Way, Raleigh, NC 27695 USA; [Blumer-Schuette, Sara E.] Oakland Univ, Dept Biol Sci, Rochester, MI 48309 USA	University of North Carolina; North Carolina State University; Oakland University	Kelly, RM (corresponding author), N Carolina State Univ, Dept Chem & Biomol Engn, EB-1,911 Partners Way, Raleigh, NC 27695 USA.	rmkelly@ncsu.edu	Blumer-Schuette, Sara/H-4081-2019	Blumer-Schuette, Sara/0000-0001-9522-4266; Conway, Jonathan/0000-0002-2715-2149; Kelly, Robert/0000-0002-0639-3592	BioEnergy Science Center, a United States Department of Energy Bioenergy Research Center - Office of Biological and Environmental Research in the Department of Energy Office of Science; United States Department of Education GAANN Fellowship [P200A100004-12]; National Institutes of Health Biotechnology Traineeship (National Institutes of Health) [T32 GM008776-11]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008776] Funding Source: NIH RePORTER	BioEnergy Science Center, a United States Department of Energy Bioenergy Research Center - Office of Biological and Environmental Research in the Department of Energy Office of Science; United States Department of Education GAANN Fellowship; National Institutes of Health Biotechnology Traineeship (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the BioEnergy Science Center, a United States Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by United States Department of Education GAANN Fellowship P200A100004-12.; Supported by a National Institutes of Health Biotechnology Traineeship (National Institutes of Health Grant T32 GM008776-11) and National Science Foundation graduate fellowship.	Abdul Halim MF, 2013, MOL MICROBIOL, V88, P1164, DOI 10.1111/mmi.12248; Adelsberger H, 2004, MICROBIOL-SGM, V150, P2257, DOI 10.1099/mic.0.27066-0; Albers SV, 2011, NAT REV MICROBIOL, V9, P414, DOI 10.1038/nrmicro2576; Ali E, 2005, BIOSCI BIOTECH BIOCH, V69, P2389, DOI 10.1271/bbb.69.2389; Ali MK, 2001, FEMS MICROBIOL LETT, V198, P79; Ali MK, 2001, BIOSCI BIOTECH BIOCH, V65, P41, DOI 10.1271/bbb.65.41; Ali MK, 1999, BIOSCI BIOTECH BIOCH, V63, P1596, DOI 10.1271/bbb.63.1596; Anderson VJ, 2011, MOL MICROBIOL, V81, P192, DOI 10.1111/j.1365-2958.2011.07688.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bergquist PL, 1999, FEMS MICROBIOL ECOL, V28, P99, DOI 10.1016/S0168-6496(98)00078-6; Blumer-Schuette SE, 2015, J BIOL CHEM, V290, P10645, DOI 10.1074/jbc.M115.641480; Blumer-Schuette SE, 2014, FEMS MICROBIOL REV, V38, P393, DOI 10.1111/1574-6976.12044; Blumer-Schuette SE, 2012, J BACTERIOL, V194, P4015, DOI 10.1128/JB.00266-12; Blumer-Schuette SE, 2011, J BACTERIOL, V193, P1483, DOI 10.1128/JB.01515-10; Blumer-Schuette SE, 2010, APPL ENVIRON MICROB, V76, P8084, DOI 10.1128/AEM.01400-10; BOOT HJ, 1995, J BACTERIOL, V177, P7222, DOI 10.1128/jb.177.24.7222-7230.1995; Brahamsha B, 1996, P NATL ACAD SCI USA, V93, P6504, DOI 10.1073/pnas.93.13.6504; Brechtel E, 1999, ARCH MICROBIOL, V171, P159, DOI 10.1007/s002030050694; Brunecky R, 2012, ACTA CRYSTALLOGR D, V68, P292, DOI 10.1107/S0907444912001680; Cha M, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-85; Charrier B, 2012, TRENDS PLANT SCI, V17, P468, DOI 10.1016/j.tplants.2012.03.003; Cheng YM, 2009, APPL MICROBIOL BIOT, V81, P1051, DOI 10.1007/s00253-008-1617-9; Chung DW, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-82; Conway JM, 2015, THERMOPHILIC MICROORGANISMS, P91; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; de la Riva L, 2011, J BACTERIOL, V193, P3276, DOI 10.1128/JB.00248-11; DUMAS C, 1983, THEOR APPL GENET, V67, P1, DOI 10.1007/BF00303914; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EGELSEER E, 1995, J BACTERIOL, V177, P1444, DOI 10.1128/jb.177.6.1444-1451.1995; Elkins JG, 2010, J BACTERIOL, V192, P6099, DOI 10.1128/JB.00950-10; Fagan RP, 2014, NAT REV MICROBIOL, V12, P211, DOI 10.1038/nrmicro3213; Fagan RP, 2011, J MED MICROBIOL, V60, P1225, DOI 10.1099/jmm.0.028472-0; Farkas J, 2013, J IND MICROBIOL BIOT, V40, P41, DOI 10.1007/s10295-012-1202-1; Feng JX, 2000, BIOSCI BIOTECH BIOCH, V64, P2614, DOI 10.1271/bbb.64.2614; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Fuchs KP, 2003, MICROBIOL-SGM, V149, P1021, DOI 10.1099/mic.0.26153-0; FUJINO T, 1993, J BACTERIOL, V175, P1891, DOI 10.1128/JB.175.7.1891-1899.1993; Geslin C, 2003, J BACTERIOL, V185, P3888, DOI 10.1128/JB.185.13.3888-3894.2003; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Gibbs MD, 2000, CURR MICROBIOL, V40, P333, DOI 10.1007/s002849910066; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Halim MFA, 2016, J BACTERIOL, V198, P808, DOI 10.1128/JB.00849-15; Han YJ, 2012, J BIOL CHEM, V287, P34946, DOI 10.1074/jbc.M112.391532; Han YJ, 2010, J BACTERIOL, V192, P4111, DOI 10.1128/JB.00257-10; HARADA T, 1992, TRENDS GLYCOSCI GLYC, V4, P309; Honma K, 2007, MICROB PATHOGENESIS, V42, P156, DOI 10.1016/j.micpath.2007.01.003; Huang XL, 2015, J AGR FOOD CHEM, V63, P6430, DOI 10.1021/acs.jafc.5b01259; Hung KS, 2011, BIOTECHNOL LETT, V33, P1441, DOI 10.1007/s10529-011-0579-7; Ito Y, 2003, APPL ENVIRON MICROB, V69, P6969, DOI 10.1128/AEM.69.12.6969-6978.2003; Itoh T, 2014, BIOSCI BIOTECH BIOCH, V78, P624, DOI 10.1080/09168451.2014.891935; Johnson BR, 2016, APPL ENVIRON MICROB, V82, P134, DOI 10.1128/AEM.01968-15; Kataeva IA, 2009, J BACTERIOL, V191, P3760, DOI 10.1128/JB.00256-09; Kern J, 2011, J BIOL CHEM, V286, P26042, DOI 10.1074/jbc.M111.248070; Kim H, 2000, APPL MICROBIOL BIOT, V54, P521, DOI 10.1007/s002530000412; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Lee LL, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00440-15; LEE SP, 1994, APPL ENVIRON MICROB, V60, P3764, DOI 10.1128/AEM.60.10.3764-3773.1994; LEMAIRE M, 1995, J BACTERIOL, V177, P2451, DOI 10.1128/jb.177.9.2451-2459.1995; Liebl WG, 2008, J BACTERIOL, V190, P1350, DOI 10.1128/JB.01149-07; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Liu SY, 1996, J BACTERIOL, V178, P1539, DOI 10.1128/jb.178.6.1539-1547.1996; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Matuschek M, 1996, MOL GEN GENET, V252, P493, DOI 10.1007/BF02173016; MATUSCHEK M, 1994, J BACTERIOL, V176, P3295, DOI 10.1128/jb.176.11.3295-3302.1994; McCarren J, 2007, J BACTERIOL, V189, P1158, DOI 10.1128/JB.01500-06; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Morris DD, 1999, EXTREMOPHILES, V3, P103, DOI 10.1007/s007920050105; Ozdemir I, 2012, APPL ENVIRON MICROB, V78, P768, DOI 10.1128/AEM.07031-11; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pham TK, 2010, PROTEOMICS, V10, P3130, DOI 10.1002/pmic.200900448; Reynolds CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002024; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; SHAO WL, 1995, APPL ENVIRON MICROB, V61, P937, DOI 10.1128/AEM.61.3.937-940.1995; Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9; St John FJ, 2006, APPL ENVIRON MICROB, V72, P1496, DOI 10.1128/AEM.72.2.1496-1506.2006; St John FJ, 2012, J STRUCT BIOL, V180, P303, DOI 10.1016/j.jsb.2012.09.007; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun ZL, 2013, APPL MICROBIOL BIOT, V97, P1941, DOI 10.1007/s00253-012-4044-x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas C, 2009, CELL MOTIL CYTOSKEL, V66, P940, DOI 10.1002/cm.20389; van de Werken HJG, 2008, APPL ENVIRON MICROB, V74, P6720, DOI 10.1128/AEM.00968-08; VanFossen AL, 2011, BIOTECHNOL BIOENG, V108, P1559, DOI 10.1002/bit.23093; VanFossen AL, 2009, APPL ENVIRON MICROB, V75, P7718, DOI 10.1128/AEM.01959-09; Veith A, 2009, MOL MICROBIOL, V73, P58, DOI 10.1111/j.1365-2958.2009.06746.x; Verma DPS, 2001, PLANT MOL BIOL, V47, P693, DOI 10.1023/A:1013679111111; Waeonukul R, 2009, J MICROBIOL BIOTECHN, V19, P277, DOI 10.4014/jmb.0804.293; Xiao ZZ, 2005, ANAL BIOCHEM, V342, P176, DOI 10.1016/j.ab.2005.01.052; Xiao ZZ, 2004, BIOTECHNOL BIOENG, V88, P832, DOI 10.1002/bit.20286; Ye LB, 2012, APPL ENVIRON MICROB, V78, P7048, DOI 10.1128/AEM.02009-12; Yi Z., 2013, PLOS ONE, V8; Zhao YY, 2013, WORLD J MICROB BIOT, V29, P327, DOI 10.1007/s11274-012-1186-z; Zurawski JV, 2015, APPL ENVIRON MICROB, V81, P7159, DOI 10.1128/AEM.01622-15	96	31	31	1	36	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6732	6747		10.1074/jbc.M115.707810	http://dx.doi.org/10.1074/jbc.M115.707810			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26814128	hybrid, Green Published			2022-12-26	WOS:000373299700013
J	Bardhan, KD; Cullis, J; Williams, NR; Arasaradnam, RP; Wilson, AJ				Bardhan, Karna D.; Cullis, James; Williams, Nigel R.; Arasaradnam, Ramesh P.; Wilson, Adrian J.			Quantification of (18)FDG in the Normal Colon-A First Step in Investigating Whether Its Presence Is a Marker of a Physiological Process	PLOS ONE			English	Article							WALL THICKNESS; CYSTIC-FIBROSIS; PET/CT; FDG; ACCUMULATION; F-18-FDG; CT	The visibility of the colon in positron emission tomography (PET) scans of patients without gastrointestinal disease indicating the presence of F-18 Fluorodeoxyglucose ((18)FDG) is well recognised, but unquantified and unexplained. In this paper a qualitative scoring system was applied to PET scans from 30 randomly selected patients without gastrointestinal disease to detect the presence of (18)FDG in 4 different sections of the colon and then both the total pixel value and the pixel value per unit length of each section of the colon were determined to quantify the amount of (18)FDG from a randomly selected subset of 10 of these patients. Analysis of the qualitative scores using a non-parametric ANOVA showed that all sections of the colon contained (18)FDG but there were differences in the amount of (18)FDG present between sections (p<0.05). Wilcoxon matched-pair signed-rank tests between pairs of segments showed statistically significant differences between all pairs (p<0.05) with the exception of the caecum and ascending colon and the descending colon. The same non-parametric statistical analysis of the quantitative measures showed no difference in the total amount of (18)FDG between sections (p>0.05), but a difference in the amount/unit length between sections (p<0.01) with only the caecum and ascending colon and the descending colon having a statistically significant difference (p<0.05). These results are consistent since the eye is drawn to focal localisation of the (18)FDG when qualitatively scoring the scans. The presence of (18)FDG in the colon is counterintuitive since it must be passing from the blood to the lumen through the colonic wall. There is no active mechanism to achieve this and therefore we hypothesise that the transport is a passive process driven by the concentration gradient of (18)FDG across the colonic wall. This hypothesis is consistent with the results obtained from the qualitative and quantitative measures analysed.	[Bardhan, Karna D.] Rotherham Gen Hosp, Dept Gastroenterol, Rotherham S60 2UD, S Yorkshire, England; [Bardhan, Karna D.] Univ Sheffield, Sch Med, Sheffield S10 2TN, S Yorkshire, England; [Cullis, James; Williams, Nigel R.] Univ Hosp, Dept Clin Phys & Bioengn, Nucl Med, Coventry CV2 2DX, W Midlands, England; [Arasaradnam, Ramesh P.] Univ Hosp, Dept Gastroenterol, Coventry CV2 2DX, W Midlands, England; [Arasaradnam, Ramesh P.] Univ Warwick, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Wilson, Adrian J.] Univ Hosp, Dept Res Dev & Innovat, Coventry CV2 2DX, W Midlands, England; [Wilson, Adrian J.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England	University of Sheffield; University of Warwick; University of Warwick; University of Warwick; University of Warwick; University of Warwick	Bardhan, KD (corresponding author), Rotherham Gen Hosp, Dept Gastroenterol, Rotherham S60 2UD, S Yorkshire, England.; Bardhan, KD (corresponding author), Univ Sheffield, Sch Med, Sheffield S10 2TN, S Yorkshire, England.	Bardhan.Sec@rothgen.nhs.uk		Arasaradnam, Ramesh/0000-0002-2231-3062				Arasaradnam RP, 2012, NUCL MED COMMUN, V33, P1312, DOI 10.1097/MNM.0b013e328359d3a6; Corman ML, 2012, CORMANS COLON RECTAL; Dialer I, 2003, J CLIN GASTROENTEROL, V37, P55, DOI 10.1097/00004836-200307000-00014; FISHER JK, 1982, RADIOLOGY, V145, P415, DOI 10.1148/radiology.145.2.7134445; Franc B, 2003, CLIN NUCL MED, V28, P541, DOI 10.1097/00003072-200307000-00001; Gontier E, 2008, EUR J NUCL MED MOL I, V35, P95, DOI 10.1007/s00259-007-0563-6; Haber HP, 1997, GUT, V40, P406, DOI 10.1136/gut.40.3.406; Kim Seok ki, 1999, Clin Positron Imaging, V2, P273, DOI 10.1016/S1095-0397(99)00030-8; LEVINE GM, 1982, AM J PHYSIOL, V242, pG455, DOI 10.1152/ajpgi.1982.242.5.G455; Miraldi F, 1998, CLIN NUCL MED, V23, P3, DOI 10.1097/00003072-199801000-00002; Murata Y, 2007, NUCL MED BIOL, V34, P961, DOI 10.1016/j.nucmedbio.2007.07.006; Nordin N, 2012, ADV ENV BIOTECHNOLOG; Otsuka H, 2005, ANN NUCL MED, V19, P101, DOI 10.1007/BF03027388; Ozguven MA, 2014, ANN NUCL MED, V28, P505, DOI 10.1007/s12149-014-0840-y; SIEGEL S., 1956, NONPARAMETRIC STAT B; Thomas JR, 1990, RES METHODS PHYS ACT; Wang K, 2012, NUCL MED COMMUN, V33, P641, DOI 10.1097/MNM.0b013e328350859b; Wiesner W, 2002, J COMPUT ASSIST TOMO, V26, P102, DOI 10.1097/00004728-200201000-00015	18	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147838	10.1371/journal.pone.0147838	http://dx.doi.org/10.1371/journal.pone.0147838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821281	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528400048
J	Li, TH; Huang, CC; Yang, YY; Lee, KC; Hsieh, SL; Hsieh, YC; Alan, L; Lin, HC; Lee, SD; Tsai, CY				Li, Tzu-Hao; Huang, Chia-Chang; Yang, Ying-Ying; Lee, Kuei-Chuan; Hsieh, Shie-Liang; Hsieh, Yun-Cheng; Alan, Lin; Lin, Han-Chieh; Lee, Shou-Dong; Tsai, Chang-Youh			Thalidomide Improves the Intestinal Mucosal Injury and Suppresses Mesenteric Angiogenesis and Vasodilatation by Down-Regulating Inflammasomes-Related Cascades in Cirrhotic Rats	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; FACTOR-ALPHA; NLRP3 INFLAMMASOME; ENDOTHELIAL-CELLS; ACTIVATION; SENSITIZATION; BIOSYNTHESIS; INHIBITION; CONTRIBUTE	Background and Aims By blocking TNF alpha-related effects, thalidomide not only inhibits hepatic fibrogenesis but improves peripheral vasodilatation and portal hypertension in cirrhotic rats. Nonetheless, the investigation of thalidomide's effects on splanchnic and collateral microcirculation has been limited. Our study explored the roles of intestinal and mesenteric TNF alpha along with inflammasome-related pathway in relation to cirrhosis and the splanchnic/collateral microcirculation. Methods Using in vivo and in vitro approaches, mechanisms of the effects of thalidomide on intestinal and mesenteric inflammatory, vasodilatory and angiogenic cascades-related abnormalities were explored in cirrhotic rats that had received 1-month thalidomide (C-T) treatment. Results In cirrhotic rats, high tumor necrosis factor (TNF)alpha, vascular endothelial growth factor (VEGF) and nitric oxide (NO)x levels were associated with the NOD-like receptors protein 3 (NLRP3), IL-1 beta and caspase-1 inflammasome over-expression in splenorenal shunt and mesenteric tissues. The thalidomide-related inhibition of mesenteric and splenorenal shunt inflammasome expression was accompanied by a significantly decreased intestinal mucosal injury and inflammasome immunohistochemical staining expression. Suppression of various angiogenic cascades, namely VEGF-NOS-NO, was paralleled by a decrease in mesenteric angiogenesis as detected by CD31 immunofluorescence staining and by reduced portosystemic shunting (PSS) in C-T rats. The down-regulation of the mesenteric and collateral vasodilatory VEGF-NOS-NO cascades resulted in a correction of vasoconstrictive hypo-responsiveness and in an attenuation of vasodilatory hyper-responsiveness when analyzed by in situ perfusion of the superior mesenteric arterial (SMA) and portosystemic collaterals. There was also a decrease in SMA blood flow and an increase in SMA resistance in the C-T rats. Additionally, acute incubation with thalidomide abolished TNF alpha-augmented VEGF-mediated migration of and tube formation of human umbilical vein endothelial cells, which was accompanied by corresponding changes in inflammatory and angiogenic substances release. Conclusions The suppression of inflammasome over-expression by chronic thalidomide treatment ameliorates inflammatory, angiogenic and vasodilatory cascades-related pathogenic changes in the splanchnic and collateral microcirculation of cirrhotic rats. Thalidomide seems to be a promising agent that might bring about beneficial changes to the disarrangements of peripheral, hepatic, splanchnic and collateral systems in cirrhosis.	[Li, Tzu-Hao; Tsai, Chang-Youh] Taipei Vet Gen Hosp, Dept Med, Div Allergy Immunol & Rheumatol, Taipei, Taiwan; [Li, Tzu-Hao; Huang, Chia-Chang; Yang, Ying-Ying; Lee, Kuei-Chuan; Hsieh, Shie-Liang; Hsieh, Yun-Cheng; Alan, Lin; Lin, Han-Chieh; Tsai, Chang-Youh] Natl Yang Ming Univ, Dept Med, Sch Med, Taipei 112, Taiwan; [Huang, Chia-Chang; Yang, Ying-Ying] Taipei Vet Gen Hosp, Dept Med, Div Gen Med, Taipei, Taiwan; [Yang, Ying-Ying] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Lee, Kuei-Chuan; Hsieh, Yun-Cheng; Lin, Han-Chieh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Hsieh, Shie-Liang] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Lee, Shou-Dong] Cheng Hsin Gen Hosp, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Academia Sinica - Taiwan; Cheng Hsin General Hospital	Yang, YY; Lin, HC (corresponding author), Natl Yang Ming Univ, Dept Med, Sch Med, Taipei 112, Taiwan.; Yang, YY (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gen Med, Taipei, Taiwan.; Yang, YY (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan.; Lin, HC (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan.	yangyy@vghtpe.gov.tw; hclin@vghtpe.gov.tw	Tsai, Chang-Youh/G-1747-2013; Hsieh, Shie-Liang Edmond/ABA-9184-2021; Lin, Han/GRF-1081-2022	Tsai, Chang-Youh/0000-0002-4154-4018; Huang, Chia-Chang/0000-0002-1313-4628; Yang, Ying-Ying/0000-0002-7719-0397	National Science Council [100-2314-B-010-059-MY3, NSC 101-2314-B-075-011]; Taipei Veterans General Hospital [V104C-023, V104C-022]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was partly supported by the grants 100-2314-B-010-059-MY3 and NSC 101-2314-B-075-011 from the National Science Council, and V104C-023 and V104C-022 by the Taipei Veterans General Hospital.	Abraldes JG, 2006, AM J PHYSIOL-GASTR L, V290, pG980, DOI 10.1152/ajpgi.00336.2005; Alvarez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071477; Anand RJ, 2008, AM J PHYSIOL-GASTR L, V294, pG109, DOI 10.1152/ajpgi.00331.2007; Baluk P, 2009, J CLIN INVEST, V119, P2954, DOI 10.1172/JCI37626; BAUDRY N, 1993, J APPL PHYSIOL, V75, P2392, DOI 10.1152/jappl.1993.75.6.2392; Buzzo CL, 2010, J BIOL CHEM, V285, P32087, DOI 10.1074/jbc.M110.124297; Carmi Y, 2009, J IMMUNOL, V183, P4705, DOI 10.4049/jimmunol.0901511; Cazzaniga M, 2009, J HEPATOL, V51, P475, DOI 10.1016/j.jhep.2009.04.017; Chang CC, 2009, J CHIN MED ASSOC, V72, P234, DOI 10.1016/S1726-4901(09)70063-2; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; DEVIERE J, 1990, HEPATOLOGY, V11, P628, DOI 10.1002/hep.1840110416; Dredge K, 2002, BRIT J CANCER, V87, P1166, DOI 10.1038/sj.bjc.6600607; Ehrenpreis ED, 1999, GASTROENTEROLOGY, V117, P1271, DOI 10.1016/S0016-5085(99)70276-3; Enomoto N, 2002, GASTROENTEROLOGY, V123, P291, DOI 10.1053/gast.2002.34161; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Geerts AM, 2006, LIVER INT, V26, P889, DOI 10.1111/j.1478-3231.2006.01308.x; Hartmann P, 2012, GASTROENTEROLOGY, V143, P1330, DOI 10.1053/j.gastro.2012.07.099; Keller M, 2009, J IMMUNOL, V183, P5593, DOI 10.4049/jimmunol.0900476; Komorowski J, 2006, LIFE SCI, V78, P2558, DOI 10.1016/j.lfs.2005.10.016; Lee JS, 2005, AM J PATHOL, V166, P1861, DOI 10.1016/S0002-9440(10)62495-9; LopezTalavera JC, 1996, HEPATOLOGY, V23, P1616, DOI 10.1053/jhep.1996.v23.pm0008675185; LOPEZTALAVERA JC, 1995, GASTROENTEROLOGY, V108, P761, DOI 10.1016/0016-5085(95)90449-2; Lv P, 2006, PATHOL RES PRACT, V202, P777, DOI 10.1016/j.prp.2006.08.002; Marneros AG, 2013, CELL REP, V4, P945, DOI 10.1016/j.celrep.2013.08.002; Mashukova A, 2011, MOL CELL BIOL, V31, P756, DOI 10.1128/MCB.00811-10; Mejias M, 2009, HEPATOLOGY, V49, P1245, DOI 10.1002/hep.22758; Miura K, 2013, HEPATOLOGY, V57, P577, DOI 10.1002/hep.26081; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; POBER JS, 1986, J IMMUNOL, V136, P1680; ROSENKRANZWEISS P, 1994, J CLIN INVEST, V93, P2236, DOI 10.1172/JCI117221; Siegmund B, 2002, BIOCHEM PHARMACOL, V64, P1, DOI 10.1016/S0006-2952(02)01064-X; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tamilarasan KP, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-17; TILG H, 1992, GASTROENTEROLOGY, V103, P264, DOI 10.1016/0016-5085(92)91122-K; Ware CF, 2003, CYTOKINE GROWTH F R, V14, P181, DOI 10.1016/S1359-6101(03)00032-7; Weinheimer-Haus EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119106; WERNERFELMAYER G, 1993, J BIOL CHEM, V268, P1842; Wiest R, 1999, J CLIN INVEST, V104, P1223, DOI 10.1172/JCI7458; Yang M, 2012, JOVE-J VIS EXP, DOI 10.3791/3954; Yang YY, 2009, LIVER INT, V29, P678, DOI 10.1111/j.1478-3231.2009.01983.x; Yang YY, 2009, BIOCHEM BIOPH RES CO, V380, P666, DOI 10.1016/j.bbrc.2009.01.160	42	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147212	10.1371/journal.pone.0147212	http://dx.doi.org/10.1371/journal.pone.0147212			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820153	Green Published, gold			2022-12-26	WOS:000369528400017
J	Ma, Y; Yin, F; Zhang, T; Zhou, XA; Li, XS				Ma, Yue; Yin, Fei; Zhang, Tao; Zhou, Xiaohua Andrew; Li, Xiaosong			Selection of the Maximum Spatial Cluster Size of the Spatial Scan Statistic by Using the Maximum Clustering Set-Proportion Statistic	PLOS ONE			English	Article							GEOGRAPHIC ANALYSIS; POWER COMPARISONS; DISEASE CLUSTERS; SURVIVAL-DATA	Spatial scan statistics are widely used in various fields. The performance of these statistics is influenced by parameters, such as maximum spatial cluster size, and can be improved by parameter selection using performance measures. Current performance measures are based on the presence of clusters and are thus inapplicable to data sets without known clusters. In this work, we propose a novel overall performance measure called maximum clustering set-proportion (MCS-P), which is based on the likelihood of the union of detected clusters and the applied dataset. MCS-P was compared with existing performance measures in a simulation study to select the maximum spatial cluster size. Results of other performance measures, such as sensitivity and misclassification, suggest that the spatial scan statistic achieves accurate results in most scenarios with the maximum spatial cluster sizes selected using MCS-P. Given that previously known clusters are not required in the proposed strategy, selection of the optimal maximum cluster size with MCS-P can improve the performance of the scan statistic in applications without identified clusters.	[Ma, Yue; Yin, Fei; Zhang, Tao; Li, Xiaosong] Sichuan Univ, West China Sch Publ Hlth, Chengdu 610041, Peoples R China; [Zhou, Xiaohua Andrew] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA	Sichuan University; University of Washington; University of Washington Seattle	Li, XS (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu 610041, Peoples R China.	publichealth.scu@gmail.com	Ma, Yue/U-7597-2019	Ma, Yue/0000-0002-1980-7520; Zhou, Xiaohua/0000-0001-7935-1222	National Natural Science Foundation of China [81402766]; National Science and Technology Mayor Project [2012ZX10004201-006]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Mayor Project; China Scholarship Council(China Scholarship Council)	This study was supported by National Natural Science Foundation of China (grant number 81402766), National Science and Technology Mayor Project (grant number 2012ZX10004201-006) and China Scholarship Council (http://en.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt V, 2014, STAT MED, V33, P1867, DOI 10.1002/sim.6075; Chaput EK, 2002, EMERG INFECT DIS, V8, P943, DOI 10.3201/eid0809.020103; Costa MA, 2012, COMPUT STAT DATA AN, V56, P1771, DOI 10.1016/j.csda.2011.11.001; Coulston JW, 2003, ENVIRON MANAGE, V31, P764, DOI 10.1007/s00267-002-0023-9; Donnan PT, 2005, MULT SCLER, V11, P403, DOI 10.1191/1352458505ms1191oa; Duczmal L, 2006, J COMPUTATIONAL GRAP, V15; Forand SP, 2002, HEALTH PLACE, V8, P191, DOI 10.1016/S1353-8292(01)00037-5; Glaz J., 2009, SCAN STAT METHODS AP, V2, P422, DOI [http://dx.doi.org/10.1007/978-0-8176-4749-0, DOI 10.1007/978-0-8176-4749-0]; Huang L, 2008, STAT MED, V27, P5111, DOI 10.1002/sim.3342; Huang L, 2007, BIOMETRICS, V63, P109, DOI 10.1111/j.1541-0420.2006.00661.x; Jacquez GM, 2009, SPAT SPATIO-TEMPORAL, V1, P19, DOI 10.1016/j.sste.2009.08.002; Jung I, 2007, STAT MED, V26, P1594, DOI 10.1002/sim.2607; Jung I, 2012, STAT MED, V31, P4040, DOI 10.1002/sim.5475; Jung I, 2010, STAT MED, V29, P1910, DOI 10.1002/sim.3951; Kulldorff, 2010, SATSCAN SOFTWARE SPA; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2003, COMPUT STAT DATA AN, V42, P665, DOI 10.1016/S0167-9473(02)00160-3; Kulldorff M, SATSCAN TM USER GUID; Kulldorff M, SELECTED APPL FIELD; Kulldorff M, 2015, NE US BENCHMARK DATA; Kulldorff M, 2006, STAT MED, V25, P3929, DOI 10.1002/sim.2490; Li XZ, 2011, MATH BIOSCI, V233, P135, DOI 10.1016/j.mbs.2011.07.004; Marek L, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/1476-072X-14-7; Neill DB, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-20; Ozonoff A, 2005, COMPUT STAT DATA AN, V48, P679, DOI 10.1016/j.csda.2004.03.012; Read S, 2013, J INF SCI, V39, P36, DOI 10.1177/0165551512469768; Read S, 2011, SPAT SPATIO-TEMPORAL, V2, P69, DOI 10.1016/j.sste.2011.01.002; Ribeiro SHR, 2012, SPAT SPATIO-TEMPORAL, V3, P107, DOI 10.1016/j.sste.2012.04.004; Savory DJ, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-1; Tango T, 2012, STAT MED, V31, P4207, DOI 10.1002/sim.5478; Tango Toshiro, 2005, Int J Health Geogr, V4, P11, DOI 10.1186/1476-072X-4-11; Torabi M, 2011, SPAT SPATIO-TEMPORAL, V2, P321, DOI 10.1016/j.sste.2011.10.003; Weisent J, 2011, GEOSPATIAL HEALTH, V6, P65, DOI 10.4081/gh.2011.158	35	15	15	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147918	10.1371/journal.pone.0147918	http://dx.doi.org/10.1371/journal.pone.0147918			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820646	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528400054
J	Rasche, L; Heiserich, L; Behrens, JR; Lenz, K; Pfuhl, C; Wakonig, K; Giess, RM; Freitag, E; Eberle, C; Wuerfel, J; Dorr, J; Bauer, P; Bellmann-Strobl, J; Paul, F; Roggenbuck, D; Ruprecht, K				Rasche, Ludwig; Heiserich, Lisa; Behrens, Janina Ruth; Lenz, Klaus; Pfuhl, Catherina; Wakonig, Katharina; Giess, Rene Markus; Freitag, Erik; Eberle, Caroline; Wuerfel, Jens; Doerr, Jan; Bauer, Peter; Bellmann-Strobl, Judith; Paul, Friedemann; Roggenbuck, Dirk; Ruprecht, Klemens			Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study	PLOS ONE			English	Article							H2AX PHOSPHORYLATION; OXIDATIVE STRESS; BIOMARKERS; BREAKS	Background In response to DNA double-strand breaks, the histone protein H2AX becomes phosphorylated at its C-terminal serine 139 residue, referred to as gamma-H2AX. Formation of gamma-H2AX foci is associated with recruitment of p53-binding protein 1 (53BP1), a regulator of the cellular response to DNA double-strand breaks. gamma-H2AX expression in peripheral blood mononuclear cells (PBMCs) was recently proposed as a diagnostic and disease activity marker for multiple sclerosis (MS). Objective To evaluate the significance of gamma-H2AX and 53BP1 foci in PBMCs as diagnostic and disease activity markers in patients with clinically isolated syndrome (CIS) and early relapsing-remitting MS (RRMS) using automated. gamma-H2AX and 53BP1 foci detection. Methods Immunocytochemistry was performed on freshly isolated PBMCs of patients with CIS/early RRMS (n = 25) and healthy controls (n = 27) with gamma-H2AX and 53BP1 specific antibodies. Nuclear gamma-H2AX and 53BP1 foci were determined using a fully automated reading system, assessing the numbers of gamma-H2AX and 53BP1 foci per total number of cells and the percentage of cells with foci. Patients underwent contrast enhanced 3 Tesla magnetic resonance imaging (MRI) and clinical examination including expanded disability status scale (EDSS) score. gamma-H2AX and 53BP1 were also compared in previously frozen PBMCs of each 10 CIS/early RRMS patients with and without contrast enhancing lesions (CEL) and 10 healthy controls. Results The median (range) number of gamma-H2AX (0.04 [0-0.5]) and 53BP1 (0.005 [0-0.2]) foci per cell in freshly isolated PBMCs across all study participants was low and similar to previously reported values of healthy individuals. For both, gamma-H2AX and 53BP1, the cellular focus number as well as the percentage of positive cells did not differ between patients with CIS/RRMS and healthy controls. gamma-H2AX and 53BP1 levels neither correlated with number nor volume of T2-weighted lesions on MRI, nor with the EDSS. Although gamma-H2AX, but not 53BP1, levels were higher in previously frozen PBMCs of patients with than without CEL, gamma-H2AX values of both groups overlapped and gamma-H2AX did not correlate with the number or volume of CEL. Conclusion gamma-H2AX and 53BP1 foci do not seem to be promising diagnostic or disease activity biomarkers in patients with early MS. Lymphocytic DNA double-strand breaks are unlikely to play a major role in the pathophysiology of MS.	[Rasche, Ludwig; Behrens, Janina Ruth; Pfuhl, Catherina; Wakonig, Katharina; Giess, Rene Markus; Freitag, Erik; Wuerfel, Jens; Doerr, Jan; Bellmann-Strobl, Judith; Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Rasche, Ludwig; Behrens, Janina Ruth; Pfuhl, Catherina; Wakonig, Katharina; Giess, Rene Markus; Freitag, Erik; Doerr, Jan; Bellmann-Strobl, Judith; Paul, Friedemann; Ruprecht, Klemens] Charite, Clin & Expt Multiple Sclerosis Res Ctr, D-13353 Berlin, Germany; [Rasche, Ludwig; Pfuhl, Catherina; Giess, Rene Markus; Paul, Friedemann; Ruprecht, Klemens] Charite, Dept Neurol, D-13353 Berlin, Germany; [Heiserich, Lisa; Eberle, Caroline; Bauer, Peter; Roggenbuck, Dirk] Medipan GmbH, Dahlewitz, Germany; [Lenz, Klaus] Charite, Dept Med Biometr & Clin Epidemiol, D-13353 Berlin, Germany; [Wuerfel, Jens] MIAC AG, Basel, Switzerland; [Wuerfel, Jens; Bellmann-Strobl, Judith] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Wuerfel, Jens; Bellmann-Strobl, Judith] Max Delbruck Ctr Mol Med, Berlin, Germany; [Wuerfel, Jens] Univ Med Gottingen, Inst Neuroradiol, Gottingen, Germany; [Roggenbuck, Dirk] Brandenburg Tech Univ Cottbus, Fac Sci, Senftenberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Gottingen; Brandenburg University of Technology Cottbus	Ruprecht, K (corresponding author), Charite, Clin & Expt Multiple Sclerosis Res Ctr, D-13353 Berlin, Germany.; Ruprecht, K (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	klemens.ruprecht@charite.de	Paul, Friedemann/ABF-9415-2020	Roggenbuck, Dirk/0000-0002-6861-6827; Bellmann-Strobl, Judith/0000-0003-2615-1643; Wuerfel, Jens/0000-0002-0034-8053; Wakonig, Katharina/0000-0003-1915-9583; paul, friedemann/0000-0002-6378-0070	German Ministry of Education and Research (BMBF/KKNMS) [01GI1312]; German Ministry of Education and Research (BMBF/KKNMS)	German Ministry of Education and Research (BMBF/KKNMS); German Ministry of Education and Research (BMBF/KKNMS)	Support was provided by the German Ministry of Education and Research (BMBF/KKNMS, Competence Network Multiple Sclerosis, grant number 01GI1312) Charite Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Medipan GmbH provided support in the form of salaries for authors (LH, CE, PB, and DR) and research materials. LH, CE, PB, and DR were involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.; The authors like to thank all participants of this study as well as Bibiane Seeger, Susan Pikol and Cynthia Kraut for excellent technical assistance. FP, JW and KR are supported by the German Ministry of Education and Research (BMBF/KKNMS, Competence Network Multiple Sclerosis).	Bielekova B, 2004, BRAIN, V127, P1463, DOI 10.1093/brain/awh176; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dorr J, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-015-0354-5; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Grecchi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044935; Heydenreich J, 2014, J NUTR METAB, V2014, DOI 10.1155/2014/478324; Kuo LJ, 2008, IN VIVO, V22, P305; Marrie RA, 2015, MULT SCLER J, V21, P294, DOI 10.1177/1352458514564489; Meyer B, 2013, NUCLEIC ACIDS RES, V41, P6109, DOI 10.1093/nar/gkt304; Miller DH, 2008, MULT SCLER J, V14, P1157, DOI 10.1177/1352458508096878; Mondal NK, 2010, MUTAT RES-GEN TOX EN, V697, P47, DOI 10.1016/j.mrgentox.2010.02.006; Oliveira SR, 2012, J NEUROL SCI, V321, P49, DOI 10.1016/j.jns.2012.07.045; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Raphael I, 2015, EXPERT REV CLIN IMMU, V11, P69, DOI 10.1586/1744666X.2015.991315; Reddig A, 2015, CYTOM PART A, V87A, P724, DOI 10.1002/cyto.a.22667; Reddig A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132702; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2015, ENVIRON MOL MUTAGEN, V56, P491, DOI 10.1002/em.21944; Runge R, 2012, INT J RADIAT BIOL, V88, P439, DOI 10.3109/09553002.2012.658468; Scarpato R, 2011, FASEB J, V25, P685, DOI 10.1096/fj.10-168427; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Sinnecker T, 2012, ARCH NEUROL-CHICAGO, V69, P739, DOI 10.1001/archneurol.2011.2450; Solier S, 2009, CELL CYCLE, V8, P1853, DOI 10.4161/cc.8.12.8865; Traboulsee A, 2007, J NEUROL SCI, V256, pS19, DOI 10.1016/j.jns.2007.01.064; Valdiglesias V, 2013, MUTAT RES-REV MUTAT, V753, P24, DOI 10.1016/j.mrrev.2013.02.001; Willitzki A, 2013, CYTOM PART A, V83, P1017, DOI 10.1002/cyto.a.22350; Willitzki A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/284740	29	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147968	10.1371/journal.pone.0147968	http://dx.doi.org/10.1371/journal.pone.0147968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820970	gold, Green Accepted, Green Published			2022-12-26	WOS:000369528400057
J	Last, M; Rabinowitz, N; Leonard, G				Last, Mark; Rabinowitz, Nitzan; Leonard, Gideon			Predicting the Maximum Earthquake Magnitude from Seismic Data in Israel and Its Neighboring Countries	PLOS ONE			English	Article							MODEL; HAZARD; FAULT	This paper explores several data mining and time series analysis methods for predicting the magnitude of the largest seismic event in the next year based on the previously recorded seismic events in the same region. The methods are evaluated on a catalog of 9,042 earthquake events, which took place between 01/01/1983 and 31/12/2010 in the area of Israel and its neighboring countries. The data was obtained from the Geophysical Institute of Israel. Each earthquake record in the catalog is associated with one of 33 seismic regions. The data was cleaned by removing foreshocks and aftershocks. In our study, we have focused on ten most active regions, which account for more than 80% of the total number of earthquakes in the area. The goal is to predict whether the maximum earthquake magnitude in the following year will exceed the median of maximum yearly magnitudes in the same region. Since the analyzed catalog includes only 28 years of complete data, the last five annual records of each region (referring to the years 2006-2010) are kept for testing while using the previous annual records for training. The predictive features are based on the Gutenberg-Richter Ratio as well as on some new seismic indicators based on the moving averages of the number of earthquakes in each area. The new predictive features prove to be much more useful than the indicators traditionally used in the earthquake prediction literature. The most accurate result (AUC = 0.698) is reached by the Multi-Objective Info-Fuzzy Network (M-IFN) algorithm, which takes into account the association between two target variables: the number of earthquakes and the maximum earthquake magnitude during the same year.	[Last, Mark] Ben Gurion Univ Negev, Dept Informat Syst Engn, IL-84105 Beer Sheva, Israel; [Rabinowitz, Nitzan] Human Monitoring Ltd, Rehovot, Israel; [Leonard, Gideon] Israel Atom Energy Commiss, Tel Aviv, Israel	Ben Gurion University	Last, M (corresponding author), Ben Gurion Univ Negev, Dept Informat Syst Engn, IL-84105 Beer Sheva, Israel.	mlast@bgu.ac.il	Last, Mark/AAF-8443-2020		Human Monitoring Ltd	Human Monitoring Ltd	One of the authors (NR) is employed by a commercial company - Human Monitoring Ltd. The funder (Human Monitoring Ltd) provided support in the form of salary for the author NR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 1995, SEISMOL RES LETT, DOI DOI 10.1785/GSSRL.66.4.8; ARIEH E, 1989, TECTONOPHYSICS, V167, P223, DOI 10.1016/0040-1951(89)90073-5; Cristianini N., 2000, INTRO SUPPORT VECTOR, DOI [10.1017/CBO9780511801389, DOI 10.1017/CBO9780511801389]; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Gutenberg B., 1944, B SEISMOL SOC AM, V34, P185, DOI [DOI 10.1785/BSSA0340040185, 10.1785/BSSA0340040185]; Hamiel Y, 2009, B SEISMOL SOC AM, V99, P2020, DOI 10.1785/0120080218; Kaufmann L, 2008, FINDING GROUPS DATA; KEILISBOROK VI, 1990, PHYS EARTH PLANET IN, V61, P73, DOI 10.1016/0031-9201(90)90096-G; Krzanowski WJ, 2009, MONOGR STAT APPL PRO, V111, P1; Last M, 2004, LECT NOTES COMPUT SC, V3201, P239; Last M, 2004, IEEE T KNOWL DATA EN, V16, P203, DOI 10.1109/TKDE.2004.1269598; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Minium E. W., 1999, ELEMENTS STAT REASON; Mitchell T.M, 2003, MACH LEARN; Morales-Esteban A, 2010, EXPERT SYST APPL, V37, P8333, DOI 10.1016/j.eswa.2010.05.050; Murck BW, 1999, GEOLOGY TODAY UNDERS; Panakkat A, 2007, INT J NEURAL SYST, V17, P13, DOI 10.1142/S0129065707000890; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Rhoades DA, 2007, SEISMOL RES LETT, V78, P110, DOI 10.1785/gssrl.78.1.110; Scholz M., 2006, P 12 ACM SIGKDD INT, P935, DOI [10.1145/1150402.1150531, DOI 10.1145/1150402.1150531]; Stein S, 2011, SEISMOL RES LETT, V82, P623, DOI 10.1785/gssrl.82.5.623; The Geophysical Institute of Israel Seismology Division, 2010, GEOPH I ISR SEISM B; Tiampo KF, 2002, EUROPHYS LETT, V60, P481, DOI 10.1209/epl/i2002-00289-y; Tormann T, 2008, B SEISMOL SOC AM, V98, P2149, DOI 10.1785/0120060217; Werner MJ, 2011, B SEISMOL SOC AM, V101, P1630, DOI 10.1785/0120090340; Ziv A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027141	27	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146101	10.1371/journal.pone.0146101	http://dx.doi.org/10.1371/journal.pone.0146101			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812351	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528000005
J	Min, PK; Cho, M; Hong, SY; Kim, JY; Choi, EY; Yoon, YW; Lee, BK; Hong, BK; Rim, SJ; Kwon, HM				Min, Pil-Ki; Cho, Minhee; Hong, Sung-Yu; Kim, Jong-Youn; Choi, Eui-Young; Yoon, Young-Won; Lee, Byoung Kwon; Hong, Bum-Kee; Rim, Se-Joong; Kwon, Hyuck Moon			Circulating Microparticles and Coronary Plaque Components Assessed by Virtual Histology Intravascular Ultrasound of the Target Lesion in Patients with Stable Angina	PLOS ONE			English	Article							HUMAN ATHEROSCLEROTIC PLAQUES; C-REACTIVE PROTEIN; ENDOTHELIAL MICROPARTICLES; BIOMARKERS; GRAYSCALE; CORRELATE; PECTORIS; BLOOD	High levels of microparticles (MPs) circulate in the blood of patients with atherosclerotic diseases where they can serve as potential biomarkers of vascular injury and cardiovascular outcome. We used virtual histology intravascular ultrasound (VH-IVUS) to evaluate the relationship between the levels of circulating MPs and the coronary plaque composition in patients with stable angina. We included 35 patients with stable angina (22 men, age 64 +/- 9 years) and a de novo target lesion. Preintervention gray-scale and VH-IVUS analysis was performed across the target lesion. Volumetric analysis was performed over a 10-mm-long segment centered at the minimum luminal site. Blood samples were obtained from the femoral artery before coronary angioplasty. MPs were measured using a solid-phase capture assay from a commercial kit. We divided participants into either a low MPs group or high MPs group based on the median value of MPs. There was no significant difference in baseline characteristics between the groups. The plaque burden and remodeling index were similar between the groups. The presence of VH-IVUS-derived thin-cap fibroatheroma was not different between the groups. The percentage of the necrotic core (NC) was significantly higher in the high MPs group than in the low MPs group, both in planar (17.0 +/- 8.8% vs. 24.1 +/- 6.9%, p = 0.012) and volumetric analyses (17.0 +/- 4.8% vs. 22.1 +/- 4.3%, p = 0.002). Circulating MPs were positively correlated with the percentage of the NC area at the minimal luminal site (r = 0.491, p = 0.003) and the percentage of the NC volume (r = 0.496, p = 0.002). Elevated levels of circulating MPs were associated with the amount of NC in the target lesion in those with stable angina, suggesting a potential role of circulating MPs as a biomarker for detecting unstable plaque in patients with stable angina.	[Min, Pil-Ki; Cho, Minhee; Kim, Jong-Youn; Choi, Eui-Young; Yoon, Young-Won; Lee, Byoung Kwon; Hong, Bum-Kee; Rim, Se-Joong; Kwon, Hyuck Moon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Cardiol Div,Dept Internal Med, Seoul 120749, South Korea; [Min, Pil-Ki; Yoon, Young-Won] Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul 120749, South Korea; [Hong, Sung-Yu] Yonsei Univ Hlth Syst, Cardiovasc Prod Evaluat Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Min, PK (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Cardiol Div,Dept Internal Med, Seoul 120749, South Korea.; Min, PK (corresponding author), Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul 120749, South Korea.	cardioblues@yuhs.ac		Rim, Se Joong/0000-0002-7631-5581; Hong, Bum Kee/0000-0002-6456-0184; Kim, Jong-Youn/0000-0001-7040-8771; Min, Pil-Ki/0000-0001-7033-7651; Lee, Byoung Kwon/0000-0001-9259-2776; Choi, Eui-Young/0000-0003-3732-0190; Kwon, Hyuck Moon/0000-0001-9901-5015	Korean Society of Lipidology and Atherosclerosis	Korean Society of Lipidology and Atherosclerosis	This study was supported by grants from the Korean Society of Lipidology and Atherosclerosis (Industrial-Educational Cooperation, 2010).	Bernal-Mizrachi L, 2003, AM HEART J, V145, P962, DOI 10.1016/S0002-8703(03)00103-0; Bernal-Mizrachi L, 2004, INT J CARDIOL, V97, P439, DOI 10.1016/j.ijcard.2003.10.029; Bernard S, 2009, ATHEROSCLEROSIS, V203, P429, DOI 10.1016/j.atherosclerosis.2008.07.039; Biasucci LM, 2012, CIRC J, V76, P2174, DOI 10.1253/circj.CJ-12-0068; Cheng JM, 2014, AM J CARDIOL, V114, P1497, DOI 10.1016/j.amjcard.2014.08.013; Jy W, 2004, J THROMB HAEMOST, V2, P1842, DOI 10.1111/j.1538-7836.2004.00936.x; Ko YG, 2012, YONSEI MED J, V53, P508, DOI 10.3349/ymj.2012.53.3.508; Kubo T, 2009, CORONARY ARTERY DIS, V20, P531, DOI 10.1097/MCA.0b013e328332a6b0; Leroyer AS, 2008, J AM COLL CARDIOL, V52, P1302, DOI 10.1016/j.jacc.2008.07.032; Leroyer AS, 2007, J AM COLL CARDIOL, V49, P772, DOI 10.1016/j.jacc.2006.10.053; Maehara A, 2012, JACC-CARDIOVASC IMAG, V5, pS1, DOI 10.1016/j.jcmg.2011.11.019; Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841; Min PK, 2013, ATHEROSCLEROSIS, V227, P323, DOI 10.1016/j.atherosclerosis.2013.01.032; Morel O, 2013, SEMIN THROMB HEMOST, V39, P477, DOI 10.1055/s-0033-1343888; Nasu K, 2006, J AM COLL CARDIOL, V47, P2405, DOI 10.1016/j.jacc.2006.02.044; Park JP, 2010, CIRC J, V74, P332, DOI 10.1253/circj.CJ-09-0570; Puddu Paolo, 2010, Can J Cardiol, V26, P140; Rautou PE, 2011, CIRC RES, V108, P335, DOI 10.1161/CIRCRESAHA.110.237420; Rodriguez-Granillo GA, 2005, J AM COLL CARDIOL, V46, P2038, DOI 10.1016/j.jacc.2005.07.064; Rodriguez-Granillo Gaston A, 2005, EuroIntervention, V1, P367; Sarlon-Bartoli G, 2013, J AM COLL CARDIOL, V62, P1436, DOI 10.1016/j.jacc.2013.03.078; Sinning JM, 2011, EUR HEART J, V32, P2034, DOI 10.1093/eurheartj/ehq478; VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5	23	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0148128	10.1371/journal.pone.0148128	http://dx.doi.org/10.1371/journal.pone.0148128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812147	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528000076
J	Charles, JJ; Paine, TD				Charles, Jennifer J.; Paine, Timothy D.			Fitness Effects of Food Resources on the Polyphagous Aphid Parasitoid, Aphidius colemani Viereck (Hymenoptera: Braconidae: Aphidiinae)	PLOS ONE			English	Article							GOSSYPII GLOVER HOMOPTERA; BIOLOGICAL-CONTROL; NATURAL ENEMIES; SUGAR COMPOSITION; FLORAL RESOURCES; HONEYDEW; LONGEVITY; FECUNDITY; FLOWERS; NECTAR	Conservation biological control involving the polyphagous aphid parasitoid, Aphidius colemani Viereck, may include provisioning resources from a variety of plant sources. The fitness of adult A. colemani was enhanced with the provision of food resources such as floral nectar from a range of both native and introduced plant species and aphid honeydew under laboratory conditions. However, enhanced fitness appeared to be species specific rather than associated with the whether the plant was a native or an introduced species. Parasitoid survival and fecundity were enhanced significantly in response to the availability of floral nectar and honeydew compared to the response to available extrafloral nectar. These positive effects on the parasitoid's reproductive activity can improve the effectiveness of conservation biological control in nursery production systems because of the abundance and diversity of floral resources within typical production areas. Additionally, surrounding areas of invasive weeds and native vegetation could serve as both floral resources and honeydew food resources for A. colemani.	[Charles, Jennifer J.; Paine, Timothy D.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Paine, TD (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	timothy.paine@ucr.edu			California Association of Nurseries and Garden Centers; UC Riverside College of Natural and Agricultural Sciences Research Support Application Program; USDA NIFA Hatch program	California Association of Nurseries and Garden Centers; UC Riverside College of Natural and Agricultural Sciences Research Support Application Program; USDA NIFA Hatch program	Funding in support of the research was provided by the California Association of Nurseries and Garden Centers, the UC Riverside College of Natural and Agricultural Sciences Research Support Application Program, and the USDA NIFA Hatch program in support of the Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt LA, 2006, BIOL CONTROL, V37, P50, DOI 10.1016/j.biocontrol.2005.12.005; BUDENBERG WJ, 1992, ENTOMOL EXP APPL, V63, P259, DOI 10.1007/BF00192774; Chaney William E., 1998, P73; Doten SB, 1911, U NEV AGR EXP STAT B; Dreistadt SH, 2001, U CALIF DIV AGR NAT, V3402; Ebert TA, 1997, SOUTHWEST ENTOMOL, V22, P116; ELLIOTT NC, 1987, J KANSAS ENTOMOL SOC, V60, P25; ELLIOTT NC, 1994, GREAT LAKES ENTOMOL, V27, P137; Fiedler AK, 2008, BIOL CONTROL, V45, P254, DOI 10.1016/j.biocontrol.2007.12.009; FURK C, 1990, ANN APPL BIOL, V116, P557, DOI 10.1111/j.1744-7348.1990.tb06638.x; FURK C, 1993, ANN APPL BIOL, V123, P9, DOI 10.1111/j.1744-7348.1993.tb04066.x; Giron D, 2002, FUNCT ECOL, V16, P750, DOI 10.1046/j.1365-2435.2002.00679.x; GRASSWITZ TR, 1993, J INSECT BEHAV, V6, P511, DOI 10.1007/BF01049529; Gurr G., 2004, ECOLOGICAL ENG PEST; Harizanova V, 1997, J ENTOMOL SCI, V32, P17, DOI 10.18474/0749-8004-32.1.17; Heimpel George E., 2005, P267, DOI 10.1017/CBO9780511542220.010; Herron GA, 2001, AUST J ENTOMOL, V40, P85, DOI 10.1046/j.1440-6055.2001.00200.x; Hogervorst PAM, 2007, FUNCT ECOL, V21, P936, DOI 10.1111/j.1365-2435.2007.01297.x; Hogervorst PAM, 2007, ENTOMOL EXP APPL, V122, P223, DOI 10.1111/j.1570-7458.2006.00505.x; Irvin NA, 2007, BIOL CONTROL, V40, P69, DOI 10.1016/j.biocontrol.2006.09.005; Irvin NA, 2007, BIOL CONTROL, V40, P80, DOI 10.1016/j.biocontrol.2006.09.004; Jacobson RJ, 1998, BIOCONTROL SCI TECHN, V8, P377, DOI 10.1080/09583159830180; JERVIS MA, 1993, J NAT HIST, V27, P67, DOI 10.1080/00222939300770051; Johansen HN, 1996, J AGR FOOD CHEM, V44, P1470, DOI 10.1021/jf950482b; Jonsson M, 2008, BIOL CONTROL, V45, P172, DOI 10.1016/j.biocontrol.2008.01.006; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Lee JC, 2006, ECOL ENTOMOL, V31, P470, DOI 10.1111/j.1365-2311.2006.00800.x; Lee JC, 2004, ENTOMOL EXP APPL, V111, P189, DOI 10.1111/j.0013-8703.2004.00165.x; LEIUS K., 1960, CANADIAN ENT, V92, P369; LEIUS K, 1967, CAN ENTOMOL, V99, P444, DOI 10.4039/Ent99444-4; Matkin O., 1957, UC SYSTEM PRODUCING, P68; OLSON DL, 1995, ENVIRON ENTOMOL, V24, P454, DOI 10.1093/ee/24.2.454; OPP SB, 1986, ANN ENTOMOL SOC AM, V79, P700, DOI 10.1093/aesa/79.4.700; Patt JM, 1997, ENTOMOL EXP APPL, V83, P21, DOI 10.1023/A:1002936210051; Perdikis DC, 2004, EUR J ENTOMOL, V101, P333, DOI 10.14411/eje.2004.044; Pickett CH, 1998, C P U CALIFORNIA, P81; POWELL W, 1983, PHYSIOL ENTOMOL, V8, P439, DOI 10.1111/j.1365-3032.1983.tb00378.x; Rose USR, 2006, FUNCT ECOL, V20, P67, DOI 10.1111/j.1365-2435.2006.01071.x; ROSENHEIM JA, 1991, J ANIM ECOL, V60, P873, DOI 10.2307/5419; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; SCOPES NEA, 1980, SCI HORTIC-ENGLAND, V31, P48; Sivarajan V. V., 1991, INTRO PRINCIPLES PLA; Sivinski J, 2006, ENTOMOL EXP APPL, V118, P193, DOI 10.1111/j.1570-7458.2006.00379.x; Slosser JE, 1986, SW ENTOMOL, V14, P302; STARY P, 1975, ACTA ENTOMOL BOHEMOS, V72, P156; Sweetman H, 1958, PRINCIPLES BIOL CONT; SYME PD, 1977, CAN ENTOMOL, V109, P995, DOI 10.4039/Ent109995-7; SYME PD, 1975, ENVIRON ENTOMOL, V4, P337, DOI 10.1093/ee/4.2.337; Tena A, 2015, J APPL ECOL, V52, P795, DOI 10.1111/1365-2664.12426; Tena A, 2013, BIOL CONTROL, V67, P117, DOI 10.1016/j.biocontrol.2013.07.018; Tylianakis JM, 2004, ECOLOGY, V85, P658, DOI 10.1890/03-0222; vam Emden HF, 2007, APHIDS CROP PESTS; van den BOSCH R., 1964, P459; van Lenteren JC, 2000, CROP PROT, V19, P375, DOI 10.1016/S0261-2194(00)00038-7; VANSTEENIS MJ, 1995, BIOCONTROL SCI TECHN, V5, P339, DOI 10.1080/09583159550039783; VANSTEENIS MJ, 1993, J APPL ENTOMOL, V116, P192, DOI 10.1111/j.1439-0418.1993.tb01188.x; Vasquez GM, 2006, J ECON ENTOMOL, V99, P1104, DOI 10.1603/0022-0493-99.4.1104; Vehrs S. L., 1991, California Agriculture, V45, P28; WAAGE JK, 1984, J ANIM ECOL, V53, P401, DOI 10.2307/4524; Wackers FL, 2008, BIOL CONTROL, V45, P176, DOI 10.1016/j.biocontrol.2008.01.007; Wackers FL, 2000, OIKOS, V90, P197, DOI 10.1034/j.1600-0706.2000.900124.x; Wackers FL, 2001, J INSECT PHYSIOL, V47, P1077, DOI 10.1016/S0022-1910(01)00088-9; Walton NJ, 2011, ENVIRON ENTOMOL, V40, P1177, DOI 10.1603/EN10321; Wilen C, 2002, CROP PROFILE CALIFOR	64	16	16	6	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147551	10.1371/journal.pone.0147551	http://dx.doi.org/10.1371/journal.pone.0147551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808191	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800131
J	Herrando-Grabulosa, M; Mulet, R; Pujol, A; Mas, JM; Navarro, X; Aloy, P; Coma, M; Casas, C				Herrando-Grabulosa, Mireia; Mulet, Roger; Pujol, Albert; Manuel Mas, Jose; Navarro, Xavier; Aloy, Patrick; Coma, Mireia; Casas, Caty			Novel Neuroprotective Multicomponent Therapy for Amyotrophic Lateral Sclerosis Designed by Networked Systems	PLOS ONE			English	Article							SPINAL-CORD MOTONEURONS; MICROGLIAL ACTIVATION; DROSOPHILA MODEL; MOUSE MODEL; DISEASE; ALS; RECEPTORS; INJURY; EXCITOTOXICITY; DEGENERATION	Amyotrophic Lateral Sclerosis is a fatal, progressive neurodegenerative disease characterized by loss of motor neuron function for which there is no effective treatment. One of the main difficulties in developing new therapies lies on the multiple events that contribute to motor neuron death in amyotrophic lateral sclerosis. Several pathological mechanisms have been identified as underlying events of the disease process, including excitotoxicity, mitochondrial dysfunction, oxidative stress, altered axonal transport, proteasome dysfunction, synaptic deficits, glial cell contribution, and disrupted clearance of misfolded proteins. Our approach in this study was based on a holistic vision of these mechanisms and the use of computational tools to identify polypharmacology for targeting multiple etiopathogenic pathways. By using a repositioning analysis based on systems biology approach (TPMS technology), we identified and validated the neuroprotective potential of two new drug combinations: Aliretinoin and Pranlukast, and Aliretinoin and Mefloquine. In addition, we estimated their molecular mechanisms of action in silico and validated some of these results in a well-established in vitro model of amyotrophic lateral sclerosis based on cultured spinal cord slices. The results verified that Aliretinoin and Pranlukast, and Aliretinoin and Mefloquine promote neuroprotection of motor neurons and reduce microgliosis.	[Herrando-Grabulosa, Mireia; Navarro, Xavier; Casas, Caty] Univ Autonoma Barcelona, Inst Neurociencies, Grp Neuroplast & Regenerat, E-08193 Barcelona, Spain; [Herrando-Grabulosa, Mireia; Navarro, Xavier; Casas, Caty] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, E-08193 Barcelona, Spain; [Herrando-Grabulosa, Mireia; Navarro, Xavier; Casas, Caty] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain; [Pujol, Albert; Aloy, Patrick] Inst Res Biomed IRB Barcelona, Joint IRB BSC CRG Program Computat Biol, Barcelona, Catalonia, Spain; [Mulet, Roger; Manuel Mas, Jose; Coma, Mireia] Anax Biotech SL, Barcelona, Catalonia, Spain; [Aloy, Patrick] ICREA, Barcelona, Catalonia, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; CIBERNED; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Casas, C (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Grp Neuroplast & Regenerat, E-08193 Barcelona, Spain.; Casas, C (corresponding author), Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, E-08193 Barcelona, Spain.; Casas, C (corresponding author), Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain.; Coma, M (corresponding author), Anax Biotech SL, Barcelona, Catalonia, Spain.	mcoma@anaxomics.com; Caty.Casas@uab.cat	Navarro, Xavier/C-9577-2011; casas, caty/E-2149-2011; Herrando-Grabulosa, Mireia/K-5364-2014; Aloy, Patrick/AAB-3538-2019	Navarro, Xavier/0000-0001-9849-902X; casas, caty/0000-0002-2273-6321; Herrando-Grabulosa, Mireia/0000-0002-6685-3220; 	Fundacio La marato-TV3 [110430]; European Union's Seventh Framework Programme for research, technological development and demonstration [306240]; Spanish Ministerio de Ciencia e Innovacion [BIO2013-48222]; European Commission [306240]; European Research Council [614944]; ICREA Funding Source: Custom	Fundacio La marato-TV3; European Union's Seventh Framework Programme for research, technological development and demonstration; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); ICREA(ICREA)	MHG was recipient of a postdoctoral fellowship from Fundacio La marato-TV3 (#110430). This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement No. 306240. PA acknowledges financial support from the Spanish Ministerio de Ciencia e Innovacion (BIO2013-48222), the European Commission (Agreement no: 306240) and the European Research Council (Agreements no: 614944). RM and MC are Anaxomics Biotech SL employees and JMM is founder and CEO of Anaxomics. RM and MC have no role in the development of Therapeutic Performance Mapping System ( TPMS) proprietary technology; however, JMM contributes in the design of TPMS. The role of Anaxomics' employees are as follows: RM carried out the ALS characterization used to construct ALS biological network, and performed the analysis of the drug candidates in the context of ALS. JMM designed and carried out the in-silico experiments. MC performed the final selection of drug candidates, designed the in-vitro experimental validation of drugs candidates and wrote the paper.	Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Casas C, 2014, BRAIN PLAST, P1; Casas C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09185; Chatr-aryamontri A, 2008, METHODS MOL BIOL, V484, P305, DOI 10.1007/978-1-59745-398-1_20; Chautard E, 2011, NUCLEIC ACIDS RES, V39, pD235, DOI 10.1093/nar/gkq830; Cheng C, 2008, ALITRETINOIN COMPREH, P437; Corse AM, 1999, NEUROBIOL DIS, V6, P335, DOI 10.1006/nbdi.1999.0253; Cozzolino M, 2013, MOL CELL NEUROSCI, V55, P44, DOI 10.1016/j.mcn.2012.06.001; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Cudkowicz ME, 2006, ANN NEUROL, V60, P22, DOI 10.1002/ana.20903; Deivasigamani S, 2014, BIOL OPEN, V3, P1127, DOI 10.1242/bio.201410066; Droppelmann CA, 2014, AMYOTROPH LATERAL SC, P1; ENGELHARDT JI, 1993, ARCH NEUROL-CHICAGO, V50, P30, DOI 10.1001/archneur.1993.00540010026013; Feige JN, 2005, J BIOL CHEM, V280, P17880, DOI 10.1074/jbc.M500786200; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Guzman-Lenis MS, 2008, NEUROSCIENCE, V155, P104, DOI 10.1016/j.neuroscience.2008.04.078; Guzman-Lenis MS, 2009, RESTOR NEUROL NEUROS, V27, P335, DOI 10.3233/RNN-2009-0482; Herrando-Grabulosa M, 2013, J NEUROCHEM, V124, P36, DOI 10.1111/jnc.12062; Jaeger S, 2012, IUBMB LIFE, V64, P529, DOI 10.1002/iub.1040; Joardar A, 2015, HUM MOL GENET, V24, P1741, DOI 10.1093/hmg/ddu587; Jokic N, 2007, J NEUROCHEM, V103, P1821, DOI 10.1111/j.1471-4159.2007.04893.x; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kerrien S, 2012, NUCL ACIDS RES, V40; Lattante S, 2013, HUM MUTAT, V34, P812, DOI 10.1002/humu.22319; Lee MS, 2007, CANCER RES, V67, P11359, DOI 10.1158/0008-5472.CAN-07-2235; Lee S, 2012, KOREAN J PHYSIOL PHA, V16, P43, DOI 10.4196/kjpp.2012.16.1.43; Lim E, 2011, EXP NEUROL, V230, P114, DOI 10.1016/j.expneurol.2011.04.003; Llado J, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00181; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Malaspina A, 2007, BRAIN RES BULL, V71, P437, DOI 10.1016/j.brainresbull.2006.10.032; Mewes HW, 2011, NUCLEIC ACIDS RES, V39, P220; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Okubo M, 2010, GLIA, V58, P599, DOI 10.1002/glia.20948; Perera S., 2014, NUTRAfoods, V13, P61; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Poppe L, 2014, EXP NEUROL ELSEV JUL; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Pujol A, 2010, TRENDS PHARMACOL SCI, V31, P115, DOI 10.1016/j.tips.2009.11.006; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Salwinski L, 2009, NAT METHODS, V6, P860, DOI 10.1038/nmeth1209-860; Semenova MM, 2007, NAT NEUROSCI, V10, P436, DOI 10.1038/nn1869; Soler-Lopez M, 2012, BIOESSAYS, V34, P532, DOI 10.1002/bies.201100193; Soler-Lopez M, 2011, GENOME RES, V21, P364, DOI 10.1101/gr.114280.110; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; STREIT WJ, 1988, J COMP NEUROL, V268, P248, DOI 10.1002/cne.902680209; Theron AJ, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/608930; Tolosa L, 2011, MOL CELL NEUROSCI, V46, P176, DOI 10.1016/j.mcn.2010.09.001; Tomari S, 2003, CLIN EXP ALLERGY, V33, P795, DOI 10.1046/j.1365-2222.2003.01656.x; Tortarolo M, 2003, MOL CELL NEUROSCI, V23, P180, DOI 10.1016/S1044-7431(03)00022-8; Turner BJ, 2014, NEUROBIOL AGING, V35, P906, DOI 10.1016/j.neurobiolaging.2013.09.030; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Valls R, 2013, ANAXOMICS METHODOLOG; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Wishart TM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002936; Wu Y, 2014, NEUROSCIENCE, V265, P302, DOI 10.1016/j.neuroscience.2014.01.059; Xenarios I, 2001, NUCLEIC ACIDS RES, V29, P239, DOI 10.1093/nar/29.1.239; Zanzoni A, 2009, FEBS LETT, V583, P1759, DOI 10.1016/j.febslet.2009.03.001	63	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147626	10.1371/journal.pone.0147626	http://dx.doi.org/10.1371/journal.pone.0147626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807587	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800154
J	Kossatz, S; Weber, WA; Reiner, T				Kossatz, Susanne; Weber, Wolfgang A.; Reiner, Thomas			Optical Imaging of PARP1 in Response to Radiation in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							PROTEIN EXPRESSION; BREAST-CANCER; IN-VIVO; POLY(ADP-RIBOSE) POLYMERASE-1; OROPHARYNGEAL CARCINOMA; DNA-DAMAGE; THERAPY; RADIOTHERAPY; CHROMATIN; SURVIVAL	Targeting and inhibiting DNA repair pathways is a powerful strategy of controlling malignant growth. One such strategy includes the inhibition of PARP1, a central element in the intracellular DNA damage response. To determine and visualize the expression and intercellular distribution of PARP1 in vivo, and to monitor the pharmacokinetics of PARP1 targeted therapeutics, fluorescent small probes were developed. To date, however, it is unclear how these probes behave in a more realistic clinical setting, where DNA damage has been induced through one or more prior lines of therapy. Here, we use one such imaging agent, PARPi-FL, in tissues both with and without prior DNA damage, and investigate its value as a probe for PARP1 imaging. We show that PARP1 expression in oral cancer is high, and that the uptake of PARPi-FL is selective, irrespective of whether cells were exposed to irradiation or not. We also show that PARPi-FL uptake increases in response to DNA damage, and that this increase is reflected in higher enzyme expression. Our findings provide a framework for measuring exposure of cells to external beam radiation, and could help to elucidate the effects of such treatments non-invasively in mouse models of cancer.	[Kossatz, Susanne; Weber, Wolfgang A.; Reiner, Thomas] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA; [Weber, Wolfgang A.; Reiner, Thomas] Weill Cornell Med Coll, Dept Radiol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Reiner, T (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA.; Reiner, T (corresponding author), Weill Cornell Med Coll, Dept Radiol, New York, NY 10065 USA.	reinert@mskcc.org	Kossatz, Susanne/Q-7453-2017	Kossatz, Susanne/0000-0002-1908-1782; Reiner, Thomas/0000-0002-7819-5480	NIH Cancer Center Support Grant [2 P30 CA008748-48]; Imaging and Radiation Sciences Program; NIH Mentored Quantitative Research Career Development [K25 EB016673]; German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [KO 4966/1-1]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K25EB016673] Funding Source: NIH RePORTER	NIH Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Imaging and Radiation Sciences Program; NIH Mentored Quantitative Research Career Development; German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors thank the Flow Cytometry Core and the Molecular Cytology Core at MSK (P30 CA008748). Technical services provided by the MSK Small-Animal Imaging Core Facility were supported in part by NIH Cancer Center Support Grant No 2 P30 CA008748-48. This work was funded in part by the Imaging and Radiation Sciences Program and a NIH Mentored Quantitative Research Career Development (T.R., K25 EB016673, http://grantome.com/grant/NIH/K25-EB016673-01). Susanne Kossatz was funded by a scholarship from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG, reference number KO 4966/1-1).	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; BENJAMIN RC, 1980, J BIOL CHEM, V255, P493; Bieche I, 1996, CLIN CANCER RES, V2, P1163; Carlucci G, 2015, MOL IMAGING BIOL MIB; Carney B, 2015, MOL IMAGING BIOL MIB; Chow JPH, 2013, MOL CANCER THER, V12, P2517, DOI 10.1158/1535-7163.MCT-13-0010; de Arruda FF, 2005, J CLIN ONCOL, V23, p503S; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Deeks ED, 2015, DRUGS, V75, P231, DOI 10.1007/s40265-015-0345-6; DOLY J, 1966, CR ACAD SCI D NAT, V263, P1341; DURKACZ BW, 1980, NATURE, V283, P593, DOI 10.1038/283593a0; Dziaman T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115558; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Galia A, 2012, EUR J HISTOCHEM, V56, P45, DOI 10.4081/ejh.2012.e9; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Green AR, 2015, BREAST CANCER RES TR, V149, P353, DOI 10.1007/s10549-014-3230-1; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Irwin CP, 2014, NEOPLASIA, V16, P432, DOI 10.1016/j.neo.2014.05.005; JUAREZSALINAS H, 1979, NATURE, V282, P740, DOI 10.1038/282740a0; Klein EE, 2005, J APPL CLIN MED PHYS, V6, P81, DOI 10.1120/jacmp.2025.25355; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Lauber K, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00116; Lee N, 2003, INT J RADIAT ONCOL, V57, P49, DOI 10.1016/S0360-3016(03)00405-X; Ling CC, 2000, INT J RADIAT ONCOL, V47, P551, DOI 10.1016/S0360-3016(00)00467-3; Lok BH, 2012, INT J RADIAT ONCOL, V82, P1851, DOI 10.1016/j.ijrobp.2011.03.029; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Menegakis A, 2009, INT J RADIAT BIOL, V85, P1032, DOI 10.3109/09553000903242149; Miah AB, 2012, INT J RADIAT ONCOL, V82, P539, DOI 10.1016/j.ijrobp.2010.09.055; Munshi A, 2005, METH MOLEC MED, V110, P21; Nosho K, 2006, EUR J CANCER, V42, P2374, DOI 10.1016/j.ejca.2006.01.061; Ossovskaya V, 2010, GENES CANC, V1, P812, DOI 10.1177/1947601910383418; Park HJ, 2012, RADIAT RES, V177, P311, DOI 10.1667/RR2773.1; Reiner T, 2012, NEOPLASIA, V14, P169, DOI 10.1593/neo.12414; Ren Y, 2012, INVEST RADIOL, V47, P25, DOI 10.1097/RLI.0b013e31823a82f6; Rieckmann T, 2013, RADIOTHER ONCOL, V107, P242, DOI 10.1016/j.radonc.2013.03.013; Rojo F, 2012, ANN ONCOL, V23, P1156, DOI 10.1093/annonc/mdr361; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Russell JS, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00157; Salemi M, 2013, EUR J HISTOCHEM, V57, P80, DOI 10.4081/ejh.2013.e13; Staibano S, 2005, HUM PATHOL, V36, P724, DOI 10.1016/j.humpath.2005.04.017; Sulzyc-Bielicka V, 2012, POL J PATHOL, V63, P87; Taylor A, 2004, Cancer Imaging, V4, P68, DOI 10.1102/1470-7330.2004.0003; Thurber GM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2506; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Xu XG, 2008, PHYS MED BIOL, V53, pR193, DOI 10.1088/0031-9155/53/13/R01	47	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147752	10.1371/journal.pone.0147752	http://dx.doi.org/10.1371/journal.pone.0147752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808835	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800206
J	Ravinet, N; Chartier, C; Bareille, N; Lehebel, A; Ponnau, A; Brisseau, N; Chauvin, A				Ravinet, Nadine; Chartier, Christophe; Bareille, Nathalie; Lehebel, Anne; Ponnau, Adeline; Brisseau, Nadine; Chauvin, Alain			Unexpected Decrease in Milk Production after Fenbendazole Treatment of Dairy Cows during Early Grazing Season	PLOS ONE			English	Article							GASTROINTESTINAL NEMATODE INFECTIONS; OSTERTAGIA-OSTERTAGI ELISA; TARGETED SELECTIVE TREATMENTS; ADULT MERINO SHEEP; ANTHELMINTIC TREATMENT; EPRINOMECTIN TREATMENT; PRODUCTION RESPONSE; TRICHOSTRONGYLID LARVAE; STOCKING MANAGEMENT; WESTERN-EUROPE	Gastrointestinal nematodes (GIN) infection can impair milk production (MP) in dairy cows. To investigate whether MP would be optimized by spring targeted-selective anthelmintic treatment in grazing cows, we assessed (1) the effect on MP of an anthelmintic treatment applied 1.5 to 2 months after turn-out, and (2) herd and individual indicators associated with the post-treatment MP response. A randomized controlled clinical trial was conducted in 13 dairy farms (578 cows) in western France in spring 2012. In each herd, lactating cows of the treatment group received fenbendazole orally, control cows remained untreated. Daily cow MP was recorded from 2 weeks before until 15 weeks after treatment. Individual serum pepsinogen and anti-Ostertagia antibody levels (expressed as ODR), faecal egg count and bulk tank milk (BTM) Ostertagia ODR were measured at treatment time. Anthelmintic treatment applied during the previous housing period was recorded for each cow. In each herd, information regarding heifers' grazing and anthelmintic treatment history was collected to assess the Time of Effective Contact (TEC, in months) with GIN infective larvae before the first calving. The effect of treatment on weekly MP averages and its relationships with herd and individual indicators were studied using linear mixed models with two nested random effects (cow within herd). Unexpectedly, spring treatment had a significant detrimental effect on MP (-0.92 kg/cow/day on average). This negative MP response was particularly marked in high producing cows, in cows not treated during the previous housing period or with high pepsinogen levels, and in cows from herds with a high TEC or a high BTM ODR. This post-treatment decrease in MP may be associated with immuno-inflammatory mechanisms. Until further studies can assess whether this unexpected result can be generalized, nonpersistent treatment of immunized adult dairy cows against GIN should not be recommended in early grazing season.	[Ravinet, Nadine] UMT Cattle Herd Hlth Management, French Livestock Inst, IDELE, Nantes, France; [Ravinet, Nadine; Chartier, Christophe; Bareille, Nathalie; Lehebel, Anne; Ponnau, Adeline; Brisseau, Nadine; Chauvin, Alain] LUNAM Univ, Oniris, Nantes Atlantic Coll Vet Med & Food Sci & Engn, UMR BioEpAR, Nantes, France; [Ravinet, Nadine; Chartier, Christophe; Bareille, Nathalie; Lehebel, Anne; Brisseau, Nadine; Chauvin, Alain] INRA, UMR Biol 1300, Epidemiol & Risk Anal Anim Hlth, Nantes, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE	Ravinet, N (corresponding author), UMT Cattle Herd Hlth Management, French Livestock Inst, IDELE, Nantes, France.; Ravinet, N (corresponding author), LUNAM Univ, Oniris, Nantes Atlantic Coll Vet Med & Food Sci & Engn, UMR BioEpAR, Nantes, France.; Ravinet, N (corresponding author), INRA, UMR Biol 1300, Epidemiol & Risk Anal Anim Hlth, Nantes, France.	ravinet.nadine@wanadoo.fr	Chauvin, Alain/A-1811-2009	Chauvin, Alain/0000-0001-6942-9372	CASDAR (Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret) [1127]	CASDAR (Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret)	The study was funded by the CASDAR project No 1127 (Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret). CASDAR: Compte d'Affectation Special Developpement Agricole et Rural. Authors who received the funding: NR, AC, CC, N. Bareille. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agneessens J, 2000, VET PARASITOL, V90, P83, DOI 10.1016/S0304-4017(00)00232-6; ANDERSON N, 1965, VET REC, V77, P1196, DOI 10.1136/vr.77.41.1196; ANDERSON N, 1988, VET PARASITOL, V27, P13, DOI 10.1016/0304-4017(88)90057-X; ARMOUR J, 1979, VET REC, V105, P500, DOI 10.1136/vr.105.22.500; ARMOUR J, 1980, VET PARASITOL, V6, P7, DOI 10.1016/0304-4017(80)90037-0; Balic A, 2000, ADV PARASIT, V45, P181, DOI 10.1016/S0065-308X(00)45005-0; BISSET SA, 1987, VET PARASITOL, V26, P107, DOI 10.1016/0304-4017(87)90081-1; Bliss D.H, 1997, COMPEND CONT ED PRAC, V4, P104; Borgsteede FHM, 2000, VET PARASITOL, V89, P287, DOI 10.1016/S0304-4017(00)00219-3; Charlier J, 2014, VET REC, V175, P250, DOI 10.1136/vr.102512; Charlier J, 2007, VET PARASITOL, V143, P322, DOI 10.1016/j.vetpar.2006.08.015; Charlier J, 2010, PREV VET MED, V93, P147, DOI 10.1016/j.prevetmed.2009.10.002; Charlier J, 2009, VET PARASITOL, V164, P70, DOI 10.1016/j.vetpar.2009.04.012; Chartier C, 2013, P WAAVP PERTH AUSTR, P540; Cramer LG, 2000, PARASITOL RES, V86, P944, DOI 10.1007/s436-000-8011-z; Demeler J, 2009, VET PARASITOL, V160, P109, DOI 10.1016/j.vetpar.2008.10.030; Eysker M, 2002, VET PARASITOL, V110, P93, DOI 10.1016/S0304-4017(02)00312-6; Forbes AB, 2004, VET PARASITOL, V125, P353, DOI 10.1016/j.vetpar.2004.07.025; FRECHETTE JL, 1981, CAN VET J, V22, P252; Gasbarre LC, 2014, VET PARASITOL, V204, P3, DOI 10.1016/j.vetpar.2014.03.017; Geurden T, 2013, P WAAVP PERTH AUSTR, P167; Gibb MJ, 2005, VET PARASITOL, V133, P79, DOI 10.1016/j.vetpar.2004.11.038; Gross SJ, 1999, VET REC, V144, P581, DOI 10.1136/vr.144.21.581; JARA W, 1984, VET REC, V115, P565, DOI 10.1136/vr.115.22.565; Kenyon F, 2012, VET PARASITOL, V186, P10, DOI 10.1016/j.vetpar.2011.11.041; Kenyon F, 2009, VET PARASITOL, V164, P3, DOI 10.1016/j.vetpar.2009.04.015; Kerboeuf D, 2002, REV MED VET-TOULOUSE, V153, P707; Kloosterman A, 1996, VET PARASITOL, V64, P197, DOI 10.1016/0304-4017(95)00919-1; Larsen JWA, 1999, INT J PARASITOL, V29, P893, DOI 10.1016/S0020-7519(99)00050-8; LARSEN JWA, 1994, AUST VET J, V71, P365, DOI 10.1111/j.1751-0813.1994.tb00930.x; Larsen JWA, 2000, AUST VET J, V78, P112, DOI 10.1111/j.1751-0813.2000.tb10537.x; Mason WA, 2012, VET PARASITOL, V189, P250, DOI 10.1016/j.vetpar.2012.05.003; MCBEATH DG, 1979, VET REC, V105, P507, DOI 10.1136/vr.105.22.507; McPherson WB, 2001, NEW ZEAL VET J, V49, P106, DOI 10.1080/00480169.2001.36212; MCQUEEN I P M, 1977, New Zealand Journal of Experimental Agriculture, V5, P115; Meeusen ENT, 1999, VET PARASITOL, V84, P259, DOI 10.1016/S0304-4017(99)00038-2; MICHEL JF, 1982, VET REC, V111, P546; MILLER HRP, 1983, RES VET SCI, V35, P357, DOI 10.1016/S0034-5288(18)32033-2; Nodtvedt A, 2002, VET PARASITOL, V105, P191, DOI 10.1016/S0304-4017(02)00024-9; O'Shaughnessy J, 2014, VET REC, V175, DOI 10.1136/vr.102556; OFARRELL KJ, 1986, IRISH VET J, V40, P116; PLOEGER HW, 1990, VET PARASITOL, V35, P103, DOI 10.1016/0304-4017(90)90120-Z; PLOEGER HW, 1989, VET PARASITOL, V34, P239, DOI 10.1016/0304-4017(89)90054-X; Ravinet N, 2014, VET PARASITOL, V201, P95, DOI 10.1016/j.vetpar.2013.12.031; RAYNAUD J-P, 1976, Annales de Recherches Veterinaires, V7, P253; Reist M, 2002, VET REC, V151, P377, DOI 10.1136/vr.151.13.377; Rose H, 2015, VET REC, V176, DOI 10.1136/vr.102982; Sanchez J, 2004, PREV VET MED, V63, P237, DOI 10.1016/j.prevetmed.2004.01.006; Sanchez J, 2005, VET PARASITOL, V130, P115, DOI 10.1016/j.vetpar.2005.03.013; Sanchez J, 2002, VET PARASITOL, V107, P209, DOI 10.1016/S0304-4017(02)00158-9; Shaw DJ, 1998, VET PARASITOL, V75, P115, DOI 10.1016/S0304-4017(97)00214-8; Shaw DJ, 1998, VET PARASITOL, V75, P133, DOI 10.1016/S0304-4017(97)00213-6; Sithole F, 2005, J DAIRY SCI, V88, P929, DOI 10.3168/jds.S0022-0302(05)72760-0; SLOCOMBE JO, 1974, CAN J COMP MED, V38, P18; SNIDER TG, 1985, VET REC, V116, P69, DOI 10.1136/vr.116.3.69; Steinbach T, 2006, VET PARASITOL, V139, P115, DOI 10.1016/j.vetpar.2006.03.028; Sutherland IA, 2011, TRENDS PARASITOL, V27, P176, DOI 10.1016/j.pt.2010.11.008; THARALDSEN J, 1989, ACTA VET SCAND, V30, P247; Van Wyk JA, 2001, ONDERSTEPOORT J VET, V68, P55; Vanderstichel R, 2013, PREV VET MED, V111, P63, DOI 10.1016/j.prevetmed.2013.04.001; Vercruysse J, 1997, VET PARASITOL, V72, P309, DOI 10.1016/S0304-4017(97)00103-9; Verschave SH, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0264-x; Waghorn TS, 2006, NEW ZEAL VET J, V54, P278, DOI 10.1080/00480169.2006.36711	63	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147835	10.1371/journal.pone.0147835	http://dx.doi.org/10.1371/journal.pone.0147835			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808824	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800221
J	Russell, S; Martin, F; Zalwango, F; Namukwaya, S; Nalugya, R; Muhumuza, R; Katongole, J; Seeley, J				Russell, Steve; Martin, Faith; Zalwango, Flavia; Namukwaya, Stella; Nalugya, Ruth; Muhumuza, Richard; Katongole, Joseph; Seeley, Janet			Finding Meaning: HIV Self-Management and Wellbeing among People Taking Antiretroviral Therapy in Uganda	PLOS ONE			English	Article							QUALITY-OF-LIFE; SUB-SAHARAN AFRICA; POSTTRAUMATIC GROWTH; OLDER-PEOPLE; SOUTH-AFRICA; HEALTH; ADHERENCE; INTERVENTIONS; COUNTRIES; HIV/AIDS	The health of people living with HIV (PLWH) and the sustained success of antiretroviral therapy (ART) programmes depends on PLWH's motivation and ability to self-manage the condition over the long term, including adherence to drugs on a daily basis. PLWH's self-management of HIV and their wellbeing are likely to be interrelated. Successful self-management sustains wellbeing, and wellbeing is likely to motivate continued self-management. Detailed research is lacking on PLWH's self-management processes on ART in resource-limited settings. This paper presents findings from a study of PLWH's self-management and wellbeing in Wakiso District, Uganda. Thirty-eight PLWH (20 women, 18 men) were purposefully selected at ART facilities run by the government and by The AIDS Support Organisation in and around Entebbe. Two in-depth interviews were completed with each participant over three or four visits. Many were struggling economically, however the recovery of health and hope on ART had enhanced wellbeing and motivated self-management. The majority were managing their condition well across three broad domains of self-management. First, they had mobilised resources, notably through good relationships with health workers. Advice and counselling had helped them to reconceptualise their condition and situation more positively and see hope for the future, motivating their work to self-manage. Many had also developed a new network of support through contacts they had developed at the ART clinic. Second, they had acquired knowledge and skills to manage their health, a useful framework to manage their condition and to live their life. Third, participants were psychologically adjusting to their condition and their new 'self': they saw HIV as a normal disease, were coping with stigma and had regained self-esteem, and were finding meaning in life. Our study demonstrates the centrality of social relationships and other non-medical aspects of wellbeing for self-management which ART programmes might explore further and encourage.	[Russell, Steve] Univ E Anglia, Sch Int Dev, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Zalwango, Flavia; Namukwaya, Stella; Nalugya, Ruth; Muhumuza, Richard; Katongole, Joseph; Seeley, Janet] Uganda Virus Res Inst, Med Res Council, Uganda Res Unit AIDS, Entebbe, Uganda; [Martin, Faith] Univ E Anglia, Sch Int Dev, External Res Associate, Norwich NR4 7TJ, Norfolk, England; [Seeley, Janet] London Sch Hyg & Trop Med, London WC1, England	University of East Anglia; Uganda Virus Research Institute; University of East Anglia; University of London; London School of Hygiene & Tropical Medicine	Russell, S (corresponding author), Univ E Anglia, Sch Int Dev, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	s.russell@uea.ac.uk		Martin, Faith/0000-0002-0141-1210; Seeley, Janet/0000-0002-0583-5272; Muhumuza, Richard/0000-0002-9931-7600	UK Economic and Social Research Council (ESRC) [RES-063-23-2663, ES/H043551/1]; Medical Research Council and Department for International Development; Economic and Social Research Council [ES/H043551/1] Funding Source: researchfish; Medical Research Council [MC_U950097150] Funding Source: researchfish; ESRC [ES/H043551/1] Funding Source: UKRI; MRC [MC_U950097150] Funding Source: UKRI	UK Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council and Department for International Development(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was funded by the UK Economic and Social Research Council (ESRC) (project number: RES-063-23-2663; Research Fish Award No: ES/H043551/1), and Medical Research Council and Department for International Development.	Aantjes CJ, 2014, PATIENT EDUC COUNS, V95, P185, DOI 10.1016/j.pec.2014.01.007; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Bajunirwe F, 2009, AIDS CARE, V21, P271, DOI 10.1080/09540120802241863; Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; Barskova T, 2009, DISABIL REHABIL, V31, P1709, DOI 10.1080/09638280902738441; Beard J, 2009, AIDS CARE, V21, P1343, DOI 10.1080/09540120902889926; Hefferon K, 2009, BRIT J HEALTH PSYCH, V14, P343, DOI 10.1348/135910708X332936; Kuteesa MO, 2012, AJAR-AFR J AIDS RES, V11, P295, DOI 10.2989/16085906.2012.754829; Martin F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105154; Martin F, 2013, AIDS PATIENT CARE ST, V27, P697, DOI 10.1089/apc.2013.0254; Mbonye M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-804; McGrath JW, 2014, MED ANTHROPOL, V33, P303, DOI 10.1080/01459740.2014.892483; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Mutabazi-Mwesigire D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-343; Negin J, 2013, J CROSS-CULT GERONTO, V28, P491, DOI 10.1007/s10823-013-9215-4; Nguyen VK, 2007, AIDS, V21, pS31, DOI 10.1097/01.aids.0000298100.48990.58; Nyirenda M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-259; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Roura M, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-22; Russell S, 2015, QUALITATIVE IN PRESS; Russell S, 2010, SOC SCI MED, V70, P375, DOI 10.1016/j.socscimed.2009.10.039; RUTA D, 2007, J SOCIOECONOMICS, V0036; Schulman-Green D, 2012, J NURS SCHOLARSHIP, V44, P136, DOI 10.1111/j.1547-5069.2012.01444.x; Sharpe L, 2006, SOC SCI MED, V62, P1153, DOI 10.1016/j.socscimed.2005.07.010; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Stangl A, 2009, AIDS CARE, V19, P626; Swendeman D, 2009, AIDS CARE, V21, P1321, DOI 10.1080/09540120902803158; Trevino KM, 2010, AIDS BEHAV, V14, P379, DOI 10.1007/s10461-007-9332-6; TVERSKY A, 1993, MANAGE SCI, V39, P1179, DOI 10.1287/mnsc.39.10.1179; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Watkins-Hayes C, 2012, SOC SCI MED, V74, P2028, DOI 10.1016/j.socscimed.2012.02.001; White S, 2009, 0944 WED U BATH ESRC; Wouters E, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-103; Wright S, 2012, J CROSS-CULT GERONTO, V27, P319, DOI 10.1007/s10823-012-9178-x; Yalom ID, 2005, THEORY PRACTICE GROU	36	25	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147896	10.1371/journal.pone.0147896	http://dx.doi.org/10.1371/journal.pone.0147896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26807932	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000369527800241
J	Shen, YQ; Song, HM; Ma, WL; Gong, Z; Ni, Y; Zhang, XY; Xu, WJ; Jiang, JF; Che, L; Xu, JH; Yan, WW; Zhou, L; Li, GH; Zhang, QP; Wang, LM				Shen, Yuqin; Song, Haoming; Ma, Wenlin; Gong, Zhu; Ni, Yi; Zhang, Xiaoyu; Xu, Wenjun; Jiang, Jinfa; Che, Lin; Xu, Jiahong; Yan, Wenwen; Zhou, Lin; Li, Guanghe; Zhang, Qiping; Wang, Lemin			The Prognostic Value of Peak Cardiac Power Output in Chinese Patients with Chronic Heart Failure	PLOS ONE			English	Article							CARDIOGENIC-SHOCK; EXERCISE; MORTALITY	Background Cardiopulmonary exercise testing has been widely used to risk stratify patients with chronic heart failure (CHF). Peak oxygen consumption (peakVO(2)) was regarded as a powerful predictor of survival, as it is a surrogate for peak cardiac output (CO), which by most is considered the "true" measure of heart failure. Therefore, it is reasonable to hypothesize that CO is an even stronger predictor than peak VO2. The present study is aimed to investigate the prognostic value of peak cardiac power output (peak CPO) in comparison with peakVO(2) in Chinese patients with CHF. Methods Participants provided written informed consent to participate in this study. Totally 129 patients with CHF underwent symptom-limited cardiopulmonary exercise testing (CPET), with mean age 59.1 +/- 11.4 years, 87.6% male, 57.4% ischemic etiology, body mass index (BMI) 24.7 +/- 3.7 kg/m(2) and LVEF 38 +/- 9%. CO was measured using an inert gas rebreathing method. The primary endpoints are cardiac deaths. Results Over median 33.7-month follow-up, 19 cardiac deaths were reported. Among peak VO2, VE/VCO2 slope and Peak CPO, their area under ROC were 0.64, 0.67, 0.68, respectively (<0.05). The optimal thresholds for predicting cardiac deaths were peak VO2 <= 13.4 ml.kg(-1). min(-1), and VE/VCO2 slope >= 39.3 and peak CPO <= 1.1 respectively by ROC analysis. Finally, in patients with a peak VO2 <= 13.4 ml.kg(-1).min(-1) those with peak CPO>1.1 W had better survival than those with peak CPO <= 1.1W. However, by multivariate analysis adjusted for age, sex, BMI, resting heart rate, LVMI, LVEF, Peak CPO was not an independent predictor of cardiac deaths (P > 0.05). Conclusions Peak CPO was not a predictor of cardiac death in Chinese CHF patients.	[Shen, Yuqin; Song, Haoming; Ma, Wenlin; Gong, Zhu; Ni, Yi; Xu, Wenjun; Jiang, Jinfa; Che, Lin; Xu, Jiahong; Yan, Wenwen; Zhou, Lin; Li, Guanghe; Zhang, Qiping; Wang, Lemin] Tongji Univ, Tongji Hosp, Dept Cardiol, Shanghai 200092, Peoples R China; [Zhang, Xiaoyu] Tongji Univ, Tongji Hosp, Dept Rheumatol, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Wang, LM (corresponding author), Tongji Univ, Tongji Hosp, Dept Cardiol, Shanghai 200092, Peoples R China.	wanglemin2003@163.com	zhang, xu/GRX-9733-2022; zhang, xu/GYE-3558-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xian/GYA-0290-2022; Ni, Yicheng/O-5887-2017; zhang, xuan/AAN-9914-2020	Ni, Yicheng/0000-0002-8553-7565; zhang, xuan/0000-0001-8775-1699	United Brainstorm Project of Shanghai New Technology [SHDC12010117]; Shanghai Health and Family Planning Committee [WSJ1324, WSJ20114322]	United Brainstorm Project of Shanghai New Technology; Shanghai Health and Family Planning Committee	This project was supported by grants from the United Brainstorm Project of Shanghai New Technology among top hospitals (SHDC12010117), from Shanghai Health and Family Planning Committee (WSJ1324), and from Shanghai Health and Family Planning Committee (WSJ20114322).	Bard RL, 2006, J HEART LUNG TRANSPL, V25, P589, DOI 10.1016/j.healun.2005.11.448; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cheitlin MD, 2003, J AM SOC ECHOCARDIOG, V16, P1091, DOI 10.1016/S0894-7317(03)00685-0; Chinese Society of Cardiology of Chinese Medical Association, 2007, Zhonghua Xin Xue Guan Bing Za Zhi, V35, P1076; Corra U, 2002, AM HEART J, V143, P418, DOI 10.1067/mhj.2002.120772; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Fincke R, 2004, J AM COLL CARDIOL, V44, P340, DOI 10.1016/j.jacc.2004.03.060; Lang CC, 2007, J CARD FAIL, V13, P672, DOI 10.1016/j.cardfail.2007.05.004; Lang CC, 2007, AM J CARDIOL, V99, P404, DOI 10.1016/j.amjcard.2006.08.047; Lang CC, 2009, CIRC-HEART FAIL, V2, P33, DOI 10.1161/CIRCHEARTFAILURE.108.798611; Radford Martha J, 2005, Circulation, V112, P1888, DOI 10.1161/CIRCULATIONAHA.105.170073; Rantner B, 2015, ATHEROSCLEROSIS, V239, P428, DOI 10.1016/j.atherosclerosis.2014.12.060; TAN LB, 1986, LANCET, V2, P1360; TAN LB, 1990, BRIT HEART J, V64, P121; Williams SG, 2001, EUR HEART J, V22, P1496, DOI 10.1053/euhj.2000.2547; Yeboah J, 2012, CIRCULATION, V126, P2713, DOI 10.1161/CIRCULATIONAHA.112.112201	17	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147423	10.1371/journal.pone.0147423	http://dx.doi.org/10.1371/journal.pone.0147423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808510	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800092
J	Stok, KS; Besler, BA; Steiner, TH; Escudero, AVV; Zulliger, MA; Wilke, M; Atal, K; Quintin, A; Koller, B; Muller, R; Nesic, D				Stok, Kathryn S.; Besler, Bryce A.; Steiner, Thomas H.; Escudero, Ana V. Villarreal; Zulliger, Martin A.; Wilke, Markus; Atal, Kailash; Quintin, Aurelie; Koller, Bruno; Mueller, Ralph; Nesic, Dobrila			Three-Dimensional Quantitative Morphometric Analysis (QMA) for In Situ Joint and Tissue Assessment of Osteoarthritis in a Preclinical Rabbit Disease Model	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; SUBCHONDRAL BONE CHANGES; MICRO-COMPUTED TOMOGRAPHY; HIGH-RESOLUTION MRI; GUINEA-PIG MODEL; ARTICULAR-CARTILAGE; TRANSECTION MODEL; CANINE MODELS; KNEE CARTILAGE; MU-CT	This work utilises advances in multi-tissue imaging, and incorporates new metrics which define in situ joint changes and individual tissue changes in osteoarthritis (OA). The aims are to (1) demonstrate a protocol for processing intact animal joints for microCT to visualise relevant joint, bone and cartilage structures for understanding OA in a preclinical rabbit model, and (2) introduce a comprehensive three-dimensional (3D) quantitative morphometric analysis (QMA), including an assessment of reproducibility. Sixteen rabbit joints with and without transection of the anterior cruciate ligament were scanned with microCT and contrast agents, and processed for histology. Semi-quantitative evaluation was performed on matching two-dimensional (2D) histology and microCT images. Subsequently, 3D QMA was performed; including measures of cartilage, subchondral cortical and epiphyseal bone, and novel tibio-femoral joint metrics. Reproducibility of the QMA was tested on seven additional joints. A significant correlation was observed in cartilage thickness from matching histology-microCT pairs. The lateral compartment of operated joints had larger joint space width, thicker femoral cartilage and reduced bone volume, while osteophytes could be detected quantitatively. Measures between the in situ tibia and femur indicated an altered loading scenario. High measurement reproducibility was observed for all new parameters; with ICC ranging from 0.754 to 0.998. In conclusion, this study provides a novel 3D QMA to quantify macro and micro tissue measures in the joint of a rabbit OA model. New metrics were established consisting of: an angle to quantitatively measure osteophytes (sigma), an angle to indicate erosion between the lateral and medial femoral condyles (rho), a vector defining altered angulation (lambda,alpha,beta,gamma) and a twist angle (tau) measuring instability and tissue degeneration between the femur and tibia, a length measure of joint space width (JSW), and a slope and intercept (m,X) of joint contact to demonstrate altered loading with disease progression, as well as traditional bone and cartilage and histo-morphometry measures. We demonstrate correlation of microCT and histology, sensitive discrimination of OA change and robust reproducibility.	[Stok, Kathryn S.; Besler, Bryce A.; Steiner, Thomas H.; Escudero, Ana V. Villarreal; Atal, Kailash; Mueller, Ralph] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Stok, Kathryn S.; Zulliger, Martin A.; Koller, Bruno] SCANCO Med AG, Bruttisellen, Switzerland; [Wilke, Markus; Quintin, Aurelie; Nesic, Dobrila] Univ Bern, Dept Clin Res, Bern, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern	Stok, KS (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.; Stok, KS (corresponding author), SCANCO Med AG, Bruttisellen, Switzerland.	kas@ethz.ch	Müller, Ralph/A-1198-2008; Stok, Kathryn S/A-4871-2011; Besler, Bryce/AAH-6837-2020; Stok, Kathryn/AAA-2667-2021	Müller, Ralph/0000-0002-5811-7725; Stok, Kathryn S/0000-0002-0522-4180; Besler, Bryce/0000-0002-2164-111X; Stok, Kathryn/0000-0002-0522-4180; Nesic, Dobrila/0000-0003-1609-9255	Swiss Commission for Technology and Innovation (CTI) [9853.1]	Swiss Commission for Technology and Innovation (CTI)	Support was provided by the Swiss Commission for Technology and Innovation (CTI), Grant No 9853.1 (RM, DN) [https://www.kti.admin.ch/kti/en/home.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal PN, 2011, J ORTHOP RES, V29, P704, DOI 10.1002/jor.21312; Batiste DL, 2004, OSTEOARTHR CARTILAGE, V12, P986, DOI 10.1016/j.joca.2004.08.010; Batiste DL, 2004, OSTEOARTHR CARTILAGE, V12, P614, DOI 10.1016/j.joca.2004.03.002; Bobinac D, 2003, BONE, V32, P284, DOI 10.1016/S8756-3282(02)00982-1; Bolbos R, 2008, NMR BIOMED, V21, P366, DOI 10.1002/nbm.1198; Borges PD, 2014, OSTEOARTHR CARTILAGE, V22, P1419, DOI 10.1016/j.joca.2014.07.014; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Burstein D, 2001, MAGNET RESON MED, V45, P36, DOI 10.1002/1522-2594(200101)45:1<36::AID-MRM1006>3.0.CO;2-W; Calvo E, 2001, OSTEOARTHR CARTILAGE, V9, P463, DOI 10.1053/joca.2001.0413; Chang DG, 1997, OSTEOARTHR CARTILAGE, V5, P357, DOI 10.1016/S1063-4584(97)80039-8; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Cockman MD, 2006, OSTEOARTHR CARTILAGE, V14, P210, DOI 10.1016/j.joca.2005.08.010; Eckstein F, 1998, CLIN ORTHOP RELAT R, P137; Freedman JD, 2014, ANGEW CHEM INT EDIT, V53, P8406, DOI 10.1002/anie.201404519; GILMORE RS, 1987, J ANAT, V155, P77; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Goebel JC, 2010, RHEUMATOLOGY, V49, P1654, DOI 10.1093/rheumatology/keq154; Goldberg VM, 2011, OSTEOARTHR CARTILAGE, V19, P509, DOI 10.1016/j.joca.2011.02.017; Gu XI, 2012, OSTEOARTHR CARTILAGE, V20, P1011, DOI 10.1016/j.joca.2012.05.004; Gushue DL, 2005, J ORTHOP RES, V23, P735, DOI 10.1016/j.orthres.2005.01.005; Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Intema F, 2010, J BONE MINER RES, V25, P1650, DOI 10.1002/jbmr.39; Joshi NS, 2009, J AM CHEM SOC, V131, P13234, DOI 10.1021/ja9053306; Kim Y-J, 2000, HARVARD ORTHOPAEDIC; Kohler T, 2007, BONE, V41, P659, DOI 10.1016/j.bone.2007.05.018; Kuroki K, 2011, OSTEOARTHR CARTILAGE, V19, P1142, DOI 10.1016/j.joca.2011.06.007; Lane NE, 2011, OSTEOARTHR CARTILAGE, V19, P478, DOI 10.1016/j.joca.2010.09.013; Laverty S, 2010, OSTEOARTHR CARTILAGE, V18, pS53, DOI 10.1016/j.joca.2010.05.029; Li G, 2005, CLIN BIOMECH, V20, P736, DOI 10.1016/j.clinbiomech.2005.04.001; Little CB, 2008, CURR RHEUMATOL REV, V4, P175, DOI 10.2174/157339708785133523; Liu F, 2010, J BIOMECH, V43, P658, DOI 10.1016/j.jbiomech.2009.10.028; Makela JTA, 2014, OSTEOARTHR CARTILAGE, V22, P869, DOI 10.1016/j.joca.2014.04.010; Marenzana M, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0127; Marenzana M, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/24/8173; Matsui H, 1997, MICROSC RES TECHNIQ, V37, P333, DOI 10.1002/(SICI)1097-0029(19970515)37:4<333::AID-JEMT8>3.0.CO;2-L; McCauley T R, 2001, Semin Musculoskelet Radiol, V5, P293, DOI 10.1055/s-2001-19040; Mosher TJ, 2004, SEMIN MUSCULOSKEL R, V8, P355, DOI 10.1055/s-2004-861764; MOSKOWITZ RW, 1973, ARTHRITIS RHEUM-US, V16, P397, DOI 10.1002/art.1780160317; Palmer AW, 2006, P NATL ACAD SCI USA, V103, P19255, DOI 10.1073/pnas.0606406103; Pastoureau P, 2003, OSTEOARTHR CARTILAGE, V11, P412, DOI 10.1016/S1063-4584(03)00050-5; Piscaer TM, 2008, OSTEOARTHR CARTILAGE, V16, P1011, DOI 10.1016/j.joca.2008.01.012; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Ruan MZC, 2013, ARTHRITIS RHEUM-US, V65, P388, DOI 10.1002/art.37766; Sah RL, 1997, J ORTHOP RES, V15, P197, DOI 10.1002/jor.1100150207; Schulte FA, 2014, COMPUT METHOD BIOMEC, V17, P539, DOI 10.1080/10255842.2012.699526; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sniekers YH, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-20; Steiner TH, 2012, OSTEOARTHR CARTILAGE, V20, pS50, DOI 10.1016/j.joca.2012.02.599; Stok KS, 2009, MICROSC RES TECHNIQ, V72, P650, DOI 10.1002/jemt.20713; Stok KS, 2009, BONE, V45, P414, DOI 10.1016/j.bone.2009.05.017; Tao HY, 2015, SKELETAL RADIOL, V44, P393, DOI 10.1007/s00256-014-2062-8; Tashman S, 2004, AM J SPORT MED, V32, P975, DOI 10.1177/0363546503261709; Trussel A.J., 2012, J BIOMECH, V45, pS108; Van de Velde SK, 2009, ARTHRITIS RHEUM-US, V60, P3693, DOI 10.1002/art.24965; Wang SX, 2007, ARTHRITIS RHEUM-US, V56, P1537, DOI 10.1002/art.22574; Xie L, 2010, OSTEOARTHR CARTILAGE, V18, P65, DOI 10.1016/j.joca.2009.07.014; Xie L, 2009, OSTEOARTHR CARTILAGE, V17, P313, DOI 10.1016/j.joca.2008.07.015; Xie ZY, 2010, LECT NOTES COMPUT SC, V6363, P57	59	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147564	10.1371/journal.pone.0147564	http://dx.doi.org/10.1371/journal.pone.0147564			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808542	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800135
J	Wheeler, SS; Ball, CS; Langevin, SA; Fang, Y; Coffey, LL; Meagher, RJ				Wheeler, Sarah S.; Ball, Cameron S.; Langevin, Stanley A.; Fang, Ying; Coffey, Lark L.; Meagher, Robert J.			Surveillance for Western Equine Encephalitis, St. Louis Encephalitis, and West Nile Viruses Using Reverse Transcription Loop-Mediated Isothermal Amplification	PLOS ONE			English	Article							REAL-TIME DETECTION; RAPID DETECTION; ASSAY; DIFFERENTIATION; QUANTIFICATION; SEROTYPES; HIV-1	Collection of mosquitoes and testing for vector-borne viruses is a key surveillance activity that directly influences the vector control efforts of public health agencies, including determining when and where to apply insecticides. Vector control districts in California routinely monitor for three human pathogenic viruses including West Nile virus (WNV), Western equine encephalitis virus (WEEV), and St. Louis encephalitis virus (SLEV). Reverse transcription quantitative polymerase chain reaction (RT-qPCR) offers highly sensitive and specific detection of these three viruses in a single multiplex reaction, but this technique requires costly, specialized equipment that is generally only available in centralized public health laboratories. We report the use of reverse transcription loop-mediated isothermal amplification (RT-LAMP) to detect WNV, WEEV, and SLEV RNA extracted from pooled mosquito samples collected in California, including novel primer sets for specific detection of WEEV and SLEV, targeting the nonstructural protein 4 (nsP4) gene of WEEV and the 3' untranslated region (3'-UTR) of SLEV. Our WEEV and SLEV RT-LAMP primers allowed detection of <0.1 PFU/reaction of their respective targets in <30 minutes, and exhibited high specificity without cross reactivity when tested against a panel of alphaviruses and flaviviruses. Furthermore, the SLEV primers do not cross-react with WNV, despite both viruses being closely related members of the Japanese encephalitis virus complex. The SLEV and WEEV primers can also be combined in a single RT-LAMP reaction, with discrimination between amplicons by melt curve analysis. Although RT-qPCR is approximately one order of magnitude more sensitive than RT-LAMP for all three targets, the RT-LAMP technique is less instrumentally intensive than RT-qPCR and provides a more cost-effective method of vector-borne virus surveillance.	[Wheeler, Sarah S.; Fang, Ying; Coffey, Lark L.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA; [Ball, Cameron S.; Langevin, Stanley A.; Meagher, Robert J.] Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA USA; [Wheeler, Sarah S.] Sacramento Yolo Mosquito & Vector Control Dist, Elk Grove, CA USA; [Langevin, Stanley A.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of California System; University of California Davis; United States Department of Energy (DOE); Sandia National Laboratories; University of Washington; University of Washington Seattle	Meagher, RJ (corresponding author), Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA USA.	rmeaghe@sandia.gov		Meagher, Robert/0000-0002-6262-2126; Coffey, Lark/0000-0002-0718-5146	Defense Threat Reduction Agency (DTRA) [DTRA1002710697]; U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	This work was supported by a grant from the Defense Threat Reduction Agency (DTRA), contract DTRA1002710697. Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy's National Nuclear Security Administration under Contract DE-AC04-94AL85000.	Ahmad F, 2011, BIOMED MICRODEVICES, V13, P929, DOI 10.1007/s10544-011-9562-2; Bergren NA, 2014, J VIROL, V88, P9260, DOI 10.1128/JVI.01463-14; Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011; Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432; Felices V, 2014, EMERG INFECT DIS, V20, P730, DOI 10.3201/eid2004.131735; Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x; Fukuta S, 2003, ARCH VIROL, V148, P1713, DOI 10.1007/s00705-003-0134-5; Iwamoto T, 2003, J CLIN MICROBIOL, V41, P2616, DOI 10.1128/JCM.41.6.2616-2622.2003; Kopp A, 2013, MBIO, V4, DOI 10.1128/mBio.00322-13; Kramer LD, 2001, ARCH VIROL, V146, P2341, DOI 10.1007/s007050170007; Kwallah AO, 2013, J VIROL METHODS, V193, P23, DOI 10.1016/j.jviromet.2013.05.004; Le Roux CA, 2009, J CLIN MICROBIOL, V47, P645, DOI 10.1128/JCM.01412-08; Li SH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-360; Liu H, 2012, VECTOR-BORNE ZOONOT, V12, P1042, DOI 10.1089/vbz.2012.0991; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Nie K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052486; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parida M, 2005, J CLIN MICROBIOL, V43, P2895, DOI 10.1128/JCM.43.6.2895-2903.2005; Parida M, 2004, J CLIN MICROBIOL, V42, P257, DOI 10.1128/JCM.42.1.257-263.2004; Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06; Parida MM, 2006, J CLIN MICROBIOL, V44, P4172, DOI 10.1128/JCM.01487-06; Peyrefitte CN, 2008, J CLIN MICROBIOL, V46, P3653, DOI 10.1128/JCM.01188-08; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Poon LLM, 2006, CLIN CHEM, V52, P303; Reisen WK, 2008, J MED ENTOMOL, V45, P494, DOI 10.1603/0022-2585(2008)45[494:PWNVTA]2.0.CO;2; Sun B, 2013, ANAL CHEM, V85, P1540, DOI 10.1021/ac3037206; Teoh BT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-387; Toriniwa H, 2006, MICROBIOL IMMUNOL, V50, P379, DOI 10.1111/j.1348-0421.2006.tb03804.x; Wang X, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-138	30	15	17	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147962	10.1371/journal.pone.0147962	http://dx.doi.org/10.1371/journal.pone.0147962			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807734	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800253
J	Etzel, JA; Valchev, N; Gazzola, V; Keysers, C				Etzel, Joset A.; Valchev, Nikola; Gazzola, Valeria; Keysers, Christian			Is Brain Activity during Action Observation Modulated by the Perceived Fairness of the Actor?	PLOS ONE			English	Article							ACTION OBSERVATION NETWORK; MIRROR-NEURON SYSTEM; PRISONERS-DILEMMA; CYTOARCHITECTONIC MAPS; EMPATHIC BRAIN; RESPONSES; MOTOR; FMRI; METAANALYSIS; COOPERATION	Perceiving other people's actions triggers activity in premotor and parietal areas, brain areas also involved in executing and sensing our own actions. Paralleling this phenomenon, observing emotional states (including pain) in others is associated with activity in the same brain areas as activated when experiencing similar emotions directly. This emotion perception associated activity has been shown to be affected by the perceived fairness of the actor, and in-group membership more generally. Here, we examine whether action observation associated brain activity is also affected by the perceived social fairness of the actors. Perceived fairness was manipulated using an alternating iterated Prisoner's Dilemma game between the participant and two confederates, one of whom played fairly and the other unfairly. During fMRI scanning the participants watched movies of the confederates performing object-directed hand actions, and then performed hand actions themselves. Massunivariate analysis showed that observing the actions triggered robust activation in regions associated with action execution, but failed to identify a strong modulation of this activation based on perceived fairness. Multivariate pattern analysis, however, identified clusters potentially carrying information about the perceived fairness of the actor in the middle temporal gyrus, left postcentral gyrus, right inferior parietal lobule, right middle cingulate cortex, right angular gyrus, and right superioroccipital gyrus. Despite being identified by a wholebrain searchlight analysis (and so without anatomical restriction), these clusters fall into areas frequently associated with action observation. We conclude that brain activity during action observation may be modulated by perceived fairness, but such modulation is subtle; robust activity is associated with observing the actions of both fair and unfair individuals.	[Etzel, Joset A.; Valchev, Nikola; Gazzola, Valeria; Keysers, Christian] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Etzel, Joset A.; Valchev, Nikola; Gazzola, Valeria; Keysers, Christian] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands; [Etzel, Joset A.] Washington Univ, Cognit Control & Psychopathol Lab, St Louis, MO USA; [Valchev, Nikola] Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol Head & Neck Surg, Groningen, Netherlands; [Gazzola, Valeria; Keysers, Christian] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Social Brain Lab, Amsterdam, Netherlands; [Gazzola, Valeria; Keysers, Christian] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands	University of Groningen; University of Groningen; Washington University (WUSTL); University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam	Etzel, JA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands.; Etzel, JA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands.; Etzel, JA (corresponding author), Washington Univ, Cognit Control & Psychopathol Lab, St Louis, MO USA.	jetzel@wustl.edu	Keysers, Christian/H-6251-2013	Keysers, Christian/0000-0002-2845-5467; Gazzola, Valeria/0000-0003-0324-0619	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (N.W.O.) VIDI; Marie Curie Excellence grant; Calouste Gulbenkian Foundation (Lisbon, Portugal) [85430]; Portuguese Foundation for Science and Technology (FCT); Program for Human Potential; European Union [SFRH/BD/47576/2008]; VENI grant of the N.W.O.;  [NCRR 1S10RR022984-01A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022984] Funding Source: NIH RePORTER	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (N.W.O.) VIDI(Netherlands Organization for Scientific Research (NWO)); Marie Curie Excellence grant(European Commission); Calouste Gulbenkian Foundation (Lisbon, Portugal); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Program for Human Potential; European Union(European Commission); VENI grant of the N.W.O.; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The research was supported by a Nederlandse Organisatie voor Wetenschappelijk Onderzoek (N.W.O.) VIDI and a Marie Curie Excellence grant to Christian Keysers. Nikola Valchev was supported by a grant from the Calouste Gulbenkian Foundation (Lisbon, Portugal, process number: 85430) and a grant from the Portuguese Foundation for Science and Technology (FCT) co-funded by the Program for Human Potential and the European Union (SFRH/BD/47576/2008). Valeria Gazzola was financed by a VENI grant of the N.W.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was supported by a Nederlandse Organisatie voor Wetenschappelijk Onderzoek (N.W.O.) VIDI and a Marie Curie Excellence grant to Christian Keysers. Nikola Valchev was supported by a grant from the Calouste Gulbenkian Foundation (Lisbon, Portugal, process number: 85430) and a grant from the Portuguese Foundation for Science and Technology (FCT) co-funded by the Program for Human Potential and the European Union (SFRH/BD/47576/2008). Valeria Gazzola was financed by a VENI grant of the N.W.O. Rudmer Menger assisted during data collection. Computations were performed using both the facilities of the Washington University (USA) Center for High Performance Computing (partially provided through grant NCRR 1S10RR022984-01A1) and the Centre for High-Performance Computing and Visualisation at the University of Groningen (The Netherlands).	Abreu AM, 2012, EUR J NEUROSCI, V35, P1646, DOI 10.1111/j.1460-9568.2012.08104.x; Avenanti A, 2013, CEREB CORTEX, V23, P570, DOI 10.1093/cercor/bhs040; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bastiaansen JACJ, 2009, PHILOS T B IN PRESS; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Cheng YW, 2007, CEREB CORTEX, V17, P1979, DOI 10.1093/cercor/bhl107; Chong TTJ, 2008, NEUROIMAGE, V40, P298, DOI 10.1016/j.neuroimage.2007.11.030; Cook R, 2014, BEHAV BRAIN SCI, V37, P177, DOI 10.1017/S0140525X13000903; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Del Giudice M, 2009, DEVELOPMENTAL SCI, V12, P350, DOI 10.1111/j.1467-7687.2008.00783.x; Dinstein I, 2007, J NEUROPHYSIOL, V98, P1415, DOI 10.1152/jn.00238.2007; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Engen HG, 2013, CURR OPIN NEUROBIOL, V23, P275, DOI 10.1016/j.conb.2012.11.003; Etzel J.A., 2012, LECT NOTES ARTIF INT, P29, DOI DOI 10.1007/978-3-642-34713-9_4; Etzel JA, 2015, 5 INT WORKSH PATT RE; Etzel JA, 2013, NEUROIMAGE, V78, P261, DOI 10.1016/j.neuroimage.2013.03.041; Etzel JA, 2009, BRAIN RES, V1282, P114, DOI 10.1016/j.brainres.2009.05.090; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; FREAN MR, 1994, P ROY SOC B-BIOL SCI, V257, P75, DOI 10.1098/rspb.1994.0096; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; Grezes J, 2003, EUR J NEUROSCI, V17, P2735, DOI 10.1046/j.1460-9568.2003.02695.x; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Hughett P., 2007, J STAT SOFTW CODE SN, V23, P1, DOI 10.18637/jss.v023.c01; Keysers C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0175; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Keysers C, 2009, CURR OPIN NEUROBIOL, V19, P666, DOI 10.1016/j.conb.2009.10.006; Keysers C, 2009, CURR BIOL, V19, pR971, DOI 10.1016/j.cub.2009.08.026; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Kim YT, 2011, BEHAV BRAIN RES, V223, P342, DOI 10.1016/j.bbr.2011.04.053; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Molenberghs P, 2013, NEUROSCI BIOBEHAV R, V37, P1530, DOI 10.1016/j.neubiorev.2013.06.002; Molenberghs P, 2012, NEUROSCI BIOBEHAV R, V36, P341, DOI 10.1016/j.neubiorev.2011.07.004; NOWAK MA, 1994, J THEOR BIOL, V168, P219, DOI 10.1006/jtbi.1994.1101; Orgs G, 2008, EUR J NEUROSCI, V27, P3380, DOI 10.1111/j.1460-9568.2008.06271.x; PRUITT DG, 1967, J PERS SOC PSYCHOL, V7, P21, DOI 10.1037/h0024914; Rizzolatti G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0420; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rozzi S, 2008, EUR J NEUROSCI, V28, P1569, DOI 10.1111/j.1460-9568.2008.06395.x; Seymour B, 2007, NAT REV NEUROSCI, V8, P300, DOI 10.1038/nrn2119; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Singh-Curry V, 2009, NEUROPSYCHOLOGIA, V47, P1434, DOI 10.1016/j.neuropsychologia.2008.11.033; Steele JD, 2004, NEUROIMAGE, V21, P868, DOI 10.1016/j.neuroimage.2003.09.066; Turella L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00637; Turella L, 2009, BRAIN LANG, V108, P10, DOI 10.1016/j.bandl.2007.11.002	59	7	7	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0145350	10.1371/journal.pone.0145350	http://dx.doi.org/10.1371/journal.pone.0145350			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GF	26820995	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528400002
J	Wrange, AL; Charrier, G; Thonig, A; Rosenblad, MA; Blomberg, A; Havenhand, JN; Jonsson, PR; Andre, C				Wrange, Anna-Lisa; Charrier, Gregory; Thonig, Anne; Rosenblad, Magnus Alm; Blomberg, Anders; Havenhand, Jonathan N.; Jonsson, Per R.; Andre, Carl			The Story of a Hitchhiker: Population Genetic Patterns in the Invasive Barnacle Balanus (Amphibalanus) improvisus Darwin 1854	PLOS ONE			English	Article							INTERTIDAL BARNACLE; DNA-SEQUENCE; GEOGRAPHICAL VARIATION; MICROSATELLITE DATA; LARVAL DISPERSAL; COMPUTER-PROGRAM; MARINE INVADER; PELAGIC LARVAE; ACORN BARNACLE; OCEAN CURRENTS	Understanding the ecological and evolutionary forces that determine the genetic structure and spread of invasive species is a key component of invasion biology. The bay barnacle, Balanus improvisus (= Amphibalanus improvisus), is one of the most successful aquatic invaders worldwide, and is characterised by broad environmental tolerance. Although the species can spread through natural larval dispersal, human-mediated transport through (primarily) shipping has almost certainly contributed to the current global distribution of this species. Despite its worldwide distribution, little is known about the phylogeography of this species. Here, we characterize the population genetic structure and model dispersal dynamics of the barnacle B. improvisus, and describe how human-mediated spreading via shipping as well as natural larval dispersal may have contributed to observed genetic variation. We used both mitochondrial DNA (cytochrome c oxidase subunit I: COI) and nuclear microsatellites to characterize the genetic structure in 14 populations of B. improvisus on a global and regional scale (Baltic Sea). Genetic diversity was high in most populations, and many haplotypes were shared among populations on a global scale, indicating that longdistance dispersal (presumably through shipping and other anthropogenic activities) has played an important role in shaping the population genetic structure of this cosmopolitan species. We could not clearly confirm prior claims that B. improvisus originates from the western margins of the Atlantic coasts; although there were indications that Argentina could be part of a native region. In addition to dispersal via shipping, we show that natural larval dispersal may play an important role for further colonisation following initial introduction.	[Wrange, Anna-Lisa; Havenhand, Jonathan N.; Jonsson, Per R.; Andre, Carl] Univ Gothenburg, Dept Marine Sci, Tjarno, Sweden; [Charrier, Gregory] IUEM, Technopole Brest Iroise, Plouzane, France; [Thonig, Anne] Roskilde Univ, Dept Environm Social & Spatial Change, Roskilde, Denmark; [Rosenblad, Magnus Alm; Blomberg, Anders] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Gothenburg; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Roskilde University; University of Gothenburg	Wrange, AL (corresponding author), Univ Gothenburg, Dept Marine Sci, Tjarno, Sweden.	annalisa.wrange@gmail.com	Andre, Carl/B-4237-2010	Andre, Carl/0000-0003-4404-7292; Havenhand, Jonathan/0000-0001-6721-7763; Blomberg, Anders/0000-0002-1260-3920	Linnaeus grant from the Swedish Research Councils, VR; FORMAS; Wilhelm and Martina Lundgren Foundation; Helge Ax:son Johnson Foundation; BILS; Stiftelsen Wilhelm och Marina Lundgrens Vetenskapsfond	Linnaeus grant from the Swedish Research Councils, VR; FORMAS(Swedish Research Council Formas); Wilhelm and Martina Lundgren Foundation; Helge Ax:son Johnson Foundation; BILS; Stiftelsen Wilhelm och Marina Lundgrens Vetenskapsfond	This work was performed within Centre for Marine Evolutionary Biology (http://www.cemeb.science.gu.se), which is supported by a Linnaeus grant from the Swedish Research Councils, VR (www.vr.se) and FORMAS (www.formas.se), as well as by Wilhelm and Martina Lundgren Foundation and Helge Ax:son Johnson Foundation. MAR was partly funded by BILS (www.bils.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a Linnaeus-grant from the Swedish Research Councils, VR and Formas (http://www.cemeb.science.gu.se), as well as from Stiftelsen Wilhelm och Marina Lundgrens Vetenskapsfond. A special thanks to our collaborators worldwide for their help with collecting barnacles for this study: Toshi Yamaguchi, Richard Emlet, Daniel Rittschof, Eric Holm, Richard Osman, Eduardo Spivak, Alireza Sari, Ventzi Karamfilow, Tiia Moller, Christian Pansch and Daniel Johansson, as well as to Zuzanna Zadrodzka and Anna-Karin Ring for assistance in the lab.	ANIL AC, 1995, MAR ECOL PROG SER, V118, P159, DOI 10.3354/meps118159; Astanei I, 2005, MOL ECOL, V14, P1655, DOI 10.1111/j.1365-294X.2005.02530.x; Banks NC, 2015, ECOL LETT, V18, P188, DOI 10.1111/ele.12397; Barber PH, 2002, MOL ECOL, V11, P659, DOI 10.1046/j.1365-294X.2002.01468.x; BARNES H., 1962, SOC SCI FENNICA COMMENTAT BIOL, V24, P3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berntsson KM, 2003, BIOFOULING, V19, P187, DOI 10.1080/0892701031000072091; Bilton DT, 2002, ESTUAR COAST SHELF S, V55, P937, DOI 10.1006/ecss.2002.1037; BLOM SVEN-ERIK, 1961, ZOOL BIDRAG UPPSALA, V33, P149; BLOM SVEN-ERIK, 1965, ZOOL BIDRAG UPPSALA, V37, P59; Bock DG, 2011, MOL ECOL, V20, P503, DOI 10.1111/j.1365-294X.2010.04971.x; Brownlow RJ, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-55; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Campo D, 2010, MAR BIOL, V157, P147, DOI 10.1007/s00227-009-1305-z; Carlton JT, 2011, INVADING NATURE SPRI, P716; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Cheang CC, 2012, J BIOGEOGR, V39, P1819, DOI 10.1111/j.1365-2699.2012.02742.x; Cheang CC, 2010, J PHYCOL, V46, P1063, DOI 10.1111/j.1529-8817.2010.00901.x; Chen HN, 2014, BIOFOULING, V30, P1067, DOI 10.1080/08927014.2014.967232; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Corell H, 2012, MAR ECOL PROG SER, V467, P29, DOI 10.3354/meps09963; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Crooks JA, 2011, BIOL INVASIONS, V13, P165, DOI 10.1007/s10530-010-9799-3; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darwin C., 1854, MONOGRAPH SUBCLASS C; de Rivera CE, 2011, DIVERS DISTRIB, V17, P1198, DOI 10.1111/j.1472-4642.2011.00790.x; DeWoody JA, 2006, MOL ECOL NOTES, V6, P951, DOI 10.1111/j.1471-8286.2006.01449.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; DOOS K, 1995, J GEOPHYS RES-OCEANS, V100, P13499, DOI 10.1029/95JC00337; Drummond AJ, 2010, GENEIOUS; DUNGAN ML, 1985, PALEOBIOLOGY, V11, P165, DOI 10.1017/S0094837300011489; Dupont L, 2003, MAR ECOL PROG SER, V253, P183, DOI 10.3354/meps253183; Duvernell DD, 2008, MOL ECOL, V17, P1344, DOI 10.1111/j.1365-294X.2007.03648.x; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flight PA, 2012, J HERED, V103, P153, DOI 10.1093/jhered/esr083; FOSTER BA, 1979, NEW ZEAL J MAR FRESH, V13, P143, DOI 10.1080/00288330.1979.9515788; Fu YX, 1997, GENETICS, V147, P915; FURMAN E, 1989, OPHELIA, V30, P35, DOI 10.1080/00785326.1989.10430834; FURMAN ER, 1989, J MAR BIOL ASSOC UK, V69, P511, DOI 10.1017/S0025315400030927; FURMAN ER, 1990, J MAR BIOL ASSOC UK, V70, P721, DOI 10.1017/S0025315400059002; FURMAN ER, 1990, J EXP MAR BIOL ECOL, V144, P235, DOI 10.1016/0022-0981(90)90030-G; FYHN HJ, 1976, COMP BIOCHEM PHYS A, V53, P19, DOI 10.1016/S0300-9629(76)80004-7; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Garroway CJ, 2013, EVOLUTION, V67, P3488, DOI 10.1111/evo.12121; Geller J, 2008, MAR ECOL PROG SER, V358, P211, DOI 10.3354/meps07466; Gislen T, 1950, FAUNA FLORA, V45, P32; Godhe A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1599; Gollasch S, 2002, BIOFOULING, V18, P105, DOI 10.1080/08927010290011361; Gomoiu MT, 1996, CHANGEMENTS RECENTS, V1, P34; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goulletquer P, 2002, OPEN ATLANTIC COAST, P276; Grigorovich IA, 2003, BIOL INVASIONS, V5, P103, DOI 10.1023/A:1024050824073; GRUET Y, 1976, CAH BIOL MAR, V17, P173; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HARPENDING HC, 1994, HUM BIOL, V66, P591; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Hoffman J, 2012, PLOS ONE, V7; Hordoir R, 2013, CONT SHELF RES, V64, P1, DOI 10.1016/j.csr.2013.05.006; Hurrell JW, 2009, J MARINE SYST, V78, P28, DOI 10.1016/j.jmarsys.2008.11.026; JOHANNESSON K, 1995, P NATL ACAD SCI USA, V92, P2602, DOI 10.1073/pnas.92.7.2602; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Johannesson K, 2011, AMBIO, V40, P179, DOI 10.1007/s13280-010-0129-x; Karlsson U, 1979, KROKSTRAND 1870 1940; Katsanevakis S, 2013, OCEAN COAST MANAGE, V76, P64, DOI 10.1016/j.ocecoaman.2013.02.024; KAWAHARA T, 1963, NATURE, V198, P301, DOI 10.1038/198301a0; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; KENNEDY VS, 1983, ESTUARIES, V6, P95, DOI 10.2307/1351700; Knutsen H, 2011, MOL ECOL, V20, P768, DOI 10.1111/j.1365-294X.2010.04979.x; Knutsen H, 2003, MOL ECOL, V12, P385, DOI 10.1046/j.1365-294X.2003.01750.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lenz M, 2011, ENVIRON RES, V111, P943, DOI 10.1016/j.envres.2011.05.001; Leppakoski E, 2002, CAN J FISH AQUAT SCI, V59, P1175, DOI 10.1139/F02-089; Leppakoski Erkki, 2000, Biological Invasions, V2, P151, DOI 10.1023/A:1010052809567; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Limborg MT, 2009, MAR ECOL PROG SER, V379, P213, DOI 10.3354/meps07889; Madec G, 2010, TECHNICAL REPORT; MANTEL N, 1967, CANCER RES, V27, P209; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Nei M., 1987, pi; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Pansch C, 2013, MAR BIOL, V160, P2023, DOI 10.1007/s00227-012-2069-4; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Qiu JW, 1999, MAR ECOL PROG SER, V188, P123, DOI 10.3354/meps188123; Rainbow PS, 2004, MAR BIOL, V144, P271, DOI 10.1007/s00227-003-1197-2; Real KM, 2009, CONSERV GENET RESOUR, V1, P411, DOI 10.1007/s12686-009-9095-7; Remerie T, 2009, J BIOGEOGR, V36, P39, DOI 10.1111/j.1365-2699.2008.01970.x; Reusch TBH, 2010, MOL ECOL, V19, P2690, DOI 10.1111/j.1365-294X.2010.04701.x; Ricciardi A, 2007, CONSERV BIOL, V21, P329, DOI 10.1111/j.1523-1739.2006.00615.x; Rius M, 2008, DIVERS DISTRIB, V14, P818, DOI 10.1111/j.1472-4642.2008.00485.x; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruiz GM, 1999, LIMNOL OCEANOGR, V44, P950, DOI 10.4319/lo.1999.44.3_part_2.0950; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Schmidt PS, 2001, EVOLUTION, V55, P1336; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Seebens H, 2013, ECOL LETT, V16, P782, DOI 10.1111/ele.12111; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; SLATKIN M, 1995, GENETICS, V139, P1463; Smit AFA, 2010, REPEATMASKER OPEN 3; Sotka EE, 2004, MOL ECOL, V13, P2143, DOI 10.1111/j.1365-294X.2004.02225.x; STANLEY SM, 1980, PALEOBIOLOGY, V6, P173, DOI 10.1017/S0094837300006734; TAJIMA F, 1989, GENETICS, V123, P585; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; Teacher AGF, 2013, EVOL APPL, V6, P549, DOI 10.1111/eva.12042; TEMPLETON AR, 1992, GENETICS, V132, P619; Tepolt CK, 2015, BIOL INVASIONS, V17, P887, DOI 10.1007/s10530-014-0825-8; Todd CD, 1998, J EXP MAR BIOL ECOL, V228, P1, DOI 10.1016/S0022-0981(98)00005-7; Turpayeva YP, 1961, T I OCEANOL, V49, P205; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veliz D, 2006, MOL ECOL, V15, P4193, DOI 10.1111/j.1365-294X.2006.03078.x; Wares JP, 2005, MECHANISMS THAT DRIV, P229; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Wrange AL, 2014, BMC EVOL BIOL, V14; Yamaguchi T, 2009, BIOFOULING, V25, P325, DOI 10.1080/08927010902738048; York KL, 2008, MOL ECOL, V17, P1948, DOI 10.1111/j.1365-294X.2008.03735.x; Zakas C, 2009, MAR ECOL PROG SER, V394, P165, DOI 10.3354/meps08265; Zardoya R, 2007, BMC EVOL BIOL, V7; Zhan AB, 2012, DIVERS DISTRIB, V18, P1042, DOI 10.1111/j.1472-4642.2012.00894.x; Zullo VA, 1979, MARINE FLORA FAUNA N; Zullo VA, 1969, EARLY RECORDS BARNAC, V75, P1	137	14	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147082	10.1371/journal.pone.0147082	http://dx.doi.org/10.1371/journal.pone.0147082			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821161	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528400014
J	Higashide, T; Ohkubo, S; Hangai, M; Ito, Y; Shimada, N; Ohno-Matsui, K; Terasaki, H; Sugiyama, K; Chew, P; Li, KKW; Yoshimura, N				Higashide, Tomomi; Ohkubo, Shinji; Hangai, Masanori; Ito, Yasuki; Shimada, Noriaki; Ohno-Matsui, Kyoko; Terasaki, Hiroko; Sugiyama, Kazuhisa; Chew, Paul; Li, Kenneth K. W.; Yoshimura, Nagahisa			Influence of Clinical Factors and Magnification Correction on Normal Thickness Profiles of Macular Retinal Layers Using Optical Coherence Tomography	PLOS ONE			English	Article							NERVE-FIBER LAYER; GANGLION-CELL COMPLEX; HEALTHY-SUBJECTS; AXIAL LENGTH; MYOPIC EYES; AGE; GLAUCOMA; SEX; REPRODUCIBILITY; DETERMINANTS	Purpose To identify the factors which significantly contribute to the thickness variabilities in macular retinal layers measured by optical coherence tomography with or without magnification correction of analytical areas in normal subjects. Methods The thickness of retinal layers {retinal nerve fiber layer (RNFL), ganglion cell layer plus inner plexiform layer (GCLIPL), RNFL plus GCLIPL (ganglion cell complex, GCC), total retina, total retina minus GCC (outer retina)} were measured by macular scans (RS-3000, NIDEK) in 202 eyes of 202 normal Asian subjects aged 20 to 60 years. The analytical areas were defined by three concentric circles (1-, 3-and 6-mm nominal diameters) with or without magnification correction. For each layer thickness, a semipartial correlation (sr) was calculated for explanatory variables including age, gender, axial length, corneal curvature, and signal strength index. Results Outer retinal thickness was significantly thinner in females than in males (sr(2), 0.07 to 0.13) regardless of analytical areas or magnification correction. Without magnification correction, axial length had a significant positive sr with RNFL (sr(2), 0.12 to 0.33) and a negative sr with GCLIPL (sr(2), 0.22 to 0.31), GCC (sr(2), 0.03 to 0.17), total retina (sr(2), 0.07 to 0.17) and outer retina (sr(2), 0.16 to 0.29) in multiple analytical areas. The significant sr in RNFL, GCLIPL and GCC became mostly insignificant following magnification correction. Conclusions The strong correlation between the thickness of inner retinal layers and axial length appeared to result from magnification effects. Outer retinal thickness may differ by gender and axial length independently of magnification correction.	[Higashide, Tomomi; Ohkubo, Shinji; Sugiyama, Kazuhisa] Kanazawa Univ, Sch Med Sci, Dept Ophthalmol & Visual Sci, Kanazawa, Ishikawa, Japan; [Hangai, Masanori] Saitama Med Univ, Dept Ophthalmol, Saitama, Japan; [Ito, Yasuki; Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan; [Shimada, Noriaki; Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Tokyo, Japan; [Chew, Paul] Natl Univ Hlth Syst, Natl Univ Hosp, Dept Ophthalmol, Singapore, Singapore; [Li, Kenneth K. W.] United Christian Hosp, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China; [Li, Kenneth K. W.] Tseung Kwan O Hosp, Hong Kong, Hong Kong, Peoples R China; [Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan	Kanazawa University; Saitama Medical University; Nagoya University; Tokyo Medical & Dental University (TMDU); National University of Singapore; United Christian Hospital; Kyoto University	Higashide, T (corresponding author), Kanazawa Univ, Sch Med Sci, Dept Ophthalmol & Visual Sci, Kanazawa, Ishikawa, Japan.	eyetomo@med.kanazawa-u.ac.jp	Ito, Yasuki/M-4876-2014; Li, Kenneth/M-4140-2017	Ito, Yasuki/0000-0001-9219-9261; Li, Kenneth/0000-0001-9440-8063	Japan Society for the Promotion of Science [26462632]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (26462632) from the Japan Society for the Promotion of Science (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037638; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Choi YJ, 2013, INVEST OPHTH VIS SCI, V54, P2296, DOI 10.1167/iovs.12-10530; Choovuthayakorn J, 2012, JPN J OPHTHALMOL, V56, P569, DOI 10.1007/s10384-012-0192-x; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Demirkaya N, 2013, INVEST OPHTH VIS SCI, V54, P4934, DOI 10.1167/iovs.13-11913; Duan XR, 2010, OPHTHALMOLOGY, V117, P1585, DOI 10.1016/j.ophtha.2009.12.036; Garway-Heath DF, 1998, BRIT J OPHTHALMOL, V82, P643, DOI 10.1136/bjo.82.6.643; Girkin CA, 2011, OPHTHALMOLOGY, V118, P2403, DOI 10.1016/j.ophtha.2011.06.013; Grover S, 2009, AM J OPHTHALMOL, V148, P266, DOI 10.1016/j.ajo.2009.03.006; Gupta P, 2013, INVEST OPHTH VIS SCI, V54, P7968, DOI 10.1167/iovs.13-12436; Harb E, 2012, OPTOMETRY VISION SCI, V89, P620, DOI 10.1097/OPX.0b013e318251293a; Hirasawa H, 2013, INVEST OPHTH VIS SCI, V54, P2562, DOI 10.1167/iovs.12-10552; Hirasawa K, 2013, JPN J OPHTHALMOL, V57, P429, DOI 10.1007/s10384-013-0241-0; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Hood DC, 2012, TRANSL VIS SCI TECHN, V1, DOI 10.1167/tvst.1.1.3; Hwang YH, 2012, CLIN EXP OPTOM, V95, P492, DOI 10.1111/j.1444-0938.2012.00749.x; Kang SH, 2010, INVEST OPHTH VIS SCI, V51, P4075, DOI 10.1167/iovs.09-4737; Kim NR, 2011, INVEST OPHTH VIS SCI, V52, P3413, DOI 10.1167/iovs.10-6648; Koh VT, 2012, INVEST OPHTH VIS SCI, V53, P5853, DOI 10.1167/iovs.12-10414; Lam DSC, 2007, INVEST OPHTH VIS SCI, V48, P376, DOI 10.1167/iovs.06-0426; Manassakorn A, 2008, JPN J OPHTHALMOL, V52, P450, DOI 10.1007/s10384-008-0538-6; Menke MN, 2009, AM J OPHTHALMOL, V147, P467, DOI 10.1016/j.ajo.2008.09.005; Monteiro MLR, 2014, INVEST OPHTH VIS SCI, V55, P3328, DOI 10.1167/iovs.14-14118; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P7872, DOI 10.1167/iovs.11-7896; Myers CE, 2015, AM J OPHTHALMOL, V159, P445, DOI 10.1016/j.ajo.2014.11.025; Nakanishi H, 2015, GRAEF ARCH CLIN EXP, V253, P1143, DOI 10.1007/s00417-015-3026-y; Nakatani Y, 2011, J GLAUCOMA, V20, P252, DOI 10.1097/IJG.0b013e3181e079ed; Nowroozizadeh S, 2014, INVEST OPHTH VIS SCI, V55, P3439, DOI 10.1167/iovs.14-13880; Odell D, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/692574; Ohkubo S, 2014, INVEST OPHTH VIS SCI, V55, P5269, DOI 10.1167/iovs.14-14153; Ohkubo S, 2012, JPN J OPHTHALMOL, V56, P68, DOI 10.1007/s10384-011-0093-4; Oner V, 2013, BRIT J OPHTHALMOL, V97, P75, DOI 10.1136/bjophthalmol-2012-301865; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Rao HL, 2011, INVEST OPHTH VIS SCI, V52, P1103, DOI 10.1167/iovs.10-5997; Raza AS, 2011, ARCH OPHTHALMOL-CHIC, V129, P1529, DOI 10.1001/archophthalmol.2011.352; Savini G, 2012, BRIT J OPHTHALMOL, V96, P57, DOI 10.1136/bjo.2010.196782; Song WK, 2010, INVEST OPHTH VIS SCI, V51, P3913, DOI 10.1167/iovs.09-4189; Sung KR, 2009, OPHTHALMOLOGY, V116, P1119, DOI 10.1016/j.ophtha.2009.01.004; Wagner-Schuman M, 2011, INVEST OPHTH VIS SCI, V52, P625, DOI 10.1167/iovs.10-5886; Wu PC, 2008, EYE, V22, P551, DOI 10.1038/sj.eye.6702789; Zhao ZN, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0080-5; Zhao ZN, 2013, CLIN EXP OPHTHALMOL, V41, P561, DOI 10.1111/ceo.12045	43	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147782	10.1371/journal.pone.0147782	http://dx.doi.org/10.1371/journal.pone.0147782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814541	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528200051
J	Berlyand, Y; Weintraub, D; Xie, SX; Mellis, IA; Doshi, J; Rick, J; McBride, J; Davatzikos, C; Shaw, LM; Hurtig, H; Trojanowski, JQ; Chen-Plotkin, AS				Berlyand, Yosef; Weintraub, Daniel; Xie, Sharon X.; Mellis, Ian A.; Doshi, Jimit; Rick, Jacqueline; McBride, Jennifer; Davatzikos, Christos; Shaw, Leslie M.; Hurtig, Howard; Trojanowski, John Q.; Chen-Plotkin, Alice S.			An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia	PLOS ONE			English	Article							PREDICTS COGNITIVE DECLINE; ALPHA-SYNUCLEIN; CEREBROSPINAL-FLUID; LEWY BODY; BRAIN PATHOLOGY; TAU-SYNUCLEIN; RISK-FACTORS; BETA; IMPACT; HUNTINGTONS	Biomarkers from multiple modalities have been shown to correlate with cognition in Parkinson's disease (PD) and in Alzheimer's disease (AD). However, the relationships of these markers with each other, and the use of multiple markers in concert to predict an outcome of interest, are areas that are much less explored. Our objectives in this study were (1) to evaluate relationships among 17 biomarkers previously reported to associate with cognition in PD or AD and (2) to test performance of a five-biomarker classifier trained to recognize AD in identifying PD with dementia (PDD). To do this, we evaluated a cross-sectional cohort of PD patients (n = 75) across a spectrum of cognitive abilities. All PD participants had 17 baseline biomarkers from clinical, genetic, biochemical, and imaging modalities measured, and correlations among biomarkers were assessed by Spearman's rho and by hierarchical clustering. We found that internal correlation among all 17 candidate biomarkers was modest, showing a maximum pairwise correlation coefficient of 0.51. However, a five-marker subset panel derived from AD (CSF total tau, CSF phosphorylated tau, CSF amyloid beta 42, APOE genotype, and SPARE-AD imaging score) discriminated cognitively normal PD patients vs. PDD patients with 80% accuracy, when employed in a classifier originally trained to recognize AD. Thus, an AD-derived biomarker signature may identify PDD patients with moderately high accuracy, suggesting mechanisms shared with AD in some PDD patients. Based on five measures readily obtained during life, this AD-derived signature may prove useful in identifying PDD patients most likely to respond to AD-based crossover therapies.	[Berlyand, Yosef; Mellis, Ian A.; Rick, Jacqueline; Hurtig, Howard; Chen-Plotkin, Alice S.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Weintraub, Daniel] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Xie, Sharon X.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Doshi, Jimit; Davatzikos, Christos] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [McBride, Jennifer; Shaw, Leslie M.; Trojanowski, John Q.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [McBride, Jennifer; Trojanowski, John Q.] Univ Penn, Perelman Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Chen-Plotkin, AS (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.	chenplot@mail.med.upenn.edu	Weintraub, Daniel/AAC-5232-2020; Davatzikos, Christos/ABE-2057-2021; Weintraub, Daniel/AAD-8309-2020	Weintraub, Daniel/0000-0003-0633-7168; Mellis, Ian/0000-0002-6239-4821; Berlyand, Yosef/0000-0003-2313-8507; Davatzikos, Christos/0000-0002-1025-8561	NIH [P50 NS053488, U01 NS082134]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS082134, P50NS053488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014971, P30AG010124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The funding for this actual study was from the NIH only (P50 NS053488, U01 NS082134).	Aarsland D, 2001, NEUROLOGY, V56, P730, DOI 10.1212/WNL.56.6.730; AstraZeneca, AN EFFICACY AND SAFE; Braak H, 2006, J NEURAL TRANSM-SUPP, P89; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brandt J, 2001, HOPKINS VERBAL LEARN; Buter TC, 2008, NEUROLOGY, V70, P1017, DOI 10.1212/01.wnl.0000306632.43729.24; Chahine LM, 2013, JAMA NEUROL, V70, P852, DOI 10.1001/jamaneurol.2013.1274; Chen-Plotkin AS, 2014, NEURON, V84, P594, DOI 10.1016/j.neuron.2014.10.031; Chen-Plotkin AS, 2011, ANN NEUROL, V69, P655, DOI 10.1002/ana.22271; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Eisai Inc, DOS FIND STUD EV SAF; Eli Lilly and Company, CLIN TRIAL SOL OLD I; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; HUGHES AJ, 1993, ARCH NEUROL-CHICAGO, V50, P140, DOI 10.1001/archneur.1993.00540020018011; Hughes TA, 2000, NEUROLOGY, V54, P1596, DOI 10.1212/WNL.54.8.1596; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Jellinger KA, 2002, J NEURAL TRANSM, V109, P329, DOI 10.1007/s007020200027; Jellinger KA, 2008, ACTA NEUROPATHOL, V116, P1, DOI 10.1007/s00401-008-0406-y; Jellinger KA, 2008, ACTA NEUROPATHOL, V115, P427, DOI 10.1007/s00401-008-0347-5; Kalaitzakis ME, 2008, J NEUROPATH EXP NEUR, V67, P155, DOI 10.1097/NEN.0b013e31816362aa; Kramer JH, 1989, NEUROPSYCHOLOGY, V3, P111, DOI 10.1037//0894-4105.3.2.111; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Lucas JA, 1998, J CLIN EXP NEUROPSYC, V20, P536, DOI 10.1076/jcen.20.4.536.1469; MARDER K, 1995, ARCH NEUROL-CHICAGO, V52, P695, DOI 10.1001/archneur.1995.00540310069018; Marek K, 2011, PROG NEUROBIOL, V95, P629, DOI 10.1016/j.pneurobio.2011.09.005; Marek K, 2008, ANN NEUROL, V64, pS111, DOI 10.1002/ana.21602; Mattila PM, 2000, ACTA NEUROPATHOL, V100, P285, DOI 10.1007/s004019900168; MAYEUX R, 1992, ARCH NEUROL-CHICAGO, V49, P492, DOI 10.1001/archneur.1992.00530290076015; Mollenhauer B, 2006, DEMENT GERIATR COGN, V22, P200, DOI 10.1159/000094871; Mollenhauer B, 2014, MOVEMENT DISORD, V29, P622, DOI 10.1002/mds.25846; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Parnetti L, 2011, MOVEMENT DISORD, V26, P1428, DOI 10.1002/mds.23670; Pellecchia MT, 2013, J NEUROL, V260, P438, DOI 10.1007/s00415-012-6648-6; PILLON B, 1993, ARCH NEUROL-CHICAGO, V50, P374, DOI 10.1001/archneur.1993.00540040036010; Pressley JC, 2003, NEUROLOGY, V60, P87, DOI 10.1212/WNL.60.1.87; Rosenthal E, 2010, MOVEMENT DISORD, V25, P1170, DOI 10.1002/mds.23073; Sabbagh MN, 2009, ALZ DIS ASSOC DIS, V23, P295, DOI 10.1097/WAD.0b013e31819c5ef4; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sherer TB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002488; Siderowf A, 2010, NEUROLOGY, V75, P1055, DOI 10.1212/WNL.0b013e3181f39a78; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Su YS, 2011, J STAT SOFTW, V45, P1; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tsuang D, 2012, NEUROLOGY, V79, P1944, DOI 10.1212/WNL.0b013e3182735e9a; Uc EY, 2009, NEUROLOGY, V73, P1469, DOI 10.1212/WNL.0b013e3181bf992f; Weiner Michael W, 2015, Alzheimers Dement, V11, pe1, DOI 10.1016/j.jalz.2014.11.001; Weintraub D, 2006, AM J GERIAT PSYCHIAT, V14, P169, DOI 10.1097/01.JGP.0000192488.66049.4b; Weintraub D, 2012, BRAIN, V135, P170, DOI 10.1093/brain/awr277; Weintraub Daniel, 2004, Cogn Behav Neurol, V17, P195; Williams-Gray CH, 2007, BRAIN, V130, P1787, DOI 10.1093/brain/awm111; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; Willis AW, 2010, NEUROEPIDEMIOLOGY, V34, P143, DOI 10.1159/000275491	65	24	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147319	10.1371/journal.pone.0147319	http://dx.doi.org/10.1371/journal.pone.0147319			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812251	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528000029
J	Yang, CY; Liu, HM; Chen, SK; Chen, YF; Lee, CW; Yeh, LR				Yang, Chung-Yi; Liu, Hon-Man; Chen, Shan-Kai; Chen, Ya-Fang; Lee, Chung-Wei; Yeh, Lee-Ren			Reproducibility of Brain Morphometry from Short-Term Repeat Clinical MRI Examinations: A Retrospective Study	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; POWER CALCULATIONS; MULTIPLE-SCLEROSIS; RELIABILITY; SEGMENTATION; DISEASE	Purpose To assess the inter session reproducibility of automatic segmented MRI-derived measures by FreeSurfer in a group of subjects with normal-appearing MR images. Materials and Methods After retrospectively reviewing a brain MRI database from our institute consisting of 14,758 adults, those subjects who had repeat scans and had no history of neurodegenerative disorders were selected for morphometry analysis using FreeSurfer. A total of 34 subjects were grouped by MRI scanner model. After automatic segmentation using FreeSurfer, label-wise comparison (involving area, thickness, and volume) was performed on all segmented results. An intraclass correlation coefficient was used to estimate the agreement between sessions. Wilcoxon signed rank test was used to assess the population mean rank differences across sessions. Mean-difference analysis was used to evaluate the difference intervals across scanners. Absolute percent difference was used to estimate the reproducibility errors across the MRI models. Kruskal-Wallis test was used to determine the across-scanner effect. Results The agreement in segmentation results for area, volume, and thickness measurements of all segmented anatomical labels was generally higher in Signa Excite and Verio models when compared with Sonata and TrioTim models. There were significant rank differences found across sessions in some labels of different measures. Smaller difference intervals in global volume measurements were noted on images acquired by Signa Excite and Verio models. For some brain regions, significant MRI model effects were observed on certain segmentation results.	[Yang, Chung-Yi; Yeh, Lee-Ren] I Shou Univ, E Da Hosp, Dept Med Imaging, Kaohsiung, Taiwan; [Yang, Chung-Yi; Liu, Hon-Man; Chen, Ya-Fang; Lee, Chung-Wei] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Yang, Chung-Yi; Liu, Hon-Man; Chen, Ya-Fang; Lee, Chung-Wei] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Shan-Kai] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan; [Yeh, Lee-Ren] I Shou Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan	E-Da Hospital; I Shou University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Central University; I Shou University	Liu, HM (corresponding author), Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan.; Liu, HM (corresponding author), Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan.	hmliu@ntu.edu.tw		LEE, CHUNG-WEI/0000-0002-3573-2506; Yang, Chung-Yi/0000-0003-1697-8823; CHEN, YA-FANG/0000-0003-2995-9189; LIU, HON-MAN/0000-0001-6715-6366	Ministry of Science and Technology, Taiwan [MOST 103-2911-I-008-001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Funded by Ministry of Science and Technology, Taiwan (http://www.most.gov.tw) MOST 103-2911-I-008-001: HML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; de Boer R, 2010, NEUROIMAGE, V51, P1047, DOI 10.1016/j.neuroimage.2010.03.012; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Durand-Dubief F, 2012, AM J NEURORADIOL, V33, P1918, DOI 10.3174/ajnr.A3107; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Fennema-Notestine C, 2007, NEUROINFORMATICS, V5, P235, DOI 10.1007/s12021-007-9003-9; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Fox NC, 2000, ARCH NEUROL-CHICAGO, V57, P339, DOI 10.1001/archneur.57.3.339; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Haubold A, 2012, J CHILD PSYCHOL PSYC, V53, P519, DOI 10.1111/j.1469-7610.2012.02539.x; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Klauschen F, 2009, HUM BRAIN MAPP, V30, P1310, DOI 10.1002/hbm.20599; Maclaren J, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.37; Mathalon DH, 2001, ARCH GEN PSYCHIAT, V58, P148, DOI 10.1001/archpsyc.58.2.148; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Morey RA, 2010, HUM BRAIN MAPP, V31, P1751, DOI 10.1002/hbm.20973; Prescott JW, 2013, J DIGIT IMAGING, V26, P97, DOI 10.1007/s10278-012-9465-7; R Core Team, 2021, R LANGUAGE ENV STAT; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Rovaris M, 2001, BRAIN, V124, P1803, DOI 10.1093/brain/124.9.1803; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Scharinger C, 2010, NEUROIMAGE, V53, P810, DOI 10.1016/j.neuroimage.2010.02.019; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Suckling J, 2014, HUM BRAIN MAPP, V35, P3569, DOI 10.1002/hbm.22465; Suckling J, 2012, HUM BRAIN MAPP, V33, P373, DOI 10.1002/hbm.21210; Suckling J, 2010, HUM BRAIN MAPP, V31, P1183, DOI 10.1002/hbm.20927; Wonderlick JS, 2009, NEUROIMAGE, V44, P1324, DOI 10.1016/j.neuroimage.2008.10.037; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	39	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146913	10.1371/journal.pone.0146913	http://dx.doi.org/10.1371/journal.pone.0146913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812647	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528000017
J	Ederer, AK; Didier, KD; Reiter, LK; Brown, M; Hardy, R; Caldwell, J; Black, CD; Larson, RD; Ade, CJ				Ederer, Austin K.; Didier, Kaylin D.; Reiter, Landon K.; Brown, Michael; Hardy, Rachel; Caldwell, Jacob; Black, Christopher D.; Larson, Rebecca D.; Ade, Carl J.			Influence of Adjuvant Therapy in Cancer Survivors on Endothelial Function and Skeletal Muscle Deoxygenation	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; PULMONARY O-2 UPTAKE; SKIN BLOOD-FLOW; OXIDATIVE-METABOLISM; OXYGEN EXTRACTION; PHYSICAL-ACTIVITY; UPTAKE KINETICS; GAS-EXCHANGE; EXERCISE; IMPAIRMENT	The cardiotoxic effects of adjuvant cancer treatments (i.e., chemotherapy and radiation treatment) have been well documented, but the effects on peripheral cardiovascular function are still unclear. We hypothesized that cancer survivors i) would have decreased resting endothelial function; and ii) altered muscle deoxygenation response during moderate intensity cycling exercise compared to cancer-free controls. A total of 8 cancer survivors (similar to 70 months post-treatment) and 9 healthy controls completed a brachial artery FMD test, an index of endothelial-dependent dilation, followed by an incremental exercise test up to the ventilatory threshold (VT) on a cycle ergometer during which pulmonary (V) over dotO(2) and changes in near-infrared spectroscopy (NIRS)-derived microvascular tissue oxygenation (TOI), total hemoglobin concentration ([Hb](total)), and muscle deoxygenation ([HHb] approximate to fractional O-2 extraction) were measured. There were no significant differences in age, height, weight, and resting blood pressure between cancer survivors and control participants. Brachial artery FMD was similar between groups (P = 0.98). During exercise at the VT, TOI was similar between groups, but [Hb](total) and [HHb] were significantly decreased in cancer survivors compared to controls (P < 0.01) The rate of change for TOI (Delta TOI Delta/(V) over dotO(2) and [HHb] (Delta[HHb]/Delta(V) over dotO(2)) relative to Delta(V) over dotO(2) were decreased in cancer survivors compared to controls (P = 0.02 and P = 0.03 respectively). In cancer survivors, a decreased skeletal muscle microvascular function was observed during moderate intensity cycling exercise. These data suggest that adjuvant cancer therapies have an effect on the integrated relationship between O-2 extraction, (V) over dotO(2) and O-2 delivery during exercise.	[Ederer, Austin K.; Didier, Kaylin D.; Reiter, Landon K.; Brown, Michael; Hardy, Rachel; Caldwell, Jacob; Black, Christopher D.; Larson, Rebecca D.; Ade, Carl J.] Univ Oklahoma, Dept Hlth & Exercise Sci, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Ade, CJ (corresponding author), Univ Oklahoma, Dept Hlth & Exercise Sci, Norman, OK 73019 USA.	cade@ou.edu		Didier, Kaylin/0000-0002-0281-8493; Black, Christopher/0000-0003-2662-8341; Ade, Carl/0000-0002-1837-2342				Ammar HI, 2011, AM J PHYSIOL-HEART C, V301, pH2413, DOI 10.1152/ajpheart.01096.2010; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Beckman JA, 2001, J AM COLL CARDIOL, V37, P761, DOI 10.1016/S0735-1097(00)01190-6; Boone J, 2009, EUR J APPL PHYSIOL, V105, P851, DOI 10.1007/s00421-008-0969-2; Bowen TS, 2013, EXP PHYSIOL, V98, P1585, DOI 10.1113/expphysiol.2013.073270; Boyle LJ, 2013, J APPL PHYSIOL, V115, P1519, DOI 10.1152/japplphysiol.00837.2013; Chin LMK, 2011, J APPL PHYSIOL, V111, P1259, DOI 10.1152/japplphysiol.01216.2010; Chow AY, 2006, J CLIN ONCOL, V24, P925, DOI 10.1200/JCO.2005.03.5956; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Davis ML, 2013, RESP PHYSIOL NEUROBI, V186, P180, DOI 10.1016/j.resp.2013.01.012; Davis SL, 2006, J APPL PHYSIOL, V100, P221, DOI 10.1152/japplphysiol.00867.2005; DeLorey DS, 2003, J APPL PHYSIOL, V95, P113, DOI 10.1152/japplphysiol.00956.2002; Dengel DR, 2008, J PEDIAT HEMATOL ONC, V30, P20, DOI 10.1097/MPH.0b013e318159a593; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Duquaine D, 2003, VASC MED, V8, P101, DOI 10.1191/1358863x03vm476oa; Ferreira LF, 2007, J APPL PHYSIOL, V103, P1999, DOI 10.1152/japplphysiol.01414.2006; Ferreira LF, 2005, J APPL PHYSIOL, V98, P1820, DOI 10.1152/japplphysiol.00907.2004; Fleg JL, 2000, CIRCULATION, V102, P1591, DOI 10.1161/01.CIR.102.13.1591; Gibson NM, 2013, J CARDIOVASC PHARM, V62, P355, DOI 10.1097/FJC.0b013e31829c9993; Grassi B, 2003, J APPL PHYSIOL, V95, P149, DOI 10.1152/japplphysiol.00695.2002; Grassi B, 2007, MUSCLE NERVE, V35, P510, DOI 10.1002/mus.20708; Harris RA, 2010, HYPERTENSION, V55, P1075, DOI 10.1161/HYPERTENSIONAHA.110.150821; Ito M, 1997, J CARDIOVASC PHARM, V29, P232, DOI 10.1097/00005344-199702000-00012; Jones LW, 2007, CANCER EPIDEM BIOMAR, V16, P1026, DOI 10.1158/1055-9965.EPI-06-0870; Jones LW, 2007, J AM COLL CARDIOL, V50, P1435, DOI 10.1016/j.jacc.2007.06.037; Kalliokoski KK, 2004, MICROVASC RES, V67, P125, DOI 10.1016/j.mvr.2003.11.004; Khouri MG, 2012, CIRCULATION, V126, P2749, DOI 10.1161/CIRCULATIONAHA.112.100560; Koga S, 2007, J APPL PHYSIOL, V103, P2049, DOI 10.1152/japplphysiol.00627.2007; Koga S, 2015, EUR J APPL PHYSIOL, V115, P335, DOI 10.1007/s00421-014-3019-2; Koga S, 2012, J APPL PHYSIOL, V112, P26, DOI 10.1152/japplphysiol.00925.2011; Kowalchuk JM, 2002, EXP PHYSIOL, V87, P601, DOI 10.1113/eph8702456; MANCINI DM, 1994, J APPL PHYSIOL, V77, P2740, DOI 10.1152/jappl.1994.77.6.2740; Mulrooney DA, 2012, J CARDIOVASC TRANSL, V5, P287, DOI 10.1007/s12265-012-9358-7; Murias JM, 2013, AM J PHYSIOL-REG I, V304, pR720, DOI 10.1152/ajpregu.00016.2013; Newcomer SC, 2004, J PHYSIOL-LONDON, V556, P1001, DOI 10.1113/jphysiol.2003.059717; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; PIIPER J, 1981, RESP PHYSIOL, V46, P193, DOI 10.1016/0034-5687(81)90121-3; Poole DC, 2011, ACTA PHYSIOL, V202, P293, DOI 10.1111/j.1748-1716.2010.02246.x; Poole DC, 2013, EXP PHYSIOL, V98, P1645, DOI 10.1113/expphysiol.2013.073874; Porcelli S, 2010, J APPL PHYSIOL, V109, P101, DOI 10.1152/japplphysiol.00782.2009; Pyke KE, 2007, J APPL PHYSIOL, V102, P1510, DOI 10.1152/japplphysiol.01024.2006; ROCA J, 1992, J APPL PHYSIOL, V73, P1067; Rossiter HB, 2011, COMPR PHYSIOL, V1, P203, DOI 10.1002/cphy.c090010; Salvadego D, 2011, J APPL PHYSIOL, V111, P1719, DOI 10.1152/japplphysiol.01380.2010; SEER Program (National Cancer Institute (U. S.)) National Center for Health Statistics (U. S.) National Cancer Institute (U. S.). Surveillance Program. National Cancer Institute (U. S.). Cancer Statistics Branch. National Cancer Institute (U. S.). Cancer Control Research Program, 1993, NIH PUBLICATION, pv; Spencer MD, 2012, EUR J APPL PHYSIOL, V112, P3349, DOI 10.1007/s00421-012-2323-y; Sugihara T, 1999, CIRCULATION, V100, P635, DOI 10.1161/01.CIR.100.6.635; Takagi S, 2014, MED SCI SPORT EXER, V46, P2062, DOI 10.1249/MSS.0000000000000334; van der Veldt AAM, 2010, ANTI-CANCER DRUG, V21, P439, DOI 10.1097/CAD.0b013e3283359c79; Vincent WJ, 2012, STAT KINESIOLOGY, Vxiv; WAGNER PD, 1992, MED SCI SPORT EXER, V24, P54	51	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147691	10.1371/journal.pone.0147691	http://dx.doi.org/10.1371/journal.pone.0147691			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807572	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800182
J	Hirata, H; Takahashi, A; Shimoda, Y; Koide, T				Hirata, Haruna; Takahashi, Aki; Shimoda, Yasushi; Koide, Tsuyoshi			Caspr3-Deficient Mice Exhibit Low Motor Learning during the Early Phase of the Accelerated Rotarod Task	PLOS ONE			English	Article							BASAL GANGLIA; NMDA RECEPTORS; NUCLEUS-ACCUMBENS; POSTNATAL-DEVELOPMENT; DORSOMEDIAL STRIATUM; SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; DORSAL STRIATUM; C-FOS; ORGANIZATION	Caspr3 (Contactin-associated protein-like 3, Cntnap3) is a neural cell adhesion molecule belonging to the Caspr family. We have recently shown that Caspr3 is expressed abundantly between the first and second postnatal weeks in the mouse basal ganglia, including the striatum, external segment of the globus pallidus, subthalamic nucleus, and substantia nigra. However, its physiological role remains largely unknown. In this study, we conducted a series of behavioral analyses on Capsr3-knockout (KO) mice and equivalent wild-type (WT) mice to investigate the role of Caspr3 in brain function. No significant differences were observed in most behavioral traits between Caspr3-KO and WT mice, but we found that Caspr3-KO mice performed poorly during the early phase of the accelerated rotarod task in which latency to falling off a rod rotating with increasing velocity was examined. In the late phase, the performance of the Caspr3-KO mice caught up to the level of WT mice, suggesting that the deletion of Caspr3 caused a delay in motor learning. We then examined changes in neural activity after training on the accelerated rotarod by conducting immunohistochemistry using antibody to c-Fos, an indirect marker for neuronal activity. Experience of the accelerated rotarod task caused increases in the number of c-Fos-positive cells in the dorsal striatum, cerebellum, and motor cortex in both Caspr3-KO and WT mice, but the number of c-Fos-positive cells was significantly lower in the dorsal striatum of Caspr3-KO mice than in that of WT mice. The expression of c-Fos in the ventral striatum of Caspr3-KO and WT mice was not altered by the training. Our findings suggest that reduced activation of neural cells in the dorsal striatum in Caspr3-KO mice leads to a decline in motor learning in the accelerated rotarod task.	[Hirata, Haruna; Shimoda, Yasushi] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 9402188, Japan; [Takahashi, Aki; Koide, Tsuyoshi] Natl Inst Genet, Mouse Genom Resource Lab, Mishima, Shizuoka 4118540, Japan; [Takahashi, Aki; Koide, Tsuyoshi] Grad Univ Adv Studies SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Takahashi, Aki; Koide, Tsuyoshi] Res Org Informat & Syst, Transdisciplinary Res Integrat Ctr, Minato Ku, Tokyo 1050001, Japan; [Takahashi, Aki] Univ Tsukuba, Lab Behav Neuroendocrinol, Tsukuba, Ibaraki 3058577, Japan	Nagaoka University of Technology; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); University of Tsukuba	Shimoda, Y (corresponding author), Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 9402188, Japan.; Koide, T (corresponding author), Natl Inst Genet, Mouse Genom Resource Lab, Mishima, Shizuoka 4118540, Japan.; Koide, T (corresponding author), Grad Univ Adv Studies SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan.; Koide, T (corresponding author), Res Org Informat & Syst, Transdisciplinary Res Integrat Ctr, Minato Ku, Tokyo 1050001, Japan.	shimo@vos.nagaokaut.ac.jp; tkoide@nig.ac.jp	Takahashi, Aki/AAC-9290-2021	Takahashi, Aki/0000-0001-8325-9744	KAKENHI [15H01298, 15H04289, 15H05724]; NIG Collaborative Research Program [2013-A45]; Grants-in-Aid for Scientific Research [15H04289] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NIG Collaborative Research Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded by Grants-in-Aid for Scientific Research (KAKENHI) (https://www.jsps.go.jp/english/e-grants/) as follows: KAKENHI 15H01298 and 15H04289 (TK), and KAKENHI 15H05724 (AT and TK). This work was also supported by the NIG Collaborative Research Program (2013-A45). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2011, CURR BIOL, V21, P557, DOI 10.1016/j.cub.2011.02.030; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Anderson GR, 2012, P NATL ACAD SCI USA, V109, P18120, DOI 10.1073/pnas.1216398109; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Belleau ML, 2000, J NEUROPHYSIOL, V84, P2204, DOI 10.1152/jn.2000.84.5.2204; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Bergeron Y, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00026; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Bradley KC, 2001, J NEUROSCI, V21, P2123, DOI 10.1523/JNEUROSCI.21-06-02123.2001; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Bureau G, 2010, NEUROBIOL LEARN MEM, V94, P107, DOI 10.1016/j.nlm.2010.04.008; CALABRESI P, 1992, EUR J NEUROSCI, V4, P929, DOI 10.1111/j.1460-9568.1992.tb00119.x; Calabresi P, 1997, J NEUROSCI, V17, P4536; Centonze D, 1999, BRAIN RES REV, V31, P1, DOI 10.1016/S0165-0173(99)00018-1; CHRONISTER RB, 1976, BRAIN RES, V108, P37, DOI 10.1016/0006-8993(76)90162-1; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Ding JB, 2012, NAT NEUROSCI, V15, P215, DOI 10.1038/nn.3003; Fernagut PO, 2002, NEUROSCIENCE, V114, P1005, DOI 10.1016/S0306-4522(02)00205-1; French CA, 2012, MOL PSYCHIATR, V17, P1077, DOI 10.1038/mp.2011.105; Galea JM, 2015, NAT NEUROSCI, V18, P597, DOI 10.1038/nn.3956; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hirata H, 2016, J NEUROSCI RES, V94, P74, DOI 10.1002/jnr.23670; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kanno K, 2014, J NEUROSCI RES, V92, P287, DOI 10.1002/jnr.23291; Karayannis T, 2014, NATURE, V511, P236, DOI 10.1038/nature13248; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kato S, 2014, HEREDITY, V113, P416, DOI 10.1038/hdy.2014.42; Koide T, 2000, MAMM GENOME, V11, P664, DOI 10.1007/s003350010129; Kosinski CM, 1998, J COMP NEUROL, V390, P63; Lemay-Clermont J, 2011, BEHAV NEUROSCI, V125, P714, DOI 10.1037/a0025213; Lett BT, 2000, APPETITE, V34, P87, DOI 10.1006/appe.1999.0274; Luft AR, 2005, MOL NEUROBIOL, V32, P205, DOI 10.1385/MN:32:3:205; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; MISGELD U, 1986, DEV BRAIN RES, V27, P59, DOI 10.1016/0165-3806(86)90232-4; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS8, DOI 10.1016/S1471-1931(00)00028-8; Palencia CA, 2004, NEUROBIOL LEARN MEM, V82, P81, DOI 10.1016/j.nlm.2004.04.004; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Rios JC, 2000, J NEUROSCI, V20, P8354, DOI 10.1523/JNEUROSCI.20-22-08354.2000; Sakurai K, 2009, DEV NEUROBIOL, V69, P811, DOI 10.1002/dneu.20742; Santos SD, 2012, J BIOL CHEM, V287, P6868, DOI 10.1074/jbc.M111.322909; Sarnyai Z, 2000, P NATL ACAD SCI USA, V97, P14731, DOI 10.1073/pnas.97.26.14731; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sieradzan KA, 2001, NEUROPATH APPL NEURO, V27, P1, DOI 10.1046/j.0305-1846.2001.00299.x; Spiegel I, 2002, MOL CELL NEUROSCI, V20, P283, DOI 10.1006/mcne.2002.1110; STANDAERT DG, 1994, J COMP NEUROL, V343, P1, DOI 10.1002/cne.903430102; Sucher NJ, 1996, TRENDS PHARMACOL SCI, V17, P348, DOI 10.1016/S0165-6147(96)10046-8; Takahashi A, 2008, GENES BRAIN BEHAV, V7, P849, DOI 10.1111/j.1601-183X.2008.00419.x; Takahashi A, 2006, BEHAV GENET, V36, P763, DOI 10.1007/s10519-005-9038-3; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tepper JM, 1998, DEV NEUROSCI-BASEL, V20, P125, DOI 10.1159/000017308; Toyoshima M, 2009, DEV BIOL, V336, P192, DOI 10.1016/j.ydbio.2009.09.043; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Traut W, 2006, MAMM GENOME, V17, P723, DOI 10.1007/s00335-005-0157-1; Vargas-Perez H, 2003, NEUROSCI LETT, V352, P81, DOI 10.1016/j.neulet.2003.08.073; Wachter T, 2010, EXP BRAIN RES, V200, P319, DOI 10.1007/s00221-009-2027-7; Wachter T, 2009, J NEUROSCI, V29, P436, DOI 10.1523/JNEUROSCI.4132-08.2009; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Willuhn I, 2006, NEUROPSYCHOPHARMACOL, V31, P2669, DOI 10.1038/sj.npp.1300995; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Yin HH, 2005, EUR J NEUROSCI, V22, P505, DOI 10.1111/j.1460-9568.2005.04219.x; Yin XL, 2011, NEURON, V70, P310, DOI 10.1016/j.neuron.2011.02.049	67	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147887	10.1371/journal.pone.0147887	http://dx.doi.org/10.1371/journal.pone.0147887			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807827	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800240
J	Jiang, MF; Lee, JN; Bionaz, M; Deng, XY; Wang, Y				Jiang, MingFeng; Lee, Jung Nam; Bionaz, Massimo; Deng, Xiao Yu; Wang, Yong			Evaluation of Suitable Internal Control Genes for RT-qPCR in Yak Mammary Tissue during the Lactation Cycle	PLOS ONE			English	Article							REAL-TIME PCR; REVERSE TRANSCRIPTION-PCR; EXPRESSION; IDENTIFICATION; NORMALIZATION; SELECTION; MODEL	The yak is primarily found throughout the Tibetan high plateau and the surrounding mountainous area of south central Asia; among its others attributes, its milk is very important for the local population. A key concern in the field of yak research is the better understanding of which genes control the production and composition of milk. The most accurate and sensitive method for gene expression analysis is quantitative reverse transcription polymerase chain reaction (RT-qPCR). It is essential for reliable RT-qPCR to be able to the normalize the data using internal control genes (ICGs). However, it is critical to assess the reliability of the normalization by testing multiple ICGs. Our objective was to uncover a reliable normalization for RT-qPCR data obtained from yak mammary tissue during the lactation cycle. We assessed the reliability of 10 ICGs (ACTB, EIF6, GAPDH, LRP10, MRPL39, MRPS15, MTG1, RPS8, RPS23, and UXT) using geNorm. The analysis revealed that all of the tested ICGs can be considered to be reliable, but the use of the 6 most stable ICGs should be applied to yield a reliable normalization factor (NF). We compared the results of 3 target genes (CSN1S1, ESR1, and MYC) normalized using 6, 3, or 1 of the best ICGs. We did not observe overall differences between the 3 normalization strategies with the exception of 1 time point in MYC. The use of only a single ICG is not recommended; thus, we concluded that the calculation of the NF using the 3 best ICGs, MRPS15, RPS23, and UXT, is a reliable normalization strategy for RT-qPCR data obtained from yak mammary tissue during pregnancy and lactation. A dilution effect of the ICGs due to a large increase in the mRNA of abundantly expressed genes in bovine and porcine mammary tissue during the lactation cycle was previously observed. To test for the presence of a dilution effect in our study, we evaluated the pattern of non-normalized RT-qPCR data of ICGs from pregnancy to lactation and compared them with the total RNA concentration, milk yield, and non-normalized RT-qPCR data of 3 target genes. With a few exceptions, the non-normalized RT-qPCR data for the tested ICGs was significantly increased by lactation and had a positive correlation with total RNA and the non-normalized RT-qPCR data of CSN1S1. These data clearly indicated the presence of a "concentration effect" of single mRNA that remains unexplained but needs to be accounted for during the normalization of RT-qPCR data. Based on our findings, we recommend that the NF of the MRPS15, RPS23, and UXT genes should be used in the normalization of RT-qPCR data obtained from mammary tissue of lactating yaks during pregnancy and lactation.	[Jiang, MingFeng; Lee, Jung Nam; Deng, Xiao Yu] Southwest Univ Nationalities, Coll Life Sci & Technol, Chengdu, Peoples R China; [Lee, Jung Nam] Natl Res Fdn Korea, Seoul, South Korea; [Bionaz, Massimo] Oregon State Univ, Coll Agr Sci, Corvallis, OR 97331 USA; [Wang, Yong] Southwest Univ Nationalities, Sichuan Key Lab Conservat & Utilizat Anim Genet R, Chengdu, Peoples R China	Southwest Minzu University; Oregon State University; Southwest Minzu University	Jiang, MF (corresponding author), Southwest Univ Nationalities, Coll Life Sci & Technol, Chengdu, Peoples R China.; Bionaz, M (corresponding author), Oregon State Univ, Coll Agr Sci, Corvallis, OR 97331 USA.	mingfengjiang@vip.sina.com; Massimo.Bionaz@oregonstate.edu	Bionaz, Massimo/I-4222-2018	Bionaz, Massimo/0000-0002-0674-1892	National Natural Science Foundation of China [31172198]; Sichuan Youth Science and Technology Fund [09ZQ026-011]; Construction Project of Postgraduate Academic Degree in Southwest University for Nationalities [2011XWD-S071007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Youth Science and Technology Fund; Construction Project of Postgraduate Academic Degree in Southwest University for Nationalities	This work was supported by the National Natural Science Foundation of China (MFJ, http://www.nsfc.gov.cn/) Grant number: 31172198, The Sichuan Youth Science and Technology Fund (MFJ, http://www.qnjj.sc.cn/) Grant number: 09ZQ026-011 and the Construction Project of Postgraduate Academic Degree in Southwest University for Nationalities (MFJ, http://mzyjy.swun.edu.cn/) Grant number: 2011XWD-S071007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bai WL, 2014, J DAIRY SCI, V97, P902, DOI 10.3168/jds.2012-6437; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chaiyabutr N, 2012, INTECH, V1, P4; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Hembruff SL, 2005, ANAL BIOCHEM, V345, P237, DOI 10.1016/j.ab.2005.07.014; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Saremi B, 2012, J DAIRY SCI, V95, P3131, DOI 10.3168/jds.2011-4803; Tramontana S, 2008, J DAIRY SCI, V91, P3057, DOI 10.3168/jds.2008-1164; Valasek MA, 2005, ADV PHYSIOL EDUC, V29, P151, DOI 10.1152/advan.00019.2005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varshney N, 2012, J DAIRY SCI, V95, P2935, DOI 10.3168/jds.2011-4442; Wathes DC, 2011, REPRODUCTION, V141, P269, DOI 10.1530/REP-10-0177; Wiener G, 2006, THE YAK, P119; Wu, 1994, P 1 INT C YAK, P27; Zhong JC, 2004, P 4 INT C YAK, P32	20	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147705	10.1371/journal.pone.0147705	http://dx.doi.org/10.1371/journal.pone.0147705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808329	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800188
J	Kosior-Jarecka, E; Lukasik, U; Wrobel-Dudzinska, D; Kocki, J; Bartosinska, J; Witczak, A; Chodorowska, G; Mosiewicz, J; Zarnowski, T				Kosior-Jarecka, Ewa; Lukasik, Urszula; Wrobel-Dudzinska, Dominika; Kocki, Janusz; Bartosinska, Joanna; Witczak, Agnieszka; Chodorowska, Grazyna; Mosiewicz, Jerzy; Zarnowski, Tomasz			Risk Factors for Normal and High-Tension Glaucoma in Poland in Connection with Polymorphisms of the Endothelial Nitric Oxide Synthase Gene	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; ASSOCIATION; ENOS; METAANALYSIS; PRESSURE; MUTATION; PATHWAY	Aim The purpose of this study was to evaluate the influence of polymorphisms of the eNOS gene on the clinical status of patients with normal and high tension glaucoma. Methods 266 Polish Caucasian patients with primary open angle glaucoma were studied. Of the 266, 156 had normal tension glaucoma (NTG) and 110 high tension glaucoma (HTG). DNA material was isolated from peripheral venous blood using commercial kits. Real-time PCR reaction was used to amplify the promoter site of the endothelial nitric oxide synthase (eNOS) gene, including the single nucleotide polymorphism (SNP) site T-786C and part of the 7th exon of eNOS, including G894T SNP. Genotypes were determined with TaqMan SNP Genotyping Assays. Results There were no significant differences in frequencies of the allelic variants of both polymorphisms. In G894T SNP, however, the wild GG form was more common in the HTG group. The SNP of the eNOS gene did not significantly influence the progression rate in either of the groups studied. There were no differences in variants of the eNOS gene regarding the necessity for and success of surgery and the progression of the disease. In the NTG group, no statistical correlation was observed between G894T, T786C polymorphism variants, and risk factors such as optic disc haemorrhages, optic disc notches, and peripapillary atrophy. Mean diastolic and systolic pressure during the day and night were lowest in NTG patients with the CC variant of the T786C polymorphism. No statistical correlation was observed between the G894T and T786C polymorphisms and capillaroscopic examination results. Conclusions Genotype frequencies are similar for both the eNOS G894T and T-786C polymorphisms in NTG and HTG patients. These polymorphisms do not correlate with risk factors and do not influence the state of the capillary system in NTG patients. Systolic blood pressure is lower in NTG patients with mutated alleles of both polymorphisms.	[Kosior-Jarecka, Ewa; Lukasik, Urszula; Wrobel-Dudzinska, Dominika; Zarnowski, Tomasz] Med Univ Lublin, Dept Diagnost & Microsurg Glaucoma, Lublin, Poland; [Kocki, Janusz] Med Univ Lublin, Dept Clin Genet, Lublin, Poland; [Bartosinska, Joanna; Chodorowska, Grazyna] Med Univ Lublin, Dept Dermatol Venerol & Paediat Dermatol, Lublin, Poland; [Witczak, Agnieszka; Mosiewicz, Jerzy] Med Univ Lublin, Dept Internal Dis, Lublin, Poland	Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin	Kosior-Jarecka, E (corresponding author), Med Univ Lublin, Dept Diagnost & Microsurg Glaucoma, Lublin, Poland.	ekosior@poczta.onet.pl	Zarnowski, Tomasz/AAM-6460-2020; Bartosińska, Joanna/GOG-8263-2022; Chodorowska, Grażyna/A-2415-2019	Chodorowska, Grażyna/0000-0002-8055-5764; Zarnowski, Tomasz/0000-0002-6978-7417; Bartosinska, Joanna/0000-0003-4106-3051; Mosiewicz, Jerzy/0000-0003-0320-1863; Wrobel-Dudzinska, Dominika/0000-0002-1325-6692				Ayub H, 2010, MOL VIS, V16, P18; Colombo MG, 2003, CLIN CHEM, V49, P389, DOI 10.1373/49.3.389; da Silva TM, 2012, GENE, V502, P142, DOI 10.1016/j.gene.2012.04.047; Dellamea BS, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-9; Flammer J, 1994, SURV OPHTHALMOL S, V38, pSS3; Ghilardi G, 2002, CLIN CHEM, V48, P989; Haefliger IO, 1999, SURV OPHTHALMOL, V43, pS51, DOI 10.1016/S0039-6257(99)00026-0; Hibi K, 1998, HYPERTENSION, V32, P521, DOI 10.1161/01.HYP.32.3.521; Hingorani AD, 2003, CURR HYPERTENS REP, V5, P19, DOI 10.1007/s11906-003-0006-0; Huttunen R, 2009, SHOCK, V31, P448, DOI 10.1097/SHK.0b013e318188e58e; Kang JH, 2014, EYE, V28, P662, DOI 10.1038/eye.2014.42; Kang JH, 2010, INVEST OPHTH VIS SCI, V51, P971, DOI 10.1167/iovs.09-4266; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Liao QO, 2011, MOL VIS, V17, P153; Lin HJ, 2005, J CLIN LAB ANAL, V19, P87, DOI 10.1002/jcla.20057; Logan JFJ, 2005, INVEST OPHTH VIS SCI, V46, P3221, DOI 10.1167/iovs.05-0368; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; Nakayama M, 2000, AM J CARDIOL, V86, P628, DOI 10.1016/S0002-9149(00)01041-9; Pereira TV, 2007, J HYPERTENS, V25, P1763, DOI 10.1097/HJH.0b013e3281de740d; QUIGLEY HA, 1993, ARCH OPHTHALMOL-CHIC, V111, P1409, DOI 10.1001/archopht.1993.01090100117038; Sakai T, 2007, GRAEF ARCH CLIN EXP, V245, P288, DOI 10.1007/s00417-005-0245-7; Stamer WD, 2011, INVEST OPHTH VIS SCI, V52, P9438, DOI 10.1167/iovs.11-7839; TIELSCH JM, 1995, ARCH OPHTHALMOL-CHIC, V113, P216, DOI 10.1001/archopht.1995.01100020100038; Tunny TJ, 1998, CLIN EXP PHARMACOL P, V25, P26, DOI 10.1111/j.1440-1681.1998.tb02138.x; Wattanapitayakul SK, 2001, TRENDS PHARMACOL SCI, V22, P361, DOI 10.1016/S0165-6147(00)01692-8; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Weiss J, 2012, MOL VIS, V18, P2174; Werner E, 1996, J GLAUCOMA, V5, P422; Yao YS, 2013, GENE, V528, P84, DOI 10.1016/j.gene.2013.06.047; Yoshimura M, 1998, HUM GENET, V103, P65, DOI 10.1007/s004390050785	30	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147540	10.1371/journal.pone.0147540	http://dx.doi.org/10.1371/journal.pone.0147540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807726	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800127
J	Xiao, M; Pang, L; Chen, SCA; Fan, X; Zhang, L; Li, HX; Hou, X; Cheng, JW; Kong, FR; Zhao, YP; Xu, YC				Xiao, Meng; Pang, Lu; Chen, Sharon C-A.; Fan, Xin; Zhang, Li; Li, Hai-Xia; Hou, Xin; Cheng, Jing-Wei; Kong, Fanrong; Zhao, Yu-Pei; Xu, Ying-Chun			Accurate Identification of Common Pathogenic Nocardia Species: Evaluation of a Multilocus Sequence Analysis Platform and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MOLECULAR-IDENTIFICATION; GENUS NOCARDIA; PHYLOGENY; TAXONOMY; SYSTEM; GENES; GYRB; PCR; DNA	Species identification of Nocardia is not straightforward due to rapidly evolving taxonomy, insufficient discriminatory power of conventional phenotypic methods and also of single gene locus analysis including 16S rRNA gene sequencing. Here we evaluated the ability of a 5-locus (16S rRNA, gyrB, secA1, hsp65 and rpoB) multilocus sequence analysis (MLSA) approach as well as that of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) in comparison with sequencing of the 5'-end 606 bp partial 16S rRNA gene to provide identification of 25 clinical isolates of Nocardia. The 5'-end 606 bp 16S rRNA gene sequencing successfully assigned 24 of 25 (96%) clinical isolates to species level, namely Nocardia cyriacigeorgica (n = 12, 48%), N. farcinica (n = 9, 36%), N. abscessus (n = 2, 8%) and N. otitidiscaviarum (n = 1, 4%). MLSA showed concordance with 16S rRNA gene sequencing results for the same 24 isolates. However, MLSA was able to identify the remaining isolate as N. wallacei, and clustered N. cyriacigeorgica into three subgroups. None of the clinical isolates were correctly identified to the species level by MALDI-TOF MS analysis using the manufacturer-provided database. A small "in-house" spectral database was established incorporating spectra of five clinical isolates representing the five species identified in this study. After complementation with the "in-house" database, of the remaining 20 isolates, 19 (95%) were correctly identified to species level (score >= 2.00) and one (an N. abscessus strain) to genus level (score >= 1.70 and < 2.00). In summary, MLSA showed superior discriminatory power compared with the 5'-end 606 bp partial 16S rRNA gene sequencing for species identification of Nocardia. MALDI-TOF MS can provide rapid and accurate identification but is reliant on a robust mass spectra database.	[Xiao, Meng; Pang, Lu; Fan, Xin; Zhang, Li; Hou, Xin; Cheng, Jing-Wei; Xu, Ying-Chun] Chinese Acad Med Sci, Dept Clin Lab, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Pang, Lu; Li, Hai-Xia] Peking Univ, Hosp 1, Dept Clin Lab, Beijing 100871, Peoples R China; [Chen, Sharon C-A.; Kong, Fanrong] Univ Sydney, Westmead Hosp, Ctr Infect Dis, Westmead, NSW 2145, Australia; [Chen, Sharon C-A.; Kong, Fanrong] Univ Sydney, Westmead Hosp, Microbiol Lab Serv, ICPMR Pathol West, Westmead, NSW 2145, Australia; [Zhao, Yu-Pei] Chinese Acad Med Sci, Dept Gen Surg, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Peking University; University of Sydney; University of Sydney; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Xu, YC (corresponding author), Chinese Acad Med Sci, Dept Clin Lab, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	xycpumch@139.com	Xiao, Meng/J-6518-2017	Xiao, Meng/0000-0003-2103-7008	National Research Special Fund for Public Welfare Industry of Health of China [201402001]; National High Technology Research and Development Program of China (the "863" Program) [2013AA020203]	National Research Special Fund for Public Welfare Industry of Health of China; National High Technology Research and Development Program of China (the "863" Program)	The study was supported by a National Research Special Fund for Public Welfare Industry of Health of China (grant number 201402001, http://www.nhfpc.gov.cn) and a National High Technology Research and Development Program of China (the "863" Program, grant number 2013AA020203, http://program.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosioni J, 2010, INFECTION, V38, P89, DOI 10.1007/s15010-009-9193-9; Brown-Elliott BA, 2006, CLIN MICROBIOL REV, V19, P259, DOI 10.1128/CMR.19.2.259-282.2006; Buckwalter SP, 2016, J CLIN MICROBIOL, V54, P376, DOI 10.1128/JCM.02128-15; Carrasco G, 2015, J CLIN MICROBIOL, V53, P997, DOI 10.1128/JCM.03072-14; Carrasco G, 2013, J CLIN MICROBIOL, V51, P3602, DOI 10.1128/JCM.00515-13; Clark NM, 2009, AM J TRANSPLANT, V9, pS70, DOI 10.1111/j.1600-6143.2009.02896.x; Conville PS, 2006, J CLIN MICROBIOL, V44, P2760, DOI 10.1128/JCM.00155-06; Conville PS, 2005, J CLIN MICROBIOL, V43, P2881, DOI 10.1128/JCM.43.6.2881-2885.2005; Dunne WM, 2014, J CLIN MICROBIOL, V52, P3654, DOI 10.1128/JCM.01728-14; Farfour E, 2012, J CLIN MICROBIOL, V50, P2702, DOI 10.1128/JCM.00368-12; Hsueh PR, 2014, J CLIN MICROBIOL, V52, P2371, DOI 10.1128/JCM.00456-14; Khot PD, 2015, J CLIN MICROBIOL, V53, P3366, DOI 10.1128/JCM.00780-15; Kong FR, 2010, J CLIN MICROBIOL, V48, P3928, DOI 10.1128/JCM.01113-10; Kong Fanrong, 2009, Open Microbiol J, V3, P97, DOI 10.2174/1874285800903010097; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu WL, 2011, EUR J CLIN MICROBIOL, V30, P1341, DOI 10.1007/s10096-011-1227-9; McTaggart LR, 2010, J CLIN MICROBIOL, V48, P4525, DOI 10.1128/JCM.00883-10; Baio PVP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002573; Rodriguez-Nava V, 2006, J CLIN MICROBIOL, V44, P536, DOI 10.1128/JCM.44.2.536-546.2006; Roth A, 2003, J CLIN MICROBIOL, V41, P851, DOI 10.1128/JCM.41.2.851-856.2003; Rudramurthy SM, 2015, J MED MICROBIOL, V64, P1216, DOI 10.1099/jmm.0.000143; Schlaberg R, 2008, J CLIN MICROBIOL, V46, P265, DOI 10.1128/JCM.00937-07; Segawa S, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9078-5; Singhal N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00791; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura T, 2012, ANTON LEEUW INT J G, V102, P481, DOI 10.1007/s10482-012-9780-5; Toyokawa Masahiro, 2013, Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi, V24, P1; Minero MV, 2009, MEDICINE, V88, P250, DOI 10.1097/MD.0b013e3181afa1c8; Verroken A, 2010, J CLIN MICROBIOL, V48, P4015, DOI 10.1128/JCM.01234-10; Versalovic J, 2011, MANUAL CLIN MICROBIO; Wang HL, 2014, AM J CLIN PATHOL, V142, P513, DOI 10.1309/AJCPW84AFTUWMHYU; Xiao M, 2010, J CLIN MICROBIOL, V48, P503, DOI 10.1128/JCM.01761-09; Yin XT, 2007, AM J OPHTHALMOL, V144, P570, DOI 10.1016/j.ajo.2007.06.031; Zhou LT, 2014, EXP THER MED, V8, P1142, DOI 10.3892/etm.2014.1883	35	24	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147487	10.1371/journal.pone.0147487	http://dx.doi.org/10.1371/journal.pone.0147487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808813	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800109
J	Meng, LX; Xie, ZL; Zhang, Q; Li, Y; Yang, F; Chen, ZY; Li, WX; Cao, ZJ; Wu, YL				Meng, Lanxia; Xie, Zili; Zhang, Qian; Li, Yang; Yang, Fan; Chen, Zongyun; Li, Wenxin; Cao, Zhijian; Wu, Yingliang			Scorpion Potassium Channel-blocking Defensin Highlights a Functional Link with Neurotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; defensin; neurotoxin; potassium channel; structure-function	K+ CHANNELS; PROTEOMIC ANALYSIS; INSECT DEFENSINS; STRUCTURAL BASIS; FUNGAL DEFENSIN; KV1.3 CHANNEL; TOXIN; INHIBITOR; PLECTASIN; PEPTIDES	The structural similarity between defensins and scorpion neurotoxins suggests that they might have evolved from a common ancestor. However, there is no direct experimental evidence demonstrating a functional link between scorpion neurotoxins and defensins. The scorpion defensin BmKDfsin4 from Mesobuthus martensii Karsch contains 37 amino acid residues and a conserved cystine-stabilized / structural fold. The recombinant BmKDfsin4, a classical defensin, has been found to have inhibitory activity against Gram-positive bacteria such as Staphylococcus aureus, Bacillus subtilis, and Micrococcus luteus as well as methicillin-resistant Staphylococcus aureus. Interestingly, electrophysiological experiments showed that BmKDfsin4,like scorpion potassium channel neurotoxins, could effectively inhibit Kv1.1, Kv1.2, and Kv1.3 channel currents, and its IC50 value for the Kv1.3 channel was 510.2 nm. Similar to the structure-function relationships of classical scorpion potassium channel-blocking toxins, basic residues (Lys-13 and Arg-19) of BmKDfsin4 play critical roles in peptide-Kv1.3 channel interactions. Furthermore, mutagenesis and electrophysiological experiments demonstrated that the channel extracellular pore region is the binding site of BmKDfsin4, indicating that BmKDfsin4adopts the same mechanism for blocking potassium channel currents as classical scorpion toxins. Taken together, our work identifies scorpion BmKDfsin4 as the first invertebrate defensin to block potassium channels. These findings not only demonstrate that defensins from invertebrate animals are a novel type of potassium channel blockers but also provide evidence of a functional link between defensins and neurotoxins.	[Meng, Lanxia; Xie, Zili; Zhang, Qian; Li, Yang; Yang, Fan; Chen, Zongyun; Li, Wenxin; Cao, Zhijian; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Li, Wenxin; Cao, Zhijian; Wu, Yingliang] Wuhan Univ, Ctr BioDrug Res, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Cao, ZJ; Wu, YL (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	zjcao@whu.edu.cn; ylwu@whu.edu.cn			National Natural Sciences Foundation of China [31470812, 31170789]; National Science Fund for Excellent Young Scholars [31422049]; Hubei Science Fund for Excellent Scholars [2015CFA042]; Wuhan University Natural Sciences Foundation [2042015kf0168]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Excellent Young Scholars; Hubei Science Fund for Excellent Scholars; Wuhan University Natural Sciences Foundation	This work was supported by National Natural Sciences Foundation of China Grants 31470812 and 31170789, National Science Fund for Excellent Young Scholars Grant 31422049, Hubei Science Fund for Excellent Scholars Grant 2015CFA042, and Wuhan University Natural Sciences Foundation Grant 2042015kf0168. The authors declare that they have no conflicts of interest with the contents of this article.	Batista CVF, 2006, PROTEOMICS, V6, P3718, DOI 10.1002/pmic.200500525; BONTEMS F, 1991, EUR J BIOCHEM, V196, P19, DOI 10.1111/j.1432-1033.1991.tb15780.x; Cao ZJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3602; CHALK R, 1995, P ROY SOC B-BIOL SCI, V261, P217, DOI 10.1098/rspb.1995.0139; Chen ZY, 2012, J BIOL CHEM, V287, P13813, DOI 10.1074/jbc.M112.343996; Chen ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09881; Chen ZY, 2014, BIOCHEM BIOPH RES CO, V447, P70, DOI 10.1016/j.bbrc.2014.03.101; COCIANCICH S, 1993, BIOCHEM BIOPH RES CO, V194, P17, DOI 10.1006/bbrc.1993.1778; CREST M, 1992, J BIOL CHEM, V267, P1640; de la Vega RCR, 2005, TRENDS GENET, V21, P330, DOI 10.1016/j.tig.2005.03.009; de Oliveira UC, 2015, TOXICON, V95, P52, DOI 10.1016/j.toxicon.2014.12.013; Dunlop JA, 2007, ARTHROPOD STRUCT DEV, V36, P245, DOI 10.1016/j.asd.2006.09.003; EhretSabatier L, 1996, J BIOL CHEM, V271, P29537, DOI 10.1074/jbc.271.47.29537; Felix JP, 1999, BIOCHEMISTRY-US, V38, P4922, DOI 10.1021/bi982954w; Feng J, 2015, J BIOL CHEM, V290, P15487, DOI 10.1074/jbc.M115.639500; Feng J, 2013, J BIOL CHEM, V288, P12544, DOI 10.1074/jbc.M112.433888; Froy O, 2004, J PEPT SCI, V10, P714, DOI 10.1002/psc.578; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Gan GL, 2008, J BIOL CHEM, V283, P24177, DOI 10.1074/jbc.M800179200; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Goyffon Max, 1998, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V192, P445; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Han S, 2010, J PROTEOME RES, V9, P3118, DOI 10.1021/pr100027k; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; MagetDana R, 1997, BIOPHYS J, V73, P2527, DOI 10.1016/S0006-3495(97)78281-X; Mouhat S, 2005, BIOCHEM J, V385, P95, DOI 10.1042/BJ20041379; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Ng TB, 2013, CURR PROTEIN PEPT SC, V14, P515, DOI 10.2174/13892037113149990068; ROMI R, 1993, J BIOL CHEM, V268, P26302; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Xiang F, 2015, TOXINS, V7, P34, DOI 10.3390/toxins7010034; Xie ZL, 2015, FASEB J, V29, P4324, DOI 10.1096/fj.15-274787; Xu XB, 2014, J PROTEOMICS, V106, P162, DOI 10.1016/j.jprot.2014.04.032; Yang WS, 2015, CELL MOL LIFE SCI, V72, P845, DOI 10.1007/s00018-014-1715-z; Yi H, 2008, PROTEINS, V70, P844, DOI 10.1002/prot.21706; Zhu S, 2005, CELL MOL LIFE SCI, V62, P2257, DOI 10.1007/s00018-005-5200-6; Zhu S, 2004, CELL MOL LIFE SCI, V61, P1751, DOI 10.1007/s00018-004-4149-1; Zhu SY, 2014, MOL BIOL EVOL, V31, P546, DOI 10.1093/molbev/msu038; Zhu SY, 2012, P NATL ACAD SCI USA, V109, P8495, DOI 10.1073/pnas.1201263109	42	35	39	2	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7097	7106		10.1074/jbc.M115.680611	http://dx.doi.org/10.1074/jbc.M115.680611			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26817841	hybrid, Green Published			2022-12-26	WOS:000373299700043
J	Clements, J; Schoville, S; Peterson, N; Lan, Q; Groves, RL				Clements, Justin; Schoville, Sean; Peterson, Nathan; Lan, Que; Groves, Russell L.			Characterizing Molecular Mechanisms of Imidacloprid Resistance in Select Populations of Leptinotarsa decemlineata in the Central Sands Region of Wisconsin	PLOS ONE			English	Article							COLORADO POTATO BEETLE; RNA-SEQ; NEONICOTINOID INSECTICIDES; CROSS-RESISTANCE; OVER-EXPRESSION; COLEOPTERA	The Colorado potato beetle, Leptinotarsa decemlineata (Say), is a major agricultural pest in the Central Sands region of Wisconsin. Imidacloprid, a neonicotinoid insecticide, has commonly been used for control of L. decemlineata since its registration in 1995. In the last 10 years, many field populations of L. decemlineata have begun to show increasing imidacloprid resistance. We studied resistance phenotype as a phenomenon that reduces neonicotinoid efficacy and has practical consequences for potato pest management. Although we have not observed complete field failure following the use of these products, multiple studies have demonstrated that the lethal concentration to kill 50% of the test organisms (LC50) in different field populations of L. decemlineata varies greatly which may suggest that resistance of L. decemlineata is heritable and involves genetic changes. An important challenge in understanding resistance is assessing the genetic mechanisms associated with resistance and classifying up-regulated genes that may be involved in combating an insecticide insult. In this study we uncovered trends in imidacloprid phenotypic response that have developed in the region by estimating the LC50 values among different field populations against a range of imidacloprid doses. The LC50 values collected in 2008-2011, and more recently in 2013 and 2014, show that some field locations remain susceptible to imidacloprid, while nearby fields (<100km) have developed high levels of resistance. We also sought to uncover potential mechanisms of resistance at each field location. We compiled a transcriptome for populations, characterized as phenotypically 'susceptible' and 'resistant', by isolating mRNA from adult beetles and analyzing gene expression level differences. Strong differences were observed in constituently up and down-regulated genes among different field populations. Most significantly, the up-regulation of 3 cytochrome p450s and a glutathione synthetase related protein in multiple resistant populations provide a mechanistic explanation of resistance evolution in L. decemlineata.	[Clements, Justin; Schoville, Sean; Peterson, Nathan; Lan, Que; Groves, Russell L.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Groves, RL (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	groves@entomology.wisc.edu	Schoville, Sean D./J-8061-2012; Clements, Justin/Q-6248-2018; Schoville, Sean D./AAY-5324-2020	Schoville, Sean D./0000-0001-7364-434X; Clements, Justin/0000-0001-5482-7984; Schoville, Sean D./0000-0001-7364-434X	Wisconsin Potato Industry Board; National Potato Council's State Cooperative Research Program; University of Wisconsin	Wisconsin Potato Industry Board; National Potato Council's State Cooperative Research Program; University of Wisconsin	This research was partially supported by a combination of funding from the: (1) Wisconsin Potato Industry Board, (2) National Potato Council's State Cooperative Research Program FY11-13, and (3) University of Wisconsin, Hatch Formula 142 Funds.	Alyokhin A, 2006, AM J POTATO RES, V83, P485, DOI 10.1007/BF02883509; Alyokhin A, 2008, AM J POTATO RES, V85, P395, DOI 10.1007/s12230-008-9052-0; Casida JE, 2011, NEONICOTINOID METABO, P2923; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Daborn P, 2001, MOL GENET GENOMICS, V266, P556, DOI 10.1007/s004380100531; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; Fox J, 2004, GETTING STARTED R CO, P1; Geer LY, 2009, NUCL ACIDS RES S1, V38, P492; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HARE JD, 1990, ANNU REV ENTOMOL, V35, P81, DOI 10.1146/annurev.en.35.010190.000501; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huseth AS, 2013, J ECON ENTOMOL, V106, P2491, DOI 10.1603/EC13277; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; Kennedy C.J., 2013, ENVIRON TOXICOL, P689, DOI DOI 10.1007/978-1-4614-5764-0_23; KUMAR A, 2014, PLOS ONE, V9; Liu ZW, 2005, P NATL ACAD SCI USA, V102, P8420, DOI 10.1073/pnas.0502901102; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; Mota-Sanchez D, 2008, GLOBAL PESTICIDE RESISTANCE IN ARTHROPODS, P32, DOI 10.1079/9781845933531.0032; Mota-Sanchez D, 2006, PEST MANAG SCI, V62, P30, DOI 10.1002/ps.1120; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SAS Institute, 2011, SAS STAT 9 3 US GUID; Sexson DL, 2005, J ECON ENTOMOL, V98, P716, DOI 10.1603/0022-0493-98.3.716; Szendrei Z, 2012, PEST MANAG SCI, V68, P941, DOI 10.1002/ps.3258; Tao T, 2008, STANDALONE BLAST SET, P1; Tomizawa M, 2009, ACCOUNTS CHEM RES, V42, P260, DOI 10.1021/ar800131p; Weber D., 2003, Pesticide Outlook, V14, P256, DOI 10.1039/b314847p; Zhao JZ, 2000, J ECON ENTOMOL, V93, P1508, DOI 10.1603/0022-0493-93.5.1508; Zhu F, 2011, PEST MANAG SCI, V67, P175, DOI 10.1002/ps.2048	29	41	45	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147844	10.1371/journal.pone.0147844	http://dx.doi.org/10.1371/journal.pone.0147844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821361	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528400049
J	Giri, AK; Midha, S; Banerjee, P; Agrawal, A; Mehdi, SJ; Dhingra, R; Kaur, I; Kumar, GR; Lakhotia, R; Ghosh, S; Das, K; Mohindra, S; Rana, S; Bhasin, DK; Garg, PK; Bharadwaj, D				Giri, Anil K.; Midha, Shallu; Banerjee, Priyanka; Agrawal, Ankita; Mehdi, Syed Jafar; Dhingra, Rajan; Kaur, Ismeet; Kumar, Ramesh G.; Lakhotia, Ritika; Ghosh, Saurabh; Das, Kshaunish; Mohindra, Samir; Rana, Surinder; Bhasin, Deepak K.; Garg, Pramod K.; Bharadwaj, Dwaipayan		INDIPAN & INDICO Consortium	Common Variants in CLDN2 and MORC4 Genes Confer Disease Susceptibility in Patients with Chronic Pancreatitis	PLOS ONE			English	Article							TROPICAL CALCIFIC PANCREATITIS; CATIONIC TRYPSINOGEN GENE; INHIBITOR MUTATIONS; RECURRENT ACUTE; ASSOCIATION; SPINK1; POLYMORPHISMS; EXPRESSION; REGION; PRSS1	A recent genome-wide association study (GWAS) identified association with variants in X-linked CLDN2 and MORC4, and PRSS1-PRSS2 loci with chronic pancreatitis (CP) in North American patients of European ancestry. We selected 9 variants from the reported GWAS and replicated the association with CP in Indian patients by genotyping 1807 unrelated Indians of Indo-European ethnicity, including 519 patients with CP and 1288 controls. The etiology of CP was idiopathic in 83.62% and alcoholic in 16.38% of 519 patients. Our study confirmed a significant association of 2 variants in CLDN2 gene (rs4409525-OR 1.71, P = 1.38 x 10(-09); rs12008279-OR 1.56, P = 1.53 x 10(-04)) and 2 variants in MORC4 gene (rs12688220-OR 1.72, P = 9.20 x 10(-09); rs6622126-OR 1.75, P = 4.04x10(-05)) in Indian patients with CP. We also found significant association at PRSS1-PRSS2 locus (OR 0.60; P = 9.92 x 10(-06)) and SAMD12-TNFRSF11B (OR 0.49, 95% CI [0.31-0.78], P = 0.0027). A variant in the gene MORC4 (rs12688220) showed significant interaction with alcohol (OR for homozygous and heterozygous risk allele -14.62 and 1.51 respectively, P = 0.0068) suggesting gene-environment interaction. A combined analysis of the genes CLDN2 and MORC4 based on an effective risk allele score revealed a higher percentage of individuals homozygous for the risk allele in CP cases with 5.09 fold enhanced risk in individuals with 7 or more effective risk alleles compared with individuals with 3 or less risk alleles (P = 1.88 x 10(-14)). Genetic variants in CLDN2 and MORC4 genes were associated with CP in Indian patients.	[Giri, Anil K.; Banerjee, Priyanka; Agrawal, Ankita; Mehdi, Syed Jafar; Kaur, Ismeet; Kumar, Ramesh G.; Lakhotia, Ritika; Bharadwaj, Dwaipayan] CSIR Inst Genom & Integrat Biol, Genom & Mol Med Unit, New Delhi, India; [Giri, Anil K.; Bharadwaj, Dwaipayan] CSIR, Acad Sci & Innovat Res, Inst Genom & Integrat Biol Campus, New Delhi 110001, India; [Midha, Shallu; Dhingra, Rajan; Garg, Pramod K.] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India; [Ghosh, Saurabh] Indian Stat Inst, Human Genet Unit, Kolkata, India; [Das, Kshaunish] Inst Post Grad Med Educ & Res, Dept Gastroenterol, Kolkata, India; [Mohindra, Samir] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow, Uttar Pradesh, India; [Rana, Surinder; Bhasin, Deepak K.] Postgrad Inst Med Educ & Res, Dept Gastroenterol, Chandigarh, India; [Bharadwaj, Dwaipayan] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Statistical Institute; Indian Statistical Institute Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Jawaharlal Nehru University, New Delhi	Bharadwaj, D (corresponding author), CSIR Inst Genom & Integrat Biol, Genom & Mol Med Unit, New Delhi, India.; Bharadwaj, D (corresponding author), CSIR, Acad Sci & Innovat Res, Inst Genom & Integrat Biol Campus, New Delhi 110001, India.; Garg, PK (corresponding author), All India Inst Med Sci, Dept Gastroenterol, New Delhi, India.; Bharadwaj, D (corresponding author), Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India.	pkgarg@aiims.ac.in; db@igib.res.in	Prabhakaran, Dorairaj/B-4147-2011; Agrawal, Ankita/R-2437-2016; Banerjee, Priyanka/N-6890-2019; Mehdi, Syed/P-3498-2019; Banerjee, Priyanka/C-3927-2019; Madhu, S/AAH-7431-2019	Prabhakaran, Dorairaj/0000-0002-3172-834X; Agrawal, Ankita/0000-0003-1055-9142; Banerjee, Priyanka/0000-0001-5054-3095; Mehdi, Syed/0000-0002-2388-0480; Banerjee, Priyanka/0000-0001-5054-3095; Madhu, S/0000-0003-0018-5984; Bharadwaj, Dwaipayan/0000-0001-5268-8482; Banerjee, Monisha/0000-0002-5371-8791; Bandesh, Khushdeep/0000-0002-5057-7313; Tabassum, Rubina/0000-0002-3120-3041; Garg, Pramod Kumar/0000-0001-7015-4396; Reddy, K Srinath/0000-0003-3416-3548; /0000-0003-0941-1458; Agrawal, Anurag/0000-0002-0340-5252	"Genome Wide Association Study of Chronic Pancreatitis" - Department of Biotechnology (DBT) [GAP-83]; "Center for Cardiovascular and Metabolic Disease Research" (CARDIOMED) - Council of Scientific and Industrial Research (CSIR), Government of India [BSC-0122-3]	"Genome Wide Association Study of Chronic Pancreatitis" - Department of Biotechnology (DBT); "Center for Cardiovascular and Metabolic Disease Research" (CARDIOMED) - Council of Scientific and Industrial Research (CSIR), Government of India	This work was supported by "Genome Wide Association Study of Chronic Pancreatitis" (GAP-83) funded by Department of Biotechnology (DBT) and "Center for Cardiovascular and Metabolic Disease Research" (CARDIOMED) (BSC-0122-3), funded by the Council of Scientific and Industrial Research (CSIR), Government of India.	Avanthi SU, 2015, J GASTROEN HEPATOL, V30, P1796, DOI 10.1111/jgh.13029; Bhatia E, 2002, GASTROENTEROLOGY, V123, P1020, DOI 10.1053/gast.2002.36028; Boulling A, 2015, GUT, V64, P1837, DOI 10.1136/gutjnl-2015-310254; Chandak GR, 2004, GUT, V53, P723, DOI 10.1136/gut.2003.026526; Chandak GR, 2002, J MED GENET, V39, P347, DOI 10.1136/jmg.39.5.347; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Cowley MJ, 2012, NUCLEIC ACIDS RES, V40, pD862, DOI 10.1093/nar/gkr967; Derikx MH, 2015, GUT, V64, P1426, DOI 10.1136/gutjnl-2014-307453; Fjeld K, 2015, NAT GENET, V47, P518, DOI 10.1038/ng.3249; Garg PK, 2004, J GASTROEN HEPATOL, V19, P998, DOI 10.1111/j.1440-1746.2004.03426.x; Garg Pramod Kumar, 2012, Curr Gastroenterol Rep, V14, P118, DOI 10.1007/s11894-012-0241-0; Gorry MC, 1997, GASTROENTEROLOGY, V113, P1063, DOI 10.1053/gast.1997.v113.pm9322498; INdian DIabetes COnsortium, 2011, Hugo J, V5, P65, DOI 10.1007/s11568-011-9157-2; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Kume K, 2009, GUT, V58, P820, DOI 10.1136/gut.2008.151688; Lee JH, 2011, ONCOL REP, V25, P971, DOI 10.3892/or.2011.1132; Liggins AP, 2007, BRIT J HAEMATOL, V138, P479, DOI 10.1111/j.1365-2141.2007.06680.x; Mahurkar S, 2006, GUT, V55, P1270, DOI 10.1136/gut.2005.087403; Masamune A, 2015, GUT, V64, P1345, DOI 10.1136/gutjnl-2015-309802; Midha S, 2010, GUT, V59, P800, DOI 10.1136/gut.2009.191239; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Sakaguchi T, 2002, J BIOL CHEM, V277, P21361, DOI 10.1074/jbc.M110261200; Santhosh S, 2008, PANCREAS, V36, P317, DOI 10.1097/MPA.0b013e31815db4b3; Satoh K, 2001, PANCREAS, V23, P251, DOI 10.1097/00006676-200110000-00005; Schrader J, 2007, DIABETOLOGIA, V50, P1243, DOI 10.1007/s00125-007-0672-6; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Soderman J, 2013, WORLD J GASTROENTERO, V19, P4935, DOI 10.3748/wjg.v19.i30.4935; Sundaresan S, 2009, PANCREATOLOGY, V9, P145, DOI 10.1159/000178885; Tabassum R, 2013, DIABETES, V62, P977, DOI 10.2337/db12-0406; Toffoli B, 2011, MOL CELL ENDOCRINOL, V331, P136, DOI 10.1016/j.mce.2010.08.019; Wang W, 2013, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2013-269; Whitcomb DC, 2012, NAT GENET, V44, P1349, DOI 10.1038/ng.2466; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 1999, GASTROENTEROLOGY, V117, P7, DOI 10.1016/S0016-5085(99)70543-3; Witt H, 2006, NAT GENET, V38, P668, DOI 10.1038/ng1797; Witt H, 2007, GASTROENTEROLOGY, V132, P1557, DOI 10.1053/j.gastro.2007.03.001; Witt H, 2013, NAT GENET, V45, P1216, DOI 10.1038/ng.2730; Yadav D, 2009, ARCH INTERN MED, V169, P1035, DOI 10.1001/archinternmed.2009.125	40	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147345	10.1371/journal.pone.0147345	http://dx.doi.org/10.1371/journal.pone.0147345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820620	gold, Green Published			2022-12-26	WOS:000369528400021
J	Francis, SC; Hou, Y; Baisley, K; van de Wijgert, J; Watson-Jones, D; Ao, TT; Herrera, C; Maganja, K; Andreasen, A; Kapiga, S; Coulton, GR; Hayes, RJ; Shattock, RJ				Francis, Suzanna C.; Hou, Yanwen; Baisley, Kathy; van de Wijgert, Janneke; Watson-Jones, Deborah; Ao, Trong T.; Herrera, Carolina; Maganja, Kaballa; Andreasen, Aura; Kapiga, Saidi; Coulton, Gary R.; Hayes, Richard J.; Shattock, Robin J.			Immune Activation in the Female Genital Tract: Expression Profiles of Soluble Proteins in Women at High Risk for HIV Infection	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; DOUBLE-BLIND; HORMONAL CONTRACEPTION; MENSTRUAL-CYCLE; BACTERIAL VAGINOSIS; MICROBICIDE SAFETY; REPRODUCTIVE-TRACT; VAGINAL FLUID; SEMINAL FLUID; TRIAL	Soluble cervicovaginal biomarkers of inflammation, immune activation and risk of HIV acquisition are needed to reliably assess the safety of new biomedical prevention strategies including vaccines and microbicides. However, a fuller understanding of expression profiles in women at high risk for HIV infection is crucial to the effective use of these potential biomarkers in Phase 3 trial settings. We have measured 45 soluble proteins and peptides in cervicovaginal lavage samples from 100 HIV negative women at high risk for HIV infection. Women were followed over one menstrual cycle to investigate modulation by hormonal contraception, menstrual cycle phase, recent sexual exposure and intravaginal practices. Women using injectable DMPA had increased concentration of several soluble proteins of the innate and adaptive immune system, including IL-1 alpha, IL-1 beta, IL-2, MIP-1 beta, IP-10, IL-8, TGF-beta, HBD4, IgA, IgG1, and IgG2. Women using combined oral contraceptives had a similar signature. There were differences in concentrations among samples from post-ovulation compared to pre-ovulation, notably increased immunoglobulins. Increased prostate-specific antigen, indicative of recent sexual exposure, was correlated with increased IL-6, MCP-1, and SLPI, and decreased GM-CSF and HBD3. The identified signature profiles may prove critical in evaluating the potential safety and impact on risk of HIV acquisition of different biomedical intervention strategies.	[Francis, Suzanna C.; Baisley, Kathy; Ao, Trong T.; Kapiga, Saidi; Hayes, Richard J.] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1, England; [Francis, Suzanna C.; Watson-Jones, Deborah; Ao, Trong T.; Maganja, Kaballa; Andreasen, Aura; Kapiga, Saidi] Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania, Tanzania; [Hou, Yanwen; Coulton, Gary R.] Univ London, St Georges Med Sch, Div Basic Med Sci, London, England; [van de Wijgert, Janneke] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Herrera, Carolina; Shattock, Robin J.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Mucosal Infect & Immun Grp, London, England; [Watson-Jones, Deborah; Andreasen, Aura] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; St Georges University London; University of London; University of Liverpool; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Francis, SC (corresponding author), London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1, England.; Francis, SC (corresponding author), Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania, Tanzania.	suzanna.francis@lshtm.ac.uk		van de Wijgert, Janneke H.H.M./0000-0003-2728-4560; Herrera, Carolina/0000-0003-3701-752X; Andreasen, Aura/0000-0003-0664-7342; Hayes, Richard/0000-0002-1729-9892; Kapiga, Saidi/0000-0003-1753-4060; Francis, Suzanna Carter/0000-0002-3724-4813	European and Developing Countries Clinical Trials Partnership [CT_ct_05_32070_002]; European Combined Highly Active Retroviral Microbicides (CHAARM-FP7) [242135]; International Partnership for Microbicides; Medical Research Council (MRC); Department for International Development (DFID) [G1002369]; MRC DFID [G0700837]; MRC [G0701039, G1002369, G0901756, G0700837] Funding Source: UKRI; Medical Research Council [MR/K012126/1, G0901756, G1002369, G0700837, G0701039] Funding Source: researchfish	European and Developing Countries Clinical Trials Partnership; European Combined Highly Active Retroviral Microbicides (CHAARM-FP7); International Partnership for Microbicides; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development (DFID); MRC DFID(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Financial support for the Biomarkers Project was provided by the European and Developing Countries Clinical Trials Partnership (project code: CT_ct_05_32070_002), the European Combined Highly Active Retroviral Microbicides (CHAARM-FP7 - Grant agreement no 242135 -www.chaarm.eu), the International Partnership for Microbicides, the Medical Research Council (MRC) and Department for International Development (DFID) with S.C. Francis (G1002369), R.J. Hayes and K. Baisley (G0700837) receiving MRC & DFID support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Al-Harthi L, 2001, AIDS, V15, P1535, DOI 10.1097/00002030-200108170-00011; Al-Harthi L, 2000, J INTERF CYTOK RES, V20, P719, DOI 10.1089/10799900050116426; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Biancotto A, 2007, BLOOD, V109, P4272, DOI 10.1182/blood-2006-11-055764; Bollen LJM, 2008, JAIDS-J ACQ IMM DEF, V47, P253, DOI 10.1097/QAI.0b013e31815d2f12; Bright PL, 2011, CONTRACEPTION, V84, P512, DOI 10.1016/j.contraception.2011.02.002; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Chandra N, 2013, AIDS RES HUM RETROV, V29, P592, DOI 10.1089/aid.2012.0271; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cummins JE, 2009, SEX TRANSM DIS, V36, pS84, DOI 10.1097/OLQ.0b013e3181994191; Deese J, 2015, AM J REPROD IMMUNOL, V74, P357, DOI 10.1111/aji.12415; Doyle AM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000287; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; Fichorova RN, 2011, CYTOKINE, V55, P134, DOI 10.1016/j.cyto.2011.03.016; Fichorova RN, 2009, J REPROD IMMUNOL, V83, P185, DOI 10.1016/j.jri.2009.08.007; Fichorova RN, 2004, JAIDS-J ACQ IMM DEF, V37, pS184, DOI 10.1097/00126334-200410013-00010; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Fichorova RN, 2001, INFECT IMMUN, V69, P5840, DOI 10.1128/IAI.69.9.5840-5848.2001; Fischetti L, 2009, AIDS, V23, P319, DOI 10.1097/QAD.0b013e328321b778; Francis SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059085; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hilber AM, 2007, SEX TRANSM INFECT, V83, P505, DOI 10.1136/sti.2007.028597; Hilber AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009119; Hochmeister MN, 1999, J FORENSIC SCI, V44, P1057; Huijbregts RPH, 2013, ENDOCRINOLOGY, V154, P1282, DOI 10.1210/en.2012-1850; Hwang LY, 2011, J REPROD IMMUNOL, V88, P66, DOI 10.1016/j.jri.2010.07.008; Kapiga SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068825; Kassam A, 1996, ENVIRON HEALTH PERSP, V104, P408, DOI 10.2307/3432685; Keller MJ, 2007, AIDS, V21, P467, DOI 10.1097/QAD.0b013e328013d9b5; Kyongo JK, 2015, CLIN VACCINE IMMUNOL, V22, P526, DOI 10.1128/CVI.00762-14; Kyongo JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043951; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Lu FX, 1999, INFECT IMMUN, V67, P6321; Macaluso M, 1999, CONTRACEPTION, V59, P195, DOI 10.1016/S0010-7824(99)00013-X; Mauck Christine, 2004, MANUAL STANDARDIZATI; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Morrison C, 2014, JAIDS-J ACQ IMM DEF, V66, P109, DOI 10.1097/QAI.0000000000000103; Morrison CS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001778; Moscicki AB, 2012, JAIDS-J ACQ IMM DEF, V59, P134, DOI 10.1097/QAI.0b013e31823f2aeb; NORVELL MK, 1984, J REPROD MED, V29, P269; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Connor KA, 2006, HUM REPROD, V21, P1442, DOI 10.1093/humrep/dei497; Rebbapragada A, 2008, JAIDS-J ACQ IMM DEF, V49, P520, DOI 10.1097/QAI.0b013e318189a7ca; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robertson SA, 2005, CELL TISSUE RES, V322, P43, DOI 10.1007/s00441-005-1127-3; Schwartz JL, 2006, CONTRACEPTION, V74, P133, DOI 10.1016/j.contraception.2006.02.008; Sharkey DJ, 2012, J IMMUNOL, V188, P2445, DOI 10.4049/jimmunol.1102736; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UN Joint Programme on HIV/AIDS, 2012, GLOB EP UNAIDS REP G; United Nations, 2013, WORLD CONTR PATT 201, P11, DOI DOI 10.1016/S0140; USALA SJ, 1989, J REPROD MED, V34, P292; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Wira CR, 2014, AM J REPROD IMMUNOL, V72, P171, DOI 10.1111/aji.12235; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	59	42	43	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0143109	10.1371/journal.pone.0143109	http://dx.doi.org/10.1371/journal.pone.0143109			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814891	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000369528200001
J	Lecarpentier, E; Bhatt, M; Bertin, GI; Deloison, B; Salomon, LJ; Deloron, P; Fournier, T; Barakat, AI; Tsatsaris, V				Lecarpentier, E.; Bhatt, M.; Bertin, G. I.; Deloison, B.; Salomon, L. J.; Deloron, P.; Fournier, T.; Barakat, A. I.; Tsatsaris, V.			Computational Fluid Dynamic Simulations of Maternal Circulation: Wall Shear Stress in the Human Placenta and Its Biological Implications	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CHONDROITIN SULFATE; BLOOD-FLOW; CELL; MICROVILLI; PREGNANCY; PROTEINS; MECHANOTRANSDUCTION; DIFFERENTIATION; INVOLVEMENT	Introduction In the human placenta the maternal blood circulates in the intervillous space (IVS). The syncytiotrophoblast (STB) is in direct contact with maternal blood. The wall shear stress (WSS) exerted by the maternal blood flow on the STB has not been evaluated. Our objective was to determine the physiological WSS exerted on the surface of the STB during the third trimester of pregnancy. Material and Methods To gain insight into the shear stress levels that the STB is expected to experience in vivo, we have formulated three different computational models of varying levels of complexity that reflect different physical representations of the IVS. Computations of the flow fields in all models were performed using the CFD module of the finite element code COMSOL Multi-physics 4.4. The mean velocity of maternal blood in the IVS during the third trimester was measured in vivo with dynamic MRI (0.94 +/- 0.14 mm.s(-1)). To investigate if the in silico results are consistent with physiological observations, we studied the cytoadhesion of human parasitized (Plasmodium falciparum) erythrocytes to primary human STB cultures, in flow conditions with different WSS values. Results The WSS applied to the STB is highly heterogeneous in the IVS. The estimated average values are relatively low (0.5 +/- 0.2 to 2.3 +/- 1.1 dyn.cm(-2)). The increase of WSS from 0.15 to 5 dyn.cm(-2) was associated with a significant decrease of infected erythrocyte cytoadhesion. No cytoadhesion of infected erythrocytes was observed above 5 dyn.cm(-2) applied for one hour. Conclusion Our study provides for the first time a WSS estimation in the maternal placental circulation. In spite of high maternal blood flow rates, the average WSS applied at the surface of the chorionic villi is low (<5 dyn.cm(-2)). These results provide the basis for future physiologicallyrelevant in vitro studies of the biological effects of WSS on the STB.	[Lecarpentier, E.; Fournier, T.; Tsatsaris, V.] INSERM, UMR S 1139, Paris, France; [Lecarpentier, E.; Deloison, B.; Salomon, L. J.; Fournier, T.; Tsatsaris, V.] Univ Paris 05, PRES Sorbonne Paris Cite, Paris, France; [Lecarpentier, E.; Tsatsaris, V.] Grp Hosp Univ Ouest, AP HP, Port Royal Matern,Dept Gynecol Obstet 1, Ctr Hosp Univ Cochin Broca Hotel Dieu, Paris, France; [Lecarpentier, E.; Fournier, T.; Tsatsaris, V.] DHU Risques & Grossesse, Paris, France; [Lecarpentier, E.; Fournier, T.; Tsatsaris, V.] PremUP Fdn, Paris, France; [Bertin, G. I.; Deloron, P.] IRD, MERIT UMR216, Paris, France; [Bhatt, M.; Barakat, A. I.] Ecole Polytechn, Lab Hydrodynam LadHyX, CNRS, F-91128 Palaiseau, France; [Deloison, B.; Salomon, L. J.] Paris Cardiovas Res Ctr PARCC, INSERM, U970, Paris, France; [Deloison, B.; Salomon, L. J.] EA FETUS 7328, Paris, France; [Deloison, B.; Salomon, L. J.] Paris Descartes Univ, Hop Necker Enfants Malad, AP HP, Dept Obstet & Fetal Med, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Lecarpentier, E (corresponding author), INSERM, UMR S 1139, Paris, France.; Lecarpentier, E (corresponding author), Univ Paris 05, PRES Sorbonne Paris Cite, Paris, France.; Lecarpentier, E (corresponding author), Grp Hosp Univ Ouest, AP HP, Port Royal Matern,Dept Gynecol Obstet 1, Ctr Hosp Univ Cochin Broca Hotel Dieu, Paris, France.; Lecarpentier, E (corresponding author), DHU Risques & Grossesse, Paris, France.; Lecarpentier, E (corresponding author), PremUP Fdn, Paris, France.	edouard.lecarpentier@wanadoo.fr	Lecarpentier, Edouard/Q-4557-2018; Deloron, Philippe/G-6305-2010; Barakat, Abdul I/AAI-3117-2020; Fournier, Thierry C/E-5836-2016	Deloron, Philippe/0000-0003-4705-2484; Barakat, Abdul I/0000-0002-7551-3631; Bertin, Gwladys/0000-0002-2218-9591; Fournier, Thierry/0000-0002-7515-339X; Deloison, Benjamin/0000-0002-3608-0837; Bhatt, Mrugank/0000-0002-3364-473X	Institut National de la Sante et de la Recherche Medicale (France); PremUP Foundation; AXA Research Fund; Ecole Polytechnique	Institut National de la Sante et de la Recherche Medicale (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); PremUP Foundation; AXA Research Fund(AXA Research Fund); Ecole Polytechnique	EL received a grant from Institut National de la Sante et de la Recherche Medicale (France) to perform this work. This work was supported by the PremUP Foundation. This work was partially funded by a permanent endowment in Cardiovascular Cellular Engineering from the AXA Research Fund (to AIB). MB was supported by an international summer scholarship from Ecole Polytechnique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrakhteh M, 2013, REV BRAS GINECOL OBS, V35, P317, DOI 10.1590/S0100-72032013000700006; ALSAT E, 1993, J CELL PHYSIOL, V154, P122, DOI 10.1002/jcp.1041540115; Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; Benirschke K, 2012, PATHOLOGY HUMAN PLAC; BERRYMAN M, 1995, J CELL BIOL, V131, P1231, DOI 10.1083/jcb.131.5.1231; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Chernyavsky IL, 2010, PLACENTA, V31, P44, DOI 10.1016/j.placenta.2009.11.003; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Choi HW, 2005, BIORHEOLOGY, V42, P493; Collins SL, 2012, ULTRASOUND OBST GYN, V40, P171, DOI 10.1002/uog.10149; ERIAN FF, 1977, J BIOMECH, V10, P807, DOI 10.1016/0021-9290(77)90095-1; Frendo JL, 2003, J CELL SCI, V116, P3413, DOI 10.1242/jcs.00648; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gysin J, 1999, INFECT IMMUN, V67, P6596; Haase RN, 2006, INFECT IMMUN, V74, P3035, DOI 10.1128/IAI.74.5.3035-3038.2006; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Kurjak A, 1997, J PERINAT MED, V25, P373, DOI 10.1515/jpme.1997.25.4.373; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Rainey A, 2010, PLACENTA, V31, P602, DOI 10.1016/j.placenta.2010.04.005; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Schmid-Schonbein H., 1988, PLACENTAL VASCULARIZ, P17, DOI 10.1007/978-1-4615-8109-3_2; Stepp DW, 2001, AM J PHYSIOL-HEART C, V281, pH796, DOI 10.1152/ajpheart.2001.281.2.H796; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TRUMAN P, 1986, PLACENTA, V7, P95, DOI 10.1016/S0143-4004(86)80001-7; TRUMAN P, 1986, PLACENTA, V7, P111, DOI 10.1016/S0143-4004(86)80002-9; VANDERPUYE OA, 1986, BIOCHEM J, V233, P351, DOI 10.1042/bj2330351; Weinbaum S, 2001, BIORHEOLOGY, V38, P119	27	33	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147262	10.1371/journal.pone.0147262	http://dx.doi.org/10.1371/journal.pone.0147262			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815115	Green Published, gold			2022-12-26	WOS:000369528200028
J	Mancini, F; Monaci, E; Lofano, G; Torre, A; Bacconi, M; Tavarini, S; Sammicheli, C; Arcidiacono, L; Galletti, B; Laera, D; Pallaoro, M; Tuscano, G; Fontana, MR; Bensi, G; Grandi, G; Rossi-Paccani, S; Nuti, S; Rappuoli, R; De Gregorio, E; Bagnoli, F; Soldaini, E; Bertholet, S				Mancini, Francesca; Monaci, Elisabetta; Lofano, Giuseppe; Torre, Antonina; Bacconi, Marta; Tavarini, Simona; Sammicheli, Chiara; Arcidiacono, Letizia; Galletti, Bruno; Laera, Donatello; Pallaoro, Michele; Tuscano, Giovanna; Fontana, Maria Rita; Bensi, Giuliano; Grandi, Guido; Rossi-Paccani, Silvia; Nuti, Sandra; Rappuoli, Rino; De Gregorio, Ennio; Bagnoli, Fabio; Soldaini, Elisabetta; Bertholet, Sylvie			One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4(+) T Cells, and IL-17A	PLOS ONE			English	Article							ALPHA-TOXIN; MOUSE MODEL; ABSCESS FORMATION; CARDIAC-SURGERY; MURINE MODEL; RISK-FACTORS; INFECTION; IMMUNITY; FHUD2; INTERLEUKIN-17A	A rapidly acting, single dose vaccine against Staphylococcus aureus would be highly beneficial for patients scheduled for major surgeries or in intensive care units. Here we show that one immunization with a multicomponent S. aureus candidate vaccine, 4C-Staph, formulated with a novel TLR7-dependent adjuvant, T7-alum, readily protected mice from death and from bacterial dissemination, both in kidney abscess and peritonitis models, outperforming alum-formulated vaccine. This increased efficacy was paralleled by higher vaccine-specific and a-hemolysin-neutralizing antibody titers and Th1/Th17 cell responses. Antibodies played a crucial protective role, as shown by the lack of protection of 4C-Staph/T7-alum vaccine in B-cell-deficient mice and by serum transfer experiments. Depletion of effector CD4(+) T cells not only reduced survival but also increased S. aureus load in kidneys of mice immunized with 4C-Staph/T7-alum. The role of IL-17A in the control of bacterial dissemination in 4C-Staph/T7-alum vaccinated mice was indicated by in vivo neutralization experiments. We conclude that single dose 4C-Staph/T7-alum vaccine promptly and efficiently protected mice against S. aureus through the combined actions of antibodies, CD4(+) effector T cells, and IL-17A. These data suggest that inclusion of an adjuvant that induces not only fast antibody responses but also IL-17-producing cell-mediated effector responses could efficaciously protect patients scheduled for major surgeries or in intensive care units.	[Mancini, Francesca; Monaci, Elisabetta; Lofano, Giuseppe; Torre, Antonina; Bacconi, Marta; Tavarini, Simona; Sammicheli, Chiara; Arcidiacono, Letizia; Galletti, Bruno; Laera, Donatello; Pallaoro, Michele; Tuscano, Giovanna; Fontana, Maria Rita; Bensi, Giuliano; Grandi, Guido; Rossi-Paccani, Silvia; Nuti, Sandra; Rappuoli, Rino; De Gregorio, Ennio; Bagnoli, Fabio; Soldaini, Elisabetta; Bertholet, Sylvie] Novartis Vaccines & Diagnost Srl, Res Ctr, Siena, Italy; [Mancini, Francesca] Univ Padua, Dept Biomed Sci, Padua, Italy; [Lofano, Giuseppe] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Bacconi, Marta] Univ Siena, Dept Biotechnol Chem & Pharm, Via Laterina 8, I-53100 Siena, Italy; [Mancini, Francesca; Monaci, Elisabetta; Torre, Antonina; Bacconi, Marta; Tavarini, Simona; Sammicheli, Chiara; Arcidiacono, Letizia; Galletti, Bruno; Laera, Donatello; Pallaoro, Michele; Tuscano, Giovanna; Fontana, Maria Rita; Bensi, Giuliano; Rossi-Paccani, Silvia; Nuti, Sandra; Rappuoli, Rino; De Gregorio, Ennio; Bagnoli, Fabio; Soldaini, Elisabetta; Bertholet, Sylvie] GlaxoSmithKline Vaccines Srl, Siena, Italy; [Lofano, Giuseppe] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Grandi, Guido] Univ Trent, Ctr Integrat Biol, Trento, Italy	Novartis; University of Padua; Sapienza University Rome; University of Siena; GlaxoSmithKline; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Trento	Soldaini, E (corresponding author), Novartis Vaccines & Diagnost Srl, Res Ctr, Siena, Italy.; Soldaini, E (corresponding author), GlaxoSmithKline Vaccines Srl, Siena, Italy.	elisabetta.x.soldaini@gsk.com	Pallaoro, Michele/AAU-7429-2020	Mancini, Francesca/0000-0003-2122-9480	Novartis Vaccines and Diagnostics S.r.l.	Novartis Vaccines and Diagnostics S.r.l.	This work was supported by internal funding by Novartis Vaccines and Diagnostics S.r.l. The funder provided support in the form of salaries for all authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Annunziato F, 2015, J ALLERGY CLIN IMMUN, V135, P626, DOI 10.1016/j.jaci.2014.11.001; Bagnoli F, 2015, P NATL ACAD SCI USA, V112, P3680, DOI 10.1073/pnas.1424924112; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; Chen LF, 2012, AM J INFECT CONTROL, V40, P963, DOI 10.1016/j.ajic.2012.01.012; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Cypowyj S, 2012, EUR J IMMUNOL, V42, P2246, DOI 10.1002/eji.201242605; Fattom A, 2015, HUM VACC IMMUNOTHER, V11, P632, DOI 10.4161/hv.34414; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Joshi A, 2012, HUM VACC IMMUNOTHER, V8, P336, DOI DOI 10.4161/HV.18946; Kanafani ZA, 2009, INFECT CONT HOSP EP, V30, P242, DOI 10.1086/596015; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Korea CG, 2014, INFECT IMMUN, V82, P4144, DOI 10.1128/IAI.01576-14; Lanternier F, 2013, CURR OPIN PEDIATR, V25, P736, DOI 10.1097/MOP.0000000000000031; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Maher BM, 2013, INFECT IMMUN, V81, P4478, DOI 10.1128/IAI.01026-13; Maisonneuve C, 2014, P NATL ACAD SCI USA, V111, P12294, DOI 10.1073/pnas.1400478111; Mariotti P, 2013, BIOCHEM J, V449, P683, DOI 10.1042/BJ20121426; Maurer K, 2015, CELL HOST MICROBE, V17, P429, DOI 10.1016/j.chom.2015.03.001; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Meller S, 2015, NAT IMMUNOL, V16, P970, DOI 10.1038/ni.3211; MENZIES BE, 1994, INFECT IMMUN, V62, P1843, DOI 10.1128/IAI.62.5.1843-1847.1994; Mishra RPN, 2012, J INFECT DIS, V206, P1041, DOI 10.1093/infdis/jis463; Murphy AG, 2014, J IMMUNOL, V192, P3697, DOI 10.4049/jimmunol.1303420; Narita K, 2010, INFECT IMMUN, V78, P4234, DOI 10.1128/IAI.00447-10; Pozzi C, 2015, FEMS MICROBIOL REV, V39, P750, DOI 10.1093/femsre/fuv024; Proctor RA, 2012, CLIN INFECT DIS, V54, P1179, DOI 10.1093/cid/cis033; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Rauch S, 2012, INFECT IMMUN, V80, P3721, DOI 10.1128/IAI.00442-12; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Schluepen C, 2013, BIOCHEM J, V455, P273, DOI 10.1042/BJ20130540; Sebulsky MT, 2001, J BACTERIOL, V183, P4994, DOI 10.1128/JB.183.17.4994-5000.2001; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; van Kessel KPM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00467; Vasilakos JP, 2013, EXPERT REV VACCINES, V12, P809, DOI 10.1586/14760584.2013.811208; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wu TYH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009980; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zhang BZ, 2015, INFECT IMMUN, V83, P339, DOI 10.1128/IAI.02498-14	47	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147767	10.1371/journal.pone.0147767	http://dx.doi.org/10.1371/journal.pone.0147767			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812180	gold, Green Submitted, Green Published			2022-12-26	WOS:000369528000052
J	Angenieux, C; Maitre, B; Eckly, A; Lanza, F; Gachet, C; de la Salle, H				Angenieux, Catherine; Maitre, Blandine; Eckly, Anita; Lanza, Francois; Gachet, Christian; de la Salle, Henri			Time-Dependent Decay of mRNA and Ribosomal RNA during Platelet Aging and Its Correlation with Translation Activity	PLOS ONE			English	Article							RETICULATED PLATELETS; PROTEIN-SYNTHESIS; THIAZOLE-ORANGE; IN-VIVO; TURNOVER; MEGAKARYOCYTE; QUIESCENCE; HEMATOLOGY; GRANULES; DYNAMICS	Previous investigations have indicated that RNAs are mostly present in the minor population of the youngest platelets, whereas translation in platelets could be biologically important. To attempt to solve this paradox, we studied changes in the RNA content of reticulated platelets, i.e., young cells brightly stained by thiazole orange (TObright), a fluorescent probe for RNAs. We provoked in mice strong thrombocytopenia followed by dramatic thrombocytosis characterized by a short period with a vast majority of reticulated platelets. During thrombocytosis, the TObright platelet count rapidly reached a maximum, after which TOdim platelets accumulated, suggesting that most of the former were converted into the latter within 12 h. Experiments on platelets, freshly isolated or incubated ex vivo at 37 degrees C, indicated that their "RNA content", here corresponding to the amounts of extracted RNA, and the percentage of TObright platelets were positively correlated. The "RNA Content" normalized to the number of platelets could be 20 to 40 fold higher when 80-90% of the cells were reticulated (20-40 fg/platelet), than when only 5-10% of control cells were TObright (less than 1fg/platelet). TObright platelets, incubated ex vivo at 37 degrees C or transfused into mice, became TOdim within 24 h. Ex vivo at 37 degrees C, platelets lost about half of their ribosomal and beta actin RNAs within 6 hours, and more than 98% of them after 24 hours. Accordingly, fluorescence in situ hybridization techniques confirmed the presence of beta actin mRNAs in most reticulated-enriched platelets, but detected them in only a minor subset of control platelets. In vitro, constitutive translation decreased considerably within less than 6 hours, questioning how protein synthesis in platelets, especially in non-reticulated ones, could have a biological function in vivo. Nevertheless, constitutive transient translation in young platelets under pathological conditions characterized by a dramatic increase in circulating reticulated platelets could deserve to be investigated.	[Angenieux, Catherine; Maitre, Blandine; Eckly, Anita; Lanza, Francois; Gachet, Christian; de la Salle, Henri] INSERM, UMR S949, Strasbourg, France; [Angenieux, Catherine; Maitre, Blandine; Eckly, Anita; Lanza, Francois; Gachet, Christian; de la Salle, Henri] EFS Alsace, Strasbourg, France; [Angenieux, Catherine; Maitre, Blandine; Eckly, Anita; Lanza, Francois; Gachet, Christian; de la Salle, Henri] FMTS, Strasbourg, France; [Angenieux, Catherine; Maitre, Blandine; Eckly, Anita; Lanza, Francois; Gachet, Christian; de la Salle, Henri] Univ Strasbourg, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	de la Salle, H (corresponding author), INSERM, UMR S949, Strasbourg, France.; de la Salle, H (corresponding author), EFS Alsace, Strasbourg, France.; de la Salle, H (corresponding author), FMTS, Strasbourg, France.; de la Salle, H (corresponding author), Univ Strasbourg, Strasbourg, France.	henri.delasalle@efs.sante.fr	De La Salle, Henri/H-9353-2016; Lanza, Francois/H-9252-2016	De La Salle, Henri/0000-0001-5136-0776; Lanza, Francois/0000-0002-5802-4748; Eckly, Anita/0000-0001-9620-4961; maitre, blandine/0000-0002-3264-7330	Association de Recherche et Developpement en Medecine et Sante Publique [UMR-S949]	Association de Recherche et Developpement en Medecine et Sante Publique	Association de Recherche et Developpement en Medecine et Sante Publique supports laboratory UMR-S949. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouElela S, 1997, NUCLEIC ACIDS RES, V25, P1788, DOI 10.1093/nar/25.9.1788; AULT KA, 1992, AM J CLIN PATHOL, V98, P637, DOI 10.1093/ajcp/98.6.637; Berger G, 1998, BLOOD, V92, P4446, DOI 10.1182/blood.V92.11.4446; BOOYSE FM, 1971, THROMB DIATH HAEMOST, V26, P167; Bray PF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-1; Briggs C, 2012, J CLIN PATHOL, V65, P1024, DOI 10.1136/jclinpath-2012-200930; BRUCE IJ, 1987, BIOCHEM PHARMACOL, V36, P1769, DOI 10.1016/0006-2952(87)90236-X; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Buttarello M, 2008, AM J CLIN PATHOL, V130, P104, DOI 10.1309/EK3C7CTDKNVPXVTN; Cesari F, 2008, THROMB HAEMOSTASIS, V99, P930, DOI [10.1160/THOS-01-0002, 10.1160/TH08-01-0002]; Cesari F, 2010, THROMB HAEMOSTASIS, V104, P804, DOI 10.1160/TH10-02-0124; Cremer M, 2010, THROMB HAEMOSTASIS, V103, P1016, DOI 10.1160/TH09-03-0148; DALE GL, 1995, BLOOD, V85, P1822, DOI 10.1182/blood.V85.7.1822.bloodjournal8571822; Defoiche J, 2009, CLIN CHEM, V55, P1824, DOI 10.1373/clinchem.2008.119446; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Eckly A, 2012, METHODS MOL BIOL, V788, P175, DOI 10.1007/978-1-61779-307-3_13; Fujiwara Y, 2013, AUTOPHAGY, V9, P403, DOI 10.4161/auto.23002; GARDEN GA, 1995, MOL CELL NEUROSCI, V6, P293, DOI 10.1006/mcne.1995.1023; Gnatenko DV, 2005, THROMB HAEMOSTASIS, V94, P412, DOI 10.1160/TH05-01-0037; Hase K, 2015, NUCLEIC ACIDS RES, V43, P6439, DOI 10.1093/nar/gkv579; Herter JM, 2014, J THROMB HAEMOST, V12, P1764, DOI 10.1111/jth.12730; Hoffmann JJML, 2014, CLIN CHEM LAB MED, V52, P1107, DOI 10.1515/cclm-2014-0165; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; INGRAM M, 1969, BRIT J HAEMATOL, V17, P225, DOI 10.1111/j.1365-2141.1969.tb01366.x; Jackson SP, 2009, J THROMB HAEMOST, V7, P17, DOI 10.1111/j.1538-7836.2009.03401.x; Kickler TS, 2006, AM J CLIN PATHOL, V125, P282, DOI 10.1309/50H8JYHN9JWCKAM7; KIEFFER N, 1987, EUR J BIOCHEM, V164, P189, DOI 10.1111/j.1432-1033.1987.tb11010.x; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; Lindemann S, 2001, J BIOL CHEM, V276, P33947, DOI 10.1074/jbc.M104281200; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; Londin ER, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-3; Manning KL, 1997, EXP HEMATOL, V25, P1019; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Matic GB, 1998, CYTOMETRY, V34, P229, DOI 10.1002/(SICI)1097-0320(19981015)34:5<229::AID-CYTO4>3.0.CO;2-2; Meintker L, 2013, CLIN CHEM LAB MED, V51, P2125, DOI 10.1515/cclm-2013-0252; NIKOLOV EN, 1987, INT J BIOCHEM, V19, P159, DOI 10.1016/0020-711X(87)90326-0; NIKOLOV EN, 1983, INT J BIOCHEM, V15, P1255, DOI 10.1016/0020-711X(83)90215-X; Parco S, 2012, ONCOTARGETS THER, V5, DOI 10.2147/OTT.S27883; Pillitteri D, 2007, PLATELETS, V18, P119, DOI 10.1080/09537100600800792; Robinson M, 2000, BRIT J HAEMATOL, V108, P859, DOI 10.1046/j.1365-2141.2000.01939.x; Robinson MSC, 1998, BRIT J HAEMATOL, V100, P351; Rosenwald IB, 2001, THROMB HAEMOSTASIS, V85, P142; Rowley JW, 2012, CURR OPIN HEMATOL, V19, P385, DOI 10.1097/MOH.0b013e328357010e; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Dusse LMS, 2015, CLIN CHIM ACTA, V439, P143, DOI 10.1016/j.cca.2014.10.024; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shashkin PN, 2008, J IMMUNOL, V181, P3495, DOI 10.4049/jimmunol.181.5.3495; Strassel C, 2012, EXP CELL RES, V318, P25, DOI 10.1016/j.yexcr.2011.10.003; Thomas MG, 2005, MOL BIOL CELL, V16, P405, DOI 10.1091/mbc.E04-06-0516; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Wada Y, 2011, CYTOTECHNOLOGY, V63, P25, DOI 10.1007/s10616-010-9315-8; Wadhawan V, 2004, ARCH BIOCHEM BIOPHYS, V422, P183, DOI 10.1016/j.abb.2003.12.024; Weyrich AS, 2009, J THROMB HAEMOST, V7, P241, DOI 10.1111/j.1538-7836.2008.03211.x; Weyrich AS, 2007, BLOOD, V109, P1975, DOI 10.1182/blood-2006-08-042192; Zhao M, 2014, NAT MED, V20, P1321, DOI 10.1038/nm.3706; Zucker-Franklin D, 2003, ATLAS BLOOD CELLS FU	57	11	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0148064	10.1371/journal.pone.0148064	http://dx.doi.org/10.1371/journal.pone.0148064			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808079	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800270
J	Drago, M; Franco-Trecu, V; Cardona, L; Inchausti, P; Tapia, W; Paez-Rosas, D				Drago, Massimiliano; Franco-Trecu, Valentina; Cardona, Luis; Inchausti, Pablo; Tapia, Washington; Paez-Rosas, Diego			Stable Isotopes Reveal Long-Term Fidelity to Foraging Grounds in the Galapagos Sea Lion (Zalophus wollebaeki)	PLOS ONE			English	Article							ANTARCTIC FUR-SEAL; OTARIA-FLAVESCENS; LIPID EXTRACTION; MARINE PREDATOR; LIFE-HISTORY; STRATEGIES; BEHAVIOR; CARBON; PREY; EVOLUTION	Most otariids have colony-specific foraging areas during the breeding season, when they behave as central place foragers. However, they may disperse over broad areas after the breeding season and individuals from different colonies may share foraging grounds at that time. Here, stable isotope ratios in the skull bone of adult Galapagos sea lions (Zalophus wollebaeki) were used to assess the long-term fidelity of both sexes to foraging grounds across the different regions of the Galapagos archipelago. Results indicated that the stable isotope ratios (delta C-13 and delta N-15) of sea lion bone significantly differed among regions of the archipelago, without any significant difference between sexes and with a non significant interaction between sex and region. Moreover, standard ellipses, estimated by Bayesian inference and used as a measure of the isotopic resource use area at the population level, overlapped widely for the sea lions from the southern and central regions, whereas the overlap of the ellipses for sea lions from the central and western regions was small and non-existing for those from the western and southern regions. These results suggest that males and females from the same region within the archipelago use similar foraging grounds and have similar diets. Furthermore, they indicate that the exchange of adults between regions is limited, thus revealing a certain degree of foraging philopatry at a regional scale within the archipelago. The constraints imposed on males by an expanded reproductive season (similar to 6 months), resulting from the weak reproductive synchrony among females, and those imposed on females by a very long lactation period (at least one year but up to three years), may explain the limited mobility of adult Galapagos sea lions of both sexes across the archipelago.	[Drago, Massimiliano] Secretaria Educ Super Ciencia Tecnol & Innovac, Programa PROMETEO SENESCYT, Quito, Ecuador; [Drago, Massimiliano; Inchausti, Pablo] Univ Republ UdeLaR, Ctr Univ Reg Este CURE, Dept Ecol & Evolut, Maldonado, Uruguay; [Franco-Trecu, Valentina] Univ Republ UdeLaR, Fac Sci, Dept Ecol & Evolut, Montevideo, Uruguay; [Cardona, Luis] Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain; [Tapia, Washington] Galapagos Natl Pk Serv, Dept Appl Res, Puerto Ayora, Galapagos, Ecuador; [Tapia, Washington] Galapagos Conservancy, Santa Cruz, Galapagos, Ecuador; [Paez-Rosas, Diego] Univ San Francisco Quito, San Cristobal, Galapagos, Ecuador; [Paez-Rosas, Diego] Galapagos Sci Ctr, San Cristobal, Galapagos, Ecuador; [Paez-Rosas, Diego] Unidad Tecn Operat San Cristobal, Direcc Parque Nacl Galapagos, Galapagos, Ecuador	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; University of Barcelona	Drago, M (corresponding author), Secretaria Educ Super Ciencia Tecnol & Innovac, Programa PROMETEO SENESCYT, Quito, Ecuador.; Drago, M (corresponding author), Univ Republ UdeLaR, Ctr Univ Reg Este CURE, Dept Ecol & Evolut, Maldonado, Uruguay.	m.drago@ub.edu	Cardona, Luis/L-1680-2014; Drago, Massimiliano/K-1863-2017; Franco-Trecu, Valentina/L-4649-2019; Páez-Rosas, Diego/X-3047-2019; Franco-Trecu, Valentina/N-5266-2019; Cardona, Luis/AAL-1354-2021	Cardona, Luis/0000-0002-7892-1323; Drago, Massimiliano/0000-0003-2764-9849; Franco-Trecu, Valentina/0000-0003-1791-010X; Páez-Rosas, Diego/0000-0002-2446-9888; Cardona, Luis/0000-0002-7892-1323; Tapia, Washington/0000-0002-5222-1804	Project "Becas PROMETEO" of the Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT), Ecuador	Project "Becas PROMETEO" of the Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT), Ecuador	The research was totally funded by the Project "Becas PROMETEO" of the Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT), Ecuador (http://prometeo.educacionsuperior.gob.ec/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alava JJ, 2006, LOW WAKE FI, P495; Altabet MA, 1999, DEEP-SEA RES PT I, V46, P655, DOI 10.1016/S0967-0637(98)00084-3; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; ANDERSSON M, 1981, ECOLOGY, V62, P538, DOI 10.2307/1937718; Arthur B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120888; Beck CA, 2003, ANIM BEHAV, V66, P777, DOI 10.1006/anbe.2003.2284; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonadonna F, 2001, MAR ECOL PROG SER, V223, P287, DOI 10.3354/meps223287; Bond AL, 2012, WATERBIRDS, V35, P324, DOI 10.1675/063.035.0213; Boness D.J., 1991, P1; Boness DJ, 1996, BIOSCIENCE, V46, P645, DOI 10.2307/1312894; Boyd IL, 2002, MAR ECOL PROG SER, V242, P285, DOI 10.3354/meps242285; Campagna C, 2001, J ZOOL, V255, P205, DOI 10.1017/S0952836901001285; Cassini MH, 1999, BEHAV ECOL, V10, P612, DOI 10.1093/beheco/10.5.612; Cherel Y, 2009, BIOL LETTERS, V5, P830, DOI 10.1098/rsbl.2009.0552; Costa DP, 2007, AQUAT CONSERV, V17, pS44, DOI 10.1002/aqc.917; COSTA DP, 1991, AM ZOOL, V31, P111; Crespo EA, 2015, MAR MAMMAL SCI, V31, P866, DOI 10.1111/mms.12199; Cullen JT, 2001, LIMNOL OCEANOGR, V46, P996; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Davies NB, 1978, BEHAV ECOLOGY EVOLUT, P149; Dellinger T, 1999, CAN J ZOOL, V77, P1204, DOI 10.1139/cjz-77-8-1204; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Drago M, 2015, MAR ECOL PROG SER, V525, P261, DOI 10.3354/meps11236; Drago M, 2009, J ZOOL, V279, P251, DOI 10.1111/j.1469-7998.2009.00613.x; Drago M, 2009, MAR ECOL PROG SER, V384, P273, DOI 10.3354/meps08017; Drago M, 2010, SCI MAR, V74, P589, DOI 10.3989/scimar.2010.74n3589; Edgar GJ, 2008, AQUAT CONSERV, V18, P955, DOI 10.1002/aqc.901; FARRELL JW, 1995, NATURE, V377, P514, DOI 10.1038/377514a0; Franco-Trecu V, 2014, MAR BIOL, V161, P609, DOI 10.1007/s00227-013-2363-9; Hamer KC, 2001, MAR ECOL PROG SER, V224, P283, DOI 10.3354/meps224283; HARRIS MP, 1969, J ZOOL, V159, P145; Heath CB, 2002, ENCY MARINE MAMMALS; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Houston AI, 1987, QUANTITATIVE ANAL BE; Irons DB, 1998, ECOLOGY, V79, P647, DOI 10.2307/176960; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jeglinski JWE, 2012, MAR ECOL PROG SER, V453, P279, DOI 10.3354/meps09649; Kernaleguen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133018; Kernaleguen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032916; Kuhn CE, 2014, CAN J ZOOL, V92, P861, DOI 10.1139/cjz-2014-0087; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; Lorrain A, 2003, ANAL CHIM ACTA, V491, P125, DOI 10.1016/S0003-2670(03)00815-8; Lowther AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074348; Merrick RL, 1997, CAN J ZOOL, V75, P776, DOI 10.1139/z97-099; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Moore SE, 2008, J MAMMAL, V89, P534, DOI 10.1644/07-MAMM-S-312R1.1; Mueller B, 2011, MAR MAMMAL SCI, V27, P350, DOI 10.1111/j.1748-7692.2010.00404.x; Newsome SD, 2006, MAR MAMMAL SCI, V22, P556, DOI 10.1111/j.1748-7692.2006.00043.x; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Orians G.H., 1979, P155; Paez-Rosas D, 2008, THESIS I POLITECNICO; Paez-Rosas D., 2011, THESIS I POLITECNICO; Paez-Rosas D, 2014, J MAR BIOL ASSOC UK, V94, P1099, DOI 10.1017/S002531541300163X; Paez-Rosas D, 2012, J EXP MAR BIOL ECOL, V424, P44, DOI 10.1016/j.jembe.2012.05.001; Paez-Rosas D, 2010, MAR BIOL, V157, P2769, DOI 10.1007/s00227-010-1535-0; Palacios DM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016232; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Porschmann U, 2010, MOL ECOL, V19, P2574, DOI 10.1111/j.1365-294X.2010.04665.x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Core Team, 2021, R LANGUAGE ENV STAT; RAU GH, 1992, GEOCHIM COSMOCHIM AC, V56, P1413, DOI 10.1016/0016-7037(92)90073-R; Raum-Suryan KL, 2002, MAR MAMMAL SCI, V18, P746, DOI 10.1111/j.1748-7692.2002.tb01071.x; Reid K, 2005, CAN J ZOOL, V83, P604, DOI 10.1139/Z05-045; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; Riet-Sapriza FG, 2013, DEEP-SEA RES PT II, V88-89, P106, DOI 10.1016/j.dsr2.2012.09.005; Riofrio-Lazo M, 2013, RAPID COMMUN MASS SP, V27, P1076, DOI 10.1002/rcm.6556; Robson BW, 2004, CAN J ZOOL, V82, P20, DOI 10.1139/Z03-208; Ruttenberg BI, 2005, OECOLOGIA, V145, P394, DOI 10.1007/s00442-005-0150-0; Ryan C, 2012, RAPID COMMUN MASS SP, V26, P2745, DOI 10.1002/rcm.6394; Salazar SK, 2005, THESIS I POLITECNICO; Schulz TM, 2005, ECOL MONOGR, V75, P159, DOI 10.1890/04-0319; Sivertsen E., 1954, Kongelige Norske Videnskabernes Selskabsforhandlinger, V26, P1; Sotiropoulos MA, 2004, ECOL FRESHW FISH, V13, P155, DOI 10.1111/j.1600-0633.2004.00056.x; Soto KH, 2006, MAR ECOL PROG SER, V312, P277, DOI 10.3354/meps312277; Soto KH, 2004, J ZOOL, V264, P419, DOI 10.1017/s0952836904005965; STAMPS J, 1995, AM NAT, V146, P41, DOI 10.1086/285786; Staniland IJ, 2007, MAR BIOL, V152, P233, DOI 10.1007/s00227-007-0698-9; Trillmich F., 1991, Ecological Studies, V88, P247; Trillmich F., 1986, P196; Trillmich F., 2015, ZALOPHUS WOLLEBAEKI, DOI [10.2305/IUCN.UK.2015-2.RLTS.T41668A45230540.en, DOI 10.2305/IUCN.UK.2015-2.RLTS.T41668A45230540.EN]; Trillmich F, 2008, BEHAV ECOL SOCIOBIOL, V62, P363, DOI 10.1007/s00265-007-0423-1; Trillmich F, 2014, SOC ECOL INTERACT GA, P61, DOI 10.1007/978-3-319-02769-2_3; Vales DG, 2015, MAR ECOL PROG SER, V525, P245, DOI 10.3354/meps11214; Villegas-Amtmann S, 2008, MAR ECOL PROG SER, V363, P299, DOI 10.3354/meps07457; Villegas-Amtmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070748; Weise MJ, 2010, ECOLOGY, V91, P1004, DOI 10.1890/08-1554.1; WERNER EE, 1974, ECOLOGY, V55, P1042, DOI 10.2307/1940354; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zenteno L, 2013, J ZOOL, V291, P119, DOI 10.1111/jzo.12051	91	13	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147857	10.1371/journal.pone.0147857	http://dx.doi.org/10.1371/journal.pone.0147857			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808381	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800231
J	Ingraham, KA; Fey, NP; Simon, AM; Hargrove, LJ				Ingraham, Kimberly A.; Fey, Nicholas P.; Simon, Ann M.; Hargrove, Levi J.			Assessing the Relative Contributions of Active Ankle and Knee Assistance to the Walking Mechanics of Transfemoral Amputees Using a Powered Prosthesis	PLOS ONE			English	Article							FOOT PROSTHESIS; PUSH-OFF; SWING INITIATION; PROGRESSION; LEG; MUSCLE; LEVEL; GAIT; SUPPORT; SIMULATION	Powered knee-ankle prostheses are capable of providing net-positive mechanical energy to amputees. Yet, there are limitless ways to deliver this energy throughout the gait cycle. It remains largely unknown how different combinations of active knee and ankle assistance affect the walking mechanics of transfemoral amputees. This study assessed the relative contributions of stance phase knee swing initiation, increasing ankle stiffness and powered plantarflexion as three unilateral transfemoral amputees walked overground at their self-selected walking speed. Five combinations of knee and ankle conditions were evaluated regarding the kinematics and kinetics of the amputated and intact legs using repeated measures analyses of variance. We found eliminating active knee swing initiation or powered plantarflexion was linked to increased compensations of the ipsilateral hip joint during the subsequent swing phase. The elimination of knee swing initiation or powered plantarflexion also led to reduced braking ground reaction forces of the amputated and intact legs, and influenced both sagittal and frontal plane loading of the intact knee joint. Gradually increasing prosthetic ankle stiffness influenced the shape of the prosthetic ankle plantarflexion moment, more closely mirroring the intact ankle moment. Increasing ankle stiffness also corresponded to increased prosthetic ankle power generation (despite a similar maximum stiffness value across conditions) and increased braking ground reaction forces of the amputated leg. These findings further our understanding of how to deliver assistance with powered knee-ankle prostheses and the compensations that occur when specific aspects of assistance are added/removed.	[Ingraham, Kimberly A.; Fey, Nicholas P.; Simon, Ann M.; Hargrove, Levi J.] Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA; [Fey, Nicholas P.; Simon, Ann M.; Hargrove, Levi J.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA	Shirley Ryan AbilityLab; Northwestern University	Fey, NP (corresponding author), Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA.; Fey, NP (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	nfey@ricres.org		Simon, Ann/0000-0002-6431-0329	US Army's Telemedicine and Advanced Technology Research Center Joint Warfighter Program [81XWH-09-2-0020, W81XWH-14-C-0105]; U.S. Department of Education [H133F130034]	US Army's Telemedicine and Advanced Technology Research Center Joint Warfighter Program; U.S. Department of Education(US Department of Education)	This study was supported by the US Army's Telemedicine and Advanced Technology Research Center Joint Warfighter Program grants 81XWH-09-2-0020 and W81XWH-14-C-0105 (PI: Hargrove), as well as U.S. Department of Education grant H133F130034 (PI: Fey).	Allen JL, 2012, J BIOMECH, V45, P2157, DOI 10.1016/j.jbiomech.2012.05.037; Au S, 2008, NEURAL NETWORKS, V21, P654, DOI 10.1016/j.neunet.2008.03.006; Browning RC, 2007, MED SCI SPORT EXER, V39, P515, DOI 10.1249/mss.0b013e31802b3562; Caputo JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep07213; Eilenberg MF, 2010, IEEE T NEUR SYS REH, V18, P164, DOI 10.1109/TNSRE.2009.2039620; Fey NP, 2014, IEEE J TRANSL ENG HE, V2, DOI 10.1109/JTEHM.2014.2343228; Fey NP, 2013, J BIOMECH, V46, P637, DOI 10.1016/j.jbiomech.2012.11.051; Fey NP, 2011, CLIN BIOMECH, V26, P1025, DOI 10.1016/j.clinbiomech.2011.06.007; Grabowski AM, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-49; Gregg RD, 2014, IEEE T ROBOT, V30, P1455, DOI 10.1109/TRO.2014.2361937; Hargrove LJ, 2015, JAMA-J AM MED ASSOC, V313, P2244, DOI 10.1001/jama.2015.4527; Hargrove LJ, 2013, NEW ENGL J MED, V369, P1237, DOI 10.1056/NEJMoa1300126; Herr HM, 2012, P ROY SOC B-BIOL SCI, V279, P457, DOI 10.1098/rspb.2011.1194; Hitt J, 2009, IND ROBOT, V36, P441, DOI 10.1108/01439910910980169; Johansson JL, 2005, AM J PHYS MED REHAB, V84, P563, DOI 10.1097/01.phm.0000174665.74933.0b; Kepple TM, 1997, GAIT POSTURE, V6, P1, DOI 10.1016/S0966-6362(96)01094-6; Lee H, 2013, IEEE MTT S INT MICR; Lenzi T., 2014, AAOP ANN M; Lenzi T, 2014, IEEE ROBOT AUTOM MAG, V21, P94, DOI 10.1109/MRA.2014.2360305; Liu MQ, 2006, J BIOMECH, V39, P2623, DOI 10.1016/j.jbiomech.2005.08.017; Malcolm P, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0014-8; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Mooney L. M., 2014, IEEE EMBC; Morgenroth DC, 2011, GAIT POSTURE, V34, P502, DOI 10.1016/j.gaitpost.2011.07.001; Neptune RR, 2004, GAIT POSTURE, V19, P194, DOI 10.1016/S0966-6362(03)00062-6; Neptune RR, 2001, J BIOMECH, V34, P1387, DOI 10.1016/S0021-9290(01)00105-1; Pfeifer S, 2015, IEEE-ASME T MECH, V20, P1384, DOI 10.1109/TMECH.2014.2337514; Pfeifer S, 2012, IEEE T BIO-MED ENG, V59, P2604, DOI 10.1109/TBME.2012.2207895; Rarick R., 2014, IEEE ACC; Rouse EJ, 2014, INT J ROBOT RES, V33, P1611, DOI 10.1177/0278364914545673; Rouse EJ, 2014, IEEE T NEUR SYS REH, V22, P870, DOI 10.1109/TNSRE.2014.2307256; Schmalz T, 2002, GAIT POSTURE, V16, P255, DOI 10.1016/S0966-6362(02)00008-5; Segal AD, 2006, J REHABIL RES DEV, V43, P857, DOI 10.1682/JRRD.2005.09.0147; Sharma L, 1998, ARTHRITIS RHEUM, V41, P1233, DOI 10.1002/1529-0131(199807)41:7<1233::AID-ART14>3.0.CO;2-L; Silverman AK, 2008, GAIT POSTURE, V28, P602, DOI 10.1016/j.gaitpost.2008.04.005; Silverman AK, 2012, J BIOMECH, V45, P2271, DOI 10.1016/j.jbiomech.2012.06.008; Simon AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099387; Sup F, 2008, INT J ROBOT RES, V27, P263, DOI 10.1177/0278364907084588; WINTER DA, 1983, CLIN ORTHOP RELAT R, P147; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005; Zmitrewicz RJ, 2007, J BIOMECH, V40, P1824, DOI 10.1016/j.jbiomech.2006.07.009	41	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147661	10.1371/journal.pone.0147661	http://dx.doi.org/10.1371/journal.pone.0147661			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807889	Green Submitted, gold, Green Published			2022-12-26	WOS:000369527800171
J	Leal, E; Granja, AG; Zarza, C; Tafalla, C				Leal, Esther; Granja, Aitor G.; Zarza, Carlos; Tafalla, Carolina			Distribution of T Cells in Rainbow Trout (Oncorhynchus mykiss) Skin and Responsiveness to Viral Infection	PLOS ONE			English	Article							CHANNEL CATFISH; IMMUNE-SYSTEM; TELEOST SKIN; B-CELLS; FISH; ANTIBODY; DISEASE; IDENTIFICATION; IMMUNOGLOBULIN; EXPRESSION	Although the skin constitutes the first line of defense against waterborne pathogens, there is a great lack of information regarding the skin associated lymphoid tissue (SALT) and whether immune components of the skin are homogeneously distributed through the surface of the fish is still unknown. In the current work, we have analyzed the transcription of several immune genes throughout different rainbow trout (Oncorhynchus mykiss) skin areas. We found that immunoglobulin and chemokine gene transcription levels were higher in a skin area close to the gills. Furthermore, this skin area as well as other anterior sections also transcribed significantly higher levels of many different immune genes related to T cell immunity such as T cell receptor alpha (TCR alpha), TCR gamma, CD3, CD4, CD8, perforin, GATA3, Tbet, FoxP3, interferon gamma (IFN gamma), CD40L and Eomes in comparison to posterior skin sections. In agreement with these results, immunohistochemical analysis revealed that anterior skin areas had a higher concentration of CD3(+) T cells and flow cytometry analysis confirmed that the percentage of CD8(+) T lymphocytes was also higher in anterior skin sections. These results demonstrate for the first time that T cells are not homogeneously distributed throughout the teleost skin. Additionally, we studied the transcriptional regulation of these and additional T cell markers in response to a bath infection with viral hemorrhagic septicemia virus (VHSV). We found that VHSV regulated the transcription of several of these T cell markers in both the skin and the spleen; with some differences between anterior and posterior skin sections. Altogether, our results point to skin T cells as major players of teleost skin immunity in response to waterborne viral infections.	[Leal, Esther; Granja, Aitor G.; Tafalla, Carolina] Ctr Invest Sanidad Anim CISA INIA, Madrid, Spain; [Zarza, Carlos] Skretting Aquaculture Res Ctr, POB 48, N-4001 Stavanger, Norway		Tafalla, C (corresponding author), Ctr Invest Sanidad Anim CISA INIA, Madrid, Spain.	tafalla@inia.es	Leal, Esther/ABA-6058-2021; Granja, Aitor/K-8102-2014; Tafalla, Carolina/J-8074-2014	, Esther/0000-0003-2847-450X; Tafalla, Carolina/0000-0002-0860-2976	European Research Council (ERC) [2011 280469]; Spanish Ministry of Economy and Competitiveness (MINECO) [AGL2014-53061-R]	European Research Council (ERC)(European Research Council (ERC)); Spanish Ministry of Economy and Competitiveness (MINECO)	This work was supported by the European Research Council (ERC Starting Grant 2011 280469) and project AGL2014-53061-R from the Spanish Ministry of Economy and Competitiveness (MINECO).	Boardman T, 2012, VET IMMUNOL IMMUNOP, V145, P511, DOI 10.1016/j.vetimm.2011.11.017; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Castro R, 2014, J IMMUNOL, V192, P1257, DOI 10.4049/jimmunol.1302471; Castro R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003098; Chettri JK, 2014, J FISH DIS, V37, P771, DOI 10.1111/jfd.12169; Edholm ES, 2010, J IMMUNOL, V185, P4082, DOI 10.4049/jimmunol.1000631; Elliott DG, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P471; Esteban M., 2015, MUCOSAL HLTH AQUACUL, P67, DOI [DOI 10.1016/B978-0-12-417186-2.00004-2, 10.1016/b978-0-12-417186-2.00004-2]; Glimcher LH, 2000, GENE DEV, V14, P1693; Gomez D, 2013, FISH SHELLFISH IMMUN, V35, P1729, DOI 10.1016/j.fsi.2013.09.032; Granja AG, 2015, J IMMUNOL, V195, P1825, DOI 10.4049/jimmunol.1500322; Jorgensen TR, 2009, FOLIA PARASIT, V56, P251, DOI 10.14411/fp.2009.029; Kanhere A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2260; Kleinewietfeld M, 2013, SEMIN IMMUNOL, V25, P305, DOI 10.1016/j.smim.2013.10.009; Koppang EO, 2010, J ANAT, V217, P728, DOI 10.1111/j.1469-7580.2010.01305.x; Laing KJ, 2011, DEV COMP IMMUNOL, V35, P1282, DOI 10.1016/j.dci.2011.03.004; Maddocks CE, 2015, J FISH DIS, V38, P653, DOI 10.1111/jfd.12306; Makesh M, 2015, FISH SHELLFISH IMMUN, V44, P156, DOI 10.1016/j.fsi.2015.02.003; Maki JL, 2003, CLIN DIAGN LAB IMMUN, V10, P876, DOI 10.1128/CDLI.10.5.876-881.2003; Maloy KJ, 2000, J EXP MED, V191, P2159, DOI 10.1084/jem.191.12.2159; Milstein O, 2011, BLOOD, V117, P1042, DOI 10.1182/blood-2010-05-283770; Montero J, 2011, MOL IMMUNOL, V48, P1102, DOI 10.1016/j.molimm.2011.02.005; Montero J, 2011, J VIROL, V85, P4046, DOI 10.1128/JVI.02519-10; Oidtmann B, 2013, J FISH DIS, V36, P921, DOI 10.1111/jfd.12086; Peeler EJ, 2014, J FISH DIS, V37, P1021, DOI 10.1111/jfd.12241; Rombout JHWM, 2011, FISH SHELLFISH IMMUN, V31, P616, DOI 10.1016/j.fsi.2010.09.001; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Schorpp M, 2006, J IMMUNOL, V177, P2463, DOI 10.4049/jimmunol.177.4.2463; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Takizawa F, 2014, FISH SHELLFISH IMMUN, V36, P215, DOI 10.1016/j.fsi.2013.11.004; Takizawa F, 2011, MOL IMMUNOL, V48, P1360, DOI 10.1016/j.molimm.2011.02.014; Takizawa F, 2011, DEV COMP IMMUNOL, V35, P752, DOI 10.1016/j.dci.2011.02.008; Xu Z, 2013, P NATL ACAD SCI USA, V110, P13097, DOI 10.1073/pnas.1304319110; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1; Zhang LJ, 2007, J CELL PHYSIOL, V211, P590, DOI 10.1002/jcp.21001; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913; Zhao XG, 2008, DEV COMP IMMUNOL, V32, P500, DOI 10.1016/j.dci.2007.08.009; Zilberg D, 1997, VET IMMUNOL IMMUNOP, V58, P171, DOI 10.1016/S0165-2427(97)00033-0	38	22	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147477	10.1371/journal.pone.0147477	http://dx.doi.org/10.1371/journal.pone.0147477			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808410	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800104
J	Lee, EJ; Cha, GW; Ju, YR; Han, MG; Lee, WJ; Jeong, YE				Lee, Eun Ju; Cha, Go-Woon; Ju, Young Ran; Han, Myung Guk; Lee, Won-Ja; Jeong, Young Eui			Prevalence of Neutralizing Antibodies to Japanese Encephalitis Virus among High-Risk Age Groups in South Korea, 2010	PLOS ONE			English	Article							TICK-BORNE ENCEPHALITIS; INTRAVENOUS IMMUNOGLOBULIN; VACCINATION; EPIDEMIOLOGY; INFECTION; GENOTYPE; VACCINES; TAIWAN; WEST	After an extensive vaccination policy, Japanese encephalitis (JE) was nearly eliminated since the mid-1980s in South Korea. Vaccination in children shifted the affected age of JE patients from children to adults. However, an abrupt increase in JE cases occurred in 2010, and this trend has continued. The present study aimed to investigate the prevalence of neutralizing antibodies to the JE virus (JEV) among high-risk age groups (>= 40 years) in South Korea. A plaque reduction neutralization test was conducted to evaluate the prevalence of neutralizing antibodies to JEV in 945 subjects within four age groups (30-39, 40-49, 50-59, and 60-69 years) in 10 provinces. Of the 945 enrolled subjects, 927 (98.1%) exhibited antibodies against JEV. No significant differences were found in the prevalence of neutralizing antibodies according to sex, age, or occupation. However, there were significant differences in the plaque reduction rate according to age and occupation; oldest age group had a higher reduction rate, and subjects who were employed in agriculture or forestry also had a higher value than the other occupations. We also found that three provinces (Gangwon, Jeonnam, and Gyeongnam) had a relatively lower plaque reduction rate than the other locations. In addition, enzyme-linked immunosorbent assays were conducted to determine recent viral infections and 12 (2.2%) subjects were found to have been recently infected by the virus. In conclusion, the present study clearly indicated that the prevalence of neutralizing antibodies has been maintained at very high levels among adult age groups owing to vaccination or natural infections, or both. In the future, serosurveillance should be conducted periodically using more representative samples to better understand the population-level immunity to JE in South Korea.	[Lee, Eun Ju; Cha, Go-Woon; Ju, Young Ran; Han, Myung Guk; Lee, Won-Ja; Jeong, Young Eui] Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Div Arboviruses, Cheongju, Chungcheongbuk, South Korea; [Lee, Eun Ju; Cha, Go-Woon; Ju, Young Ran; Han, Myung Guk; Lee, Won-Ja; Jeong, Young Eui] WHO Western Pacific Reg, Japanese Encephalitis Reg Reference Lab, Cheongju, Chungcheongbuk, South Korea; [Jeong, Young Eui] Hallym Univ, Grad Sch, Dept Biomed Sci, Cheongju, Chungcheongbuk, South Korea; [Ju, Young Ran] Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Div Med Entomol, Cheongju, Chungcheongbuk, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Hallym University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology	Jeong, YE (corresponding author), Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Div Arboviruses, Cheongju, Chungcheongbuk, South Korea.; Jeong, YE (corresponding author), WHO Western Pacific Reg, Japanese Encephalitis Reg Reference Lab, Cheongju, Chungcheongbuk, South Korea.; Jeong, YE (corresponding author), Hallym Univ, Grad Sch, Dept Biomed Sci, Cheongju, Chungcheongbuk, South Korea.	yougeui58@gmail.com	Hegde, Nagendra/J-5920-2014	Hegde, Nagendra/0000-0001-5260-2159	National Institute of Health, Korea Centers for Disease Control and Prevention [2011-N53002-00, 4835-300-210, 4835-301-210]	National Institute of Health, Korea Centers for Disease Control and Prevention(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was undertaken with a grant from the National Institute of Health, Korea Centers for Disease Control and Prevention (2011-N53002-00, 4835-300-210, and 4835-301-210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2003, VACCINE, V21, P1989, DOI 10.1016/S0264-410X(02)00772-7; Abraham S, 2011, FLAVIVIRUS ENCEPHALI, P349; Arai S, 2008, JPN J INFECT DIS, V61, P333; Baldovin T, 2012, J MED VIROL, V84, P1274, DOI 10.1002/jmv.23313; Bayry J, 2004, TRENDS PHARMACOL SCI, V25, P306, DOI 10.1016/j.tips.2004.04.002; BURKE DS, 1985, J INFECT DIS, V151, P1093, DOI 10.1093/infdis/151.6.1093; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Caramello P, 2006, CLIN INFECT DIS, V43, P1620, DOI 10.1086/509644; Cha Go Woon, 2014, Osong Public Health Res Perspect, V5, P286, DOI 10.1016/j.phrp.2014.08.003; Endy TP, 2002, CURR TOP MICROBIOL, V267, P11; Hegde NR, 2009, IMMUNOTHERAPY-UK, V1, P691, DOI [10.2217/IMT.09.26, 10.2217/imt.09.26]; Hombach J, 2005, VACCINE, V23, P5205, DOI 10.1016/j.vaccine.2004.11.040; Hsu LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003030; Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040; Jacobson JA, 2007, AM J TROP MED HYG, V77, P164, DOI 10.4269/ajtmh.2007.77.164; Jeong Young Eui, 2011, Osong Public Health Res Perspect, V2, P34, DOI 10.1016/j.phrp.2011.04.002; KIM DH, 2013, KOREAN J PEDIAT INFE, V20, P131; Kim KH, 1968, ANN REP NATL I HLTH, V1, P31; Kim SY, 2009, MED VET ENTOMOL, V23, P15, DOI 10.1111/j.1365-2915.2008.00755.x; Konishi E, 2010, VACCINE, V28, P2664, DOI 10.1016/j.vaccine.2010.01.008; Korea Centers for Disease Control and Prevention, 2015, INF DIS SURV YB 2014, V8-GL2015001; Lee CH, 1980, KOREAN J VIROL, V10, P65; Lee DW, 2012, INT J INFECT DIS, V16, pE448, DOI 10.1016/j.ijid.2012.02.006; Lee YT, 1986, J KOREAN ACAD PERIOD, V15, P1; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Litzba N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000883; Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008; Park B, 2011, J KOREAN MED SCI, V26, P711, DOI 10.3346/jkms.2011.26.6.711; Rayamajhi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122608; Saxena SK, 2011, FLAVIVIRUS ENCEPHALI, P295, DOI DOI 10.5772/22145; Sohn YM, 2000, EMERG INFECT DIS, V6, P17; Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003; Srivastava R, 2015, J GEN VIROL, V96, P1347, DOI 10.1099/vir.0.000079; Takhampunya R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-449; Tsai T., 1999, MANUAL CLIN MICROBIO, P1118; Uchil PD, 2001, AM J TROP MED HYG, V65, P242, DOI 10.4269/ajtmh.2001.65.242; Wiwanitkit V, 2009, INT J GEN MED, V2, P195; Wu YC, 1999, AM J TROP MED HYG, V61, P78, DOI 10.4269/ajtmh.1999.61.78	38	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147841	10.1371/journal.pone.0147841	http://dx.doi.org/10.1371/journal.pone.0147841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807709	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800225
J	Yi, LC; Sartor, CD; Souza, FT; Sacco, ICN				Yi, Liu Chiao; Sartor, Cristina D.; Souza, Francis Trombini; Sacco, Isabel C. N.			Intralimb Coordination Patterns in Absent, Mild, and Severe Stages of Diabetic Neuropathy: Looking Beyond Kinematic Analysis of Gait Cycle	PLOS ONE			English	Article							PEAK PLANTAR PRESSURES; GROUND REACTION FORCES; FOOT ULCERATION; PERIPHERAL NEUROPATHY; MUSCLE ACTIVATION; INDIVIDUALS; WALKING; STIFFNESS; MOBILITY; PHASE	Aim Diabetes Mellitus progressively leads to impairments in stability and joint motion and might affect coordination patterns, mainly due to neuropathy. This study aims to describe changes in intralimb joint coordination in healthy individuals and patients with absent, mild and, severe stages of neuropathy. Methods Forty-seven diabetic patients were classified into three groups of neuropathic severity by a fuzzy model: 18 without neuropathy (DIAB), 7 with mild neuropathy (MILD), and 22 with moderate to severe neuropathy (SVRE). Thirteen healthy subjects were included as controls (CTRL). Continuous relative phase (CRP) was calculated at each instant of the gait cycle for each pair of lower limb joints. Analysis of Variance compared each frame of the CRP time series and its standard deviation among groups (alpha = 5%). Results For the ankle-hip CRP, the SVRE group presented increased variability at the propulsion phase and a distinct pattern at the propulsion and initial swing phases compared to the DIAB and CTRL groups. For the ankle-knee CRP, the 3 diabetic groups presented more anti-phase ratios than the CTRL group at the midstance, propulsion, and terminal swing phases, with decreased variability at the early stance phase. For the knee-hip CRP, the MILD group showed more in-phase ratio at the early stance and terminal swing phases and lower variability compared to all other groups. All diabetic groups were more in-phase at early the midstance phase (with lower variability) than the control group. Conclusion The low variability and coordination differences of the MILD group showed that gait coordination might be altered not only when frank evidence of neuropathy is present, but also when neuropathy is still incipient. The ankle-knee CRP at the initial swing phase showed distinct patterns for groups from all degrees of neuropathic severity and CTRLs. The anklehip CRP pattern distinguished the SVRE patients from other diabetic groups, particularly in the transitional phase from stance to swing.	[Yi, Liu Chiao; Sartor, Cristina D.] Univ Fed Sao Paulo, Santos, Brazil; [Sartor, Cristina D.; Sacco, Isabel C. N.] Univ Sao Paulo, Phys Therapy Speech & Occupat Therapy Dept, Sao Paulo, Brazil; [Souza, Francis Trombini] Univ Pernambuco, Dept Phys Therapy, Petrolina, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Pernambuco (UPE)	Sacco, ICN (corresponding author), Univ Sao Paulo, Phys Therapy Speech & Occupat Therapy Dept, Sao Paulo, Brazil.	icnsacco@usp.br	Sacco, Isabel/T-2630-2019; Sacco, Isabel/D-7172-2011; Yi, Liu C/K-8705-2013; Trombini-Souza, Francis/T-7359-2017; Sartor, Cristina D/C-6806-2013	Sacco, Isabel/0000-0003-1254-0007; Sacco, Isabel/0000-0003-1254-0007; Yi, Liu C/0000-0003-0202-2337; Trombini-Souza, Francis/0000-0001-8862-4691; Sartor, Cristina D/0000-0002-8461-8048	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/04997-2, 2013/01941-3]; Conselho Nacional de desenvolvimento cientifico e tecnologico [500716/2013-7]; Sao Paulo Research Foundation (FAPESP) [LCY 2013/01941-3, FTS 2014/04997-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [500716/2013-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de desenvolvimento cientifico e tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2014/04997-2 (FTS); Conselho Nacional de desenvolvimento cientifico e tecnologico 500716/2013-7 (CDS); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2013/01941-3 (LCY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by Sao Paulo Research Foundation (FAPESP LCY 2013/01941-3, FAPESP FTS 2014/04997-2), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, process number 500716/2013-7).	Abboud RJ, 2000, CLIN BIOMECH, V15, P37, DOI 10.1016/S0268-0033(99)00038-8; Akashi PMH, 2008, CLIN BIOMECH, V23, P584, DOI 10.1016/j.clinbiomech.2007.11.015; Allet L, 2008, DIABETES-METAB RES, V24, P173, DOI 10.1002/dmrr.809; Armstrong DG, 1998, J BONE JOINT SURG AM, V80A, P365, DOI 10.2106/00004623-199803000-00009; Bakker K, 2012, DIABETES-METAB RES, V28, P225, DOI 10.1002/dmrr.2253; Bennetts CJ, 2013, J BIOMECH, V46, P19, DOI 10.1016/j.jbiomech.2012.09.007; Brown SJ, 2014, J BIOMECH, V47, P3639, DOI 10.1016/j.jbiomech.2014.10.005; Campbell K., 1987, ASME INT COMP ENG C; Cavanagh PR, 1991, BIOMECHANICS DIABETI; Childs JD, 2004, CLIN BIOMECH, V19, P44, DOI 10.1016/j.clinbiomech.2003.08.007; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Esposito ER, 2014, GAIT POSTURE, V40, P640, DOI 10.1016/j.gaitpost.2014.07.019; FERNANDO DJS, 1991, DIABETES CARE, V14, P8, DOI 10.2337/diacare.14.1.8; Fernando M, 2013, CLIN BIOMECH BRISTOL; Fernando ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099050; Ghanavati T, 2014, J BIOMECH, V47, P2300, DOI 10.1016/j.jbiomech.2014.04.038; Giacomozzi C, 2005, CLIN BIOMECH, V20, P532, DOI 10.1016/j.clinbiomech.2005.01.011; Giacomozzi C, 2002, DIABETES CARE, V25, P1451, DOI 10.2337/diacare.25.8.1451; Glasoe WM, 2004, FOOT ANKLE INT, V25, P550, DOI 10.1177/107110070402500807; Gomes AA, 2011, MUSCLE NERVE, V44, P258, DOI 10.1002/mus.22051; Guiotto A, 2014, J BIOMECH, V47, P3064, DOI 10.1016/j.jbiomech.2014.06.029; Haddad JM, 2010, J APPL BIOMECH, V26, P109, DOI 10.1123/jab.26.1.109; Hamill J, 1999, CLIN BIOMECH, V14, P297, DOI 10.1016/S0268-0033(98)90092-4; Kwon OY, 2003, GAIT POSTURE, V18, P105, DOI 10.1016/S0966-6362(02)00166-2; Lamb PF, 2014, CLIN BIOMECH, V29, P484, DOI 10.1016/j.clinbiomech.2014.03.008; Lamola G, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0093-6; Lavery LA, 2002, J AM PODIAT MED ASSN, V92, P479, DOI 10.7547/87507315-92-9-479; Perkins BA, 2001, DIABETES CARE, V24, P250, DOI 10.2337/diacare.24.2.250; Pham H, 2000, DIABETES CARE, V23, P606, DOI 10.2337/diacare.23.5.606; Powers Christopher M, 2012, J Orthop Sports Phys Ther, V42, pA1, DOI 10.2519/jospt.2012.0301; Rao ST, 2007, CLIN BIOMECH, V22, P464, DOI 10.1016/j.clinbiomech.2006.11.013; Rao S, 2006, GAIT POSTURE, V24, P295, DOI 10.1016/j.gaitpost.2005.10.004; Rao S, 2010, GAIT POSTURE, V31, P251, DOI 10.1016/j.gaitpost.2009.10.016; Sacco ICN, 2009, CLIN BIOMECH, V24, P687, DOI 10.1016/j.clinbiomech.2009.05.003; Sacco IC, 2015, DIABETES TECHNOL THE; Sacco ICN, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-24; Savelberg HHCM, 2010, CLIN BIOMECH, V25, P468, DOI 10.1016/j.clinbiomech.2010.02.005; Sawacha Z, 2012, GAIT POSTURE, V35, P101, DOI 10.1016/j.gaitpost.2011.08.016; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; van Schie C H M, 2005, Int J Low Extrem Wounds, V4, P160; VEVES A, 1992, DIABETOLOGIA, V35, P660, DOI 10.1007/BF00400259; Watari R, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-11; Williams DSB, 2007, J APPL BIOMECH, V23, P251, DOI 10.1123/jab.23.4.251; Wu WH, 2014, HUM MOVEMENT SCI, V33, P194, DOI 10.1016/j.humov.2013.09.002; Yavuzer G, 2006, Eura Medicophys, V42, P127	48	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147300	10.1371/journal.pone.0147300	http://dx.doi.org/10.1371/journal.pone.0147300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807858	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800072
J	Wang, Y; Zhou, XL; Ruan, ZR; Liu, RJ; Eriani, G; Wang, ED				Wang, Yong; Zhou, Xiao-Long; Ruan, Zhi-Rong; Liu, Ru-Juan; Eriani, Gilbert; Wang, En-Duo			A Human Disease-causing Point Mutation in Mitochondrial Threonyl-tRNA Synthetase Induces Both Structural and Functional Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; aminoacyl-tRNA synthetase; enzyme kinetics; mitochondria; mitochondrial disease; threonyl-tRNA synthetase	EDITING ACTIVITY; QUALITY-CONTROL; PROTEIN; DOMAIN; CODON; MISTRANSLATION; TRANSLATION; MECHANISM; ERRORS	Mitochondria require all translational components, including aminoacyl-tRNA synthetases (aaRSs), to complete organelle protein synthesis. Some aaRS mutations cause mitochondrial disorders, including human mitochondrial threonyl-tRNA synthetase (hmtThrRS) (encoded by TARS2), the P282L mutation of which causes mitochondrial encephalomyopathies. However, its catalytic and structural consequences remain unclear. Herein, we cloned TARS2 and purified the wild-type and P282L mutant hmtThrRS. hmtThrRS misactivates non-cognate Ser and uses post-transfer editing to clear erroneously synthesized products. In vitro and in vivo analyses revealed that the mutation induces a decrease in Thr activation, aminoacylation, and proofreading activities and a change in the protein structure and/or stability, which might cause reduced catalytic efficiency. We also identified a splicing variant of TARS2 mRNA lacking exons 8 and 9, the protein product of which is targeted into mitochondria. In HEK293T cells, the variant does not dimerize and cannot complement the ThrRS knock-out strain in yeast, suggesting that the truncated protein is inactive and might have a non-canonical function, as observed for other aaRS fragments. The present study describes the aminoacylation and editing properties of hmtThrRS, clarifies the molecular consequences of the P282L mutation, and shows that the yeast ThrRS-deletion model is suitable to test pathology-associated point mutations or alternative splicing variants of mammalian aaRS mRNAs.	[Wang, Yong; Zhou, Xiao-Long; Ruan, Zhi-Rong; Liu, Ru-Juan; Wang, En-Duo] Univ Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol,Inst Biochem & Cell Biol, Chinese Acad Sci,Ctr Excellence Mol Cell Sci, Shanghai 200031, Peoples R China; [Wang, Yong; Wang, En-Duo] ShanghaiTech Univ, Sch Life Sci & Technol, 319 Yue Yang Rd, Shanghai 200031, Peoples R China; [Eriani, Gilbert] Univ Strasbourg, Inst Biol Mol & Cellulaire, CNRS, Architecture & React ARN,UPR9002, 15 Rue Rene Descartes, F-67084 Strasbourg, France	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Zhou, XL; Wang, ED (corresponding author), Univ Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol,Inst Biochem & Cell Biol, Chinese Acad Sci,Ctr Excellence Mol Cell Sci, Shanghai 200031, Peoples R China.; Wang, ED (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, 319 Yue Yang Rd, Shanghai 200031, Peoples R China.	xlzhou@sibcb.ac.cn; edwang@sibcb.ac.cn	Ruan, Zhi-Rong/GYI-8935-2022	Eriani, Gilbert/0000-0002-8518-4675; , Yong/0000-0002-3698-123X; Ruan, Zhi-Rong/0000-0002-1806-2942; Liu, Ru-Juan/0000-0001-7459-3126	National Key Basic Research Foundation of China [2012CB911000]; Natural Science Foundation of China [31130064, 91440204]; Committee of Science and Technology in Shanghai [12JC1409700, 15ZR1446500]; Youth Innovation Promotion Association (Chinese Academy of Sciences)	National Key Basic Research Foundation of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology in Shanghai(Shanghai Science & Technology Committee); Youth Innovation Promotion Association (Chinese Academy of Sciences)	This work was supported by Grant 2012CB911000 from the National Key Basic Research Foundation of China, Grants 31130064 and 91440204 from the Natural Science Foundation of China, and Grants 12JC1409700 and 15ZR1446500 from the Committee of Science and Technology in Shanghai. This work was also supported by the Youth Innovation Promotion Association (Chinese Academy of Sciences) (to X. L. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen JF, 1996, J MOL EVOL, V42, P482, DOI 10.1007/BF02352278; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; BOUADLOUN F, 1983, EMBO J, V2, P1351, DOI 10.1002/j.1460-2075.1983.tb01591.x; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; EDELMANN P, 1977, CELL, V10, P131, DOI 10.1016/0092-8674(77)90147-7; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Guitart T, 2010, J BIOL CHEM, V285, P38157, DOI 10.1074/jbc.M110.167486; Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064; HOLZWARTH G, 1965, J AM CHEM SOC, V87, P218, DOI 10.1021/ja01080a015; Hussain T, 2006, EMBO J, V25, P4152, DOI 10.1038/sj.emboj.7601278; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAZWINSKI SM, 1990, METHOD ENZYMOL, V182, P154; Korencic D, 2004, P NATL ACAD SCI USA, V101, P10260, DOI 10.1073/pnas.0403926101; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Ling C, 2005, J BIOL CHEM, V280, P34755, DOI 10.1074/jbc.M413511200; Ling JQ, 2012, P NATL ACAD SCI USA, V109, P3281, DOI 10.1073/pnas.1200109109; Liu Y, 2014, P NATL ACAD SCI USA, V111, P17570, DOI 10.1073/pnas.1420196111; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo WS, 2014, SCIENCE, V345, P328, DOI 10.1126/science.1252943; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v; Michel SLJ, 2003, BIOCHEMISTRY-US, V42, P4626, DOI 10.1021/bi034073h; Minajigi A, 2010, J BIOL CHEM, V285, P23810, DOI 10.1074/jbc.M110.105320; NAMEKI N, 1995, NUCLEIC ACIDS RES, V23, P2831, DOI 10.1093/nar/23.15.2831; Nangle LA, 2002, J BIOL CHEM, V277, P45729, DOI 10.1074/jbc.M208093200; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Ross-Inta C, 2008, BIOSCIENCE REP, V28, P239, DOI 10.1042/BSR20080090; Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200; Ruan ZR, 2015, J BIOL CHEM, V290, P1664, DOI 10.1074/jbc.M114.599886; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; YARUS M, 1970, ANAL BIOCHEM, V35, P450, DOI 10.1016/0003-2697(70)90207-1; Zhou XL, 2014, NUCLEIC ACIDS RES, V42, P13873, DOI 10.1093/nar/gku1218; Zhou XL, 2013, NUCLEIC ACIDS RES, V41, P302, DOI 10.1093/nar/gks982; Zhou XL, 2011, NUCLEIC ACIDS RES, V39, P8857, DOI 10.1093/nar/gkr595; Zhou XL, 2008, J BIOL CHEM, V283, P36608, DOI 10.1074/jbc.M806745200; Zhou XL, 2013, SCI CHINA LIFE SCI, V56, P921, DOI 10.1007/s11427-013-4542-9	47	29	32	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6507	6520		10.1074/jbc.M115.700849	http://dx.doi.org/10.1074/jbc.M115.700849			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26811336	Green Published, hybrid			2022-12-26	WOS:000372894200037
J	Bonde, Y; Eggertsen, G; Rudling, M				Bonde, Ylva; Eggertsen, Gosta; Rudling, Mats			Mice Abundant in Muricholic Bile Acids Show Resistance to Dietary Induced Steatosis, Weight Gain, and to Impaired Glucose Metabolism	PLOS ONE			English	Article							INTESTINAL-ABSORPTION; INSULIN-RESISTANCE; INDUCED OBESITY; CHOLIC-ACID; MODULATION; FXR	High endogenous production of, or treatment with muricholic bile acids, strongly reduces the absorption of cholesterol. Mice abundant in muricholic bile acids may therefore display an increased resistance against dietary induced weight gain, steatosis, and glucose intolerance due to an anticipated general reduction in lipid absorption. To test this hypothesis, mice deficient in steroid 12-alpha hydroxylase (Cyp8b1(-/-)) and therefore abundant inmuricholic acids were monitored for 11 weeks while fed a high fat diet. Food intake and body and liver weights were determined, and lipids in liver, serum and feces were measured. Further, responses during oral glucose and intraperitoneal insulin tolerance tests were evaluated. On the high fat diet, Cyp8b1(-/-) mice displayed less weight gain compared to wildtype littermates (Cyp8b1(+/+)). In addition, liver enlargement with steatosis and increases in serum LDL-cholesterol were strongly attenuated in Cyp8b1(-/-) mice on high fat diet. Fecal excretion of cholesterol was increased and there was a strong trend for doubled fecal excretion of free fatty acids, while excretion of triglycerides was unaltered, indicating dampened lipid absorption. On high fat diet, Cyp8b1(-/-) mice also presented lower serum glucose levels in response to oral glucose gavage or to intraperitoneal insulin injection compared to Cyp8b1(+/+). In conclusion, following exposure to a high fat diet, Cyp8b1(-/-) mice are more resistant against weight gain, steatosis, and to glucose intolerance than Cyp8b1(+/+) mice. Reduced lipid absorption may in part explain these findings. Overall, the results suggest that muricholic bile acids may be beneficial against the metabolic syndrome.	[Bonde, Ylva; Rudling, Mats] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Med, Stockholm, Sweden; [Bonde, Ylva; Rudling, Mats] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Eggertsen, Gosta] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Bonde, Y; Rudling, M (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Med, Stockholm, Sweden.; Bonde, Y; Rudling, M (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden.	ylva.bonde@ki.se; mats.rudling@ki.se			 [K2013-55X-15075-10-3];  [20130518];  [DIA 2014-064];  [20130327]	; ; ; 	This work was supported by http://www.vr.se, Grant no. K2013-55X-15075-10-3, http://www.hjart-lungfonden. se, Grant no. 20130518, http://www.diabetes.se/diabetesfonden, Grant no. DIA 2014-064, http://www.cardiovascular.se, Grant no. Not applicable, and http://www.sll.se/, Grant no. 20130327. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; BOTHAM KM, 1983, EUR J BIOCHEM, V134, P191, DOI 10.1111/j.1432-1033.1983.tb07550.x; Chen WD, 2011, BBA-MOL BASIS DIS, V1812, P888, DOI 10.1016/j.bbadis.2010.12.006; Galman C, 2008, GASTROENTEROLOGY, V134, P1127, DOI 10.1053/j.gastro.2008.01.032; Ge HF, 2014, J BIOL CHEM, V289, P30470, DOI 10.1074/jbc.M114.592022; Hu X, 2014, J INTERN MED, V275, P27, DOI 10.1111/joim.12140; Kaur A, 2015, DIABETES, V64, P1168, DOI [10.2337/db14-0716, 10.2337/db15-0518]; Kuipers F, 2014, NAT REV ENDOCRINOL, V10, P488, DOI 10.1038/nrendo.2014.60; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; MIETTINEN TA, 1990, AM J EPIDEMIOL, V131, P20, DOI 10.1093/oxfordjournals.aje.a115479; Murphy C, 2005, BBA-MOL CELL BIOL L, V1735, P167, DOI 10.1016/j.bbalip.2005.06.001; Naugler WE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097426; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; Rabot S, 2010, FASEB J, V24, P4948, DOI 10.1096/fj.10-164921; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Rudling M, 2015, DIGEST DIS, V33, P376, DOI 10.1159/000371690; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Uriarte I, 2013, GUT, V62, P899, DOI 10.1136/gutjnl-2012-302945; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012; Zhang YC, 2010, J LIPID RES, V51, P3230, DOI 10.1194/jlr.M007641	22	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147772	10.1371/journal.pone.0147772	http://dx.doi.org/10.1371/journal.pone.0147772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824238	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528600058
J	Chen, HL; Koprowski, JL				Chen, Hsiang Ling; Koprowski, John L.			Differential Effects of Roads and Traffic on Space Use and Movements of Native Forest-Dependent and Introduced Edge-Tolerant Species	PLOS ONE			English	Article							SQUIRRELS TAMIASCIURUS-HUDSONICUS; GRAHAM RED SQUIRREL; SMALL MAMMALS; ABERTS SQUIRRELS; MIXED-CONIFER; HOME RANGES; HABITAT USE; CANE TOADS; FRAGMENTATION; POPULATION	Anthropogenic infrastructure such as roads and non-native species are major causes of species endangerment. Understanding animal behavioral responses to roads and traffic provides insight into causes and mechanisms of effects of linear development on wildlife and aids effective mitigation and conservation. We investigated effects of roads and traffic on space use and movements of two forest-dwelling species: endemic, forest-dependent Mount Graham red squirrels (Tamiasciurus hudsonicus grahamensis) and introduced, edge-tolerant Abert's squirrels (Sciurus aberti). To assess the effects of roads on space use and movement patterns, we compared the probability that a squirrel home range included roads and random lines in forests, and assessed effects of traffic intensity on rate of road crossing and movement patterns. Red squirrels avoided areas adjacent to roads and rarely crossed roads. In contrast, Abert's squirrels were more likely to include roads in their home ranges compared to random lines in forests. Both red squirrels and Abert's squirrels increased speed when crossing roads, compared to before and after road crossings. Increased hourly traffic volume reduced the rate of road crossings by both species. Behavioral responses of red squirrels to roads and traffic resemble responses to elevated predation risk, including reduced speed near roads and increased tortuosity of movement paths with increased traffic volume. In contrast, Abert's squirrels appeared little affected by roads and traffic with tortuosity of movement paths reduced as distance to roads decreased. We found that species with similar body size category (< 1 kg) but different habitat preference and foraging strategy responded to roads differently and demonstrated that behavior and ecology are important when considering effects of roads on wildlife. Our results indicate that roads restricted movements and space use of a native forest-dependent species while creating habitat preferred by an introduced, edge-tolerant species.	[Chen, Hsiang Ling; Koprowski, John L.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA	University of Arizona	Chen, HL (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA.	hchen@mail.sdsu.edu		Koprowski, John/0000-0003-1406-9853	University of Arizona; Arizona Agriculture Experiment Station; TE Inc; American Society of Mammalogists	University of Arizona; Arizona Agriculture Experiment Station; TE Inc; American Society of Mammalogists	This study was funded by University of Arizona http://www.arizona.edu/, Arizona Agriculture Experiment Station https://ag.arizona.edu/aes/, T&E Inc. Incorporated's Grants for Conservation Research, and the American Society of Mammalogists' Grants-in-Aid Program http://www.mammalsociety.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SM, 2005, CAN GEOGR-GEOGR CAN, V49, P321, DOI 10.1111/j.0008-3658.2005.00099.x; Andrews KM, 2005, COPEIA, P772, DOI 10.1643/0045-8511(2005)005[0772:HDHISM]2.0.CO;2; Angold PG, 1997, J APPL ECOL, V34, P409, DOI 10.2307/2404886; [Anonymous], 1998, QUANTITATIVE ANAL MO; Bakker VJ, 2006, J MAMMAL, V87, P124, DOI 10.1644/04-MAMM-A-050R2.1; Bakker VJ, 2004, CONSERV BIOL, V18, P689, DOI 10.1111/j.1523-1739.2004.00149.x; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Bates D. M., 2013, LME4 LINEAR MIXED EF; Beyer H. L, 2012, GEOSPATIAL MODELLING; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bhattacharya M, 2003, BIOL CONSERV, V109, P37, DOI 10.1016/S0006-3207(02)00130-1; Bissonette JA, 2009, ECOL SOC, V14; Bowker JM, 2012, SRS160 US FISH WILDL; Bowman J, 2010, CAN J ZOOL, V88, P454, DOI 10.1139/Z10-019; Brehme CS, 2013, CONSERV BIOL, V27, P710, DOI 10.1111/cobi.12081; BROWN DE, 1984, ARIZONAS TREE SQUIRR; Brown GP, 2006, BIOL CONSERV, V133, P88, DOI 10.1016/j.biocon.2006.05.020; BROWN JS, 1994, ECOLOGY, V75, P2286, DOI 10.2307/1940884; Buenau KE, 2004, ANIM CONSERV, V7, P17, DOI 10.1017/S1367943003001124; BURNETT SE, 1992, WILDLIFE RES, V19, P95, DOI 10.1071/WR9920095; Central Intelligence Agency, 2014, WORLD FACTBOOK; Chen HL, 2015, BARRIER EFFECTS ROAD; Clevenger AP, 2001, J APPL ECOL, V38, P1340, DOI 10.1046/j.0021-8901.2001.00678.x; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; COLEMAN JS, 1989, J WILDLIFE MANAGE, V53, P782, DOI 10.2307/3809213; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Czech B, 2000, BIOSCIENCE, V50, P593, DOI 10.1641/0006-3568(2000)050[0593:EAACOS]2.0.CO;2; DAVIS R, 1988, SOUTHWEST NAT, V33, P490, DOI 10.2307/3672222; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Dodd NL, 2006, RESTOR ECOL, V14, P537, DOI 10.1111/j.1526-100X.2006.00165.x; Dussault C, 2007, J WILDLIFE MANAGE, V71, P2338, DOI 10.2193/2006-499; Dyer SJ, 2002, CAN J ZOOL, V80, P839, DOI [10.1139/z02-060, 10.1139/Z02-060]; Edelman AJ, 2006, CAN J ZOOL, V84, P404, DOI 10.1139/z06-009; Edelman AJ, 2005, SOUTHWEST NAT, V50, P461, DOI 10.1894/0038-4909(2005)050[0461:DATUOA]2.0.CO;2; Edelman Andrew J., 2009, P358; Edelman AJ, 2009, J MAMMAL, V90, P167, DOI 10.1644/07-MAMM-A-282.1; EMMONS LH, 1980, ECOL MONOGR, V50, P31, DOI 10.2307/2937245; FAHRIG L, 1988, THEOR POPUL BIOL, V34, P194, DOI 10.1016/0040-5809(88)90042-1; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2009, ECOL SOC, V14; FERNER J W, 1974, Southwestern Naturalist, V18, P470, DOI 10.2307/3670306; Flaherty EA, 2008, CAN J ZOOL, V86, P1050, DOI 10.1139/Z08-084; Food and Agriculture Organization of the United Nations, 2010, 163 FAO UN; Ford AT, 2008, J MAMMAL, V89, P895, DOI 10.1644/07-MAMM-A-320.1; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2000, CONSERV BIOL, V14, P36, DOI 10.1046/j.1523-1739.2000.99088.x; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Frid A, 2002, CONSERV ECOL, V6; Fuentes-Montemayor E, 2009, J ANIM ECOL, V78, P857, DOI 10.1111/j.1365-2656.2009.01551.x; Goosem M, 1997, WILDLIFE RES, V24, P613, DOI 10.1071/WR96063; Goosem M, 2000, WILDLIFE RES, V27, P151, DOI 10.1071/WR98091; Goosem M, 2002, WILDLIFE RES, V29, P277, DOI 10.1071/WR01058; Goosem M, 2001, WILDLIFE RES, V28, P351, DOI 10.1071/WR99093; Goosem M, 2007, CURR SCI INDIA, V93, P1587; Gurnell J, 2004, J ANIM ECOL, V73, P26, DOI 10.1111/j.1365-2656.2004.00791.x; Haddad NM, 1999, AM NAT, V153, P215, DOI 10.1086/303163; Holderegger R, 2010, BASIC APPL ECOL, V11, P522, DOI 10.1016/j.baae.2010.06.006; Hurly TA, 1997, J MAMMAL, V78, P529, DOI 10.2307/1382904; Hutton KA, 2003, SOUTHWEST NAT, V48, P257, DOI 10.1894/0038-4909(2003)048&lt;0257:UOMASF&gt;2.0.CO;2; Jaeger JAG, 2005, ECOL MODEL, V185, P329, DOI 10.1016/j.ecolmodel.2004.12.015; James ARC, 2000, J WILDLIFE MANAGE, V64, P154, DOI 10.2307/3802985; KEITH JO, 1965, ECOLOGY, V46, P150, DOI 10.2307/1935266; Kerth G., 2009, BIOL CONSERV, V142, P270, DOI DOI 10.1016/j.biocon.2008.10.022; Koprowski JL, 2005, ANIM CONSERV, V8, P369, DOI 10.1017/S1367943005002416; Koprowski John L., 2008, Endangered Species Research, V4, P227, DOI 10.3354/esr00026; LARSEN KW, 1994, ECOLOGY, V75, P214, DOI 10.2307/1939395; Laurance SGW, 2004, CONSERV BIOL, V18, P1099, DOI 10.1111/j.1523-1739.2004.00268.x; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Leonard KM, 2009, AM MIDL NAT, V162, P125, DOI 10.1674/0003-0031-162.1.125; Lurz PWW, 2001, LANDSCAPE ECOL, V16, P407, DOI 10.1023/A:1017508711713; Manchester SJ, 2000, J APPL ECOL, V37, P845, DOI 10.1046/j.1365-2664.2000.00538.x; Marsh DM, 2005, CONSERV BIOL, V19, P2004, DOI 10.1111/j.1523-1739.2005.00238.x; McGregor RL, 2008, J APPL ECOL, V45, P117, DOI 10.1111/j.1365-2664.2007.01403.x; MCLELLAN BN, 1988, J APPL ECOL, V25, P451, DOI 10.2307/2403836; Merrick MJ, 2007, J WILDLIFE MANAGE, V71, P1958, DOI 10.2193/2006-260; Millennium Ecosystem Assessment, 2005, ECOSYSTEM HUMAN WELL; Minckley WL., 1968, J ARIZONA ACAD SCI, V5, P110; Minor RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143927; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; NASH D J, 1977, Mammalian Species, V80, P1; Pepper H, 1994, 191 UK FOR COMM; Reed RA, 1996, CONSERV BIOL, V10, P1098, DOI 10.1046/j.1523-1739.1996.10041098.x; Rico A, 2007, ACTA THERIOL, V52, P85, DOI 10.1007/BF03194203; RIEGE DA, 1991, J MAMMAL, V72, P152, DOI 10.2307/1381990; Roedenbeck IA, 2007, ECOL SOC, V12; Roever CL, 2010, ECOGRAPHY, V33, P1113, DOI 10.1111/j.1600-0587.2010.06077.x; Rondinini C, 2002, FUNCT ECOL, V16, P504, DOI 10.1046/j.1365-2435.2002.00651.x; Rushton SP, 2006, BIOL CONSERV, V131, P121, DOI 10.1016/j.biocon.2006.02.010; Rytwinski T, 2007, LANDSCAPE ECOL, V22, P1501, DOI 10.1007/s10980-007-9134-2; Rytwinski T, 2012, BIOL CONSERV, V147, P87, DOI 10.1016/j.biocon.2011.11.023; Sanderson H.R., 2009, LAST REFUGE MT GRAHA; Saunders SC, 2002, BIOL CONSERV, V103, P209, DOI 10.1016/S0006-3207(01)00130-6; Schauffert CA, 2002, SOUTHWEST NAT, V47, P498, DOI 10.2307/3672515; Schubert GH, 1970, RM58 USDA FOR SERV; Seabrook WA, 1996, J WILDLIFE MANAGE, V60, P363, DOI 10.2307/3802236; Shepard DB, 2008, ANIM CONSERV, V11, P288, DOI 10.1111/j.1469-1795.2008.00183.x; SMITH AA, 1994, J WILDLIFE MANAGE, V58, P437, DOI 10.2307/3809314; Steele M. A., 2001, N AM TREE SQUIRRELS; Steele Michael A., 1998, Mammalian Species, V586, P1; Stiles JH, 1998, LANDSCAPE ECOL, V13, P335, DOI 10.1023/A:1008073813734; Strasburg JL, 2006, NATURE, V440, P875, DOI 10.1038/440875a; SWIHART RK, 1984, J MAMMAL, V65, P357, DOI 10.2307/1381184; TEMPLE SA, 1987, ECOLOGY, V68, P669, DOI 10.2307/1938472; Theobald DM, 2010, LANDSCAPE ECOL, V25, P999, DOI 10.1007/s10980-010-9484-z; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; U. S. Fish and Wildlife Service, 1993, MOUNT GRAH RED SQUIR; U.S. Fish and Wildlife Service, 1987, FED REGISTER, V52, P20994; U.S. Fish and Wildlife Service, 2011, DRAFT REC PLAN MOUNT; Urban Land Institute, 2013, INFR 2013 GLOB PRIOR; van der Ree R, 2010, ECOL SOC, V15; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Whittington J, 2004, ECOL SOC, V9; World Population Clock, 2015, WORLD POP CLOCK WORL; Zugmeyer CA, 2009, FOREST ECOL MANAG, V257, P464, DOI 10.1016/j.foreco.2008.09.020	115	18	18	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148121	10.1371/journal.pone.0148121	http://dx.doi.org/10.1371/journal.pone.0148121			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821366	gold, Green Submitted, Green Published			2022-12-26	WOS:000369528400070
J	Thomas, BE; Velayutham, B; Thiruvengadam, K; Nair, D; Barman, SB; Jayabal, L; Ovung, S; Swaminathan, S				Thomas, Beena Elizabeth; Velayutham, Banurekha; Thiruvengadam, Kannan; Nair, Dina; Barman, Sukendu Bikas; Jayabal, Lavanya; Ovung, Senthanro; Swaminathan, Soumya			Perceptions of Private Medical Practitioners on Tuberculosis Notification: A Study from Chennai, South India	PLOS ONE			English	Article							SEEKING BEHAVIOR; TAMIL-NADU; SECTOR; IMPACT; CARE; PROGRAM; MIX	Background The Government of India declared TB as a notifiable disease in 2012. There is a paucity of information on the government's mandatory TB notification order from the perspective of private medical practitioners (PPs). Objective To understand the awareness, perception and barriers on TB notification among PPs in Chennai, India. Methods Total of 190 PPs were approached in their clinics by trained field staff who collected data using a semi-structured and pre-coded questionnaire after getting informed consent. The data collected included PPs' specialization, TB management practices, awareness about the TB notification order, barriers in its implementation and their suggestions to improve notification. Results Of 190 PPs from varied specializations, 138 (73%) had diagnosed TB cases in the prior three months, of whom 78% referred these patients to government facilities. Of 138 PPs, 73% were aware of the order on mandatory TB notification, of whom 46 (33%) had ever notified a TB case. Of 120 PPs, 63% reported reasons for not notifying TB cases. The main reasons reported for not notifying were lack of time (50%), concerns regarding patients' confidentiality (24%) and fear of offending patients (11%). Of 145 PPs, 76% provided feedback about information they felt uncomfortable reporting during notification. PPs felt most uncomfortable reporting patient's government-issued Aadhar number (77%), followed by patient's phone number (37%) and residential address (26%). The preferred means of notification was through mobile phone communication (24%), SMS (18%) and e-mail (17%). Conclusion This study highlights that one-fourth of PPs were not aware of the TB notification order and not all those who were aware were notifying. While it is important to sensitize PPs on the importance of TB notification it is also important to understand the barriers faced by PPs and to make the process user-friendly in order to increase TB notification.	[Thomas, Beena Elizabeth; Velayutham, Banurekha; Thiruvengadam, Kannan; Nair, Dina; Ovung, Senthanro] ICMR, Natl Inst Res TB, Madras, Tamil Nadu, India; [Barman, Sukendu Bikas] ICMR, Natl Inst Res Tribal Hlth, Jabalpur, India; [Jayabal, Lavanya] Corp Chennai, Madras, Tamil Nadu, India; [Swaminathan, Soumya] Dept Hlth Res, New Delhi, India; [Swaminathan, Soumya] Indian Council Med Res, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH); Indian Council of Medical Research (ICMR)	Thomas, BE (corresponding author), ICMR, Natl Inst Res TB, Madras, Tamil Nadu, India.	beenaelli09@gmail.com	Thiruvengadam, Kannan/AAQ-8532-2021	Thiruvengadam, Kannan/0000-0002-3758-1094				Central TB Division Directorate General of Health Services Ministry of Health and Family Welfare Government of India, 2014, TB IND 2014 REV NAT; Charles N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012379; Datta Kisalay, 2010, Indian J Tuberc, V57, P199; Government of India, 2012, Z2801522012TB GOV IN; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Lal SS, 2011, INT J TUBERC LUNG D, V15, P97; Lonnroth K, 2006, B WORLD HEALTH ORGAN, V84, P876; Mahendradhata Y, 2007, TROP MED INT HEALTH, V12, P315, DOI 10.1111/j.1365-3156.2007.01816.x; Mills A, 2002, B WORLD HEALTH ORGAN, V80, P325; Nagaraja SB, 2014, INT J TUBERC LUNG D, V18, P1353, DOI 10.5588/ijtld.13.0836; Philip S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123286; Quy HT, 2003, INT J TUBERC LUNG D, V7, P464; Sachdeva KS, 2012, INDIAN J MED RES, V135, P690; Selvam JM, 2007, INT J TUBERC LUNG D, V11, P161; Sudha G, 2003, TROP MED INT HEALTH, V8, P336, DOI 10.1046/j.1365-3156.2003.01010.x; Ullah AZ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001534; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; Vyas RM, 2003, INT J TUBERC LUNG D, V7, P543; World Health Organization (WHO), 2014, GLOB TB REP 2014	19	16	16	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147579	10.1371/journal.pone.0147579	http://dx.doi.org/10.1371/journal.pone.0147579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820750	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000369528400033
J	Adrian-Kalchhauser, I; Burkhardt-Holm, P				Adrian-Kalchhauser, Irene; Burkhardt-Holm, Patricia			An eDNA Assay to Monitor a Globally Invasive Fish Species from Flowing Freshwater	PLOS ONE			English	Article							GOBY NEOGOBIUS-MELANOSTOMUS; ENVIRONMENTAL DNA SAMPLES; ROUND GOBY; GREAT-LAKES; SURVEILLANCE; EXTRACTION; PROGRAM; RHINE; BASIN; BIODIVERSITY	Ponto-Caspian gobies are a flock of five invasive fish species that have colonized freshwaters and brackish waters in Europe and North America. One of them, the round goby Neogobius melanostomus, figures among the 100 worst invaders in Europe. Current methods to detect the presence of Ponto-Caspian gobies involve catching or sighting the fish. These approaches are labor intense and not very sensitive. Consequently, populations are usually detected only when they have reached high densities and when management or containment efforts are futile. To improve monitoring, we developed an assay based on the detection of DNA traces (environmental DNA, or eDNA) of Ponto-Caspian gobies in river water. The assay specifically detects invasive goby DNA and does not react to any native fish species. We apply the assay to environmental samples and demonstrate that parameters such as sampling depth, sampling location, extraction protocol, PCR protocol and PCR inhibition greatly impact detection. We further successfully outline the invasion front of Ponto-Caspian gobies in a large river, the High Rhine in Switzerland, and thus demonstrate the applicability of the assay to lotic environments. The eDNA assay requires less time, equipment, manpower, skills, and financial resources than the conventional monitoring methods such as electrofishing, angling or diving. Samples can be taken by untrained individuals, and the assay can be performed by any molecular biologist on a conventional PCR machine. Therefore, this assay enables environment managers to map invaded areas independently of fishermen's' reports and fish community monitorings.	[Adrian-Kalchhauser, Irene; Burkhardt-Holm, Patricia] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Burkhardt-Holm, Patricia] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Basel; University of Alberta	Adrian-Kalchhauser, I (corresponding author), Univ Basel, Dept Environm Sci, Basel, Switzerland.	irene.adrian-kalchhauser@unibas.ch	Adrian-Kalchhauser, Irene/O-7338-2017	Adrian-Kalchhauser, Irene/0000-0002-7563-2577	Federal Office for the Environment; Canton Basel Stadt; Cantons Solothurn, Aargau and Basel Land	Federal Office for the Environment; Canton Basel Stadt; Cantons Solothurn, Aargau and Basel Land	This work was supported by funding from the Federal Office for the Environment (http://www.bafu.admin.ch/), from the Canton Basel Stadt (http://www.aue.bs.ch/), and the lottery funds of the Cantons Solothurn, Aargau and Basel Land. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Borcherding J, 2013, LIMNOLOGICA, V43, P49, DOI 10.1016/j.limno.2012.08.003; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dell'Anno A, 2004, APPL ENVIRON MICROB, V70, P4384, DOI 10.1128/AEM.70.7.4384-4386.2004; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Fukumoto S, 2015, J APPL ECOL, V52, P358, DOI 10.1111/1365-2664.12392; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Green HC, 2012, WATER RES, V46, P3251, DOI 10.1016/j.watres.2012.03.041; Hensler SR, 2007, J GREAT LAKES RES, V33, P295, DOI 10.3394/0380-1330(2007)33[295:DVMORG]2.0.CO;2; Hirsch PE, 2015, AMBIO; Janac M, 2013, ECOL FRESHW FISH, V22, P430, DOI 10.1111/eff.12037; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2013, CAN J FISH AQUAT SCI, V70, P522, DOI 10.1139/cjfas-2012-0478; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Johnson TB, 2005, J GREAT LAKES RES, V31, P78, DOI 10.1016/S0380-1330(05)70239-2; Kalchhauser Irene, 2013, BioInvasions Records, V2, P79; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Kornis MS, 2012, J FISH BIOL, V80, P235, DOI 10.1111/j.1095-8649.2011.03157.x; Laramie MB, 2015, BIOL CONSERV, V183, P29, DOI 10.1016/j.biocon.2014.11.025; LaRue EA, 2011, HYDROBIOLOGIA, V663, P71, DOI 10.1007/s10750-010-0555-6; Machler E, 2014, FRESHW SCI, V33, P1174, DOI 10.1086/678128; Manne S, 2013, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2013069; Maruyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114639; McKee AM, 2015, BIOL CONSERV, V183, P70, DOI 10.1016/j.biocon.2014.11.031; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; Nathan LR, 2015, CONSERV BIOL, V29, P430, DOI 10.1111/cobi.12381; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Poulos HM, 2012, AQUAT INVASIONS, V7, P59, DOI 10.3391/ai.2012.7.1.007; Ray WJ, 2001, J GREAT LAKES RES, V27, P329, DOI 10.1016/S0380-1330(01)70648-X; Renshaw MA, 2015, MOL ECOL RESOUR, V15, P168, DOI 10.1111/1755-0998.12281; Sigsgaard EE, 2015, BIOL CONSERV, V183, P46, DOI 10.1016/j.biocon.2014.11.023; Spear SF, 2015, BIOL CONSERV, V183, P38, DOI 10.1016/j.biocon.2014.11.016; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; TAKAHARA T, 2012, PLOS ONE, V7; Takahara T, 2015, BIOL CONSERV, V183, P64, DOI 10.1016/j.biocon.2014.11.014; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Treguier A, 2014, J APPL ECOL, V51, P871, DOI 10.1111/1365-2664.12262; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Turner CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114329; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wiesner C, 2005, J APPL ICHTHYOL, V21, P324, DOI 10.1111/j.1439-0426.2005.00681.x	50	34	36	3	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147558	10.1371/journal.pone.0147558	http://dx.doi.org/10.1371/journal.pone.0147558			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814998	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000369528200040
J	Krupka, J; May, F; Weimer, T; Pragst, I; Kleinschnitz, C; Stoll, G; Panousis, C; Dickneite, G; Nolte, MW				Krupka, Jennifer; May, Frauke; Weimer, Thomas; Pragst, Ingo; Kleinschnitz, Christoph; Stoll, Guido; Panousis, Con; Dickneite, Gerhard; Nolte, Marc W.			The Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in Rats	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; THROMBUS FORMATION; PROVIDES PROTECTION; CONTACT PATHWAY; STROKE; ACTIVATION; SYSTEM; MICE; INFESTIN-4; DEFICITS	Background and Purpose Ischemic stroke provokes severe brain damage and remains a predominant disease in industrialized countries. The coagulation factor XII (FXII)-driven contact activation system plays a central, but not yet fully defined pathogenic role in stroke development. Here, we investigated the efficacy of the FXIIa inhibitor rHA-Infestin-4 in a rat model of ischemic stroke using both a prophylactic and a therapeutic approach. Methods For prophylactic treatment, animals were treated intravenously with 100 mg/kg rHA-Infestin-4 or an equal volume of saline 15 min prior to transient middle cerebral artery occlusion (tMCAO) of 90 min. For therapeutic treatment, 100 mg/kg rHA-Infestin-4, or an equal volume of saline, was administered directly after the start of reperfusion. At 24 h after tMCAO, rats were tested for neurological deficits and blood was drawn for coagulation assays. Finally, brains were removed and analyzed for infarct area and edema formation. Results Within prophylactic rHA-Infestin-4 treatment, infarct areas and brain edema formation were reduced accompanied by better neurological scores and survival compared to controls. Following therapeutic treatment, neurological outcome and survival were still improved although overall effects were less pronounced compared to prophylaxis. Conclusions With regard to the central role of the FXII-driven contact activation system in ischemic stroke, inhibition of FXIIa may represent a new and promising treatment approach to prevent cerebral ischemia/reperfusion injury.	[Krupka, Jennifer; May, Frauke; Weimer, Thomas; Pragst, Ingo; Dickneite, Gerhard; Nolte, Marc W.] CSL Behring GmbH, Marburg, Germany; [Kleinschnitz, Christoph; Stoll, Guido] Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, Wurzburg, Germany; [Panousis, Con] CSL Ltd, Inst Bio21, Parkville, Vic, Australia	CSL; University of Wurzburg; CSL	Nolte, MW (corresponding author), CSL Behring GmbH, Marburg, Germany.	marc.nolte@cslbehring.com		Kleinschnitz, Christoph/0000-0002-1650-8875	CSL Behring GmbH; CSL Limited	CSL Behring GmbH; CSL Limited	JK, FM, TW, IP and MWN are employees of CSL Behring GmbH, GD has been an employee of CSL Behring GmbH and CP is an employee of CSL Limited. Thereby, CSL Behring GmbH and CSL Limited provided support in the form of salaries and/or research materials for authors JK, FM, TW, IP, MWN, GD and CP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, GS has been a consultant of CSL Behring GmbH. CK receives financial support from CSL Behring GmbH to conduct research on FXII in experimental stroke. Thereby, GS and CK received no funding for this work.	Adams RJ, 2008, STROKE, V39, P1647, DOI 10.1161/STROKEAHA.107.189063; Albert-Weissenberger C, 2013, PROG NEUROBIOL, V101, P65, DOI 10.1016/j.pneurobio.2012.11.004; Arboix A, 2015, WORLD J CLIN CASES, V3, P418, DOI 10.12998/wjcc.v3.i5.418; Austinat M, 2009, STROKE, V40, P285, DOI 10.1161/STROKEAHA.108.526673; Baker AH, 2007, P NATL ACAD SCI USA, V104, P3597, DOI 10.1073/pnas.0611112104; Bendszus M, 2006, LANCET NEUROL, V5, P364, DOI 10.1016/S1474-4422(06)70412-4; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Bjorkqvist J, 2015, J CLIN INVEST, V125, P3132, DOI 10.1172/JCI77139; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Cai TQ, 2015, BLOOD COAGULATION FI; Campos ITN, 2004, ACTA CRYSTALLOGR D, V60, P2051, DOI 10.1107/S0907444904021596; Candelario-Jalil E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-3; Cao ZH, 2015, J ALLERGY CLIN IMMUN, V135, pAB194, DOI 10.1016/j.jaci.2014.12.1570; Chen JW, 2012, JACC-CARDIOVASC IMAG, V5, P1127, DOI 10.1016/j.jcmg.2012.01.025; Davis AE, 2008, MOL IMMUNOL, V45, P4057, DOI 10.1016/j.molimm.2008.06.028; Deb Prabal, 2010, Pathophysiology, V17, P197, DOI 10.1016/j.pathophys.2009.12.001; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Dunnett SB, 1998, NEUROSCI LETT, V246, P1, DOI 10.1016/S0304-3940(98)00194-3; Edmunds LH, 2002, PERFUSION-UK, V17, P243, DOI 10.1191/0267659102pf585oa; Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Fluri F, 2015, DRUG DES DEV THER, V9, P3445, DOI 10.2147/DDDT.S56071; Gob E, 2015, ANN NEUROL, V77, P784, DOI 10.1002/ana.24380; Grotta JC, 2015, STROKE, V46, P1447, DOI 10.1161/STROKEAHA.115.008384; Gruber A, 2014, THROMB RES, V133, pS45, DOI 10.1016/j.thromres.2014.03.019; Hagedorn I, 2010, CIRCULATION, V121, P1510, DOI 10.1161/CIRCULATIONAHA.109.924761; Heydenreich N, 2012, STROKE, V43, P2457, DOI 10.1161/STROKEAHA.112.660340; Hopp S, 2014, 87 K DTSCH GES NEUR; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Kenna E, 2014, DRUG DISCOV TODAY, V19, P1459, DOI 10.1016/j.drudis.2014.06.024; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Kuijpers MJE, 2014, ARTERIOSCL THROM VAS, V34, P1674, DOI 10.1161/ATVBAHA.114.303315; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Langhauser F, 2012, BLOOD, V120, P4082, DOI 10.1182/blood-2012-06-440057; Larsson M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006804; Leung PY, 2012, TRANSL STROKE RES, V3, P381, DOI 10.1007/s12975-012-0186-5; Li JS, 2009, NEUROSCIENCE, V159, P1309, DOI 10.1016/j.neuroscience.2009.01.011; Maas C, 2011, SEMIN THROMB HEMOST, V37, P375, DOI 10.1055/s-0031-1276586; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; Pham M, 2012, J MOL MED, V90, P119, DOI 10.1007/s00109-011-0812-9; Muller F, 2008, CURR OPIN HEMATOL, V15, P516, DOI 10.1097/MOH.0b013e328309ec85; Muller F, 2011, CURR OPIN HEMATOL, V18, P349, DOI 10.1097/MOH.0b013e3283497e61; Muller T, 2013, DTSCH ARZTEBL INT, V110, P159, DOI 10.3238/arztebl.2013.0159; Nieswandt B, 2011, J PHYSIOL-LONDON, V589, P4115, DOI 10.1113/jphysiol.2011.212886; O'Carroll CB, 2015, NEUROHOSPITALIST, V5, P122, DOI 10.1177/1941874415587681; Paciaroni M, 2007, STROKE, V38, P423, DOI 10.1161/01.STR.0000254600.92975.1f; Prabhakaran S, 2015, JAMA-J AM MED ASSOC, V313, P1451, DOI 10.1001/jama.2015.3058; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Renne Thomas, 2007, Expert Rev Cardiovasc Ther, V5, P733, DOI 10.1586/14779072.5.4.733; Renne T, 2012, BLOOD, V120, P4296, DOI 10.1182/blood-2012-07-292094; Salomon O, 2008, BLOOD, V111, P4113, DOI 10.1182/blood-2007-10-120139; Sandercock PAG, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000029.pub3; Schmaier AH, 2008, J CLIN INVEST, V118, P3006, DOI 10.1172/JCI36617; Schmaier AH, 2010, THROMB RES, V125, P105, DOI 10.1016/j.thromres.2009.09.023; Schousboe I, 2008, BIOCHEM PHARMACOL, V75, P1007, DOI 10.1016/j.bcp.2007.10.003; Siegerink B, 2010, CIRCULATION, V122, P1854, DOI 10.1161/CIRCULATIONAHA.110.943738; Sniecinski RM, 2011, ANESTH ANALG, V113, P1319, DOI 10.1213/ANE.0b013e3182354b7e; Stavrou E, 2010, THROMB RES, V125, P210, DOI 10.1016/j.thromres.2009.11.028; Undas A, 2014, POL ARCH MED WEWN, V124, P124, DOI 10.20452/pamw.2138; Wagner S, 2002, J NEUROL SCI, V202, P75, DOI 10.1016/S0022-510X(02)00208-3; Winter B, 2004, STROKE, V35, P191, DOI 10.1161/01.STR.0000107188.29688.2C; Woodruff RS, 2011, J THROMB THROMBOLYS, V32, P9, DOI 10.1007/s11239-011-0578-5	62	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146783	10.1371/journal.pone.0146783	http://dx.doi.org/10.1371/journal.pone.0146783			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815580	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528200019
J	Trigoso, YD; Evans, RC; Karsten, WE; Chooback, L				Trigoso, Yvonne D.; Evans, Russell C.; Karsten, William E.; Chooback, Lilian			Cloning, Expression, and Purification of Histidine-Tagged Escherichia coli Dihydrodipicolinate Reductase	PLOS ONE			English	Article							LYSINE BIOSYNTHESIS	The enzyme dihydrodipicolinate reductase (DHDPR) is a component of the lysine biosynthetic pathway in bacteria and higher plants. DHDPR catalyzes the NAD(P) H dependent reduction of 2,3-dihydrodipicolinate to the cyclic imine L-2,3,4,5,-tetrahydropicolinic acid. The dapB gene that encodes dihydrodipicolinate reductase has previously been cloned, but the expression of the enzyme is low and the purification is time consuming. Therefore the E. coli dapB gene was cloned into the pET16b vector to improve the protein expression and simplify the purification. The dapB gene sequence was utilized to design forward and reverse oligonucleotide primers that were used to PCR the gene from Escherichia coli genomic DNA. The primers were designed with NdeI or BamHI restriction sites on the 5' and 3' terminus respectively. The PCR product was sequenced to confirm the identity of dapB. The gene was cloned into the expression vector pET16b through NdeI and BamHI restriction endonuclease sites. The resulting plasmid containing dapB was transformed into the bacterial strain BL21 (DE3). The transformed cells were utilized to grow and express the histidine-tagged reductase and the protein was purified using Ni-NTA affinity chromatography. SDS/PAGE gel analysis has shown that the protein was 95% pure and has approximate subunit molecular weight of 28 kDa. The protein purification is completed in one day and 3 liters of culture produced approximately 40-50 mgs of protein, an improvement on the previous protein expression and multistep purification.	[Trigoso, Yvonne D.; Evans, Russell C.; Chooback, Lilian] Univ Cent Oklahoma, Dept Chem, 100 N Univ Dr, Edmond, OK 73034 USA; [Karsten, William E.] Univ Oklahoma, Dept Chem & Biochem, 101 Stephenson Pkwy, Norman, OK 73019 USA	University of Central Oklahoma; University of Oklahoma System; University of Oklahoma - Norman	Chooback, L (corresponding author), Univ Cent Oklahoma, Dept Chem, 100 N Univ Dr, Edmond, OK 73034 USA.	Lchooback@UCO.edu	Evans, Russell/L-9579-2019	Evans, Russell/0000-0002-2134-238X	Oklahoma State Regent Grant for Higher Education [021606]; National Center for Research Resources (NCRR) a component of National Institute of Health (NIH) [P20RR016478]; University of Central Oklahoma office of Research [011574]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103447] Funding Source: NIH RePORTER	Oklahoma State Regent Grant for Higher Education; National Center for Research Resources (NCRR) a component of National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Central Oklahoma office of Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funds from an Oklahoma State Regent Grant for Higher Education (021606), P20RR016478 grant from the National Center for Research Resources (NCRR) a component of National Institute of Health (NIH), and a grant from University of Central Oklahoma office of Research (011574, www.uco.edu) and Grants to L.C.	BOUVIER J, 1984, J BIOL CHEM, V259, P4829; Cirilli M, 2003, BIOCHEMISTRY-US, V42, P10644, DOI 10.1021/bi030044v; Cornish-Bowden A, 1999, FUNDAMENTALS ENZYME; CREMER J, 1988, J GEN MICROBIOL, V134, P3221; Dommaraju SR, 2011, ARCH BIOCHEM BIOPHYS, V512, P167, DOI 10.1016/j.abb.2011.06.006; FARKAS W, 1965, J BIOL CHEM, V240, P4717; Girish TS, 2011, FEBS LETT, V585, P2561, DOI 10.1016/j.febslet.2011.07.021; Gunji Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1449, DOI 10.1271/bbb.68.1449; Hutton CA, 2007, MOL BIOSYST, V3, P458, DOI 10.1039/b705624a; Hutton CA, 2003, MINI-REV MED CHEM, V3, P115, DOI 10.2174/1389557033405359; Karsten WE, 1977, BIOCHEMISTRY-US, V36, P1730; Kefala G, 2005, ACTA CRYSTALLOGR F, V61, P718, DOI 10.1107/S174430910501938X; KIMURA K, 1975, J BIOCHEM, V77, P405, DOI 10.1093/oxfordjournals.jbchem.a130739; KIMURA K, 1977, J BIOCHEM-TOKYO, V81, P1367; Marisch K, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-58; Pearce FG, 2008, J BIOCHEM, V143, P617, DOI 10.1093/jb/mvn012; REDDY SG, 1995, BIOCHEMISTRY-US, V34, P3492, DOI 10.1021/bi00011a002	17	12	12	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146525	10.1371/journal.pone.0146525	http://dx.doi.org/10.1371/journal.pone.0146525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815040	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528200016
J	Lin, CW; Tang, W; Wen, F; Chen, JJ; Zeng, XL; Chen, ZG				Lin, Chun-wang; Tang, Wen; Wen, Fang; Chen, Jin-jin; Zeng, Xiang-lin; Chen, Zong-geng			Diagnostic Accuracy of NT-ProBNP for Heart Failure with Sepsis in Patients Younger than 18 Years	PLOS ONE			English	Article							NATRIURETIC PEPTIDE LEVELS; B-TYPE; SEPTIC SHOCK; CHILDREN; BIOMARKERS; VALUES; RISK; MECHANISMS; PREDICTION; DISEASE	This clinical study investigated plasma NT-proBNP levels as a potential predictor of heart failure in pediatric patients with sepsis. Plasma NT-ProBNP levels of 211 pediatric patients with sepsis and 126 healthy children were measured. Patients were stratified as with heart failure (HF) or without heart failure (non-HF). Patients were graded as having sepsis, severe sepsis, or septic shock. The optimal cut-off values of plasma NT-ProBNP for heart failure were determined by analyzing the receiver operating characteristic (ROC). In the HF, non-HF and control groups, the median plasma NT-proBNP levels were 3640, 656, and 226 ng/L, respectively. For all patients with sepsis, the optimal diagnostic cut-off value was 1268 ng/L for differentiating heart failure. In the severe sepsis patients and septic shock patients, the optimal diagnostic cut-off values were 1368 ng/L and 1525 ng/L, respectively. This report is the first one to reveal that NT-proBNP may predict heart failure in children with sepsis. It provides an important clinical reference for the diagnosis of heart failure in pediatric patients with sepsis, and enables monitoring septic children for cardiac involvement.	[Lin, Chun-wang; Wen, Fang; Chen, Jin-jin; Zeng, Xiang-lin] Jinan Univ, Affiliated Shunde Women & Childrens Hosp, Shunde 528300, Guangdong, Peoples R China; [Tang, Wen; Chen, Zong-geng] Zhongshan Univ, Affiliated Hosp 1, Guangzhou 510632, Guangdong, Peoples R China	Jinan University; Sun Yat Sen University	Lin, CW (corresponding author), Jinan Univ, Affiliated Shunde Women & Childrens Hosp, Shunde 528300, Guangdong, Peoples R China.; Tang, W (corresponding author), Zhongshan Univ, Affiliated Hosp 1, Guangzhou 510632, Guangdong, Peoples R China.	1933500933@qq.com; tangwenr@21cn.com			Department of Science and Technology of Guangdong Province in China [2011B031800134]; Bureau of Science and Technology of Foshan City in China [201008189]	Department of Science and Technology of Guangdong Province in China; Bureau of Science and Technology of Foshan City in China	This study was supported by the Department of Science and Technology of Guangdong Province in China (grant no. 2011B031800134) and the Bureau of Science and Technology of Foshan City in China (grant no. 201008189). These funders were not involved in the study design, or the collection, analysis, or interpretation of the data, in the writing of the report, or in the decision to submit the article for publication.	Caksen H, 2002, JPN HEART J, V43, P9, DOI 10.1536/jhj.43.9; deFilippi CR, 2012, J AM COLL CARDIOL, V60, P2539, DOI 10.1016/j.jacc.2012.08.1006; Moutinho MAE, 2008, ARQ BRAS CARDIOL, V90, P145, DOI 10.1590/S0066-782X2008000200011; Eurlings LW, 2014, J CARD FAIL, V20, P881, DOI 10.1016/j.cardfail.2014.08.014; Flynn A, 2010, HEART FAIL REV, V15, P605, DOI 10.1007/s10741-010-9176-4; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Gruson D, 2012, CLIN BIOCHEM, V45, P171, DOI 10.1016/j.clinbiochem.2011.07.012; Guazzi M, 2012, J CARD FAIL, V18, P313, DOI 10.1016/j.cardfail.2012.01.006; Iqbal N, 2013, EXPERT REV CARDIOVAS, V11, P1155, DOI 10.1586/14779072.2013.832476; Johns MC, 2008, AM J CARDIOL, V101, p76A, DOI 10.1016/j.amjcard.2007.11.028; Kumar A, 1996, J EXP MED, V183, P949, DOI 10.1084/jem.183.3.949; Laer S, 2002, AM HEART J, V143, P916, DOI 10.1067/mhj.2002.121265; Lin CW, 2014, J CARD FAIL, V20, P168, DOI 10.1016/j.cardfail.2013.12.013; Madamanchi C, 2014, INT J CARDIOL, V176, P611, DOI 10.1016/j.ijcard.2014.08.007; McGrady M, 2013, INT J CARDIOL, V169, P133, DOI 10.1016/j.ijcard.2013.08.089; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; Pellicori P, 2014, INT J CARDIOL, V170, P364, DOI 10.1016/j.ijcard.2013.11.015; Popelova J, 2012, CAN J CARDIOL, V28, P471, DOI 10.1016/j.cjca.2012.01.015; Ross RD, 2012, PEDIATR CARDIOL, V33, P1295, DOI 10.1007/s00246-012-0306-8; Samransamruajkit R, 2014, INDIAN J CRIT CARE M, V18, P70, DOI 10.4103/0972-5229.126075; Seronde MF, 2013, INT J CARDIOL, V168, P3404, DOI 10.1016/j.ijcard.2013.04.164; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; Wang F, 2012, CRIT CARE, V16, DOI 10.1186/cc11331; Wong DTH, 2011, AM J CARDIOL, V107, P573, DOI 10.1016/j.amjcard.2010.10.015; Xue Yang, 2010, Congest Heart Fail, V16 Suppl 1, pS62, DOI 10.1111/j.1751-7133.2010.00169.x; Zhang XH, 2013, EUR REV MED PHARMACO, V17, P517	26	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147930	10.1371/journal.pone.0147930	http://dx.doi.org/10.1371/journal.pone.0147930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812689	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528000065
J	Cerny, KL; Ribeiro, RAC; Jeoung, M; Ko, C; Bridges, PJ				Cerny, Katheryn L.; Ribeiro, Rosanne A. C.; Jeoung, Myoungkun; Ko, CheMyong; Bridges, Phillip J.			Estrogen Receptor Alpha (ESR1)-Dependent Regulation of the Mouse Oviductal Transcriptome	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; EPITHELIAL-CELLS; GENE-EXPRESSION; IN-VITRO; PROSTAGLANDIN E-2; TUBAL OCCLUSION; FALLOPIAN-TUBE; PROGESTERONE; SECRETION; LOCALIZATION	Estrogen receptor-alpha (ESR1) is an important transcriptional regulator in the mammalian oviduct, however ESR1-dependent regulation of the transcriptome of this organ is not well defined, especially at the genomic level. The objective of this study was therefore to investigate estradiol-and ESR1-dependent regulation of the transcriptome of the oviduct using transgenic mice, both with (ESR1KO) and without (wild-type, WT) a global deletion of ESR1. Oviducts were collected from ESR1KO and WT littermates at 23 days of age, or ESR1KO and WT mice were treated with 5 IU PMSG to stimulate follicular development and the production of ovarian estradiol, and the oviducts collected 48 h later. RNA extracted from whole oviducts was hybridized to Affymetrix Genechip Mouse Genome 430-2.0 arrays (n = 3 arrays per genotype and treatment) or reverse transcribed to cDNA for analysis of the expression of selected mRNAs by real-time PCR. Following microarray analysis, a statistical two-way ANOVA and pairwise comparison (LSD test) revealed 2428 differentially expressed transcripts (DEG's, P < 0.01). Genotype affected the expression of 2215 genes, treatment (PMSG) affected the expression of 465 genes, and genotype x treatment affected the expression of 438 genes. With the goal of determining estradiol/ESR1-regulated function, gene ontology (GO) and bioinformatic pathway analyses were performed on DEG's in the oviducts of PMSG-treated ESR1KO versus PMSG-treated WT mice. Significantly enriched GO molecular function categories included binding and catalytic activity. Significantly enriched GO cellular component categories indicated the extracellular region. Significantly enriched GO biological process categories involved a single organism, modulation of a measurable attribute and developmental processes. Bioinformatic analysis revealed ESR1-regulation of the immune response within the oviduct as the primary canonical pathway. In summary, a transcriptomal profile of estradiol-and ESR1-regulated gene expression and related bioinformatic analysis is presented to increase our understanding of how estradiol/ESR1 affects function of the oviduct, and to identify genes that may be proven as important regulators of fertility in the future.	[Cerny, Katheryn L.; Ribeiro, Rosanne A. C.; Bridges, Phillip J.] Univ Kentucky, Dept Anim & Food Sci, Lexington, KY 40546 USA; [Jeoung, Myoungkun; Bridges, Phillip J.] Univ Kentucky, Dept Clin Sci, Lexington, KY 40536 USA; [Ko, CheMyong] Univ Illinois, Dept Comparat Biosci, Urbana, IL 61802 USA	University of Kentucky; University of Kentucky; University of Illinois System; University of Illinois Urbana-Champaign	Bridges, PJ (corresponding author), Univ Kentucky, Dept Anim & Food Sci, Lexington, KY 40546 USA.; Bridges, PJ (corresponding author), Univ Kentucky, Dept Clin Sci, Lexington, KY 40536 USA.	phillip.bridges@uky.edu	Ko, CheMyong Jay/A-7475-2019	Ko, CheMyong Jay/0000-0002-0963-3731	National Institutes of Health [P20 RR15592, K12 DA014040, P01 HD071875]; University of Kentucky; Kentucky Agricultural Experiment Station [16-07-008]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD071875] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K12DA014040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kentucky; Kentucky Agricultural Experiment Station; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants P20 RR15592 (P.B., C.K.), K12 DA014040 (P.B.), and P01 HD071875 (P.B., C.K.), the University of Kentucky, and Kentucky Agricultural Experiment Station.; This work was supported by National Institutes of Health Grants P20 RR15592 (P.B., C.K.), K12 DA014040 (P.B.), and P01 HD071875 (P.B., C.K), the University of Kentucky, and Kentucky Agricultural Experiment Station. The information reported in this paper (publication no. 16-07-008) is part of a project of the Kentucky Agricultural Experiment Station and is published with approval of the Director.	Andrew DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076664; Asquith KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001339; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Boraschi D, 2006, EUR CYTOKINE NETW, V17, P224; Briceag I, 2015, J Med Life, V8, P129; Bridges PJ, 2012, ENDOCRINOLOGY, V153, P1925, DOI 10.1210/en.2011-1900; Bridges PJ, 2011, REPROD BIOMED ONLINE, V23, P234, DOI 10.1016/j.rbmo.2011.04.007; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; Dixon D, 1997, TOXICOL PATHOL, V25, P518, DOI 10.1177/019262339702500516; Dong ZH, 2017, REPROD FERT DEVELOP, V29, P482, DOI 10.1071/RD15246; DONNEZ J, 1988, EUR J OBSTET GYN R B, V29, P33, DOI 10.1016/0028-2243(88)90162-1; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Garcia-Ulloa AC, 2005, MED HYPOTHESES, V65, P908, DOI 10.1016/j.mehy.2005.03.031; Gieske MC, 2008, ENDOCRINOLOGY, V149, P20, DOI 10.1210/en.2007-1084; Hamilton KJ, 2014, REPROD BIOL, V14, P3, DOI 10.1016/j.repbio.2013.12.002; Hedl M, 2014, J IMMUNOL, V192, P5924, DOI 10.4049/jimmunol.1302727; Huang N, 2015, PROSTAG OTH LIPID M, V121, P170, DOI 10.1016/j.prostaglandins.2015.08.002; Hvid M, 2007, CELL MICROBIOL, V9, P2795, DOI 10.1111/j.1462-5822.2007.00996.x; Jeoung M, 2010, ENDOCRINOLOGY, V151, P2858, DOI 10.1210/en.2009-1155; Kowsar R, 2014, MOL REPROD DEV, V81, P861, DOI 10.1002/mrd.22355; Kowsar R, 2013, J REPROD DEVELOP, V59, P470, DOI 10.1262/jrd.2013-036; Koy M, 2013, VET IMMUNOL IMMUNOP, V155, P162, DOI 10.1016/j.vetimm.2013.07.002; Liu JH, 2014, J REPROD DEVELOP, V60, P342, DOI 10.1262/jrd.2014-049; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maisey K, 2003, INFECT IMMUN, V71, P527, DOI 10.1128/IAI.71.1.527-532.2003; Marey MA, 2014, REPRODUCTION, V147, P211, DOI 10.1530/REP-13-0375; Martinez SP, 2006, PROSTAG OTH LIPID M, V80, P155, DOI 10.1016/j.prostaglandins.2006.06.002; Maxion HK, 2004, INFECT IMMUN, V72, P6330, DOI 10.1128/IAI.72.11.6330-6340.2004; Nagarajan UM, 2012, J IMMUNOL, V188, P2866, DOI 10.4049/jimmunol.1103461; Okada A, 2003, J MOL ENDOCRINOL, V30, P301, DOI 10.1677/jme.0.0300301; Orihuela PA, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-139; Otsuki M, 2007, J REPROD DEVELOP, V53, P59, DOI 10.1262/jrd.18036; Partek D., 2009, PARTEK DOCUMENTATION; Perfettini JL, 2000, INFECT IMMUN, V68, P2237, DOI 10.1128/IAI.68.4.2237-2244.2000; Popli P, 2015, J STEROID BIOCHEM, V154, P130, DOI 10.1016/j.jsbmb.2015.07.019; Punnonen R, 1984, Acta Eur Fertil, V15, P39; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Shao R, 2007, AM J PHYSIOL-ENDOC M, V293, pE1430, DOI 10.1152/ajpendo.00384.2007; Steffl M, 2008, ANN ANAT, V190, P46, DOI 10.1016/j.aanat.2007.04.003; Sweet Richard L, 2011, Infect Dis Obstet Gynecol, V2011, P561909, DOI 10.1155/2011/561909; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Ulbrich SE, 2003, J STEROID BIOCHEM, V84, P279, DOI 10.1016/S0960-0760(03)00039-6; Verhage HG, 1997, HUM REPROD UPDATE, V3, P541, DOI 10.1093/humupd/3.6.541; WALTER P, 1985, P NATL ACAD SCI USA, V82, P7889, DOI 10.1073/pnas.82.23.7889; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Wijayagunawardane MPB, 1999, ANIM REPROD SCI, V56, P11, DOI 10.1016/S0378-4320(99)00021-4	46	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147685	10.1371/journal.pone.0147685	http://dx.doi.org/10.1371/journal.pone.0147685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808832	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800179
J	Duda, JP; Van Kranendonk, MJ; Thiel, V; Ionescu, D; Strauss, H; Schafer, N; Reitner, J				Duda, Jan-Peter; Van Kranendonk, Martin J.; Thiel, Volker; Ionescu, Danny; Strauss, Harald; Schaefer, Nadine; Reitner, Joachim			A Rare Glimpse of Paleoarchean Life: Geobiology of an Exceptionally Preserved Microbial Mat Facies from the 3.4 Ga Strelley Pool Formation, Western Australia	PLOS ONE			English	Article							PILBARA CRATON; STROMATOLITE REEF; WARRAWOONA GROUP; NORTH-POLE; SULFUR; OLD; REDUCTION; CHERT; BIOGENICITY; ORIGIN	Paleoarchean rocks from the Pilbara Craton of Western Australia provide a variety of clues to the existence of early life on Earth, such as stromatolites, putative microfossils and geo-chemical signatures of microbial activity. However, some of these features have also been explained by non-biological processes. Further lines of evidence are therefore required to convincingly argue for the presence of microbial life. Here we describe a new type of microbial mat facies from the 3.4 Ga Strelley Pool Formation, which directly overlies well known stromatolitic carbonates from the same formation. This microbial mat facies consists of laminated, very fine-grained black cherts with discontinuous white quartz layers and lenses, and contains small domical stromatolites and wind-blown crescentic ripples. Light-and cathodoluminescence microscopy, Raman spectroscopy, and time of flight-secondary ion mass spectrometry (ToF-SIMS) reveal a spatial association of carbonates, organic material, and highly abundant framboidal pyrite within the black cherts. Nano secondary ion mass spectrometry (NanoSIMS) confirmed the presence of distinct spheroidal carbonate bodies up to several tens of mu m that are surrounded by organic material and pyrite. These aggregates are interpreted as biogenic. Comparison with Phanerozoic analogues indicates that the facies represents microbial mats formed in a shallow marine environment. Carbonate precipitation and silicification by hydrothermal fluids occurred during sedimentation and earliest diagenesis. The deciphered environment, as well as the delta C-13 signature of bulk organic matter (-35.3 parts per thousand), are in accord with the presence of photoautotrophs. At the same time, highly abundant framboidal pyrite exhibits a sulfur isotopic signature (delta S-34 = +3.05 parts per thousand;Delta S-33 = 0.268 parts per thousand; and Delta S-36 = -0.282 parts per thousand) that is consistent with microbial sulfate reduction. Taken together, our results strongly support a microbial mat origin of the black chert facies, thus providing another line of evidence for life in the 3.4 Ga Strelley Pool Formation.	[Duda, Jan-Peter; Thiel, Volker; Schaefer, Nadine; Reitner, Joachim] Univ Gottingen, Geosci Ctr, Dept Geobiol, Goldschmidtstr 3, D-37077 Gottingen, Germany; [Duda, Jan-Peter; Reitner, Joachim] Gottingen Acad Sci & Humanities, Origin Life Grp, Theaterstr 7, Gottingen, Germany; [Van Kranendonk, Martin J.] Univ New S Wales, Australian Ctr Astrobiol, Kensington, NSW 2052, Australia; [Van Kranendonk, Martin J.] Univ New S Wales, Sch Biol Earth & Environm Sci, Kensington, NSW 2052, Australia; [Ionescu, Danny] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Expt Limnol, Alte Fischerhutte 2, D-16775 Stechlin, Germany; [Strauss, Harald] Univ Munster, Inst Geol & Palaontol, Corrensstr 24, D-48149 Munster, Germany	University of Gottingen; University of New South Wales Sydney; University of New South Wales Sydney; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Munster	Duda, JP (corresponding author), Univ Gottingen, Geosci Ctr, Dept Geobiol, Goldschmidtstr 3, D-37077 Gottingen, Germany.; Duda, JP (corresponding author), Gottingen Acad Sci & Humanities, Origin Life Grp, Theaterstr 7, Gottingen, Germany.	jan-peter.duda@geo.uni-goettingen.de	Ionescu, Danny/P-3261-2017	Ionescu, Danny/0000-0002-4658-8597; Duda, Jan-Peter/0000-0002-8959-097X; Thiel, Volker/0000-0003-4758-2784; Van Kranendonk, Martin/0000-0002-0611-2703	Deutsche Forschungsgemeinschaft (DFG Priority Programme 1833, "Building a Habitable Earth") [DU 1450/3-1]; Courant Research Centre of the University Gottingen (DFG, German Excellence Program); Gottingen Academy of Sciences and Humanities; University of New South Wales; Sloan Foundation; National Institute for Mathematical and Biological Synthesis (NIMBioS); National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF Award [EF-0832858]; University of Tennessee, Knoxville; University of Gottingen	Deutsche Forschungsgemeinschaft (DFG Priority Programme 1833, "Building a Habitable Earth")(German Research Foundation (DFG)); Courant Research Centre of the University Gottingen (DFG, German Excellence Program); Gottingen Academy of Sciences and Humanities; University of New South Wales; Sloan Foundation(Alfred P. Sloan Foundation); National Institute for Mathematical and Biological Synthesis (NIMBioS)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF Award; University of Tennessee, Knoxville; University of Gottingen	Financial support was provided by Deutsche Forschungsgemeinschaft (grant DU 1450/3-1, DFG Priority Programme 1833, "Building a Habitable Earth"), Courant Research Centre of the University Gottingen (DFG, German Excellence Program), Gottingen Academy of Sciences and Humanities, University of New South Wales, and the Sloan Foundation. University of Gottingen provided financial support for open access (open Access Publication Funds).; The authors acknowledge the support of the National Institute for Mathematical and Biological Synthesis (NIMBioS), an Institute sponsored by the National Science Foundation, the U.S. Department of Homeland Security, and the U.S. Department of Agriculture through NSF Award # EF-0832858, with additional support from The University of Tennessee, Knoxville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank the members of the NIMBioS working group for their valuable comments regarding our within-host modeling of MAP infections.	Allwood A.C., 2007, STRATIGRAPHY FACIES; Allwood AC, 2007, PRECAMBRIAN RES, V158, P198, DOI 10.1016/j.precamres.2007.04.013; Allwood AC, 2010, CHEM GEOL, V270, P148, DOI 10.1016/j.chemgeo.2009.11.013; Allwood AC, 2009, P NATL ACAD SCI USA, V106, P9548, DOI 10.1073/pnas.0903323106; Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764; Arp G, 2012, GEOMICROBIOL J, V29, P29, DOI 10.1080/01490451.2010.521436; Benzerara K, 2014, BIO WEB CONF, V2, DOI 10.1051/bioconf/20140202002; BERNER RA, 1970, AM J SCI, V268, P1, DOI 10.2475/ajs.268.1.1; BERNER RA, 1984, GEOCHIM COSMOCHIM AC, V48, P605, DOI 10.1016/0016-7037(84)90089-9; Brasier M, 2006, PHILOS T R SOC B, V361, P887, DOI 10.1098/rstb.2006.1835; Brasier MD, 2011, EARLIEST LIFE ON EARTH: HABITATS, ENVIORNMENTS AND METHODS OF DETECTION, P115, DOI 10.1007/978-90-481-8794-2_5; Brasier MD, 2005, PRECAMBRIAN RES, V140, P55, DOI 10.1016/j.precamres.2005.06.008; BUICK R, 1981, ALCHERINGA, V5, P161, DOI 10.1080/03115518108566999; Buick R, 1985, THESIS U W AUSTR; CANFIELD DE, 1986, CHEM GEOL, V54, P149, DOI 10.1016/0009-2541(86)90078-1; Canfield DE, 2001, REV MINERAL GEOCHEM, V43, P607, DOI 10.2138/gsrmg.43.1.607; Couradeau E, 2012, SCIENCE, V336, P459, DOI 10.1126/science.1216171; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Fischer A.G., 1964, KANS GEOL SURV BULL, V169, P107; Flugel E., 1991, CALCAREOUS ALGAE STR, P481; Flugel E., 1982, INTRO FACIES ANAL BT, P1, DOI [10.1007/978-3-642-68423-4_1, DOI 10.1007/978-3-642-68423-4_1]; Grotzinger JP, 1999, ANNU REV EARTH PL SC, V27, P313, DOI 10.1146/annurev.earth.27.1.313; Grotzinger JP, 1996, NATURE, V383, P423, DOI 10.1038/383423a0; Habermann D, 2000, CATHODOLUMINESCENCE; Head IM, 2000, FEMS MICROBIOL ECOL, V33, P171; Hickman A.H, 2008, REGIONAL REV 3426 33; Hickman AH, 2012, 34 INT GEOL C IGC BR, P66; Hofmann HJ, 1999, GEOL SOC AM BULL, V111, P1256, DOI 10.1130/0016-7606(1999)111<1256:OOGCSI>2.3.CO;2; HULSTON JR, 1965, J GEOPHYS RES, V70, P3475, DOI 10.1029/JZ070i014p03475; Johnston DT, 2011, EARTH-SCI REV, V106, P161, DOI 10.1016/j.earscirev.2011.02.003; Kashefi K, 2000, APPL ENVIRON MICROB, V66, P1050, DOI 10.1128/AEM.66.3.1050-1056.2000; Kilburn M.R., 2014, PRINCIPLES PRACTICE; Lindsay JF, 2005, PRECAMBRIAN RES, V143, P1, DOI 10.1016/j.precamres.2005.09.003; Lindsay JF, 2003, ASTROBIOLOGY, V3, P739, DOI 10.1089/153110703322736060; LOWE DR, 1980, NATURE, V284, P441, DOI 10.1038/284441a0; LOWE DR, 1994, GEOLOGY, V22, P387, DOI 10.1130/0091-7613(1994)022<0387:AOODSO>2.3.CO;2; LOWE DR, 1983, PRECAMBRIAN RES, V19, P239, DOI 10.1016/0301-9268(83)90016-5; MacLean LCW, 2008, GEOBIOLOGY, V6, P471, DOI 10.1111/j.1472-4669.2008.00174.x; Marshall CP, 2007, PRECAMBRIAN RES, V155, P1, DOI 10.1016/j.precamres.2006.12.014; Mcloughlin N, 2008, GEOBIOLOGY, V6, P95, DOI 10.1111/j.1472-4669.2007.00141.x; MYERS CR, 1990, J BACTERIOL, V172, P6232, DOI 10.1128/jb.172.11.6232-6238.1990; Nelson D.R., COMPILATION GEOCHRON, P190; Oehler DZ, 2006, ASTROBIOLOGY, V6, P838, DOI 10.1089/ast.2006.6.838; Oehler DZ, 2010, ASTROBIOLOGY, V10, P413, DOI 10.1089/ast.2009.0426; Oehler DZ, 2009, PRECAMBRIAN RES, V173, P70, DOI 10.1016/j.precamres.2009.01.001; Ohfuji H, 2005, EARTH-SCI REV, V71, P147, DOI 10.1016/j.earscirev.2005.02.001; Ono S, 2006, GEOCHIM COSMOCHIM AC, V70, P2238, DOI 10.1016/j.gca.2006.01.022; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Polerecky L, 2012, ENVIRON MICROBIOL, V14, P1009, DOI 10.1111/j.1462-2920.2011.02681.x; Popa R, 2004, GEOMICROBIOL J, V21, P193, DOI 10.1080/01490450490275497; Powell CL, 2000, GEOL SOC SPEC PUBL, V180, P439, DOI 10.1144/GSL.SP.2000.180.01.23; RICHTER DK, 1981, GEOL RUNDSCH, V70, P1276, DOI 10.1007/BF01820192; RODEN EE, 1993, APPL ENVIRON MICROB, V59, P734, DOI 10.1128/AEM.59.3.734-742.1993; Rust GW, 1935, J GEOL, V43, P398, DOI 10.1086/624318; Sandberg PA, 1985, CARBONATE CEMENTS SE, V36, P33; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SEMIKHATOV MA, 1979, CAN J EARTH SCI, V16, P992, DOI 10.1139/e79-088; SHINN EA, 1983, J SEDIMENT PETROL, V53, P619; SHINN EA, 1968, J SEDIMENT PETROL, V38, P215, DOI 10.1306/74D7191F-2B21-11D7-8648000102C1865D; Sugitani K, 2015, GEOBIOLOGY, P1; Sugitani K, 2013, PRECAMBRIAN RES, V226, P59, DOI 10.1016/j.precamres.2012.11.005; Sugitani K, 2010, ASTROBIOLOGY, V10, P899, DOI 10.1089/ast.2010.0513; THORPE RI, 1992, PRECAMBRIAN RES, V56, P169, DOI 10.1016/0301-9268(92)90100-3; Tice MM, 2006, EARTH-SCI REV, V76, P259, DOI 10.1016/j.earscirev.2006.03.003; Tice MM, 2009, ASTROBIOLOGY, V9, P989, DOI 10.1089/ast.2008.0330; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; TREWIN NH, 1994, T ROY SOC EDIN-EARTH, V84, P433; Trewin NH, 1996, EVOLUTION HYDROTHERM; Tucker M., 1990, CARBONATE SEDIMENTOL; Van Kranendonk M.J., 2011, ADV STROMATOLITE GEO; Van Kranendonk M.J., 2006, REVISED LITHOSTRATIG; Van Kranendonk MJ, 2003, GEOBIOLOGY, V1, P91, DOI 10.1046/j.1472-4669.2003.00014.x; Van Kranendonk MJ, 2008, PRECAMBRIAN RES, V167, P93, DOI 10.1016/j.precamres.2008.07.003; Van Kranendonk MJ, 2006, EARTH-SCI REV, V74, P197, DOI 10.1016/j.earscirev.2005.09.005; Van Kranendonk MJ, 2004, GEOCHEM-EXPLOR ENV A, V4, P253, DOI 10.1144/1467-7873/04-205; Van Kranendonk MJ, 2002, ECON GEOL BULL SOC, V97, P695; VanKranendonk MJ, 2007, DEV PREC G, V15, P1; Von Knorre H, 2000, MICROBIAL SEDIMENTS, P25; Wacey D, 2010, GEOL SURV WA RECORD; Wacey D, 2015, GEOLOGY, V43, P27, DOI 10.1130/G36048.1; Wacey D, 2011, NAT GEOSCI, V4, P698, DOI 10.1038/NGEO1238; Wacey D, 2011, EARTH PLANET SC LETT, V301, P393, DOI 10.1016/j.epsl.2010.11.025; Wacey D, 2010, GEOLOGY, V38, P1115, DOI 10.1130/G31329.1; Wacey D, 2010, ASTROBIOLOGY, V10, P381, DOI 10.1089/ast.2009.0423; Walter M. R., 1976, STROMATOLITES; WALTER MR, 1980, NATURE, V284, P443, DOI 10.1038/284443a0; Williford KW, 2015, LPI CONTRIBUTION; Wright DT, 2005, GEOMICROBIOL J, V22, P27, DOI 10.1080/01490450590922532	88	29	30	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147629	10.1371/journal.pone.0147629	http://dx.doi.org/10.1371/journal.pone.0147629			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807732	Green Published, gold			2022-12-26	WOS:000369527800155
J	Kang, H; Weiss, TM; Bang, I; Weis, WI; Choi, HJ				Kang, Hyunook; Weiss, Thomas M.; Bang, Injin; Weis, William I.; Choi, Hee-Jung			Structure of the Intermediate Filament-Binding Region of Desmoplakin	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; X-RAY SOLUTION; PLAKIN DOMAIN; BIOLOGICAL MACROMOLECULES; PALMOPLANTAR KERATODERMA; HAPLOINSUFFICIENCY; CRYSTALLOGRAPHY; CARDIOMYOPATHY; PREDICTION; TERMINUS	Desmoplakin (DP) is a cytoskeletal linker protein that connects the desmosomal cadherin/plakoglobin/plakophilin complex to intermediate filaments (IFs). The C-terminal region of DP (DPCT) mediates IF binding, and contains three plakin repeat domains (PRDs), termed PRD-A, PRD-B and PRD-C. Previous crystal structures of PRDs B and C revealed that each is formed by 4.5 copies of a plakin repeat (PR) and has a conserved positively charged groove on its surface. Although PRDs A and B are linked by just four amino acids, B and C are separated by a 154 residue flexible linker, which has hindered crystallographic analysis of the full DPCT. Here we present the crystal structure of a DPCT fragment spanning PRDs A and B, and elucidate the overall architecture of DPCT by small angle X-ray scattering (SAXS) analysis. The structure of PRD-A is similar to that of PRD-B, and the two domains are arranged in a quasi-linear arrangement, and separated by a 4 amino acid linker. Analysis of the B-C linker region using secondary structure prediction and the crystal structure of a homologous linker from the cytolinker periplakin suggests that the N-terminal similar to 100 amino acids of the linker form two PR-like motifs. SAXS analysis of DPCT indicates an elongated but non-linear shape with R-g = 51.5 angstrom and D-max = 178 angstrom. These data provide the first structural insights into an IF binding protein containing multiple PRDs and provide a foundation for studying the molecular basis of DP-IF interactions.	[Kang, Hyunook; Bang, Injin; Choi, Hee-Jung] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Weiss, Thomas M.] SLAC Natl Lab, Menlo Pk, CA USA; [Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA USA; [Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA USA	Seoul National University (SNU); Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Stanford University	Choi, HJ (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea.; Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA USA.; Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA USA.	bill.weis@stanford.edu; choihj@snu.ac.kr	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Kang, Hyunook/0000-0002-7017-4597; Choi, Hee-Jung/0000-0002-1167-1526; Bang, Injin/0000-0003-0247-6056	Interdisciplinary Research Program from the Research Institute for Basic Sciences; Seoul National University Research Grant; Basic Research Laboratory through the National Research Foundation of Korea [NRF-2014R1A4A10052590]; U.S. National Institutes of Health [GM56169, GM09463]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; Seoul National University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169, P41GM103393] Funding Source: NIH RePORTER	Interdisciplinary Research Program from the Research Institute for Basic Sciences; Seoul National University Research Grant; Basic Research Laboratory through the National Research Foundation of Korea(National Research Foundation of Korea); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Seoul National University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Interdisciplinary Research Program from the Research Institute for Basic Sciences, Seoul National University, the Seoul National University Research Grant, and a grant from the Basic Research Laboratory (NRF-2014R1A4A10052590) through the National Research Foundation of Korea (HJC), and the U.S. National Institutes of Health (GM56169 and GM09463) (WIW). Portions of this work were performed at the Stanford Synchrotron Radiation Lightsource (SSRL). The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ai-Jassar C, 2013, J MOL BIOL, V425, P4006, DOI 10.1016/j.jmb.2013.07.035; Al-Jassar C, 2011, J MOL BIOL, V411, P1049, DOI 10.1016/j.jmb.2011.06.047; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bornslaeger EA, 1996, J CELL BIOL, V134, P985, DOI 10.1083/jcb.134.4.985; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi HJ, 2011, J MOL BIOL, V409, P800, DOI 10.1016/j.jmb.2011.04.046; Choi HJ, 2009, J BIOL CHEM, V284, P31776, DOI 10.1074/jbc.M109.047928; Choi HJ, 2002, NAT STRUCT BIOL, V9, P612, DOI 10.1038/nsb818; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Favre B, 2011, EUR J CELL BIOL, V90, P390, DOI 10.1016/j.ejcb.2010.11.013; Fontao L, 2003, MOL BIOL CELL, V14, P1978, DOI 10.1091/mbc.e02-08-0548; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Jefferson JJ, 2007, J MOL BIOL, V366, P244, DOI 10.1016/j.jmb.2006.11.036; Jonkman MF, 2005, AM J HUM GENET, V77, P653, DOI 10.1086/496901; Keith D, 1999, HUM MOL GENET, V8, P143, DOI 10.1093/hmg/8.1.143; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kowalczyk AP, 1997, J CELL BIOL, V139, P773, DOI 10.1083/jcb.139.3.773; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Leung CL, 2002, TRENDS CELL BIOL, V12, P37, DOI 10.1016/S0962-8924(01)02180-8; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng JJ, 1997, J BIOL CHEM, V272, P21495, DOI 10.1074/jbc.272.34.21495; Nikolic B, 1996, J CELL BIOL, V134, P1455, DOI 10.1083/jcb.134.6.1455; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; STAPPENBECK TS, 1992, J CELL BIOL, V116, P1197, DOI 10.1083/jcb.116.5.1197; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Whittock NV, 1999, J INVEST DERMATOL, V113, P940, DOI 10.1046/j.1523-1747.1999.00783.x	38	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147641	10.1371/journal.pone.0147641	http://dx.doi.org/10.1371/journal.pone.0147641			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808545	Green Submitted, gold, Green Published			2022-12-26	WOS:000369527800163
J	Maquart, M; Boyer, S; Rakotoharinome, VM; Ravaomanana, J; Tantely, ML; Heraud, JM; Cardinale, E				Maquart, Marianne; Boyer, Sebastien; Rakotoharinome, Vincent Michel; Ravaomanana, Julie; Tantely, Michael Luciano; Heraud, Jean-Michel; Cardinale, Eric			High Prevalence of West Nile Virus in Domestic Birds and Detection in 2 New Mosquito Species in Madagascar	PLOS ONE			English	Article							TRANSMISSION	West Nile virus is an arthropod-borne zoonosis transmitted by a large number of mosquito species, and birds play a key role as reservoir of the virus. Its distribution is largely widespread over Africa, Asia, the Americas and Europe. Since 1978, it has frequently been reported in Madagascar. Studies described a high seroprevalence level of the virus in humans in different areas of the island and a human fatal case of WNV infection was reported in 2011. Despite these reports, the epidemiology of WNV in Madagascar, in particular, viral circulation remains unclear. To explore the transmission of WNV in two rural human populations of Madagascar, we investigated local mosquitoes and poultry for evidence of current infections, and determined seroprevalence of candidate sentinel species among the local poultry. These 2 areas are close to lakes where domestic birds, migratory wild birds and humans coexist. Serological analysis revealed WNV antibodies in domestic birds (duck, chicken, goose, turkey and guinea fowl) sampled in both districts (Antsalova 29.4% and Mitsinjo 16.7%). West Nile virus nucleic acid was detected in one chicken and in 8 pools of mosquitoes including 2 mosquito species (Aedeomyia madagascarica and Anopheles pauliani) that have not been previously described as candidate vectors for WNV. Molecular analysis of WNV isolates showed that all viruses detected were part of the lineage 2 that is mainly distributed in Africa, and were most closely matched by the previous Malagasy strains isolated in 1988. Our study showed that WNV circulates in Madagascar amongst domestic birds and mosquitoes, and highlights the utility of poultry as a surveillance tool to detect WNV transmission in a peri-domestic setting.	[Maquart, Marianne; Heraud, Jean-Michel] Inst Pasteur Madagascar, Virol Unit, Antananarivo, Madagascar; [Boyer, Sebastien; Tantely, Michael Luciano] Inst Pasteur Madagascar, Unit Entomol Med, Antananarivo, Madagascar; [Rakotoharinome, Vincent Michel] Minist Elevage, Direct Serv Vet, Antananarivo, Madagascar; [Ravaomanana, Julie] Ctr Natl Rech Appl Dev Rural, Dept Rech Zootech & Vet, Antananarivo, Madagascar; [Maquart, Marianne; Cardinale, Eric] Ctr Cooperat Int Rech Agronom Dev, UMR CMAEE 15, St Clotilde, Reunion, France; [Cardinale, Eric] Inst Natl Rech Agronom, UMR CMAEE 1309, St Clotilde, Reunion, France; [Cardinale, Eric] Ctr Rech & Veille Malad Emergentes Ocean Indie, St Clotilde, Reunion, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; CIRAD; INRAE	Maquart, M (corresponding author), Inst Pasteur Madagascar, Virol Unit, Antananarivo, Madagascar.; Maquart, M (corresponding author), Ctr Cooperat Int Rech Agronom Dev, UMR CMAEE 15, St Clotilde, Reunion, France.	mariannemaquart@yahoo.fr	maquart, marianne/AAX-8356-2021; Heraud, Jean-Michel/O-1464-2013; Tantely, Luciano Michaël/J-1385-2019	Heraud, Jean-Michel/0000-0003-1107-0859; Tantely, Luciano Michaël/0000-0002-4658-6372; Boyer, Sebastien/0000-0002-2946-586X	FEDER POCT (European Union); FEDER POCT (Regional Council of Reunion); FEDER POCT (French government); French Embassy of Madagascar	FEDER POCT (European Union); FEDER POCT (Regional Council of Reunion); FEDER POCT (French government); French Embassy of Madagascar	This study was conducted in the framework of AnimalRisk-OI, a research program on emerging animal diseases in the Indian Ocean, funded by FEDER POCT (European Union, Regional Council of Reunion and the French government). The study was also partially funded by the French Embassy of Madagascar.	Aharonson-Raz K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113149; Berthet FX, 1997, J GEN VIROL, V78, P2293, DOI 10.1099/0022-1317-78-9-2293; Boyer S. M., 2014, ARCH I PASTEUR MADAG, V71, P1; Cernescu C., 1997, Romanian Journal of Virology, V48, P13; Donadieu E, 2013, VIRUSES-BASEL, V5, P2856, DOI 10.3390/v5112856; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FONTENILLE D, 1989, ANN SOC BELG MED TR, V69, P233; Garcia-Bocanegra I, 2011, VECTOR-BORNE ZOONOT, V11, P1107, DOI 10.1089/vbz.2009.0237; Gouagna LC, 2015, ACTA TROP, V143, P89, DOI 10.1016/j.actatropica.2014.12.011; Kilpatrick AM, 2007, AUK, V124, P1121, DOI 10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Komar N, 2001, ANN NY ACAD SCI, V951, P58; Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3; Larrieu S, 2013, AM J TROP MED HYG, V89, P211, DOI 10.4269/ajtmh.12-0003; Lonchampt C., 2003, Archives de l'Institut Pasteur de Madagascar, V69, P33; MATHIOT C, 1984, Archives de l'Institut Pasteur de Madagascar, V51, P113; MORVAN J, 1991, B SOC PATHOL EXOT, V84, P225; Nemeth N, 2006, J WILDLIFE DIS, V42, P1, DOI 10.7589/0090-3558-42.1.1; PEIRIS JSM, 1994, HDB ZOONOSES B, P139; Petersen LR, 2001, EMERG INFECT DIS, V7, P611; Petrovic T, 2013, EUROSURVEILLANCE, V18; R Core Team R. C, 2013, R LANG ENV STAT COMP; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121	24	25	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147589	10.1371/journal.pone.0147589	http://dx.doi.org/10.1371/journal.pone.0147589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807720	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800141
J	Moss, P; Knight, E; Wright, A				Moss, Penny; Knight, Emma; Wright, Anthony			Subjects with Knee Osteoarthritis Exhibit Widespread Hyperalgesia to Pressure and Cold	PLOS ONE			English	Article							QUALITY-OF-LIFE; LOW-BACK-PAIN; THERMAL HYPERALGESIA; SENSITIZATION; WHIPLASH; SENSITIVITY; DISABILITY; SEVERITY; ABNORMALITIES; MANAGEMENT	Hyperalgesia to mechanical and thermal stimuli are characteristics of a range of disorders such as tennis elbow, whiplash and fibromyalgia. This study evaluated the presence of local and widespread mechanical and thermal hyperalgesia in individuals with knee osteoarthritis, compared to healthy control subjects. Twenty-three subjects with knee osteoarthritis and 23 healthy controls, matched for age, gender and body mass index, were recruited for the study. Volunteers with any additional chronic pain conditions were excluded. Pain thresholds to pressure, cold and heat were tested at the knee, ipsilateral heel and ipsilateral elbow, in randomized order, using standardised methodology. Significant between-groups differences for pressure pain and cold pain thresholds were found with osteoarthritic subjects demonstrating significantly increased sensitivity to both pressure (p =.018) and cold (p=.003) stimuli, compared with controls. A similar pattern of results extended to the pain-free ipsilateral ankle and elbow indicating widespread pressure and cold hyperalgesia. No significant differences were found between groups for heat pain threshold, although correlations showed that subjects with greater sensitivity to pressure pain were also likely to be more sensitive to both cold pain and heat pain. This study found widespread elevated pain thresholds in subjects with painful knee osteoarthritis, suggesting that altered nociceptive system processing may play a role in ongoing arthritic pain for some patients.	[Moss, Penny; Knight, Emma; Wright, Anthony] Curtin Univ Technol, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia	Curtin University	Moss, P (corresponding author), Curtin Univ Technol, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia.	p.moss@curtin.edu.au						Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Bajaj P, 2001, PAIN, V93, P107, DOI 10.1016/S0304-3959(01)00300-1; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Berglund B, 2002, PAIN, V96, P177, DOI 10.1016/S0304-3959(01)00443-2; Cameron AJ, 2003, MED J AUSTRALIA, V178, P427, DOI 10.5694/j.1326-5377.2003.tb05283.x; Coombes BK, 2012, CLIN J PAIN, V28, P595, DOI 10.1097/AJP.0b013e31823dd333; Creamer P, 1998, CLIN GERIATR MED, V14, P435; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Dodo N, 2015, INT J PSYCHOL BEHAV, V5, P179, DOI DOI 10.5923/J.IJPBS.20150505.01; Ferreira AH, 2015, REV BRAS REUMATOL, V55, P434, DOI 10.1016/j.rbr.2015.03.001; Finan PH, 2013, ARTHRITIS RHEUM-US, V65, P363, DOI 10.1002/art.34646; Fingleton C, 2015, OSTEOARTHR CARTILAGE, V23, P1043, DOI 10.1016/j.joca.2015.02.163; FRUHSTORFER H, 1976, J NEUROL NEUROSUR PS, V39, P1071, DOI 10.1136/jnnp.39.11.1071; George SZ, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-68; Goldsmith R, 2012, MANUAL THER, V17, P402, DOI 10.1016/j.math.2012.02.014; Graven-Nielsen T, 2012, ARTHRITIS RHEUM-US, V64, P2907, DOI 10.1002/art.34466; Harden RN, 2013, J PAIN, V14, P281, DOI 10.1016/j.jpain.2012.11.009; HOCHBERG MC, 1995, ARTHRITIS RHEUM, V38, P1541, DOI 10.1002/art.1780381104; Hubscher M, 2014, CLIN J PAIN, V30, P886, DOI 10.1097/AJP.0000000000000045; Imamura M, 2008, ARTHRIT RHEUM-ARTHR, V59, P1424, DOI 10.1002/art.24120; Jinks C, 2002, PAIN, V100, P55, DOI 10.1016/S0304-3959(02)00239-7; Jorum ET, 2003, PAIN, V101, P9; King CD, 2013, OSTEOARTHR CARTILAGE, V21, P1243, DOI 10.1016/j.joca.2013.05.015; Kosek E, 2000, EUR J PAIN, V4, P229, DOI 10.1053/eujp.2000.0175; Lee YC, 2011, ARTHRIT CARE RES, V63, P320, DOI 10.1002/acr.20373; Moss P, 2007, MANUAL THER, V12, P109, DOI 10.1016/j.math.2006.02.009; Neogi T, 2015, ANN RHEUM DIS, V74, P682, DOI 10.1136/annrheumdis-2013-204191; O'Sullivan P, 2014, MANUAL THER, V19, P311, DOI 10.1016/j.math.2014.03.006; Riek S, 2000, J ELECTROMYOGR KINES, V10, P249, DOI 10.1016/S1050-6411(00)00017-1; Smith BW, 2008, PAIN, V140, P420, DOI 10.1016/j.pain.2008.09.018; Smith J, 1999, J MUSCULOSKELET PAIN, V7, P55, DOI 10.1300/J094v07n04_06; Spielberger SD, 1970, MANUAL STATE TRAIT A; Sterling M, 2006, J PSYCHOSOM RES, V60, P387, DOI 10.1016/j.jpsychores.2005.08.016; Sterling M, 2009, MANUAL THER, V14, P173, DOI 10.1016/j.math.2008.01.009; Sterling M, 2006, PAIN, V122, P102, DOI 10.1016/j.pain.2006.01.014; Suokas AK, 2012, OSTEOARTHR CARTILAGE, V20, P1075, DOI 10.1016/j.joca.2012.06.009; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Wright A., 1992, Pain Clinic, V5, P221; Wright A, 1994, J MUSCULOSKELET PAIN, V2, P85; Wylde V, 2012, RHEUMATOLOGY, V51, P535, DOI 10.1093/rheumatology/ker343	40	36	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147526	10.1371/journal.pone.0147526	http://dx.doi.org/10.1371/journal.pone.0147526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809009	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800122
J	Valentim, AM; Felix, LM; Carvalho, L; Diniz, E; Antunes, LM				Valentim, Ana M.; Felix, Luis M.; Carvalho, Leonor; Diniz, Enoque; Antunes, Luis M.			A New Anaesthetic Protocol for Adult Zebrafish (Danio rerio): Propofol Combined with Lidocaine	PLOS ONE			English	Article							NEUROSCIENCE RESEARCH; CLOVE OIL; TRICAINE; FISH; LIGNOCAINE; EFFICACY; MODELS	Background The increasing use of zebrafish model has not been accompanied by the evolution of proper anaesthesia for this species in research. The most used anaesthetic in fishes, MS222, may induce aversion, reduction of heart rate, and consequently high mortality, especially during long exposures. Therefore, we aim to explore new anaesthetic protocols to be used in zebrafish by studying the quality of anaesthesia and recovery induced by different concentrations of propofol alone and in combination with different concentrations of lidocaine. Material and Methods In experiment A, eighty-three AB zebrafish were randomly assigned to 7 different groups: control, 2.5 (2.5P), 5 (5P) or 7.5 mu g/ml (7.5P) of propofol; and 2.5 mu g/ml of propofol combined with 50, (P/50L), 100 (P/100L) or 150 mu g/ml (P/150L) of lidocaine. Zebrafish were placed in an anaesthetic water bath and time to lose the equilibrium, reflex to touch, reflex to a tail pinch, and respiratory rate were measured. Time to gain equilibrium was also assessed in a clean tank. Five and 24 hours after anaesthesia recovery, zebrafish were evaluated concerning activity and reactivity. Afterwards, in a second phase of experiments (experiment B), the best protocol of the experiment A was compared with a new group of 8 fishes treated with 100 mg/L of MS222 (100M). Results In experiment A, only different concentrations of propofol/lidocaine combination induced full anaesthesia in all animals. Thus only these groups were compared with a standard dose of MS222 in experiment B. Propofol/lidocaine induced a quicker loss of equilibrium, and loss of response to light and painful stimuli compared with MS222. However zebrafish treated with MS222 recovered quickly than the ones treated with propofol/lidocaine. Conclusion In conclusion, propofol/lidocaine combination and MS222 have advantages in different situations. MS222 is ideal for minor procedures when a quick recovery is important, while propofol/lidocaine is best to induce a quick and complete anaesthesia.	[Valentim, Ana M.; Felix, Luis M.; Antunes, Luis M.] Univ Porto, Lab Anim Sci Grp, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Valentim, Ana M.; Felix, Luis M.; Antunes, Luis M.] Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Valentim, Ana M.; Felix, Luis M.; Carvalho, Leonor; Diniz, Enoque; Antunes, Luis M.] Univ Tras Os Montes & Alto Douro, CITAB, Vila Real, Portugal; [Diniz, Enoque] UJES, DSA, FMV, Huambo, Angola	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; University of Tras-os-Montes & Alto Douro	Valentim, AM (corresponding author), Univ Porto, Lab Anim Sci Grp, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.; Valentim, AM (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal.; Valentim, AM (corresponding author), Univ Tras Os Montes & Alto Douro, CITAB, Vila Real, Portugal.	amaria@ibmc.up.pt	Félix, Luis/G-5426-2011; Valentim, Ana/C-3389-2013	Félix, Luis/0000-0001-9870-6666; Valentim, Ana/0000-0003-1428-0691; Antunes, Luis/0000-0002-9757-6879; Carvalho, Ana Leonor/0000-0002-8881-3887	"Fundo Europeu de Desenvolvimento Regional" through Operational Competitiveness Programme; National Funds through "Fundacao para a Ciencia e a Tecnologia" [FCOMP-01-0124-FEDER-028683 (PTDC/CVT-WEL/4672/2012)]	"Fundo Europeu de Desenvolvimento Regional" through Operational Competitiveness Programme; National Funds through "Fundacao para a Ciencia e a Tecnologia"	This work was funded by "Fundo Europeu de Desenvolvimento Regional" through the Operational Competitiveness Programme and by National Funds through "Fundacao para a Ciencia e a Tecnologia" under the project FCOMP-01-0124-FEDER-028683 (PTDC/CVT-WEL/4672/2012) (https://www.fct.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablain J, 2013, TRENDS CELL BIOL, V23, P584, DOI 10.1016/j.tcb.2013.09.009; Alves HC, 2007, LAB ANIM-UK, V41, P329, DOI 10.1258/002367707781282767; Carter KM, 2011, REV FISH BIOL FISHER, V21, P51, DOI 10.1007/s11160-010-9188-0; Collymore C, 2014, J AM ASSOC LAB ANIM, V53, P198; Eriksson M, 1997, BRIT J ANAESTH, V78, P502, DOI 10.1093/bja/78.5.502; Fleming GJ, 2003, J ZOO WILDLIFE MED, V34, P153, DOI 10.1638/1042-7260(2003)034[0153:EOPAMF]2.0.CO;2; Ghanawi J, 2013, AQUAC RES, V44, P359, DOI 10.1111/j.1365-2109.2011.03039.x; GholipourKanani H, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-76; Gibaldi M., 2007, GIBALDIS DRUG DELIVE; Gomulka P, 2015, POL J VET SCI, V18, P147, DOI 10.1515/pjvs-2015-0019; Gressler LT, 2015, FISH PHYSIOL BIOCHEM, V41, P463, DOI 10.1007/s10695-014-9997-5; Huang WC, 2010, ZEBRAFISH, V7, P297, DOI 10.1089/zeb.2010.0653; Kalueff AV, 2014, PROG NEURO-PSYCHOPH, V55, P1, DOI 10.1016/j.pnpbp.2014.01.022; Lilley EMM, 1996, ANAESTHESIA, V51, P815, DOI 10.1111/j.1365-2044.1996.tb12607.x; Masaki Y, 2000, ANESTH ANALG, V90, P989, DOI 10.1213/00000539-200004000-00039; Muir WW., 2015, VET ANESTHESIA ANALG, V5th, P415; Oda A, 2014, JAVMA-J AM VET MED A, V245, P1286, DOI 10.2460/javma.245.11.1286; Park IS, 2011, LAB ANIMAL, V40, P45, DOI 10.1038/laban0211-45; Park JW, 2003, ANESTH ANALG, V97, P769, DOI 10.1213/01.ANE.0000074797.70349.CA; Popovic NT, 2012, J APPL ICHTHYOL, V28, P553, DOI 10.1111/j.1439-0426.2012.01950.x; Readman GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073773; Reed B., 2011, GUIDANCE HOUSING CAR; Renier C, 2007, PHARMACOGENET GENOM, V17, P237, DOI 10.1097/FPC.0b013e3280119d62; Ross LG, 2008, ANAESTHETIC AND SEDATIVE TECHNIQUES FOR AQUATIC ANIMALS, 3RD EDITION, P1, DOI 10.1002/9781444302264; Russell WMS, 1992, PRINCIPLES HUMANE EX; Sneddon LU, 2012, J EXOT PET MED, V21, P32, DOI 10.1053/j.jepm.2011.11.009; Stewart AM, 2014, TRENDS NEUROSCI, V37, P264, DOI 10.1016/j.tins.2014.02.011; Warren KS, 2001, AM J PHYSIOL-HEART C, V281, pH1711, DOI 10.1152/ajpheart.2001.281.4.H1711; Wong D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088030; Yamakage M, 2005, ANESTH ANALG, V101, P385, DOI 10.1213/01.ANE.0000154191.86608.AC; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1	31	35	36	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147747	10.1371/journal.pone.0147747	http://dx.doi.org/10.1371/journal.pone.0147747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808508	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800203
J	Wood, FM; Phillips, M; Jovic, T; Cassidy, JT; Cameron, P; Edgar, DW				Wood, Fiona M.; Phillips, Michael; Jovic, Tom; Cassidy, John T.; Cameron, Peter; Edgar, Dale W.		Steering Comm Burn Registry Austra	Water First Aid Is Beneficial In Humans Post-Burn: Evidence from a Bi-National Cohort Study	PLOS ONE			English	Article							BURN VICTIMS; HYPOTHERMIA; KNOWLEDGE; MORTALITY; INTERNET; CARE	Introduction Reported first aid application, frequency and practices around the world vary greatly. Based primarily on animal and observational studies, first aid after a burn injury is considered to be integral in reducing scar and infection, and the need for surgery. The current recommendation for optimum first aid after burn is water cooling for 20 minutes within three hours. However, compliance with this guideline is reported as poor to moderate at best and evidence exists to suggest that overcooling can be detrimental. This prospective cohort study of a binational burn patient registry examined data collected between 2009 and 2012. The aim of the study was to quantify the magnitude of effects of water cooling first aid after burn on indicators of burn severity in a large human cohort. Method The data for the analysis was provided by the Burn Registry of Australia and New Zealand (BRANZ). The application of first aid cooling prior to admission to a dedicated burn service, was analysed for its influence on four outcomes related to injury severity. The patient related outcomes were whether graft surgery occurred, and death while the health system (cost) outcomes included total hospital length of stay and admission to ICU. Robust regression analysis using bootstrapped estimation adjusted using a propensity score was used to control for confounding and to estimate the strength of association with first aid. Dose-response relationships were examined to determine associations with duration of first aid. The influence of covariates on the impact of first aid was assessed. Results Cooling was provided before Burn Centre admission for 68% of patients, with at least twenty minutes duration for 46%. The results indicated a reduction in burn injury severity associated with first aid. Patients probability for graft surgery fell by 0.070 from 0.537 (13% reduction) (p = 0.014). The probability for ICU admission fell by 0.084 from 0.175 (48% reduction) (p < 0.001) and hospital length of stay (LOS) fell by 2.27 days from 12.9 days (18% reduction) (p = 0.001). All outcomes except death showed a dose-response relationship with the duration of first aid. The size of burn and age interacted with many of the relationships between first aid and outcome and these are described and discussed. Discussion & Conclusion This study suggests that there are significant patient and health system benefits from cooling water first aid, particularly if applied for up to 20 minutes. The results of this study estimate the effect size of post-burn first aid and confirm that efforts to promote first aid knowledge are not only warranted, but provide potential cost savings.	[Wood, Fiona M.; Edgar, Dale W.] Fiona Stanley Hosp, State Adult Burn Unit, Burn Serv Western Australia, Murdoch, WA, Australia; [Wood, Fiona M.] Univ Western Australia, Burn Injury Res Unit, Crawley, WA, Australia; [Wood, Fiona M.; Edgar, Dale W.] Fiona Wood Fdn, Murdoch, WA, Australia; [Phillips, Michael] Royal Perth Hosp, Perkins Inst Med Res, Perth, WA 6001, Australia; [Phillips, Michael] Univ Western Australia, Crawley, WA, Australia; [Jovic, Tom] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Jovic, Tom; Cassidy, John T.] Royal Perth Hosp, Burn Serv Western Australia, Burn Unit, Perth, WA 6001, Australia; [Cassidy, John T.] James Connolly Mem Hosp, Dublin, Ireland; [Cameron, Peter] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Edgar, Dale W.] Univ Notre Dame Australia, Burn Injury Res Node, Fremantle, WA, Australia	University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Edinburgh; Royal Perth Hospital; Monash University; University of Notre Dame Australia	Wood, FM (corresponding author), Fiona Stanley Hosp, State Adult Burn Unit, Burn Serv Western Australia, Murdoch, WA, Australia.; Wood, FM (corresponding author), Univ Western Australia, Burn Injury Res Unit, Crawley, WA, Australia.; Wood, FM (corresponding author), Fiona Wood Fdn, Murdoch, WA, Australia.	Fiona.wood@health.wa.gov.au	Jovic, Thomas H/N-7155-2019; Edgar, Dale W/AAV-9394-2021; fiona, wood/F-4703-2013	Jovic, Thomas H/0000-0002-8325-0931; Edgar, Dale W/0000-0001-7336-9317; Wood, Fiona Melanie/0000-0002-3284-6540; Phillips, Michael/0000-0002-0252-9085; Cameron, Peter/0000-0002-1443-557X; fiona, wood/0000-0001-5427-6588	Australian Commission on Safety and Quality in Health Care; Helen Macpherson Smith Trust; Thyne Reid Foundation; Fiona Wood Foundation	Australian Commission on Safety and Quality in Health Care; Helen Macpherson Smith Trust; Thyne Reid Foundation; Fiona Wood Foundation	The study is unfunded and completed with support of the Fiona Wood Foundation http://www.fionawoodfoundation.com/ research team in their routine capacity. The Burn Registry of Australia and New Zealand is co-funded by ANZBA http://anzba.org.au/ and the Julian Burton Burns Trust http://www.burnstrust.com.au/ with additional funding received from the Australian Commission on Safety and Quality in Health Care (2008-2009) http://www.safetyandquality.gov.au/, Helen Macpherson Smith Trust (2010) http://hmstrust.org.au/ and the Thyne Reid Foundation (2011-2012). The BRANZ did not contribute funds to this project.	Bartlett N, 2008, J BURN CARE RES, V29, P828, DOI 10.1097/BCR.0b013e3181855c9a; Cuttle L, 2009, J BURN CARE RES, V30, P1028, DOI 10.1097/BCR.0b013e3181bfb7d1; Cuttle L, 2009, BURNS, V35, P768, DOI 10.1016/j.burns.2008.10.011; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; JACKSON DM, 1979, ANN ROY COLL SURG, V61, P335; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; Maitz PM, 2014, EMERGENCY MANAGEMENT; Mlcak R, 1998, PEDIATR EMERG CARE, V14, P51, DOI 10.1097/00006565-199802000-00013; MUNSTER AM, 1994, BURNS, V20, P61, DOI 10.1016/0305-4179(94)90109-0; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Rea S, 2005, BURNS, V31, P1029, DOI 10.1016/j.burns.2005.05.010; Singer AJ, 2010, ACAD EMERG MED, V17, P456, DOI 10.1111/j.1553-2712.2010.00702.x; Skinner A, 2002, NZ MED J, V115, P199; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Tiller G, 2006, BURNS, V32, P897, DOI 10.1016/j.burns.2006.02.020; Tung KY, 2005, BURNS, V31, pS12, DOI 10.1016/j.burns.2004.10.006; Wallace HJ, 2013, BURNS, V39, P1162, DOI 10.1016/j.burns.2013.02.007; Watterson D, 2011, BURNS, V37, P1296, DOI 10.1016/j.burns.2011.08.007	18	55	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147259	10.1371/journal.pone.0147259	http://dx.doi.org/10.1371/journal.pone.0147259			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808839	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800068
J	Wood, R; Morrow, C; Barry, CE; Bryden, WA; Call, CJ; Hickey, AJ; Rodes, CE; Scriba, TJ; Blackburn, J; Issarow, C; Mulder, N; Woodward, J; Moosa, A; Singh, V; Mizrahi, V; Warner, DF				Wood, Robin; Morrow, Carl; Barry, Clifton E., III; Bryden, Wayne A.; Call, Charles J.; Hickey, Anthony J.; Rodes, Charles E.; Scriba, Thomas J.; Blackburn, Jonathan; Issarow, Chacha; Mulder, Nicola; Woodward, Jeremy; Moosa, Atica; Singh, Vinayak; Mizrahi, Valerie; Warner, Digby F.			Real-Time Investigation of Tuberculosis Transmission: Developing the Respiratory Aerosol Sampling Chamber (RASC)	PLOS ONE			English	Article							AIRBORNE MYCOBACTERIUM-TUBERCULOSIS; AIR; INFECTION; COMPLEX; CYCLE	Knowledge of the airborne nature of respiratory disease transmission owes much to the pioneering experiments of Wells and Riley over half a century ago. However, the mechanical, physiological, and immunopathological processes which drive the production of infectious aerosols by a diseased host remain poorly understood. Similarly, very little is known about the specific physiological, metabolic and morphological adaptations which enable pathogens such as Mycobacterium tuberculosis (Mtb) to exit the infected host, survive exposure to the external environment during airborne carriage, and adopt a form that is able to enter the respiratory tract of a new host, avoiding innate immune and physical defenses to establish a nascent infection. As a first step towards addressing these fundamental knowledge gaps which are central to any efforts to interrupt disease transmission, we developed and characterized a small personal clean room comprising an array of sampling devices which enable isolation and representative sampling of airborne particles and organic matter from tuberculosis (TB) patients. The complete unit, termed the Respiratory Aerosol Sampling Chamber (RASC), is instrumented to provide real-time information about the particulate output of a single patient, and to capture samples via a suite of particulate impingers, impactors and filters. Applying the RASC in a clinical setting, we demonstrate that a combination of molecular and microbiological assays, as well as imaging by fluorescence and scanning electron microscopy, can be applied to investigate the identity, viability, and morphology of isolated aerosolized particles. Importantly, from a preliminary panel of active TB patients, we observed the real-time production of large numbers of airborne particles including Mtb, as confirmed by microbiological culture and polymerase chain reaction (PCR) genotyping. Moreover, direct imaging of captured samples revealed the presence of multiple rod-like Mtb organisms whose physical dimensions suggested the capacity for travel deep into the alveolar spaces of the human lung.	[Wood, Robin; Morrow, Carl; Barry, Clifton E., III; Scriba, Thomas J.; Blackburn, Jonathan; Issarow, Chacha; Mulder, Nicola; Moosa, Atica; Singh, Vinayak; Mizrahi, Valerie; Warner, Digby F.] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med IDM, ZA-7925 Cape Town, South Africa; [Wood, Robin; Morrow, Carl] Univ Cape Town, IDM, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Barry, Clifton E., III] NIAID, Lab Clin Infect Dis, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Bryden, Wayne A.; Call, Charles J.] Zeteo Tech LLC, Ellicott City, MD USA; [Hickey, Anthony J.] RTI Int, Res Triangle Pk, NC USA; [Rodes, Charles E.] Aerosol Exposure Dimens, Cary, NC USA; [Scriba, Thomas J.] Univ Cape Town, Dept Paediat & Child Hlth, South African TB Vaccine Initiat, Cape Town, South Africa; [Blackburn, Jonathan; Issarow, Chacha; Mulder, Nicola; Woodward, Jeremy] Univ Cape Town, Fac Hlth Sci, Dept Integrat Biomed Sci, Struct Biol Res Unit, ZA-7925 Cape Town, South Africa; [Moosa, Atica; Singh, Vinayak; Mizrahi, Valerie; Warner, Digby F.] Univ Cape Town, Fac Hlth Sci, MRC NHLS UCT Mol Mycobacteriol Res Unit, Cape Town, South Africa; [Moosa, Atica; Singh, Vinayak; Mizrahi, Valerie; Warner, Digby F.] Univ Cape Town, Fac Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, Dept Pathol, Cape Town, South Africa	University of Cape Town; University of Cape Town; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Research Triangle Institute; University of Cape Town; University of Cape Town; University of Cape Town; National Research Foundation - South Africa; University of Cape Town	Morrow, C (corresponding author), Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med IDM, ZA-7925 Cape Town, South Africa.; Morrow, C (corresponding author), Univ Cape Town, IDM, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa.	Carl.Morrow@hiv-research.org.za	Scriba, Thomas/GPX-2573-2022; Warner, Digby F/K-4355-2012; Barry, III, Clifton/H-3839-2012; Barry, Clifton E/ABE-7992-2020; Singh, Vinayak/O-5099-2019; Scriba, Thomas/AAH-9413-2020; SINGH, VINAYAK/L-8442-2016	Scriba, Thomas/0000-0002-0641-1359; Warner, Digby F/0000-0002-4146-0930; Barry, III, Clifton/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X; Singh, Vinayak/0000-0001-9002-2489; SINGH, VINAYAK/0000-0001-9002-2489; Mulder, Nicola J/0000-0003-4905-0941; Woodward, Jeremy/0000-0002-7350-8302; Moosa, Atica/0000-0001-9012-3634	Bill & Melinda Gates Foundation [OPP1116641, 26123]; National Treasury under Economic Competitiveness and Support Package [MRC-RFA-UFSP-01-2013/CCAMP]; Intramural Research Program of the NIAID, NIH; South African Medical Research Council (MRC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001214] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Treasury under Economic Competitiveness and Support Package; Intramural Research Program of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); South African Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded by grants from the Bill & Melinda Gates Foundation (OPP1116641), and the South African Medical Research Council (MRC) with funds from National Treasury under the Economic Competitiveness and Support Package (MRC-RFA-UFSP-01-2013/CCAMP) (RW CM TJS JB CI NM JW AM VS VM DFW); the Intramural Research Program of the NIAID, NIH (CEB); and Bill & Melinda Gates Foundation Investment ID 26123 (WAB CJC AJH CER).; Academic and technical support was provided from The Tuberculosis Aerobiology Advisory Group (TAAG) funded by the Bill and Melinda Gates Foundation.	ANDERSEN AA, 1958, J BACTERIOL, V76, P471, DOI 10.1128/JB.76.5.471-484.1958; Andrews JR, 2015, AM J RESP CRIT CARE, V191, P584, DOI 10.1164/rccm.201409-1704OC; Andrews JR, 2014, J INFECT DIS, V210, P597, DOI 10.1093/infdis/jiu138; Caceres N, 2013, TUBERCULOSIS, V93, P690, DOI 10.1016/j.tube.2013.08.003; Chan K, 2002, P NATL ACAD SCI USA, V99, P3920, DOI 10.1073/pnas.002024599; Chen PS, 2005, AEROSOL SCI TECH, V39, P371, DOI 10.1080/027868290945767; Crowder TM, 2002, PHARMACEUT RES, V19, P239, DOI 10.1023/A:1014426530935; Dharmadhikari AS, 2011, TUBERCULOSIS, V91, P329, DOI 10.1016/j.tube.2011.03.002; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Fennelly KP, 2012, AM J RESP CRIT CARE, V186, P450, DOI 10.1164/rccm.201203-0444OC; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; GORDON RE, 1953, J BACTERIOL, V66, P41, DOI 10.1128/JB.66.1.41-48.1953; Issarow CM, 2015, J THEOR BIOL, V372, P100, DOI 10.1016/j.jtbi.2015.02.010; KOCH R, 1882, AETIOLOGY TUBERCULOS; Mastorides SM, 1999, CHEST, V115, P19, DOI 10.1378/chest.115.1.19; Matuka O, 2015, J HOSP INFECT, V89, P192, DOI 10.1016/j.jhin.2014.11.013; Middelkoop K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-156; Richardson ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096334; RILEY RL, 1962, AM REV RESPIR DIS, V85, P511; RILEY RL, 1959, AM J HYG, V70, P185, DOI 10.1093/oxfordjournals.aje.a120069; Swift D, 2007, INHALATION AEROSOLS, P55; Thanky NR, 2007, TUBERCULOSIS, V87, P231, DOI 10.1016/j.tube.2006.10.004; van Belkum A, 2012, J CLIN MICROBIOL, V50, P1513, DOI 10.1128/JCM.00420-12; Wan GH, 2004, AM J INFECT CONTROL, V32, P17, DOI 10.1016/S0196-6553(03)00090-7; Warren RM, 2006, INT J TUBERC LUNG D, V10, P818; Wood R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106622	29	30	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146658	10.1371/journal.pone.0146658	http://dx.doi.org/10.1371/journal.pone.0146658			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807816	Green Published, gold			2022-12-26	WOS:000369527800030
J	Yang, T; Scholl, ES; Pan, N; Fritzsch, B; Haeseleer, F; Lee, A				Yang, Tian; Scholl, Elizabeth S.; Pan, Ning; Fritzsch, Bernd; Haeseleer, Francoise; Lee, Amy			Expression and Localization of CaBP Ca2+ Binding Proteins in the Mouse Cochlea	PLOS ONE			English	Article							AUDITORY HAIR-CELLS; CALCIUM-CHANNELS; DEPENDENT INACTIVATION; CA2+-BINDING PROTEINS; CA(V)1.3 CHANNELS; SCHWANN-CELLS; CALMODULIN; INNER; CALDENDRIN; BRAIN	CaBPs are a family of EF-hand Ca2+ binding proteins that are structurally similar to calmodulin. CaBPs can interact with, and yet differentially modulate, effectors that are regulated by calmodulin, such as Ca(v)1 voltage-gated Ca2+ channels. Immunolabeling studies suggest that multiple CaBP family members (CaBP1, 2, 4, and 5) are expressed in the cochlea. To gain insights into the respective auditory functions of these CaBPs, we characterized the expression and cellular localization of CaBPs in the mouse cochlea. By quantitative reverse transcription PCR, we show that CaBP1 and CaBP2 are the major CaBPs expressed in mouse cochlea both before and after hearing onset. Of the three alternatively spliced variants of CaBP1 (caldendrin, CaBP1-L, and CaBP1-S) and CaBP2 (CaBP2-alt, CaBP2-L, CaBP2-S), caldendrin and CaBP2-alt are the most abundant. By in situ hybridization, probes recognizing caldendrin strongly label the spiral ganglion, while probes designed to recognize all three isoforms of CaBP1 weakly label both the inner and outer hair cells as well as the spiral ganglion. Within the spiral ganglion, caldendrin/CaBP1 labeling is associated with cells resembling satellite glial cells. CaBP2-alt is strongly expressed in inner hair cells both before and after hearing onset. Probes designed to recognize all three variants of CaBP2 strongly label inner hair cells before hearing onset and outer hair cells after the onset of hearing. Thus, CaBP1 and CaBP2 may have overlapping roles in regulating Ca2+ signaling in the hair cells, and CaBP1 may have an additional function in the spiral ganglion. Our findings provide a framework for understanding the role of CaBP family members in the auditory periphery.	[Yang, Tian; Scholl, Elizabeth S.; Lee, Amy] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA; [Yang, Tian; Scholl, Elizabeth S.; Fritzsch, Bernd; Lee, Amy] Univ Iowa, Dept Otolaryngol Head Neck Surg, Iowa City, IA USA; [Yang, Tian; Scholl, Elizabeth S.; Lee, Amy] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Pan, Ning; Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Haeseleer, Francoise] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Washington; University of Washington Seattle	Lee, A (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA.; Lee, A (corresponding author), Univ Iowa, Dept Otolaryngol Head Neck Surg, Iowa City, IA USA.; Lee, A (corresponding author), Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA.	amy-lee@uiowa.edu		Lee, Amy/0000-0001-8021-0443; Fritzsch, Bernd/0000-0002-4882-8398	NIH [NS084190, DC009433, DC010362, EY020850]; Carver Research Program of Excellence Award; NATIONAL EYE INSTITUTE [R01EY020850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC009433, R01DC009433, P30DC010362] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Research Program of Excellence Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was support by grants from the NIH (NS084190, DC009433, to A.L.; DC010362 (Iowa Center for Molecular Auditory Neuroscience); EY020850 to F.H.), and a Carver Research Program of Excellence Award to A.L.; This work was support by grants from the NIH (NS084190, DC009433, to A.L.; DC010362 (Iowa Center for Molecular Auditory Neuroscience); EY020850 to F.H.), and a Carver Research Program of Excellence Award to A.L.	Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Bhattacharya R, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-50; Cheli VT, 2015, EXP NEUROL, V265, P69, DOI 10.1016/j.expneurol.2014.12.012; Chen WC, 2011, HEARING RES, V278, P52, DOI 10.1016/j.heares.2011.01.016; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cui GY, 2007, J PHYSIOL-LONDON, V585, P791, DOI 10.1113/jphysiol.2007.142307; Duncan JS, 2011, INT J DEV BIOL, V55, P297, DOI 10.1387/ijdb.103178jd; Grant L, 2008, J NEUROPHYSIOL, V99, P2183, DOI 10.1152/jn.01174.2007; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Haynes LP, 2004, J BIOL CHEM, V279, P547, DOI 10.1074/jbc.M309617200; Inagaki A, 2013, CHANNELS, V7, P171, DOI 10.4161/chan.24104; Jahan I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011661; Kasri NN, 2004, EMBO J, V23, P312, DOI 10.1038/sj.emboj.7600037; KAWASAKI H, 1995, PROTEIN PROFILE, V2, P297; Kim KY, 2014, NEUROSCIENCE, V268, P33, DOI 10.1016/j.neuroscience.2014.02.052; Knirsch M, 2007, J NEUROSCI, V27, P6442, DOI 10.1523/JNEUROSCI.5364-06.2007; Laube G, 2002, MOL CELL NEUROSCI, V19, P459, DOI 10.1006/mcne.2001.1078; Lee SW, 2007, J PHYSIOL-LONDON, V583, P909, DOI 10.1113/jphysiol.2007.135582; Liu HZ, 2014, J NEUROSCI, V34, P11085, DOI 10.1523/JNEUROSCI.1690-14.2014; Luo BE, 2014, J NEUROSCI RES, V92, P893, DOI 10.1002/jnr.23365; Michna M, 2003, J PHYSIOL-LONDON, V553, P747, DOI 10.1113/jphysiol.2003.053256; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Redecker P, 2003, J HISTOCHEM CYTOCHEM, V51, P809, DOI 10.1177/002215540305100612; Schnee ME, 2003, J PHYSIOL-LONDON, V549, P697, DOI 10.1113/jphysiol.2002.037481; Schrauwen I, 2012, AM J HUM GENET, V91, P636, DOI 10.1016/j.ajhg.2012.08.018; Seidenbecher CI, 1998, J BIOL CHEM, V273, P21324, DOI 10.1074/jbc.273.33.21324; Tippens AL, 2007, J BIOL CHEM, V282, P8464, DOI 10.1074/jbc.M611384200; Weisz C, 2009, NATURE, V461, P1126, DOI 10.1038/nature08487; Westenbroek RE, 2004, J NEUROSCI RES, V75, P371, DOI 10.1002/jnr.10863; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Yang PS, 2014, NAT CHEM BIOL, V10, P231, DOI [10.1038/NCHEMBIO.1436, 10.1038/nchembio.1436]; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200; Zhou H, 2004, J NEUROSCI, V24, P4698, DOI 10.1523/JNEUROSCI.5523-03.2004	37	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147495	10.1371/journal.pone.0147495	http://dx.doi.org/10.1371/journal.pone.0147495			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809054	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800111
J	Zhang, C; Jia, XJ; Wang, K; Bao, JL; Li, P; Chen, MW; Wan, JB; Su, HX; Mei, ZN; He, CW				Zhang, Chao; Jia, Xuejing; Wang, Kai; Bao, Jiaolin; Li, Peng; Chen, Meiwan; Wan, Jian-Bo; Su, Huanxing; Mei, Zhinan; He, Chengwei			Polyphyllin VII Induces an Autophagic Cell Death by Activation of the JNK Pathway and Inhibition of PI3K/AKT/mTOR Pathway in HepG2 Cells	PLOS ONE			English	Article							REVERSES MULTIDRUG-RESISTANCE; PARIS SAPONIN VII; CANCER-CELLS; SIGNALING PATHWAY; APOPTOSIS; PHOSPHORYLATION; GROWTH; BCL-2; SURVIVAL; TARGET	Polyphyllin VII (PP7), a pennogenyl saponin isolated from Rhizoma Paridis, exhibited strong anticancer activities in various cancer types. Previous studies found that PP7 induced apoptotic cell death in human hepatoblastoma cancer (HepG2) cells. In the present study, we investigated whether PP7 could induce autophagy and its role in PP7-induced cell death, and elucidated its mechanisms. PP7 induced a robust autophagy in HepG2 cells as demonstrated by the conversion of LC3B-I to LC3B-II, degradation of P62, formation of punctate LC3-positive structures, and autophagic vacuoles tested by western blot analysis or InCell 2000 confocal microscope. Inhibition of autophagy by treating cells with autophagy inhibitor (chloroquine) abolished the cell death caused by PP7, indicating that PP7 induced an autophagic cell death in HepG2 cells. C-Jun N-terminal kinase (JNK) was activated after treatment with PP7 and pretreatment with SP600125, a JNK inhibitor, reversed PP7induced autophagy and cell death, suggesting that JNK plays a critical role in autophagy caused by PP7. Furthermore, our study demonstrated that PP7 increased the phosphorylation of AMPK and Bcl-2, and inhibited the phosphorylation of PI3K, AKT and mTOR, suggesting their roles in the PP7-induced autophagy. This is the first report that PP7 induces an autophagic cell death in HepG2 cells via inhibition of PI3K/AKT/mTOR, and activation of JNK pathway, which induces phosphorylation of Bcl-2 and dissociation of Beclin-1 from Beclin-1/Bcl-2 complex, leading to induction of autophagy.	[Zhang, Chao; Jia, Xuejing; Wang, Kai; Bao, Jiaolin; Li, Peng; Chen, Meiwan; Wan, Jian-Bo; Su, Huanxing; He, Chengwei] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau 999078, Peoples R China; [Mei, Zhinan] South Cent Univ Nationalities, Coll Pharm, Wuhan 430074, Peoples R China	University of Macau; South Central Minzu University	He, CW (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau 999078, Peoples R China.; Mei, ZN (corresponding author), South Cent Univ Nationalities, Coll Pharm, Wuhan 430074, Peoples R China.	meizhinan@163.com; chengweihe@umac.mo	Su, Huanxing/X-3954-2019; Bao, Jiaolin/GRJ-8416-2022; Su, Huanxing/X-3980-2019; Wang, Kai/AIE-2501-2022; Wan, Jian-Bo/D-8368-2014	Su, Huanxing/0000-0003-3254-825X; Su, Huanxing/0000-0002-0513-4943; Bao, Jiaolin/0000-0003-0630-071X; He, Chengwei/0000-0003-4701-2984; Wan, Jian-Bo/0000-0002-6750-2617	Macao Science and Technology Development Fund [074/2013/A]; University of Macau [MYRG107(Y1-L3)-ICMS13-HCW, MYRG2015-00081-ICMS-QRCM]; National Key Technology R&D Program in 12th Five Year Plan of China [2012BAI27B06]; Hubei Province Natural Science Foundation of China [2013CFA013]; College of Pharmacy at South Central University for Nationalities	Macao Science and Technology Development Fund; University of Macau; National Key Technology R&D Program in 12th Five Year Plan of China(National Key Technology R&D Program); Hubei Province Natural Science Foundation of China(Natural Science Foundation of Hubei Province); College of Pharmacy at South Central University for Nationalities	This study was supported by the Macao Science and Technology Development Fund (code: 074/2013/A to CH) (http://www.fdct.gov.mo/), the Research Fund of the University of Macau (code: MYRG107(Y1-L3)-ICMS13-HCW to CH and MYRG2015-00081-ICMS-QRCM to CH) (www.umac.mo), the National Key Technology R&D Program in 12th Five Year Plan of China (code: 2012BAI27B06 to ZM) (http://program.most.gov.cn/) and the Hubei Province Natural Science Foundation of China (code: 2013CFA013 to ZM) (http://dzzw.ynstc.gov.cn/eWAP/) in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Zhinan Mei is employed by College of Pharmacy at South Central University for Nationalities, which provided support in the form of salary for author ZM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Chen YS, 2014, STEROIDS, V83, P39, DOI 10.1016/j.steroids.2014.01.014; Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Duan WJ, 2011, BIOL PHARM BULL, V34, P47, DOI 10.1248/bpb.34.47; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hippert MM, 2006, CANCER RES, V66, P9349, DOI 10.1158/0008-5472.CAN-06-1597; Huang XX, 2011, LAT AM J PHARM, V30, P540; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Jung KH, 2012, HEPATOLOGY, V56, P644, DOI 10.1002/hep.25699; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim A, 2013, BMC COMPLEM ALTERN M, V13, P1; Kim AD, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.273; Kim A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098703; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Li CM, 2010, INT J ONCOL, V37, P1023, DOI 10.3892/ijo_00000754; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Li YH, 2014, J ETHNOPHARMACOL, V154, P728, DOI 10.1016/j.jep.2014.04.049; Li YH, 2014, BIOCHEM PHARMACOL, V88, P150, DOI 10.1016/j.bcp.2014.01.018; Liu B, 2009, CANCER LETT, V275, P54, DOI 10.1016/j.canlet.2008.09.042; Liu B, 2013, CHIN J CANCER, V32, P113, DOI 10.5732/cjc.012.10010; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Miller WH, 2002, CANCER RES, V62, P3893; Moretti L, 2007, DRUG RESIST UPDATE, V10, P135, DOI 10.1016/j.drup.2007.05.001; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Park KJ, 2009, BIOCHEM BIOPH RES CO, V382, P726, DOI 10.1016/j.bbrc.2009.03.095; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qin XJ, 2012, STEROIDS, V77, P1242, DOI 10.1016/j.steroids.2012.07.007; Shimizu S, 2010, ONCOGENE, V29, P2070, DOI 10.1038/onc.2009.487; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Sun T, 2011, J TRANSL MED, V9, P1; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Turcotte S, 2010, CURR OPIN CELL BIOL, V22, P246, DOI 10.1016/j.ceb.2009.12.007; Wang H, 2013, PHYTOMEDICINE, V20, P985, DOI 10.1016/j.phymed.2013.04.014; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Xu MY, 2013, FOOD CHEM TOXICOL, V59, P703, DOI 10.1016/j.fct.2013.06.059; Xu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113479; Zhang L, 2014, TOXICOL LETT, V228, P248, DOI 10.1016/j.toxlet.2014.05.015; ZHANG W., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0099693; Zhang YB, 2014, J JINAN U NATURAL SC, V35, P67; Zhang YX, 2010, J CELL BIOCHEM, V109, P764, DOI 10.1002/jcb.22455; 王艳霞, 2005, [中草药, Chinese Traditional and Herbal Drugs], V36, P628	51	52	58	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147405	10.1371/journal.pone.0147405	http://dx.doi.org/10.1371/journal.pone.0147405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808193	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800089
J	Tandon, M; Chen, Z; Othman, AH; Pratap, J				Tandon, M.; Chen, Z.; Othman, A. H.; Pratap, J.			Role of Runx2 in IGF-1R beta/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis	ONCOGENE			English	Article							TRANSCRIPTION FACTOR RUNX2; MAMMARY EPITHELIAL-CELLS; ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; SIGNALING PATHWAYS; ECTOPIC EXPRESSION; PROSTATE-CANCER; DNA-DAMAGE; PROGRESSION; INVASION	The mechanisms underlying reprogramming of growth factor signaling and metabolic pathways during bone metastasis of breast cancer are not clear. The Runt-related transcription factor (Runx2) regulates cell signaling during mammary epithelial morphogenesis and promotes invasion; therefore, we investigated its role in cell growth and metabolic signaling in bone-seeking breast cancer cells. We performed systemic inoculation of control or Runx2 knockdown invasive MDA-MB-231 cells in NOD/SCID mice, and compared parental and bone-derived variants for phenotypic and molecular alterations. The Runx2 knockdown showed early (0-2 weeks) inhibition of metastatic spread but late (4-6 weeks) outgrowth, suggesting Runx2-dependent bi-phasic response and reprogramming of metastatic cells. The late-stage tumor outgrowth of bone-derived Runx2 knockdown cells was associated with increased insulin-like growth factor-1R beta (IGF-1R beta) levels. Interestingly, glucose uptake and glycolysis were reduced in the bone-derived Runx2 knockdown cells that could be further reduced by extracellular-regulated protein kinase (Erk1/2) inhibition. Furthermore, the Runx2 knockdown cells displayed activation of AMP-activated protein kinase (AMPK alpha), the sensor of cellular metabolism. Importantly, the Runx2 knockdown in bone-derived cells resulted in increased sensitivity to both Erk1/2 inhibition and AMPK alpha activation by PD184161 and metformin, respectively, despite increased IGF-1R beta and AMPK alpha levels. Our results reveal that Runx2 promotes metastatic spread of mammary tumor cells. The growth of late-stage tumor cells can be targeted by Runx2 knockdown in combination with Mek-Erk1/2 inhibition and metformin treatment.	[Tandon, M.; Chen, Z.; Othman, A. H.; Pratap, J.] Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA	Rush University	Pratap, J (corresponding author), Rush Univ, Med Ctr, Armour Acad Ctr, Dept Anat & Cell Biol, 600 South Paulina St,Suite 507, Chicago, IL 60612 USA.	jitesh_pratap@rush.edu		Othman, Ahmad/0000-0001-9995-1233	Bears Care Foundation	Bears Care Foundation	We thank Rush University Medical Center investigators; Dr Rick Sumner and his lab members, Dr Ryan Ross and Maleeha Mashiatulla for assistance with mu CT data acquisition and analysis; Dr Amarjit Virdi for help with the ex vivo bone tumor co-culture model. We thank Dr Carl Maki and members of his lab, Dr Lei Duan and Ricardo Perez for helpful discussions throughout this study; Dr Elena Dedkova and Dr Lothar Blatter for assistance with sea horse data acquisition and analysis. This study was supported by the grant from Bears Care Foundation.	Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Ali SA, 2012, J CELL SCI, V125, P2732, DOI 10.1242/jcs.100909; ARTEAGA CL, 1992, BREAST CANCER RES TR, V22, P101, DOI 10.1007/BF01833338; Barnes GL, 2004, CANCER RES, V64, P4506, DOI 10.1158/0008-5472.CAN-03-3851; Barnes GL, 2003, CANCER RES, V63, P2631; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Boumah CE, 2009, MOL ENDOCRINOL, V23, P1255, DOI 10.1210/me.2008-0217; Campbell JP, 2012, JOVE-J VIS EXP, DOI 10.3791/4260; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chimge NO, 2013, ONCOGENE, V32, P2121, DOI 10.1038/onc.2012.328; COLEMAN RE, 1987, BRIT J CANCER, V55, P61, DOI 10.1038/bjc.1987.13; Dowling RJO, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-33; Drissi H, 2002, J CELL BIOCHEM, V86, P403, DOI 10.1002/jcb.10238; Dunn SE, 1998, CANCER RES, V58, P3353; Foley John, 2010, Semin Cell Dev Biol, V21, P951, DOI 10.1016/j.semcdb.2010.08.009; Franceschi RT, 2009, CELLS TISSUES ORGANS, V189, P144, DOI 10.1159/000151747; Ge C, 2016, ONCOGENE, V35, P366, DOI 10.1038/onc.2015.91; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Ge CX, 2009, J BIOL CHEM, V284, P32533, DOI 10.1074/jbc.M109.040980; Guise T, 2010, SEMIN ONCOL, V37, pS2, DOI 10.1053/j.seminoncol.2010.10.007; Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368; Hatoum D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/548436; Henkels KM, 2015, FASEB J, V29, P1299, DOI 10.1096/fj.14-260992; Hiraga T, 2012, CANCER RES, V72, P4238, DOI 10.1158/0008-5472.CAN-11-3061; Ibrahim T, 2013, ONCOL LETT, V6, P306, DOI 10.3892/ol.2013.1372; Inman CK, 2005, MOL CELL BIOL, V25, P3182, DOI 10.1128/MCB.25.8.3182-3193.2005; Inman CK, 2003, J BIOL CHEM, V278, P48684, DOI 10.1074/jbc.M308001200; Jonason JH, 2009, J DENT RES, V88, P693, DOI 10.1177/0022034509341629; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kato K, 2002, ONCOGENE, V21, P6082, DOI 10.1038/sj.onc.1205737; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Leong DT, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2762; Lian JB, 2003, CONNECT TISSUE RES, V44, P141, DOI 10.1080/03008200390152232; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Liu XN, 2014, MOL CANCER THER, V13, P596, DOI 10.1158/1535-7163.MCT-13-0579; Lucero CMJ, 2013, J CELL PHYSIOL, V228, P714, DOI 10.1002/jcp.24218; Martin TJ, 2001, TRENDS ENDOCRIN MET, V12, P2, DOI 10.1016/S1043-2760(00)00351-9; McDonald L, 2014, DIS MODEL MECH, V7, P525, DOI 10.1242/dmm.015040; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Morales DR, 2015, ANNU REV MED, V66, P17, DOI 10.1146/annurev-med-062613-093128; MUNDY GR, 1991, BONE, V12, pS1, DOI 10.1016/8756-3282(91)90057-P; Oakley RH, 2012, P NATL ACAD SCI USA, V109, P17591, DOI 10.1073/pnas.1209411109; Oh JS, 2002, NEOPLASIA, V4, P204, DOI 10.1038/sj.neo.7900229; Onodera Y, 2010, CANCER SCI, V101, P2670, DOI 10.1111/j.1349-7006.2010.01742.x; Ozaki T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.127; Pande S, 2013, J CELL PHYSIOL, V228, P1784, DOI 10.1002/jcp.24339; Park HU, 2009, MOL CANCER THER, V8, P733, DOI 10.1158/1535-7163.MCT-08-0631; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Pratap J, 2003, CANCER RES, V63, P5357; Pratap J, 2008, CANCER RES, V68, P7795, DOI 10.1158/0008-5472.CAN-08-1078; Pratap J, 2009, CANCER RES, V69, P6807, DOI 10.1158/0008-5472.CAN-09-1471; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Robey IF, 2008, NEOPLASIA, V10, P745, DOI 10.1593/neo.07724; Robey IF, 2005, NEOPLASIA, V7, P324, DOI 10.1593/neo.04430; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Ross RD, 2014, J BONE MINER RES, V29, P1597, DOI 10.1002/jbmr.2188; Sachdev D, 2010, ONCOGENE, V29, P251, DOI 10.1038/onc.2009.316; Suva LJ, 2011, NAT REV ENDOCRINOL, V7, P208, DOI 10.1038/nrendo.2010.227; Taipaleenmaki H, 2015, CANCER RES, V75, P1433, DOI 10.1158/0008-5472.CAN-14-1026; Taliaferro-Smith L, 2009, ONCOGENE, V28, P2621, DOI 10.1038/onc.2009.129; Tandon M, 2014, J CELL BIOCHEM, V115, P2208, DOI 10.1002/jcb.24939; Tandon M, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3611; Tandon M, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-27; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; Westendorf JJ, 2006, J CELL BIOCHEM, V98, P54, DOI 10.1002/jcb.20805; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Wingender E, 1997, NUCLEIC ACIDS RES, V25, P265, DOI 10.1093/nar/25.1.265; Wu H, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r52; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Yee D, 2012, JNCI-J NATL CANCER I, V104, P975, DOI 10.1093/jnci/djs258; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18; Zhuang YX, 2011, MOL CANCER RES, V9, P603, DOI 10.1158/1541-7786.MCR-10-0343; Zordoky BNM, 2014, BBA-GEN SUBJECTS, V1840, P1943, DOI 10.1016/j.bbagen.2014.01.023	79	30	32	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 8	2016	35	36					4730	4740		10.1038/onc.2015.518	http://dx.doi.org/10.1038/onc.2015.518			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0IS	26804175				2022-12-26	WOS:000383324700006
J	Liao, JF; Ma, L; Du, XJ; Lan, M; Guo, Y; Zheng, L; Xia, YF; Luo, W				Liao, Jun-Fang; Ma, Li; Du, Xiao-Jing; Lan, Mei; Guo, Ying; Zheng, Lie; Xia, Yun-Fei; Luo, Wei			Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy	PLOS ONE			English	Article							CONVENTIONAL 2-DIMENSIONAL RADIOTHERAPY; BARR-VIRUS DNA; CLINICAL-OUTCOMES; FAILURE; CHEMOTHERAPY; METAANALYSIS; PATTERNS; TRIAL; MRI	Purpose To investigate the prognostic value of cavernoussinus invasion (CSI) in patients with nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiotherapy (IMRT). Patients and Methods Retrospective review of data from 1,087 patients with biopsy-proven, non-metastatic NPC. All patients were diagnosed using magnetic resonance imaging (MRI) scans and received IMRT as the primary treatment. Results The incidence of cavernoussinus invasion in this cohort was 12.1%. In univariate analysis, 5-year overall survival (OS) (70.6% vs. 88.5%, P < 0.001) and distant metastasis-free survival (DMFS) (71.4% vs. 87.7%, P < 0.001), but not locoregional relapse-free survival (LRFS) (93.9% vs. 93.7%, P = 0.341), were significantly different between patients with and without cavernoussinus invasion. In the T4 subgroup, the 5-year OS, DMFS, and LRFS of patients with and without cavernoussinus extension were 70.6% vs. 81.9%(P = 0.011), 71.4% vs. 84.1% (P = 0.011), and 91.2% vs. 89.7% (P = 0.501), respectively. In multivariate analysis, cavernoussinus invasion was an independent prognostic factor for poorer OS (HR = 1.782; P = 0.013) and DMFS (HR = 1.771; P = 0.016), but not LRFS (HR = 0.632; P = 0.294). In patients with lymph node metastasis, the DMFS rates of patients with and without cavernoussinus invasion were significantly different (P < 0.001). Preliminaryanalysis indicated that neoadjuvant chemotherapy led to better DMFS and OS in patients with cavernoussinus invasion than concurrent chemotherapy or radiotherapy alone; however, the differences were not significant. Conclusions In the IMRT era, cavernoussinus invasion remains a prognostic factor for poor DMFS and OS in NPC, even in patients with T4 disease.	[Liao, Jun-Fang; Ma, Li; Du, Xiao-Jing; Lan, Mei; Xia, Yun-Fei; Luo, Wei] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China; [Guo, Ying] Sun Yat Sen Univ, Ctr Canc, Dept Med Stat & Epidemiol, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China; [Zheng, Lie] Sun Yat Sen Univ, Ctr Canc, Dept Imaging Dept, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Luo, W (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China.	luowei@sysucc.org.cn	luo, wei/GPW-6269-2022	Lan, Mei/0000-0002-5591-2678	Crossing Research Projects Situations [B2013-002-01]	Crossing Research Projects Situations	This work was supported by a Crossing Research Projects Situations (No. B2013-002-01).	Bakan AA, 2015, CLIN NEURORADIOL, V25, P109, DOI 10.1007/s00062-014-0360-0; Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; Blanchard P, 2015, LANCET ONCOL, V16, P645, DOI 10.1016/S1470-2045(15)70126-9; Brigette BY, 2008, ORAL ONCOL, V44, P1067, DOI [10.1016/j.oraloncology.2008.02.001, DOI 10.1016/J.ORALONCOLOGY.2008.02.001]; Cao CN, 2013, ORAL ONCOL, V49, P175, DOI 10.1016/j.oraloncology.2012.08.013; Chen L, 2012, INT J RADIAT ONCOL, V84, P196, DOI 10.1016/j.ijrobp.2011.11.021; Chen L, 2011, HEAD NECK-J SCI SPEC, V33, P1309, DOI 10.1002/hed.21606; Cheng SH, 2005, INT J RADIAT ONCOL, V61, P456, DOI 10.1016/j.ijrobp.2004.05.047; COX DR, 1972, J R STAT SOC B, V34, P187; Ding Jian-hui, 2006, Zhonghua Zhongliu Zazhi, V28, P530; Edge SB, 2010, AJCC CANC STAGING MA, P41, DOI [10.1007/978-0-387-88441-7_4, DOI 10.1007/978-0-387-88441-7_4]; Feng M, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-208; Hui EP, 2009, J CLIN ONCOL, V27, P242, DOI 10.1200/JCO.2008.18.1545; Hung TM, 2014, ORAL ONCOL, V50, P228, DOI 10.1016/j.oraloncology.2013.12.005; Jinkins JR, 2000, ATLAS OF NEURORADIOL; Kam MKM, 2003, INT J RADIAT ONCOL, V56, P145, DOI 10.1016/S0360-3016(03)00075-0; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; King AD, 2011, RADIOLOGY, V258, P531, DOI 10.1148/radiol.10101241; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Leung SF, 2003, CANCER, V98, P288, DOI 10.1002/cncr.11496; Liu X, 2014, BRIT J CANCER, V110, P1465, DOI 10.1038/bjc.2014.27; Lo YMD, 2000, ANN NY ACAD SCI, V906, P99; MILLER RG, 1981, SURVIVAL ANAL, P114; Ng WT, 2011, INT J RADIAT ONCOL, V79, P420, DOI 10.1016/j.ijrobp.2009.11.024; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; Tan T, 2015, INT J RADIAT ONCOL, V91, P952, DOI 10.1016/j.ijrobp.2015.01.002; Yu MC, 1990, PROG CLIN BIOL RES, V346, P93; Zhao Chong, 2004, Ai Zheng, V23, P1532	28	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0146787	10.1371/journal.pone.0146787	http://dx.doi.org/10.1371/journal.pone.0146787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824230	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528600010
J	Ansseau, E; Eidahl, JO; Lancelot, C; Tassin, A; Matteotti, C; Yip, C; Liu, J; Leroy, B; Hubeau, C; Gerbaux, C; Cloet, S; Wauters, A; Zorbo, S; Meyer, P; Pirson, I; Laoudj-Chenivesse, D; Wattiez, R; Harper, SQ; Belayew, A; Coppee, F				Ansseau, Eugenie; Eidahl, Jocelyn O.; Lancelot, Celine; Tassin, Alexandra; Matteotti, Christel; Yip, Cassandre; Liu, Jian; Leroy, Baptiste; Hubeau, Celine; Gerbaux, Cecile; Cloet, Samuel; Wauters, Armelle; Zorbo, Sabrina; Meyer, Pierre; Pirson, Isabelle; Laoudj-Chenivesse, Dalila; Wattiez, Ruddy; Harper, Scott Q.; Belayew, Alexandra; Coppee, Frederique			Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; DOUBLE HOMEOBOX GENE; RNA HELICASE DDX5; MYOTUBE FORMATION; OXIDATIVE STRESS; CANDIDATE GENE; EXPRESSION; BINDING; MICROTUBULE; D4Z4	Hundreds of double homeobox (DUX) genes map within 3.3-kb repeated elements dispersed in the human genome and encode DNA-binding proteins. Among these, we identified DUX4, a potent transcription factor that causes facioscapulohumeral muscular dystrophy (FSHD). In the present study, we performed yeast two-hybrid screens and protein co-purifications with HaloTag-DUX fusions or GST-DUX4 pull-down to identify protein partners of DUX4, DUX4c (which is identical to DUX4 except for the end of the carboxyl terminal domain) and DUX1 (which is limited to the double homeodomain). Unexpectedly, we identified and validated (by co-immunoprecipitation, GST pull-down, co-immunofluorescence and in situ Proximal Ligation Assay) the interaction of DUX4, DUX4c and DUX1 with type III intermediate filament protein desmin in the cytoplasm and at the nuclear periphery. Desmin filaments link adjacent sarcomere at the Z-discs, connect them to sarcolemma proteins and interact with mitochondria. These intermediate filament also contact the nuclear lamina and contribute to positioning of the nuclei. Another Z-disc protein, LMCD1 that contains a LIM domain was also validated as a DUX4 partner. The functionality of DUX4 or DUX4c interactions with cytoplasmic proteins is underscored by the cytoplasmic detection of DUX4/DUX4c upon myoblast fusion. In addition, we identified and validated (by co-immunoprecipitation, co-immunofluorescence and in situ Proximal Ligation Assay) as DUX4/4c partners several RNA-binding proteins such as C1QBP, SRSF9, RBM3, FUS/TLS and SFPQ that are involved in mRNA splicing and translation. FUS and SFPQ are nuclear proteins, however their cytoplasmic translocation was reported in neuronal cells where they associated with ribonucleoparticles (RNPs). Several other validated or identified DUX4/DUX4c partners are also contained in mRNP granules, and the co-localizations with cytoplasmic DAPI-positive spots is in keeping with such an association. Large muscle RNPs were recently shown to exit the nucleus via a novel mechanism of nuclear envelope budding. Following DUX4 or DUX4c overexpression in muscle cell cultures, we observed their association with similar nuclear buds. In conclusion, our study demonstrated unexpected interactions of DUX4/4c with cytoplasmic proteins playing major roles during muscle differentiation. Further investigations are on-going to evaluate whether these interactions play roles during muscle regeneration as previously suggested for DUX4c.	[Ansseau, Eugenie; Lancelot, Celine; Tassin, Alexandra; Matteotti, Christel; Yip, Cassandre; Hubeau, Celine; Gerbaux, Cecile; Cloet, Samuel; Wauters, Armelle; Zorbo, Sabrina; Belayew, Alexandra; Coppee, Frederique] Univ Mons, Res Inst Hlth Sci & Technol, Mol Biol Lab, B-7000 Mons, Belgium; [Eidahl, Jocelyn O.; Liu, Jian; Harper, Scott Q.] Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA; [Leroy, Baptiste; Wattiez, Ruddy] Univ Mons, Res Inst Biosci, Lab Prote & Microbiol, B-7000 Mons, Belgium; [Meyer, Pierre] CHRU Montpellier, Dept Pediat, Montpellier, France; [Pirson, Isabelle] Free Univ Brussels, IRIBHM, 808 Route Lennik, Brussels, Belgium; [Laoudj-Chenivesse, Dalila] INSERM, U1046, Lab Physiol & Expt Med, Montpellier, France; [Harper, Scott Q.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	University of Mons; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Mons; Universite de Montpellier; CHU de Montpellier; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University System of Ohio; Ohio State University	Coppee, F (corresponding author), Univ Mons, Res Inst Hlth Sci & Technol, Mol Biol Lab, B-7000 Mons, Belgium.	Frederique.coppee@umons.ac.be	BELAYEW, Alexandra/D-5205-2013; Laoudj-Chenivesse, dalila/N-7097-2018	BELAYEW, Alexandra/0000-0001-5115-2424; Laoudj-Chenivesse, dalila/0000-0003-4356-9187; Meyer, Pierre/0000-0001-5710-7376; Leroy, Baptiste/0000-0001-7166-4478; wattiez, ruddy/0000-0003-2071-4310	ABMM; AFM; FSH Society; FSH Stichting; NIH [NS046242, 5T32NS077984-02, 5 R01 AR 062123 -03, 758814]; FNRS/FRIA; FSH Society [FSHS-MGBF-020 82013-03, 82096215]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD060848] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS077984] Funding Source: NIH RePORTER	ABMM; AFM(Association Francaise contre les Myopathies); FSH Society; FSH Stichting; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FNRS/FRIA(Fonds de la Recherche Scientifique - FNRS); FSH Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by ABMM [http://www.telethon.be/]; AFM [http://www.afm-telethon.fr/association]; FSH Society [https://www.fshsociety.org/]; FSH Stichting [http://www.fshd.nl/index.php/en/]; NIH NS046242 [http://www.nih.gov/]; and FNRS/FRIA [http://www.fnrs.be/]. Scott Q. Harper at the Center for Gene Therapy, Research Institute at Nationwide Children's Hospital, Columbus, OH, USA:-NIH T32 Postdoctoral Fellowship 5T32NS077984-02 (T32 Fellowship)-Sponsor Reference # KL2RR025754 - Children's # 627011 (KL2)-NIH Sponsor Reference # 5 R01 AR 062123 -03 - Children's # 758814 (RO1) (web site already refer in point 1)-FSH Society Fellowship FSHS-MGBF-020 82013-03 (FSH Society Fellowship) (web site already refer in point 1)-Sponsor Reference # none-Children's # 82096215 (Chris Carrino Foundation) http://www.chriscarrinofoundation.org/. The T32, FSH Society and Carrino have funded salary of JOE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2004, J CELL SCI, V117, P6523, DOI 10.1242/jcs.01574; Ansseau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007482; Ayala FJ, 2009, FASEB J, V23, P2022, DOI [DOI 10.1096/FJ.09-0703, 10.1096/fj.09-0703]; Barro M, 2010, J CELL MOL MED, V14, P275, DOI 10.1111/j.1582-4934.2008.00368.x; Beckers MC, 2001, GENE, V264, P51, DOI 10.1016/S0378-1119(00)00602-8; Bian ZY, 2010, HYPERTENSION, V55, P257, DOI 10.1161/HYPERTENSIONAHA.109.135665; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Bosnakovski D, 2008, EXP NEUROL, V214, P87, DOI 10.1016/j.expneurol.2008.07.022; Buchan JR, 2014, RNA BIOL, V11, P1019, DOI 10.4161/15476286.2014.972208; Cadot B, 2012, EMBO REP, V13, P741, DOI 10.1038/embor.2012.89; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; Coppee F, 2004, FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: CLINICAL MEDICINE AND MOLECULAR CELL BIOLOGY, P117; Costa ML, 2004, BRAZ J MED BIOL RES, V37, P1819, DOI 10.1590/S0100-879X2004001200007; Cottle DL, 2007, J CELL SCI, V120, P1423, DOI 10.1242/jcs.004739; Cozzolino M, 2013, MOL CELL NEUROSCI, V55, P44, DOI 10.1016/j.mcn.2012.06.001; Dandapat A, 2013, STEM CELLS DEV, V22, P2440, DOI 10.1089/scd.2012.0643; Corona ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075614; Dardenne E, 2014, CELL REP, V7, P1900, DOI 10.1016/j.celrep.2014.05.010; Davidovic L, 2008, J MED GENET, V45, P679, DOI 10.1136/jmg.2008.060541; Ding H, 1998, HUM MOL GENET, V7, P1681, DOI 10.1093/hmg/7.11.1681; Ding H, 1996, DNA CELL BIOL, V15, P429, DOI 10.1089/dna.1996.15.429; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dmitriev P, 2009, NEUROMUSCULAR DISORD, V19, P17, DOI 10.1016/j.nmd.2008.09.004; Dresios J, 2005, P NATL ACAD SCI USA, V102, P1865, DOI 10.1073/pnas.0409764102; Feng Q, 2015, ELIFE, V4, DOI 10.7554/eLife.04996; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fiesel FC, 2011, FEBS J, V278, P3550, DOI 10.1111/j.1742-4658.2011.08258.x; Frank D, 2010, J MOL CELL CARDIOL, V49, P673, DOI 10.1016/j.yjmcc.2010.06.009; Fuller-Pace FV, 2011, FUTURE ONCOL, V7, P239, DOI 10.2217/FON.11.1; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Gao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086808; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Grunwald M, 2013, EMBO J, V32, P899, DOI 10.1038/emboj.2013.29; Hall MP, 2013, RNA, V19, P627, DOI 10.1261/rna.038422.113; Hendricks AG, 2012, CURR BIOL, V22, P632, DOI 10.1016/j.cub.2012.02.023; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Hnia K, 2015, CELL TISSUE RES, V360, P591, DOI 10.1007/s00441-014-2016-4; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Homma S, 2015, ANN CLIN TRANSL NEUR, V2, P151, DOI 10.1002/acn3.158; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Huang LJ, 2008, INVEST OPHTH VIS SCI, V49, P5243, DOI 10.1167/iovs.07-1625; Huang LQ, 2002, ACTA BIOCH BIOPH SIN, V34, P219; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Janknecht R, 2010, AM J TRANSL RES, V2, P223; Jayasena CS, 2012, J CELL BIOL, V199, P453, DOI 10.1083/jcb.201204138; Jin DH, 2010, GENES CELLS, V15, P1158, DOI 10.1111/j.1365-2443.2010.01446.x; Jones TI, 2012, HUM MOL GENET, V21, P4419, DOI 10.1093/hmg/dds284; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kapranov Philipp, 2012, Frontiers in Genetics, V3, P60, DOI 10.3389/fgene.2012.00060; Kar A, 2011, MOL CELL BIOL, V31, P1812, DOI 10.1128/MCB.01149-10; Kato Y, 2012, DEV GROWTH DIFFER, V54, P19, DOI 10.1111/j.1440-169X.2011.01314.x; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Kawazu M, 2007, J IMMUNOL, V179, P5335, DOI 10.4049/jimmunol.179.8.5335; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Krom YD, 2012, AM J PATHOL, V181, P1387, DOI 10.1016/j.ajpath.2012.07.007; Landeras-Bueno S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002397; Laoudj-Chenivesse D, 2005, J MOL MED, V83, P216, DOI 10.1007/s00109-004-0583-7; Lassche S, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-144; Leidenroth A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-364; Leinhart K, 2011, GENES-BASEL, V2, P210, DOI 10.3390/genes2010210; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lete C, 2012, J VIROL, V86, P11567, DOI 10.1128/JVI.00456-12; Li HQ, 2009, FASEB J, V23, P1988, DOI 10.1096/fj.08-125542; Li Y, 2014, J VIROL, V88, P7199, DOI 10.1128/JVI.00225-14; Lin Jung-Chun, 2012, Front Biosci (Schol Ed), V4, P181; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Lopez MP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5778; Lukong KE, 2009, CELL SIGNAL, V21, P1415, DOI 10.1016/j.cellsig.2009.04.008; Lundin VF, 2010, TRENDS BIOCHEM SCI, V35, P288, DOI 10.1016/j.tibs.2009.12.007; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; Mancini A, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-36; Maragh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105460; McLendon PM, 2011, AM J PHYSIOL-HEART C, V301, pH1220, DOI 10.1152/ajpheart.00601.2011; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Miyamoto S, 2009, GENES CELLS, V14, P1241, DOI 10.1111/j.1365-2443.2009.01347.x; Musa H, 2003, J MUSCLE RES CELL M, V24, P301; Myhre JL, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/712315; Olive M, 2009, J NEUROPATH EXP NEUR, V68, P262, DOI 10.1097/NEN.0b013e3181996d8f; Ostlund C, 2005, BIOCHEMISTRY-US, V44, P2378, DOI 10.1021/bi047992w; Petersen-Mahrt SK, 1999, EMBO J, V18, P1014, DOI 10.1093/emboj/18.4.1014; Pistoni M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003186; Pizon V, 2005, EMBO J, V24, P3781, DOI 10.1038/sj.emboj.7600842; Ploski JE, 2004, MOL CELL BIOL, V24, P4824, DOI 10.1128/MCB.24.11.4824-4834.2004; Poon KL, 2012, CARDIOVASC RES, V94, P418, DOI 10.1093/cvr/cvs095; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Reed P, 2006, ANN NEUROL, V59, P289, DOI 10.1002/ana.20750; Richards M, 2012, HUM GENET, V131, P325, DOI 10.1007/s00439-011-1100-z; Richardson BE, 2008, TRAFFIC, V9, P1050, DOI 10.1111/j.1600-0854.2008.00756.x; Rickard AM, 2015, HUM MOL GENET, V24, P5901, DOI 10.1093/hmg/ddv315; Rivas FV, 2004, MOL CELL BIOL, V24, P1628, DOI 10.1128/MCB.24.4.1628-1639.2004; Rogers MT, 2004, FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: CLINICAL MEDICINE AND MOLECULAR CELL BIOLOGY, P277; ROSS KFA, 1964, Q J MICROSC SCI, V105, P423; Sancisi V, 2014, AM J PHYSIOL-REG I, V306, pR124, DOI 10.1152/ajpregu.00379.2013; Sanger JW, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/858606; Saporita AJ, 2011, CANCER RES, V71, P6708, DOI 10.1158/0008-5472.CAN-11-1472; Satoh M, 1999, J BIOL CHEM, V274, P34598, DOI 10.1074/jbc.274.49.34598; Serebriiskii I, 2000, BIOTECHNIQUES, V28, P328, DOI 10.2144/00282rr03; Sharma V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064691; Sharon N, 2012, STEM CELL RES, V9, P261, DOI 10.1016/j.scr.2012.08.003; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; Strong MJ, 2011, FEBS J, V278, P3569, DOI 10.1111/j.1742-4658.2011.08277.x; Sury MD, 2015, MOL CELL PROTEOMICS, V14, P50, DOI 10.1074/mcp.M114.039370; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Tassin A, 2013, J CELL MOL MED, V17, P76, DOI 10.1111/j.1582-4934.2012.01647.x; Tassin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051865; Tawil R, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-12; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Tsumagari K, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-67; Turki A, 2012, FREE RADICAL BIO MED, V53, P1068, DOI 10.1016/j.freeradbiomed.2012.06.041; Vandenbroere I, 2003, BIOCHEM BIOPH RES CO, V300, P494, DOI 10.1016/S0006-291X(02)02894-2; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; Wellmann S, 2010, PEDIATR RES, V67, P35, DOI 10.1203/PDR.0b013e3181c13326; Winokur ST, 1996, HUM MOL GENET, V5, P1567, DOI 10.1093/hmg/5.10.1567; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Winter DL, 2014, HISTOCHEM CELL BIOL, V141, P1, DOI 10.1007/s00418-013-1148-z; Wu SL, 2014, CELL TISSUE RES, V358, P551, DOI 10.1007/s00441-014-1974-x; Wu SL, 2010, DEV DYNAM, V239, P927, DOI 10.1002/dvdy.22210; Yamamoto DL, 2008, J HISTOCHEM CYTOCHEM, V56, P881, DOI 10.1369/jhc.2008.951228; Yang JW, 2014, DEV CELL, V31, P87, DOI 10.1016/j.devcel.2014.08.025; Yao ZZ, 2014, HUM MOL GENET, V23, P5342, DOI 10.1093/hmg/ddu251; Ye WD, 2011, BBA-MOL CELL RES, V1813, P1654, DOI 10.1016/j.bbamcr.2011.01.013; Yoshikawa H, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006148; Yotov WV, 1996, GENE DEV, V10, P1763, DOI 10.1101/gad.10.14.1763; Young JM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003947; Zhang T, 2009, J CELL SCI, V122, P1401, DOI 10.1242/jcs.039255; Zhong YF, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-169; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	133	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146893	10.1371/journal.pone.0146893	http://dx.doi.org/10.1371/journal.pone.0146893			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816005	gold, Green Submitted, Green Published			2022-12-26	WOS:000369528200022
J	Huang, H; Veien, ES; Zhang, H; Ayers, DC; Song, J				Huang, Henry; Veien, Eric S.; Zhang, Hong; Ayers, David C.; Song, Jie			Skeletal Characterization of Smurf2-Deficient Mice and In Vitro Analysis of Smurf2-Deficient Chondrocytes	PLOS ONE			English	Article							TGF-BETA; UBIQUITIN LIGASE; BONE; SMURF2; OSTEOARTHRITIS; DIFFERENTIATION; DEGRADATION; CARTILAGE; AGE; HISTOPATHOLOGY	Overexpression of Smad ubiquitin regulatory factor 2 (Smurf2) in chondrocytes was reported to cause spontaneous osteoarthritis (OA) in mice. However, it is unclear whether Smurf2 is involved in bone and cartilage homeostasis and if it is required for OA pathogenesis. Here we characterized age-related changes in the bone and articular cartilage of Smurf2-deficient (MT) mice by microCT and histology, and examined whether reduced Smurf2 expression affected the severity of OA upon surgical destabilization of the medial meniscus (DMM). Using immature articular chondrocytes (iMAC) from MT and wild-type (WT) mice, we also examined how Smurf2 deficiency affects chondrogenic and catabolic gene expressions and Smurf2 and Smurf1 proteins upon TGF-beta 3 or IL-1 beta treatment in culture. We found no differences in cortical, subchondral and trabecular bone between WT and MT in young (4 months) and old mice (16-24 months). The articular cartilage and age-related alterations between WT and MT were also similar. However, 2 months following DMM, young MT showed milder OA compared toWT (similar to 70% vs similar to 30% normal or exhibiting only mild OA cartilage phenotype). The majority of the older WT and MT mice developed moderate/severe OA 2 months after DMM, but a higher subset of aged MT cartilage (27% vs. 9% WT) remained largely normal. Chondrogenic gene expression (Sox9, Col2, Acan) trended higher in MT iMACs than WT with/without TGF-beta 3 treatment. IL-1 beta treatment suppressed chondrgenic gene expression, but Sox9 expression in MT remained significantly higher than WT. Smurf2 protein inWT iMACs increased upon TGF-beta 3 treatment and decreased upon IL-1 beta treatment in a dose-dependent manner. Smurf1 protein elevated more in MT than WT upon TGF-beta 3 treatment, suggesting a potential, but very mild compensatory effect. Overall, our data support a role of Smurf2 in regulating OA development but suggest that inhibiting Smurf2 alone may not be sufficient to prevent or consistently mitigate post-traumatic OA across a broad age range.	[Huang, Henry; Veien, Eric S.; Ayers, David C.; Song, Jie] Univ Massachusetts, Sch Med, Dept Orthoped & Phys Rehabil, Worcester, MA 01605 USA; [Huang, Henry; Zhang, Hong; Song, Jie] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Song, J (corresponding author), Univ Massachusetts, Sch Med, Dept Orthoped & Phys Rehabil, Worcester, MA 01605 USA.; Song, J (corresponding author), Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA.	Jie.Song@umassmed.edu		Song, Jie/0000-0001-7554-5564	University of Massachusetts Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM107000] Funding Source: NIH RePORTER	University of Massachusetts Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is funded by the University of Massachusetts Medical School. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauge C, 2014, AGING DIS, V5, P394, DOI 10.14336/AD.2014.0500394; Bizet AA, 2012, J CELL BIOCHEM, V113, P238, DOI 10.1002/jcb.23349; Blank M, 2012, NAT MED, V18, P227, DOI 10.1038/nm.2596; Burr DB, 2012, NAT REV RHEUMATOL, V8, P665, DOI 10.1038/nrrheum.2012.130; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Davidson ENB, 2007, OSTEOARTHR CARTILAGE, V15, P597, DOI 10.1016/j.joca.2007.02.005; Davidson ENB, 2006, ANN RHEUM DIS, V65, P1414, DOI 10.1136/ard.2005.045971; Davidson ENB, 2005, ARTHRITIS RES THER, V7, pR1338, DOI 10.1186/ar1833; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Keller B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016421; Li TF, 2010, ARTHRITIS RHEUM-US, V62, P2359, DOI 10.1002/art.27537; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; McNulty MA, 2012, OSTEOARTHR CARTILAGE, V20, P949, DOI 10.1016/j.joca.2012.05.001; Rahman MS, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.5; Ramkumar C, 2012, CANCER RES, V72, P2714, DOI 10.1158/0008-5472.CAN-11-3773; REDINI F, 1988, FEBS LETT, V234, P172, DOI 10.1016/0014-5793(88)81327-9; Rowan AD, 2007, FRONT BIOSCI-LANDMRK, V12, P536, DOI 10.2741/2080; Seeman E, 2013, J GERONTOL A-BIOL, V68, P1218, DOI 10.1093/gerona/glt071; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Stok KS, 2009, BONE, V45, P414, DOI 10.1016/j.bone.2009.05.017; Suire C, 2012, BLOOD, V119, pE86, DOI 10.1182/blood-2011-08-372334; Tang LY, 2011, EMBO J, V30, P4777, DOI 10.1038/emboj.2011.393; Tetlow LC, 2001, ARTHRITIS RHEUM-US, V44, P585, DOI 10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C; Verdier MP, 2005, RHEUMATOL INT, V25, P118, DOI 10.1007/s00296-003-0409-x; Wu QQ, 2008, ARTHRITIS RHEUM-US, V58, P3132, DOI 10.1002/art.23946; Wu QQ, 2008, J ORTHOP RES, V26, P704, DOI 10.1002/jor.20563; Xing LP, 2010, J CELL BIOCHEM, V110, P554, DOI 10.1002/jcb.22586; Yamamoto K, 2005, J Orthop Surg (Hong Kong), V13, P8; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35	38	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0148088	10.1371/journal.pone.0148088	http://dx.doi.org/10.1371/journal.pone.0148088			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815610	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528200072
J	Kohlmann, R; Gatermann, SG				Kohlmann, Rebekka; Gatermann, Soeren G.			Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data - The Influence of Different Parameters in a Routine Clinical Microbiology Laboratory	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC SUSCEPTIBILITY; ESCHERICHIA-COLI; HOSPITAL-WIDE; 1ST ISOLATE; ANTIBIOGRAMS; PREVALENCE; SURVEILLANCE; ELIMINATION; DUPLICATE	Introduction Many clinical microbiology laboratories report on cumulative antimicrobial susceptibility testing (cAST) data on a regular basis. Criteria for generation of cAST reports, however, are often obscure and inconsistent. Whereas the CLSI has published a guideline for analysis and presentation of cAST data, national guidelines directed at clinical microbiology laboratories are not available in Europe. Thus, we sought to describe the influence of different parameters in the process of cAST data analysis in the setting of a German routine clinical microbiology laboratory during 2 consecutive years. Material and Methods We developed various program scripts to assess the consequences ensuing from different algorithms for calculation of cumulative antibiograms from the data collected in our clinical microbiology laboratory in 2013 and 2014. Results One of the most pronounced effects was caused by exclusion of screening cultures for multi-drug resistant organisms which decreased the MRSA rate in some cases to one third. Dependent on the handling of duplicate isolates, i.e. isolates of the same species recovered from successive cultures on the same patient during the time period analyzed, we recorded differences in resistance rates of up to 5 percentage points for S. aureus, E. coli and K. pneumoniae and up to 10 percentage points for P. aeruginosa. Stratification by site of care and specimen type, testing of antimicrobials selectively on resistant isolates, change of interpretation rules and analysis at genus level instead of species level resulted in further changes of calculated antimicrobial resistance rates. Conclusion The choice of parameters for cAST data analysis may have a substantial influence on calculated antimicrobial resistance rates. Consequently, comparability of cAST reports from different clinical microbiology laboratories may be limited. We suggest that laboratories communicate the strategy used for cAST data analysis as long as national guidelines for standardized cAST data analysis and reporting do not exist in Europe.	[Kohlmann, Rebekka; Gatermann, Soeren G.] Ruhr Univ Bochum, Dept Med Microbiol, Univ Str 150, Bochum, Germany; [Kohlmann, Rebekka; Gatermann, Soeren G.] Bochum GmbH, Inst Med Lab Diagnost IML, Bochum, Germany	Ruhr University Bochum	Kohlmann, R (corresponding author), Ruhr Univ Bochum, Dept Med Microbiol, Univ Str 150, Bochum, Germany.; Kohlmann, R (corresponding author), Bochum GmbH, Inst Med Lab Diagnost IML, Bochum, Germany.	rebekka.kohlmann@rub.de		Laufenberg, Rebekka/0000-0003-4317-1347				Alvarez-Paredes L, 2013, CHEMOTHERAPY, V59, P453, DOI 10.1159/000362785; Anderson DJ, 2012, INFECT CONT HOSP EP, V33, P589, DOI 10.1086/665721; Boggan JC, 2012, PEDIATRICS, V130, pE615, DOI 10.1542/peds.2012-0563; Bosso JA, 2006, ANN PHARMACOTHER, V40, P1946, DOI 10.1345/aph.1H377; Bosso John A, 2013, Hosp Pharm, V48, P295, DOI 10.1310/hpj4804-295.test; Cebrian L, 2005, INT J ANTIMICROB AG, V25, P173, DOI 10.1016/j.ijantimicag.2004.09.017; CLSI, 2009, M39A4 CLSI; Cornaglia G, 2004, CLIN MICROBIOL INFEC, V10, P349, DOI 10.1111/j.1198-743X.2004.00887.x; Daxboeck F, 2004, J ANTIMICROB CHEMOTH, V54, P163, DOI 10.1093/jac/dkh277; Fridkin SK, 2001, CLIN INFECT DIS, V33, P324, DOI 10.1086/321893; Heginbothom ML, 2004, J ANTIMICROB CHEMOTH, V53, P1010, DOI 10.1093/jac/dkh229; Hindler JF, 2007, CLIN INFECT DIS, V44, P867, DOI 10.1086/511864; Hombach M, 2012, J ANTIMICROB CHEMOTH, V67, P622, DOI 10.1093/jac/dkr524; Horvat RT, 2003, J CLIN MICROBIOL, V41, P4611, DOI 10.1128/JCM.41.10.4611-4616.2003; Kaufman D, 1998, ARCH SURG-CHICAGO, V133, P1041, DOI 10.1001/archsurg.133.10.1041; Kuster SP, 2008, J ANTIMICROB CHEMOTH, V62, P1451, DOI 10.1093/jac/dkn384; Lamoth F, 2010, INFECTION, V38, P249, DOI 10.1007/s15010-010-0033-0; Laupland KB, 2007, CLIN INVEST MED, V30, pE159, DOI 10.25011/cim.v30i4.1777; Lee SO, 2004, J CLIN MICROBIOL, V42, P4776, DOI 10.1128/JCM.42.10.4776-4779.2004; Li FF, 2005, EMERG INFECT DIS, V11, P1552, DOI 10.3201/eid1110.050162; Lubowski TJ, 2001, INFECT CONT HOSP EP, V22, P379, DOI 10.1086/501918; Magee JT, 2004, J ANTIMICROB CHEMOTH, V54, P155, DOI 10.1093/jac/dkh295; McGregor JC, 2013, DIAGN MICR INFEC DIS, V76, P73, DOI 10.1016/j.diagmicrobio.2013.01.026; Rabs N, 2014, AM J INFECT CONTROL, V42, P393, DOI 10.1016/j.ajic.2013.11.004; Rodriguez JC, 2003, J ANTIMICROB CHEMOTH, V52, P132, DOI 10.1093/jac/dkg298; Rodriguez-Bano J, 2012, CLIN INFECT DIS, V54, P167, DOI 10.1093/cid/cir790; Shannon KP, 2002, J ANTIMICROB CHEMOTH, V50, P965, DOI 10.1093/jac/dkf225; Sundqvist M, 2007, J ANTIMICROB CHEMOTH, V59, P913, DOI 10.1093/jac/dkm040; Swami SK, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-63; The European Committee on Antimicrobial Susceptibility Testing, 2015, BREAKP TABL INT MICS; Weber SG, 2009, J ANTIMICROB CHEMOTH, V64, P1291, DOI 10.1093/jac/dkp349; White RL, 2001, DIAGN MICR INFEC DIS, V39, P39, DOI 10.1016/S0732-8893(00)00219-4; Wolfensberger A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079130; Xu R, 2012, AM J HEALTH-SYST PH, V69, P598, DOI 10.2146/ajhp110332	34	22	25	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147965	10.1371/journal.pone.0147965	http://dx.doi.org/10.1371/journal.pone.0147965			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814675	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528200065
J	Zhao, HJ; Leppert, JT; Peehl, DM				Zhao, Hongjuan; Leppert, John T.; Peehl, Donna M.			A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data	PLOS ONE			English	Article							BREAST-CANCER; CIRCADIAN REGULATION; GENE-EXPRESSION; KIDNEY; THERAPY; PATHWAY; PROTEIN; TUMORS	Androgen receptor (AR) is expressed in normal murine and human kidneys of both genders, but its physiologic role is uncertain. Several studies showed loss of AR in renal cell carcinoma (RCC) in conjunction with increasing clinical stage and pathological grade, but others found that higher AR expression correlated with worse outcomes. Limited functional studies with renal cell lines suggested tumor-promoting activity of AR. In this study, we queried transcriptomic, proteomic, epigenetic and survival data from The Cancer Genome Atlas (TCGA) to evaluate AR expression and its association with overall survival in three subtypes of RCC (clear cell [ccRCC], papillary [pRCC], and chromophobe [chRCC]). We found that although there was no significant difference in AR mRNA expression in ccRCC of males vs. females, AR protein expression in ccRCC was significantly higher in male compared to female patients. More importantly, higher expression of AR at both transcript and protein levels was associated with improved overall survival in both genders with ccRCC, but did not predict survival of either gender with pRCC or chRCC. Genes whose transcript levels were associated with AR mRNA levels significantly overlapped between ccRCC and pRCC, but not with chRCC, suggesting a similar transcriptional program mediated by AR in ccRCC and pRCC. Ingenuity pathway analysis also identified overlapping pathways and upstream regulators enriched in AR-associated genes in ccRCC and pRCC. Hypermethylation of CpG sites located in the promoter and first exon of AR was associated with loss of AR expression and poor overall survival. Our findings support a tumor suppressor role for AR in both genders that might be exploited to decrease the incidence or progression of ccRCC.	[Zhao, Hongjuan; Leppert, John T.; Peehl, Donna M.] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Leppert, John T.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Peehl, DM (corresponding author), Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA.	dpeehl@stanford.edu		Leppert, John/0000-0001-9980-3863	Department of Urology at Stanford University	Department of Urology at Stanford University	The authors thank the Department of Urology at Stanford University for funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139267; Barton VN, 2015, MOL CANCER THER, V14, P769, DOI 10.1158/1535-7163.MCT-14-0926; Bonny O, 2013, CURR OPIN NEPHROL HY, V22, P439, DOI 10.1097/MNH.0b013e32836213b8; Brown DF, 1998, MODERN PATHOL, V11, P55; BULLOCK LP, 1974, ENDOCRINOLOGY, V94, P746, DOI 10.1210/endo-94-3-746; CATTERALL JF, 1986, RECENT PROG HORM RES, V42, P71; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; Furutani T, 2002, BIOCHEM BIOPH RES CO, V294, P779, DOI 10.1016/S0006-291X(02)00564-8; Gucalp A, 2013, CLIN CANCER RES, V19, P5505, DOI 10.1158/1078-0432.CCR-12-3327; Ha YS, 2015, J UROLOGY, V194, P1441, DOI 10.1016/j.juro.2015.03.078; Harries LW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-315; He DL, 2014, CANCER RES, V74, P4420, DOI 10.1158/0008-5472.CAN-13-2681; Huang R, 2015, MOL CANCER THER, V14, P1066, DOI 10.1158/1535-7163.MCT-14-0620; King SC, 2014, J UROLOGY, V191, P1665, DOI 10.1016/j.juro.2013.12.046; Langner C, 2004, J UROLOGY, V171, P611, DOI 10.1097/01.ju.0000108040.14303.c2; Linehan WM, 2014, NAT REV UROL, V11, P614, DOI 10.1038/nrurol.2014.262; Liu Q, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0117-z; Mazzoccoli G, 2014, TUMOR BIOL, V35, P1, DOI 10.1007/s13277-013-1076-5; Naderi A, 2015, EXP CELL RES, V331, P239, DOI 10.1016/j.yexcr.2014.10.002; Niemeier LA, 2010, MODERN PATHOL, V23, P205, DOI 10.1038/modpathol.2009.159; Noh SJ, 2013, PATHOLOGY, V45, P574, DOI 10.1097/PAT.0b013e3283652c7a; Okazaki H, 2014, CANCER RES, V74, P543, DOI 10.1158/0008-5472.CAN-12-3241; PAPAC RJ, 1993, EUR J CANCER, V29A, P997, DOI 10.1016/S0959-8049(05)80209-6; Pihlajamaa P, 2014, EMBO J, V33, P312, DOI 10.1002/embj.201385895; Quinkler M, 2005, HYPERTENSION, V46, P787, DOI 10.1161/01.HYP.0000184362.61744.c1; Shuch B, 2015, EUR UROL, V67, P85, DOI 10.1016/j.eururo.2014.04.029; Stone L, 2014, NAT REV UROL, V11, P425, DOI 10.1038/nrurol.2014.159; Stow LR, 2011, J AM SOC NEPHROL, V22, P598, DOI 10.1681/ASN.2010080803; Thong AE, 2014, UROL ONCOL, V32, P43, DOI DOI 10.1016/J.UR0L0NC.2013.05.008; Tobert CM, 2013, UROL ONCOL-SEMIN ORI, V31, P1316, DOI 10.1016/j.urolonc.2011.12.014; Tokonami N, 2014, J AM SOC NEPHROL, V25, P1430, DOI 10.1681/ASN.2013060641; Williams EM, 2015, INT UROL NEPHROL, V47, P81, DOI 10.1007/s11255-014-0834-7; Wuerzner G, 2014, NEPHROL DIAL TRANSPL, V29, P1475, DOI 10.1093/ndt/gft525; Zhu G, 2014, UROLOGY, V83, P510	35	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146505	10.1371/journal.pone.0146505	http://dx.doi.org/10.1371/journal.pone.0146505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814892	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528200015
J	Yuan, SQ; Qu, L; Shou, CC				Yuan, Shiqin; Qu, Like; Shou, Chengchao			N-Terminal Polypeptide of Annexin A2 Decreases Infection of Mycoplasma hyorhinis to Gastric Cancer Cells	PLOS ONE			English	Article							MACROLIDE RESISTANCE; CONTAMINATION; ELIMINATION; GENITALIUM; CULTURE; EXPRESSION; CARCINOMA; HOMINIS	Mycoplasma infection in human and its contamination in cell cultures are worldwide problems. The drugs currently available for preventing or treating mycoplasma infection suffer from low sensitivity, strong resistance and high toxicity. Our previous work showed that Mycoplasma hyorhinis (M. hyorhinis) infection was mediated by the interaction between p37 of M. hyorhinis and Annexin A2 (ANXA2) of host cells, however the translational value of this mechanism was unknown. Herein, we synthesized the N-terminal of ANXA2 polypeptide (A2PP) and found that A2PP could decrease the infection of M. hyorhinis to gastric cancer cells and block M. hyorhinis infection-induced cell migration. Furthermore, we found that A2PP could reduce M. hyorhinis contamination of passage cells. Moreover, compared with the commercial antibiotics commonly used in cell culture to prevent M. hyorhinis infection, A2PP demonstrated a more effectiveness but a low toxicity on cell growth. Thus, our study for the first time revealed A2PP's potential for the treatment and prevention of M. hyorhinis infection.	[Yuan, Shiqin; Qu, Like; Shou, Chengchao] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Biochem & Mol Biol, Beijing 100871, Peoples R China	Peking University	Shou, CC (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Biochem & Mol Biol, Beijing 100871, Peoples R China.	cshou@vip.sina.com			National Natural Science Foundation of China [81572532]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by National Natural Science Foundation of China (81572532). http://www.nsfc.gov.cn/publish/portal1/. SCC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Callaway E, 2014, NATURE, V511, P518, DOI 10.1038/511518a; Cazanave C, 2012, MED MALADIES INFECT, V42, P381, DOI 10.1016/j.medmal.2012.05.006; Chrisment D, 2012, J ANTIMICROB CHEMOTH, V67, P2598, DOI 10.1093/jac/dks263; Darin N, 2003, BMC BIOCH, V4, P4; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; Duan HY, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0135-3; Duan HY, 2014, CANCER RES, V74, P5782, DOI 10.1158/0008-5472.CAN-14-0650; Dziduszko A, 2013, J VIROL, V87, P7502, DOI 10.1128/JVI.00519-13; GURNEY T, 1981, IN VITRO CELL DEV B, V17, P993, DOI 10.1007/BF02618424; HAYFLICK L, 1960, ANN NY ACAD SCI, V79, P433, DOI 10.1111/j.1749-6632.1960.tb42709.x; HENDERSHOT L, 1985, INFECT IMMUN, V49, P36, DOI 10.1128/IAI.49.1.36-39.1985; Huang S, 2001, WORLD J GASTROENTERO, V7, P266; Krausse R, 2010, CLIN MICROBIOL INFEC, V16, P1649, DOI [10.1111/j.1469-0691.2009.03155.x, 10.1111/j.1469-0691.2010.03155.x]; Langdon WB, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-3; Lo SC, 2011, ONCOTARGET, V2, P352, DOI 10.18632/oncotarget.282; MANILOFF J, 1972, BACTERIOL REV, V36, P263, DOI 10.1128/MMBR.36.3.263-290.1972; MANILOFF J, 1969, J BACTERIOL, V100, P1402, DOI 10.1128/JB.100.3.1402-1408.1969; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Namiki K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006872; Ning JY, 2003, WORLD J GASTROENTERO, V9, P2164; Olarerin-George AO, 2015, NUCLEIC ACIDS RES, V43, P2535, DOI 10.1093/nar/gkv136; PATON GR, 1965, NATURE, V207, P43, DOI 10.1038/207043a0; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Roediger W E W, 2004, Novartis Found Symp, V263, P85; Rogers MB, 2011, ONCOTARGET, V2, P271; Rottem S, 2012, BIOMEDICAL TISSUE CU, V17, P35, DOI 10.5772/51518; SCHMITT K, 1988, J IMMUNOL METHODS, V109, P17, DOI 10.1016/0022-1759(88)90437-1; Shetty PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044299; Sun GP, 2008, INFECT IMMUN, V76, P4405, DOI 10.1128/IAI.00575-08; Tagg KA, 2013, J CLIN MICROBIOL, V51, P2245, DOI 10.1128/JCM.00495-13; Takei A, 2001, ATHEROSCLEROSIS, V154, P79, DOI 10.1016/S0021-9150(00)00465-2; TAYLOR G, 1974, ANN RHEUM DIS, V33, P376, DOI 10.1136/ard.33.4.376; Taylor-Robinson D, 2011, CLIN MICROBIOL REV, V24, P498, DOI 10.1128/CMR.00006-11; Tocqueville V, 2014, J CLIN MICROBIOL, V52, P1664, DOI 10.1128/JCM.03437-13; TSAI S, 1995, P NATL ACAD SCI USA, V92, P10197, DOI 10.1073/pnas.92.22.10197; Twin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035593; Urbanek C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-233; Wang CY, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/308976; Whitson WJ, 2014, J NEUROSURG-PEDIATR, V14, P212, DOI 10.3171/2014.4.PEDS13547; Yang H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-132	40	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147776	10.1371/journal.pone.0147776	http://dx.doi.org/10.1371/journal.pone.0147776			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812398	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528000054
J	Cottrell, RS; Black, KD; Hutchison, ZL; Last, KS				Cottrell, Richard S.; Black, Kenny D.; Hutchison, Zoe L.; Last, Kim S.			The Influence of Organic Material and Temperature on the Burial Tolerance of the Blue Mussel, Mytilus edulis: Considerations for the Management of Marine Aggregate Dredging	PLOS ONE			English	Article							EASTERN ENGLISH-CHANNEL; BENTHIC COMMUNITY STRUCTURE; ANOXIC SURVIVAL; SULFATE REDUCTION; ENVIRONMENTAL-STRESS; SEDIMENT COMPOSITION; MEDITERRANEAN SEA; HYDROGEN-SULFIDE; MACOMA-BALTHICA; UNITED-KINGDOM	Rationale and Experimental Approach Aggregate dredging is a growing source of anthropogenic disturbance in coastal UK waters and has the potential to impact marine systems through the smothering of benthic fauna with organically loaded screening discards. This study investigates the tolerance of the blue mussel, Mytilus edulis to such episodic smothering events using a multi-factorial design, including organic matter concentration, temperature, sediment fraction size and duration of burial as important predictor variables. Results and Discussion Mussel mortality was significantly higher in organically loaded burials when compared to control sediments after just 2 days. Particularly, M. edulis specimens under burial in fine sediment with high (1%) concentrations of organic matter experienced a significantly higher mortality rate (p< 0.01) than those under coarse control aggregates. Additionally, mussels exposed to the summer maximum temperature treatment (20 degrees C) exhibited significantly increased mortality (p< 0.01) compared to those in the ambient treatment group (15 degrees C). Total Oxygen Uptake rates of experimental aggregates were greatest (112.7 mmol m(-2) day(-1)) with 1% organic loadings in coarse sediment at 20 degrees C. Elevated oxygen flux rates in porous coarse sediments are likely to be a function of increased vertical migration of anaerobically liberated sulphides to the sediment-water interface. However, survival of M. edulis under bacterial mats of Beggia-toa spp. indicates the species' resilience to sulphides and so we propose that the presence of reactive organic matter within the burial medium may facilitate bacterial growth and increase mortality through pathogenic infection. This may be exacerbated under the stable interstitial conditions in fine sediment and increased bacterial metabolism under high temperatures. Furthermore, increased temperature may impose metabolic demands upon the mussel that cannot be met during burial-induced anaerobiosis. Summary Lack of consideration for the role of organic matter and temperature during sedimentation events may lead to an overestimation of the tolerance of benthic species to smothering from dredged material.	[Cottrell, Richard S.; Black, Kenny D.; Hutchison, Zoe L.; Last, Kim S.] Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland; [Cottrell, Richard S.] Univ St Andrews, Sch Biol, St Andrews KY16 9ST, Fife, Scotland	UHI Millennium Institute; University of St Andrews	Last, KS (corresponding author), Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland.	kim.last@sams.ac.uk	Black, Kenneth/GXV-2598-2022; Cottrell, Richard S./AAT-8401-2020; Black, Kenneth D/A-7089-2010	Cottrell, Richard S./0000-0002-6499-7503; Black, Kenneth D/0000-0002-7626-2926; Hutchison, Zoe/0000-0003-1866-7877				Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Aksnes A, 1997, AQUACULTURE, V153, P251, DOI [10.1016/S0044-8486(97)00046-X, 10.1016/S0044-8486(97)00025-2]; Arnosti C, 1998, MAR ECOL PROG SER, V165, P59, DOI 10.3354/meps165059; Atkins JP, 2011, MAR POLLUT BULL, V62, P215, DOI 10.1016/j.marpolbul.2010.12.012; Attard K., 2010, THESIS UHI; Attramadal KJK, 2012, AQUACULT ENG, V49, P23, DOI 10.1016/j.aquaeng.2012.02.003; Avnimelech Y, 2001, AQUACULT ENG, V25, P25, DOI 10.1016/S0144-8609(01)00068-1; Babarro JMF, 2002, J EXP MAR BIOL ECOL, V273, P33, DOI 10.1016/S0022-0981(02)00139-9; Babarro JMF, 2001, COMP BIOCHEM PHYS C, V128, P325, DOI 10.1016/S1532-0456(00)00207-6; Bauer LJ, 2010, ESTUAR COAST, V33, P668, DOI 10.1007/s12237-010-9277-2; Birchenough SNR, 2010, ESTUAR COAST SHELF S, V87, P420, DOI 10.1016/j.ecss.2010.01.005; Black K. D., 2008, SALMON AQUACULTURE D; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Calvert S.E., 1987, MAR PET SOURCE ROCKS, V26, P137, DOI [DOI 10.1144/GSL.SP.1987.026.01.08, 10.1144/gsl.sp.1987.026.01.08]; Ceia FR, 2013, OCEAN COAST MANAGE, V72, P80, DOI 10.1016/j.ocecoaman.2011.07.009; Cooper K, 2011, ESTUAR COAST SHELF S, V91, P121, DOI 10.1016/j.ecss.2010.10.011; Cooper KM, 2008, J EXP MAR BIOL ECOL, V366, P82, DOI 10.1016/j.jembe.2008.07.011; Cromey CJ, 2002, AQUACULTURE, V214, P211, DOI 10.1016/S0044-8486(02)00368-X; Dando PR, 2004, MAR ECOL PROG SER, V280, P181, DOI 10.3354/meps280181; Davies AJ, 2009, J EXP MAR BIOL ECOL, V370, P35, DOI 10.1016/j.jembe.2008.11.015; Daviesl SL, 2006, INT STAT REV, V74, P161, DOI 10.1111/j.1751-5823.2006.tb00167.x; De Silva SS, 2012, BIODIVERS CONSERV, V21, P3187, DOI 10.1007/s10531-012-0360-9; de Zwaan A, 2002, COMP BIOCHEM PHYS A, V131, P615, DOI 10.1016/S1095-6433(01)00513-X; de Zwaan A, 2001, MAR BIOL, V138, P1021, DOI 10.1007/s002270000515; de Zwaan A, 2001, MAR ECOL PROG SER, V211, P169, DOI 10.3354/meps211169; Denny MW, 2011, J EXP MAR BIOL ECOL, V400, P175, DOI 10.1016/j.jembe.2011.02.006; Desprez M, 2010, ICES J MAR SCI, V67, P270, DOI 10.1093/icesjms/fsp245; Desprez M, 2000, ICES J MAR SCI, V57, P1428, DOI 10.1006/jmsc.2000.0926; deZwaan A, 1996, COMP BIOCHEM PHYS C, V113, P299; Diana JS, 2009, BIOSCIENCE, V59, P27, DOI 10.1525/bio.2009.59.1.7; Dijkstra P, 2011, SOIL BIOL BIOCHEM, V43, P2023, DOI 10.1016/j.soilbio.2011.05.018; EERTMAN RHM, 1993, J EXP MAR BIOL ECOL, V170, P179, DOI 10.1016/0022-0981(93)90151-D; Elsasser B, 2013, J SEA RES, V77, P11, DOI 10.1016/j.seares.2012.12.006; ELSGAARD L, 1994, GEOCHIM COSMOCHIM AC, V58, P3335, DOI 10.1016/0016-7037(94)90089-2; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Frojan CRSB, 2008, ESTUAR COAST SHELF S, V79, P204, DOI 10.1016/j.ecss.2008.03.023; Garren M, 2012, ISME J, V6, P1159, DOI 10.1038/ismej.2011.180; GERBA CP, 1976, APPL ENVIRON MICROB, V32, P114, DOI 10.1128/AEM.32.1.114-120.1976; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; Gray JS, 2002, MAR ECOL PROG SER, V238, P249, DOI 10.3354/meps238249; Grieshaber MK, 1998, ANNU REV PHYSIOL, V60, P33, DOI 10.1146/annurev.physiol.60.1.33; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hendrick V, PLOS ONE UNPUB; Hitchcock DR, 2004, J COASTAL RES, V20, P101, DOI 10.2112/1551-5036(2004)20[101:PIOMAD]2.0.CO;2; Holmer M, 2002, MAR POLLUT BULL, V44, P685, DOI 10.1016/S0025-326X(02)00048-6; Howell JM, 1996, J ENVIRON QUAL, V25, P1216, DOI 10.2134/jeq1996.00472425002500060007x; Hutchison Z, PLOS ONE UNPUB; Jansen JM, 2007, OECOLOGIA, V154, P23, DOI 10.1007/s00442-007-0808-x; Jansen JM, 2009, COMP BIOCHEM PHYS A, V153, P399, DOI 10.1016/j.cbpa.2009.03.013; Janssen F, 2005, LIMNOL OCEANOGR, V50, P779, DOI 10.4319/lo.2005.50.3.0779; Jorgensen B, 1983, MAJOR BIOGEOCHEMICAL, V21, P477; Karakassis I, 1998, MAR ECOL PROG SER, V162, P243, DOI 10.3354/meps162243; Kenny AJ, 1996, MAR POLLUT BULL, V32, P615, DOI 10.1016/0025-326X(96)00024-0; Koivisto ME, 2010, MAR BIOL, V157, P1463, DOI 10.1007/s00227-010-1421-9; Kristensen E, 2000, HYDROBIOLOGIA, V426, P1, DOI 10.1023/A:1003980226194; Kutti T, 2007, AQUACULTURE, V262, P355, DOI 10.1016/j.aquaculture.2006.10.008; Laudien J, 2002, J EXP MAR BIOL ECOL, V271, P9, DOI 10.1016/S0022-0981(02)00030-8; Le Bot S, 2010, ESTUAR COAST SHELF S, V89, P221, DOI 10.1016/j.ecss.2010.06.012; Lenihan HS, 1999, LIMNOL OCEANOGR, V44, P910, DOI 10.4319/lo.1999.44.3_part_2.0910; LIVINGSTONE DR, 1977, J COMP PHYSIOL, V114, P143, DOI 10.1007/BF00688965; Looney EE, 2010, ENVIRON MICROBIOL, V12, P2479, DOI 10.1111/j.1462-2920.2010.02221.x; Lozach S, 2012, J SEA RES, V71, P14, DOI 10.1016/j.seares.2012.03.007; Martinez-Garcia E, 2015, BIOGEOCHEMISTRY, V125, P133, DOI 10.1007/s10533-015-0119-y; Mestre NC, 2009, P ROY SOC B-BIOL SCI, V276, P717, DOI 10.1098/rspb.2008.1376; Naglerkerke N., 1991, BIOMETRIKA, V78, P691; Natale F, 2013, MAR POLICY, V38, P205, DOI 10.1016/j.marpol.2012.05.037; Newell RC, 1998, OCEANOGR MAR BIOL<D>, V36, P127; Newell RC, 2004, J COASTAL RES, V20, P115, DOI 10.2112/1551-5036(2004)20[115:IOMADO]2.0.CO;2; Newell RC, 1999, MAR POLLUT BULL, V38, P809, DOI 10.1016/S0025-326X(99)00045-4; NICHOLLS P, 1982, CAN J BIOCHEM CELL B, V60, P613, DOI 10.1139/o82-076; Nickell LA, 2003, J EXP MAR BIOL ECOL, V285, P221, DOI 10.1016/S0022-0981(02)00529-4; NILSSON HC, 1994, MAR ECOL PROG SER, V115, P209, DOI 10.3354/meps115209; Norling P, 2007, MAR ECOL PROG SER, V351, P163, DOI 10.3354/meps07033; Papageorgiou N, 2010, MAR ENVIRON RES, V69, P326, DOI 10.1016/j.marenvres.2009.12.007; Porrello S, 2005, AQUACULTURE, V249, P145, DOI 10.1016/j.aquaculture.2005.02.042; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; Robinson JE, 2005, MAR ENVIRON RES, V60, P51, DOI 10.1016/j.marenvres.2004.09.001; Seiderer LJ, 1999, ICES J MAR SCI, V56, P757, DOI 10.1006/jmsc.1999.0495; Smith SDA, 2001, MAR POLLUT BULL, V42, P1040, DOI 10.1016/S0025-326X(01)00059-5; SUCHANEK TH, 1978, J EXP MAR BIOL ECOL, V31, P105, DOI 10.1016/0022-0981(78)90139-9; Szymelfenig M, 2006, ESTUAR COAST SHELF S, V68, P489, DOI 10.1016/j.ecss.2006.02.018; Tang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041204; Tyler-Walters H., 2008, COMMON MUSSEL MARINE; WALLIS RL, 1975, MAR BIOL, V30, P183, DOI 10.1007/BF00390741; WANG WX, 1993, MAR ECOL PROG SER, V95, P205, DOI 10.3354/meps095205; Westerbom M, 2002, MAR BIOL, V140, P991, DOI 10.1007/s00227-001-0765-6; WESTRICH JT, 1988, GEOMICROBIOL J, V6, P99, DOI 10.1080/01490458809377828; WIDDOWS J, 1971, J MAR BIOL ASSOC UK, V51, P827, DOI 10.1017/S0025315400018002; Wilber DH, 2007, MAR POLLUT BULL, V54, P42, DOI 10.1016/j.marpolbul.2006.08.042; ZANDEE DI, 1986, NETH J ZOOL, V36, P322; Zippay ML, 2012, INTEGR ZOOL, V7, P312, DOI 10.1111/j.1749-4877.2012.00310.x	91	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147534	10.1371/journal.pone.0147534	http://dx.doi.org/10.1371/journal.pone.0147534			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809153	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800125
J	Hallstrom, T; Singh, B; Kraiczy, P; Hammerschmidt, S; Skerka, C; Zipfel, PF; Riesbeck, K				Hallstroem, Teresia; Singh, Birendra; Kraiczy, Peter; Hammerschmidt, Sven; Skerka, Christine; Zipfel, Peter F.; Riesbeck, Kristian			Conserved Patterns of Microbial Immune Escape: Pathogenic Microbes of Diverse Origin Target the Human Terminal Complement Inhibitor Vitronectin via a Single Common Motif	PLOS ONE			English	Article							MEMBRANE ATTACK COMPLEX; EXTRACELLULAR-MATRIX PROTEINS; CANDIDA-ALBICANS; FACTOR-H; SERUM RESISTANCE; EPITHELIAL-CELLS; SURFACE PROTEIN; STREPTOCOCCUS-PNEUMONIAE; PSEUDOMONAS-AERUGINOSA; NEISSERIA-GONORRHOEAE	Pathogenicity of many microbes relies on their capacity to resist innate immunity, and to survive and persist in an immunocompetent human host microbes have developed highly efficient and sophisticated complement evasion strategies. Here we show that different human pathogens including Gram-negative and Gram-positive bacteria, as well as the fungal pathogen Candida albicans, acquire the human terminal complement regulator vitronectin to their surface. By using truncated vitronectin fragments we found that all analyzed microbial pathogens (n = 13) bound human vitronectin via the same C-terminal heparin-binding domain (amino acids 352-374). This specific interaction leaves the terminal complement complex (TCC) regulatory region of vitronectin accessible, allowing inhibition of C5b-7 membrane insertion and C9 polymerization. Vitronectin complexed with the various microbes and corresponding proteins was thus functionally active and inhibited complement-mediated C5b-9 deposition. Taken together, diverse microbial pathogens expressing different structurally unrelated vitronectin-binding molecules interact with host vitronectin via the same conserved region to allow versatile control of the host innate immune response.	[Hallstroem, Teresia; Skerka, Christine; Zipfel, Peter F.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Singh, Birendra; Riesbeck, Kristian] Lund Univ, Dept Translat Med, Clin Microbiol, Malmo, Sweden; [Kraiczy, Peter] Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Interfaculty Inst Genet & Funct Genom, Greifswald, Germany; [Zipfel, Peter F.] Univ Jena, Fac Biol, Jena, Germany	Hans Knoll Institute (HKI); Lund University; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Ernst Moritz Arndt Universitat Greifswald; Friedrich Schiller University of Jena	Riesbeck, K (corresponding author), Lund Univ, Dept Translat Med, Clin Microbiol, Malmo, Sweden.	kristian.riesbeck@med.lu.se	Hammerschmidt, Sven/G-2598-2010; Singh, Birendra/H-3592-2011	Hammerschmidt, Sven/0000-0002-6382-6681; Singh, Birendra/0000-0002-7246-1442; Riesbeck, Kristian/0000-0001-6274-6965	Alfred Osterlund Foundation; Anna and Edwin Berger Foundation; Greta and Johan Kock Foundation; Swedish Medical Research Council [K2015-57X-03163-43-4]; Physiographical Society (NMT and Forssman's Foundation); Skane County Council's Research and Development Foundation	Alfred Osterlund Foundation; Anna and Edwin Berger Foundation; Greta and Johan Kock Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Physiographical Society (NMT and Forssman's Foundation); Skane County Council's Research and Development Foundation	This work was supported by grants from the Alfred Osterlund, the Anna and Edwin Berger, and the Greta and Johan Kock Foundations, the Swedish Medical Research Council (Grant K2015-57X-03163-43-4, http://www.vr.se), the Physiographical Society (NMT and Forssman's Foundation), and the Skane County Council's Research and Development Foundation.	Akiyama SK, 2013, CURR PROTOC CELL BIO, V60; Albiger B, 2003, INFECT IMMUN, V71, P155, DOI 10.1128/IAI.71.1.155-162.2003; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; ARKO RJ, 1991, J CLIN MICROBIOL, V29, P70, DOI 10.1128/JCM.29.1.70-75.1991; Attia AS, 2006, INFECT IMMUN, V74, P1597, DOI 10.1128/IAI.74.3.1597-1611.2006; Berends ETM, 2013, CELL MICROBIOL, V15, P1955, DOI 10.1111/cmi.12170; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Buommino E, 2014, FRONT BIOSCI-LANDMRK, V19, P408, DOI 10.2741/4215; CHHATWAL GS, 1987, INFECT IMMUN, V55, P1878, DOI 10.1128/IAI.55.8.1878-1883.1987; Cunha CSE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000911; da Silva LB, 2015, INFECT IMMUN, V83, P888, DOI 10.1128/IAI.02844-14; Dehio C, 1998, EXP CELL RES, V242, P528, DOI 10.1006/excr.1998.4116; Dehio M, 1998, FEBS LETT, V424, P84, DOI 10.1016/S0014-5793(98)00144-6; Duensing TD, 1998, BIOCHEM J, V334, P133, DOI 10.1042/bj3340133; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; Griffiths NJ, 2011, MOL MICROBIOL, V82, P1129, DOI 10.1111/j.1365-2958.2011.07876.x; Hadders MA, 2012, CELL REP, V1, P200, DOI 10.1016/j.celrep.2012.02.003; Hallstrom T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137630; Hallstrom T, 2012, J IMMUNOL, V189, P4939, DOI 10.4049/jimmunol.1200386; Hallstrom T, 2006, J IMMUNOL, V177, P430, DOI 10.4049/jimmunol.177.1.430; Hallstrom T, 2009, J IMMUNOL, V183, P2593, DOI 10.4049/jimmunol.0803226; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Heilmann C, 2003, MICROBIOL-SGM, V149, P2769, DOI 10.1099/mic.0.26527-0; Hubert K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045132; Jordan RPC, 2014, MED MYCOL, V52, P254, DOI 10.1093/mmy/myt032; KILGORE KS, 1995, J IMMUNOL, V155, P1434; Kohler S, 2015, THROMB HAEMOSTASIS, V113, P125, DOI 10.1160/TH14-06-0561; Kohler TP, 2014, J BIOL CHEM, V289, P4070, DOI 10.1074/jbc.M113.521229; KOSTRZYNSKA M, 1992, MICROBIOS, V71, P179; Leduc I, 2008, INFECT IMMUN, V76, P1608, DOI 10.1128/IAI.00994-07; Leduc I, 2009, INFECT IMMUN, V77, P657, DOI 10.1128/IAI.00819-08; Leroy-Dudal J, 2004, MICROBES INFECT, V6, P875, DOI 10.1016/j.micinf.2004.05.004; Li DQ, 2001, CURR MICROBIOL, V42, P361, DOI 10.1007/s002840010230; LIANG OD, 1995, BBA-PROTEIN STRUCT M, V1250, P110, DOI 10.1016/0167-4838(95)00076-7; Liang OD, 1997, BIOCHEM BIOPH RES CO, V234, P445, DOI 10.1006/bbrc.1997.6663; Liang OD, 1997, FEBS LETT, V407, P169, DOI 10.1016/S0014-5793(97)00330-X; LIMPER AH, 1994, IMMUNOL LETT, V42, P139, DOI 10.1016/0165-2478(94)90077-9; LIMPER AH, 1993, INFECT IMMUN, V61, P4302, DOI 10.1128/IAI.61.10.4302-4309.1993; Lopez CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090796; Luo SS, 2010, J IMMUNOL, V185, P2164, DOI 10.4049/jimmunol.1001011; Meri T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003308; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; PODACK ER, 1984, ACTA PATH MICRO IM C, V92, P89; PREISSNER KT, 1991, THROMB HAEMOSTASIS, V66, P123; PREISSNER KT, 1985, J IMMUNOL, V135, P445; Reuter M, 2010, J BIOL CHEM, V285, P38473, DOI 10.1074/jbc.M110.143727; Riley SP, 2014, CELL MICROBIOL, V16, P849, DOI 10.1111/cmi.12243; RINGNER M, 1994, FEMS IMMUNOL MED MIC, V9, P29, DOI 10.1016/0928-8244(94)00012-3; Rooijakkers SHM, 2007, MOL IMMUNOL, V44, P23, DOI 10.1016/j.molimm.2006.06.011; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; SHEEHAN M, 1995, CLIN EXP IMMUNOL, V101, P136; Singh B, 2014, INFECT IMMUN, V82, P2378, DOI 10.1128/IAI.01636-13; Singh B, 2011, MOL MICROBIOL, V81, P80, DOI 10.1111/j.1365-2958.2011.07678.x; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Singh B, 2010, MOL MICROBIOL, V75, P1426, DOI 10.1111/j.1365-2958.2010.07066.x; Spreghini E, 1999, J INFECT DIS, V180, P156, DOI 10.1086/314822; Styriak I, 2003, CURR MICROBIOL, V46, P435, DOI 10.1007/s00284-002-3879-2; Styriak I, 1999, VET MICROBIOL, V67, P99, DOI 10.1016/S0378-1135(99)00037-1; Su YC, 2013, MICROBES INFECT, V15, P375, DOI 10.1016/j.micinf.2013.02.004; Su YC, 2013, MOL MICROBIOL, V87, P1245, DOI 10.1111/mmi.12164; Triantafilou K, 2013, J CELL SCI, V126, P2903, DOI 10.1242/jcs.124388; VAKEVA A, 1993, AM J PATHOL, V143, P65; Virkola R, 2000, INFECT IMMUN, V68, P5696, DOI 10.1128/IAI.68.10.5696-5701.2000; Voss S, 2013, J BIOL CHEM, V288, P15614, DOI 10.1074/jbc.M112.443507; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Zipfel PF, 2013, MOL IMMUNOL, V56, P152, DOI 10.1016/j.molimm.2013.05.222; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zomer A, 2012, J BACTERIOL, V194, P6969, DOI 10.1128/JB.01833-12	70	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147709	10.1371/journal.pone.0147709	http://dx.doi.org/10.1371/journal.pone.0147709			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808444	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800189
J	Kim, M; Or, D				Kim, Minsu; Or, Dani			Individual-Based Model of Microbial Life on Hydrated Rough Soil Surfaces	PLOS ONE			English	Article							POROUS-MEDIA; COMMUNITY STRUCTURE; BACTERIAL MOTILITY; FRACTURE SURFACES; HYDRAULIC CONDUCTIVITY; ESCHERICHIA-COLI; CLIMATE-CHANGE; DIVERSITY; WATER; PORE	Microbial life in soil is perceived as one of the most interesting ecological systems, with microbial communities exhibiting remarkable adaptability to vast dynamic environmental conditions. At the same time, it is a notoriously challenging system to understand due to its complexity including physical, chemical, and biological factors in synchrony. This study presents a spatially-resolved model of microbial dynamics on idealised rough soil surfaces represented as patches with different (roughness) properties that preserve the salient hydration physics of real surfaces. Cell level microbial interactions are considered within an individual-based formulation including dispersion and various forms of trophic dependencies (competition, mutualism). The model provides new insights into mechanisms affecting microbial community dynamics and gives rise to spontaneous formation of microbial community spatial patterns. The framework is capable of representing many interacting species and provides diversity metrics reflecting surface conditions and their evolution over time. A key feature of the model is its spatial scalability that permits representation of microbial processes from cell-level (micro-metric scales) to soil representative volumes at sub-metre scales. Several illustrative examples of microbial trophic interactions and population dynamics highlight the potential of the proposed modelling framework to quantitatively study soil microbial processes. The model is highly applicable in a wide range spanning from quantifying spatial organisation of multiple species under various hydration conditions to predicting microbial diversity residing in different soils.	[Kim, Minsu; Or, Dani] Swiss Fed Inst Technol, Dept Environm Syst Sci USYS, STEP, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Kim, M (corresponding author), Swiss Fed Inst Technol, Dept Environm Syst Sci USYS, STEP, CH-8092 Zurich, Switzerland.	minsu.kim@usys.ethz.ch	Or, Dani/D-8768-2012	Or, Dani/0000-0002-3236-2933; Kim, Minsu/0000-0002-3942-3743	Swiss National Science Foundation [200020-132154/1]; European Research Council (ERC) [320499-SoilLife]; SystemsX.ch [2013-158: MicroScapesX]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); SystemsX.ch	This work was supported by the Swiss National Science Foundation (200020-132154/1) (http://www.snf.ch/en/Pages/default.aspx), the European Research Council (ERC) Advanced Grant (320499-SoilLife) (http://erc.europa.eu/), and by SystemsX.ch (2013-158: MicroScapesX project) (http://www.systemsx.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Bachar A, 2010, MICROB ECOL, V60, P453, DOI 10.1007/s00248-010-9727-1; BADER FG, 1978, BIOTECHNOL BIOENG, V20, P183, DOI 10.1002/bit.260200203; Bar M, 2002, P ROY SOC B-BIOL SCI, V269, P937, DOI 10.1098/rspb.2002.1958; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Becker JM, 2006, MICROB ECOL, V51, P220, DOI 10.1007/s00248-005-0002-9; Bell CW, 2009, MICROB ECOL, V58, P827, DOI 10.1007/s00248-009-9529-5; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Bhatnagar A, 2005, CURR SCI INDIA, V89, P91; Bird NRA, 2000, EUR J SOIL SCI, V51, P55, DOI 10.1046/j.1365-2389.2000.00278.x; Carson JK, 2010, APPL ENVIRON MICROB, V76, P3936, DOI 10.1128/AEM.03085-09; Christofi N, 2002, J APPL MICROBIOL, V93, P915, DOI 10.1046/j.1365-2672.2002.01774.x; Colwell R.K., 2009, PRINCET GUIDE ECOL P, V663, P257, DOI DOI 10.1515/9781400833023.257; CORAPCIOGLU MY, 1984, J HYDROL, V72, P149; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crawford JW, 2012, J R SOC INTERFACE, V9, P1302, DOI 10.1098/rsif.2011.0679; CRAWFORD JW, 1993, GEODERMA, V56, P157, DOI 10.1016/0016-7061(93)90107-V; Curtis TP, 2004, CURR OPIN MICROBIOL, V7, P221, DOI 10.1016/j.mib.2004.04.010; Dai J, 2013, ANAL CHEM, V85, P5892, DOI 10.1021/ac400648z; De Angelis D., 1992, INDIVIDUAL BASED MOD, DOI 10.1201/9781351073462; DeAngelis DL, 2005, ANNU REV ECOL EVOL S, V36, P147, DOI 10.1146/annurev.ecolsys.36.102003.152644; Dechesne A, 2008, APPL ENVIRON MICROB, V74, P5195, DOI 10.1128/AEM.00313-08; Dechesne A, 2010, P NATL ACAD SCI USA, V107, P14369, DOI 10.1073/pnas.1008392107; Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197; Du C, 1996, AICHE J, V42, P2392, DOI 10.1002/aic.690420831; Duhour A, 2009, APPL SOIL ECOL, V43, P83, DOI 10.1016/j.apsoil.2009.06.004; Ebrahimi AN, 2014, WATER RESOUR RES, V50, P7406, DOI 10.1002/2014WR015897; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Ferrer J, 2008, J BIOL PHYS, V34, P19, DOI 10.1007/s10867-008-9082-3; FORD RM, 1991, BIOTECHNOL BIOENG, V37, P661, DOI 10.1002/bit.260370708; Ford RM, 2007, ADV WATER RESOUR, V30, P1608, DOI 10.1016/j.advwatres.2006.05.019; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Garbisu C, 2011, APPL SOIL ECOL, V49, P1, DOI 10.1016/j.apsoil.2011.04.018; Ghanbarian-Alavijeh B, 2011, CAN J SOIL SCI, V91, P1, DOI 10.4141/CJSS10008; Gimenez D, 1997, ENG GEOL, V48, P161, DOI 10.1016/S0013-7952(97)00038-0; Ginovart M, 2005, NONLINEAR ANAL-REAL, V6, P773, DOI 10.1016/j.nonrwa.2004.12.005; Graham DE, 2012, ISME J, V6, P709, DOI 10.1038/ismej.2011.163; Griffiths RI, 2003, FEMS MICROBIOL ECOL, V43, P35, DOI 10.1111/j.1574-6941.2003.tb01043.x; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grundmann GL, 2000, FEMS MICROBIOL ECOL, V34, P57, DOI 10.1111/j.1574-6941.2000.tb00754.x; Grundmann GL, 2001, SOIL SCI SOC AM J, V65, P1709, DOI 10.2136/sssaj2001.1709; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hellweger FL, 2009, ECOL MODEL, V220, P8, DOI 10.1016/j.ecolmodel.2008.09.004; Hillen T, 2009, J MATH BIOL, V58, P183, DOI 10.1007/s00285-008-0201-3; Holden PA, 2011, ARCHITECTURE AND BIOLOGY OF SOILS: LIFE IN INNER SPACE, P118, DOI 10.1079/9781845935320.0118; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Huang GH, 2005, GEODERMA, V127, P52, DOI 10.1016/j.geoderma.2004.11.016; ISICHENKO MB, 1992, REV MOD PHYS, V64, P961, DOI 10.1103/RevModPhys.64.961; Jeffery S., 2010, EUROPEAN ATLAS SOIL; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Kampichler C, 1999, GEODERMA, V88, P283, DOI 10.1016/S0016-7061(98)00110-4; KAMPICHLER C, 1993, GEODERMA, V56, P223, DOI 10.1016/0016-7061(93)90112-X; KELLER EF, 1971, J THEOR BIOL, V30, P235, DOI 10.1016/0022-5193(71)90051-8; Kim M, 2013, J ARID ENVIRON, V89, P38, DOI 10.1016/j.jaridenv.2012.09.014; Kreft JU, 1998, MICROBIOL-UK, V144, P3275, DOI 10.1099/00221287-144-12-3275; LAWTON JH, 1994, OIKOS, V71, P367, DOI 10.2307/3545824; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; LEVINS RICHARD, 1968; Long T, 2007, WATER RESOUR RES, V43, DOI 10.1029/2005WR004781; Long T, 2009, MICROB ECOL, V58, P262, DOI 10.1007/s00248-009-9510-3; LOVELY PS, 1975, J THEOR BIOL, V50, P477, DOI 10.1016/0022-5193(75)90094-6; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; MANDELBROT BB, 1984, NATURE, V308, P721, DOI 10.1038/308721a0; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; Miller TE, 2005, AM NAT, V165, P439, DOI 10.1086/428681; Moldrup P, 2003, SOIL SCI, V168, P321, DOI 10.1097/00010694-200305000-00002; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Monod J., 1942, ACTUALITES SCI IND; Murphy EM, 2000, HYDROGEOL J, V8, P142, DOI 10.1007/s100409900043; O'Donnell AG, 2007, NAT REV MICROBIOL, V5, P689, DOI 10.1038/nrmicro1714; Or D, 2007, ADV WATER RESOUR, V30, P1505, DOI 10.1016/j.advwatres.2006.05.025; Or D, 2000, WATER RESOUR RES, V36, P1165, DOI 10.1029/2000WR900020; OTHMER HG, 1988, J MATH BIOL, V26, P263, DOI 10.1007/BF00277392; Paerl HW, 2000, ENVIRON MICROBIOL, V2, P11, DOI 10.1046/j.1462-2920.2000.00071.x; PFEIFER P, 1984, APPL SURF SCI, V18, P146, DOI 10.1016/0378-5963(84)90042-4; PRAKASH S, 1992, PHYS REV A, V46, pR1724, DOI 10.1103/PhysRevA.46.R1724; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; Rajeev L, 2013, ISME J, V7, P2178, DOI 10.1038/ismej.2013.83; Ranjard L, 2000, MICROBIAL ECOL, V39, P263; Ranjard L, 2001, RES MICROBIOL, V152, P707, DOI 10.1016/S0923-2508(01)01251-7; Rockhold ML, 2002, ADV WATER RESOUR, V25, P477, DOI 10.1016/S0309-1708(02)00023-4; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Sahimi M, 1998, PHYS REP, V306, P214; SCHMITTBUHL J, 1995, J GEOPHYS RES-SOL EA, V100, P5953, DOI 10.1029/94JB02885; SCHMITTBUHL J, 1993, J PHYS A-MATH GEN, V26, P6115, DOI 10.1088/0305-4470/26/22/014; SENN H, 1994, BBA-GEN SUBJECTS, V1201, P424, DOI 10.1016/0304-4165(94)90072-8; Sessitsch A, 2001, APPL ENVIRON MICROB, V67, P4215, DOI 10.1128/AEM.67.9.4215-4224.2001; Smith Val H., 1993, Advances in Microbial Ecology, V13, P1; Stal LJ, 2012, ECOLOGY CYANOBACTERI, P65, DOI [DOI 10.1007/978-94-007-3855-3_4, 10.1007/978-94-007-3855-3_4]; STARK JM, 1995, APPL ENVIRON MICROB, V61, P218, DOI 10.1128/AEM.61.1.218-221.1995; Stein ML, 2002, J COMPUT GRAPH STAT, V11, P587, DOI 10.1198/106186002466; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Thullner M, 2002, J CONTAM HYDROL, V58, P169, DOI 10.1016/S0169-7722(02)00033-5; Thullner Martin, 1999, BIOREMEDIAT J, P247, DOI DOI 10.1080/10889869991219352; Tiedje J. M., 2001, Sustainable management of soil organic matter, P393, DOI 10.1079/9780851994659.0393; Tikhonovich IA, 2011, ANN APPL BIOL, V159, P155, DOI 10.1111/j.1744-7348.2011.00489.x; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D., 1997, SPATIAL ECOLOGY ROLE, V30; Tokunaga TK, 1997, WATER RESOUR RES, V33, P1287, DOI 10.1029/97WR00473; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Tufenkji N, 2007, ADV WATER RESOUR, V30, P1455, DOI 10.1016/j.advwatres.2006.05.014; Tuller M, 2005, WATER RESOUR RES, V41, DOI 10.1029/2005WR004142; Tuller M, 1999, WATER RESOUR RES, V35, P1949, DOI 10.1029/1999WR900098; Tuomisto H, 2012, OIKOS, V121, P1203, DOI 10.1111/j.1600-0706.2011.19897.x; TYLER SW, 1992, SOIL SCI SOC AM J, V56, P362, DOI 10.2136/sssaj1992.03615995005600020005x; Van Elsas JD., 2006, MODERN SOIL MICROBIO, DOI [10.1201/9781420015201, DOI 10.1201/9781420015201]; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Vlachos C, 2004, COMP FUNCT GENOM, V5, P100, DOI 10.1002/cfg.368; Vogel J, 2003, APPL ENVIRON MICROB, V69, P1482, DOI 10.1128/AEM.69.3.1482-1487.2003; Vogel TM, 2009, NAT REV MICROBIOL, V7, P252, DOI 10.1038/nrmicro2119; Vos M, 2013, FEMS MICROBIOL REV, V37, P936, DOI 10.1111/1574-6976.12023; Wang G, 2014, SCI REPORTS, V4; Wang G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00881; Wang G, 2010, ENVIRON MICROBIOL, V12, P1363, DOI 10.1111/j.1462-2920.2010.02180.x; Wang K, 2005, SOIL SCI SOC AM J, V69, P776, DOI 10.2136/sssaj2004.0247; Warren-Rhodes KA, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000305; Weiss J, 2001, INT J FRACTURE, V109, P365, DOI 10.1023/A:1011078531887; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; YAO KM, 1971, ENVIRON SCI TECHNOL, V5, P1105, DOI 10.1021/es60058a005; Young IM, 2008, ADV AGRON, V100, P81, DOI 10.1016/S0065-2113(08)00604-4; Young IM, 1998, SOIL BIOL BIOCHEM, V30, P1229, DOI 10.1016/S0038-0717(97)00263-0; Zelenev VV, 2005, ECOL MODEL, V188, P404, DOI 10.1016/j.ecolmodel.2005.01.046; Zhou JZ, 2002, APPL ENVIRON MICROB, V68, P326, DOI 10.1128/AEM.68.1.326-334.2002	131	57	58	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147394	10.1371/journal.pone.0147394	http://dx.doi.org/10.1371/journal.pone.0147394			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807803	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800086
J	Ledesma-Escobar, CA; Priego-Capote, F; de Castro, MDL				Ledesma-Escobar, Carlos A.; Priego-Capote, Feliciano; Luque de Castro, Maria D.			Comparative Study of the Effect of Sample Pretreatment and Extraction on the Determination of Flavonoids from Lemon (Citrus limon)	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; FRUITS; QUERCETIN; CULTIVARS; MICROWAVE; DAMAGE	Background Flavonoids have shown to exert multiple beneficial effects on human health, being also appreciated by both food and pharmaceutical industries. Citrus fruits are a key source of flavonoids, thus promoting studies to obtain them. Characteristics of these studies are the discrepancies among sample pretreatments and among extraction methods, and also the scant number of comparative studies developed so far. Objective Evaluate the effect of both the sample pretreatment and the extraction method on the profile of flavonoids isolated from lemon. Results Extracts from fresh, lyophilized and air-dried samples obtained by shaking extraction (SE), ultrasound-assisted extraction (USAE), microwave-assisted extraction (MAE) and superheated liquid extraction (SHLE) were analyzed by LC-QTOF MS/MS, and 32 flavonoids were tentatively identified using MS/MS information. ANOVA applied to the data from fresh and dehydrated samples and from extraction by the different methods revealed that 26 and 32 flavonoids, respectively, were significant (p <= 0.01). The pairwise comparison (Tukey HSD; p <= 0.01) showed that lyophilized samples are more different from fresh samples than from air-dried samples; also, principal component analysis (PCA) showed a clear discrimination among sample pretreatment strategies and suggested that such differences are mainly created by the abundance of major flavonoids. On the other hand, pairwise comparison of extraction methods revealed that USAE and MAE provided quite similar extracts, being SHLE extracts different from the other two. In this case, PCA showed a clear discrimination among extraction methods, and their position in the scores plot suggests a lower abundance of flavonoids in the extracts from SHLE. In the two PCA the loadings plots revealed a trend to forming groups according to flavonoid aglycones. Conclusions The present study shows clear discrimination caused by both sample pretreatments and extraction methods. Under the studied conditions, liophilization provides extracts with higher amounts of flavonoids, and USAE is the best method for isolation of these compounds, followed by MAE and SE. On the contrary, the SHLE method was the less favorable to extract flavonoids from citrus owing to degradation.	[Ledesma-Escobar, Carlos A.; Priego-Capote, Feliciano; Luque de Castro, Maria D.] Univ Cordoba, Dept Analyt Chem, Annex C-3,Campus Rabanales, E-14071 Cordoba, Spain; [Ledesma-Escobar, Carlos A.; Priego-Capote, Feliciano; Luque de Castro, Maria D.] Univ Cordoba Agroalimentary Excellence Campus, ceiA3, Campus Rabanales, E-14071 Cordoba, Spain; [Priego-Capote, Feliciano; Luque de Castro, Maria D.] Univ Cordoba, Reina Sofia Hosp, Inst Biomed Res Maimonides IMIBIC, E-14071 Cordoba, Spain; [Ledesma-Escobar, Carlos A.] Technol Inst Veracruz, Chem & Biochem Engn Dept, Ave Miguel Angel de Quevedo 2779, Veracruz 91897, Veracruz, Mexico	Universidad de Cordoba; Universidad de Cordoba; Hospital Universitario Reina Sofia - Cordoba; Universidad de Cordoba	Priego-Capote, F; de Castro, MDL (corresponding author), Univ Cordoba, Dept Analyt Chem, Annex C-3,Campus Rabanales, E-14071 Cordoba, Spain.; Priego-Capote, F; de Castro, MDL (corresponding author), Univ Cordoba Agroalimentary Excellence Campus, ceiA3, Campus Rabanales, E-14071 Cordoba, Spain.; Priego-Capote, F; de Castro, MDL (corresponding author), Univ Cordoba, Reina Sofia Hosp, Inst Biomed Res Maimonides IMIBIC, E-14071 Cordoba, Spain.	q72prcaf@uco.es; qa1lucam@uco.es	Priego-Capote, Feliciano/C-7977-2014; Ledesma Escobar, Carlos A./I-3885-2019; Ledesma-Escobar, Carlos A./H-6603-2016	Priego-Capote, Feliciano/0000-0003-0697-719X; Ledesma Escobar, Carlos A./0000-0002-4658-8212; Ledesma-Escobar, Carlos A./0000-0002-4658-8212	Spanish Ministerio de Economia y Competitividad (MINECO) [CTQ2012-37428]; FEDER [CTQ2012-37428]; Ministerio de Ciencia e Innovacion (MICINN) through a Ramon y Cajal Contract [RYC-2009-03921]; Mexican National Council for Science and Technology (CONACYT, Mexico) [224905]; Mexican National Council for Science and Technology (CONACYT)	Spanish Ministerio de Economia y Competitividad (MINECO); FEDER(European Commission); Ministerio de Ciencia e Innovacion (MICINN) through a Ramon y Cajal Contract; Mexican National Council for Science and Technology (CONACYT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Mexican National Council for Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The Spanish Ministerio de Economia y Competitividad (MINECO) and FEDER program are thanked for financial support through Project CTQ2012-37428. FPC was sponsored by Ministerio de Ciencia e Innovacion (MICINN) through a Ramon y Cajal Contract (RYC-2009-03921). CALE was sponsored by Mexican National Council for Science and Technology (CONACYT No. 224905, Mexico).; The Spanish Ministerio de Economia y Competitividad (MINECO) and FEDER program are thanked for financial support through Project CTQ2012-37428. F.P.C. is sponsored by Ministerio de Ciencia e Innovacion (MICINN) through a Ramon y Cajal Contract (RYC-2009-03921). C.A.L.E. also thanks the Mexican National Council for Science and Technology (CONACYT) for grants to support his research in both countries.	Abad-Garcia B, 2012, J AGR FOOD CHEM, V60, P3635, DOI 10.1021/jf300022u; Alam MM, 2014, LIFE SCI, V109, P8, DOI 10.1016/j.lfs.2014.06.005; Chen ML, 2011, INT J FOOD SCI TECH, V46, P1179, DOI 10.1111/j.1365-2621.2011.02605.x; Dahmoune F, 2013, IND CROP PROD, V50, P77, DOI 10.1016/j.indcrop.2013.07.013; DAVIS WB, 1947, ANAL CHEM, V19, P476, DOI 10.1021/ac60007a016; FAO, 2012, CITR FRUIT FRESH PRO; Garcia- Castello EM, LWT FOOD SCI TECHNOL; Gonzalez-Molina E, 2010, J PHARMACEUT BIOMED, V51, P327, DOI 10.1016/j.jpba.2009.07.027; Hayat K, 2010, FOOD CHEM, V123, P423, DOI 10.1016/j.foodchem.2010.04.060; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Herrmann K, 1976, INT J FOOD SCI TECH, V11, P433; Hu XT, 2015, EUR J PHARMACOL, V754, P133, DOI 10.1016/j.ejphar.2015.02.007; Ignat I, 2011, FOOD CHEM, V126, P1821, DOI 10.1016/j.foodchem.2010.12.026; Ledesma-Escobar C.A., 2015, GREEN EXTRACTION NAT, P265; Ledesma-Escobar CA, 2015, TALANTA, V144, P522, DOI 10.1016/j.talanta.2015.07.011; Ledesma-Escobar CA, 2014, TRENDS FOOD SCI TECH, V39, P63, DOI 10.1016/j.tifs.2014.07.002; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Materska M, 2015, FOOD CHEM, V168, P546, DOI 10.1016/j.foodchem.2014.07.023; Molina-Calle M, 2015, TALANTA, V144, P349, DOI 10.1016/j.talanta.2015.05.054; Nabavi SF, 2015, FOOD CHEM, V179, P305, DOI 10.1016/j.foodchem.2015.02.006; Ortuno A, 1997, SCI HORTIC-AMSTERDAM, V68, P231, DOI 10.1016/S0304-4238(96)00988-0; Roohbakhsh A, 2015, LIFE SCI, V124, P64, DOI 10.1016/j.lfs.2014.12.030; Sdiri S, 2012, FOOD RES INT, V49, P462, DOI 10.1016/j.foodres.2012.07.040; Sun YJ, 2015, LWT-FOOD SCI TECHNOL, V60, P1269, DOI 10.1016/j.lwt.2014.09.001; Tripoli E, 2007, FOOD CHEM, V104, P466, DOI 10.1016/j.foodchem.2006.11.054; Ueyama Y, 2002, PLANT SCI, V163, P253, DOI 10.1016/S0168-9452(02)00098-5; Ye XQ, 2011, FOOD CHEM, V124, P1561, DOI 10.1016/j.foodchem.2010.08.013	27	25	26	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0148056	10.1371/journal.pone.0148056	http://dx.doi.org/10.1371/journal.pone.0148056			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807979	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800269
J	Yoon, SY; Bae, SH; Shin, YJ; Park, SG; Hwang, SH; Hyon, JY; Wee, WR				Yoon, Sam Young; Bae, Seok Hyun; Shin, Young Joo; Park, Shin Goo; Hwang, Sang-Hee; Hyon, Joon Young; Wee, Won Ryang			Low Serum 25-Hydroxyvitamin D Levels Are Associated with Dry Eye Syndrome	PLOS ONE			English	Article							KOREA NATIONAL-HEALTH; VITAMIN-D LEVELS; EXAMINATION SURVEY KNHANES; D-RECEPTOR KNOCKOUT; RISK-FACTORS; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; SJOGRENS-SYNDROME; PREVALENCE; DISEASE; EXPOSURE	Background Dry eye syndrome (DES) is a common tear film and ocular surface disease that results in discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface. Systemic diseases associated with DES include diabetes mellitus, rheumatoid arthritis, depression, anxiety, thyroid disease, allergic diseases, irritable bowel syndrome, chronic pain syndrome, and hyperlipidemia. Interestingly, it has been found that most of these are associated with low levels of serum 25-hydroxyvitamin D (25(OH) D) or inadequate sunlight exposure. Methods In this cross-sectional data analysis, noninstitutionalized adults aged >= 19 years (N = 17,542) who participated in Korean National Health and Nutrition Examination Survey 2010-2012 were included. Information regarding duration of sunlight exposure was collected from the survey participants. Serum 25(OH) D and zinc levels were measured. The confounding variables were age, gender, sunlight exposure time, region of residence, obesity, serum 25(OH) D level, diabetes mellitus, rheumatoid arthritis, depression, thyroid disorder, atopic dermatitis, history of ocular surgery, regular exercise, and walking exercise. Results Mean serum 25(OH) D levels of subjects with and without DES were 16.90 +/- 6.0 and 17.52 +/- 6.07 (p< 0.001). Inadequate sunlight exposure time (odds ratio [OR], 1.554; 95% confidence interval [CI], 1.307-1.848), urban residence (OR, 1.669; 95% CI, 1.456-1.913), indoor occupation (OR, 1.578; 95% CI, 1.389-1.814), and low serum 25(OH) D level (OR, 1.158; 95% CI, 1.026-1.308) were the risk factors for DES. After adjusting for age, sex, obesity, diabetes mellitus, rheumatoid arthritis, depression, thyroid disorder, atopic dermatitis, history of ocular surgery, regular exercise, and occupation, low serum 25(OH) D level (OR, 1.178; 95% CI, 1.010-1.372) and deficient sunlight exposure time (OR, 1.383; 95% CI, 1.094-1.749) were the risk factors for diagnosed DES. Conclusion Low serum 25(OH) D levels and inadequate sunlight exposure are associated with DES in Korean adults. These results suggest that sufficient sunlight exposure or vitamin D supplementation may be useful in DES treatment.	[Yoon, Sam Young; Bae, Seok Hyun; Shin, Young Joo] Hallym Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Park, Shin Goo] Inha Univ, Sch Med, Dept Occupat & Environm Med, Inchon, South Korea; [Hwang, Sang-Hee] Keimyung Univ, Sch Med, Dept Dent, Daegu, South Korea; [Hyon, Joon Young; Wee, Won Ryang] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Hyon, Joon Young] Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Songnam, Gyeonggi, South Korea	Hallym University; Inha University; Keimyung University; Seoul National University (SNU); Seoul National University (SNU)	Shin, YJ (corresponding author), Hallym Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	schinn@hanmail.net		Hyon, Joon Young/0000-0003-3620-1536	National Research Foundation (NRF) - Korean government [NRF-2015R1D1A1A09058505]	National Research Foundation (NRF) - Korean government(Korean Government)	This study was supported by the National Research Foundation (NRF) grant (NRF-2015R1D1A1A09058505) funded by the Korean government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JM, 2014, AM J OPHTHALMOL, V158, P1205, DOI 10.1016/j.ajo.2014.08.021; Alsalem JA, 2014, INVEST OPHTH VIS SCI, V55, P2140, DOI 10.1167/iovs.13-13019; Axelsson Johann, 2004, Int J Circumpolar Health, V63, P267; Barabino S, 2012, PROG RETIN EYE RES, V31, P271, DOI 10.1016/j.preteyeres.2012.02.003; Beaven CM, 2011, J STRENGTH COND RES, V25, P1072, DOI 10.1519/JSC.0b013e3181bf4414; Berridge MJ, 2015, BIOCHEM BIOPH RES CO, V460, P53, DOI 10.1016/j.bbrc.2015.01.008; Binkley N, 2007, J CLIN ENDOCR METAB, V92, P2130, DOI 10.1210/jc.2006-2250; Blum M, 2008, ENDOCRINE, V33, P90, DOI 10.1007/s12020-008-9051-4; Brown NAP, 1998, EYE, V12, P127, DOI 10.1038/eye.1998.21; Buchholz P, 2006, OCUL SURF, V4, P155, DOI 10.1016/S1542-0124(12)70043-5; Chao C, 2014, OCUL SURF, V12, P32, DOI 10.1016/j.jtos.2013.09.001; Cheng HM, 2014, J ALLERGY CLIN IMMUN, V133, P1048, DOI 10.1016/j.jaci.2013.10.055; Choi CJ, 2013, J CLIN ENDOCR METAB, V98, P1703, DOI 10.1210/jc.2012-3901; Choi HS, 2008, J CLIN ENDOCR METAB, V96, P643, DOI DOI 10.1210/JC.2010-2133; Doganay Z, 2003, AM J EMERG MED, V21, P271, DOI 10.1016/S0735-6757(03)00039-1; Dolin P J, 1994, Ophthalmic Epidemiol, V1, P155, DOI 10.3109/09286589409047224; Elizondo RA, 2014, INVEST OPHTH VIS SCI, V55, P5245, DOI 10.1167/iovs.13-13553; Erten S, 2015, INT J RHEUM DIS, V18, P70, DOI 10.1111/1756-185X.12298; Fujita M, 2005, AM J OPHTHALMOL, V140, P808, DOI 10.1016/j.ajo.2005.05.025; Galor A, 2014, OPHTHALMOLOGY, V121, P972, DOI 10.1016/j.ophtha.2013.11.036; Galor A, 2014, CORNEA, V33, P437, DOI 10.1097/ICO.0000000000000089; Geldenhuys S, 2014, DIABETES, V63, P3759, DOI 10.2337/db13-1675; Goto E, 2002, AM J OPHTHALMOL, V133, P181, DOI 10.1016/S0002-9394(01)01365-4; Han SB, 2011, ARCH OPHTHALMOL-CHIC, V129, P633, DOI 10.1001/archophthalmol.2011.78; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Institute of Medicine of the National Academies, 2010, DIETARY REFERENCE IN; Jie Y, 2009, EYE, V23, P688, DOI 10.1038/sj.eye.6703101; Kawashima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033148; Kramer C, 2009, J STEROID BIOCHEM, V113, P9, DOI 10.1016/j.jsbmb.2008.10.010; Kurtul BE, 2015, EYE, V29, P1081, DOI 10.1038/eye.2015.96; Lee AJ, 2002, BRIT J OPHTHALMOL, V86, P1347, DOI 10.1136/bjo.86.12.1347; Lemp MA, 2007, OCUL SURF, V5, P75; LO CW, 1986, AM J CLIN NUTR, V44, P683, DOI 10.1093/ajcn/44.5.683; Lois N, 2008, BRIT J OPHTHALMOL, V92, P1304, DOI 10.1136/bjo.2008.141168; Lu XW, 2014, INVEST OPHTH VIS SCI, V55, P2975, DOI 10.1167/iovs.13-13788; Lucas RM, 2006, PROG BIOPHYS MOL BIO, V92, P140, DOI 10.1016/j.pbiomolbio.2006.02.019; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060; Mosher CE, 2010, ARCH DERMATOL, V146, P412, DOI 10.1001/archdermatol.2009.385; Muehleisen B, 2013, J ALLERGY CLIN IMMUN, V131, P324, DOI 10.1016/j.jaci.2012.12.1562; Nam GE, 2014, PUBLIC HEALTH NUTR, V17, P186, DOI 10.1017/S1368980012004855; Nichols GA, 2007, DIABETES CARE, V30, P228, DOI 10.2337/dc06-1392; onsiglio M, 2015, EXP DERMATOL; PETERFY C, 1988, J PHYSIOL-LONDON, V398, P1, DOI 10.1113/jphysiol.1988.sp017025; Rhee SY, 2012, DIABETIC MED, V29, P1003, DOI 10.1111/j.1464-5491.2012.03575.x; Routsias JG, 2004, J MED CHEM, V47, P4327, DOI 10.1021/jm049844+; Schaumberg DA, 2002, ADV EXP MED BIOL, V506, P989; Selter JH, 2015, CLIN OPHTHALMOL, V9, P57, DOI 10.2147/OPTH.S76583; Stevenson W, 2012, ARCH OPHTHALMOL-CHIC, V130, P90, DOI 10.1001/archophthalmol.2011.364; Stumpf WE, 2007, EUR J DRUG METAB PH, V32, P123, DOI 10.1007/BF03190474; Suzuki T, 2000, CURR EYE RES, V20, P127, DOI 10.1076/0271-3683(200002)20:2;1-D;FT127; Suzuki T, 2000, INVEST OPHTH VIS SCI, V41, P154; Truong S, 2014, CLIN EXP OPTOM, V97, P324, DOI 10.1111/cxo.12147; Uchino M, 2008, OPHTHALMOLOGY, V115, P1982, DOI 10.1016/j.ophtha.2008.06.022; Vehof J, 2014, BRIT J OPHTHALMOL, V98, P1712, DOI 10.1136/bjophthalmol-2014-305201; Vyssoki B, 2014, JAMA PSYCHIAT, V71, P1231, DOI 10.1001/jamapsychiatry.2014.1198; Wang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127863; WEBB AR, 1990, AM J CLIN NUTR, V51, P1075, DOI 10.1093/ajcn/51.6.1075; Wickham LA, 2000, ACTA OPHTHALMOL SCAN, V78, P146, DOI 10.1034/j.1600-0420.2000.078002146.x; Wolkoff P, 2007, ENVIRON INT, V33, P850, DOI 10.1016/j.envint.2007.04.004; Wong J, 2011, OCUL SURF, V9, P212, DOI 10.1016/S1542-0124(11)70034-9; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Yin ZH, 2011, INVEST OPHTH VIS SCI, V52, P7359, DOI 10.1167/iovs.11-7605	62	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147847	10.1371/journal.pone.0147847	http://dx.doi.org/10.1371/journal.pone.0147847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807908	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800227
J	Lee, SG; Poole, K; Linn, CE; Vickers, NJ				Lee, Seong-Gyu; Poole, Kathy; Linn, Charles E., Jr.; Vickers, Neil J.			Transplant Antennae and Host Brain Interact to Shape Odor Perceptual Space in Male Moths	PLOS ONE			English	Article							OLFACTORY RECEPTOR NEURONS; TOBACCO BUDWORM MOTH; PHEROMONE-BLEND DISCRIMINATION; ASSULTA GUENEE LEPIDOPTERA; LOBE PROJECTION PATTERNS; FEMALE SEX-PHEROMONE; HELIOTHIS-VIRESCENS; MACROGLOMERULAR COMPLEX; CHEMICAL COMMUNICATION; HELICOVERPA-ZEA	6 Behavioral responses to odors rely first upon their accurate detection by peripheral sensory organs followed by subsequent processing within the brain's olfactory system and higher centers. These processes allow the animal to form a unified impression of the odor environment and recognize combinations of odorants as single entities. To investigate how interactions between peripheral and central olfactory pathways shape odor perception, we transplanted antennal imaginal discs between larval males of two species of moth Heliothis virescens and Heliothis subflexa that utilize distinct pheromone blends. During metamorphic development olfactory receptor neurons originating from transplanted discs formed connections with host brain neurons within olfactory glomeruli of the adult antennal lobe. The normal antennal receptor repertoire exhibited by males of each species reflects the differences in the pheromone blends that these species employ. Behavioral assays of adult transplant males revealed high response levels to two odor blends that were dissimilar from those that attract normal males of either species. Neurophysiological analyses of peripheral receptor neurons and central olfactory neurons revealed that these behavioral responses were a result of: 1. the specificity of H. virescens donor olfactory receptor neurons for odorants unique to the donor pheromone blend and, 2. central odor recognition by the H. subflexa host brain, which typically requires peripheral receptor input across 3 distinct odor channels in order to elicit behavioral responses.	[Lee, Seong-Gyu; Vickers, Neil J.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Poole, Kathy; Linn, Charles E., Jr.] Cornell Univ, Dept Entomol, Geneva, NY 14456 USA; [Lee, Seong-Gyu] Shin Hwa Tech Co Ltd, Ulsan Technopk Rm A-409, Ulsan, South Korea	Utah System of Higher Education; University of Utah; Cornell University	Vickers, NJ (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	vickers@biology.utah.edu		Vickers, Neil/0000-0002-0378-8724	National Science Foundation [0640655, 0641014, 1147233]; NSF-IOS [0640655, 0641014, 1147233]; Direct For Biological Sciences [1147233] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NSF-IOS(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation 0640655 (CEL), National Science Foundation 0641014 (NJV), and National Science Foundation 1147233 (NJV) (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Callie Musto (Cornell University) for helping to rear the heliothine moths and for conducting some of the flight tunnel tests. We thank Lindsey Enright and Katy Schramm (University of Utah) for technical assistance. Supported by NSF-IOS 0641014 and NSF-IOS 1147233 to NJV and NSF-IOS 0640655 to CEL.	ALMAAS TJ, 1990, J CHEM ECOL, V16, P1331, DOI 10.1007/BF01021030; ALMAAS TJ, 1991, J CHEM ECOL, V17, P953, DOI 10.1007/BF01395602; Anton S, 1999, P ROY SOC B-BIOL SCI, V266, P1813, DOI 10.1098/rspb.1999.0851; Anton S, 2003, ARTHROPOD STRUCT DEV, V32, P319, DOI 10.1016/j.asd.2003.09.002; BACON JP, 1977, BRAIN RES, V138, P359, DOI 10.1016/0006-8993(77)90753-3; Baker TC, 2006, BRAIN BEHAV EVOLUT, V68, P75, DOI 10.1159/000093375; Baker TC, 2004, J COMP PHYSIOL A, V190, P155, DOI 10.1007/s00359-003-0483-2; BENNETT HS, 1976, STAIN TECHNOL, V51, P71, DOI 10.3109/10520297609116677; Berg Bente G., 2014, Insects, V5, P742, DOI 10.3390/insects5040742; Berg BG, 1998, J COMP PHYSIOL A, V183, P669, DOI 10.1007/s003590050290; CHRISTENSEN TA, 1995, J COMP PHYSIOL A, V177, P545, DOI 10.1007/BF00207184; Cork A, 2003, ENTOMOL EXP APPL, V107, P201, DOI 10.1046/j.1570-7458.2003.00052.x; CORK A, 1992, J CHEM ECOL, V18, P403, DOI 10.1007/BF00994240; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Galizia CG, 2008, ENTOMOL EXP APPL, V128, P81, DOI 10.1111/j.1570-7458.2007.00661.x; GODDE J, 1989, J NEUROSCI METH, V29, P77, DOI 10.1016/0165-0270(89)90111-8; Gould F, 2010, P NATL ACAD SCI USA, V107, P8660, DOI 10.1073/pnas.0910945107; HANSSON BS, 1995, J COMP PHYSIOL A, V177, P535, DOI 10.1007/BF00207183; HANSSON BS, 1992, SCIENCE, V256, P1313, DOI 10.1126/science.1598574; Hansson BS, 1997, INSECT PHEROMONE RESEARCH, P164; Hillier NK, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.0401; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; JURENKA RA, 1991, ARCH INSECT BIOCHEM, V17, P81, DOI 10.1002/arch.940170203; Kaissling KE, 1974, BIOCH SENSORY FUNCTI, P243; Kalberer NM, 2010, J EXP BIOL, V213, P1272, DOI 10.1242/jeb.033167; Karpati Z, 2008, J EXP BIOL, V211, P2841, DOI 10.1242/jeb.017319; Karpati Z, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-286; LAVENSEAU L, 1982, INT J INSECT MORPHOL, V11, P359, DOI 10.1016/0020-7322(82)90025-3; Lee SG, 2006, CHEM SENSES, V31, P821, DOI 10.1093/chemse/bjl025; Lee SG, 2006, J COMP PHYSIOL A, V192, P351, DOI 10.1007/s00359-005-0071-8; Lei H, 2008, J CHEM ECOL, V34, P915, DOI 10.1007/s10886-008-9487-2; Linn C, 1999, J COMP PHYSIOL A, V184, P273, DOI 10.1007/s003590050325; MITTER C, 1993, ANNU REV ENTOMOL, V38, P207, DOI 10.1146/annurev.en.38.010193.001231; Ochieng SA, 2003, J COMP PHYSIOL A, V189, P19, DOI 10.1007/s00359-002-0371-1; OCHIENG SA, 1995, TISSUE CELL, V27, P221, DOI 10.1016/S0040-8166(95)80024-7; Rossler W, 1999, J NEUROBIOL, V38, P521, DOI 10.1002/(SICI)1097-4695(199903)38:4<521::AID-NEU8>3.0.CO;2-9; Sakuma C, 2014, GENES GENET SYST, V89, P17, DOI 10.1266/ggs.89.17; SCHNEIDERMAN AM, 1982, NATURE, V298, P844, DOI 10.1038/298844a0; SCHNEIDERMAN AM, 1986, NATURE, V323, P801, DOI 10.1038/323801a0; SUGIE H, 1991, APPL ENTOMOL ZOOL, V26, P151, DOI 10.1303/aez.26.151; Todd JL, 1995, PHYSIOL ENTOMOL, V20, P349, DOI 10.1111/j.1365-3032.1995.tb00826.x; VANDERPERS JNC, 1978, J INSECT PHYSIOL, V24, P337, DOI 10.1016/0022-1910(78)90033-1; Vickers NJ, 2006, BRAIN BEHAV EVOLUT, V68, P90, DOI 10.1159/000093376; Vickers NJ, 2006, BRAIN BEHAV EVOLUT, V68, P63, DOI 10.1159/000093374; Vickers NJ, 1998, J COMP NEUROL, V400, P35; Vickers NJ, 2003, CHEM SENSES, V28, P325, DOI 10.1093/chemse/28.4.325; Vickers NJ, 2005, J COMP NEUROL, V491, P141, DOI 10.1002/cne.20725; Vickers NJ, 2003, J COMP NEUROL, V466, P377, DOI 10.1002/cne.10890; Vickers NJ, 2002, J CHEM ECOL, V28, P1255, DOI 10.1023/A:1016242019571; WILLIS MA, 1995, J COMP PHYSIOL A, V176, P205, DOI 10.1007/BF00239923; Wu H, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00206; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652	53	2	2	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147906	10.1371/journal.pone.0147906	http://dx.doi.org/10.1371/journal.pone.0147906			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816291	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528200063
J	Stevenson, JW; Conaty, EA; Walsh, RB; Poidomani, PJ; Samoriski, CM; Scollins, BJ; DeGiorgis, JA				Stevenson, James W.; Conaty, Eliza A.; Walsh, Rylie B.; Poidomani, Paul J.; Samoriski, Colin M.; Scollins, Brianne J.; DeGiorgis, Joseph A.			The Amyloid Precursor Protein of Alzheimer's Disease Clusters at the Organelle/Microtubule Interface on Organelles that Bind Microtubules in an ATP Dependent Manner	PLOS ONE			English	Article							SQUID GIANT-AXON; SYNAPTIC PLASTICITY; VESICLE TRANSPORT; FAMILY-MEMBERS; IN-VITRO; BETA; GENE; CELL; KINESIN; IDENTIFICATION	The amyloid precursor protein (APP) is a causal agent in the pathogenesis of Alzheimer's disease and is a transmembrane protein that associates with membrane-limited organelles. APP has been shown to co-purify through immunoprecipitation with a kinesin light chain suggesting that APP may act as a trailer hitch linking kinesin to its intercellular cargo, however this hypothesis has been challenged. Previously, we identified an mRNA transcript that encodes a squid homolog of human APP(770). The human and squid isoforms share 60% sequence identity and 76% sequence similarity within the cytoplasmic domain and share 15 of the final 19 amino acids at the C-terminus establishing this highly conserved domain as a functionally import segment of the APP molecule. Here, we study the distribution of squid APP in extruded axoplasm as well as in a well-characterized reconstituted organelle/microtubule preparation from the squid giant axon in which organelles bind microtubules and move towards the microtubule plus-ends. We find that APP associates with microtubules by confocal microscopy and co-purifies with KI-washed axoplasmic organelles by sucrose density gradient fractionation. By electron microscopy, APP clusters at a single focal point on the surfaces of organelles and localizes to the organelle/microtubule interface. In addition, the association of APP-organelles with microtubules is an ATP dependent process suggesting that the APP-organelles contain a microtubule-based motor protein. Although a direct kinesin/APP association remains controversial, the distribution of APP at the organelle/microtubule interface strongly suggests that APP-organelles have an orientation and that APP like the Alzheimer's protein tau has a microtubule-based function.	[Stevenson, James W.; Conaty, Eliza A.; Walsh, Rylie B.; Poidomani, Paul J.; Samoriski, Colin M.; Scollins, Brianne J.; DeGiorgis, Joseph A.] Providence Coll, Dept Biol, Providence, RI 02918 USA; [Stevenson, James W.; Conaty, Eliza A.; Walsh, Rylie B.; Poidomani, Paul J.; Samoriski, Colin M.; Scollins, Brianne J.; DeGiorgis, Joseph A.] Marine Biol Lab, Bell Ctr, Woods Hole, MA 02543 USA	Providence College; Marine Biological Laboratory - Woods Hole	DeGiorgis, JA (corresponding author), Providence Coll, Dept Biol, Providence, RI 02918 USA.; DeGiorgis, JA (corresponding author), Marine Biol Lab, Bell Ctr, Woods Hole, MA 02543 USA.	jdegiorg@providence.edu			Institutional Development Award (IDeA) National Institute of General Medical Sciences of the National Institutes of Health [P20GM103430]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103430. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RD, 1982, SCIENCE, V218, P1127, DOI 10.1126/science.6183744; Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200; BRADY ST, 1982, SCIENCE, V218, P1129, DOI 10.1126/science.6183745; BREEN KC, 1991, J NEUROSCI RES, V28, P90, DOI 10.1002/jnr.490280109; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; Brunholz S, 2012, EXP BRAIN RES, V217, P353, DOI 10.1007/s00221-011-2870-1; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Coburger I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081926; CRAWFORD F, 1991, NEUROSCI LETT, V133, P1, DOI 10.1016/0304-3940(91)90042-R; DeGiorgis JA, 2008, TRAFFIC, V9, P1867, DOI 10.1111/j.1600-0854.2008.00809.x; DeGiorgis JA, 2011, CYTOSKELETON, V68, P566, DOI 10.1002/cm.20531; DeLuca JG, 2001, J BIOL CHEM, V276, P28014, DOI 10.1074/jbc.M102801200; DYRKS T, 1988, EMBO J, V7, P949, DOI 10.1002/j.1460-2075.1988.tb02900.x; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fanutza T, 2015, ELIFE, V4, DOI 10.7554/eLife.09743; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Groemer TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018754; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Gunawardena S, 2013, HUM MOL GENET, V22, P3828, DOI 10.1093/hmg/ddt237; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Heber S, 2000, J NEUROSCI, V20, P7951; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Karnovsky MJ, 1982, BIOCHEMISTRY-US, V94, P1; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Koo EH, 1996, J CELL SCI, V109, P991; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kuznetsov SA, 2001, METH MOL B, V164, P1; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Lichtenthaler SF, 2012, CURR ALZHEIMER RES, V9, P165; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mileusnic R, 2005, ANN NY ACAD SCI, V1048, P149, DOI 10.1196/annals.1342.014; Muresan V, 2009, J NEUROSCI, V29, P3565, DOI 10.1523/JNEUROSCI.2558-08.2009; Owen DJ, 2010, CURR BIOL, V20, pR413, DOI 10.1016/j.cub.2010.03.017; PALACIOS G, 1995, EUR J NEUROSCI, V7, P501, DOI 10.1111/j.1460-9568.1995.tb00346.x; Paliga K, 1997, EUR J BIOCHEM, V250, P354, DOI 10.1111/j.1432-1033.1997.0354a.x; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; ROTH M, 1966, NATURE, V209, P109, DOI 10.1038/209109a0; Satpute-Krishnan P, 2006, P NATL ACAD SCI USA, V103, P16532, DOI 10.1073/pnas.0607527103; SCHNAPP BJ, 1985, CELL, V40, P455, DOI 10.1016/0092-8674(85)90160-6; SCHNAPP BJ, 1992, J CELL BIOL, V119, P389, DOI 10.1083/jcb.119.2.389; SCHNAPP BJ, 1989, P NATL ACAD SCI USA, V86, P1548, DOI 10.1073/pnas.86.5.1548; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SHIGEMATSU K, 1992, BRAIN RES, V592, P353, DOI 10.1016/0006-8993(92)91697-D; Sigua R, 2014, J VIS EXP; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Tabb JS, 1998, J CELL SCI, V111, P3221; Thonberg Hakan, 2011, BMC Res Notes, V4, P476, DOI 10.1186/1756-0500-4-476; VALE RD, 1985, CELL, V43, P623, DOI 10.1016/0092-8674(85)90234-X; VALE RD, 1985, CELL, V40, P449, DOI 10.1016/0092-8674(85)90159-X; VEGA JA, 1995, NEUROSCI LETT, V192, P132, DOI 10.1016/0304-3940(95)11618-7; Villegas C, 2014, HUM MOL GENET, V23, P1631, DOI 10.1093/hmg/ddt555; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; Yamazaki T, 1996, J CELL SCI, V109, P999; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Ziegler-Graham K, 2008, ALZHEIMERS DEMENT, V4, P316, DOI 10.1016/j.jalz.2008.05.2479	67	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147808	10.1371/journal.pone.0147808	http://dx.doi.org/10.1371/journal.pone.0147808			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814888	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528200053
J	Tulino, R; Benjamin, AC; Jolinon, N; Smith, DL; Chini, EN; Carnemolla, A; Bates, GP				Tulino, Raffaella; Benjamin, Agnesska C.; Jolinon, Nelly; Smith, Donna L.; Chini, Eduardo N.; Carnemolla, Alisia; Bates, Gillian P.			SIRT1 Activity Is Linked to Its Brain Region-Specific Phosphorylation and Is Impaired in Huntington's Disease Mice	PLOS ONE			English	Article							IN MOUSE MODEL; ACTIVATED PROTEIN-KINASE; MOLECULAR CHAPERONES; P53 ACETYLATION; GENE-EXPRESSION; CELL-SURVIVAL; DEACETYLASE; EXON-1; NEURODEGENERATION; AGGREGATION	Huntington's disease (HD) is a neurodegenerative disorder for which there are no disease-modifying treatments. SIRT1 is a NAD(+) -dependent protein deacetylase that is implicated in maintaining neuronal health during development, differentiation and ageing. Previous studies suggested that the modulation of SIRT1 activity is neuroprotective in HD mouse models, however, the mechanisms controlling SIRT1 activity are unknown. We have identified a striatum- specific phosphorylation-dependent regulatory mechanism of SIRT1 induction under normal physiological conditions, which is impaired in HD. We demonstrate that SIRT1 activity is down-regulated in the brains of two complementary HD mouse models, which correlated with altered SIRT1 phosphorylation levels. This SIRT1 impairment could not be rescued by the ablation of DBC1, a negative regulator of SIRT1, but was linked to changes in the sub-cellular distribution of AMPK-alpha 1, a positive regulator of SIRT1 function. This work provides insights into the regulation of SIRT1 activity with the potential for the development of novel therapeutic strategies.	[Tulino, Raffaella; Benjamin, Agnesska C.; Jolinon, Nelly; Smith, Donna L.; Carnemolla, Alisia; Bates, Gillian P.] Univ London, Kings Coll London, Dept Med & Mol Genet, London SW3 6LX, England; [Chini, Eduardo N.] Mayo Clin, Coll Med, Rochester, MN USA	University of London; King's College London; Mayo Clinic	Carnemolla, A; Bates, GP (corresponding author), Univ London, Kings Coll London, Dept Med & Mol Genet, London SW3 6LX, England.	alisia.carnemolla@kcl.ac.uk; gillian.bates@kcl.ac.uk	Carnemolla, Alisia/AAV-2154-2021; Bates, Gillian/E-1146-2012	Bates, Gillian/0000-0002-4041-6305	European Community Program FP7 [264508]; CHDI Foundation; MRC [G0801314] Funding Source: UKRI; Medical Research Council [G0801314] Funding Source: researchfish	European Community Program FP7; CHDI Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	RT was funded by a Marie Curie Training Network from the European Community Program FP7/2010 under grant agreement no. 264508 and this funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by the CHDI Foundation, a not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. Some of this research conducted at King's College London was performed in collaboration with and funded by the CHDI Foundation.	Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Cha YI, 2013, BMB REP, V46, P429, DOI 10.5483/BMBRep.2013.46.9.180; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; Douglas PM, 2009, PRION, V3, P51, DOI 10.4161/pri.3.2.8587; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; HDCRG, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E; Hockly E, 2006, NEUROBIOL DIS, V21, P228, DOI 10.1016/j.nbd.2005.07.007; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Hoffmann E, 2013, BRIT J CLIN PHARMACO, V75, P186, DOI 10.1111/j.1365-2125.2012.04340.x; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Jiang ML, 2014, ANN CLIN TRANSL NEUR, V1, P1047, DOI 10.1002/acn3.135; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; Jones L, 2014, HUNTINGTONS DIS, P410, DOI [10.1093/med/9780199929146.003.0016, DOI 10.1093/MED/9780199929146.003.0016]; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lau AW, 2014, AM J CANCER RES, V4, P245; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mielcarek M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005021; Mielcarek M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004550; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nin V, 2012, J BIOL CHEM, V287, P23489, DOI 10.1074/jbc.M112.365874; Novak MJU, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3109; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Satoh A, 2010, J NEUROSCI, V30, P10220, DOI 10.1523/JNEUROSCI.1385-10.2010; Smith MR, 2014, HUM MOL GENET, V23, P2995, DOI 10.1093/hmg/ddu010; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sussmuth SD, 2015, BRIT J CLIN PHARMACO, V79, P465, DOI 10.1111/bcp.12512; Waldvogel H. J, 2014, HUNTINGTONS DIS, P185; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Zschoernig B, 2009, BIOCHEM BIOPH RES CO, V381, P372, DOI 10.1016/j.bbrc.2009.02.085	51	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0145425	10.1371/journal.pone.0145425	http://dx.doi.org/10.1371/journal.pone.0145425			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815359	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528200004
J	Wu, SQ; Zhu, XL; Liu, ZX; Shao, ES; Rebeca, CL; Guo, YJ; Xiong, YT; Mou, YN; Xu, RX; Hu, X; Liang, GH; Zou, SQ; Guan, X; Zhang, FP				Wu, Songqing; Zhu, Xiaoli; Liu, Zhaoxia; Shao, Ensi; Rebeca, Carballar-Lejarazu; Guo, Yajie; Xiong, Yueting; Mou, Yani; Xu, Runxue; Hu, Xia; Liang, Guanghong; Zou, Shuangquan; Guan, Xiong; Zhang, Feiping			Identification of Genes Relevant to Pesticides and Biology from Global Transcriptome Data of Monochamus alternatus Hope (Coleoptera: Cerambycidae) Larvae	PLOS ONE			English	Article							RED FLOUR BEETLE; MANDUCA-SEXTA AMINOPEPTIDASE; PATTERN-RECOGNITION RECEPTOR; GLUTATHIONE S-TRANSFERASES; MOSQUITO INNATE IMMUNITY; COMPLEMENT-LIKE PROTEIN; BRUSH-BORDER MEMBRANE; BACILLUS-THURINGIENSIS; ANOPHELES-GAMBIAE; SCAVENGER RECEPTORS	Monochamus alternatus Hope is the main vector in China of the Pine Wilt Disease caused by the pine wood nematode Bursaphelenchus xylophilus. Although chemical control is traditionally used to prevent pine wilt disease, new strategies based in biological control are promising ways for the management of the disease. However, there is no deep sequence analysis of Monochamus alternatus Hope that describes the transcriptome and no information is available about gene function of this insect vector. We used next generation sequencing technology to sequence the whole fourth instar larva transcriptome of Monochamus alternatus Hope and successfully built a Monochamus alternatus Hope transcriptome database. In total, 105,612 unigenes were assigned for Gene Ontology (GO) terms, information for 16,730 classified unigenes was obtained in the Clusters of Orthologous Groups (COGs) database, and 13,024 unigenes matched with 224 predicted pathways in the Kyoto Encyclopedia of Genes and Genome (KEGG). In addition, genes related to putative insecticide resistance-related genes, RNAi, the Bt receptor, intestinal digestive enzymes, possible future insect control targets and immune-related molecules are described. This study provides valuable basic information that can be used as a gateway to develop new molecular tools for Monochamus alternatus Hope control strategies.	[Wu, Songqing; Guo, Yajie; Xiong, Yueting; Mou, Yani; Hu, Xia; Liang, Guanghong; Zou, Shuangquan; Zhang, Feiping] Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou 350002, Peoples R China; [Wu, Songqing; Zhu, Xiaoli; Liu, Zhaoxia; Shao, Ensi; Xiong, Yueting; Mou, Yani; Xu, Runxue; Guan, Xiong] Fujian Agr & Forestry Univ, Fujian Taiwan Joint Ctr Ecol Control Crop Pests, Fuzhou 350002, Peoples R China; [Wu, Songqing; Zhu, Xiaoli; Liu, Zhaoxia; Shao, Ensi; Guan, Xiong] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou 350002, Peoples R China; [Rebeca, Carballar-Lejarazu] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; University of California System; University of California Irvine	Zhang, FP (corresponding author), Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou 350002, Peoples R China.; Guan, X (corresponding author), Fujian Agr & Forestry Univ, Fujian Taiwan Joint Ctr Ecol Control Crop Pests, Fuzhou 350002, Peoples R China.; Guan, X (corresponding author), Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou 350002, Peoples R China.	guanxfafu@126.com; fpzhang1@163.com	hu, xia hong/GQP-8544-2022		Special Fund for Forestry Research in the Public Interest of China [201304401]; Project of Fujian-Taiwan Joint Center for Ecological Control of Crop Pests [51]; United Fujian Provincial Health and Education Project for Tackling Key Research [WKJ-FJ-25]; National Natural Science Foundation of China [31301724, 31201574, 31401802]; Education Department Foundation of Fujian Province Distinguished Young Scholars in Universities of Fujian Province [JA12092]; Science Fund for Distinguished Young Scholars of Fujian Agriculture and Forestry University [xjq201203]; Key Projects of Fujian Provincial Department of Science and Technology [2013N0003, 2011\ N5003]; Natural Science Foundation of Fujian Province [2013J01079]; Programme for New Century Excellent Talents in Fujian Province [JA13089]; Special Fund for Grain Research in the Public Interest of China [201313002-3]; Special Fund for Key Construction Project of Fujian Agriculture and Forestry University [6112C035003]; National Undergraduate Training Programme for Innovation and Entrepreneurship [201510389013, 201510389018, 201510389023, 201510389025, 201510389028, 201510389101, 201510389173]; Science and Technology Project in Fujian Province Department of Education [JA15161]; Central Finance Forestry Science and Technology Demonstration Project [Min] [TG017]	Special Fund for Forestry Research in the Public Interest of China; Project of Fujian-Taiwan Joint Center for Ecological Control of Crop Pests; United Fujian Provincial Health and Education Project for Tackling Key Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department Foundation of Fujian Province Distinguished Young Scholars in Universities of Fujian Province; Science Fund for Distinguished Young Scholars of Fujian Agriculture and Forestry University; Key Projects of Fujian Provincial Department of Science and Technology; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Programme for New Century Excellent Talents in Fujian Province; Special Fund for Grain Research in the Public Interest of China; Special Fund for Key Construction Project of Fujian Agriculture and Forestry University; National Undergraduate Training Programme for Innovation and Entrepreneurship; Science and Technology Project in Fujian Province Department of Education; Central Finance Forestry Science and Technology Demonstration Project [Min]	This study was supported by the Special Fund for Forestry Research in the Public Interest of China [Grant No. 201304401], Project of Fujian-Taiwan Joint Center for Ecological Control of Crop Pests [Minjiaoke (2013) 51], the United Fujian Provincial Health and Education Project for Tackling Key Research [Grant No. WKJ-FJ-25], National Natural Science Foundation of China [Grant No. 31301724, No. 31201574 and No. 31401802], Education Department Foundation of Fujian Province Distinguished Young Scholars in Universities of Fujian Province [Grant No. JA12092], Science Fund for Distinguished Young Scholars of Fujian Agriculture and Forestry University [Grant No. xjq201203], Key Projects of Fujian Provincial Department of Science and Technology [No. 2011 vertical bar N5003 and No. 2013N0003], Natural Science Foundation of Fujian Province [Grant No. 2013J01079] and Programme for New Century Excellent Talents in Fujian Province [JA13089], the Special Fund for Grain Research in the Public Interest of China [Grant No. 201313002-3], the Special Fund for Key Construction Project of Fujian Agriculture and Forestry University [Grant No. 6112C035003], National Undergraduate Training Programme for Innovation and Entrepreneurship [Grant No. 201510389013, No. 201510389018, No. 201510389023, No. 201510389025, No. 201510389028, No. 201510389101 and No. 201510389173]. Science and Technology Project in Fujian Province Department of Education [JA15161], Central Finance Forestry Science and Technology Demonstration Project [Min (2015) TG017].	Adema CM, 1997, P NATL ACAD SCI USA, V94, P8691, DOI 10.1073/pnas.94.16.8691; Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Agaisse H, 2004, IMMUNOL REV, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Ai JW, 2011, GENE, V480, P42, DOI 10.1016/j.gene.2011.03.002; Akov S., 1982, Current Themes in Tropical Science, V1, P197; Altincicek B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arakane Y, 2008, MECH DEVELOP, V125, P984, DOI 10.1016/j.mod.2008.09.002; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Barrett AJ, 1980, PROTEIN DEGRADATION, P37; Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bayyareddy K, 2009, INSECT BIOCHEM MOLEC, V39, P279, DOI 10.1016/j.ibmb.2009.01.002; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Borovsky D, 2003, IUBMB LIFE, V55, P435, DOI 10.1080/15216540310001597721; Bown DP, 2004, INSECT BIOCHEM MOLEC, V34, P305, DOI 10.1016/j.ibmb.2003.11.005; Bravo A, 2013, MICROB BIOTECHNOL, V6, P17, DOI 10.1111/j.1751-7915.2012.00342.x; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Burand JP, 2013, J INVERTEBR PATHOL, V112, pS68, DOI 10.1016/j.jip.2012.07.012; Cancino-Rodezno A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037034; CARLSSON A, 1991, INFECT IMMUN, V59, P3040, DOI 10.1128/IAI.59.9.3040-3045.1991; Carrillo L, 2011, TRANSGENIC RES, V20, P305, DOI 10.1007/s11248-010-9417-2; CHEN CL, 1995, BIOCHEM J, V310, P23, DOI 10.1042/bj3100023; Contreras E, 2013, J BIOL CHEM, V288, P18013, DOI 10.1074/jbc.M113.474445; Crava CM, 2010, INSECT BIOCHEM MOLEC, V40, P506, DOI 10.1016/j.ibmb.2010.04.010; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daimon T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002486; De Cadiz AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074840; Deist BR, 2014, TOXINS, V6, P3005, DOI 10.3390/toxins6103005; [邓泱泱 DENG Yangyang], 2006, [计算机工程, Computer Engineering], V32, P71; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Dimopoulos G, 2000, P NATL ACAD SCI USA, V97, P6619, DOI 10.1073/pnas.97.12.6619; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; Dobson AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076521; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; ENGLISH LH, 1989, INSECT BIOCHEM, V19, P145, DOI 10.1016/0020-1790(89)90085-1; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Flores-Escobar B, 2013, APPL ENVIRON MICROB, V79, P4543, DOI 10.1128/AEM.01062-13; Franc NC, 2000, MICROBES INFECT, V2, P243, DOI 10.1016/S1286-4579(00)00304-X; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Friedman R, 2011, MOL PHYLOGENET EVOL, V61, P924, DOI 10.1016/j.ympev.2011.08.027; Fujita K, 2006, BIOCHEM BIOPH RES CO, V345, P502, DOI 10.1016/j.bbrc.2006.04.126; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; GARCZYNSKI SF, 1995, INSECT BIOCHEM MOLEC, V25, P409, DOI 10.1016/0965-1748(94)00072-7; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Gough PJ, 2000, MICROBES INFECT, V2, P305, DOI 10.1016/S1286-4579(00)00297-5; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRISWOLD CM, 1993, GENETICS, V134, P781; Gullipalli D, 2010, COMP BIOCHEM PHYS B, V156, P33, DOI 10.1016/j.cbpb.2010.01.016; Hajek AE, 2008, USE OF MICROBES FOR; Hamilton KA, 2003, INT J PARASITOL, V33, P773, DOI 10.1016/S0020-7519(03)00089-4; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Heckel DG, 2012, PESTIC BIOCHEM PHYS, V104, P103, DOI 10.1016/j.pestbp.2012.05.007; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Hetru C, 2003, J INFECT DIS, V187, pS327, DOI 10.1086/374758; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hossain M, 2008, INSECT BIOCHEM MOLEC, V38, P1001, DOI 10.1016/j.ibmb.2008.08.006; Hughes AL, 2014, MOL PHYLOGENET EVOL, V76, P127, DOI 10.1016/j.ympev.2014.03.014; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; IIJIMA R, 1993, J BIOL CHEM, V268, P12055; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; JOMORI T, 1992, FEBS LETT, V296, P283, DOI 10.1016/0014-5793(92)80305-Z; Jose AM, 2007, ANNU REV GENET, V41, P305, DOI 10.1146/annurev.genet.41.110306.130216; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; KNIGHT PJK, 1995, J BIOL CHEM, V270, P17765, DOI 10.1074/jbc.270.30.17765; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Krishnamoorthy M, 2007, INSECT BIOCHEM MOLEC, V37, P189, DOI 10.1016/j.ibmb.2006.10.004; Kuwar S, 2015, INSECT BIOCH MOL BIO; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Li X, 2013, PLOS ONE, V8, P374; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; LOWENBERGER C, 1995, INSECT BIOCHEM MOLEC, V25, P867, DOI 10.1016/0965-1748(95)00043-U; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; MATSUYAMA K, 1988, J BIOL CHEM, V263, P17117; McNall RJ, 2003, INSECT BIOCHEM MOLEC, V33, P999, DOI 10.1016/S0965-1748(03)00114-0; Miller SC, 2008, DEV GENES EVOL, V218, P505, DOI 10.1007/s00427-008-0238-8; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; MURDOCK LL, 1987, COMP BIOCHEM PHYS B, V87, P783, DOI 10.1016/0305-0491(87)90388-9; Niu GD, 2011, INSECT BIOCHEM MOLEC, V41, P244, DOI 10.1016/j.ibmb.2010.12.009; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Ohnishi A, 2006, P NATL ACAD SCI USA, V103, P4398, DOI 10.1073/pnas.0511270103; Pace KE, 2002, GLYCOCONJUGATE J, V19, P607, DOI 10.1023/B:GLYC.0000014092.86763.2f; Parthasarathy R, 2009, ARCH INSECT BIOCHEM, V70, P57, DOI 10.1002/arch.20288; PEARSON A, 1995, P NATL ACAD SCI USA, V92, P4056, DOI 10.1073/pnas.92.9.4056; Peiser L, 2002, INFECT IMMUN, V70, P5346, DOI 10.1128/IAI.70.10.5346-5354.2002; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Peiser L, 2001, MICROBES INFECT, V3, P149, DOI 10.1016/S1286-4579(00)01362-9; PEMBLE SE, 1992, BIOCHEM J, V287, P957, DOI 10.1042/bj2870957; PICKETT CB, 1989, ANNU REV BIOCHEM, V58, P743, DOI 10.1146/annurev.bi.58.070189.003523; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Quan GX, 2002, INSECT MOL BIOL, V11, P217, DOI 10.1046/j.1365-2583.2002.00328.x; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Rausell C, 2007, BBA-BIOMEMBRANES, V1768, P2293, DOI 10.1016/j.bbamem.2007.06.014; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; SANGADALA S, 1994, J BIOL CHEM, V269, P10088; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schuler MA, 2013, J CHEM ECOL, V39, P1232, DOI 10.1007/s10886-013-0335-7; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smith C, 2015, TRENDS IMMUNOL, V36, P59, DOI 10.1016/j.it.2014.12.007; Srinivasan A, 2006, CELL MOL BIOL LETT, V11, P132, DOI 10.2478/s11658-006-0012-8; State Forestry Bureau of China, 2014, THE ANNOUNCEMENT OF; Tanaka S, 2013, FEBS J, V280, P1782, DOI 10.1111/febs.12200; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; VADLAMUDI RK, 1995, J BIOL CHEM, V270, P5490, DOI 10.1074/jbc.270.10.5490; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Vinokurov KS, 2006, COMP BIOCHEM PHYS B, V145, P126, DOI 10.1016/j.cbpb.2006.05.005; Walters FS, 2008, APPL ENVIRON MICROB, V74, P367, DOI 10.1128/AEM.02165-07; Wang LH, 2006, EMBO J, V25, P5005, DOI 10.1038/sj.emboj.7601363; Wang XG, 2005, MOL BIOCHEM PARASIT, V139, P65, DOI 10.1016/j.molbiopara.2004.09.009; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Y-H, 2011, J NANJING AGR U EDIT, P4; Welchman David P, 2009, Cell Host Microbe, V6, P107, DOI 10.1016/j.chom.2009.07.008; Wu XQ, 2013, INT J BIOL SCI, V9, P34, DOI 10.7150/ijbs.5071; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia X, 2015, SCIENTIFIC REPORTS, P5; Xu WN, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3001; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yang YuanLiang, 2013, Scientia Silvae Sinicae, V49, P103; Yang ZQ, 2014, BIOL CONTROL, V68, P117, DOI 10.1016/j.biocontrol.2013.06.010; Yu XQ, 2003, DEV COMP IMMUNOL, V27, P189, DOI 10.1016/S0145-305X(02)00099-X; Yu XQ, 1999, INSECT BIOCHEM MOLEC, V29, P585, DOI 10.1016/S0965-1748(99)00036-3; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhang Yan-Long, 2012, Acta Entomologica Sinica, V55, P426; Zhao B.G., 2008, PINE WILT DIS, DOI DOI 10.1007/978-4-431-75655-2; Zhu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032291	149	16	20	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147855	10.1371/journal.pone.0147855	http://dx.doi.org/10.1371/journal.pone.0147855			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815657	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528200059
J	Benamar, T; Tajounte, L; Alla, A; Khebba, F; Ahmed, H; Mulders, MN; Filali-Maltouf, A; El Aouad, R				Benamar, Touria; Tajounte, Latifa; Alla, Amal; Khebba, Fatima; Ahmed, Hinda; Mulders, Mick N.; Filali-Maltouf, Abdelkarim; El Aouad, Rajae			Real-Time PCR for Measles Virus Detection on Clinical Specimens with Negative IgM Result in Morocco	PLOS ONE			English	Article							LABORATORY CONFIRMATION; MOLECULAR DIAGNOSIS; INFECTION; ELIMINATION; IDENTIFICATION; EXPERIENCE; GENOTYPES; SETTINGS; OUTBREAK; ASSAYS	Since the confirmation of measles cases represents an important indicator regarding the performance of the measles-elimination program, the aim of this study was to evaluate the effectiveness of the routine procedures followed in Morocco for the laboratory confirmation of measles cases. Suspected cases reported between January 2010 and December 2012 were assessed for the timeliness of the sample collection, occurrence of measles clinical symptoms, and the results of the laboratory diagnoses. For 88% of the 2,708 suspected cases, a clinical specimen was collected within 7d of rash onset, of which 50% were IgM-positive and 2.6% were equivocal. The measles symptoms were reported in 91.4% of the cases; the occurrence of symptoms showed a positive association with the serological results (odds ratio [OR] = 2.9883, 95% confidence interval [CI] 2.2238-4.0157). Of the negative samples, 52% (n = 116) tested positive by real-time polymerase chain reaction (PCR). These results are in favor of using molecular detection to complement serological diagnosis in the context of measles surveillance approach in Morocco. In addition, the introduction of additional laboratory methods for differential diagnosis is required for the final classification of suspected cases with maculopapular rash and fever in the context of the measles elimination program.	[Benamar, Touria; Tajounte, Latifa; Khebba, Fatima] Minist Hlth, Natl Inst Hyg, Rabat, Morocco; [Alla, Amal] Minist Hlth, Dept Epidemiol, Rabat, Morocco; [Ahmed, Hinda] WHO EMRO, Dept Communicable Dis Prevent & Control, Cairo, Egypt; [Mulders, Mick N.] WHO, Expanded Programme Immunizat, CH-1211 Geneva, Switzerland; [Filali-Maltouf, Abdelkarim] Univ Mohammed 5, Fac Sci, Microbiol & Mol Biol Lab, Rabat, Morocco; [El Aouad, Rajae] Univ Mohamed V Souissi, Sch Med & Pharm, Rabat, Morocco	Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization; Mohammed V University in Rabat; Mohammed V University in Rabat	Benamar, T (corresponding author), Minist Hlth, Natl Inst Hyg, Rabat, Morocco.	t_benamar@yahoo.com	Filali-Maltouf, Abdelkarim/AAD-3681-2022	Filali-Maltouf, Abdelkarim/0000-0002-2727-3389; EL AOUAD, Rajae/0000-0002-2686-6924; BENAMAR, Touria/0000-0002-8284-6821	CDC; WHO	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); WHO(World Health Organization)	The authors would like to acknowledge all of the Ministry of Health teams for their efforts and cooperation in carrying out the measles-elimination program. The authors would also like to thank the CDC and WHO for their support for the program.	Akiyoshi K, 2010, JPN J INFECT DIS, V63, P225; Al-Ghamdi AMA, 2011, ANN EPIDEMIOL, V21, P262, DOI 10.1016/j.annepidem.2010.12.004; Alla A, 2002, J MED VIROL, V68, P441, DOI 10.1002/jmv.10223; Alla A, 2006, J MED VIROL, V78, P1465, DOI 10.1002/jmv.20720; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; [Anonymous], 2003, J INFECT DIS S, V187, pS264; Benamar T, 2014, EUR SCI J, V10, P228; Sanz JC, 2010, APMIS, V118, P203, DOI 10.1111/j.1600-0463.2009.02581.x; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P657; de Moraes JC, 2011, J INFECT DIS, V204, pS627, DOI 10.1093/infdis/jir490; Dietz V, 2004, B WORLD HEALTH ORGAN, V82, P852; Featherstone DA, 2011, J INFECT DIS, V204, pS491, DOI 10.1093/infdis/jir107; Garcia, 2010, OPEN VACCINE J, V3, P65; Helfand RF, 1997, J INFECT DIS, V175, P195, DOI 10.1093/infdis/175.1.195; Hickman CJ, 2011, J INFECT DIS, V204, pS549, DOI 10.1093/infdis/jir106; Hummel KB, 2006, J VIROL METHODS, V132, P166, DOI 10.1016/j.jviromet.2005.10.006; Hutse V, 2010, INT J INFECT DIS, V14, pE991, DOI 10.1016/j.ijid.2010.06.009; Hyde TB, 2009, B WORLD HEALTH ORGAN, V87, P93, DOI 10.2471/BLT.07.045484; Ito M, 2010, PEDIATR INT, V52, P611, DOI 10.1111/j.1442-200X.2010.03124.x; Jayamaha J, 2012, J CLIN VIROL, V54, P168, DOI 10.1016/j.jcv.2012.02.025; Michel Y, 2013, J MED VIROL, V85, P723, DOI 10.1002/jmv.23515; MoH-Morocco, 2009, SYST SURV ROUG PHAS; MoH-Morocco/ WHO, 2005, POL SANT ENF MAROC A; Mosquera MM, 2005, J CLIN MICROBIOL, V43, P5117, DOI 10.1128/JCM.43.10.5117-5121.2005; Ozoemena LC, 2004, J MED VIROL, V73, P79, DOI 10.1002/jmv.20050; Pull L, 2012, J TRAVEL MED, V19, P268, DOI 10.1111/j.1708-8305.2012.00628.x; Ratnam S, 2000, J CLIN MICROBIOL, V38, P99; Rota PA, 2011, J INFECT DIS, V204, pS506, DOI 10.1093/infdis/jir117; Saraswathy TS, 2009, SE ASIAN J TROP MED, V40, P742; Thomas B, 2007, J MED VIROL, V79, P1587, DOI 10.1002/jmv.20997; Tischer A, 2004, J CLIN VIROL, V31, P165, DOI 10.1016/j.jcv.2004.05.007; WHO/ Morocco, 2008, CAMP NAT VACC CONTR; WHO-EMRO, 2013, MEAL TOT SUSP CAS ME; WHO-EMRO, 2006, MEASL EL PREV CONG R; Woo GKS, 2010, J MED VIROL, V82, P1773, DOI 10.1002/jmv.21888; World Health Organization, 2015, IMMUNIZATION VACCINE; World Health Organization, IMMUNIZATION VACCINE	37	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147154	10.1371/journal.pone.0147154	http://dx.doi.org/10.1371/journal.pone.0147154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812434	Green Published, gold			2022-12-26	WOS:000369528000022
J	Nakazato, H; Takeshima, H; Kishino, T; Kubo, E; Hattori, N; Nakajima, T; Yamashita, S; Igaki, H; Tachimori, Y; Kuniyoshi, Y; Ushijima, T				Nakazato, Hidetsugu; Takeshima, Hideyuki; Kishino, Takayoshi; Kubo, Emi; Hattori, Naoko; Nakajima, Takeshi; Yamashita, Satoshi; Igaki, Hiroyasu; Tachimori, Yuji; Kuniyoshi, Yukio; Ushijima, Toshikazu			Early-Stage Induction of SWI/SNF Mutations during Esophageal Squamous Cell Carcinogenesis	PLOS ONE			English	Article							IDENTIFIES FREQUENT MUTATION; EPIGENETIC FIELD DEFECT; HEPATOCELLULAR-CARCINOMA; HYPERCALCEMIC TYPE; SMARCA4 MUTATIONS; SOMATIC MUTATIONS; CANCER; GENE; METHYLATION; ARID1A	The SWI/SNF chromatin remodeling complex is frequently inactivated by somatic mutations of its various components in various types of cancers, and also by aberrant DNA methylation. However, its somatic mutations and aberrant methylation in esophageal squamous cell carcinomas (ESCCs) have not been fully analyzed. In this study, we aimed to clarify in ESCC, what components of the SWI/SNF complex have somatic mutations and aberrant methylation, and when somatic mutations of the SWI/SNF complex occur. Deep sequencing of components of the SWI/SNF complex using a bench-top next generation sequencer revealed that eight of 92 ESCCs (8.7%) had 11 somatic mutations of 7 genes, ARID1A, ARID2, ATRX, PBRM1, SMARCA4, SMARCAL1, and SMARCC1. The SMARCA4 mutations were located in the Forkhead (85Ser>Leu) and SNF2 family N-terminal (882Glu>Lys) domains. The PBRM1 mutations were located in a bromodomain (80Asn>Ser) and an HMG-box domain (1,377Glu>Lys). For most mutations, their mutant allele frequency was 31-77% (mean 61%) of the fraction of cancer cells in the same samples, indicating that most of the cancer cells in individual ESCC samples had the SWI/SNF mutations on one allele, when present. In addition, a BeadChip array analysis revealed that a component of the SWI/SNF complex, ACTL6B, had aberrant methylation at its promoter CpG island in 18 of 52 ESCCs (34.6%). These results showed that genetic and epigenetic alterations of the SWI/SNF complex are present in ESCCs, and suggested that genetic alterations are induced at an early stage of esophageal squamous cell carcinogenesis.	[Nakazato, Hidetsugu; Takeshima, Hideyuki; Kishino, Takayoshi; Kubo, Emi; Hattori, Naoko; Yamashita, Satoshi; Ushijima, Toshikazu] Natl Canc Ctr, Res Inst, Div Epigen, Tokyo 104, Japan; [Nakazato, Hidetsugu; Igaki, Hiroyasu; Tachimori, Yuji] Natl Canc Ctr, Esophageal Surg Div, Tokyo, Japan; [Nakazato, Hidetsugu; Kuniyoshi, Yukio] Univ Ryukyus, Dept Thorac & Cardiovasc Surg, Grad Sch Med, Okinawa, Japan; [Nakajima, Takeshi] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan; University of the Ryukyus; National Cancer Center - Japan	Ushijima, T (corresponding author), Natl Canc Ctr, Res Inst, Div Epigen, Tokyo 104, Japan.	tushijim@ncc.go.jp	Ushijima, Toshikazu/AAP-5742-2021; NAKAJIMA, Takeshi/HCH-0703-2022	Ushijima, Toshikazu/0000-0003-3405-7817; NAKAJIMA, TAKESHI/0000-0002-6825-3165; Takeshima, Hideyuki/0000-0002-8552-2427; Kishino, Takayoshi/0000-0002-3137-8730; Hattori, Naoko/0000-0002-0901-4869; Yamashita, Satoshi/0000-0002-8609-5797	Project for Development of Innovative Research on Cancer Therapeutics [15cm0106040h0005]; Applied Research for Innovative Treatment of Cancer from the Japan Agency for Medical Research and Development (AMED) [15ck0106023h0002]; Japan Society for the Promotion of Science (JSPS) [15K18422]; Grants-in-Aid for Scientific Research [15K18422] Funding Source: KAKEN	Project for Development of Innovative Research on Cancer Therapeutics; Applied Research for Innovative Treatment of Cancer from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	A research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct, http://p-direct.mext.go.jp/) (15cm0106040h0005); Applied Research for Innovative Treatment of Cancer (15ck0106023h0002) from the Japan Agency for Medical Research and Development (AMED, http://www.amed.go.jp/en/); A Grant-in-Aid for Young Scientists (B) (15K18422) from the Japan Society for the Promotion of Science (JSPS, https://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada K, 2013, ONCOGENE, V32, P2140, DOI 10.1038/onc.2012.228; Baba Y, 2015, ANN SURG ONCOL, V22, P3659, DOI 10.1245/s10434-015-4445-z; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Jelinic P, 2014, NAT GENET, V46, P424, DOI 10.1038/ng.2922; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Khursheed M, 2013, BRIT J CANCER, V108, P2056, DOI 10.1038/bjc.2013.200; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; Ramos P, 2014, NAT GENET, V46, P427, DOI 10.1038/ng.2928; Revill K, 2013, GASTROENTEROLOGY, V145, P1424, DOI 10.1053/j.gastro.2013.08.055; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082302; Takeshima H, 2015, CANCER LETT, V357, P328, DOI 10.1016/j.canlet.2014.11.038; Takeshima H, 2011, GENOMICS, V98, P182, DOI 10.1016/j.ygeno.2011.06.003; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Ushijima T, 2012, CLIN CANCER RES, V18, P923, DOI 10.1158/1078-0432.CCR-11-2011; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang XF, 2014, CLIN CANCER RES, V20, P21, DOI 10.1158/1078-0432.CCR-13-0280; Weaver JMJ, 2014, NAT GENET, V46, P837, DOI 10.1038/ng.3013; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Witkowski L, 2014, NAT GENET, V46, P438, DOI 10.1038/ng.2931; Yoda Y, 2015, GASTRIC CANCER, V18, P65, DOI 10.1007/s10120-014-0348-0; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060781, 10.1371/journal.pone.0053931, 10.1371/journal.pone.0061922]	31	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147372	10.1371/journal.pone.0147372	http://dx.doi.org/10.1371/journal.pone.0147372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812616	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528000032
J	Priyadarshani, N; Marsland, S; Castro, I; Punchihewa, A				Priyadarshani, Nirosha; Marsland, Stephen; Castro, Isabel; Punchihewa, Amal			Birdsong Denoising Using Wavelets	PLOS ONE			English	Article							COURTSHIP SONGS; SIGNAL; TERRITORIAL; SOUNDS	Automatic recording of birdsong is becoming the preferred way to monitor and quantify bird populations worldwide. Programmable recorders allow recordings to be obtained at all times of day and year for extended periods of time. Consequently, there is a critical need for robust automated birdsong recognition. One prominent obstacle to achieving this is low signal to noise ratio in unattended recordings. Field recordings are often very noisy: birdsong is only one component in a recording, which also includes noise from the environment (such as wind and rain), other animals (including insects), and human-related activities, as well as noise from the recorder itself. We describe a method of denoising using a combination of the wavelet packet decomposition and band-pass or low-pass filtering, and present experiments that demonstrate an order of magnitude improvement in noise reduction over natural noisy bird recordings.	[Priyadarshani, Nirosha; Marsland, Stephen] Massey Univ, Sch Engn & Adv Technol, Palmerston North, New Zealand; [Castro, Isabel] Massey Univ, Inst Agr & Environm, Palmerston North, New Zealand; [Punchihewa, Amal] Asia Pacific Broadcasting Union, Kuala Lumpur, Malaysia	Massey University; Massey University	Priyadarshani, N; Marsland, S (corresponding author), Massey Univ, Sch Engn & Adv Technol, Palmerston North, New Zealand.; Castro, I (corresponding author), Massey Univ, Inst Agr & Environm, Palmerston North, New Zealand.	N.Priyadarshani@massey.ac.nz; S.R.Marsland@massey.ac.nz; I.C.Castro@massey.ac.nz	Priyardarshani, Nirosha/AAB-5268-2019; Castro, Isabel C/B-4447-2011; Castro, Isabel/L-7653-2019	Priyardarshani, Nirosha/0000-0002-4302-5262; Castro, Isabel C/0000-0002-3335-2024; Castro, Isabel/0000-0002-3335-2024	Higher Education for the Twenty First Century (HETC), Sri Lanka [KLN/O-Sci/N6]; School of Engineering and Advanced Technology, Massey University, New Zealand; RSNZ Marsden Fund [MAU0908]; Massey University Research Fund (Massey University) [RM1000015982 P-MURF]; University of Kelaniya, Sri Lanka; WWF Conservation Innovation Awards New Ideas for Nature (research innovation) [CIA 14/05]	Higher Education for the Twenty First Century (HETC), Sri Lanka; School of Engineering and Advanced Technology, Massey University, New Zealand; RSNZ Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Massey University Research Fund (Massey University); University of Kelaniya, Sri Lanka; WWF Conservation Innovation Awards New Ideas for Nature (research innovation)	NP received a PhD grant (KLN/O-Sci/N6) from Higher Education for the Twenty First Century (HETC, http://www.hetc.lk/), Sri Lanka, and a research fund from School of Engineering and Advanced Technology, Massey University, New Zealand, during this study. NP was awarded with the runner up prize (CIA 14/05) in WWF Conservation Innovation Awards 2014-New Ideas for Nature (research innovation). SM was supported by RSNZ Marsden Fund (MAU0908). Recordings by IC were made with funding from Massey University Research Fund, 2011 (RM1000015982 P-MURF, 7003-Massey University). NP is on study leave and is supported by University of Kelaniya, Sri Lanka.	Aboufadel E., 2011, DISCOVERING WAVELETS; Bee SS, REAL TIME SPEECH DEN; Burrus CS, 1997, INTRO WAVELETS WAVEL, P98; Buxton RT, 2012, J FIELD ORNITHOL, V83, P47, DOI 10.1111/j.1557-9263.2011.00355.x; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; CATCHPOLE CK, 1983, ANIM BEHAV, V31, P1217, DOI 10.1016/S0003-3472(83)80028-1; Chih-Hsun Chou, 2009, 2009 Symposia and Workshops on Ubiquitous, Autonomic and Trusted Computing in conjunction with the UIC 2009 and ATC 2009 Conferences, P189, DOI 10.1109/UIC-ATC.2009.85; Cornec C, 2014, ETHOLOGY, V120, P726, DOI 10.1111/eth.12244; Digby A, 2013, METHODS ECOL EVOL, V4, P675, DOI 10.1111/2041-210X.12060; Duan S, 2013, P 25 INN APPL ART IN; Farina A., 2014, SOUNDSCAPE ECOLOGY; GRAPS A, 1995, IEEE COMPUT SCI ENG, V2, P50, DOI 10.1109/99.388960; Gur BM, 2007, J ACOUST SOC AM, V122, P188, DOI 10.1121/1.2735111; Hagstrum JT, 2000, J EXP BIOL, V203, P1103; Hore Alain, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P2366, DOI 10.1109/ICPR.2010.579; Huynh-Thu Q, 2008, ELECTRON LETT, V44, P800, DOI 10.1049/el:20080522; Kroodsma DE., 1982, ACOUSTIC COMMUNICATI; Kroodsma Donald, 2005, SINGING LIFE BIRDS; LEIN MR, 1972, NATURE, V237, P48, DOI 10.1038/237048a0; Ma H., 2012, FUTURE CONTROL AUTOM, V173, P35, DOI [DOI 10.1007/978-3-642-31003-45, 10.1007/978-3-642-31003-45]; Ma X, 2002, IEEE ELECTR INSUL M, V18, P37, DOI 10.1109/57.995398; Marsland S., 2014, MACHINE LEARNING ALG; Mertins A., 2001, SIGNAL ANAL, P210, DOI [10.1002/0470841834.ch8., DOI 10.1002/0470841834.CH8]; MORLET J, 1982, GEOPHYSICS, V47, P203, DOI 10.1190/1.1441328; MORSE DH, 1970, NATURE, V226, P659, DOI 10.1038/226659a0; Najafipour A, 2013, IET SCI MEAS TECHNOL, V7, P112, DOI 10.1049/iet-smt.2012.0113; Patil S, 2014, INT J COMPUT SCI NET, V14, P56; Pedersen M., 2007, MULTICHANNEL SPEECH, P1065; Potamitis I, 2014, APPL ACOUST, V80, P1, DOI 10.1016/j.apacoust.2014.01.001; Priyadarshani PGN, 2012, MIDWEST SYMP CIRCUIT, P892, DOI 10.1109/MWSCAS.2012.6292164; Ren Y, 2008, J ACOUST SOC AM, V124, P316, DOI 10.1121/1.2932070; Selin A, 2007, EURASIP J APPL SIG P, V1, P141; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sharma R., 2013, IEEE CIRC SYST MAG, V4, P459; Shim I, 2001, IEEE ELECTR INSUL M, V17, P6, DOI 10.1109/57.901611; Shufei Duan, 2011, Proceedings of the 2011 Seventh International Conference on Intelligent Sensors, Sensor Networks and Information Processing (ISSNIP), P514, DOI 10.1109/ISSNIP.2011.6146597; Somervuo P, 2006, IEEE T AUDIO SPEECH, V14, P2252, DOI 10.1109/TASL.2006.872624; Swiston KA, 2009, J FIELD ORNITHOL, V80, P42, DOI 10.1111/j.1557-9263.2009.00204.x; Tsai SJS, 2002, POWER TRANSFORMER PA; Turunen J, 2006, ADV BIOACOUSTICS; Vaisman S, 2012, COMPUT BIOL MED, V42, P171, DOI 10.1016/j.compbiomed.2011.11.005; Varady P, 2001, P ANN INT IEEE EMBS, V23, P1846, DOI 10.1109/IEMBS.2001.1020582; Vaseghi S.V., 2008, ADV DIGITAL SIGNAL P; Wang D, 2011, EXPERT SYST APPL, V38, P14314, DOI 10.1016/j.eswa.2011.05.096	44	31	31	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146790	10.1371/journal.pone.0146790	http://dx.doi.org/10.1371/journal.pone.0146790			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812391	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528000014
J	Wang, L; Shao, HL; Luo, XH; Wang, R; Li, YF; Li, YN; Luo, YP; Chen, ZX				Wang, Li; Shao, Huili; Luo, Xiaohu; Wang, Ren; Li, Yongfu; Li, Yanan; Luo, Yingpeng; Chen, Zhengxing			Effect of Ozone Treatment on Deoxynivalenol and Wheat Quality	PLOS ONE			English	Article							FUSARIUM MYCOTOXINS NIVALENOL; AFLATOXIN B-1; PHYSICOCHEMICAL PROPERTIES; TRICHOTHECENE MYCOTOXINS; OZONATED WATER; FUMONISIN B-1; HEAD BLIGHT; DEGRADATION; FLOUR; GRAIN	Deoxynivalenol (DON) is a secondary metabolite produced by Fusarium fungi, which is found in a wide range of agricultural products, especially in wheat, barley, oat and corn. In this study, the distribution of DON in the wheat kernel and the effect of exposure time to ozone on DON detoxification were investigated. A high concentration of toxin was found in the outer part of the kernel, and DON was injected from the outside to the inside. The degradation rates of DON were 26.40%, 39.16%, and 53.48% after the samples were exposed to 75 mg/L ozone for 30, 60, and 90 min, respectively. The effect of ozonation on wheat flour quality and nutrition was also evaluated. No significant differences (P > 0.05) were found in protein content, fatty acid value, amino acid content, starch content, carbonyl and carboxyl content, and swelling power of ozone-treated samples. Moreover, the ozone-treated samples exhibited higher tenacity and whiteness, as well as lower extensibility and yellowness. This finding indicated that ozone treatment can simultaneously reduce DON levels and improve flour quality.	[Wang, Li; Wang, Ren; Chen, Zhengxing] Jiangnan Univ, Collaborat Innovat Ctr Food Safety & Qual Control, State Key Lab Food Sci & Technol, Key Lab Carbohydrate Chem & Biotechnol,Minist Edu, Wuxi 214122, Jiangsu, Peoples R China; [Wang, Li; Shao, Huili; Luo, Xiaohu; Wang, Ren; Li, Yongfu; Li, Yanan; Luo, Yingpeng; Chen, Zhengxing] Jiangnan Univ, Sch Food Sci & Technol, Natl Engn Lab Cereal Fermentat Technol, Wuxi 214122, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University	Wang, L; Chen, ZX (corresponding author), Jiangnan Univ, Collaborat Innovat Ctr Food Safety & Qual Control, State Key Lab Food Sci & Technol, Key Lab Carbohydrate Chem & Biotechnol,Minist Edu, Wuxi 214122, Jiangsu, Peoples R China.; Wang, L; Chen, ZX (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, Natl Engn Lab Cereal Fermentat Technol, Wuxi 214122, Jiangsu, Peoples R China.	legend0318@hotmail.com; zxchen_2008@126.com			Special Fund for Grain-Scientific Research in the Public Interest of China [201313005]; Special Fund for Agro-Scientific Research in the Public Interest of China [201203037]; National Natural Science Foundation of China [31371874, 31171785, 31201381, 31471616, 31501579]; Fundamental Research Funds for the Central Universities [JUSRP11510]; National Key Technology RD Program [2012BAD34B02]; Jiangsu Province science and technology support project [BE2012404, BE2012428]	Special Fund for Grain-Scientific Research in the Public Interest of China; Special Fund for Agro-Scientific Research in the Public Interest of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Key Technology RD Program(National Key Technology R&D Program); Jiangsu Province science and technology support project	This research was financially supported by the Special Fund for Grain-Scientific Research in the Public Interest of China (201313005), Special Fund for Agro-Scientific Research in the Public Interest of China (201203037), National Natural Science Foundation of China (31371874, 31171785, 31201381, 31471616, 31501579), Fundamental Research Funds for the Central Universities (JUSRP11510), National Key Technology R&D Program (2012BAD34B02), Jiangsu Province science and technology support project (BE2012404 & BE2012428).	ABBAS HK, 1985, APPL ENVIRON MICROB, V50, P482, DOI 10.1128/AEM.50.2.482-486.1985; Akbas MY, 2006, J SCI FOOD AGR, V86, P2099, DOI 10.1002/jsfa.2579; American Association of Cereal Chemists, 2000, APPR METH AM ASS CER, V10th ed.; Bata A, 1999, TRENDS FOOD SCI TECH, V10, P223, DOI 10.1016/S0924-2244(99)00050-3; Blandino M, 2006, EUR J AGRON, V25, P193, DOI 10.1016/j.eja.2006.05.001; Brera C, 2004, J FOOD PROTECT, V67, P1261, DOI 10.4315/0362-028X-67.6.1261; Cabanas R, 2008, FOOD MICROBIOL, V25, P642, DOI 10.1016/j.fm.2008.04.003; CAULFIELD MJ, 1979, CANCER RES, V39, P2155; Chan HT, 2009, J AGR FOOD CHEM, V57, P5965, DOI 10.1021/jf9008789; Chattopadhyay S, 1997, CARBOHYD POLYM, V34, P203, DOI 10.1016/S0144-8617(97)87306-7; Chen R, 2014, FOOD CHEM, V146, P284, DOI 10.1016/j.foodchem.2013.09.059; Chittrakorn S, 2008, USE OZONE ALTERNATIV; CRIEGEE R, 1975, ANGEW CHEM INT EDIT, V14, P745, DOI 10.1002/anie.197507451; Cullen PJ, 2009, TRENDS FOOD SCI TECH, V20, P125, DOI 10.1016/j.tifs.2009.01.049; de Alencar ER, 2012, J SCI FOOD AGR, V92, P899, DOI 10.1002/jsfa.4668; Desvignes C, 2008, J CEREAL SCI, V47, P245, DOI 10.1016/j.jcs.2007.04.004; Dexter JE, 1996, CEREAL CHEM, V73, P695; Diao EJ, 2012, J AGR FOOD CHEM, V60, P9364, DOI 10.1021/jf302528e; Ding WP, 2015, INT J FOOD SCI TECH, V50, P744, DOI 10.1111/ijfs.12691; DWARAKANATH CT, 1968, J AM OIL CHEM SOC, V45, P93, DOI 10.1007/BF02890715; Food and Drug Administration, 2001, FED REGISTER, V66, P33829; GB/T, 2009, DET DEOX FOOD HIGH P; Huwig A, 2001, TOXICOL LETT, V122, P179, DOI 10.1016/S0378-4274(01)00360-5; IARC, 1993, SOM NAT OCC SUBST FO, P397; Ibanoglu S, 2001, J FOOD ENG, V48, P345, DOI 10.1016/S0260-8774(00)00177-1; Inan F, 2007, J STORED PROD RES, V43, P425, DOI 10.1016/j.jspr.2006.11.004; Indrani D, 2007, J FOOD ENG, V78, P1202, DOI 10.1016/j.jfoodeng.2005.12.032; Jackson LS, 2012, WORLD MYCOTOXIN J, V5, P251, DOI 10.3920/WMJ2012.1431; Katta SK, 1997, CEREAL CHEM, V74, P858, DOI 10.1094/CCHEM.1997.74.6.858; Khadre MA, 2001, J FOOD SCI, V66, P1242, DOI 10.1111/j.1365-2621.2001.tb15196.x; Kuakpetoon D, 2001, STARCH-STARKE, V53, P211, DOI 10.1002/1521-379X(200105)53:5<211::AID-STAR211>3.0.CO;2-M; Lancova K, 2008, FOOD ADDIT CONTAM A, V25, P650, DOI 10.1080/02652030701660536; LEE US, 1987, J AGR FOOD CHEM, V35, P126, DOI 10.1021/jf00073a027; Li MM, 2015, FOOD ADDIT CONTAM A, V32, P544, DOI 10.1080/19440049.2014.976596; Li M, 2013, INNOV FOOD SCI EMERG, V20, P223, DOI 10.1016/j.ifset.2013.06.004; Luo XH, 2014, FOOD CONTROL, V37, P171, DOI 10.1016/j.foodcont.2013.09.043; Luo XH, 2013, FOOD CONTROL, V31, P331, DOI 10.1016/j.foodcont.2012.10.030; MCCORMICK KM, 1991, AUST J AGR RES, V42, P317, DOI 10.1071/AR9910317; McDonough MX, 2011, J STORED PROD RES, V47, P249, DOI 10.1016/j.jspr.2011.04.001; Mendez F, 2003, J STORED PROD RES, V39, P33, DOI 10.1016/S0022-474X(02)00015-2; Naito S, 1989, NIPPON SHOKHIN KOGYO, V36, P878; Nations. FaAOotU, 2004, 1 FAAOOTU; Park DL, 2002, ADV EXP MED BIOL, V504, P173; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Pestka JJ, 2007, ANIM FEED SCI TECH, V137, P283, DOI 10.1016/j.anifeedsci.2007.06.006; Proctor AD, 2004, FOOD ADDIT CONTAM A, V21, P786, DOI 10.1080/02652030410001713898; Richard Y, 1984, HDB OZONE TECHNOLOGY; Rose DJ, 2008, CEREAL CHEM, V85, P218, DOI 10.1094/CCHEM-85-2-0218; Rotter BA, 1996, J TOXICOL ENV HEALTH, V48, P1, DOI 10.1080/009841096161447; Rupollo G, 2011, CARBOHYD POLYM, V86, P1403, DOI 10.1016/j.carbpol.2011.06.055; Sandhu HPS, 2012, CARBOHYD POLYM, V87, P1261, DOI 10.1016/j.carbpol.2011.09.003; Sandhu HPS, 2011, J SCI FOOD AGR, V91, P1576, DOI 10.1002/jsfa.4350; Sangseethong K, 2010, CARBOHYD POLYM, V82, P446, DOI 10.1016/j.carbpol.2010.05.003; Savi GD, 2014, J STORED PROD RES, V59, P245, DOI 10.1016/j.jspr.2014.03.008; Scussel VM, 2011, INT J ANAL CHEM, P1687; Smith R.J., 1967, STARCH CHEM TECHNOLO, VII, P620; TANAKA T, 1988, J AGR FOOD CHEM, V36, P979, DOI 10.1021/jf00083a019; Tiwari BK, 2010, J CEREAL SCI, V51, P248, DOI 10.1016/j.jcs.2010.01.007; Vanier NL, 2012, FOOD CHEM, V131, P1255, DOI 10.1016/j.foodchem.2011.09.114; Violleau F, 2012, J CEREAL SCI, V55, P392, DOI 10.1016/j.jcs.2012.01.014; Visconti A, 2004, TOXICOL LETT, V153, P181, DOI 10.1016/j.toxlet.2004.04.032; Wang Y, 2008, J AGR FOOD CHEM, V56, P7942, DOI 10.1021/jf801562v; Wijnands L.M., 2000, 257852004 RIVM; Yeh AI, 1999, CEREAL CHEM, V76, P614, DOI 10.1094/CCHEM.1999.76.5.614; Young JC, 2006, FOOD CHEM TOXICOL, V44, P417, DOI 10.1016/j.fct.2005.08.015; YOUNG JC, 1984, J AGR FOOD CHEM, V32, P659, DOI 10.1021/jf00123a058; YOUNG JC, 1986, J AGR FOOD CHEM, V34, P461, DOI 10.1021/jf00069a021; Zhang HJ, 2014, FOOD CONTROL, V44, P86, DOI 10.1016/j.foodcont.2014.03.037; Zheng YZ, 2014, FOOD CONTROL, V40, P193, DOI 10.1016/j.foodcont.2013.11.043; Zhong YueTong, 2008, China Tropical Medicine, V8, P132; Zorlugenc B, 2008, FOOD CHEM TOXICOL, V46, P3593, DOI 10.1016/j.fct.2008.09.003	71	53	57	5	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147613	10.1371/journal.pone.0147613	http://dx.doi.org/10.1371/journal.pone.0147613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812055	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528000043
J	Xie, DH; Yang, TB; Liu, ZY; Wang, H				Xie, Donghua; Yang, Tubao; Liu, Zhiyu; Wang, Hua			Epidemiology of Birth Defects Based on a Birth Defect Surveillance System from 2005 to 2014 in Hunan Province, China	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; METAANALYSIS; PREVENTION; PREVALENCE; DISEASE	Objective To describe the epidemiology of birth defects (BDs) in perinatal infants in Hunan Province, China, between 2005 and 2014. Methods The BD surveillance data of perinatal infants (for stillbirth, dead fetus or live birth between 28 weeks of gestation and 7 days after birth) were collected from 52 registered hospitals of Hunan between 2005 and 2014. The prevalence rates of BDs with 95% confidence interval (CI) and crude odds ratio (ORs) were calculated to examine the associations of infant gender, maternal age, and region (urban vs rural) with BDs. Results From 2005 to 2014, there were a total of 925413 perinatal infants of which 17753 had BDs, with the average prevalence of 191.84 per 10000 PIs (perinatal infants), showing a significant uptrend. The risks of BDs are higher in urban areas versus rural areas (OR = 1.20), in male infants versus female infants (OR = 1.19), and in mothers above age 35 versus those below age 35 (OR = 1.24). The main five types of BDs are Congenital heart defects (CHD), Other malformation of external ear (OMEE), Polydactyly, Congenital malformation of kidney (CMK), and Congenital talipes equinovarus (CTE). From 2005 to 2014, the prevalence rates (per 10000 PIs) of CHD and CMK increased significantly from 22.56 to 74 (OR = 3.29, 95% CI: 2.65-4.11) and from 7.61 to 14.62 (OR = 1.92, 95% CI: 1.30-2.84), respectively; the prevalence rates of congenital hydrocephalus and neural tube defects (NTDs) decreased significantly from 11.8 to 5.29 (OR = 0.45, 95% CI: 0.31-0.65) and from 7.87 to 1.74 (OR = 0.22, 95% CI: 0.13-0.38), respectively. Conclusions The prevalence rates of specific BDs in perinatal infants in Hunan have changed in the last decade. Urban pregnant women, male perinatal infants, and mothers above age 35 present different prevalence rates of BDs. Wider use of new diagnosis technology, improving the ability of monitoring, strengthening the publicity and education are important to reduce the prevalence of BDs.	[Xie, Donghua; Yang, Tubao] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China; [Xie, Donghua; Liu, Zhiyu; Wang, Hua] Maternal & Children Hosp Hunan Prov, Dept Informat Management, 58 Xiangchun Rd, Changsha 410078, Hunan, Peoples R China	Central South University	Xie, DH; Yang, TB (corresponding author), Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.; Xie, DH (corresponding author), Maternal & Children Hosp Hunan Prov, Dept Informat Management, 58 Xiangchun Rd, Changsha 410078, Hunan, Peoples R China.	Yangtbcsu@163.com						Annas GJ, 1999, AM J PUBLIC HEALTH, V89, P98, DOI 10.2105/AJPH.89.1.98; [Anonymous], 1999, N Engl J Med, V341, P1864; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Carmona RH, 2005, LANCET, V366, P1142, DOI 10.1016/S0140-6736(05)67459-4; Czeizel Andrew E, 2005, Int J Med Sci, V2, P91; Dai L, 2011, WORLD J PEDIATR, V7, P302, DOI 10.1007/s12519-011-0326-0; Deng XX, 2014, NAT REV GENET, V15, P367, DOI 10.1038/nrg3687; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Fan LC, 2013, BIRTH DEFECTS RES A, V97, P750, DOI 10.1002/bdra.23148; Garne E, 2004, SCAND CARDIOVASC J, V38, P357, DOI 10.1080/14017430410024379; Garne E, 2010, BJOG-INT J OBSTET GY, V117, P660, DOI 10.1111/j.1471-0528.2010.02531.x; ICBDMS, 2007, INT CLEAR BIRTH DEF; International clearinghouse for birth defects monitoring systems, 1998, TERATOLOGY, V57, P30; Li C., 2012, MINISTRY HLTH PRC, V3, DOI [10.46234/ccdcw2021.191, DOI 10.46234/CCDCW2021.191]; Li S, 2003, PAEDIATR PERINAT EP, V17, P287, DOI 10.1046/j.1365-3016.2003.00478.x; Li Shu-ping, 2001, Chinese Journal of Luminescence, V22, P172; Li Ying, 2009, Beijing Da Xue Xue Bao Yi Xue Ban, V41, P414; Luo YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081369; Reefhuis J, 2004, BIRTH DEFECTS RES A, V70, P572, DOI 10.1002/bdra.20065; Sokal R, 2014, BIRTH DEFECTS RES A, V100, P79, DOI 10.1002/bdra.23218; The foundation of March of Dimes in American, 2006, GLOB REP BIRTH DEF; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Wu JL, 2008, BIOMED ENVIRON SCI, V21, P432, DOI 10.1016/S0895-3988(08)60065-3; Xia L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131874; Xu Xiao-Yan, 2015, Zhongguo Dang Dai Er Ke Za Zhi, V17, P350; Yang M, 2015, J MATERN-FETAL NEO M, V28, P799, DOI 10.3109/14767058.2014.932767; Zhu L, 2008, FOOD NUTR BULL, V29, pS196, DOI 10.1177/15648265080292S123	27	39	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147280	10.1371/journal.pone.0147280	http://dx.doi.org/10.1371/journal.pone.0147280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812057	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528000027
J	Fukumoto, J; Cox, R; Fukumoto, I; Cho, Y; Parthasarathy, PT; Galam, L; Lockey, RF; Kolliputi, N				Fukumoto, Jutaro; Cox, Ruan, Jr.; Fukumoto, Itsuko; Cho, Young; Parthasarathy, Prasanna Tamarapu; Galam, Lakshmi; Lockey, Richard F.; Kolliputi, Narasaiah			Deletion of ASK1 Protects against Hyperoxia-Induced Acute Lung Injury	PLOS ONE			English	Article							SIGNAL-REGULATING KINASE-1; II EPITHELIAL-CELLS; APOPTOSIS; MACROPHAGES; ACTIVATION; PATHWAYS; INFLAMMATION; RELEASE; DEATH; GENE	Apoptosis signal-regulating kinase 1 (ASK1), a member of the MAPK kinase kinase kinase (MAP3K) family, is activated by various stimuli, which include oxidative stress, endoplasmic reticulum (ER) stress, calcium influx, DNA damage-inducing agents and receptor-mediated signaling through tumor necrosis factor receptor (TNFR). Inspiration of a high concentration of oxygen is a palliative therapy which counteracts hypoxemia caused by acute lung injury (ALI)-induced pulmonary edema. However, animal experiments so far have shown that hyperoxia itself could exacerbate ALI through reactive oxygen species (ROS). Our previous data indicates that ASK1 plays a pivotal role in hyperoxia-induced acute lung injury (HALI). However, it is unclear whether or not deletion of ASK1 in vivo protects against HALI. In this study, we investigated whether ASK1 deletion would lead to attenuation of HALI. Our results show that ASK1 deletion in vivo significantly suppresses hyperoxia-induced elevation of inflammatory cytokines (i.e. IL-1 beta and TNF-alpha), cell apoptosis in the lung, and recruitment of immune cells. In summary, the results from the study suggest that deletion of ASK1 in mice significantly inhibits hyperoxic lung injury.	[Fukumoto, Jutaro; Cox, Ruan, Jr.; Fukumoto, Itsuko; Cho, Young; Parthasarathy, Prasanna Tamarapu; Galam, Lakshmi; Lockey, Richard F.; Kolliputi, Narasaiah] Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL USA; [Cox, Ruan, Jr.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Kolliputi, N (corresponding author), Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL USA.	nkollipu@health.usf.edu			National Institutes of Health [HL105932]; Joy McCann Culverhouse Endowment; American Heart Association [14POST18200004, 13PRE17070137]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joy McCann Culverhouse Endowment; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health R01 grant HL105932 (NK), Joy McCann Culverhouse Endowment (NK) (http://health.usf.edu/medicine/internalmedicine/allergy/overviewoftheairwaycenter), American Heart Association postdoctoral fellowship award 14POST18200004 (JF), and American Heart Association predoctoral fellowship award 13PRE17070137 (RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cox RR, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00445; CRESTANI B, 1994, J CLIN INVEST, V94, P731, DOI 10.1172/JCI117392; Fukumoto J, 2013, AM J PHYSIOL-CELL PH, V305, pC182, DOI 10.1152/ajpcell.00086.2013; Galam L, 2015, FREE RADICAL BIO MED, V84, P196, DOI 10.1016/j.freeradbiomed.2015.03.036; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Hayakawa R, 2012, P JPN ACAD B-PHYS, V88, P434, DOI 10.2183/pjab.88.434; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; Kolliputi N, 2012, J CELL PHYSIOL, V227, P3310, DOI 10.1002/jcp.24026; Kolliputi N, 2010, J IMMUNOL, V184, P5819, DOI 10.4049/jimmunol.0902766; Kolliputi N, 2009, AM J RESP CELL MOL, V40, P314, DOI 10.1165/rcmb.2007-0287OC; Lagishetty V, 2014, AM J PHYSIOL-CELL PH, V306, pC999, DOI 10.1152/ajpcell.00064.2013; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; Makena PS, 2012, AM J RESP CELL MOL, V46, P461, DOI 10.1165/rcmb.2011-0234OC; Marques LJ, 1997, AM J RESP CRIT CARE, V156, P1700, DOI 10.1164/ajrccm.156.5.9611052; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P214, DOI 10.1513/pats.200504-031AC; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Mo JS, 2013, P NATL ACAD SCI USA, V110, P6865, DOI 10.1073/pnas.1209078110; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Nakagawa H, 2012, WORLD J GASTROENTERO, V18, P4071, DOI 10.3748/wjg.v18.i31.4071; Noguchi T, 2008, J ORAL BIOSCI, V50, P107, DOI 10.2330/joralbiosci.50.107; Nyunoya T, 2005, J BIOL CHEM, V280, P26295, DOI 10.1074/jbc.M500185200; Osaka N, 2007, J CELL BIOL, V176, P903, DOI 10.1083/jcb.200611015; Phillips O, 2015, AM J RESP CELL MOL B; Savill J, 1997, BRIT MED BULL, V53, P491; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Ward NS, 2000, AM J RESP CELL MOL, V22, P535, DOI 10.1165/ajrcmb.22.5.3808; Watanabe T, 2005, BIOCHEM BIOPH RES CO, V333, P562, DOI 10.1016/j.bbrc.2005.05.151; Waxman AB, 2009, AM J RESP CELL MOL, V41, P385, DOI 10.1165/rcmb.2008-0302OC; Yamada T, 2007, PULM PHARMACOL THER, V20, P650, DOI 10.1016/j.pupt.2006.07.004; Zaher TE, 2007, FREE RADICAL BIO MED, V42, P897, DOI 10.1016/j.freeradbiomed.2007.01.021	32	18	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147652	10.1371/journal.pone.0147652	http://dx.doi.org/10.1371/journal.pone.0147652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807721	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800169
J	Jiao, Y; Ma, S; Wang, YR; Li, J; Shan, LQ; Liu, Q; Liu, Y; Song, Q; Yu, F; Yu, HH; Liu, H; Huang, L; Chen, JH				Jiao, Yang; Ma, Sai; Wang, Yirong; Li, Jing; Shan, Lequn; Liu, Qian; Liu, Ying; Song, Qian; Yu, Fan; Yu, Haohan; Liu, Huan; Huang, Li; Chen, Jihua			N-Acetyl Cysteine Depletes Reactive Oxygen Species and Prevents Dental Monomer-Induced Intrinsic Mitochondrial Apoptosis In Vitro in Human Dental Pulp Cells	PLOS ONE			English	Article							METHACRYLATE-INDUCED APOPTOSIS; HUMAN GINGIVAL FIBROBLASTS; CYTOCHROME-C RELEASE; 2-HYDROXYETHYL METHACRYLATE; RESIN MONOMERS; PHOSPHOLIPID LIPOSOMES; SUPEROXIDE DISMUTASES; OXIDATIVE STRESS; REDOX REGULATION; ADDUCT FORMATION	Purpose To investigate the involvement of intrinsic mitochondrial apoptosis in dental monomer-induced cytotoxicity and the influences of N/acetyl cysteine (NAC) on this process. Methods Human dental pulp cells (hDPCs) were exposed to several dental monomers in the absence or presence of NAC, and cell viability, intracellular redox balance, morphology and function of mitochondria and key indicators of intrinsic mitochondrial apoptosis were evaluated using various commercial kits. Results Dental monomers exerted dose-dependent cytotoxic effects on hDPCs. Concomitant to the over-production of reactive oxygen species (ROS) and depletion of glutathione (GSH), differential changes in activities of superoxide dismutase, glutathione peroxidase, and catalase were detected. Apoptosis, as indicated by positive Annexin V/propidium iodide (PI) staining and activation of caspase-3, was observed after dental monomer treatment. Dental monomers impaired the morphology and function of mitochondria, and induced intrinsic mitochondrial apoptosis in hDPCs via up-regulation of p53, Bax and cleaved caspase-3, and down-regulation of Bcl-2. NAC restored cell viability, relieved oxidative stress and blocked the apoptotic effects of dental monomers. Conclusions Dental monomers induced oxidative stress and mitochondrial intrinsic apoptosis in hDPCs. NAC could reduce the oxidative stress and thus protect hDPCs against dental monomer-induced apoptosis.	[Jiao, Yang; Ma, Sai; Liu, Ying; Song, Qian; Yu, Fan; Yu, Haohan; Liu, Huan; Chen, Jihua] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Jiao, Yang; Ma, Sai; Wang, Yirong; Liu, Ying; Song, Qian; Yu, Fan; Yu, Haohan; Liu, Huan; Chen, Jihua] Shaanxi Key Lab Mil Stomatol, Xian, Shaanxi, Peoples R China; [Wang, Yirong] Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Li, Jing] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed Oncol, Xian 710032, Peoples R China; [Shan, Lequn] Fourth Mil Med Univ, Tangdu Hosp, Dept Orthopaed Surg, Xian 710032, Peoples R China; [Liu, Qian] Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Huang, Li] Fourth Mil Med Univ, Sch Stomatol, Dept Gen & Emergency, State Key Lab Mil Stomatol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Chen, JH (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.; Chen, JH (corresponding author), Shaanxi Key Lab Mil Stomatol, Xian, Shaanxi, Peoples R China.	jhchen@fmmu.edu.cn	Yu, Fan/GXF-5805-2022; song, qian/HDL-9868-2022	Yu, Fan/0000-0002-9917-593X; Chen, Ji-hua/0000-0002-1151-0693	Natural Science Foundation of Shaanxi Province [2015JQ8301]; National Nature Science Foundation of China [81130078, 81300927, 81272072, 81200816]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT13051]	Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This study was financially supported by grant 2015JQ8301 (principal investigator SM) from the Natural Science Foundation of Shaanxi Province, grant 81130078 (principal investigator JC), grant 81300927 (principal investigator SM), grant 81272072 (principal investigator LS) and grant 81200816 (principal investigator LH) from the National Nature Science Foundation of China, and Program No. IRT13051 from the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang MC, 2010, BIOMATERIALS, V31, P8164, DOI 10.1016/j.biomaterials.2010.07.049; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Demarco FF, 2012, DENT MATER, V28, P87, DOI 10.1016/j.dental.2011.09.003; Eckhardt A, 2010, DENT MATER, V26, P232, DOI 10.1016/j.dental.2009.10.005; Engelmann J, 2004, BIOMATERIALS, V25, P4573, DOI 10.1016/j.biomaterials.2003.11.048; Ferracane JL, 2011, DENT MATER, V27, P29, DOI 10.1016/j.dental.2010.10.020; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; FUJISAWA S, 1988, J DENT RES, V67, P1438, DOI 10.1177/00220345880670111501; FUJISAWA S, 1984, J BIOMED MATER RES, V18, P1105, DOI 10.1002/jbm.820180912; Hilkens P, 2013, CELL TISSUE RES, V353, P65, DOI 10.1007/s00441-013-1630-x; Jiao Y, 2015, MED SCI MONITOR, V21, P3197, DOI 10.12659/MSM.895628; Jiao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135815; Jiao Y, 2015, PEERJ, V3, DOI 10.7717/peerj.868; Jimbo A, 2003, EXP CELL RES, V283, P156, DOI 10.1016/S0014-4827(02)00033-2; Kim JH, 2010, FOOD CHEM TOXICOL, V48, P807, DOI 10.1016/j.fct.2009.12.012; Kim NR, 2011, J BIOMED MATER RES B, V98B, P300, DOI 10.1002/jbm.b.31852; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Krifka S, 2013, BIOMATERIALS, V34, P4555, DOI 10.1016/j.biomaterials.2013.03.019; Krifka S, 2012, BIOMATERIALS, V33, P5177, DOI 10.1016/j.biomaterials.2012.04.013; Krifka S, 2012, CLIN ORAL INVEST, V16, P215, DOI 10.1007/s00784-010-0508-5; Ma S, 2013, DENT MATER, V29, P1219, DOI 10.1016/j.dental.2013.09.008; Miller AF, 2012, FEBS LETT, V586, P585, DOI 10.1016/j.febslet.2011.10.048; Nocca G, 2010, BIOMATERIALS, V31, P2508, DOI 10.1016/j.biomaterials.2009.12.015; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Paranjpe A, 2008, J ENDODONT, V34, P1191, DOI 10.1016/j.joen.2008.06.011; Ramp U, 2003, BRIT J CANCER, V88, P1800, DOI 10.1038/sj.bjc.6600984; Saikumar P, 1998, ONCOGENE, V17, P3401, DOI 10.1038/sj.onc.1202590; Schweikl H, 2007, DENT MATER, V23, P688, DOI 10.1016/j.dental.2006.06.021; Schweikl H, 2006, J DENT RES, V85, P870, DOI 10.1177/154405910608501001; Schweikl H, 2001, J DENT RES, V80, P1615, DOI 10.1177/00220345010800070401; Schweikl H, 2014, BIOMATERIALS, V35, P2890, DOI 10.1016/j.biomaterials.2013.12.044; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Slee EA, 2004, ONCOGENE, V23, P2809, DOI 10.1038/sj.onc.1207516; Song XD, 2011, BIOL PHARM BULL, V34, P839, DOI 10.1248/bpb.34.839; Spagnuolo G, 2013, DENT MATER, V29, pE153, DOI 10.1016/j.dental.2013.04.023; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Urcan E, 2010, BIOMATERIALS, V31, P2010, DOI 10.1016/j.biomaterials.2009.11.065; Volk J, 2006, DENT MATER, V22, P499, DOI 10.1016/j.dental.2005.06.002; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang P, 2007, J TOXICOL ENV HEAL A, V70, P976, DOI 10.1080/15287390701290832; Yoshii E, 1997, J BIOMED MATER RES, V37, P517, DOI 10.1002/(SICI)1097-4636(19971215)37:4<517::AID-JBM10>3.0.CO;2-5	42	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147858	10.1371/journal.pone.0147858	http://dx.doi.org/10.1371/journal.pone.0147858			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808507	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800232
J	Kretschmar, C; Oyarzun, C; Villablanca, C; Jaramillo, C; Alarcon, S; Perez, G; Diaz-Encarnacion, MM; Pastor-Anglada, M; Garrido, W; Quezada, C; Martin, RS				Kretschmar, Catalina; Oyarzun, Carlos; Villablanca, Cristopher; Jaramillo, Catherinne; Alarcon, Sebastian; Perez, Gustavo; Diaz-Encarnacion, Montserrat M.; Pastor-Anglada, Marcal; Garrido, Wallys; Quezada, Claudia; San Martin, Rody			Reduced Adenosine Uptake and Its Contribution to Signaling that Mediates Profibrotic Activation in Renal Tubular Epithelial Cells: Implication in Diabetic Nephropathy	PLOS ONE			English	Article							EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; TO-MESENCHYMAL TRANSITION; EXPRESSION LEVEL; RECEPTORS; INSULIN; KIDNEY; MYOFIBROBLASTS; INTERVENTION; INFLAMMATION; INHIBITION	Altered nucleoside levels may be linked to pathogenic signaling through adenosine receptors. We hypothesized that adenosine dysregulation contributes to fibrosis in diabetic kidney disease. Our findings indicate that high glucose levels and experimental diabetes decreased uptake activity through the equilibrative nucleoside transporter 1 (ENT1) in proximal tubule cells. In addition, a correlation between increased plasma content of adenosine and a marker of renal fibrosis in diabetic rats was evidenced. At the cellular level, exposure of HK2 cells to high glucose, TGF-beta and the general adenosine receptor agonist NECA, induced the expression of profibrotic cell activation markers alpha-SMA and fibronectin. These effects can be avoided by using a selective antagonist of the adenosine A(3) receptor subtype in vitro. Furthermore, induction of fibrosis marker alpha-SMA was prevented by the A(3) receptor antagonist in diabetic rat kidneys. In conclusion, we evidenced the contribution of purinergic signaling to renal fibrosis in experimental diabetic nephropathy.	[Kretschmar, Catalina; Oyarzun, Carlos; Villablanca, Cristopher; Jaramillo, Catherinne; Alarcon, Sebastian; Perez, Gustavo; Garrido, Wallys; Quezada, Claudia; San Martin, Rody] Univ Austral Chile, Fac Sci, Inst Microbiol & Biochem, Valdivia, Chile; [Diaz-Encarnacion, Montserrat M.] Biomed Res Inst St Pau IIB St Pau, Nephrol Serv Fdn Puigvert, Barcelona, Spain; [Pastor-Anglada, Marcal] Univ Barcelona, Dept Biochem & Mol Biol, Natl Biomed Res Inst Liver & Gastrointestinal Dis, Inst Biomed & Oncol Programme, Barcelona, Spain	Universidad Austral de Chile; Fundacio Puigvert; University of Barcelona	Martin, RS (corresponding author), Univ Austral Chile, Fac Sci, Inst Microbiol & Biochem, Valdivia, Chile.	rodysanmartin@uach.cl	Pastor-Anglada, Marçal/C-3730-2017	Pastor-Anglada, Marçal/0000-0003-3712-1773; Jaramillo, Catherinne/0000-0002-0538-2912; Alarcon, Sebastian/0000-0002-8413-8028	FONDECYT from Comision Nacional de Ciencia y Tecnologia-Chile (CONICYT-Chile) [1130414, 3150548, 1121121]; Universidad Austral de Chile [S-2013-15]; Ministerio de Economia de Espana [SAF2011-23660]; Comision Nacional de Ciencia y Tecnologia-Chile (CONICYT-Chile)	FONDECYT from Comision Nacional de Ciencia y Tecnologia-Chile (CONICYT-Chile); Universidad Austral de Chile; Ministerio de Economia de Espana; Comision Nacional de Ciencia y Tecnologia-Chile (CONICYT-Chile)	Funded by grants FONDECYT 1130414 to RSM, 3150548 to WG and 1121121 to CQ from Comision Nacional de Ciencia y Tecnologia-Chile (CONICYT-Chile), www.conicyt.cl. Funded by grant S-2013-15 to CO from Universidad Austral de Chile, www.uach.cl. Funded by grant SAF2011-23660 to MPA from Ministerio de Economia de Espana, www.mineco.gob.es. SA hold doctoral fellowship from Comision Nacional de Ciencia y Tecnologia-Chile (CONICYT-Chile), www.conicyt.cl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackley MA, 2003, J PHYSIOL-LONDON, V548, P507, DOI 10.1113/jphysiol.2002.038091; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Awad AS, 2006, AM J PHYSIOL-RENAL, V290, pF828, DOI 10.1152/ajprenal.00310.2005; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Cardenas A, 2013, LAB INVEST, V93, P135, DOI 10.1038/labinvest.2012.143; Carrier EJ, 2006, P NATL ACAD SCI USA, V103, P7895, DOI 10.1073/pnas.0511232103; Choi DS, 2004, NAT NEUROSCI, V7, P855, DOI 10.1038/nn1288; Dai YB, 2011, J AM SOC NEPHROL, V22, P890, DOI 10.1681/ASN.2010080890; Damaraju VL, 2007, AM J PHYSIOL-RENAL, V293, pF200, DOI 10.1152/ajprenal.00007.2007; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Essawy M, 1997, NEPHROL DIAL TRANSPL, V12, P43, DOI 10.1093/ndt/12.1.43; Farias M, 2006, J CELL PHYSIOL, V208, P451, DOI 10.1002/jcp.20680; Faulhaber-Walter R, 2008, J AM SOC NEPHROL, V19, P722, DOI 10.1681/ASN.2007060721; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Gadalla AE, 2004, J NEUROCHEM, V88, P1272, DOI 10.1046/j.1471-4159.2003.02253.x; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Govindarajan R, 2007, AM J PHYSIOL-REG I, V293, pR1809, DOI 10.1152/ajpregu.00293.2007; Grenz A, 2012, J CLIN INVEST, V122, P693, DOI 10.1172/JCI60214; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Guillen-Gomez E, 2012, J CELL PHYSIOL, V227, P1521, DOI 10.1002/jcp.22869; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hills CE, 2010, AM J NEPHROL, V31, P68, DOI 10.1159/000256659; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Lee J, 2013, AM J PATHOL, V183, P1488, DOI 10.1016/j.ajpath.2013.07.010; Mubagwa K, 2001, CARDIOVASC RES, V52, P25, DOI 10.1016/S0008-6363(01)00358-3; Munoz G, 2006, J CELL PHYSIOL, V209, P826, DOI 10.1002/jcp.20769; Nath KA, 1998, KIDNEY INT, V54, P992, DOI 10.1046/j.1523-1755.1998.00079.x; Pawelczyk T, 2005, AM J PATHOL, V167, P315, DOI 10.1016/S0002-9440(10)62977-X; Pawelczyk T, 2003, MOL PHARMACOL, V63, P81, DOI 10.1124/mol.63.1.81; Pedagogos E, 1997, AM J KIDNEY DIS, V29, P912, DOI 10.1016/S0272-6386(97)90466-2; Peng Z, 2008, FASEB J, V22, P2263, DOI 10.1096/fj.07-100685; Qi WE, 2006, INT J BIOCHEM CELL B, V38, P1, DOI 10.1016/j.biocel.2005.09.005; Quezada C, 2013, CURR DRUG TARGETS, V14, P490; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Riksen NP, 2005, ARTERIOSCL THROM VAS, V25, P109, DOI 10.1161/01.ATV.0000150651.85907.69; Roa H, 2009, FEBS LETT, V583, P3192, DOI 10.1016/j.febslet.2009.09.003; Sakowicz M, 2004, BIOCHEM PHARMACOL, V68, P1309, DOI 10.1016/j.bcp.2004.06.020; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Simonson MS, 2007, KIDNEY INT, V71, P846, DOI 10.1038/sj.ki.5002180; Sonoki K, 2003, EUR J PHARMACOL, V475, P139, DOI 10.1016/S0014-2999(03)02109-5; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Tak E, 2014, J AM SOC NEPHROL, V25, P547, DOI 10.1681/ASN.2012101014; Vallon V, 2009, NEPHRON PHYSIOL, V111, P30, DOI 10.1159/000208211; VINAY P, 1981, AM J PHYSIOL, V241, pF403, DOI 10.1152/ajprenal.1981.241.4.F403; Westermeier F, 2011, DIABETES, V60, P1677, DOI 10.2337/db11-0155; Xia JF, 2010, CLIN BIOCHEM, V43, P957, DOI 10.1016/j.clinbiochem.2010.05.013; Xia JF, 2009, J CHROMATOGR B, V877, P1930, DOI 10.1016/j.jchromb.2009.05.047; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3	50	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147430	10.1371/journal.pone.0147430	http://dx.doi.org/10.1371/journal.pone.0147430			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808537	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800093
J	Ng, JYS; Wong, ML				Ng, Junice Y. S.; Wong, Mee-Lian			Determinants of Heterosexual Adolescents Having Sex with Female Sex Workers in Singapore	PLOS ONE			English	Article							MALE CLIENTS; CONDOM USE; PROTECTIVE FACTORS; SELF-ESTEEM; RISK; BEHAVIORS; HIV; PREVALENCE; ATTITUDES	Objectives We assessed the proportion of and socio-ecological factors associated with ever having had sex with female sex workers (FSWs) among heterosexual adolescents. We also described the characteristics of the adolescents who reported inconsistent condom use with FSWs. Methods This is a cross-sectional study (response rate: 73%) of 300 heterosexually active male adolescents of 16 to 19 years attending a national STI clinic in Singapore between 2009 and 2014. We assessed the ecological factors (individual, parental, peer, school and medial influences) and sexual risk behaviors using a self-reported questionnaire. Poisson regression was used to obtain the adjusted prevalence ratios (aPR) and confidence intervals (CI). Results The proportion of heterosexual male adolescents who had ever had sex with FSWs was 39%. Multivariate analysis showed that significant factors associated with ever having had sex with FSWs were sex initiation before 16 years old (aPR 1.79 CI: 1.30-2.46), never had a sexually active girlfriend (aPR 1.75 CI 1.28-2.38), reported lower self-esteem score (aPR 0.96 CI: 0.93-0.98), higher rebelliousness score (aPR 1.03 CI: 1.00-1.07) and more frequent viewing of pornography (aPR 1.47 CI: 1.04-2.09). Lifetime inconsistent condom use with FSWs was 30%. Conclusions A significant proportion of heterosexual male adolescents attending the public STI clinic had ever had sex with FSWs. A targeted intervention that addresses different levels of influence to this behavior is needed. This is even more so because a considerable proportion of adolescents reported inconsistent condom use with FSWs, who may serve as a bridge of STI transmission to the community. National surveys on adolescent health should include the assessment of frequency of commercial sex visits and condom use with FSWs for long-term monitoring and surveillance.	[Ng, Junice Y. S.; Wong, Mee-Lian] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore	National University of Singapore	Wong, ML (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	mee_lian_wong@nuhs.edu.sg			National Medical Research Council (NMRC), Singapore	National Medical Research Council (NMRC), Singapore(National Medical Research Council, Singapore)	This study is funded by National Medical Research Council (NMRC), Singapore. There is no conflict of interest. NMRC is NOT involved in 1) study design; (2) the collection, analysis, and interpretation of data; (3) the writing of the report; and (4) the decision to submit the paper for publication.; We thank the management and staff of DSC clinic who facilitated the study. We also thank Dede Tham and Raymond Lim who assisted in the data collection. The study was part of a behavioral intervention study for adolescents funded by National Medical Research Council.	[Anonymous], 2015, ALL END ADOLESCENTS; [Anonymous], 2014, DSC CLIN 2013 ANN RE; Belza MJ, 2008, SEX TRANSM INFECT, V84, P207, DOI 10.1136/sti.2008.029827; Coughlan E, 2001, INT J STD AIDS, V12, P665, DOI 10.1258/0956462011923895; Decker MR, 2010, JAIDS-J ACQ IMM DEF, V53, P240, DOI 10.1097/QAI.0b013e3181c2fb2e; Goodson P, 2006, J ADOLESCENT HEALTH, V38, P310, DOI 10.1016/j.jadohealth.2005.05.026; Idele P, 2014, JAIDS-J ACQ IMM DEF, V66, pS144, DOI 10.1097/QAI.0000000000000176; Jackson C, 1998, HEALTH EDUC BEHAV, V25, P319, DOI 10.1177/109019819802500307; Jackson CA, 2012, J PUBLIC HEALTH-UK, V34, pI31, DOI 10.1093/pubmed/fdr113; JESSOR R, 1995, DEV PSYCHOL, V31, P923, DOI 10.1037/0012-1649.31.6.923; Kaestle CE, 2012, PREV SCI, V13, P314, DOI 10.1007/s11121-011-0268-8; KROSNICK JA, 1989, J PERS SOC PSYCHOL, V57, P416, DOI 10.1037/0022-3514.57.3.416; Lavoie F, 2010, ARCH SEX BEHAV, V39, P1147, DOI 10.1007/s10508-010-9605-4; Mahapatra B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113599; McLaughlin MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071394; MCLAUGHLIN SD, 1983, J MARRIAGE FAM, V45, P47, DOI 10.2307/351294; MIRANDE AM, 1968, J MARRIAGE FAM, V30, P572, DOI 10.2307/349497; Nguyen TTT, 1999, AIDS, V13, P719, DOI 10.1097/00002030-199904160-00013; Robinson ML, 2007, J YOUTH ADOLESCENCE, V36, P453, DOI 10.1007/s10964-006-9116-8; Rosenberg M., 1965, SOC ADOLESCENT SELF, Vxi; Sargent JD, 2001, BRIT MED J, V323, P1394, DOI 10.1136/bmj.323.7326.1394; SMALL SA, 1994, J MARRIAGE FAM, V56, P181, DOI 10.2307/352712; Sok P, 2008, SEX HEALTH, V5, P353, DOI 10.1071/SH08001; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wong ML, 2013, J PEDIATR-US, V162, P574, DOI 10.1016/j.jpeds.2012.08.010; Wong ML, 2009, PEDIATRICS, V124, pE44, DOI 10.1542/peds.2008-2954; Wong ML, 2004, AIDS, V18, P1195, DOI 10.1097/00002030-200405210-00013; Xantidis L, 2000, ARCH SEX BEHAV, V29, P165, DOI 10.1023/A:1001907806062; Yang C, 2010, AIDS CARE, V22, P246, DOI 10.1080/09540120903111437	29	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147110	10.1371/journal.pone.0147110	http://dx.doi.org/10.1371/journal.pone.0147110			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808561	gold, Green Submitted, Green Published			2022-12-26	WOS:000369527800051
J	Miller, AS; Shepherd, GR; Fratantoni, PS				Miller, Alicia S.; Shepherd, Gary R.; Fratantoni, Paula S.			Offshore Habitat Preference of Overwintering Juvenile and Adult Black Sea Bass, Centropristis striata, and the Relationship to Year-Class Success	PLOS ONE			English	Article							MIDDLE ATLANTIC BIGHT; ENGLAND SHELFBREAK FRONT; OF-THE-YEAR; NORTH-CAROLINA; INTERANNUAL VARIABILITY; WINTER MORTALITY; MORONE-SAXATILIS; CAPE-HATTERAS; GEORGES BANK; RED DRUM	Black sea bass (Centropristis striata) migrations are believed to play a role in overwinter survival and connectivity between juvenile and adult populations. This study investigated oceanographic drivers of winter habitat choice and regional differences between populations of juvenile and adult black sea bass. Trends in cohort strength, as a result of juvenile survival, were also identified. Oceanographic and fisheries survey data were analyzed using generalized additive models. Among the oceanographic variables investigated, salinity was the main driver in habitat selection with an optimal range of 33-35 practical salinity units (PSU) for both juveniles and adults. Preferred temperature ranges varied between juveniles and adults, but held a similar minimum preference of >8 degrees C. Salinity and temperature ranges also differed by regions north and south of Hudson Canyon. Shelf water volume had less of an effect than temperature or salinity, but showed an overall negative relationship with survey catch. The effect of winter conditions on juvenile abundance was also observed across state and federal survey index trends. A lack of correlation observed among surveys in the fall paired with a strong correlation in the spring identifies the winter period as a factor determining year-class strength of new recruits to the population. A rank order analysis of spring indices identified three of the largest year classes occurring during years with reduced shelf water volumes, warmer winter shelf waters, and a 34 PSU isohaline aligned farther inshore. While greater catches of black sea bass in the northwest Atlantic Ocean remain south of Hudson Canyon, the species' range has expanded north in recent years.	[Miller, Alicia S.; Shepherd, Gary R.; Fratantoni, Paula S.] Natl Marine Fisheries Serv, Northeast Fisheries Sci Ctr, 166 Water St, Woods Hole, MA 02543 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Miller, AS (corresponding author), Natl Marine Fisheries Serv, Northeast Fisheries Sci Ctr, 166 Water St, Woods Hole, MA 02543 USA.	Alicia.Miller@noaa.gov						Anderson DA, 2014, ICES J MAR SCI, V71, P1010, DOI 10.1093/icesjms/fst041; [Anonymous], 2014, R LANG ENV STAT COMP; Atwood HL, 2001, N AM J AQUACULT, V63, P285, DOI 10.1577/1548-8454(2001)063&lt;0285:SATTOB&gt;2.0.CO;2; Beardsley R. C., 1976, Memoires de la Societe Royal des Sciences de Liege. Collection in-8, V10, P209; Bell R.J., 2014, ICES J MARINE SCI; Berlinsky DL, 2004, J WORLD AQUACULT SOC, V35, P335, DOI 10.1111/j.1749-7345.2004.tb00097.x; Bisagni JJ, 2009, J MARINE SYST, V78, P337, DOI 10.1016/j.jmarsys.2008.11.020; CHAPMAN DC, 1989, J PHYS OCEANOGR, V19, P384, DOI 10.1175/1520-0485(1989)019<0384:OTOOSW>2.0.CO;2; CHAPMAN DC, 1986, J PHYS OCEANOGR, V16, P758, DOI 10.1175/1520-0485(1986)016<0758:OTCOMF>2.0.CO;2; Fabrizio MC, 2014, FISH B-NOAA, V112, P82, DOI 10.7755/FB.112.1.6; Fratantoni PS, 2007, J PHYS OCEANOGR, V37, P2509, DOI 10.1175/JPO3123.1; Gartner JV, 2008, MAR BIOL, V153, P825, DOI 10.1007/s00227-007-0855-1; Gawarkiewicz G, 2001, J PHYS OCEANOGR, V31, P2783, DOI 10.1175/1520-0485(2001)031<2783:IOASEW>2.0.CO;2; Gawarkiewicz GG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00553; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Gong D, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005520; Hales LS, 2001, MAR BIOL, V139, P45; Hare JA, 2007, FISH OCEANOGR, V16, P31, DOI 10.1111/j.1365-2419.2006.00407.x; Hartel KE, 2008, NORTHEAST NAT, V15, P317, DOI 10.1656/1092-6194-15.3.317; Houghton RW, 2006, PROG OCEANOGR, V70, P289, DOI 10.1016/j.pocean.2006.05.001; HUNT RL, 1969, J FISH RES BOARD CAN, V26, P1473, DOI 10.1139/f69-138; Hurst TP, 1998, CAN J FISH AQUAT SCI, V55, P1122, DOI 10.1139/cjfas-55-5-1122; Hurst TP, 2007, JOURNAL OF FISH BIOL, V55, P1122; Jorgensen C, 2008, ECOLOGY, V89, P3436, DOI 10.1890/07-1469.1; Kendall AW, 1977, 7 NEFC SAND HOOK LAB; Kerr LA, 2009, REV FISH SCI, V17, P267, DOI 10.1080/10641260802667067; Lankford TE, 2001, T AM FISH SOC, V130, P236, DOI 10.1577/1548-8659(2001)130&lt;0236:LTTOAA&gt;2.0.CO;2; Lentz SJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001859; LEVITUS S, 1987, J PHYS OCEANOGR, V17, P197, DOI 10.1175/1520-0485(1987)017<0197:ACOTAC>2.0.CO;2; Linder CA, 1998, J GEOPHYS RES-OCEANS, V103, P18405, DOI 10.1029/98JC01438; Lozier MS, 2002, J PHYS OCEANOGR, V32, P924, DOI 10.1175/1520-0485(2002)032<0924:IOASF>2.0.CO;2; MANNING J, 1991, CONT SHELF RES, V11, P123, DOI 10.1016/0278-4343(91)90058-E; Martino EJ, 2012, CAN J FISH AQUAT SCI, V69, P430, DOI 10.1139/F2011-149; McCartney MA, 2013, J BIOGEOGR, V40, P1386, DOI 10.1111/jbi.12103; Miller TJ, 2010, NEFSC CENTER REFEREN; Moser J, 2009, J NW ATLANTIC FISHER, V139, P241; MOUNTAIN DG, 1991, CONT SHELF RES, V11, P251, DOI 10.1016/0278-4343(91)90068-H; Mountain DG, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001044; Murase H, 2009, ICES J MAR SCI, V66, P1417, DOI 10.1093/icesjms/fsp105; MUSICK JA, 1977, T AM FISH SOC, V106, P12, DOI 10.1577/1548-8659(1977)106<12:SDOBSB>2.0.CO;2; Myers RA, 1998, REV FISH BIOL FISHER, V8, P285, DOI 10.1023/A:1008828730759; Northeast Fisheries Science Center (NEFSC), 2012, 53 NE REG STOCK ASS; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pickart RS, 2000, J PHYS OCEANOGR, V30, P2668, DOI 10.1175/1520-0485(2001)031<2668:BBLSAD>2.0.CO;2; Post DM, 1998, CAN J FISH AQUAT SCI, V55, P2588, DOI 10.1139/cjfas-55-12-2588; Roy EM, 2012, MAR COAST FISH, V4, P391, DOI 10.1080/19425120.2012.675983; Ryan JP, 1999, LIMNOL OCEANOGR, V44, P1, DOI 10.4319/lo.1999.44.1.0001; Sagarese SR, 2014, CAN J FISH AQUAT SCI, V71, P847, DOI 10.1139/cjfas-2013-0342; Shepherd GR, 1994, 122 NOAA; STEIMLE FW, 1999, NMFSNE149 NOAA; Stewart CB, 2008, T AM FISH SOC, V137, P1089, DOI 10.1577/T07-176.1; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zhang WFG, 2013, J GEOPHYS RES-OCEANS, V118, P517, DOI 10.1002/jgrc.20068	54	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147627	10.1371/journal.pone.0147627	http://dx.doi.org/10.1371/journal.pone.0147627			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824350	Green Published, gold			2022-12-26	WOS:000369528600043
J	Lin, H; Travisano, M; Kazlauskas, RJ				Lin, Hui; Travisano, Michael; Kazlauskas, Romas J.			Experimental Evolution of Trichoderma citrinoviride for Faster Deconstruction of Cellulose	PLOS ONE			English	Article							ESCHERICHIA-COLI; REESEI; BIOMASS; GENE; IMPROVEMENT; ADAPTATION; EXPRESSION; STRATEGIES; DYNAMICS	Engineering faster cellulose deconstruction is difficult because it is a complex, cooperative, multi-enzyme process. Here we use experimental evolution to select for populations of Trichoderma citrinoviride that deconstruct up to five-fold more cellulose. Ten replicate populations of T. citrinoviride were selected for growth on filter paper by serial culture. After 125 periods of growth and transfer to fresh media, the filter paper deconstruction increased an average of 2.5 fold. Two populations were examined in more detail. The activity of the secreted cellulase mixtures increased more than two-fold relative to the ancestor and the largest increase was in the extracellular beta-glucosidase activity. qPCR showed at least 16-fold more transcribed RNA for egl4 (endoglucanase IV gene), cbh1 (cellobiohydrolase I gene) and bgl1 (extracellular beta-glucosidase I gene) in selected populations as compared to the ancestor, and earlier peak expressions of these genes. Deep sequencing shows that the regulatory strategies used to alter cellulase secretion differ in the two strains. The improvements in cellulose deconstruction come from earlier expression of all cellulases and increased relative amount of beta-glucosidase, but with small increases in the total secreted protein and therefore little increase in metabolic cost.	[Lin, Hui; Travisano, Michael; Kazlauskas, Romas J.] Univ Minnesota, Inst Biotechnol, St Paul, MN USA; [Travisano, Michael] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN USA; [Kazlauskas, Romas J.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Travisano, M; Kazlauskas, RJ (corresponding author), Univ Minnesota, Inst Biotechnol, St Paul, MN USA.; Travisano, M (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN USA.; Kazlauskas, RJ (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN USA.	travisan@umn.edu; rjk@umn.edu	Travisano, Michael/AAI-4809-2020; Lin, Hui/C-9747-2013	Kazlauskas, Romas/0000-0002-3570-2411; Travisano, Michael/0000-0001-8168-0842	University of Minnesota Biotechnology Institute	University of Minnesota Biotechnology Institute(University of Minnesota System)	This work was supported by the University of Minnesota Biotechnology Institute (HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghcheh RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112799; Amore A, 2013, CURR GENOMICS, V14, P230, DOI 10.2174/1389202911314040002; Andric P, 2010, BIOTECHNOL ADV, V28, P308, DOI 10.1016/j.biotechadv.2010.01.003; Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Aro N, 2003, APPL ENVIRON MICROB, V69, P56, DOI 10.1128/AEM.69.1.56-65.2003; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Chandra M, 2010, BIOMASS BIOENERG, V34, P805, DOI 10.1016/j.biombioe.2010.01.024; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Freimoser FM, 1999, APPL ENVIRON MICROB, V65, P3727; GESSNER MO, 1991, MICROBIAL ECOL, V22, P285, DOI 10.1007/BF02540230; Greig D, 2004, P ROY SOC B-BIOL SCI, V271, pS25, DOI 10.1098/rsbl.2003.0083; Hakkinen M, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-14; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim Yu-Kyoung, 2012, ISRN Microbiol, V2012, P650563, DOI 10.5402/2012/650563; Kindermann J, 1998, FUNGAL GENET BIOL, V24, P298, DOI 10.1006/fgbi.1998.1049; Kubicek CP, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-19; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Mandels M., 1971, J POLYM SCI, V36, P445, DOI DOI 10.1002/POLC.5070360133; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nitta M, 2012, FUNGAL GENET BIOL, V49, P388, DOI 10.1016/j.fgb.2012.02.009; Parekh S, 2000, APPL MICROBIOL BIOT, V54, P287, DOI 10.1007/s002530000403; Peterson R, 2012, MICROBIOL-SGM, V158, P58, DOI 10.1099/mic.0.054031-0; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuster A, 2011, APPL ENVIRON MICROB, V77, P4553, DOI 10.1128/AEM.00513-11; Seiboth B, 2011, BIOFUEL PRODUCTION R, DOI [10.5772/16848, DOI 10.5772/16848]; Seiboth B, 2012, MOL MICROBIOL, V84, P1150, DOI 10.1111/j.1365-2958.2012.08083.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Steiger MG, 2010, J BIOTECHNOL, V145, P30, DOI 10.1016/j.jbiotec.2009.10.012; STERNBERG D, 1976, APPL ENVIRON MICROB, V31, P648, DOI 10.1128/AEM.31.5.648-654.1976; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024; Zingaro KA, 2012, MBIO, V3, DOI 10.1128/mBio.00308-12	40	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147024	10.1371/journal.pone.0147024	http://dx.doi.org/10.1371/journal.pone.0147024			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820897	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528400012
J	Tata, M; Wolfinger, MT; Amman, F; Roschanski, N; Dotsch, A; Sonnleitner, E; Haussler, S; Blasi, U				Tata, Muralidhar; Wolfinger, Michael T.; Amman, Fabian; Roschanski, Nicole; Doetsch, Andreas; Sonnleitner, Elisabeth; Haeussler, Susanne; Blaesi, Udo			RNA(Seq) Based Transcriptional Profiling of Pseudomonas aeruginosa PA14 after Short- and Long-Term Anoxic Cultivation in Synthetic Cystic Fibrosis Sputum Medium	PLOS ONE			English	Article							OUTER-MEMBRANE-PROTEIN; MOLYBDENUM COFACTOR BIOSYNTHESIS; MULTIDRUG EFFLUX PUMPS; BIOFILM FORMATION; ESCHERICHIA-COLI; GENE-EXPRESSION; ANAEROBIC GROWTH; STENOTROPHOMONAS-MALTOPHILIA; ANTIBIOTIC-RESISTANCE; PLANKTONIC CULTURES	The opportunistic human pathogen Pseudomonas aeruginosa can thrive under microaerophilic to anaerobic conditions in the lungs of cystic fibrosis patients. RNASeq based comparative RNA profiling of the clinical isolate PA14 cultured in synthetic cystic fibrosis medium was performed after planktonic growth (OD600 = 2.0; P), 30 min after shift to anaerobiosis (A-30) and after anaerobic biofilm growth for 96h (B-96) with the aim to reveal differentially regulated functions impacting on sustained anoxic biofilm formation as well as on tolerance towards different antibiotics. Most notably, functions involved in sulfur metabolism were found to be up-regulated in B-96 cells when compared to A-30 cells. Based on the transcriptome studies a set of transposon mutants were screened, which revealed novel functions involved in anoxic biofilm growth. In addition, these studies revealed a decreased and an increased abundance of the oprD and the mexCD-oprJ operon transcripts, respectively, in B-96 cells, which may explain their increased tolerance towards meropenem and to antibiotics that are expelled by the MexCD-OprD efflux pump. The OprI protein has been implicated as a target for cationic antimicrobial peptides, such as SMAP-29. The transcriptome and subsequent Northern-blot analyses showed that the abundance of the oprI transcript encoding the OprI protein is strongly decreased in B-96 cells. However, follow up studies revealed that the susceptibility of a constructed PA14.oprI mutant towards SMAP-29 was indistinguishable from the parental wild-type strain, which questions OprI as a target for this antimicrobial peptide in strain PA14.	[Tata, Muralidhar; Roschanski, Nicole; Sonnleitner, Elisabeth; Blaesi, Udo] Univ Vienna, Max F Perutz Labs, Ctr Mol Biol, Dept Microbiol Immunobiol & Genet, Dr Bohr Gasse 9, A-1030 Vienna, Austria; [Wolfinger, Michael T.] Univ Vienna, Max F Perutz Labs, Ctr Mol Biol, Ctr Integrat Bioinformat Vienna, Dr Bohr Gasse 9, A-1030 Vienna, Austria; [Amman, Fabian] Univ Vienna, Max F Perutz Labs, Ctr Mol Biol, Dept Chromosome Biol, Dr Bohr Gasse 9, A-1030 Vienna, Austria; [Roschanski, Nicole] Free Univ Berlin, Inst Anim Hyg & Environm Hlth, Robert von Ostertag Str 7-13, D-14163 Berlin, Germany; [Doetsch, Andreas; Haeussler, Susanne] Helmholtz Ctr Infect Res, Dept Mol Bacteriol, Inhoffenstr 7, D-38124 Braunschweig, Germany; [Haeussler, Susanne] Ctr Expt & Clin Infect Res, Twincore, Inst Mol Bacteriol, Feodor Lynen Str 7, D-30625 Hannover, Germany; [Wolfinger, Michael T.; Amman, Fabian] Univ Vienna, Inst Theoret Chem, Wahringer Str 17, A-1090 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Free University of Berlin; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; University of Vienna	Blasi, U (corresponding author), Univ Vienna, Max F Perutz Labs, Ctr Mol Biol, Dept Microbiol Immunobiol & Genet, Dr Bohr Gasse 9, A-1030 Vienna, Austria.	udo.blaesi@univie.ac.at	Häussler, Susanne/I-2605-2014; Pohl, Sarah/B-3102-2016; Muralidhar, Tata/ABG-2075-2021; Dötsch, Andreas/AAL-6015-2020; Dötsch, Andreas/H-1383-2013; Wolfinger, Michael Thomas/N-9538-2014	Häussler, Susanne/0000-0001-6141-9102; Pohl, Sarah/0000-0003-2655-7037; Muralidhar, Tata/0000-0001-6026-6167; Dötsch, Andreas/0000-0001-9086-2584; Dötsch, Andreas/0000-0001-9086-2584; Wolfinger, Michael Thomas/0000-0003-0925-5205; Amman, Fabian/0000-0002-8646-859X; Sonnleitner, Elisabeth/0000-0002-6961-9536	Austrian Science Fund through the Special Research Program [RNA-REG F43, AF4311]; doctoral program RNA-Biology [W-1207]	Austrian Science Fund through the Special Research Program; doctoral program RNA-Biology	The work was supported by the Austrian Science Fund (www.fwf.ac.at/en) through the Special Research Program RNA-REG F43, subproject AF4311(UB), and the doctoral program RNA-Biology W-1207 (MT).	Aendekerk S, 2005, MICROBIOL-SGM, V151, P1113, DOI 10.1099/mic.0.27631-0; Aendekerk S, 2002, MICROBIOL-SGM, V148, P2371, DOI 10.1099/00221287-148-8-2371; ALLISON DG, 1994, J BASIC MICROB, V34, P217, DOI 10.1002/jobm.3620340403; An BC, 2010, INT J RADIAT BIOL, V86, P400, DOI 10.3109/09553000903567953; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arai H, 1997, MOL MICROBIOL, V25, P1141, DOI 10.1046/j.1365-2958.1997.5431906.x; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Broderick JB, 2001, COENZYMES COFACTORS; Campanini B, 2015, CURR MED CHEM, V22, P187; Dotsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031092; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; DUCHENE M, 1989, J BACTERIOL, V171, P4130; Eichner A, 2014, INT J MED MICROBIOL, V304, P1050, DOI 10.1016/j.ijmm.2014.07.014; Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004; He FQ, 2014, INTEGR BIOL-UK, V6, P215, DOI 10.1039/c3ib40180d; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Hill D, 2005, J CLIN MICROBIOL, V43, P5085, DOI 10.1128/JCM.43.10.5085-5090.2005; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hogan D, 2002, CURR OPIN MICROBIOL, V5, P472, DOI 10.1016/S1369-5274(02)00357-0; Iobbi-Nivol C, 2013, BBA-BIOENERGETICS, V1827, P1086, DOI 10.1016/j.bbabio.2012.11.007; KATZ E, 1977, BACTERIOL REV, V41, P449, DOI 10.1128/MMBR.41.2.449-474.1977; Kertesz MA, 1999, J BACTERIOL, V181, P1464, DOI 10.1128/JB.181.5.1464-1473.1999; Kolpen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084353; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; Lenz AP, 2008, APPL ENVIRON MICROB, V74, P4463, DOI 10.1128/AEM.00710-08; Li XZ, 2003, J ANTIMICROB CHEMOTH, V51, P803, DOI 10.1093/jac/dkg148; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Lin YM, 2010, J BIOL CHEM, V285, P8985, DOI 10.1074/jbc.M109.078725; Linares JF, 2010, ENVIRON MICROBIOL, V12, P3196, DOI 10.1111/j.1462-2920.2010.02292.x; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Mac Aogain M, 2012, MICROBIOL-SGM, V158, P2598, DOI 10.1099/mic.0.058636-0; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; Manos J, 2009, FEMS MICROBIOL LETT, V292, P107, DOI 10.1111/j.1574-6968.2008.01472.x; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Mikkelsen H, 2007, J BACTERIOL, V189, P2411, DOI 10.1128/JB.01687-06; MIZUNO T, 1979, J BIOCHEM-TOKYO, V85, P115, DOI 10.1093/oxfordjournals.jbchem.a132300; Monds RD, 2001, MOL MICROBIOL, V42, P415, DOI 10.1046/j.1365-2958.2001.02641.x; Moreno R, 2009, PROTEOMICS, V9, P2910, DOI 10.1002/pmic.200800918; Morita Y, 2001, FEMS MICROBIOL LETT, V202, P139, DOI 10.1111/j.1574-6968.2001.tb10794.x; Musken M, 2010, MICROBIOL-SGM, V156, P431, DOI 10.1099/mic.0.033290-0; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Platt MD, 2008, J BACTERIOL, V190, P2739, DOI 10.1128/JB.01683-07; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; RIVERS SL, 1993, MOL MICROBIOL, V8, P1071, DOI 10.1111/j.1365-2958.1993.tb01652.x; Sanchez MB, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-148; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Schnider-Keel U, 2000, J BACTERIOL, V182, P1215, DOI 10.1128/JB.182.5.1215-1225.2000; Schreiber K, 2007, J BACTERIOL, V189, P4310, DOI 10.1128/JB.00240-07; Sekiya H, 2003, ANTIMICROB AGENTS CH, V47, P2990, DOI 10.1128/AAC.47.9.2990-2992.2003; Sheldon Albert T Jr, 2005, Clin Lab Sci, V18, P170; Shih PC, 2002, J ANTIMICROB CHEMOTH, V49, P309, DOI 10.1093/jac/49.2.309; Southey-Pillig CJ, 2005, J BACTERIOL, V187, P8114, DOI 10.1128/JB.187.23.8114-8126.2005; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Srikumar R, 1997, J BACTERIOL, V179, P7875, DOI 10.1128/jb.179.24.7875-7881.1997; Sriramulu DD, 2005, J MED MICROBIOL, V54, P667, DOI 10.1099/jmm.0.45969-0; Su HC, 2010, ANTIMICROB AGENTS CH, V54, P4626, DOI 10.1128/AAC.00762-10; Tielen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071845; TRIAS J, 1990, ANTIMICROB AGENTS CH, V34, P52, DOI 10.1128/AAC.34.1.52; Ueda A, 2009, MICROB BIOTECHNOL, V2, P62, DOI 10.1111/j.1751-7915.2008.00060.x; van der Ploeg JR, 2001, ARCH MICROBIOL, V176, P1, DOI 10.1007/s002030100298; VANDERWAUVEN C, 1984, J BACTERIOL, V160, P928, DOI 10.1128/JB.160.3.928-934.1984; Vilain S, 2004, ANAL BIOCHEM, V329, P120, DOI 10.1016/j.ab.2004.02.014; Waite RD, 2005, J BACTERIOL, V187, P6571, DOI 10.1128/JB.187.18.6571-6576.2005; Waite RD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-162; Wessel AK, 2013, J BACTERIOL, V195, P213, DOI 10.1128/JB.01253-12; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Wolfinger Michael T, 2015, F1000Res, V4, P50, DOI 10.12688/f1000research.6157.2; Wu MH, 2005, J BACTERIOL, V187, P8185, DOI 10.1128/JB.187.23.8185-8190.2005; YE RW, 1995, J BACTERIOL, V177, P3606, DOI 10.1128/jb.177.12.3606-3609.1995; Yin YS, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01031-13; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	77	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147811	10.1371/journal.pone.0147811	http://dx.doi.org/10.1371/journal.pone.0147811			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821182	Green Published, gold			2022-12-26	WOS:000369528400047
J	Valletta, E; Kucera, L; Prokes, L; Amato, F; Pivetta, T; Hampl, A; Havel, J; Vanhara, P				Valletta, Elisa; Kucera, Lukas; Prokes, Lubomir; Amato, Filippo; Pivetta, Tiziana; Hampl, Ales; Havel, Josef; Vanhara, Petr			Multivariate Calibration Approach for Quantitative Determination of Cell-Line Cross Contamination by Intact Cell Mass Spectrometry and Artificial Neural Networks	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; LASER-DESORPTION/IONIZATION-TIME; LEAST-SQUARES REGRESSION; MALDI-TOF; EXPERIMENTAL-DESIGN; CANCER-DIAGNOSIS; MAMMALIAN-CELLS; CLASSIFICATION; SPECTRA; CULTURE	Cross-contamination of eukaryotic cell lines used in biomedical research represents a highly relevant problem. Analysis of repetitive DNA sequences, such as Short Tandem Repeats (STR), or Simple Sequence Repeats (SSR), is a widely accepted, simple, and commercially available technique to authenticate cell lines. However, it provides only qualitative information that depends on the extent of reference databases for interpretation. In this work, we developed and validated a rapid and routinely applicable method for evaluation of cell culture cross-contamination levels based on mass spectrometric fingerprints of intact mammalian cells coupled with artificial neural networks (ANNs). We used human embryonic stem cells (hESCs) contaminated by either mouse embryonic stem cells (mESCs) or mouse embryonic fibroblasts (MEFs) as a model. We determined the contamination level using a mass spectra database of known calibration mixtures that served as training input for an ANN. The ANN was then capable of correct quantification of the level of contamination of hESCs by mESCs or MEFs. We demonstrate that MS analysis, when linked to proper mathematical instruments, is a tangible tool for unraveling and quantifying heterogeneity in cell cultures. The analysis is applicable in routine scenarios for cell authentication and/or cell phenotyping in general.	[Valletta, Elisa; Prokes, Lubomir; Amato, Filippo; Havel, Josef] Masaryk Univ, Fac Sci, Dept Chem, Brno, Czech Republic; [Valletta, Elisa; Pivetta, Tiziana] Univ Cagliari, Dept Chem & Geol Sci, Monserrato, CA, Italy; [Kucera, Lukas; Hampl, Ales; Vanhara, Petr] Masaryk Univ, Fac Med, Dept Histol & Embryol, Brno, Czech Republic; [Hampl, Ales] St Annes Univ Hosp Brno, Int Clin Res Ctr, Pekarska 53, Brno 65691, Czech Republic	Masaryk University Brno; University of Cagliari; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Vanhara, P (corresponding author), Masaryk Univ, Fac Med, Dept Histol & Embryol, Brno, Czech Republic.	pvanhara@med.muni.cz	Pivetta, Tiziana/AAB-2372-2021; Vanhara, Petr/G-5363-2011; Mendez, Eladia María Peña/AAB-2431-2019; Prokes, Lubomir/AAK-3363-2021; Prokeš, Lubomír/V-1045-2019; Pivetta, Tiziana/AAA-4922-2020; Hampl, Ales/N-1632-2016; Prokeš, Lubomír/AAF-2109-2020	Pivetta, Tiziana/0000-0001-9881-3584; Vanhara, Petr/0000-0002-7470-177X; Mendez, Eladia María Peña/0000-0002-1474-3134; Prokes, Lubomir/0000-0001-6044-3602; Hampl, Ales/0000-0002-8963-9235; 	Grant Agency of Masaryk University [MUNI/M/0041/2013, MUNI/A/1558/2014]; European Regional Development Fund [CZ.1.05/1.1.00/02.0123, CZ.1.07/2.3.00/20.0185]; Faculty of Medicine MU; Masaryk University, Department of Chemistry	Grant Agency of Masaryk University; European Regional Development Fund(European Commission); Faculty of Medicine MU; Masaryk University, Department of Chemistry	This study was supported by Grant Agency of Masaryk University (MUNI/M/0041/2013 and MUNI/A/1558/2014), from the European Regional Development Fund (CZ.1.05/1.1.00/02.0123 and CZ.1.07/2.3.00/20.0185) and by funds from the Faculty of Medicine MU to junior researcher (Petr Vanhara). Elisa Valletta gratefully acknowledges the Masaryk University and its Department of Chemistry, for the kind hospitality and for funding her stay in Brno. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Alfassi ZB, 2004, J AM SOC MASS SPECTR, V15, P385, DOI 10.1016/j.jasms.2003.11.008; Amato F, 2013, J APPL BIOMED, V11, P47, DOI 10.2478/v10136-012-0031-x; Amato F, 2012, TALANTA, V93, P72, DOI 10.1016/j.talanta.2012.01.044; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Asakawa Daiki, 2012, Mass Spectrom (Tokyo), V1, pA0002, DOI 10.5702/massspectrometry.A0002; Baradez MO, 2015, CYTOM PART A, V87A, P624, DOI 10.1002/cyto.a.22637; Barta T, 2010, STEM CELLS, V28, P1143, DOI 10.1002/stem.451; Bas D, 2007, J FOOD ENG, V78, P836, DOI 10.1016/j.jfoodeng.2005.11.024; Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3; Brougham DF, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/158094; Buchanan CM, 2007, RAPID COMMUN MASS SP, V21, P3452, DOI 10.1002/rcm.3253; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Chiu NHL, 2015, ENVIRON TOXICOL CHEM, V34, P161, DOI 10.1002/etc.2774; Chun H, 2010, J R STAT SOC B, V72, P3, DOI 10.1111/j.1467-9868.2009.00723.x; Didion JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-847; Dong HJ, 2011, ANALYST, V136, P5181, DOI 10.1039/c1an15750g; Filzmoser P, 2012, J CHEMOMETR, V26, P42, DOI 10.1002/cem.1418; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hanrieder J, 2011, ANAL BIOANAL CHEM, V401, P135, DOI 10.1007/s00216-011-5043-y; Hilario M, 2006, MASS SPECTROM REV, V25, P409, DOI 10.1002/mas.20072; Holubcova Z, 2011, STEM CELLS, V29, P46, DOI 10.1002/stem.549; Houska J, 2014, J APPL BIOMED, V12, P119, DOI 10.1016/j.jab.2013.12.001; Hynds RE, 2013, STEM CELLS, V31, P417, DOI 10.1002/stem.1290; Ibanez AJ, 2015, ELECTROPHORESIS; Kober SL, 2015, ANAL BIOANAL CHEM; Kotasova H, 2012, J CELL BIOCHEM, V113, P563, DOI 10.1002/jcb.23380; Li H, 2002, ACTA CHIM SINICA, V60, P1264; Lokhov P, 2009, RAPID COMMUN MASS SP, V23, P680, DOI 10.1002/rcm.3928; Lui H, 2012, CANCER RES, V72, P2491, DOI 10.1158/0008-5472.CAN-11-4061; Marx V, 2014, NAT METHODS, V11, P483, DOI 10.1038/nmeth.2932; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; Maurer K, 2013, ORAL ONCOL, V49, P152, DOI 10.1016/j.oraloncology.2012.08.012; Mehling M, 2014, CURR OPIN BIOTECH, V25, P95, DOI 10.1016/j.copbio.2013.10.005; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Munteanu B, 2014, ANAL CHEM, V86, P4642, DOI 10.1021/ac500038j; Munteanu B, 2013, BIOANALYSIS, V5, P885, DOI [10.4155/BIO.13.47, 10.4155/bio.13.47]; Munteanu B, 2012, ANAL BIOANAL CHEM, V404, P2277, DOI 10.1007/s00216-012-6357-0; Nardone RM, 2007, CELL BIOL TOXICOL, V23, P367, DOI 10.1007/s10565-007-9019-9; Nienow AW, 2006, CYTOTECHNOLOGY, V50, P9, DOI 10.1007/s10616-006-9005-8; Pivetta T, 2013, TALANTA, V115, P84, DOI 10.1016/j.talanta.2013.04.031; Povey JF, 2014, J BIOTECHNOL, V184, P84, DOI 10.1016/j.jbiotec.2014.04.028; Rasmussen MA, 2012, CHEMOMETR INTELL LAB, V119, P21, DOI 10.1016/j.chemolab.2012.10.003; Volta P, 2012, J LIMNOL, V71, P164, DOI 10.4081/jlimnol.2012.e17; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Xie WY, 2015, ANAL CHEM, V87, P7052, DOI 10.1021/acs.analchem.5b00010; Zhang X, 2006, J AM SOC MASS SPECTR, V17, P490, DOI 10.1016/j.jasms.2005.12.007	48	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147414	10.1371/journal.pone.0147414	http://dx.doi.org/10.1371/journal.pone.0147414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821236	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528400026
J	Begun, A; Morbach, S; Rumenapf, G; Icks, A				Begun, Alexander; Morbach, Stephan; Ruemenapf, Gerhard; Icks, Andrea			Study of Disease Progression and Relevant Risk Factors in Diabetic Foot Patients Using a Multistate Continuous-Time Markov Chain Model	PLOS ONE			English	Article							AMPUTATION; MORTALITY; SURVIVAL; RATES; ULCERS; IMPACT	The diabetic foot is a lifelong disease. The longer patients with diabetes and foot ulcers are observed, the higher the likelihood that they will develop comorbidities that adversely influence ulcer recurrence, amputation and survival (for example peripheral arterial disease, renal failure or ischaemic heart disease). The purpose of our study was to quantify person and limb-related disease progression and the time-dependent influence of any associated factors (present at baseline or appearing during observation) based on which effective prevention and/or treatment strategies could be developed. Using a nine-state continuous-time Markov chain model with time-dependent risk factors, all living patients were divided into eight groups based on their ulceration (previous or current) and previous amputation (none, minor or major) status. State nine is an absorbing state (death). If all transitions are fully observable, this model can be decomposed into eight submodels, which can be analyzed using the methods of survival analysis for competing risks. The dependencies of the risk factors (covariates) were included in the submodels using Cox-like regression. The transition intensities and relative risks for covariates were calculated from long-term data of patients with diabetic foot ulcers collected in a single specialized center in North-Rhine Westphalia (Germany). The detected estimates were in line with previously published, but scarce, data. Together with the interesting new results obtained, this indicates that the proposed model may be useful for studying disease progression in larger samples of patients with diabetic foot ulcers.	[Begun, Alexander; Morbach, Stephan; Icks, Andrea] Univ Dusseldorf, German Diabet Ctr, Paul Langerhans Grp Hlth Serv Res & Hlth Econ, Dusseldorf, Germany; [Morbach, Stephan] Dept Diabet & Angiol, Marienkrankenhaus, Soest, Germany; [Ruemenapf, Gerhard] Gefasszentrum Oberrhein, Dept Vasc Surg, Diakonissen Stiftungs Krankenhaus Speyer, Mannheim, Germany; [Icks, Andrea] Univ Dusseldorf, Ctr Hlth & Soc, Dept Publ Hlth, Dusseldorf, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; St. Marien Hospital; Heinrich Heine University Dusseldorf	Begun, A (corresponding author), Univ Dusseldorf, German Diabet Ctr, Paul Langerhans Grp Hlth Serv Res & Hlth Econ, Dusseldorf, Germany.	alexander.begun@ddz.uni-duesseldorf.de						APELQVIST J, 1993, J INTERN MED, V233, P485, DOI 10.1111/j.1365-2796.1993.tb01003.x; Armstrong David G, 2007, Int Wound J, V4, P286; Armstrong DG, 2013, J AM PODIAT MED ASSN, V103, P161, DOI 10.7547/1030161; Begun A, 2013, MED DECIS MAKING, V33, P298, DOI 10.1177/0272989X12466731; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Brownrigg JRW, 2014, J VASC SURG, V60, P982, DOI 10.1016/j.jvs.2014.04.052; de Wreede LC, 2011, J STAT SOFTW, V38, P1; Faglia E, 2001, DIABETES CARE, V24, P78, DOI 10.2337/diacare.24.1.78; Hoffmann F, 2013, J DIABETES COMPLICAT, V27, P467, DOI 10.1016/j.jdiacomp.2013.05.001; Icks A, 2009, EXP CLIN ENDOCR DIAB, V117, P500, DOI 10.1055/s-0029-1225333; Icks A, 2011, DIABETES CARE, V34, P1350, DOI 10.2337/dc10-2341; Izumi Y, 2009, DIABETES RES CLIN PR, V83, P126, DOI 10.1016/j.diabres.2008.09.005; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Morbach S, 2013, DIABETES CARE, V36, pE62, DOI 10.2337/dc12-2335; Morbach S, 2012, DIABETES CARE, V35, P2021, DOI 10.2337/dc12-0200; Oakes D, 1996, ANAL SURVIVAL DATA; PECORARO RE, 1990, DIABETES CARE, V13, P513, DOI 10.2337/diacare.13.5.513; Pound N, 2005, DIABETIC MED, V22, P1306, DOI 10.1111/j.1464-5491.2005.01640.x; Robbins JM, 2008, J AM PODIAT MED ASSN, V98, P489, DOI 10.7547/0980489; Tanudjaja T, 1995, P 2 INT S DIAB FOOT; Welton NJ, 2005, MED DECIS MAKING, V25, P633, DOI 10.1177/0272989X05282637	21	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147533	10.1371/journal.pone.0147533	http://dx.doi.org/10.1371/journal.pone.0147533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814723	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528200039
J	Temeles, EJ; Newman, JT; Newman, JH; Cho, SY; Mazzotta, AR; Kress, WJ				Temeles, Ethan J.; Newman, Julia T.; Newman, Jennifer H.; Cho, Se Yeon; Mazzotta, Alexandra R.; Kress, W. John			Pollinator Competition as a Driver of Floral Divergence: An Experimental Test	PLOS ONE			English	Article							FLOWER COLOR POLYMORPHISM; PURPLE-THROATED CARIBS; RESOURCE COMPETITION; MEDIATED SELECTION; HUMMINGBIRD; POPULATIONS; EVOLUTION; FIDELITY; TERRITORIALITY; BUMBLEBEES	Optimal foraging models of floral divergence predict that competition between two different types of pollinators will result in partitioning, increased assortative mating, and divergence of two floral phenotypes. We tested these predictions in a tropical plant-pollinator system using sexes of purple-throated carib hummingbirds (Anthracothorax jugularis) as the pollinators, red and yellow inflorescence morphs of Heliconia caribaea as the plants, and fluorescent dyes as pollen analogs in an enclosed outdoor garden. When foraging alone, males exhibited a significant preference for the yellow morph of H. caribaea, whereas females exhibited no preference. In competition, males maintained their preference for the yellow morph and through aggression caused females to over-visit the red morph, resulting in resource partitioning. Competition significantly increased within-morph dye transfer (assortative mating) relative to non-competitive environments. Competition and partitioning of color morphs by sexes of purple-throated caribs also resulted in selection for floral divergence as measured by dye deposition on stigmas. Red and yellow morphs did not differ significantly in dye deposition in the competition trials, but differences in dye deposition and preferences for morphs when sexes of purple-throated caribs foraged alone implied fixation of one or the other color morph in the absence of competition. Competition also resulted in selection for divergence in corolla length, with the red morph experiencing directional selection for longer corollas and the yellow morph experiencing stabilizing selection on corolla length. Our results thus support predictions of foraging models of floral divergence and indicate that pollinator competition is a viable mechanism for divergence in floral traits of plants.	[Temeles, Ethan J.; Newman, Julia T.; Newman, Jennifer H.; Cho, Se Yeon; Mazzotta, Alexandra R.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA; [Kress, W. John] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, MRC 166, Washington, DC 20560 USA	Amherst College; Smithsonian Institution; Smithsonian National Museum of Natural History	Temeles, EJ (corresponding author), Amherst Coll, Dept Biol, Amherst, MA 01002 USA.	ejtemeles@amherst.edu	Temeles, Ethan J./AAD-7366-2021		Amherst College; Smithsonian Institution; National Science Foundation [DEB-614218, DEB-1353783]	Amherst College; Smithsonian Institution(Smithsonian Institution); National Science Foundation(National Science Foundation (NSF))	This research was supported by awards from Amherst College (www.amherst.edu), The Smithsonian Institution (www.si.edu), and the National Science Foundation (www.nsf.gov) grants DEB-614218 and DEB-1353783. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizmendi MC, 1996, FUNCT ECOL, V10, P119, DOI 10.2307/2390270; Berry F., 1991, HELICONIA IDENTIFICA; Carlson JE, 2010, AM J BOT, V97, P934, DOI 10.3732/ajb.0900348; Darwin C, 1859, ORIGIN SPECIES MEANS; Endler J.A., 1986, Monographs in Population Biology, pviii; FAIRBAIRN DJ, 2001, EVOLUTIONARY ECOLOGY, P35; Foellmer MW, 2005, J EVOLUTION BIOL, V18, P629, DOI 10.1111/j.1420-9101.2005.00868.x; Gegear RJ, 2004, CAN J ZOOL, V82, P587, DOI 10.1139/Z04-029; GILL FB, 1975, ECOLOGY, V56, P333, DOI 10.2307/1934964; Gill SA, 2006, BEHAV ECOL SOCIOBIOL, V61, P245, DOI 10.1007/s00265-006-0255-4; GOLDSMITH TH, 1980, SCIENCE, V207, P786, DOI 10.1126/science.7352290; Gowda V, 2009, THESIS G WASHINGTON; Gowda V, 2013, BIOTROPICA, V45, P224, DOI 10.1111/j.1744-7429.2012.00915.x; Gowda V, 2012, WILSON J ORNITHOL, V124, P81, DOI 10.1676/11-061.1; Graham L, 1996, AM MIDL NAT, V136, P401, DOI 10.2307/2426743; Greenberg R, 1997, J AVIAN BIOL, V28, P103, DOI 10.2307/3677303; Gumbert A, 1999, P ROY SOC B-BIOL SCI, V266, P1711, DOI 10.1098/rspb.1999.0836; HEINRICH B, 1976, ECOLOGY, V57, P874, DOI 10.2307/1941054; INOUYE DW, 1978, ECOLOGY, V59, P672, DOI 10.2307/1938769; Irwin RE, 2003, ECOLOGY, V84, P1733, DOI 10.1890/0012-9658(2003)084[1733:TROHIT]2.0.CO;2; Jones EI, 2012, ANN NY ACAD SCI, V1256, P66, DOI 10.1111/j.1749-6632.2012.06552.x; Jones KN, 2001, AM J BOT, V88, P447, DOI 10.2307/2657109; Kearns C. A., 1993, TECHNIQUES POLLINATI; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Law BS, 1996, OIKOS, V77, P447, DOI 10.2307/3545934; Maglianesi MA, 2015, J ANIM ECOL, V84, P655, DOI 10.1111/1365-2656.12319; McDonald J.H., 2009, HDB BIOL STAT; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Nattero J, 2010, OIKOS, V119, P852, DOI 10.1111/j.1600-0706.2009.17766.x; Pfennig D. W., 2012, EVOLUTIONS WEDGE COM; POSSINGHAM HP, 1992, ECOLOGY, V73, P1903, DOI 10.2307/1940041; RANTA E, 1980, OIKOS, V35, P298, DOI 10.2307/3544643; Rathcke B., 1983, P305; Remsen JV, 2015, ZOOTAXA, V3957, P143, DOI 10.11646/zootaxa.3957.1.13; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rodriguez-Girones M. A., 2010, OPEN ECOLOGY J, V3, P1, DOI [DOI 10.2174/1874213001003040001, 10.2174/1874213001003040001]; Rodriguez-Girones MA, 2004, PLOS BIOL, V2, P1515, DOI 10.1371/journal.pbio.0020350; Rodriguez-Girones MA, 2005, P ROY SOC B-BIOL SCI, V272, P187, DOI 10.1098/rspb.2005.2936; Rodriguez-Girones MA, 2007, AM NAT, V170, P455, DOI 10.1086/520121; Rodriguez-Girones MA, 2006, BEHAV ECOL, V17, P905, DOI 10.1093/beheco/arl024; Rodriguez-Girones MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002992; Sandlin EA, 2000, BEHAV ECOL, V11, P550, DOI 10.1093/beheco/11.5.550; Schemske DW, 2007, EVOLUTION, V61, P2528, DOI 10.1111/j.1558-5646.2007.00219.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sobral M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132522; Temeles EJ, 2013, J EVOLUTION BIOL, V26, P347, DOI 10.1111/jeb.12053; Temeles EJ, 2000, SCIENCE, V289, P441, DOI 10.1126/science.289.5478.441; Temeles EJ, 2005, AUK, V122, P187, DOI 10.1642/0004-8038(2005)122[0187:FATEOS]2.0.CO;2; Temeles EJ, 2003, SCIENCE, V300, P630, DOI 10.1126/science.1080003; Temeles EJ, 2006, BEHAV ECOL SOCIOBIOL, V61, P163, DOI 10.1007/s00265-006-0247-4; Temeles EJ, 2010, P ROY SOC B-BIOL SCI, V277, P1607, DOI 10.1098/rspb.2009.2188; Temeles EJ, 2009, ECOLOGY, V90, P1147, DOI 10.1890/08-0695.1; Whitfield M, 2014, BEHAV ECOL, V25, P328, DOI 10.1093/beheco/art115	53	14	15	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146431	10.1371/journal.pone.0146431	http://dx.doi.org/10.1371/journal.pone.0146431			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814810	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528200014
J	Dong, JF; Song, YQ; Li, WL; Shi, J; Wang, ZY				Dong, Junfeng; Song, Yueqin; Li, Wenliang; Shi, Jie; Wang, Zhenying			Identification of Putative Chemosensory Receptor Genes from the Athetis dissimilis Antennal Transcriptome	PLOS ONE			English	Article							OLFACTORY RECEPTORS; CHEMORECEPTOR SUPERFAMILY; MEMBRANE TOPOLOGY; ODORANT RECEPTORS; EVOLUTION; MOTH; SPECIALIZATION; FAMILY; EXPANSION; LINEAGE	Olfaction plays a crucial role in insect population survival and reproduction. Identification of the genes associated with the olfactory system, without the doubt will promote studying the insect chemical communication system. In this study, RNA-seq technology was used to sequence the antennae transcriptome of Athetis dissimilis, an emerging crop pest in China with limited genomic information, with the purpose of identifying the gene set involved in olfactory recognition. Analysis of the transcriptome of female and male antennae generated 13.74 Gb clean reads in total from which 98,001 unigenes were assembled, and 25,930 unigenes were annotated. Total of 60 olfactory receptors (ORs), 18 gustatory receptors (GRs), and 12 ionotropic receptors (IRs) were identified by Blast and sequence similarity analyzes. One obligated olfactory receptor co-receptor (Orco) and four conserved sex pheromone receptors (PRs) were annotated in 60 ORs. Among the putative GRs, five genes (AdisGR1, 6, 7, 8 and 94) clustered in the sugar receptor family, and two genes (AdisGR3 and 93) involved in CO2 detection were identified. Finally, AdisIR8a.1 and AdisIR8a.2 co-receptors were identified in the group of candidate IRs. Furthermore, expression levels of these chemosensory receptor genes in female and male antennae were analyzed by mapping the Illumina reads.	[Dong, Junfeng; Song, Yueqin; Li, Wenliang] Henan Univ Sci & Technol, Coll Forestry, Luoyang 471003, Peoples R China; [Shi, Jie] Hebei Acad Agr & Forestry Sci, Inst Plant Protect, Baoding 071000, Peoples R China; [Wang, Zhenying] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Henan University of Science & Technology; Hebei Academy of Agricultural & Forestry Sciences; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wang, ZY (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	zywang@ippcaas.cn	Li, Wenliang/AAO-1408-2021		Special Fund for Agro-scientific Research in the Public Interest [201303026]; Youth Scientific Fund of Henan University of Science and Technology [2015QN029]	Special Fund for Agro-scientific Research in the Public Interest; Youth Scientific Fund of Henan University of Science and Technology	This research was supported by Special Fund for Agro-scientific Research in the Public Interest (201303026) grant and the Youth Scientific Fund of Henan University of Science and Technology (2015QN029).	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; ANDO T, 1977, AGR BIOL CHEM TOKYO, V41, P1485, DOI 10.1080/00021369.1977.10862690; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Cao DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101187; Cho YH, 2010, J NATL PARK RES, V1, P108; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Gardiner A, 2008, MOL ECOL, V17, P1648, DOI 10.1111/j.1365-294X.2008.03713.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Han Hui-Lin, 2008, Acta Zootaxonomica Sinica, V33, P696; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Leitch O, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1466-8; [李静雯 Li Jingwen], 2014, [植物保护, Plant Protection], V40, P193; Liu S, 2015, COMP BIOCHEM PHYS D, V13, P44, DOI 10.1016/j.cbd.2015.01.004; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Lombarkia N, 2008, ENTOMOL EXP APPL, V128, P57, DOI 10.1111/j.1570-7458.2008.00741.x; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; McBride CS, 2007, GENETICS, V177, P1395, DOI 10.1534/genetics.107.078683; Mitchell RF, 2012, INSECT BIOCHEM MOLEC, V42, P499, DOI 10.1016/j.ibmb.2012.03.007; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Obiero GFO, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002663; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Rinker DC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-749; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Robertson HM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1901; Sato K, 2009, RESULTS PROBL CELL D, V47, P121, DOI 10.1007/400_2008_10; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Takahashi M., 1975, Japanese J Sanit Zool, V26, P66; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang ZF, 2015, CELL MOL LIFE SCI, V72, P4429, DOI 10.1007/s00018-015-2009-9; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Xu W, 2015, INSECT MOL BIOL, V24, P253, DOI 10.1111/imb.12153; Zhang DY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056312, 10.1371/journal.pone.0077345]	52	24	31	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147768	10.1371/journal.pone.0147768	http://dx.doi.org/10.1371/journal.pone.0147768			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812239	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528000053
J	Romero-Soriano, V; Guerreiro, MPG				Romero-Soriano, Valeria; Garcia Guerreiro, Maria Pilar			Expression of the Retrotransposon Helena Reveals a Complex Pattern of TE Deregulation in Drosophila Hybrids	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; RNA PATHWAY; DNA LOSS; GENOME; TRANSPOSITION; BUZZATII; HYBRIDIZATION; GERMLINE; MELANOGASTER; INSTABILITY	Transposable elements (TEs), repeated mobile sequences, are ubiquitous in the eukaryotic kingdom. Their mobilizing capacity confers on them a high mutagenic potential, which must be strongly regulated to guarantee genome stability. In the Drosophila germline, a small RNA-mediated silencing system, the piRNA (Piwi-interacting RNA) pathway, is the main responsible TE regulating mechanism, but some stressful conditions can destabilize it. For instance, during interspecific hybridization, genomic stress caused by the shock of two different genomes can lead, in both animals and plants, to higher transposition rates. A recent study in D. buzatii-D. koepferae hybrids detected mobilization of 28 TEs, yet little is known about the molecular mechanisms explaining this transposition release. We have characterized one of the mobilized TEs, the retrotransposon Helena, and used quantitative expression to assess whether its high transposition rates in hybrids are preceded by increased expression. We have also localized Helena expression in the gonads to see if cellular expression patterns have changed in the hybrids. To give more insight into changes in TE regulation in hybrids, we analysed Helena-specific piRNA populations of hybrids and parental species. Helena expression is not globally altered in somatic tissues, but male and female gonads have different patterns of deregulation. In testes, Helena is repressed in F1, increasing then its expression up to parental values. This is linked with a mislocation of Helena transcripts along with an increase of their specific piRNA levels. Ovaries have additive levels of Helena expression, but the ping-pong cycle efficiency seems to be reduced in F1 hybrids. This could be at the origin of new Helena insertions in hybrids, which would be transmitted to F1 hybrid female progeny.	[Romero-Soriano, Valeria; Garcia Guerreiro, Maria Pilar] Univ Autonoma Barcelona, Dept Genet & Microbiol, Grp Genom Bioinformat & Biol Evolut, Edifici C, E-08193 Barcelona, Spain	Autonomous University of Barcelona	Guerreiro, MPG (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, Grp Genom Bioinformat & Biol Evolut, Edifici C, E-08193 Barcelona, Spain.	mariapilar.garcia.guerreiro@uab.cat	Guerreiro, Maria Pilar Garcia/AAB-5507-2019	Guerreiro, Maria Pilar Garcia/0000-0001-9951-1879; Romero-Soriano, Valeria/0000-0003-1717-2928	Ministerio de Economia y Competitividad (Spain) [CGL2013-42432-P]; Generalitat de Catalunya [SGR 1346]; Universitat Autonoma de Barcelona (Spain)	Ministerio de Economia y Competitividad (Spain)(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Universitat Autonoma de Barcelona (Spain)	This work was supported by research grant CGL2013-42432-P from the Ministerio de Economia y Competitividad (Spain) and grant 2014 SGR 1346 from Generalitat de Catalunya to the Grup de Genomica, Bioinformatica i Biologia Evolutiva (GGBE). VRS was supported by a PIF PhD fellowship from the Universitat Autonoma de Barcelona (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkouche A, 2013, EMBO REP, V14, P458, DOI 10.1038/embor.2013.38; Akkouche A, 2012, J VIROL, V86, P3675, DOI 10.1128/JVI.07146-11; Antoniewski C, 2014, METHODS MOL BIOL, V1173, P135, DOI 10.1007/978-1-4939-0931-5_12; Borie N, 2002, HEREDITY, V89, P247, DOI 10.1038/sj.hdy.6800135; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; EVGENEV MB, 1982, CHROMOSOMA, V85, P375, DOI 10.1007/BF00330360; Fablet M, 2014, GENE, V537, P149, DOI 10.1016/j.gene.2013.11.095; Filatov DA, 1998, MOL GEN GENET, V258, P646, DOI 10.1007/s004380050778; FINNEGAN DJ, 1989, TRENDS GENET, V5, P103, DOI 10.1016/0168-9525(89)90039-5; Fontdevila A, 2005, CYTOGENET GENOME RES, V110, P49, DOI 10.1159/000084937; Franco FF, 2010, J ZOOL SYST EVOL RES, V48, P322, DOI 10.1111/j.1439-0469.2010.00564.x; Guerreiro MPG, 2015, MOL GENET GENOMICS, V290, P1471, DOI 10.1007/s00438-015-1012-z; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Gomez GA, 2003, MOL BIOL EVOL, V20, P410, DOI 10.1093/molbev/msg051; Granzotto A, 2011, MOL GENET GENOMICS, V286, P57, DOI 10.1007/s00438-011-0629-9; Granzotto A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-174; Grentzinger T, 2014, METHODS, V67, P91, DOI 10.1016/j.ymeth.2013.05.011; Guillen Y, 2015, GENOME BIOL EVOL, V7, P349, DOI 10.1093/gbe/evu291; Hirst J, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-22; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelleher ES, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001428; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Labrador M, 1999, MOL BIOL EVOL, V16, P931, DOI 10.1093/oxfordjournals.molbev.a026182; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levine MT, 2011, CELL, V147, P1440, DOI 10.1016/j.cell.2011.12.001; Liu B, 2000, GENOME, V43, P874, DOI 10.1139/gen-43-5-874; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marin I, 1998, J HERED, V89, P336, DOI 10.1093/jhered/89.4.336; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Metcalfe CJ, 2007, GENETICS, V177, P2507, DOI 10.1534/genetics.107.082313; Mirkovic-Hosle M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084994; Modolo L, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0546-8; Moehring AJ, 2007, MOL BIOL EVOL, V24, P137, DOI 10.1093/molbev/msl142; Moran T, 2014, J HERED, V105, P381, DOI 10.1093/jhered/esu003; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; O'Neill RJW, 1998, NATURE, V393, P68, DOI 10.1038/29985; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Olovnikov IA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P572, DOI 10.1134/S0006297913060035; Petrov DA, 1998, MOL BIOL EVOL, V15, P293, DOI 10.1093/oxfordjournals.molbev.a025926; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Petrov DA, 1995, P NATL ACAD SCI US; Piccinali R, 2004, MOL BIOL EVOL, V21, P141, DOI [10.1093/molbev/msh006, 10.1093/molbev.msh006]; PINOL J, 1988, NUCLEIC ACIDS RES, V16, P2736, DOI 10.1093/nar/16.6.2736; Rebollo R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-149; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rozhkov NV, 2013, GENES DEV; Schaack S, 2010, TRENDS ECOL EVOL, V25, P537, DOI 10.1016/j.tree.2010.06.001; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Senerchia N, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2874; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Simkin A, 2013, EVOLUTION, V67, P1081, DOI 10.1111/evo.12011; Siomi MC, 2008, FEBS LETT, V582, P2473, DOI 10.1016/j.febslet.2008.06.018; Soto EM, 2008, ENTOMOL EXP APPL, V126, P18, DOI 10.1111/j.1570-7458.2007.00631.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Theron E, 2014, MOBILE DNA-UK, V5, P1; Ungerer MC, 2006, CURR BIOL, V16, pR872, DOI 10.1016/j.cub.2006.09.020; Vela D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088992; Vela D, 2011, BIOTECHNIQUES, V50, P247, DOI 10.2144/000113655; Wang NN, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-190; White-Cooper Helen, 2012, Spermatogenesis, V2, P11; Wicker T, 2007, NAT REV GENET, V10, P276; Xie WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072163	68	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147903	10.1371/journal.pone.0147903	http://dx.doi.org/10.1371/journal.pone.0147903			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812285	Green Published, gold			2022-12-26	WOS:000369528000061
J	Tebruegge, M; Pantazidou, A; MacGregor, D; Gonis, G; Leslie, D; Sedda, L; Ritz, N; Connell, T; Curtis, N				Tebruegge, Marc; Pantazidou, Anastasia; MacGregor, Duncan; Gonis, Gena; Leslie, David; Sedda, Luigi; Ritz, Nicole; Connell, Tom; Curtis, Nigel			Nontuberculous Mycobacterial Disease in Children - Epidemiology, Diagnosis & Management at a Tertiary Center	PLOS ONE			English	Article							VITAMIN-D; CERVICOFACIAL LYMPHADENITIS; CERVICAL LYMPHADENITIS; TUBERCULOSIS; PREVALENCE; INFECTION; SURVEILLANCE; MULTICENTER; SEASONALITY; ASSAYS	Background There are limited data on the epidemiology, diagnosis and optimal management of nontuberculous mycobacterial (NTM) disease in children. Methods Retrospective cohort study of NTM cases over a 10-year-period at a tertiary referral hospital in Australia. Results A total of 140 children with NTM disease, including 107 with lymphadenitis and 25 with skin and soft tissue infections (SSTIs), were identified. The estimated incidence of NTM disease was 0.6-1.6 cases / 100,000 children / year; no increasing trend was observed over the study period. Temporal analyses revealed a seasonal incidence cycle around 12 months, with peaks in late winter/spring and troughs in autumn. Mycobacterium-avium-complex accounted for most cases (77.8%), followed by Mycobacterium ulcerans (14.4%) and Mycobacterium marinum (3.3%). Polymerase chain reaction testing had higher sensitivity than culture and microscopy for acid-fast bacilli (92.0%, 67.2% and 35.7%, respectively). The majority of lymphadenitis cases underwent surgical excision (97.2%); multiple recurrences in this group were less common in cases treated with clarithromycin and rifampicin compared with clarithromycin alone or no anti-mycobacterial drugs (0% versus 7.1%; OR: 0.73). SSTI recurrences were also less common in cases treated with two anti-mycobacterial drugs compared with one or none (10.5% versus 33.3%; OR: 0.23). Conclusions There was seasonal variation in the incidence of NTM disease, analogous to recently published observations in tuberculosis, which have been linked to seasonal variation in vitamin D. Our finding that anti-mycobacterial combination therapy was associated with a reduced risk of recurrences in patients with NTM lymphadenitis or SSTI requires further confirmation in prospective trials.	[Tebruegge, Marc; Ritz, Nicole; Connell, Tom; Curtis, Nigel] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Tebruegge, Marc; Pantazidou, Anastasia; Connell, Tom; Curtis, Nigel] Royal Childrens Hosp Melbourne, Infect Dis Unit, Parkville, Vic, Australia; [Tebruegge, Marc; Connell, Tom; Curtis, Nigel] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Tebruegge, Marc] Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Tebruegge, Marc] Univ Hosp Southampton NHS Fdn Trust, NIHR Resp Biomed Res Unit, Southampton, Hants, England; [MacGregor, Duncan] Royal Childrens Hosp Melbourne, Dept Anat Pathol, Parkville, Vic, Australia; [Gonis, Gena] Royal Childrens Hosp Melbourne, Dept Microbiol, Parkville, Vic, Australia; [Leslie, David] Victorian Infect Dis Reference Lab, Mycobacterium Reference Lab, North Melbourne, Australia; [Sedda, Luigi] Univ Southampton, Dept Geog & Environm, Southampton, Hants, England; [Ritz, Nicole] Univ Childrens Hosp Basel, Infect Dis Unit, Basel, Switzerland	University of Melbourne; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Victorian Infectious Diseases Reference Laboratory; University of Southampton; University of Basel	Tebruegge, M (corresponding author), Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia.; Tebruegge, M (corresponding author), Royal Childrens Hosp Melbourne, Infect Dis Unit, Parkville, Vic, Australia.; Tebruegge, M (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.; Tebruegge, M (corresponding author), Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England.; Tebruegge, M (corresponding author), Univ Hosp Southampton NHS Fdn Trust, NIHR Resp Biomed Res Unit, Southampton, Hants, England.	m.tebruegge@soton.ac.uk	Curtis, Nigel/B-3491-2012; Sedda, Luigi/ABD-8784-2020; Ritz, Nicole/L-1452-2019; Ritz, Nicole/G-2924-2015	Curtis, Nigel/0000-0003-3446-4594; Ritz, Nicole/0000-0002-1498-1685; Ritz, Nicole/0000-0002-1498-1685; Sedda, Luigi/0000-0002-9271-6596	UK National Institute for Health Research (NIHR); National Institute for Health Research [CL-2011-26-004] Funding Source: researchfish	UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	MT was supported by a Clinical Lectureship provided by the UK National Institute for Health Research (NIHR).	[Anonymous], 2008, YB AUSTR; Blyth CC, 2009, PEDIATR INFECT DIS J, V28, P801, DOI 10.1097/INF.0b013e31819f7b3f; Boyages S, 2012, CLIN ENDOCRINOL, V77, P515, DOI 10.1111/j.1365-2265.2012.04398.x; Bureau of Meterology TAG, 2013, AV DAIL SUNSH HOURS; Cruz AT, 2010, PEDIATR INFECT DIS J, V29, P772, DOI 10.1097/INF.0b013e3181da5795; Fyfe JA, 2008, J CLIN MICROBIOL, V46, P618, DOI 10.1128/JCM.01186-07; Fyfe JAM, 2007, APPL ENVIRON MICROB, V73, P4733, DOI 10.1128/AEM.02971-06; Gelder CM, 2000, J INFECT DIS, V181, P2099, DOI 10.1086/315489; GRANGE JM, 1995, ARCH DIS CHILD, V72, P516, DOI 10.1136/adc.72.6.516; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Haverkamp MH, 2004, CLIN INFECT DIS, V39, P450, DOI 10.1086/422319; HORSBURGH CR, 1989, AM REV RESPIR DIS, V139, P4, DOI 10.1164/ajrccm/139.1.4; Jeon K, 2013, RESPIROLOGY, V18, P983, DOI 10.1111/resp.12109; KUTH G, 1995, ORL J OTO-RHINO-LARY, V57, P36, DOI 10.1159/000276704; Lindeboom JA, 2007, CLIN INFECT DIS, V44, P1057, DOI 10.1086/512675; Lopez-Varela E, 2015, LANCET RESP MED, V3, P244, DOI 10.1016/S2213-2600(15)00062-4; MACCALLUM P, 1948, J PATHOL BACTERIOL, V60, P93, DOI 10.1002/path.1700600111; Maltezou HC, 1999, PEDIATR INFECT DIS J, V18, P968, DOI 10.1097/00006454-199911000-00006; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Naranbat N, 2009, EUR RESPIR J, V34, P921, DOI 10.1183/09031936.00035309; Nienhuis WA, 2010, LANCET, V375, P664, DOI 10.1016/S0140-6736(09)61962-0; Nolt D, 2003, PEDIATRICS, V112, pE434, DOI 10.1542/peds.112.5.e434; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Pham-Huy A, 2010, PAED CHILD HEALT-CAN, V15, P276, DOI 10.1093/pch/15.5.276; Pierre-Audigier C, 2005, J CLIN MICROBIOL, V43, P3467, DOI 10.1128/JCM.43.7.3467-3470.2005; Pilkington EF, 2010, INT J PEDIATR OTORHI, V74, P343, DOI 10.1016/j.ijporl.2009.08.029; Ralph AR, 2013, LANCET INFECT DIS, V13, P77, DOI 10.1016/S1473-3099(12)70275-X; Reuss AM, 2009, PEDIATR INFECT DIS J, V28, P642, DOI 10.1097/INF.0b013e3181978e8e; ROMANUS V, 1995, TUBERCLE LUNG DIS, V76, P300, DOI 10.1016/S0962-8479(05)80028-0; Schaaf HS, 1996, TUBERCLE LUNG DIS, V77, P43, DOI 10.1016/S0962-8479(96)90074-X; Tebruegge M, 2010, EUR RESPIR J, V36, P214, DOI 10.1183/09031936.00025510; Tebruegge M., 2012, PRINCIPLES PRACTICE, VVolume 4, P786; Tebruegge M, 2011, ADV EXP MED BIOL, V719, P201, DOI 10.1007/978-1-4614-0204-6_17; Tebruegge M, 2010, INT J INFECT DIS, V14, pE305, DOI 10.1016/j.ijid.2010.02.2246; Thorpe LE, 2004, LANCET, V364, P1613, DOI 10.1016/S0140-6736(04)17316-9; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; WHITE MP, 1986, ARCH DIS CHILD, V61, P368, DOI 10.1136/adc.61.4.368; WOLINSKY E, 1979, AM REV RESPIR DIS, V119, P107; Zimmermann P, 2015, J INFECTION, V71, P9, DOI 10.1016/j.jinf.2015.02.010	39	53	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147513	10.1371/journal.pone.0147513	http://dx.doi.org/10.1371/journal.pone.0147513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812154	Green Published, gold, Green Accepted			2022-12-26	WOS:000369528000036
J	Aslam, M; Aggarwal, S; Sharma, KK; Galav, V; Madhu, SV				Aslam, Mohammad; Aggarwal, Sarla; Sharma, Krishna Kumar; Galav, Vikas; Madhu, Sri Venkata			Postprandial Hypertriglyceridemia Predicts Development of Insulin Resistance Glucose Intolerance and Type 2 Diabetes	PLOS ONE			English	Article							METABOLIC SYNDROME; PIOGLITAZONE; ROSIGLITAZONE; LIPOPROTEINS; SENSITIVITY; MELLITUS; LIPEMIA; WISTAR; MODEL; DIET	Insulin resistance (IR) and type 2 diabetes mellitus (T2DM) have been found to be associated with postprandial hypertriglyceridemia (PPHTg). However, whether PPHTg can cause IR and diabetes is not clear. We therefore investigated the role of PPHTg in development of T2DM in rat model of T2DM. 96 male Wistar rats were randomized into four groups (24 rats each). Control Group A, high sucrose diet (HSD) Group B, HSD+Pioglitazone (10mg/kg/day) Group C and HSD+Atorvastatin (20mg/kg/day) Group D. Fat and glucose tolerance tests were done at regular intervals in all groups besides insulin and body weight measurement. At 26 weeks, low dose streptozotocin (15mg/kg,i.p.) was given to half of the rats. All rats were followed up till 48 weeks. PPHTg developed as early as week 2 in Group B and stabilized by week 14. Group B displayed highest PPHTg compared to other groups. Atorvastatin treatment (Group D) abolished PPHTg which became comparable to controls, pioglitazone treatment partially blunted PPHTg resulting in intermediate PPHTg. Group B with highest PPHTg showed highest subsequent IR, glucose intolerance (GI) and highest incidence of prediabetes at week 26 and diabetes at week 34 and 46 compared to other groups. Group D rats displayed lower IR, GI, low incidence of prediabetes and diabetes at these time points compared to Groups B and C. ROC analysis showed that triglyceride area under the curve of each time point significantly predicts the risk of diabetes. Present study provides the evidence that PPHTg predicts the development of IR, GI and T2DM in rat model of diet induced T2DM.	[Aslam, Mohammad; Madhu, Sri Venkata] Univ Delhi, Ctr Diabet Endocrinol & Metab, Dept Med, Univ Coll Med Sci, Delhi 110007, India; [Aslam, Mohammad; Aggarwal, Sarla; Sharma, Krishna Kumar; Galav, Vikas; Madhu, Sri Venkata] GTB Hosp, Delhi, India; [Aggarwal, Sarla] Univ Delhi, Dept Pathol, Univ Coll Med Sci, Delhi 110007, India; [Sharma, Krishna Kumar; Galav, Vikas] Univ Delhi, Dept Pharmacol, Univ Coll Med Sci, Delhi 110007, India	University of Delhi; University College of Medical Sciences; University of Delhi; University College of Medical Sciences; University of Delhi; University College of Medical Sciences; University of Delhi; University College of Medical Sciences	Madhu, SV (corresponding author), Univ Delhi, Ctr Diabet Endocrinol & Metab, Dept Med, Univ Coll Med Sci, Delhi 110007, India.; Madhu, SV (corresponding author), GTB Hosp, Delhi, India.	drsvmadhu@gmail.com	Madhu, S/AAH-7431-2019	Madhu, S/0000-0003-0018-5984; Galav, Vikas/0000-0002-9059-4302	Department of Biotechnology, Ministry of Science and Technology, India [BT/PR14215/MED/30/403/2010/]	Department of Biotechnology, Ministry of Science and Technology, India	The work was supported by Department of Biotechnology, Ministry of Science and Technology, India, Grant ID: BT/PR14215/MED/30/403/2010/. Grant received by S.V.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghamohammadzadeh N, 2015, THER ADV ENDOCRINOL, V6, P56, DOI 10.1177/2042018815574229; Aoki T, 2002, EUR J PHARMACOL, V444, P107, DOI 10.1016/S0014-2999(02)01547-9; Axelsen M, 1999, ANN INTERN MED, V131, P27, DOI 10.7326/0003-4819-131-1-199907060-00006; Battula SB, 2000, METABOLISM, V49, P1049, DOI 10.1053/meta.2000.7744; BECKNIELSEN H, 1994, J CLIN INVEST, V94, P1714, DOI 10.1172/JCI117518; Burnett JR, 1998, ARTERIOSCL THROM VAS, V18, P1906, DOI 10.1161/01.ATV.18.12.1906; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; Chappuis B, 2007, DIABETES-METAB RES, V23, P392, DOI 10.1002/dmrr.715; Del Zotto H, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740225; Derosa G, 2006, CLIN THER, V28, P679, DOI 10.1016/j.clinthera.2006.05.012; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; FOLCH J, 1957, J BIOL CHEM, V226, P497; Funatsu T, 2003, METABOLISM, V52, P609, DOI 10.1053/meta.2003.50097; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Harris WS, 1997, AM J CLIN NUTR, V65, P5; Kamgang R, 2005, DIABETES RES CLIN PR, V69, P224, DOI 10.1016/j.diabres.2005.02.005; King Allen B, 2002, Diabetes Technol Ther, V4, P145, DOI 10.1089/15209150260007354; Leahy Jack L, 2005, JOSLINS DIABETES MEL, P454; Madhu SV, 2008, DIABETES RES CLIN PR, V80, P380, DOI 10.1016/j.diabres.2008.01.016; Mingrone G, 1999, DIABETES, V48, P1258, DOI 10.2337/diabetes.48.6.1258; Mori Y, 2005, NUTRITION, V21, P933, DOI 10.1016/j.nut.2005.01.009; Park S, 2001, J KOREAN MED SCI, V16, P386, DOI 10.3346/jkms.2001.16.4.386; Pedrini MT, 2006, DIABETOLOGIA, V49, P1612, DOI 10.1007/s00125-006-0262-z; Peng J, 2014, PPAR RES, V2014, DOI 10.1155/2014/538183; Rajendran A, J APPL SCI RES, V3, P1434; REBUFFESCRIVE M, 1993, METABOLISM, V42, P1405, DOI 10.1016/0026-0495(93)90190-Y; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; SANE T, 1993, DIABETES CARE, V16, P1494, DOI 10.2337/diacare.16.11.1494; Savage DB, 2003, DIABETES, V52, P910, DOI 10.2337/diabetes.52.4.910; Sinha B, 2008, THESIS U DELHI; Wang HJ, 2007, ASIA PAC J CLIN NUTR, V16, P412; Zhang N, 2010, ACTA PHARMACOL SIN, V31, P35, DOI 10.1038/aps.2009.176	32	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0145730	10.1371/journal.pone.0145730	http://dx.doi.org/10.1371/journal.pone.0145730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808523	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800009
J	Kowalczyk-Pachel, D; Iciek, M; Wydra, K; Nowak, E; Gorny, M; Filip, M; Wlodek, L; Lorenc-Koci, E				Kowalczyk-Pachel, Danuta; Iciek, Malgorzata; Wydra, Karolina; Nowak, Ewa; Gorny, Magdalena; Filip, Malgorzata; Wlodek, Lidia; Lorenc-Koci, Elzbieta			Cysteine Metabolism and Oxidative Processes in the Rat Liver and Kidney after Acute and Repeated Cocaine Treatment	PLOS ONE			English	Article							MITOCHONDRIAL BIOENERGETIC FUNCTION; HYDROGEN-SULFIDE; 3-MERCAPTOPYRUVATE SULFURTRANSFERASE; SULFANE SULFUR; INORGANIC SULFATE; ELECTRON-TRANSFER; MAMMALIAN-CELLS; MALE-MICE; IN-VITRO; STRESS	The role of cocaine in modulating the metabolism of sulfur-containing compounds in the peripheral tissues is poorly understood. In the present study we addressed the question about the effects of acute and repeated (5 days) cocaine (10 mg/kg i.p.) administration on the total cysteine (Cys) metabolism and on the oxidative processes in the rat liver and kidney. The whole pool of sulfane sulfur, its bound fraction and hydrogen sulfide (H2S) were considered as markers of anaerobic Cys metabolism while the sulfate as a measure of its aerobic metabolism. The total-, non-protein- and protein- SH group levels were assayed as indicators of the redox status of thiols. Additionally, the activities of enzymes involved in H2S formation (cystathionine gamma-lyase, CSE; 3-mercaptopyruvate sulfurtransferase, 3-MST) and GSH metabolism (gamma-glutamyl transpeptidase,gamma-GT; glutathione S-transferase, GST) were determined. Finally, we assayed the concentrations of reactive oxygen species (ROS) and malondialdehyde (MDA) as markers of oxidative stress and lipid peroxidation, respectively. In the liver, acute cocaine treatment, did not change concentrations of the whole pool of sulfane sulfur, its bound fraction, H2S or sulfate but markedly decreased levels of nonprotein SH groups (NPSH), ROS and GST activity while gamma-GT was unaffected. In the kidney, acute cocaine significantly increased concentration of the whole pool of sulfane sulfur, reduced the content of its bound fraction but H2S, sulfate and NPSH levels were unchanged while ROS and activities of GST and gamma-GT were reduced. Acute cocaine enhanced activity of the CSE and 3-MST in the liver and kidney, respectively. Repeatedly administered cocaine enhanced the whole pool of sulfane sulfur and reduced H2S level simultaneously increasing sulfate content both in the liver and kidney. After repeated cocaine, a significant decrease in ROS was still observed in the liver while in the kidney, despite unchanged ROS content, a marked increase in MDA level was visible. The repeated cocaine decreased 3-MST and increased gamma-GT activities in both organs but reduced GST in the kidney. Our results show that cocaine administered at a relatively low dose shifts Cys metabolism towards the formation of sulfane sulfur compounds which possess antioxidant and redox regulatory properties and are a source of H2S which can support mitochondrial bioenergetics.	[Kowalczyk-Pachel, Danuta; Iciek, Malgorzata; Gorny, Magdalena; Wlodek, Lidia] Jagiellonian Univ, Coll Med, Chair Med Biochem, Krakow, Poland; [Wydra, Karolina; Nowak, Ewa; Filip, Malgorzata] Polish Acad Sci, Inst Pharmacol, Lab Drug Addict Pharmacol, Krakow, Poland; [Lorenc-Koci, Elzbieta] Polish Acad Sci, Inst Pharmacol, Dept Neuropsychopharmacol, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Polish Academy of Sciences; Polish Academy of Sciences	Lorenc-Koci, E (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Neuropsychopharmacol, Krakow, Poland.	lorenc@if-pan.krakow.pl	Iciek, Małgorzata/GNP-4844-2022	Gorny, Magdalena/0000-0002-6393-9977; Lorenc-Koci, Elzbieta/0000-0002-9970-8548; Iciek, Malgorzata/0000-0002-0422-0428; Filip, Malgorzata/0000-0002-4321-7942	Statuary Founds of Institute Pharmacology Polish Academy of Sciences; KNOW (Leading National Research Centre, Krakow, Poland)	Statuary Founds of Institute Pharmacology Polish Academy of Sciences; KNOW (Leading National Research Centre, Krakow, Poland)	This work was supported by Statuary Founds of Institute Pharmacology Polish Academy of Sciences. The cost of this publication was financed by KNOW (Leading National Research Centre, Krakow, Poland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTHOLOMEW TC, 1980, BIOCHEM PHARMACOL, V29, P2431, DOI 10.1016/0006-2952(80)90346-9; Bilska A, 2007, NEUROSCIENCE, V146, P1758, DOI 10.1016/j.neuroscience.2007.04.002; Bilska A, 2008, PHARMACOL REP, V60, P225; BOELSTERLI UA, 1991, ARCH TOXICOL, V65, P351, DOI 10.1007/BF02284256; BONDY SC, 1994, EUR J PHARM-ENVIRON, V270, P349, DOI 10.1016/0926-6917(94)90011-6; Bouillaud F, 2011, ANTIOXID REDOX SIGN, V15, P379, DOI 10.1089/ars.2010.3678; Brannan RG, 2010, J AGR FOOD CHEM, V58, P3767, DOI 10.1021/jf903587n; Cerretani D, 2012, CURR MED CHEM, V19, P5619, DOI 10.2174/092986712803988785; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; COMMANDEUR JNM, 1995, PHARMACOL REV, V47, P271; Cunha-Oliveira T, 2013, LIFE SCI, V92, P1157, DOI 10.1016/j.lfs.2013.04.016; Cunha-Oliveira T, 2013, TOXICOL LETT, V219, P298, DOI 10.1016/j.toxlet.2013.03.025; Devi BG, 1997, LIFE SCI, V60, P849, DOI 10.1016/S0024-3205(97)00013-1; Devi BG, 1999, J CARDIOVASC PHARM, V33, P1, DOI 10.1097/00005344-199901000-00001; DODGSON KS, 1961, BIOCHEM J, V78, P312, DOI 10.1042/bj0780312; EVERETT SA, 1994, FREE RADICAL RES, V20, P387, DOI 10.3109/10715769409145638; Feng CJ, 2007, BBA-PROTEINS PROTEOM, V1774, P527, DOI 10.1016/j.bbapap.2007.03.006; Furne J, 2001, BIOCHEM PHARMACOL, V62, P255, DOI 10.1016/S0006-2952(01)00657-8; Giles GI, 2001, FREE RADICAL BIO MED, V31, P1279, DOI 10.1016/S0891-5849(01)00710-9; Giles GI, 2002, BIOL CHEM, V383, P375, DOI 10.1515/BC.2002.042; Glauser J, 2007, J EMERG MED, V32, P181, DOI 10.1016/j.jemermed.2006.05.044; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hatfield MJ, 2010, BRIT J PHARMACOL, V160, P1916, DOI 10.1111/j.1476-5381.2010.00700.x; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Heard Kennon, 2008, Open Pharmacol J, V2, P70, DOI 10.2174/1874143600802010070; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; HINCHMAN CA, 1990, BIOCHEM PHARMACOL, V40, P1131, DOI 10.1016/0006-2952(90)90503-D; Huang J, 1998, CHEM-BIOL INTERACT, V110, P189, DOI 10.1016/S0009-2797(98)00015-5; Huseby NE, 2003, BIOFACTORS, V17, P151, DOI 10.1002/biof.5520170115; Iciek M, 2001, POL J PHARMACOL, V53, P215; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; Jacob C, 2011, BIOCHEM SOC T, V39, P1247, DOI 10.1042/BST0391247; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kamendulis LM, 1996, J PHARMACOL EXP THER, V279, P713; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; Kimura H, 2014, ANTIOXID REDOX SIGN, V20, P783, DOI 10.1089/ars.2013.5309; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; KLOSS MW, 1983, TOXICOL LETT, V15, P65, DOI 10.1016/0378-4274(83)90171-6; KOJ A, 1967, BIOCHEM J, V103, P791, DOI 10.1042/bj1030791; Kovacic P, 2005, MED HYPOTHESES, V64, P350, DOI 10.1016/j.mehy.2004.06.028; Kowalczyk-Pachel D, 2013, NEUROTOX RES, V24, P377, DOI 10.1007/s12640-013-9403-6; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Labib R, 2002, J TOXICOL ENV HEAL A, V65, P977, DOI 10.1080/00984100290071252; Labib R, 2001, TOXICOL LETT, V125, P29, DOI 10.1016/S0378-4274(01)00412-X; Lagoutte E, 2010, BBA-BIOENERGETICS, V1797, P1500, DOI 10.1016/j.bbabio.2010.04.004; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu CY, 2013, METHODS, V62, P177, DOI 10.1016/j.ymeth.2013.05.020; MATSUO Y, 1959, J BIOL CHEM, V234, P516; MEHANNY SZ, 1991, TOXICOL PATHOL, V19, P24, DOI 10.1177/019262339101900103; Mikami Y, 2011, BIOCHEM J, V439, P479, DOI 10.1042/BJ20110841; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834; Modis K, 2014, BRIT J PHARMACOL, V171, P2123, DOI 10.1111/bph.12368; Modis K, 2013, FASEB J, V27, P601, DOI 10.1096/fj.12-216507; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Ndikum-Moffor FM, 1998, J PHARMACOL EXP THER, V284, P413; OGASAWARA Y, 1994, BIOL PHARM BULL, V17, P1535; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; ORLOWSKI M, 1963, BIOCHIM BIOPHYS ACTA, V73, P679; Ranguelova K, 2012, FREE RADICAL BIO MED, V52, P1264, DOI 10.1016/j.freeradbiomed.2012.01.016; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Shibuya N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2371; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; SODA K, 1967, AGR BIOL CHEM TOKYO, V31, P1054, DOI 10.1080/00021369.1967.10858916; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; STEWART DJ, 1979, CLIN PHARMACOL THER, V25, P464; Stipanuk MH, 2011, J INHERIT METAB DIS, V34, P17, DOI 10.1007/s10545-009-9006-9; Szabo C, 2014, BRIT J PHARMACOL, V171, P2099, DOI 10.1111/bph.12369; SZCZEPKOWSKI T, 1961, NATURE, V189, P1007, DOI 10.1038/1891007a0; Tamizhselvi R, 2007, J CELL MOL MED, V11, P315, DOI 10.1111/j.1582-4934.2007.00024.x; Toohey JI, 2011, ANAL BIOCHEM, V413, P1, DOI 10.1016/j.ab.2011.01.044; Turhan H, 2007, INT J CARDIOL, V114, P106, DOI 10.1016/j.ijcard.2005.11.020; Valente MJ, 2012, CURR MED CHEM, V19, P5601, DOI 10.2174/092986712803988938; Valente MJ, 2012, ARCH TOXICOL, V86, P249, DOI 10.1007/s00204-011-0749-3; VALENTINE WN, 1974, CLIN CHIM ACTA, V51, P205, DOI 10.1016/0009-8981(74)90031-X; Visalli T, 2005, INT J TOXICOL, V24, P43, DOI 10.1080/10915810590918715; Visalli T, 2004, INT J TOXICOL, V23, P163, DOI 10.1080/10915810490471334; Vitcheva V, 2012, CURR MED CHEM, V19, P5677, DOI 10.2174/092986712803988929; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; WIENER HL, 1990, BIOCHEM PHARMACOL, V40, P1763, DOI 10.1016/0006-2952(90)90353-M; WINTERBOURN CC, 1994, ARCH BIOCHEM BIOPHYS, V314, P284, DOI 10.1006/abbi.1994.1444; WOOD JL, 1987, METHOD ENZYMOL, V143, P25; Xiao YJ, 2000, J PHARMACOL EXP THER, V292, P8; Yadav A, 2013, J MOL MODEL, V19, P767, DOI 10.1007/s00894-012-1601-2; Yong R, 2001, COMP BIOCHEM PHYS B, V129, P129, DOI 10.1016/S1096-4959(01)00309-8	88	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147238	10.1371/journal.pone.0147238	http://dx.doi.org/10.1371/journal.pone.0147238			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808533	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800065
J	Swatton, JE; Davenport, PW; Maunders, EA; Griffin, JL; Lilley, KS; Welch, M				Swatton, J. E.; Davenport, P. W.; Maunders, E. A.; Griffin, J. L.; Lilley, K. S.; Welch, M.			Impact of Azithromycin on the Quorum Sensing-Controlled Proteome of Pseudomonas aeruginosa	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CYSTIC-FIBROSIS; SUBINHIBITORY CONCENTRATIONS; MACROLIDE ANTIBIOTICS; VIRULENCE FACTORS; BIOFILM FORMATION; GROWTH-PHASE; INFECTION; GENES; PAO1	The macrolide antibiotic, azithromycin (AZM), has been reported to improve the clinical outcome of cystic fibrosis patients, many of whom are chronically-infected with Pseudomonas aeruginosa. However, the highest clinically-achievable concentrations of this drug are well-below the minimum inhibitory concentration for P. aeruginosa, raising the question of why AZM exhibits therapeutic activity. One possibility that has been raised by earlier studies is that AZM inhibits quorum sensing (QS) by P. aeruginosa. To explicitly test this hypothesis the changes brought about by AZM treatment need to be compared with those associated with specific QS mutants grown alongside in the same growth medium, but this has not been done. In this work, we used quantitative 2D-difference gel electrophoresis and H-1-NMR spectroscopy footprint analysis to examine whether a range of clinically-relevant AZM concentrations elicited proteomic and metabolomic changes in wild-type cultures that were similar to those seen in cultures of defined QS mutants. Consistent with earlier reports, over half of the AZM-induced spot changes on the 2D gels were found to affect QS-regulated proteins. However, AZM modulated very few protein spots overall (compared with QS) and collectively, these modulated proteins comprised only a small fraction (12-13%) of the global QS regulon. We conclude that AZM perturbs a sub-regulon of the QS system but does not block QS per se. Reinforcing this notion, we further show that AZM is capable of attenuating virulence factor production in another Gram-negative species that secretes copious quantities of exoenzymes (Serratia marcescens), even in the absence of a functional QS system.	[Swatton, J. E.; Davenport, P. W.; Maunders, E. A.; Griffin, J. L.; Welch, M.] Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England; [Lilley, K. S.] Cambridge Ctr Prote, Tennis Court Rd, Cambridge CB2 1QW, England; [Swatton, J. E.] Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England; [Davenport, P. W.] Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England; [Griffin, J. L.] Elsie Widdowson Lab, MRC Human Nutr Res, 120 Fulbourn Rd, Cambridge CB1 9NL, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Welch, M (corresponding author), Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	mw240@cam.ac.uk	Lilley, Kathryn/ABF-5787-2020; Maunders, Eve/GVU-3355-2022	Lilley, Kathryn/0000-0003-0594-6543; Maunders, Eve/0000-0003-2812-6943	Biotechnology and Biological Sciences Research Council [BB/C/500252/1, BB/M019411/1]; BBSRC (UK); Biotechnology and Biological Sciences Research Council [BB/C500252/1] Funding Source: researchfish; Medical Research Council [MR/P011705/1, MC_UP_A090_1006, 1509178] Funding Source: researchfish; MRC [MR/P011705/1, MC_UP_A090_1006] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grants (BB/C/500252/1) and (BB/M019411/1) from the Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have no conflicting financial interests. This work was supported by the BBSRC (UK). Pfizer (UK) is thanked for generously supplying azithromycin.	Arevalo-Ferro C, 2003, ENVIRON MICROBIOL, V5, P1350, DOI 10.1046/j.1462-2920.2003.00532.x; Atherton HJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.18; Baraquet C, 2016, J BACTERIOL, V198, P178, DOI 10.1128/JB.00539-15; Baumann Ulrich, 2004, Can Respir J, V11, P151; Becher A, 2000, BIOTECHNIQUES, V29, P948, DOI 10.2144/00295bm04; Borlee BR, 2010, MOL MICROBIOL, V75, P827, DOI 10.1111/j.1365-2958.2009.06991.x; Boulette ML, 2009, J BACTERIOL, V191, P6329, DOI 10.1128/JB.00817-09; BRINT JM, 1995, J BACTERIOL, V177, P7155, DOI 10.1128/jb.177.24.7155-7163.1995; Chugani S, 2012, P NATL ACAD SCI USA, V109, pE2823, DOI 10.1073/pnas.1214128109; Coulthurst SJ, 2006, MICROBIOL-SGM, V152, P1899, DOI 10.1099/mic.0.28803-0; D'Argenio DA, 2001, J BACTERIOL, V183, P1466, DOI 10.1128/JB.183.4.1466-1471.2001; Davenport PW, 2015, J BACTERIOL, V197, P2072, DOI 10.1128/JB.02557-14; Dekimpe V, 2009, MICROBIOL-SGM, V155, P712, DOI 10.1099/mic.0.022764-0; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; Diggle SP, 2006, INT J MED MICROBIOL, V296, P83, DOI 10.1016/j.ijmm.2006.01.038; Duan K, 2007, J BACTERIOL, V189, P4827, DOI 10.1128/JB.00043-07; Favre-Bonte S, 2003, J ANTIMICROB CHEMOTH, V52, P598, DOI 10.1093/jac/dkg397; Foweraker J, 2009, BRIT MED BULL, V89, P93, DOI 10.1093/bmb/ldn050; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Gillis RJ, 2005, ANTIMICROB AGENTS CH, V49, P3858, DOI 10.1128/AAC.49.9.3858-3867.2005; Gillis RJ, 2004, J CLIN MICROBIOL, V42, P5842, DOI 10.1128/JCM.42.12.5842-5845.2004; Glansdorp FG, 2008, ORG BIOMOL CHEM, V6, P4120, DOI 10.1039/b813157k; Godeke J, 2013, ANTIMICROB AGENTS CH, V57, P1617, DOI 10.1128/AAC.02582-12; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Gross J, 2013, FUTURE MICROBIOL, V8, P697, DOI [10.2217/fmb.13.40, 10.2217/FMB.13.40]; Harris SJ, 1998, MOL MICROBIOL, V28, P705, DOI 10.1046/j.1365-2958.1998.00825.x; Hoffmann N, 2007, ANTIMICROB AGENTS CH, V51, P3677, DOI 10.1128/AAC.01011-06; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Howe RA, 1997, J ANTIMICROB CHEMOTH, V40, P153, DOI 10.1093/jac/40.2.153; Imperi F, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00178; Kai T, 2009, PULM PHARMACOL THER, V22, P483, DOI 10.1016/j.pupt.2009.04.004; Karp NA, 2005, PROTEOMICS, V5, P81, DOI 10.1002/pmic.200400881; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Kohler T, 2007, ANTIMICROB AGENTS CH, V51, P4243, DOI 10.1128/AAC.00613-07; Marvig RL, 2012, ANTIMICROB AGENTS CH, V56, P4519, DOI 10.1128/AAC.00630-12; MCDONALD PJ, 1991, EUR J CLIN MICROBIOL, V10, P828, DOI 10.1007/BF01975835; Mikkelsen H, 2007, J BACTERIOL, V189, P2411, DOI 10.1128/JB.01687-06; Mikkelsen H, 2009, MICROBIOL-SGM, V155, P687, DOI 10.1099/mic.0.025551-0; MOLINARI G, 1993, J ANTIMICROB CHEMOTH, V31, P681, DOI 10.1093/jac/31.5.681; Nalca Y, 2006, ANTIMICROB AGENTS CH, V50, P1680, DOI 10.1128/AAC.50.5.1680-1688.2006; Nouwens AS, 2003, MICROBIOL-SGM, V149, P1311, DOI 10.1099/mic.0.25967-0; Passmore IJ, 2015, J BACTERIOL, V197, P762, DOI 10.1128/JB.02404-14; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; Perez-Martinez I, 2011, ANTIMICROB AGENTS CH, V55, P3399, DOI 10.1128/AAC.01801-10; Phelan VV, 2015, J AM SOC MASS SPECTR, V26, P873, DOI 10.1007/s13361-015-1101-6; Plotnikova JM, 2000, PLANT PHYSIOL, V124, P1766, DOI 10.1104/pp.124.4.1766; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Retsema J, 2001, INT J ANTIMICROB AG, V18, pS3, DOI 10.1016/S0924-8579(01)00401-0; Robert-Genthon M, 2013, MBIO, V4, DOI 10.1128/mBio.00309-13; Rumbaugh KP, 1999, INFECT IMMUN, V67, P5854, DOI 10.1128/IAI.67.11.5854-5862.1999; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; Saiman L, 2010, JAMA-J AM MED ASSOC, V303, P1707, DOI 10.1001/jama.2010.563; Sams T, 2016, ISR J CHEM, V56, P282, DOI 10.1002/ijch.201400128; Sana TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076030; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2004, P NATL ACAD SCI USA, V101, P15833, DOI 10.1073/pnas.0407229101; Sibley CD, 2010, FUTURE MICROBIOL, V5, P1315, DOI [10.2217/fmb.10.99, 10.2217/FMB.10.99]; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Skindersoe ME, 2008, ANTIMICROB AGENTS CH, V52, P3648, DOI 10.1128/AAC.01230-07; Smith Debra, 2006, Science Progress, V89, P167, DOI 10.3184/003685006783238335; Tateda K, 2001, ANTIMICROB AGENTS CH, V45, P1930, DOI 10.1128/AAC.45.6.1930-1933.2001; Tsai WC, 2009, INFLAMM RES, V58, P491, DOI 10.1007/s00011-009-0015-9; Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Wozniak DJ, 2004, CHEST, V125, p62S, DOI 10.1378/chest.125.2_suppl.62S; Xiao GP, 2006, MOL MICROBIOL, V62, P1689, DOI 10.1111/j.1365-2958.2006.05462.x	68	28	33	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147698	10.1371/journal.pone.0147698	http://dx.doi.org/10.1371/journal.pone.0147698			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808156	Green Published, gold			2022-12-26	WOS:000369527800187
J	Wan, CY; Xiang, JM; Li, YW; Guo, DZ				Wan, Chunyun; Xiang, Jinmei; Li, Youwen; Guo, Dingzong			Differential Gene Expression Patterns in Chicken Cardiomyocytes during Hydrogen Peroxide-Induced Apoptosis	PLOS ONE			English	Article							CELL-CYCLE; OXIDATIVE STRESS; ACTIVATION; ARREST; HEART; CDK4; MITOCHONDRIA; INHIBITION; RESISTANCE; PROFILES	Hydrogen peroxide (H2O2) is both an exogenous and endogenous cytotoxic agent that can reliably induce apoptosis in numerous cell types for studies on apoptosis signaling pathways. However, little is known of these apoptotic processes in myocardial cells of chicken, a species prone to progressive heart failure. Sequencing of mRNA transcripts (RNA-Seq) allows for the identification of differentially expressed genes under various physiological and pathological conditions to elucidate the molecular pathways involved, including cellular responses to exogenous and endogenous toxins. We used RNA-seq to examine genes differentially expressed during H2O2-induced apoptosis in primary cultures of embryonic chicken cardiomyocytes. Following control or H2O2 treatment, RNA was extracted and sequencing performed to identify novel transcripts up-or downregulated in the H2O2 treatment group and construct protein - protein interaction networks. Of the 19,268 known and 2,160 novel transcripts identified in both control and H2O2 treatment groups, 4,650 showed significant differential expression. Among them, 55.63% were upregulated and 44.37% downregulated. Initiation of apoptosis by H2O2 was associated with upregulation of caspase-8, caspase-9, and caspase-3, and downregulation of anti-apoptotic genes API5 and TRIA1. Many other differentially expressed genes were associated with metabolic pathways (including 'Fatty acid metabolism', 'Alanine, aspartate, and glutamate metabolism', and 'Biosynthesis of unsaturated fatty acids') and cell signaling pathways (including 'PPAR signaling pathway', 'Adipocytokine signaling pathway', 'TGF-beta signaling pathway', 'MAPK signaling pathway', and 'p53 signaling pathway'). In chicken cardiomyocytes, H2O2 alters the expression of numerous genes linked to cell signaling and metabolism as well as genes directly associated with apoptosis. In particular, H2O2 also affects the biosynthesis and processing of proteins and unsaturated fatty acids. These results highlight the value of RNAseq for revealing unexpected molecular contributors to oxidative stress responses, thereby identifying novel potential therapeutic targets.	[Wan, Chunyun; Xiang, Jinmei; Li, Youwen; Guo, Dingzong] Huazhong Agr Univ, Coll Vet Med, Wuhan, Hubei, Peoples R China; [Wan, Chunyun] Yangtze Univ, Coll Anim Sci, Jingzhou, Hubei, Peoples R China; [Xiang, Jinmei] Hubei Vocat Coll Biotechnol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Yangtze University	Guo, DZ (corresponding author), Huazhong Agr Univ, Coll Vet Med, Wuhan, Hubei, Peoples R China.	hlgdz@163.com			Huazhong agricultural university [52209-814112]	Huazhong agricultural university	This work was supported by preliminary research project of Huazhong agricultural university (52209-814112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082322; Briede JJ, 2010, TOXICOL SCI, V114, P193, DOI 10.1093/toxsci/kfp309; Chang GC, 2004, BIOCHEM PHARMACOL, V68, P1453, DOI 10.1016/j.bcp.2004.06.006; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Choi CH, 2007, LEUKEMIA RES, V31, P1267, DOI 10.1016/j.leukres.2006.11.006; Chua PJ, 2009, EXP BIOL MED, V234, P1086, DOI 10.3181/0903-RM-98; Clerk A, 2007, PHYSIOL GENOMICS, V29, P118, DOI 10.1152/physiolgenomics.00168.2006; Connell S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040409; DEHAAN RL, 1967, CIRCULATION, V35, P821, DOI 10.1161/01.CIR.35.5.821; EWEN ME, 1995, GENE DEV, V9, P204, DOI 10.1101/gad.9.2.204; Fong CC, 2007, TOXICOLOGY, V236, P16, DOI 10.1016/j.tox.2007.03.024; Fortin A, 2004, J BIOL CHEM, V279, P28706, DOI 10.1074/jbc.M400376200; Fry DW, 2001, J BIOL CHEM, V276, P16617, DOI 10.1074/jbc.M008867200; Fukuda K, 2005, FUTUR CARDIOL, V1, P167, DOI 10.1517/14796678.1.2.167; Furukawa Junya, 2011, Nihon Rinsho, V69 Suppl 5, P117; Gaballa MA, 2002, J CARD FAIL, V8, pS476, DOI 10.1054/jcaf.2002.129270; Gregoli PA, 1999, J CELL PHYSIOL, V178, P133, DOI 10.1002/(SICI)1097-4652(199902)178:2<133::AID-JCP2>3.3.CO;2-X; Grossmann J, 2001, CELL GROWTH DIFFER, V12, P147; Gruss-Fischer T, 2002, BIOCHEM PHARMACOL, V63, P1325, DOI 10.1016/S0006-2952(02)00863-8; Jiang BM, 2005, CELL STRESS CHAPERON, V10, P252, DOI 10.1379/CSC-124R.1; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karuppagounder SS, 2012, J CEREBR BLOOD F MET, V32, P1347, DOI 10.1038/jcbfm.2012.28; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mueller T, 2003, CANCER RES, V63, P513; Olkowski AA, 2007, POULTRY SCI, V86, P999, DOI 10.1093/ps/86.5.999; Park KJ, 2012, KOREAN CIRC J, V42, P23, DOI 10.4070/kcj.2012.42.1.23; Piccoli MT, 2015, J MOL CELL CARDIOL; Platel A, 2010, MUTAT RES-FUND MOL M, V689, P21, DOI 10.1016/j.mrfmmm.2010.04.004; Renfro DP, 2012, NUCLEIC ACIDS RES, V40, pD1262, DOI 10.1093/nar/gkr907; Shibanuma M, 2011, FREE RADICAL RES, V45, P672, DOI 10.3109/10715762.2011.564169; Skomedal H, 1999, J PATHOL, V187, P556, DOI 10.1002/(SICI)1096-9896(199904)187:5<556::AID-PATH294>3.0.CO;2-Y; Solaini G, 2005, BIOCHEM J, V390, P377, DOI 10.1042/BJ20042006; Suzuki T, 2014, BIOCHEM BIOPH RES CO, V444, P248, DOI 10.1016/j.bbrc.2014.01.058; Takeuchi T, 2014, DEV GROWTH DIFFER, V56, P402, DOI 10.1111/dgd.12134; Tamim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085591; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Uchida S, 2015, CIRC RES, V116, P737, DOI 10.1161/CIRCRESAHA.116.302521; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Wu J, 2006, CELL MOL LIFE SCI, V63, P2538, DOI 10.1007/s00018-006-6138-z; Zeiger AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037904; Zhang J, 2014, MOL MED REP, V9, P621, DOI 10.3892/mmr.2013.1848; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025284; Zhao WY, 2013, MOL CELL BIOCHEM, V379, P243, DOI 10.1007/s11010-013-1646-2	46	7	7	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147950	10.1371/journal.pone.0147950	http://dx.doi.org/10.1371/journal.pone.0147950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808997	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800250
J	Bagci, C; Allmer, J				Bagci, Caner; Allmer, Jens			One Step Forward, Two Steps Back; Xeno-MicroRNAs Reported in Breast Milk Are Artifacts	PLOS ONE			English	Article							SMALL RNAS; GENE; ALIGNMENT	Background MicroRNAs (miRNAs) are short RNA sequences that guide post-transcriptional regulation of gene expression via complementarity to their target mRNAs. Discovered only recently, miRNAs have drawn a lot of attention. Multiple protein complexes interact to first cleave a hairpin from nascent RNA, export it into the cytosol, trim its loop, and incorporate it into the RISC complex which is important for binding its target mRNA. This process works within one cell, but circulating miRNAs have been described suggesting a role in cell-cell communication. Motivation Viruses and intracellular parasites like Toxoplasma gondii use miRNAs to manipulate host gene expression from within the cellular environment. However, recent research has claimed that a rice miRNA may regulate human gene expression. Despite ongoing debates about these findings and general reluctance to accept them, a recent report claimed that foodborne plant miRNAs pass through the digestive tract, travel through blood to be incorporated by alveolar cells excreting milk. The miRNAs are then said to have some immune-related function in the newborn. Principal Findings We acquired the data that supports their claim and performed further analyses. In addition to the reported miRNAs, we were able to detect almost complete mRNAs and found that the foreign RNA expression profiles among samples are exceedingly similar. Inspecting the source of the data helped understand how RNAs could contaminate the samples. Conclusion Viewing these findings in context with the difficulties foreign RNAs face on their route into breast milk and the fact that many identified foodborne miRNAs are not from actual food sources, we can conclude beyond reasonable doubt that the original claims and evidence presented may be due to artifacts. We report that the study claiming their existence is more likely to have detected RNA contamination than miRNAs.	[Bagci, Caner] Izmir Inst Technol, Dept Biotechnol, Izmir, Turkey; [Allmer, Jens] Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey; [Allmer, Jens] Bionia Inc, IZTEKGEB A8, Izmir, Turkey	Izmir Institute of Technology; Izmir Institute of Technology; Izmir Metropolitan Municipality	Allmer, J (corresponding author), Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey.; Allmer, J (corresponding author), Bionia Inc, IZTEKGEB A8, Izmir, Turkey.	jens@allmer.de	Allmer, Jens/E-2335-2016; Bağcı, Caner/ABB-6795-2020	Allmer, Jens/0000-0002-2164-7335; Bağcı, Caner/0000-0003-4428-9515	Scientific and Technological Research Council of Turkey (TUBITAK) [113E326]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This study was supported by a grant to JA from the The Scientific and Technological Research Council of Turkey (TUBITAK; http://www.tubitak.gov.tr/en) with the grant number 113E326. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bionia Incorporated provided support in the form of computational resources for author JA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S., 2010, BIOINFORMATICS; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Dong QF, 2004, NUCLEIC ACIDS RES, V32, pD354, DOI 10.1093/nar/gkh046; Erson-Bensan AE, 2014, METHODS MOL BIOL, V1107, P1, DOI 10.1007/978-1-62703-748-8_1; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Gu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043691; Hamid SM, 2014, METHODS MOL BIOL, V1107, P303, DOI 10.1007/978-1-62703-748-8_18; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li CF, 2014, PROTEIN CELL, V5, P348, DOI 10.1007/s13238-014-0039-y; Lukasik A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099963; Lusk RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110808; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Sacar Muserref Duygu, 2014, Genomics Proteomics & Bioinformatics, V12, P228, DOI 10.1016/j.gpb.2014.09.002; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Tufekci KU, 2014, METHODS MOL BIOL, V1107, P33, DOI 10.1007/978-1-62703-748-8_3; Zhang Lixiao, 2011, AGR ENG, V1, P1, DOI DOI 10.1038/CR.2011.158; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	24	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0145065	10.1371/journal.pone.0145065	http://dx.doi.org/10.1371/journal.pone.0145065			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824347	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600003
J	He, GL; Luo, Z; Yang, J; Shen, TT; Chen, Y; Yang, XS				He, Gen-Lin; Luo, Zhen; Yang, Ju; Shen, Ting-ting; Chen, Yi; Yang, Xue-Sen			Curcumin Ameliorates the Reduction Effect of PGE(2) on Fibrillar beta-Amyloid Peptide (1-42)-Induced Microglial Phagocytosis through the Inhibition of EP2-PKA Signaling in N9 Microglial Cells	PLOS ONE			English	Article							REDUCES OXIDATIVE DAMAGE; ALZHEIMERS-DISEASE; MOUSE MODEL; PROSTAGLANDIN E-2; A-BETA; IN-VITRO; CYTOKINES; NEUROPATHOLOGY; NEUROTOXICITY; ACCUMULATION	Inflammatory activation of microglia and beta amyloid (A beta) deposition are considered to work both independently and synergistically to contribute to the increased risk of Alzheimer's disease (AD). Recent studies indicate that long-term use of phenolic compounds provides protection against AD, primarily due to their anti-inflammatory actions. We previously suggested that phenolic compound curcumin ameliorated phagocytosis possibly through its anti-inflammatory effects rather than direct regulation of phagocytic function in electromagnetic field-exposed N9 microglial cells (N9 cells). Here, we explored the prostaglandin-E-2 (PGE(2))-related signaling pathway that involved in curcumin-mediated phagocytosis in fibrillar beta-amyloid peptide (1-42) (fA beta(42))-stimulated N9 cells. Treatment with fA beta(42) increased phagocytosis of fluorescent-labeled latex beads in N9 cells. This increase was attenuated in a dose-dependent manner by endogenous and exogenous PGE(2), as well as a selective EP2 or protein kinase A (PKA) agonist, but not by an EP4 agonist. We also found that an antagonist of EP2, but not EP4, abolished the reduction effect of PGE(2) on fA beta(42)-induced microglial phagocytosis. Additionally, the increased expression of endogenous PGE(2), EP2, and cyclic adenosine monophosphate (AMP), and activation of vasodilator-stimulated phosphoprotein, cyclic AMP responsive element-binding protein, and PKA were depressed by curcumin administration. This reduction led to the amelioration of the phagocytic abilities of PGE(2)-stimulated N9 cells. Taken together, these data suggested that curcumin restored the attenuating effect of PGE(2) on fA beta(42)-induced microglial phagocytosis via a signaling mechanism involving EP2 and PKA. Moreover, due to its immune modulatory effects, curcumin may be a promising pharmacological candidate for neurodegenerative diseases.	[He, Gen-Lin; Luo, Zhen; Yang, Ju; Shen, Ting-ting; Chen, Yi; Yang, Xue-Sen] Third Mil Med Univ, Inst Trop Med, Dept Trop Hyg, Chongqing, Peoples R China	Army Medical University	Yang, XS (corresponding author), Third Mil Med Univ, Inst Trop Med, Dept Trop Hyg, Chongqing, Peoples R China.	xuesenyyy@aliyun.com	He, Gen-Lin/B-5715-2016	He, Gen-Lin/0000-0002-5625-4347	National Natural Science Foundation of China [81172647]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (81172647). The funder's website is http://www.nsfc.gov.cn/. The corresponding author XY received the funding for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; Babcock AA, 2015, BRAIN BEHAV IMMUN, V48, P86, DOI 10.1016/j.bbi.2015.03.006; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Benz PM, 2008, INT IMMUNOPHARMACOL, V8, P319, DOI 10.1016/j.intimp.2007.10.004; Jin CY, 2007, ACTA PHARMACOL SIN, V28, P1645, DOI 10.1111/j.1745-7254.2007.00651.x; Cimino PJ, 2013, EXP MOL PATHOL, V94, P366, DOI 10.1016/j.yexmp.2013.01.002; Cole GM, 2004, ANN NY ACAD SCI, V1035, P68, DOI 10.1196/annals.1332.005; Combrinck M, 2006, J NEUROL NEUROSUR PS, V77, P85, DOI 10.1136/jnnp.2005.063131; Comerford KM, 2002, FASEB J, V16, P583, DOI 10.1096/fj.01-0739fje; CORRADIN SB, 1993, GLIA, V7, P255, DOI 10.1002/glia.440070309; El Khoury J, 2008, TRENDS PHARMACOL SCI, V29, P626, DOI 10.1016/j.tips.2008.08.004; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; He GL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-49; Jimenez S, 2008, J NEUROSCI, V28, P11650, DOI 10.1523/JNEUROSCI.3024-08.2008; Johansson JU, 2015, J CLIN INVEST, V125, P350, DOI 10.1172/JCI77487; Kang G, 2004, J PHARMACOL SCI, V94, P325, DOI 10.1254/jphs.94.325; Karlstetter M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-125; Keene CD, 2010, AM J PATHOL, V177, P346, DOI 10.2353/ajpath.2010.090840; Kim HY, 2003, J IMMUNOL, V171, P6072, DOI 10.4049/jimmunol.171.11.6072; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Kojima F, 2009, PROSTAG OTH LIPID M, V89, P26, DOI 10.1016/j.prostaglandins.2009.03.001; Liang XB, 2005, J NEUROSCI, V25, P10180, DOI 10.1523/JNEUROSCI.3591-05.2005; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Nagano T, 2010, BRAIN RES, V1323, P11, DOI 10.1016/j.brainres.2010.01.086; Pan XD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-45; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; RIGHI M, 1989, EUR J IMMUNOL, V19, P1443, DOI 10.1002/eji.1830190815; Shi J, 2012, ANN NEUROL, V72, P788, DOI 10.1002/ana.23677; Shie FS, 2005, AM J PATHOL, V166, P1163, DOI 10.1016/S0002-9440(10)62336-X; Smith ME, 1998, J NEUROSCI RES, V54, P68, DOI 10.1002/(SICI)1097-4547(19981001)54:1<68::AID-JNR8>3.0.CO;2-F; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Wang P, 2014, AGING CELL, V13, P605, DOI 10.1111/acel.12209; Woodling NS, 2014, J NEUROSCI, V34, P5882, DOI 10.1523/JNEUROSCI.0410-14.2014; Xiang ZM, 2002, GENE EXPRESSION, V10, P271, DOI 10.3727/000000002783992352; Yamada M, 2015, ADV EXP MED BIOL, V863, P79, DOI 10.1007/978-3-319-18365-7_4; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; YANKNER BA, 1991, NEW ENGL J MED, V325, P1849; Zhang L, 2006, J ALZHEIMERS DIS, V10, P1; Zhang T, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0275-y; Zhen GH, 2012, NEUROBIOL AGING, V33, P2215, DOI 10.1016/j.neurobiolaging.2011.09.017	45	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147721	10.1371/journal.pone.0147721	http://dx.doi.org/10.1371/journal.pone.0147721			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824354	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600051
J	Zhao, H; Hu, CZ; Zhang, D; Liu, HJ; Qu, JH				Zhao, He; Hu, Chengzhi; Zhang, Di; Liu, Huijuan; Qu, Jiuhui			Probing Coagulation Behavior of Individual Aluminum Species for Removing Corresponding Disinfection Byproduct Precursors: The Role of Specific Ultraviolet Absorbance	PLOS ONE			English	Article							NATURAL ORGANIC-MATTER; SIZE-EXCLUSION CHROMATOGRAPHY; WATER-TREATMENT; DRINKING-WATER; POLYALUMINUM CHLORIDE; ENHANCED COAGULATION; HUMIC ACIDS; CHLORINATION; SPECIATION; AL-13	Coagulation behavior of aluminum chloride and polyaluminum chloride (PACl) for removing corresponding disinfection byproduct (DBP) precursors was discussed in this paper. CHCl3, bromine trihalomethanes (THM-Br), dichloroacetic acid (DCAA) and trichloroacetic acid (TCAA) formation potential yields were correlated with specific ultraviolet absorbance (SUVA) values in different molecular weight (MW) fractions of humic substances (HS), respectively. Correlation analyses and principal component analysis were performed to examine the relationships between SUVA and different DBP precursors. To acquire more structural characters of DBP precursors and aluminum speciation, freeze-dried precipitates were analyzed by fourier transform infrared (FTIR) and C 1s, Al 2p X-ray photoelectron spectroscopy (XPS). The results indicated that TCAA precursors (no MW limits), DCAA and CHCl3 precursors in low MWfractions (MW<30 kDa) had a relatively good relations with SUVA values. These DBP precursors were coagulated more easily by in situ Al-13 of AlCl3 at pH 5.0. Due to relatively low aromatic content and more aliphatic structures, THM-Br precursors (no MW limits) and CHCl3 precursors in high MW fractions (MW>30 kDa) were preferentially removed by PACl coagulation with preformed Al-13 species at pH 5.0. Additionally, for DCAA precursors in high MWfractions (MW>30 kDa) with relatively low aromatic content and more carboxylic structures, the greatest removal occurred at pH 6.0 through PACl coagulation with aggregated Al-13 species.	[Zhao, He; Hu, Chengzhi; Liu, Huijuan] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State key Lab Environm Aquat Chem, Beijing 100085, Peoples R China; [Zhao, He; Zhang, Di] Chinese Acad Sci, Inst Proc Engn, Key Lab Green Proc & Engn, Beijing Engn Res Ctr Proc Pollut Control, Beijing 100190, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; Institute of Process Engineering, CAS	Liu, HJ (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State key Lab Environm Aquat Chem, Beijing 100085, Peoples R China.	hjliu@rcees.ac.cn	Zhao, He/D-6011-2014	Zhao, He/0000-0002-0162-7388	National Natural Science Foundation of China [51108441, 50921064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, grant number 51108441 (HZ) and grant number 50921064 (JHQ).	Abouelwafa R, 2008, BIORESOURCE TECHNOL, V99, P6112, DOI 10.1016/j.biortech.2007.12.033; Allpike BP, 2005, ENVIRON SCI TECHNOL, V39, P2334, DOI 10.1021/es0496468; CHADIK PA, 1987, J ENVIRON ENG-ASCE, V113, P1234, DOI 10.1061/(ASCE)0733-9372(1987)113:6(1234); Chang EE, 2001, CHEMOSPHERE, V44, P1231, DOI 10.1016/S0045-6535(00)00499-9; Chen C, 2008, SCI TOTAL ENVIRON, V397, P140, DOI 10.1016/j.scitotenv.2008.02.032; Chow CWK, 2008, ENVIRON SCI TECHNOL, V42, P6683, DOI 10.1021/es800794r; Chow CWK, 2009, DESALINATION, V245, P120, DOI 10.1016/j.desal.2008.06.014; COLLINS MR, 1986, ENVIRON SCI TECHNOL, V20, P1028, DOI 10.1021/es00152a011; Duong LV, 2005, MATER LETT, V59, P1932, DOI 10.1016/j.matlet.2005.02.029; Edzwald JK, 1999, WATER SCI TECHNOL, V40, P63, DOI 10.2166/wst.1999.0444; Her N, 2003, WATER RES, V37, P4295, DOI 10.1016/S0043-1354(03)00317-8; Hu CZ, 2006, ENVIRON SCI TECHNOL, V40, P325, DOI 10.1021/es051423+; Hua GH, 2006, ENVIRON SCI TECHNOL, V40, P3050, DOI 10.1021/es0519278; Hua GH, 2007, ENVIRON SCI TECHNOL, V41, P3309, DOI 10.1021/es062178c; HUNDT TR, 1988, J AM WATER WORKS ASS, V80, P176; Hyun-Chul K, 2007, J HAZARD MATER, V143, P486, DOI 10.1016/j.jhazmat.2006.09.063; Kazpard V, 2006, WATER RES, V40, P1965, DOI 10.1016/j.watres.2006.03.014; Kitis M, 2002, WATER RES, V36, P3834, DOI 10.1016/S0043-1354(02)00094-5; Korshin G, 2009, WATER RES, V43, P1541, DOI 10.1016/j.watres.2008.12.041; Leenheer JA, 2003, ENVIRON SCI TECHNOL, V37, p18A, DOI 10.1021/es032333c; Liang L, 2003, ENVIRON SCI TECHNOL, V37, P2920, DOI 10.1021/es026230q; Lin JL, 2008, WATER RES, V42, P4281, DOI 10.1016/j.watres.2008.07.028; Lin JL, 2009, WATER RES, V43, P4285, DOI 10.1016/j.watres.2009.06.023; Lu JF, 2009, J HAZARD MATER, V162, P140, DOI 10.1016/j.jhazmat.2008.05.058; Matilainen A, 2011, CHEMOSPHERE, V83, P1431, DOI 10.1016/j.chemosphere.2011.01.018; Matilainen A, 2010, ADV COLLOID INTERFAC, V159, P189, DOI 10.1016/j.cis.2010.06.007; Monteil-Rivera F, 2000, ANAL CHIM ACTA, V424, P243, DOI 10.1016/S0003-2670(00)01139-9; RECKHOW DA, 1990, ENVIRON SCI TECHNOL, V24, P1655, DOI 10.1021/es00081a005; RECKHOW DA, 1984, J AM WATER WORKS ASS, V76, P151; Shi BY, 2007, SEP PURIF TECHNOL, V54, P88, DOI 10.1016/j.seppur.2006.08.011; STEVENS AA, 1976, J AM WATER WORKS ASS, V68, P615; STEVENSON FJ, 1971, GEOCHIM COSMOCHIM AC, V35, P471, DOI 10.1016/0016-7037(71)90044-5; USEPA, 1990, EPA CINCINNATI; VANBENSCHOTEN JE, 1990, WATER RES, V24, P1527, DOI 10.1016/0043-1354(90)90087-M; Wang DS, 2004, COLLOID SURFACE A, V243, P1, DOI 10.1016/j.colsurfa.2004.04.073; Wassink JK, 2011, WATER SCI TECH-W SUP, V11, P621, DOI 10.2166/ws.2011.101; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; Xing LA, 2012, J ENVIRON SCI-CHINA, V24, P1174, DOI 10.1016/S1001-0742(11)60923-6; Yang X, 2008, WATER RES, V42, P2329, DOI 10.1016/j.watres.2007.12.021; Zhao H, 2008, ENVIRON SCI TECHNOL, V42, P5752, DOI 10.1021/es8006035; Zhao H, 2009, J COLLOID INTERF SCI, V330, P105, DOI 10.1016/j.jcis.2008.10.020; Zhao H, 2009, ENVIRON SCI TECHNOL, V43, P5067, DOI 10.1021/es8034347	42	2	2	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148020	10.1371/journal.pone.0148020	http://dx.doi.org/10.1371/journal.pone.0148020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824243	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528600090
J	Wostmann, B; Simon, T; Neuhauser-Berthold, M; Rehmann, P				Woestmann, Bernd; Simon, Teresa; Neuhaeuser-Berthold, Monika; Rehmann, Peter			Pilot Study on the Influence of Nutritional Counselling and Implant Therapy on the Nutritional Status in Dentally Compromised Patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; ORAL-HEALTH; CHEWING ABILITY; NUTRIENT INTAKE; MASTICATORY PERFORMANCE; EDENTULOUS PATIENTS; DIETARY-INTAKE; TOOTH LOSS; OVERDENTURES; SATISFACTION	Objectives To investigate the impact of implant-prosthetic rehabilitation combined with nutritional counseling on the nutritional status of patients with severely reduced dentitions. Design An explorative intervention study including an intra-individual comparison of 20 patients with severely reduced dentitions in terms of nutrition-and quality of life-related parameters recorded at baseline and at six and twelve months after implant-prosthetic rehabilitation. Participants Twenty patients from the Department of Prosthetic Dentistry of Justus-Liebig University of Giessen, with an mean age of 63 years, who had fewer than ten pairs of antagonists. Measurements The baseline data collection included dental status, a chewing ability test, laboratory parameters, anthropometric data (body mass index), energy supply, a 3-day dietary record, an analysis of the oral health-related quality of life (OHRQoL) with the OHIP-G14, the Mini-Mental Status (MMS) and Mini Nutritional Assessment (MNA). Six months after implantation and prosthetic rehabilitation, individual nutritional counseling was performed by a dietician. Data were again collected and analyzed. A final follow-up was conducted 12 months after prosthetic rehabilitation. Results Despite the highly significant improvement in masticatory ability and OHRQoL after implant-prosthetic rehabilitation, no significant changes were observed regarding MNA, anthropometric data or energy supply. Except for cholinesterase (p = 0.012), ferritin (p = 0.003), folic acid (p = 0.019) and vitamin A (p = 0.004), no laboratory parameter changed significantly during the investigation period. In addition, no general significant differences were observed for nutrient intake or food choice. Conclusion The present study does not confirm the assumption that the implant-prosthetic rehabilitation of patients with severely reduced residual dentitions with or without an individual nutritional counseling influences nutritional status.	[Woestmann, Bernd; Simon, Teresa; Rehmann, Peter] Univ Giessen, Dept Prosthodont, D-35390 Giessen, Germany; [Neuhaeuser-Berthold, Monika] Univ Giessen, Dept Agr Sci Nutr Sci & Environm Management, Inst Nutr Sci, D-35390 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Wostmann, B (corresponding author), Univ Giessen, Dept Prosthodont, D-35390 Giessen, Germany.	bernd.woestmann@dentist.med.uni-giessen.de						Allen F, 2002, CLIN ORAL IMPLAN RES, V13, P320, DOI 10.1034/j.1600-0501.2002.130313.x; Allen PF, 2006, J DENT RES, V85, P547, DOI 10.1177/154405910608500613; Allen PF, 2001, J PROSTHET DENT, V85, P141, DOI 10.1067/mpr.2001.113214; Awad MA, 2012, J DENT RES, V91, P39, DOI 10.1177/0022034511423396; Awad MA, 2003, INT J PROSTHODONT, V16, P117; Borges TD, 2011, BRIT J NUTR, V105, P990, DOI 10.1017/S000711451000471X; Bradbury J, 2006, J DENT RES, V85, P463, DOI 10.1177/154405910608500513; Brennan DS, 2008, QUAL LIFE RES, V17, P227, DOI 10.1007/s11136-007-9293-2; Brennan M, 2010, INT J ORAL MAX IMPL, V25, P791; BRODEUR JM, 1993, J PROSTHET DENT, V70, P468, DOI 10.1016/0022-3913(93)90087-5; Cousson PY, 2012, GERODONTOLOGY, V29, pE685, DOI 10.1111/j.1741-2358.2011.00545.x; de Oliveira Terezinha R C, 2004, Gerodontology, V21, P205, DOI 10.1111/j.1741-2358.2004.00032.x; Ellis JS, 2010, CLIN ORAL IMPLAN RES, V21, P386, DOI 10.1111/j.1600-0501.2009.01859.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Guigoz Y, 1996, NUTR REV, V54, pS59; Heydecke G, 2003, COMMUNITY DENT ORAL, V31, P161, DOI 10.1034/j.1600-0528.2003.00029.x; Heydecke G, 2003, CLIN ORAL IMPLAN RES, V14, P125, DOI 10.1034/j.1600-0501.2003.140117.x; Inoue M, 2011, J ORAL REHABIL, V38, P818, DOI 10.1111/j.1365-2842.2011.02222.x; Inukai M, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-118; John MT, 2006, COMMUNITY DENT ORAL, V34, P277, DOI 10.1111/j.1600-0528.2006.00279.x; Kossioni AE, 2007, CLIN INTERV AGING, V2, P591; Luhrmann PM, 1999, EUR J NUTR, V38, P235, DOI 10.1007/s003940050066; Marcenes Wagner, 2003, Cad. Saúde Pública, V19, P809, DOI 10.1590/S0102-311X2003000300013; McKenna G, 2012, GERODONTOLOGY, V29, pE883, DOI 10.1111/j.1741-2358.2011.00579.x; Millwood J, 2000, Gerodontology, V17, P25, DOI 10.1111/j.1741-2358.2000.00025.x; Mojon P, 1999, AGE AGEING, V28, P463, DOI 10.1093/ageing/28.5.463; Morais JA, 2003, J DENT RES, V82, P53, DOI 10.1177/154405910308200112; Moynihan PJ, 2012, J DENT, V40, P843, DOI 10.1016/j.jdent.2012.07.001; Moynihan PJ, 2000, J DENT, V28, P557, DOI 10.1016/S0300-5712(00)00044-0; Muller F, 2012, CLIN ORAL IMPLAN RES, V23, P144, DOI 10.1111/j.1600-0501.2011.02213.x; Muller F, 2005, Z GERONTOL GERIATR, V38, P334, DOI 10.1007/s00391-005-0329-3; Muller Katia, 2008, Braz. Dent. J., V19, P145, DOI 10.1590/S0103-64402008000200011; Nakata M, 1998, Int Dent J, V48, P540; Nguyen C, 1999, EURO J GER, V1, P84; Llamas FP, 2011, NUTR HOSP, V26, P1134, DOI [10.3305/nh.2011.26.5.5248, 10.1590/S0212-16112011000500033]; Saletti A, 2005, GERONTOLOGY, V51, P192, DOI 10.1159/000083993; Sheiham A, 2001, PUBLIC HEALTH NUTR, V4, P797, DOI 10.1079/PHN2000116; Sheiham A, 2001, J DENT RES, V80, P408, DOI 10.1177/00220345010800020201; Singh KA, 2012, GERODONTOLOGY, V29, P106, DOI 10.1111/j.1741-2358.2010.00412.x; Slade G D, 1994, Community Dent Health, V11, P3; Soini Helena, 2003, Spec Care Dentist, V23, P209, DOI 10.1111/j.1754-4505.2003.tb00314.x; Thomason J Mark, 2012, J Evid Based Dent Pract, V12, P182, DOI 10.1016/S1532-3382(12)70032-5; Volkert D., 2000, KLIN GERIATRIE; Volkert D, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/247315; Walls AWG, 2004, MECH AGEING DEV, V125, P853, DOI 10.1016/j.mad.2004.07.011; WAYLER AH, 1984, J GERONTOL, V39, P284, DOI 10.1093/geronj/39.3.284; Wostmann B, 2008, J DENT, V36, P816, DOI 10.1016/j.jdent.2008.05.017	47	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147193	10.1371/journal.pone.0147193	http://dx.doi.org/10.1371/journal.pone.0147193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821352	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528400016
J	Li, ZY; Ren, BB; Tan, HY; Liu, SR; Wang, W; Pang, Y; Lin, JZ; Zeng, C				Li, Zhangyong; Ren, Binbin; Tan, Haiyan; Liu, Shengrong; Wang, Wei; Pang, Yu; Lin, Jinzhao; Zeng, Chen			Capsule Design for Blue Light Therapy against Helicobacter pylori	PLOS ONE			English	Article							ENDOSCOPY; SYSTEMS; SENSOR; CORE	A photo-medical capsule that emits blue light for Helicobacter pylori treatment was described in this paper. The system consists of modules for pH sensing and measuring, light-emitting diode driver circuit, radio communication and microcontroller, and power management. The system can differentiate locations by monitoring the pH values of the gastrointestinal tract, and turn on and off the blue light according to the preset range of pH values. Our experimental tests show that the capsule can operate in the effective light therapy mode for more than 32 minutes and the wireless communication module can reliably transmit the measured pH value to a receiver located outside the body.	[Li, Zhangyong; Ren, Binbin; Tan, Haiyan; Liu, Shengrong; Wang, Wei; Pang, Yu; Lin, Jinzhao; Zeng, Chen] Chongqing Univ Posts & Telecommun, Biomed Engn Res Ctr, Chongqing, Peoples R China; [Zeng, Chen] George Washington Univ, Dept Phys, Washington, DC 20052 USA	Chongqing University of Posts & Telecommunications; George Washington University	Li, ZY (corresponding author), Chongqing Univ Posts & Telecommun, Biomed Engn Res Ctr, Chongqing, Peoples R China.	lizy@cqupt.edu.cn			National Natural Science Foundation of China [60901045]; Science Fund of Chongqing China [cstc2012jjA10148, KJ1400427]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund of Chongqing China	This project is supported by the National Natural Science Foundation of China (No. 60901045), Science Fund of Chongqing China (No. cstc2012jjA10148 and No. KJ1400427). The author Zhangyong Li plays a role in charge for both the funders.	Banerjee SS, 2015, J MATER CHEM B, V3, P3931, DOI 10.1039/c5tb00534e; Chen WW, 2014, INT J MED ROBOT COMP, V10, P147, DOI 10.1002/rcs.1520; Dai TH, 2012, DRUG RESIST UPDATE, V15, P223, DOI 10.1016/j.drup.2012.07.001; Ganz RA, 2015, LASER SURG MED, V36, P260; Halbritter H, 2014, IEEE PHOTONIC TECH L, V26, P1871, DOI 10.1109/LPT.2014.2336732; Hamblin MR, 2005, ANTIMICROB AGENTS CH, V49, P2822, DOI 10.1128/AAC.49.7.2822-2827.2005; Jia ZW, 2015, AIP ADV, V5, DOI 10.1063/1.4907170; Jia Zhiwei, 2014, Journal of Medical Engineering & Technology, V38, P351, DOI 10.3109/03091902.2014.937835; Khan TH, 2014, SENSORS-BASEL, V14, P20779, DOI 10.3390/s141120779; Kwak SS, 2014, INT J ELECTRON, V101, P1683, DOI 10.1080/00207217.2014.888780; Lembo AJ, 2009, LASER SURG MED, V41, P337, DOI 10.1002/lsm.20770; Li J, 2013, J NANOPART RES, V15, P1; Makobongo MO, 2014, J MICROBIOL, V52, P259, DOI 10.1007/s12275-014-3603-5; Nakamura T, 2008, J GASTROENTEROL, V43, P93, DOI 10.1007/s00535-007-2153-6; Oppong P., 2015, MEDICINE, V43, P215, DOI [10.1016/j.mpmed.2015.01.008, DOI 10.1016/J.MPMED.2015.01.008]; Pedersen PB, 2014, PHARM RES-DORDR, V31, P2044, DOI 10.1007/s11095-014-1306-6; Qi Shao, 2014, IEEE Sensors 2014. Proceedings, P339, DOI 10.1109/ICSENS.2014.6985003; Qin YX, 2010, IEEE T POWER ELECTR, V25, P507, DOI 10.1109/TPEL.2009.2026752; Sri LR, 2013, INT J ENG TECHNOLOGY, V1, P46; Taylor NAS, 2014, J THERM BIOL, V46, P72, DOI 10.1016/j.jtherbio.2014.10.006; Than TD, 2012, IEEE T BIO-MED ENG, V59, P2387, DOI 10.1109/TBME.2012.2201715; Woods SP, 2013, IEEE T BIO-MED ENG, V60, P945, DOI 10.1109/TBME.2012.2228647; Xu F, 2015, MEASUREMENT, V64, P49, DOI 10.1016/j.measurement.2014.12.044; Yamasue K, 2012, ADV BIOMED ENG, V1, P9, DOI 10.14326/abe.1.9; Yim S, 2014, INT J CONTROL AUTOM, V12, P383, DOI 10.1007/s12555-013-0078-9	25	7	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147531	10.1371/journal.pone.0147531	http://dx.doi.org/10.1371/journal.pone.0147531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814481	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528200038
J	Meher, A; Randhir, K; Mehendale, S; Wagh, G; Joshi, S				Meher, Akshaya; Randhir, Karuna; Mehendale, Savita; Wagh, Girija; Joshi, Sadhana			Maternal Fatty Acids and Their Association with Birth Outcome: A Prospective Study	PLOS ONE			English	Article							GENETIC-VARIANTS; GESTATIONAL-AGE; PRETERM BIRTH; BREAST-MILK; PREGNANCY; WEIGHT; SUPPLEMENTATION; MOTHERS; PLASMA; OMEGA-3-FATTY-ACIDS	Maternal nutrition, especially LCPUFA, is an important factor in determining fetal growth and development. Our earlier cross sectional study reports lower docosahexanoic acid (DHA) levels at the time of delivery in mothers delivering low birth weight (LBW) babies. This study was undertaken to examine the role of the maternal omega-3 and omega-6 fatty acid profile across the gestation in fetal growth. This is a hospital based study where women were recruited in early gestation. Maternal blood was collected at 3 time points, i.e., T1 = 16th-20th week, T2 = 26th-30th week and T3 = at delivery. Cord blood was collected at delivery. At delivery, these women were divided into 2 groups: those delivering at term a baby weighing >2.5kg [Normal birth weight (NBW) group] and those delivering at term a baby weighing <2.5kg [LBW group]. The study reports data on 111 women recruited at T1, out of which 60 women delivered an NBW baby at term and 51 women delivered an LBW baby at term. Fatty acids were analysed using gas chromatography. At T1 of gestation, maternal erythrocyte DHA levels were positively (p<0.05) associated with baby weight. Maternal plasma and erythrocyte arachidonic acid and total erythrocyte omega-6 fatty acid levels at T2 were higher (p<0.05 for both) in the LBW group. Total erythrocyte omega-3 fatty acid levels were lower (p<0.05) while total erythrocyte omega-6 fatty acid levels were higher (p<0.05) in the LBW group at delivery. Our data demonstrates the possible role of LCPUFA in the etiology of LBW babies right from early pregnancy.	[Meher, Akshaya; Randhir, Karuna; Joshi, Sadhana] Bharati Vidyapeeth Univ, Dept Nutrit Med, Interact Res Sch Hlth Affairs, Pune 411043, Maharashtra, India; [Mehendale, Savita; Wagh, Girija] Bharati Vidyapeeth Univ, Bharati Med Coll & Hosp, Dept Obstet & Gynaecol, Pune 411043, Maharashtra, India	Bharati Vidyapeeth Deemed University; Bharati Vidyapeeth Deemed University	Joshi, S (corresponding author), Bharati Vidyapeeth Univ, Dept Nutrit Med, Interact Res Sch Hlth Affairs, Pune 411043, Maharashtra, India.	srjoshi62@gmail.com	Joshi, Sudhanshu/L-2284-2019	Joshi, Sudhanshu/0000-0003-4748-5001	Department of Biotechnology [BT/PR-10593/MED/12/396/2008]; 'Department of Science and Technology', Government of India	Department of Biotechnology; 'Department of Science and Technology', Government of India(Department of Science & Technology (India))	This study was partially funded by the Department of Biotechnology (No BT/PR-10593/MED/12/396/2008). Author AM received the 'INSPIRE fellowship' from 'Department of Science and Technology', Government of India.	Alvino G, 2008, PEDIATR RES, V64, P615, DOI 10.1203/PDR.0b013e31818702a2; Bobinski R, 2013, J MATERN-FETAL NEO M, V26, P96, DOI 10.3109/14767058.2012.722717; Calder PC, 2011, EUR J PHARMACOL, V668, pS50, DOI 10.1016/j.ejphar.2011.05.085; Carlson SE, 2013, AM J CLIN NUTR, V97, P808, DOI 10.3945/ajcn.112.050021; Cetin I, 2009, J PHYSIOL-LONDON, V587, P3441, DOI 10.1113/jphysiol.2009.173062; Dangat KD, 2010, NEONATOLOGY, V97, P190, DOI 10.1159/000252971; Dhobale MV, 2011, PROSTAG LEUKOTR ESS, V85, P149, DOI 10.1016/j.plefa.2011.06.003; Dirix CEH, 2009, BRIT J NUTR, V101, P399, DOI 10.1017/S0007114508006740; Duttaroy AK, 2009, PROG LIPID RES, V48, P52, DOI 10.1016/j.plipres.2008.11.001; Gopalan C., 2003, NFI Bulletin, V24, P1; Haggarty P, 2014, CURR OPIN CLIN NUTR, V17, P151, DOI 10.1097/MCO.0000000000000036; Haggarty P, 2010, ANNU REV NUTR, V30, P237, DOI 10.1146/annurev.nutr.012809.104742; Innis SM, 2011, MATERN CHILD NUTR, V7, P112, DOI 10.1111/j.1740-8709.2011.00318.x; Kale A, 2010, PSYCHIAT RES, V175, P47, DOI 10.1016/j.psychres.2009.01.013; Kilari A, 2011, AM J HUM BIOL, V23, P319, DOI 10.1002/ajhb.21129; Kilari AS, 2010, J PERINAT MED, V38, P659, DOI [10.1515/JPM.2010.112, 10.1515/jpm.2010.112]; Kilari AS, 2009, J PERINAT MED, V37, P513, DOI 10.1515/JPM.2009.096; Kulkarni A, 2011, CLIN NUTR, V30, P60, DOI 10.1016/j.clnu.2010.07.007; Kulkarni AV, 2011, PROSTAG LEUKOTR ESS, V84, P51, DOI 10.1016/j.plefa.2010.09.005; Larque E, 2012, BRIT J NUTR, V107, pS77, DOI 10.1017/S0007114512001481; Lattka E, 2013, BRIT J NUTR, V109, P1196, DOI 10.1017/S0007114512003108; MATORRAS R, 1994, EUR J OBSTET GYN R B, V57, P189, DOI 10.1016/0028-2243(94)90299-2; Mehendale S, 2008, INT J GYNECOL OBSTET, V100, P234, DOI 10.1016/j.ijgo.2007.08.011; Muthayya S, 2009, EUR J CLIN NUTR, V63, P340, DOI 10.1038/sj.ejcn.1602933; Muthayya S, 2009, INDIAN J MED RES, V130, P600; Olsen SF, 2007, EUR J CLIN NUTR, V61, P976, DOI 10.1038/sj.ejcn.1602609; Ortega-Senovilla H, 2010, CLIN SCI, V118, P351, DOI 10.1042/CS20090292; Ramakrishnan U, 2010, FOOD NUTR BULL, V31, pS108, DOI 10.1177/15648265100312S203; Reynolds LP, 2012, MOL CELL ENDOCRINOL, V354, P54, DOI 10.1016/j.mce.2011.11.013; Rump P, 2001, AM J CLIN NUTR, V73, P797; Saccone G, 2015, ULTRASOUND IN PRESS; Saccone G, 2016, J MATERN-FETAL NEO M, V29, P2389, DOI 10.3109/14767058.2015.1086742; Saccone G, 2015, AM J OBSTET GYNECOL, V213, P135, DOI 10.1016/j.ajog.2015.03.013; Saccone G, 2015, OBSTET GYNECOL, V125, P663, DOI 10.1097/AOG.0000000000000668; Smits LJM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-23; Smuts CM, 2003, LIPIDS, V38, P407, DOI 10.1007/s11745-003-1076-y; Sukla KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071587; Sundrani D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054153; van Eijsden M, 2008, AM J CLIN NUTR, V87, P887, DOI 10.1093/ajcn/87.4.887; VILBERGSSON G, 1991, INT J GYNECOL OBSTET, V36, P277, DOI 10.1016/0020-7292(91)90481-J; Wadhwani NS, 2013, MATERN CHIL IN PRESS; WHO, 2018, GUIDELINES OPTIMAL F; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156	43	41	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147359	10.1371/journal.pone.0147359	http://dx.doi.org/10.1371/journal.pone.0147359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815428	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528200030
J	Some, D; Edwards, JK; Reid, T; Van den Bergh, R; Kosgei, RJ; Wilkinson, E; Baruani, B; Kizito, W; Khabala, K; Shah, S; Kibachio, J; Musembi, P				Some, David; Edwards, Jeffrey K.; Reid, Tony; Van den Bergh, Rafael; Kosgei, Rose J.; Wilkinson, Ewan; Baruani, Bienvenu; Kizito, Walter; Khabala, Kelly; Shah, Safieh; Kibachio, Joseph; Musembi, Phylles			Task Shifting the Management of Non-Communicable Diseases to Nurses in Kibera, Kenya: Does It Work?	PLOS ONE			English	Article							HEALTH-CARE; AFRICA; QUALITY	Background In sub-Saharan Africa there is an increasing need to leverage available health care workers to provide care for non-communicable diseases (NCDs). This study was conducted to evaluate adherence to Medecins Sans Frontieres clinical protocols when the care of five stable NCDs (hypertension, diabetes mellitus type 2, epilepsy, asthma, and sickle cell) was shifted from clinical officers to nurses. Methods Descriptive, retrospective review of routinely collected clinic data from two integrated primary health care facilities within an urban informal settlement, Kibera, Nairobi, Kenya (May to August 2014). Results There were 3,554 consultations (2025 patients); 733 (21%) were by nurses out of which 725 met the inclusion criteria among 616 patients. Hypertension (64%, 397/616) was the most frequent NCD followed by asthma (17%, 106/616) and diabetes mellitus (15%, 95/616). Adherence to screening questions ranged from 65% to 86%, with an average of 69%. Weight and blood pressure measurements were completed in 89% and 96% of those required. Laboratory results were reviewed in 91% of indicated visits. Laboratory testing per NCD protocols was higher in those with hypertension (88%) than diabetesmellitus (67%) upon review. Only 17 (2%) consultations were referred back to clinical officers. Conclusion Nurses are able to adhere to protocols for managing stable NCD patients based on clear and standardized protocols and guidelines, thus paving the way towards task shifting of NCD care to nurses to help relieve the significant healthcare gap in developing countries.	[Some, David; Edwards, Jeffrey K.; Baruani, Bienvenu; Kizito, Walter; Khabala, Kelly] Med Sans Frontieres, Nairobi, Kenya; [Edwards, Jeffrey K.; Reid, Tony; Van den Bergh, Rafael; Kizito, Walter; Shah, Safieh] Operat Res Unit, Med Sans Frontieres, Brussels, Belgium; [Kosgei, Rose J.] Univ Nairobi, Dept Obstet & Gynaecol, Coll Hlth Sci, Nairobi, Kenya; [Wilkinson, Ewan] Chester Univ, Chester, Cheshire, England; [Kibachio, Joseph] Non Communicable Dis Control Unit, Minist Hlth, Nairobi, Kenya; [Musembi, Phylles] Minist Hlth, Sub Cty Med Officer Hlth, Nairobi, Kenya	Doctors Without Borders; University of Nairobi; University of Chester	Some, D (corresponding author), Med Sans Frontieres, Nairobi, Kenya.	kdsome@yahoo.com	Shah, Safieh/Z-2078-2018; Shah, Safieh/AAK-3257-2020	Shah, Safieh/0000-0001-5358-9240; Shah, Safieh/0000-0001-5358-9240; Van den Bergh, Rafael/0000-0001-6277-8713	Union, MSF; Department for International Development (DFID); WHO	Union, MSF; Department for International Development (DFID); WHO(World Health Organization)	The programme was funded by The Union, MSF, the Department for International Development (DFID) and WHO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu YK, 2009, INT J QUAL HEALTH C, V21, P356, DOI 10.1093/intqhc/mzp030; Ayah R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-371; Coleman R, 1998, B WORLD HEALTH ORGAN, V76, P633; Daniels ME, 2014, COUNCIL FOREIGN RELA; Gill GV, 2008, DIABETIC MED, V25, P606, DOI 10.1111/j.1464-5491.2008.02421.x; Kengne AP, 2009, J CLIN HYPERTENS, V11, P564, DOI 10.1111/j.1751-7176.2009.00165.x; Kenya Ministry of Health, KEN HLTH POL 2012 20; Kenya Ministry of Health, KEN NAT DIAB STRAT 2; Kenya National Bureau of Statistics, 2009, KEN POP HOUS CENS; Khabala KB, 2015, TROP MED INT HEALTH, V20, P1265, DOI 10.1111/tmi.12539; Kirkman MS, 2002, DIABETES CARE, V25, P1946, DOI 10.2337/diacare.25.11.1946; Kosgei R, 2010, E AFR MED J, V87, P7; Kredo T, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007331.pub3; Mant J, 2001, INT J QUAL HEALTH C, V13, P475, DOI 10.1093/intqhc/13.6.475; Medecins San Frontieres Belgium Kibera Project, 2009, MEDECINS SAN FRONTIE; Ogedegbe G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005983; Sobry A, 2013, TROP MED INT HEALTH, DOI [10.1111/tmi.1221, DOI 10.1111/TMI.1221]; Unger A, 2007, PLOS MED, V4, P1561, DOI 10.1371/journal.pmed.0040295; WHO, 2007, TREAT TRAIN RETR TAS; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; World Medical Association, WORLD MED ASS RES TA; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	22	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0145634	10.1371/journal.pone.0145634	http://dx.doi.org/10.1371/journal.pone.0145634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812079	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528000003
J	Venkatesan, N; Kanwar, J; Deepa, PR; Khetan, V; Crowley, TM; Raguraman, R; Sugneswari, G; Rishi, P; Natarajan, V; Biswas, J; Krishnakumar, S				Venkatesan, Nalini; Kanwar, Jagat; Deepa, Perinkulam Ravi; Khetan, Vikas; Crowley, Tamsyn M.; Raguraman, Rajeswari; Sugneswari, Ganesan; Rishi, Pukhraj; Natarajan, Viswanathan; Biswas, Jyotirmay; Krishnakumar, Subramanian			Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations	PLOS ONE			English	Article							MICRORNA EXPRESSION; CANCER-DIAGNOSIS; PROGNOSTIC TEST; OVARIAN-CANCER; METASTASIS; GENE; PROFILE; ACTIVATION; DEATH; PTEN	Purpose To correlate the differentially expressed miRNAs with clinico-pathological features in uveal melanoma (UM) tumors harbouring chromosomal 3 aberrations among South Asian Indian cohort. Methods Based on chromosomal 3 aberration, UM (n = 86) were grouped into monosomy 3 (M3; n = 51) and disomy 3 (D3; n = 35) by chromogenic in-situ hybridisation (CISH). The clinico-pathological features were recorded. miRNA profiling was performed in formalin fixed paraffin embedded (FFPE) UM samples (n = 6) using Agilent, Human miRNA microarray, 8x15KV3 arrays. The association between miRNAs and clinico-pathological features were studied using univariate and multivariate analysis. miRNA-gene targets were predicted using Target-scan and MiRanda database. Significantly dys-regulatedmiRNAs were validated in FFPE UM (n = 86) and mRNAs were validated in frozen UM(n = 10) by qRT-PCR. Metastasis free-survival and miRNA expressions were analysed by Kaplen-Meier analysis in UM tissues (n = 52). Results Unsupervised analysis revealed 585 differentially expressed miRNAs while supervised analysis demonstrated 82 miRNAs (FDR; Q = 0.0). Differential expression of 8 miRNAs: miR-214, miR-149*, miR-143, miR-146b, miR-199a, let7b, miR-1238 and miR-134 were studied. Gene target prediction revealed SMAD4, WISP1, HIPK1, HDAC8 and C-KIT as the post-transcriptional regulators of miR-146b, miR-199a, miR-1238 and miR-134. Five miRNAs (miR-214, miR146b, miR-143, miR-199a and miR-134) were found to be differentially expressed in M3/D3 UM tumors. In UM patients with liver metastasis, miR-149* and miR134 expressions were strongly correlated. Conclusion UM can be stratified using miRNAs from FFPE sections. miRNAs predicting liver metastasis and survival have been identified. Mechanistic linkage of de-regulated miRNA/mRNA expressions provide new insights on their role in UM progression and aggressiveness.	[Venkatesan, Nalini; Raguraman, Rajeswari; Biswas, Jyotirmay; Krishnakumar, Subramanian] Vis Res Fdn, Larsen & Toubro Dept Ocular Pathol, Sankara Nethralaya 18-41,Coll Rd, Madras 600006, Tamil Nadu, India; [Kanwar, Jagat] Deakin Univ, Fac Hlth, Mol & Med Res MMR Strateg Res Ctr, NLIMBR,SoM, Pigdons Rd, Geelong, Vic 3217, Australia; [Venkatesan, Nalini; Deepa, Perinkulam Ravi] BITS, Dept Biol Sci, Pilani 333031, Rajasthan, India; [Khetan, Vikas; Sugneswari, Ganesan; Rishi, Pukhraj] Med Res Fdn, Dept Vitreoretinal & Ocular Oncol, Sankara Nethralaya 18-41,Coll Rd, Madras 600006, Tamil Nadu, India; [Crowley, Tamsyn M.] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia; [Crowley, Tamsyn M.] CSIRO, Australian Anim Hlth Labs, Clayton, Vic, Australia; [Natarajan, Viswanathan] Med Res Fdn, Dept Biostat, Sankara Nethralaya 41,Coll Rd, Madras 600006, Tamil Nadu, India	Deakin University; Birla Institute of Technology & Science Pilani (BITS Pilani); Deakin University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Krishnakumar, S (corresponding author), Vis Res Fdn, Larsen & Toubro Dept Ocular Pathol, Sankara Nethralaya 18-41,Coll Rd, Madras 600006, Tamil Nadu, India.	drkrishnakumar_2000@yahoo.com	Rishi, Pukhraj/AAZ-5296-2020	Crowley, Tamsyn/0000-0002-3698-8917; Khetan, Vikas/0000-0003-4396-9877	Department of Science and Technology (DST), Government of India [F.NO.SR/SO/HS30/2009]; Department of Biotechnology, Government of India [BT/01/CE1B/11/V/16]	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was funded by the Department of Science and Technology (DST), Government of India (Grant Identification Number: F.NO.SR/SO/HS30/2009) and in part by Department of Biotechnology, Government of India (Grant identification number BT/01/CE1B/11/V/16-programme support on Retinoblastoma).	Aalto Y, 2001, INVEST OPHTH VIS SCI, V42, P313; Biswas Jyotirmay, 2004, Indian Journal of Ophthalmology, V52, P41; Brantley MA, 2000, AM J PATHOL, V157, P1795, DOI 10.1016/S0002-9440(10)64817-1; Cheng GF, 2015, ADV DRUG DELIVER REV, V81, P75, DOI 10.1016/j.addr.2014.09.001; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Damato B, 2012, EYE, V26, P1157, DOI 10.1038/eye.2012.126; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Danda R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083398; Dror R, 2010, INVEST OPHTH VIS SCI, V51, P1811, DOI 10.1167/iovs.09-3392; el Filali M, 2010, INVEST OPHTH VIS SCI, V51, P2329, DOI 10.1167/iovs.09-4739; Ferracin M, 2010, EXPERT REV MOL DIAGN, V10, P297, DOI 10.1586/ERM.10.11; Field MG, 2014, CURR OPIN OPHTHALMOL, V25, P234, DOI 10.1097/ICU.0000000000000051; Harbour JW, 2014, METHODS MOL BIOL, V1102, P427, DOI 10.1007/978-1-62703-727-3_22; Harbour JW, 2013, PLOS CURR, P5; Herlihy N, 2015, INVEST OPHTH VIS SCI, V56, P1447, DOI 10.1167/iovs.14-15250; Jmor F, 2012, ACTA OPHTHALMOL, V90, P534, DOI 10.1111/j.1755-3768.2010.02038.x; Khetan V, 2014, INDIAN J OPHTHALMOL, V62, P158, DOI 10.4103/0301-4738.128618; Klufas MA, 2015, JAMA OPHTHALMOL, V133, P1073, DOI 10.1001/jamaophthalmol.2015.1790; Larsen AC, 2014, ACTA OPHTHALMOL, V92, P541, DOI 10.1111/aos.12322; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Liu CJ, 2014, INT J CANCER, V134, P811, DOI 10.1002/ijc.28358; Madhunapantula SV, 2013, PIGM CELL MELANOMA R, V26, P886, DOI DOI 10.1111/PCMR.12156; Mensink HW, 2009, INVEST OPHTH VIS SCI, V50, P500, DOI 10.1167/iovs.08-2279; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Njauw CNJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035295; Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750; Radhakrishnan A, 2009, MOL VIS, V15, P2146; Rey C, 2013, CELL CYCLE, V12, P1879, DOI 10.4161/cc.24927; SI ZY, 1993, INT J CANCER, V54, P37, DOI 10.1002/ijc.2910540107; Su F, 2002, GENE DEV, V16, P46, DOI 10.1101/gad.942902; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Ventura BV, 2014, ECANCERMEDICALSCIENC, V8, DOI 10.3332/ecancer.2014.410; Venza M, 2014, TUMORI J, V100, pE4, DOI 10.1700/1430.15828; Wang Chun-lei, 2006, Chinese Medical Sciences Journal, V21, P33; Willson JKV, 2001, ARCH OPHTHALMOL-CHIC, V119, P670; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Worley LA, 2008, MELANOMA RES, V18, P184, DOI 10.1097/CMR.0b013e3282feeac6; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xu B, 2011, MOL CELL BIOCHEM, V350, P207, DOI 10.1007/s11010-010-0700-6; Xu CX, 2012, J BIOL CHEM, V287, P34970, DOI 10.1074/jbc.M112.374611; Yang CH, 2011, SCI CHINA LIFE SCI, V54, P351, DOI 10.1007/s11427-011-4149-y; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zeller C, 2003, ONCOGENE, V22, P2972, DOI 10.1038/sj.onc.1206474; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008	44	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146128	10.1371/journal.pone.0146128	http://dx.doi.org/10.1371/journal.pone.0146128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812476	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528000006
J	Assareh, H; Achat, HM; Stubbs, JM; Guevarra, VM; Hill, K				Assareh, Hassan; Achat, Helen M.; Stubbs, Joanne M.; Guevarra, Veth M.; Hill, Kim			Incidence and Variation of Discrepancies in Recording Chronic Conditions in Australian Hospital Administrative Data	PLOS ONE			English	Article							COMORBIDITY INFORMATION; MEANINGFUL VARIATION; HEART-DISEASE; QUALITY; RISK; EXPERIENCE; CARE; DIAGNOSIS; IMPACT	Diagnostic data routinely collected for hospital admitted patients and used for case-mix adjustment in care provider comparisons and reimbursement are prone to biases. We aim to measure discrepancies, variations and associated factors in recorded chronic morbidities for hospital admitted patients in New South Wales (NSW), Australia. Of all admissions between July 2010 and June 2014 in all NSW public and private acute hospitals, admissions with over 24 hours stay and one or more of the chronic conditions of diabetes, smoking, hepatitis, HIV, and hypertension were included. The incidence of a non-recorded chronic condition in an admission occurring after the first admission with a recorded chronic condition (index admission) was considered as a discrepancy. Poisson models were employed to (i) derive adjusted discrepancy incidence rates (IR) and rate ratios (IRR) accounting for patient, admission, comorbidity and hospital characteristics and (ii) quantify variation in rates among hospitals. The discrepancy incidence rate was highest for hypertension (51% of 262,664 admissions), followed by hepatitis (37% of 12,107), smoking (33% of 548,965), HIV (27% of 1500) and diabetes (19% of 228,687). Adjusted rates for all conditions declined over the four-year period; with the sharpest drop of over 80% for diabetes (47.7% in 2010 vs. 7.3% in 2014), and 20% to 55% for the other conditions. Discrepancies were more common in private hospitals and smaller public hospitals. Inter-hospital differences were responsible for 1% (HIV) to 9.4% (smoking) of variation in adjusted discrepancy incidences, with an increasing trend for diabetes and HIV. Chronic conditions are recorded inconsistently in hospital administrative datasets, and hospitals contribute to the discrepancies. Adjustment for patterns and stratification in risk adjustments; and furthermore longitudinal accumulation of clinical data at patient level, refinement of clinical coding systems and standardisation of comorbidity recording across hospitals would enhance accuracy of datasets and validity of case-mix adjustment.	[Assareh, Hassan; Achat, Helen M.; Stubbs, Joanne M.; Guevarra, Veth M.] Western Sydney Local Hlth Dist, Epidemiol & Hlth Analyt, Sydney, NSW, Australia; [Hill, Kim] Western Sydney Local Hlth Dist, Execut Med Serv, Sydney, NSW, Australia		Assareh, H (corresponding author), Western Sydney Local Hlth Dist, Epidemiol & Hlth Analyt, Sydney, NSW, Australia.	Hassan.Assareh@health.nsw.gov.au	Stubbs, Joanne/GLT-4827-2022	Stubbs, Joanne/0000-0002-6846-0324				[Anonymous], 2004, INT STAT CLASS DIS R; Assareh H, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005502; Assareh H, 2013, THER INNOV REGUL SCI, V47, P70, DOI 10.1177/2168479012469957; Australian Bureau of Statistics, 2011, SOCIO EC INDEXES ARE; Australian Institute of Health and Welfare, 2010, COD WORKF SHORTF; Bottle A, 2011, HEALTH SERV RES, V46, P1741, DOI 10.1111/j.1475-6773.2011.01295.x; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng P, 2009, HEALTH INF MANAG J, V38, P35, DOI 10.1177/183335830903800105; Coory M, 2005, AUST NZ J PUBL HEAL, V29, P143, DOI 10.1111/j.1467-842X.2005.tb00064.x; Demand and Performance Evaluation, 2010, DEM PERF EV; Eagar K., 2011, ABF INFORM SERIES, V1; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fung V, 2010, MED CARE, V48, P140, DOI 10.1097/MLR.0b013e3181bd4dc3; Hedin K, 2006, SCAND J PRIM HEALTH, V24, P44, DOI 10.1080/02813430500240744; Henderson T, 2006, MED CARE, V44, P1011, DOI 10.1097/01.mlr.0000228018.48783.34; Hennessy DA, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-99; Knight L, 2011, IMPACT CHANGES DIABE; Kronick Richard, 2014, Medicare Medicaid Res Rev, V4, DOI 10.5600/mmrr2014-004-02-a06; Lorence DP, 2002, J HLTH CARE FINANCE, V29, P29; Lujic S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005768; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Mohammed MA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b780; National Centre for Classification in Health, 2010, AUSTR COD STAND ICD; Nedkoff L, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-121; Nicholl J, 2007, J EPIDEMIOL COMMUN H, V61, P1010, DOI 10.1136/jech.2007.061747; O'Reilly J, 2012, HEALTH ECON POLICY L, V7, P73, DOI 10.1017/S1744133111000314; Ou LX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096164; Paddison C, 2012, BMJ QUAL SAF, V21, P634, DOI 10.1136/bmjqs-2011-000737; Powell H, 2001, J CLIN EPIDEMIOL, V54, P687, DOI 10.1016/S0895-4356(00)00364-4; Preen DB, 2004, J CLIN EPIDEMIOL, V57, P1295, DOI 10.1016/j.jclinepi.2004.03.016; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; R Core Team, 2021, R LANGUAGE ENV STAT; Rangachari Pavani, 2007, Perspect Health Inf Manag, V4, P3; Rostami R, 2009, CLIN TRIALS, V6, P141, DOI 10.1177/1740774509102590; Santos S, 2008, HEALTH INF MANAG J, V37, P25, DOI 10.1177/183335830803700103; SAS Institute, 2013, SAS ENT GUID; Selby JV, 2010, MED CARE, V48, P133, DOI 10.1097/MLR.0b013e3181c15a6e; Seymour CW, 2012, HEALTH SERV RES, V47, P2060, DOI 10.1111/j.1475-6773.2012.01402.x; Simpson JM, 2003, QUAL SAF HEALTH CARE, V12, P257, DOI 10.1136/qhc.12.4.257; Soo Martin, 2014, BMC Res Notes, V7, P253, DOI 10.1186/1756-0500-7-253; Stavrou E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-331; Steinbusch PJM, 2007, HEALTH POLICY, V81, P289, DOI 10.1016/j.healthpol.2006.06.002; Stryhn H., 2006, P 11 INT S VET EP EC; Welch HG, 2011, JAMA-J AM MED ASSOC, V305, P1113, DOI 10.1001/jama.2011.307	45	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147087	10.1371/journal.pone.0147087	http://dx.doi.org/10.1371/journal.pone.0147087			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808428	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800049
J	Breen, M; Nogales, A; Baker, SF; Perez, DR; Marinez-Sobrido, L				Breen, Michael; Nogales, Aitor; Baker, Steven F.; Perez, Daniel R.; Martinez-Sobrido, Luis			Replication-Competent Influenza A and B Viruses Expressing a Fluorescent Dynamic Timer Protein for In Vitro and In Vivo Studies	PLOS ONE			English	Article							INFECTION; TOOLS; PROTECTION; RESCUE; COLOR; GFP	Influenza A and B viruses (IAV and IBV, respectively) cause annual seasonal human respiratory disease epidemics. In addition, IAVs have been implicated in occasional pandemics with inordinate health and economic consequences. Studying influenza viruses in vitro or in vivo requires the use of laborious secondary methodologies to identify infected cells. To circumvent this requirement, replication-competent infectious influenza viruses expressing an easily traceable fluorescent reporter protein can be used. Timer is a fluorescent protein that undergoes a time-dependent color emission conversion from green to red. The rate of spectral change is independent of Timer protein concentration and can be used to chronologically measure the duration of its expression. Here, we describe the generation of replication-competent IAV and IBV where the viral non-structural protein 1 (NS1) was fused to the fluorescent dynamic Timer protein. Timer-expressing IAV and IBV displayed similar plaque phenotypes and growth kinetics to wild-type viruses in tissue culture. Within infected cells, Timer's spectral shift can be used to measure the rate and cell-to-cell spread of infection using fluorescent microscopy, plate readers, or flow cytometry. The progression of Timer-expressing IAV infection was also evaluated in a mouse model, demonstrating the feasibility to characterize IAV cell-to-cell infections in vivo. By providing the ability to chronologically track viral spread, Timer-expressing influenza viruses are an excellent option to evaluate the in vitro and in vivo dynamics of viral infection.	[Breen, Michael; Nogales, Aitor; Baker, Steven F.; Martinez-Sobrido, Luis] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA; [Perez, Daniel R.] Univ Georgia, Dept Populat Hlth, 953 Coll Stn Rd, Athens, GA 30602 USA	University of Rochester; University System of Georgia; University of Georgia	Marinez-Sobrido, L (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.	luis_martinez@urmc.rochester.edu	Martinez-Sobrido, Luis/ACJ-7853-2022; NOGALES, AITOR/AAY-1590-2020; NOGALES, AITOR/W-3948-2017; Perez, Daniel R./D-5044-2016	Martinez-Sobrido, Luis/0000-0001-7084-0804; NOGALES, AITOR/0000-0002-2424-7900; Perez, Daniel R./0000-0002-6569-5689; Baker, Steven/0000-0001-8379-283X	Rochester Academy of Science Student Grant; University of Rochester [T32 AI 007285-26]; University of Rochester; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007285] Funding Source: NIH RePORTER	Rochester Academy of Science Student Grant; University of Rochester; University of Rochester; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	M.B. was supported by the Rochester Academy of Science Student Grant. S.F.B. was supported by the University of Rochester Immunology Training Grant T32 AI 007285-26. This research was funded by the 2014 University of Rochester Research Award to LM-S.	Avilov SV, 2012, J VIROL, V86, P1433, DOI 10.1128/JVI.05820-11; Baker SF, 2014, J VIROL, V88, P10778, DOI 10.1128/JVI.01440-14; Baker SF, 2013, J VIROL, V87, P8591, DOI 10.1128/JVI.01081-13; CDC, 2013, DEATHS FIN DAT 2013; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Dauber B, 2004, J VIROL, V78, P1865, DOI 10.1128/JVI.78.4.1865-1872.2004; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Eckert N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097695; Fiege JK, 2015, J VIROL, V89, P6167, DOI 10.1128/JVI.00462-15; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Fukuyama S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7600; Fulton BO, 2015, J VIROL, V89, P12226, DOI 10.1128/JVI.02164-15; Gabor KA, 2014, DIS MODEL MECH, V7, P1227, DOI 10.1242/dmm.014746; Gambaryan AS, 1998, VIROLOGY, V247, P223, DOI 10.1006/viro.1998.9274; Go JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-627; Hai R, 2008, J VIROL, V82, P10580, DOI 10.1128/JVI.01213-08; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Heaton NS, 2013, J VIROL, V87, P8272, DOI 10.1128/JVI.00969-13; Influenza-associated pediatric deaths, 2011, MMWR-MORBID MORTAL W, V60, P1233; Karlsson EA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7378; Kittel C, 2004, VIROLOGY, V324, P67, DOI 10.1016/j.virol.2004.03.035; KRUG RM, 1973, VIROLOGY, V56, P334, DOI 10.1016/0042-6822(73)90310-3; Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352; Machado AV, 2006, VIROLOGY, V345, P73, DOI 10.1016/j.virol.2005.09.050; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Martinez-Sobrido Luis, 2010, J Vis Exp, DOI 10.3791/2057; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Nogales A, 2015, VIROLOGY, V476, P206, DOI 10.1016/j.virol.2014.12.006; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Ozawa M, 2011, VIRUS RES, V162, P8, DOI 10.1016/j.virusres.2011.09.035; Palese P, 2013, FIELDS VIROLOGY, VI; Pan WQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3369; Pena L, 2013, J VIROL, V87, P5118, DOI 10.1128/JVI.02490-12; Perez J. T, 2013, CURRENT PROTOCOLS MI; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; Reuther P, 2015, SCI REP-UK, V5, DOI 10.1038/srep11346; Roberts KL, 2015, J VIROL, V89, P1537, DOI 10.1128/JVI.03306-14; Sadler AJ, 2011, IMMUNITY, V35, P491, DOI 10.1016/j.immuni.2011.10.005; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Spronken MI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133888; Subbarao K, 2004, CURR TOP MICROBIOL, V283, P313; Sutton TC, 2014, VIRUS RES, V189, P14, DOI 10.1016/j.virusres.2014.05.003; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Tran V, 2013, J VIROL, V87, P13321, DOI 10.1128/JVI.02381-13; Yan D, 2015, BIOCHEMISTRY-US, V54, P5589, DOI 10.1021/acs.biochem.5b00623; Zhao DM, 2015, J VIROL, V89, P11337, DOI 10.1128/JVI.01886-15; Zhao DM, 2012, PROTEOMICS, V12, P1970, DOI 10.1002/pmic.201100619	47	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147723	10.1371/journal.pone.0147723	http://dx.doi.org/10.1371/journal.pone.0147723			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809059	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800195
J	Cheng, STW; Chen, LH; Li, SYT; Mayoux, E; Leung, PS				Cheng, Sam Tsz Wai; Chen, Lihua; Li, Stephen Yu Ting; Mayoux, Eric; Leung, Po Sing			The Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic beta-Cell Mass and Glucose Homeostasis in Type 1 Diabetes	PLOS ONE			English	Article							IMPROVES GLYCEMIC CONTROL; MELLITUS; INSULIN; DAPAGLIFLOZIN; KIDNEY; POTENT; RATS; MICE	The novel sodium glucose co-transporter 2 (SGLT2) inhibitor empagliflozin has recently been reported to improve glycemic control in streptozotocin-induced type 1 diabetic rats in an insulin-independent manner, via an increase in urinary glucose output. We investigated the potential of empagliflozin to recover insulin pathways in type 1 diabetes by improving pancreatic beta-cell mass. Blood glucose homeostasis was assessed by an intraperitoneal glucose tolerance test. Serum insulin levels and insulin mRNA expression were determined using commercial insulin ELISA kits and real-time quantitative polymerase chain reaction, respectively. Immunohistochemistry was used to investigate beta-cell areas, beta-cell proliferation, apoptosis of pancreatic beta-cells, and reactive oxygen species production in the pancreatic beta-cells. Results showed that glucose tolerance was significantly improved in streptozotocin-induced type 1 diabetic mice treated with empagliflozin. Empagliflozin-treated mice also showed an increase in insulin mRNA expression. Higher serum insulin levels were detected in mice treated with empagliflozin compared with the vehicle group. Immunohistochemistry indicated that beta-cell area/total pancreatic area and the expression of cell proliferation marker Ki-67 (co-stained with insulin) were significantly enhanced by empagliflozin treatment. These effects were due, probably, to a reduction in apoptosis and reactive oxygen species in the pancreatic beta-cells. Taken together, the results of this study indicate that empagliflozin may have a beneficial effect on preserving beta-cell regeneration, thus improving blood glucose homeostasis in type 1 diabetes mellitus, probably via the protection of pancreatic beta-cell from glucotoxicity-induced oxidative stress.	[Cheng, Sam Tsz Wai; Chen, Lihua; Li, Stephen Yu Ting; Leung, Po Sing] Chinese Univ Hong Kong, Sch Biomed Sci, Sha Tin, Hong Kong, Peoples R China; [Mayoux, Eric] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany	Chinese University of Hong Kong; Boehringer Ingelheim	Leung, PS (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Sha Tin, Hong Kong, Peoples R China.	psleung@cuhk.edu.hk	Li, Stephen Yu Ting/L-7657-2017; Leung, Po Sing/P-5758-2014	Leung, Po Sing/0000-0001-8074-3178; Chen, Lihua/0000-0003-3369-1875	Boehringer-Ingelheim Pharma GmbH & Co KG, Biberach, Germany (CUHK) [TB127545]; Boehringer-Ingelheim Pharma GmbH Co KG	Boehringer-Ingelheim Pharma GmbH & Co KG, Biberach, Germany (CUHK); Boehringer-Ingelheim Pharma GmbH Co KG(Boehringer Ingelheim)	This work was supported by Boehringer-Ingelheim Pharma GmbH & Co KG, Biberach, Germany (CUHK Ref. No.: TB127545). Boehringer-Ingelheim Pharma GmbH & Co KG provided support in the form of a salary for author EM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bonner C, 2015, NAT MED, V21, P512, DOI 10.1038/nm.3828; Chen Jian, 2010, Diabetes Ther, V1, P57, DOI 10.1007/s13300-010-0006-4; Chen L, 2012, CURR MOL MED, V12, P995, DOI 10.2174/156652412802480970; de Koning EJP, 2008, TRENDS PHARMACOL SCI, V29, P218, DOI 10.1016/j.tips.2008.02.001; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Fowler MJ., 2008, CLIN DIABETES, V26, P170, DOI DOI 10.2337/DIACLIN.26.4.170; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; Henry RR, 2015, DIABETES CARE, V38, P412, DOI 10.2337/dc13-2955; Jurczak MJ, 2011, DIABETES, V60, P890, DOI 10.2337/db10-1328; Lamos EM, 2014, EXPERT OPIN INV DRUG, V23, P875, DOI 10.1517/13543784.2014.909407; Luippold G, 2012, DIABETES OBES METAB, V14, P601, DOI 10.1111/j.1463-1326.2012.01569.x; MOGENSEN CE, 1971, SCAND J CLIN LAB INV, V28, P101, DOI 10.3109/00365517109090668; Mosley Juan F 2nd, 2015, P T, V40, P451; OLSON LK, 1993, J CLIN INVEST, V92, P514, DOI 10.1172/JCI116596; Perkins BA, 2014, DIABETES CARE, V37, P1480, DOI 10.2337/dc13-2338; Rahmoune H, 2005, DIABETES, V54, P3427, DOI 10.2337/diabetes.54.12.3427; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Roep BO, 2014, NAT REV ENDOCRINOL, V10, P229, DOI 10.1038/nrendo.2014.2; Rosenthal N, 2015, ANN NY ACAD SCI, P1; Sabolic I, 2012, AM J PHYSIOL-CELL PH, V302, pC1174, DOI 10.1152/ajpcell.00450.2011; SCHIFFRIN A, 1988, DIABETES, V37, P920, DOI 10.2337/diabetes.37.7.920; Thomas L, 2012, DIABETES OBES METAB, V14, P94, DOI 10.1111/j.1463-1326.2011.01518.x; Triplitt Curtis L, 2012, Am J Manag Care, V18, pS11; Vallon V, 2015, ANNU REV MED, V66, P255, DOI 10.1146/annurev-med-051013-110046; Vallon V, 2014, AM J PHYSIOL-RENAL, V306, pF194, DOI 10.1152/ajprenal.00520.2013; Vallon V, 2012, ANNU REV PHYSIOL, V74, P351, DOI 10.1146/annurev-physiol-020911-153333; Vallon V, 2011, J AM SOC NEPHROL, V22, P104, DOI 10.1681/ASN.2010030246; Vargas Roberto, 2010, Rev Obstet Gynecol, V3, P92; Washburn WN, 2013, EXPERT OPIN INV DRUG, V22, P463, DOI 10.1517/13543784.2013.774372; Yang T, 2015, EFFICACY TOLERABILIT; Zhang L, 2011, J DIABETES, V3, P48, DOI 10.1111/j.1753-0407.2010.00102.x	31	47	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147391	10.1371/journal.pone.0147391	http://dx.doi.org/10.1371/journal.pone.0147391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807719	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800085
J	Kovacevic, D; Baker, AR; Staugaitis, SM; Kim, MS; Ricchetti, ET; Derwin, KA				Kovacevic, David; Baker, Andrew R.; Staugaitis, Susan M.; Kim, Myung-Sun; Ricchetti, Eric T.; Derwin, Kathleen A.			Development of an Arthroscopic Joint Capsule Injury Model in the Canine Shoulder	PLOS ONE			English	Article							ROTATOR CUFF TEARS; FATTY INFILTRATION; ANIMAL-MODEL; ATROPHY; MUSCLE; TENDON; DEGENERATION; OUTCOMES; REPAIR; DOGS	Background The natural history of rotator cuff tears can be unfavorable as patients develop fatty infiltration and muscle atrophy that is often associated with a loss of muscle strength and shoulder function. To facilitate study of possible biologic mechanisms involved in early degenerative changes to rotator cuff muscle and tendon tissues, the objective of this study was to develop a joint capsule injury model in the canine shoulder using arthroscopy. Methods Arthroscopic surgical methods for performing a posterior joint capsulectomy in the canine shoulder were first defined in cadavers. Subsequently, one canine subject underwent bilateral shoulder joint capsulectomy using arthroscopy, arthroscopic surveillance at 2, 4 and 8 weeks, and gross and histologic examination of the joint at 10 weeks. Results The canine subject was weight-bearing within eight hours after index and follow-up surgeries and had no significant soft tissue swelling of the shoulder girdle or gross lameness. Chronic synovitis and macroscopic and microscopic evidence of pathologic changes to the rotator cuff bony insertions, tendons, myotendinous junctions and muscles were observed. Conclusions This study demonstrates feasibility and proof-of-concept for a joint capsule injury model in the canine shoulder. Future work is needed to define the observed pathologic changes and their role in the progression of rotator cuff disease. Ultimately, better understanding of the biologic mechanisms of early progression of rotator cuff disease may lead to clinical interventions to halt or slow this process and avoid the more advanced and often irreversible conditions of large tendon tears with muscle fatty atrophy.	[Kovacevic, David; Ricchetti, Eric T.] Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44106 USA; [Baker, Andrew R.; Derwin, Kathleen A.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Baker, Andrew R.; Derwin, Kathleen A.] Cleveland Clin, Orthopaed Res Ctr, Cleveland, OH 44106 USA; [Staugaitis, Susan M.] Cleveland Clin, Dept Pathol, Cleveland, OH 44106 USA; [Kim, Myung-Sun] Chonnam Natl Univ, Coll Med, Dept Orthopaed Surg, Gwangju, South Korea; [Kovacevic, David] Yale Univ, Dept Orthopaed Surg, New Haven, CT USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Chonnam National University; Yale University	Derwin, KA (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA.; Derwin, KA (corresponding author), Cleveland Clin, Orthopaed Res Ctr, Cleveland, OH 44106 USA.	derwink@ccf.org		Kovacevic, David/0000-0002-1900-5181	Cleveland Clinic George W. Crile Research Fellowship; Cleveland Clinic Department of Orthopaedic Surgery; Clinical and Translational Science Collaborative of Cleveland [UL1TR000439]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	Cleveland Clinic George W. Crile Research Fellowship; Cleveland Clinic Department of Orthopaedic Surgery; Clinical and Translational Science Collaborative of Cleveland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding for this work was provided by a Cleveland Clinic George W. Crile Research Fellowship (DK), the Cleveland Clinic Department of Orthopaedic Surgery (DK) and the Clinical and Translational Science Collaborative of Cleveland (UL1TR000439) (KAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin M, 2000, ARTHRITIS RHEUM-US, V43, P576, DOI 10.1002/1529-0131(200003)43:3<576::AID-ANR14>3.0.CO;2-A; Boyce MK, 2013, OSTEOARTHR CARTILAGE, V21, P746, DOI 10.1016/j.joca.2013.02.653; Cook JL, 2009, VET SURG, V38, P224, DOI 10.1111/j.1532-950X.2008.00490.x; Derwin KA, 2010, TISSUE ENG PART B-RE, V16, P21, DOI [10.1089/ten.teb.2009.0209, 10.1089/ten.TEB.2009.0209]; Devitt CM, 2007, VET SURG, V36, P661, DOI 10.1111/j.1532-950X.2007.00318.x; Frey E, 2009, J ORTHOP RES, V27, P504, DOI 10.1002/jor.20695; Gerber C, 2007, J SHOULDER ELB SURG, V16, P691, DOI 10.1016/j.jse.2007.02.122; Gladstone JN, 2007, AM J SPORT MED, V35, P719, DOI 10.1177/0363546506297539; GOUTALLIER D, 1994, CLIN ORTHOP RELAT R, P78; Itoigawa Y, 2011, J ORTHOP RES, V29, P861, DOI 10.1002/jor.21317; Kim HM, 2012, J SHOULDER ELB SURG, V21, P847, DOI 10.1016/j.jse.2011.05.004; Lajtai G, 2009, AM J SPORT MED, V37, P1375, DOI 10.1177/0363546509333850; Liu Xuhui, 2012, J Bone Joint Surg Am, V94, pe41, DOI 10.2106/JBJS.K.00620; Liu XH, 2011, J ORTHOP RES, V29, P588, DOI 10.1002/jor.21266; Longo UG, 2008, AM J SPORT MED, V36, P533, DOI 10.1177/0363546507308549; Longo UG, 2011, SPORTS MED ARTHROSC, V19, P227, DOI 10.1097/JSA.0b013e318213bccb; Melis B, 2009, ORTHOP TRAUMATOL-SUR, V95, P319, DOI 10.1016/j.otsr.2009.05.001; Melis B, 2010, J SHOULDER ELB SURG, V19, P757, DOI 10.1016/j.jse.2009.12.002; Melis B, 2010, CLIN ORTHOP RELAT R, V468, P1498, DOI 10.1007/s11999-009-1207-x; Pullin JG, 1997, J SHOULDER ELB SURG, V6, P272, DOI 10.1016/S1058-2746(97)90016-1; Rowshan K, 2010, J BONE JOINT SURG AM, V92A, P2270, DOI 10.2106/JBJS.I.00812; Safran O, 2005, J BONE JOINT SURG AM, V87A, P2662, DOI 10.2106/JBJS.D.02421; Shindle MK, 2011, J SHOULDER ELB SURG, V20, P917, DOI 10.1016/j.jse.2011.02.015; Tajana M S, 2009, Chir Organi Mov, V93 Suppl 1, pS41, DOI 10.1007/s12306-009-0004-8; Yoshihara Y, 2001, J ORTHOP RES, V19, P573, DOI 10.1016/S0736-0266(00)00063-2; Zingg PO, 2007, J BONE JOINT SURG AM, V89A, P1928, DOI 10.2106/JBJS.F.01073	26	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147949	10.1371/journal.pone.0147949	http://dx.doi.org/10.1371/journal.pone.0147949			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808837	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800249
J	Likanonsakul, S; Suntisuklappon, B; Nitiyanontakij, R; Prasithsirikul, W; Nakayama, EE; Shioda, T; Sangsajja, C				Likanonsakul, Sirirat; Suntisuklappon, Bussakorn; Nitiyanontakij, Ravee; Prasithsirikul, Wisit; Nakayama, Emi E.; Shioda, Tatsuo; Sangsajja, Chariya			A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection	PLOS ONE			English	Article							KIDNEY TUBULAR DYSFUNCTION; GLOMERULAR-FILTRATION-RATE; RENAL-FUNCTION; PLASMA-CONCENTRATIONS; ANTIRETROVIRAL-NAIVE; DRUG; SAFETY; NEPHROTOXICITY; TRANSPORTERS; THERAPY	Background In Thailand, the combined generic anti-retroviral drug stavudine/lamivudine/nevirapine (d4T/3TC/NVP) has been used to treat human immunodeficiency virus (HIV)-infected individuals since 2001. Due to relatively frequent adverse effects, d4T gradually has been replaced with tenofovir disoproxil fumarate (TDF). Although the frequency of adverse drug effects with TDF is lower than that with d4T, TDF is known to induce kidney dysfunction, especially in the proximal tubules. It has been reported that renal tubular transporters, including members of the multi-drug resistant (MDR) protein family, are implicated in tenofovir extrusion and may, therefore, confer susceptibility to TDF-induced kidney tubular dysfunction (KTD). We have explored the association between KTD and polymorphisms in genes that encode adenosine triphosphate-binding cassette (ABC)-type MDRs. Methods HIV-infected patients receiving TDF-containing antiretroviral regimens for at least one year were enrolled in the study. The levels of beta2-microglobulin in urine and creatinine (Cr) were measured. Three single-nucleotide polymorphisms, ABCC2 C-24T (rs717620), ABCC2 G1429A (rs2273697), and ABCC4 T4976C (rs1059751), were analyzed using Taq-Man SNP genotyping assays. Results A total of 273 HIV-infected patients were recruited. The median number of years of TDF treatment was 5.04 with interquartile range (IQR) of 3.9-6.7. Despite the length of treatment with TDF, 98.5% patients maintained an estimated glomerular filtration rate (eGFR) of >60 mL/min as calculated by the CKD-EPI formula. Fifty-four patients (19.8%) showed beta2-microglobulinuria (median 2636 mu g/g Cr with IQR of 1519-13197 mu g/g Cr). The allele frequency of ABCC4 T4976C among those 54 patients was 0.602, compared to 0.475 among the 219 remaining patients (p = 0.018). Conclusions Approximately 20% of HIV-infected patients receiving TDF showed beta2-microglobulinuria. The C allele at position 4976 of the ABCC4 gene was associated with beta2-microglobulinuria in this population. This polymorphism may help to identify patients at greater risk for developing TDF-associated KTD.	[Likanonsakul, Sirirat; Suntisuklappon, Bussakorn; Nitiyanontakij, Ravee; Prasithsirikul, Wisit; Sangsajja, Chariya] Minist Publ Hlth, Dept Dis Control, Bamrasnaradura Infect Dis Inst, Nonthaburi, Thailand; [Nakayama, Emi E.; Shioda, Tatsuo] Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan	Ministry of Public Health - Thailand; Osaka University	Shioda, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan.	shioda@biken.osaka-u.ac.jp	Prasithsirikul, Wisit/AAH-6284-2020	ying mei, zhong shan/0000-0002-0477-0980	Ministry of Health, Labor, and Welfare in Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Initiative for Global Research Network on Infectious Diseases; Bamrasnaradura Infectious Diseases Institute, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand	Ministry of Health, Labor, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Initiative for Global Research Network on Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bamrasnaradura Infectious Diseases Institute, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand	This work was supported by the grant from the Ministry of Health, Labor, and Welfare in Japan, the Ministry of Education, Culture, Sports, Science, and Technology, Japan; the Japan Initiative for Global Research Network on Infectious Diseases, directed by the Ministry of Education, Culture, Sports, Science, and Technology of Japan and Bamrasnaradura Infectious Diseases Institute, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calcagno A, 2016, PHARMACOGENOMICS J, V16, P514, DOI 10.1038/tpj.2015.71; Calcagno A, 2013, ANTIMICROB AGENTS CH, V57, P1840, DOI 10.1128/AAC.02434-12; Charoenpak R, 2014, J BAMRASNARADURA INF, V8, P94; Cihlar T, 2001, NUCLEOS NUCLEOT NUCL, V20, P641, DOI 10.1081/NCN-100002341; Ezinga M, 2014, ANTIVIR THER, V19, P765, DOI 10.3851/IMP2761; Gupta SK, 2008, AIDS PATIENT CARE ST, V22, P99, DOI 10.1089/apc.2007.0052; Horberg M, 2010, JAIDS-J ACQ IMM DEF, V53, P62, DOI 10.1097/QAI.0b013e3181be6be2; Izzedine H, 2004, AIDS, V18, P1074, DOI 10.1097/00002030-200404300-00019; Izzedine H, 2005, AM J KIDNEY DIS, V45, P804, DOI 10.1053/j.ajkd.2005.02.010; Izzedine H, 2006, J INFECT DIS, V194, P1481, DOI 10.1086/508546; Izzedine H, 2009, NAT REV NEPHROL, V5, P564, DOI 10.1038/nrneph.2009.142; Labarga P, 2009, AIDS, V23, P689, DOI 10.1097/QAD.0b013e3283262a64; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lubomirov R, 2011, J INFECT DIS, V203, P246, DOI 10.1093/infdis/jiq043; Manosuthi W, 2014, J ANTIMICROB CHEMOTH, V69, P2195, DOI 10.1093/jac/dku129; Moss DM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00248; Nelson MR, 2007, AIDS, V21, P1273, DOI 10.1097/QAD.0b013e3280b07b33; Nishijima T, 2012, CLIN INFECT DIS, V55, P1558, DOI 10.1093/cid/cis772; Perazella MA, 2010, KIDNEY INT, V78, P1060, DOI 10.1038/ki.2010.344; Peyriere H, 2004, JAIDS-J ACQ IMM DEF, V35, P269, DOI 10.1097/00126334-200403010-00007; Post FA, 2010, CURR OPIN HIV AIDS, V5, P524, DOI 10.1097/COH.0b013e32833f203e; Post FA, 2010, JAIDS-J ACQ IMM DEF, V55, P49, DOI 10.1097/QAI.0b013e3181dd911e; Pushpakom SP, 2011, J INFECT DIS, V204, P145, DOI 10.1093/infdis/jir215; Ray AS, 2006, ANTIMICROB AGENTS CH, V50, P3297, DOI 10.1128/AAC.00251-06; Robertson EE, 2006, PHARMACOL THERAPEUT, V109, P399, DOI 10.1016/j.pharmthera.2005.07.005; Rodriguez-Novoa S, 2010, AIDS, V24, P1064, DOI 10.1097/QAD.0b013e32833202e2; Rodriguez-Novoa S, 2009, CLIN INFECT DIS, V48, pE108, DOI 10.1086/598507; Uwai Y, 2007, PHARM RES, V24, P811, DOI 10.1007/s11095-006-9196-x; Van Aubel RAMH, 2005, AM J PHYSIOL-RENAL, V288, pF327, DOI 10.1152/ajprenal.00133.2004; Woodward CLN, 2009, HIV MED, V10, P482, DOI 10.1111/j.1468-1293.2009.00716.x; Zimmermann AE, 2006, CLIN INFECT DIS, V42, P283, DOI 10.1086/499048	31	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147724	10.1371/journal.pone.0147724	http://dx.doi.org/10.1371/journal.pone.0147724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807589	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800196
J	Pane, K; Durante, L; Pizzo, E; Varcamonti, M; Zanfardino, A; Sgambati, V; Di Maro, A; Carpentieri, A; Izzo, V; Di Donato, A; Cafaro, V; Notomista, E				Pane, Katia; Durante, Lorenzo; Pizzo, Elio; Varcamonti, Mario; Zanfardino, Anna; Sgambati, Valeria; Di Maro, Antimo; Carpentieri, Andrea; Izzo, Viviana; Di Donato, Alberto; Cafaro, Valeria; Notomista, Eugenio			Rational Design of a Carrier Protein for the Production of Recombinant Toxic Peptides in Escherichia coli	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; ANTIMICROBIAL PEPTIDES; FUSION EXPRESSION; INCLUSION-BODIES; HUMAN THROMBIN; PURIFICATION; CLEAVAGE; ONCONASE; SYSTEM; LL-37	Commercial uses of bioactive peptides require low cost, effective methods for their production. We developed a new carrier protein for high yield production of recombinant peptides in Escherichia coli very well suited for the production of toxic peptides like antimicrobial peptides. GKY20, a short antimicrobial peptide derived from the C-terminus of human thrombin, was fused to the C-terminus of Onconase, a small ribonuclease (104 amino acids), which efficiently drove the peptide into inclusion bodies with very high expression levels (about 200-250 mg/L). After purification of the fusion protein by immobilized metal ion affinity chromatography, peptide was obtained by chemical cleavage in diluted acetic acid of an acid labile Asp-Pro sequence with more than 95% efficiency. To improve peptide purification, Onconase was mutated to eliminate all acid labile sequences thus reducing the release of unwanted peptides during the acid cleavage. Mutations were chosen to preserve the differential solubility of Onconase as function of pH, which allows its selective precipitation at neutral pH after the cleavage. The improved carrier allowed the production of 15-18 mg of recombinant peptide per liter of culture with 96-98% purity without the need of further chromatographic steps after the acid cleavage. The antimicrobial activity of the recombinant peptide, with an additional proline at the N-terminus, was tested on Gram-negative and Gram-positive strains and was found to be identical to that measured for synthetic GKY20. This finding suggests that N-terminal proline residue does not change the antimicrobial properties of recombinant (P) GKY20. The improved carrier, which does not contain cysteine and methionine residues, Asp-Pro and Asn-Gly sequences, is well suited for the production of peptides using any of the most popular chemical cleavage methods.	[Pane, Katia; Durante, Lorenzo; Pizzo, Elio; Varcamonti, Mario; Zanfardino, Anna; Sgambati, Valeria; Di Donato, Alberto; Cafaro, Valeria; Notomista, Eugenio] Univ Naples Federico II, Dept Biol, Naples, Italy; [Di Maro, Antimo] Seconda Univ Napoli, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [Carpentieri, Andrea] Univ Naples Federico II, Dept Chem Sci, Naples, Italy; [Izzo, Viviana] Univ Salerno, Dept Med & Surg, I-84081 Baronissi, Italy	University of Naples Federico II; Universita della Campania Vanvitelli; University of Naples Federico II; University of Salerno	Notomista, E (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	notomist@unina.it	Pane, Katia/AAA-6429-2020; Cafaro, Valeria/GLV-3363-2022; Pizzo, Elio/Q-4722-2017; Izzo, Viviana/Q-2076-2015	Pane, Katia/0000-0002-7594-7931; Pizzo, Elio/0000-0002-3652-8865; Izzo, Viviana/0000-0001-6066-7569; Carpentieri, Andrea/0000-0002-1944-5355; NOTOMISTA, Eugenio/0000-0003-0097-6487	Italian Cystic Fibrosis Research Foundation [FFC 9/2012, FFC 11/2013, FFC 12/2014]; Programma F.A.R.O IV tornata [CUP: E68C12000260003]; Polo delle Scienze e Tecnologie, Universita di Napoli Federico II	Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Programma F.A.R.O IV tornata; Polo delle Scienze e Tecnologie, Universita di Napoli Federico II	This work was supported by grants FFC#9/2012, FFC#11/2013, and FFC#12/2014 from "Italian Cystic Fibrosis Research Foundation" (http://www.fibrosicisticaricerca.it) and "Programma F.A.R.O IV tornata" (CUP: E68C12000260003) funded by Polo delle Scienze e Tecnologie, Universita di Napoli Federico II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu A, 2014, RSC ADV, V4, P31564, DOI 10.1039/c4ra04056b; Beaulieu L, 2007, CAN J MICROBIOL, V53, P1246, DOI 10.1139/W07-089; Bornstein P, 1977, Methods Enzymol, V47, P132; Crimmins Dan L, 2005, Curr Protoc Protein Sci, VChapter 11, DOI 10.1002/0471140864.ps1104s40; Feng X, 2006, PROTEIN EXPRES PURIF, V47, P110, DOI 10.1016/j.pep.2005.08.016; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Gaspar D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00294; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gibbs GM, 2004, APPL ENVIRON MICROB, V70, P3292, DOI 10.1128/AEM.70.6.3292-3297.2004; Green MR, 2012, MOL CLONING LAB MANU, V1; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Houen G, 1999, ACTA CHEM SCAND, V53, P1122, DOI 10.3891/acta.chem.scand.53-1122; Hwang PM, 2014, FEBS LETT, V588, P247, DOI 10.1016/j.febslet.2013.09.028; Ingham AB, 2007, BIOTECHNOL APPL BIOC, V47, P1, DOI 10.1043/BA20060207; Joshi AB, 2005, J PHARM SCI-US, V94, P1912, DOI 10.1002/jps.20405; Joshi AB, 2004, INT J PHARMACEUT, V273, P213, DOI 10.1016/j.ijpharm.2004.01.006; Kasetty G, 2011, ANTIMICROB AGENTS CH, V55, P2880, DOI 10.1128/AAC.01515-10; Katoch J, 2012, NANO LETT, V12, P2342, DOI 10.1021/nl300286k; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landon, 1977, Methods Enzymol, V47, P145; Lee J, 2010, METHODS MOL BIOL, V634, P137, DOI 10.1007/978-1-60761-652-8_10; Li N, 2009, J PHARMACEUT BIOMED, V50, P73, DOI 10.1016/j.jpba.2009.03.020; Li XJ, 2006, J PHYS CHEM B, V110, P12621, DOI 10.1021/jp061518d; Li YF, 2006, PROTEIN EXPRES PURIF, V47, P498, DOI 10.1016/j.pep.2005.10.022; Li YF, 2007, PROTEIN EXPRES PURIF, V54, P157, DOI 10.1016/j.pep.2007.02.003; Li YF, 2011, PROTEIN EXPRES PURIF, V80, P260, DOI 10.1016/j.pep.2011.08.001; Li YF, 2009, BIOTECHNOL APPL BIOC, V54, P1, DOI 10.1042/BA20090087; Mant CT, 2009, BIOPOLYMERS, V92, P573, DOI 10.1002/bip.21316; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Merza M, 2014, AM J PHYSIOL-GASTR L, V307, pG914, DOI 10.1152/ajpgi.00237.2014; Montigny C, 2004, BBA-BIOMEMBRANES, V1660, P53, DOI 10.1016/j.bbamem.2003.10.013; Moon JY, 2006, BBA-BIOMEMBRANES, V1758, P1351, DOI 10.1016/j.bbamem.2006.02.003; Notomista E, 2001, BIOCHEMISTRY-US, V40, P9097, DOI 10.1021/bi010741s; Notomista E, 2000, BIOCHEMISTRY-US, V39, P8711, DOI 10.1021/bi000415x; Notomista E, 1999, FEBS LETT, V463, P211, DOI 10.1016/S0014-5793(99)01623-3; Pan SH, 2000, BIOTECHNIQUES, V29, P1234, DOI 10.2144/00296st03; Papareddy P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000857; Pizzo E, 2008, FEBS J, V275, P1283, DOI 10.1111/j.1742-4658.2008.06289.x; Reissmann S, 2014, J PEPT SCI, V20, P760, DOI 10.1002/psc.2672; Rodriguez V, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-65; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; Singh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0222-8; STECK G, 1980, ANAL BIOCHEM, V107, P21, DOI 10.1016/0003-2697(80)90486-8; Tian ZG, 2009, APPL MICROBIOL BIOT, V83, P143, DOI 10.1007/s00253-009-1893-z; Vidovic V, 2009, J PEPT SCI, V15, P278, DOI 10.1002/psc.1112; Wang J, 2015, PROCESS BIOCHEM, V50, P1767, DOI 10.1016/j.procbio.2015.08.005; Wang L, 2009, PRION, V3, P139, DOI 10.4161/pri.3.3.9922; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Wu GQ, 2011, APPL MICROBIOL BIOT, V92, P85, DOI 10.1007/s00253-011-3379-z; Zhang C., 2014, PROC VLDB ENDOW, V7, P9, DOI DOI 10.1371/J0URNAL.P0NE.0103456; Zhang LC, 2015, J IND MICROBIOL BIOT, V42, P1369, DOI 10.1007/s10295-015-1673-y; Zhao CX, 2015, BIOTECHNOL BIOENG, V112, P957, DOI 10.1002/bit.25505; Zhou QF, 2007, CURR MICROBIOL, V54, P366, DOI 10.1007/s00284-006-0466-y; Zorko M, 2010, METHODS MOL BIOL, V618, P61, DOI 10.1007/978-1-60761-594-1_5; Zorko M, 2009, BBA-BIOMEMBRANES, V1788, P314, DOI 10.1016/j.bbamem.2008.10.015	56	34	35	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146552	10.1371/journal.pone.0146552	http://dx.doi.org/10.1371/journal.pone.0146552			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808536	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800024
J	Rahman, MA; Tanaka, N; Usui, K; Kawahara, S				Rahman, Md Ashrafur; Tanaka, Norifumi; Usui, Koji; Kawahara, Shigenori			Role of Muscarinic Acetylcholine Receptors in Serial Feature-Positive Discrimination Task during Eyeblink Conditioning in Mice	PLOS ONE			English	Article							NICTITATING-MEMBRANE RESPONSE; DECEREBRATE GUINEA-PIGS; IBOTENATE LESIONS; HIPPOCAMPUS; RETENTION; RATS; SCOPOLAMINE; RABBITS; ACQUISITION; MEMORY	We investigated the role of muscarinic acetylcholine receptors (mAChRs) in eyeblink serial feature-positive discrimination learning in mice using the mAChR antagonist. A 2-s light cue was delivered 5 or 6 s before the presentation of a 350-ms tone paired with a 100-ms periorbital electrical shock (cued trial) but not before the tone-alone presentation (non-cued trial). Mice received 30 cued and 30 non-cued trials each day in a random order. We found that saline-injected control mice were successfully discriminating between cued and non-cued trials within a few days of conditioning. The mice responded more frequently to the tone in cued trials than in non-cued trials. Analysis of conditioned response (CR) dynamics revealed that the CR onset latency was shorter in cued trials than in non-cued trials, despite the CR peak amplitude not differing significantly between the two conditions. In contrast, scopolamine-injected mice developed an equal number of CRs with similar temporal patterns irrespective of the presence of the cue during the 7 days of conditioning, indicating in a failure to acquire conditional discrimination. In addition, the scopolamine administration to the control mice after they had successfully acquired discrimination did not impair the conditional discrimination and expression of pre-acquired CR. These results suggest that mAChRs may play a pivotal role in memory formation in the conditional brain state associated with the feature cue; however they are unlikely to be involved in the development of discrimination after conditional memory had formed in the serial feature-positive discrimination task during eyeblink conditioning.	[Rahman, Md Ashrafur; Tanaka, Norifumi; Usui, Koji; Kawahara, Shigenori] Toyama Univ, Grad Sch Innovat Life Sci, 3190 Gofuku, Toyama 9308555, Japan; [Usui, Koji; Kawahara, Shigenori] Toyama Univ, Grad Sch Sci & Engn, 3190 Gofuku, Toyama 9308555, Japan	University of Toyama; University of Toyama	Kawahara, S (corresponding author), Toyama Univ, Grad Sch Innovat Life Sci, 3190 Gofuku, Toyama 9308555, Japan.; Kawahara, S (corresponding author), Toyama Univ, Grad Sch Sci & Engn, 3190 Gofuku, Toyama 9308555, Japan.	kawahara@eng.u-toyama.ac.jp		rahman, Md ashrafur/0000-0003-0146-5312				Berry SD, 2011, NEUROBIOL LEARN MEM, V95, P185, DOI 10.1016/j.nlm.2010.11.014; Bouger PCM, 2005, EUR NEUROPSYCHOPHARM, V15, P331, DOI 10.1016/j.euroneuro.2004.11.006; BRANDON SE, 1991, J EXP PSYCHOL ANIM B, V17, P299, DOI 10.1037/0097-7403.17.3.299; Bushnell PJ, 1997, PSYCHOPHARMACOLOGY, V134, P230, DOI 10.1007/s002130050446; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; DAUM I, 1991, BEHAV NEUROSCI, V105, P396, DOI 10.1037/0735-7044.105.3.396; DAVIDSON TL, 1989, PSYCHOBIOLOGY, V17, P49; DUNNE MP, 1986, PSYCHOPHARMACOLOGY, V89, P94; Fortier CB, 2003, BEHAV NEUROSCI, V117, P1181, DOI 10.1037/0735-7044.117.6.1181; Green JT, 2000, PSYCHOL BULL, V126, P138, DOI 10.1037/0033-2909.126.1.138; GRILLON C, 1991, PSYCHOPHYSIOLOGY, V28, P588, DOI 10.1111/j.1469-8986.1991.tb01999.x; Jarrard L E, 1991, Hippocampus, V1, P107, DOI 10.1002/hipo.450010110; JARRARD LE, 1990, PSYCHOBIOLOGY, V18, P68; Kaneko T, 1997, PSYCHOPHARMACOLOGY, V131, P161, DOI 10.1007/s002130050279; KEHOE EJ, 1987, J EXP PSYCHOL ANIM B, V13, P17, DOI 10.1037/0097-7403.13.1.17; Kotani S, 2003, EUR J NEUROSCI, V17, P1445, DOI 10.1046/j.1460-9568.2003.02566.x; Kotani S, 2002, EUR J NEUROSCI, V15, P1267, DOI 10.1046/j.1460-9568.2002.01963.x; Kuc KA, 2006, GENES BRAIN BEHAV, V5, P355, DOI 10.1111/j.1601-183X.2005.00168.x; LOECHNER KJ, 1987, BEHAV BRAIN RES, V26, P63, DOI 10.1016/0166-4328(87)90017-9; MAUK MD, 1987, BRAIN RES, V403, P89, DOI 10.1016/0006-8993(87)90126-0; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; MCKINNEY M, 1983, J COMP NEUROL, V217, P103, DOI 10.1002/cne.902170109; MOYER JR, 1990, BEHAV NEUROSCI, V104, P243, DOI 10.1037/0735-7044.104.2.243; Robinson L, 2011, BEHAV BRAIN RES, V221, P443, DOI 10.1016/j.bbr.2011.01.055; ROSS RT, 1981, ANIM LEARN BEHAV, V9, P293, DOI 10.3758/BF03197835; ROSS RT, 1984, BEHAV NEUROSCI, V98, P211, DOI 10.1037/0735-7044.98.2.211; SOLOMON PR, 1983, SCIENCE, V220, P329, DOI 10.1126/science.6836277; SOLOMON PR, 1986, BEHAV NEUROSCI, V100, P729, DOI 10.1037/0735-7044.100.5.729; SPENCER DG, 1986, BRAIN RES, V380, P59, DOI 10.1016/0006-8993(86)91429-0; Steinmetz JE, 2000, BEHAV BRAIN RES, V110, P13, DOI 10.1016/S0166-4328(99)00181-3; STEVENS R, 1981, PHYSIOL BEHAV, V27, P385, DOI 10.1016/0031-9384(81)90285-7; Takatsuki K, 2003, J NEUROSCI, V23, P17; Takatsuki K, 2002, NEUROREPORT, V13, P159, DOI 10.1097/00001756-200201210-00036; Takehara K, 2002, BRAIN RES, V951, P183, DOI 10.1016/S0006-8993(02)03159-1; Takehara K, 2003, J NEUROSCI, V23, P9897; Tokuda K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112927; WAGNER AR, 1975, ANIM LEARN BEHAV, V3, P370, DOI 10.3758/BF03213461; Weidemann G, 1997, Q J EXP PSYCHOL-B, V50, P295; Weiss C, 2011, BEHAV NEUROSCI, V125, P318, DOI 10.1037/a0023520	39	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147572	10.1371/journal.pone.0147572	http://dx.doi.org/10.1371/journal.pone.0147572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808980	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800138
J	Wanyenze, RK; Musinguzi, G; Matovu, JKB; Kiguli, J; Nuwaha, F; Mujisha, G; Musinguzi, J; Arinaitwe, J; Wagner, GJ				Wanyenze, Rhoda K.; Musinguzi, Geofrey; Matovu, Joseph K. B.; Kiguli, Juliet; Nuwaha, Fred; Mujisha, Geoffrey; Musinguzi, Joshua; Arinaitwe, Jim; Wagner, Glenn J.			"If You Tell People That You Had Sex with a Fellow Man, It Is Hard to Be Helped and Treated": Barriers and Opportunities for Increasing Access to HIV Services among Men Who Have Sex with Men in Uganda	PLOS ONE			English	Article							HEALTH-SERVICES; STIGMA; CARE	Background Despite the high HIV prevalence among men who have sex with men (MSM) in sub-Saharan Africa, little is known about their access to HIV services. This study assessed barriers and opportunities for expanding access to HIV services among MSM in Uganda. Methods In October-December 2013, a cross-sectional qualitative study was conducted in 12 districts of Uganda. Semi-structured in-depth interviews were conducted with 85 self-identified MSM by snowball sampling and 61 key informants including HIV service providers and policy makers. Data were analysed using manifest content analysis and Atlas.ti software. Results Three quarters of the MSM (n = 62, 72.9%) were not comfortable disclosing their sexual orientation to providers and 69 (81.1%) felt providers did not respect MSM. Half (n = 44, 51.8%) experienced difficulties in accessing health services. Nine major barriers to access were identified, including: (i) unwelcoming provider behaviours; (ii) limited provider skills and knowledge; (iii) negative community perceptions towards MSM; (iv) fear of being exposed as MSM; (v) limited access to MSM-specific services; (vi) high mobility of MSM, (vii) lack of guidelines on MSM health services; viii) a harsh legal environment; and ix) HIV related stigma. Two-thirds (n = 56, 66%) participated in MSM social networks and 86% of these (48) received support from the networks to overcome barriers to accessing services. Conclusions Negative perceptions among providers and the community present barriers to service access among MSM. Guidelines, provider skills building and use of social networks for mobilization and service delivery could expand access to HIV services among MSM in Uganda.	[Wanyenze, Rhoda K.; Musinguzi, Geofrey; Nuwaha, Fred] Makerere Univ, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda; [Matovu, Joseph K. B.; Kiguli, Juliet] Makerere Univ, Sch Publ Hlth, Dept Community Hlth, Kampala, Uganda; [Mujisha, Geoffrey] MARPS Network, Kampala, Uganda; [Musinguzi, Joshua; Arinaitwe, Jim] Minist Hlth, Kampala, Uganda; [Wagner, Glenn J.] RAND Corp, Santa Monica, CA USA	Makerere University; Makerere University; RAND Corporation	Wanyenze, RK (corresponding author), Makerere Univ, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda.	rwanyenze@hotmail.com	Matovu, Joseph/AAO-5790-2020		Uganda Ministry of Health through a Grant from the Global Fund; RAND	Uganda Ministry of Health through a Grant from the Global Fund; RAND	This research was funded by the Uganda Ministry of Health through a Grant from the Global Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author GJW is employed by RAND. RAND provided support in the form of salaries for author GJW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Batist E, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18754; Bowring A, 2019, 10 IAS C HIV SCI; Delany-Moretlwe S, 2015, J INT AIDS SOC, V18, P29, DOI 10.7448/IAS.18.2.19833; Dijkstra M, 2015, INT HEALTH, V7, P151, DOI 10.1093/inthealth/ihu101; Graneheim U. H., NURSE ED TODAY, V24, P105; Hakim AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125218; Hladik W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038143; Holland CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122881; King R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082937; Lewis-Beck M. S., 2004, ENCY SOCIAL SCI RES, V1-3; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Ministry of Health Uganda and OR Macro, 2012, UG AIDS IND SURV 201; Musinguzi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132297; Rankin WW, 2005, PLOS MED, V2, P702, DOI 10.1371/journal.pmed.0020247; Ross MW, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.26096; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; Scott Geibel, 2010, HORIZONS SYNTHESIS B; Smit PJ, 2012, AIDS CARE, V24, P405, DOI 10.1080/09540121.2011.613910; Taegtmeyer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064527; Uganda AIDS Commission, UG HIV AIDS COUNTR S; Uganda AIDS Commission, 2014, CAS MOR STRAT INCR I; UNAIDS, 2014 GLOB STAT; UNAIDS, 2014, 90 90 90 AMB TREAT T; van der Elst EM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18741; World Health Organization, 2011, PREVENTION TREATMENT; World Health Organization, 2014, CONS GUID KAPS CONS	27	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147714	10.1371/journal.pone.0147714	http://dx.doi.org/10.1371/journal.pone.0147714			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808653	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800192
J	Warlaumont, AS; Finnegan, MK				Warlaumont, Anne S.; Finnegan, Megan K.			Learning to Produce Syllabic Speech Sounds via Reward-Modulated Neural Plasticity	PLOS ONE			English	Article							SOCIAL FEEDBACK; MOTOR CORTEX; INFANTS; MODEL; EVOLUTION; DOPAMINE; HEARING; VOCALIZATION; ORGANIZATION; OSCILLATIONS	At around 7 months of age, human infants begin to reliably produce well-formed syllables containing both consonants and vowels, a behavior called canonical babbling. Over subsequent months, the frequency of canonical babbling continues to increase. How the infant's nervous system supports the acquisition of this ability is unknown. Here we present a computational model that combines a spiking neural network, reinforcement-modulated spike-timing-dependent plasticity, and a human-like vocal tract to simulate the acquisition of canonical babbling. Like human infants, the model's frequency of canonical babbling gradually increases. The model is rewarded when it produces a sound that is more auditorily salient than sounds it has previously produced. This is consistent with data from human infants indicating that contingent adult responses shape infant behavior and with data from deaf and tracheostomized infants indicating that hearing, including hearing one's own vocalizations, is critical for canonical babbling development. Reward receipt increases the level of dopamine in the neural network. The neural network contains a reservoir with recurrent connections and two motor neuron groups, one agonist and one antagonist, which control the masseter and orbicularis oris muscles, promoting or inhibiting mouth closure. The model learns to increase the number of salient, syllabic sounds it produces by adjusting the base level of muscle activation and increasing their range of activity. Our results support the possibility that through dopamine-modulated spike-timing-dependent plasticity, the motor cortex learns to harness its natural oscillations in activity in order to produce syllabic sounds. It thus suggests that learning to produce rhythmic mouth movements for speech production may be supported by general cortical learning mechanisms. The model makes several testable predictions and has implications for our understanding not only of how syllabic vocalizations develop in infancy but also for our understanding of how they may have evolved.	[Warlaumont, Anne S.] Univ Calif Merced, Cognit & Informat Sci, Merced, CA USA; [Finnegan, Megan K.] Univ Illinois, Speech & Hearing Sci, Champaign, IL USA	University of California System; University of California Merced; University of Illinois System; University of Illinois Urbana-Champaign	Warlaumont, AS (corresponding author), Univ Calif Merced, Cognit & Informat Sci, Merced, CA USA.	awarlaumont2@ucmerced.edu	Finnegan, Megan/GXA-0133-2022	Finnegan, Megan/0000-0003-4095-1225	Merced Undergraduate Research in Computational Biology Program; National Science Foundation [DBI-1040962]; University of California	Merced Undergraduate Research in Computational Biology Program; National Science Foundation(National Science Foundation (NSF)); University of California(University of California System)	MKF's efforts were funded by the University of California, Merced Undergraduate Research in Computational Biology Program, sponsored by National Science Foundation Grant DBI-1040962 (http://www.nsf.gov/awardsearch/showAward?AWD_ID=1040962).; We thank Thomas Hannagan, Chris Kello, and members of the UC Merced Emergence of Communication Lab for helpful comments on an earlier draft of this paper. MKF's efforts were funded by the University of California, Merced Undergraduate Research in Computational Biology Program, sponsored by National Science Foundation Grant DBI-1040962.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Andrew RJ, 1998, BEHAV BRAIN SCI, V21, P513, DOI 10.1017/S0140525X98241264; Barlow SM, 2009, HDB MAMMALIAN VOCALI, P351; Beaumont S., 1993, FIRST LANG, V13, P235, DOI DOI 10.1177/014272379301303805; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLOOM K, 1993, INFANT BEHAV DEV, V16, P109, DOI 10.1016/0163-6383(93)80032-4; BLOOM K, 1988, J CHILD LANG, V15, P469, DOI 10.1017/S0305000900012502; Boersma P., 2015, PRAAT; Boersma Paul, 1998, FUNCTIONAL PHONOLOGY; Bouchard KE, 2013, NATURE, V495, P327, DOI 10.1038/nature11911; Brickner RM, 1940, J NEUROPHYSIOL, V3, P128, DOI 10.1152/jn.1940.3.2.128; Chorley P, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00021; Coath M, 2007, P ACM INT MEAS C SAN, P1; Coath M, 2009, CONNECT SCI, V21, P193, DOI 10.1080/09540090902733905; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Darshan R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003377; Davis B, 2013, EMERGENCE APPROACH S; de Jong NH, 2008, PRAAT SCRIPT SYLLABL; de Jong NH, 2009, BEHAV RES METHODS, V41, P385, DOI 10.3758/BRM.41.2.385; Deacon T.W., 1989, Human Evolution, V4, P367, DOI 10.1007/BF02436435; DePaolis RA, 2011, INFANT BEHAV DEV, V34, P590, DOI 10.1016/j.infbeh.2011.06.005; Eckel HE, 1999, ANN OTO RHINOL LARYN, V108, P232, DOI 10.1177/000348949910800303; Ejiri K, 2001, DEVELOPMENTAL SCI, V4, P40, DOI 10.1111/1467-7687.00147; Endo N, 2014, IEEE-RAS INT C HUMAN, P1063, DOI 10.1109/HUMANOIDS.2014.7041496; Ertmer DJ, 2010, OXFORD U HDB DEAF ST, V2, P360; FERNALD A, 1987, INFANT BEHAV DEV, V10, P279, DOI 10.1016/0163-6383(87)90017-8; FERNALD A, 1985, INFANT BEHAV DEV, V8, P181, DOI 10.1016/S0163-6383(85)80005-9; Ghazanfar AA, 1998, BEHAV BRAIN SCI, V21, P516, DOI 10.1017/S0140525X9828126X; Ghazanfar AA, 2014, J COGNITIVE NEUROSCI, V26, P1196, DOI 10.1162/jocn_a_00575; Giulivi S, 2011, LANG LEARN DEV, V7, P202, DOI 10.1080/15475441.2011.564569; Goldstein MH, 1999, J COMP PSYCHOL, V113, P52, DOI 10.1037/0735-7036.113.1.52; Goldstein MH, 2008, PSYCHOL SCI, V19, P515, DOI 10.1111/j.1467-9280.2008.02117.x; Goldstein MH, 2010, TRENDS COGN SCI, V14, P249, DOI 10.1016/j.tics.2010.02.004; Goldstein UG, 1980, THESIS MIT; Grillner S, 1982, SPEECH MOTOR CONTROL; Gros-Louis J, 2006, INT J BEHAV DEV, V30, P509, DOI 10.1177/0165025406071914; GUENTHER FH, 1994, BIOL CYBERN, V72, P43, DOI 10.1007/BF00206237; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Heintz I, 2009, INTERSPEECH 2009: 10TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2009, VOLS 1-5, P684; Hosp JA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00145; Hosp JA, 2011, J NEUROSCI, V31, P2481, DOI 10.1523/JNEUROSCI.5411-10.2011; Howard IS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110334; Howard IS, 2011, MOTOR CONTROL, V15, P85, DOI 10.1123/mcj.15.1.85; HUANG CS, 1989, J NEUROPHYSIOL, V61, P635, DOI 10.1152/jn.1989.61.3.635; Iverson JM, 2007, BRAIN LANG, V101, P198, DOI 10.1016/j.bandl.2006.11.004; Iyer SN, 2008, VOLTA REV, V108, P115; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; JONAS S, 1981, J COMMUN DISORD, V14, P349, DOI 10.1016/0021-9924(81)90019-8; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; Jurgens U, 1974, BRAIN RES, V18; Kanda H, 2009, IEEE INT CONF ROBOT, P4036; Kello CT, 2013, PSYCHOL REV, V120, P230, DOI 10.1037/a0030970; Koopmans-van Beinum FJ., 1986, PRECURSORS EARLY SPE, P37, DOI DOI 10.1007/978-1-349-08023-6_4; Kozma R, 2015, CURR OPIN NEUROBIOL, V31, P181, DOI 10.1016/j.conb.2014.11.005; Kroger BJ, 2014, EPJ NONLINEAR BIOMED, V2, DOI 10.1140/epjnbp15; Kroger BJ, 2009, SPEECH COMMUN, V51, P793, DOI 10.1016/j.specom.2008.08.002; Locke JL, 1995, BRAIN LANG, V51, P498, DOI 10.1006/brln.1995.1073; LOCKE JL, 1990, J CHILD LANG, V17, P1, DOI 10.1017/S0305000900013076; Locke JL, 1989, FIRST LANG, V9, P191, DOI [10.1177/014272378900900606, DOI 10.1177/014272378900900606]; MacNeilage PF, 1998, BEHAV BRAIN SCI, V21, P499, DOI 10.1017/S0140525X98001265; MacNeilage PF, 2000, CHILD DEV, V71, P153, DOI 10.1111/1467-8624.00129; MASATAKA N, 1994, INFANT BEHAV DEV, V17, P461, DOI 10.1016/0163-6383(94)90038-8; McCune L, 2001, J SPEECH LANG HEAR R, V44, P670, DOI 10.1044/1092-4388(2001/054); Meier RP, 1997, PHONETICA, V54, P153, DOI 10.1159/000262219; Menard L, 2004, J SPEECH LANG HEAR R, V47, P1059, DOI 10.1044/1092-4388(2004/079); Miura K, 2012, ADV ROBOTICS, V26, P23, DOI 10.1163/016918611X607347; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Morrill RJ, 2012, DEVELOPMENTAL SCI, V15, P557, DOI 10.1111/j.1467-7687.2012.01149.x; Moulin-Frier C, 2012, P 2012 IEEE INT C DE, P1; Moulin-Frier C, J PHON IN PRESS; Moulin-Frier C, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01006; Munhall KG, 1998, BEHAV BRAIN SCI, V21, P524, DOI 10.1017/S0140525X98391268; Murakami M, 2015, P 2015 IEEE INT C DE; Nam H, 2013, J PHONETICS, V41, P63, DOI 10.1016/j.wocn.2012.11.002; Ohala JJ, 1996, J ACOUST SOC AM, V99, P1718, DOI 10.1121/1.414696; Ohala JJ, 1998, BEHAV BRAIN SCI, V21, P525, DOI 10.1017/S0140525X98401262; Oller D. K., 1980, CHILD PHONOLOGY, V1, P93, DOI [10.1016/B978-0-12-770601-6.50011-5, DOI 10.1016/B978-0-12-770601-6.50011-5]; Oller D.K., 2000, EMERGENCE SPEECH CAP; Oller DK, 2001, DEVELOPMENTAL SCI, V4, P49, DOI 10.1111/1467-7687.00148; OLLER DK, 1988, CHILD DEV, V59, P441, DOI 10.1111/j.1467-8624.1988.tb01479.x; Oller DK, 1997, J CHILD LANG, V24, P407; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; PENFIELD W, 1951, AMA ARCH NEUROL PSY, V66, P289, DOI 10.1001/archneurpsyc.1951.02320090038004; Philippsen AK, 2014, J IEEE I C DEVELOP L, P195, DOI 10.1109/DEVLRN.2014.6982981; Schauwers K, 2004, OTOL NEUROTOL, V25, P263, DOI 10.1097/00129492-200405000-00011; Schulz GM, 2005, CEREB CORTEX, V15, P1835, DOI 10.1093/cercor/bhi061; Stark R. E., 1980, CHILD PHONOLOGY, V1, P73, DOI DOI 10.1016/B978-0-12-770601-6.50010-3; STEVENS KN, 1989, J PHONETICS, V17, P3, DOI 10.1016/S0095-4470(19)31520-7; STOELGAMMON C, 1986, J SPEECH HEAR DISORD, V51, P33, DOI 10.1044/jshd.5101.33; THELEN E, 1981, DEV PSYCHOL, V17, P237, DOI 10.1037/0012-1649.17.3.237; Vihman M. M., 1996, PHONOLOGICAL DEV ORI; Vorperian HK, 2005, J ACOUST SOC AM, V117, P338, DOI 10.1121/1.1835958; Warlaumont Anne S., 2013, 2013 IEEE Third Joint International Conference on Development and Learning and Epigenetic Robotics (ICDL), DOI 10.1109/DevLrn.2013.6652547; Warlaumont AS, 2014, J IEEE I C DEVELOP L, P262, DOI 10.1109/DEVLRN.2014.6982991; Warlaumont AS, 2014, PSYCHOL SCI, V25, P1314, DOI 10.1177/0956797614531023; Warlaumont AS, 2013, NEURAL NETWORKS, V38, P64, DOI 10.1016/j.neunet.2012.11.012; Warlaumont AS, 2011, AISB 2011 COMPUTATIO, P23; Warlaumont AS, J PHON IN PRESS; Warlaumont AS, 2014, COMPUTATIONAL MODELS, P113; Warlaumont AS, 2012, IEEE INT C DEV LEARN, P1; Westermann G, 2004, BRAIN LANG, V89, P393, DOI 10.1016/S0093-934X(03)00345-6	102	24	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0145096	10.1371/journal.pone.0145096	http://dx.doi.org/10.1371/journal.pone.0145096			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DC9FZ	26808148	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800005
J	Bergom, C; Hauser, AD; Rymaszewski, A; Gonyo, P; Prokop, JW; Jennings, BC; Lawton, AJ; Frei, A; Lorimer, EL; Aguilera-Barrantes, I; Mackinnon, AC; Noon, K; Fierke, CA; Williams, CL				Bergom, Carmen; Hauser, Andrew D.; Rymaszewski, Amy; Gonyo, Patrick; Prokop, Jeremy W.; Jennings, Benjamin C.; Lawton, Alexis J.; Frei, Anne; Lorimer, Ellen L.; Aguilera-Barrantes, Irene; Mackinnon, Alexander C.; Noon, Kathleen; Fierke, Carol A.; Williams, Carol L.			The Tumor-suppressive Small GTPase DiRas1 Binds the Noncanonical Guanine Nucleotide Exchange Factor SmgGDS and Antagonizes SmgGDS Interactions with Oncogenic Small GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; glioblastoma; GTPase Kras (KRAS); Ras homolog gene family; member A (RhoA); Ras-related protein 1 (Rap1); Di-Ras1; NF-kappaB (NF-KB); Rap1GDS1; Rig; SmgGDS	NONSMALL CELL LUNG; KAPPA-B ACTIVITY; BREAST CANCERS; RAS ONCOGENES; FORCE-FIELD; ACTIVATION; RAC1; CARCINOMA; PROTEIN; PATHWAY	The small GTPase DiRas1 has tumor-suppressive activities, unlike the oncogenic properties more common to small GTPases such as K-Ras and RhoA. Although DiRas1 has been found to be a tumor suppressor in gliomas and esophageal squamous cell carcinomas, the mechanisms by which it inhibits malignant phenotypes have not been fully determined. In this study, we demonstrate that DiRas1 binds to SmgGDS, a protein that promotes the activation of several oncogenic GTPases. In silico docking studies predict that DiRas1 binds to SmgGDS in a manner similar to other small GTPases. SmgGDS is a guanine nucleotide exchange factor for RhoA, but we report here that SmgGDS does not mediate GDP/GTP exchange on DiRas1. Intriguingly, DiRas1 acts similarly to a dominant-negative small GTPase, binding to SmgGDS and inhibiting SmgGDS binding to other small GTPases, including K-Ras4B, RhoA, and Rap1A. DiRas1 is expressed in normal breast tissue, but its expression is decreased in most breast cancers, similar to its family member DiRas3 (ARHI). DiRas1 inhibits RhoA- and SmgGDS-mediated NF-B transcriptional activity in HEK293T cells. We also report that DiRas1 suppresses basal NF-B activation in breast cancer and glioblastoma cell lines. Taken together, our data support a model in which DiRas1 expression inhibits malignant features of cancers in part by nonproductively binding to SmgGDS and inhibiting the binding of other small GTPases to SmgGDS.	[Bergom, Carmen; Hauser, Andrew D.; Rymaszewski, Amy; Gonyo, Patrick; Frei, Anne; Lorimer, Ellen L.; Mackinnon, Alexander C.; Williams, Carol L.] Med Coll Wisconsin, Canc Ctr, Milwaukee, WI 53226 USA; [Bergom, Carmen; Hauser, Andrew D.; Frei, Anne] Med Coll Wisconsin, Dept Radiat Oncol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Hauser, Andrew D.; Rymaszewski, Amy; Gonyo, Patrick; Lorimer, Ellen L.; Williams, Carol L.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Aguilera-Barrantes, Irene; Mackinnon, Alexander C.] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Prokop, Jeremy W.] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [Noon, Kathleen] Med Coll Wisconsin, Mass Spect Facil Prote, Milwaukee, WI 53226 USA; [Hauser, Andrew D.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Jennings, Benjamin C.; Lawton, Alexis J.; Fierke, Carol A.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Lawton, Alexis J.] Univ Michigan, Biochem Undergrad Program, Ann Arbor, MI 48109 USA; [Fierke, Carol A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; New York University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bergom, C (corresponding author), Med Coll Wisconsin, Dept Radiat Oncol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	cbergom@mcw.edu	Prokop, Jeremy/AAG-4931-2019	Lawton, Alexis/0000-0002-1065-0846; Mackinnon, Alexander/0000-0002-2036-8529; Prokop, Jeremy/0000-0002-1818-9695; Bergom, Carmen/0000-0002-0886-5055	Medical College of Wisconsin Cancer Center and Research Affairs Committee, Advancing a Healthier Wisconsin; Radiological Society of North America; Robert D. and Patricia E. Kern Family Foundation; National Center for Research Resources; National Center for Advancing Translational Sciences; Office of the Director of the National Institutes of Health [8KL2TR000056]; Nancy Laning Sobczak; Breast Cancer Research Award; Institutional Research from the American Cancer Society [86-004-26]; National Institutes of Health [RO1CA188871, F32GM112317, RO1GM040602]; NATIONAL CANCER INSTITUTE [R01CA188871] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000056, KL2TR001438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K01ES025435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM112317, R01GM040602] Funding Source: NIH RePORTER	Medical College of Wisconsin Cancer Center and Research Affairs Committee, Advancing a Healthier Wisconsin; Radiological Society of North America; Robert D. and Patricia E. Kern Family Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy Laning Sobczak; Breast Cancer Research Award; Institutional Research from the American Cancer Society; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by funding from the Medical College of Wisconsin Cancer Center and Research Affairs Committee, Advancing a Healthier Wisconsin, the Radiological Society of North America, and the Robert D. and Patricia E. Kern Family Foundation (to C. B.). This work was also supported by the National Center for Research Resources, the National Center for Advancing Translational Sciences, and the Office of the Director of the National Institutes of Health through Grant 8KL2TR000056 (to C. B.) and by the Nancy Laning Sobczak, PhD., Breast Cancer Research Award (to C. B. and C. L. W.), Institutional Research Grant 86-004-26 from the American Cancer Society (to C. B.), and National Institutes of Health Grants RO1CA188871 (to C. L. W.), F32GM112317 (to B. C. J.), and RO1GM040602 (to C. A. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alan Jamie K, 2013, Small GTPases, V4, P159, DOI 10.4161/sgtp.26530; Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Berg TJ, 2010, J BIOL CHEM, V285, P35255, DOI 10.1074/jbc.M110.129916; BOS JL, 1989, CANCER RES, V49, P4682; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ellis CA, 2002, P NATL ACAD SCI USA, V99, P9876, DOI 10.1073/pnas.142193799; FARNSWORTH CL, 1991, MOL CELL BIOL, V11, P4822, DOI 10.1128/MCB.11.10.4822; Gasper Raphael, 2010, Small GTPases, V1, P133, DOI 10.4161/sgtp.1.3.14742; Gastonguay AJ, 2012, CANCER BIOL THER, V13, P647, DOI 10.4161/cbt.20082; Hamel B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191122; Hauser AD, 2014, MOL CANCER RES, V12, P130, DOI 10.1158/1541-7786.MCR-13-0362; Kang J, 2013, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00206; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kontani K, 2002, J BIOL CHEM, V277, P41070, DOI 10.1074/jbc.M202150200; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Lin G, 2012, ONCOL REP, V27, P1527, DOI 10.3892/or.2012.1669; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Montaner S, 1999, J BIOL CHEM, V274, P8506, DOI 10.1074/jbc.274.13.8506; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nogueira L, 2011, ONCOTARGET, V2, P646, DOI 10.18632/oncotarget.322; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Rojas RJ, 2003, COMB CHEM HIGH T SCR, V6, P409; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SAKODA T, 1992, ONCOGENE, V7, P1705; Schuld NJ, 2014, CELL CYCLE, V13, P941, DOI 10.4161/cc.27804; Shin EY, 2006, J BIOL CHEM, V281, P35954, DOI 10.1074/jbc.M602399200; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tew GW, 2008, J BIOL CHEM, V283, P963, DOI 10.1074/jbc.M707526200; Yu YH, 2006, METHOD ENZYMOL, V407, P455, DOI 10.1016/S0076-6879(05)07037-0; Zhang BL, 2004, MOL CELL BIOL, V24, P6205, DOI 10.1128/MCB.24.14.6205-6214.2004; Zhi H, 2009, J PATHOL, V217, P389, DOI 10.1002/path.2456; Zhu YH, 2013, CANCER RES, V73, P2298, DOI 10.1158/0008-5472.CAN-12-2663	39	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6534	6545		10.1074/jbc.M115.696831	http://dx.doi.org/10.1074/jbc.M115.696831			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26814130	hybrid, Green Published			2022-12-26	WOS:000372894200039
J	Chowdhury, B; Seetharam, A; Wang, ZP; Liu, YL; Lossie, AC; Thimmapuram, J; Irudayaraj, J				Chowdhury, Basudev; Seetharam, Arun; Wang, Zhiping; Liu, Yunlong; Lossie, Amy C.; Thimmapuram, Jyothi; Irudayaraj, Joseph			A Study of Alterations in DNA Epigenetic Modifications (5mC and 5hmC) and Gene Expression Influenced by Simulated Microgravity in Human Lymphoblastoid Cells	PLOS ONE			English	Article							STRESS-RESPONSE; SPACE-FLIGHT; METHYLATION; GENOME; 5-HYDROXYMETHYLCYTOSINE; INSTABILITY; ACTIVATION; METHYLOME; APOPTOSIS; EPIGENOME	Cells alter their gene expression in response to exposure to various environmental changes. Epigenetic mechanisms such as DNA methylation are believed to regulate the alterations in gene expression patterns. In vitro and in vivo studies have documented changes in cellular proliferation, cytoskeletal remodeling, signal transduction, bone mineralization and immune deficiency under the influence of microgravity conditions experienced in space. However microgravity induced changes in the epigenome have not been well characterized. In this study we have used Next-generation Sequencing (NGS) to profile ground-based "simulated" microgravity induced changes on DNA methylation (5-methylcytosine or 5mC), hydroxymethylation (5-hydroxymethylcytosine or 5hmC), and simultaneous gene expression in cultured human lymphoblastoid cells. Our results indicate that simulated microgravity induced alterations in the methylome (similar to 60% of the differentially methylated regions or DMRs are hypomethylated and similar to 92% of the differentially hydroxymethylated regions or DHMRs are hyperhydroxymethylated). Simulated microgravity also induced differential expression in 370 transcripts that were associated with crucial biological processes such as oxidative stress response, carbohydrate metabolism and regulation of transcription. While we were not able to obtain any global trend correlating the changes of methylation/hydroxylation with gene expression, we have been able to profile the simulated microgravity induced changes of 5mC over some of the differentially expressed genes that includes five genes undergoing differential methylation over their promoters and twenty five genes undergoing differential methylation over their gene-bodies. To the best of our knowledge, this is the first NGS-based study to profile epigenomic patterns induced by short time exposure of simulated microgravity and we believe that our findings can be a valuable resource for future explorations.	[Chowdhury, Basudev] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Chowdhury, Basudev; Lossie, Amy C.; Irudayaraj, Joseph] Purdue Univ, Bindley Biosci Ctr, Discovery Pk, W Lafayette, IN 47907 USA; [Wang, Zhiping; Liu, Yunlong] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Wang, Zhiping; Liu, Yunlong] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Thimmapuram, Jyothi] Purdue Univ, Bioinformat Core, W Lafayette, IN 47907 USA; [Lossie, Amy C.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Irudayaraj, Joseph] Purdue Univ, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA; [Lossie, Amy C.] NIH, Off Behav & Social Sci Res, Bldg 10, Bethesda, MD 20892 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA	Irudayaraj, J (corresponding author), Purdue Univ, Bindley Biosci Ctr, Discovery Pk, W Lafayette, IN 47907 USA.; Thimmapuram, J (corresponding author), Purdue Univ, Bioinformat Core, W Lafayette, IN 47907 USA.; Irudayaraj, J (corresponding author), Purdue Univ, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA.	jyothit@purdue.edu; josephi@purdue.edu		Seetharam, Arun/0000-0002-6789-9298; Irudayaraj, Joseph/0000-0002-0630-1520	NASA [NNX12AN09G]; NIH, NCI, Cancer Prevention Internship Program [R25CA128770]; Indiana CTSI [TR000006]; W.M. Keck Foundation; Purdue Center for Cancer Research [P30CA023168]; National Aeronautics and Space Administration (NASA) [NNX12AN09G]; National Institute of Health (NIH), National Cancer Institute (NCI), Cancer Prevention Internship Program [R25CA128770]; Indiana Clinical and Translational Sciences Institute (CTSI) [TR000006]; NATIONAL CANCER INSTITUTE [R25CA128770, P30CA023168] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108, UL1TR000006] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NIH, NCI, Cancer Prevention Internship Program; Indiana CTSI; W.M. Keck Foundation(W.M. Keck Foundation); Purdue Center for Cancer Research; National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); National Institute of Health (NIH), National Cancer Institute (NCI), Cancer Prevention Internship Program; Indiana Clinical and Translational Sciences Institute (CTSI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors would like to acknowledge the following agencies for their support in funding this study: a) NASA (NNX12AN09G); b) NIH, NCI R25CA128770 Cancer Prevention Internship Program; c) Indiana CTSI (TR000006); d) W.M. Keck Foundation; e) Purdue Center for Cancer Research (P30CA023168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the National Aeronautics and Space Administration (NASA) task "Defining Epigenetic Programming During Flight Expeditions in Differentiating Embryonic Stem Cells" (NNX12AN09G) for the funding. Partial support provided by the W. M. Keck Foundation; National Institute of Health (NIH), National Cancer Institute (NCI) R25CA128770 Cancer Prevention Internship Program; Indiana Clinical and Translational Sciences Institute (CTSI) (TR000006) and Purdue Center for Cancer Research (P30CA023168) is appreciated. We thank Dr. Phillip Miguel for generating the NGS data and Dr. Hongyu Gao for submitting the Sequencing data in NCBI GEO.	Andrews S., 2009, FASTQC QUALITY CONTR; Aponte VM, 2006, LIFE SCI, V79, P1317, DOI 10.1016/j.lfs.2006.04.007; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Baudouin-Cornu P, 2006, BIOCHIMIE, V88, P1673, DOI 10.1016/j.biochi.2006.03.001; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Breese MR, 2013, BIOINFORMATICS, V29, P494, DOI 10.1093/bioinformatics/bts731; Butcher LM, 2010, METHODS, V52, P223, DOI 10.1016/j.ymeth.2010.04.003; Carmeliet G, 2001, CRIT REV EUKAR GENE, V11, P131; Chowdhury B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09281; Dang BR, 2014, LIFE SCI, V97, P123, DOI 10.1016/j.lfs.2013.12.008; Degan P, 2001, J Gravit Physiol, V8, pP21; Degan P, 2005, J CELL BIOCHEM, V94, P460, DOI 10.1002/jcb.20302; Dietrich LCaJ, 2010, MEDIPS MEDIP SEQ DAT; Haffner MC, 2011, ONCOTARGET, V2, P627; Hammond TG, 2000, PHYSIOL GENOMICS, V3, P163, DOI 10.1152/physiolgenomics.2000.3.3.163; Hammond TG, 1999, NAT MED, V5, P359, DOI 10.1038/7331; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Herranz R, 2013, ASTROBIOLOGY, V13, P1, DOI 10.1089/ast.2012.0876; Hussain T, 2012, INT J MOL CELL MED, V1, P75; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaiser P, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-16; Kellinger MW, 2012, NAT STRUCT MOL BIOL, V19, P831, DOI 10.1038/nsmb.2346; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; LEVY JA, 1968, CANCER-AM CANCER SOC, V22, P517, DOI 10.1002/1097-0142(196809)22:3<517::AID-CNCR2820220305>3.0.CO;2-A; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Li WW, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/870726; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Londin ER, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-464; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Lou SK, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0408-0; Mangala LS, 2011, J BIOL CHEM, V286, P32483, DOI 10.1074/jbc.M111.267765; Marinov GK, 2014, G3-GENES GENOM GENET, V4, P209, DOI 10.1534/g3.113.008680; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Morey-Holton E R, 1991, Adv Space Biol Med, V1, P37; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Ou XF, 2010, GENOME, V53, P524, DOI [10.1139/G10-030, 10.1139/g10-030]; Ou XF, 2009, MUTAT RES-FUND MOL M, V662, P44, DOI 10.1016/j.mrfmmm.2008.12.004; Pai AA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001316; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Roman TN, 2015, BIOTECHNOLOGY; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Schwartz JL, 2004, MUTAGENESIS, V19, P477, DOI 10.1093/mutage/geh060; Shimada N, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-10; Singh KP, 2010, J CELL BIOCHEM, V111, P123, DOI 10.1002/jcb.22674; Sonnenfeld Gerald, 2003, Rev Environ Health, V18, P1; Strollo F, 1998, AVIAT SPACE ENVIR MD, V69, P777; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Wan J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1271-4; WATANABE T, 1995, LEUKEMIA, V9, P1926; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wilson GA, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-3; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Wilson JW, 2002, APPL ENVIRON MICROB, V68, P5408, DOI 10.1128/AEM.68.11.5408-5416.2002; Yen JL, 2012, MOL CELL, V48, P288, DOI 10.1016/j.molcel.2012.08.015; Yu YJ, 1998, CANCER RES, V58, P4277	72	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147514	10.1371/journal.pone.0147514	http://dx.doi.org/10.1371/journal.pone.0147514			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820575	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528400031
J	Heo, H; Kim, S; Lee, HH; Cho, HR; Xu, WJ; Lee, SH; Park, CK; Park, S; Choi, SH; Kim, H				Heo, Hwon; Kim, Sungjin; Lee, Hyeong Hun; Cho, Hye Rim; Xu, Wen Jun; Lee, Se-Hoon; Park, Chul-Kee; Park, Sunghyouk; Choi, Seung Hong; Kim, Hyeonjin			On the Utility of Short Echo Time (TE) Single Voxel 1H-MRS in Non-Invasive Detection of 2-Hydroxyglutarate (2HG); Challenges and Potential Improvement Illustrated with Animal Models Using MRUI and LCModel	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; IN-VIVO; HUMAN BRAIN; RAT-BRAIN; H-1 MRS; NEUROCHEMICAL PROFILE; H-1-NMR SPECTROSCOPY; SPECTRA; QUANTIFICATION; SIGNAL	Mutations in isocitrate dehydrogenase 1 and 2 (IDH1/2) are frequently found in brain tumors, and the resulting onco-metabolite, 2-hydroxyglutarate (2HG), has been suggested to be a potential diagnostic and prognostic biomarker of the diseases. Indeed, recent studies have demonstrated the feasibility of non-invasively detecting 2HG by using proton magnetic resonance spectroscopy (1H-MRS). Due to severe spectral overlaps of 2HG with its background metabolites and spectral baselines, however, the majority of those previous studies employed spectral editing methods with long echo times (TEs) instead of the most commonly used short TE approach with spectral fitting. Consequently, the results obtained with spectral editing methods may potentially be prone to errors resulting from substantial signal loss due to relaxation. Given that the spectral region where the main signal of 2HG resides is particularly sensitive to spectral baseline in metabolite quantification, we have investigated the impact of incorporating voxel-specifically measured baselines into the spectral basis set on the performance of the conventional short TE approach in 2HG detection in rodent models (Fisher 344 rats; n = 19) of IDH1/2 mutant-overexpressing F98 glioma at 9.4T. Metabolite spectra were acquired (SPECIAL sequence) for a tumor region and the contralateral normal region of the brain for each animal. For the estimation of spectral baselines metabolite-nulled spectra were obtained (double-inversion-recovery SPECIAL sequence) for each individual voxels. Data were post-processed with and without the measured baselines using MRUI and LCModel-the two most widely used data post-processing packages. Our results demonstrate that in-vivo detection of 2HG using the conventional short TE approach is challenging even at 9.4T. However, incorporation of voxel-specifically measured spectral baselines may potentially improve its performance. Upon more thorough validation in a larger number of animals and more importantly in human patients, the potential utility of the proposed short TE acquisition with voxel-specific baseline measurement approach in 2HG detection may need to be considered in the study design.	[Heo, Hwon; Kim, Sungjin; Lee, Hyeong Hun; Kim, Hyeonjin] Seoul Natl Univ, Dept Biomed Sci, Seoul, South Korea; [Cho, Hye Rim; Choi, Seung Hong; Kim, Hyeonjin] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Xu, Wen Jun; Park, Sunghyouk] Seoul Natl Univ, Nat Product Res Inst, Coll Pharm, Seoul, South Korea; [Lee, Se-Hoon] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Park, Chul-Kee] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 110744, South Korea; [Choi, Seung Hong; Kim, Hyeonjin] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, H (corresponding author), Seoul Natl Univ, Dept Biomed Sci, Seoul, South Korea.; Choi, SH; Kim, H (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea.; Choi, SH; Kim, H (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.	verocay1@snu.ac.kr; hyeonjinkim@snu.ac.kr	Park, Chul-Kee/J-5499-2012; Park, Chul-Kee/O-7842-2019; Kim, Hyeonjin/M-3761-2019	Park, Chul-Kee/0000-0002-2350-9876; Seo, Munjun/0000-0002-6805-2267	Ministry for Health, Welfare & Family Affairs in Korea [HI13C0015]	Ministry for Health, Welfare & Family Affairs in Korea	This study was supported by a grant from the Ministry for Health, Welfare & Family Affairs (HI13C0015) in Korea.	Allen PS, 1997, NMR BIOMED, V10, P435, DOI 10.1002/(SICI)1099-1492(199712)10:8<435::AID-NBM480>3.0.CO;2-D; Andronesi OC, 2013, J CLIN INVEST, V123, P3659, DOI 10.1172/JCI67229; Andronesi OC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002693; Auer DP, 2001, MAGN RESON MED, V46, P615, DOI 10.1002/mrm.1235; Barth RF, 1998, J NEURO-ONCOL, V36, P91, DOI 10.1023/A:1005805203044; BEHAR KL, 1994, MAGNET RESON MED, V32, P294, DOI 10.1002/mrm.1910320304; Cabanes E, 2001, J MAGN RESON, V150, P116, DOI 10.1006/jmre.2001.2318; Cairns RA, 2013, CANCER DISCOV, V3, P730, DOI 10.1158/2159-8290.CD-13-0083; Chaumeil MM, 2014, CANCER RES, V74, P4247, DOI 10.1158/0008-5472.CAN-14-0680; Choi CH, 2013, NMR BIOMED, V26, P1242, DOI 10.1002/nbm.2943; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; Chronaiou I, 2014, ACTA ONCOL, V53, P580, DOI 10.3109/0284186X.2014.891046; Cudalbu C, 2008, NMR BIOMED, V21, P627, DOI 10.1002/nbm.1234; Cudalbu C, 2012, J ALZHEIMERS DIS, V31, pS101, DOI 10.3233/JAD-2012-120100; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; de Graaf RA, 2006, MAGN RESON MED, V56, P386, DOI 10.1002/mrm.20946; DIXON WT, 1991, MAGN RESON MED, V18, P257, DOI 10.1002/mrm.1910180202; Gottschalk M, 2008, NMR BIOMED, V21, P507, DOI 10.1002/nbm.1219; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Hofmann L, 2002, MAGNET RESON MED, V48, P440, DOI 10.1002/mrm.10246; Kanowski M, 2004, MAGNET RESON MED, V51, P904, DOI 10.1002/mrm.20063; Kim H, 2005, MAGNET RESON MED, V53, P760, DOI 10.1002/mrm.20434; Kim H, 2004, MAGNET RESON MED, V51, P263, DOI 10.1002/mrm.10697; Lee Y, 2013, MAGN RESON MED, V70, P620, DOI 10.1002/mrm.24510; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; McLean MA, 2002, PROC INTL SOC MAG RE, V10, P529; Mlynarik V, 2006, MAGN RESON MED, V56, P965, DOI 10.1002/mrm.21043; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Olar A, 2014, J PATHOL, V232, P165, DOI 10.1002/path.4282; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Opstad KS, 2008, MAGN RESON MED, V60, P1237, DOI 10.1002/mrm.21496; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pels P, 2006, NMR BIOMED, V19, P188, DOI 10.1002/nbm.1008; Penner J, 2015, MAGN RESON MED, V74, P4, DOI 10.1002/mrm.25380; Pfeuffer J, 1999, J MAGN RESON, V141, P104, DOI 10.1006/jmre.1999.1895; Pope WB, 2012, J NEURO-ONCOL, V107, P197, DOI 10.1007/s11060-011-0737-8; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Provencher SW., 2014, LCMODEL LCMGUI USERS; Ratiney H, 2004, MAGN RESON MATER PHY, V16, P284, DOI 10.1007/s10334-004-0037-9; Schaller B, 2014, MAGN RESON MED, V72, P934, DOI 10.1002/mrm.24995; Seeger U, 2003, MAGNET RESON MED, V49, P19, DOI 10.1002/mrm.10332; Shi JL, 2015, TUMOR BIOL, V36, P655, DOI 10.1007/s13277-014-2644-z; SLOTBOOM J, 1994, J MAGN RESON SER A, V108, P38, DOI 10.1006/jmra.1994.1086; SMITH SA, 1994, J MAGN RESON SER A, V106, P75, DOI 10.1006/jmra.1994.1008; Stanley JA, 2001, MAGNET RESON MED, V45, P390, DOI 10.1002/1522-2594(200103)45:3<390::AID-MRM1051>3.0.CO;2-D; Tkac I, 2005, APPL MAGN RESON, V29, P139, DOI 10.1007/BF03166960; Tkac I, 2003, MAGN RESON MED, V50, P24, DOI 10.1002/mrm.10497; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; VANDENBOOGAART A, 1994, MAGNET RESON MED, V31, P347, DOI 10.1002/mrm.1910310402; Wen H, 2015, J NEUROCHEM, V132, P183, DOI 10.1111/jnc.12950; Wylezinska M, 2011, NMR BIOMED, V24, P231, DOI 10.1002/nbm.1578; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	54	10	11	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147794	10.1371/journal.pone.0147794	http://dx.doi.org/10.1371/journal.pone.0147794			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820720	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528400044
J	Sur, S; Swier, VJ; Radwan, MM; Agrawal, DK				Sur, Swastika; Swier, Vicki J.; Radwan, Mohamed M.; Agrawal, Devendra K.			Increased Expression of Phosphorylated Polo-Like Kinase 1 and Histone in Bypass Vein Graft and Coronary Arteries following Angioplasty	PLOS ONE			English	Article							MUSCLE-CELL PROLIFERATION; INTERFERON-GAMMA; INTIMAL HYPERPLASIA; DOWN-REGULATION; SAPHENOUS-VEIN; DNA-DAMAGE; PLK1; CANCER; CYTOKINESIS; ACTIVATION	Interventional procedures, including percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass surgery (CABG) to re-vascularize occluded coronary arteries, injure the vascular wall and cause endothelial denudation and medial vascular smooth muscle cell (VSMCs) metaplasia. Proliferation of the phenotypically altered SMCs is the key event in the pathogenesis of intimal hyperplasia (IH). Several kinases and phosphatases regulate cell cycle in SMC proliferation. It is our hypothesis that increased expression and activity of polo-like kinase-1 (PLK1) in SMCs, following PTCA and CABG, contributes to greater SMC proliferation in the injured than uninjured blood vessels. Using immunofluorescence (IF), we assessed the expression of PLK1 and phosphorylated-PLK1 (pPLK1) in post-PTCA coronary arteries, and superficial epigastric vein grafts (SEV) and compared it with those in the corresponding uninjured vessels. We also compared the expressions of mitotic marker phospho-histone, synthetic-SMC marker, contractile SMC marker, IFN-gamma and phosphorylated STAT-3 in the post-PTCA arteries, SEV-grafts, and the uninjured vessels. Immunostaining demonstrated an increase in the number of cells expressing PLK1 and pPLK1 in the neointima of post PTCA-coronary arteries and SEV grafts compared to their uninjured counterparts. VSMCs in the neointima showed an increased expression of phospho-histone, synthetic and contractile SMC markers, IFN-gamma and phosphorylated STAT-3. However, VSMCs of uninjured coronaries and SEV had no significant expression of the aforementioned proteins. These data suggest that PLK1 might play a critical role in VSMC mitosis in hyperplastic intima of the injured vessels. Thus, novel therapies to inhibit PLK1 could be developed to inhibit the mitogenesis of VSMCs and control neointimal hyperplasia.	[Sur, Swastika; Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Swier, Vicki J.; Radwan, Mohamed M.; Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE 68178 USA	Creighton University; Creighton University	Agrawal, DK (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA.; Agrawal, DK (corresponding author), Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE 68178 USA.	dkagr@creighton.edu	Agrawal, Devendra/GLR-3925-2022; Sur, Swastika/AAI-9802-2020	Agrawal, Devendra/0000-0001-5445-0013; Swier, Vicki/0000-0001-7509-9920; Radwan Ahmed, Mohamed/0000-0002-8074-2535	National Institutes of Health, USA [R01HL104516, R01HL112597, R01HL116042, R01HL128063]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128063, R01HL104516, R01HL116042, R01HL112597] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research work was supported by research grants R01HL104516, R01HL112597, R01HL116042, and R01HL128063 from the National Institutes of Health, USA, to DK Agrawal. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript.	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Donaldson MM, 2001, J CELL SCI, V114, P2357; FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9; Foijer F, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-8; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Gupta GK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042789; Hinohara T, 2001, Keio J Med, V50, P152; HOLTRICH U, 1994, P NATL ACAD SCI USA, V91, P1736, DOI 10.1073/pnas.91.5.1736; Jia GH, 2009, J CELL MOL MED, V13, P547, DOI 10.1111/j.1582-4934.2008.00384.x; Kneisel L, 2002, J CUTAN PATHOL, V29, P354, DOI 10.1034/j.1600-0560.2002.290605.x; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lin DC, 2011, CLIN CANCER RES, V17, P4285, DOI 10.1158/1078-0432.CCR-10-3236; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Luo JJ, 2012, PROTEIN CELL, V3, P182, DOI 10.1007/s13238-012-2020-y; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Macmillan JC, 2001, ANN SURG ONCOL, V8, P729, DOI 10.1245/aso.2001.8.9.729; Paschal CR, 2012, CHROMOSOMA, V121, P565, DOI 10.1007/s00412-012-0375-8; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Rose ML, 2007, CIRC RES, V101, P542, DOI 10.1161/CIRCRESAHA.107.160911; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Rudolph D, 2009, CLIN CANCER RES, V15, P3094, DOI 10.1158/1078-0432.CCR-08-2445; Shan WW, 2012, CLIN CANCER RES, V18, P3352, DOI 10.1158/1078-0432.CCR-11-3058; Spankuch-Schmitt B, 2002, ONCOGENE, V21, P3162, DOI 10.1038/sj.onc.1205412; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Sur S, 2014, CAN J PHYSIOL PHARM, V92, P531, DOI 10.1139/cjpp-2013-0445; Swier V. J., 2015, HISTOL HISTOPATHOL, P11652, DOI DOI 10.14670/HH-11-652; Takai N, 2001, CANCER LETT, V169, P41, DOI 10.1016/S0304-3835(01)00522-5; Takai N, 2001, CANCER LETT, V164, P41, DOI 10.1016/S0304-3835(00)00703-5; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; VEITH FJ, 1986, J VASC SURG, V3, P104; Wang YN, 2007, CIRC RES, V101, P560, DOI 10.1161/CIRCRESAHA.107.151068; Weichert W, 2004, PROSTATE, V60, P240, DOI 10.1002/pros.20050; Wolf G, 2000, PATHOL RES PRACT, V196, P753, DOI 10.1016/S0344-0338(00)80107-7; Yuan JP, 1997, AM J PATHOL, V150, P1165; Zhou Z, 2013, EXP CELL RES, V319, P3104, DOI 10.1016/j.yexcr.2013.09.012; Zitouni S, 2014, NAT REV MOL CELL BIO, V15, P433, DOI 10.1038/nrm3819	45	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147937	10.1371/journal.pone.0147937	http://dx.doi.org/10.1371/journal.pone.0147937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820885	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528400056
J	Vidal, F; Guerby, P; Luyckx, M; Haddad, P; Stoeckle, E; Morice, P; Leblanc, E; Lecuru, F; Darai, E; Classe, JM; Pomel, C; Filleron, T; Ferron, G; Querleu, D; Rafii, A				Vidal, Fabien; Guerby, Paul; Luyckx, Mathieu; Haddad, Pascale; Stoeckle, Eberhard; Morice, Philippe; Leblanc, Eric; Lecuru, Fabrice; Darai, Emile; Classe, Jean Marc; Pomel, Christophe; Filleron, Thomas; Ferron, Gwenael; Querleu, Denis; Rafii, Arash			Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?	PLOS ONE			English	Article							EPITHELIAL OVARIAN; 1ST-LINE TREATMENT; IV OVARIAN; CYTOREDUCTIVE SURGERY; INTERGROUP TRIAL; DES CANCERS; PACLITAXEL; CARCINOMA; CHEMOTHERAPY; CARBOPLATIN	Objective Early recurrence (ER) after completion of therapeutic regimen in advanced-stage ovarian cancer is a challenging clinical situation. Patients are perceived as invariably having a poor prognosis. We investigated the possibility of defining different prognostic subgroups and the parameters implicated in prognosis of ER patients. Study Design We analyzed a multi-centric database of 527 FIGO stage IIIC and IV ovarian cancer patients. We defined patients relapsing within 12 months as ER and investigated using Cox logistic regression the prognostic factors in ER group. We subsequently divided ER patients into good and poor prognosis groups according to a lower or higher overall survival (OS) at 12 months after relapse and determined parameters associated to poor prognosis. Results The median follow up was 49 months. One hundred and thirty eight patients recurred within 12 months. OS and Disease Free Survival (DFS) were 24.6 and 8.6 months, respectively, in this group of patients. Among the ER patients, 73 had a poor prognosis with an OS after relapse below 12 months (mean OS = 5.2 months) and 65 survived after one year (mean OS = 26.9 months). Residual disease (RD) after debulking surgery and mucinous histological subtype negatively impacted prognosis (HR = 1.758, p = 0.017 and HR = 8.641, p = 0.001 respectively). The relative risk of death within 12 months following relapse in ER patients was 1.61 according to RD status. However, RD did not affect DFS (HR = 0.889, p = 0.5). Conclusion ER in advanced-stage ovarian cancer does not inevitably portend a short-term poor prognosis. RD status after initial cytoreduction strongly modulates OS, that gives additional support to the concept of maximum surgical effort even in patients who will experience early recurrence. The heterogeneity in outcomes within the ER group suggests a role for tumor biology in addition to classical clinical parameters.	[Vidal, Fabien; Rafii, Arash] Qatar Fdn, Weill Cornell Med Coll Qatar, Stem Cell & Microenvironm Lab, Doha, Qatar; [Vidal, Fabien; Rafii, Arash] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Vidal, Fabien; Guerby, Paul] Toulouse Acad Hosp, Dept Gynecol Surg, F-31059 Toulouse, France; [Luyckx, Mathieu] Catholic Univ Louvain, St Luc Acad Hosp, Dept Gynecol Surg, Brussels, Belgium; [Haddad, Pascale] Qatar Fdn, Weill Cornell Med Coll Qatar, Biostat Core, Doha, Qatar; [Stoeckle, Eberhard] Ctr Comprehens Canc, Inst Bergonie, Dept Surg, Bordeaux, France; [Morice, Philippe] Inst Gustave Roussy, Dept Gynecol, Canc Campus, Villejuif, France; [Leblanc, Eric] Ctr Oscar Lambret, Dept Gynecol Oncol, F-59037 Lille, France; [Lecuru, Fabrice] Georges Pompidou European Hosp, Dept Gynecol Oncol, Paris, France; [Darai, Emile] Tenon Hosp, Dept Gynecol Surg, Paris, France; [Classe, Jean Marc] Ctr Comprehens Canc, Ctr Gauducheau, Dept Surg Oncol, St Herblain, France; [Pomel, Christophe] Jean Perrin Canc Ctr, Dept Surg Oncol, Clermont Ferrand, France; [Filleron, Thomas; Ferron, Gwenael] Ctr Comprehens Canc, Inst Claudius Regaud, Dept Surg Oncol, F-31052 Toulouse, France	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Qatar Foundation (QF); Weill Cornell Medical College Qatar; UNICANCER; Centre Eugene Marquis; Institut Bergonie; UNICANCER; Gustave Roussy; UNICANCER; Centre Oscar Lambret; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UNICANCER; Centre Eugene Marquis; UNICANCER; Centre Jean Perrin; UNICANCER; Centre Eugene Marquis; Institut Claudius Regaud	Vidal, F (corresponding author), Qatar Fdn, Weill Cornell Med Coll Qatar, Stem Cell & Microenvironm Lab, Doha, Qatar.; Vidal, F (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY USA.; Vidal, F (corresponding author), Toulouse Acad Hosp, Dept Gynecol Surg, F-31059 Toulouse, France.	dox_94@yahoo.fr	Ferron, Gwenael/P-6193-2014; filleron, thomas/C-3554-2014; Morice, Philippe/ABC-3179-2021	Ferron, Gwenael/0000-0002-8545-4700; filleron, thomas/0000-0003-0724-0659; leblanc, eric/0000-0001-7299-0339; Morice, Philippe/0000-0003-0579-9993	Qatar Foundation; NPRP [09-1099-3-279]; Qatar Foundation [06-116-1-023]	Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); NPRP; Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF))	This work was funded by Qatar Foundation and NPRP Grant 09-1099-3-279; Qatar Foundation 44 UREP Grant 06-116-1-023; and a Qatar Foundation Qatar Technology Transfer Grant. Its Manuscript2 45 contents are solely the responsibility of the authors and do not necessarily represent the official 46 views of the Qatar National Research Fund.	Alberts DS, 2008, GYNECOL ONCOL, V108, P90, DOI 10.1016/j.ygyno.2007.08.075; Alexandre J, 2010, ANN ONCOL, V21, P2377, DOI 10.1093/annonc/mdq257; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; BURKE TW, 1994, OBSTET GYN CLIN N AM, V21, P167; du Bois A, 2006, J CLIN ONCOL, V24, P1127, DOI 10.1200/JCO.2005.03.2938; du Bois A, 2003, JNCI-J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; du Bois A, 2009, CANCER-AM CANCER SOC, V115, P1234, DOI 10.1002/cncr.24149; Esquivel J, 1999, G Chir, V20, P81; Harter P, 2006, ANN SURG ONCOL, V13, P1702, DOI 10.1245/s10434-006-9058-0; Impellizzeri P, 2014, EUR J PEDIATR SURG, V24, P174, DOI 10.1055/s-0033-1333634; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Lis R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038340; Luyckx M, 2012, INT J GYNECOL CANCER, V22, P1337, DOI 10.1097/IGC.0b013e31826a3559; MARKMAN M, 1991, J CLIN ONCOL, V9, P389, DOI 10.1200/JCO.1991.9.3.389; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Naumann RW, 2011, DRUGS, V71, P1397, DOI 10.2165/11591720-000000000-00000; Pfisterer J, 2006, JNCI-J NATL CANCER I, V98, P1036, DOI 10.1093/jnci/djj296; Pujade-Lauraine E, 2010, J CLIN ONCOL, V28, P3323, DOI 10.1200/JCO.2009.25.7519; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singer CF, 2009, ENDOCR-RELAT CANCER, V16, P73, DOI 10.1677/ERC-08-0065; Tagliabue E, 2003, LANCET, V362, P527, DOI 10.1016/S0140-6736(03)14112-8; Touboul C, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-28; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Wang Y, 2011, CYTOKINE, V56, P365, DOI 10.1016/j.cyto.2011.06.005; Wang Y, 2010, CANCER LETT, V295, P110, DOI 10.1016/j.canlet.2010.02.019	25	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147787	10.1371/journal.pone.0147787	http://dx.doi.org/10.1371/journal.pone.0147787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820579	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528400042
J	Phyu, WK; Ong, KC; Wong, KT				Phyu, Win Kyaw; Ong, Kien Chai; Wong, Kum Thong			A Consistent Orally-Infected Hamster Model for Enterovirus A71 Encephalomyelitis Demonstrates Squamous Lesions in the Paws, Skin and Oral Cavity Reminiscent of Hand-Foot-and-Mouth Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MOUSE MODEL; RHABDOMYOSARCOMA CELLS; 71 NEUROPATHOGENESIS; CYNOMOLGUS MONKEYS; TAIWAN; FEATURES; HUMAN-ENTEROVIRUS-71; MANIFESTATIONS; INFLAMMATION	Enterovirus A71 (EV-A71) causes self-limiting, hand-foot-and-mouth disease (HFMD) that may rarely be complicated by encephalomyelitis. Person-to-person transmission is usually by fecal-oral or oral-oral routes. To study viral replication sites in the oral cavity and other tissues, and to gain further insights into virus shedding and neuropathogenesis, we developed a consistent, orally-infected, 2-week-old hamster model of HFMD and EV-A71 encephalomyelitis. Tissues from orally-infected, 2-week-old hamsters were studied by light microscopy, immunohistochemistry and in situ hybridization to detect viral antigens and RNA, respectively, and by virus titration. Hamsters developed the disease and died after 4-8 days post infection; LD50 was 25 CCID50. Macroscopic cutaneous lesions around the oral cavity and paws were observed. Squamous epithelium in the lip, oral cavity, paw, skin, and esophagus, showed multiple small inflammatory foci around squamous cells that demonstrated viral antigens/RNA. Neurons (brainstem, spinal cord, sensory ganglia), acinar cells (salivary gland, lacrimal gland), lymphoid cells (lymph node, spleen), and muscle fibres (skeletal, cardiac and smooth muscles), liver and gastric epithelium also showed varying amounts of viral antigens/RNA. Intestinal epithelium, Peyer's patches, thymus, pancreas, lung and kidney were negative. Virus was isolated from oral washes, feces, brain, spinal cord, skeletal muscle, serum, and other tissues. Our animal model should be useful to study squamous epitheliotropism, neuropathogenesis, oral/fecal shedding in EV-A71 infection, person-to-person transmission, and to test anti-viral drugs and vaccines.	[Phyu, Win Kyaw; Wong, Kum Thong] Univ Malaya, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia; [Ong, Kien Chai] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Wong, KT (corresponding author), Univ Malaya, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia.	wongkt@ummc.edu.my	Ibrahim, Essam Hassan/G-1960-2018; ONG, KIEN CHAI/B-9452-2010; ONG, KIEN CHAI/D-6582-2015; Wong, Kum Thong/B-2788-2010	Ibrahim, Essam Hassan/0000-0003-0130-2257; ONG, KIEN CHAI/0000-0003-3845-9303; 	UM/MoHE High Impact Research Grant [H-20001-E00004]; Ministry of Higher Education, Malaysia; University of Malaya, Kuala Lumpur, Malaysia [RG141/09HTM]	UM/MoHE High Impact Research Grant; Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); University of Malaya, Kuala Lumpur, Malaysia(Universiti Malaya)	This work was supported by the UM/MoHE High Impact Research Grant H-20001-E00004, Ministry of Higher Education, Malaysia, and the research grant RG141/09HTM, University of Malaya, Kuala Lumpur, Malaysia.	Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Ch'ng WC, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-155; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chatproedprai S, 2010, JPN J INFECT DIS, V63, P229; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Chen YC, 2004, J GEN VIROL, V85, P69, DOI 10.1099/vir.0.19423-0; Fujii K, 2013, P NATL ACAD SCI USA, V110, P14753, DOI 10.1073/pnas.1217563110; He Y, 2013, AM J PATHOL, V184, P715; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsiung G. D., 2000, Journal of Microbiology Immunology and Infection, V33, P1; Khong WX, 2012, J VIROL, V86, P2121, DOI 10.1128/JVI.06103-11; Knipe DM, 2001, ENTEROVIRUSES POLIOV; Li CC, 2002, SCAND J INFECT DIS, V34, P104, DOI 10.1080/00365540110077119; Lin YW, 2009, J VIROL, V83, P6477, DOI 10.1128/JVI.00434-09; Lin YW, 2013, POPULAR TRIBUNE, P8; Liu LD, 2011, VIROLOGY, V412, P91, DOI 10.1016/j.virol.2010.12.058; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; McMinn PC, 2003, NEUROL J SE ASIA, V8, P57; Nagata N, 2004, J GEN VIROL, V85, P2981, DOI 10.1099/vir.0.79883-0; Nagata N, 2002, J MED VIROL, V67, P207, DOI 10.1002/jmv.2209; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Ong KC, 2015, BRAIN PATHOL, V25, P614, DOI 10.1111/bpa.12279; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shi WF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-327; Shieh SJ, 2001, EMERG INFECT DIS, V7, P146; Sperling T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002833; Tan SH, 2014, J NEUROPATH EXP NEUR, V73, P999, DOI 10.1097/NEN.0000000000000122; Taylor SL, 2005, J VIROL, V79, P11501, DOI 10.1128/JVI.79.17.11501-11506.2005; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Wong KT, 2012, NEUROPATH APPL NEURO, V38, P443, DOI 10.1111/j.1365-2990.2011.01247.x; Wong KT, 2008, J NEUROPATH EXP NEUR, V67, P162, DOI 10.1097/nen.0b013e318163a990; World Health Organization, 2004, POL LAB MAN, V4th; Yang XD, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.35; Yu P, 2014, VIRUS RES, V189, P121, DOI 10.1016/j.virusres.2014.05.006; Zhang W, 2014, BIOCHEM BIOPH RES CO, V447, P550, DOI 10.1016/j.bbrc.2014.04.021	40	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147463	10.1371/journal.pone.0147463	http://dx.doi.org/10.1371/journal.pone.0147463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815859	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528200034
J	Reiser, K; Mathys, L; Curbo, S; Pannecouque, C; Noppen, S; Liekens, S; Engman, L; Lundberg, M; Balzarini, J; Karlsson, A				Reiser, Kathrin; Mathys, Leen; Curbo, Sophie; Pannecouque, Christophe; Noppen, Sam; Liekens, Sandra; Engman, Lars; Lundberg, Mathias; Balzarini, Jan; Karlsson, Anna			The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry Inhibition	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN DISULFIDE-ISOMERASE; NECROSIS-FACTOR-ALPHA; THIOREDOXIN REDUCTASE; REVERSE-TRANSCRIPTASE; DIORGANYL TELLURIDES; HUMAN CANCER; IN-VITRO; TYPE-1; CELLS	Background The entry of HIV into its host cell is an interesting target for chemotherapeutic intervention in the life-cycle of the virus. During entry, reduction of disulfide bridges in the viral envelope glycoprotein gp120 by cellular oxidoreductases is crucial. The cellular thioredoxin reductase-1 plays an important role in this oxidoreduction process by recycling electrons to thioredoxin-1. Therefore, thioredoxin reductase-1 inhibitors may inhibit gp120 reduction during HIV-1 entry. In this present study, tellurium-based thioredoxin reductase-1 inhibitors were investigated as potential inhibitors of HIV entry. Results The organotellurium compounds inhibited HIV-1 and HIV-2 replication in cell culture at low micromolar concentrations by targeting an early event in the viral infection cycle. Time-of-drug-addition studies pointed to virus entry as the drug target, more specifically: the organotellurium compound TE-2 showed a profile similar or close to that of the fusion inhibitor enfuvirtide (T-20). Surface plasmon resonance-based interaction studies revealed that the compounds do not directly interact with the HIV envelope glycoproteins gp120 and gp41, nor with soluble CD4, but instead, dose-dependently bind to thioredoxin reductase-1. By inhibiting the thioredoxin-1/thioredoxin reductase-1-directed oxidoreduction of gp120, the organotellurium compounds prevent conformational changes in the viral glycoprotein which are necessary during viral entry. Conclusion Our findings revealed that thioredoxin-1/thioredoxin reductase-1 acts as a cellular target for the inhibition of HIV entry.	[Reiser, Kathrin; Curbo, Sophie; Lundberg, Mathias; Karlsson, Anna] Karolinska Inst, Div Clin Microbiol, Dept Lab Med, F68, Huddinge, Sweden; [Mathys, Leen; Pannecouque, Christophe; Noppen, Sam; Liekens, Sandra; Balzarini, Jan] Katholieke Univ Leuven, Rega Inst Med Res, Minderbroederstr 10, Leuven, Belgium; [Engman, Lars] Uppsala Univ, Dept Chem BMC, BOX 576, Uppsala, Sweden	Karolinska Institutet; KU Leuven; Uppsala University	Reiser, K (corresponding author), Karolinska Inst, Div Clin Microbiol, Dept Lab Med, F68, Huddinge, Sweden.	Kathrin.Reiser@ki.se	Pannecouque, Christophe/C-2793-2018; curbo, sophie/AAA-8614-2020; Karlsson, Anna/E-7945-2018; Noppen, Sam/F-8681-2018	Pannecouque, Christophe/0000-0002-1254-4473; curbo, sophie/0000-0002-0964-0712; Noppen, Sam/0000-0002-2831-5042; Karlsson, Anna/0000-0001-6843-6685	KU Leuven [GOA 10/014, PF 10/018, FWO G.0528.12N]; Swedish Research Council [AK 521-2010-2828, LE 621-2011-4006]; Karolinska Institute; Stiftelsen Sigurd och Elsa Goljes Minne; L'Oreal-UNESCO, in collaboration with the Belgian FWO: fellowship	KU Leuven(KU Leuven); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institute(Karolinska Institutet); Stiftelsen Sigurd och Elsa Goljes Minne; L'Oreal-UNESCO, in collaboration with the Belgian FWO: fellowship(L'Oreal Group)	This work was supported by the following grants: KU Leuven: GOA 10/014 (JB, LM, SL, SN, CP), PF 10/018 (JB, LM, SL, SN) and FWO G.0528.12N (JB), URL: http://www.kuleuven.be; the Swedish Research Council: AK 521-2010-2828 (AK, SC, KR) and LE 621-2011-4006 (LE), URL: http://www.vr.se/; the Karolinska Institute (AK, SC, KR), URL: www.ki.se; Stiftelsen Sigurd och Elsa Goljes Minne (KR), URL: http://www.lindhes.se/stiftelseforvaltning/stiftelseforvaltning-2; and L'Oreal-UNESCO, in collaboration with the Belgian FWO: fellowship (LM), URL: http://www.loreal.com/csrcommitments/foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLASHI DV, 1995, CLIN DIAGN VIROL, V4, P1, DOI 10.1016/0928-0197(95)00005-S; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Auwerx J, 2009, INT J BIOCHEM CELL B, V41, P1269, DOI 10.1016/j.biocel.2008.10.031; Baker A, 1997, CANCER RES, V57, P5162; BALZARINI J, 1992, J BIOL CHEM, V267, P11831; Balzarini J, 2004, ANTIMICROB AGENTS CH, V48, P3858, DOI 10.1128/AAC.48.10.3858-3870.2004; Borkow G, 2002, AIDS RES HUM RETROV, V18, P711, DOI 10.1089/088922202760072339; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Daelemans D, 2011, NAT PROTOC, V6, P925, DOI 10.1038/nprot.2011.330; Davis DA, 1997, J BIOL CHEM, V272, P25935, DOI 10.1074/jbc.272.41.25935; De Clercq E, 2010, CURR OPIN PHARMACOL, V10, P507, DOI 10.1016/j.coph.2010.04.011; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Engman L, 2003, ANTI-CANCER DRUG, V14, P153, DOI 10.1097/00001813-200302000-00009; Engman L, 2000, ANTI-CANCER DRUG DES, V15, P323; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Frentz D, 2012, AIDS REV, V14, P17; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Hoorelbeke B, 2010, ANTIMICROB AGENTS CH, V54, P3287, DOI 10.1128/AAC.00254-10; HORWITZ JP, 1964, J ORG CHEM, V29, P2076, DOI 10.1021/jo01030a546; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; JAPOUR AJ, 1993, ANTIMICROB AGENTS CH, V37, P1095, DOI 10.1128/AAC.37.5.1095; Kanda T, 1999, J ORG CHEM, V64, P8161, DOI 10.1021/jo990842k; Kean W. F., 2008, Inflammopharmacology, V16, P112, DOI 10.1007/s10787-007-0021-x; LaBonte J, 2003, NAT REV DRUG DISCOV, V2, P345, DOI 10.1038/nrd1091; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; McNaughton M, 2004, J MED CHEM, V47, P233, DOI 10.1021/jm030916r; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; PAUWELS R, 1990, NATURE, V343, P470, DOI 10.1038/343470a0; Pennings PS, 2013, INFECT DIS REP, V5, P21, DOI 10.4081/idr.2013.s1.e5; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Reiser K, 2012, INT J BIOCHEM CELL B, V44, P556, DOI 10.1016/j.biocel.2011.12.015; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; Ryser HJP, 2005, DRUG DISCOV TODAY, V10, P1085, DOI 10.1016/S1359-6446(05)03550-6; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; Sahaf B, 1997, EXP CELL RES, V236, P181, DOI 10.1006/excr.1997.3699; Shapiro DL, 1996, J RHEUMATOL, V23, P1818; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Spielberger JC, 2008, J CELL BIOCHEM, V104, P1879, DOI 10.1002/jcb.21762; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Urig S, 2006, SEMIN CANCER BIOL, V16, P452, DOI 10.1016/j.semcancer.2006.09.004; van Anken E, 2008, MOL BIOL CELL, V19, P4298, DOI 10.1091/mbc.E07-12-1282; Vandamme AM, 2000, METH MOLEC MED, V24, P223, DOI 10.1385/1-59259-245-7:223; VANDAMME EJM, 1988, PHYSIOL PLANTARUM, V73, P52, DOI 10.1111/j.1399-3054.1988.tb09192.x; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; World C, 2011, ARTERIOSCL THROM VAS, V31, P1890, DOI 10.1161/ATVBAHA.111.226340; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897	48	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147773	10.1371/journal.pone.0147773	http://dx.doi.org/10.1371/journal.pone.0147773			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816344	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528200050
J	Lu, T; Yu, S; Liu, Y; Yin, CC; Ye, JJ; Liu, Z; Ma, DX; Ji, CY				Lu, Ting; Yu, Shuang; Liu, Yan; Yin, Congcong; Ye, Jingjing; Liu, Zhi; Ma, Daoxin; Ji, Chunyan			Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin's Lymphoma	PLOS ONE			English	Article							T-CELLS; ELEVATED TH22; EXPRESSION; IL-17; INTERLEUKIN-17; T(H)17; INFLAMMATION; PHENOTYPE; CYTOKINE; DISTINCT	Non-Hodgkin's lymphomas (NHLs) are a heterogeneous group of neoplasm in which 90% are B-cell lymphomas and 10% T-cell lymphomas. Although T-helper 17 (Th17) cells have been implicated to be essential in the pathogenesis of autoimmune and inflammatory diseases, its role in B-cell non-Hodgkin's lymphoma (B-NHL) remains unknown. In this study, we observed a significantly decreased frequency of Th17 cells in peripheral blood from B-NHL patients compared with healthy individuals, accompanied with increased Th1 cells. IL-17AF plasma levels were remarkably decreased in B-NHL patients, accompanied with undetectable IL-17FF and unchangeable IL-17AA. Moreover, Th17 and Th1 cells became normalized after one or two cycles of chemotherapy. Interestingly, in B-NHL, circulating Th17 cells frequencies were significantly higher in relapsed patients than those in untreated patients or normal individuals. Meanwhile, there was no statistical difference regarding the frequencies of Th1 cells between relapsed and untreated patients. Taken these data together, circulating Th17 subset immune response may be associated with the response of patients to treatment and with different stages of disease.	[Lu, Ting; Yu, Shuang; Liu, Yan; Yin, Congcong; Ye, Jingjing; Ma, Daoxin; Ji, Chunyan] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China; [Liu, Zhi] Shandong Univ, Coll Informat Sci & Engn, Jinan 250100, Peoples R China	Shandong University; Shandong University	Ma, DX; Ji, CY (corresponding author), Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China.	daoxinma@sdu.edu.cn; jichunyan@sdu.edu.cn			National Natural Science Foundation of China [81370662]; Major Research plan of the National Natural Science Foundation of China [91442126]; Fundamental Research Funds of Shandong University [2014JC026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Research plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of Shandong University	This work was supported by the National Natural Science Foundation of China (81370662) to CJ, by grants from the Major Research plan of the National Natural Science Foundation of China (91442126) to CJ, and from the Fundamental Research Funds of Shandong University (2014JC026) to JY. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Alexandrakis MG, 2006, EUR J INTERN MED, V17, P412, DOI 10.1016/j.ejim.2006.02.012; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Bailey SR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00276; Chen P, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/416123; Cire A, 2004, INT J CANCER, V112, P113, DOI 10.1002/ijc.20373; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Ersvaer Elisabeth, 2010, BMC Immunol, V11, P38, DOI 10.1186/1471-2172-11-38; Fitch Erin, 2007, Curr Rheumatol Rep, V9, P461, DOI 10.1007/s11926-007-0075-1; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jaffe ES, 2009, HEMATOL-AM SOC HEMAT, V2009, P523, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.523; Kato T, 2001, BIOCHEM BIOPH RES CO, V282, P735, DOI 10.1006/bbrc.2001.4618; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Krejsgaard T, 2013, BLOOD, V122, P943, DOI 10.1182/blood-2013-01-480889; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Maggio E, 2002, ANN ONCOL, V13, P52, DOI 10.1093/annonc/13.S1.52; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Sfanos KS, 2008, CLIN CANCER RES, V14, P3254, DOI 10.1158/1078-0432.CCR-07-5164; Shankland KR, 2012, LANCET, V380, P848, DOI 10.1016/S0140-6736(12)60605-9; Sundrud MS, 2013, SEMIN IMMUNOL, V25, P263, DOI 10.1016/j.smim.2013.10.021; Tian T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/915873; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Wang M, 2015, ONCOTARGET, V6, P17958, DOI 10.18632/oncotarget.4641; Yang ZZ, 2009, CANCER RES, V69, P5522, DOI 10.1158/0008-5472.CAN-09-0266; Yin QS, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0085-9; Yu S, 2014, INT J MOL SCI, V15, P1927, DOI 10.3390/ijms15021927; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060; Zhang Y, 2011, CLIN CHIM ACTA, V412, P894, DOI 10.1016/j.cca.2011.01.015; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195	36	19	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0148044	10.1371/journal.pone.0148044	http://dx.doi.org/10.1371/journal.pone.0148044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812681	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528000073
J	Gleason, JM; Zhou, YH; Hackett, JL; Harris, BR; Greenfield, MD				Gleason, Jennifer M.; Zhou, Yihong; Hackett, Jennifer L.; Harris, Bethany R.; Greenfield, Michael D.			Development of a Genomic Resource and Quantitative Trait Loci Mapping of Male Calling Traits in the Lesser Wax Moth, Achroia grisella	PLOS ONE			English	Article							X ENVIRONMENT INTERACTION; SEXUAL SELECTION; FEMALE CHOICE; GENETIC VARIANCE; ACOUSTIC MOTH; LEPIDOPTERA; SIGNAL; SONG; DISCRIMINATION; PHYLOGEOGRAPHY	In the study of sexual selection among insects, the Lesser Waxmoth, Achroia grisella (Lepidoptera: Pyralidae), has been one of the more intensively studied species over the past 20 years. Studies have focused on how the male calling song functions in pair formation and on the quantitative genetics of male song characters and female preference for the song. Recent QTL studies have attempted to elucidate the genetic architecture of male song and female preference traits using AFLP markers. We continued these QTL studies using SNP markers derived from an EST library that allowed us to measure both DNA sequence variation and map loci with respect to the lepidopteran genome. We report that the level of sequence variation within A. grisella is typical among other Lepidoptera that have been examined, and that comparison with the Bombyx mori genome shows that macrosynteny is conserved. Our QTL map shows that a QTL for a male song trait, pulse-pair rate, is situated on the Z chromosome, a prediction for sexually selected traits in Lepidoptera. Our findings will be useful for future studies of genetic architecture of this model species and may help identify the genetics associated with the evolution of its novel acoustic communication.	[Gleason, Jennifer M.; Zhou, Yihong; Harris, Bethany R.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Hackett, Jennifer L.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Greenfield, Michael D.] Univ Tours, IRBI, CNRS, UMR 7261, Tours, France; [Zhou, Yihong] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Hackett, Jennifer L.] Univ Kansas, Higuchi Biosci Ctr, Lawrence, KS 66045 USA; [Harris, Bethany R.] Univ Calif San Diego, UC San Diego Lib, La Jolla, CA 92093 USA	University of Kansas; University of Kansas; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Tours; University System of Georgia; University of Georgia; University of Kansas; University of California System; University of California San Diego	Gleason, JM (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	jgleason@ku.edu	; Gleason, Jennifer/E-7089-2012	Greenfield, Michael D./0000-0003-1935-3423; Gleason, Jennifer/0000-0002-0544-3404	National Science Foundation [IOB-0516634]	National Science Foundation(National Science Foundation (NSF))	The work was supported by National Science Foundation grant IOB-0516634 to MDG, PI and JMG, co-PI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alem S, 2013, J EVOLUTION BIOL, V26, P2581, DOI 10.1111/jeb.12252; Allison J, PHEROMONE COMMUNICAT; Arias CF, 2014, MOL ECOL, V23, P4137, DOI 10.1111/mec.12844; Basten C.J., 1997, QTL CARTOGRAPHER REF; Beldade P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000366; Brandt LSE, 2005, ETHOLOGY, V111, P609, DOI 10.1111/j.1439-0310.2005.01085.x; Brandt LSE, 2004, J EVOLUTION BIOL, V17, P821, DOI 10.1111/j.1420-9101.2004.00716.x; Collins RD, 1999, HEREDITY, V83, P644, DOI 10.1038/sj.hdy.6885540; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; d'Alencon E, 2009, P NATL ACAD SCI USA, V197, P7680, DOI [10.1073/pnas.091041310, DOI 10.1073/PNAS.091041310]; Danielson-Francois AM, 2006, J EVOLUTION BIOL, V19, P532, DOI 10.1111/j.1420-9101.2005.01006.x; Danielson-Francois AM, 2009, GENETICA, V136, P27, DOI 10.1007/s10709-008-9297-z; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.01; Espeland M, 2007, BIOL J LINN SOC, V92, P727, DOI 10.1111/j.1095-8312.2007.00873.x; Gleason JM, 2009, HEREDITY, V103, P416, DOI 10.1038/hdy.2009.79; Gleason JM, 2005, BEHAV GENET, V35, P265, DOI 10.1007/s10519-005-3219-y; Gleason JM, 2002, HEREDITY, V89, P1, DOI 10.1038/sj.hdy.6800099; Gompert Z, 2014, MOL ECOL, V23, P4555, DOI 10.1111/mec.12811; Greenfield MD, 2012, J EVOLUTION BIOL, V25, P601, DOI 10.1111/j.1420-9101.2012.02450.x; GREENFIELD MD, 1981, FLA ENTOMOL, V64, P4, DOI 10.2307/3494597; GREENFIELD MD, 1983, BEHAVIOUR, V84, P287, DOI 10.1163/156853983X00534; Greenfield MD, 2000, ETHOL ECOL EVOL, V12, P259; Greenfield MD, INSECT HEARING ACOUS, V1, P81; Greenfield MD, 2014, INSECT HEARING ACOUS, P81; Greig EI, 2004, BEHAVIOUR, V141, P799, DOI 10.1163/1568539042265626; Jang YW, 2000, HEREDITY, V84, P73, DOI 10.1046/j.1365-2540.2000.00631.x; Jang YW, 1996, ANIM BEHAV, V51, P1095, DOI 10.1006/anbe.1996.0111; Jang YW, 1998, EVOLUTION, V52, P1383, DOI [10.2307/2411308, 10.1111/j.1558-5646.1998.tb02020.x]; Jia FY, 2001, J INSECT BEHAV, V14, P19, DOI 10.1023/A:1007893411662; Jia FY, 2000, EVOLUTION, V54, P953; Jia FY, 1997, P ROY SOC B-BIOL SCI, V264, P1057, DOI 10.1098/rspb.1997.0146; Kause A, 1999, J EVOLUTION BIOL, V12, P471, DOI 10.1046/j.1420-9101.1999.00045.x; Kirkpatrick M, 2004, EVOLUTION, V58, P683; Kunike G., 1930, Zeitschrift fuer Angewandte Entomologie, V16, P304; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lassance JM, 2010, NATURE, V466, P486, DOI 10.1038/nature09058; Li XH, 2011, THEOR APPL GENET, V123, P667, DOI 10.1007/s00122-011-1617-5; Limousin D, 2009, J EXP BIOL, V212, P4091, DOI 10.1242/jeb.035345; Limousin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044554; Milum VG, 1940, GLEANINGS BEE CULT, V68, P424; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Moehring AJ, 2011, EVOLUTION, V65, P2621, DOI 10.1111/j.1558-5646.2011.01325.x; Powell Jerry A., 2009, ENCY INSECTS, P557; Pringle EG, 2007, GENETICS, V177, P417, DOI 10.1534/genetics.107.073122; Reeve HK, 2003, P NATL ACAD SCI USA, V100, P1089, DOI 10.1073/pnas.0337427100; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Rodriguez RL, 2003, EVOLUTION, V57, P1304, DOI 10.1111/j.0014-3820.2003.tb00338.x; Roff Derek A., 1992; Shaw KL, 2007, MOL ECOL, V16, P2879, DOI 10.1111/j.1365-294X.2007.03321.x; Silberglied RE, 1977, ANIMALS COMMUNICATE, P362; SPANGLER HG, 1984, PHYSIOL ENTOMOL, V9, P87, DOI 10.1111/j.1365-3032.1984.tb00684.x; Stearns S., 1992, EVOLUTION LIFE HIST; TRAUT W, 1977, GENETICA, V47, P135, DOI 10.1007/BF00120178; Van't Hof AE, 2013, HEREDITY, V110, P283, DOI 10.1038/hdy.2012.84; Vandewoestijne S, 2004, MOL PHYLOGENET EVOL, V31, P630, DOI 10.1016/j.ympev.2003.09.007; Vedenina VY, 2007, J EVOLUTION BIOL, V20, P260, DOI 10.1111/j.1420-9101.2006.01204.x; Villalta I, 2005, THEOR APPL GENET, V110, P881, DOI 10.1007/s00122-004-1906-3; Wahlberg N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080875; Yasukochi Y, 2006, GENETICS, V173, P1319, DOI 10.1534/genetics.106.055541; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhou YH, 2008, EVOLUTION, V62, P1317, DOI 10.1111/j.1558-5646.2008.00371.x; Zhou YH, 2011, EVOL ECOL, V25, P307, DOI 10.1007/s10682-010-9421-2	64	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147014	10.1371/journal.pone.0147014	http://dx.doi.org/10.1371/journal.pone.0147014			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807910	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800045
J	Hatanaka, M; Kaimori, JY; Yamamoto, S; Matsui, I; Hamano, T; Takabatake, Y; Ecelbarger, CM; Takahara, S; Isaka, Y; Rakugi, H				Hatanaka, Masaki; Kaimori, Jun-Ya; Yamamoto, Satoko; Matsui, Isao; Hamano, Takayuki; Takabatake, Yoshitsugu; Ecelbarger, Carolyn M.; Takahara, Shiro; Isaka, Yoshitaka; Rakugi, Hiromi			Azilsartan Improves Salt Sensitivity by Modulating the Proximal Tubular Na+-H+ Exchanger-3 in Mice	PLOS ONE			English	Article							BLOOD-PRESSURE; ANGIOTENSIN-II; JAPANESE PATIENTS; SODIUM SENSITIVITY; HYPERTENSIVE-RATS; MORNING SURGE; RECEPTOR; CANDESARTAN; MORTALITY; NHE3	A potent angiotensin II type-1 receptor blocker, azilsartan, has been reported to reduce blood pressure more effectively than candesartan. Interestingly, azilsartan can also restore the circadian rhythm of blood pressure. We hypothesized that azilsartan could also improve salt sensitivity; thus, we examined the effect of azilsartan on sodium handling in renal tubules. Subtotal nephrectomized C57BL/6 mice received azilsartan (1.0 mg/kg/day), candesartan (0.3 mg/kg/day), or vehicle via the oral route in conjunction with a normal-(0.3%) or high-salt (8.0%) diet. Two weeks later, the azilsartan group showed significantly lower blood pressure during the light period than the candesartan and vehicle groups (azilsartan: 103.1 +/- 1.0; candesartan: 111.7 +/- 2.7; vehicle: 125.5 +/- 2.5 mmHg; P < 0.05; azilsartan or candesartan vs. vehicle). The azilsartan group also showed higher urinary fractional excretion of sodium during the dark period than the candesartan and vehicle groups (azilsartan: 21.37 +/- 3.69%; candesartan: 14.17 +/- 1.42%; vehicle: 13.85 +/- 5.30%; P < 0.05 azilsartan vs. candesartan or vehicle). A pressure-natriuresis curve demonstrated that azilsartan treatment restored salt sensitivity. Immunofluorescence and western blotting showed lower levels of Na+-H+ exchanger-3 (NHE3) protein (the major sodium transporter in renal proximal tubules) in the azilsartan group, but not in the candesartan or vehicle groups. However, azilsartan did not affect NHE3 transcription levels. Interestingly, we did not observe increased expression of downstream sodium transporters, which would have compensated for the increased flow of sodium and water due to non-absorption by NHE3. We also confirmed the mechanism stated above using cultured opossum kidney proximal tubular cells. Results revealed that a proteasomal inhibitor (but not a lysosomal inhibitor) blocked the azilsartan-induced decrease in NHE3 protein expression, suggesting that azilsartan increases NHE3 ubiquitination. In conclusion, azilsartan (but not candesartan) improved salt sensitivity possibly by decreasing NHE3 expression via ubiquitin-proteasomal degradation.	[Hatanaka, Masaki; Kaimori, Jun-Ya; Yamamoto, Satoko; Matsui, Isao; Hamano, Takayuki; Takabatake, Yoshitsugu; Isaka, Yoshitaka; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka, Japan; [Kaimori, Jun-Ya; Takahara, Shiro] Osaka Univ, Grad Sch Med, Dept Adv Technol Transplantat, Suita, Osaka, Japan; [Hamano, Takayuki] Osaka Univ, Grad Sch Med, Dept Comprehens Kidney Dis Res, Suita, Osaka, Japan; [Ecelbarger, Carolyn M.] Georgetown Univ, Dept Med, Div Endocrinol & Metab, Washington, DC USA	Osaka University; Osaka University; Osaka University; Georgetown University	Kaimori, JY (corresponding author), Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka, Japan.; Kaimori, JY (corresponding author), Osaka Univ, Grad Sch Med, Dept Adv Technol Transplantat, Suita, Osaka, Japan.	kaimori@kid.med.osaka-u.ac.jp	Hamano, TAKAYUKI/AAZ-4837-2021	Hamano, TAKAYUKI/0000-0002-2100-9106; Rakugi, Hiromi/0000-0001-6508-4338; Matsui, Isao/0000-0001-8378-6130	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by Japan Society for the Promotion of Science (http://www.jsps.go.jp/).	Alexander RT, 2009, J EXP BIOL, V212, P1630, DOI 10.1242/jeb.027375; [Anonymous], 2004, STAT ANAL EPIDEMIOLO; Armando I, 2014, FASEB J, V28, P1422, DOI 10.1096/fj.13-243840; Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; Bobulescu IA, 2009, PFLUG ARCH EUR J PHY, V458, P5, DOI 10.1007/s00424-008-0595-1; Brooks HL, 2001, J PHYSIOL-LONDON, V530, P359, DOI 10.1111/j.1469-7793.2001.0359k.x; CANO A, 1994, AM J PHYSIOL, V266, pC1603, DOI 10.1152/ajpcell.1994.266.6.C1603; Carmosino M, 2011, PFLUG ARCH EUR J PHY, V462, P281, DOI 10.1007/s00424-011-0967-9; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Di Sole F, 2011, KIDNEY INT, V80, P822, DOI 10.1038/ki.2011.229; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Duncan JL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2958; Endo S, 2009, HYPERTENS RES, V32, P513, DOI 10.1038/hr.2009.40; Fang ZW, 1999, J HYPERTENS, V17, P983, DOI 10.1097/00004872-199917070-00015; GEIBEL J, 1990, P NATL ACAD SCI USA, V87, P7917, DOI 10.1073/pnas.87.20.7917; Gurley SB, 2011, CELL METAB, V13, P469, DOI 10.1016/j.cmet.2011.03.001; HARRIS PJ, 1977, PFLUG ARCH EUR J PHY, V367, P295, DOI 10.1007/BF00581370; Herlitz Hans, 1998, Blood Pressure, V7, P47; Hu MC, 2013, AM J PHYSIOL-RENAL, V304, pF1169, DOI 10.1152/ajprenal.00630.2012; JOURDAIN M, 1992, AM J PHYSIOL, V263, pC1141, DOI 10.1152/ajpcell.1992.263.6.C1141; Kario K, 2010, HYPERTENSION, V56, P765, DOI 10.1161/HYPERTENSIONAHA.110.157149; KIMURA G, 1988, AM J HYPERTENS, V1, P372, DOI 10.1093/ajh/1.4.372; Kren S, 1999, KIDNEY INT, V56, P333, DOI 10.1046/j.1523-1755.1999.00527.x; KUROO M, 1995, CIRC RES, V76, P148, DOI 10.1161/01.RES.76.1.148; Kurtz TW, 2012, VASC HEALTH RISK MAN, V8, P133, DOI 10.2147/VHRM.S22595; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; LOPEZ MJ, 1995, NATURE, V378, P65, DOI 10.1038/378065a0; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Miura S, 2013, HYPERTENS RES, V36, P134, DOI 10.1038/hr.2012.147; MORDUCHOWICZ GA, 1991, J MEMBRANE BIOL, V122, P43, DOI 10.1007/BF01872738; Morimoto A, 1997, LANCET, V350, P1734, DOI 10.1016/S0140-6736(97)05189-1; Morimoto S, 2006, HYPERTENS RES, V29, P567, DOI 10.1291/hypres.29.567; Mu S, 2011, NAT MED, V17, P573, DOI 10.1038/nm.2337; Ohkubo T, 2002, J HYPERTENS, V20, P2183, DOI 10.1097/00004872-200211000-00017; Oikawa R, 2010, CARDIOVASC RES, V87, P187, DOI 10.1093/cvr/cvq034; Ojima M, 2011, J PHARMACOL EXP THER, V336, P801, DOI 10.1124/jpet.110.176636; Rakugi H, 2014, BLOOD PRESS MONIT, V19, P164, DOI 10.1097/MBP.0000000000000042; Rakugi H, 2013, BLOOD PRESSURE, V22, P22, DOI 10.3109/08037051.2013.818758; Rakugi H, 2012, HYPERTENS RES, V35, P552, DOI 10.1038/hr.2012.8; Schulman IH, 2007, HYPERTENSION, V49, P270, DOI 10.1161/01.HYP.0000253966.21795.d3; Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B; Seldin DW G G, 1985, KIDNEY PHYSL PATHOPH; Takagi H, 2014, HYPERTENS RES, V37, P432, DOI 10.1038/hr.2013.142; Takimoto E, 1996, SCIENCE, V274, P995, DOI 10.1126/science.274.5289.995; Ushio-Yamana H, 2012, NEPHRON EXP NEPHROL, V122, P95, DOI 10.1159/000348660; Uzu T, 1997, CIRCULATION, V96, P1859, DOI 10.1161/01.CIR.96.6.1859; Uzu T, 1996, HYPERTENSION, V28, P139, DOI 10.1161/01.HYP.28.1.139; VERDECCHIA P, 1994, HYPERTENSION, V24, P793, DOI 10.1161/01.HYP.24.6.793; Verdecchia P, 2012, HYPERTENSION, V60, P34, DOI 10.1161/HYPERTENSIONAHA.112.191858; Whitesall SE, 2004, AM J PHYSIOL-HEART C, V286, pH2408, DOI 10.1152/ajpheart.01089.2003; Widdop RE, 2008, CLIN EXP PHARMACOL P, V35, P386, DOI 10.1111/j.1440-1681.2008.04883.x; Xu L, 1997, HYPERTENSION, V29, P450, DOI 10.1161/01.HYP.29.1.450; Yu HCM, 1998, CIRCULATION, V98, P2621, DOI 10.1161/01.CIR.98.23.2621; Zeng CY, 2003, HYPERTENSION, V41, P724, DOI 10.1161/01.HYP.0000047880.78462.0E	54	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147786	10.1371/journal.pone.0147786	http://dx.doi.org/10.1371/journal.pone.0147786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807585	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800210
J	Mouser, EEIM; Pollakis, G; Yazdanbakhsh, M; Harnett, W; de Jong, EC; Paxton, WA				Mouser, Emily E. I. M.; Pollakis, Georgios; Yazdanbakhsh, Maria; Harnett, William; de Jong, Esther C.; Paxton, William A.			Brugia malayi Antigen (BmA) Inhibits HIV-1 Trans-Infection but Neither BmA nor ES-62 Alter HIV-1 Infectivity of DC Induced CD4(+) Th-Cells	PLOS ONE			English	Article							NEMATODE-SECRETED PRODUCT; PHOSPHORYLCHOLINE-CONTAINING GLYCOPROTEIN; HUMAN DENDRITIC CELLS; FILARIAL NEMATODES; IN-VIVO; ACANTHOCHEILONEMA-VITEAE; ENVELOPE GLYCOPROTEIN; IMMUNE ACTIVATION; HELMINTH PRODUCT; SIGN	One of the hallmarks of HIV-1 disease is the association of heightened CD4(+) T-cell activation with HIV-1 replication. Parasitic helminths including filarial nematodes have evolved numerous and complex mechanisms to skew, dampen and evade human immune responses suggesting that HIV-1 infection may be modulated in co-infected individuals. Here we studied the effects of two filarial nematode products, adult worm antigen from Brugia malayi (BmA) and excretory-secretory product 62 (ES-62) from Acanthocheilonema viteae on HIV-1 infection in vitro. Neither BmA nor ES-62 influenced HIV-1 replication in CD4(+) enriched T-cells, with either a CCR5- or CXCR4- using virus. BmA, but not ES-62, had the capacity to bind the C-type lectin dendritic cell-specific intercellular adhesion molecule3-grabbing non-integrin (DC-SIGN) thereby inhibiting HIV-1 trans-infection of CD4(+) enriched T-cells. As for their effect on DCs, neither BmA nor ES-62 could enhance or inhibit DC maturation as determined by CD83, CD86 and HLA-DR expression, or the production of IL-6, IL-10, IL-12 and TNF-alpha. As expected, due to the unaltered DC phenotype, no differences were found in CD4(+) T helper (Th) cell phenotypes induced by DCs treated with either BmA or ES-62. Moreover, the HIV-1 susceptibility of the Th-cell populations induced by BmA or ES-62 exposed DCs was unaffected for both CCR5- and CXCR4- using HIV-1 viruses. In conclusion, although BmA has the potential capacity to interfere with HIV-1 transmission or initial viral dissemination through preventing the virus from interacting with DCs, no differences in the Th-cell polarizing capacity of DCs exposed to BmA or ES-62 were observed. Neither antigenic source demonstrated beneficial or detrimental effects on the HIV-1 susceptibility of CD4(+) Th-cells induced by exposed DCs.	[Mouser, Emily E. I. M.; Pollakis, Georgios; Paxton, William A.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Pollakis, Georgios; Paxton, William A.] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol CIMI, Liverpool L69 3BX, Merseyside, England; [Yazdanbakhsh, Maria] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Harnett, William] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [de Jong, Esther C.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; University of Liverpool; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Strathclyde; University of Amsterdam	Paxton, WA (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; Paxton, WA (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol CIMI, Liverpool L69 3BX, Merseyside, England.; de Jong, EC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.c.dejong@amc.uva.nl; w.a.paxton@liverpool.ac.uk	paxton, william/R-9747-2019; Yazdanbakhsh, Maria/AAI-3996-2020; Georgios, Pollakis/Y-2341-2019	Yazdanbakhsh, Maria/0000-0002-7666-1441; Paxton, William/0000-0001-5200-0801; Pollakis, Georgios/0000-0002-9659-5461; Harnett, William/0000-0001-9545-9401; Paxton, William/0000-0002-2654-5186	European Community's Seventh Framework Programme [41642]	European Community's Seventh Framework Programme	This work was supported by European Community's Seventh Framework Programme Grant 41642 (IDEA).	Annunziato F, 2000, BLOOD, V95, P1167, DOI 10.1182/blood.V95.4.1167.004k11_1167_1174; Aprahamian TR, 2015, INT J PARASITOL, V45, P203, DOI 10.1016/j.ijpara.2014.12.006; Baribaud F, 2001, VIROLOGY, V286, P1, DOI 10.1006/viro.2001.0975; Bashi T, 2015, J AUTOIMMUN, V59, P1, DOI 10.1016/j.jaut.2015.03.001; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; BENTWICH Z, 1995, IMMUNOL TODAY, V16, P187, DOI 10.1016/0167-5699(95)80119-7; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Bluml S, 2005, J IMMUNOL, V175, P501, DOI 10.4049/jimmunol.175.1.501; Brattig NW, 2004, J IMMUNOL, V173, P437, DOI 10.4049/jimmunol.173.1.437; Ceballos A, 2007, IMMUNOLOGY, V121, P328, DOI 10.1111/j.1365-2567.2007.02578.x; de Jong EC, 2005, SPRINGER SEMIN IMMUN, V26, P289, DOI 10.1007/s00281-004-0167-1; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Gallagher M, 2005, AIDS, V19, P1849, DOI 10.1097/01.aids.0000189846.90946.5d; Garcia-Vallejo JJ, 2013, TRENDS IMMUNOL, V34, P482, DOI 10.1016/j.it.2013.03.001; Garg R, 2012, VIROLOGY, V432, P271, DOI 10.1016/j.virol.2012.05.032; Geijtenbeek TBH, 2003, APMIS, V111, P698, DOI 10.1034/j.1600-0463.2003.11107803.x; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090; Goodridge HS, 2007, PARASITE IMMUNOL, V29, P127, DOI 10.1111/j.1365-3024.2006.00926.x; Goodridge HS, 2005, IMMUNOLOGY, V115, P296, DOI 10.1111/j.1365-2567.2005.02167.x; Goodridge HS, 2005, J IMMUNOL, V174, P284, DOI 10.4049/jimmunol.174.1.284; Goodridge HS, 2001, J IMMUNOL, V167, P940, DOI 10.4049/jimmunol.167.2.940; Gopinath R, 2000, J INFECT DIS, V182, P1804, DOI 10.1086/317623; Grivel JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S6; Harnett MM, 2008, ANN RHEUM DIS, V67, P518, DOI 10.1136/ard.2007.073502; Harnett MM, 1998, PARASITE IMMUNOL, V20, P551, DOI 10.1046/j.1365-3024.1998.00181.x; Harnett W, 1999, PARASITE IMMUNOL, V21, P601, DOI 10.1046/j.1365-3024.1999.00267.x; HARNETT W, 1993, EXP PARASITOL, V77, P498, DOI 10.1006/expr.1993.1113; Harnett W, 2005, PARASITOLOGY, V130, pS63, DOI 10.1017/S0031182005008164; Harnett W, 1999, IMMUNOL TODAY, V20, P125, DOI 10.1016/S0167-5699(98)01419-4; Hewitson JR, 2008, MOL BIOCHEM PARASIT, V160, P8, DOI 10.1016/j.molbiopara.2008.02.007; Houston KM, 2000, INFECT IMMUN, V68, P5466, DOI 10.1128/IAI.68.9.5466-5468.2000; Klatt NR, 2013, IMMUNOL REV, V254, P326, DOI 10.1111/imr.12065; LAWRENCE RA, 1994, J IMMUNOL, V153, P1216; Loke P, 2000, EUR J IMMUNOL, V30, P2669, DOI 10.1002/1521-4141(200009)30:9&lt;2669::AID-IMMU2669&gt;3.0.CO;2-1; Loke P, 2000, EUR J IMMUNOL, V30, P1127, DOI 10.1002/(SICI)1521-4141(200004)30:4&lt;1127::AID-IMMU1127&gt;3.0.CO;2-#; Maizels RM, 2001, INT J PARASITOL, V31, P889, DOI 10.1016/S0020-7519(01)00213-2; Mariani SA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S8; Marshall FA, 2005, J IMMUNOL, V175, P5817, DOI 10.4049/jimmunol.175.9.5817; McInnes IB, 2003, J IMMUNOL, V171, P2127, DOI 10.4049/jimmunol.171.4.2127; Melendez AJ, 2007, NAT MED, V13, P1375, DOI 10.1038/nm1654; Melnikow E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002151; Moonis M, 2001, AIDS, V15, P1941, DOI 10.1097/00002030-200110190-00005; Moreno-Fernandez ME, 2009, J VIROL, V83, P12925, DOI 10.1128/JVI.01352-09; Naarding MA, 2006, ANTIMICROB AGENTS CH, V50, P3367, DOI 10.1128/AAC.00593-06; Nielsen NO, 2007, T ROY SOC TROP MED H, V101, P602, DOI 10.1016/j.trstmh.2007.02.009; Nowak RG, 2011, J INFECT DIS, V203, P1182, DOI 10.1093/infdis/jiq172; Paily K P, 2009, J Parasit Dis, V33, P3, DOI 10.1007/s12639-009-0005-4; Pineda MA, 2012, ARTHRITIS RHEUM-US, V64, P3168, DOI 10.1002/art.34581; Plier DA, 1997, CLIN IMMUNOL IMMUNOP, V82, P216, DOI 10.1006/clin.1996.4317; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Raposo RAS, 2014, J VIROL, V88, P11624, DOI 10.1128/JVI.01771-14; Rzepecka J, 2013, INT J PARASITOL, V43, P211, DOI 10.1016/j.ijpara.2012.12.001; Sabatte J, 2011, J IMMUNOL, V187, P5299, DOI 10.4049/jimmunol.1101889; Semnani RT, 2003, J IMMUNOL, V171, P1950, DOI 10.4049/jimmunol.171.4.1950; Stax MJ, 2009, VIROLOGY, V391, P203, DOI 10.1016/j.virol.2009.06.011; Stepek G, 2002, PARASITOLOGY, V125, P155, DOI 10.1017/S0031182002001920; Talaat KR, 2008, AM J TROP MED HYG, V79, P558, DOI 10.4269/ajtmh.2008.79.558; Taylor MJ, 2000, J EXP MED, V191, P1429, DOI 10.1084/jem.191.8.1429; van der Aar AMG, 2011, J ALLERGY CLIN IMMUN, V127, P1532, DOI 10.1016/j.jaci.2011.01.068; van Liempt E, 2007, MOL IMMUNOL, V44, P2605, DOI 10.1016/j.molimm.2006.12.012; Wang CH, 2011, J INFECT DIS, V203, P479, DOI 10.1093/infdis/jiq083; Whelan M, 2000, J IMMUNOL, V164, P6453, DOI 10.4049/jimmunol.164.12.6453; WHO, 2014, LYMPH FIL; Wilson EH, 2003, IMMUNOLOGY, V109, P238, DOI 10.1046/j.1365-2567.2003.01661.x	68	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146527	10.1371/journal.pone.0146527	http://dx.doi.org/10.1371/journal.pone.0146527			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808476	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000369527800022
J	Nguyen, TMD; Combarnous, Y; Praud, C; Duittoz, A; Blesbois, E				Thi Mong Diep Nguyen; Combarnous, Yves; Praud, Christophe; Duittoz, Anne; Blesbois, Elisabeth			Ca2+/Calmodulin-Dependent Protein Kinase Kinases (CaMKKs) Effects on AMP-Activated Protein Kinase (AMPK) Regulation of Chicken Sperm Functions	PLOS ONE			English	Article							SOLUBLE ADENYLYL-CYCLASE; ACROSOME REACTION; FOWL SPERMATOZOA; MAMMALIAN SPERMATOZOA; CALCIUM REGULATION; MOUSE SPERMATOZOA; MOLECULAR-CLONING; HAMSTER SPERM; DOMESTIC-FOWL; CALMODULIN	Sperm require high levels of energy to ensure motility and acrosome reaction (AR) accomplishment. The AMP-activated protein kinase (AMPK) has been demonstrated to be strongly involved in the control of these properties. We address here the question of the potential role of calcium mobilization on AMPK activation and function in chicken sperm through the Ca2+/calmodulin-dependent protein kinase kinases (CaMKKs) mediated pathway. The presence of CaMKKs and their substrates CaMKI and CaMKIV was evaluated by western-blotting and indirect immunofluorescence. Sperm were incubated in presence or absence of extracellular Ca2+, or of CaMKKs inhibitor (STO-609). Phosphorylations of AMPK, CaMKI, and CaMKIV, as well as sperm functions were evaluated. We demonstrate the presence of both CaMKKs (alpha and beta), CaMKI and CaMKIV in chicken sperm. CaMKK alpha and CaMKI were localized in the acrosome, themidpiece, and atmuch lower fluorescence in the flagellum, whereas CaMKK beta was mostly localized in the flagellum and much less in the midpiece and the acrosome. CaMKIV was only present in the flagellum. The presence of extracellular calcium induced an increase in kinases phosphorylation and sperm activity. STO-609 reduced AMPK phosphorylation in the presence of extracellular Ca2+ but not in its absence. STO-609 did not affect CaMKIV phosphorylation but decreased CaMKI phosphorylation and this inhibition was quicker in the presence of extracellular Ca2+ than in its absence. STO-609 efficiently inhibited sperm motility and AR, both in the presence and absence of extracellular Ca2+. Our results show for the first time the presence of CaMKKs (alpha and beta) and one of its substrate, CaMKI in different subcellular compartments in germ cells, as well as the changes in the AMPK regulation pathway, sperm motility and AR related to Ca2+ entry in sperm through the Ca2+/CaM/ CaMKKs/CaMKI pathway. The Ca2+/CaMKKs/AMPK pathway is activated only under conditions of extracellular Ca2+ entry in the cells.	[Thi Mong Diep Nguyen; Combarnous, Yves; Duittoz, Anne; Blesbois, Elisabeth] INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France; [Thi Mong Diep Nguyen; Combarnous, Yves; Duittoz, Anne; Blesbois, Elisabeth] CNRS, UMR7247, F-37380 Nouzilly, France; [Thi Mong Diep Nguyen; Combarnous, Yves; Duittoz, Anne; Blesbois, Elisabeth] Univ Tours, F-37000 Tours, France; [Thi Mong Diep Nguyen; Combarnous, Yves; Duittoz, Anne; Blesbois, Elisabeth] IFCE, F-37380 Nouzilly, France; [Praud, Christophe] INRA, Unit Rech Avicoles, F-37380 Nouzilly, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; INRAE	Blesbois, E (corresponding author), INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France.; Blesbois, E (corresponding author), CNRS, UMR7247, F-37380 Nouzilly, France.; Blesbois, E (corresponding author), Univ Tours, F-37000 Tours, France.; Blesbois, E (corresponding author), IFCE, F-37380 Nouzilly, France.	Elisabeth.Blesbois@tours.inra.fr	Praud, Christophe/AAT-9553-2020; Combarnous, Yves/K-4161-2019; Nguyen, Thi Mong Diep/AAB-3939-2020	Combarnous, Yves/0000-0002-0574-2025; Nguyen, Thi Mong Diep/0000-0001-6534-9041	French Agence Nationale de la Recherche; INRA; French National Science Infrastructure CRB-Anim - "Investissements d'avenir" [ANR-11-INBS-0003]; Vietnam Education Ministry; French National Science Infrastructure CRB-Anim	French Agence Nationale de la Recherche(French National Research Agency (ANR)); INRA; French National Science Infrastructure CRB-Anim - "Investissements d'avenir"(French National Research Agency (ANR)); Vietnam Education Ministry; French National Science Infrastructure CRB-Anim	This study was performed with the financial support of the French Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/), INRA (http://www.inra.fr), and the French National Science Infrastructure CRB-Anim funded by "Investissements d'avenir", ANR-11-INBS-0003 (http://www.crb-anim.fr). Thi Mong Diep Nguyen is a PhD student supported by a grant from the Vietnam Education Ministry (http://www.moet.gov.vn/). We also thank Isabelle Grasseau, Sabine Alves, Aurore Thelie (INRA) and Daniele Klett (CNRS) for help regarding the methodology and discussions, and the staff of the INRA experimental unit PEAT for the animal breeding and participation in semen collections.; This study was performed with the financial support of the French Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/) INRA (http://www.inra.fr), and the French National Science Infrastructure CRB-Anim. Thi Mong Diep Nguyen is a PhD student supported by a grant from the Vietnam Education Ministry (http://www.moet.gov.vn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Anderson KA, 2012, MOL ENDOCRINOL, V26, P281, DOI 10.1210/me.2011-1299; ASHIZAWA K, 1990, COMP BIOCHEM PHYS A, V96, P297, DOI 10.1016/0300-9629(90)90696-P; Ashizawa K, 2006, REPRODUCTION, V131, P1017, DOI 10.1530/rep.1.01069; Ashizawa K, 2004, REPRODUCTION, V128, P783, DOI 10.1530/rep.1.00327; ASHIZAWA K, 1994, J REPROD FERTIL, V101, P265, DOI 10.1530/jrf.0.1010265; BABCOCK DF, 1976, J BIOL CHEM, V251, P3881; Bendahmane M, 2001, ARCH BIOCHEM BIOPHYS, V390, P1, DOI 10.1006/abbi.2001.2364; Blackmore PF, 1999, STEROIDS, V64, P149, DOI 10.1016/S0039-128X(98)00109-3; Blesbois E, 2007, ANIMAL, V1, P1472, DOI 10.1017/S175173110700081X; Blesbois E, 2008, THERIOGENOLOGY, V69, P252, DOI 10.1016/j.theriogenology.2007.09.019; Blesbois E, 2012, J POULT SCI, V49, P141, DOI 10.2141/jpsa.011120; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; BURROWS W. H., 1937, POULTRY SCI, V16, P19, DOI 10.3382/ps.0160019; Campbell AK, 1983, INTRACELLULAR CA2 IT; Chalah T, 1998, THERIOGENOLOGY, V50, P487, DOI 10.1016/S0093-691X(98)00155-1; DAVIS BK, 1978, P SOC EXP BIOL MED, V157, P54, DOI 10.3181/00379727-157-39989; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Ferey JLA, 2014, AM J PHYSIOL-ENDOC M, V307, pE686, DOI 10.1152/ajpendo.00322.2014; FLORMAN HM, 1992, DEV BIOL, V152, P304, DOI 10.1016/0012-1606(92)90137-6; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GROSS MK, 1987, J BIOL CHEM, V262, P8672; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Ho HC, 2002, DEV BIOL, V250, P208, DOI 10.1006/dbio.2002.0797; Horrocks AJ, 2000, BIOCHEM BIOPH RES CO, V278, P84, DOI 10.1006/bbrc.2000.3766; HOWARTH B, 1983, BIOL REPROD, V28, P586, DOI 10.1095/biolreprod28.3.586; Hurtado de Llera A, 2014, BIOL REPROD, V90, P29, DOI [10.1095/biolreprod.113.112797, DOI 10.1095/BI0LREPR0D.113.112797]; Ignotz GG, 2005, BIOL REPROD, V73, P519, DOI 10.1095/biolreprod.105.040733; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; JONES HP, 1980, P NATL ACAD SCI-BIOL, V77, P2772, DOI 10.1073/pnas.77.5.2772; LAKE PE, 1981, BRIT POULTRY SCI, V22, P71, DOI 10.1080/00071688108447865; Lemoine M, 2008, REPRODUCTION, V136, P391, DOI 10.1530/REP-08-0094; Lemoine M, 2009, BIOL REPROD, V81, P657, DOI 10.1095/biolreprod.108.072660; Liguori L, 2004, J HISTOCHEM CYTOCHEM, V52, P833, DOI 10.1369/jhc.3B6141.2004; LINDEMANN CB, 1988, CELL MOTIL CYTOSKEL, V10, P420, DOI 10.1002/cm.970100309; Marin-Briggiler CI, 2005, J CELL SCI, V118, P2013, DOI 10.1242/jcs.02326; Means AR, 2008, MOL ENDOCRINOL, V22, P2759, DOI 10.1210/me.2008-0312; MEANS AR, 1991, MOL CELL BIOL, V11, P3960, DOI 10.1128/MCB.11.8.3960; MORTON B, 1974, BIOCHEM BIOPH RES CO, V56, P372, DOI 10.1016/0006-291X(74)90852-3; MORTON BE, 1978, FERTIL STERIL, V29, P695; Nguyen TMD, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121855; NYS Y, 1991, POULTRY SCI, V70, P1236, DOI 10.3382/ps.0701236; OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866; OKAMURA F, 1978, CELL TISSUE RES, V188, P497; Ozawa E, 2011, P JPN ACAD B-PHYS, V87, P486, DOI 10.2183/pjab.87.486; Peron A, 2006, POULTRY SCI, V85, P462, DOI 10.1093/ps/85.3.462; Schlingmann K, 2007, J ANDROL, V28, P706, DOI 10.2164/jandrol.106.001669; Si YM, 2000, BIOL REPROD, V62, P1231, DOI 10.1095/biolreprod62.5.1231; Smith EF, 2002, MOL BIOL CELL, V13, P3303, DOI 10.1091/mbc.E02-04-0185; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; SUAREZ SS, 1993, P NATL ACAD SCI USA, V90, P4660, DOI 10.1073/pnas.90.10.4660; TASH JS, 1988, J CELL BIOL, V106, P1625, DOI 10.1083/jcb.106.5.1625; TASH JS, 1987, METHOD ENZYMOL, V139, P808; Tokumitsu H, 1996, J BIOL CHEM, V271, P5617, DOI 10.1074/jbc.271.10.5617; Tokumitsu H, 2003, J BIOL CHEM, V278, P10908, DOI 10.1074/jbc.M213183200; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; YANAGIMACHI R, 1975, BIOL REPROD, V13, P519, DOI 10.1095/biolreprod13.5.519; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Zeng HT, 2003, J CELL SCI, V116, P1981, DOI 10.1242/jcs.00396	61	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147559	10.1371/journal.pone.0147559	http://dx.doi.org/10.1371/journal.pone.0147559			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808520	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800134
J	Vashi, P; Edwin, P; Popiel, B; Lammersfeld, C; Gupta, D				Vashi, Pankaj; Edwin, Persis; Popiel, Brenten; Lammersfeld, Carolyn; Gupta, Digant			Methylmalonic Acid and Homocysteine as Indicators of Vitamin B-12 Deficiency in Cancer	PLOS ONE			English	Article							PERIPHERAL NEUROPATHY CIPN; COBALAMIN DEFICIENCY; FOLATE; HOLOTRANSCOBALAMIN; DIAGNOSIS; PLASMA	Background/Aims Normal or high serum vitamin B-12 levels can sometimes be seen in a B-12 deficient state, and can therefore be misleading. High levels of Methymalonic Acid (MMA) and Homocysteine (HC) have been identified as better indicators of B-12 deficiency than the actual serum B-12 level itself. We evaluated the prevalence of vitamin B-12 deficiency using appropriate cut-off levels of vitamin B-12, MMA and HC, and determined the relationship between serum levels of vitamin B-12, MMA and HC in cancer. Methods This is a cross-sectional study using a consecutive case series of 316 cancer patients first seen at Cancer Treatment Centers of America (R) (CTCA) at Midwestern Regional Medical Center between April 2014 and June 2014. All patients were evaluated at baseline for vitamin B-12 (pg/mL), MMA (nmol/L) and HC (mu mol/L) levels. In accordance with previously published research, the following cut-offs were used to define vitamin B-12 deficiency: <300 pg/mL for vitamin B-12, >260 nmol/L for MMA and >12 mu mol/L for HC. The relationship between B-12, MMA and HC was evaluated using Spearman's rho correlation coefficient and cross-tabulation analysis. Receiver Operating Characteristic (ROC) curves were estimated using the non-parametric method to further evaluate the diagnostic accuracy of vitamin B-12 using Fedosov quotient as the "gold standard". Results Mean age at presentation was 52.5 years. 134 (42.4%) patients were males while 182 (57.6%) were females. Median vitamin B-12, MMA and HC levels were 582.5 pg/mL, 146.5 nmol/L and 8.4 mu mol/L respectively. Of 316 patients, 28 (8.9%) were vitamin B-12 deficient based on vitamin B-12 (<300pg/mL), 34 (10.8%) were deficient based on MMA (>260 nmol/L) while 55 (17.4%) were deficient based on HC (>12 mu mol/L). Correlation analysis revealed a significant weak negative correlation between vitamin B-12 and MMA (rho = -0.22) as well as B-12 and HC (rho = -0.35). ROC curves suggested MMA to have the best discriminatory power in predicting B-12 deficiency. Conclusion Vitamin B-12 is poorly correlated with MMA and HC in cancer. Using serum vitamin B-12 alone to evaluate B-12 status in cancer may fail to identify those with functional deficiency. A thorough clinical assessment is important to identify patients that may have risk factors and/or symptoms suggestive of deficiency. These patients should have additional testing of MMA and HC regardless of their B-12 levels.	[Vashi, Pankaj; Edwin, Persis; Popiel, Brenten; Lammersfeld, Carolyn; Gupta, Digant] Midwestern Reg Med Ctr, CTCA, 2520 Elisha Ave, Zion, IL 60099 USA		Gupta, D (corresponding author), Midwestern Reg Med Ctr, CTCA, 2520 Elisha Ave, Zion, IL 60099 USA.	gupta.digant@gmail.com	GUPTA, DIGANT/ABA-9729-2020	GUPTA, DIGANT/0000-0002-1963-8886				Allen LH, 2009, AM J CLIN NUTR, V89, p693S, DOI 10.3945/ajcn.2008.26947A; Andres E, 2013, QJM-INT J MED, V106, P505, DOI 10.1093/qjmed/hct051; Bailey RL, 2011, AM J CLIN NUTR, V94, P552, DOI 10.3945/ajcn.111.015222; Bolann BJ, 2000, CLIN CHEM, V46, P1744; Carmel R, 2012, CURR OPIN GASTROEN, V28, P151, DOI 10.1097/MOG.0b013e3283505852; Fedosov SN, 2015, CLIN CHEM LAB MED, V53, P1215, DOI 10.1515/cclm-2014-0818; Green R, 2011, AM J CLIN NUTR, V94, p666S, DOI 10.3945/ajcn.110.009613; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Herrmann W, 2000, EUR J CLIN INVEST, V30, P1083, DOI 10.1046/j.1365-2362.2000.00746.x; Herrmann W, 2003, CLIN CHEM LAB MED, V41, P1478, DOI 10.1515/CCLM.2003.227; Klee GG, 2000, CLIN CHEM, V46, P1277; Lee EY, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/848963; McMullin MF, 2001, CLIN LAB HAEMATOL, V23, P161, DOI 10.1046/j.1365-2257.2001.00370.x; Obeid R, 2013, BIOCHIMIE, V95, P1056, DOI 10.1016/j.biochi.2012.10.028; Oh RC, 2003, AM FAM PHYSICIAN, V67, P979; Palacios G, 2013, NUTR HOSP, V28, P1447, DOI 10.3305/nh.2013.28.5.6821; Piccolo J, 2014, AM J HEALTH-SYST PH, V71, P19, DOI 10.2146/ajhp130126; Refsum H, 2001, AM J CLIN NUTR, V74, P233; Risch M, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0060-x; SAVAGE DG, 1994, AM J MED, V96, P239, DOI 10.1016/0002-9343(94)90149-X; Schloss JM, 2015, SUPPORT CARE CANCER, V23, P1843, DOI 10.1007/s00520-015-2725-6; Schloss JM, 2013, CLIN NUTR, V32, P888, DOI 10.1016/j.clnu.2013.04.007; SCHNEEDE J, 1994, PEDIATR RES, V36, P194, DOI 10.1203/00006450-199408000-00010; Schroder TH, 2014, J NUTR, V144, P1658, DOI 10.3945/jn.114.194829; Selhub J, 2008, FOOD NUTR BULL, V29, pS67, DOI 10.1177/15648265080292S110; Solomon LR, 2011, DIABETES CARE, V34, P1077, DOI 10.2337/dc11-0009; Valente E, 2011, CLIN CHEM, V57, P856, DOI 10.1373/clinchem.2010.158154; Vincenzi B, 2013, SUPPORT CARE CANCER, V21, P1313, DOI 10.1007/s00520-012-1667-5; ZWEIG MH, 1993, CLIN CHEM, V39, P561	29	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147843	10.1371/journal.pone.0147843	http://dx.doi.org/10.1371/journal.pone.0147843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807790	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800226
J	Wei, XJ; Liu, CZ; Wang, HX; Wang, LS; Xiao, FJ; Guo, ZK; Zhang, HC				Wei, Xiaojuan; Liu, Chaozhong; Wang, Hengxiang; Wang, Lisheng; Xiao, Fengjun; Guo, Zikuan; Zhang, Hongchao			Surface Phosphatidylserine Is Responsible for the Internalization on Microvesicles Derived from Hypoxia-Induced Human Bone Marrow Mesenchymal Stem Cells into Human Endothelial Cells	PLOS ONE			English	Article							APOPTOTIC CELLS; ANNEXIN-V; PROMOTE ANGIOGENESIS; EXTRACELLULAR VESICLES; STROMAL CELLS; IN-VITRO; EXOSOMES; RECEPTOR; CLEARANCE; THERAPY	Background Previous data have proven that microvesicles derived from hypoxia-induced mesenchymal stem cells (MSC-MVs) can be internalized into endothelial cells, enhancing their proliferation and vessel structure formation and promoting in vivo angiogenesis. However, there is a paucity of information about how the MSC-MVs are up-taken by endothelial cells. Methods MVs were prepared from the supernatants of human bone marrow MSCs that had been exposed to a hypoxic and/or serum-deprivation condition. The incorporation of hypoxia-induced MSC-MVs into human umbilical cord endothelial cells (HUVECs) was observed by flow cytometry and confocal microscopy in the presence or absence of recombinant human Annexin-V (Anx-V) and antibodies against human CD29 and CD44. Further, small interfering RNA (siRNA) targeted at Anx-V and PSR was delivered into HUVECs, or HUVECs were treated with a monoclonal antibody against phosphatidylserine receptor (PSR) and the cellular internalization of MVs was re-assessed. Results The addition of exogenous Anx-V could inhibit the uptake of MVs isolated from hypoxia-induced stem cells by HUVECs in a dose-and time-dependent manner, while the antiCD29 and CD44 antibodies had no effect on the internalization process. The suppression was neither observed in Anx-V siRNA-transfected HUVECs, however, addition of anti-PSR antibody and PSR siRNA-transfected HUVECs greatly blocked the incorporation of MVs isolated from hypoxia-induced stem cells into HUVECs. Conclusion PS on the MVs isolated from hypoxia-induced stem cells is the critical molecule in the uptake by HUVECs.	[Wei, Xiaojuan; Liu, Chaozhong; Zhang, Hongchao] Gen Hosp Air Force, Dept Cardiol Surg, Beijing, Peoples R China; [Wang, Hengxiang] Gen Hosp Air Force, Dept Hematol, Beijing, Peoples R China; [Wang, Lisheng; Xiao, Fengjun; Guo, Zikuan] Beijing Inst Radiat Med, Dept Expt Hematol, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Zhang, HC (corresponding author), Gen Hosp Air Force, Dept Cardiol Surg, Beijing, Peoples R China.	zhcxw2015@163.com			Chinese High-Tech "863" Program [2012AA020807, 2012AA02A211]; National Natural Science Foundation [81270219]	Chinese High-Tech "863" Program(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Chinese High-Tech "863" Program (No. 2012AA020807, 2012AA02A211) and National Natural Science Foundation (No. 81270219). The funders had great support in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Bian SY, 2014, J MOL MED, V92, P387, DOI 10.1007/s00109-013-1110-5; Boya Penga, 2014, CLIN CHIM ACTA, V427, P42, DOI [10.1016/j.cca.2013.09.048, DOI 10.1016/J.CCA.2013.09.048]; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chai Lai Ruenn, 2013, REGEN MED, V8, P197, DOI [10.2217/rme.13.4, DOI 10.2217/RME.13.4]; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Fonsato V, 2012, STEM CELLS, V30, P1985, DOI 10.1002/stem.1161; Frey B, 2011, SEMIN IMMUNOPATHOL, V33, P497, DOI 10.1007/s00281-010-0228-6; Gyorgy B, 2014, THROMB RES, V133, P285, DOI 10.1016/j.thromres.2013.11.010; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Janko C, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/6/065006; Jayachandran M, 2012, J IMMUNOL METHODS, V375, P207, DOI 10.1016/j.jim.2011.10.012; Jin JD, 2008, BIOCHEM BIOPH RES CO, V376, P191, DOI 10.1016/j.bbrc.2008.08.131; Keller S, 2009, CANCER LETT, V278, P73, DOI 10.1016/j.canlet.2008.12.028; Kinnaird T, 2004, CIRC RES, V95, P354, DOI 10.1161/01.RES.0000137878.26174.66; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kolb S, 2007, J PATHOL, V212, P249, DOI 10.1002/path.2190; Lasala GP, 2010, ANGIOLOGY, V61, P551, DOI 10.1177/0003319710364213; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Li JW, 2013, J MOL HISTOL, V44, P213, DOI 10.1007/s10735-012-9475-2; Lima LG, 2013, THROMB RES, V132, P450, DOI 10.1016/j.thromres.2013.07.026; Lima LG, 2011, THROMB HAEMOSTASIS, V106, P712, DOI 10.1160/TH11-03-0143; Liu Y, 2014, ACTA PHARMACOL SIN, V35, P230, DOI 10.1038/aps.2013.141; Lopatina T, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-26; Minguell JJ, 2013, STEM CELLS DEV, V22, P193, DOI 10.1089/scd.2012.0417; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Qayyum AA, 2012, REGEN MED, V7, P421, DOI [10.2217/rme.12.17, 10.2217/RME.12.17]; Qu JM, 2000, BBA-MOL BASIS DIS, V1501, P99, DOI 10.1016/S0925-4439(00)00022-3; RAVANAT C, 1992, BIOCHEM J, V282, P7, DOI 10.1042/bj2820007; Rosado-de-Castro PH, 2013, STEM CELLS DEV, V22, P2095, DOI 10.1089/scd.2013.0089; Setty BNY, 2008, BLOOD, V111, P905, DOI 10.1182/blood-2007-07-099465; Shang YJ, 2013, ONCOL LETT, V6, P490, DOI 10.3892/ol.2013.1410; Shen HH, 2013, BIOMATERIALS, V34, P8361, DOI 10.1016/j.biomaterials.2013.07.042; Smith RR, 2008, HEART RHYTHM, V5, P880, DOI 10.1016/j.hrthm.2008.02.011; Soleti R, 2012, FREE RADICAL BIO MED, V53, P2159, DOI 10.1016/j.freeradbiomed.2012.09.021; Svensson Katrin J, 2013, J BIOL CHEM, V288, P17713, DOI [10.1074/jbc.M112.445403, DOI 10.1074/JBC.M112.445403]; Terrisse AD, 2010, J THROMB HAEMOST, V8, P2810, DOI 10.1111/j.1538-7836.2010.04088.x; THIAGARAJAN P, 1990, J BIOL CHEM, V265, P17420; Wang X, 2001, PLACENTA, V22, P837, DOI 10.1053/plac.2001.0724; Watt SM, 2013, BRIT MED BULL, V108, P25, DOI 10.1093/bmb/ldt031; Wehder L, 2009, CELL CYCLE, V8, P1552, DOI 10.4161/cc.8.10.8404; Xiong J, 2012, J CARDIOVASC PHARM, V59, P124, DOI 10.1097/FJC.0b013e31820c6254; Zakharova L, 2007, J CELL PHYSIOL, V212, P174, DOI 10.1002/jcp.21013; Zhang HC, 2012, STEM CELLS DEV, V21, P3289, DOI 10.1089/scd.2012.0095; Zhou Z, 2007, DEV CELL, V13, P759, DOI 10.1016/j.devcel.2007.11.009	53	52	54	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147360	10.1371/journal.pone.0147360	http://dx.doi.org/10.1371/journal.pone.0147360			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808539	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800079
J	Zhang, SN; Fitzpatrick, PF				Zhang, Shengnan; Fitzpatrick, Paul F.			Identification of the Allosteric Site for Phenylalanine in Rat Phenylalanine Hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-HYDROXYLASE; REGULATORY DOMAIN; SUBSTRATE-BINDING; ACTIVATION; PROTEIN; SYSTEM	Liver phenylalanine hydroxylase (PheH) is an allosteric enzyme that requires activation by phenylalanine for full activity. The location of the allosteric site for phenylalanine has not been established. NMR spectroscopy of the isolated regulatory domain (RDPheH(25-117) is the regulatory domain of PheH lacking residues 1-24) of the rat enzyme in the presence of phenylalanine is consistent with formation of a side-by-side ACT dimer. Six residues in RDPheH(25-117) were identified as being in the phenylalanine-binding site on the basis of intermolecular NOEs between unlabeled phenylalanine and isotopically labeled protein. The location of these residues is consistent with two allosteric sites per dimer, with each site containing residues from both monomers. Site-specific variants of five of the residues (E44Q, A47G, L48V, L62V, and H64N) decreased the affinity of RDPheH(25-117) for phenylalanine based on the ability to stabilize the dimer. Incorporation of the A47G, L48V, and H64N mutations into the intact protein increased the concentration of phenylalanine required for activation. The results identify the location of the allosteric site as the interface of the regulatory domain dimer formed in activated PheH.	[Zhang, Shengnan; Fitzpatrick, Paul F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Fitzpatrick, PF (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	fitzpatrickp@uthscsa.edu			Office of the Vice President for Research at University of Texas Health Science Center at San Antonio; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047291, R01GM098140] Funding Source: NIH RePORTER	Office of the Vice President for Research at University of Texas Health Science Center at San Antonio; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Andrew P. Hinck and Dmitri Ivanov for helpful suggestions during the course of this work. The assistance of Virgil Schirf with the analytical ultracentrifugation and Dr. Kristin Cano-McCue with the NMR spectroscopy is gratefully acknowledged. Support for the Center for Macromolecular Interactions and the Center for NMR Spectroscopy from the Office of the Vice President for Research at University of Texas Health Science Center at San Antonio is gratefully acknowledged.	BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Carluccio C, 2016, J BIOMOL STRUCT DYN, V34, P497, DOI 10.1080/07391102.2015.1052016; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doskeland AP, 1996, BIOCHEM J, V313, P409, DOI 10.1042/bj3130409; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; EISENSMITH RC, 1991, MOL BIOL MED, V8, P3; Fitzpatrick PF, 2012, ARCH BIOCHEM BIOPHYS, V519, P194, DOI 10.1016/j.abb.2011.09.012; Fitzpatrick PF, 2003, BIOCHEMISTRY-US, V42, P14083, DOI 10.1021/bi035656u; Flydal MI, 2013, IUBMB LIFE, V65, P341, DOI 10.1002/iub.1150; Flydal MI, 2010, AMINO ACIDS, V39, P1463, DOI 10.1007/s00726-010-0611-6; Gabrielson JP, 2007, ANAL BIOCHEM, V361, P24, DOI 10.1016/j.ab.2006.11.012; Gjetting T, 2001, AM J HUM GENET, V68, P1353, DOI 10.1086/320604; Goodwill KE, 1997, NAT STRUCT BIOL, V4, P578, DOI 10.1038/nsb0797-578; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Jaffe EK, 2013, ARCH BIOCHEM BIOPHYS, V530, P73, DOI 10.1016/j.abb.2012.12.017; Jennings IG, 2001, FEBS LETT, V488, P196, DOI 10.1016/S0014-5793(00)02426-1; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Lang EJM, 2014, CURR OPIN STRUC BIOL, V29, P102, DOI 10.1016/j.sbi.2014.10.007; Li J, 2011, ARCH BIOCHEM BIOPHYS, V505, P250, DOI 10.1016/j.abb.2010.10.009; Li J, 2010, BIOCHEMISTRY-US, V49, P3327, DOI 10.1021/bi1001294; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIPS RS, 1984, BIOCHEMISTRY-US, V23, P3836, DOI 10.1021/bi00312a007; Roberts KM, 2014, BIOCHEMISTRY-US, V53, P7846, DOI 10.1021/bi501183x; Ronau JA, 2013, EUR BIOPHYS J BIOPHY, V42, P691, DOI 10.1007/s00249-013-0919-8; SCHULLER DJ, 1995, NAT STRUCT BIOL, V2, P69, DOI 10.1038/nsb0195-69; SHIMAN R, 1979, J BIOL CHEM, V254, P1300; SHIMAN R, 1994, J BIOL CHEM, V269, P24647; Tan KM, 2008, J STRUCT BIOL, V162, P94, DOI 10.1016/j.jsb.2007.11.009; Thorolfsson M, 2002, BIOCHEMISTRY-US, V41, P7573, DOI 10.1021/bi0160720; Wang L, 2002, BIOCHEMISTRY-US, V41, P12569, DOI 10.1021/bi026561f; Zhang SN, 2015, BIOCHEMISTRY-US, V54, P5167, DOI 10.1021/acs.biochem.5b00616; Zhang SN, 2014, BIOCHEMISTRY-US, V53, P6625, DOI 10.1021/bi501109s; Zhang SN, 2014, J MOL BIOL, V426, P1483, DOI 10.1016/j.jmb.2013.12.015	36	19	20	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7418	7425		10.1074/jbc.M115.709998	http://dx.doi.org/10.1074/jbc.M115.709998			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26823465	hybrid, Green Published			2022-12-26	WOS:000383447600018
J	Drees, SL; Li, C; Prasetya, F; Saleem, M; Dreveny, I; Williams, P; Hennecke, U; Emsley, J; Fetzner, S				Drees, Steffen Lorenz; Li, Chan; Prasetya, Fajar; Saleem, Muhammad; Dreveny, Ingrid; Williams, Paul; Hennecke, Ulrich; Emsley, Jonas; Fetzner, Susanne			PqsBC, a Condensing Enzyme in the Biosynthesis of the Pseudomonas aeruginosa Quinolone Signal: CRYSTAL STRUCTURE, INHIBITION, AND REACTION MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; crystal structure; Pseudomonas aeruginosa (P; aeruginosa); quorum sensing; secondary metabolism; 2-alkyl-4(1H)-quinolones; FabH; Pseudomonas quinolone signal; condensing enzyme	PROTEIN SYNTHASE-III; CATALYTIC CYSTEINE; CHALCONE SYNTHASE; MOLECULES; 2,4-DIHYDROXYQUINOLINE; IDENTIFICATION; COMMUNICATION; ANTHRANILATE; COEFFICIENTS; ABSORPTION	Pseudomonas aeruginosa produces a number of alkylquinolone-type secondary metabolites best known for their antimicrobial effects and involvement in cell-cell communication. In the alkylquinolone biosynthetic pathway, the -ketoacyl-(acyl carrier protein) synthase III (FabH)-like enzyme PqsBC catalyzes the condensation of octanoyl-coenzyme A and 2-aminobenzoylacetate (2-ABA) to form the signal molecule 2-heptyl-4(1H)-quinolone. PqsBC, a potential drug target, is unique for its heterodimeric arrangement and an active site different from that of canonical FabH-like enzymes. Considering the sequence dissimilarity between the subunits, a key question was how the two subunits are organized with respect to the active site. In this study, the PqsBC structure was determined to a 2 angstrom resolution, revealing that PqsB and PqsC have a pseudo-2-fold symmetry that unexpectedly mimics the FabH homodimer. PqsC has an active site composed of Cys-129 and His-269, and the surrounding active site cleft is hydrophobic in character and approximately twice the volume of related FabH enzymes that may be a requirement to accommodate the aromatic substrate 2-ABA. From physiological and kinetic studies, we identified 2-aminoacetophenone as a pathway-inherent competitive inhibitor of PqsBC, whose fluorescence properties could be used for in vitro binding studies. In a time-resolved setup, we demonstrated that the catalytic histidine is not involved in acyl-enzyme formation, but contributes to an acylation-dependent increase in affinity for the second substrate 2-ABA. Introduction of Asn into the PqsC active site led to significant activity toward the desamino substrate analog benzoylacetate, suggesting that the substrate 2-ABA itself supplies the asparagine-equivalent amino function that assists in catalysis.	[Fetzner, Susanne] Univ Munster, Inst Mol Microbiol & Biotechnol, D-48149 Munster, Germany; [Hennecke, Ulrich] Univ Munster, Inst Organ Chem, D-48149 Munster, Germany; [Li, Chan; Prasetya, Fajar; Saleem, Muhammad; Dreveny, Ingrid; Emsley, Jonas] Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Nottingham NG7 2RD, England; [Williams, Paul] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England	University of Munster; University of Munster; University of Nottingham; University of Nottingham	Fetzner, S (corresponding author), Univ Munster, Inst Mol Microbiol & Biotechnol, D-48149 Munster, Germany.; Emsley, J (corresponding author), Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Nottingham NG7 2RD, England.	jonas.emsley@nottingham.ac.uk; fetzner@uni-muenster.de	Dreveny, Ingrid/E-8939-2017; emsley, jonas/A-8509-2016; Williams, Paul/P-5224-2019; Drees, Steffen Lorenz/Q-3510-2019; Hennecke, Ulrich/A-7723-2010; Saleem, Muhammad/W-4014-2017	Dreveny, Ingrid/0000-0003-2256-642X; emsley, jonas/0000-0002-8949-8030; Williams, Paul/0000-0002-1920-5036; Drees, Steffen Lorenz/0000-0001-9140-0111; Hennecke, Ulrich/0000-0002-4904-6793; Saleem, Muhammad/0000-0002-0994-9701; Prasetya, Fajar/0000-0002-1020-0423; Fetzner, Susanne/0000-0002-7228-1871	Deutsche Forschungsgemeinschaft [FE 383/23-1]; Directorate General of Indonesia Higher Education	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Directorate General of Indonesia Higher Education	This work was supported by Deutsche Forschungsgemeinschaft Grant FE 383/23-1 (to S. F.) and by a Ph.D. studentship (to F. P.) from the Directorate General of Indonesia Higher Education. The authors declare that they have no conflicts of interest with the contents of this article.	Bandyopadhaya A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003024; Bera AK, 2009, BIOCHEMISTRY-US, V48, P8644, DOI 10.1021/bi9009055; BIRDSALL B, 1983, ANAL BIOCHEM, V132, P353, DOI 10.1016/0003-2697(83)90020-9; Bredenbruch F, 2006, ENVIRON MICROBIOL, V8, P1318, DOI 10.1111/j.1462-2920.2006.01025.x; Cabrita LD, 2007, PROTEIN SCI, V16, P2360, DOI 10.1110/ps.072822507; Coleman JP, 2008, J BACTERIOL, V190, P1247, DOI 10.1128/JB.01140-07; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; COX CD, 1979, J CLIN MICROBIOL, V9, P479; Davies C, 2000, STRUCTURE, V8, P185, DOI 10.1016/S0969-2126(00)00094-0; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; Drees SL, 2015, CHEM BIOL, V22, P611, DOI 10.1016/j.chembiol.2015.04.012; Dulcey CE, 2013, CHEM BIOL, V20, P1481, DOI 10.1016/j.chembiol.2013.09.021; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hansch GM, 2014, J APPL BIOMATER FUNC, V12, P21, DOI 10.5301/jabfm.5000204; Haussler S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000166; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Heeb S, 2011, FEMS MICROBIOL REV, V35, P247, DOI 10.1111/j.1574-6976.2010.00247.x; Hooi DSW, 2004, INFECT IMMUN, V72, P6463, DOI 10.1128/IAI.72.11.6463-6470.2004; Huse H, 2011, CHEM REV, V111, P152, DOI 10.1021/cr100063u; Ilangovan A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003508; Jez JM, 2000, J BIOL CHEM, V275, P39640, DOI 10.1074/jbc.M008569200; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Kesarwani M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002192; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lepine F, 2007, BIOL CHEM, V388, P839, DOI 10.1515/BC.2007.100; Lu CB, 2014, ANGEW CHEM INT EDIT, V53, P1109, DOI 10.1002/anie.201307547; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Needham ER, 1904, J CHEM SOC, V85, P148, DOI 10.1039/ct9048500148; Niewerth H, 2011, APPL MICROBIOL BIOT, V91, P1399, DOI 10.1007/s00253-011-3378-0; Pan H, 2002, STRUCTURE, V10, P1559, DOI 10.1016/S0969-2126(02)00889-4; Qiu XY, 2001, J MOL BIOL, V307, P341, DOI 10.1006/jmbi.2000.4457; Que YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080140; Rampioni G, 2014, BIOORG CHEM, V55, P60, DOI 10.1016/j.bioorg.2014.04.005; Sachdeva S, 2008, CHEM BIOL, V15, P402, DOI 10.1016/j.chembiol.2008.03.007; Schertzer JW, 2010, MOL MICROBIOL, V77, P1527, DOI 10.1111/j.1365-2958.2010.07303.x; SCHOPF C, 1956, CHEM BER-RECL, V89, P2877, DOI 10.1002/cber.19560891233; Shimada H, 2005, PHOTOCH PHOTOBIO SCI, V4, P367, DOI 10.1039/b416284f; SICKER D, 1988, COLLECT CZECH CHEM C, V53, P839, DOI 10.1135/cccc19880839; Skindersoe ME, 2009, FEMS IMMUNOL MED MIC, V55, P335, DOI 10.1111/j.1574-695X.2008.00533.x; Starkey M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004321; Steinbach A, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-10; Storz MP, 2012, J AM CHEM SOC, V134, P16143, DOI 10.1021/ja3072397; Suh DY, 2000, BIOCHEM BIOPH RES CO, V275, P725, DOI 10.1006/bbrc.2000.3368; Tzika AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074528; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X; Zhang YM, 2008, J BIOL CHEM, V283, P28788, DOI 10.1074/jbc.M804555200; Zhang ZM, 2011, BIOINFORMATICS, V27, P2083, DOI 10.1093/bioinformatics/btr331	56	46	48	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6610	6624		10.1074/jbc.M115.708453	http://dx.doi.org/10.1074/jbc.M115.708453			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26811339	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000373299700001
J	Gloux, K; Anba-Mondoloni, J				Gloux, Karine; Anba-Mondoloni, Jamila			Unique beta-Glucuronidase Locus in Gut Microbiomes of Crohn's Disease Patients and Unaffected First-Degree Relatives	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INVASIVE ESCHERICHIA-COLI; GENOME-WIDE ASSOCIATION; FAECALIBACTERIUM-PRAUSNITZII; INTESTINAL MICROFLORA; MUTAGENIC ACTIVATION; BILIARY METABOLITES; ULCERATIVE-COLITIS; ILEAL MUCOSA; BACTERIA	Crohn's disease, an incurable chronic inflammatory bowel disease, has been attributed to both genetic predisposition and environmental factors. A dysbiosis of the gut microbiota, observed in numerous patients but also in at least one hundred unaffected first-degree relatives, was proposed to have a causal role. Gut microbiota beta-D-glucuronidases (EC 3.2.1.33) hydrolyse beta-D-glucuronate from glucuronidated compounds. They include a GUS group, that is homologous to the Escherichia coli GusA, and a BG group, that is homologous to metagenomically identified H11G11 BG and has unidentified natural substrates. H11G11 BG is part of the functional core of the human gut microbiota whereas GusA, known to regenerate various toxic products, is variably found in human subjects. We investigated potential risk markers for Crohn's disease using DNA-sequence-based exploration of the beta-D-glucuronidase loci (GUS or Firmicute H11G11-BG and the respective co-encoded glucuronide transporters). Crohn's disease-related microbiomes revealed a higher frequency of a C7D2 glucuronide transporter (12/13) compared to unrelated healthy subjects (8/32). This transporter was in synteny with the potential harmful GUS beta-D-glucuronidase as only observed in a Eubacterium eligens plasmid. A conserved NH2-terminal sequence in the transporter (FGDFGND motif) was found in 83% of the disease-related subjects and only in 12% of controls. We propose a microbiota-pathology hypothesis in which the presence of this unique beta-glucuronidase locus may contribute to an increase risk for Crohn's disease.	[Gloux, Karine; Anba-Mondoloni, Jamila] Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, F-78350 Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Gloux, K (corresponding author), Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, F-78350 Jouy En Josas, France.	karine.gloux@jouy.inra.fr	Gloux, karine/AAC-4451-2019	gloux, karine/0000-0002-8880-6628				Ahmad Syed, 2011, Curr Chem Genomics, V5, P13, DOI 10.2174/1875397301105010013; Ardizzone S, 2007, INFLAMM BOWEL DIS, V13, P516, DOI 10.1002/ibd.20108; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Baker Phillip I, 2009, Expert Rev Gastroenterol Hepatol, V3, P535, DOI 10.1586/egh.09.47; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Blokzijl H, 2007, INFLAMM BOWEL DIS, V13, P710, DOI 10.1002/ibd.20088; Blokzijl H, 2008, J BIOL CHEM, V283, P35630, DOI 10.1074/jbc.M804374200; Chan SSM, 2013, AM J GASTROENTEROL, V108, P575, DOI 10.1038/ajg.2012.453; Chen G, 2010, CANCER RES, V70, P7543, DOI 10.1158/0008-5472.CAN-09-4582; Cohen O, 2010, MOL BIOL EVOL, V27, P703, DOI 10.1093/molbev/msp240; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Duong CN, 2011, WATER SCI TECHNOL, V64, P1750, DOI 10.2166/wst.2011.739; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gloux K, 2011, P NATL ACAD SCI USA, V108, P4539, DOI 10.1073/pnas.1000066107; Hedin C, 2016, GUT, V65, P944, DOI 10.1136/gutjnl-2014-308896; Hemminki K, 2009, ANN ONCOL, V20, P574, DOI 10.1093/annonc/mdn595; Humblot C, 2007, CARCINOGENESIS, V28, P2419, DOI 10.1093/carcin/bgm170; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Jia WJ, 2010, FEMS MICROBIOL LETT, V310, P138, DOI 10.1111/j.1574-6968.2010.02057.x; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Khalili H, 2015, INFLAMM BOWEL DIS, V21, P361, DOI 10.1097/MIB.0000000000000283; Kim DH, 2001, ARCH PHARM RES, V24, P564, DOI 10.1007/BF02975166; Klimesova K, 2013, INFLAMM BOWEL DIS, V19, P1266, DOI 10.1097/MIB.0b013e318281330a; Knasmuller S, 2001, MUTAT RES-FUND MOL M, V480, P129, DOI 10.1016/S0027-5107(01)00176-2; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Li Y, 2015, INT J CLIN EXP MED, V8, P5310; Liu JZ, 2014, BEST PRACT RES CL GA, V28, P373, DOI 10.1016/j.bpg.2014.04.009; LoGuidice A, 2012, J PHARMACOL EXP THER, V341, P447, DOI 10.1124/jpet.111.191122; Lopez-Siles M, 2012, APPL ENVIRON MICROB, V78, P420, DOI 10.1128/AEM.06858-11; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P152, DOI 10.1038/nrgastro.2011.3; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; McIntosh FM, 2012, ENVIRON MICROBIOL, V14, P1876, DOI 10.1111/j.1462-2920.2012.02711.x; Michielan A, 2013, DIGEST LIVER DIS, V45, P894, DOI 10.1016/j.dld.2013.01.017; MOROTOMI M, 1985, MUTAT RES, V149, P171, DOI 10.1016/0027-5107(85)90023-5; Muller J, 2009, J ANTIMICROB CHEMOTH, V64, P1187, DOI 10.1093/jac/dkp363; NANNO M, 1986, J MED MICROBIOL, V22, P351, DOI 10.1099/00222615-22-4-351; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Patel AG, 2010, SCIENCE, V330, P766, DOI 10.1126/science.1198310; Pfeiffer E, 2006, MOL NUTR FOOD RES, V50, P385, DOI 10.1002/mnfr.200500198; Pituch-Zdanowska A, 2016, ADV MED SCI-POLAND, V61, P28, DOI 10.1016/j.advms.2015.07.004; Prindiville T, 2004, INFLAMM BOWEL DIS, V10, P824, DOI 10.1097/00054725-200411000-00017; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sartor RB, 1997, RES IMMUNOL, V148, P567, DOI 10.1016/S0923-2494(98)80151-X; Schaubeck M, 2016, GUT, V65, P225, DOI 10.1136/gutjnl-2015-309333; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; Tachibana M, 2005, DRUG METAB DISPOS, V33, P803, DOI 10.1124/dmd.104.003178; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; WAKABAYASHI M, 1961, J BIOL CHEM, V236, P996; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Wenzl P, 2005, MOL BIOL EVOL, V22, P308, DOI 10.1093/molbev/msi018; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Yang J, 2013, J BIOL CHEM, V288, P31115, DOI 10.1074/jbc.M113.503912; Yang J, 2011, TRENDS MICROBIOL, V19, P128, DOI 10.1016/j.tim.2010.12.001; Yang QF, 2015, J DIGEST DIS, V16, P22, DOI 10.1111/1751-2980.12205	63	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148291	10.1371/journal.pone.0148291	http://dx.doi.org/10.1371/journal.pone.0148291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824357	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600115
J	Tong, JF; Li, LJ; Ballermann, B; Wang, ZX				Tong, Junfeng; Li, Laiji; Ballermann, Barbara; Wang, Zhixiang			Phosphorylation and Activation of RhoA by ERK in Response to Epidermal Growth Factor Stimulation	PLOS ONE			English	Article							KINASE SIGNALING PATHWAY; VASCULAR SMOOTH-MUSCLE; STRESS FIBER FORMATION; NUCLEAR-LOCALIZATION; CANCER CELLS; REGULATED KINASE; POLYBASIC REGION; DOCKING DOMAINS; RAC1 FUNCTION; MAP KINASES	The small GTPase RhoA has been implicated in various cellular activities, including the formation of stress fibers, cell motility, and cytokinesis. In addition to the canonical GTPase cycle, recent findings have suggested that phosphorylation further contributes to the tight regulation of Rho GTPases. Indeed, RhoA is phosphorylated on serine 188 (S-188) by a number of protein kinases. We have recently reported that Rac1 is phosphorylated on threonine 108 (T-108) by extracellular signal-regulated kinases (ERK) in response to epidermal growth factor (EGF) stimulation. Here, we provide evidence that RhoA is phosphorylated by ERK on S-88 and T-100 in response to EGF stimulation. We show that ERK interacts with RhoA and that this interaction is dependent on the ERK docking site (D-site) at the C-terminus of RhoA. EGF stimulation enhanced the activation of the endogenous RhoA. The phosphomimetic mutant, GFP-RhoA S88E/T100E, when transiently expressed in COS-7 cells, displayed higher GTP-binding than wild type RhoA. Moreover, the expression of GFP-RhoA S88E/T100E increased actin stress fiber formation in COS-7 cells, which is consistent with its higher activity. In contrast to Rac1, phosphorylation of RhoA by ERK does not target RhoA to the nucleus. Finally, we show that regardless of the phosphorylation status of RhoA and Rac1, substitution of the RhoA PBR with the Rac1 PBR targets RhoA to the nucleus and substitution of Rac1 PBR with RhoA PBR significantly reduces the nuclear localization of Rac1. In conclusion, ERK phosphorylates RhoA on S-88 and T-100 in response to EGF, which upregulates RhoA activity.	[Tong, Junfeng; Wang, Zhixiang] Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB T6G 2H7, Canada; [Li, Laiji; Ballermann, Barbara] Univ Alberta, Dept Med, Fac Med & Dent, Edmonton, AB T6G 2H7, Canada; [Tong, Junfeng; Li, Laiji; Ballermann, Barbara; Wang, Zhixiang] Univ Alberta, Fac Med & Dent, Signal Transduct Res Grp, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta; University of Alberta	Wang, ZX (corresponding author), Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB T6G 2H7, Canada.; Wang, ZX (corresponding author), Univ Alberta, Fac Med & Dent, Signal Transduct Res Grp, Edmonton, AB T6G 2H7, Canada.	zhixiang.wang@ualberta.ca	Ballermann, Barbara J/G-5349-2016	Ballermann, Barbara J/0000-0002-8220-6381	Alberta Cancer Foundation; Canadian Institutes of Health Research (CIHR) [RES0006924]	Alberta Cancer Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants from the Alberta Cancer Foundation and the Canadian Institutes of Health Research (CIHR: RES0006924).	Amiri A, 2007, MOL CANCER RES, V5, P933, DOI 10.1158/1541-7786.MCR-06-0362; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Baldassare JJ, 1997, J BIOL CHEM, V272, P4911, DOI 10.1074/jbc.272.8.4911; Bellizzi A, 2008, INT J MOL MED, V22, P25; Benitah SA, 2004, BBA-REV CANCER, V1705, P121, DOI 10.1016/j.bbcan.2004.10.002; Bolshakova A, 2015, HISTOCHEM CELL BIOL; Burbelo P, 2004, BREAST CANCER RES TR, V84, P43, DOI 10.1023/B:BREA.0000018422.02237.f9; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chang FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028587; Chauhan BK, 2011, P NATL ACAD SCI USA, V108, P18289, DOI 10.1073/pnas.1108993108; Colucci-Guyon E, 2005, CURR BIOL, V15, P2007, DOI 10.1016/j.cub.2005.09.051; Dubash AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017380; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Enslen H, 2001, BIOL CELL, V93, P5, DOI 10.1016/S0248-4900(01)01156-X; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Fujishiro SH, 2008, BIOCHEM BIOPH RES CO, V368, P162, DOI 10.1016/j.bbrc.2008.01.066; Gayard M, 2011, ARTERIOSCL THROM VAS, V31, P2634, DOI 10.1161/ATVBAHA.111.228304; Gest C, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-63; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; Julian Linda, 2014, Small GTPases, V5, pe29846, DOI 10.4161/sgtp.29846; Kakiashvili E, 2011, J BIOL CHEM, V286, P9268, DOI 10.1074/jbc.M110.179903; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Kusama T, 2001, CANCER RES, V61, P4885; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Li H, 2009, BIOINFORMATICS, V25, P358, DOI 10.1093/bioinformatics/btn635; Li XR, 2006, EJSO-EUR J SURG ONC, V32, P1130, DOI 10.1016/j.ejso.2006.05.012; Li YY, 2011, MOL MED REP, V4, P1115, DOI 10.3892/mmr.2011.556; Lincoln TM, 2007, CIRC RES, V100, P10, DOI 10.1161/01.RES.0000255894.25293.82; Liu M, 2012, TRENDS CELL BIOL, V22, P365, DOI 10.1016/j.tcb.2012.04.004; Loirand G, 2006, TRENDS CARDIOVAS MED, V16, P199, DOI 10.1016/j.tcm.2006.03.010; Mettouchi Amel, 2012, Small GTPases, V3, P102, DOI 10.4161/sgtp.19221; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Navarro-Lerida I, 2012, EMBO J, V31, P534, DOI 10.1038/emboj.2011.446; Ngok SP, 2014, J CELL SCI, V127, P3205, DOI 10.1242/jcs.153197; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Nusser N, 2006, CELL SIGNAL, V18, P704, DOI 10.1016/j.cellsig.2005.06.010; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Ojaniemi M, 1997, J BIOL CHEM, V272, P25993, DOI 10.1074/jbc.272.41.25993; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Ren XD, 2000, METHOD ENZYMOL, V325, P264; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rolli-Derkinderen M, 2005, CIRC RES, V96, P1152, DOI 10.1161/01.RES.0000170084.88780.ea; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Sawada N, 2001, BIOCHEM BIOPH RES CO, V280, P798, DOI 10.1006/bbrc.2000.4194; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Tang J, 2014, J NEUROSCI, V34, P7425, DOI 10.1523/JNEUROSCI.5449-13.2014; Tao Y, 2008, WORLD J GASTROENTERO, V14, P1175, DOI 10.3748/wjg.14.1175; Tao Y, 2012, ONCOL LETT, V3, P1283, DOI 10.3892/ol.2012.667; Tong JF, 2013, MOL CELL BIOL, V33, P4538, DOI 10.1128/MCB.00822-13; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; von Thun A, 2013, MOL CELL BIOL, V33, P4526, DOI 10.1128/MCB.00585-13; Wang ZX, 1999, MOL BIOL CELL, V10, P1621, DOI 10.1091/mbc.10.5.1621; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Wu P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041354; Xu D, 2012, CELL SIGNAL, V24, P282, DOI 10.1016/j.cellsig.2011.09.013; Xu J, 2013, ONCOL REP, V30, P1878, DOI 10.3892/or.2013.2638; Zhao XS, 2009, CANCER RES, V69, P483, DOI 10.1158/0008-5472.CAN-08-2907; Zuckerbraun BS, 2003, CIRCULATION, V108, P876, DOI 10.1161/01.CIR.0000081947.00070.07	69	28	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147103	10.1371/journal.pone.0147103	http://dx.doi.org/10.1371/journal.pone.0147103			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816343	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528200024
J	Wakabayashi, I; Marumo, M; Nonaka, D; Shimomura, T; Eguchi, R; Lee, LJ; Tanaka, K; Hatake, K				Wakabayashi, Ichiro; Marumo, Mikio; Nonaka, Daisuke; Shimomura, Tomoko; Eguchi, Ryoji; Lee, Lyang-Ja; Tanaka, Kenji; Hatake, Katsuhiko			Potential Biomarker Peptides Associated with Acute Alcohol-Induced Reduction of Blood Pressure	PLOS ONE			English	Article							DIRECT TRANSFER TECHNOLOGY; CORONARY-HEART-DISEASE; ETHANOL; HYPERTENSION; METAANALYSIS; WEIGHT; SEARCH	The purpose of this study was to explore the peptides that are related to acute reduction of blood pressure after alcohol drinking. Venous blood was collected from male healthy volunteers before and after drinking white wine (3 ml/kg weight) containing 13% of ethanol. Peptidome analysis for serum samples was performed using a new target plate, BLOTCHIP (R). Alcohol caused significant decreases in systolic and diastolic blood pressure levels at 45 min. The peptidome analysis showed that the levels of three peptides of m/z 1467, 2380 and 2662 changed significantly after drinking. The m/z 1467 and 2662 peptides were identified to be fragments of fibrinogen alpha chain, and the m/z 2380 peptide was identified to be a fragment of complement C4. The intensities of the m/z 2380 and m/z 1467 peptides before drinking were associated with % decreases in systolic and diastolic blood pressure levels at 45 min after drinking compared with the levels before drinking, while there were no significant correlations between the intensity of the m/z 2662 peptide and % decreases in systolic and diastolic blood pressure levels after drinking. The m/z 1467 and 2380 peptides are suggested to be markers for acute reduction of blood pressure after drinking alcohol.	[Wakabayashi, Ichiro; Marumo, Mikio; Shimomura, Tomoko; Eguchi, Ryoji] Hyogo Coll Med, Dept Environm & Prevent Med, Nishinomiya, Hyogo 6638501, Japan; [Nonaka, Daisuke; Lee, Lyang-Ja; Tanaka, Kenji] Protosera Inc, Membrane Prot & Ligand Anal Ctr, Amagasaki, Hyogo 6600083, Japan; [Hatake, Katsuhiko] Nara Med Univ, Dept Legal Med, Kashihara, Nara 6348521, Japan	Hyogo College of Medicine; Nara Medical University	Wakabayashi, I (corresponding author), Hyogo Coll Med, Dept Environm & Prevent Med, Nishinomiya, Hyogo 6638501, Japan.	wakabaya@hyo-med.ac.jp		Nonaka, Daisuke/0000-0002-3510-7559; Eguchi, Ryoji/0000-0002-2417-7578	Japan Society for the Promotion of Science [24659341]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (No. 24659341) from the Japan Society for the Promotion of Science.	Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; ALTURA BM, 1982, FED PROC, V41, P2447; An YM, 2010, DIS MARKERS, V29, P11, DOI [10.1155/2010/681876, 10.3233/DMA-2010-0721]; Araki Y, 2011, PROTEOMICS, V11, P2727, DOI 10.1002/pmic.201000753; BANNAN LT, 1984, CLIN SCI, V66, P659, DOI 10.1042/cs0660659; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; GUIVERNAU M, 1987, J PHARMACOL EXP THER, V240, P59; HATAKE K, 1990, PHARMACOL BIOCHEM BE, V35, P437; Jahn H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026540; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; KAWANO Y, 1992, HYPERTENSION, V20, P219, DOI 10.1161/01.HYP.20.2.219; KING AC, 1991, ALCOHOL CLIN EXP RES, V15, P478, DOI 10.1111/j.1530-0277.1991.tb00546.x; Klatsky AL, 2003, J CARDIOVASC RISK, V10, P21, DOI 10.1097/00043798-200302000-00005; KROBOT K, 1992, ARTERIOSCLER THROMB, V12, P780, DOI 10.1161/01.ATV.12.7.780; KUPARI M, 1983, BRIT HEART J, V49, P174, DOI 10.1136/hrt.49.2.174; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; MIZOI Y, 1983, PHARMACOL BIOCHEM BE, V18, P127, DOI 10.1016/0091-3057(83)90159-4; MURAMATSU T, 1989, ALCOHOL CLIN EXP RES, V13, P229, DOI 10.1111/j.1530-0277.1989.tb00317.x; Potter J F, 1983, J Hypertens Suppl, V1, P97; Puddey IB, 2001, CLIN EXP PHARMACOL P, V28, P1020, DOI 10.1046/j.1440-1681.2001.03572.x; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; RUBIN R, 1994, ALCOHOL CLIN EXP RES, V18, P105, DOI 10.1111/j.1530-0277.1994.tb00888.x; Scheid S, 2004, IEEE ACM T COMPUT BI, V1, P98, DOI 10.1109/TCBB.2004.24; Sogawa K, 2009, PROTEOM CLIN APPL, V3, P821, DOI 10.1002/prca.200800174; SUDDENDORF RF, 1989, PUBLIC HEALTH REP, V104, P615; Takeshita T, 1998, ALCOHOL CLIN EXP RES, V22, P1409, DOI 10.1111/j.1530-0277.1998.tb03928.x; Tanaka K, 2009, BIOCHEM BIOPH RES CO, V379, P110, DOI 10.1016/j.bbrc.2008.12.016; Taylor B, 2009, ADDICTION, V104, P1981, DOI 10.1111/j.1360-0443.2009.02694.x; Uchiyama K, 2015, J PROTEOM BIOINFORM, DOI [10.4172/jpb.S5-005, DOI 10.4172/JPB.S5-005]	30	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147297	10.1371/journal.pone.0147297	http://dx.doi.org/10.1371/journal.pone.0147297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815288	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528200029
J	Graham, CF; Eberts, RL; Morgan, TD; Boreham, DR; Lance, SL; Manzon, RG; Martino, JA; Rogers, SM; Wilson, JY; Somers, CM				Graham, Carly F.; Eberts, Rebecca L.; Morgan, Thomas D.; Boreham, Douglas R.; Lance, Stacey L.; Manzon, Richard G.; Martino, Jessica A.; Rogers, Sean M.; Wilson, Joanna Y.; Somers, Christopher M.			Fine-Scale Ecological and Genetic Population Structure of Two Whitefish (Coregoninae) Species in the Vicinity of Industrial Thermal Emissions	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; NUCLEAR-POWER-PLANT; TROPHIC NICHE WIDTH; LAKE WHITEFISH; ROUND WHITEFISH; ATLANTIC SALMON; INDIVIDUAL IDENTIFICATION; PROSOPIUM-CYLINDRACEUM; SOCKEYE-SALMON; LIFE-HISTORY	Thermal pollution from industrial processes can have negative impacts on the spawning and development of cold-water fish. Point sources of thermal effluent may need to be managed to avoid affecting discrete populations. Correspondingly, we examined fine-scale ecological and genetic population structure of two whitefish species (Coregonus clupeaformis and Prosopium cylindraceum) on Lake Huron, Canada, in the immediate vicinity of thermal effluent from nuclear power generation. Niche metrics using delta C-13 and delta N-15 stable isotopes showed high levels of overlap (48.6 to 94.5%) in resource use by adult fish captured in areas affected by thermal effluent compared to nearby reference locations. Isotopic niche size, a metric of resource use diversity, was 1.3- to 2.8-fold higher than reference values in some thermally affected areas, indicative of fish mixing. Microsatellite analyses of genetic population structure (F-st, STRUCTURE and DAPC) indicated that fish captured at all locations in the vicinity of the power plant were part of a larger population extending beyond the study area. In concert, ecological and genetic markers do not support the presence of an evolutionarily significant unit in the vicinity of the power plant. Thus, future research should focus on the potential impacts of thermal emissions on development and recruitment.	[Graham, Carly F.; Eberts, Rebecca L.; Morgan, Thomas D.; Manzon, Richard G.; Martino, Jessica A.; Somers, Christopher M.] Univ Regina, Dept Biol, Regina, SK, Canada; [Boreham, Douglas R.] Northern Ontario Sch Med, Med Sci, Greater Sudbury, ON, Canada; [Lance, Stacey L.] Univ Georgia, Savannah River Ecol Lab, Athens, GA 30602 USA; [Rogers, Sean M.] Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada; [Wilson, Joanna Y.] McMaster Univ, Dept Biol, Hamilton, ON, Canada	University of Regina; Northern Ontario School of Medicine; United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia; University of Calgary; McMaster University	Somers, CM (corresponding author), Univ Regina, Dept Biol, Regina, SK, Canada.	chris.somers@uregina.ca	Morgan, Tom/AAM-2532-2021; Somers, Christopher/AAE-6390-2019; Lance, Stacey/K-9203-2013	Lance, Stacey/0000-0003-2686-1733	Natural Sciences and Engineering Research Council of Canada - Collaborative Research and Development Grants [433617-12]; Bruce Power: matching industrial funds as part of above NSERC CRD application; Canada Research Chairs: chair awarded in Genes & Environment to CMS; University of Regina: funds awarded as part of Canada Research Chair support; McMaster University: overhead funds reinvested in program; Northern Ontario School of Medicine: overhead funds reinvested in program; Canada Foundation for Innovation: infrastructure grant as part of Canada Research Chair; Natural Sciences and Engineering Research Council of Canada; Bruce Power; Canada Research Chairs Program; Canada Foundation for Innovation; McMaster University; Northern Ontario School of Medicine; University of Regina; University of Regina's Institute of Environmental Change and Society; U.S. Department of Energy [DE-FC09-07SR22506]	Natural Sciences and Engineering Research Council of Canada - Collaborative Research and Development Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Bruce Power: matching industrial funds as part of above NSERC CRD application; Canada Research Chairs: chair awarded in Genes & Environment to CMS; University of Regina: funds awarded as part of Canada Research Chair support; McMaster University: overhead funds reinvested in program; Northern Ontario School of Medicine: overhead funds reinvested in program; Canada Foundation for Innovation: infrastructure grant as part of Canada Research Chair; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Bruce Power; Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); McMaster University; Northern Ontario School of Medicine; University of Regina; University of Regina's Institute of Environmental Change and Society; U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by Natural Sciences and Engineering Research Council of Canada - Collaborative Research and Development Grants (award # 433617-12, http://www.nserc-crsng.gc.ca/Professors-Professeurs/RPP-PP/CRD-RDC_eng.asp); Bruce Power: matching industrial funds as part of above NSERC CRD application (http://www.brucepower.com/); Canada Research Chairs: chair awarded in Genes & Environment to CMS; University of Regina: funds awarded to CMS as part of Canada Research Chair support (technician salary); McMaster University: overhead funds reinvested in program; Northern Ontario School of Medicine: overhead funds reinvested in program; Canada Foundation for Innovation: infrastructure grant awarded to CMS as part of Canada Research Chair (http://www.innovation.ca/). The designation of the 8 geographic zones adjacent to the nuclear plant and the collection of fish as described in the manuscript were conducted by Bruce Power as part of their Environmental Impact Assessment Follow-up Monitoring Program (http://www.brucepower.com/environment/environmental-policy/). The funders had no other roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Natural Sciences and Engineering Research Council of Canada, Bruce Power, the Canada Research Chairs Program, the Canada Foundation for Innovation, McMaster University, the Northern Ontario School of Medicine, and the University of Regina. We are grateful for in-kind support from the University of Regina's Institute of Environmental Change and Society. We would like to thank J. Thompson, C.L. Fietsch, and M.E. Cybulski for coordinating sample collection. Preparation of this manuscript was partially supported by U.S. Department of Energy under Award Number DE-FC09-07SR22506 to the University of Georgia Research Foundation	Beacham TD, 2005, T AM FISH SOC, V134, P1124, DOI 10.1577/T05-005.1; Beacham TD, 2010, CAN J FISH AQUAT SCI, V67, P1274, DOI 10.1139/F10-061; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Bernatchez L, 2010, PHILOS T R SOC B, V365, P1783, DOI 10.1098/rstb.2009.0274; Borodczak N, 1978, CANADIAN WATER RESOU, V3, P142; Bradbury IR, 2015, CAN J FISH AQUAT SCI, V72, P83, DOI 10.1139/cjfas-2014-0058; Bruce Power, 2009, BREP0053100035 BRUC; Bruce Power, 2010, BREP0053100040 BRUC; BRYAN JE, 1975, J FISH RES BOARD CAN, V32, P283, DOI 10.1139/f75-026; Bryce Effer, 1975, THERMAL DISCHARGE ST, P371; Cabe PR, 2007, HEREDITY, V98, P53, DOI 10.1038/sj.hdy.6800905; Carl LM, 2006, ENVIRON BIOL FISH, V75, P315, DOI 10.1007/s10641-006-0030-4; Casselman JM, 1995, J GREAT LAKES RES, V21, P384, DOI 10.1016/S0380-1330(95)71112-1; CASSELMAN JM, 1981, CAN J FISH AQUAT SCI, V38, P1772, DOI 10.1139/f81-225; Clarke, 1973, EFFECTS THERMAL DISC; Cooke SJ, 2003, WATER AIR SOIL POLL, V142, P113, DOI 10.1023/A:1022082003932; COUTANT CC, 1977, J FISH RES BOARD CAN, V34, P739, DOI 10.1139/f77-115; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Ebener M. P., 2012, COMM SPEC PUB, V13-01, P29; Ebener M.P., 2008, INT GOVERNANCE FISHE, P99; Ebener MP, 2010, J GREAT LAKES RES, V36, P38, DOI 10.1016/j.jglr.2010.02.002; Ebener MP, 1997, FISHERIES, V22, P18; Eldridge WH, 2007, MOL ECOL, V16, P2407, DOI 10.1111/j.1365-294X.2007.03271.x; Eme J, 2015, COMP BIOCHEM PHYS A, V179, P71, DOI 10.1016/j.cbpa.2014.09.005; Encina L, 2008, J THERM BIOL, V33, P444, DOI 10.1016/j.jtherbio.2008.08.002; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fink P, 2012, OIKOS, V121, P1985, DOI 10.1111/j.1600-0706.2012.20185.x; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Gagnaire PA, 2013, MOL ECOL, V22, P3036, DOI 10.1111/mec.12127; Golder & Associates, 2005, BRUC REF LIF EXT CON, V1; Guzzo MM, 2015, J GREAT LAK IN PRESS; Hamidan N, 2016, ECOL FRESHW FISH, V25, P455, DOI 10.1111/eff.12226; Hart J.L., 1931, CONTRIB CAN BIOL FIS, V6, P165, DOI DOI 10.1139/F31-007; Harvey CJ, 2000, CAN J FISH AQUAT SCI, V57, P1395, DOI 10.1139/cjfas-57-7-1395; Hayes Hebert, 1972, 44 ANZAAS C S; Hobson KA, 2012, J GREAT LAKES RES, V38, P58, DOI 10.1016/j.jglr.2010.11.008; Hoyle JA, 2011, AQUAT ECOSYST HEALTH, V14, P66, DOI 10.1080/14634988.2011.548730; IHSSEN PE, 1981, CAN J FISH AQUAT SCI, V38, P1790, DOI 10.1139/f81-226; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Johnsen A, 2014, FISHERIES MANAG ECOL, V21, P32, DOI 10.1111/fme.12049; Jombart T, 2010, BMC GENET, P11, DOI [10.1186/1471-2156-11-11, DOI 10.1186/1471-2156-11-11]; Kanno Y, 2011, MOL ECOL, V20, P3711, DOI 10.1111/j.1365-294X.2011.05210.x; KELSO JRM, 1974, J FISH RES BOARD CAN, V31, P1507, DOI 10.1139/f74-181; Lance SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081853; Lardicci C, 1999, MAR POLLUT BULL, V38, P296, DOI 10.1016/S0025-326X(98)00149-0; Latch EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027794; Lindholm E, 2004, HUM HERED, V58, P164, DOI 10.1159/000083543; Liu NJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S26; LUKSIENE D, 1994, J FISH BIOL, V45, P613, DOI 10.1111/j.1095-8649.1994.tb00928.x; Luksiene D, 2000, J FISH BIOL, V56, P37, DOI 10.1111/j.1095-8649.2000.tb02085.x; Macpherson A, 2010, CURR ZOOL, V56, P109, DOI 10.1093/czoolo/56.1.109; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; McCracken GR, 2014, CONSERV GENET RESOUR, V6, P1023, DOI 10.1007/s12686-014-0276-7; McNickle GG, 2006, J GREAT LAKES RES, V32, P180, DOI 10.3394/0380-1330(2006)32[180:CIBICO]2.0.CO;2; Mee JA, 2015, EVOL APPL, V8, P423, DOI 10.1111/eva.12247; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Mohr Lloyd C., 2005, Great Lakes Fishery Commission Technical Report, V66, P105; Moore JS, 2014, MOL ECOL, V23, P5680, DOI 10.1111/mec.12972; Morin R, 1982, CANADIAN J FISHERIES, V39, P959; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Mueller CA, 2015, J COMP PHYSIOL B, V185, P315, DOI 10.1007/s00360-015-0886-8; Munroe SEM, 2015, J FISH BIOL, V86, P1567, DOI 10.1111/jfb.12660; Nalepa TF, 2009, AQUAT ECOSYST HEALTH, V12, P2, DOI 10.1080/14634980802715175; Newman RA, 2001, MOL ECOL, V10, P1087, DOI 10.1046/j.1365-294X.2001.01255.x; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; O'Bryhim J, 2013, CONSERV GENET RESOUR, V5, P89, DOI 10.1007/s12686-012-9740-4; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Parnell A. C., 2013, SIAR STABLE ISOTOPE; Patrick PH, 2013, N AM J FISH MANAGE, V33, P1091, DOI 10.1080/02755947.2013.824937; Patton JC, 1997, CAN J FISH AQUAT SCI, V54, P1548, DOI 10.1139/cjfas-54-7-1548; Perga ME, 2005, OECOLOGIA, V144, P598, DOI 10.1007/s00442-005-0069-5; Pigeon D, 1997, EVOLUTION, V51, P196, DOI [10.2307/2410973, 10.1111/j.1558-5646.1997.tb02401.x]; Pothoven SA, 2008, N AM J FISH MANAGE, V28, P308, DOI 10.1577/M07-022.1; Pothoven SA, 2006, J GREAT LAKES RES, V32, P489, DOI 10.3394/0380-1330(2006)32[489:FEOLWI]2.0.CO;2; Pothoven SA, 2013, N AM J FISH MANAGE, V33, P1194, DOI 10.1080/02755947.2013.839973; Pritchard JK, 2000, GENETICS, V155, P945; Prugh LR, 2005, MOL ECOL, V14, P1585, DOI 10.1111/j.1365-294X.2005.02533.x; R Development Core Team, 2014, R LANG ENV STAT COMP; RAWSON D. S., 1951, JOUR FISH RES BD CANADA, V8, P207; Renaut S, 2011, MOL ECOL, V20, P545, DOI 10.1111/j.1365-294X.2010.04952.x; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Rennie MD, 2009, OECOLOGIA, V159, P789, DOI 10.1007/s00442-008-1271-z; REUTTER J M, 1976, Ohio Journal of Science, V76, P39; Richoux NB, 2014, MARINE ECOLOGY; Rogers SM, 2006, J EVOLUTION BIOL, V19, P1979, DOI 10.1111/j.1420-9101.2006.01150.x; Rogers SM, 2004, MOL ECOL NOTES, V4, P89, DOI 10.1046/j.1471-8286.2003.00578.x; ROSEMAN EF, 2007, J GREAT LAKES RES, V33, P397; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; ROSS MJ, 1982, CAN J FISH AQUAT SCI, V39, P346, DOI 10.1139/f82-047; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruzzante DE, 2000, ECOL APPL, V10, P1090, DOI 10.1890/1051-0761(2000)010[1090:MSAOAC]2.0.CO;2; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Sandstrom O, 1997, J FISH BIOL, V51, P1015, DOI 10.1006/jfbi.1997.0506; SANDSTROM O, 1995, J FISH BIOL, V47, P652, DOI 10.1006/jfbi.1995.0169; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sierszen ME, 2006, CAN J FISH AQUAT SCI, V63, P1496, DOI 10.1139/F06-057; Smythe A.G., 2000, ENVIRON SCI POLICY, V3, P225; Spidle AP, 2001, CONSERV GENET, V2, P11, DOI 10.1023/A:1011580217381; Steinhart GB, 2007, T31 NYSDEC BUR WILDL; Stott W, 2004, ANN ZOOL FENN, V41, P51; Stott W, 2008, ADV LIMNOLOGY, V63, P241; Stott W, 2013, ADV LIMNOL, V64, P205, DOI 10.1127/1612-166X/2013/0064-0015; Stott W, 2010, J GREAT LAKES RES, V36, P59, DOI 10.1016/j.jglr.2010.01.004; SYLVESTER J R, 1972, Environmental Pollution, V3, P205, DOI 10.1016/0013-9327(72)90004-3; Syvaranta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056094; Takai N, 1999, CAN J ZOOL, V77, P258, DOI 10.1139/cjz-77-2-258; Taylor EB, 2011, CAN J ZOOL, V89, P255, DOI 10.1139/Z10-114; Teixeira TP, 2012, HYDROBIOLOGIA, V684, P161, DOI 10.1007/s10750-011-0980-1; Teixeira TP, 2009, MAR ENVIRON RES, V68, P188, DOI 10.1016/j.marenvres.2009.06.004; Thome C, CANADIAN J FIS UNPUB; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vandehey JA, 2009, CAN J FISH AQUAT SCI, V66, P382, DOI 10.1139/F08-213; Vander Zanden MJ, 1999, AM NAT, V154, P406, DOI 10.1086/303250; Verones F, 2010, ENVIRON SCI TECHNOL, V44, P9364, DOI 10.1021/es102260c; VOGLER AP, 1994, CONSERV BIOL, V8, P354, DOI 10.1046/j.1523-1739.1994.08020354.x; Waples R.S., 1991, MAR FISH REV, V53, P11; Weidel BC, 2011, CAN J FISH AQUAT SCI, V68, P387, DOI 10.1139/F10-158; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wismer DA, 1987, GREAT LAKES FISHERY, V87-3	122	8	8	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146656	10.1371/journal.pone.0146656	http://dx.doi.org/10.1371/journal.pone.0146656			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807722	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800029
J	Nam, W; Epureanu, BI				Nam, Woochul; Epureanu, Bogdan I.			Effects of Obstacles on the Dynamics of Kinesins, Including Velocity and Run Length, Predicted by a Model of Two Dimensional Motion	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; AXONAL-TRANSPORT; MOLECULAR MOTORS; ATP HYDROLYSIS; BINDING STATE; FORCE CLAMP; TAU; MICROTUBULES; CYCLE	Kinesins are molecular motors which walk along microtubules by moving their heads to different binding sites. The motion of kinesin is realized by a conformational change in the structure of the kinesin molecule and by a diffusion of one of its two heads. In this study, a novel model is developed to account for the 2D diffusion of kinesin heads to several neighboring binding sites (near the surface of microtubules). To determine the direction of the next step of a kinesin molecule, this model considers the extension in the neck linkers of kinesin and the dynamic behavior of the coiled-coil structure of the kinesin neck. Also, the mechanical interference between kinesins and obstacles anchored on the microtubules is characterized. The model predicts that both the kinesin velocity and run length (i.e., the walking distance before detaching from the microtubule) are reduced by static obstacles. The run length is decreased more significantly by static obstacles than the velocity. Moreover, our model is able to predict the motion of kinesin when other (several) motors also move along the same microtubule. Furthermore, it suggests that the effect of mechanical interaction/interference between motors is much weaker than the effect of static obstacles. Our newly developed model can be used to address unanswered questions regarding degraded transport caused by the presence of excessive tau proteins on microtubules.	[Nam, Woochul; Epureanu, Bogdan I.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Epureanu, BI (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	epureanu@umich.edu		Nam, Woochul/0000-0002-2747-4850	National Science Foundation [DMI-0800202]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation, DMI-0800202 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asenjo AB, 2009, P NATL ACAD SCI USA, V106, P5657, DOI 10.1073/pnas.0808355106; ASTUMIAN RD, 1994, PHYS REV LETT, V72, P1766, DOI 10.1103/PhysRevLett.72.1766; Beeg J, 2008, BIOPHYS J, V94, P532, DOI 10.1529/biophysj.106.097881; Bier M, 2011, BIOSYSTEMS, V103, P355, DOI 10.1016/j.biosystems.2010.11.005; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Bornschlogl T, 2009, P NATL ACAD SCI USA, V106, P6992, DOI 10.1073/pnas.0812620106; Crevel IMTC, 1996, J MOL BIOL, V257, P66, DOI 10.1006/jmbi.1996.0147; Cross RA, 2000, PHILOS T ROY SOC B, V355, P459, DOI 10.1098/rstb.2000.0587; DAVIS C, 1983, J PARASITOL, V69, P1094, DOI 10.2307/3280872; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Dreblow K, 2010, BIOCHEM BIOPH RES CO, V395, P490, DOI 10.1016/j.bbrc.2010.04.035; Dreblow Kerstin, 2009, Biophysical Reviews and Letters, V4, P139, DOI 10.1142/S1793048009000958; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Guydosh NR, 2009, NATURE, V461, P125, DOI 10.1038/nature08259; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hancock WO, 1999, P NATL ACAD SCI USA, V96, P13147, DOI 10.1073/pnas.96.23.13147; Hariharan V, 2009, CELL MOL BIOENG, V2, P177, DOI 10.1007/s12195-009-0059-5; Hendricks AG, 2008, NONLINEAR DYNAM, V53, P303, DOI 10.1007/s11071-007-9315-1; Hoeprich GJ, 2014, BIOPHYS J, V106, P1691, DOI 10.1016/j.bpj.2014.02.034; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Kolomeisky AB, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.031902; Korten T, 2008, LAB CHIP, V8, P1441, DOI 10.1039/b803585g; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Leduc C, 2012, P NATL ACAD SCI USA, V109, P6100, DOI 10.1073/pnas.1107281109; Mandelkow E, 1998, TRENDS BIOCHEM SCI, V23, P429, DOI 10.1016/S0968-0004(98)01278-X; Mandelkow EM, 2003, NEUROBIOL AGING, V24, P1079, DOI 10.1016/j.neurobiolaging.2003.04.007; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; McVicker DP, 2011, J BIOL CHEM, V286, P42873, DOI 10.1074/jbc.M111.292987; Muresan V, 2009, FUTUR NEUROL, V4, P761, DOI 10.2217/FNL.09.54; MURMANIS L, 1971, NEW PHYTOL, V70, P1089, DOI 10.1111/j.1469-8137.1971.tb04591.x; Nam W, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003981; Nam W, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/37/375103; Nishiyama M, 2002, NAT CELL BIOL, V4, P790, DOI 10.1038/ncb857; ROMBERG L, 1993, NATURE, V361, P168, DOI 10.1038/361168a0; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Seitz A, 2006, EMBO J, V25, P267, DOI 10.1038/sj.emboj.7600937; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; SVOBODA K, 1994, P NATL ACAD SCI USA, V91, P11782, DOI 10.1073/pnas.91.25.11782; SWANSON E, 1978, J CHEM PHYS, V68, P5097, DOI 10.1063/1.435628; Taniguchi Y, 2005, NAT CHEM BIOL, V1, P342, DOI 10.1038/nchembio741; Telley IA, 2009, BIOPHYS J, V96, P3341, DOI 10.1016/j.bpj.2009.01.015; Trinczek B, 1999, J CELL SCI, V112, P2355; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018; Zhang ZC, 2012, STRUCTURE, V20, P628, DOI 10.1016/j.str.2012.02.013	55	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147676	10.1371/journal.pone.0147676	http://dx.doi.org/10.1371/journal.pone.0147676			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808534	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800177
J	Santos, I; Ball, K; Crawford, D; Teixeira, PJ				Santos, Ines; Ball, Kylie; Crawford, David; Teixeira, Pedro J.			Motivation and Barriers for Leisure-Time Physical Activity in Socioeconomically Disadvantaged Women	PLOS ONE			English	Article							SINGLE-ITEM MEASURES; WEIGHT-LOSS; SELF-DETERMINATION; EXERCISE; OVERWEIGHT; DETERMINANTS; RESILIENCE; STRATEGIES; BEHAVIOR; OBESITY	Introduction The aim of this study was to examine cross-sectional and longitudinal associations between motivation and barriers for physical activity, and physical activity behavior in women living in socioeconomic disadvantage. This study also examined whether weight control intentions moderate those associations. Methods Data from 1664 women aged 18-46 years was collected at baseline and three-year follow-up as part of the Resilience for Eating and Activity Despite Inequality study. In mail-based surveys, women reported sociodemographic and neighborhood environmental characteristics, intrinsic motivation, goals and perceived family barriers to be active, weight control intentions and leisure-time physical activity (assessed through the IPAQ-L). Linear regression models assessed the association of intrinsic motivation, goals and barriers with physical activity at baseline and follow-up, adjusting for environmental characteristics and also physical activity at baseline (for longitudinal analyses), and the moderating effects of weight control intentions were examined. Results Intrinsic motivation and, to a lesser extent, appearance and relaxation goals for being physically active were consistently associated with leisure-time physical activity at baseline and follow-up. Perceived family barriers, health, fitness, weight and stress relief goals were associated with leisure-time physical activity only at baseline. Moderated regression analyses revealed that weight control intentions significantly moderated the association between weight goals and leisure-time physical activity at baseline (beta = 0.538, 99% CI = 0.057, 0.990) and between intrinsic motivation and leisure-time physical activity at follow-up (beta = 0.666, 99% CI = 0.188, 1.145). For women actively trying to control their weight, intrinsic motivation was significantly associated with leisure-time physical activity at follow-up (beta = 0.184, 99% CI = 0.097, 0.313). Conclusions Results suggest that, especially in women trying to control their weight, intrinsic motivation plays an important role in sustaining physical activity participation over time. Also, weight goals for being physically active seem to play a role regarding short-term physical activity participation in this particular population. Addressing these motivational features may be important when promoting physical activity participation in women living in socioeconomically disadvantaged neighborhoods.	[Santos, Ines; Teixeira, Pedro J.] Univ Lisbon, Interdisciplinary Ctr Study Human Performance, Fac Human Kinet, Lisbon, Portugal; [Ball, Kylie; Crawford, David] Deakin Univ, Ctr Phys Activ & Nutr Res, Fac Hlth, Melbourne, Vic, Australia	Universidade de Lisboa; Deakin University	Teixeira, PJ (corresponding author), Univ Lisbon, Interdisciplinary Ctr Study Human Performance, Fac Human Kinet, Lisbon, Portugal.	pteixeira@fmh.ulisboa.pt	Teixeira, Pedro/C-9817-2010; Teixeira, Pedro J./AAA-9438-2021; Ball, Kylie/B-5866-2015; Crawford, David A/K-6301-2015; Santos, Inês/N-1856-2016	Teixeira, Pedro/0000-0001-7202-0527; Teixeira, Pedro J./0000-0001-7202-0527; Ball, Kylie/0000-0003-2893-8415; Crawford, David A/0000-0002-2467-7556; Santos, Inês/0000-0002-1638-8551	Portuguese Science and Technology Foundation [SFRH/BD/80739/2011]; Marie Curie Actions [FP7-PEOPLE-2009-IRSES-247630]; Australian National Health & Medical Research Council Strategic Award [374241]	Portuguese Science and Technology Foundation(Portuguese Foundation for Science and Technology); Marie Curie Actions(European Commission); Australian National Health & Medical Research Council Strategic Award	This study was funded by the Portuguese Science and Technology Foundation (grant number SFRH/BD/80739/2011 attributed to Ines Santos). Analyses for the current paper were part of the MeMo International Exchange programme funded under Marie Curie Actions (FP7-PEOPLE-2009-IRSES-247630). The READI study was funded by an Australian National Health & Medical Research Council Strategic Award [Grant number 374241].	Andreyeva T, 2010, J AM DIET ASSOC, V110, P535, DOI 10.1016/j.jada.2009.12.029; Ball K, 2012, INT J OBESITY, V36, P855, DOI 10.1038/ijo.2011.183; Ball K, 2013, INT J EPIDEMIOL, V42, P1629, DOI 10.1093/ije/dys165; Bauman AE, 2002, AM J PREV MED, V23, P5, DOI 10.1016/S0749-3797(02)00469-5; Bergkvist L, 2007, J MARKETING RES, V44, P175, DOI 10.1509/jmkr.44.2.175; Bergkvist L, 2009, INT J ADVERT, V28, P607, DOI 10.2501/S0265048709200783; Brownson RC, 2001, AM J PUBLIC HEALTH, V91, P1995, DOI 10.2105/AJPH.91.12.1995; Catenacci VA, 2007, NAT CLIN PRACT ENDOC, V3, P518, DOI 10.1038/ncpendmet0554; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Deci EL, 2008, CAN PSYCHOL, V49, P182, DOI 10.1037/a0012801; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Duncan Mitch J, 2005, Int J Behav Nutr Phys Act, V2, P11, DOI 10.1186/1479-5868-2-11; El Ansari W, 2009, INT J ENV RES PUB HE, V6, P1443, DOI 10.3390/ijerph6041443; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gidlow C., 2006, HEALTH EDUC J, V65, P338, DOI DOI 10.1177/0017896906069378; Giles-Corti B, 2002, PREV MED, V35, P601, DOI 10.1006/pmed.2002.1115; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Jackson SE, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003693; Jeffery RW, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-52; Korkeila M, 1999, AM J CLIN NUTR, V70, P965; Linde JA, 2006, HEALTH PSYCHOL, V25, P282, DOI 10.1037/0278-6133.25.3.282; Markland D., 2007, INTRINSIC MOTIVATION, P23, DOI DOI 10.5040/9781718206632.CH-001; MCAULEY E, 1989, RES Q EXERCISE SPORT, V60, P48, DOI 10.1080/02701367.1989.10607413; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; Ryan RM., 1996, P7; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Salmon J, 2000, PREV MED, V30, P191, DOI 10.1006/pmed.1999.0619; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Santos I, 2015, OBESITY, V23, P957, DOI 10.1002/oby.21082; Sebire SJ, 2009, J SPORT EXERCISE PSY, V31, P189, DOI 10.1123/jsep.31.2.189; Segar M, 2006, SEX ROLES, V54, P175, DOI 10.1007/s11199-006-9336-5; Silva M., 2012, ENCY EXERCISE MED HL, P727; Silva MN, 2011, MED SCI SPORT EXER, V43, P728, DOI 10.1249/MSS.0b013e3181f3818f; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; Vansteenkiste M, 2004, J SPORT EXERCISE PSY, V26, P232, DOI 10.1123/jsep.26.2.232; VERHOEF MJ, 1992, WOMEN HEALTH, V19, P15, DOI 10.1300/J013v19n04_02; Yaemsiri S, 2011, INT J OBESITY, V35, P1063, DOI 10.1038/ijo.2010.229	38	14	15	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147735	10.1371/journal.pone.0147735	http://dx.doi.org/10.1371/journal.pone.0147735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808440	Green Published, gold			2022-12-26	WOS:000369527800202
J	Silva, PAGC; Guerreiro, A; Santos, JM; Braks, JAM; Janse, CJ; Mair, GR				Silva, Patricia A. G. C.; Guerreiro, Ana; Santos, Jorge M.; Braks, Joanna A. M.; Janse, Chris J.; Mair, Gunnar R.			Translational Control of UIS4 Protein of the Host-Parasite Interface Is Mediated by the RNA Binding Protein Puf2 in Plasmodium berghei Sporozoites	PLOS ONE			English	Article							HIGH-EFFICIENCY TRANSFECTION; HUNCHBACK MESSENGER-RNA; MALARIA PARASITES; MEMBRANE-PROTEINS; CELL INTERFACE; PUMILIO; NANOS; IDENTIFICATION; INFECTIVITY; EXPRESSION	UIS4 is a key protein component of the host-parasite interface in the liver stage of the rodent malaria parasite Plasmodium berghei and required for parasite survival after invasion. In the infectious sporozoite, UIS4 protein has variably been shown to be translated but also been reported to be translationally repressed. Here we show that uis4 mRNA translation is regulated by the P. berghei RNA binding protein Pumilio-2 (PbPuf2 or Puf2 from here on forward) in infectious salivary gland sporozoites in the mosquito vector. Using RNA immunoprecipitation we show that uis4 mRNA is bound by Puf2 in salivary gland sporozoites. In the absence of Puf2, uis4 mRNA translation is de-regulated and UIS4 protein expression upregulated in salivary gland sporozoites. Here, using RNA immunoprecipitation, we reveal the first Puf2-regulated mRNA in this parasite.	[Silva, Patricia A. G. C.; Guerreiro, Ana; Santos, Jorge M.; Mair, Gunnar R.] Univ Lisbon, Fac Med, Inst Med Mol, Ave Prof Egas Moniz, P-1649028 Lisbon, Portugal; [Braks, Joanna A. M.; Janse, Chris J.] Dept Parasitol, Leiden, Netherlands; [Mair, Gunnar R.] Heidelberg Univ, Sch Med, Dept Infect Dis, Parasitol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany	Instituto Superior de Ciencias da Saude Egas Moniz; Universidade de Lisboa; Ruprecht Karls University Heidelberg	Mair, GR (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Ave Prof Egas Moniz, P-1649028 Lisbon, Portugal.; Mair, GR (corresponding author), Heidelberg Univ, Sch Med, Dept Infect Dis, Parasitol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	gunnarmair@yahoo.com	Santos, Jorge M./AAE-1904-2021	Santos, Jorge M./0000-0002-4940-5207; Janse, Chris J/0000-0002-6410-6205; Mair, Gunnar/0000-0002-5187-3691; Guerreiro, Ana/0000-0002-2173-6514	Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/SAU-MIC/122082/2010, PTDC/BIA-BCM/105610/2008, SFRH/BPD/72619/2010]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) grants PTDC/SAU-MIC/122082/2010 and PTDC/BIA-BCM/105610/2008 to GRM, and SFRH/BPD/72619/2010 to PAGCS.	Aly ASI, 2008, MOL MICROBIOL, V69, P152, DOI 10.1111/j.1365-2958.2008.06271.x; Aly ASI, 2011, MOL MICROBIOL, V79, P929, DOI 10.1111/j.1365-2958.2010.07497.x; Andreadaki M, 2014, CELL MICROBIOL, V16, P751, DOI 10.1111/cmi.12274; Annoura T, 2014, FASEB J, V28, P2158, DOI 10.1096/fj.13-241570; BARKER DD, 1992, GENE DEV, V6, P2312, DOI 10.1101/gad.6.12a.2312; Braks JAM, 2008, NUCLEIC ACIDS RES, V36, P1176, DOI 10.1093/nar/gkm1142; Douglas RG, 2015, TRENDS PARASITOL, V31, P357, DOI 10.1016/j.pt.2015.04.010; Friend K, 2012, NAT STRUCT MOL BIOL, V19, P176, DOI 10.1038/nsmb.2214; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; Ginter-Matuszewska B, 2011, HISTOCHEM CELL BIOL, V136, P279, DOI 10.1007/s00418-011-0842-y; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Gomes-Santos CSS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002046; Guerreiro A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0493-0; Hanson KK, 2013, P NATL ACAD SCI USA, V110, pE2838, DOI 10.1073/pnas.1306097110; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Kaiser K, 2004, MOL MICROBIOL, V51, P1221, DOI 10.1046/j.1365-2958.2003.03909.x; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; Lindner SE, 2013, CELL MICROBIOL, V15, P1266, DOI 10.1111/cmi.12116; Lindner SE, 2013, MOL CELL PROTEOMICS, V12, P1127, DOI 10.1074/mcp.M112.024505; Luitjens C, 2000, GENE DEV, V14, P2596, DOI 10.1101/gad.831700; MacKellar DC, 2010, EUKARYOT CELL, V9, P784, DOI 10.1128/EC.00336-09; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; Miao J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003268; Morris AR, 2008, MOL CELL BIOL, V28, P4093, DOI 10.1128/MCB.00155-08; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Muller K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019860; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; Santos JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16034; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Silvie O, 2014, MOL MICROBIOL, V91, P1200, DOI 10.1111/mmi.12528; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Spielmann T, 2006, MOL MICROBIOL, V59, P779, DOI 10.1111/j.1365-2958.2005.04983.x; Spielmann T, 2003, MOL BIOL CELL, V14, P1529, DOI 10.1091/mbc.E02-04-0240; van Schaijk BCL, 2014, ELIFE, V3, DOI 10.7554/eLife.03582; Vera IM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002197; Wharton Robin P, 2006, Sci STKE, V2006, ppe37, DOI 10.1126/stke.3542006pe37; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Zhang M, 2010, J EXP MED, V207, P1, DOI 10.1084/jem.20091975	46	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147940	10.1371/journal.pone.0147940	http://dx.doi.org/10.1371/journal.pone.0147940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808677	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800248
J	Slivicki, RA; Ali, YO; Lu, HC; Hohmann, AG				Slivicki, Richard A.; Ali, Yousuf O.; Lu, Hui-Chen; Hohmann, Andrea G.			Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo	PLOS ONE			English	Article							AXONAL DEGENERATION; VINCRISTINE; EXPRESSION; CAPSAICIN; MODEL; PAIN; RAT; MAINTENANCE; ACTIVATION; NEURONS	Nicotinamide mononucleotide adenylyl transferases (NMNATs) are essential neuronal maintenance factors postulated to preserve neuronal function and protect against axonal degeneration in various neurodegenerative disease states. We used in vitro and in vivo approaches to assess the impact of NMNAT2 reduction on cellular and physiological functions induced by treatment with a vinca alkaloid (vincristine) and a taxane-based (paclitaxel) chemotherapeutic agent. NMNAT2 null (NMNAT2-/-) mutant mice die at birth and cannot be used to probe functions of NMNAT2 in adult animals. Nonetheless, primary cortical cultures derived from NMNAT2-/- embryos showed reduced cell viability in response to either vincristine or paclitaxel treatment whereas those derived from NMNAT2 heterozygous (NMNAT2+/-) mice were preferentially sensitive to vincristine-induced degeneration. Adult NMNAT2+/- mice, which survive to adulthood, exhibited a 50% reduction of NMNAT2 protein levels in dorsal root ganglia relative to wildtype (WT) mice with no change in levels of other NMNAT isoforms (NMNAT1 or NMNAT3), NMNAT enzyme activity (i.e. NAD/NADH levels) or microtubule associated protein-2 (MAP2) or neurofilament protein levels. We therefore compared the impact of NMNAT2 knockdown on the development and maintenance of chemotherapy-induced peripheral neuropathy induced by vincristine and paclitaxel treatment using NMNAT2+/- and WT mice. NMNAT2+/- did not differ from WT mice in either the development or maintenance of either mechanical or cold allodynia induced by either vincristine or paclitaxel treatment. Intradermal injection of capsaicin, the pungent ingredient in hot chili peppers, produced equivalent hypersensitivity in NMNAT2+/- and WT mice receiving vehicle in lieu of paclitaxel. Capsaicin-evoked hypersensitivity was enhanced by prior paclitaxel treatment but did not differ in either NMNAT2+/- or WT mice. Thus, capsaicin failed to unmask differences in nociceptive behaviors in either paclitaxel-treated or paclitaxel-untreated NMNAT2+/- and WT mice. Moreover, no differences in motor behavior were detected between genotypes in the rotarod test. Our studies do not preclude the possibility that complete knockout of NMNAT2 in a conditional knockout animal could unmask a role for NMNAT2 in protection against detrimental effects of chemotherapeutic treatment.	[Slivicki, Richard A.; Lu, Hui-Chen; Hohmann, Andrea G.] Indiana Univ, Program Neurosci, Bloomington, IN USA; [Slivicki, Richard A.; Ali, Yousuf O.; Lu, Hui-Chen; Hohmann, Andrea G.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Ali, Yousuf O.; Lu, Hui-Chen] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Cain Fdn Labs, Houston, TX 77030 USA; [Ali, Yousuf O.; Lu, Hui-Chen] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Baylor College of Medicine; Baylor College of Medicine	Lu, HC; Hohmann, AG (corresponding author), Indiana Univ, Program Neurosci, Bloomington, IN USA.; Lu, HC; Hohmann, AG (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA.; Lu, HC (corresponding author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Cain Fdn Labs, Houston, TX 77030 USA.; Lu, HC (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	hclu@indiana.edu; hohmanna@indiana.edu			integrative predoctoral training in drug abuse research at Indiana University [T32DA024628]; Belfer Neurodegeneration Consortium; Lilly Presidential Life Science Professorship;  [DA037673]; NATIONAL CANCER INSTITUTE [R01CA200417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA037673, T32DA024628] Funding Source: NIH RePORTER	integrative predoctoral training in drug abuse research at Indiana University; Belfer Neurodegeneration Consortium; Lilly Presidential Life Science Professorship; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	RAS is a Harlan Research Scholar and is supported by T32DA024628 integrative predoctoral training in drug abuse research at Indiana University. HCL and YOA were supported by the Belfer Neurodegeneration Consortium created by the Robert A. and Renee E. Belfer Family Foundation. AGH is supported by a Lilly Presidential Life Science Professorship and DA037673. The authors also want to thank Dr. Paul Overbeek for providing NMNAT2-Blad mice.; RAS is a Harlan Research Scholar and is supported by T32DA024628 integrative predoctoral training in drug abuse research at Indiana University. HCL and YOA were supported by the Belfer Neurodegeneration Consortium created by the Robert A. and Renee E. Belfer Family Foundation. AGH is supported by a Lilly Presidential Life Science Professorship and DA037673. We also want to thank Dr. Paul Overbeek for providing NMNAT2-Blad mice.	Ali YO, 2013, TRENDS NEUROSCI, V36, P632, DOI 10.1016/j.tins.2013.07.002; Avery MA, 2012, CURR BIOL, V22, P596, DOI 10.1016/j.cub.2012.02.043; BELLAMY WT, 1992, DRUGS, V44, P690, DOI 10.2165/00003495-199244050-00002; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bourke JL, 2014, TISSUE ENG PT A, V20, P1089, DOI [10.1089/ten.tea.2013.0295, 10.1089/ten.TEA.2013.0295]; Brunden KR, 2014, BIOORGAN MED CHEM, V22, P5040, DOI 10.1016/j.bmc.2013.12.046; CAROZZI VA, 2014, NEUROSCI LETT; Cashman C. R., 2015, NEUROSCI LETT; Chiang H, 2015, ACTA NEUROPATHOL, V129, P81, DOI 10.1007/s00401-014-1354-3; Conforti L, 2007, CELL DEATH DIFFER, V14, P116, DOI 10.1038/sj.cdd.4401944; Crowe MS Leishman E Banks ML Gujjar R Mahadevan A, 2014, BR J PHARM; Deng LT, 2015, BIOL PSYCHIAT, V77, P475, DOI 10.1016/j.biopsych.2014.04.009; Deng LT, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-71; Fang YS, 2012, CURR BIOL, V22, P590, DOI 10.1016/j.cub.2012.01.065; Gilchrist HD, 1996, PAIN, V67, P179, DOI 10.1016/0304-3959(96)03104-1; Gilley J, 2013, J NEUROSCI, V33, P13410, DOI 10.1523/JNEUROSCI.1534-13.2013; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Hicks AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047869; Horste GMZ, 2011, NEUROBIOL DIS, V42, P1, DOI 10.1016/j.nbd.2010.12.006; Ljungberg MC, 2012, HUM MOL GENET, V21, P251, DOI 10.1093/hmg/ddr492; Mayer PR, 2010, J BIOL CHEM, V285, P40387, DOI 10.1074/jbc.M110.178913; Milde Stefan, 2013, Bioarchitecture, V3, P133, DOI 10.4161/bioa.27049; Moulin DE, 2014, PAIN RES MANAG, V19, P328; Rahn EJ, 2007, BRIT J PHARMACOL, V152, P765, DOI 10.1038/sj.bjp.0707333; Rahn EJ, 2011, PHARMACOL BIOCHEM BE, V98, P493, DOI 10.1016/j.pbb.2011.02.024; SAHENK Z, 1994, ARCH NEUROL-CHICAGO, V51, P726, DOI 10.1001/archneur.1994.00540190110024; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Scuteri A, 2006, ANTICANCER RES, V26, P1065; Spradley JM, 2010, PHARMACOL RES, V62, P249, DOI 10.1016/j.phrs.2010.03.007; Tanner KD, 1998, J COMP NEUROL, V395, P481; Topp KS, 2000, J COMP NEUROL, V424, P563; Watanabe M, 2007, NEUROSCI LETT, V411, P228, DOI 10.1016/j.neulet.2006.09.068; Xiao WH, 2008, PAIN, V135, P262, DOI 10.1016/j.pain.2007.06.001; Yan TT, 2010, NEUROCHEM INT, V56, P101, DOI 10.1016/j.neuint.2009.09.007; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	35	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147620	10.1371/journal.pone.0147620	http://dx.doi.org/10.1371/journal.pone.0147620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808812	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800151
J	Woo, HW; Choi, BY; Kim, MK				Woo, Hye Won; Choi, Bo Youl; Kim, Mi Kyung			Cross-Sectional and Longitudinal Associations between Egg Consumption and Metabolic Syndrome in Adults >= 40 Years Old: The Yangpyeong Cohort of the Korean Genome and Epidemiology Study (KoGES_Yangpyeong)	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PLASMA HDL CHOLESTEROL; DIETARY-CHOLESTEROL; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; WHOLE-EGG; RISK; MORTALITY; MEN; LIPOPROTEINS	Since the 1970s, the public has been advised to limit egg consumption even though there is little evidence of any harmful effect of eggs on blood cholesterol. The purpose of this cross-sectional and prospective study was to evaluate the potential association between egg consumption and metabolic syndrome (MetS) and MetS components in adults >= 40 years in KoGES_Yangpyeong. Yangpyeong is a rural area in South Korea. A total of 2,887 subjects (men 1,115, women 1,772) were recruited from 2005 to 2009, based on a physical examination and questionnaires administered using standardized protocol. After excluding subjects who had MetS at baseline, 1,663 subjects (675 men, 958 women) were followed for 3.20 years (range: 0.34-8.70). During the follow-up period, MetS occurred in 289 subjects. More than 3 eggs per week was significantly associated with decreased risk of MetS in both men (RR = 0.46, 95% CI, 0.26-0.82, P for trend = 0.1093) and women (RR = 0.54, 95% CI, 0.31-0.93, P for trend 0.0325) compared to non-users. There was a cross-sectional inverse relationship between egg consumption and abdominal obesity in men and women. Also, prospectively, higher egg consumption in men was associated with a decreased risk of high fasting blood glucose (RR = 0.39, 95% CI, 0.22-0.67, P for trend = 0.0042) and high triglycerides (RR = 0.42, 95% CI, 0.22-0.80, P for trend = 0.1080). In conclusion, our findings suggest that higher egg consumption may reduce the risk of MetS both in men and women, and the risk of high fasting blood glucose and high triglycerides in men. Current guidelines regarding egg consumption may need to be re-visited for healthy middle-aged and elderly people.	[Woo, Hye Won; Choi, Bo Youl; Kim, Mi Kyung] Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea; [Woo, Hye Won; Choi, Bo Youl; Kim, Mi Kyung] Hanyang Univ, Inst Hlth & Soc, Seoul 133791, South Korea	Hanyang University; Hanyang University	Kim, MK (corresponding author), Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea.; Kim, MK (corresponding author), Hanyang Univ, Inst Hlth & Soc, Seoul 133791, South Korea.	kmkkim@hanyang.ac.kr		Woo, Hye Won/0000-0001-6072-6119	Research Program - Korea Centers for Disease Control and Prevention [2004-E71004-00, 2005-E71011-00, 2006-E71009-00, 2007-E71002-00, 2008-E71004-00, 2009-E71006-00, 2010-E71003-00, 2011-E71002-00, 2012-E71007-00, 2013-E71008-00]	Research Program - Korea Centers for Disease Control and Prevention	This work was supported by the Research Program funded by the Korea Centers for Disease Control and Prevention (2004-E71004-00, 2005-E71011-00, 2006-E71009-00, 2007-E71002-00, 2008-E71004-00, 2009-E71006-00, 2010-E71003-00, 2011-E71002-00, 2012-E71007-00, 2013-E71008-00). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Barbosa-Leiker C, 2011, ANN EPIDEMIOL, V21, P111, DOI 10.1016/j.annepidem.2010.10.001; Blesso CN, 2013, J CLIN LIPIDOL, V7, P463, DOI 10.1016/j.jacl.2013.03.008; Blesso CN, 2013, METABOLISM, V62, P400, DOI 10.1016/j.metabol.2012.08.014; Blesso CN, 2013, FOOD FUNCT, V4, P213, DOI 10.1039/c2fo30154g; Borggreve SE, 2003, EUR J CLIN INVEST, V33, P1051, DOI 10.1111/j.1365-2362.2003.01263.x; British Heart Foundation, 2007, PREV HEART DIS CHOL; Callas PW, 1998, AM J IND MED, V33, P33; Chung HY, 2004, J NUTR, V134, P1887, DOI 10.1093/jn/134.8.1887; Djousse L, 2009, DIABETES CARE, V32, P295, DOI 10.2337/dc08-1271; Djousse L, 2008, AM J CLIN NUTR, V87, P964, DOI 10.1093/ajcn/87.4.964; Djousse L, 2010, AM J CLIN NUTR, V92, P422, DOI 10.3945/ajcn.2010.29406; Food and Agriculture Organization of the United Nations, 2009, STAT FOOD AGR; GUTHRIE HA, 1981, J AM DIET ASSOC, V78, P240; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1999, JAMA-J AM MED ASSOC, V281, P1387, DOI 10.1001/jama.281.15.1387; Kant AK, 2000, JAMA-J AM MED ASSOC, V283, P2109, DOI 10.1001/jama.283.16.2109; Kathiresan S, 2006, CIRCULATION, V113, P20, DOI 10.1161/CIRCULATIONAHA.105.567107; Korea Centers for Disease Control and Prevention & Korea Health Industry Development Institute, 2007, IN DEPTH AN 3 KOR HL; Krauss RM, 2000, CIRCULATION, V102, P2284; Kurotani K, 2014, BRIT J NUTR, V112, P1636, DOI 10.1017/S000711451400258X; Lee SY, 2007, DIABETES RES CLIN PR, V75, P72, DOI 10.1016/j.diabres.2006.04.013; Lichtenstein AH, 2000, ATHEROSCLEROSIS, V150, P227, DOI 10.1016/S0021-9150(99)00504-3; MacMahon B, 1970, EPIDEMIOLOGY PRINCIP; McNamara DJ, 2000, J AM COLL NUTR, V19, p540S, DOI 10.1080/07315724.2000.10718978; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Mutungi G, 2008, J NUTR, V138, P272, DOI 10.1093/jn/138.2.272; Nakamura Y, 2006, BRIT J NUTR, V96, P921, DOI 10.1017/BJN20061937; National Rural Living Science Institute, 2006, 7 REV FOOD COMP TABL; OH SY, 1991, AM J CLIN NUTR, V54, P689, DOI 10.1093/ajcn/54.4.689; Pearce KL, 2011, BRIT J NUTR, V105, P584, DOI 10.1017/S0007114510003983; Pelletier X, 1996, ANN NUTR METAB, V40, P109, DOI 10.1159/000177903; Rong Y, 2013, BMJ-BRIT MED J, P346; Scrafford CG, 2011, PUBLIC HEALTH NUTR, V14, P261, DOI 10.1017/S1368980010001874; Song WO, 2000, J AM COLL NUTR, V19, p556S, DOI 10.1080/07315724.2000.10718980; STAMLER J, 1988, ARCH PATHOL LAB MED, V112, P1032; The Korean Nutrition Society, 2009, FOOD VAL; Virtanen JK, 2015, AM J CLIN NUTR, V101, P1088, DOI 10.3945/ajcn.114.104109; WHO J Consultation FE, 2003, WHO TECH REP SER, P916; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	43	23	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147729	10.1371/journal.pone.0147729	http://dx.doi.org/10.1371/journal.pone.0147729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808174	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800200
J	Zhang, XR; Dong, JN; Liu, HL; Wang, J; Qi, YX; Liang, ZS				Zhang, Xiaoru; Dong, Juane; Liu, Hailong; Wang, Jiao; Qi, Yuexin; Liang, Zongsuo			Transcriptome Sequencing in Response to Salicylic Acid in Salvia miltiorrhiza	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; PLANT DEFENSE RESPONSE; GOSSYPIUM-HIRSUTUM L.; RNA-SEQ DATA; ARABIDOPSIS-THALIANA; DISEASE RESISTANCE; OXIDATIVE STRESS; FUNCTIONAL-ANALYSIS; NEGATIVE REGULATION; SIGNALING PATHWAYS	Salvia miltiorrhiza is a traditional Chinese herbal medicine, whose quality and yield are often affected by diseases and environmental stresses during its growing season. Salicylic acid (SA) plays a significant role in plants responding to biotic and abiotic stresses, but the involved regulatory factors and their signaling mechanisms are largely unknown. In order to identify the genes involved in SA signaling, the RNA sequencing (RNA-seq) strategy was employed to evaluate the transcriptional profiles in S. miltiorrhiza cell cultures. A total of 50,778 unigenes were assembled, in which 5,316 unigenes were differentially expressed among 0-, 2-, and 8-h SA induction. The up-regulated genes were mainly involved in stimulus response and multi-organism process. A core set of candidate novel genes coding SA signaling component proteins was identified. Many transcription factors (e.g., WRKY, bHLH and GRAS) and genes involved in hormone signal transduction were differentially expressed in response to SA induction. Detailed analysis revealed that genes associated with defense signaling, such as antioxidant system genes, cytochrome P450s and ATP-binding cassette transporters, were significantly overexpressed, which can be used as genetic tools to investigate disease resistance. Our transcriptome analysis will help understand SA signaling and its mechanism of defense systems in S. miltiorrhiza.	[Zhang, Xiaoru; Dong, Juane; Liu, Hailong; Wang, Jiao; Qi, Yuexin] Northwest Agr & Forestry Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Liang, Zongsuo] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Northwest A&F University - China; Zhejiang Sci-Tech University	Dong, JN (corresponding author), Northwest Agr & Forestry Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.; Liang, ZS (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	dzsys@nwsuaf.edu.cn; liangzs@iswc.ms.ac.cn			National Natural Science Foundation of China [31170274]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (grant No. 31170274, URL.www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2005, FEBS LETT, V579, P2307, DOI 10.1016/j.febslet.2005.03.025; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2012, NEURAL METABOLISM IN; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Balazadeh S, 2008, PLANT BIOLOGY, V10, P63, DOI 10.1111/j.1438-8677.2008.00088.x; Baron KN, 2012, PLANT SCI, V188, P48, DOI 10.1016/j.plantsci.2012.03.001; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berrocal-Lobo M, 2004, MOL PLANT MICROBE IN, V17, P763, DOI 10.1094/MPMI.2004.17.7.763; Bolwell GP, 1999, FREE RADICAL RES, V31, pS137; Brunetti P, 2015, J EXP BOT, V66, P3815, DOI 10.1093/jxb/erv185; Carr JP, 2010, ADV VIRUS RES, V76, P57, DOI 10.1016/S0065-3527(10)76003-6; Chaturvedi R, 2008, PLANT J, V54, P106, DOI 10.1111/j.1365-313X.2007.03400.x; Chen CH, 2002, PLANT PHYSIOL, V129, P706, DOI 10.1104/pp.001057; Chen S, 2011, PLANT CELL REP, V30, P1593, DOI 10.1007/s00299-011-1070-6; Chen YN, 2008, CURR OPIN PLANT BIOL, V11, P695, DOI 10.1016/j.pbi.2008.10.005; COMMANDEUR JNM, 1995, PHARMACOL REV, V47, P271; Cote CL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-273; Daviere JM, 2013, DEVELOPMENT, V140, P1147, DOI 10.1242/dev.087650; Despres C, 2000, PLANT CELL, V12, P279, DOI 10.1105/tpc.12.2.279; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Dong CJ, 2014, PLANTA, V240, P687, DOI 10.1007/s00425-014-2115-1; Dong JA, 2010, J BIOTECHNOL, V148, P99, DOI 10.1016/j.jbiotec.2010.05.009; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Dubreuil-Maurizi C, 2011, PLANT PHYSIOL, V157, P2000, DOI 10.1104/pp.111.182667; Encinas-Villarejo S, 2009, J EXP BOT, V60, P3043, DOI 10.1093/jxb/erp152; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Frye CA, 2001, P NATL ACAD SCI USA, V98, P373, DOI 10.1073/pnas.011405198; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Gao CY, 2015, INT J MOL SCI, V16, P2052, DOI 10.3390/ijms16012052; Gao QM, 2011, PLANT PHYSIOL, V155, P464, DOI 10.1104/pp.110.166876; Gleason JE, 2014, J BIOL INORG CHEM, V19, P595, DOI 10.1007/s00775-013-1045-x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Han Y, 2013, ANTIOXID REDOX SIGN, V18, P2106, DOI 10.1089/ars.2012.5052; Harris JC, 2011, NEW PHYTOL, V190, P823, DOI 10.1111/j.1469-8137.2011.03733.x; Hayat S, 2014, Z NATURFORSCH C, V69, P452, DOI [10.5560/znc.2014-0036, 10.5560/ZNC.2014-0036]; Herrera-Vasquez A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00171; Hua WP, 2011, GENOMICS, V98, P272, DOI 10.1016/j.ygeno.2011.03.012; Irmisch S, 2014, PLANT J, V80, P1095, DOI 10.1111/tpj.12711; Jaubert M, 2011, PLANT PHYSIOL, V156, P1556, DOI 10.1104/pp.111.178012; Ji LH, 2001, MOL PLANT MICROBE IN, V14, P715, DOI 10.1094/MPMI.2001.14.6.715; Journot-Catalino N, 2006, PLANT CELL, V18, P3289, DOI 10.1105/tpc.106.044149; Kang DG, 2003, PHYTOTHER RES, V17, P917, DOI 10.1002/ptr.1250; KATAGIRI F, 1989, NATURE, V340, P727, DOI 10.1038/340727a0; Kesarwani M, 2007, PLANT PHYSIOL, V144, P336, DOI 10.1104/pp.106.095299; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Kumar D, 2003, P NATL ACAD SCI USA, V100, P16101, DOI 10.1073/pnas.0307162100; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leon-Reyes A, 2010, PLANTA, V232, P1423, DOI 10.1007/s00425-010-1265-z; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Li JZ, 2015, J EXP BOT, V66, P2723, DOI 10.1093/jxb/erv076; Li TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109492; Li XM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1046; Li YG, 2009, J CHROMATOGR A, V1216, P1941, DOI 10.1016/j.chroma.2008.12.032; Liu CT, 2014, PLANT MOL BIOL, V84, P19, DOI 10.1007/s11103-013-0115-3; Liu GS, 2005, PLANT J, V41, P304, DOI 10.1111/j.1365-313X.2004.02296.x; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llorca CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00169; Luo HM, 2014, PHYSIOL PLANTARUM, V152, P241, DOI 10.1111/ppl.12193; Ma HS, 2010, J EXP BOT, V61, P4011, DOI 10.1093/jxb/erq217; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Manosalva PM, 2010, MOL PLANT MICROBE IN, V23, P1151, DOI 10.1094/MPMI-23-9-1151; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Mateo A, 2006, J EXP BOT, V57, P1795, DOI 10.1093/jxb/erj196; Melvin P, 2015, PLANT MOL BIOL, V87, P287, DOI 10.1007/s11103-014-0276-8; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; Mitsuhara I, 2008, MOL GENET GENOMICS, V279, P415, DOI 10.1007/s00438-008-0322-9; Mutlu S, 2009, BIOL PLANTARUM, V53, P334, DOI 10.1007/s10535-009-0061-8; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Nazar R, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2014.1003751; Ndamukong I, 2007, PLANT J, V50, P128, DOI 10.1111/j.1365-313X.2007.03039.x; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Qi X, 2006, P NATL ACAD SCI USA, V103, P18848, DOI 10.1073/pnas.0607849103; Quan LJ, 2008, J INTEGR PLANT BIOL, V50, P2, DOI 10.1111/j.1744-7909.2007.00599.x; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Rao MV, 1997, PLANT PHYSIOL, V115, P137, DOI 10.1104/pp.115.1.137; RASKIN I, 1992, PLANT PHYSIOL, V99, P799, DOI 10.1104/pp.99.3.799; Remy E, 2013, PLANT CELL, V25, P901, DOI 10.1105/tpc.113.110353; Schulze SK, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-524; Shah J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00030; Shi GY, 2015, PLANT CELL REP, V34, P1005, DOI 10.1007/s00299-015-1761-5; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Sun LJ, 2015, INT J MOL SCI, V16, P4306, DOI 10.3390/ijms16024306; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI [10.1016/S0005-2736(00)00132-2, 10.1199/tab.0153]; Thurow C, 2005, PLANT J, V44, P100, DOI 10.1111/j.1365-313X.2005.02513.x; To JPC, 2007, PLANT CELL, V19, P3901, DOI 10.1105/tpc.107.052662; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van Huylenbroeck JM, 2000, PLANT SCI, V155, P59, DOI 10.1016/S0168-9452(00)00201-6; Canet JV, 2010, PLANT CELL ENVIRON, V33, P1911, DOI 10.1111/j.1365-3040.2010.02194.x; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Wang MM, 2007, J BIOCHEM MOL BIOL, V40, P325; Wang XD, 2013, FUNCT INTEGR GENOMIC, V13, P155, DOI 10.1007/s10142-013-0309-4; Wong CE, 2002, MOL PLANT MICROBE IN, V15, P75, DOI 10.1094/MPMI.2002.15.1.75; Wu KL, 2005, DNA RES, V12, P9, DOI 10.1093/dnares/12.1.9; Xia XJ, 2015, J EXP BOT, V66, P2839, DOI 10.1093/jxb/erv089; Xing Y, 2015, J EXP BOT; Yang Huimin, 2006, J Tradit Chin Med, V26, P120; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080464; Yang YX, 2015, CURR PROTEIN PEPT SC, V16, P450, DOI 10.2174/1389203716666150330141638; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206; Zabala MD, 2009, PLANT J, V59, P375, DOI 10.1111/j.1365-313X.2009.03875.x; Zhang L, 2012, J EXP BOT, V63, P3935, DOI 10.1093/jxb/ers086; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894; Zhang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003244; Zhang YL, 2006, PLANT J, V48, P647, DOI 10.1111/j.1365-313X.2006.02903.x; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zhu SY, 2014, GENE, V552, P67, DOI 10.1016/j.gene.2014.09.014; Zwicker S, 2007, MOL PLANT PATHOL, V8, P385, DOI [10.1111/j.1364-3703.2007.00399.x, 10.1111/J.1364-3703.2007.00399.X]	114	28	29	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147849	10.1371/journal.pone.0147849	http://dx.doi.org/10.1371/journal.pone.0147849			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808150	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800229
J	Kiessling, MK; Curioni-Fontecedro, A; Samaras, P; Lang, S; Scharl, M; Aguzzi, A; Oldrige, DA; Maris, JM; Rogler, G				Kiessling, Michael K.; Curioni-Fontecedro, Alessandra; Samaras, Panagiotis; Lang, Silvia; Scharl, Michael; Aguzzi, Adriano; Oldrige, Derek A.; Maris, John M.; Rogler, Gerhard			Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma	PLOS ONE			English	Article							HARBORING NRAS; IN-VITRO; MUTATIONS; MELANOMA; PATHWAY; BRAF; ARRY-142886; COMBINATION; INHIBITOR; LANDSCAPE	High-risk neuroblastoma remains lethal in about 50% of patients despite multimodal treatment. Recent attempts to identify molecular targets for specific therapies have shown that Neuroblastoma RAS (NRAS) is significantly mutated in a small number of patients. However, few inhibitors for the potential treatment for NRAS mutant neuroblastoma have been investigated so far. In this in-vitro study, we show that MEK inhibitors AZD6244, MEK162 and PD0325901 block cell growth in NRAS mutant neuroblastoma cell lines but not in NRAS wild-type cell lines. Several studies show that mutant NRAS leads to PI3K pathway activation and combined inhibitors of PI3K/mTOR effectively block cell growth. However, we observed the combination of MEK inhibitors with PI3K or AKT inhibitors did not show synergestic effects on cell growth. Thus, we tested single mTOR inhibitors Everolimus and AZD8055. Interestingly, Everolimus and AZD8055 alone were sufficient to block cell growth in NRAS mutant cell lines but not in wild-type cell lines. We found that Everolimus alone induced apoptosis in NRAS mutant neuroblastoma. Furthermore, the combination of mTOR and MEK inhibitors resulted in synergistic growth inhibition. Taken together, our results show that NRAS mutant neuroblastoma can be targeted by clinically available Everolimus alone or in combination with MEK inhibitors which could impact future clinical studies.	[Kiessling, Michael K.; Lang, Silvia; Scharl, Michael; Rogler, Gerhard] Univ Zurich Hosp, Dept Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Kiessling, Michael K.; Curioni-Fontecedro, Alessandra; Samaras, Panagiotis] Univ Zurich Hosp, Dept Oncol, CH-8091 Zurich, Switzerland; [Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Oldrige, Derek A.; Maris, John M.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Kiessling, MK (corresponding author), Univ Zurich Hosp, Dept Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.; Kiessling, MK (corresponding author), Univ Zurich Hosp, Dept Oncol, CH-8091 Zurich, Switzerland.	Michael.kiessling@usz.ch	Rogler, Gerhard/O-5308-2015; Curioni-Fontecedro, Alessandra/R-4950-2018	Rogler, Gerhard/0000-0002-1733-9188; Aguzzi, Adriano/0000-0002-0344-6708; Curioni-Fontecedro, Alessandra/0000-0002-5778-5270; Scharl, Michael/0000-0002-6729-1469	Forschungskredit Zurich University; Stiftung zur Krebsbekaempfung; US National Institutes of Health [RC1MD004418, CA98543, CA98413]; NATIONAL CANCER INSTITUTE [U10CA098543, U10CA098413] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [RC1MD004418] Funding Source: NIH RePORTER	Forschungskredit Zurich University; Stiftung zur Krebsbekaempfung; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	M.K.K. was supported by Forschungskredit Zurich University and Stiftung zur Krebsbekaempfung. D.O. and J.M.M. were supported in part by US National Institutes of Health grants RC1MD004418 to the TARGET consortium, and CA98543 and CA98413 to the Children's Oncology Group for patient sample acquisition and annotation.	Adjei A, 2015, ASCO ANN M; Ascierto PA, 2013, LANCET ONCOL, V14, P249, DOI 10.1016/S1470-2045(13)70024-X; Catalanotti F, 2013, CLIN CANCER RES, V19, P2257, DOI 10.1158/1078-0432.CCR-12-3476; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; COSMIC G, 2015, CATALOGUE OF SOMATIC; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; DA Eleveld Thomas F. O., 2015, NATURE GENE IN PRESS; Davies Barry R A L, 2007, MOL CANC THER, V6; Finn R. S., 2012, PHASE 1 STUDY MEK IN; Fouladi M, 2007, J CLIN ONCOL, V25, P4806, DOI 10.1200/JCO.2007.11.4017; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Hauschild Axel JJG, 2012, 2012 ASCO ANN M; Heist RS, 2013, J CLIN ONCOL, V31; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Huynh H, 2007, MOL CANCER THER, V6, P138, DOI 10.1158/1535-7163.MCT-06-0436; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Jin HO, 2006, J CELL PHYSIOL, V206, P477, DOI 10.1002/jcp.20488; Kiessling MK, 2011, BLOOD, V117, P2433, DOI 10.1182/blood-2010-09-305128; Lee JH, 2011, BRIT J DERMATOL, V164, P776, DOI 10.1111/j.1365-2133.2010.10185.x; Louis CU, 2015, ANNU REV MED, V66, P49, DOI 10.1146/annurev-med-011514-023121; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Moore NF, 2014, ONCOTARGET, V5, P8737, DOI 10.18632/oncotarget.2372; Ohashi K, 2013, CLIN CANCER RES, V19, P2584, DOI 10.1158/1078-0432.CCR-12-3173; Posch C, 2013, P NATL ACAD SCI USA, V110, P4015, DOI 10.1073/pnas.1216013110; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Tolcher AW, 2015, CLIN CANCER RES, V21, P739, DOI 10.1158/1078-0432.CCR-14-1901; Vujic I, 2014, ONCOTARGET, V5, P7936, DOI 10.18632/oncotarget.2326	32	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147682	10.1371/journal.pone.0147682	http://dx.doi.org/10.1371/journal.pone.0147682			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821351	Green Published, gold			2022-12-26	WOS:000369528400038
J	Uezu, A; Metzger, JP				Uezu, Alexandre; Metzger, Jean Paul			Time-Lag in Responses of Birds to Atlantic Forest Fragmentation: Restoration Opportunity and Urgency	PLOS ONE			English	Article							LANDSCAPE ECOLOGY PERSPECTIVE; EXTINCTION DEBT; BIODIVERSITY CONSERVATION; HABITAT FRAGMENTATION; SPECIES RICHNESS; UNDERSTORY BIRDS; CONNECTIVITY; COVER; THRESHOLDS; HISTORY	There are few opportunities to evaluate the relative importance of landscape structure and dynamics upon biodiversity, especially in highly fragmented tropical landscapes. Conservation strategies and species risk evaluations often rely exclusively on current aspects of landscape structure, although such limited assumptions are known to be misleading when time-lag responses occur. By relating bird functional-group richness to forest patch size and isolation in ten-year intervals (1956, 1965, 1978, 1984, 1993 and 2003), we revealed that birds with different sensitivity to fragmentation display contrasting responses to landscape dynamics in the Brazilian Atlantic Forest. For non-sensitive groups, there was no time-lag in response: the recent degree of isolation best explains their variation in richness, which likely relates to these species' flexibility to adapt to changes in landscape structure. However, for sensitive bird groups, the 1978 patch area was the best explanatory variable, providing evidence for a 25-year time-lag in response to habitat reduction. Time-lag was more likely in landscapes that encompass large patches, which can support temporarily the presence of some sensitive species, even when habitat cover is relatively low. These landscapes potentially support the most threatened populations and should be priorities for restoration efforts to avoid further species loss. Although time-lags provide an opportunity to counteract the negative consequences of fragmentation, it also reinforces the urgency of restoration actions. Fragmented landscapes will be depleted of biodiversity if landscape structure is only maintained, and not improved. The urgency of restoration action may be even higher in landscapes where habitat loss and fragmentation history is older and where no large fragment remained to act temporarily as a refuge.	[Uezu, Alexandre] Inst Pesquisas Ecol, Nazare Paulista, SP, Brazil; [Metzger, Jean Paul] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, SP, Brazil	Instituto de Pesquisas Ecologicas; Universidade de Sao Paulo	Uezu, A (corresponding author), Inst Pesquisas Ecol, Nazare Paulista, SP, Brazil.	aleuezu@ipe.org.br	Uezu, Alexandre/G-5435-2014; Metzger, Jean Paul/C-2514-2012	Metzger, Jean Paul/0000-0002-0087-5240	FAPESP (The Sao Paulo State Research Foundation) [02/01746-1]; Idea Wild and the Association of Field Ornithologists; Brazilian Science Council (Conselho Nacional de Desenvolvimento Cientifico) [307934/2011-0]	FAPESP (The Sao Paulo State Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Idea Wild and the Association of Field Ornithologists; Brazilian Science Council (Conselho Nacional de Desenvolvimento Cientifico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by FAPESP (The Sao Paulo State Research Foundation, process no. 02/01746-1), Idea Wild and the Association of Field Ornithologists. J.P. Metzger thanks the Brazilian Science Council (Conselho Nacional de Desenvolvimento Cientifico) for his research fellowship (process no. 307934/2011-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleixo Alexandre, 1995, Revista Brasileira de Zoologia, V12, P493, DOI 10.1590/S0101-81751995000300004; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Antunes Alexsander Zamorano, 2005, ARARAJUBA, V13, P47; Awade M, 2008, AUSTRAL ECOL, V33, P863, DOI 10.1111/j.1442-9993.2008.01857.x; Banks-leite AC, 2016, SOURCE, V93, P2560; Blondel J, ALAUDA, V38, P55; Bommarco R, 2014, DIVERS DISTRIB, V20, P591, DOI 10.1111/ddi.12187; Brooks T, 1999, ANIM CONSERV, V2, P211, DOI 10.1111/j.1469-1795.1999.tb00067.x; Brown JH, 2008, ADV SCI, V292, P101; Bulman CR, 2007, ECOL APPL, V17, P1460, DOI 10.1890/06-1032.1; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Christiansen MB, 1997, SPECIES LOSS FOREST, P80; Cousins SAO, 2009, J VEG SCI, V20, P3, DOI 10.1111/j.1654-1103.2009.05647.x; Cowlishaw G, 1999, CONSERV BIOL, V13, P1183, DOI 10.1046/j.1523-1739.1999.98433.x; DAFONSECA GAB, 1985, BIOL CONSERV, V34, P17, DOI 10.1016/0006-3207(85)90055-2; Dean Warren, 1996, FERRO FOGO HIST DEVA, V6; Develey PF, 2001, CONSERV BIOL, V15, P1416, DOI 10.1046/j.1523-1739.2001.00170.x; Dobson AJ, 2008, INTRO GEN LINEAR MOD; Elkie P, 1999, PATCH ANAL USERS MAN; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Ferreira Develey Pedro, 2006, P269; Rigueira DMG, 2013, BIODIVERS CONSERV, V22, P3141, DOI 10.1007/s10531-013-0575-4; Greenberg R, 1989, CAN J ZOOL; Guardiola M, 2013, DIVERS DISTRIB, V19, P825, DOI 10.1111/ddi.12045; Hansbauer MM, 2010, LANDSCAPE ECOL, V25, P407, DOI 10.1007/s10980-009-9418-9; Hanski I, 2002, CONSERV BIOL, V16, P666, DOI 10.1046/j.1523-1739.2002.00342.x; Huxel GR, 1999, RESTOR ECOL, V7, P309, DOI 10.1046/j.1526-100X.1999.72024.x; Hylander K, 2013, TRENDS ECOL EVOL, V28, P341, DOI 10.1016/j.tree.2013.01.010; Joly CA, 2014, NEW PHYTOL, V204, P459, DOI 10.1111/nph.12989; Knick ST, 2000, ECOLOGY, V81, P220, DOI 10.1890/0012-9658(2000)081[0220:GOHPCO]2.0.CO;2; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Leite MD, 2013, NAT CONSERVACAO, V11, P108; Lindborg R, 2004, ECOLOGY, V85, P1840, DOI 10.1890/04-0367; Lira PK, 2012, J APPL ECOL, V49, P1325, DOI 10.1111/j.1365-2664.2012.02214.x; Martensen AC, 2008, BIOL CONSERV, V141, P2184, DOI 10.1016/j.biocon.2008.06.008; Martensen AC, 2012, CONSERV BIOL, V26, P1100, DOI 10.1111/j.1523-1739.2012.01940.x; Menendez R, 2006, P ROY SOC B-BIOL SCI, V273, P1465, DOI 10.1098/rspb.2006.3484; Metzger JP, 2013, NAT CONSERVACAO, V11, P103, DOI 10.4322/natcon.2013.018; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagelkerke K, 2002, APPLYING LANDSCAPE ECOLOGY IN BIOLOGICAL CONSERVATION, P330; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Parker Theodore A. Iii, 1996, P113; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Rappaport DI, 2015, J APPL ECOL, V52, P590, DOI 10.1111/1365-2664.12405; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ribon R, 2003, CONSERV BIOL, V17, P1827, DOI 10.1111/j.1523-1739.2003.00377.x; Ridgely RS, 2003, DIGITAL DISTRIBUTION, P0; Sekercioglu CH, 2002, P NATL ACAD SCI USA, V99, P263, DOI 10.1073/pnas.012616199; Stouffer PC, 2009, 20 YEARS UNDERSTOREY, P88; Tabanez AAJ, 2000, BIOTROPICA, V32, P925; Tabarelli M, 2010, BIOL CONSERV, V143, P2328, DOI 10.1016/j.biocon.2010.02.005; Tambosi LR, 2014, RESTOR ECOL, V22, P169, DOI 10.1111/rec.12049; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Uezu A, 2005, BIOL CONSERV; Uezu A, 2011, BIODIVERS CONSERV, V20, P3627, DOI 10.1007/s10531-011-0154-5; WILLIS E O, 1979, Papeis Avulsos de Zoologia (Sao Paulo), V33, P1	59	26	28	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147909	10.1371/journal.pone.0147909	http://dx.doi.org/10.1371/journal.pone.0147909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820548	gold, Green Submitted, Green Published			2022-12-26	WOS:000369528400053
J	Gubrij, IB; Pangle, AK; Pang, L; Johnson, LG				Gubrij, Igor B.; Pangle, Amanda K.; Pang, Li; Johnson, Larry G.			Reversal of MicroRNA Dysregulation in an Animal Model of Pulmonary Hypertension	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ARTERIAL-HYPERTENSION; MOLECULAR PATHOGENESIS; CHRONIC HYPOXIA; DISEASE; PROLIFERATION; MONOCROTALINE; GENE; SURVIVAL; INHIBITION	Background Animals models have played an important role in enhancing our understanding of the pathogenesis of pulmonary arterial hypertension (PAH). Dysregulation of the profile of microRNAs (miRNAs) has been demonstrated in human tissues from PAH patients and in animal models. In this study, we measured miRNA levels in the monocrotaline (MCT) rat model of PAH and examined whether blocking a specific dysregulated miRNA not previously reported in this model, attenuated PAH. We also evaluated changes in miRNA expression in lung specimens from MCT PAH rats overexpressing human prostacyclin synthase, which has been shown to attenuate MCT PAH. Methods Expression levels of a panel of miRNAs were measured in MCT-PAH rats as compared to naive (saline) control rats. Subsequently, MCT PAH rats were injected with a specific inhibitor (antagomiR) for miR-223 (A223) or a nonspecific control oligonucleotide (A-control) 4 days after MCT administration, then weekly. Three weeks later, RV systolic pressure and RV mass were measured. Total RNA, isolated from the lungs, microdissected pulmonary arteries, and right ventricle, was reverse transcribed and real-time quantitative PCR was performed. MiRNA levels were also measured in RNA isolated from paraffin sections of MCT-PAH rats overexpressing prostacyclin synthase. Results MiRs 17, 21, and 223 were consistently upregulated, whereas miRs 126, 145, 150, 204, 424, and 503 were downregulated in MCT PAH as compared to vehicle control. A223 significantly reduced levels of miR-223 in PA and lungs of MCT PAH rats as compared to levels measured in A-control or control MCT PAH rats, but A223 did not attenuate MCT PAH. Right ventricular mass and right ventricular systolic pressure in rats treated with A223 were not different from values in A-control or MCT PAH rats. In contrast, analysis of total RNA from lung specimens of MCT PAH rats overexpressing human prostacyclin synthase (hPGIS) demonstrated reversal of MCT-induced upregulation of miRs 17, 21, and 223 and an increase in levels of miR-424 and miR-503. Reduction in bone morphogenetic receptor 2 (BMPR2) messenger (m) RNA expression was not altered by A223, whereas human prostacyclin synthase overexpression restored BMPR2 mRNA to levels in MCT PAH to levels measured in naive controls. Conclusions Inhibition of miR-223 did not attenuate MCT PAH, whereas human prostacyclin synthase overexpression restored miRNA levels in MCT PAH to levels detected in naive rats. These data may establish a paradigm linking attenuation of PAH to restoration of BMPR2 signaling.	[Gubrij, Igor B.; Pangle, Amanda K.; Johnson, Larry G.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Gubrij, Igor B.; Pangle, Amanda K.; Johnson, Larry G.] Univ Arkansas Med Sci, Dept Internal Med, Div Pulm & Crit Med, Little Rock, AR 72205 USA; [Pang, Li] Univ Arkansas Med Sci, Dept Pharmacol, Little Rock, AR 72205 USA; [Pang, Li] US FDA, Natl Ctr Toxicol Res, Div Biochem Toxicol, Jefferson, AR 72079 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Food & Drug Administration (FDA)	Johnson, LG (corresponding author), Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA.; Johnson, LG (corresponding author), Univ Arkansas Med Sci, Dept Internal Med, Div Pulm & Crit Med, Little Rock, AR 72205 USA.	lgjohnson@uams.edu		Pang, Li/0000-0002-0212-2090	U.S. Dept. of Veterans Affairs; Arkansas Biosciences Institute; Canadian Heart Centre and Actelion Pharmaceuticals	U.S. Dept. of Veterans Affairs(US Department of Veterans Affairs); Arkansas Biosciences Institute; Canadian Heart Centre and Actelion Pharmaceuticals	This manuscript was supported by a VA Merit Grant (LGJ) from the U.S. Dept. of Veterans Affairs and a grant from the Arkansas Biosciences Institute (LGJ). LGJ is an investigator on the PAHQueri trial sponsored by the Canadian Heart Centre and Actelion Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bockmeyer CL, 2012, J HEART LUNG TRANSPL, V31, P764, DOI 10.1016/j.healun.2012.03.010; Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Chavali S, 2013, RNA, V19, P1552, DOI 10.1261/rna.038414.113; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Ezzie ME, 2012, THORAX, V67, P122, DOI 10.1136/thoraxjnl-2011-200089; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Greco S, 2012, DIABETES, V61, P1633, DOI 10.2337/db11-0952; Gubrij IB, 2014, HUM GENE THER, V25, P498, DOI 10.1089/hum.2013.187; Guo L, 2012, HYPERTENSION, V59, P1006, DOI 10.1161/HYPERTENSIONAHA.111.185413; Hadri L, 2013, CIRCULATION, V128, P512, DOI 10.1161/CIRCULATIONAHA.113.001585; Huang JB, 2013, LUNG, V191, P601, DOI 10.1007/s00408-013-9505-1; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kang K, 2013, J BIOL CHEM, V288, P25414, DOI 10.1074/jbc.M113.460287; Kim J, 2014, MOL CELLS, V37, P196, DOI 10.14348/molcells.2014.2308; Kim J, 2013, NAT MED, V19, P74, DOI 10.1038/nm.3040; Kim JD, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.45; Kim S, 2014, J CELL BIOCHEM, V115, P889, DOI 10.1002/jcb.24730; Li SS, 2013, BIOCHEM J, V452, P281, DOI 10.1042/BJ20120680; Liu D, 2013, CURR HYPERTENS REP, V15, P632, DOI 10.1007/s11906-013-0393-9; Lu TX, 2013, J IMMUNOL, V190, P1576, DOI 10.4049/jimmunol.1202897; McLaughlin VV, 2006, EUR J CLIN INVEST, V36, P10, DOI 10.1111/j.1365-2362.2006.01688.x; McLaughlin VV, 2010, CIRCULATION, V122, P106, DOI 10.1161/CIRCULATIONAHA.110.963983; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; Meloche J, 2013, CURRENT VASCULAR PHA; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; Newman JH, 2001, NEW ENGL J MED, V345, P319, DOI 10.1056/NEJM200108023450502; Ogo T, 2013, AM J RESP CELL MOL, V48, P733, DOI 10.1165/rcmb.2012-0049OC; PAN LC, 1993, TOXICOLOGY, V79, P21, DOI 10.1016/0300-483X(93)90203-5; Parikh VN, 2012, CIRCULATION, V125, P1520, DOI 10.1161/CIRCULATIONAHA.111.060269; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Rhodes CJ, 2013, AM J RESP CRIT CARE, V187, P294, DOI 10.1164/rccm.201205-0839OC; Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Takemoto M, 2002, CIRCULATION, V106, P57, DOI 10.1161/01.CIR.0000020682.73694.AB; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wang DR, 2014, CIRC RES, V114, P67, DOI 10.1161/CIRCRESAHA.114.301633; Wei CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064396; White K, 2014, HYPERTENSION, V64, P185, DOI 10.1161/HYPERTENSIONAHA.113.03037; Yang J, 2013, ARTERIOSCL THROM VAS, V33, P34, DOI 10.1161/ATVBAHA.112.300121; Yang SZ, 2012, AM J PHYSIOL-LUNG C, V302, pL521, DOI 10.1152/ajplung.00316.2011; Yu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078769; Zhou GF, 2015, AM J RESP CELL MOL, V52, P139, DOI 10.1165/rcmb.2014-0166TR	49	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147827	10.1371/journal.pone.0147827	http://dx.doi.org/10.1371/journal.pone.0147827			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815432	Green Published, gold			2022-12-26	WOS:000369528200057
J	Liu, B; Gao, FQ; Guo, J; Wu, D; Hao, B; Li, YR; Zhao, CF				Liu, Bin; Gao, Fengqin; Guo, Jun; Wu, Dubala; Hao, Bayasihuliang; Li, Yurong; Zhao, Cunfa			A Microarray-Based Analysis Reveals that a Short Photoperiod Promotes Hair Growth in the Arbas Cashmere Goat	PLOS ONE			English	Article							COMPREHENSIVE GUIDE; FOLLICLE; EXPRESSION; SKIN; MELATONIN; ANAGEN; CLASSIFICATION; LOCALIZATION; CYTOSKELETON; RECEPTORS	Many animals exhibit different behaviors in different seasons. The photoperiod can have effects on migration, breeding, fur growth, and other processes. The cyclic growth of the fur and feathers of some species of mammals and birds, respectively, is stimulated by the photoperiod as a result of hormone-dependent regulation of the nervous system. To further examine this phenomenon, we evaluated the Arbas Cashmere goat (Capra hircus), a species that is often used in this type of research. The goats were exposed to an experimentally controlled short photoperiod to study the regulation of cyclic cashmere growth. Exposure to a short photoperiod extended the anagen phase of the Cashmere goat hair follicle to increase cashmere production. Assessments of tissue sections indicated that the short photoperiod significantly induced cashmere growth. This conclusion was supported by a comparison of the differences in gene expression between the short photoperiod and natural conditions using gene chip technology. Using the gene chip data, we identified genes that showed altered expression under the short photoperiod compared to natural conditions, and these genes were found to be involved in the biological processes of hair follicle growth, structural composition of the hair follicle, and the morphogenesis of the surrounding skin appendages. Knowledge about differences in the expression of these genes as well as their functions and periodic regulation patterns increases our understanding of Cashmere goat hair follicle growth. This study also provides preliminary data that may be useful for the development of an artificial method to improve cashmere production by controlling the light cycle, which has practical significance for livestock breeding.	[Liu, Bin; Wu, Dubala; Li, Yurong; Zhao, Cunfa] Acad Agr & Stockbreeding Sci, Inst Anim Husb, Hohhot, Inner Mongolia, Peoples R China; [Liu, Bin] Chinese Acad Sci, Kunming Inst Anim Sci, Yunna, Inner Mongolia, Peoples R China; [Gao, Fengqin] Chinese Acad Agr Sci, Grassland Res Inst, Hohhot, Peoples R China; [Guo, Jun] Inner Mongolia Agr Univ, Coll Life Sci, Hohhot, Inner Mongolia, Peoples R China; [Hao, Bayasihuliang] Etuokeqianqi Arctic God Res Inst Cashmere & Lives, Erdos, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Inner Mongolia Agricultural University	Li, YR; Zhao, CF (corresponding author), Acad Agr & Stockbreeding Sci, Inst Anim Husb, Hohhot, Inner Mongolia, Peoples R China.	yurong622003@126.com; zhaocunfa@163.com			National Natural Science Foundation of China [31260545]; Special Fund for Agro-scientific Research in the Public Interest [201303059]; Natural Science Foundation Project of Inner Mongolia Autonomous Region [2014BS0333]; Young Scholars Innovative Foundation for Academy of Agriculture and Stockbreeding Sciences of Inner Mongolia Autonomous Region [2013QNJJM05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundation Project of Inner Mongolia Autonomous Region; Young Scholars Innovative Foundation for Academy of Agriculture and Stockbreeding Sciences of Inner Mongolia Autonomous Region	This work was supported by the National Natural Science Foundation of China (31260545); Special Fund for Agro-scientific Research in the Public Interest (201303059); Natural Science Foundation Project of Inner Mongolia Autonomous Region (2014BS0333); and Young Scholars Innovative Foundation for Academy of Agriculture and Stockbreeding Sciences of Inner Mongolia Autonomous Region (2013QNJJM05).	Aoki N, 1997, J BIOL CHEM, V272, P30512, DOI 10.1074/jbc.272.48.30512; Bawden CS, 2001, J INVEST DERMATOL, V116, P157, DOI 10.1046/j.1523-1747.2001.00215.x; Breitkopf T, 2013, J INVEST DERMATOL, V133, P1722, DOI 10.1038/jid.2013.53; BURNS R. H., 1962, Journal of the Textile Institute, V53, pT45; Chang TH, 2014, BIOMATERIALS, V35, P3934, DOI 10.1016/j.biomaterials.2014.01.028; [崔志峰 CUI Zhifeng], 2008, [山东大学学报. 理学版, Journal of Shangdong University], V43, P1; Dicks P, 1996, J ENDOCRINOL, V151, P55, DOI 10.1677/joe.0.1510055; Dicks P, 1994, EUROPEAN FINE FIBRE, V2, P109; Ebling F, 1991, BIOCH PHYSL SKIN, V1, P522; Fischer TW, 2008, J PINEAL RES, V44, P1, DOI 10.1111/j.1600-079X.2007.00512.x; Geng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062704; Hardman JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121878; IBRAHEEM M, 1994, J ANAT, V185, P135; Jin M, 2011, MOL BIOL REP, V38, P3023, DOI 10.1007/s11033-010-9968-6; Langbein L, 2001, J BIOL CHEM, V276, P35123, DOI 10.1074/jbc.M103305200; [李长青 Li Changqing], 2005, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V36, P674; Li SW, 2009, EXP DERMATOL, V18, P134, DOI 10.1111/j.1600-0625.2008.00774.x; Man XY, 2009, CLIN EXP DERMATOL, V34, P396, DOI 10.1111/j.1365-2230.2008.03104.x; McGregor BA, 1998, SMALL RUMINANT RES, V28, P199, DOI 10.1016/S0921-4488(97)00100-4; Mecklenburg L, 2000, J INVEST DERMATOL, V114, P909, DOI 10.1046/j.1523-1747.2000.00954.x; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nixon AJ, 2002, J ENDOCRINOL, V172, P605, DOI 10.1677/joe.0.1720605; Ozeki M, 2003, BIOMATERIALS, V24, P2387, DOI 10.1016/S0142-9612(03)00045-0; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Paus R, 2005, TRENDS IMMUNOL, V26, P32, DOI 10.1016/j.it.2004.09.014; Paus R, 2003, J INVEST DERM SYMP P, V8, P188, DOI 10.1046/j.1087-0024.2003.00807.x; Pearson AJ, 1996, J ENDOCRINOL, V148, P157, DOI 10.1677/joe.0.1480157; Plonka PM, 2008, J DERMATOL SCI, V49, P227, DOI 10.1016/j.jdermsci.2007.09.010; Rebora A, 2004, ARCH DERMATOL, V140, P619, DOI 10.1001/archderm.140.5.619; Rowe JM, 2008, J INVEST DERMATOL, V128, P1866, DOI 10.1038/sj.jid.5701236; Schlake T, 2007, SEMIN CELL DEV BIOL, V18, P267, DOI 10.1016/j.semcdb.2007.01.005; Shimomura Y, 2010, J INVEST DERMATOL, V130, P892, DOI 10.1038/jid.2009.341; Simonetti O, 2004, BRIT J DERMATOL, V150, P940, DOI 10.1111/j.1365-2133.2004.05881.x; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; SLOMINSKI A, 1993, J INVEST DERMATOL, V101, pS90, DOI 10.1111/1523-1747.ep12362991; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski RM, 2012, MOL CELL ENDOCRINOL, V351, P152, DOI 10.1016/j.mce.2012.01.004; Stenn K, 2005, J AM ACAD DERMATOL, V52, P374, DOI 10.1016/j.jaad.2004.07.040; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Storbeck KH, 2009, MOL CELL ENDOCRINOL, V300, P121, DOI 10.1016/j.mce.2008.09.009; Todini L, 2005, ATTI SOC ITALIANA SC, V59, P39; Wang YL, 1991, CURR OPIN CELL BIOL, V3, P27, DOI 10.1016/0955-0674(91)90162-R; Wu JH, 2012, J INTEGR AGR, V11, P1159, DOI 10.1016/S2095-3119(12)60110-5; Wu XJ, 2014, J DERMATOL SCI, V73, P152, DOI 10.1016/j.jdermsci.2013.10.002; Xu T, 2013, GENE, V520, P30, DOI 10.1016/j.gene.2013.01.068; Yano K, 2001, J CLIN INVEST, V107, P409, DOI 10.1172/JCI11317; Zhang W, 2011, J INNER MONGOLIA AGR, V32, P199; Zhu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076282	52	20	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147124	10.1371/journal.pone.0147124	http://dx.doi.org/10.1371/journal.pone.0147124			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814503	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528200025
J	Agomo, CO; Oyibo, WA; Sutherland, C; Hallet, R; Oguike, M				Agomo, Chimere Obiora; Oyibo, Wellington Aghoghovwia; Sutherland, Colin; Hallet, Rachael; Oguike, Mary			Assessment of Markers of Antimalarial Drug Resistance in Plasmodium falciparum Isolates from Pregnant Women in Lagos, Nigeria	PLOS ONE			English	Article							DIHYDROFOLATE-REDUCTASE; CHLOROQUINE RESISTANCE; IN-VIVO; SULFADOXINE-PYRIMETHAMINE; DIHYDROPTEROATE SYNTHASE; TYROSINE-86 ALLELE; MALARIA; MUTATIONS; AMODIAQUINE; PREVALENCE	Background The use of antimalarial drugs for prevention and treatment is a major strategy in the prevention of malaria in pregnancy. Although sulphadoxine-pyrimethamine (SP) is currently recommended for intermittent preventive treatment of malaria during pregnancy in Nigeria, previously used drugs for prophylaxis such as chloroquine (CQ) and pyrimethamine are accessible as they are purchased over the counter. This study describes the markers of absence or presence of resistance to quinoline (Pfcrt and Pfmdr 1) and type 1 antifolate antimalarial medicines (Pfdhfr). Methods Plasmodium falciparum-positive dried blood spots from pregnant women attending antenatal clinics for the first time during current pregnancy were investigated for the presence of mutations at codons 72-76 of Plasmodium falciparum chloroquine resistance transporter (Pfcrt) gene by real time polymerase chain reaction (PCR) using haplotype-specific probes. PCR followed by sequence analysis was used to identify mutations at codons 86, 184, 1034, 1042 and 1246 of P. falciparum multi-drug resistance-1 (Pfmdr1) gene; and codons 16, 50, 51, 59, 108, 140 and 164 of Pfdhfr gene. Results Two haplotypes of Pfcrt (n = 54) were observed: CVMNK 13(24.2%) and CVIET 41 (75.9%) of the samples. The SVMNT haplotype was absent in this population. The Pfmdr1 (n = 28) haplotypes were NYSND 15(53.6%), YYSND 5(17.9%), NFSND 6(21.4%) and YFSND 2 (7.1%). The Pfdhfr (n = 15) were ACNCSVI 4(26.7%), and ACICNSVI 1(6.7%) and ACIRNVI 10 (66.7%). The rate of occurrence of Pfcrt 76T, Pfdhfr108N, Pfmdr186Yand184F were 75.9%, 73.3%, 25% and 28.1% respectively. The Pfmdr1 86Y was associated with low parasitaemia (median = 71 parasites/mu l, P = 0.024) while Pfcrt 76T was associated with young maternal age (mean 24.1 +/- 4.5 years; P = 0.006). The median parasitaemia were similar (P>0.05) in wild and mutant strains of Pfcrt 76, Pfmdr1 184 and Pfdhfr 108. There was no association between gravidity or gestational age of the women and presence of mutations in the Pfcrt, Pfmdr1 or Pfdhfr genes (P> 0.05). Conclusion Markers of resistance to chloroquine and pyrimethamine were high, whereas cycloguanil-resistance marker was not present in the studied population. The low level of mutations in the Pfmdr1gene indicates likely efficacy of amodiaquine against malaria in pregnancy.	[Agomo, Chimere Obiora] Nigerian Inst Med Res, Malaria Res Lab, Lagos, Nigeria; [Oyibo, Wellington Aghoghovwia] Univ Lagos, Coll Med, ANDI Ctr Excellence Malaria Diag, WHO,TDR,FIND Malaria Specimen Bank Site, Lagos, Nigeria; [Sutherland, Colin; Hallet, Rachael; Oguike, Mary] Univ London London Sch Hyg & Trop Med, Dept Immunol, Keppel St, London WC1E 7HT, England	University of Lagos; World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Oyibo, WA (corresponding author), Univ Lagos, Coll Med, ANDI Ctr Excellence Malaria Diag, WHO,TDR,FIND Malaria Specimen Bank Site, Lagos, Nigeria.	wellao@yahoo.com	Agomo, Chimere/CAF-0649-2022; Sutherland, Colin/AAN-3939-2020	Sutherland, Colin/0000-0003-1592-6407; Agomo, Chimere/0000-0002-6248-2725; Oyibo, Wellington/0000-0002-5730-5396	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Agomo CO, 2009, KOREAN J PARASITOL, V47, P179, DOI 10.3347/kjp.2009.47.2.179; Agomo CO, 2011, MALAR RES TREAT, V2011, P6, DOI 10.4061/2011/932895; Aina Oluwagbemiga O, 2013, Malar Res Treat, V2013, P487250, DOI 10.1155/2013/487250; Bertin G, 2005, J ANTIMICROB CHEMOTH, V55, P788, DOI 10.1093/jac/dki097; Bloland PB., 2001, DRUG RESISTANCE MALA; Dlamini SV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-68; Duraisingh MT, 2000, MOL BIOCHEM PARASIT, V108, P13, DOI 10.1016/S0166-6851(00)00201-2; Duraisingh MT, 1997, PARASITOLOGY, V114, P205, DOI 10.1017/S0031182096008487; Federal Ministry of Health, 2005, NAT GUID STRAT MAL P, P50; Gama BE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-156; Happi CT, 2006, AM J TROP MED HYG, V75, P155, DOI 10.4269/ajtmh.2006.75.155; Holmgren G, 2006, INFECT GENET EVOL, V6, P309, DOI 10.1016/j.meegid.2005.09.001; Humphreys GS, 2007, ANTIMICROB AGENTS CH, V51, P991, DOI 10.1128/AAC.00875-06; HYDE JE, 1990, PHARMACOL THERAPEUT, V48, P45, DOI 10.1016/0163-7258(90)90017-V; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032; Lekana-Douki JB, 2011, INFECT GENET EVOL, V11, P512, DOI 10.1016/j.meegid.2011.01.003; Menegon M, 2009, TROP MED INT HEALTH, V14, P1251, DOI 10.1111/j.1365-3156.2009.02369.x; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; Mkulama MAP, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-87; Ndiaye D, 2005, TROP MED INT HEALTH, V10, P1176, DOI 10.1111/j.1365-3156.2005.01506.x; Niang M, 2008, J ANTIMICROB CHEMOTH, V62, P921, DOI 10.1093/jac/dkn299; Ojurongbe O, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-41; Pearce RJ, 2003, ANTIMICROB AGENTS CH, V47, P1347, DOI 10.1128/AAC.47.4.1347-1354.2003; PETERSON DS, 1990, P NATL ACAD SCI USA, V87, P3018, DOI 10.1073/pnas.87.8.3018; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Schwenke A, 2001, WIEN KLIN WOCHENSCHR, V113, P63; Sutherland CJ, 2007, J ANTIMICROB CHEMOTH, V59, P1197, DOI 10.1093/jac/dkm104; Sutherland CJ, 2009, ANTIMICROB AGENTS CH, V53, P3405, DOI 10.1128/AAC.00024-09; Tukwasibwe S, 2014, J INFECT DIS, V210, P154, DOI 10.1093/infdis/jiu044; Wang XH, 2005, AM J TROP MED HYG, V72, P410, DOI 10.4269/ajtmh.2005.72.410; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; White NJ, 2003, MALARIA	35	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146908	10.1371/journal.pone.0146908	http://dx.doi.org/10.1371/journal.pone.0146908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808627	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800038
J	Hodac, L; Ulum, FB; Opfermann, N; Breidenbach, N; Hojsgaard, D; Tjitrosoedirdjo, SS; Vornam, B; Finkeldey, R; Horand, E				Hodac, Ladislav; Ulum, Fuad Bahrul; Opfermann, Nicole; Breidenbach, Natalie; Hojsgaard, Diego; Tjitrosoedirdjo, Sri Sudarmiyati; Vornam, Barbara; Finkeldey, Reiner; Hoerand, Elvira			Population Genetic Structure and Reproductive Strategy of the Introduced Grass Centotheca lappacea in Tropical Land-Use Systems in Sumatra	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; BREEDING SYSTEMS; ALIEN PLANTS; DIVERSITY; ASTERACEAE; PATTERNS; DOMINANT; APOMIXIS; LOCI; AFLP	Intensive transformation of lowland rainforest into oil palm and rubber monocultures is the most common land-use practice in Sumatra (Indonesia), accompanied by invasion of weeds. In the Jambi province, Centotheca lappacea is one of the most abundant alien grass species in plantations and in jungle rubber (an extensively used agroforest), but largely missing in natural rainforests. Here, we investigated putative genetic differentiation and signatures for adaptation in the introduced area. We studied reproductive mode and ploidy level as putative factors for invasiveness of the species. We sampled 19 populations in oil palm and rubber monocultures and in jungle rubber in two regions (Bukit Duabelas and Harapan). Amplified fragment length polymorphisms (AFLP) revealed a high diversity of individual genotypes and only a weak differentiation among populations (F-ST = 0.173) and between the two regions (F-ST = 0.065). There was no significant genetic differentiation between the three land-use systems. The metapopulation of C. lappacea consists of five genetic partitions with high levels of admixture; all partitions appeared in both regions, but with different proportions. Within the Bukit Duabelas region we observed significant isolation-by-distance. Nine AFLP loci (5.3% of all loci) were under natural diversifying selection. All studied populations of C. lappacea were diploid, outcrossing and self-incompatible, without any hints of apomixis. The estimated residence time of c. 100 years coincides with the onset of rubber and oil palm planting in Sumatra. In the colonization process, the species is already in a phase of establishment, which may be enhanced by efficient selection acting on a highly diverse gene pool. In the land-use systems, seed dispersalmight be enhanced by adhesive spikelets. At present, the abundance of established populations in intensively managed land-use systems might provide opportunities for rapid dispersal of C. lappacea across rural landscapes in Sumatra, while the invasion potential in rainforest ecosystems appears to bemoderate as long as they remain undisturbed.	[Hodac, Ladislav; Ulum, Fuad Bahrul; Opfermann, Nicole; Hojsgaard, Diego; Hoerand, Elvira] Univ Gottingen, Dept Systemat Biodivers & Evolut Plants Herbarium, D-37073 Gottingen, Germany; [Tjitrosoedirdjo, Sri Sudarmiyati] Bogor Agr Univ, Fac Math & Nat Sci, IPB, Dept Biol, Bogor, Indonesia; [Breidenbach, Natalie; Vornam, Barbara; Finkeldey, Reiner] Univ Gottingen, Dept Forest Genet & Forest Tree Breeding, D-37073 Gottingen, Germany	University of Gottingen; Bogor Agricultural University; University of Gottingen	Hodac, L (corresponding author), Univ Gottingen, Dept Systemat Biodivers & Evolut Plants Herbarium, D-37073 Gottingen, Germany.	lhodac@uni-goettingen.de	Hojsgaard, Diego H/O-5969-2017; Hodac, Ladislav/AAP-7284-2021; Finkeldey, Reiner/ABD-4392-2021	Hojsgaard, Diego H/0000-0002-8709-4091; Hodac, Ladislav/0000-0002-6885-1317; Finkeldey, Reiner/0000-0003-3500-5656; bahrul ulum, fuad/0000-0002-1969-6322	Deutsche Forschungsgemeinschaft; Ecological and Socioeconomic Functions of Tropical Lowland Rainforest Transformation Systems (Sumatra, Indonesia) [CRC990]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ecological and Socioeconomic Functions of Tropical Lowland Rainforest Transformation Systems (Sumatra, Indonesia)	This work was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/), CRC990: Ecological and Socioeconomic Functions of Tropical Lowland Rainforest Transformation Systems (Sumatra, Indonesia) project B12 (EH) and project B03 (RF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abywijaya IK, 2014, THESIS BOGOR AGR U, P63; Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253; BAKER HG, 1967, EVOLUTION, V21, P853, DOI 10.1111/j.1558-5646.1967.tb03440.x; Barrett SCH, 2008, MOL ECOL, V17, P373, DOI 10.1111/j.1365-294X.2007.03503.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BIOTROP, 2014, DATABASE; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Coart E, 2005, CONSERV GENET, V6, P259, DOI 10.1007/s10592-004-7833-7; Cosendai AC, 2010, ANN BOT-LONDON, V105, P457, DOI 10.1093/aob/mcp304; Dellinger AS, 2016, NEW PHYTOL, V209, P1313, DOI 10.1111/nph.13694; DeWalt SJ, 2004, AM J BOT, V91, P1155, DOI 10.3732/ajb.91.8.1155; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Duchesne P, 2009, MOL ECOL RESOUR, V9, P1333, DOI 10.1111/j.1755-0998.2009.02571.x; Duchesne P, 2012, J HERED, V103, P734, DOI 10.1093/jhered/ess038; Ersts PJ, 2014, GEOGRAPHIC DISTANCE; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; EXCOFFIER L, 2006, ARLEQUIN INTEGRATED; Fennell M, 2014, ECOL EVOL, V4, P1648, DOI 10.1002/ece3.1043; FOC, 2006, FLORA CHINA; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foxcroft LC, 2010, BIOL INVASIONS, V12, P3913, DOI 10.1007/s10530-010-9823-7; Guillaume T, 2015, GLOBAL CHANGE BIOL, V21, P3548, DOI 10.1111/gcb.12907; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hao JH, 2011, BIOL INVASIONS, V13, P571, DOI 10.1007/s10530-010-9850-4; Hardesty BD, 2012, DIVERS DISTRIB, V18, P147, DOI 10.1111/j.1472-4642.2011.00832.x; Hazalin NAMN, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-46; Hojsgaard D, 2014, CRIT REV PLANT SCI, V33, P414, DOI 10.1080/07352689.2014.898488; Hojsgaard D, 2009, GENET RESOUR CROP EV, V56, P533, DOI 10.1007/s10722-008-9384-0; Hojsgaard DH, 2013, NEW PHYTOL, V197, P336, DOI 10.1111/j.1469-8137.2012.04381.x; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Jiwan N, 2013, PALM OIL CONTROVERSY, P48; Laumonier Y, 2010, BIODIVERS CONSERV, V19, P1153, DOI 10.1007/s10531-010-9784-2; Levy AA, 2002, PLANT PHYSIOL, V130, P1587, DOI 10.1104/pp.015727; Ma JW, 2011, WEED RES, V51, P363, DOI 10.1111/j.1365-3180.2011.00856.x; Mariette S, 2001, HEREDITY, V86, P469, DOI 10.1046/j.1365-2540.2001.00852.x; Matzk F, 2000, PLANT J, V21, P97, DOI 10.1046/j.1365-313x.2000.00647.x; Morrone O, 2012, CLADISTICS, V28, P333, DOI 10.1111/j.1096-0031.2011.00384.x; Mubarok H, 2010, THESIS BOGOR AGR U, P85; Novak SJ, 2000, CAN J BOT, V78, P1469, DOI 10.1139/cjb-78-11-1469; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Ohwi J., 1971, TONAN AJIA KENKYU, V9, P194; OLORODE O, 1975, BRITTONIA, V27, P63, DOI 10.2307/2805647; Ortiz JPA, 2013, ANN BOT-LONDON, V112, P767, DOI 10.1093/aob/mct152; Otto F, 1990, Methods Cell Biol, V33, P105; Peh KSH, 2010, BIODIVERS CONSERV, V19, P1083, DOI 10.1007/s10531-009-9755-7; Poulin J, 2005, DIVERS DISTRIB, V11, P241, DOI 10.1111/j.1366-9516.2005.00136.x; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Pritchard JK, 2000, GENETICS, V155, P945; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Ramana MV, 2014, NORD J BOT, V32, P559, DOI 10.1111/j.1756-1051.2013.00302.x; Rambuda TD, 2004, DIVERS DISTRIB, V10, P409, DOI 10.1111/j.1366-9516.2004.00100.x; Renno JF, 1995, PLANT SYST EVOL, V198, P89, DOI 10.1007/BF00985108; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; Soerjani M., 1987, WEEDS RICE INDONESIA; Subrata SA, 2007, J ILMU KEHUTANAN, V1, P39; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Tjitrosoedirdjo S, 1990, WEED INFO SHEET 3; Tjitrosoedirdjo SS, 1993, WEED INFO SHEET 19; Ulum FB, 2014, THESIS GEORG AUGUST, P58; USDA, 2015, GERMPLASM RESOURCES; Uthicke S, 2005, CORAL REEFS, V24, P103, DOI 10.1007/s00338-004-0441-7; VEKEMANS X, 2002, AFLP SURV VERSION 1; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vu LV, 2009, J ZOOL, V277, P15, DOI 10.1111/j.1469-7998.2008.00498.x; Wang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041310; Ye shu J, 1810, FLORA CHINA, V22, p[189, 445]; YOUNG BA, 1979, CAN J BOT, V57, P1668, DOI 10.1139/b79-204; Yu XQ, 2014, BIOL INVASIONS, V16, P2351, DOI 10.1007/s10530-014-0669-2; Zhao SY, 2015, WEED RES, V55, P163, DOI 10.1111/wre.12130	73	0	0	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147633	10.1371/journal.pone.0147633	http://dx.doi.org/10.1371/journal.pone.0147633			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807958	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800157
J	Marland, JRK; Smillie, KJ; Cousin, MA				Marland, Jamie R. K.; Smillie, Karen J.; Cousin, Michael A.			Synaptic Vesicle Recycling Is Unaffected in the Ts65Dn Mouse Model of Down Syndrome	PLOS ONE			English	Article							DEPENDENT BULK ENDOCYTOSIS; LONG-TERM POTENTIATION; SYNDROME CRITICAL REGION; ALZHEIMERS-DISEASE; NEUROTRANSMITTER RELEASE; HIPPOCAMPAL SYNAPSES; NERVE-TERMINALS; CALCINEURIN; PHOSPHORYLATION; DEFICITS	Down syndrome (DS) is the most common genetic cause of intellectual disability, and arises from trisomy of human chromosome 21. Accumulating evidence from studies of both DS patient tissue and mouse models has suggested that synaptic dysfunction is a key factor in the disorder. The presence of several genes within the DS trisomy that are either directly or indirectly linked to synaptic vesicle (SV) endocytosis suggested that presynaptic dysfunction could underlie some of these synaptic defects. Therefore we determined whether SV recycling was altered in neurons from the Ts65Dn mouse, the best characterised model of DS to date. We found that SV exocytosis, the size of the SV recycling pool, clathrin-mediated endocytosis, activity-dependent bulk endocytosis and SV generation from bulk endosomes were all unaffected by the presence of the Ts65Dn trisomy. These results were obtained using battery of complementary assays employing genetically-encoded fluorescent reporters of SV cargo trafficking, and fluorescent and morphological assays of fluid-phase uptake in primary neuronal culture. The absence of presynaptic dysfunction in central nerve terminals of the Ts65Dn mouse suggests that future research should focus on the established alterations in excitatory / inhibitory balance as a potential route for future pharmacotherapy.	[Marland, Jamie R. K.; Smillie, Karen J.; Cousin, Michael A.] Univ Edinburgh, Ctr Integrat Physiol, Hugh Robson Bldg,15 George Sq, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh	Cousin, MA (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Hugh Robson Bldg,15 George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	M.Cousin@ed.ac.uk		Cousin, Michael/0000-0002-1762-160X; Smillie, Karen/0000-0003-4369-0470; Marland, Jamie/0000-0001-6442-082X	UK Medical Research Council [G1002117]; MRC [G1002117] Funding Source: UKRI; Medical Research Council [G1002117] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by a grant from the UK Medical Research Council http://www.mrc.ac.uk/ (Grant number: G1002117).	Adayev T, 2006, BIOCHEM BIOPH RES CO, V351, P1060, DOI 10.1016/j.bbrc.2006.10.169; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; BECKER LE, 1986, ANN NEUROL, V20, P520, DOI 10.1002/ana.410200413; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 2003, J NEUROSCI, V23, P6788; Chen CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5246; Cheung G, 2013, J NEUROSCI, V33, P3370, DOI 10.1523/JNEUROSCI.4697-12.2013; Cheung G, 2012, J NEUROSCI, V32, P6014, DOI 10.1523/JNEUROSCI.6305-11.2012; Cheung G, 2010, J NEUROSCI, V30, P8151, DOI 10.1523/JNEUROSCI.0293-10.2010; Clayton EL, 2008, J NEUROSCI, V28, P6627, DOI 10.1523/JNEUROSCI.1445-08.2008; Clayton EL, 2009, J NEUROCHEM, V111, P901, DOI 10.1111/j.1471-4159.2009.06384.x; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Colas D, 2013, BRIT J PHARMACOL, V169, P963, DOI 10.1111/bph.12169; Cossec JC, 2012, HUM MOL GENET, V21, P3156, DOI 10.1093/hmg/dds142; Costa ACS, 2005, NEUROSCI LETT, V382, P317, DOI 10.1016/j.neulet.2005.03.031; Cottrell JR, 2013, J NEUROSCI, V33, P10938, DOI 10.1523/JNEUROSCI.5362-12.2013; Cousin MA, 2014, NEUROSCIENTIST; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dierssen M, 2012, NAT REV NEUROSCI, V13, P844, DOI 10.1038/nrn3314; Duchon A, 2011, MAMM GENOME, V22, P674, DOI 10.1007/s00335-011-9356-0; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; Evans GJO, 2007, J NEUROSCI, V27, P401, DOI 10.1523/JNEUROSCI.3809-06.2007; Evergren E, 2007, J NEUROSCI, V27, P379, DOI 10.1523/JNEUROSCI.4683-06.2007; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Granholm ACE, 2000, EXP NEUROL, V161, P647, DOI 10.1006/exnr.1999.7289; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Groemer TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018754; Hoeffer CA, 2007, J NEUROSCI, V27, P13161, DOI 10.1523/JNEUROSCI.3974-07.2007; Jung MS, 2011, J BIOL CHEM, V286, P40401, DOI 10.1074/jbc.M111.253971; Keating DJ, 2008, HUM MOL GENET, V17, P1020, DOI 10.1093/hmg/ddm374; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Kim Y, 2010, NEUROSIGNALS, V18, P164, DOI 10.1159/000321994; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Kokotos AC, 2015, TRAFFIC, V16, P229, DOI 10.1111/tra.12235; Martin KR, 2012, HUM MOL GENET, V21, P3025, DOI 10.1093/hmg/dds134; Martinez-Cue C, 2013, J NEUROSCI, V33, P3953, DOI 10.1523/JNEUROSCI.1203-12.2013; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Murakami N, 2006, J BIOL CHEM, V281, P23712, DOI 10.1074/jbc.M513497200; Murakami N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034845; Nosheny RL, 2015, NEUROBIOL DIS, V77, P173, DOI 10.1016/j.nbd.2015.02.022; Pechstein A, 2010, P NATL ACAD SCI USA, V107, P4206, DOI 10.1073/pnas.0911073107; PETIT TL, 1984, EXP NEUROL, V83, P13, DOI 10.1016/0014-4886(84)90041-4; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Reinholdt LG, 2011, MAMM GENOME, V22, P685, DOI 10.1007/s00335-011-9357-z; REYNOLDS GP, 1988, NEUROSCI LETT, V94, P224, DOI 10.1016/0304-3940(88)90299-6; Risser D, 1997, LIFE SCI, V60, P1231, DOI 10.1016/S0024-3205(97)00067-2; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rozas JL, 2010, BIOCHEM SOC T, V38, P488, DOI 10.1042/BST0380488; Rueda N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/584071; Ruparelia A, 2012, CURR OPIN NEUROBIOL, V22, P880, DOI 10.1016/j.conb.2012.05.002; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Sakaba T, 2013, P NATL ACAD SCI USA, V110, P8266, DOI 10.1073/pnas.1219234110; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Siarey RJ, 1997, NEUROPHARMACOLOGY, V36, P1549, DOI 10.1016/S0028-3908(97)00157-3; Siarey RJ, 1999, NEUROPHARMACOLOGY, V38, P1917, DOI 10.1016/S0028-3908(99)00083-0; Smillie KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3394; Sturgeon X, 2011, MAMM GENOME, V22, P261, DOI 10.1007/s00335-011-9321-y; Sun T, 2010, J NEUROSCI, V30, P11838, DOI 10.1523/JNEUROSCI.1481-10.2010; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Waites CL, 2011, TRENDS NEUROSCI, V34, P326, DOI 10.1016/j.tins.2011.03.004; Watanabe S, 2013, NATURE, V504, P242, DOI 10.1038/nature12809; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P59; Wiseman FK, 2015, NAT REV NEUROSCI, V16, P564, DOI 10.1038/nrn3983; Wu XS, 2014, CELL REP, V7, P982, DOI 10.1016/j.celrep.2014.04.020; Xie W, 2012, BIOCHEMISTRY-US, V51, P6786, DOI 10.1021/bi2017798; Zanin MP, 2013, J NEUROCHEM, V124, P290, DOI 10.1111/jnc.12086; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhang N, 2015, J NEUROSCI, V35, P2492, DOI 10.1523/JNEUROSCI.4248-14.2015	75	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147974	10.1371/journal.pone.0147974	http://dx.doi.org/10.1371/journal.pone.0147974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808141	Green Published, gold			2022-12-26	WOS:000369527800256
J	Schroeder, AM; Bin Wang, H; Park, S; Jordan, MC; Gao, FY; Coppola, G; Fishbein, MC; Roos, KP; Ghiani, CA; Colwell, CS				Schroeder, Analyne M.; Bin Wang, Huei; Park, Saemi; Jordan, Maria C.; Gao, Fuying; Coppola, Giovanni; Fishbein, Michael C.; Roos, Kenneth P.; Ghiani, Cristina A.; Colwell, Christopher S.			Cardiac Dysfunction in the BACHD Mouse Model of Huntington's Disease	PLOS ONE			English	Article							MYOCARDIAL FIBROSIS; NATRIURETIC PEPTIDE; MUTATION CARRIERS; DEATH; FIBROBLASTS; ACTIVATION; EXPRESSION; PROFILE	While Huntington's disease (HD) is classified as a neurological disorder, HD patients exhibit a high incidence of cardiovascular events leading to heart failure and death. In this study, we sought to better understand the cardiovascular phenotype of HD using the BACHD mouse model. The age- related decline in cardiovascular function was assessed by echocardiograms, electrocardiograms, histological and microarray analysis. We found that structural and functional differences between WT and BACHD hearts start at 3 months of age and continue throughout life. The aged BACHD mice develop cardiac fibrosis and ultimately apoptosis. The BACHD mice exhibited adaptive physiological changes to chronic isoproterenol treatment; however, the medication exacerbated fibrotic lesions in the heart. Gene expression analysis indicated a strong tilt toward apoptosis in the young mutant heart as well as changes in genes involved in cellular metabolism and proliferation. With age, the number of genes with altered expression increased with the large changes occurring in the cardiovascular disease, cellular metabolism, and cellular transport clusters. The BACHD model of HD exhibits a number of changes in cardiovascular function that start early in the disease progress and may provide an explanation for the higher cardiovascular risk in HD.	[Schroeder, Analyne M.; Bin Wang, Huei; Park, Saemi; Gao, Fuying; Coppola, Giovanni; Ghiani, Cristina A.; Colwell, Christopher S.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Jordan, Maria C.; Roos, Kenneth P.] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Jordan, Maria C.; Roos, Kenneth P.] Univ Calif Los Angeles, Cardiovasc Res Lab, Los Angeles, CA 90095 USA; [Fishbein, Michael C.; Ghiani, Cristina A.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Colwell, CS (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.	ccolwell@mednet.ucla.edu	Jordan, Maria/HHN-5358-2022; Ghiani, Cristina/Q-9385-2019; Colwell, Chris/AAM-6111-2020	Ghiani, Cristina/0000-0002-9867-6185; Colwell, Christopher/0000-0002-1059-184X; Wang, Huei-Bin/0000-0002-7141-0950	CHDI Foundation [A4339]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS062691] Funding Source: NIH RePORTER	CHDI Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by CHDI Foundation, A4339, CSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrich J, 2002, J NEUROL NEUROSUR PS, V72, P726, DOI 10.1136/jnnp.72.6.726; Aukrust P, 2008, ARTERIOSCL THROM VAS, V28, P1909, DOI 10.1161/ATVBAHA.107.161240; Aziz NA, 2010, EUR J NEUROL, V17, P1068, DOI 10.1111/j.1468-1331.2010.02973.x; Bar KJ, 2008, EUR J NEUROL, V15, P869, DOI 10.1111/j.1468-1331.2008.02173.x; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Buonincontri G, 2014, J HUNTINGTONS DIS, V3, P25, DOI 10.3233/JHD-130083; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; CHIU E, 1982, MED J AUSTRALIA, V1, P153, DOI 10.5694/j.1326-5377.1982.tb132224.x; Ciammola A, 2006, CELL DEATH DIFFER, V13, P2068, DOI 10.1038/sj.cdd.4401967; Coppola G, 2011, METHODS MOL BIOL, V793, P417, DOI 10.1007/978-1-61779-328-8_28; Dalrymple A, 2007, J PROTEOME RES, V6, P2833, DOI 10.1021/pr0700753; Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Henkel DM, 2012, AM J CARDIOL, V109, P390, DOI 10.1016/j.amjcard.2011.09.027; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Kapoun AM, 2004, CIRC RES, V94, P453, DOI 10.1161/01.RES.0000117070.86556.9F; Kiriazis H, 2012, J PHYSIOL-LONDON, V590, P5845, DOI 10.1113/jphysiol.2012.238113; Kobal J, 2004, EUR J NEUROL, V11, P842, DOI 10.1111/j.1468-1331.2004.00894.x; Kobal J, 2010, ACTA NEUROL SCAND, V121, P392, DOI 10.1111/j.1600-0404.2009.01251.x; Kudo T, 2011, EXP NEUROL, V228, P80, DOI 10.1016/j.expneurol.2010.12.011; Kuljis Dika, 2012, Minerva Pneumol, V51, P93; Lalic NM, 2008, ARCH NEUROL-CHICAGO, V65, P476, DOI 10.1001/archneur.65.4.476; LANSKA DJ, 1988, ARCH NEUROL-CHICAGO, V45, P878, DOI 10.1001/archneur.1988.00520320068017; Marchina E, 2014, J NEUROL SCI, V337, P42, DOI 10.1016/j.jns.2013.11.014; Margolis RL, 2003, CLIN CHEM, V49, P1726, DOI 10.1373/49.10.1726; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Melkani GC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004024; Mielcarek M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004550; Mihm MJ, 2007, NEUROBIOL DIS, V25, P297, DOI 10.1016/j.nbd.2006.09.016; Nguyen TP, 2014, J MOL CELL CARDIOL, V70, P83, DOI 10.1016/j.yjmcc.2013.10.018; Nickel A, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0358-9; Pattison JS, 2008, CIRCULATION, V117, P2743, DOI 10.1161/CIRCULATIONAHA.107.750232; Pouladi MA, 2013, NAT REV NEUROSCI, V14, P708, DOI 10.1038/nrn3570; Rozen S, 2000, Methods Mol Biol, V132, P365; Saft C, 2005, MOVEMENT DISORD, V20, P674, DOI 10.1002/mds.20373; Sassone J, 2009, EXP NEUROL, V219, P385, DOI 10.1016/j.expneurol.2009.05.012; Schroeder Analyne M, 2011, PLoS Curr, V3, pRRN1266, DOI 10.1371/currents.RRN1266; Sharma KR, 1999, ARCH NEUROL-CHICAGO, V56, P1248, DOI 10.1001/archneur.56.10.1248; Silvestroni A, 2009, NEUROREPORT, V20, P1098, DOI 10.1097/WNR.0b013e32832e34ee; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SORENSEN SA, 1992, J MED GENET, V29, P911, DOI 10.1136/jmg.29.12.911; Suzuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035353; Valor LM, 2014, MOL NEUROBIOL; Vondriska TM, 2008, CIRC RES, V103, P1194, DOI 10.1161/CIRCRESAHA.108.189118; Wood NI, 2012, J HUNTINGTONS DIS, V1, P57, DOI 10.3233/JHD-2012-120004; Yang SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029652, 10.1371/journal.pone.0035836]	46	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147269	10.1371/journal.pone.0147269	http://dx.doi.org/10.1371/journal.pone.0147269			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807590	Green Published, gold			2022-12-26	WOS:000369527800070
J	Shuryak, I; Dadachova, E				Shuryak, Igor; Dadachova, Ekaterina			Quantitative Modeling of Microbial Population Responses to Chronic Irradiation Combined with Other Stressors	PLOS ONE			English	Article							IONIZING-RADIATION; CHRONIC EXPOSURE; GAMMA-RADIATION; DOSE-RATE; FUNGI; CHERNOBYL; GROWTH; RADIOSENSITIVITY; BIOREMEDIATION; INVERTEBRATES	Microbial population responses to combined effects of chronic irradiation and other stressors (chemical contaminants, other sub-optimal conditions) are important for ecosystem functioning and bioremediation in radionuclide-contaminated areas. Quantitative mathematical modeling can improve our understanding of these phenomena. To identify general patterns of microbial responses to multiple stressors in radioactive environments, we analyzed three data sets on: (1) bacteria isolated from soil contaminated by nuclear waste at the Hanford site (USA); (2) fungi isolated from the Chernobyl nuclear-power plant (Ukraine) buildings after the accident; (3) yeast subjected to continuous.-irradiation in the laboratory, where radiation dose rate and cell removal rate were independently varied. We applied generalized linear mixed-effects models to describe the first two data sets, whereas the third data set was amenable to mechanistic modeling using differential equations. Machine learning and information-theoretic approaches were used to select the best-supported formalism( s) among biologically-plausible alternatives. Our analysis suggests the following: (1) Both radionuclides and co-occurring chemical contaminants (e.g. NO2) are important for explaining microbial responses to radioactive contamination. (2) Radionuclides may produce non-monotonic dose responses: stimulation of microbial growth at low concentrations vs. inhibition at higher ones. (3) The extinction-defining critical radiation dose rate is dramatically lowered by additional stressors. (4) Reproduction suppression by radiation can be more important for determining the critical dose rate, than radiation-induced cell mortality. In conclusion, the modeling approaches used here on three diverse data sets provide insight into explaining and predicting multi-stressor effects on microbial communities: (1) the most severe effects (e.g. extinction) on microbial populations may occur when unfavorable environmental conditions (e.g. fluctuations of temperature and/or nutrient levels) coincide with radioactive contamination; (2) an organism's radioresistance and bioremediation efficiency in rich laboratory media may be insufficient to carry out radionuclide bioremediation in the field-robustness against multiple stressors is needed.	[Shuryak, Igor] Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA; [Dadachova, Ekaterina] Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA; [Dadachova, Ekaterina] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Columbia University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Shuryak, I (corresponding author), Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA.	is144@cumc.columbia.edu	Dadachova, Ekaterina/I-7838-2013					Alonzo F, 2008, J ENVIRON RADIOACTIV, V99, P1464, DOI 10.1016/j.jenvrad.2007.11.021; Bezrukov V, 2015, ECOL INDIC, V52, P128, DOI 10.1016/j.ecolind.2014.11.014; Bolker B, 2008, ECOLOGICAL MODELS DA; BRENNER DJ, 1988, RADIAT ENVIRON BIOPH, V27, P189, DOI 10.1007/BF01210836; Browne E, 2007, NUCL DATA SHEETS, V108, P2173, DOI 10.1016/j.nds.2007.09.002; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chen PQ, 2009, GENETICS, V183, P639, DOI 10.1534/genetics.109.106492; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; Dadachova E, 2008, CURR OPIN MICROBIOL, V11, P525, DOI 10.1016/j.mib.2008.09.013; Dallas LJ, 2012, RADIAT RES, V177, P693, DOI 10.1667/RR2687.1; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Fredrickson JK, 2004, APPL ENVIRON MICROB, V70, P4230, DOI 10.1128/AEM.70.7.4230-4241.2004; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; Garnier-Laplace J, 2013, J ENVIRON RADIOACTIV, V121, P12, DOI 10.1016/j.jenvrad.2012.01.013; Gotelli Nicholas J., 2011, P39; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hendriks AJ, 2005, ENVIRON TOXICOL CHEM, V24, P2267, DOI 10.1897/05-122.1; Hilborn Ray, 1997, V28; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; KIEFER J, 1988, RADIAT RES, V113, P71, DOI 10.2307/3577181; KIEFER J, 1977, RADIAT RES, V69, P230, DOI 10.2307/3574431; Kohavi R., 1995, P 1995 INT JOINT C A; Kumar R, 2007, OMICS, V11, P295, DOI 10.1089/omi.2007.0013; Martins LR, 2015, J ENV ENG; Mitchel REJ, 2007, NATO SCI PEACE SECUR, P31, DOI 10.1007/978-1-4020-6335-0_3; Moller AP, 2012, OECOLOGIA, V170, P1155, DOI 10.1007/s00442-012-2374-0; Mongodin EF, 2006, SECRETS SOIL SURVIVA; Mousseau TA, 2014, OECOLOGIA, V175, P429, DOI 10.1007/s00442-014-2908-8; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Parisot F, 2015, AQUAT TOXICOL, V163, P27, DOI 10.1016/j.aquatox.2015.03.002; Ragon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021764; Ruggiero CE, 2005, ENVIRON MICROBIOL, V7, P88, DOI 10.1111/j.1462-2920.2004.00666.x; Sachs RK, 1997, INT J RADIAT BIOL, V72, P351, DOI 10.1080/095530097143149; SALEH YG, 1988, APPL ENVIRON MICROB, V54, P2134, DOI 10.1128/AEM.54.8.2134-2135.1988; Sazykina TG, 2012, RADIAT ENVIRON BIOPH, V51, P215, DOI 10.1007/s00411-012-0404-2; Shuryak I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085561; Singal AG, 2013, AM J GASTROENTEROL, V108, P1723, DOI 10.1038/ajg.2013.332; Song L, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-5; Springman R, 2010, GENETICS, V184, P221, DOI 10.1534/genetics.109.108803; Tugay T, 2006, MYCOLOGIA, V98, P521, DOI 10.3852/mycologia.98.4.521; Vanhoudt N, 2012, ENVIRON POLLUT, V168, P177, DOI 10.1016/j.envpol.2012.04.023; Batlle JVI, 2012, RADIAT ENVIRON BIOPH, V51, P399, DOI 10.1007/s00411-012-0430-0; WELCH GP, 1968, RADIAT RES, V36, P274, DOI 10.2307/3572652; YI PN, 1993, RADIAT RES, V133, P163, DOI 10.2307/3578352; ZAIDER M, 1993, RADIAT RES, V133, P20, DOI 10.2307/3578252; Zhdanova NN, 2004, MYCOL RES, V108, P1089, DOI 10.1017/S0953756204000966; Zhdanova NN, 2000, MYCOL RES, V104, P1421, DOI 10.1017/S0953756200002756	50	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147696	10.1371/journal.pone.0147696	http://dx.doi.org/10.1371/journal.pone.0147696			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808049	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800186
J	Yamamoto, T; Suzuki, T; Ohashi, S; Miyazaki, A; Tsutsui, T				Yamamoto, Takehisa; Suzuki, Tohru; Ohashi, Seiichi; Miyazaki, Ayako; Tsutsui, Toshiyuki			Genomic Motifs as a Novel Indicator of the Relationship between Strains Isolated from the Epidemic of Porcine Epidemic Diarrhea in 2013-2014	PLOS ONE			English	Article							UNITED-STATES; SEQUENCE-ANALYSIS; VIRUS; EMERGENCE; OUTBREAK; KOREA; PEDV	Porcine epidemic diarrhea virus (PEDV) is a positive-sense RNA virus that causes infectious gastroenteritis in pigs. Following a PED outbreak that occurred in China in 2010, the disease was identified for the first time in the United States in April 2013, and was reported in many other countries worldwide from 2013 to 2014. As a novel approach to elucidate the epidemiological relationship between PEDV strains, we explored their genome sequences to identify the motifs that were shared within related strains. Of PED outbreaks reported in many countries during 2013-2014, 119 PEDV strains in Japan, USA, Canada, Mexico, Germany, and Korea were selected and used in this study. We developed a motif mining program, which aimed to identify a specific region of the genome that was exclusively shared by a group of PEDV strains. Eight motifs were identified (M1-M8) and they were observed in 41, 9, 18, 6, 10, 14, 2, and 2 strains, respectively. Motifs M1-M6 were shared by strains from more than two countries, and seemed to originate from one PEDV strain, Indiana12.83/USA/2013, among the 119 strains studied. BLAST search for motifs M1-M6 revealed that M3-M5 were almost identical to the strain ZMDZY identified in 2011 in China, while M1 and M2 were similar to other Chinese strains isolated in 2011-2012. Consequently, the PED outbreaks in these six countries may be closely related, and multiple transmissions of PEDV strains between these countries may have occurred during 2013-2014. Although tools such as phylogenetic tree analysis with whole genome sequences are increasingly applied to reveal the connection between isolates, its interpretation is sometimes inconclusive. Application of motifs as a tool to examine the whole genome sequences of causative agents will be more objective and will be an explicit indicator of their relationship.	[Yamamoto, Takehisa; Suzuki, Tohru; Ohashi, Seiichi; Miyazaki, Ayako; Tsutsui, Toshiyuki] Natl Agr & Res Org, Natl Inst Anim Hlth, Virol & Epidemiol Res Div, Tsukuba, Ibaraki 3050856, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Yamamoto, T (corresponding author), Natl Agr & Res Org, Natl Inst Anim Hlth, Virol & Epidemiol Res Div, Tsukuba, Ibaraki 3050856, Japan.	mtbook@affrc.go.jp			Science and Technology Research Promotion Program for Agriculture, Forestry and Fisheries, and Food Industry	Science and Technology Research Promotion Program for Agriculture, Forestry and Fisheries, and Food Industry	This work was supported by the Science and Technology Research Promotion Program for Agriculture, Forestry and Fisheries, and Food Industry.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bridgen A, 1998, ADV EXP MED BIOL, V440, P781; Chen X, 2012, VIRUS GENES, V45, P499, DOI 10.1007/s11262-012-0794-x; Chiou HY, 2017, TRANSBOUND EMERG DIS, V64, P157, DOI 10.1111/tbed.12357; Chiou M, 2014, AUSTIN VIROL RETRO V, V1, P2; Choi JC, 2014, INFECT GENET EVOL, V26, P348, DOI 10.1016/j.meegid.2014.06.005; Vui DT, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00753-14; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; DUARTE M, 1993, ADV EXP MED BIOL, V342, P55; Gao YY, 2013, ARCH VIROL, V158, P711, DOI 10.1007/s00705-012-1541-2; Grad YH, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0538-4; Grasland B, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00535-15; Hanke D, 2015, EMERG INFECT DIS, V21, P493, DOI 10.3201/eid2103.141165; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Jung K, 2014, EMERG INFECT DIS, V20, P662, DOI 10.3201/eid2004.131685; Kim SH, 2015, ARCH VIROL, V160, P1055, DOI 10.1007/s00705-015-2353-y; Kocherhans R, 2001, VIRUS GENES, V23, P137, DOI 10.1023/A:1011831902219; Lee S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01116-14; Lee S, 2014, EMERG INFECT DIS, V20, P1223, DOI 10.3201/eid2007.140294; Li WT, 2012, EMERG INFECT DIS, V18, P1350, DOI 10.3201/eid1808.120002; Marthaler D, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00555-13; Oka T, 2014, VET MICROBIOL, V173, P258, DOI 10.1016/j.vetmic.2014.08.012; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Park SJ, 2008, VIRUS GENES, V36, P95, DOI 10.1007/s11262-007-0164-2; Park SJ, 2012, J VIROL, V86, P5964, DOI 10.1128/JVI.00557-12; Pasick J, 2014, TRANSBOUND EMERG DIS, V61, P397, DOI 10.1111/tbed.12269; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; Sato T, 2011, VIRUS GENES, V43, P72, DOI 10.1007/s11262-011-0617-5; Sintchenko V, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1314; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; Song DP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120310; Stadler J, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0454-1; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Sun DB, 2008, VET MICROBIOL, V131, P73, DOI 10.1016/j.vetmic.2008.02.022; Sun M, 2015, J CLIN MICROBIOL, V53, P1484, DOI 10.1128/JCM.02898-14; Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259; Suzuki T, 2015, INFECT GENET EVOL, V36, P363, DOI 10.1016/j.meegid.2015.10.017; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian PF, 2014, EMERG INFECT DIS, V20, P1735, DOI 10.3201/eid2010.140338; Vlasova AN, 2014, EMERG INFECT DIS, V20, P1620, DOI 10.3201/eid2010.140491; Wang LY, 2014, EMERG INFECT DIS, V20, P917, DOI 10.3201/eid2005.140195; Yang DQ, 2014, ARCH VIROL, V159, P2777, DOI 10.1007/s00705-014-2102-7; Zhao PD, 2015, CAN J VET RES, V79, P8	45	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147994	10.1371/journal.pone.0147994	http://dx.doi.org/10.1371/journal.pone.0147994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808527	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800260
J	Paranjape, AN; Soundararajan, R; Werden, SJ; Joseph, R; Taube, JH; Liu, H; Rodriguez-Canales, J; Sphyris, N; Wistuba, I; Miura, N; Dhillon, J; Mahajan, N; Mahajan, K; Chang, JT; Ittmann, M; Maity, SN; Logothetis, C; Tang, DG; Mani, SA				Paranjape, A. N.; Soundararajan, R.; Werden, S. J.; Joseph, R.; Taube, J. H.; Liu, H.; Rodriguez-Canales, J.; Sphyris, N.; Wistuba, I.; Miura, N.; Dhillon, J.; Mahajan, N.; Mahajan, K.; Chang, J. T.; Ittmann, M.; Maity, S. N.; Logothetis, C.; Tang, D. G.; Mani, S. A.			Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties	ONCOGENE			English	Article							TO-MESENCHYMAL TRANSITION; ANDROGEN RECEPTOR; BREAST-CANCER; NEUROENDOCRINE DIFFERENTIATION; AGGRESSIVE PHENOTYPE; KINASE INHIBITORS; RESISTANCE; METASTASIS; ACTIVATION; P38	Advanced prostate adenocarcinomas enriched in stem-cell features, as well as variant androgen receptor (AR)-negative neuroendocrine (NE)/small-cell prostate cancers are difficult to treat, and account for up to 30% of prostate cancer-related deaths every year. While existing therapies for prostate cancer such as androgen deprivation therapy (ADT), destroy the bulk of the AR-positive cells within the tumor, eradicating this population eventually leads to castration-resistance, owing to the continued survival of AR-/lo stem-like cells. In this study, we identified a critical nexus between p38MAPK signaling, and the transcription factor Forkhead Box Protein C2 (FOXC2) known to promote cancer stem-cells and metastasis. We demonstrate that prostate cancer cells that are insensitive to ADT, as well as high-grade/NE prostate tumors, are characterized by elevated FOXC2, and that targeting FOXC2 using a well-tolerated p38 inhibitor restores epithelial attributes and ADT-sensitivity, and reduces the shedding of circulating tumor cells in vivo with significant shrinkage in the tumor mass. This study thus specifies a tangible mechanism to target the AR-/lo population of prostate cancer cells with stem-cell properties.	[Paranjape, A. N.; Soundararajan, R.; Werden, S. J.; Joseph, R.; Taube, J. H.; Liu, H.; Rodriguez-Canales, J.; Sphyris, N.; Wistuba, I.; Mani, S. A.] UT MD Anderson Canc Ctr, Dept Translat Mol Pathol, 2130 West Holcombe Blvd,LSP9-2001, Houston, TX USA; [Miura, N.] Hamamatsu Univ, Sch Med, Dept Biochem, Hamamatsu, Shizuoka, Japan; [Dhillon, J.; Mahajan, N.; Mahajan, K.] Univ S Florida, Dept Oncol Sci, Moffitt Canc Ctr, Tampa, FL USA; [Chang, J. T.] UT Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Sch Med, Sch Biomed Informat, Houston, TX USA; [Ittmann, M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Maity, S. N.; Logothetis, C.] UT MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX USA; [Tang, D. G.] UT MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Sci Pk, Smithville, TX USA; [Mani, S. A.] UT MD Anderson Canc Ctr, Metastasis Res Ctr, Houston, TX USA; [Mani, S. A.] UT MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; Hamamatsu University School of Medicine; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Mani, SA (corresponding author), UT MD Anderson Canc Ctr, Dept Translat Mol Pathol, 2130 West Holcombe Blvd,LSP9-2001, Houston, TX USA.	mani@mdanderson.org	Tang, Dean/AAI-3457-2020; Paranjape, Anurag N./P-1255-2018; SPHYRIS, NATHALIE/GQY-6349-2022; Liu, Hui/AAJ-4339-2020; Mani, Sendurai A./A-7244-2009	Tang, Dean/0000-0001-5029-1174; Paranjape, Anurag N./0000-0001-6119-0766; Liu, Hui/0000-0002-7669-9386; Mani, Sendurai A./0000-0002-5918-4276; Sphyris, Nathalie/0000-0003-1860-1958; Taube, Joseph/0000-0002-3636-5189; Joseph, Robiya/0000-0003-3214-890X; Mahajan, Kiran/0000-0001-7192-396X; Maity, Sankar/0000-0002-2387-6545	American Cancer Society M Patricia Alexander Research Scholar award; MDACC Prostate-SPORE [NIH R01 CA155243]; NATIONAL CANCER INSTITUTE [R01CA155243, P30CA016672] Funding Source: NIH RePORTER	American Cancer Society M Patricia Alexander Research Scholar award; MDACC Prostate-SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Ms Neeraja Bhangre for technical assistance and Dr Sue-Hwa Lin for helpful discussions. This research was supported by grants from MDACC Prostate-SPORE, NIH R01 CA155243 and the American Cancer Society M Patricia Alexander Research Scholar award.	Aggarwal R, 2014, J NATL COMPR CANC NE, V12, P719, DOI 10.6004/jnccn.2014.0073; Aparicio A, 2011, PROSTATE, V71, P846, DOI 10.1002/pros.21301; Balbas MD, 2013, ELIFE, V2, DOI 10.7554/eLife.00499; Castillo V, 2014, INT J ONCOL, V45, P985, DOI 10.3892/ijo.2014.2529; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Cheriyan J, 2011, CIRCULATION, V123, P515, DOI 10.1161/CIRCULATIONAHA.110.971986; Cohen S, 2010, CURR OPIN RHEUMATOL, V22, P330, DOI 10.1097/BOR.0b013e3283378e6f; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Davis JN, 2006, CANCER RES, V66, P11897, DOI 10.1158/0008-5472.CAN-06-2497; Friedlander TW, 2014, INT J CANCER, V134, P2284, DOI 10.1002/ijc.28561; Gan L, 2011, PROSTATE, V71, P1158, DOI 10.1002/pros.21331; Hollier BG, 2013, CANCER RES, V73, P1981, DOI 10.1158/0008-5472.CAN-12-2962; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Izumi K, 2013, EMBO MOL MED, V5, P1383, DOI 10.1002/emmm.201202367; Khandrika L, 2009, ONCOGENE, V28, P1248, DOI 10.1038/onc.2008.476; Koul Hari K, 2013, Genes Cancer, V4, P342, DOI 10.1177/1947601913507951; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Li P, 2014, EXP BIOL MED, V239, P813, DOI 10.1177/1535370214538727; Li P, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-55; Ma B, 2014, J BIOL CHEM, V289, P11153, DOI 10.1074/jbc.M113.540237; MacNee W, 2013, THORAX, V68, P738, DOI 10.1136/thoraxjnl-2012-202744; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Marin-Aguilera M, 2014, MOL CANCER THER, V13, P1270, DOI 10.1158/1535-7163.MCT-13-0775; McKeithen D, 2010, PROSTATE, V70, P982, DOI 10.1002/pros.21132; Milone MR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.165; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Nouri M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00370; Paranjape AN, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-785; Parimi V, 2014, AM J CLIN EXP UROL, V2, P273; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pulukuri SM, 2005, J BIOL CHEM, V280, P36529, DOI 10.1074/jbc.M503111200; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; Ricote M, 2006, APOPTOSIS, V11, P1969, DOI 10.1007/s10495-006-0086-9; Santoni M, 2014, BBA-REV CANCER, V1846, P630, DOI 10.1016/j.bbcan.2014.10.008; Sarkar TR, 2015, ONCOGENE, V34, P2958, DOI 10.1038/onc.2014.245; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Shida Y, 2007, BIOCHEM BIOPH RES CO, V353, P744, DOI 10.1016/j.bbrc.2006.12.077; Shiota M, 2012, CANCER RES, V72, P5261, DOI 10.1158/0008-5472.CAN-12-0254; Sun YT, 2012, CANCER RES, V72, P527, DOI 10.1158/0008-5472.CAN-11-3004; Tamaki H, 2014, ONCOTARGET, V5, P11399, DOI 10.18632/oncotarget.2550; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tzelepi V, 2012, CLIN CANCER RES, V18, P666, DOI 10.1158/1078-0432.CCR-11-1867; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Zhu ML, 2010, FASEB J, V24, P769, DOI 10.1096/fj.09-136994	47	51	53	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 17	2016	35	46					5963	5976		10.1038/onc.2015.498	http://dx.doi.org/10.1038/onc.2015.498			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ED0CA	26804168	hybrid, Green Published			2022-12-26	WOS:000388509400004
J	Park, CS; Kim, TK; Kim, HG; Kim, YJ; Jeoung, MH; Lee, WR; Go, NK; Heo, K; Lee, S				Park, C. S.; Kim, T-K; Kim, H. G.; Kim, Y-J; Jeoung, M. H.; Lee, W. R.; Go, N. K.; Heo, K.; Lee, S.			Therapeutic targeting of tetraspanin8 in epithelial ovarian cancer invasion and metastasis	ONCOGENE			English	Article							COLORECTAL-CANCER; BREAST-CANCER; TUMOR-GROWTH; CO-029; ANTIBODY; DOMAIN; BEVACIZUMAB; MECHANISMS; CD151; CELLS	Epithelial ovarian cancer (EOC) invasion and metastasis are complex phenomena that result from the coordinated action of many metastatic regulators and must be overcome to improve clinical outcomes for patients with these cancers. The identification of novel therapeutic targets is critical because of the limited success of current treatment regimens, particularly in advanced-stage ovarian cancers. In this study, we found that tetraspanin 8 (TSPAN8) is overexpressed in about 52% (14/27) of EOC tissues and correlates with poor survival. Using small interfering RNA-mediated TSPAN8 knockdown and a competition assay with purified TSPAN8 large extracellular loop (TSPAN8-LEL) protein, we identified TSPAN8-LEL as a key regulator of EOC cell invasion. Furthermore, monotherapy with TSPAN8-blocking antibody we developed shows that antibody-based modulation of TSPAN8-LEL can significantly reduce the incidence of EOC metastasis without severe toxicity in vivo. Finally, we demonstrated that the TSPAN8-blocking antibody promotes the internalization and concomitant downregulation of cell surface TSPAN8. Collectively, our data suggest TSPAN8 as a potential novel therapeutic target in EOCs and antibody targeting of TSPAN8 as an effective strategy for inhibiting invasion and metastasis of TSPAN8-expressing EOCs.	[Park, C. S.; Kim, T-K; Jeoung, M. H.; Lee, W. R.; Go, N. K.; Lee, S.] Scripps Korea Antibody Inst, Lab Mol Canc Therapeut, Hyoja 2 Dong, Chuncheon Si 200701, Gangwon Do, South Korea; [Kim, H. G.; Heo, K.] Natl Canc Ctr, Res Inst, New Expt Therapeut Branch, 323 Ilsan Ro, Goyang Si 410769, South Korea; [Kim, Y-J] Natl Canc Ctr, Res Inst, Specif Organs Canc Branch, Goyang Si, South Korea; [Park, C. S.] Korea Inst Ceram Engn & Technol, Eco & Bio Convergence Team, 101 Soho Ro, Jinju Si 661031, Gyeongsangnam D, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Korea Institute of Ceramic Engineering & Technology	Lee, S (corresponding author), Scripps Korea Antibody Inst, Lab Mol Canc Therapeut, Hyoja 2 Dong, Chuncheon Si 200701, Gangwon Do, South Korea.; Heo, K (corresponding author), Natl Canc Ctr, Res Inst, New Expt Therapeut Branch, 323 Ilsan Ro, Goyang Si 410769, South Korea.	hk@ncc.re.kr; lees@skai.or.kr			Scripps Korea Antibody Institute [10TS03]	Scripps Korea Antibody Institute	This work was supported by a research grant (10TS03) from the Scripps Korea Antibody Institute.	Ailane N, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00364; Albanell J, 1999, J MAMMARY GLAND BIOL, V4, P337, DOI 10.1023/A:1018762216147; [Anonymous], 2011, J Natl Cancer Inst, V103, P1287, DOI 10.1093/jnci/djr342; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Gesierich S, 2005, CLIN CANCER RES, V11, P2840, DOI 10.1158/1078-0432.CCR-04-1935; Hemler ME, 2014, NAT REV CANCER, V14, P49, DOI 10.1038/nrc3640; Huynh H, 2007, MOL CANCER THER, V6, P2959, DOI 10.1158/1535-7163.MCT-07-0237; Kanetaka K, 2003, J GASTROEN HEPATOL, V18, P1309, DOI 10.1046/j.1440-1746.2003.03182.x; Kanetaka K, 2001, J HEPATOL, V35, P637, DOI 10.1016/S0168-8278(01)00183-0; Keating GM, 2014, DRUGS, V74, P1891, DOI 10.1007/s40265-014-0302-9; Ki MK, 2013, ONCOGENE, V32, P5449, DOI 10.1038/onc.2013.156; Kim A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-14; Kudo-Saito C, 2014, CANCER RES, V74, P1361, DOI 10.1158/0008-5472.CAN-13-1349; Kuhn S, 2007, MOL CANCER RES, V5, P553, DOI 10.1158/1541-7786.MCR-06-0384; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lee S, 2012, J IMMUNOL, V189, P4592, DOI 10.4049/jimmunol.1103803; Lennon S, 2009, J CLIN ONCOL, V27, P1685, DOI 10.1200/JCO.2008.16.8351; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Novoa-Vargas Arturo, 2014, Ginecol Obstet Mex, V82, P613; Okada Y, 2014, DIGESTION, V89, P18, DOI 10.1159/000356202; Payne SJL, 2008, HISTOPATHOLOGY, V52, P82, DOI 10.1111/j.1365-2559.2007.02897.x; SZALA S, 1990, P NATL ACAD SCI USA, V87, P6833, DOI 10.1073/pnas.87.17.6833; Teo MCC, 2014, CURR OPIN OBSTET GYN, V26, P3, DOI 10.1097/GCO.0000000000000034; Thibault B, 2014, CANCER METAST REV, V33, P17, DOI 10.1007/s10555-013-9456-2; Xu Y, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-16; Yue SJ, 2013, EUR J CANCER, V49, P2934, DOI 10.1016/j.ejca.2013.03.032; Zhou Z, 2008, CLIN EXP METASTAS, V25, P537, DOI 10.1007/s10585-008-9168-0; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	28	42	42	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	34					4540	4548		10.1038/onc.2015.520	http://dx.doi.org/10.1038/onc.2015.520			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU4AC	26804173				2022-12-26	WOS:000382153100011
J	Lawrance, W; Banerji, S; Day, AJ; Bhattacharjee, S; Jackson, DG				Lawrance, William; Banerji, Suneale; Day, Anthony J.; Bhattacharjee, Shaumick; Jackson, David G.			Binding of Hyaluronan to the Native Lymphatic Vessel Endothelial Receptor LYVE-1 Is Critically Dependent on Receptor Clustering and Hyaluronan Organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; complex; endothelial cell; extracellular matrix; hyaluronan; macrophage; LYVE-1; TSG-6; lymphatic endothelium; transmigration	ALPHA-TRYPSIN INHIBITOR; SMOOTH-MUSCLE-CELLS; EZRIN/RADIXIN/MOESIN ERM PROTEINS; HEAVY-CHAINS; LINK MODULE; HUMAN TSG-6; EXTRACELLULAR-MATRIX; LEUKOCYTE ADHESION; CYTOPLASMIC DOMAIN; DENDRITIC CELLS	The lymphatic endothelial receptor LYVE-1 has been implicated in both uptake of hyaluronan (HA) from tissue matrix and in facilitating transit of leukocytes and tumor cells through lymphatic vessels based largely on in vitro studies with recombinant receptor in transfected fibroblasts. Curiously, however, LYVE-1 in lymphatic endothelium displays little if any binding to HA in vitro, and this has led to the conclusion that the native receptor is functionally silenced, a feature that is difficult to reconcile with its proposed in vivo functions. Nonetheless, as we reported recently, LYVE-1 can function as a receptor for HA-encapsulated Group A streptococci and mediate lymphatic dissemination in mice. Here we resolve these paradoxical findings and show that the capacity of LYVE-1 to bind HA is strictly dependent on avidity, demanding appropriate receptor self-association and/or HA multimerization. In particular, we demonstrate the prerequisite of a critical LYVE-1 threshold density and show that HA binding may be elicited in lymphatic endothelium by surface clustering with divalent LYVE-1 mAbs. In addition, we show that cross-linking of biotinylated HA in streptavidin multimers or supramolecular complexes with the inflammation-induced protein TSG-6 enables binding even in the absence of LYVE-1 cross-linking. Finally, we show that endogenous HA on the surface of macrophages can engage LYVE-1, facilitating their adhesion and transit across lymphatic endothelium. These results reveal LYVE-1 as a low affinity receptor tuned to discriminate between different HA configurations through avidity and establish a new mechanistic basis for the functions ascribed to LYVE-1 in matrix HA binding and leukocyte trafficking in vivo.	[Lawrance, William; Banerji, Suneale; Bhattacharjee, Shaumick; Jackson, David G.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England; [Day, Anthony J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Oxford; University of Manchester	Jackson, DG (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England.	david.jackson@imm.ox.ac.uk	Day, Anthony/O-1658-2015	Day, Anthony/0000-0002-1415-3134; banerji, suneale/0000-0002-1179-3152; , david/0000-0002-4133-9364	United Kingdom Medical Research Council; Medical Research Council [1093777, MC_U137884182, MC_UU_12010/2] Funding Source: researchfish; MRC [MC_UU_12010/2, MC_U137884182] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in whole or in part by the United Kingdom Medical Research Council through funding to the MRC Human Immunology Unit (to D. G. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Armstrong SE, 2002, AM J PHYSIOL-HEART C, V283, pH2485, DOI 10.1152/ajpheart.00385.2002; Armstrong SE, 2002, ANAL BIOCHEM, V308, P255, DOI 10.1016/S0003-2697(02)00239-7; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Banerji S, 2010, J BIOL CHEM, V285, P10724, DOI 10.1074/jbc.M109.047647; Baranova NS, 2013, J BIOL CHEM, V288, P29642, DOI 10.1074/jbc.M113.477422; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; Briggs DC, 2015, J BIOL CHEM, V290, P28708, DOI 10.1074/jbc.M115.669838; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; Chang MY, 2014, MATRIX BIOL, V34, P1, DOI 10.1016/j.matbio.2014.01.011; Chang MY, 2012, J BIOL CHEM, V287, P14122, DOI 10.1074/jbc.M111.324988; Cueni LN, 2009, EXP CELL RES, V315, P1715, DOI 10.1016/j.yexcr.2009.02.021; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; DeGrendele HC, 1997, J IMMUNOL, V159, P2549; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Dubacheva GV, 2015, P NATL ACAD SCI USA, V112, P5579, DOI 10.1073/pnas.1500622112; Dubacheva GV, 2014, J AM CHEM SOC, V136, P1722, DOI 10.1021/ja411138s; English NM, 1998, CANCER RES, V58, P3736; Evanko SP, 2012, MATRIX BIOL, V31, P90, DOI 10.1016/j.matbio.2011.10.004; FRASER JRE, 1988, BIOCHEM J, V256, P153, DOI 10.1042/bj2560153; FRASER JRE, 1989, CIBA F SYMP, V143, P41; Gee K, 2003, J BIOL CHEM, V278, P37275, DOI 10.1074/jbc.M302309200; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; Higman VA, 2014, J BIOL CHEM, V289, P5619, DOI 10.1074/jbc.M113.542357; Hou WH, 2012, FEBS LETT, V586, P1480, DOI 10.1016/j.febslet.2012.04.001; HUANG L, 1993, J BIOL CHEM, V268, P26725; Huang SS, 2003, J BIOL CHEM, V278, P43855, DOI 10.1074/jbc.M306411200; Jackson D. G., 2014, J CLIN CELL IMMUNOL, V5, P255; Jackson DG, 2009, IMMUNOL REV, V230, P216, DOI 10.1111/j.1600-065X.2009.00803.x; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; Jackson DG, 2004, APMIS, V112, P526, DOI 10.1111/j.1600-0463.2004.apm11207-0811.x; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Johnson LA, 2013, J CELL SCI, V126, P5259, DOI 10.1242/jcs.135343; Johnson LA, 2010, INT IMMUNOL, V22, P839, DOI 10.1093/intimm/dxq435; Kahmann JD, 1997, PROTEIN EXPRES PURIF, V9, P315, DOI 10.1006/prep.1996.0694; Katoh S, 2010, CLIN EXP IMMUNOL, V161, P233, DOI 10.1111/j.1365-2249.2010.04165.x; KATOH S, 1995, J EXP MED, V182, P419, DOI 10.1084/jem.182.2.419; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2000, J BIOL CHEM, V275, P26967; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; LESLEY J, 1993, EUR J IMMUNOL, V23, P1902, DOI 10.1002/eji.1830230826; LESLEY J, 1992, EUR J IMMUNOL, V22, P2719, DOI 10.1002/eji.1830221036; LESLEY J, 1995, J EXP MED, V182, P431, DOI 10.1084/jem.182.2.431; LESLEY J, 1992, J EXP MED, V175, P257, DOI 10.1084/jem.175.1.257; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Levesque MC, 1999, CELL IMMUNOL, V193, P209, DOI 10.1006/cimm.1999.1456; LOKESHWAR VB, 1994, J CELL BIOL, V126, P1099, DOI 10.1083/jcb.126.4.1099; Lynskey NN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005137; Mahaffey CL, 2007, J IMMUNOL, V179, P8191, DOI 10.4049/jimmunol.179.12.8191; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; McDonald B, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00068; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Monslow J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00231; Mummert ME, 2005, IMMUNOL RES, V31, P189, DOI 10.1385/IR:31:3:189; Mummert ME, 2002, J IMMUNOL, V169, P4322, DOI 10.4049/jimmunol.169.8.4322; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; Nightingale TD, 2009, J BIOL CHEM, V284, P3935, DOI 10.1074/jbc.M805105200; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Platt AM, 2013, ADV IMMUNOL, V120, P51, DOI 10.1016/B978-0-12-417028-5.00002-8; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2008, J BIOL CHEM, V283, P33919, DOI 10.1074/jbc.M804240200; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Teijeira A, 2014, SEMIN IMMUNOPATHOL, V36, P261, DOI 10.1007/s00281-013-0410-8; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Tewalt EF, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00305; Thiemann S, 2015, J BIOL CHEM, V290, P22662, DOI 10.1074/jbc.M115.644799; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Wang Y, 2014, J BIOL CHEM, V289, P35159, DOI 10.1074/jbc.M114.600767; Wolny PM, 2010, J BIOL CHEM, V285, P30170, DOI 10.1074/jbc.M110.137562; Wu C, 2014, IMMUNITY, V41, P270, DOI 10.1016/j.immuni.2014.06.011; Wu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092857; Yao LC, 2012, AM J PATHOL, V180, P2561, DOI 10.1016/j.ajpath.2012.02.019; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yu MS, 2015, EXP CELL RES, V336, P150, DOI 10.1016/j.yexcr.2015.06.014; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200	95	69	69	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8014	8030		10.1074/jbc.M115.708305	http://dx.doi.org/10.1074/jbc.M115.708305			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26823460	hybrid, Green Published			2022-12-26	WOS:000374056700022
J	Luff, SA; Papoutsakis, ET				Luff, Stephanie A.; Papoutsakis, Eleftherios T.			Megakaryocytic Maturation in Response to Shear Flow Is Mediated by the Activator Protein 1 (AP-1) Transcription Factor via Mitogen-activated Protein Kinase (MAPK) Mechanotransduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP1 transcription factor (AP-1); c-Jun N-terminal kinase (JNK); p38 MAPK; shear stress; transcriptomics; Megakaryocyte; megakaryopoiesis; polyploidization	SIGNAL-REGULATED KINASE; N-TERMINAL KINASE; ENDOTHELIAL-CELLS; PLATELET PRODUCTION; STEM-CELLS; DIFFERENTIATION; STRESS; P38; APOPTOSIS; PATHWAYS	Megakaryocytes (MKs) are exposed to shear flow as they migrate from the bone marrow hematopoietic compartment into circulation to release pro/preplatelets into circulating blood. Shear forces promote DNA synthesis, polyploidization, and maturation in MKs, and platelet biogenesis. To investigate mechanisms underlying these MK responses to shear, we carried out transcriptional analysis on immature and mature stem cell-derived MKs exposed to physiological shear. In immature (day (d)9) MKs, shear exposure up-regulated genes related to growth and MK maturation, whereas in mature (d12) MKs, it up-regulated genes involved in apoptosis and intracellular transport. Following shear-flow exposure, six activator protein 1 (AP-1) transcripts (ATF4, JUNB, JUN, FOSB, FOS, and JUND) were up-regulated at d9 and two AP-1 proteins (JunD and c-Fos) were up-regulated both at d9 and d12. We show that mitogen-activated protein kinase (MAPK) signaling is linked to both the shear stress response and AP-1 up-regulation. c-Jun N-terminal kinase (JNK) phosphorylation increased significantly following shear stimulation, whereas JNK inhibition reduced shear-induced JunD expression. Although p38 phosphorylation did not increase following shear flow, its inhibition reduced shear-induced JunD and c-Fos expression. JNK inhibition reduced fibrinogen binding and P-selectin expression of d12 platelet-like particles (PLPs), whereas p38 inhibition reduced fibrinogen binding of d12 PLPs. AP-1 expression correlated with increased MK DNA synthesis and polyploidization, which might explain the observed impact of shear on MKs. To summarize, we show that MK exposure to shear forces results in JNK activation, AP-1 up-regulation, and downstream transcriptional changes that promote maturation of immature MKs and platelet biogenesis in mature MKs.	[Luff, Stephanie A.; Papoutsakis, Eleftherios T.] Univ Delaware, Dept Biol Sci, Newark, DE 19711 USA; [Luff, Stephanie A.; Papoutsakis, Eleftherios T.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA; [Papoutsakis, Eleftherios T.] Univ Delaware, Dept Biomol & Chem Engn, Newark, DE 19711 USA	University of Delaware; University of Delaware; University of Delaware	Papoutsakis, ET (corresponding author), 15 Innovat Way, Newark, DE 19711 USA.	epaps@udel.edu		Luff, Stephanie/0000-0003-4259-3839	National Institutes of Health [R21HL106397]; National Institutes of Health Shared Instrumentation Grant [S10 RR0272773]; National Science Foundation Fellowship at the University of Delaware [IGERT SBE2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Fellowship at the University of Delaware; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21HL106397, National Institutes of Health Shared Instrumentation Grant S10 RR0272773, and the National Science Foundation Fellowship IGERT SBE2 program at the University of Delaware (to S. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Apostolidis PA, 2012, PHYSIOL GENOMICS, V44, P638, DOI 10.1152/physiolgenomics.00028.2012; Apostolidis PA, 2012, EXP HEMATOL, V40, P131, DOI 10.1016/j.exphem.2011.10.006; Azuma N, 2001, AM J PHYSIOL-HEART C, V280, pH189, DOI 10.1152/ajpheart.2001.280.1.H189; Baan B, 2006, MOL ENDOCRINOL, V20, P1786, DOI 10.1210/me.2005-0289; Bender M, 2015, BLOOD, V125, P860, DOI 10.1182/blood-2014-09-600858; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bhattacharyya S, 2012, ACTA BIOCH BIOPH SIN, V44, P463, DOI 10.1093/abbs/gms027; Chang Y, 2007, J THROMB HAEMOST, V5, P318, DOI 10.1111/j.1538-7836.2007.02472.x; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Chen C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-384; Clarke MCH, 2003, J CELL BIOL, V160, P577, DOI 10.1083/jcb.200210111; Clichici S, 2012, TOXICOL APPL PHARM, V259, P281, DOI 10.1016/j.taap.2012.01.004; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Damle S, 2006, DEV BIOL, V299, P543, DOI 10.1016/j.ydbio.2006.06.016; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dumas JF, 2009, J BIOL CHEM, V284, P15117, DOI 10.1074/jbc.M900926200; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Dunois-Larde C, 2009, BLOOD, V114, P1875, DOI 10.1182/blood-2009-03-209205; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eriksson M, 2005, EXP CELL RES, V304, P175, DOI 10.1016/j.yexcr.2004.10.017; Ferrara DE, 2006, AM J PHYSIOL-REG I, V290, pR114, DOI 10.1152/ajpregu.00449.2005; Fish KN, 2008, BRAIN RES, V1240, P62, DOI 10.1016/j.brainres.2008.08.060; Fu MM, 2014, TRENDS CELL BIOL, V24, P564, DOI 10.1016/j.tcb.2014.05.002; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Fuhrken PG, 2008, PHYSIOL GENOMICS, V33, P159, DOI 10.1152/physiolgenomics.00127.2007; Fuhrken PG, 2007, EXP HEMATOL, V35, P476, DOI 10.1016/j.exphem.2006.10.017; Go YM, 1998, AM J PHYSIOL-HEART C, V275, pH1898, DOI 10.1152/ajpheart.1998.275.5.H1898; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032; Hsieh HJ, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-3; Italiano JE, 2003, J THROMB HAEMOST, V1, P1174, DOI 10.1046/j.1538-7836.2003.00290.x; Jiang JL, 2014, BLOOD, V124, P2094, DOI 10.1182/blood-2014-01-547927; Jo H, 1997, J BIOL CHEM, V272, P1395, DOI 10.1074/jbc.272.2.1395; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kamkin A., 2011, MECHANOSENSITIVITY C; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kaushansky K, 2008, BLOOD, V111, P981, DOI 10.1182/blood-2007-05-088500; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; King SM, 2002, SEMIN CELL DEV BIOL, V13, P293, DOI 10.1016/S1084952102000599; Kodiha M., 2009, PROTOC EXCH, DOI [10. 1038/nprot. 2009. 16, DOI 10.1038/NPROT.2009.16]; Lambert MP, 2013, BLOOD, V121, P3319, DOI 10.1182/blood-2012-09-455428; Li S, 2005, J CELL BIOCHEM, V96, P1110, DOI 10.1002/jcb.20614; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Lordier L, 2008, BLOOD, V112, P3164, DOI 10.1182/blood-2008-03-144956; Meng RH, 2012, BLOOD, V120, P404, DOI 10.1182/blood-2011-11-389551; Mostafa SS, 2000, BRIT J HAEMATOL, V111, P879, DOI 10.1046/j.1365-2141.2000.02457.x; Nagata Y, 1998, BLOOD, V92, P1859, DOI 10.1182/blood.V92.6.1859.418k37_1859_1869; Ordureau A, 2013, J BIOL CHEM, V288, P24569, DOI 10.1074/jbc.M113.479550; Palmieri D, 2010, EXP CELL RES, V316, P789, DOI 10.1016/j.yexcr.2009.12.006; Panuganti S, 2013, TISSUE ENG PT A, V19, P998, DOI [10.1089/ten.tea.2011.0111, 10.1089/ten.TEA.2011.0111]; Patel SR, 2005, BLOOD, V106, P4076, DOI 10.1182/blood-2005-06-2204; Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284; Pereira AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026182; Qin YX, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/863421; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Schlam D, 2013, J BIOL CHEM, V288, P23090, DOI 10.1074/jbc.M113.457606; Severin S, 2010, J THROMB HAEMOST, V8, P17, DOI 10.1111/j.1538-7836.2009.03658.x; Shi ZD, 2011, ANN BIOMED ENG, V39, P1608, DOI 10.1007/s10439-011-0309-2; Shi ZD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012196; Shin JW, 2011, P NATL ACAD SCI USA, V108, P11458, DOI 10.1073/pnas.1017474108; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Shyu KG, 2005, HYPERTENSION, V46, P614, DOI 10.1161/01.HYP.0000175811.79863.e2; SMEAL T, 1994, EMBO J, V13, P6006, DOI 10.1002/j.1460-2075.1994.tb06946.x; Spinier KR, 2015, BLOOD, V125, P525, DOI 10.1182/blood-2014-05-576462; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vittorio O, 2013, INTEGR BIOL-UK, V5, P291, DOI 10.1039/c2ib20152f; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang P, 2015, ONCOGENE, V34, P4558, DOI 10.1038/onc.2014.397; Wang P, 2014, BBA-MOL CELL RES, V1843, P923, DOI 10.1016/j.bbamcr.2014.01.018; Waters JC, 2009, J CELL BIOL, V185, P1135, DOI 10.1083/jcb.200903097; Weyrich AS, 2013, ANNU REV PHYSIOL, V75, P569, DOI 10.1146/annurev-physiol-030212-183752; Whitaker BI, 2013, REPORT US DEP HLTH H; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Wong AKT, 2013, EXPERT REV HEMATOL, V6, P205, DOI [10.1586/ehm.13.5, 10.1586/EHM.13.5]; Yang H, 2003, P NATL ACAD SCI USA, V100, P1122, DOI 10.1073/pnas.0237337100; Zhang W, 2015, BLOOD, V125, P562, DOI 10.1182/blood-2014-07-589507; Zhao Y, 2012, MOL CELL BIOCHEM, V359, P217, DOI 10.1007/s11010-011-1016-x	81	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7831	7843		10.1074/jbc.M115.707174	http://dx.doi.org/10.1074/jbc.M115.707174			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26814129	hybrid, Green Published			2022-12-26	WOS:000374056700007
J	Budelli, G; Sun, Q; Ferreira, J; Butler, A; Santi, CM; Salkoff, L				Budelli, Gonzalo; Sun, Qi; Ferreira, Juan; Butler, Alice; Santi, Celia M.; Salkoff, Lawrence			SLO2 Channels Are Inhibited by All Divalent Cations That Activate SLO1 K+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL; CA-2&-ACTIVATED K; HIGH-CONDUCTANCE; OUTWARD CURRENT; ION CHANNELS; SLACK; NA+; NEURONS; FAMILY; LOCALIZATION	Two members of the family of high conductance K+ channels SLO1 and SLO2 are both activated by intracellular cations. However, SLO1 is activated by Ca2+ and other divalent cations, while SLO2 (Slack or SLO2.2 from rat) is activated by Na+. Curiously though, we found that SLO2.2 is inhibited by all divalent cations that activate SLO1, with Zn2+ being the most effective inhibitor with an IC50 of similar to 8 mu M in contrast to Mg2+, the least effective, with an IC50 of similar to 1.5 mM. Our results suggest that divalent cations are not SLO2 pore blockers, but rather inhibit channel activity by an allosteric modification of channel gating. By site-directed mutagenesis we show that a histidine residue (His-347) downstream of S6 reduces inhibition by divalent cations. An analogous His residue present in some CNG channels is an inhibitory cation binding site. To investigate whether inhibition by divalent cations is conserved in an invertebrate SLO2 channel we cloned the SLO2 channel from Drosophila (dSLO2) and compared its properties to those of rat SLO2.2. We found that, like rat SLO2.2, dSLO2 was also activated by Na+ and inhibited by divalent cations. Inhibition of SLO2 channels in mammals and Drosophila by divalent cations that have second messenger functions may reflect the physiological regulation of these channels by one or more of these ions.	[Budelli, Gonzalo; Sun, Qi; Ferreira, Juan; Butler, Alice; Santi, Celia M.; Salkoff, Lawrence] Washington Univ, Sch Med, Dept Neurosci, 660 S Euclid Ave, St Louis, MO 63110 USA; [Salkoff, Lawrence] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Budelli, Gonzalo] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02458 USA; [Budelli, Gonzalo] Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02458 USA	Washington University (WUSTL); Washington University (WUSTL); Brandeis University; Brandeis University	Salkoff, L (corresponding author), Washington Univ, Sch Med, Dept Neurosci, 660 S Euclid Ave, St Louis, MO 63110 USA.	salkoffl@wustl.edu	Ferreira, Juan/GNW-6445-2022	Budelli, Gonzalo/0000-0002-2157-5511; Ferreira, Juan/0000-0001-8175-9067	National Institutes of Health [R21 NS088611, R21 MH107955, R01 HD069631]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH107955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS088611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R21 NS088611 and R21 MH107955 (to L. S.) and R01 HD069631 (to C. M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bhattacharjee A, 2002, J COMP NEUROL, V454, P241, DOI 10.1002/cne.10439; Budelli G, 2009, NAT NEUROSCI, V12, P745, DOI 10.1038/nn.2313; Contreras GF, 2013, CHANNELS, V7, P442, DOI 10.4161/chan.26242; DRYER SE, 1994, TRENDS NEUROSCI, V17, P155, DOI 10.1016/0166-2236(94)90093-0; EGAN TM, 1992, BRAIN RES, V584, P319, DOI 10.1016/0006-8993(92)90913-T; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; Hage TA, 2012, J NEUROSCI, V32, P2714, DOI 10.1523/JNEUROSCI.5088-11.2012; Henrich M, 2008, AM J PHYSIOL-CELL PH, V294, pC280, DOI 10.1152/ajpcell.00345.2007; Hou SW, 2010, J BIOL CHEM, V285, P6434, DOI 10.1074/jbc.M109.069211; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; Jegla T, 1997, J NEUROSCI, V17, P32, DOI 10.1523/JNEUROSCI.17-01-00032.1997; Kaczmarek Leonard K, 2013, ISRN Neurosci, V2013; KAMEYAMA M, 1984, NATURE, V309, P354, DOI 10.1038/309354a0; Lu SQ, 2010, J NEUROPHYSIOL, V103, P3311, DOI 10.1152/jn.00607.2009; MILLER C, 1987, J GEN PHYSIOL, V90, P427, DOI 10.1085/jgp.90.3.427; Nuwer MO, 2010, J NEUROSCI, V30, P14165, DOI 10.1523/JNEUROSCI.3150-10.2010; OBERHAUSER A, 1988, J GEN PHYSIOL, V92, P67, DOI 10.1085/jgp.92.1.67; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; Paulais M, 2006, J GEN PHYSIOL, V127, P205, DOI 10.1085/jgp.200509360; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; Ruffin VA, 2008, NEUROSCIENCE, V151, P410, DOI 10.1016/j.neuroscience.2007.10.031; SAITO M, 1991, J NEUROSCI, V11, P2135; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Santi CM, 2006, J NEUROSCI, V26, P5059, DOI 10.1523/JNEUROSCI.3372-05.2006; Shi JY, 2001, J GEN PHYSIOL, V118, P589, DOI 10.1085/jgp.118.5.589; VERGARA C, 1983, J GEN PHYSIOL, V82, P543, DOI 10.1085/jgp.82.4.543; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Yuan A, 2000, NAT NEUROSCI, V3, P771, DOI 10.1038/77670; Zhang Z, 2010, J NEUROSCI, V30, P7554, DOI 10.1523/JNEUROSCI.0525-10.2010; Zhou Y, 2012, P NATL ACAD SCI USA, V109, P11413, DOI 10.1073/pnas.1204444109	33	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7347	7356		10.1074/jbc.M115.709436	http://dx.doi.org/10.1074/jbc.M115.709436			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26823461	hybrid, Green Published			2022-12-26	WOS:000383447600012
J	Zhang, H; Yang, J; Wu, S; Gong, WB; Chen, C; Perrett, S				Zhang, Hong; Yang, Jie; Wu, Si; Gong, Weibin; Chen, Chang; Perrett, Sarah			Glutathionylation of the Bacterial Hsp70 Chaperone DnaK Provides a Link between Oxidative Stress and the Heat Shock Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70 kilodalton heat shock protein (Hsp70); chaperone; chaperone DnaK (DnaK); glutathionylation; oxidative stress; S-glutathionylation; deglutathionylation; thiol modification	NUCLEOTIDE EXCHANGE FACTOR; ESCHERICHIA-COLI; S-NITROSYLATION; ATP HYDROLYSIS; CONFORMATIONAL-CHANGES; SMALL MOLECULES; BINDING DOMAIN; PROTEINS; GRPE; IDENTIFICATION	DnaK is the major bacterial Hsp70, participating in DNA replication, protein folding, and the stress response. DnaK cooperates with the Hsp40 co-chaperone DnaJ and the nucleotide exchange factor GrpE. Under non-stress conditions, DnaK binds to the heat shock transcription factor sigma(32) and facilitates its degradation. Oxidative stress results in temporary inactivation of DnaK due to depletion of cellular ATP and thiol modifications such as glutathionylation until normal cellular ATP levels and a reducing environment are restored. However, the biological significance of DnaK glutathionylation remains unknown, and the mechanisms by which glutathionylation may regulate the activity of DnaK are also unclear. We investigated the conditions under which Escherichia coli DnaK undergoes S-glutathionylation. We observed glutathionylation of DnaK in lysates of E. coli cells that had been subjected to oxidative stress. We also obtained homogeneously glutathionylated DnaK using purified DnaK in the apo state. We found that glutathionylation of DnaK reversibly changes the secondary structure and tertiary conformation, leading to reduced nucleotide and peptide binding ability. The chaperone activity of DnaK was reversibly down-regulated by glutathionylation, accompanying the structural changes. We found that interaction of DnaK with DnaJ, GrpE, or sigma(32) becomes weaker when DnaK is glutathionylated, and the interaction is restored upon deglutathionylation. This study confirms that glutathionylation down-regulates the functions of DnaK under oxidizing conditions, and this down-regulation may facilitate release of sigma(32) from its interaction with DnaK, thus triggering the heat shock response. Such a mechanism provides a link between oxidative stress and the heat shock response in bacteria.	[Zhang, Hong; Yang, Jie; Wu, Si; Gong, Weibin; Chen, Chang; Perrett, Sarah] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China; [Yang, Jie] Univ Chinese Acad Sci, 19 Yuquan Rd, Beijing 100049, Peoples R China; [Chen, Chang] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, C; Perrett, S (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	changchen@moon.ibp.ac.cn; sarah.perrett@cantab.net	Perrett, Sarah/AAS-9483-2020	Perrett, Sarah/0000-0003-0137-0997; chen, chang/0000-0003-1008-1062	Chinese Ministry of Science and Technology 973 Program [2012CB911000, 2013CB910700]; National Natural Science Foundation of China [31270794, 31300631, 31200578, 31030023, 31225012, 31110103914, 31570780]	Chinese Ministry of Science and Technology 973 Program(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Ministry of Science and Technology 973 Program Grants 2012CB911000 and 2013CB910700 (to S. P.) and National Natural Science Foundation of China Grants 31270794 (to H. Z.), 31300631 (to S. W.), 31200578 (to W. G.), 31030023 and 31225012 (to C. C.), and 31110103914 and 31570780 (to S. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Ansong C, 2013, P NATL ACAD SCI USA, V110, P10153, DOI 10.1073/pnas.1221210110; Arsene F, 2000, INT J FOOD MICROBIOL, V55, P3, DOI 10.1016/S0168-1605(00)00206-3; Baler R, 1996, CELL STRESS CHAPERON, V1, P33, DOI 10.1379/1466-1268(1996)001<0033:EFAROH>2.3.CO;2; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Carbone DL, 2004, CHEM RES TOXICOL, V17, P1459, DOI 10.1021/tx049838g; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Chi BK, 2013, ANTIOXID REDOX SIGN, V18, P1273, DOI 10.1089/ars.2012.4686; Chirico WJ, 1998, BIOCHEMISTRY-US, V37, P13862, DOI 10.1021/bi980597j; Dahl JU, 2015, J MOL BIOL, V427, P1549, DOI 10.1016/j.jmb.2015.02.014; Fratelli M, 2005, P NATL ACAD SCI USA, V102, P13998, DOI 10.1073/pnas.0504398102; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; GROSSMAN AD, 1987, GENE DEV, V1, P179, DOI 10.1101/gad.1.2.179; GROSSMAN AD, 1984, CELL, V38, P383, DOI 10.1016/0092-8674(84)90493-8; Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200; Han WJ, 2003, BIOCHEM J, V369, P627, DOI 10.1042/BJ20020943; Harrison C, 2003, CELL STRESS CHAPERON, V8, P218, DOI 10.1379/1466-1268(2003)008<0218:GANEFF>2.0.CO;2; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hermawan A, 1999, ARCH BIOCHEM BIOPHYS, V369, P157, DOI 10.1006/abbi.1999.1354; Hoppe G, 2004, EXP EYE RES, V78, P1085, DOI 10.1016/j.exer.2004.02.001; Huang B, 2009, CARDIOVASC RES, V83, P536, DOI 10.1093/cvr/cvp154; HYSLOP PA, 1988, J BIOL CHEM, V263, P1665; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Kang YL, 2008, BIOORG MED CHEM LETT, V18, P3749, DOI 10.1016/j.bmcl.2008.05.046; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; KOBAYASHI N, 1993, MOL CELL BIOL, V13, P248, DOI 10.1128/MCB.13.1.248; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; Lefievre L, 2007, PROTEOMICS, V7, P3066, DOI 10.1002/pmic.200700254; Leichert LIO, 2003, J BACTERIOL, V185, P1967, DOI 10.1128/JB.185.6.1967-1975.2003; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu QL, 1996, J BIOL CHEM, V271, P29937, DOI 10.1074/jbc.271.47.29937; Matagne A, 2000, J MOL BIOL, V297, P193, DOI 10.1006/jmbi.2000.3540; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; MCCARTY JS, 1991, P NATL ACAD SCI USA, V88, P9513, DOI 10.1073/pnas.88.21.9513; Michelet L, 2008, J BIOL CHEM, V283, P21571, DOI 10.1074/jbc.M802331200; Mieyal JJ, 2012, ANTIOXID REDOX SIGN, V16, P471, DOI 10.1089/ars.2011.4454; Miyata Y, 2012, CHEM BIOL, V19, P1391, DOI 10.1016/j.chembiol.2012.07.026; MONTGOMERY D, 1993, J MOL BIOL, V232, P680, DOI 10.1006/jmbi.1993.1418; Muller A, 2013, J BACTERIOL, V195, P2807, DOI 10.1128/JB.00127-13; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Noguchi A, 2014, J BACTERIOL, V196, P1694, DOI 10.1128/JB.01197-13; Packschies L, 1997, BIOCHEMISTRY-US, V36, P3417, DOI 10.1021/bi962835l; PALLEROS DR, 1993, BIOCHEMISTRY-US, V32, P4314, DOI 10.1021/bi00067a021; PALLEROS DR, 1992, J BIOL CHEM, V267, P5279; Pierpaoli EV, 1998, J BIOL CHEM, V273, P6643, DOI 10.1074/jbc.273.12.6643; Popp S, 2005, J MOL BIOL, V347, P1039, DOI 10.1016/j.jmb.2005.02.026; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Ramsey AJ, 2009, BIOCHEM J, V423, P411, DOI 10.1042/BJ20090543; Reid KL, 1996, CELL STRESS CHAPERON, V1, P127, DOI 10.1379/1466-1268(1996)001<0127:PIBMOT>2.3.CO;2; Revington M, 2004, J BIOL CHEM, V279, P33958, DOI 10.1074/jbc.M313967200; Ricci Laura, 2008, Curr Chem Genomics, V2, P90, DOI 10.2174/1875397300802010090; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Russell R, 1999, BIOCHEMISTRY-US, V38, P4165, DOI 10.1021/bi9824036; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; SPRAGG RG, 1985, J CLIN INVEST, V76, P1471, DOI 10.1172/JCI112126; Swain JF, 2001, BIOCHEM SOC SYMP, V68, P69; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Taylor DM, 2007, CELL STRESS CHAPERON, V12, P151, DOI 10.1379/CSC-254R.1; Thompson AD, 2012, CELL STRESS CHAPERON, V17, P313, DOI 10.1007/s12192-011-0307-1; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Wang YY, 2012, MOL BIOL CELL, V23, P3290, DOI 10.1091/mbc.E12-06-0447; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Wei PC, 2012, MOL CELL, V48, P747, DOI 10.1016/j.molcel.2012.10.007; Westerheide SD, 2012, CURR PROTEIN PEPT SC, V13, P86; Wiktorowicz JE, 2011, BIOCHEMISTRY-US, V50, P5601, DOI 10.1021/bi200008b; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; Wisen S, 2008, ANAL BIOCHEM, V374, P371, DOI 10.1016/j.ab.2007.12.009; Zhang H, 2009, MOL MICROBIOL, V71, P702, DOI 10.1111/j.1365-2958.2008.06557.x; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002; Zhuravleva A, 2011, P NATL ACAD SCI USA, V108, P6987, DOI 10.1073/pnas.1014448108	77	26	28	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6967	6981		10.1074/jbc.M115.673608	http://dx.doi.org/10.1074/jbc.M115.673608			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26823468	Green Published, hybrid			2022-12-26	WOS:000373299700033
J	O'Brien, LM; Stewart, LD; Strain, SAJ; Grant, IR				O'Brien, Lorna M.; Stewart, Linda D.; Strain, Sam A. J.; Grant, Irene R.			Novel Monoclonal Antibody and Peptide Binders for Mycobacterium avium subsp paratuberculosis and Their Application for Magnetic Separation	PLOS ONE			English	Article							MEDIATED CAPTURE PCR; IMMUNOMAGNETIC SEPARATION; SALMONELLA-TYPHIMURIUM; ACCURATE ENUMERATION; JOHNES-DISEASE; PHAGE ASSAY; MILK; TUBERCULOSIS; SPECIFICITY; CULTURE	The generation of novel Mycobacterium avium subsp. paratuberculosis (MAP)-specific monoclonal antibodies and phage-display derived peptide binders, along with their application for the magnetic separation (MS) of MAP cells, is described. Our aim was to achieve even greater MAP capture capability than is possible with peptide-mediated magnetic separation (PMS) using a 50: 50 mix of biotinylated-aMp3 and biotinylated-aMptD peptide-coated beads. Gamma-irradiated whole MAP cells and ethanol extracted antigens (EEA) from these cells were used to elicit an immune response and as phage-display biopanning targets. A range of novel binders was obtained and coated onto paramagnetic beads, both individually and in various combinations, for MS evaluation. IS900 PCR was employed after MS to provide quick results. Capture sensitivity was assessed using a range of MAP concentrations after which the most promising beads were tested for their specificity for MAP, by performing MS followed by culture using 10 other Mycobacterium species. Magnetic beads coated with the biotinylated EEA402 peptide demonstrated a greater level of MAP capture than the current PMS method, even when low numbers of MAP (< 10 cfu/ml) were present; however these beads also captured a range of other mycobacteria and so lacked capture specificity. Magnetic beads coated with monoclonal antibodies 6G11 and 15D10 (used as a 50: 50 mix or as dually coated beads) also demonstrated improved MAP capture relative to the current PMS method, but with little cross-reactivity to other Mycobacterium spp. Therefore, two new MS protocols are suggested, the application of which would be dependent upon the required endpoint. Biotinylated EEA402-coated beads could potentially be used with a MAP-specific PCR to ensure detection specificity, while beads coated with 6G11 and 15D10 monoclonal antibodies could be used with culture or the phage amplification assay.	[O'Brien, Lorna M.; Stewart, Linda D.; Grant, Irene R.] Queens Univ Belfast, Ctr Med Biol, Sch Biol Sci, Inst Global Food Secur, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland; [Strain, Sam A. J.] Anim Hlth & Welf Northern Ireland, 97 Moy Rd, Dungannon BT71 7DX, Tyrone, North Ireland	Queens University Belfast	Grant, IR (corresponding author), Queens Univ Belfast, Ctr Med Biol, Sch Biol Sci, Inst Global Food Secur, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	i.grant@qub.ac.uk	Stewart, Linda/AFS-8631-2022; Strain, Sam/AAI-7289-2020	Grant, Irene/0000-0001-5860-3769; Stewart, Linda/0000-0002-2400-6162	PhD studentship to Lorna M. O'Brien as part of a larger project (ICONMAP) [11S141]; Department of Agriculture, Food and Marine, Republic of Ireland under the Food Institutional Research Measure (FIRM); Department of Agriculture, Food and the Marine, Republic of Ireland [RSF11/S/141 ICONMAP]	PhD studentship to Lorna M. O'Brien as part of a larger project (ICONMAP); Department of Agriculture, Food and Marine, Republic of Ireland under the Food Institutional Research Measure (FIRM); Department of Agriculture, Food and the Marine, Republic of Ireland	Research was funded by a PhD studentship to Lorna M. O'Brien as part of a larger project (ICONMAP, Project no. 11S141) funded by the Department of Agriculture, Food and Marine, Republic of Ireland under the Food Institutional Research Measure (FIRM). This work was supported by a research grant from the Department of Agriculture, Food and the Marine, Republic of Ireland (RSF11/S/141 ICONMAP). The authors sincerely thank Dr Antonio Foddai for his advice in relation to magnetic separation, and Dr Douwe Bakker, Central Veterinary Institute of Wageningen University, Lelystad, for providing several additional monoclonal antibodies for evaluation during this study. Funder website: http://www.agriculture.gov.ie/research/foodinstitutionalresearchmeasurefirm/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2007, J APPL MICROBIOL, V103, P892, DOI 10.1111/j.1365-2672.2007.03339.x; COCITO C, 1994, CLIN MICROBIOL REV, V7, P328, DOI 10.1128/CMR.7.3.328-345.1994; de Juan L, 2006, APPL ENVIRON MICROB, V72, P5927, DOI 10.1128/AEM.00451-06; Dennis MM, 2008, VET MICROBIOL, V131, P154, DOI 10.1016/j.vetmic.2008.02.017; Eda S, 2006, CLIN VACCINE IMMUNOL, V13, P837, DOI 10.1128/CVI.00148-06; Foddai A, 2011, J CLIN MICROBIOL, V49, P2017, DOI 10.1128/JCM.00429-11; Foddai A, 2010, APPL ENVIRON MICROB, V76, P7550, DOI 10.1128/AEM.01432-10; Foddai A, 2009, APPL ENVIRON MICROB, V75, P3896, DOI 10.1128/AEM.00294-09; Foddai ACG, 2015, INT DAIRY J, V51, P16, DOI 10.1016/j.idairyj.2015.07.004; GlatmanFreedman A, 1996, J CLIN MICROBIOL, V34, P2795, DOI 10.1128/JCM.34.11.2795-2802.1996; Grant IR, 1998, APPL ENVIRON MICROB, V64, P3153; Huang J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/101932; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KOLK AHJ, 1984, CLIN EXP IMMUNOL, V58, P511; Lavers CJ, 2014, J DAIRY SCI, V97, P299, DOI 10.3168/jds.2013-7101; Marce C, 2011, PREV VET MED, V100, P116, DOI 10.1016/j.prevetmed.2011.02.004; More SJ, 2013, J DAIRY SCI, V96, P1581, DOI 10.3168/jds.2012-5918; Morton J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074312; Mutharia LM, 1997, INFECT IMMUN, V65, P387, DOI 10.1128/IAI.65.2.387-394.1997; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Naser SA, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-14; Paoli GC, 2004, J IMMUNOL METHODS, V289, P147, DOI 10.1016/j.jim.2004.04.001; Plain KM, 2014, J CLIN MICROBIOL, V52, P745, DOI 10.1128/JCM.03233-13; Sevilla IA, 2014, APPL ENVIRON MICROB, V80, P3757, DOI 10.1128/AEM.01026-14; Slana I, 2008, VET MED-CZECH, V53, P283, DOI 10.17221/1859-VETMED; Steingroewer J, 2005, ENG LIFE SCI, V5, P267, DOI 10.1002/elsc.200420072; Steingroewer J, 2007, J MAGN MAGN MATER, V311, P295, DOI 10.1016/j.jmmm.2006.10.1192; Stewart LD, 2012, J CLIN MICROBIOL, V50, P1598, DOI 10.1128/JCM.05747-11; Stratmann J, 2002, J CLIN MICROBIOL, V40, P4244, DOI 10.1128/JCM.40.11.4244-4250.2002; Stratmann J, 2006, APPL ENVIRON MICROB, V72, P5150, DOI 10.1128/AEM.00590-06; SWEENEY RW, 1992, J CLIN MICROBIOL, V30, P166, DOI 10.1128/JCM.30.1.166-171.1992; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790; Whitlock RH, 1996, VET CLIN N AM-FOOD A, V12, P345, DOI 10.1016/S0749-0720(15)30410-2	33	13	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147870	10.1371/journal.pone.0147870	http://dx.doi.org/10.1371/journal.pone.0147870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815790	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528200060
J	Bush, M; Setiaputra, D; Yip, CK; Molday, RS				Bush, Martin; Setiaputra, Dheva; Yip, Calvin K.; Molday, Robert S.			Cog-Wheel Octameric Structure of RS1, the Discoidin Domain Containing Retinal Protein Associated with X-Linked Retinoschisis	PLOS ONE			English	Article							JUVENILE RETINOSCHISIS; ELECTRON-MICROSCOPY; MOUSE MODEL; GENE; VISUALIZATION; MECHANISMS; RESOLUTION; MUTATIONS	RS1, also known as retinoschisin, is a disulphide-linked, discoidin domain containing homo-oligomeric protein that plays a crucial role in maintaining the cellular and synaptic organization of the retina. This is highlighted by the finding that over 130 mutations in RS1 cause X-linked retinoschisis, a retinal degenerative disease characterized by the splitting of the retinal cell layers, disruption of the photoreceptor-bipolar synapses, degeneration of photoreceptors, and severe loss in central vision. In this study, we investigated the arrangement of the RS1 subunits within the oligomer complex using single particle electron microscopy. RS1 was seen as two stacked rings with each ring displaying a symmetrical cog wheel-like structure with eight teeth or projections corresponding to the RS1 subunits. Three dimensional reconstruction and molecular modelling indicated that the discoidin domain, the principal functional unit of RS1, projects outward, and the Rs1 domain and C-terminal segment containing intermolecular disulphide bonds are present in the inner ring to form the core octameric structure. These studies provide a basis for further understanding the role of the novel core RS1 octameric complex in retinal cell biology and X-linked retinoschisis.	[Bush, Martin; Setiaputra, Dheva; Yip, Calvin K.; Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Molday, RS (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	molday@mail.ubc.ca		Setiaputra, Dheva/0000-0003-2956-6422; Yip, Calvin/0000-0003-1779-9501	National Institutes of Health [EY002422]; Macula Vision Research Foundation; Natural Sciences and Engineering Research Council of Canada Discovery [418157]; Canadian Institutes of Health Research operating [MOP-126126]; NATIONAL EYE INSTITUTE [R01EY002422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macula Vision Research Foundation; Natural Sciences and Engineering Research Council of Canada Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research operating(Canadian Institutes of Health Research (CIHR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health EY002422 (RSM), Macula Vision Research Foundation (RSM), Natural Sciences and Engineering Research Council of Canada Discovery Grant 418157 (CKY), and Canadian Institutes of Health Research operating grant (MOP-126126) (CKY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; CONSORTIUM R, 1998, HUM MOL GENET, V7, P1185; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dyka FM, 2008, BIOCHEMISTRY-US, V47, P9098, DOI 10.1021/bi800938g; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fraternali F, 2003, FEBS LETT, V544, P21, DOI 10.1016/S0014-5793(03)00433-2; Friedrich U, 2011, HUM MOL GENET, V20, P1132, DOI 10.1093/hmg/ddq557; Genead MA, 2010, ARCH OPHTHALMOL-CHIC, V128, P190, DOI 10.1001/archophthalmol.2009.398; Goyal P, 2014, NATURE, V516, P250, DOI 10.1038/nature13768; Grigorieff N, 2011, CURR OPIN STRUC BIOL, V21, P265, DOI 10.1016/j.sbi.2011.01.008; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KELLNER U, 1990, GRAEF ARCH CLIN EXP, V228, P432, DOI 10.1007/BF00927256; Kiedzierska A, 2007, BBA-PROTEINS PROTEOM, V1774, P1069, DOI 10.1016/j.bbapap.2007.07.007; Kotova S, 2010, BIOCHEMISTRY-US, V49, P7023, DOI 10.1021/bi1007029; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Macedo-Ribeiro S, 1999, NATURE, V402, P434, DOI 10.1038/46594; Molday LL, 2007, J BIOL CHEM, V282, P32792, DOI 10.1074/jbc.M706321200; Molday RS, 2012, PROG RETIN EYE RES, V31, P195, DOI 10.1016/j.preteyeres.2011.12.002; Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Ou JX, 2015, J CLIN INVEST, V125, P2891, DOI 10.1172/JCI81380; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sauer CG, 1997, NAT GENET, V17, P164, DOI 10.1038/ng1097-164; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sergeev YV, 2010, HUM MOL GENET, V19, P1302, DOI 10.1093/hmg/ddq006; Shi L, 2009, J BIOL CHEM, V284, P3966, DOI 10.1074/jbc.M806333200; Sikkink SK, 2007, J MED GENET, V44, P225, DOI 10.1136/jmg.2006.047340; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Wang T, 2002, HUM MOL GENET, V11, P3097, DOI 10.1093/hmg/11.24.3097; Weber BHF, 2002, P NATL ACAD SCI USA, V99, P6222, DOI 10.1073/pnas.092528599; Wu WWH, 2005, J BIOL CHEM, V280, P10721, DOI 10.1074/jbc.M413117200; Wu WWH, 2003, J BIOL CHEM, V278, P28139, DOI 10.1074/jbc.M302464200; Xu J, 2009, INVEST OPHTH VIS SCI, V50, P2989, DOI 10.1167/iovs.08-2542; Zeng Y, 2004, INVEST OPHTH VIS SCI, V45, P3279, DOI 10.1167/iovs.04-0576; Zhang LJ, 2015, DOC OPHTHALMOL, V131, P63, DOI 10.1007/s10633-015-9496-8	37	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147653	10.1371/journal.pone.0147653	http://dx.doi.org/10.1371/journal.pone.0147653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812435	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528000046
J	Hielscher, A; Ellis, K; Qiu, C; Porterfield, J; Gerecht, S				Hielscher, Abigail; Ellis, Kim; Qiu, Connie; Porterfield, Josh; Gerecht, Sharon			Fibronectin Deposition Participates in Extracellular Matrix Assembly and Vascular Morphogenesis	PLOS ONE			English	Article							3-DIMENSIONAL COLLAGEN MATRICES; ENDOTHELIAL-CELL MIGRATION; ANGIOGENESIS IN-VITRO; TUMOR-GROWTH; INTEGRIN; EXPRESSION; RECEPTOR; PROMOTES; SURFACE; TUBE	The extracellular matrix (ECM) has been demonstrated to facilitate angiogenesis. In particular, fibronectin has been documented to activate endothelial cells, resulting in their transition from a quiescent state to an active state in which the cells exhibit enhanced migration and proliferation. The goal of this study is to examine the role of polymerized fibronectin during vascular tubulogenesis using a 3 dimensional (3D) cell-derived de-cellularized matrix. A fibronectin-rich 3D de-cellularized ECM was used as a scaffold to study vascular morphogenesis of endothelial cells (ECs). Confocal analyses of several matrix proteins reveal high intra-and extra-cellular deposition of fibronectin in formed vascular structures. Using a small peptide inhibitor of fibronectin polymerization, we demonstrate that inhibition of fibronectin fibrillogenesis in ECs cultured atop de-cellularized ECM resulted in decreased vascular morphogenesis. Further, immunofluorescence and ultrastructural analyses reveal decreased expression of stromal matrix proteins in the absence of polymerized fibronectin with high co-localization of matrix proteins found in association with polymerized fibronectin. Evaluating vascular kinetics, live cell imaging showed that migration, migration velocity, and mean square displacement, are disrupted in structures grown in the absence of polymerized fibronectin. Additionally, vascular organization failed to occur in the absence of a polymerized fibronectin matrix. Consistent with these observations, we tested vascular morphogenesis following the disruption of EC adhesion to polymerized fibronectin, demonstrating that block of integrins alpha(5)beta(1) and alpha(v)beta(3), abrogated vascular morphogenesis. Overall, fibronectin deposition in a 3D cell-derived de-cellularized ECM appears to be imperative for matrix assembly and vascular morphogenesis.	[Hielscher, Abigail; Ellis, Kim; Qiu, Connie; Porterfield, Josh; Gerecht, Sharon] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Hielscher, Abigail; Gerecht, Sharon] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Gerecht, Sharon] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Hielscher, Abigail] Georgia Philadelphia Coll Osteopath Med, Dept Biomed Sci, Suwanee, GA 30024 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Gerecht, S (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.; Gerecht, S (corresponding author), Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA.; Gerecht, S (corresponding author), Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA.	gerecht@jhu.edu	Gerecht, Sharon/HCH-8629-2022; Porterfield, Joshua/HCH-8115-2022	Gerecht, Sharon/0000-0002-8542-4835; Qiu, Connie/0000-0002-1623-9871	National Cancer Institute [U54CA143868]; National Institutes of Health [R01HL107938]; NATIONAL CANCER INSTITUTE [U54CA143868] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107938] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Cancer Institute (U54CA143868, SG) and the National Institutes of Health (R01HL107938, SG).	Abaci HE, 2011, AM J PHYSIOL-CELL PH, V301, pC431, DOI 10.1152/ajpcell.00074.2011; Altrock E, 2015, J HEPATOL, V62, P625, DOI 10.1016/j.jhep.2014.06.010; Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445; Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Berndt A, 2010, HISTOCHEM CELL BIOL, V133, P467, DOI 10.1007/s00418-010-0685-y; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; Davis GE, 2001, J CELL SCI, V114, P917; Dickinson LE, 2012, J BIOMED MATER RES A, V100A, P1457, DOI 10.1002/jbm.a.34059; DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165; Frankowski H, 2012, METHODS MOL BIOL, V814, P221, DOI 10.1007/978-1-61779-452-0_15; FRIDMAN R, 1995, CANCER RES, V55, P2548; George EL, 1997, BLOOD, V90, P3073, DOI 10.1182/blood.V90.8.3073; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Hanjaya-Putra D, 2010, J CELL MOL MED, V14, P2436, DOI 10.1111/j.1582-4934.2009.00981.x; Hao XS, 2004, CANCER-AM CANCER SOC, V100, P1110, DOI 10.1002/cncr.20095; Hielscher A, 2013, CARCINOGENESIS MUTAG, DOI [10.4172/2157-2518.S13-005, DOI 10.4172/2157-2518.S13-005]; Hielscher AC, 2012, AM J PHYSIOL-CELL PH, V302, pC1243, DOI 10.1152/ajpcell.00011.2012; Hilario E, 1996, HISTOL HISTOPATHOL, V11, P915; INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317; Kim MC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002926; Laura E, 2010, SOFT MATTER, V6, P5109; Malik G, 2010, CANCER RES, V70, P4327, DOI 10.1158/0008-5472.CAN-09-3312; NICOSIA RF, 1993, J CELL PHYSIOL, V154, P654, DOI 10.1002/jcp.1041540325; Oakes PW, 2009, BLOOD, V114, P1387, DOI 10.1182/blood-2008-11-191445; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Park KM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5075; Pola C, 2013, CANCER RES, V73, P4571, DOI 10.1158/0008-5472.CAN-13-0218; Rajagopalan P, 2004, BIOPHYS J, V87, P2818, DOI 10.1529/biophysj.103.037218; Roy R, 2005, EXP CELL RES, V312, P14; Rybak JN, 2007, CANCER RES, V67, P10948, DOI 10.1158/0008-5472.CAN-07-1436; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sauer S, 2009, BLOOD, V113, P2265, DOI 10.1182/blood-2008-06-160416; Sevilla CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077316; Shi F, 2010, AM J PHYSIOL-CELL PH, V298, pC1265, DOI 10.1152/ajpcell.00341.2009; Shiu YT, 2004, BIOPHYS J, V86, P2558, DOI 10.1016/S0006-3495(04)74311-8; Smith JT, 2004, LANGMUIR, V20, P8279, DOI 10.1021/la0489763; Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Soucy PA, 2009, MATRIX BIOL, V28, P273, DOI 10.1016/j.matbio.2009.04.005; Stahl PJ, 2014, ADV FUNCT MATER, V24, P3213, DOI 10.1002/adfm.201303217; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Taverna D, 2001, CANCER RES, V61, P5255; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Toth M, 2001, Methods Mol Med, V57, P163, DOI 10.1385/1-59259-136-1:163; Van Obberghen-Schilling E, 2011, INT J DEV BIOL, V55, P511, DOI 10.1387/ijdb.103243eo; Vo E, 2010, STEM CELL REV REP, V6, P237, DOI 10.1007/s12015-010-9144-3; Wang J, 2006, J NEUROCHEM, V96, P148, DOI 10.1111/j.1471-4159.2005.03521.x; Wautier MP, 2007, BLOOD, V110, P894, DOI 10.1182/blood-2006-10-048298; WU CY, 1993, J BIOL CHEM, V268, P21883; Yang JT, 1996, MOL BIOL CELL, V7, P1737, DOI 10.1091/mbc.7.11.1737; Ye Zhaohui, 2008, V430, P243, DOI 10.1007/978-1-59745-182-6_17; Yee D, 2011, TISSUE ENG PT A, V17, P1351, DOI [10.1089/ten.TEA.2010.0481, 10.1089/ten.tea.2010.0481]; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308; Zou L, 2012, J BIOL CHEM, V287, P7190, DOI 10.1074/jbc.M111.304972	57	53	56	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147600	10.1371/journal.pone.0147600	http://dx.doi.org/10.1371/journal.pone.0147600			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811931	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528000042
J	Mapder, T; Talukder, S; Chattopadhyay, S; Banik, SK				Mapder, Tarunendu; Talukder, Srijeeta; Chattopadhyay, Sudip; Banik, Suman K.			Deciphering Parameter Sensitivity in the BvgAS Signal Transduction	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEMS; VIRULENCE GENE-EXPRESSION; BORDETELLA-PERTUSSIS; POSITIVE FEEDBACK; DNA-BINDING; PHOSPHORELAY; OPTIMIZATION; PHOSPHORYLATION; AMPLIFICATION; ROBUSTNESS	To understand the switching of different phenotypic phases of Bordetella pertussis, we propose an optimized mathematical framework for signal transduction through BvgAS two-component system. The response of the network output to the sensory input has been demonstrated in steady state. An analysis in terms of local sensitivity amplification characterizes the nature of the molecular switch. The sensitivity analysis of the model parameters within the framework of various correlation coefficients helps to decipher the contribution of the modular structure in signal propagation. Once classified, the model parameters are tuned to generate the behavior of some novel strains using simulated annealing, a stochastic optimization technique.	[Mapder, Tarunendu; Chattopadhyay, Sudip] Indian Inst Engn Sci & Technol, Dept Chem, Sibpur 711103, Howrah, India; [Talukder, Srijeeta] Univ Calcutta, Dept Chem, 92 APC Rd, Kolkata 700009, W Bengal, India; [Banik, Suman K.] Bose Inst, Dept Chem, 93-1 APC Rd, Kolkata 700009, W Bengal, India	Indian Institute of Engineering Science Technology Shibpur (IIEST); University of Calcutta; Department of Science & Technology (India); Bose Institute	Chattopadhyay, S (corresponding author), Indian Inst Engn Sci & Technol, Dept Chem, Sibpur 711103, Howrah, India.; Banik, SK (corresponding author), Bose Inst, Dept Chem, 93-1 APC Rd, Kolkata 700009, W Bengal, India.	sudip_chattopadhyay@rediffmail.com; skbanik@jcbose.ac.in	Chattopadhyay, Sudip/AAE-6820-2019; Mapder, Tarunendu/U-5406-2019	Chattopadhyay, Sudip/0000-0002-3477-6013; Mapder, Tarunendu/0000-0002-1630-0716	CSIR (Council of Scientific & Industrial Research), India [01(2771)/14/EMR-II]; Bose Institute, Kolkata, India for research fund	CSIR (Council of Scientific & Industrial Research), India(Council of Scientific & Industrial Research (CSIR) - India); Bose Institute, Kolkata, India for research fund	TM, SC, and SKB acknowledge financial support from CSIR (Council of Scientific & Industrial Research), India [01(2771)/14/EMR-II]. SKB is thankful to Bose Institute, Kolkata, India for research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, INTRO SYSTEMS BIOL D; Alves R, 2003, MOL MICROBIOL, V48, P25, DOI 10.1046/j.1365-2958.2003.03344.x; Appleby JL, 1996, CELL, V86, P845, DOI 10.1016/S0092-8674(00)80158-0; Bandyopadhyay A, 2012, BIOSYSTEMS, V110, P107, DOI 10.1016/j.biosystems.2012.08.004; Banik SK, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046008; Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; Beier D, 2008, ADV EXP MED BIOL, V631, P149, DOI 10.1007/978-0-387-78885-2_10; Boucher PE, 1997, J BACTERIOL, V179, P1755, DOI 10.1128/jb.179.5.1755-1763.1997; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; Csikasz-Nagy A, 2011, J R SOC INTERFACE, V8, P480, DOI 10.1098/rsif.2010.0336; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hot D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-207; Igoshin OA, 2008, MOL MICROBIOL, V68, P1196, DOI 10.1111/j.1365-2958.2008.06221.x; Jones AM, 2005, MOL MICROBIOL, V58, P700, DOI 10.1111/j.1365-2958.2005.04875.x; Kato A, 2007, P NATL ACAD SCI USA, V104, P12063, DOI 10.1073/pnas.0704462104; Kierzek AM, 2010, MOL BIOSYST, V6, P531, DOI 10.1039/b906951h; KIRKPATRICK S, 1984, J STAT PHYS, V34, P975, DOI 10.1007/BF01009452; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Melvin JA, 2014, NAT REV MICROBIOL, V12, P274, DOI 10.1038/nrmicro3235; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; Miyashiro T, 2008, P NATL ACAD SCI USA, V105, P17457, DOI 10.1073/pnas.0807278105; Prajapat MK, 2013, MOL BIOSYST, V9, P2635, DOI 10.1039/c3mb70213h; ROY CR, 1990, P NATL ACAD SCI USA, V87, P3763, DOI 10.1073/pnas.87.10.3763; Salteli A, 2004, SENSITIVITY ANAL PRA; Saltelli A, 2005, CHEM REV, V105, P2811, DOI 10.1021/cr040659d; Savageau M, 1976, BIOCH SYSTEMS ANAL S; SCARLATO V, 1991, EMBO J, V10, P3971, DOI 10.1002/j.1460-2075.1991.tb04967.x; SCARLATO V, 1990, P NATL ACAD SCI USA, V87, P10067; Shinar G, 2007, P NATL ACAD SCI USA, V104, P19931, DOI 10.1073/pnas.0706792104; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sureka K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001771; Talukder S, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4869112; Talukder S, 2013, J CHEM SCI, V125, P1619, DOI 10.1007/s12039-013-0502-y; Talukder S, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3654958; Tiwari A, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/3/036005; Wei K, 2014, MOL BIOSYST, V10, P2338, DOI 10.1039/c4mb00264d	41	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147281	10.1371/journal.pone.0147281	http://dx.doi.org/10.1371/journal.pone.0147281			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812153	gold, Green Submitted, Green Published			2022-12-26	WOS:000369528000028
J	Kilpatrick, S; Dreistadt, M; Frowde, P; Powell, R; Milne, E; Smith, S; Morrison, L; Gow, AG; Handel, I; Mellanby, RJ				Kilpatrick, Scott; Dreistadt, Margaret; Frowde, Polly; Powell, Roger; Milne, Elspeth; Smith, Sionagh; Morrison, Linda; Gow, Adam G.; Handel, Ian; Mellanby, Richard J.			Presence of Systemic Inflammatory Response Syndrome Predicts a Poor Clinical Outcome in Dogs with a Primary Hepatitis	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; ALCOHOLIC HEPATITIS; CIRRHOTIC-PATIENTS; MORTALITY; HYPONATREMIA; RISK; DISEASE; IL-6; TRANSPLANTATION; INTERLEUKIN-6	Primary hepatopathies are a common cause of morbidity and mortality in dogs. The underlying aetiology of most cases of canine hepatitis is unknown. Consequently, treatments are typically palliative and it is difficult to provide accurate prognostic information to owners. In human hepatology there is accumulating data which indicates that the presence of systemic inflammatory response syndrome (SIRS) is a common and debilitating event in patients with liver diseases. For example, the presence of SIRS has been linked to the development of complications such as hepatic encephalopathy (HE) and is associated with a poor clinical outcome in humans with liver diseases. In contrast, the relationship between SIRS and clinical outcome in dogs with a primary hepatitis is unknown. Seventy dogs with histologically confirmed primary hepatitis were enrolled into the study. Additional clinical and clinicopathological information including respiratory rate, heart rate, temperature, white blood cell count, sodium, potassium, sex, presence of ascites, HE score, alanine aminotransferase (ALT), alkaline phosphatase (ALP), bilirubin and red blood cell concentration were available in all cases. The median survival of dogs with a SIRS score of 0 or 1 (SIRS low) was 231 days compared to a median survival of 7 days for dogs with a SIRS score of 2, 3 or 4 (SIRS high) (p<0.001). A Cox proportional hazard model, which included all other co-variables, revealed that a SIRS high score was an independent predictor of a poor clinical outcome. The effect of modulating inflammation on treatment outcomes in dogs with a primary hepatitis is deserving of further study.	[Kilpatrick, Scott; Dreistadt, Margaret; Milne, Elspeth; Smith, Sionagh; Morrison, Linda; Gow, Adam G.; Handel, Ian; Mellanby, Richard J.] Univ Edinburgh, Hosp Small Anim, Easter Bush Vet Ctr, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Kilpatrick, Scott; Dreistadt, Margaret; Milne, Elspeth; Smith, Sionagh; Morrison, Linda; Gow, Adam G.; Handel, Ian; Mellanby, Richard J.] Univ Edinburgh, Hosp Small Anim, Easter Bush Vet Ctr, Roslin Inst, Roslin, Midlothian, Scotland; [Frowde, Polly] Davies Vet Specialists Ltd, Manor Farm Business Pk, Higham Gobion, Herts, England; [Powell, Roger] PTDS, Unit 2a, Manor Farm Business Pk, Higham Gobion, Herts, England	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Mellanby, RJ (corresponding author), Univ Edinburgh, Hosp Small Anim, Easter Bush Vet Ctr, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland.; Mellanby, RJ (corresponding author), Univ Edinburgh, Hosp Small Anim, Easter Bush Vet Ctr, Roslin Inst, Roslin, Midlothian, Scotland.	Richard.Mellanby@ed.ac.uk	Frowde, Polly/AAG-8430-2020; Gow, Adam/H-6623-2019	Gow, Adam/0000-0002-4297-8870; Kilpatrick, Scott/0000-0002-1469-757X; Mellanby, Richard John/0000-0002-3467-7007; Morrison, Linda/0000-0003-0495-4592; Frowde, Polly/0000-0002-7299-2761				Abdel-Khalek Ehab E, 2011, Arab J Gastroenterol, V12, P173, DOI 10.1016/j.ajg.2011.11.006; Aleksandrova K, 2014, HEPATOLOGY, V60, P858, DOI 10.1002/hep.27016; Angeli P, 2006, HEPATOLOGY, V44, P1535, DOI 10.1002/hep.21412; BOLOGNESI M, 1994, HEPATOLOGY, V19, P628, DOI 10.1002/hep.1840190313; Borroni G, 2000, DIGEST LIVER DIS, V32, P605, DOI 10.1016/S1590-8658(00)80844-0; Carey RG, 2010, PEDIATR TRANSPLANT, V14, P115, DOI 10.1111/j.1399-3046.2009.01142.x; Cazzaniga M, 2009, J HEPATOL, V51, P475, DOI 10.1016/j.jhep.2009.04.017; Cordoba J, 2013, J HEPATOL; Cullen JM, 2009, VET CLIN N AM-SMALL, V39, P395, DOI 10.1016/j.cvsm.2009.02.003; Favier RP, 2013, VET QUART, V33, P113, DOI 10.1080/01652176.2013.826881; Fuentealba C, 1997, CAN VET J, V38, P365; Garg H, 2012, DIGEST LIVER DIS, V44, P166, DOI 10.1016/j.dld.2011.08.029; Guevara M, 2009, AM J GASTROENTEROL, V104, P1382, DOI 10.1038/ajg.2009.293; Gupta RK, 2010, METAB BRAIN DIS, V25, P355, DOI 10.1007/s11011-010-9206-x; Hammad LN, 2013, J IMMUNOTOXICOL, V10, P380, DOI 10.3109/1547691X.2012.758198; Hauptman JG, 1997, VET SURG, V26, P393, DOI 10.1111/j.1532-950X.1997.tb01699.x; Jiang XF, 2013, MOL MED REP, V7, P73, DOI 10.3892/mmr.2012.1136; Kilpatrick S, 2014, VET J; Li C, 2012, ANN HEPATOL, V11, P471, DOI 10.1016/S1665-2681(19)31460-7; Martinez D, 2015, LIVER INT, V35, P463, DOI 10.1111/liv.12473; Mathurin P, 2011, GUT, V60, P255, DOI 10.1136/gut.2010.224097; Mehta G, 2015, LIVER INT, V35, P724, DOI 10.1111/liv.12559; Michelena J, 2015, HEPATOLOGY; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Nystrom PO, 1998, J ANTIMICROB CHEMOTH, V41, P1, DOI 10.1093/jac/41.suppl_1.1; Poldervaart JH, 2009, J VET INTERN MED, V23, P72, DOI 10.1111/j.1939-1676.2008.0215.x; Puri K, 2013, J PEDIATR GASTR NUTR, V57, P114, DOI 10.1097/MPG.0b013e318291fefe; Rambaldi A, 2008, ALIMENT PHARM THER, V27, P1167, DOI 10.1111/j.1365-2036.2008.03685.x; Rolando N, 2000, HEPATOLOGY, V32, P734, DOI 10.1053/jhep.2000.17687; Salgado M, 2013, COMPENDIUM, V35, pE10; Salgado Melissa, 2013, Compend Contin Educ Vet, V35, pE1; Schuttler J, 2015, VET CLIN PATH, V44, P223, DOI 10.1111/vcp.12255; Selgas AG, 2014, J VET DIAGN INVEST, V26, P246, DOI 10.1177/1040638713520602; Shawcross DL, 2011, J HEPATOL, V54, P640, DOI 10.1016/j.jhep.2010.07.045; Shin HS, 2014, YONSEI MED J, V55, P953, DOI 10.3349/ymj.2014.55.4.953; Thabut D, 2007, HEPATOLOGY, V46, P1872, DOI 10.1002/hep.21920; Thursz MR, 2015, NEW ENGL J MED, V372, P1619, DOI 10.1056/NEJMoa1412278; TILG H, 1992, GASTROENTEROLOGY, V103, P264, DOI 10.1016/0016-5085(92)91122-K; Tivers MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082303; Watson PJ, 2010, J SMALL ANIM PRACT, V51, P566, DOI 10.1111/j.1748-5827.2010.00996.x; Weaver JD, 2002, NEUROLOGY, V59, P371, DOI 10.1212/WNL.59.3.371; Weingarten MA, 2015, J VET EMERG CRIT CAR, V25, P455, DOI 10.1111/vec.12304; Wu HL, 2014, J GASTROEN HEPATOL, V29, P1629, DOI 10.1111/jgh.12606; Xie XM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000577	44	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146560	10.1371/journal.pone.0146560	http://dx.doi.org/10.1371/journal.pone.0146560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808672	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800025
J	Ramalho, T; Meyer, A; Mucki, A; Kapsner, K; Gerland, U; Simmel, FC				Ramalho, Tiago; Meyer, Andrea; Mueckl, Andrea; Kapsner, Korbinian; Gerland, Ulrich; Simmel, Friedrich C.			Single Cell Analysis of a Bacterial Sender-Receiver System	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; PROGRAMMED POPULATION-CONTROL; QUORUM; COMMUNICATION; DIFFUSION; BIOLOGY; DISTRIBUTIONS; PHENOTYPES; LOGARITHM; DYNAMICS	Monitoring gene expression dynamics on the single cell level provides important information on cellular heterogeneity and stochasticity, and potentially allows for more accurate quantitation of gene expression processes. We here study bacterial senders and receivers genetically engineered with components of the quorum sensing system derived from Aliivibrio fischeri on the single cell level using microfluidics-based bacterial chemostats and fluorescence video microscopy. We track large numbers of bacteria over extended periods of time, which allows us to determine bacterial lineages and filter out subpopulations within a heterogeneous population. We quantitatively determine the dynamic gene expression response of receiver bacteria to varying amounts of the quorum sensing inducer N-3-oxo-C6-homoserine lactone (AHL). From this we construct AHL response curves and characterize gene expression dynamics of whole bacterial populations by investigating the statistical distribution of gene expression activity over time. The bacteria are found to display heterogeneous induction behavior within the population. We therefore also characterize gene expression in a homogeneous bacterial subpopulation by focusing on single cell trajectories derived only from bacteria with similar induction behavior. The response at the single cell level is found to be more cooperative than that obtained for the heterogeneous total population. For the analysis of systems containing both AHL senders and receiver cells, we utilize the receiver cells as 'bacterial sensors' for AHL. Based on a simple gene expression model and the response curves obtained in receiver-only experiments, the effective AHL concentration established by the senders and their 'sending power' is determined.	[Ramalho, Tiago; Meyer, Andrea; Mueckl, Andrea; Kapsner, Korbinian; Gerland, Ulrich; Simmel, Friedrich C.] TU Mnchen, Dept Phys, Garching, Germany; [Meyer, Andrea; Mueckl, Andrea; Kapsner, Korbinian; Simmel, Friedrich C.] TU Mnchen, ZNN WSI, Garching, Germany; [Gerland, Ulrich; Simmel, Friedrich C.] Nanosyst Initiat Munich, Munich, Germany		Gerland, U; Simmel, FC (corresponding author), TU Mnchen, Dept Phys, Garching, Germany.; Simmel, FC (corresponding author), TU Mnchen, ZNN WSI, Garching, Germany.; Gerland, U; Simmel, FC (corresponding author), Nanosyst Initiat Munich, Munich, Germany.	gerland@tum.de; simmel@tum.de	Gerland, Ulrich/I-9902-2016; Simmel, Friedrich/G-3281-2010	Gerland, Ulrich/0000-0002-0859-6422; Simmel, Friedrich/0000-0003-3829-3446	European Commission FP7 [248919-BACTOCOM]; Deutsche Forschungsgemeinschaft (Cluster of Excellence Nanosystems Initiative Munich-NIM); DFG [SPP 1617]	European Commission FP7(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft (Cluster of Excellence Nanosystems Initiative Munich-NIM)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by European Commission FP7 (grant no. 248919 - BACTOCOM, http://ec.europa.eu/research/fp7/index_en.cfm) and Deutsche Forschungsgemeinschaft (Cluster of Excellence Nanosystems Initiative Munich - NIM and DFG priority program SPP 1617, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge financial support by the European Commission FP7 (grant no. 248919-BACTOCOM) and the Deutsche Forschungsgemeinschaft (Cluster of Excellence Nanosystems Initiative Munich-NIM). UG acknowledges support by the DFG priority program SPP 1617.	Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0; Carbonell-Ballestero M, 2014, NUCLEIC ACIDS RES, V42, P14060, DOI 10.1093/nar/gku964; Choi WS, 2011, BIOMATERIALS, V32, P2500, DOI 10.1016/j.biomaterials.2010.12.014; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cox Chris D., 2003, OMICS A Journal of Integrative Biology, V7, P317, DOI 10.1089/153623103322452422; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Dertinger SKW, 2001, ANAL CHEM, V73, P1240, DOI 10.1021/ac001132d; Dilanji GE, 2012, J AM CHEM SOC, V134, P5618, DOI 10.1021/ja211593q; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784; Haseltine EL, 2008, APPL ENVIRON MICROB, V74, P437, DOI 10.1128/AEM.01688-07; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Hense BA, 2012, SENSORS-BASEL, V12, P4156, DOI 10.3390/s120404156; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KOCH AL, 1966, J THEOR BIOL, V12, P276, DOI 10.1016/0022-5193(66)90119-6; KOCH AL, 1969, J THEOR BIOL, V23, P251, DOI 10.1016/0022-5193(69)90040-X; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Ramo P, 2009, BIOINFORMATICS, V25, P3028, DOI 10.1093/bioinformatics/btp524; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Silander OK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002443; Sohka T, 2009, P NATL ACAD SCI USA, V106, P10135, DOI 10.1073/pnas.0901246106; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tanouchi Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000167; Tsimring LS, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/026601; Urbanowski AL, 2004, J BACTERIOL, V186, P631, DOI 10.1128/JB.186.3.631-637.2004; Wang QL, 2010, CYTOM PART A, V77A, P101, DOI 10.1002/cyto.a.20812; Wang YF, 2011, BIOPHYS J, V100, P3045, DOI 10.1016/j.bpj.2011.05.006; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Weiss R, 2000, 6 INT M DNA BAS COMP, V2054, P1; Weitz M, 2014, J AM CHEM SOC, V136, P72, DOI 10.1021/ja411132w; West SA, 2012, TRENDS MICROBIOL, V20, P586, DOI 10.1016/j.tim.2012.09.004; Yan L, 2007, J MICROBIOL METH, V68, P40, DOI 10.1016/j.mimet.2006.06.002; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	48	16	16	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0145829	10.1371/journal.pone.0145829	http://dx.doi.org/10.1371/journal.pone.0145829			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808777	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800012
J	Ranjbar, N; Mehrali, M; Behnia, A; Pordsari, AJ; Mehrali, M; Alengaram, UJ; Jumaat, MZ				Ranjbar, Navid; Mehrali, Mehdi; Behnia, Arash; Pordsari, Alireza Javadi; Mehrali, Mohammad; Alengaram, U. Johnson; Jumaat, Mohd Zamin			A Comprehensive Study of the Polypropylene Fiber Reinforced Fly Ash Based Geopolymer	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; MICROSTRUCTURAL ANALYSIS; COMPRESSIVE STRENGTH; SHRINKAGE; COMPOSITES; BEHAVIOR	As a cementitious material, geopolymers show a high quasi-brittle behavior and a relatively low fracture energy. To overcome such a weakness, incorporation of fibers to a brittle matrix is a well-known technique to enhance the flexural properties. This study comprehensively evaluates the short and long term impacts of different volume percentages of polypropylene fiber (PPF) reinforcement on fly ash based geopolymer composites. Different characteristics of the composite were compared at fresh state by flow measurement and hardened state by variation of shrinkage over time to assess the response of composites under flexural and compressive load conditions. The fiber-matrix interface, fiber surface and toughening mechanisms were assessed using field emission scan electron microscopy (FESEM) and atomic force microscopy (AFM). The results show that incorporation of PPF up to 3 wt % into the geopolymer paste reduces the shrinkage and enhances the energy absorption of the composites. While, it might reduce the ultimate flexural and compressive strength of the material depending on fiber content.	[Ranjbar, Navid; Behnia, Arash; Pordsari, Alireza Javadi; Alengaram, U. Johnson; Jumaat, Mohd Zamin] Univ Malaya, Dept Civil Engn, Kuala Lumpur 50603, Malaysia; [Mehrali, Mehdi] Tech Univ Denmark, Dept Micro & Nanotechnol, DTU Nanotech, DK-2800 Lyngby, Denmark; [Mehrali, Mohammad] Univ Malaya, Dept Mech Engn, Kuala Lumpur 50603, Malaysia; [Mehrali, Mohammad] Univ Malaya, Ctr Adv Mat, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Technical University of Denmark; Universiti Malaya; Universiti Malaya	Ranjbar, N (corresponding author), Univ Malaya, Dept Civil Engn, Kuala Lumpur 50603, Malaysia.	navidr@siswa.um.edu.my	JUMAAT, MOHD ZAMIN/B-9138-2010; Jumaat, Mohd Zamin/ABD-3988-2020; Pordesari, Alireza Javadi/AAJ-8046-2020; Alengaram, U. Johnson/B-9980-2010; Ranjbar, Navid/L-4274-2018; Alengaram, U. Johnson/B-1036-2011; Mehrali, Mehdi/G-6395-2011; mehrali, mohammad/A-7328-2018; Mehrali, Mohammad/ABE-7990-2020	JUMAAT, MOHD ZAMIN/0000-0002-8783-1274; Pordesari, Alireza Javadi/0000-0003-3496-322X; Alengaram, U. Johnson/0000-0001-6153-9999; Ranjbar, Navid/0000-0002-1485-3931; Mehrali, Mehdi/0000-0002-5084-1823; mehrali, mohammad/0000-0001-6667-9368; Mehrali, Mohammad/0000-0001-6667-9368; Alengaram, U.Johnson/0000-0001-9358-2975	University of Malaya under a High Impact Research Grant (HIRG) [UM.C/HIR/MOHE/ENG/36/ D0000036-16001]; High Impact Research Grant (HIRG) [UM.C/HIR/MOHE/ENG/36/ D0000036-16001]	University of Malaya under a High Impact Research Grant (HIRG); High Impact Research Grant (HIRG)	This research work was funded by the University of Malaya under a High Impact Research Grant (HIRG) No. UM.C/HIR/MOHE/ENG/36/ D0000036-16001 (Strengthening structural elements for load and fatigue).; The work was supported by High Impact Research Grant (HIRG) No. UM.C/HIR/MOHE/ENG/36/ D0000036-16001 (Strengthening structural elements for load and fatigue).	Alhozaimy AM, 1996, CEMENT CONCRETE COMP, V18, P85, DOI 10.1016/0958-9465(95)00003-8; Alomayri T, 2014, COMPOS PART B-ENG, V60, P36, DOI 10.1016/j.compositesb.2013.12.036; Alzeer M, 2012, J MATER SCI, V47, P6958, DOI 10.1007/s10853-012-6644-3; [Anonymous], 1997, STANDARD TEST METHOD, P544; [Anonymous], 2015, C2000 ASTM INT, P1; ASTM, 2013, C143713 ASTM, P1; ASTM, 2013, C19113 ASTM; Aulia T.B., 2002, EFFECTS POLYPROPYLEN; Bakharev T, 2005, CEMENT CONCRETE RES, V35, P1224, DOI 10.1016/j.cemconres.2004.06.031; BAZANT ZP, 1992, J ENG MECH-ASCE, V118, P540, DOI 10.1061/(ASCE)0733-9399(1992)118:3(540); Bernal S, 2010, CONSTR BUILD MATER, V24, P208, DOI 10.1016/j.conbuildmat.2007.10.027; BRE, 2000, DES BUILD; Carstens PAB, 2000, J FLUORINE CHEM, V104, P97, DOI 10.1016/S0022-1139(00)00232-3; DAVIDOVITS J, 1991, J THERM ANAL, V37, P1633, DOI 10.1007/BF01912193; Davidovits J., 2020, GEOPOLYMER CHEM APPL, V5th ed.; Dias DP, 2005, CEMENT CONCRETE COMP, V27, P49, DOI 10.1016/j.cemconcomp.2004.02.044; Duxson P, 2007, J MATER SCI, V42, P2917, DOI 10.1007/s10853-006-0637-z; He PG, 2010, CERAM INT, V36, P1447, DOI 10.1016/j.ceramint.2010.02.012; Kuenzel C, 2012, J AM CERAM SOC, V95, P3270, DOI 10.1111/j.1551-2916.2012.05380.x; Lopez-Buendia AM, 2013, CEMENT CONCRETE RES, V54, P29, DOI 10.1016/j.cemconres.2013.08.004; MacKenzie KJD, 2014, WOODH PUB S COMPOS S, P445, DOI 10.1533/9780857098825.3.445; Morent R, 2008, SURF INTERFACE ANAL, V40, P597, DOI 10.1002/sia.2619; Pan Z, 2011, MAG CONCRETE RES, V63, P763, DOI 10.1680/macr.2011.63.10.763; Perera DS, 2007, J MATER SCI, V42, P3099, DOI 10.1007/s10853-006-0533-6; Puertas F, 2003, CEMENT CONCRETE RES, V33, P2031, DOI 10.1016/s0008-8846(03)00222-9; Ranjbar N, 2016, COMPOS SCI TECHNOL, V122, P73, DOI 10.1016/j.compscitech.2015.11.009; Ranjbar N, 2016, J CLEAN PROD, V112, P723, DOI 10.1016/j.jclepro.2015.07.033; Ranjbar N, 2015, CEMENT CONCRETE RES, V76, P222, DOI 10.1016/j.cemconres.2015.06.003; Ranjbar N, 2014, CONSTR BUILD MATER, V65, P114, DOI 10.1016/j.conbuildmat.2014.04.064; Ranjbar N, 2014, MATER DESIGN, V59, P532, DOI 10.1016/j.matdes.2014.03.037; Richardson AE, 2006, STRUCT SURV, V24, P138, DOI [DOI 10.1108/02630800610666673, 10.1108/02630800610666673]; Ridtirud C, 2011, INT J MIN MET MATER, V18, P100, DOI 10.1007/s12613-011-0407-z; Sakulich AR, 2011, SUSTAIN CITIES SOC, V1, P195, DOI 10.1016/j.scs.2011.07.009; SCHERER GW, 1990, J AM CERAM SOC, V73, P3, DOI 10.1111/j.1151-2916.1990.tb05082.x; Silva FD, 2010, CONSTR BUILD MATER, V24, P777, DOI 10.1016/j.conbuildmat.2009.10.030; Singh S, 2004, CEMENT CONCRETE RES, V34, P1919, DOI 10.1016/j.cemconres.2004.02.014; Stang H, 1996, ADV CEM BASED MATER, V4, P106, DOI 10.1016/S1065-7355(96)00075-2; Tchadjie LN, 2016, CERAM INT, V42, P3046, DOI 10.1016/j.ceramint.2015.10.091; Zhang YS, 2008, CONSTR BUILD MATER, V22, P370, DOI 10.1016/j.conbuildmat.2006.08.006; Zhang ZH, 2009, J CENT SOUTH UNIV T, V16, P49, DOI 10.1007/s11771-009-0008-4; Zuhua Z, 2009, APPL CLAY SCI, V43, P218, DOI 10.1016/j.clay.2008.09.003	41	79	78	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147546	10.1371/journal.pone.0147546	http://dx.doi.org/10.1371/journal.pone.0147546			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807825	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800128
J	Yasumoto, Y; Miyazaki, H; Vaidyan, LK; Kagawa, Y; Ebrahimi, M; Yamamoto, Y; Ogata, M; Katsuyama, Y; Sadahiro, H; Suzuki, M; Owada, Y				Yasumoto, Yuki; Miyazaki, Hirofumi; Vaidyan, Linda Koshy; Kagawa, Yoshiteru; Ebrahimi, Majid; Yamamoto, Yui; Ogata, Masaki; Katsuyama, Yu; Sadahiro, Hirokazu; Suzuki, Michiyasu; Owada, Yuji			Inhibition of Fatty Acid Synthase Decreases Expression of Stemness Markers in Glioma Stem Cells	PLOS ONE			English	Article							PHARMACOLOGICAL INHIBITORS; BINDING PROTEIN-7; B-FABP; CANCER; OVEREXPRESSION; PROGRESSION; CULTURE; TARGET; EVENT	Cellular metabolic changes, especially to lipid metabolism, have recently been recognized as a hallmark of various cancer cells. However, little is known about the significance of cellular lipid metabolism in the regulation of biological activity of glioma stem cells (GSCs). In this study, we examined the expression and role of fatty acid synthase (FASN), a key lipogenic enzyme, in GSCs. In the de novo lipid synthesis assay, GSCs exhibited higher lipogenesis than differentiated non-GSCs. Western blot and immunocytochemical analyses revealed that FASN is strongly expressed in multiple lines of patient-derived GSCs (G144 and Y10), but its expression was markedly reduced upon differentiation. When GSCs were treated with 20 mu M cerulenin, a pharmacological inhibitor of FASN, their proliferation and migration were significantly suppressed and de novo lipogenesis decreased. Furthermore, following cerulenin treatment, expression of the GSC markers nestin, Sox2 and fatty acid binding protein (FABP7), markers of GCSs, decreased while that of glial fibrillary acidic protein (GFAP) expression increased. Taken together, our results indicate that FASN plays a pivotal role in the maintenance of GSC stemness, and FASN-mediated de novo lipid biosynthesis is closely associated with tumor growth and invasion in glioblastoma.	[Yasumoto, Yuki; Miyazaki, Hirofumi; Vaidyan, Linda Koshy; Kagawa, Yoshiteru; Ebrahimi, Majid; Yamamoto, Yui; Owada, Yuji] Yamaguchi Univ, Grad Sch Med, Dept Organ Anat, Ube, Yamaguchi 755, Japan; [Sadahiro, Hirokazu; Suzuki, Michiyasu] Yamaguchi Univ, Grad Sch Med, Dept Neurosurg, Ube, Yamaguchi 755, Japan; [Yasumoto, Yuki; Miyazaki, Hirofumi; Kagawa, Yoshiteru; Ebrahimi, Majid; Ogata, Masaki; Katsuyama, Yu; Owada, Yuji] Tohoku Univ, Grad Sch Med, Dept Organ Anat, Sendai, Miyagi 980, Japan	Yamaguchi University; Yamaguchi University; Tohoku University	Owada, Y (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Organ Anat, Ube, Yamaguchi 755, Japan.; Owada, Y (corresponding author), Tohoku Univ, Grad Sch Med, Dept Organ Anat, Sendai, Miyagi 980, Japan.	owada@med.tohoku.ac.jp		Owada, Yuji/0000-0002-5109-0531; Yasumoto, Yuki/0000-0001-9882-4478; Kagawa, Yoshiteru/0000-0003-2963-7905				Berezovsky AD, 2014, NEOPLASIA, V16, DOI 10.1016/j.neo.2014.03.006; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brescia P, 2013, STEM CELLS, V31, P857, DOI 10.1002/stem.1317; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Cabarcas SM, 2010, CURR MOL MED, V10, P741; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; De Rosa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052113; Diehn M, 2009, SEMIN RADIAT ONCOL, V19, P78, DOI 10.1016/j.semradonc.2008.11.002; Godbout R, 1998, ONCOGENE, V16, P1955, DOI 10.1038/sj.onc.1201740; Grube S, 2014, J NEURO-ONCOL, V118, P277, DOI 10.1007/s11060-014-1452-z; Kagawa Y, 2015, GLIA, V63, P780, DOI 10.1002/glia.22784; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Liao JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084941; Lupu R, 2006, CURR PHARM BIOTECHNO, V7, P483, DOI 10.2174/138920106779116928; Menendez JA, 2009, CLIN CHEM, V55, P425, DOI 10.1373/clinchem.2008.115352; Mita R, 2007, NEOPLASIA, V9, P734, DOI 10.1593/neo.07439; Mita R, 2010, J BIOL CHEM, V285, P37005, DOI 10.1074/jbc.M110.170076; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Morihiro Y, 2013, PATHOL INT, V63, P546, DOI 10.1111/pin.12109; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Piyathilake CJ, 2000, HUM PATHOL, V31, P1068, DOI 10.1053/hupa.2000.9842; Pizer ES, 1996, CANCER RES, V56, P1189; Pizer ES, 1996, CANCER RES, V56, P2745; Pizer ES, 1998, CANCER RES, V58, P4611; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Rashid A, 1997, AM J PATHOL, V150, P201; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sadahiro H, 2014, BRAIN TUMOR PATHOL, V31, P77, DOI 10.1007/s10014-013-0149-x; Singh SK, 2003, CANCER RES, V63, P5821; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Swinnen JV, 2003, BIOCHEM BIOPH RES CO, V302, P898, DOI 10.1016/S0006-291X(03)00265-1; Swinnen JV, 2002, INT J CANCER, V98, P19, DOI 10.1002/ijc.10127; Tirinato L, 2015, STEM CELLS, V33, P35, DOI 10.1002/stem.1837; Vazquez-Martin A, 2013, CELL CYCLE, V12, P207, DOI 10.4161/cc.23352; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Wang Y, 2001, CANCER LETT, V167, P99, DOI 10.1016/S0304-3835(01)00464-5; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward RJ, 2007, ANNU REV PATHOL-MECH, V2, P175, DOI 10.1146/annurev.pathol.2.010506.091847; Wolf A, 2010, ONCOTARGET, V1, P552, DOI 10.18632/oncotarget.190; Zhao W, 2006, BRIT J CANCER, V95, P869, DOI 10.1038/sj.bjc.6603350	41	82	86	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147717	10.1371/journal.pone.0147717	http://dx.doi.org/10.1371/journal.pone.0147717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808816	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800193
J	Zhao, TT; Sun, SF; Zhang, HJ; Huang, XR; Yan, MH; Dong, X; Wen, YM; Wang, H; Lan, HY; Li, P				Zhao, TingTing; Sun, SiFan; Zhang, HaoJun; Huang, XiaoRu; Yan, MeiHua; Dong, Xi; Wen, YuMin; Wang, Hua; Lan, Hui Yao; Li, Ping			Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats	PLOS ONE			English	Article							UNILATERAL URETERAL OBSTRUCTION; GROWTH-FACTOR-BETA; RENAL FIBROSIS; DIVERSE ROLES; MOUSE MODEL; INFLAMMATION; SMAD7; MECHANISMS; RECEPTOR; DEGRADATION	Objective Inflammation and fibrosis are essential promoters in the pathogenesis of diabetic nephropathy (DN) in type 2 diabetes. The present study examined the anti-inflammation and anti-fibrosis effect of Tangshen Formula (TSF), a traditional Chinese medicine, on DN. Research Design and Methods Protective role of TSF in DN was examined in a rat model of type 2 DN that was established by high-fat diet-fed and low-dose-streptozotocin injection. TSF was suspended in 0.5% CMC-Na solution and delivered by oral gavage at a dosage of 1.67g/Kg body weight/day. The therapeutic effects and mechanisms of TSF on diabetic kidney injury were examined. Results We found that TSF treatment for 20 weeks attenuated DN by significantly inhibiting urinary excretion of albumin and renal histological injuries. These beneficial effects were associated with an inactivation of NF-kappa B signaling, thereby blocking the upregulation of pro-inflammatory cytokines (IL-1 beta, TNF alpha), chemokine (MCP-1), and macrophage infiltration in the TSF-treated rats with type 2 DN. In addition, TSF treatment also inactivated TGF-beta/Smad3 signaling and therefore suppressed renal fibrosis including expressions of fibronectin, collagen I, and collagen IV. Further studies revealed that the inhibitory effect of TSF on TGF-beta/Smad3 and NF-kappa B signaling in DN was associated with inhibition of Smurf2-dependent ubiquitin degradation of Smad7. Conclusions The present study reveals that TSF has therapeutic potential for type 2 DN in rats. Blockade of NF-kappa B-driven renal inflammation and TGF-beta/Smad3-mediated renal fibrosis by preventing the Smurf2-mediated Smad7 degradation pathway may be mechanisms through which TSF inhibits type 2 DN.	[Zhao, TingTing; Sun, SiFan; Zhang, HaoJun; Yan, MeiHua; Dong, Xi; Wen, YuMin; Wang, Hua; Li, Ping] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing Key Lab Immune Mediated Inflammatory Dis, Beijing, Peoples R China; [Huang, XiaoRu; Lan, Hui Yao] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Huang, XiaoRu; Lan, Hui Yao] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Huang, XiaoRu; Lan, Hui Yao] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China	China-Japan Friendship Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Lan, HY; Li, P (corresponding author), China Japan Friendship Hosp, Inst Clin Med Sci, Beijing Key Lab Immune Mediated Inflammatory Dis, Beijing, Peoples R China.; Lan, HY (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.; Lan, HY (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.; Lan, HY (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.	hylan@cuhk.edu.hk; lp8675@163.com	Lan, Hui Yao/C-9734-2015	Lan, Hui Yao/0000-0003-4283-9755; Zhang, Haojun/0000-0002-5993-5260	National Natural Science Foundation of China [81173422, 81130066, 81473526, 81373795, 81302942]; Beijing Natural Science Foundation [7142143]; China-International S T Cooperation [2011DFA31860]; Major State Basic Research Development Program of China (973 program) [2012CB517705]; Research Grant Council of Hong Kong [CUHK3/CRF/12R]; Chinese University of Hong Kong; China-Japan Friendship Hospital Youth Science and Technology Excellence Project [2015-QNYC-B-09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); China-International S T Cooperation; Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China); Research Grant Council of Hong Kong(Hong Kong Research Grants Council); Chinese University of Hong Kong(Chinese University of Hong Kong); China-Japan Friendship Hospital Youth Science and Technology Excellence Project	This work was supported by grants from the National Natural Science Foundation of China (No: 81173422 and 81130066 to PL, No: 81473526 to TTZ, No: 81373795 to HJZ, No: 81302942 to MHY), http://www.nsfc.gov.cn/; Beijing Natural Science Foundation (No: 7142143 to TTZ), http://www.bjnsf.org/; the China-International S & T Cooperation (No: 2011DFA31860 to PL), the Major State Basic Research Development Program of China (973 program, 2012CB517705 to HYL), http://www.most.gov.cn/; the Research Grant Council of Hong Kong (CUHK3/CRF/12R to HYL), http://www.most.gov.cn/; The Focused Investment Scheme A from Chinese University of Hong Kong (HYL), http://www.cuhk.edu.hk/chinese/index.html, and the China-Japan Friendship Hospital Youth Science and Technology Excellence Project. Award Number: 2015-QNYC-B-09. Recipient: Ting Ting Zhao, Ph.D.	Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Chen HY, 2011, DIABETES, V60, P590, DOI 10.2337/db10-0403; Chung ACK, 2009, NEPHROL DIAL TRANSPL, V24, P1443, DOI 10.1093/ndt/gfn699; Committee NP, 2010, PHARMACOPOEIA PEOPLE; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Duran-Salgado MB, 2014, WORLD J DIABETES, V5, P393, DOI 10.4239/wjd.v5.i3.393; El Mesallamy HO, 2012, CLIN BIOCHEM, V45, P646, DOI 10.1016/j.clinbiochem.2012.02.021; Fukasawa H, 2004, P NATL ACAD SCI USA, V101, P8687, DOI 10.1073/pnas.0400035101; Glasgow E, 2008, ENDOCR-RELAT CANCER, V15, P59, DOI 10.1677/ERC-07-0168; Hong SW, 2001, AM J PATHOL, V158, P1653; Huang W, 2013, BIOCHEM BIOPH RES CO, V438, P568, DOI 10.1016/j.bbrc.2013.07.065; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lan HY, 2011, CONTRIB NEPHROL, V170, P75, DOI 10.1159/000324949; LAN HY, 1995, J HISTOCHEM CYTOCHEM, V43, P97, DOI 10.1177/43.1.7822770; Li JH, 2004, FASEB J, V18, P176, DOI 10.1096/fj.02-1117fje; Li P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126027; Lim AKH, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/146154; Liu GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053573; Liu Z, 2012, LAB INVEST, V92, P650, DOI 10.1038/labinvest.2012.2; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Meng XM, 2012, J PATHOL, V227, P175, DOI 10.1002/path.3976; Ng YY, 2005, KIDNEY INT, V67, pS83, DOI 10.1111/j.1523-1755.2005.09421.x; Nguyen D, 2006, NEPHROLOGY, V11, P226, DOI 10.1111/j.1440-1797.2006.00576.x; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Wang WS, 2005, J AM SOC NEPHROL, V16, P1371, DOI 10.1681/ASN.2004121070; Wen XY, 2012, J ETHNOPHARMACOL, V142, P144, DOI 10.1016/j.jep.2012.04.028; Williams Michael D, 2007, Curr Diab Rep, V7, P242, DOI 10.1007/s11892-007-0038-y; Zhang HJ, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/613737; Zhao TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090807; Zhu B, 2014, MOL CELL BIOCHEM, V393, P23, DOI 10.1007/s11010-014-2043-1	33	37	43	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147693	10.1371/journal.pone.0147693	http://dx.doi.org/10.1371/journal.pone.0147693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807792	Green Submitted, gold, Green Published			2022-12-26	WOS:000369527800184
J	Peeters, MC; Mos, I; Lenselink, EB; Lucchesi, M; IJzerman, AP; Schwartz, TW				Peeters, Miriam C.; Mos, Iris; Lenselink, Eelke B.; Lucchesi, Martina; IJzerman, Adriaan P.; Schwartz, Thue W.			Getting from A to B-exploring the activation motifs of the class B adhesion G protein-coupled receptor subfamily G member 4/GPR112	FASEB JOURNAL			English	Article						constitutive activity; receptor signaling; structure-function; relationship; activation mechanism; bioinformatics	YEAST; MUTAGENESIS; INSERTION; TERMINUS; SECRETIN; RESIDUES; AGONIST; BINDING; FAMILY; DOMAIN	The adhesion G protein-coupled receptors [ADGRs/class B2 G protein-coupled receptors (GPCRs)] constitute an ancient family of GPCRs that have recently been demonstrated to play important roles in cellular and developmental processes. Here, we describe a first insight into the structure-function relationship of ADGRs using the family member ADGR subfamily G member 4 (ADGRG4)/GPR112 as a model receptor. In a bioinformatics approach, we compared conserved, functional elements of the well-characterized class A and class B1 secretin-like GPCRs with the ADGRs. We identified several potential equivalent motifs and subjected those to mutational analysis. The importance of the mutated residues was evaluated by examining their effect on the high constitutive activity of the N-terminally truncated ADGRG4/GPR112 in a 1-receptor-1-G protein Saccharomyces cerevisiae screening system and was further confirmed in a transfected mammalian human embryonic kidney 293 cell line. We evaluated the results in light of the crystal structures of the class A adenosine A(2A) receptor and the class B1 corticotropin-releasing factor receptor 1. ADGRG4 proved to have functionally important motifs resembling class A, class B, and combined elements, but also a unique highly conserved ADGR motif (H3.33). Given the high conservation of these motifs and residues across the adhesion GPCR family, it can be assumed that these are general elements of ADGR function.	[Peeters, Miriam C.; Mos, Iris; Lenselink, Eelke B.; Lucchesi, Martina; IJzerman, Adriaan P.] Leiden Univ, Div Med Chem, Leiden Acad Ctr Drug Res, POB 9502, NL-2300 RA Leiden, Netherlands; [Peeters, Miriam C.; Schwartz, Thue W.] Univ Copenhagen, Sect Metab Receptol, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth Sci, DK-1168 Copenhagen, Denmark	Leiden University; Leiden University - Excl LUMC; Novo Nordisk Foundation; University of Copenhagen	Peeters, MC (corresponding author), Leiden Univ, Div Med Chem, Leiden Acad Ctr Drug Res, POB 9502, NL-2300 RA Leiden, Netherlands.	m.c.peeters@lacdr.leidenuniv.nl	IJzerman, Ad/ABG-1353-2020	IJzerman, Ad/0000-0002-1182-2259; Lenselink, Bart/0000-0001-5459-2978; Schwartz, Thue W./0000-0002-0261-6904; Mos, Iris/0000-0003-1882-772X	NNF Center for Basic Metabolic Research [Schwartz Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0013655] Funding Source: researchfish	NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)		Arac D, 2012, ANN NY ACAD SCI, V1276, P1, DOI 10.1111/j.1749-6632.2012.06820.x; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Beukers MW, 2004, MOL PHARMACOL, V65, P702, DOI 10.1124/mol.65.3.702; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chugunov AO, 2010, MOL PHARMACOL, V78, P394, DOI 10.1124/mol.110.063578; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; Cordomi A, 2015, BIOCHEM PHARMACOL, V96, P237, DOI 10.1016/j.bcp.2015.05.015; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dromey Jasmin R., 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P51, DOI 10.2174/187153008783928352; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Frimurer TM, 1999, PROTEINS, V35, P375, DOI 10.1002/(SICI)1097-0134(19990601)35:4<375::AID-PROT1>3.0.CO;2-2; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; HODGES RS, 1988, J BIOL CHEM, V263, P11768; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Isberg V, 2014, NUCLEIC ACIDS RES, V42, pD422, DOI 10.1093/nar/gkt1255; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Kishore A., 2015, J BIOL CHEM; Knudsen SM, 2001, FEBS LETT, V503, P126, DOI 10.1016/S0014-5793(01)02716-8; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Krishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029817; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Nordstrom KJV, 2009, MOL BIOL EVOL, V26, P71, DOI 10.1093/molbev/msn228; Okajima D, 2010, J RECEPT SIG TRANSD, V30, P143, DOI 10.3109/10799891003671139; Olesnicky NS, 1999, EMBO J, V18, P2756, DOI 10.1093/emboj/18.10.2756; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Peeters MC, 2014, BIOCHEM PHARMACOL, V92, P348, DOI 10.1016/j.bcp.2014.08.022; Peeters MC, 2012, PURINERG SIGNAL, V8, P23, DOI 10.1007/s11302-011-9251-x; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Sexton PM, 2013, NATURE, V499, P417, DOI 10.1038/nature12413; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vohra S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0846; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110	49	14	14	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1836	1848		10.1096/fj.201500110	http://dx.doi.org/10.1096/fj.201500110			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26823453				2022-12-26	WOS:000374879400014
J	Stewart, MJ; Wang, TF; Koene, JM; Storey, KB; Cummins, SF				Stewart, Michael J.; Wang, Tianfang; Koene, Joris M.; Storey, Kenneth B.; Cummins, Scott F.			A "Love" Dart Allohormone Identified in the Mucous Glands of Hermaphroditic Land Snails	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						invertebrate; molecular biology; neuropeptide; peptide hormone; pheromone; proteomics	SMALL CARDIOACTIVE PEPTIDE; CENTRAL-NERVOUS-SYSTEM; HELIX-ASPERSA; SEXUAL SELECTION; APLYSIA-CALIFORNICA; GARDEN SNAIL; BUCCALIN; MUCUS; NEUROPEPTIDES; COURTSHIP	Animals have evolved many ways to enhance their own reproductive success. One bizarre sexual ritual is the love dart shooting of helicid snails, which has courted many theories regarding its precise function. Acting as a hypodermic needle, the dart transfers an allohormone that increases paternity success. Its precise physiological mechanism of action within the recipient snail is to close off the entrance to the sperm digestion organ via a contraction of the copulatory canal, thereby delaying the digestion of most donated sperm. In this study, we used the common garden snail Cornu aspersum to identify the allohormone that is responsible for this physiological change in the female system of this simultaneous hermaphrodite. The love dart allohormone (LDA) was isolated from extracts derived from mucous glands that coat the dart before it is stabbed through the partner's body wall. We isolated LDA from extracts using bioassay-guided contractility measurement of the copulatory canal. LDA is encoded within a 235-amino acid precursor protein containing multiple cleavage sites that, when cleaved, releases multiple bioactive peptides. Synthetic LDA also stimulated copulatory canal contractility. Combined with our finding that the protein amino acid sequence resembles previously described molluscan buccalin precursors, this indicates that LDA is partially conserved in helicid snails and less in other molluscan species. In summary, our study provides the full identification of an allohormone that is hypodermically injected via a love dart. More importantly, our findings have important consequences for understanding reproductive biology and the evolution of alternative reproductive strategies.	[Stewart, Michael J.; Wang, Tianfang; Cummins, Scott F.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol Res Ctr, Maroochydore, Qld 4558, Australia; [Koene, Joris M.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Ecol Sci, NL-1081 HV Amsterdam, Netherlands; [Storey, Kenneth B.] Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada; [Storey, Kenneth B.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	University of the Sunshine Coast; Vrije Universiteit Amsterdam; Carleton University; Carleton University	Cummins, SF (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol Res Ctr, Maroochydore, Qld 4558, Australia.; Cummins, SF (corresponding author), Univ Sunshine Coast, Dept Sci & Educ, 90 Sippy Downs Dr, Sippy Downs, Qld 4556, Australia.	scummins@usc.edu.au	Wang, Tianfang/GRO-0844-2022; Koene, Joris M./B-4502-2009; Wang, Tianfang/L-5192-2016; Wang, Tianfang/AAG-4290-2020	Wang, Tianfang/0000-0002-4876-7767; Koene, Joris M./0000-0001-8188-3439; Wang, Tianfang/0000-0002-4876-7767; Wang, Tianfang/0000-0002-4876-7767	Grains Research and Development Corporation Innovation and Investment Grants [USU00001]; Australian Research Council	Grains Research and Development Corporation Innovation and Investment Grants(Grains R&D Corp); Australian Research Council(Australian Research Council)	This work was supported by Grains Research and Development Corporation Innovation and Investment Grants USU00001 (to M. J. S., T. W., and S. F. C.) and by funds from the Australian Research Council (to S. F. C. and K. B. S.). The authors declare that they have no conflicts of interest with the contents of this article.	ADAMO SA, 1990, J EXP ZOOL, V255, P80, DOI 10.1002/jez.1402550111; ADAMO SA, 1990, BEHAV NEURAL BIOL, V54, P115, DOI 10.1016/0163-1047(90)91310-8; ADAMO SA, 1988, CAN J ZOOL, V66, P1446, DOI 10.1139/z88-211; Adamson K. J., 2015, GEN COMP ENDOCRINOL; Adamson KJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1510-8; [Anonymous], 1998, SPERM COMPETITION SE; Baur Bruno, 1998, P255, DOI 10.1016/B978-012100543-6/50033-7; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Bernard A., 1930, R SOC BIOL PARIS, V103, P1110; Birkhead T. R., 2008, SPERM BIOL EVOLUTION, P207; CHARNOV EL, 1979, P NATL ACAD SCI USA, V76, P2480, DOI 10.1073/pnas.76.5.2480; Chase R, 2006, P ROY SOC B-BIOL SCI, V273, P1471, DOI 10.1098/rspb.2006.3474; CHUNG DJD, 1987, VELIGER, V30, P24; Conzelmann M, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-23; CROPPER EC, 1990, BRAIN RES, V512, P175, DOI 10.1016/0006-8993(90)91189-N; CROPPER EC, 1988, P NATL ACAD SCI USA, V85, P6177, DOI 10.1073/pnas.85.16.6177; Gioti A, 2012, P ROY SOC B-BIOL SCI, V279, P4423, DOI 10.1098/rspb.2012.1634; Greenberg MJ, 1997, PEPTIDES, V18, P1099, DOI 10.1016/S0196-9781(97)00149-6; HIGGINS WJ, 1978, EUR J PHARMACOL, V48, P425, DOI 10.1016/0014-2999(78)90170-X; HUNT S, 1979, TISSUE CELL, V11, P51, DOI 10.1016/0040-8166(79)90005-3; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kimura K, 2013, ANIM BEHAV, V85, P631, DOI 10.1016/j.anbehav.2012.12.026; Koene JM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-25; Koene JM, 1998, J EXP BIOL, V201, P2313; Koene JM, 1998, J MOLLUS STUD, V64, P75, DOI 10.1093/mollus/64.1.75; Koene JM, 2001, J COMP PHYSIOL A, V187, P323, DOI 10.1007/s003590100214; Kuanpradit C, 2012, FEBS J, V279, P437, DOI 10.1111/j.1742-4658.2011.08436.x; Leonard JL, 2006, INTEGR COMP BIOL, V46, P349, DOI 10.1093/icb/icj041; LEONARD JL, 1992, J THEOR BIOL, V159, P513, DOI 10.1016/S0022-5193(05)80695-2; LIND H, 1973, J ZOOL, V169, P39; MILLER MW, 1992, J COMP NEUROL, V320, P182, DOI 10.1002/cne.903200204; Morishita F, 2010, CAN J ZOOL, V88, P825, DOI 10.1139/Z10-041; Nakadera Y, 2013, CAN J ZOOL, V91, P367, DOI 10.1139/cjz-2012-0272; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Pomiankowski A, 2001, TRENDS ECOL EVOL, V16, P533, DOI 10.1016/S0169-5347(01)02243-1; PRICE DA, 1989, BIOL BULL, V177, P198, DOI 10.2307/1541933; Rogers DW, 2001, BEHAV ECOL SOCIOBIOL, V50, P122, DOI 10.1007/s002650100345; SANTAMA N, 1994, J COMP NEUROL, V342, P335, DOI 10.1002/cne.903420303; Scharer L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0052; Veenstra JA, 2010, GEN COMP ENDOCR, V167, P86, DOI 10.1016/j.ygcen.2010.02.010; VILIM FS, 1994, PEPTIDES, V15, P959, DOI 10.1016/0196-9781(94)90058-2; Wyatt TD, 2009, NATURE, V457, P262, DOI 10.1038/457262a	42	15	15	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7938	7950		10.1074/jbc.M115.704395	http://dx.doi.org/10.1074/jbc.M115.704395			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26817846	Green Published, hybrid			2022-12-26	WOS:000374056700016
J	Gray, LR; Rauckhorst, AJ; Taylor, EB				Gray, Lawrence R.; Rauckhorst, Adam J.; Taylor, Eric B.			A Method for Multiplexed Measurement of Mitochondrial Pyruvate Carrier Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; TRANSPORT; GLUCONEOGENESIS; CELLS	The discovery that the MPC1 and MPC2 genes encode the protein components of the mitochondrial pyruvate carrier (MPC) has invigorated studies of mitochondrial pyruvate transport and its regulation in normal and disease states. Indeed, recent reports have demonstrated MPC involvement in the control of cell fate in cancer and gluconeogenesis in models of type 2 diabetes. Biochemical measurements of MPC activity are foundational for understanding the role of pyruvate transport in health and disease. We developed a 96-well scaled method of [C-14] pyruvate uptake that markedly decreases sample requirements and increases throughput relative to previous techniques. This method was applied to determine the mouse liver MPC Km (28.0 +/- 3.9 mu M) and V-max (1.08 +/- 0.05 nmol/min/mg), which have not previously been reported. Km and Vmax of the rat liver MPC were found to be 71.2 +/- 17 mu M and 1.42 +/- 0.14 nmol/min/mg, respectively. Additionally, we performed parallel pyruvate uptake and oxidation experiments with the same biological samples and show differential results in response to fasting, demonstrating the continued importance of a direct MPC activity assay. We expect this method will be of value for understanding the contribution of the MPC activity to health and disease states where pyruvate metabolism is expected to play a prominent role.	Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; Univ Iowa, Carver Coll Med, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; Univ Iowa, Carver Coll Med, Abboud Cardiovasc Res Ctr, Iowa City, IA 52242 USA; Univ Iowa, Carver Coll Med, Pappajohn Biomed Inst, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Taylor, EB (corresponding author), Univ Iowa, Carver Coll Med, 169 Newton Rd,3316 Pappajohn Biomed Res Bldg, Iowa City, IA 52242 USA.	eric-taylor@uiowa.edu		Rauckhorst, Adam/0000-0002-4101-0075; Taylor, Eric/0000-0003-4549-6567	National Institutes of Health [R01 DK104998, R00 AR059190, F32 DK101183, T32 HL007121, T32 HL007638, P30CA086862]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007638, T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R00AR059190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104998, F32DK101183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK104998 (to E. B. T.), R00 AR059190 (to E. B. T.), F32 DK101183 (to L. R. G.), T32 HL007121 to Francois Abboud (to L. R. G.), T32 HL007638 to Michael Welsh (to A. J. R.), and P30CA086862 to George Weiner, which contributed to support of core facilities utilized for this work. The authors declare no conflict of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aires CCP, 2008, FEBS LETT, V582, P3359, DOI 10.1016/j.febslet.2008.08.028; Bender T, 2015, EMBO J, V34, P911, DOI 10.15252/embj.201490197; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Compan V, 2015, MOL CELL, V59, P491, DOI 10.1016/j.molcel.2015.06.035; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Fernandez-Vizarra E, 2010, MITOCHONDRION, V10, P253, DOI 10.1016/j.mito.2009.12.148; Gogvadze V, 2006, BBA-BIOENERGETICS, V1757, P639, DOI 10.1016/j.bbabio.2006.03.016; Gray LR, 2015, CELL METAB, V22, P669, DOI 10.1016/j.cmet.2015.07.027; Gray LR, 2014, CELL MOL LIFE SCI, V71, P2577, DOI 10.1007/s00018-013-1539-2; HALESTRAP AP, 1974, BIOCHEM J, V138, P313, DOI 10.1042/bj1380313; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Angaman DM, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-1; McCommis KS, 2015, CELL METAB, V22, P682, DOI 10.1016/j.cmet.2015.07.028; PAPA S, 1971, FEBS LETT, V12, P285, DOI 10.1016/0014-5793(71)80200-4; PARADIES G, 1990, BIOCHIM BIOPHYS ACTA, V1016, P207, DOI 10.1016/0005-2728(90)90060-H; PARADIES G, 1983, CANCER RES, V43, P5068; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Saudek V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030876; Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026; TITHERADGE MA, 1976, FEBS LETT, V63, P45, DOI 10.1016/0014-5793(76)80191-3; TITHERADGE MA, 1975, BIOCHEM J, V150, P553, DOI 10.1042/bj1500553; Vacanti NM, 2014, MOL CELL, V56, P425, DOI 10.1016/j.molcel.2014.09.024; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025; ZAHLTEN RN, 1972, FEBS LETT, V21, P11, DOI 10.1016/0014-5793(72)80150-9; Zhang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057766; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027553	28	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7409	7417		10.1074/jbc.M115.711663	http://dx.doi.org/10.1074/jbc.M115.711663			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26823462	Green Published, hybrid			2022-12-26	WOS:000383447600017
J	Lin, CS; Uboldi, AD; Epp, C; Bujard, H; Tsuboi, T; Czabotar, PE; Cowman, AF				Lin, Clara S.; Uboldi, Alessandro D.; Epp, Christian; Bujard, Hermann; Tsuboi, Takafumi; Czabotar, Peter E.; Cowman, Alan F.			Multiple Plasmodium falciparum Merozoite Surface Protein 1 Complexes Mediate Merozoite Binding to Human Erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBIT PARASITE GROWTH; RED-BLOOD-CELLS; MALARIA PARASITE; BALANCING SELECTION; SERINE-PROTEASE; IN-VITRO; INVASION; ANTIBODIES; IDENTIFICATION; RECEPTOR	Successful invasion of human erythrocytes by Plasmodium falciparum merozoites is required for infection of the host and parasite survival. The early stages of invasion are mediated via merozoite surface proteins that interact with human erythrocytes. The nature of these interactions are currently not well understood, but it is known that merozoite surface protein 1 (MSP1) is critical for successful erythrocyte invasion. Here we show that the peripheral merozoite surface proteins MSP3, MSP6, MSPDBL1, MSPDBL2, and MSP7 bind directly to MSP1, but independently of each other, to form multiple forms of the MSP1 complex on the parasite surface. These complexes have overlapping functions that interact directly with human erythrocytes. We also show that targeting the p83 fragment of MSP1 using inhibitory antibodies inhibits all forms of MSP1 complexes and disrupts parasite growth in vitro.	[Lin, Clara S.; Uboldi, Alessandro D.; Czabotar, Peter E.; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Lin, Clara S.; Czabotar, Peter E.; Cowman, Alan F.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Epp, Christian] Heidelberg Univ, Dept Infect Dis, Parasitol, INF 324, D-69120 Heidelberg, Germany; [Bujard, Hermann] Heidelberg Univ, Zentrum Mol Biol, Neuenheimer Feld 282, D-69120 Heidelberg, Germany; [Tsuboi, Takafumi] Ehime Univ, Proteosci Ctr, Matsuyama, Ehime 7908577, Japan	Walter & Eliza Hall Institute; University of Melbourne; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ehime University	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia.; Cowman, AF (corresponding author), Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia.	cowman@wehi.edu.au	Tsuboi, Takafumi/AAK-6145-2021; Cowman, Alan/C-7642-2013	Czabotar, Peter/0000-0002-2594-496X; Tsuboi, Takafumi/0000-0002-7415-1325; Cowman, Alan/0000-0001-5145-9004				Amambua-Ngwa A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002992; Baldwin MR, 2015, BLOOD, V125, P2704, DOI 10.1182/blood-2014-11-611707; BLACKMAN MJ, 1992, MOL BIOCHEM PARASIT, V50, P307, DOI 10.1016/0166-6851(92)90228-C; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P29, DOI 10.1016/0166-6851(91)90127-R; Blackman MJ, 2004, CELL MICROBIOL, V6, P893, DOI 10.1111/j.1462-5822.2004.00437.x; BLACKMAN MJ, 1993, MOL BIOCHEM PARASIT, V62, P103, DOI 10.1016/0166-6851(93)90182-W; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P35, DOI 10.1016/0166-6851(91)90128-S; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Burgess BR, 2005, J BIOL CHEM, V280, P37236, DOI 10.1074/jbc.M506753200; Campanale N, 2003, J BIOL CHEM, V278, P27354, DOI 10.1074/jbc.M303634200; Chiu CYH, 2015, J INFECT DIS, V212, P406, DOI 10.1093/infdis/jiv057; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; CREWTHER PE, 1990, EXP PARASITOL, V70, P193, DOI 10.1016/0014-4894(90)90100-Q; Das S, 2015, CELL HOST MICROBE, V18, P433, DOI 10.1016/j.chom.2015.09.007; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; Gondeau C, 2009, MOL BIOCHEM PARASIT, V165, P153, DOI 10.1016/j.molbiopara.2009.01.015; Harris KS, 2005, INFECT IMMUN, V73, P6981, DOI 10.1128/IAI.73.10.6981-6989.2005; Hodder AN, 2012, J BIOL CHEM, V287, P32922, DOI 10.1074/jbc.M112.350504; HOLDER AA, 1987, PARASITOLOGY, V94, P199, DOI 10.1017/S0031182000053889; Howell SA, 2001, J BIOL CHEM, V276, P31311, DOI 10.1074/jbc.M103076200; Imam M, 2014, J BIOL CHEM, V289, P3856, DOI 10.1074/jbc.M113.520239; Kadekoppala M, 2010, EUKARYOT CELL, V9, P1064, DOI 10.1128/EC.00048-10; Kauth CW, 2006, J BIOL CHEM, V281, P31517, DOI 10.1074/jbc.M604641200; Li XR, 2004, J BIOL CHEM, V279, P5765, DOI 10.1074/jbc.M308716200; Lin CS, 2014, J BIOL CHEM, V289, P25655, DOI 10.1074/jbc.M114.586495; MCBRIDE JS, 1987, MOL BIOCHEM PARASIT, V23, P71, DOI 10.1016/0166-6851(87)90189-7; Mills KE, 2002, MOL MICROBIOL, V43, P1401, DOI 10.1046/j.1365-2958.2002.02834.x; Moss DK, 2012, INFECT IMMUN, V80, P1280, DOI 10.1128/IAI.05887-11; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Ochola LI, 2010, MOL BIOL EVOL, V27, P2344, DOI 10.1093/molbev/msq119; OEUVRAY C, 1994, BLOOD, V84, P1594; Osier FH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008705; Pachebat JA, 2001, MOL BIOCHEM PARASIT, V117, P83, DOI 10.1016/S0166-6851(01)00336-X; Pachebat JA, 2007, MOL BIOCHEM PARASIT, V151, P59, DOI 10.1016/j.molbiopara.2006.10.006; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Rodriguez LE, 2005, PROTEIN SCI, V14, P1778, DOI 10.1110/ps.041304505; Sakamoto H, 2012, VACCINE, V30, P1972, DOI 10.1016/j.vaccine.2012.01.010; Sanders PR, 2007, MOL BIOCHEM PARASIT, V154, P148, DOI 10.1016/j.molbiopara.2007.04.013; SIM BKL, 1994, EXP PARASITOL, V78, P259, DOI 10.1006/expr.1994.1027; Singh S, 2005, INFECT IMMUN, V73, P1235, DOI 10.1128/IAI.73.2.1235-1238.2005; Singh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005410; STAFFORD WHL, 1994, MOL BIOCHEM PARASIT, V66, P157, DOI 10.1016/0166-6851(94)90048-5; Stafford WHL, 1996, MOL BIOCHEM PARASIT, V80, P159, DOI 10.1016/0166-6851(96)02696-5; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Tetteh KKA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005568; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; Trucco C, 2001, MOL BIOCHEM PARASIT, V112, P91, DOI 10.1016/S0166-6851(00)00350-9; Van Tyne D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001383; Weedall GD, 2010, TRENDS PARASITOL, V26, P363, DOI 10.1016/j.pt.2010.04.002; Wickramarachchi T, 2009, INT J PARASITOL, V39, P763, DOI 10.1016/j.ijpara.2008.12.004; Woehlbier U, 2006, INFECT IMMUN, V74, P1313, DOI 10.1128/IAI.74.2.1313-1322.2006	56	47	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2016	291	14					7703	7715		10.1074/jbc.M115.698282	http://dx.doi.org/10.1074/jbc.M115.698282			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DW2BJ	26823464	Green Published, hybrid			2022-12-26	WOS:000383447600040
J	Kobayashi, S; Suzuki, T; Kawaguchi, A; Phongphaew, W; Yoshii, K; Iwano, T; Harada, A; Kariwa, H; Orba, Y; Sawa, H				Kobayashi, Shintaro; Suzuki, Tadaki; Kawaguchi, Akira; Phongphaew, Wallaya; Yoshii, Kentaro; Iwano, Tomohiko; Harada, Akihiro; Kariwa, Hiroaki; Orba, Yasuko; Sawa, Hirofumi			Rab8b Regulates Transport of West Nile Virus Particles from Recycling Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavivirus; infection; Rab; transport; vesicles	DENGUE-VIRUS; ENDOPLASMIC-RETICULUM; ENVELOPE PROTEIN; EPITHELIAL-CELLS; HEPG2 CELLS; INFECTION; RAB11; CILIOGENESIS; REPLICATION; PATHOGENESIS	West Nile virus (WNV) particles assemble at and bud into the endoplasmic reticulum (ER) and are secreted from infected cells through the secretory pathway. However, the host factor related to these steps is not fully understood. Rab proteins, belonging to the Ras superfamily, play essential roles in regulating many aspects of vesicular trafficking. In this study, we sought to determine which Rab proteins are involved in intracellular trafficking of nascent WNV particles. RNAi analysis revealed that Rab8b plays a role in WNV particle release. We found that Rab8 and WNV antigen were colocalized in WNV-infected human neuroblastoma cells, and that WNV infection enhanced Rab8 expression in the cells. In addition, the amount of WNV particles in the supernatant of Rab8b-deficient cells was significantly decreased compared with that of wild-type cells. We also demonstrated that WNV particles accumulated in the recycling endosomes in WNV-infected cells. In summary, these results suggest that Rab8b is involved in trafficking of WNV particles from recycling endosomes to the plasma membrane.	[Kobayashi, Shintaro; Kawaguchi, Akira; Phongphaew, Wallaya; Orba, Yasuko; Sawa, Hirofumi] Hokkaido Univ, Div Mol Pathobiol, Res Ctr Zoonosis Control, Kita Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan; [Kobayashi, Shintaro; Yoshii, Kentaro; Kariwa, Hiroaki] Hokkaido Univ, Publ Hlth Lab, Grad Sch Vet Med, Kita Ku, N18,W9, Sapporo, Hokkaido 0600818, Japan; [Suzuki, Tadaki] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan; [Iwano, Tomohiko] Univ Yamanashi, Dept Anat & Cell Biol, Interdisciplinary Grad Sch Med & Engn, 1110 Shimo Kateau, Chuo, Yamanashi 4093898, Japan; [Harada, Akihiro] Osaka Univ, Dept Cell Biol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Sawa, Hirofumi] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Kita Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan; [Sawa, Hirofumi] Hokkaido Univ, GVN, Kita Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan	Hokkaido University; Hokkaido University; National Institute of Infectious Diseases (NIID); University of Yamanashi; Osaka University; Hokkaido University; Hokkaido University	Sawa, H (corresponding author), Hokkaido Univ, Div Mol Pathobiol, Res Ctr Zoonosis Control, Kta Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan.	h-sawa@czc.hokudai.ac.jp	Suzuki, Tadaki/ABH-2661-2020; Orba, Yasuko/F-6888-2012; Kobayashi, Shintaro/AFR-4313-2022; YOSHII, Kentaro/A-4808-2012; Sawa, Hirofumi/F-6954-2012; Sawa, Hirofumi/AAW-8816-2021	Kobayashi, Shintaro/0000-0002-8735-5722; Sawa, Hirofumi/0000-0003-2569-2755; 	JSPS [15K19069]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Ministry of Health, Labour, and Welfare of Japan; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Grant from MEXT for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University; Grants-in-Aid for Scientific Research [15K19069] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant from MEXT for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by JSPS KAKENHI Grant Number 15K19069 and grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); the Ministry of Health, Labour, and Welfare of Japan; and the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); as well as by the Grant from MEXT for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University. The authors declare that they have no conflicts of interest with the contents of this article.	Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Brinton MA, 2002, ANNU REV MICROBIOL, V56, P371, DOI 10.1146/annurev.micro.56.012302.160654; Chen S, 2001, J BIOL CHEM, V276, P13209, DOI 10.1074/jbc.M010798200; Chu JJH, 2002, J GEN VIROL, V83, P2427, DOI 10.1099/0022-1317-83-10-2427; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Das A, 2011, TRENDS CELL BIOL, V21, P383, DOI 10.1016/j.tcb.2011.03.006; de Kreuk BJ, 2012, J BIOL CHEM, V287, P43438, DOI 10.1074/jbc.M112.391078; Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Garg H, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-197; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Guarner J, 2004, HUM PATHOL, V35, P983, DOI 10.1016/j.humpath.2004.04.008; Guichard A, 2014, NAT REV MICROBIOL, V12, P624, DOI 10.1038/nrmicro3325; Hasebe R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-165; Hayes EB, 2005, EMERG INFECT DIS, V11, P1174, DOI 10.3201/eid1108.050289b; Henry L, 2008, MOL BIOL CELL, V19, P2059, DOI 10.1091/mbc.E07-09-0902; KIMURA T, 1994, ARCH VIROL, V139, P239, DOI 10.1007/BF01310788; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Kobayashi S, 2014, VIRUS RES, V191, P83, DOI 10.1016/j.virusres.2014.07.016; Kobayashi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076668; Kobayashi S, 2012, NEUROPATHOLOGY, V32, P398, DOI 10.1111/j.1440-1789.2011.01275.x; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Ooi YS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003835; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030; Puig-Basagoiti F, 2005, ANTIMICROB AGENTS CH, V49, P4980, DOI 10.1128/AAC.49.12.4980-4988.2005; Rowe RK, 2008, VIROLOGY, V382, P239, DOI 10.1016/j.virol.2008.09.021; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Sato T, 2014, J CELL SCI, V127, P422, DOI 10.1242/jcs.136903; Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0; Shirato K, 2004, J MED VIROL, V74, P507, DOI 10.1002/jmv.20205; Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Xu XF, 2008, INTERVIROLOGY, V51, P182, DOI 10.1159/000151531; Xu XF, 2009, INTERVIROLOGY, V52, P258, DOI 10.1159/000230669; Yu SY, 2014, EMBO J, V33, P1882, DOI 10.15252/embj.201487888	46	20	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6559	6568		10.1074/jbc.M115.712760	http://dx.doi.org/10.1074/jbc.M115.712760			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26817838	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000372894200041
J	Bourmoum, M; Charles, R; Claing, A				Bourmoum, Mohamed; Charles, Ricardo; Claing, Audrey			The GTPase ARF6 Controls ROS Production to Mediate Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; DOWNSTREAM ACTIVATION; TYROSINE KINASE; PROTEIN; GROWTH; RECEPTOR; RAC1; MIGRATION; PATHWAYS; COMPLEX	High reactive oxygen species (ROS) levels and enhanced vascular smooth muscle cells (VSMC) proliferation are observed in numerous cardiovascular diseases. The mechanisms by which hormones such as angiotensin II (Ang II) acts to promote these cellular responses remain poorly understood. We have previously shown that the ADP-ribosylation factor 6 (ARF6), a molecular switch that coordinates intracellular signaling events can be activated by the Ang II receptor (AT(1)R). Whether this small GTP-binding protein controls the signaling events leading to ROS production and therefore Ang II-dependent VSMC proliferation, remains however unknown. Here, we demonstrate that in rat aortic VSMC, Ang II stimulation led to the subsequent activation of ARF6 and Rac1, a key regulator of NADPH oxidase activity. Using RNA interference, we showed that ARF6 is essential for ROS generation since in conditions where this GTPase was knocked down, Ang II could no longer promote superoxide anion production. In addition to regulating Rac1 activity, ARF6 also controlled expression of the NADPH oxidase 1 (Nox 1) as well as the ability of the EGFR to become transactivated. Finally, ARF6 also controlled MAPK (Erk1/2, p38 and Jnk) activation, a key pathway of VSMC proliferation. Altogether, our findings demonstrate that Ang II promotes activation of ARF6 to controls ROS production by regulating Rac1 activation and Nox1 expression. In turn, increased ROS acts to activate the MAPK pathway. These signaling events represent a new molecular mechanism by which Ang II can promote proliferation of VSMC.	[Bourmoum, Mohamed; Charles, Ricardo; Claing, Audrey] Univ Montreal, Dept Pharmacol, Fac Med, Montreal, PQ H3T 1J4, Canada	Universite de Montreal	Claing, A (corresponding author), Univ Montreal, Dept Pharmacol, Fac Med, Montreal, PQ H3T 1J4, Canada.	audrey.claing@umontreal.ca			Canadian Institutes of Health Research [MOP-79470]; Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by the Canadian Institutes of Health Research [grant number: MOP-79470]; and the Heart and Stroke Foundation of Canada to AC. AC is a scholar of the Fonds de Recherche du Quebec-Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertinazzi C, 2003, MOL BIOL CELL, V14, P1295, DOI 10.1091/mbc.E02-07-0406; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Braun-Dullaeus RC, 1998, CIRCULATION, V98, P82, DOI 10.1161/01.CIR.98.1.82; Brewer AC, 2006, FREE RADICAL BIO MED, V40, P260, DOI 10.1016/j.freeradbiomed.2005.08.022; Cai Hua, 2007, V139, P293; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Ferrario CM, 2006, J RENIN-ANGIO-ALDO S, V7, P3, DOI 10.3317/jraas.2006.003; Frank GD, 2000, ENDOCRINOLOGY, V141, P3120, DOI 10.1210/en.141.9.3120; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Huckle William R., 1994, Progress in Growth Factor Research, V5, P177, DOI 10.1016/0955-2235(94)90004-3; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Knizhnik AV, 2012, J CELL BIOCHEM, V113, P360, DOI 10.1002/jcb.23362; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Kyaw M, 2001, HYPERTENS RES, V24, P251, DOI 10.1291/hypres.24.251; Lepore JJ, 2005, ARTERIOSCL THROM VAS, V25, P309, DOI 10.1161/01.ATV.0000152725.76020.3c; Li M, 2009, CANCER-AM CANCER SOC, V115, P4959, DOI 10.1002/cncr.24550; Mifune M, 2005, J BIOL CHEM, V280, P26592, DOI 10.1074/jbc.M502906200; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Pinzar E, 2005, FEBS LETT, V579, P5100, DOI 10.1016/j.febslet.2005.08.019; Samarakoon R, 2009, CELL SIGNAL, V21, P986, DOI 10.1016/j.cellsig.2009.02.007; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Satoh K, 2010, ANTIOXID REDOX SIGN, V12, P675, DOI 10.1089/ars.2009.2875; SCHWARTZ SM, 1986, CIRC RES, V58, P427, DOI 10.1161/01.RES.58.4.427; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; Touyz RM, 2005, ARTERIOSCL THROM VAS, V25, P512, DOI 10.1161/01.ATV.0000154141.66879.98; Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018; Touyz RM, 2003, CAN J PHYSIOL PHARM, V81, P159, DOI 10.1139/Y02-164; Touyz RM, 2000, PHARMACOL REV, V52, P639; Ushio-Fukai M, 1999, MOL PHARMACOL, V55, P142, DOI 10.1124/mol.55.1.142; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P19772, DOI 10.1074/jbc.273.31.19772; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Viedt C, 2000, ARTERIOSCL THROM VAS, V20, P940, DOI 10.1161/01.ATV.20.4.940; Wang ZB, 2004, J MOL CELL CARDIOL, V36, P49, DOI 10.1016/j.yjmcc.2003.09.014; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	42	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148097	10.1371/journal.pone.0148097	http://dx.doi.org/10.1371/journal.pone.0148097			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824355	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528600099
J	Kim, SK; Castro, A; Kim, ES; Dinkel, AP; Liu, XY; Castro, M				Kim, Sung-Kun; Castro, Aaron; Kim, Edward S.; Dinkel, Austin P.; Liu, Xiaoyun; Castro, Miguel			Inhibitory Effect of Bridged Nucleosides on Thermus aquaticus DNA Polymerase and Insight into the Binding Interactions	PLOS ONE			English	Article							PARTICLE MESH EWALD; NUCLEIC-ACID; CRYSTAL-STRUCTURE; 2',4'-BNA(NC); MECHANISMS; NUCLEOTIDE; GROMACS	Modified nucleosides have the potential to inhibit DNA polymerases for the treatment of viral infections and cancer. With the hope of developing potent drug candidates by the modification of the 2', 4'-position of the ribose with the inclusion of a bridge, efforts were focused on the inhibition of Taq DNA polymerase using quantitative real time PCR, and the results revealed the significant inhibitory effects of 2', 4'-bridged thymidine nucleoside on the polymerase. Study on the mode of inhibition revealed the competitive mechanism with which the 2', 4'-bridged thymidine operates. With a K-i value of 9.7 +/- 1.1 mu M, the 2', 4'-bridged thymidine proved to be a very promising inhibitor. Additionally, docking analysis showed that all the nucleosides including 2', 4'-bridged thymidine were able to dock in the active site, indicating that the substrate analogs reflect a structural complementarity to the enzyme active site. The analysis also provided evidence that Asp610 was a key binding site for 2', 4'-bridged thymidine. Molecular dynamics (MD) simulations were performed to further understand the conformational variations of the binding. The root-mean-square deviation (RMSD) values for the peptide backbone of the enzyme and the nitrogenous base of the inhibitor stabilized within 0.8 and 0.2 ns, respectively. Furthermore, the MD analysis indicates substantial conformational change in the ligand (inhibitor) as the nitrogenous base rotated anticlockwise with respect to the sugar moiety, complemented by the formation of several new hydrogen bonds where Arg587 served as a pivot axis for binding formation. In conclusion, the active site inhibition of Taq DNA polymerase by 2', 4'-bridged thymidine suggests the potential of bridged nucleosides as drug candidates.	[Kim, Sung-Kun; Dinkel, Austin P.] Northeastern State Univ, Dept Nat Sci, Tahlequah, OK USA; [Castro, Aaron; Kim, Edward S.; Liu, Xiaoyun; Castro, Miguel] Biosynth Inc, Lewisville, TX USA		Kim, SK (corresponding author), Northeastern State Univ, Dept Nat Sci, Tahlequah, OK USA.	kim03@nsuok.edu	Kim, Sung-Kun/I-4193-2019	Kim, Sung-Kun/0000-0002-2325-245X	Bio-Synthesis Inc. [14-9089]	Bio-Synthesis Inc.	This work was supported by a grant from Bio-Synthesis Inc. (14-9089) to SK. AC, ESK, XL and MC are employed by Bio-Synthesis Inc. Bio-Synthesis Inc. provided support in the form of salaries for authors AC, ESK, XL and MC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson VR, 2007, DRUGS, V67, P1633, DOI 10.2165/00003495-200767110-00008; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Clercq E, 2011, ANNU REV PHARMACOL, V51, P1, DOI 10.1146/annurev-pharmtox-010510-100228; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FURMAN PA, 1984, J BIOL CHEM, V259, P9575; Hari Y, 2006, BIOORGAN MED CHEM, V14, P1029, DOI 10.1016/j.bmc.2005.09.020; Havelka AM, 2007, MINI-REV MED CHEM, V7, P1035, DOI 10.2174/138955707782110196; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kim S.-K., 2015, J BIOCH MOL BIOL RES, V1, P67, DOI 10.17554/j.issn.2313-7177.2015.01.13; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200; Lindow M, 2012, J CELL BIOL, V199, P407, DOI 10.1083/jcb.201208082; Lundin KE, 2013, ADV GENET, V82, P47, DOI 10.1016/B978-0-12-407676-1.00002-0; Mitsuoka Y, 2009, NUCLEIC ACIDS RES, V37, P1225, DOI 10.1093/nar/gkn1062; Miyashita K, 2007, CHEM COMMUN, P3765, DOI 10.1039/b707352f; Morris Garrett M., 2008, V443, P365, DOI 10.1007/978-1-59745-177-2_19; Obika Satoshi, 2002, Nucleic Acids Res Suppl, P25; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pungitore CR, 2004, J NAT PROD, V67, P357, DOI 10.1021/np030238b; Rahman SMA, 2008, J AM CHEM SOC, V130, P4886, DOI 10.1021/ja710342q; Scatena R, 2007, AM J PHYSIOL-CELL PH, V293, pC12, DOI 10.1152/ajpcell.00314.2006; Sharma VK, 2014, RSC ADV, V4, P16618, DOI 10.1039/c3ra47841f; Sofia MJ, 2012, J MED CHEM, V55, P2481, DOI 10.1021/jm201384j; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Sutlovic D, 2008, ELECTROPHORESIS, V29, P1467, DOI 10.1002/elps.200700699; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Watts JK, 2013, CHEM COMMUN, V49, P5618, DOI 10.1039/c3cc40340h; Wengel J, 1999, ACCOUNTS CHEM RES, V32, P301, DOI 10.1021/ar980051p; Yamamoto T, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/707323; YARCHOAN R, 1990, ANN NY ACAD SCI, V616, P328	42	3	4	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147234	10.1371/journal.pone.0147234	http://dx.doi.org/10.1371/journal.pone.0147234			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820310	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528400018
J	Molina, L; Udaondo, Z; Duque, E; Fernandez, M; Bernal, P; Roca, A; de la Torre, J; Ramos, JL				Molina, Lazaro; Udaondo, Zulema; Duque, Estrella; Fernandez, Matilde; Bernal, Patricia; Roca, Amalia; de la Torre, Jesus; Luis Ramos, Juan			Specific Gene Loci of Clinical Pseudomonas putida Isolates	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; METALLO-BETA-LACTAMASE; SECRETION SYSTEM; CYSTIC-FIBROSIS; ANTIMICROBIAL RESISTANCE; AERUGINOSA; FLUORESCENS; ACQUISITION; ADAPTATION; VIRULENCE	Pseudomonas putida are ubiquitous inhabitants of soils and clinical isolates of this species have been seldom described. Clinical isolates show significant variability in their ability to cause damage to hosts because some of them are able to modulate the host's immune response. In the current study, comparisons between the genomes of different clinical and environmental strains of P. putida were done to identify genetic clusters shared by clinical isolates that are not present in environmental isolates. We show that in clinical strains specific genes are mostly present on transposons, and that this set of genes exhibit high identity with genes found in pathogens and opportunistic pathogens. The set of genes prevalent in P. putida clinical isolates, and absent in environmental isolates, are related with survival under oxidative stress conditions, resistance against biocides, amino acid metabolism and toxin/antitoxin (TA) systems. This set of functions have influence in colonization and survival within human tissues, since they avoid host immune response or enhance stress resistance. An in depth bioinformatic analysis was also carried out to identify genetic clusters that are exclusive to each of the clinical isolates and that correlate with phenotypical differences between them, a secretion system type III-like was found in one of these clinical strains, a determinant of pathogenicity in Gram-negative bacteria.	[Molina, Lazaro; Udaondo, Zulema; Duque, Estrella; Fernandez, Matilde; de la Torre, Jesus; Luis Ramos, Juan] CSIC, Estn Expt Zaidin, Environm Protect Dept, C Prof Albareda 1, Granada, Spain; [Udaondo, Zulema; Duque, Estrella; Luis Ramos, Juan] Abengoa Res, Campus Palmas Altas, Seville, Spain; [Bernal, Patricia] Univ London Imperial Coll Sci Technol & Med, South Kensington Campus, London, England; [Roca, Amalia] Bioiliberis R&D, C Capileira 7, Granada 18210, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Imperial College London	Molina, L (corresponding author), CSIC, Estn Expt Zaidin, Environm Protect Dept, C Prof Albareda 1, Granada, Spain.	lazaro.molina@eez.csic.es	Hernandez, Amalia Roca/AAD-3048-2019; Molina, Lazaro/K-9645-2014; Bernal, Patricia/K-6399-2014; Udaondo, Zulema/ABI-7810-2020; Fernandez, Matilde/F-5980-2013; Roca, Amalia/AAB-9240-2021	Hernandez, Amalia Roca/0000-0003-2332-3112; Molina, Lazaro/0000-0002-8483-9203; Bernal, Patricia/0000-0002-6228-0496; Fernandez, Matilde/0000-0002-7064-670X; Ramos, Juan L./0000-0002-8731-7435; Fernandez, Matilde/0000-0002-5832-5161; De la Torre Zuniga, Jesus/0000-0001-8111-6299; Duque, Estrella/0000-0002-4857-8974; Udaondo, Zulema/0000-0003-3445-6842	ERANET Pathogenomics programme through the ADHERS project [BIO2008-04419-E]; Fondos FEDER from the European Union through Ministry of Economy and Competitivity of Spain [BIO2010-17227]; Bio-Iliberis RD	ERANET Pathogenomics programme through the ADHERS project; Fondos FEDER from the European Union through Ministry of Economy and Competitivity of Spain; Bio-Iliberis RD	Work in the authors' laboratories was supported by ERANET Pathogenomics programme through the ADHERS project (Ref: BIO2008-04419-E) and Fondos FEDER from the European Union through project BIO2010-17227 of the Ministry of Economy and Competitivity of Spain. Bio-Iliberis R&D provided support in the form of salary and material for Amalia Roca, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bhattacharya D., 2015, New Microbes and New Infections, V5, P5, DOI 10.1016/j.nmni.2015.02.002; Bielecki P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024235; Bossis E, 2000, AGRONOMIE, V20, P51, DOI 10.1051/agro:2000112; Butt A, 2014, BIOCHEM J, V459, P333, DOI 10.1042/BJ20140073; Choi EN, 2003, MICROBIOL-SGM, V149, P795, DOI 10.1099/mic.0.26046-0; Chung JCS, 2012, J BACTERIOL, V194, P4857, DOI 10.1128/JB.01050-12; Cornelissen CN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00117; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; Daniels C, 2010, J BACTERIOL, V192, P2169, DOI 10.1128/JB.01129-09; Darbari VC, 2015, ANNU REV BIOCHEM, V84, P603, DOI 10.1146/annurev-biochem-062911-102821; Darling AE, 2011, BIOINFORMATICS, V27, P2756, DOI 10.1093/bioinformatics/btr451; de Pace F, 2010, INFECT IMMUN, V78, P4990, DOI 10.1128/IAI.00531-10; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Di Bonito M, 2012, TRANSL MED UNISA, V3, P15; Docquier JD, 2003, ANTIMICROB AGENTS CH, V47, P1522, DOI 10.1128/AAC.47.5.1522-1528.2003; dos Santos VAPM, 2004, ENVIRON MICROBIOL, V6, P1264, DOI 10.1111/j.1462-2920.2004.00734.x; Dutta C, 2012, CURR GENOMICS, V13, P153, DOI 10.2174/138920212799860698; Elomari M, 1997, INT J SYST BACTERIOL, V47, P846, DOI 10.1099/00207713-47-3-846; Fernandez M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00871; Frapolli M, 2007, ENVIRON MICROBIOL, V9, P1939, DOI 10.1111/j.1462-2920.2007.01310.x; FURUTA T, 1992, J BIOL CHEM, V267, P12600; Gilarranz R, 2013, CLIN MICROBIOL INFEC, V19, pE424, DOI 10.1111/1469-0691.12248; Girerd-Genessay I, 2015, J BURN CARE RES; GRAEVENITZ AV, 1971, YALE J BIOL MED, V44, P265; Han XL, 2011, J ANTIMICROB CHEMOTH, V66, P323, DOI 10.1093/jac/dkq427; Harvey RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019650; Hobman JL, 2015, J MED MICROBIOL, V64, P471, DOI 10.1099/jmm.0.023036-0; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; Hong SJ, 2015, GENOME ANNOUNC, V3, DOI [10.1128/genomeA.00810-15, DOI 10.1128/GEN0MEA.00810-15]; Hottes AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003617; Iacovelli V, 2014, UROLOGIA J, V81, P222, DOI 10.5301/uro.5000092; Iyer RS, 2013, ADV BIOL CHEM, V3, P564, DOI DOI 10.4236/ABC.2013.36065; JANSE JD, 1982, INT J SYST BACTERIOL, V32, P166, DOI 10.1099/00207713-32-2-166; Juan C, 2010, J ANTIMICROB CHEMOTH, V65, P474, DOI 10.1093/jac/dkp491; Kaihami GH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004442; Kim J, 2014, APPL MICROBIOL BIOT, V98, P6933, DOI 10.1007/s00253-014-5883-4; Klevens RM, 2002, PUBLIC HLTH REP, V122, P160; Koprivnjak T, 2011, J BACTERIOL, V193, P4134, DOI 10.1128/JB.00288-11; Kossel H, 1894, Z HYG INFEKTIONSKR, V16, P368; Kuhn S, 2015, INT J MED MICROBIOL, V305, P196, DOI 10.1016/j.ijmm.2014.12.016; Leavis HL, 2007, PLOS PATHOG, V3, P75, DOI 10.1371/journal.ppat.0030007; Leighton TL, 2015, ENVIRON MICROBIOL, V17, P4148, DOI 10.1111/1462-2920.12849; Lisher JP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00091; Liu YL, 2014, ADV CANCER RES, V122, P69, DOI 10.1016/B978-0-12-420117-0.00002-5; LOISEAUMAROLLEAU ML, 1977, PATHOL BIOL, V25, P637; Loper JE, 1997, APPL ENVIRON MICROB, V63, P99, DOI 10.1128/AEM.63.1.99-105.1997; Mao ZJ, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00586-13; Marcelletti S, 2014, PHYTOPATHOLOGY, V104, P1274, DOI 10.1094/PHYTO-12-13-0344-R; Martinez P, 2005, MOL CELL BIOL, V25, P9435, DOI 10.1128/MCB.25.21.9435-9446.2005; Marvig RL, 2015, FUTURE MICROBIOL, V10, P599, DOI [10.2217/FMB.15.3, 10.2217/fmb.15.3]; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Matilla MA, 2011, J BACTERIOL, V193, P1290, DOI 10.1128/JB.01281-10; Matthijs S, 2009, BIOMETALS, V22, P951, DOI 10.1007/s10534-009-9247-y; Mavrodi DV, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-8; Mazurier S, 2015, APPL ENVIRON MICROB, V81, P2579, DOI 10.1128/AEM.04160-14; Mehrad B, 2015, CHEST, V147, P1413, DOI 10.1378/chest.14-2171; Meyer JM, 2000, ARCH MICROBIOL, V174, P135, DOI 10.1007/s002030000188; Micek ST, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0926-5; Molina L, 2007, PLANT CELL, V19, P2293, DOI 10.1105/tpc.107.052332; Molina L, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00496-13; Molina L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081604; Munteanu A, 2015, EXTREMOPHILES, V19, P707, DOI 10.1007/s00792-015-0759-9; Nakazawa T, 2002, ENVIRON MICROBIOL, V4, P782, DOI 10.1046/j.1462-2920.2002.00310.x; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Ohji S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00029-14; Ottosen J, 2014, SURG CLIN N AM, V94, P1305, DOI 10.1016/j.suc.2014.09.001; Oyinloye BE, 2015, PHARMACEUTICALS-BASE, V8, P151, DOI 10.3390/ph8020151; Palma M, 2004, J BACTERIOL, V186, P248, DOI 10.1128/JB.186.1.248-252.2004; Picot L, 2001, MICROBES INFECT, V3, P985, DOI 10.1016/S1286-4579(01)01462-9; Poon IKH, 2011, BLOOD, V117, P2093, DOI 10.1182/blood-2010-09-303842; Qi J, 2004, NUCLEIC ACIDS RES, V32, pW45, DOI 10.1093/nar/gkh362; Qiu X, 2009, GENOME DYNAM, V6, P126, DOI 10.1159/000235767; RAMOS JL, 1995, J BACTERIOL, V177, P3911, DOI 10.1128/jb.177.14.3911-3916.1995; Roca A, 2013, ENVIRON MICROBIOL, V15, P780, DOI 10.1111/1462-2920.12037; ROSSON RA, 1982, J BACTERIOL, V151, P1027, DOI 10.1128/JB.151.2.1027-1034.1982; Runyen-Janecky LJ, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00055; Schuller-Levis GB, 2004, NEUROCHEM RES, V29, P117, DOI 10.1023/B:NERE.0000010440.37629.17; Sharma PK, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0037-8; Sharma P, 2014, EXPERT REV ANTI-INFE, V12, P343, DOI 10.1586/14787210.2014.887441; Soo VWC, 2013, SCI REP-UK, V3, DOI 10.1038/srep03186; Struelens MJ, 1998, BRIT MED J, V317, P652, DOI 10.1136/bmj.317.7159.652; Taghavi S, 2005, APPL ENVIRON MICROB, V71, P8500, DOI 10.1128/AEM.71.12.8500-8505.2005; Tillett D, 2001, APPL ENVIRON MICROB, V67, P2810, DOI 10.1128/AEM.67.6.2810-2818.2001; Tiwari P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7059; Tymensen LD, 2015, J APPL MICROBIOL, V119, P263, DOI 10.1111/jam.12814; Udaondo Z, 2013, MICROB BIOTECHNOL, V6, P598, DOI 10.1111/1751-7915.12061; Udaondo Z, 2012, FEBS LETT, V586, P2932, DOI 10.1016/j.febslet.2012.07.031; Unterholzner Simon J, 2013, Mob Genet Elements, V3, pe26219; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; von Tils D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00160; Vraspir JM, 2009, ANNU REV MAR SCI, V1, P43, DOI 10.1146/annurev.marine.010908.163712; Wang SN, 2007, MICROBIOL-SGM, V153, P1556, DOI 10.1099/mic.0.2006/005223-0; Wargo MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056850; Watson CM, 2014, SURG CLIN N AM, V94, P1233, DOI 10.1016/j.suc.2014.08.003; Witholt, 1992, PSEUDOMONAS MOL BIOL; Woods EJ, 2009, VET MICROBIOL, V138, P325, DOI 10.1016/j.vetmic.2009.03.023; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x; Yadav UCS, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/690545; Ye LM, 2013, BIOMETALS, V26, P561, DOI 10.1007/s10534-013-9653-z; Yomoda S, 2003, J CLIN MICROBIOL, V41, P4246, DOI 10.1128/JCM.41.9.4246-4251.2003; Yoshino Y, 2011, J INFECT CHEMOTHER, V17, P278, DOI 10.1007/s10156-010-0114-0; Yu H, 2011, J BACTERIOL, V193, P5541, DOI 10.1128/JB.05663-11	106	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147478	10.1371/journal.pone.0147478	http://dx.doi.org/10.1371/journal.pone.0147478			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820467	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528400030
J	Norden, PR; Kim, DJ; Barry, DM; Cleaver, OB; Davis, GE				Norden, Pieter R.; Kim, Dae Joong; Barry, David M.; Cleaver, Ondine B.; Davis, George E.			Cdc42 and k-Ras Control Endothelial Tubulogenesis through Apical Membrane and Cytoskeletal Polarization: Novel Stimulatory Roles for GTPase Effectors, the Small GTPases, Rac2 and Rap1b, and Inhibitory Influence of Arhgap31 and Rasa1	PLOS ONE			English	Article							3-DIMENSIONAL EXTRACELLULAR MATRICES; VASCULAR LUMEN FORMATION; BLOOD-VESSEL FORMATION; MOLECULAR-MECHANISMS; IN-VITRO; CELL MORPHOGENESIS; ACTIVATING PROTEIN; CAPILLARY LUMEN; COLLAGEN MATRIX; ANGIOGENESIS	A critical and understudied property of endothelial cells is their ability to form lumens and tube networks. Although considerable information has been obtained concerning these issues, including the role of Cdc42 and Rac1 and their effectors such as Pak2, Pak4, Par6b, and co-regulators such as integrins, MT1-MMP and Par3; many key questions remain that are necessary to elucidate molecular and signaling requirements for this fundamental process. In this work, we identify new small GTPase regulators of EC tubulogenesis including k-Ras, Rac2 and Rap1b that act in conjunction with Cdc42 as well as the key downstream effectors, IQGAP1, MRCK beta, beta-Pix, GIT1, and Rasip1 (which can assemble into multiprotein complexes with key regulators including alpha 2 beta 1 integrin and MT1-MMP). In addition, we identify the negative regulators, Arhgap31 (by inactivating Cdc42 and Rac) and Rasa1 (by inactivating k-Ras) and the positive regulator, Arhgap29 (by inactivating RhoA) which play a major functional role during the EC tubulogenic process. Human EC siRNA suppression or mouse knockout of Rasip1 leads to identical phenotypes where ECs form extensive cord networks, but cannot generate lumens or tubes. Essential roles for these molecules during EC tubulogenesis include; i) establishment of asymmetric EC cytoskeletal polarization (subapical distribution of acetylated tubulin and basal membrane distribution of F-actin); and ii) directed membrane trafficking of pinocytic vacuoles or other intracellular vesicles along acetylated tubulin tracks to the developing apical membrane surface. Cdc42 co-localizes subapically with acetylated tubulin, while Rac1 and k-Ras strongly label vacuole/vesicle membranes which accumulate and fuse together in a polarized, perinuclear manner. We observe polarized apical membrane and subapical accumulation of key GTPases and effectors regulating EC lumen formation including Cdc42, Rac1, Rac2, k-Ras, Rap1b, activated c-Raf and Rasip1 to control EC tube network assembly. Overall, this work defines novel key regulators and their functional roles during human EC tubulogenesis.	[Norden, Pieter R.; Kim, Dae Joong; Davis, George E.] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Barry, David M.; Cleaver, Ondine B.] UT Southwesten Med Ctr, Dept Mol Biol, Dallas, TX USA	University of Missouri System; University of Missouri Columbia	Davis, GE (corresponding author), Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA.	davisgeo@health.missouri.edu		Cleaver, Ondine/0000-0003-2454-6641; Norden, Pieter/0000-0002-5960-5245	National Institutes of Health, National Heart Lung and Blood Institute [HL126518, HL128584]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126518, R01HL128584] Funding Source: NIH RePORTER	National Institutes of Health, National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health, National Heart Lung and Blood Institute, HL126518 (GD, OC) and HL128584 (GD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Barry DM, 2015, DEVELOPMENT, V142, P3058, DOI 10.1242/dev.125260; Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; Bayless KJ, 2004, J BIOL CHEM, V279, P11686, DOI 10.1074/jbc.M308373200; Bayless KJ, 2002, J CELL SCI, V115, P1123; Boon LM, 2005, CURR OPIN GENET DEV, V15, P265, DOI 10.1016/j.gde.2005.03.004; Bowers SLK, 2015, METHODS MOL BIOL, V1189, P171, DOI 10.1007/978-1-4939-1164-6_12; Callow MG, 2005, J CELL SCI, V118, P1861, DOI 10.1242/jcs.02313; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis George E., 2007, Birth Defects Research, V81, P270, DOI 10.1002/bdrc.20107; Davis GE, 2015, CELL POLARITY 1: BIOLOGICAL ROLE AND BASIC MECHANISMS, P205, DOI 10.1007/978-3-319-14463-4_9; Davis GE, 2015, CONNECT TISSUE RES, V56, P392, DOI 10.3109/03008207.2015.1066781; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Giglione C, 2001, EUR J BIOCHEM, V268, P3275, DOI 10.1046/j.1432-1327.2001.02230.x; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hoang MV, 2011, MICROVASC RES, V81, P34, DOI 10.1016/j.mvr.2010.09.001; Im E, 2007, J BIOL CHEM, V282, P29122, DOI 10.1074/jbc.M702637200; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Jenna S, 2002, J BIOL CHEM, V277, P6366, DOI 10.1074/jbc.M105516200; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kim DJ, 2013, BLOOD, V121, P3521, DOI 10.1182/blood-2012-11-470179; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Koh W, 2009, J CELL SCI, V122, P1812, DOI 10.1242/jcs.045799; Lamarche-Vane N, 1998, J BIOL CHEM, V273, P29172, DOI 10.1074/jbc.273.44.29172; Lampugnani MG, 2010, J CELL SCI, V123, P1073, DOI 10.1242/jcs.059329; Matsunaga H, 2014, BIOCHEM BIOPH RES CO, V444, P360, DOI 10.1016/j.bbrc.2014.01.041; Mitin NY, 2004, J BIOL CHEM, V279, P22353, DOI 10.1074/jbc.M312867200; Post A, 2015, MOL CELL BIOL, V35, P2495, DOI 10.1128/MCB.01453-14; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Sacharidou A, 2012, CELLS TISSUES ORGANS, V195, P122, DOI 10.1159/000331410; Sacharidou A, 2010, BLOOD, V115, P5259, DOI 10.1182/blood-2009-11-252692; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; Sigurbjornsdottir S, 2014, NAT REV MOL CELL BIO, V15, P665, DOI 10.1038/nrm3871; Smith AO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085147; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; Stratman AN, 2012, MICROSC MICROANAL, V18, P68, DOI 10.1017/S1431927611012402; Stratman AN, 2011, BLOOD, V117, P3709, DOI 10.1182/blood-2010-11-316752; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Verma A, 2001, CELL MICROBIOL, V3, P169, DOI 10.1046/j.1462-5822.2001.00104.x; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Xu K, 2011, SEMIN CELL DEV BIOL, V22, P993, DOI 10.1016/j.semcdb.2011.05.001; Xu K, 2011, DEV CELL, V20, P526, DOI 10.1016/j.devcel.2011.02.010; Yu JXA, 2015, DEVELOPMENT, V142, P2951, DOI 10.1242/dev.123174; Zhao Zhuoshen, 2015, Small GTPases, V6, P81, DOI 10.1080/21541248.2014.1000699; Zheng XJ, 2012, DEV CELL, V23, P342, DOI 10.1016/j.devcel.2012.06.004; Zovein AC, 2010, DEV CELL, V18, P39, DOI 10.1016/j.devcel.2009.12.006	54	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147758	10.1371/journal.pone.0147758	http://dx.doi.org/10.1371/journal.pone.0147758			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812085	gold, Green Published			2022-12-26	WOS:000369528000051
J	Wang, XF; Wu, CY; Hirafuji, M				Wang, Xuefeng; Wu, Chunyan; Hirafuji, Masayuki			Visible Light Image-Based Method for Sugar Content Classification of Citrus	PLOS ONE			English	Article							FRUITS	Visible light imaging of citrus fruit from Mie Prefecture of Japan was performed to determine whether an algorithm could be developed to predict the sugar content. This nondestructive classification showed that the accurate segmentation of different images can be realized by a correlation analysis based on the threshold value of the coefficient of determination. There is an obvious correlation between the sugar content of citrus fruit and certain parameters of the color images. The selected image parameters were connected by addition algorithm. The sugar content of citrus fruit can be predicted by the dummy variable method. The results showed that the small but orange citrus fruits often have a high sugar content. The study shows that it is possible to predict the sugar content of citrus fruit and to perform a classification of the sugar content using light in the visible spectrum and without the need for an additional light source.	[Wang, Xuefeng; Wu, Chunyan] Chinese Acad Forestry, Res Inst Forest Resource Informat Tech, Beijing 100091, Peoples R China; [Hirafuji, Masayuki] Hokkaido Agr Res Ctr, Memuro, Hokkaido 0820071, Japan	Chinese Academy of Forestry; Research Institute of Forest Resources Information Technique, CAF	Hirafuji, M (corresponding author), Hokkaido Agr Res Ctr, Memuro, Hokkaido 0820071, Japan.	hirafuji@affrc.go.jp		Wang, xuefeng/0000-0002-2703-9293	Japan Society for the promotion of Science [JSPS07-09]; National Science and Technology Major Projects of China [21-Y30B05-9001-13/15]	Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Science and Technology Major Projects of China	This project was supported by Japan Society for the promotion of Science (JSPS07-09) and National Science and Technology Major Projects of China (21-Y30B05-9001-13/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai Jianrong, 2007, Microcomputer Information, V23, P224; Cao Leping, 2009, Journal of Test and Measurement Technology, V23, P63; Jamshidi B, 2012, COMPUT ELECTRON AGR, V85, P64, DOI 10.1016/j.compag.2012.03.008; Liu MuHua, 2007, Acta Agriculturae Universitatis Jiangxiensis, V29, P443; Lleo L, 2009, J FOOD ENG, V93, P229, DOI 10.1016/j.jfoodeng.2009.01.028; Lopez-Garcia F, 2010, COMPUT ELECTRON AGR, V71, P189, DOI 10.1016/j.compag.2010.02.001; Omid M, 2010, J FOOD ENG, V100, P315, DOI 10.1016/j.jfoodeng.2010.04.015; Peng YK, 2008, POSTHARVEST BIOL TEC, V48, P52, DOI 10.1016/j.postharvbio.2007.09.019; Rajkumar P, 2012, J FOOD ENG, V108, P194, DOI 10.1016/j.jfoodeng.2011.05.002; Suphamitmongkol W, 2013, COMPUT ELECTRON AGR, V91, P87, DOI 10.1016/j.compag.2012.11.014; Wang J.H., 2009, OPT OPTOELECTRON TEC, V7, P62; Xu HuiRong, 2005, Transactions of the Chinese Society of Agricultural Engineering, V21, P98; Zhou ZhiYu, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P21	13	3	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147419	10.1371/journal.pone.0147419	http://dx.doi.org/10.1371/journal.pone.0147419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811935	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528000034
J	Yeadon, PJ; Bowring, FJ; Catcheside, DEA				Yeadon, Patricia Jane; Bowring, Frederick James; Catcheside, David E. A.			Meiotic Recombination in Neurospora crassa Proceeds by Two Pathways with Extensive Holliday Junction Migration	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; GENE CONVERSION; MISMATCH REPAIR; CROSSING-OVER; SORDARIA-FIMICOLA; INITIATION SITE; BUDDING YEAST; UNPAIRED DNA; G LOCUS	Analysis of thousands of Delta msh-2 octads using our fluorescent recombination system indicates that, as in other filamentous fungi, symmetric heteroduplex is common in the his-3 region of Neurospora crassa. Symmetric heteroduplex arises from Holliday junction migration, and we suggest this mechanism explains the high frequency of His(+) spores in heteroallelic crosses in which recombination is initiated cis to the his-3 allele further from the initiator, cog(+). In contrast, when recombination is initiated cis to the his-3 allele closer to cog(+), His(+) spores are mainly a result of synthesis-dependent strand annealing, yielding asymmetric heteroduplex. Loss of Msh-2 function increases measures of allelic recombination in both his-3 and the fluorescent marker gene, indicating that mismatches in asymmetric heteroduplex, as in Saccharomyces cerevisiae, tend to be repaired in the direction of restoration. Furthermore, the presence of substantial numbers of conversion octads in crosses lacking Msh-2 function suggests that the disjunction pathway described in S. cerevisiae is also active in Neurospora, adding to evidence for a universal model for meiotic recombination.	[Yeadon, Patricia Jane; Bowring, Frederick James; Catcheside, David E. A.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia	Flinders University South Australia	Yeadon, PJ (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	jane.yeadon@flinders.edu.au	Yeadon, Jane/D-4654-2013	Yeadon, Jane/0000-0002-0158-8227; Catcheside, David/0000-0002-7101-6849	National Institutes of Health [R01 GM088338-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health provided initial funding (R01 GM088338-01A1), although the authors received no specific funding for most of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALANI E, 1994, GENETICS, V137, P19; Angel T, 1970, AUST J BIOL SCI, V23, P229; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Borts RH, 2000, MUTAT RES-FUND MOL M, V451, P129, DOI 10.1016/S0027-5107(00)00044-0; Bowring FJ, 1996, GENETICS, V143, P129; Bowring FJ, 2012, FUNGAL GENET BIOL, V49, P619, DOI 10.1016/j.fgb.2012.05.012; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; CARPENTER AT, 1974, GENETICS, V76, P453; CATCHESIDE DG, 1974, AUST J BIOL SCI, V27, P219, DOI 10.1071/BI9740219; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Crismani W, 2012, SCIENCE, V336, P1588, DOI 10.1126/science.1220381; de los Santos T, 2003, GENETICS, V164, P81; de los Santos T, 2001, GENETICS, V159, P1511; DETLOFF P, 1992, GENETICS, V132, P113; Dong Z, 2003, NUCLEIC ACIDS RES, V31, P2576, DOI 10.1093/nar/gkg352; Ebbole D, 1990, FUNGAL GENET NEWSLET, V37; Evans E, 2000, MOL CELL BIOL, V20, P7839, DOI 10.1128/MCB.20.21.7839-7844.2000; FOGEL S, 1979, COLD SPRING HARB SYM, V43, P1325, DOI 10.1101/SQB.1979.043.01.152; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Getz TJ, 2008, GENETICS, V178, P1251, DOI 10.1534/genetics.106.067603; HAMZA H, 1981, P NATL ACAD SCI-BIOL, V78, P7648, DOI 10.1073/pnas.78.12.7648; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; KITANI Y, 1974, GENET RES, V24, P229, DOI 10.1017/S0016672300015263; KITANI Y, 1967, GENETICS, V57, P767; KITANI Y, 1978, GENETICS, V89, P467; Knoll A, 2012, PLANT CELL, V24, P1448, DOI 10.1105/tpc.112.096644; Koh LY, 2007, FUNGAL GENET BIOL, V44, P575, DOI 10.1016/j.fgb.2007.02.008; Kohl KP, 2013, GENETICS, V194, P327, DOI 10.1534/genetics.113.150581; Kohl KP, 2012, SCIENCE, V338, P1363, DOI 10.1126/science.1228190; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; Lamb BC, 1996, MYCOL RES, V100, P1025, DOI 10.1016/S0953-7562(96)80212-7; LINDEGREN CC, 1953, J GENET, V51, P625, DOI 10.1007/BF02982949; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; Martini E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002305; Mitchell MB, 1955, P NATL ACAD SCI USA, V41, P216; NAG DK, 1989, NATURE, V340, P318, DOI 10.1038/340318a0; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; ORBACH MJ, 1994, GENE, V150, P159, DOI 10.1016/0378-1119(94)90877-X; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petes T. D., 1991, MOL CELLULAR BIOL YE, P407; Qi J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-475; REENAN RAG, 1992, GENETICS, V132, P975; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Shiu PKT, 2002, GENETICS, V161, P1483; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; STADLER DR, 1970, GENETICS, V66, P429; Stahl FW, 2008, GENETICS, V178, P1141; Stahl FW, 2010, GENETICS, V186, P515, DOI 10.1534/genetics.110.121194; Stahl FW, 2004, GENETICS, V168, P35, DOI 10.1534/genetics.104.027789; Stahl FW, 2000, GENETICS, V154, P1913; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Yeadon PJ, 2010, FUNGAL GENET BIOL, V47, P847, DOI 10.1016/j.fgb.2010.07.003; Yeadon PJ, 2004, GENETICS, V167, P1143, DOI 10.1534/genetics.103.025080; Yeadon PJ, 2004, CURR GENET, V45, P289, DOI 10.1007/s00294-004-0491-y; Yeadon PJ, 2002, GENETICS, V162, P747; Yeadon PJ, 1999, CURR GENET, V35, P631, DOI 10.1007/s002940050462; Yeadon PJ, 1998, GENETICS, V148, P113; YEADON PJ, 1995, CURR GENET, V28, P155, DOI 10.1007/BF00315782; Yeadon PJ, 2001, GENETICS, V159, P571; Yeadon PJ, 2011, MOL GENET GENOMICS, V287, P255; Zalevsky J, 1999, GENETICS, V153, P1271	67	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147815	10.1371/journal.pone.0147815	http://dx.doi.org/10.1371/journal.pone.0147815			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812651	Green Published, gold			2022-12-26	WOS:000369528000057
J	Bradley, A; Yao, J; Dewald, J; Richter, CP				Bradley, Allison; Yao, Jun; Dewald, Jules; Richter, Claus-Peter			Evaluation of Electroencephalography Source Localization Algorithms with Multiple Cortical Sources	PLOS ONE			English	Article							EEG SOURCE LOCALIZATION; ELECTROMAGNETIC TOMOGRAPHY LORETA; HEAD MODELS; BRAIN; RESOLUTION; SLORETA; EEG/MEG; HUMANS; NOISE; FMRI	Background Source localization algorithms often show multiple active cortical areas as the source of electroencephalography (EEG). Yet, there is little data quantifying the accuracy of these results. In this paper, the performance of current source density source localization algorithms for the detection of multiple cortical sources of EEG data has been characterized. Methods EEG data were generated by simulating multiple cortical sources (2-4) with the same strength or two sources with relative strength ratios of 1:1 to 4:1, and adding noise. These data were used to reconstruct the cortical sources using current source density (CSD) algorithms: sLORETA, MNLS, and LORETA using a p-norm with p equal to 1, 1.5 and 2. Precision (percentage of the reconstructed activity corresponding to simulated activity) and Recall (percentage of the simulated sources reconstructed) of each of the CSD algorithms were calculated. Results While sLORETA has the best performance when only one source is present, when two or more sources are present LORETA with p equal to 1.5 performs better. When the relative strength of one of the sources is decreased, all algorithms have more difficulty reconstructing that source. However, LORETA 1.5 continues to outperform other algorithms. If only the strongest source is of interest sLORETA is recommended, while LORETA with p equal to 1.5 is recommended if two or more of the cortical sources are of interest. These results provide guidance for choosing a CSD algorithm to locate multiple cortical sources of EEG and for interpreting the results of these algorithms.	[Bradley, Allison; Dewald, Jules; Richter, Claus-Peter] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Bradley, Allison; Richter, Claus-Peter] Northwestern Univ, Dept Otolaryngol, Feinberg Sch Med, Chicago, IL 60611 USA; [Yao, Jun; Dewald, Jules] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Dewald, Jules] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Richter, Claus-Peter] Northwestern Univ, Dept Commun Sci & Disorders, Hugh Knowles Ctr, Evanston, IL USA; [Bradley, Allison] Cincinnati Childrens Hosp, Commun Sci Res Ctr, Cincinnati, OH USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Cincinnati Children's Hospital Medical Center	Bradley, A (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.; Bradley, A (corresponding author), Northwestern Univ, Dept Otolaryngol, Feinberg Sch Med, Chicago, IL 60611 USA.; Bradley, A (corresponding author), Cincinnati Childrens Hosp, Commun Sci Res Ctr, Cincinnati, OH USA.	allison.bradley@cchmc.org	Yao, Jun/AAK-2006-2020		E.R. Capita Foundation	E.R. Capita Foundation	This study was funded by the E.R. Capita Foundation (http://www.capitafoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors SP, 2010, HUM BRAIN MAPP, V31, P140, DOI 10.1002/hbm.20851; Bai XX, 2007, NEUROIMAGE, V35, P598, DOI 10.1016/j.neuroimage.2006.12.026; Baillet S, 2001, PHYS MED BIOL, V46, P77, DOI 10.1088/0031-9155/46/1/306; Becker H, 2014, NEUROIMAGE, V96, P143, DOI 10.1016/j.neuroimage.2014.03.043; Becker H, 2015, IEEE SIGNAL PROC MAG, V32, P100, DOI 10.1109/MSP.2015.2413711; Bradley A., 2014, EVALUATION EEG SOURC; Brookes MJ, 2008, NEUROIMAGE, V40, P1090, DOI 10.1016/j.neuroimage.2007.12.030; CUFFIN BN, 1986, IEEE T BIO-MED ENG, V33, P854, DOI 10.1109/TBME.1986.325779; Cuffin BN, 2001, CLIN NEUROPHYSIOL, V112, P2288, DOI 10.1016/S1388-2457(01)00669-1; Ding L, 2007, NEUROIMAGE, V34, P575, DOI 10.1016/j.neuroimage.2006.09.042; Fuchs M, 1998, IEEE T BIO-MED ENG, V45, P980, DOI 10.1109/10.704867; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Grova C, 2006, NEUROIMAGE, V29, P734, DOI 10.1016/j.neuroimage.2005.08.053; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Haufe S, 2011, NEUROIMAGE, V54, P851, DOI 10.1016/j.neuroimage.2010.09.003; Liu ZM, 2006, IEEE ENG MED BIOL, V25, P46, DOI 10.1109/MEMB.2006.1657787; Menendez RGD, 2001, BRAIN TOPOGR, V14, P131, DOI 10.1023/A:1012944913650; Miao LF, 2013, IEEE T SIGNAL PROCES, V61, DOI 10.1109/TSP.2012.2226172; Michel CM, 2004, J CLIN NEUROPHYSIOL, V21, P71, DOI 10.1097/00004691-200403000-00001; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Mizuhara H, 2012, NEUROIMAGE, V62, P1884, DOI 10.1016/j.neuroimage.2012.05.072; Murzin V, 2011, EXP BRAIN RES, V214, P515, DOI 10.1007/s00221-011-2850-5; Ou WM, 2009, NEUROIMAGE, V44, P932, DOI 10.1016/j.neuroimage.2008.05.063; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; Sasaoka T., 2013, J COGN NEUROSCI; Shahbazi Avarvand F., 2012, COMPUTATIONAL MATH M, V2012; VANRIJSBERGEN C, 1979, INFORM RETRIEVAL; Vergallo P., 2014, MED MEAS APPL MEMEA, P1; Wagner M, 2004, BRAIN TOPOGR, V16, P277; Wipf DP, 2010, NEUROIMAGE, V49, P641, DOI 10.1016/j.neuroimage.2009.06.083; Yao J, 2005, NEUROIMAGE, V25, P369, DOI 10.1016/j.neuroimage.2004.11.036; Zhang YC, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2398883	35	41	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147266	10.1371/journal.pone.0147266	http://dx.doi.org/10.1371/journal.pone.0147266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809000	gold, Green Submitted, Green Published			2022-12-26	WOS:000369527800069
J	Jensen, RK; Kjaer, P; Jensen, TS; Albert, H; Kent, P				Jensen, Rikke K.; Kjaer, Per; Jensen, Tue S.; Albert, Hanne; Kent, Peter			Degenerative Pathways of Lumbar Motion Segments - A Comparison in Two Samples of Patients with Persistent Low Back Pain	PLOS ONE			English	Article							RESONANCE-IMAGING CHANGES; SIGNAL MODIC CHANGES; DISC DEGENERATION; ASSOCIATION; PREVALENCE; PATTERNS; AGE; REPRODUCIBILITY; INTRAOBSERVER	Background Magnetic resonance imaging (MRI) is used to identify spinal pathoanatomy in people with persistent low back pain. However, the clinical relevance of spinal degenerative MRI findings remains uncertain. Although multiple MRI findings are almost always present at the same time, research into the association with clinical outcomes (such as pain) has predominantly focused on individual MRI findings. This study aimed to: (i) investigate how multiple MRI lumbar spine findings cluster together within two different samples of patients with low back pain, (ii) classify these clusters into hypothetical pathways of degeneration based on scientific knowledge of disco-vertebral degeneration, and (iii) compare these clusters and degenerative pathways between samples. Methods We performed a secondary cross-sectional analysis on two dissimilar MRI samples collected in a hospital department: (1) data from the spinal MRI reports of 4,162 low back pain patients and (2) data from an MRI research protocol of 631 low back pain patients. Latent Class Analysis was used in both samples to cluster MRI findings from lumbar motion segments. Using content analysis, each cluster was then categorised into hypothetical pathways of degeneration. Results Six clusters of MRI findings were identified in each of the two samples. The content of the clusters in the two samples displayed some differences but had the same overall pattern of MRI findings. Although the hypothetical degenerative pathways identified in the two samples were not identical, the overall pattern of increasing degeneration within the pathways was the same. Conclusions It was expected that different clusters could emerge from different samples, however, when organised into hypothetical pathways of degeneration, the overall pattern of increasing degeneration was similar and biologically plausible. This evidence of reproducibility suggests that Latent Class Analysis may provide a new approach to investigating the relationship between MRI findings and clinically important characteristics such as pain and activity limitation.	[Jensen, Rikke K.; Kjaer, Per; Jensen, Tue S.] Univ Southern Denmark, Inst Reg Hlth Res, Hosp Lillebaelt, Res Dept,Spine Ctr Southern Denmark, Middelfart, Denmark; [Kjaer, Per; Kent, Peter] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Odense, Denmark; [Albert, Hanne] Bartholomews Hosp, Dept Orthopaed, London, England	University of Southern Denmark; University of Southern Denmark; University of London; Queen Mary University London	Jensen, RK (corresponding author), Univ Southern Denmark, Inst Reg Hlth Res, Hosp Lillebaelt, Res Dept,Spine Ctr Southern Denmark, Middelfart, Denmark.	rikke.kruger.jensen@rsyd.dk	albert, hanne/L-7201-2019; Jensen, Rikke Krüger/AAF-6196-2019; Kjaer, Per/C-1210-2009; Jensen, Tue Secher/P-7400-2019; Jensen, Tue S/P-6882-2017	Jensen, Rikke Krüger/0000-0001-7528-3234; Kjaer, Per/0000-0001-5340-8649; Jensen, Tue Secher/0000-0002-7456-4306; Jensen, Tue S/0000-0002-7456-4306; Kent, Peter/0000-0002-2429-9233	Danish Chiropractors' Foundation;  [09/74]	Danish Chiropractors' Foundation; 	Number 09/74. The authors are grateful to The Danish Chiropractors' Foundation for funding this project (RKJ, TSJ, PMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://regioner.dk/Sundhed/Fonde%20vejledninger%20og%20databaser/Forskningsfonde/Kiropraktorfonden.aspx	Albert HB, 2007, EUR SPINE J, V16, P977, DOI 10.1007/s00586-007-0336-8; Albert HB, 2011, EUR SPINE J, V20, P1355, DOI 10.1007/s00586-011-1794-6; Arnbak B, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-274; Beales DJ, 2012, J ADOLESCENT HEALTH, V50, P509, DOI 10.1016/j.jadohealth.2011.09.017; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Chou D, 2011, SPINE, V36, pS43, DOI 10.1097/BRS.0b013e31822ef700; Endean A, 2011, SPINE, V36, P160, DOI 10.1097/BRS.0b013e3181cd9adb; Jensen RK, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-198; Jensen RK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-22; Jensen TS, 2007, ACTA RADIOL, V48, P748, DOI 10.1080/02841850701422112; Jensen TS, 2010, EUR SPINE J, V19, P129, DOI 10.1007/s00586-009-1184-5; Kanna RM, 2014, SPINE J, V14, P300, DOI 10.1016/j.spinee.2013.10.042; Kent P, 2012, CHIROPR MAN THER, V20, DOI 10.1186/2045-709X-20-20; Kent P, 2011, CHIROPR MAN THER, V19, DOI 10.1186/2045-709X-19-16; Kjaer P, 2005, SPINE, V30, P1173, DOI 10.1097/01.brs.0000162396.97739.76; Kovacs FM, 2014, NEURORADIOLOGY, V56, P25, DOI 10.1007/s00234-013-1294-y; Meyerding HW, 1941, J BONE JOINT SURG, V23, P461; Schmid G, 2004, RADIOLOGY, V231, P352, DOI 10.1148/radiol.2312021708; Sorensen JS, 2006, ACTA RADIOL, V47, P947, DOI 10.1080/02841850600965062; Takatalo J, 2012, SPINE, V37, P1231, DOI 10.1097/BRS.0b013e3182443855; Takatalo J, 2011, SPINE, V36, P2180, DOI 10.1097/BRS.0b013e3182077122; Wang Y, 2012, SPINE J, V12, P411, DOI 10.1016/j.spinee.2012.03.026	23	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146998	10.1371/journal.pone.0146998	http://dx.doi.org/10.1371/journal.pone.0146998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807697	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800043
J	Koessler, J; Hermann, S; Weber, K; Koessler, A; Kuhn, S; Boeck, M; Kobsar, A				Koessler, Juergen; Hermann, Stephanie; Weber, Katja; Koessler, Angela; Kuhn, Sabine; Boeck, Markus; Kobsar, Anna			Role of Purinergic Receptor Expression and Function for Reduced Responsiveness to Adenosine Diphosphate in Washed Human Platelets	PLOS ONE			English	Article							VASP-PHOSPHORYLATION; MOLECULAR-BASIS; PROTEIN-KINASE; ADP; ACTIVATION; SURFACE; ASSAY; VI	Background Washing of platelets is an important procedure commonly used for experimental studies, e. g. in cardiovascular research. As a known phenomenon, responsiveness to adenosine diphosphate (ADP) is reduced in washed platelets, although underlying molecular mechanisms- potentially interfering with experimental results-have not been thoroughly studied. Objectives Since ADP mediates its effects via three purinergic receptors P2Y1, P2X1 and P2Y12, their surface expression and function were investigated in washed platelets and, for comparison, in platelet-rich-plasma (PRP) at different time points for up to 2 hours after preparation. Results In contrast to PRP, flow cytometric analysis of surface expression in washed platelets revealed an increase of all receptors during the first 60 minutes after preparation followed by a significant reduction, which points to an initial preactivation of platelets and consecutive degeneration. The activity of the P2X1 receptor (measured by selectively induced calcium flux) was substantially maintained in both PRP and washed platelets. P2Y12 function (determined by flow cytometry as platelet reactivity index) was partially reduced after platelet washing compared to PRP, but remained stable in course of ongoing storage. However, the function of the P2Y1 receptor (measured by selectively induced calcium flux) continuously declined after preparation of washed platelets. Conclusion In conclusion, decreasing ADP responsiveness in washed platelets is particularly caused by impaired activity of the P2Y1 receptor associated with disturbed calcium regulation, which has to be considered in the design of experimental studies addressing ADP mediated platelet function.	[Koessler, Juergen; Hermann, Stephanie; Weber, Katja; Koessler, Angela; Kuhn, Sabine; Boeck, Markus; Kobsar, Anna] Univ Wurzburg, Inst Transfus Med & Haemotherapy, D-97070 Wurzburg, Germany	University of Wurzburg	Koessler, J (corresponding author), Univ Wurzburg, Inst Transfus Med & Haemotherapy, D-97070 Wurzburg, Germany.	koessler_j@ukw.de			Open Access Publication Fund of the University of Wuerzburg	Open Access Publication Fund of the University of Wuerzburg	This publication was supported by the Open Access Publication Fund of the University of Wuerzburg.	Bigalke B, 2006, EUR HEART J, V27, P2165, DOI 10.1093/eurheartj/ehl192; Cabeza N, 2004, DIABETES, V53, P2117, DOI 10.2337/diabetes.53.8.2117; Cauwenberghs S, 2006, TRANSFUSION, V46, P1018, DOI 10.1111/j.1537-2995.2006.00837.x; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; de Stoppelaar SF, 2014, THROMB HAEMOSTASIS, V112, P666, DOI 10.1160/TH14-02-0126; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Duerschmied D, 2014, THROMB HAEMOSTASIS, V112, P678, DOI 10.1160/TH14-02-0146; Floyd CN, 2012, JRSM CARDIOVASC DIS, V1, DOI 10.1258/cvd.2012.012007; Geiger J, 2005, CLIN CHEM, V51, P957, DOI 10.1373/clinchem.2004.047050; Geiger TL, 2007, TRANSFUS MED REV, V21, P1, DOI 10.1016/j.tmrv.2006.09.001; Gresele P, 2002, PLATELETS THROMBOTIC, P1124; HEDDLE NM, 1993, TRANSFUSION, V33, P794, DOI 10.1046/j.1537-2995.1993.331094054613.x; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Jin JG, 1998, J BIOL CHEM, V273, P2030, DOI 10.1074/jbc.273.4.2030; Keuren JFW, 2006, TRANSFUSION, V46, P204, DOI 10.1111/j.1537-2995.2006.00702.x; Kunapuli Satva P, 2002, ScientificWorldJournal, V2, P424; Kunapuli SP, 1998, PLATELETS, V9, P343, DOI 10.1080/09537109876401; Kunapuli SP, 2003, CURR OPIN PHARMACOL, V3, P175, DOI 10.1016/S1471-4892(03)00007-9; Li ZY, 2003, CELL, V112, P77, DOI 10.1016/S0092-8674(02)01254-0; Liu ECK, 2006, ANAL BIOCHEM, V357, P216, DOI 10.1016/j.ab.2006.06.034; McCabe White M, 1999, PROPERTIES MAT, P116; Pampuch A, 2006, THROMB HAEMOSTASIS, V96, P767, DOI 10.1160/TH06-09-0491; Schwarz UR, 1999, THROMB HAEMOSTASIS, V82, P1145, DOI 10.1055/s-0037-1614344; Shou LM, 2013, ONCOL REP, V30, P1059, DOI 10.3892/or.2013.2601; SILVER WP, 1993, J VASC SURG, V17, P726, DOI 10.1016/0741-5214(93)90117-5; van der Meer PF, 2007, TRANSFUS CLIN BIOL, V14, P522, DOI 10.1016/j.tracli.2008.03.004; Vial C, 2002, BRIT J PHARMACOL, V135, P363, DOI 10.1038/sj.bjp.0704486; WALSH PN, 1977, BRIT J HAEMATOL, V36, P281, DOI 10.1111/j.1365-2141.1977.tb00649.x; Wayne PA, 2008, PLATELET FUNCTION TE, pH58	29	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147370	10.1371/journal.pone.0147370	http://dx.doi.org/10.1371/journal.pone.0147370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808867	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800081
J	Li, ZY; Wang, H				Li, Zhongyi; Wang, Hao			Ocean Wave Simulation Based on Wind Field	PLOS ONE			English	Article								Ocean wave simulation has a wide range of applications in movies, video games and training systems. Wind force is the main energy resource for generating ocean waves, which are the result of the interaction between wind and the ocean surface. While numerous methods to handle simulating oceans and other fluid phenomena have undergone rapid development during the past years in the field of computer graphic, few of them consider to construct ocean surface height field from the perspective of wind force driving ocean waves. We introduce wind force to the construction of the ocean surface height field through applying wind field data and wind-driven wave particles. Continual and realistic ocean waves result from the overlap of wind-driven wave particles, and a strategy was proposed to control these discrete wave particles and simulate an endless ocean surface. The results showed that the new method is capable of obtaining a realistic ocean scene under the influence of wind fields at real time rates.	[Li, Zhongyi; Wang, Hao] Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan 430074, Hubei Province, Peoples R China	Huazhong University of Science & Technology	Wang, H (corresponding author), Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan 430074, Hubei Province, Peoples R China.	wanghao4110@hust.edu.cn		Wang, Hao/0000-0001-9355-1319				Clavet S., 2005, P 2005 ACM SIGGRAPH, P219, DOI [DOI 10.1145/1073368.1073400, DOI 10.1145/1073368]; Fournier A., 1986, Computer Graphics, V20, P75, DOI 10.1145/15886.15894; GASCUEL Mathieu Desbrun Marie-Paule, 2012, COMPUTER ANIMATION S; Gerstner F., 1809, ANN PHYS, V2, P412, DOI DOI 10.1002/ANDP.18090320808; Hasselmann K., 1973, ERGAENZUNGSHEFT DTSC; Jos Stam, 1995, P 22 ANN C COMP GRAP, P129, DOI [10.1145/218380.218430, DOI 10.1145/218380.218430]; LeBlanc G., 2012, J GRAPH TOOL, V16, P57, DOI [10.1080/2165347X.2012.680854, DOI 10.1080/2165347X.2012.680854]; MASTIN GA, 1987, IEEE COMPUT GRAPH, V7, P16, DOI 10.1109/MCG.1987.276961; Max N. L., 1981, Computer Graphics, V15, P317, DOI 10.1145/965161.806820; Mitchell J.L., 2005, REAL TIME SYNTHESIS, P121; Muller M., 2003, ACM SIGGRAPH/Eurographics Symposium on Computer Animation, P154; Peachey D. R., 1986, Computer Graphics, V20, P65, DOI 10.1145/15886.15893; PHILLIPS OM, 1985, J FLUID MECH, V156, P505, DOI 10.1017/S0022112085002221; PIERSON WJ, 1964, J GEOPHYS RES, V69, P5181, DOI 10.1029/JZ069i024p05181; Premoze S, 2001, COMPUT GRAPH FORUM, V20, P189, DOI 10.1111/1467-8659.00548; REEVES WT, 1983, ACM T GRAPHIC, V2, P91, DOI 10.1145/964967.801167; SCHACHTER B, 1980, COMPUT VISION GRAPH, V12, P187, DOI 10.1016/0146-664X(80)90011-8; Tessendorf J., 2001, SIGGRAPH, V1, P5; Yuksel C, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1239451.1239550	19	1	1	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147123	10.1371/journal.pone.0147123	http://dx.doi.org/10.1371/journal.pone.0147123			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808718	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800053
J	Lu, SZ; Natarajan, SK; Mott, JL; Kharbanda, KK; Harrison-Findik, DD				Lu, Sizhao; Natarajan, Sathish Kumar; Mott, Justin L.; Kharbanda, Kusum K.; Harrison-Findik, Duygu Dee			Ceramide Induces Human Hepcidin Gene Transcription through JAK/STAT3 Pathway	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; ENDOPLASMIC-RETICULUM STRESS; ER STRESS; ANTIMICROBIAL PEPTIDE; INSULIN-RESISTANCE; IRON-METABOLISM; STEATOHEPATITIS; INFLAMMATION; ACTIVATION; EXPRESSION	Changes in lipid metabolism and iron content are observed in the livers of patients with fatty liver disease. The expression of hepcidin, an iron-regulatory and acute phase protein synthesized by the liver, is also modulated. The potential interaction of lipid and iron metabolism is largely unknown. We investigated the role of lipid intermediate, ceramide in the regulation of human hepcidin gene, HAMP. Human hepatoma HepG2 cells were treated with cell-permeable ceramide analogs. Ceramide induced significant up-regulation of HAMP mRNA expression in HepG2 cells. The effect of ceramide on HAMP expression was mediated through transcriptional mechanisms because it was completely blocked with actinomycin D treatment. Reporter assays also confirmed the activation of 0.6 kb HAMP promoter by ceramide. HepG2 cells treated with ceramide displayed increased phosphorylation of STAT3, JNK, and NF-kappa B proteins. However, ceramide induced the binding of STAT3, but not NF-kappa B or c-Jun, to HAMP promoter, as shown by the chromatin immunoprecipitation assays. The mutation of STAT3 response element within 0.6 kb HAMP promoter region significantly inhibited the stimulatory effect of ceramide on HAMP promoter activity. Similarly, the inhibition of STAT3 with a pan-JAK kinase inhibitor and STAT3 siRNA pool also diminished the induction of both HAMP promoter activity and mRNA expression by ceramide. In conclusion, we have shown a direct role for ceramide in the activation of hepatic HAMP transcription via STAT3. Our findings suggest a crosstalk between lipid and iron metabolism in the liver, which may contribute to the pathogenesis of obesity-related fatty liver disease.	[Lu, Sizhao; Natarajan, Sathish Kumar; Mott, Justin L.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, 985870 Nebraska Med Ctr, Omaha, NE 68198 USA; [Kharbanda, Kusum K.; Harrison-Findik, Duygu Dee] Univ Nebraska Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, 982000 Nebraska Med Ctr, Omaha, NE 68198 USA; [Lu, Sizhao] Univ Colorado Denver, Dept Renal Med & Hypertens, 12700 East 19th Ave, Aurora, CO 80045 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Harrison-Findik, DD (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, 982000 Nebraska Med Ctr, Omaha, NE 68198 USA.	dufindik@gmail.com		Lu, Sizhao/0000-0002-9892-8784	NIH [R01AA017738, P20GM104320]; University of Nebraska Medical Center Graduate Assistantship/Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017738] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001155] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nebraska Medical Center Graduate Assistantship/Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH grant R01AA017738 (to D. Harrison-Findik), NIH grant P20GM104320 (to J.L. Mott) and University of Nebraska Medical Center Graduate Assistantship/Fellowship (to S. Lu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner E, 2008, AM J CLIN NUTR, V87, P1374, DOI 10.1093/ajcn/87.5.1374; Aigner E, 2015, WORLD J HEPATOL, V7, P177, DOI 10.4254/wjh.v7.i2.177; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Contreras C, 2014, CELL REP, V9, P366, DOI 10.1016/j.celrep.2014.08.057; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; Czaja MJ, 2010, TRENDS ENDOCRIN MET, V21, P707, DOI 10.1016/j.tem.2010.08.010; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Demarchi F, 2005, CELL DEATH DIFFER, V12, P512, DOI 10.1038/sj.cdd.4401592; Diehl AM, 2005, GUT, V54, P303, DOI 10.1136/gut.2003.024935; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Fillet M, 2003, BIOCHEM PHARMACOL, V65, P1633, DOI 10.1016/S0006-2952(03)00125-4; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Ganz T, 2015, CLIN CHEM, V61, P577, DOI 10.1373/clinchem.2014.229179; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Gentil B, 2003, MOL CELL BIOCHEM, V254, P203, DOI 10.1023/A:1027359832177; Gerjevic LN, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/459278; Gill JMR, 2009, DIABETOLOGIA, V52, P2475, DOI 10.1007/s00125-009-1546-x; Gong T, 2012, BIOCHEM BIOPH RES CO, V427, P461, DOI 10.1016/j.bbrc.2012.08.068; Harrison-Findik DD, 2006, J BIOL CHEM, V281, P22974, DOI 10.1074/jbc.M602098200; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hunter HN, 2002, J BIOL CHEM, V277, P37597, DOI 10.1074/jbc.M205305200; Kasumov T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126910; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; Kreydiyyeh SI, 2014, INT J BIOCHEM CELL B, V53, P102, DOI 10.1016/j.biocel.2014.04.027; Kurek K, 2014, LIVER INT, V34, P1074, DOI 10.1111/liv.12331; Kurinna SM, 2004, CANCER RES, V64, P7852, DOI 10.1158/0008-5472.CAN-04-1552; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Martinelli N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048250; Maziere C, 2001, FEBS LETT, V507, P163, DOI 10.1016/S0014-5793(01)02977-5; Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4; Nelson JE, 2012, HEPATOLOGY, V56, P1730, DOI 10.1002/hep.25856; Nelson James E, 2012, Curr Gastroenterol Rep, V14, P8, DOI 10.1007/s11894-011-0234-4; Nelson JE, 2011, HEPATOLOGY, V53, P448, DOI 10.1002/hep.24038; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005; Pehar M, 2012, J BIOL CHEM, V287, P29921, DOI 10.1074/jbc.M112.363911; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Promrat K, 2011, HEPATOL RES, V41, P754, DOI 10.1111/j.1872-034X.2011.00815.x; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Saslowsky DE, 2009, FASEB J, V23, P259, DOI 10.1096/fj.08-116467; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Truksa J, 2007, BLOOD CELL MOL DIS, V39, P255, DOI 10.1016/j.bcmd.2007.06.014; Valenti L, 2010, GASTROENTEROLOGY, V138, P905, DOI 10.1053/j.gastro.2009.11.013; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Watt MJ, 2012, DIABETOLOGIA, V55, P2741, DOI 10.1007/s00125-012-2649-3; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	63	14	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147474	10.1371/journal.pone.0147474	http://dx.doi.org/10.1371/journal.pone.0147474			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807955	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800101
J	Majtanova, Z; Choleva, L; Symonova, R; Rab, P; Kotusz, J; Pekarik, L; Janko, K				Majtanova, Zuzana; Choleva, Lukas; Symonova, Radka; Rab, Petr; Kotusz, Jan; Pekarik, Ladislav; Janko, Karel			Asexual Reproduction Does Not Apparently Increase the Rate of Chromosomal Evolution: Karyotype Stability in Diploid and Triploid Clonal Hybrid Fish (Cobitis, Cypriniformes, Teleostei)	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; FRESH-WATER FISH; UNISEXUAL SALAMANDERS; MOLECULAR EVOLUTION; LOACHES COBITIS; GENUS AMBYSTOMA; LIKELIHOOD; POLYPLOIDY; IDENTIFICATION; REARRANGEMENTS	Interspecific hybridization, polyploidization and transitions from sexuality to asexuality considerably affect organismal genomes. Especially the last mentioned process has been assumed to play a significant role in the initiation of chromosomal rearrangements, causing increased rates of karyotype evolution. We used cytogenetic analysis and molecular dating of cladogenetic events to compare the rate of changes of chromosome morphology and karyotype in asexually and sexually reproducing counterparts in European spined loach fish (Cobitis). We studied metaphases of three sexually reproducing species and their diploid and polyploid hybrid clones of different age of origin. The material includes artificial F1 hybrid strains, representatives of lineage originated in Holocene epoch, and also individuals of an oldest known age to date ( roughly 0.37 MYA). Thereafter we applied GISH technique as a marker to differentiate parental chromosomal sets in hybrids. Although the sexual species accumulated remarkable chromosomal rearrangements after their speciation, we observed no differences in chromosome numbers and/or morphology among karyotypes of asexual hybrids. These hybrids possess chromosome sets originating from respective parental species with no cytogenetically detectable recombinations, suggesting their integrity even in a long term. The switch to asexual reproduction thus did not provoke any significant acceleration of the rate of chromosomal evolution in Cobitis. Asexual animals described in other case studies reproduce ameiotically, while Cobitis hybrids described here produce eggs likely through modified meiosis. Therefore, our findings indicate that the effect of asexuality on the rate of chromosomal change may be context-dependent rather than universal and related to particular type of asexual reproduction.	[Majtanova, Zuzana; Choleva, Lukas; Symonova, Radka; Rab, Petr; Janko, Karel] CAS, Inst Anim Physiol & Genet, Lab Fish Genet, Vvi, Libechov, Czech Republic; [Majtanova, Zuzana] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Choleva, Lukas; Janko, Karel] Univ Ostrava, Fac Sci, Dept Biol & Ecol, CZ-70103 Ostrava, Czech Republic; [Symonova, Radka] Univ Innsbruck, Res Inst Limnol, Mondsee, Austria; [Kotusz, Jan] Univ Wroclaw, Museum Nat Hist, PL-50138 Wroclaw, Poland; [Pekarik, Ladislav] SAS, Inst Bot, Bratislava, Slovakia; [Pekarik, Ladislav] Trnava Univ, Dept Biol, Fac Educ, Trnava, Slovakia	Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Charles University Prague; University of Ostrava; University of Innsbruck; University of Wroclaw; SAS Institute Inc; Slovak Academy of Sciences; University of Trnava	Majtanova, Z (corresponding author), CAS, Inst Anim Physiol & Genet, Lab Fish Genet, Vvi, Libechov, Czech Republic.; Majtanova, Z (corresponding author), Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.	majtanova@iapg.cas.cz	Pekárik, Ladislav/E-6218-2011	Pekárik, Ladislav/0000-0002-7253-2837; Kotusz, Jan/0000-0001-6229-7610; Majtanova, Zuzana/0000-0002-7100-2922	Grant Agency of the Charles University in Prague [158110]; Czech Science Foundation [GAP506/10/1155, GPP506/12/P857, 14-02940S, GA13-12580S]; Academy of Sciences of the Czech Republic [RVO 67985904]; National Science Centre in Poland [DEC-2011/03/B/NZ8/02095]	Grant Agency of the Charles University in Prague; Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); National Science Centre in Poland(National Science Centre, Poland)	This study was supported by the Grant Agency of the Charles University in Prague (www.cuni.cz; project number 158110), Czech Science Foundation (www.gacr.cz; project number GAP506/10/1155 to KJ, PR and LC; GPP506/12/P857 to LC; 14-02940S PR and RS; GA13-12580S to KJ and LC), by the Academy of Sciences of the Czech Republic (www.cas.cz; project number RVO 67985904) and by the National Science Centre in Poland (http://www. ncn.gov.pl; project number DEC-2011/03/B/NZ8/02095) to JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MJ, 2001, GENETICA, V111, P375, DOI 10.1023/A:1013783029921; Arai K, 1997, J EXP ZOOL, V278, P412, DOI 10.1002/(SICI)1097-010X(19970815)278:6&lt;412::AID-JEZ9&gt;3.0.CO;2-R; Arai R., 2011, FISH KARYOTYPES CHEC, DOI [10.1007/978-4-431-53877-6, DOI 10.1007/978-4-431-53877-6]; Arkhipova I, 2000, P NATL ACAD SCI USA, V97, P14473, DOI 10.1073/pnas.97.26.14473; Bi K, 2006, CYTOGENET GENOME RES, V112, P307, DOI 10.1159/000089885; Bi K, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-238; Blackman RL, 2000, HEREDITY, V84, P254, DOI 10.1046/j.1365-2540.2000.00667.x; Bohlen J, 2006, MOL PHYLOGENET EVOL, V39, P552, DOI 10.1016/j.ympev.2005.12.007; Boron A, 2003, GENETICA, V119, P51, DOI 10.1023/A:1024475823321; Choleva L, 2008, PHILOS T R SOC B, V363, P2911, DOI 10.1098/rstb.2008.0059; Choleva L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080641; Choleva L, 2012, EVOLUTION, V66, P2191, DOI 10.1111/j.1558-5646.2012.01589.x; da Barbiano LA, 2013, P NATL ACAD SCI USA, V110, P13797, DOI 10.1073/pnas.1303730110; Doadrio I, 2005, MOL PHYLOGENET EVOL, V37, P484, DOI 10.1016/j.ympev.2005.07.009; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; GRIFFITHS RC, 1994, THEOR POPUL BIOL, V46, P131, DOI 10.1006/tpbi.1994.1023; HICKEY DA, 1982, GENETICS, V101, P519; Itono M, 2006, J EXP ZOOL PART A, V305A, P513, DOI 10.1002/jez.a.283; Janko K, 2007, J FISH BIOL, V71, P387, DOI 10.1111/j.1095-8649.2007.01663.x; Janko K, 2005, MOL ECOL, V14, P2991, DOI 10.1111/j.1365-294X.2005.02583.x; Janko K, 2007, GENETICA, V131, P185, DOI 10.1007/s10709-006-9130-5; Janko K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045384; Juchno D, 2014, ACTA BIOL CRACOV BOT, P64; Knytl M, 2013, CYTOGENET GENOME RES, V139, P276, DOI 10.1159/000350689; Kohn M, 2006, TRENDS GENET, V22, P203, DOI 10.1016/j.tig.2006.02.008; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lutes AA, 2010, NATURE, V464, P283, DOI 10.1038/nature08818; Mank JE, 2006, GENETICA, V127, P321, DOI 10.1007/s10709-005-5248-0; Martens K, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P187, DOI 10.1007/978-90-481-2770-2_9; MAYER VW, 1990, MUTAT RES, V231, P177, DOI 10.1016/0027-5107(90)90024-X; Mikulicek P, 2014, J EVOLUTION BIOL, V27, P628, DOI 10.1111/jeb.12332; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Normark BB, 2003, BIOL J LINN SOC, V79, P69, DOI 10.1046/j.1095-8312.2003.00182.x; Normark BB, 1999, EVOLUTION, V53, P1458, DOI [10.2307/2640892, 10.1111/j.1558-5646.1999.tb05410.x]; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Paradis E, 2006, USE R, P8; Paradis E, 2013, MOL PHYLOGENET EVOL, V67, P436, DOI 10.1016/j.ympev.2013.02.008; Pereira CSA, 2014, HEREDITY, V112, P343, DOI 10.1038/hdy.2013.110; Pereira CSA, 2013, CYTOGENET GENOME RES, V141, P143, DOI 10.1159/000354582; Phillips R, 2001, BIOL REV, V76, P1, DOI 10.1017/S1464793100005613; Pokorna M, 2014, CYTOGENET GENOME RES, V142, P190, DOI 10.1159/000358847; Rab P, 1988, METHODS CHROMOSOME A, P115; Rab Petr, 2007, P215; Rabova M, 2007, ECI 12 EUR C ICHTH C, P59; Rampin M, 2012, COMP CYTOGENET, V6, P287, DOI 10.3897/CompCytogen.v6i3.3543; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Robertson AV, 2006, MOL ECOL, V15, P3339, DOI 10.1111/j.1365-294X.2006.03005.x; Saat TV, 1991, SOVIET J DEV BIOL, V22, P332; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schmid M., 2010, Cytogenetic and Genome Research, V130-131, P1, DOI 10.1159/000301339; Schneider MC, 2010, J HERED, V101, P491, DOI 10.1093/jhered/esq004; Slechtova V, 2008, MOL PHYLOGENET EVOL, V47, P812, DOI 10.1016/j.ympev.2007.12.018; Snowdon RJ, 1997, THEOR APPL GENET, V95, P1320, DOI 10.1007/s001220050699; Spence JM, 2000, CHROMOSOMA, V109, P490, DOI 10.1007/s004120000100; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stenberg P, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P63, DOI 10.1007/978-90-481-2770-2_4; Sunnucks P, 1996, GENETICS, V144, P747; Suomalainen E, 1987, CYTOLOGY EVOLUTION P; Symonova R, 2013, CYTOGENET GENOME RES, V141, P153, DOI 10.1159/000354882; Symonova R., 2015, FISH CYTOGENETIC TEC, P118; Tang QY, 2008, HYDROBIOLOGIA, V605, P17, DOI 10.1007/s10750-008-9296-1; TRIANTAPHYLLOU AC, 1981, J NEMATOL, V13, P95; UZZELL T, 1976, P ACAD NAT SCI PHILA, V128, P147; Valente GT, 2009, CHROMOSOME RES, V17, P791, DOI 10.1007/s10577-009-9067-5; Volker M, 2015, FISH CYTOGENETIC TEC, P37, DOI [10.1201/b18534-4, DOI 10.1201/B18534-4]; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Welch JLM, 2004, P NATL ACAD SCI USA, V101, P1618, DOI 10.1073/pnas.0307677100; WILSON AC, 1974, P NATL ACAD SCI USA, V71, P2843, DOI 10.1073/pnas.71.7.2843; Yang ZH, 2002, GENETICS, V162, P1811; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zalesna A, 2011, CYTOGENET GENOME RES, V134, P206, DOI 10.1159/000327716; Zhu HP, 2007, AQUACULTURE, V265, P109, DOI 10.1016/j.aquaculture.2006.10.026	73	25	25	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146872	10.1371/journal.pone.0146872	http://dx.doi.org/10.1371/journal.pone.0146872			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808475	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800036
J	Saraswathy, S; Tan, JCH; Yu, F; Francis, BA; Hinton, DR; Weinreb, RN; Huang, AS				Saraswathy, Sindhu; Tan, James C. H.; Yu, Fei; Francis, Brian A.; Hinton, David R.; Weinreb, Robert N.; Huang, Alex S.			Aqueous Angiography: Real-Time and Physiologic Aqueous Humor Outflow Imaging	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; EPISCLERAL VENOUS-PRESSURE; TRABECULAR MESHWORK; INNER-WALL; CATIONIC FERRITIN; CATARACT-SURGERY; BOVINE EYES; FACILITY; CANALOPLASTY; ENDOTHELIUM	Purpose Trabecular meshwork (TM) bypass surgeries attempt to enhance aqueous humor outflow (AHO) to lower intraocular pressure (IOP). While TM bypass results are promising, inconsistent success is seen. One hypothesis for this variability rests upon segmental (non-360 degrees uniform) AHO. We describe aqueous angiography as a real-time and physiologic AHO imaging technique in model eyes as a way to simulate live AHO imaging. Methods Pig (n = 46) and human (n = 6) enucleated eyes were obtained, orientated based upon inferior oblique insertion, and pre-perfused with balanced salt solution via a Lewicky AC maintainer through a 1 mm side-port. Fluorescein (2.5%) was introduced intracamerally at 10 or 30 mm Hg. With an angiographer, infrared and fluorescent (486 nm) images were acquired. Image processing allowed for collection of pixel information based on intensity or location for statistical analyses. Concurrent OCT was performed, and fixable fluorescent dextrans were introduced into the eye for histological analysis of angiographically active areas. Results Aqueous angiography yielded high quality images with segmental patterns (p<0.0001; Kruskal-Wallis test). No single quadrant was consistently identified as the primary quadrant of angiographic signal (p = 0.06-0.86; Kruskal-Wallis test). Regions of high proximal signal did not necessarily correlate with regions of high distal signal. Angiographically positive but not negative areas demonstrated intrascleral lumens on OCT images. Aqueous angiography with fluorescent dextrans led to their trapping in AHO pathways. Conclusions Aqueous angiography is a real-time and physiologic AHO imaging technique in model eyes.	[Saraswathy, Sindhu; Tan, James C. H.; Francis, Brian A.; Huang, Alex S.] Doheny Eye Inst, 1355 San Pablo St, Los Angeles, CA 90033 USA; [Tan, James C. H.; Francis, Brian A.; Huang, Alex S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Yu, Fei] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA 90095 USA; [Hinton, David R.] Univ So Calif, Dept Ophthalmol & Pathol, Los Angeles, CA USA; [Weinreb, Robert N.] Univ Calif San Diego, Hamilton Glaucoma Ctr, San Diego, CA 92103 USA; [Weinreb, Robert N.] Univ Calif San Diego, Shiley Eye Inst, San Diego, CA 92103 USA	Doheny Eye Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; University of California System; University of California San Diego; University of California System; University of California San Diego	Huang, AS (corresponding author), Doheny Eye Inst, 1355 San Pablo St, Los Angeles, CA 90033 USA.; Huang, AS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA.	Ahuang@Doheny.org			National Institutes of Health, Bethesda, MD [K08EY024674, P30EY03040]; American Glaucoma Society (AGS) Mentoring for Physician Scientists Award; AGS Young Clinician Scientist Award; Research to Prevent Blindness, New York, NY; NATIONAL EYE INSTITUTE [K08EY024674, P30EY003040] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Glaucoma Society (AGS) Mentoring for Physician Scientists Award; AGS Young Clinician Scientist Award; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding for this work came from National Institutes of Health, Bethesda, MD (Grant Numbers K08EY024674 [ASH]; P30EY03040 [Doheny Cell and Tissue Imaging Core]); American Glaucoma Society (AGS) Mentoring for Physician Scientists Award 2013 [ASH] and 2014 [ASH]; AGS Young Clinician Scientist Award 2015 [ASH]; Research to Prevent Blindness, New York, NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hassan D.W., 2014, J OCUL BIOL, V2; Ahmed IIK, 2014, J CATARACT REFR SURG, V40, P1295, DOI 10.1016/j.jcrs.2014.07.004; Ahuja Y, 2013, AM J OPHTHALMOL, V156, P927, DOI 10.1016/j.ajo.2013.06.001; Aktas Z, 2014, J OCUL PHARMACOL TH, V30, P277, DOI 10.1089/jop.2013.0203; ASHTON N, 1951, BRIT J OPHTHALMOL, V35, P291, DOI 10.1136/bjo.35.5.291; Battista SA, 2008, INVEST OPHTH VIS SCI, V49, P5346, DOI 10.1167/iovs.08-1707; Braakman ST, 2015, EXP EYE RES, V130, P87, DOI 10.1016/j.exer.2014.11.008; Camras LJ, 2012, INVEST OPHTH VIS SCI, V53, P5242, DOI [10.1167/iovs.12-9825, 10.1167/iovs.12-9825a]; Chang JYH, 2014, J OCUL PHARMACOL TH, V30, P213, DOI 10.1089/jop.2013.0182; Cobb B, 1969, Trans Ophthalmol Soc U K, V88, P211; Craven ER, 2012, J CATARACT REFR SURG, V38, P1339, DOI 10.1016/j.jcrs.2012.03.025; Eagle R, 2001, EYE PATHOLOGY ATLAS; Ethier CR, 2001, INVEST OPHTH VIS SCI, V42, P1795; Fellman RL, 2014, J GLAUCOMA, V23, P347, DOI 10.1097/IJG.0b013e31827a06d8; Goel M, 2010, OPEN OPHTHALMOL J, V4, P52, DOI 10.2174/1874364101004010052; Gong H, 2014, SURG INNOVATIONS GLA; Grieshaber MC, 2012, DEV OPHTHALMOL, V50, P109, DOI 10.1159/000334793; Grieshaber MC, 2010, INVEST OPHTH VIS SCI, V51, P1498, DOI 10.1167/iovs.09-4327; Hann CR, 2005, INVEST OPHTH VIS SCI, V46, P1, DOI 10.1167/iovs.04-0800; Hariri S, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.106013; Jacobs DS, 2006, OPHTHALMOLOGY, V113, P707, DOI 10.1016/j.ophtha.2006.01.024; Johnson DH, 2002, ARCH OPHTHALMOL-CHIC, V120, P67; Johnson M, 2006, EXP EYE RES, V82, P545, DOI 10.1016/j.exer.2005.10.011; Kagemann L, 2012, OPHTHALMOLOGY, V119, P1563, DOI 10.1016/j.ophtha.2012.02.032; Keller KE, 2011, INVEST OPHTH VIS SCI, V52, P5049, DOI 10.1167/iovs.10-6948; Lei YA, 2010, INVEST OPHTH VIS SCI, V51, P5744, DOI 10.1167/iovs.10-5703; Li P, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.4.046013; Li P, 2013, BIOMED OPT EXPRESS, V4, P2051, DOI 10.1364/BOE.4.002051; Lindsey JD, 2009, INVEST OPHTH VIS SCI, V50, P5754, DOI 10.1167/iovs.09-3398; Lindsey JD, 2002, INVEST OPHTH VIS SCI, V43, P2201; Lu Z, 2008, EXP EYE RES, V86, P271, DOI 10.1016/j.exer.2007.10.018; LUTJENDRECOLL E, 1986, EXP EYE RES, V42, P443, DOI 10.1016/0014-4835(86)90004-7; Marvasti AH, BMC OPHTHALMOL UNPUB; Minckler D, 2008, T AM OPHTHALMOL SOC, V106, P149; Minckler D., 2008, T AM OPHTHAL SOC, V106, P59; Overby DR, 2009, EXP EYE RES, V88, P656, DOI 10.1016/j.exer.2008.11.033; Radcliffe NM, 2013, GLAUCOMA TODAY; Sabanay I, 2000, ARCH OPHTHALMOL-CHIC, V118, P955; Samuelson TW, 2011, OPHTHALMOLOGY, V118, P459, DOI 10.1016/j.ophtha.2010.07.007; Sit AJ, 2011, EXP EYE RES, V93, P291, DOI 10.1016/j.exer.2011.05.003; Sit AJ, 2011, EXP EYE RES, V92, P537, DOI 10.1016/j.exer.2011.03.018; Swaminathan SS, 2014, J CATARACT REFR SURG, V40, P1263, DOI 10.1016/j.jcrs.2014.06.020; Swaminathan SS, 2013, INVEST OPHTH VIS SCI, V54, P2035, DOI 10.1167/iovs.12-10950; Vandewalle E, 2014, J GLAUCOMA, V23, P95, DOI 10.1097/IJG.0b013e318269806a; Vranka JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122483; Yang CYC, 2013, INVEST OPHTH VIS SCI, V54, P5859, DOI 10.1167/iovs.12-10930; Zeppa Lucio, 2014, JAMA Ophthalmol, V132, P1281, DOI 10.1001/jamaophthalmol.2014.567	47	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147176	10.1371/journal.pone.0147176	http://dx.doi.org/10.1371/journal.pone.0147176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807586	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800056
J	She, XD; Calderone, R; Kruppa, M; Lowman, D; Williams, D; Zhang, LL; Gao, Y; Khamooshi, K; Liu, WD; Li, DM				She, Xiaodong; Calderone, Richard; Kruppa, Michael; Lowman, Douglas; Williams, David; Zhang, Lili; Gao, Ying; Khamooshi, Kasra; Liu, Weida; Li, Dongmei			Cell Wall N-Linked Mannoprotein Biosynthesis Requires Goa1p, a Putative Regulator of Mitochondrial Complex I in Candida albicans	PLOS ONE			English	Article							RECOGNITION; MANNAN; HYPHAL; YEAST; VIRULENCE; KINASE; GROWTH; MUTANT; GENE; ARCHITECTURE	The Goa1p of Candida albicans regulates mitochondrial Complex I (CI) activities in its role as a putative CI accessory protein. Transcriptional profiling of goa1 Delta revealed a down regulation of genes encoding beta-oligomannosyl transferases. Herein, we present data on cell wall phenotypes of goa1 Delta (strain GOA31). We used transmission electron microscopy (TEM), GPC/MALLS, and NMR to compare GOA31 to a gene-reconstituted strain (GOA32) and parental cells. We note by TEM a reduction in outer wall fibrils, increased inner wall transparency, and the loss of a defined wall layer close to the plasma membrane. GPC-MALLS revealed a reduction in high and intermediate Mw mannan by 85% in GOA31. A reduction of beta-mannosyl but not a-mannosyl linkages was noted in GOA31 cells. beta-(1,6)-linked glucan side chains were branched about twice as often but were shorter in length for GOA31. We conclude that mitochondrial CI energy production is highly integrated with cell wall formation. Our data also suggest that not all cell wall biosynthetic processes are dependent upon Goa1p even though it provides high levels of ATP to cells. The availability of both broadly conserved and fungal-specific mutants lacking CI subunit proteins should be useful in assessing functions of fungal-specific functions subunit proteins.	[She, Xiaodong; Calderone, Richard; Khamooshi, Kasra; Li, Dongmei] Georgetown Univ, Med Ctr, Dept Microbiol & Immunol, Washington, DC 20057 USA; [She, Xiaodong; Zhang, Lili; Gao, Ying; Liu, Weida] Chinese Acad Med Sci, Jiangsu Key Lab Mol Biol Skin Dis & STIs, Inst Dermatol, Nanjing 210029, Jiangsu, Peoples R China; [Kruppa, Michael; Lowman, Douglas; Williams, David] E Tennessee State Univ, Dept Surg, Dept Biomed Sci, Johnson City, TN 37614 USA; [Kruppa, Michael; Lowman, Douglas; Williams, David] E Tennessee State Univ, Ctr Excellence Inflammat Infect Dis & Immun, Johnson City, TN 37614 USA	Georgetown University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; East Tennessee State University; East Tennessee State University	Calderone, R (corresponding author), Georgetown Univ, Med Ctr, Dept Microbiol & Immunol, Washington, DC 20057 USA.	calderor@georgetown.edu	Kruppa, Michael D/B-6052-2009	Kruppa, Michael D/0000-0002-1747-2333	Georgetown University Biomedical Research Organization (BGRO); National Natural Science Foundation of China [81401652]; National Natural Science Foundation of Jiangsu Province, China [BK20130063]; NIH-NIAID [AI090290]; NIH [CC06RR0306551];  [NIHGM53522]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083016] Funding Source: NIH RePORTER	Georgetown University Biomedical Research Organization (BGRO); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the support of the Georgetown University Biomedical Research Organization (BGRO) to DL. We also wish to thank the National Natural Science Foundation of China (81401652) and the National Natural Science Foundation of Jiangsu Province, China (BK20130063) to XS and the NIH-NIAID, AI090290 to RC. This research was also supported, in part, by NIHGM53522 to DW. DW and MK would like to acknowledge partial support of this project through NIH CC06RR0306551.; The authors acknowledge the support of the Georgetown University Biomedical Research Organization (BGRO) to DL. We also wish to thank the National Natural Science Foundation of China (81401652) and the National Natural Science Foundation of Jiangsu Province, China (BK20130063) to XS and the NIH-NIAID, AI090290 to RC. This research was also supported, in part, by NIHGM53522 to DW. DW and MK would like to acknowledge partial support of this project through NIH CC06RR0306551.	Bambach A, 2009, EUKARYOT CELL, V8, P1706, DOI 10.1128/EC.00066-09; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Chen H, 2012, FUNGAL GENET BIOL, V49, P1023, DOI 10.1016/j.fgb.2012.09.007; Devillers A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084771; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x; Fabre E, 2014, BIOCHEM J, V457, P347, DOI 10.1042/BJ20131012; Galello F, 2014, J PROTEOMICS, V109, P261, DOI 10.1016/j.jprot.2014.07.008; GOPAL PK, 1984, J GEN MICROBIOL, V130, P3295; GOW NAR, 1994, P NATL ACAD SCI USA, V91, P6216, DOI 10.1073/pnas.91.13.6216; Gow NAR, 2012, CURR OPIN MICROBIOL, V15, P406, DOI 10.1016/j.mib.2012.04.005; Hall RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003276; Han Y, 2000, INFECT IMMUN, V68, P1649, DOI 10.1128/IAI.68.3.1649-1654.2000; HECTOR RF, 1993, CLIN MICROBIOL REV, V6, P1; Jimenez-Lopez C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003741; Johnson MA, 2013, CHEM SOC REV, V42, P4327, DOI 10.1039/c2cs35382b; Jouault T, 2003, J INFECT DIS, V188, P165, DOI 10.1086/375784; Jouault T, 2001, GLYCOBIOLOGY, V11, P693, DOI 10.1093/glycob/11.8.693; Khamooshi K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-56; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; KOCOUREK J, 1969, J BACTERIOL, V100, P1175, DOI 10.1128/JB.100.3.1175-1181.1969; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Kruppa M, 2003, FEMS YEAST RES, V3, P289, DOI 10.1016/S1567-1356(02)00164-2; Kruppa M, 2011, GLYCOBIOLOGY, V21, P1173, DOI 10.1093/glycob/cwr051; Li DM, 2009, FUNGAL GENET BIOL, V46, P731, DOI 10.1016/j.fgb.2009.06.008; Li DM, 2011, EUKARYOT CELL, V10, P672, DOI 10.1128/EC.00303-10; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Lowman DW, 2014, J BIOL CHEM, V289, P3432, DOI 10.1074/jbc.M113.529131; Lowman DW, 2011, CARBOHYD RES, V346, P2752, DOI 10.1016/j.carres.2011.09.029; Lowman DW, 2003, CARBOHYD RES, V338, P1491, DOI 10.1016/S0008-6215(03)00169-1; Lung A, 1999, APPL ENVIRON MICROB, V65, P5398; Martinez JP, 1998, CLIN MICROBIOL REV, V11, P121, DOI 10.1128/CMR.11.1.121; Masuoka J, 2004, CLIN MICROBIOL REV, V17, P281, DOI 10.1128/CMR.17.2.281-310.2004; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; REES DA, 1971, J CHEM SOC B, P469, DOI 10.1039/j29710000469; Riquelme M, 2014, CURR OPIN MICROBIOL, V20, P27, DOI 10.1016/j.mib.2014.04.003; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sandai D, 2012, MBIO, V3, DOI 10.1128/mBio.00495-12; She XD, 2015, CELL MICROBIOL, V17, P1350, DOI 10.1111/cmi.12438; She XD, 2013, CELL MICROBIOL, V15, P1572, DOI 10.1111/cmi.12135; STYNEN D, 1995, J CLIN MICROBIOL, V33, P497, DOI 10.1128/JCM.33.2.497-500.1995; West L, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.478743; Wilson W, 2015, FISH SHELLFISH IMMUN, V43, P346, DOI 10.1016/j.fsi.2014.12.032; Xin H, 2008, P NATL ACAD SCI USA, V105, P13526, DOI 10.1073/pnas.0803195105; Xin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035106; Yin QY, 2008, TRENDS MICROBIOL, V16, P20, DOI 10.1016/j.tim.2007.10.011; Yuan HX, 2013, MOL CELL, V49, P379, DOI 10.1016/j.molcel.2013.01.019	48	18	18	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147175	10.1371/journal.pone.0147175	http://dx.doi.org/10.1371/journal.pone.0147175			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809064	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800055
J	Vera, B; Martinez-Velez, N; Xipell, E; de la Rocha, AA; Patino-Garcia, A; Saez-Castresana, J; Gonzalez-Huarriz, M; Cascallo, M; Alemany, R; Alonso, MM				Vera, Beatriz; Martinez-Velez, Naiara; Xipell, Enric; Acanda de la Rocha, Arlet; Patino-Garcia, Ana; Saez-Castresana, Javier; Gonzalez-Huarriz, Marisol; Cascallo, Manel; Alemany, Ramon; Alonso, Marta M.			Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01	PLOS ONE			English	Article							MOUSE MACROPHAGES; HYALURONAN FRAGMENTS; GENE-EXPRESSION; BRAIN-TUMOR; TOXICITY; PROMOTER; SURVIVAL; GLIOMA; GLIOBLASTOMA; TEMOZOLOMIDE	Despite the recent advances in the development of antitumor therapies, the prognosis for patients with malignant gliomas remains dismal. Therapy with tumor-selective viruses is emerging as a treatment option for this devastating disease. In this study we characterize the anti-glioma effect of VCN-01, an improved hyaluronidase-armed pRB-pathway-selective oncolytic adenovirus that has proven safe and effective in the treatment of several solid tumors. VCN-01 displayed a significant cytotoxic effect on glioma cells in vitro. In vivo, in two different orthotopic glioma models, a single intra-tumoral administration of VCN-01 increased overall survival significantly and led to long-term survivors free of disease.	[Vera, Beatriz; Martinez-Velez, Naiara; Xipell, Enric; Acanda de la Rocha, Arlet; Patino-Garcia, Ana; Saez-Castresana, Javier; Gonzalez-Huarriz, Marisol; Alonso, Marta M.] Navarras Hlth Res Inst IDISNA, Pamplona, Spain; [Vera, Beatriz; Martinez-Velez, Naiara; Xipell, Enric; Acanda de la Rocha, Arlet; Gonzalez-Huarriz, Marisol; Alonso, Marta M.] Fdn Appl Med Res, Program Solid Tumors & Biomarkers, Pamplona, Spain; [Vera, Beatriz; Martinez-Velez, Naiara; Xipell, Enric; Acanda de la Rocha, Arlet; Gonzalez-Huarriz, Marisol; Alonso, Marta M.] Univ Hosp Navarra, Dept Med Oncol, Pamplona 31008, Spain; [Patino-Garcia, Ana] Univ Hosp Navarra, Dept Pediat, Pamplona 31008, Spain; [Saez-Castresana, Javier] Univ Navarra, Sch Sci, Brain Tumor Biol Unit, Pamplona 31008, Spain; [Cascallo, Manel] VCN Biosci, Barcelona 08174, Spain; [Alemany, Ramon] Hosp Llobregat, IDIBELL Inst Catala Oncol, Translat Res Lab, Barcelona 08907, Spain	Servicio Navarro de Salud - Osasunbidea; University of Navarra; Servicio Navarro de Salud - Osasunbidea; University of Navarra; University of Navarra; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Alonso, MM (corresponding author), Navarras Hlth Res Inst IDISNA, Pamplona, Spain.; Alonso, MM (corresponding author), Fdn Appl Med Res, Program Solid Tumors & Biomarkers, Pamplona, Spain.; Alonso, MM (corresponding author), Univ Hosp Navarra, Dept Med Oncol, Pamplona 31008, Spain.	mmalonso@unav.es	Patiño-Garcia, Ana/I-4299-2012; Alonso, Marta M/AAI-9457-2020	Patiño-Garcia, Ana/0000-0002-4066-8203; Alonso, Marta M/0000-0002-7520-7351; Castresana, Javier S./0000-0002-2373-482X; gonzalez-huarriz, marisol/0000-0002-0438-0077; Martinez-Velez, Naiara/0000-0003-2248-7692	European Union (Marie Curie) [IRG270459]; Instituto de Salud Carlos III y los Fondos Feder Europeos [PI13/125]; Spanish Ministry of Science and Innovation [RYC-2009-05571]; L'OREAL-Unesco Foundation; Department of Health of the Government of Navarra; Basque Foundation for Health Research (BIOEF) [BIO13/CI/005]; Caja Navarra Foundation; Credit Andorra Foundation; University of Navarra; Spanish Ministry of Education and Science [BIO2011-30299-C02-01]; VCN bioscience	European Union (Marie Curie)(European Commission); Instituto de Salud Carlos III y los Fondos Feder Europeos; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); L'OREAL-Unesco Foundation(L'Oreal Group); Department of Health of the Government of Navarra; Basque Foundation for Health Research (BIOEF); Caja Navarra Foundation; Credit Andorra Foundation; University of Navarra; Spanish Ministry of Education and Science(Spanish Government); VCN bioscience	This work was supported by the European Union (Marie Curie IRG270459 to MMA), the Instituto de Salud Carlos III y los Fondos Feder Europeos (PI13/125 to MMA), the Spanish Ministry of Science and Innovation (Ramon y Cajal contract RYC-2009-05571 to MMA), The L'OREAL-Unesco Foundation (to MMA), The Department of Health of the Government of Navarra (to MMA), The Basque Foundation for Health Research (BIOEF, BIO13/CI/005) and the Caja Navarra Foundation (to MMA). EX is supported by a fellowship from the Credit Andorra Foundation. AAR is supported by a fellowship from Friends of the University of Navarra (ADA). RA is supported by BIO2011-30299-C02-01 from the Spanish Ministry of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. VCN bioscience provided support in the form of salaries or research support for authors MC and RA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by the European Union (Marie Curie IRG270459 to MMA), the Instituto de Salud Carlos III y los Fondos Feder Europeos (PI13/125 to MMA), the Spanish Ministry of Science and Innovation (Ramon y Cajal contract RYC-2009-05571 to MMA), The L'OREAL-Unesco Foundation (to MMA), The Department of Health of the Government of Navarra (to MMA), The Basque Foundation for Health Research (BIOEF, BIO13/CI/005) and the Caja Navarra Foundation (to MMA). EX is supported by a fellowship from the Credit Andorra Foundation. AAR is supported by a fellowship from Friends of the University of Navarra (ADA). RA is supported by BIO2011-30299-C02-01 from the Spanish Ministry of Education and Science.	Alemany R, 2007, MOL ASPECTS MED, V28, P42, DOI 10.1016/j.mam.2006.12.002; Alonso MM, 2007, CANCER RES, V67, P11499, DOI 10.1158/0008-5472.CAN-07-5312; Alonso MM, 2007, CANCER RES, V67, P8255, DOI 10.1158/0008-5472.CAN-06-4675; Alonso MM, 2005, JNCI-J NATL CANCER I, V97, P1589, DOI 10.1093/jnci/dji340; Baier C, 2007, MATRIX BIOL, V26, P348, DOI 10.1016/j.matbio.2007.02.002; Ballman KV, 2007, NEURO-ONCOLOGY, V9, P29, DOI 10.1215/15228517-2006-025; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Cascallo M, 2007, MOL THER, V15, P1607, DOI 10.1038/sj.mt.6300239; Cascallo M, 2006, HUM GENE THER, V17, P929, DOI 10.1089/hum.2006.17.929; Chiarella P, 2013, HUM GENE THER, V24, P406, DOI 10.1089/hum.2012.215; Fueyo J, 2003, J NATL CANCER I, V95, P652, DOI 10.1093/jnci/95.9.652; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; HodgeDufour J, 1997, J IMMUNOL, V159, P2492; Horton MR, 1999, J IMMUNOL, V162, P4171; Horton MR, 1998, J BIOL CHEM, V273, P35088, DOI 10.1074/jbc.273.52.35088; Horton MR, 1998, J IMMUNOL, V160, P3023; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; Lal S, 2000, J NEUROSURG, V92, P326, DOI 10.3171/jns.2000.92.2.0326; Majem M, 2006, CANCER GENE THER, V13, P696, DOI 10.1038/sj.cgt.7700940; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Rodriguez-Garcia A, 2015, CLIN CANCER RES, V21, P1406, DOI 10.1158/1078-0432.CCR-14-2213; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Ulasov IV, 2009, INT J ONCOL, V34, P729, DOI 10.3892/ijo_00000199	26	21	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147211	10.1371/journal.pone.0147211	http://dx.doi.org/10.1371/journal.pone.0147211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808201	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800061
J	Wibroe, EA; Yri, HM; Jensen, RH; Wibroe, MA; Hamann, S				Wibroe, Elisabeth A.; Yri, Hanne M.; Jensen, Rigmor H.; Wibroe, Morten A.; Hamann, Steffen			Osmolality of Cerebrospinal Fluid from Patients with Idiopathic Intracranial Hypertension (IIH)	PLOS ONE			English	Article							PSEUDOTUMOR CEREBRI; DIAGNOSTIC-CRITERIA; OBESITY; SERUM	Introduction Idiopathic intracranial hypertension (IIH) is a disorder of increased intracranial fluid pressure (ICP) of unknown etiology. This study aims to investigate osmolality of cerebrospinal fluid (CSF) from patients with IIH. Methods We prospectively collected CSF from individuals referred on suspicion of IIH from 2011-2013. Subjects included as patients fulfilled Friedman and Jacobson's diagnostic criteria for IIH. Individuals in whom intracranial hypertension was refuted were included as controls. Lumbar puncture with ICP measurement was performed at inclusion and repeated for patients after three months of treatment. Osmolality was measured with a Vapor Pressure Osmometer. Results We collected 90 CSF samples from 38 newly diagnosed patients and 28 controls. At baseline 27 IIH-samples and at 3 months follow-up 35 IIH-samples were collected from patients. We found no significant differences in osmolality between 1) patients at baseline and controls (p = 0. 86), 2) patients at baseline and after 3 months treatment (p = 0.97), and 3) patients with normalized pressure after 3 months and their baseline values (p = 0.79). Osmolality in individuals with normal ICP from 6-25 cmH(2)O (n = 41) did not differ significantly from patients with moderately elevated ICP from 26-45 cmH(2)O (n = 21) (p = 0.86) and patients with high ICP from 46-70 cmH(2)O (n = 4) (p = 0.32), respectively. There was no correlation between osmolality and ICP, BMI, age and body height, respectively. Mean CSF osmolality was 270 mmol/kg (+/- 1 SE, 95% confidence interval 267-272) for both patients and controls. Conclusions CSF osmolality was normal in patients with IIH, and there was no relation to treatment, ICP, BMI, age and body height. Mean CSF osmolality was 270 mmol/kg and constitutes a reference for future studies. Changes in CSF osmolality are not responsible for development of IIH. Other underlying pathophysiological mechanisms must be searched.	[Wibroe, Elisabeth A.; Hamann, Steffen] Univ Copenhagen, Rigshosp, Dept Ophthalmol, Glostrup, Denmark; [Yri, Hanne M.; Jensen, Rigmor H.] Univ Copenhagen, Rigshosp, Dept Neurol, Danish Headache Ctr, Glostrup, Denmark; [Wibroe, Morten A.] Univ Copenhagen, Rigshosp, Dept Pediat & Adolescent Med, Glostrup, Denmark; [Wibroe, Morten A.] Univ Copenhagen, Rigshosp, Dept Neurosurg, Glostrup, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Wibroe, EA (corresponding author), Univ Copenhagen, Rigshosp, Dept Ophthalmol, Glostrup, Denmark.	elisabeth.arnberg@gmail.com	Wibroe, Elisabeth A./N-2701-2016; Hamann, Steffen/E-2090-2013	Hamann, Steffen/0000-0003-4318-2716	Region Hovedstadens Forskningsfond; A. P. Moller Fonden til Laegevidenskabens Fremme [12-375]	Region Hovedstadens Forskningsfond; A. P. Moller Fonden til Laegevidenskabens Fremme	This work was supported by Region Hovedstadens Forskningsfond and A. P. Moller Fonden til Laegevidenskabens Fremme, grant number 12-375 (https://www.regionh.dk/til-fagfolk/forskning-og-innovation/Finansiering/ansoegningsfrister/Loebende-ansoegningsfrister/ Sider/Region-Hovedstadens-Forskningsfond-til-Sundhedsforskning.aspx, http://www.apmollerfonde.dk/ansoegning/laegefonden.aspx). HMY received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews LE, 2014, HORM RES PAEDIAT; Ball AK, 2009, CLIN ENDOCRINOL, V70, P863, DOI 10.1111/j.1365-2265.2008.03401.x; Baykan B, 2015, AGRI, V27, P63, DOI 10.5505/agri.2015.22599; Daniels AB, 2007, AM J OPHTHALMOL, V143, P635, DOI 10.1016/j.ajo.2006.12.040; Dhungana S, 2009, HEADACHE, V49, P282, DOI 10.1111/j.1526-4610.2008.001329.x; Edwards LJ, 2013, AM J CLIN EXP IMMUNO, V2, P234; Friedman DI, 2013, NEUROLOGY, V81, P1159, DOI 10.1212/WNL.0b013e3182a55f17; Friedman DI, 2002, NEUROLOGY, V59, P1492, DOI 10.1212/01.WNL.0000029570.69134.1B; GIUSEFFI V, 1991, NEUROLOGY, V41, P239, DOI 10.1212/WNL.41.2_Part_1.239; GOLDBERG NB, 1965, ANESTHESIOLOGY, V26, P829, DOI 10.1097/00000542-196511000-00021; IRELAND B, 1990, ARCH NEUROL-CHICAGO, V47, P315, DOI 10.1001/archneur.1990.00530030091021; Jonas JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086678; Kosmorsky GS, 2014, HEADACHE, V54, P389, DOI 10.1111/head.12284; Lecube A, 2012, J NEUROENDOCRINOL, V24, P944, DOI 10.1111/j.1365-2826.2012.02288.x; MacAulay N, 2010, NEUROSCIENCE, V168, P941, DOI 10.1016/j.neuroscience.2009.09.016; Marzoli SB, 2013, NEUROL SCI, V34, pS143, DOI 10.1007/s10072-013-1373-1; Ooi LY, 2008, BRIT J NEUROSURG, V22, P187, DOI 10.1080/02688690701827340; Paredes-Andrade E, 2012, NEUROCRIT CARE, V17, P204, DOI 10.1007/s12028-011-9574-z; Rowe FJ, 1999, INT J OBESITY, V23, P54, DOI 10.1038/sj.ijo.0800758; Salpietro V, 2014, J PEDIATR ENDOCR MET, V27, P107, DOI 10.1515/jpem-2013-0156; Salpietro V, 2013, J PEDIATR-US, V162, P1084, DOI 10.1016/j.jpeds.2013.01.048; Salpietro V, 2012, NEUROENDOCRINOL LETT, V33, P569; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stiebel-Kalish H, 2014, INT J OBESITY, V38, P1475, DOI 10.1038/ijo.2014.44; Thurtell MJ, 2013, CURR TREAT OPTION NE, V15, P1, DOI 10.1007/s11940-012-0207-4; Walker RWH, 2001, J NEUROL NEUROSUR PS, V71, P1, DOI 10.1136/jnnp.71.1.1; Wall M, 2014, JAMA NEUROL, V71, P693, DOI 10.1001/jamaneurol.2014.133; Warner JEA, 2007, J NEURO-OPHTHALMOL, V27, P258, DOI 10.1097/WNO.0b013e31815b9af0; Yri Hanne M, 2012, Ugeskr Laeger, V174, P1737; Yri HM, 2012, J NEUROL, V259, P886, DOI 10.1007/s00415-011-6273-9; Yri HM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004376	31	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146793	10.1371/journal.pone.0146793	http://dx.doi.org/10.1371/journal.pone.0146793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808050	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800032
J	Muntean, BS; Martemyanov, KA				Muntean, Brian S.; Martemyanov, Kirill A.			Association with the Plasma Membrane Is Sufficient for Potentiating Catalytic Activity of Regulators of G Protein Signaling (RGS) Proteins of the R7 Subfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; G protein; G protein-coupled receptor (GPCR); GTPase-activating protein (GAP); regulator of G protein signaling (RGS); signal transduction	HETEROTRIMERIC G-PROTEINS; NUCLEAR-LOCALIZATION; LIVING CELLS; BETA-SUBUNIT; DEP DOMAIN; COMPLEX; STRIATUM; ANCHOR; FAMILY; BRAIN	Regulators of G protein Signaling (RGS) promote deactivation of heterotrimeric G proteins thus controlling the magnitude and kinetics of responses mediated by G protein-coupled receptors (GPCR). In the nervous system, RGS7 and RGS9-2 play essential role in vision, reward processing, and movement control. Both RGS7 and RGS9-2 belong to the R7 subfamily of RGS proteins that form macromolecular complexes with R7-binding protein (R7BP). R7BP targets RGS proteins to the plasma membrane and augments their GTPase-accelerating protein (GAP) activity, ultimately accelerating deactivation of G protein signaling. However, it remains unclear if R7BP serves exclusively as a membrane anchoring subunit or further modulates RGS proteins to increase their GAP activity. To directly answer this question, we utilized a rapidly reversible chemically induced protein dimerization system that enabled us to control RGS localization independent from R7BP in living cells. To monitor kinetics of G deactivation, we coupled this strategy with measuring changes in the GAP activity by bioluminescence resonance energy transfer-based assay in a cellular system containing -opioid receptor. This approach was used to correlate changes in RGS localization and activity in the presence or absence of R7BP. Strikingly, we observed that RGS activity is augmented by membrane recruitment, in an orientation independent manner with no additional contributions provided by R7BP. These findings argue that the association of R7 RGS proteins with the membrane environment provides a major direct contribution to modulation of their GAP activity.	[Muntean, Brian S.; Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA	Scripps Research Institute	Martemyanov, KA (corresponding author), Scripps Res Inst, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA.	kirill@scripps.edu			National Institutes of Health [DA036596, DA026405]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036596, K02DA026405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants DA036596 and DA026405 (to K. A. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson GR, 2007, J NEUROSCI, V27, P14117, DOI 10.1523/JNEUROSCI.3884-07.2007; Anderson GR, 2007, J BIOL CHEM, V282, P4772, DOI 10.1074/jbc.M610518200; Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Bouhamdan M, 2004, BBA-MOL CELL RES, V1691, P141, DOI 10.1016/j.bbamcr.2004.01.005; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Cao Y, 2012, P NATL ACAD SCI USA, V109, P7905, DOI 10.1073/pnas.1202332109; Carter AM, 2014, J BIOL CHEM, V289, P19737, DOI 10.1074/jbc.M114.564930; Charpentier TH, 2014, J BIOL CHEM, V289, P29545, DOI 10.1074/jbc.M114.586784; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Drenan RM, 2006, J BIOL CHEM, V281, P28222, DOI 10.1074/jbc.M604428200; Feng SH, 2014, ANGEW CHEM INT EDIT, V53, P6720, DOI 10.1002/anie.201402294; Gold SJ, 2007, J NEUROSCI, V27, P14338, DOI 10.1523/JNEUROSCI.4223-07.2007; Hillenbrand M, 2015, P NATL ACAD SCI USA, V112, pE1181, DOI 10.1073/pnas.1417573112; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Liapis E, 2012, J NEUROCHEM, V122, P568, DOI 10.1111/j.1471-4159.2012.07811.x; MacNamara A, 2015, BIOORGAN MED CHEM, V23, P2868, DOI 10.1016/j.bmc.2015.04.074; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Masuho I, 2013, J BIOL CHEM, V288, P25129, DOI 10.1074/jbc.M113.462283; Masuho I, 2010, J BIOL CHEM, V285, P4781, DOI 10.1074/jbc.M109.058511; Medina F, 2013, J BIOL CHEM, V288, P11325, DOI 10.1074/jbc.M113.450056; Mitsi V, 2015, P NATL ACAD SCI USA, V112, pE5088, DOI 10.1073/pnas.1504283112; Narayanan V, 2007, BIOCHEMISTRY-US, V46, P6859, DOI 10.1021/bi700524w; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Nini Lylia, 2007, BMC Biochemistry, V8, P18, DOI 10.1186/1471-2091-8-18; Orlandi C, 2015, J BIOL CHEM, V290, P13622, DOI 10.1074/jbc.M115.645374; Orlandi C, 2012, J CELL BIOL, V197, P711, DOI 10.1083/jcb.201202123; Ostrovskaya O, 2014, ELIFE, V3, DOI 10.7554/eLife.02053; Posokhova E, 2010, J PROTEOME RES, V9, P1510, DOI 10.1021/pr901022m; Psigfogeorgou K, 2011, J NEUROSCI, V31, P5617, DOI 10.1523/JNEUROSCI.4146-10.2011; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rojkova AM, 2003, J BIOL CHEM, V278, P12507, DOI 10.1074/jbc.M207302200; Rose JJ, 2000, J NEUROCHEM, V75, P2103, DOI 10.1046/j.1471-4159.2000.0752103.x; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Schifferer M, 2015, BIOORGAN MED CHEM, V23, P2862, DOI 10.1016/j.bmc.2015.03.048; Song JH, 2006, J BIOL CHEM, V281, P15361, DOI 10.1074/jbc.M600749200; Sutton LP, 2016, BIOL PSYCHIAT, V80, P235, DOI 10.1016/j.biopsych.2015.07.026; Takida S, 2005, MOL PHARMACOL, V67, P132, DOI 10.1124/mol.104.003418; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Xie KQ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002922; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhang JH, 2001, J BIOL CHEM, V276, P10284, DOI 10.1074/jbc.M009247200; Zhou H, 2012, P NATL ACAD SCI USA, V109, P19977, DOI 10.1073/pnas.1214337109	51	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7195	7204		10.1074/jbc.M115.713446	http://dx.doi.org/10.1074/jbc.M115.713446			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26811338	Green Published, hybrid			2022-12-26	WOS:000373299700051
J	George, CX; Ramaswami, G; Li, JB; Samuel, CE				George, Cyril X.; Ramaswami, Gokul; Li, Jin Billy; Samuel, Charles E.			Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; interferon; protein kinase RNA-activated (PKR); RNA editing; stress granule; adenosine deaminase acting on RNA (ADAR)	DOUBLE-STRANDED-RNA; PROTEIN-KINASE PKR; SPLICE-SITE VARIANTS; PRE-MESSENGER-RNA; N-TERMINAL REGION; INTERFERON ACTION; MEASLES-VIRUS; HUMAN-CELLS; ENZYME ADAR1; C PROTEIN	Adenosine deaminases acting on double-stranded RNA (ADARs) catalyze the deamination of adenosine (A) to produce inosine (I) in double-stranded (ds) RNA structures, a process known as A-to-I RNA editing. dsRNA is an important trigger of innate immune responses, including interferon (IFN) production and action. We examined the role of A-to-I RNA editing by two ADARs, ADAR1 and ADAR2, in the sensing of self-RNA in the absence of pathogen infection, leading to activation of IFN-induced, RNA-mediated responses in mouse embryo fibroblasts. IFN treatment of Adar1(-/-) cells lacking both the p110 constitutive and p150 IFN-inducible ADAR1 proteins induced formation of stress granules, whereas neither wild-type (WT) nor Adar2(-/-) cells displayed a comparable stress granule response following IFN treatment. Phosphorylation of protein synthesis initiation factor eIF2 at serine 51 was increased in IFN-treated Adar1(-/-) cells but not in either WT or Adar2(-/-) cells following IFN treatment. Analysis by deep sequencing of mouse exonic loci containing A-to-I-editing sites revealed that the majority of editing in mouse embryo fibroblasts was carried out by ADAR1. IFN treatment increased editing in both WT and Adar2(-/-) cells but not in either Adar1(-/-) or Adar1(-/-p150) cells or Stat1(-/-) or Stat2(-/-) cells. Hyper-edited sites found in predicted duplex structures showed strand bias of editing for some RNAs. These results implicate ADAR1 p150 as the major A-to-I editor in mouse embryo fibroblasts, acting as a feedback suppressor of innate immune responses otherwise triggered by self-RNAs possessing regions of double-stranded character.	[George, Cyril X.; Samuel, Charles E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Samuel, Charles E.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; [Ramaswami, Gokul; Li, Jin Billy] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Stanford University	Samuel, CE (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.; Samuel, CE (corresponding author), Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA.	samuel@lifesci.ucsb.edu			National Institutes of Health [AI-12520]; NIAID [AI-20611]; NIGMS [GM-202484]; Stanford Graduate Fellowship; Ellison Medical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020611, R37AI012520, R01AI012520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102484, T32GM007790] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stanford Graduate Fellowship(Stanford University); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Research Grants AI-12520 and AI-20611 from the NIAID (to C. E. S.) and GM-202484 from the NIGMS (to J. B. L.), a Stanford Graduate Fellowship (to G. R.), and by the Ellison Medical Foundation (to J. B. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Barraud P, 2012, CURR TOP MICROBIOL, V353, P35, DOI 10.1007/82_2011_145; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004; Bevilacqua PC, 1998, BIOCHEMISTRY-US, V37, P6303, DOI 10.1021/bi980113j; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; Dalet A, 2015, FEBS LETT, V589, P1539, DOI 10.1016/j.febslet.2015.05.006; Danecek P, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r26; Das S, 2006, J BIOL CHEM, V281, P3244, DOI 10.1074/jbc.M510612200; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Gelinas JF, 2011, J VIROL, V85, P8460, DOI 10.1128/JVI.00240-11; George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621; George CX, 2005, J BIOL CHEM, V280, P15020, DOI 10.1074/jbc.M500476200; George CX, 2015, VIROLOGY, V485, P363, DOI 10.1016/j.virol.2015.08.001; George CX, 2011, J VIROL, V85, P8338, DOI 10.1128/JVI.02666-10; George CX, 2011, J INTERF CYTOK RES, V31, P99, DOI 10.1089/jir.2010.0097; Goodman RA, 2012, CURR TOP MICROBIOL, V353, P1, DOI 10.1007/82_2011_144; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hood JL, 2012, CURR TOP MICROBIOL, V353, P61, DOI 10.1007/82_2011_157; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; John L, 2014, VIROLOGY, V454, P299, DOI 10.1016/j.virol.2014.02.025; Kedersha N, 2009, PROG MOL BIOL TRANSL, V90, P155, DOI 10.1016/S1877-1173(09)90004-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kuhen KL, 1997, VIROLOGY, V227, P119, DOI 10.1006/viro.1996.8306; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li ZQ, 2012, J VIROL, V86, P3787, DOI 10.1128/JVI.06307-11; Li ZQ, 2010, VIROLOGY, V396, P316, DOI 10.1016/j.virol.2009.10.026; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Liu Y, 1996, J VIROL, V70, P1961, DOI 10.1128/JVI.70.3.1961-1968.1996; Liu Y, 1999, J BIOL CHEM, V274, P5070, DOI 10.1074/jbc.274.8.5070; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351; Lloyd RE, 2013, WIRES RNA, V4, P317, DOI 10.1002/wrna.1162; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; MCCORMACK SJ, 1992, VIROLOGY, V188, P47, DOI 10.1016/0042-6822(92)90733-6; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mizrahi RA, 2012, NUCLEIC ACIDS RES, V40, P9825, DOI 10.1093/nar/gks752; Neeman Y, 2006, RNA, V12, P1802, DOI 10.1261/rna.165106; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Okonski KM, 2013, J VIROL, V87, P756, DOI 10.1128/JVI.02270-12; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; PATTERSON JB, 1995, VIROLOGY, V210, P508, DOI 10.1006/viro.1995.1370; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Pfaller CK, 2015, J VIROL, V89, P7735, DOI 10.1128/JVI.01017-15; Pfaller CK, 2014, J VIROL, V88, P456, DOI 10.1128/JVI.02572-13; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pinto Y, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r5; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/nmeth.2330, 10.1038/NMETH.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; RendeFournier R, 1997, VIROLOGY, V238, P410, DOI 10.1006/viro.1997.8824; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1979, P NATL ACAD SCI USA, V76, P600, DOI 10.1073/pnas.76.2.600; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Samuel CE, 2011, VIROLOGY, V411, P180, DOI 10.1016/j.virol.2010.12.004; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; TANAKA H, 1994, P NATL ACAD SCI USA, V91, P7995, DOI 10.1073/pnas.91.17.7995; THOMIS DC, 1995, J VIROL, V69, P5195, DOI 10.1128/JVI.69.8.5195-5198.1995; Toth AM, 2006, PROG NUCLEIC ACID RE, V81, P369, DOI 10.1016/S0079-6603(06)81010-X; Toth AM, 2009, J BIOL CHEM, V284, P29350, DOI 10.1074/jbc.M109.045146; Toth AM, 2009, J VIROL, V83, P961, DOI 10.1128/JVI.01669-08; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; Vazquez C, 2015, J VIROL, V89, P6974, DOI 10.1128/JVI.01918-14; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang R, 2014, NAT METHODS, V11, P51, DOI 10.1038/nmeth.2736	83	81	84	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6158	6168		10.1074/jbc.M115.709014	http://dx.doi.org/10.1074/jbc.M115.709014			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26817845	hybrid, Green Published			2022-12-26	WOS:000372894200010
J	Khor, EC; Fanshawe, B; Qi, Y; Zolotukhin, S; Kulkarni, RN; Enriquez, RF; Purtell, L; Lee, NJ; Wee, NK; Croucher, PI; Campbell, L; Herzog, H; Baldock, PA				Khor, Ee-Cheng; Fanshawe, Bruce; Qi, Yue; Zolotukhin, Sergei; Kulkarni, Rishikesh N.; Enriquez, Ronaldo F.; Purtell, Louise; Lee, Nicola J.; Wee, Natalie K.; Croucher, Peter I.; Campbell, Lesley; Herzog, Herbert; Baldock, Paul A.			Prader-Willi Critical Region, a Non-Translated, Imprinted Central Regulator of Bone Mass: Possible Role in Skeletal Abnormalities in Prader-Willi Syndrome	PLOS ONE			English	Article							SMALL NUCLEOLAR RNAS; MINERAL DENSITY; TRANSLOCATION BREAKPOINT; BODY-COMPOSITION; SNORNA SNORD116; NEUROPEPTIDE-Y; MICE; DEFICIENCY; PATHWAYS; RECEPTOR	Prader-Willi Syndrome (PWS), a maternally imprinted disorder and leading cause of obesity, is characterised by insatiable appetite, poor muscle development, cognitive impairment, endocrine disturbance, short stature and osteoporosis. A number of causative loci have been located within the imprinted Prader-Willi Critical Region (PWCR), including a set of small non-translated nucleolar RNA's (snoRNA). Recently, micro-deletions in humans identified the snoRNA Snord116 as a critical contributor to the development of PWS exhibiting many of the classical symptoms of PWS. Here we show that loss of the PWCR which includes Snord116 in mice leads to a reduced bone mass phenotype, similar to that observed in humans. Consistent with reduced stature in PWS, PWCR KO mice showed delayed skeletal development, with shorter femurs and vertebrae, reduced bone size and mass in both sexes. The reduction in bone mass in PWCR KO mice was associated with deficiencies in cortical bone volume and cortical mineral apposition rate, with no change in cancellous bone. Importantly, while the length difference was corrected in aged mice, consistent with continued growth in rodents, reduced cortical bone formation was still evident, indicating continued osteoblastic suppression by loss of PWCR expression in skeletally mature mice. Interestingly, deletion of this region included deletion of the exclusively brain expressed Snord116 cluster and resulted in an upregulation in expression of both NPY and POMC mRNA in the arcuate nucleus. Importantly, the selective deletion of the PWCR only in NPY expressing neurons replicated the bone phenotype of PWCR KO mice. Taken together, PWCR deletion in mice, and specifically in NPY neurons, recapitulates the short stature and low BMD and aspects of the hormonal imbalance of PWS individuals. Moreover, it demonstrates for the first time, that a region encoding non-translated RNAs, expressed solely within the brain, can regulate bone mass in health and disease.	[Khor, Ee-Cheng; Fanshawe, Bruce; Kulkarni, Rishikesh N.; Enriquez, Ronaldo F.; Wee, Natalie K.; Croucher, Peter I.; Baldock, Paul A.] Garvan Inst Med Res, Bone & Mineral Res Div, Sydney, NSW, Australia; [Qi, Yue; Purtell, Louise; Lee, Nicola J.; Herzog, Herbert] Garvan Inst Med Res, Neurosci Div, Sydney, NSW, Australia; [Campbell, Lesley] Garvan Inst Med Res, Diabet & Obes Res Div, Sydney, NSW, Australia; [Lee, Nicola J.; Croucher, Peter I.; Campbell, Lesley; Herzog, Herbert; Baldock, Paul A.] Univ NSW, Sch Med Sci, Sydney, NSW, Australia; [Zolotukhin, Sergei] Univ Florida, Coll Med, Dept Pediat, Ctr Smell & Taste, Gainesville, FL USA	Garvan Institute of Medical Research; Garvan Institute of Medical Research; Garvan Institute of Medical Research; University of New South Wales Sydney; State University System of Florida; University of Florida	Herzog, H (corresponding author), Garvan Inst Med Res, Neurosci Div, Sydney, NSW, Australia.; Herzog, H (corresponding author), Univ NSW, Sch Med Sci, Sydney, NSW, Australia.	h.herzog@garvan.org.au	/B-2038-2013; Baldock, Paul/B-3840-2012; Wee, Natalie/AAF-2134-2019	/0000-0001-7766-6095; Croucher, Peter/0000-0002-7102-2413; , Herbert/0000-0002-1713-1029; Wee, Natalie/0000-0002-7314-2646	National Health and Medical Research Council (NHMRC) of Australia [1028882]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the National Health and Medical Research Council (NHMRC) of Australia project grant #1028882 by providing funds for reagents.	Allison SJ, 2009, J BONE MINER RES, V24, P294, DOI [10.1359/jbmr.081013, 10.1359/JBMR.081013]; Baldock PA, 2005, J BONE MINER RES, V20, P1851, DOI 10.1359/JBMR.050523; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI14588; Baldock PA, 2006, J BONE MINER RES, V21, P1600, DOI 10.1359/JBMR.060705; Baldock PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008415; Bervini S, 2013, FRONT NEUROENDOCRIN, V34, P107, DOI 10.1016/j.yfrne.2013.01.002; Burman P, 2001, ENDOCR REV, V22, P787, DOI 10.1210/er.22.6.787; Butler MG, 2001, AM J MED GENET, V103, P216, DOI 10.1002/ajmg.1556; Cassidy SB, 1997, J MED GENET, V34, P917, DOI 10.1136/jmg.34.11.917; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Chen C, 2007, CLIN PEDIATR, V46, P580, DOI 10.1177/0009922807299314; Deal CL, 2013, J CLIN ENDOCR METAB, V98, pE1072, DOI 10.1210/jc.2012-3888; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Edouard T, 2012, J CLIN ENDOCR METAB, V97, pE275, DOI 10.1210/jc.2011-2406; Gallagher RC, 2002, AM J HUM GENET, V71, P669, DOI 10.1086/342408; Hogler W, 2010, CLIN ENDOCRINOL, V72, P281, DOI 10.1111/j.1365-2265.2009.03686.x; Hoybye C, 2002, J CLIN ENDOCR METAB, V87, P3590, DOI 10.1210/jc.87.8.3590; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Lee NJ, 2011, BONE, V48, P461, DOI 10.1016/j.bone.2010.10.174; Lee NJ, 2010, J BONE MINER RES, V25, P1736, DOI 10.1002/jbmr.61; Mohan S, 2003, ENDOCRINOLOGY, V144, P929, DOI 10.1210/en.2002-220948; Peters J, 2008, NAT GENET, V40, P688, DOI 10.1038/ng0608-688; Qi Y, 2015, SCI REPORTS IN PRESS; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Schule B, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-18; Schulze A, 1996, NAT GENET, V12, P452, DOI 10.1038/ng0496-452; Shi YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011361; Sims NA, 2000, J CLIN INVEST, V106, P1095, DOI 10.1172/JCI10753; SONTAG W, 1986, BONE, V7, P63, DOI 10.1016/8756-3282(86)90153-5; Swaab DF, 1997, ACTA PAEDIATR, V86, P50; van Mil EGAH, 2001, J PEDIATR-US, V139, P708, DOI 10.1067/mpd.2001.118399; van Wijnen AJ, 2013, CURR OSTEOPOROS REP, V11, P72, DOI 10.1007/s11914-013-0143-6; van Wijngaarden RFAD, 2009, J CLIN ENDOCR METAB, V94, P3763, DOI 10.1210/jc.2009-0270; Vestergaard P, 2004, J PEDIATR-US, V144, P614, DOI 10.1016/j.jpeds.2004.01.056; Wirth J, 2001, HUM MOL GENET, V10, P201, DOI 10.1093/hmg/10.3.201; Zhang Q, 2012, INT J DEV NEUROSCI, V30, P479, DOI 10.1016/j.ijdevneu.2012.05.005; Zieba J, 2015, NEUROPEPTIDES, V53, P71, DOI 10.1016/j.npep.2015.06.009	37	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148155	10.1371/journal.pone.0148155	http://dx.doi.org/10.1371/journal.pone.0148155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824232	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600106
J	Maissen-Villiger, CA; Schweighauser, A; van Dorland, HA; Morel, C; Bruckmaier, RM; Zurbriggen, A; Francey, T				Maissen-Villiger, Carla A.; Schweighauser, Ariane; van Dorland, H. Anette; Morel, Claudine; Bruckmaier, Rupert M.; Zurbriggen, Andreas; Francey, Thierry			Expression Profile of Cytokines and Enzymes mRNA in Blood Leukocytes of Dogs with Leptospirosis and Its Associated Pulmonary Hemorrhage Syndrome	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GROWTH-FACTOR-BETA; CHRONIC ENTEROPATHIES; GENE-EXPRESSION; DISEASE; INTERROGANS; HAMSTERS; FIBROSIS; SEPSIS; KIDNEY	Background Dogs with leptospirosis show similar organ manifestations and disease course as human patients, including acute kidney injury and pulmonary hemorrhage, making this naturally-occurring infection a good animalmodel for human leptospirosis. Expression patterns of cytokines and enzymes have been correlated with disease manifestations and clinical outcome in humans and animals. The aim of this study was to describe mRNA expression of pro- and anti-inflammatory mediators in canine leptospirosis and to compare it with other renal diseases to identify patterns characterizing the disease and especially its pulmonary form. Methodology and Principal Findings The mRNA abundance of cytokines (IL-1 alpha, IL-1 beta, IL-8, IL-10, TNF-alpha, TGF-beta) and enzymes (5-LO, iNOS) was measured prospectively in blood leukocytes from 34 dogs with severe leptospirosis and acute kidney injury, including 22 dogs with leptospirosis-associated pulmonary hemorrhages. Dogs with leptospirosis were compared to 14 dogs with acute kidney injury of other origin than leptospirosis, 8 dogs with chronic kidney disease, and 10 healthy control dogs. Canine leptospirosis was characterized by high 5-LO and low TNF-alpha expression compared to other causes of acute kidney injury, although the decreased TNF-alpha expression was also seen in chronic kidney disease. Leptospirosis-associated pulmonary hemorrhage was not characterized by a specific pattern, with only mild changes noted, including increased IL-10 and decreased 5-LO expression on some days in affected dogs. Fatal outcome from pulmonary hemorrhages was associated with low TNF-alpha, high IL-1 beta, and high iNOS expression, a pattern possibly expressed also in dogs with other forms of acute kidney injury. Conclusion The patterns of cytokine and enzyme expression observed in the present study indicate a complex pro- and anti-inflammatory response to the infection with leptospires. The recognition of these signatures may be of diagnostic and prognostic relevance for affected individuals and they may indicate options for newer therapies targeting the identified pathways.	[Maissen-Villiger, Carla A.; Schweighauser, Ariane; Francey, Thierry] Univ Bern, Dept Clin Vet Med, Div Small Anim Internal Med, Vetsuisse Fac, Bern, Switzerland; [van Dorland, H. Anette; Morel, Claudine; Bruckmaier, Rupert M.] Univ Bern, Dept Clin Res & Vet Publ Hlth, Div Vet Physiol, Vetsuisse Fac, Bern, Switzerland; [Zurbriggen, Andreas] Univ Bern, Dept Clin Res & Vet Publ Hlth, Div Expt Clin Res, Vetsuisse Fac, Bern, Switzerland	University of Bern; University of Bern; University of Bern	Francey, T (corresponding author), Univ Bern, Dept Clin Vet Med, Div Small Anim Internal Med, Vetsuisse Fac, Bern, Switzerland.	thierry.francey@vetsuisse.unibe.ch	Francey, Thierry/C-2106-2014	Francey, Thierry/0000-0002-6693-5365	Robmar Foundation for Human-Animal Bond Unrestricted grant	Robmar Foundation for Human-Animal Bond Unrestricted grant	Funded by Robmar Foundation for Human-Animal Bond (www.fondation-robmar.ch) Unrestricted grant for research in canine leptospirosis and renal replacement therapies in small animals (TF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ashy R, 2006, CYTOKINE, V36, P1, DOI 10.1016/j.cyto.2006.10.003; Albrecht EWJA, 2002, AM J TRANSPLANT, V2, P448, DOI 10.1034/j.1600-6143.2002.20509.x; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; [Anonymous], 2003, HUM LEPT GUID DIAGN; Baumann D, 2001, VET RADIOL ULTRASOUN, V42, P305, DOI 10.1111/j.1740-8261.2001.tb00944.x; Baylis C, 2008, AM J PHYSIOL-RENAL, V294, pF1, DOI 10.1152/ajprenal.00424.2007; Beineke A, 2008, VIRAL IMMUNOL, V21, P401, DOI 10.1089/vim.2008.0043; Berg DT, 2007, J BIOL CHEM, V282, P36837, DOI 10.1074/jbc.M706909200; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; CAVAILLON JM, 1992, CIRC SHOCK, V38, P145; Chierakul W, 2004, CLIN IMMUNOL, V113, P140, DOI 10.1016/j.clim.2004.08.006; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cowgill LD, 2011, NEPHROLOGY AND UROLOGY OF SMALL ANIMALS, P472; d'Andon MF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002664; De Brito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071743; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Dolhnikoff M, 2007, BRAZ J INFECT DIS, V11, P142, DOI 10.1590/S1413-86702007000100029; Dumusc SD, 2014, J VET INTERN MED, V28, P1684, DOI 10.1111/jvim.12463; Fraune CK, 2013, JAVMA-J AM VET MED A, V242, P1373, DOI 10.2460/javma.242.10.1373; Funk CD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002040; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Haeggstrom JZ, 2010, BIOCHEM BIOPH RES CO, V396, P135, DOI 10.1016/j.bbrc.2010.03.140; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Klopfleisch R., 2010, VET MED INT, DOI DOI 10.4061/2010/928541; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Kohn B, 2010, J VET INTERN MED, V24, P1277, DOI 10.1111/j.1939-1676.2010.0585.x; Kyriakidis I, 2011, CYTOKINE, V54, P117, DOI 10.1016/j.cyto.2011.01.014; Lowanitchapat A, 2010, COMP IMMUNOL MICROB, V33, P423, DOI 10.1016/j.cimid.2009.05.001; Maciel EAP, 2006, ACTA TROP, V100, P256, DOI 10.1016/j.actatropica.2006.11.006; Major A, 2014, INT J ENV RES PUB HE, V11, P7242, DOI 10.3390/ijerph110707242; Marinho M, 2009, AM J TROP MED HYG, V80, P832, DOI 10.4269/ajtmh.2009.80.832; Martinez-Clemente M, 2011, CURR OPIN CLIN NUTR, V14, P347, DOI 10.1097/MCO.0b013e32834777fa; Mathis SP, 2010, J IMMUNOL, V185, P3049, DOI 10.4049/jimmunol.1001031; Matsui M, 2011, INFECT IMMUN, V79, P4480, DOI 10.1128/IAI.05727-11; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Medeiros FD, 2010, ACTA TROP, V115, P155, DOI 10.1016/j.actatropica.2010.02.016; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Monteiro APT, 2014, AM J RESP CELL MOL, V50, P87, DOI 10.1165/rcmb.2012-0525OC; Noris M, 1999, P ASSOC AM PHYSICIAN, V111, P602, DOI 10.1046/j.1525-1381.1999.99256.x; Philippart Francois, 2007, Curr Infect Dis Rep, V9, P358, DOI 10.1007/s11908-007-0056-6; Pretre G, 2011, MICROB PATHOGENESIS, V51, P203, DOI 10.1016/j.micpath.2011.03.011; Rau S, 2007, VET CLIN PATH, V36, P253, DOI 10.1111/j.1939-165X.2007.tb00220.x; Reis EAG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002457; Rizvi M, 2011, ANN TROP MED PARASIT, V105, P499, DOI 10.1179/1364859411Y.0000000041; Sauter SN, 2005, DOMEST ANIM ENDOCRIN, V29, P605, DOI 10.1016/j.domaniend.2005.04.006; Schuller S, 2015, J SMALL ANIM PRACT, V56, P159, DOI 10.1111/jsap.12328; Spichiger AC, 2005, J VET MED A, V52, P491, DOI 10.1111/j.1439-0442.2005.00770.x; Spichler AS, 2008, AM J TROP MED HYG, V79, P911, DOI 10.4269/ajtmh.2008.79.911; Stylianou E, 1998, INT J BIOCHEM CELL B, V30, P1075, DOI 10.1016/S1357-2725(98)00081-8; Sykes JE, 2011, J VET INTERN MED, V25, P1, DOI 10.1111/j.1939-1676.2010.0654.x; Tajiki, 1997, Braz J Infect Dis, V1, P138; Tajiki MH, 1996, CLIN INFECT DIS, V23, P1177, DOI 10.1093/clinids/23.5.1177; van de Maele I, 2008, VET REC, V163, P409, DOI 10.1136/vr.163.14.409; Vaziri ND, 2001, AM J KIDNEY DIS, V38, pS74, DOI 10.1053/ajkd.2001.27409; Vernel-Pauillac F, 2006, INFECT IMMUN, V74, P4172, DOI 10.1128/IAI.00447-06; Vernel-Pauillac F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000582; Wada T, 2007, KIDNEY INT, V72, P269, DOI 10.1038/sj.ki.5002325; Wagenaar JFP, 2009, J INFECTION, V58, P425, DOI 10.1016/j.jinf.2009.04.004; Wagenaar JFP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000453; Zager RA, 2009, AM J PHYSIOL-RENAL, V297, pF961, DOI 10.1152/ajprenal.00381.2009	61	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148029	10.1371/journal.pone.0148029	http://dx.doi.org/10.1371/journal.pone.0148029			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824356	gold, Green Submitted, Green Published			2022-12-26	WOS:000369528600091
J	Sujitha, SP; Kumar, DT; Doss, CGP; Aavula, K; Ramesh, R; Lakshmanan, S; Gunasekaran, S; Anilkumar, G				Sujitha, S. P.; Kumar, D. Thirumal; Doss, C. George Priya; Aavula, K.; Ramesh, R.; Lakshmanan, S.; Gunasekaran, S.; Anilkumar, G.			DNA Repair Gene (XRCC1) Polymorphism (Arg399Gln) Associated with Schizophrenia in South Indian Population: A Genotypic and Molecular Dynamics Study	PLOS ONE			English	Article							NICOTINE DEPENDENCE; TOBACCO USE; CANCER; SUSCEPTIBILITY; SMOKING; MUTATIONS; APOPTOSIS; EXPRESSION; DISORDERS; PSYCHOSIS	This paper depicts the first report from an Indian population on the association between the variant Arg399Gln of XRCC1 locus in the DNA repair system and schizophrenia, the debilitating disease that affects 1% of the world population. Genotypic analysis of a total of 523 subjects (260 patients and 263 controls) revealed an overwhelming presence of Gln399Gln in the case subjects against the controls (P < 0.0068), indicating significant level of association of this nsSNP with schizophrenia; the Gln399 allele frequency was also perceptibly more in cases than in controls (p < 0.003; OR = 1.448). The results of the genotypic studies were further validated using pathogenicity and stability prediction analysis employing computational tools [I-Mutant Suite, iStable, PolyPhen2, SNAP, and PROVEAN], with a view toassess the magnitude of deleteriousness of the mutation. The pathogenicity analysis reveals that the nsSNP could be deleterious inasmuch as it could affect the functionality of the gene, and interfere with protein function. Molecular dynamics simulation of 60ns was performed using GROMACS to analyse structural change due to a mutation (Arg399Gln) that was never examined before. RMSD, RMSF, hydrogen bonds, radius of gyration and SASA analysis showedthe existence of asignificant difference between the native and the mutant protein. The present study gives astrong indication that the XRCC1 locus deserves serious attention, as it could be a potential candidatecontributing to the etio-pathogenesis of the disease.	[Sujitha, S. P.; Kumar, D. Thirumal; Doss, C. George Priya; Aavula, K.; Ramesh, R.; Gunasekaran, S.; Anilkumar, G.] VIT Univ, Sch Biosci & Technol, Med Biotechnol Div, Vellore 632014, Tamil Nadu, India; [Lakshmanan, S.] Govt Vellore Med Coll, Dept Psychiat, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Anilkumar, G (corresponding author), VIT Univ, Sch Biosci & Technol, Med Biotechnol Div, Vellore 632014, Tamil Nadu, India.	gopianilkumar@gmail.com	Alizadeh/AAK-1398-2021; C, George/ABE-4676-2021; Kumar, Thirumal/G-2276-2017; Aavula, Kumar/GQH-9683-2022	Kumar, Thirumal/0000-0002-5545-606X; Aavula, Kumar/0000-0002-7884-6730; gopinathan, anilkumar/0000-0001-9486-9118; C, George Priya Doss/0000-0002-5971-8290	Department of Biotechnology (DBT), Government of India [BT/ PR14216/MED/30/404/2010]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	The financial support from the Department of Biotechnology (DBT), Government of India, [BT/ PR14216/MED/30/404/2010] is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alderson HL, 2015, LANCET PSYCHIAT, V2, P672, DOI 10.1016/S2215-0366(15)00239-4; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bardia A, 2012, INFLAMM RES, V61, P359, DOI 10.1007/s00011-011-0418-2; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Catts VS, 2008, ACTA PSYCHIAT SCAND, V117, P323, DOI 10.1111/j.1600-0447.2008.01163.x; Catts VS, 2012, WORLD J BIOL PSYCHIA, V13, P114, DOI 10.3109/15622975.2011.565073; Catts VS, 2000, SCHIZOPHR RES, V41, P405, DOI 10.1016/S0920-9964(99)00077-8; Catts VS, 2006, SCHIZOPHR RES, V84, P20, DOI 10.1016/j.schres.2006.03.016; Chacko P, 2005, BREAST CANCER RES TR, V89, P15, DOI 10.1007/s10549-004-1004-x; Chen CW, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S5; Chen JY, 2012, NEUROIMAGE, V61, P866, DOI 10.1016/j.neuroimage.2012.03.022; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Clements PM, 2004, DNA REPAIR, V3, P1493, DOI 10.1016/j.dnarep.2004.06.017; Cohen ME, 2002, SCHIZOPHR RES, V57, P139, DOI 10.1016/S0920-9964(01)00308-5; Contreras J, 2010, J NEUROGENET, V24, P83, DOI 10.3109/01677060903583994; de Leon J, 2005, SCHIZOPHR RES, V76, P135, DOI 10.1016/j.schres.2005.02.010; Derakhshandeh S, 2009, PSYCHIAT RES, V169, P186, DOI 10.1016/j.psychres.2009.03.022; Divine KK, 2001, MUTAT RES-DNA REPAIR, V461, P273, DOI 10.1016/S0921-8777(00)00059-8; Duell EJ, 2001, CANCER EPIDEM BIOMAR, V10, P217; El-Domyati MM, 2009, FERTIL STERIL, V91, P2221, DOI 10.1016/j.fertnstert.2008.03.027; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; Grinshpoon A, 2005, SCHIZOPHR RES, V73, P333, DOI 10.1016/j.schres.2004.06.016; Gurillo P, 2015, LANCET PSYCHIAT, V2, P718, DOI 10.1016/S2215-0366(15)00152-2; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hodgson ME, 2010, CANCER EPIDEM BIOMAR, V19, P3055, DOI 10.1158/1055-9965.EPI-10-0877; Jarskog LF, 2005, PROG NEURO-PSYCHOPH, V29, P846, DOI 10.1016/j.pnpbp.2005.03.010; Jorgensen TJ, 2009, CANCER EPIDEM BIOMAR, V18, P346, DOI 10.1158/1055-9965.EPI-08-0659; Kaplan W, 2002, BRIEF BIOINFORM, V2, P195; Kelly C., 2000, ADV PSYCHIAT TREATME, V6, P327, DOI [10.1192/apt.6.5.37, DOI 10.1192/apt.6.5.327, DOI 10.1192/APT.6.5.327]; Korytina GF, MOLBIOL MOSK, V48, P939; LAMERDIN JE, 1995, GENOMICS, V25, P547, DOI 10.1016/0888-7543(95)80056-R; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Li WQ, 2013, PROG NEURO-PSYCHOPH, V44, P290, DOI 10.1016/j.pnpbp.2013.04.003; Marintchev A, 1999, NAT STRUCT BIOL, V6, P884; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Melkersson K, 2009, NEUROENDOCRINOL LETT, V30, P343; Molnar S, 2010, COLLEGIUM ANTROPOL, V34, P1427; Myles N, 2012, J CLIN PSYCHIAT, V73, P468, DOI 10.4088/JCP.11r07222; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Qian Y, 2010, J NEUROL SCI, V295, P62, DOI 10.1016/j.jns.2010.05.002; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Saadat I, 2012, ARCH GYNECOL OBSTET, V286, P1459, DOI 10.1007/s00404-012-2471-7; Saadat M, 2008, PSYCHIAT RES, V157, P241, DOI 10.1016/j.psychres.2007.07.014; Saadat M, 2015, J MED BIOCHEM, V34, P409, DOI 10.2478/jomb-2014-0051; Sagud M, 2009, PSYCHIAT DANUB, V21, P371; Salin-Pascual RJ, 2003, REV INVEST CLIN, V55, P677; Sambrook J., 2001, MOL CLONING LAB MANU; Schneider J, 2008, EXPERT REV MOL DIAGN, V8, P761, DOI 10.1586/14737159.8.6.761; Shen MR, 1998, CANCER RES, V58, P604; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sujitha SP, 2014, INDIAN J MED RES, V140, P736; Tebbs RS, 2003, DNA REPAIR, V2, P1405, DOI 10.1016/j.dnarep.2003.08.007; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Vijayan NN, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-34; Vijayan NN, 2009, J HUM GENET, V54, P538, DOI 10.1038/jhg.2009.76; Volkow ND, 2009, SCHIZOPHRENIA BULL, V35, P469, DOI 10.1093/schbul/sbp016; Weng HC, 2009, MUTAT RES-GEN TOX EN, V679, P59, DOI 10.1016/j.mrgentox.2009.07.005; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Yao J, 2015, AM J MED GENET B, V168, P1, DOI 10.1002/ajmg.b.32281; YOO HY, 1992, BIOCHEM BIOPH RES CO, V186, P900, DOI 10.1016/0006-291X(92)90831-5; Zhang XD, 1998, EMBO J, V17, P6404, DOI 10.1093/emboj/17.21.6404; ZHOU ZQ, 1995, MUTAT RES LETT, V348, P111, DOI 10.1016/0165-7992(95)00053-4	67	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147348	10.1371/journal.pone.0147348	http://dx.doi.org/10.1371/journal.pone.0147348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824244	gold, Green Submitted, Green Published			2022-12-26	WOS:000369528600026
J	Gomez-Aristizabal, A; Kim, KP; Viswanathan, S				Gomez-Aristizabal, Alejandro; Kim, Kyung-Phil; Viswanathan, Sowmya			A Systematic Study of the Effect of Different Molecular Weights of Hyaluronic Acid on Mesenchymal Stromal Cell-Mediated Immunomodulation	PLOS ONE			English	Article							REGULATORY T-CELLS; STEM-CELLS; BONE-MARROW; KNEE OSTEOARTHRITIS; CHONDROGENIC DIFFERENTIATION; INTRAARTICULAR INJECTION; MACROPHAGES; ACTIVATION; EXPRESSION; ARTHRITIS	Introduction Osteoarthritis (OA) is associated with chronic inflammation, and mesenchymal stromal cells (MSCs) have been shown to provide pain relief and reparative effects in clinical investigations. MSCs are often delivered with hyaluronic acid (HA), although the combined mechanism of action is not fully understood; we thus investigated the immunomodulatory effects of combining MSCs with different molecular weights (MW) of HA. Methods HAs with MWs of 1.6 MDa (hHA), 150 kDa or 7.5 kDa, were added to MSCs alone or MSC-immune cell co-cultures. Gene expression analyses, flow cytometry and cytokine measurements were assessed to determine the effect of HAs on the MSC interactions with immune cells. Results MSCs in the presence of HAs, in both normal and lymphocyte-conditioned medium, showed negligible changes in gene expression. While addition of hHA resulted in increased proliferation of activated lymphocytes, both in the presence and absence of MSCs, the overall combined effect was a more regulated, homeostatic one; this was supported by higher ratios of secreted IL10/IFN. and IL10/IL2, in lymphocyte cultures, than with lower MW HAs or no HA, both in the presence and absence of MSCs. In addition, examination of monocyte-derived macrophages showed an increased M2 macrophage frequency (CD14 +CD163+CD206+) in the presence of hHA, both with and without MSCs. Conclusions hHA produces a less pro-inflammatory environment than lower MW HAs. Moreover, combining hHA with MSCs has an additive effect on the MSC-mediated immunomodulation, suggestive of a more potent combination treatment modality for OA.	[Gomez-Aristizabal, Alejandro; Viswanathan, Sowmya] Toronto Western Hosp, Arthritis Program, Toronto, ON M5T 2S8, Canada; [Kim, Kyung-Phil; Viswanathan, Sowmya] Princess Margaret Canc Ctr, Cell Therapy Program, Toronto, ON, Canada; [Viswanathan, Sowmya] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Viswanathan, S (corresponding author), Toronto Western Hosp, Arthritis Program, Toronto, ON M5T 2S8, Canada.; Viswanathan, S (corresponding author), Princess Margaret Canc Ctr, Cell Therapy Program, Toronto, ON, Canada.; Viswanathan, S (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	sowmya.viswanathan@uhnresearch.ca	Viswanathan, Sowmya/N-1983-2019; Viswanathan, Sowmya/GRO-4533-2022	Viswanathan, Sowmya/0000-0002-4552-0179; Gomez-Aristizabal, Alejandro/0000-0003-0853-881X	Toronto General and Western Hospital Foundation	Toronto General and Western Hospital Foundation	This research was funded by the Toronto General and Western Hospital Foundation.; This research was funded by the Toronto General and Western Hospital Foundation. The authors wish to thank Dr. Xing-Hua Wang for providing us MSCs. We also thank Dr. Armand Keating for sharing his laboratory, Dr. Dorothy Rego for her assistance with some of the experiments and Melania Pintilie for her advice on statistical analysis.	Abumaree MH, 2013, STEM CELL REV REP, V9, P620, DOI 10.1007/s12015-013-9455-2; Adutler-Lieber S, 2013, J CARDIOVASC PHARM T, V18, P78, DOI 10.1177/1074248412453875; Al Faqeh H, 2012, EXP GERONTOL, V47, P458, DOI 10.1016/j.exger.2012.03.018; Ashford Susan, 2014, Nurse Pract, V39, P1, DOI 10.1097/01.NPR.0000445886.71205.c4; Baeva LF, 2014, J BIOMED MATER RES A, V102, P305, DOI 10.1002/jbm.a.34704; Band PA, 2015, OSTEOARTHR CARTILAGE, V23, P70, DOI 10.1016/j.joca.2014.09.017; Berenbaum F, 2012, ANN RHEUM DIS, V71, P1454, DOI 10.1136/annrheumdis-2011-200972; Blom AB, 2007, ARTHRITIS RHEUM, V56, P147, DOI 10.1002/art.22337; Bollyky PL, 2009, J IMMUNOL, V183, P2232, DOI 10.4049/jimmunol.0900191; Bottero Virginie, 2003, Mol Diagn, V7, P187, DOI 10.2165/00066982-200307030-00008; BROWN TJ, 1991, EXP PHYSIOL, V76, P125, DOI 10.1113/expphysiol.1991.sp003474; Campo GM, 2010, BIOCHEM PHARMACOL, V80, P480, DOI 10.1016/j.bcp.2010.04.024; Campo GM, 2010, INNATE IMMUN-LONDON, V16, P48, DOI 10.1177/1753425909340419; Chinnadurai R, 2014, J IMMUNOL, V192, P1491, DOI 10.4049/jimmunol.1301828; Colen S, 2012, BIODRUGS, V26, P257, DOI 10.2165/11632580-000000000-00000; DARZYNKIEWICZ Z, 1971, EXP CELL RES, V66, P113, DOI 10.1016/S0014-4827(71)80018-6; Dayan V, 2012, INTERACT CARDIOV TH, V14, P516, DOI 10.1093/icvts/ivs048; de Lange-Brokaar BJE, 2012, OSTEOARTHR CARTILAGE, V20, P1484, DOI 10.1016/j.joca.2012.08.027; Del Papa B, 2013, EUR J IMMUNOL, V43, P182, DOI 10.1002/eji.201242643; Duchman KR, 2014, J BONE JOINT SURG AM, V96A, P1387, DOI 10.2106/JBJS.M.01048; Dvorakova J, 2008, NEUROENDOCRINOL LETT, V29, P685; Edsman K, 2011, CARTILAGE, V2, P384, DOI 10.1177/1947603511400184; Essendoubi M, 2016, SKIN RES TECHNOL, V22, P55, DOI 10.1111/srt.12228; Fahy N, 2014, OSTEOARTHR CARTILAGE, V22, P1167, DOI 10.1016/j.joca.2014.05.021; FARAHAT MN, 1993, ANN RHEUM DIS, V52, P870, DOI 10.1136/ard.52.12.870; Fellows I, 2012, J STAT SOFTW, V49, P1; Foger N, 2000, EUR J IMMUNOL, V30, P2888; Fuchs K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.364; Gomez-Aristizabal A, 2014, RECENT PAT REGEN MED, V4, P1, DOI [10.2174/2210296504666140307010938, DOI 10.2174/2210296504666140307010938]; Hagmann S, 2013, CLIN EXP IMMUNOL, V173, P454, DOI 10.1111/cei.12122; Karatay S, 2004, ANN CLIN LAB SCI, V34, P330; Larsen NE, 2012, J BIOMED MATER RES B, V100B, P457, DOI 10.1002/jbm.b.31971; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maheu E, 2011, CLIN EXP RHEUMATOL, V29, P527; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mokbel AN, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-259; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Ottaviani RA, 2007, J BONE JOINT SURG AM, V89A, P148, DOI 10.2106/JBJS.E.01135; Petrella RJ, 2011, RHEUMATOL REP, V3, P16, DOI 10.4081/rr.2011.e4; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Sall I, 2007, POLYM DEGRAD STABIL, V92, P915, DOI 10.1016/j.polymdegradstab.2006.11.020; Sato M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3735; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shen PC, 2011, OSTEOARTHR CARTILAGE, V19, P728, DOI 10.1016/j.joca.2011.02.014; Shiedlin A, 2004, BIOMACROMOLECULES, V5, P2122, DOI 10.1021/bm0498427; Singh A, 2014, BONE JOINT RES, V3, P32, DOI 10.1302/2046-3758.32.2000187; Suhaeb AM, 2012, INDIAN J EXP BIOL, V50, P383; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Vangsness CT, 2011, BULL HOSP JT DIS, V69, P122; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Vincent Heather K, 2013, Open Orthop J, V7, P378, DOI 10.2174/1874325001307010378; Wong KL, 2013, ARTHROSCOPY, V29, P2020, DOI 10.1016/j.arthro.2013.09.074; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209	55	22	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147868	10.1371/journal.pone.0147868	http://dx.doi.org/10.1371/journal.pone.0147868			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820314	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528400051
J	Han, ZZ; Wan, JH; Deng, LM; Liu, KW				Han, Zhongzhi; Wan, Jianhua; Deng, Limiao; Liu, Kangwei			Oil Adulteration Identification by Hyperspectral Imaging Using QHM and ICA	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; SUPPORT VECTOR MACHINE; PREDICTION; SPECTRA	To investigate the feasibility of identification of qualified and adulterated oil product using hyperspectral imaging(HIS) technique, a novel feature set based on quantized histogram matrix (QHM) and feature selection method using improved kernel independent component analysis (iKICA) is proposed for HSI. We use UV and Halogen excitations in this study. Region of interest(ROI) of hyperspectral images of 256 oil samples from four varieties are obtained within the spectral region of 400-720nm. Radiation indexes extracted from each ROI are used as feature vectors. These indexes are individual band radiation index (RI), difference of consecutive spectral band radiation index (DRI), ratio of consecutive spectral band radiation index (RRI) and normalized DRI (NDRI). Another set of features called quantized histogram matrix (QHM) are extracted by applying quantization on the image histogram from these features. Based on these feature sets, improved kernel independent component analysis (iKICA) is used to select significant features. For comparison, algorithms such as plus L reduce R (plusLrR), Fisher, multidimensional scaling (MDS), independent component analysis (ICA), and principle component analysis (PCA) are also used to select the most significant wavelengths or features. Support vector machine (SVM) is used as the classifier. Experimental results show that the proposed methods are able to obtain robust and better classification performance with fewer number of spectral bands and simplify the design of computer vision systems.	[Han, Zhongzhi; Deng, Limiao] Qingdao Agr Univ, Informat Coll, Qingdao, Peoples R China; [Han, Zhongzhi; Wan, Jianhua; Liu, Kangwei] China Univ Petr Huadong, Sch Geosci, Qingdao, Peoples R China	Qingdao Agricultural University; China University of Petroleum	Wan, JH (corresponding author), China Univ Petr Huadong, Sch Geosci, Qingdao, Peoples R China.	wjh66310@163.com.cn	zhongzhi, Han/M-6564-2015; Deng, Limiao/AAT-1194-2020		National Scientific Research Fund of China [31201133]	National Scientific Research Fund of China	This research was made possible by a grant from the National Scientific Research Fund of China, project 31201133.	Atas M, 2012, COMPUT ELECTRON AGR, V87, P129, DOI 10.1016/j.compag.2012.06.001; Bach FR, 2003, J MACH LEARN RES, V3, P1, DOI 10.1162/153244303768966085; Berry M, 1997, DATA MINING TECHNIQU; Bonaccorsi IL, 1999, J AGR FOOD CHEM, V47, P4237, DOI 10.1021/jf990417s; Chang C.C., 2011, LIBSVM LIB SUPPORT V; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Geranian H, 2015, APPL DISCRIMINANT AN, P1; Hahn S, 2006, APPL OPTICS, V45, P8374, DOI 10.1364/AO.45.008374; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Hyvarinen A., 2001, INDEPENDENT COMPONEN, DOI [10.1002/0471221317, DOI 10.1002/0471221317]; Jebur MN, 2015, IEEE J-STARS, V8, P674, DOI 10.1109/JSTARS.2014.2341276; Kessler JD, 2011, SCIENCE, V331, P312, DOI 10.1126/science.1199697; Kim M, 2000, COMPUT CHEM ENG, V24, P513, DOI 10.1016/S0098-1354(00)00522-6; Wang GQ, 2007, ANAL CHIM ACTA, V594, P101, DOI 10.1016/j.aca.2007.05.004; [王晶 Wang Jing], 2013, [海洋通报, Marine Science Bulletin], V32, P452; Wassenaar HJ, 2005, J MECH DESIGN, V127, P514, DOI 10.1115/1.1897408; Xu XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096441; Yin X, 2012, THESIS OCEAN U CHINA, P5; Zheng BJ, 2015, INT J APPL EARTH OBS, V34, P103, DOI 10.1016/j.jag.2014.07.002	19	8	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0146547	10.1371/journal.pone.0146547	http://dx.doi.org/10.1371/journal.pone.0146547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820311	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528400007
J	Kotlinski, M; Rutowicz, K; Knizewski, L; Palusinski, A; Oledzki, J; Fogtman, A; Rubel, T; Koblowska, M; Dadlez, M; Ginalski, K; Jerzmanowski, A				Kotlinski, Maciej; Rutowicz, Kinga; Knizewski, Lukasz; Palusinski, Antoni; Oledzki, Jacek; Fogtman, Anna; Rubel, Tymon; Koblowska, Marta; Dadlez, Michal; Ginalski, Krzysztof; Jerzmanowski, Andrzej			Histone H1 Variants in Arabidopsis Are Subject to Numerous Post-Translational Modifications, Both Conserved and Previously Unknown in Histones, Suggesting Complex Functions of H1 in Plants	PLOS ONE			English	Article							LINKER HISTONE; GLOBULAR DOMAIN; LYSINE PROPIONYLATION; BINDING; IDENTIFICATION; MASS; PROTEINS; GENE; PYRROLYSINE; METHYLATION	Linker histones (H1s) are conserved and ubiquitous structural components of eukaryotic chromatin. Multiple non-allelic variants of H1, which differ in their DNA/nucleosome binding properties, co-exist in animal and plant cells and have been implicated in the control of genetic programs during development and differentiation. Studies in mammals and Drosophila have revealed diverse post-translational modifications of H1s, most of which are of unknown function. So far, it is not known how this pattern compares with that of H1s from other major lineages of multicellular Eukaryotes. Here, we show that the two main H1 variants of a model flowering plant Arabidopsis thaliana are subject to a rich and diverse array of post-translational modifications. The distribution of these modifications in the H1 molecule, especially in its globular domain (GH1), resembles that occurring in mammalian H1s, suggesting that their functional significance is likely to be conserved. While the majority of modifications detected in Arabidopsis H1s, including phosphorylation, acetylation, mono and dimethylation, formylation, crotonylation and propionylation, have also been reported in H1s of other species, some others have not been previously identified in histones.	[Kotlinski, Maciej; Palusinski, Antoni; Koblowska, Marta; Jerzmanowski, Andrzej] Univ Warsaw, Fac Biol, Lab Syst Biol, Warsaw, Poland; [Rutowicz, Kinga; Oledzki, Jacek; Fogtman, Anna; Koblowska, Marta; Dadlez, Michal; Jerzmanowski, Andrzej] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Knizewski, Lukasz; Ginalski, Krzysztof] Univ Warsaw, Ctr New Technol, Lab Bioinformat & Syst Biol, Warsaw, Poland; [Rubel, Tymon] Warsaw Univ Technol, Inst Radioelect & Multimedia Technol, Warsaw, Poland; [Dadlez, Michal] Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, Warsaw, Poland	University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw; Warsaw University of Technology; University of Warsaw	Jerzmanowski, A (corresponding author), Univ Warsaw, Fac Biol, Lab Syst Biol, Warsaw, Poland.; Jerzmanowski, A (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	andyj@ibb.waw.pl	Rubel, Tymon/L-6861-2017	Rubel, Tymon/0000-0002-1342-414X; Fogtman, Anna/0000-0002-5331-7840; Knizewski, Lukasz/0000-0003-1882-4051; Dadlez, Michal/0000-0001-8811-5176; Kotlinski, Maciej/0000-0002-0821-077X; Koblowska, Marta/0000-0003-4497-6200; Oledzki, Jacek/0000-0002-8622-3218	University of Warsaw [BW2006, BW2007]; Polish Ministry of Science and Higher Education [PBZ-MNiI-2/1/2005]; Foundation for Polish Science; Polish National Science Centre [2011/02/A/NZ2/00014]; National Centre for Research and Development [PBS1/A9/16/2012]; Centre for Preclinical Research and Technology (CePT); European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland	University of Warsaw; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Polish National Science Centre; National Centre for Research and Development(National Centre for Research & Development, Poland); Centre for Preclinical Research and Technology (CePT); European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland	Support was provided by University of Warsaw, Faculty of Biology grants BW2006 and BW2007 to M. Kotlinski, Polish Ministry of Science and Higher Education grant PBZ-MNiI-2/1/2005 to M. Koblowska, Foundation for Polish Science (TEAM), Polish National Science Centre (2011/02/A/NZ2/00014) and National Centre for Research and Development (PBS1/A9/16/2012) grants to K. Ginalski. The equipment used was sponsored in part by the Centre for Preclinical Research and Technology (CePT), a project co-sponsored by European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by: University of Warsaw, Faculty of Biology grants BW2006 and BW2007 to M. Kotlinski, Polish Ministry of Science and Higher Education grant PBZ-MNiI-2/1/2005 to M. Koblowska, Foundation for Polish Science (TEAM), Polish National Science Centre (2011/02/A/NZ2/00014) and National Centre for Research and Development (PBS1/A9/16/2012) grants to K. Ginalski. The equipment used was sponsored in part by the Centre for Preclinical Research and Technology (CePT), a project co-sponsored by European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnaudo AM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-24; Ascenzi R, 1997, PLANT MOL BIOL, V34, P629, DOI 10.1023/A:1005886011722; Barra JL, 2000, MOL CELL BIOL, V20, P61, DOI 10.1128/MCB.20.1.61-69.2000; Bonet-Costa C, 2012, J PROTEOMICS, V75, P4124, DOI 10.1016/j.jprot.2012.05.034; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; CERF C, 1994, BIOCHEMISTRY-US, V33, P11079, DOI 10.1021/bi00203a004; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; Cui F, 2009, NUCLEIC ACIDS RES, V37, P2818, DOI 10.1093/nar/gkp113; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Garcia BA, 2004, J PROTEOME RES, V3, P1219, DOI 10.1021/pr0498887; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Ginalski K, 2003, PROTEINS, V53, P410, DOI 10.1002/prot.10548; Goytisolo FA, 1996, EMBO J, V15, P3421, DOI 10.1002/j.1460-2075.1996.tb00708.x; Hansen JC, 2010, J CELL PHYSIOL, V224, P289, DOI 10.1002/jcp.22150; Jerzmanowski A, 2000, PLANT BIOLOGY, V2, P586, DOI 10.1055/s-2000-16648; Jiang T, 2007, P NATL ACAD SCI USA, V104, P60, DOI 10.1073/pnas.0606775103; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; McBryant SJ, 2010, CELL RES, V20, P519, DOI 10.1038/cr.2010.35; Michalski A, 2012, J PROTEOME RES, V11, P5479, DOI 10.1021/pr3007045; Pei JM, 2003, BIOINFORMATICS, V19, P427, DOI 10.1093/bioinformatics/btg008; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Rutowicz K, 2015, PLANT PHYSL; Sabari BR, 2015, MOL CELL, V58, P203, DOI 10.1016/j.molcel.2015.02.029; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Sharma P, 1999, J BIOL CHEM, V274, P9600, DOI 10.1074/jbc.274.14.9600; She WJ, 2013, DEVELOPMENT, V140, P4008, DOI 10.1242/dev.095034; Snijders APL, 2008, J PROTEOME RES, V7, P4326, DOI 10.1021/pr800260a; Soares JA, 2005, J BIOL CHEM, V280, P36962, DOI 10.1074/jbc.M506402200; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Stasevich TJ, 2010, EMBO J, V29, P1225, DOI 10.1038/emboj.2010.24; Syed SH, 2010, P NATL ACAD SCI USA, V107, P9620, DOI 10.1073/pnas.1000309107; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tweedie-Cullen RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036980; Villar-Garea A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001553; Wierzbicki AT, 2005, GENETICS, V169, P997, DOI 10.1534/genetics.104.031997; Wisniewski JR, 2008, NUCLEIC ACIDS RES, V36, P570, DOI 10.1093/nar/gkm1057; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Xie ZY, 2012, MOL CELL PROTEOMICS, V11, P100, DOI 10.1074/mcp.M111.015875; Yang SM, 2013, P NATL ACAD SCI USA, V110, P1708, DOI 10.1073/pnas.1213266110; Zhang K, 2009, J PROTEOME RES, V8, P900, DOI 10.1021/pr8005155; Zhou BR, 2013, P NATL ACAD SCI USA, V110, P19390, DOI 10.1073/pnas.1314905110; Zlatanova J, 2000, FASEB J, V14, P1697, DOI 10.1096/fj.99-0869rev	47	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147908	10.1371/journal.pone.0147908	http://dx.doi.org/10.1371/journal.pone.0147908			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820416	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000369528400052
J	Hanada, S; Iwata, S; Kishi, K; Morozumi, M; Chiba, N; Wajima, T; Takata, M; Ubukata, K				Hanada, Shigeo; Iwata, Satoshi; Kishi, Kazuma; Morozumi, Miyuki; Chiba, Naoko; Wajima, Takeaki; Takata, Misako; Ubukata, Kimiko		Invasive Pneumococcal Dis Surveill	Host Factors and Biomarkers Associated with Poor Outcomes in Adults with Invasive Pneumococcal Disease	PLOS ONE			English	Article							AGED GREATER-THAN-OR-EQUAL-TO-65 YEARS; STREPTOCOCCUS-PNEUMONIAE; POLYSACCHARIDE VACCINE; LACTATE-DEHYDROGENASE; CONJUGATE VACCINE; DRUG-RESISTANCE; RISK; BACTEREMIA; MORTALITY; SEPSIS	Background Invasive pneumococcal disease (IPD) causes considerable morbidity and mortality. We aimed to identify host factors and biomarkers associated with poor outcomes in adult patients with IPD in Japan, which has a rapidly-aging population. Methods In a large-scale surveillance study of 506 Japanese adults with IPD, we investigated the role of host factors, disease severity, biomarkers based on clinical laboratory data, treatment regimens, and bacterial factors on 28-day mortality. Results Overall mortality was 24.1%, and the mortality rate increased from 10.0% in patients aged <50 years to 33.1% in patients aged >= 80 years. Disease severity also increased 28-day mortality, from 12.5% among patients with bacteraemia without sepsis to 35.0% in patients with severe sepsis and 56.9% with septic shock. The death rate within 48 hours after admission was high at 54.9%. Risk factors for mortality identified by multivariate analysis were as follows: white blood cell (WBC) count <4000 cells/mu L (odds ratio [OR], 6.9; 95% confidence interval [CI], 3.7-12.8, p < .001); age >= 80 years (OR, 6.5; 95% CI, 2.0-21.6, p = .002); serum creatinine >= 2.0 mg/dL (OR, 4.5; 95% CI, 2.5-8.1, p < .001); underlying liver disease (OR, 3.5; 95% CI, 1.6-7.8, p = .002); mechanical ventilation (OR, 3.0; 95% CI, 1.7-5.6, p < 001); and lactate dehydrogenase >= 300 IU/L (OR, 2.4; 95% CI, 1.4-4.0, p = .001). Pneumococcal serotype and drug resistance were not associated with poor outcomes. Conclusions Host factors, disease severity, and biomarkers, especially WBC counts and serum creatinine, were more important determinants of mortality than bacterial factors.	[Hanada, Shigeo; Kishi, Kazuma] Toranomon Gen Hosp, Resp Ctr, Dept Resp Med, Tokyo, Japan; [Hanada, Shigeo; Iwata, Satoshi; Morozumi, Miyuki; Chiba, Naoko; Takata, Misako; Ubukata, Kimiko] Keio Univ, Dept Infect Dis, Sch Med, Tokyo, Japan; [Hanada, Shigeo; Kishi, Kazuma] Okinaka Mem Inst Med Res, Tokyo, Japan; [Wajima, Takeaki] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Microbiol, Tokyo, Japan	Toranomon Hospital; Keio University; Tokyo University of Pharmacy & Life Sciences	Ubukata, K (corresponding author), Keio Univ, Dept Infect Dis, Sch Med, Tokyo, Japan.	ubukatak@keio.jp	ubukata, kimiko/AAE-5599-2020; Wajma, Takeaki/AAF-4743-2020	Wajma, Takeaki/0000-0001-9506-707X	Japanese Ministry of Health, Labour, and Welfare [H22-013]; Grants-in-Aid for Scientific Research [26870612] Funding Source: KAKEN	Japanese Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant under the category "Research on Emerging and Re-emerging Infectious Diseases" (H22-013) from the Japanese Ministry of Health, Labour, and Welfare to K. Ubukata (http://www.mhlw.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanee SRJ, 2007, CLIN INFECT DIS, V45, P46, DOI 10.1086/518538; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Boyd AR, 2012, EXP GERONTOL, V47, P507, DOI 10.1016/j.exger.2012.04.004; Chiba N, 2014, EMERG INFECT DIS, V20, P1132, DOI 10.3201/eid2007.131485; Christensen JS, 2012, EUR J CLIN MICROBIOL, V31, P2719, DOI 10.1007/s10096-012-1619-5; De Gaudio AR, 2009, CURR DRUG TARGETS, V10, P60, DOI 10.2174/138945009787122879; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Esteves F, 2014, EUR J CLIN MICROBIOL, V33, P1173, DOI 10.1007/s10096-014-2054-6; Gavazzi G, 2002, LANCET INFECT DIS, V2, P659, DOI 10.1016/S1473-3099(02)00437-1; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Inamura N, 2014, J INFECT CHEMOTHER, V20, P270, DOI 10.1016/j.jiac.2014.01.001; JANOFF EN, 1992, ANN INTERN MED, V117, P314, DOI 10.7326/0003-4819-117-4-314; Kalin M, 2000, J INFECT DIS, V182, P840, DOI 10.1086/315760; Klemets P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-96; Kyaw MH, 2005, J INFECT DIS, V192, P377, DOI 10.1086/431521; Leventer-Roberts M, 2015, CLIN INFECT DIS, V60, P1472, DOI 10.1093/cid/civ096; Metlay JP, 2000, CLIN INFECT DIS, V30, P520, DOI 10.1086/313716; Naucler P, 2013, THORAX, V68, P571, DOI 10.1136/thoraxjnl-2012-203106; O'Brien JM, 2007, CRIT CARE MED, V35, P345, DOI 10.1097/01.CCM.0000254340.91644.B2; Pastor P, 1998, CLIN INFECT DIS, V26, P590, DOI 10.1086/514589; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Talbot TR, 2005, NEW ENGL J MED, V352, P2082, DOI 10.1056/NEJMoa044113; Tasaka S, 2007, CHEST, V131, P1173, DOI 10.1378/chest.06-1467; Thomsen RW, 2004, DIABETES CARE, V27, P1143, DOI 10.2337/diacare.27.5.1143; Tomczyk S, 2014, MMWR-MORBID MORTAL W, V63, P822; Ubukata K, 2015, EMERG INFECT DIS, V21, P1956, DOI 10.3201/eid2111.142029; van Hoek AJ, 2012, J INFECTION, V65, P17, DOI 10.1016/j.jinf.2012.02.017; Venditti M, 2009, ANN INTERN MED, V150, P19, DOI 10.7326/0003-4819-150-1-200901060-00005; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Yu VL, 2003, CLIN INFECT DIS, V37, P230, DOI 10.1086/377534	31	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147877	10.1371/journal.pone.0147877	http://dx.doi.org/10.1371/journal.pone.0147877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815915	Green Published, gold			2022-12-26	WOS:000369528200061
J	Hsiao, CT; Tsai, PC; Lin, CC; Liu, YT; Huang, YH; Liao, YC; Huang, HW; Lin, KP; Soong, BW; Lee, YC				Hsiao, Cheng-Tsung; Tsai, Pei-Chien; Lin, Chou-Ching; Liu, Yo-Tsen; Huang, Yen-Hua; Liao, Yi-Chu; Huang, Han-Wei; Lin, Kon-Ping; Soong, Bing-Wen; Lee, Yi-Chung			Clinical and Molecular Characterization of BSCL2 Mutations in a Taiwanese Cohort with Hereditary Neuropathy	PLOS ONE			English	Article							SEIP CONGENITAL LIPODYSTROPHY; MOTOR NEUROPATHY; PROTEIN SEIPIN	Background A small group of patients with inherited neuropathy that has been shown to be caused by mutations in the BSCL2 gene. However, little information is available about the role of BSCL2 mutations in inherited neuropathies in Taiwan. Methodology and Principal Findings Utilizing targeted sequencing, 76 patients with molecularly unassigned Charcot-Marie-Tooth disease type 2 (CMT2) and 8 with distal hereditary motor neuropathy (dHMN), who were selected from 348 unrelated patients with inherited neuropathies, were screened for mutations in the coding regions of BSCL2. Two heterozygous BSCL2 mutations, p.S90L and p.R96H, were identified, of which the p.R96H mutation is novel. The p.S90L was identified in a pedigree with CMT2 while the p.R96H was identified in a patient with apparently sporadic dHMN. In vitro studies demonstrated that the p.R96H mutation results in a remarkably low seipin expression and reduced cell viability. Conclusion BSCL2 mutations account for a small number of patients with inherited neuropathies in Taiwan. The p.R96H mutation is associated with dHMN. This study expands the molecular spectrum of BSCL2 mutations and also emphasizes the pathogenic role of BSCL2 mutations in molecularly unassigned hereditary neuropathies.	[Hsiao, Cheng-Tsung; Tsai, Pei-Chien; Liu, Yo-Tsen; Liao, Yi-Chu; Lin, Kon-Ping; Soong, Bing-Wen; Lee, Yi-Chung] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Hsiao, Cheng-Tsung; Tsai, Pei-Chien; Liu, Yo-Tsen; Liao, Yi-Chu; Lin, Kon-Ping; Soong, Bing-Wen; Lee, Yi-Chung] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan; [Tsai, Pei-Chien; Soong, Bing-Wen; Lee, Yi-Chung] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Lin, Chou-Ching; Huang, Han-Wei] Natl Cheng Kung Univ Hosp, Sch Med, Dept Neurol, Taipei, Taiwan; [Huang, Yen-Hua] Natl Yang Ming Univ, Inst Biomed Informat, Sch Med, Taipei 112, Taiwan; [Huang, Yen-Hua] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Cheng Kung University; National Cheng Kung University Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lee, YC (corresponding author), Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan.; Lee, YC (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan.; Lee, YC (corresponding author), Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan.	ycli@vghtpe.gov.tw	Lin, Chou-Ching K/I-1451-2019; Lee, Yi-Chung/H-8813-2019; Lee, Yi-Chung/GZK-7162-2022	Lin, Chou-Ching K/0000-0002-3070-5787; Lee, Yi-Chung/0000-0003-0102-164X; Liao, Yi-Chu/0000-0002-9644-2086; Tsai, Pei-Chien/0000-0001-7303-0516	Ministry of Science and Technology, Taiwan [102-2628-B-075-006-MY3]; Taipei Veterans General Hospital [V104C-041]; High-throughput Genome Analysis Core Facility of National Core Facility Program for Biotechnology of Taiwan [NSC-101-2319-B-010-001]; High-throughput Genome and Big Data Analysis Core Facility of National Core Facility Program for Biotechnology, the Ministry of Science and Technology, Taiwan [MOST104-2319-B-010-001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); High-throughput Genome Analysis Core Facility of National Core Facility Program for Biotechnology of Taiwan; High-throughput Genome and Big Data Analysis Core Facility of National Core Facility Program for Biotechnology, the Ministry of Science and Technology, Taiwan	This work was supported by the grants from Ministry of Science and Technology, Taiwan (102-2628-B-075-006-MY3) and Taipei Veterans General Hospital (V104C-041). The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.; We would like to thank the patients who participated in this study. We thank the High-throughput Genome Analysis Core Facility of National Core Facility Program for Biotechnology of Taiwan (NSC-101-2319-B-010-001) for the service of nucleotide sequencing. We also thank the High-throughput Genome and Big Data Analysis Core Facility of National Core Facility Program for Biotechnology, the Ministry of Science and Technology, Taiwan (MOST104-2319-B-010-001), for the bioinformatics support.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Auer-Grumbach M, 2005, ANN NEUROL, V57, P415, DOI 10.1002/ana.20410; Chen WQ, 2012, MOL CELL BIOL, V32, P1099, DOI 10.1128/MCB.06465-11; Choi BO, 2013, NEUROGENETICS, V14, P35, DOI 10.1007/s10048-012-0346-5; Drew AP, 2015, MOL GENET GENOM MED, V3, P143, DOI 10.1002/mgg3.126; Fei WH, 2011, J LIPID RES, V52, P2136, DOI 10.1194/jlr.M017566; Fridman V, 2015, J NEUROL NEUROSUR PS, V86, P873, DOI 10.1136/jnnp-2014-308826; Guillen-Navarro E, 2013, J MED GENET, V50, P401, DOI 10.1136/jmedgenet-2013-101525; Irobi J, 2004, BRAIN, V127, P2124, DOI 10.1093/brain/awh232; Ito D, 2007, ANN NEUROL, V61, P237, DOI 10.1002/ana.21070; Ito D, 2009, BRAIN, V132, P8, DOI 10.1093/brain/awn216; Klein CJ, 2014, J NEUROL NEUROSUR PS, V85, P1265, DOI 10.1136/jnnp-2013-306740; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee YC, 2010, J NEUROL, V257, P1661, DOI 10.1007/s00415-010-5590-8; Liao YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133423; Lin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029393; Lundin C, 2006, FEBS LETT, V580, P2281, DOI 10.1016/j.febslet.2006.03.040; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Murphy SM, 2015, J NEUROL NEUROSUR PS, V86, P873; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sim MFM, 2013, DIABETOLOGIA, V56, P2498, DOI 10.1007/s00125-013-3029-3; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Tsai PC, 2014, NEUROLOGY, V83, P903, DOI 10.1212/WNL.0000000000000758; Villanova M, 1998, NEUROMUSCULAR DISORD, V8, P392, DOI 10.1016/S0960-8966(98)00044-3; Wei SH, 2014, J NEUROCHEM, V129, P328, DOI 10.1111/jnc.12638; Wei SH, 2013, J NEUROCHEM, V124, P478, DOI 10.1111/jnc.12099; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Yang WL, 2014, HUM MOL GENET, V23, P502, DOI 10.1093/hmg/ddt444; Yang WL, 2013, BIOCHEM J, V452, P37, DOI 10.1042/BJ20121870; Yum SW, 2002, NEUROBIOL DIS, V11, P43, DOI 10.1006/nbdi.2002.0545	31	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147677	10.1371/journal.pone.0147677	http://dx.doi.org/10.1371/journal.pone.0147677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815532	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528200044
J	Cignini, P; Giorlandino, M; Brutti, P; Mangiafico, L; Aloisi, A; Giorlandino, C				Cignini, Pietro; Giorlandino, Maurizio; Brutti, Pierpaolo; Mangiafico, Lucia; Aloisi, Alessia; Giorlandino, Claudio			Reference Charts for Fetal Cerebellar Vermis Height: A Prospective Cross-Sectional Study of 10605 Fetuses	PLOS ONE			English	Article							DANDY-WALKER MALFORMATION; SONOGRAPHIC DIAGNOSIS; POSTERIOR-FOSSA; WORM PLOT; HYPOPLASIA; PITFALLS; ANATOMY; BRAIN; FIT	Objective To establish reference charts for fetal cerebellar vermis height in an unselected population. Methods A prospective cross-sectional study between September 2009 and December 2014 was carried out at ALTAMEDICA Fetal-Maternal Medical Centre, Rome, Italy. Of 25203 fetal biometric measurements, 12167 (48%) measurements of the cerebellar vermis were available. After excluding 1562 (12.8%) measurements, a total of 10605 (87.2%) fetuses were considered and analyzed once only. Parametric and nonparametric quantile regression models were used for the statistical analysis. In order to evaluate the robustness of the proposed reference charts regarding various distributional assumptions on the ultrasound measurements at hand, we compared the gestational age-specific reference curves we produced through the statistical methods used. Normal mean height based on parametric and nonparametric methods were defined for each week of gestation and the regression equation expressing the height of the cerebellar vermis as a function of gestational age was calculated. Finally the correlation between dimension/gestation was measured. Results The mean height of the cerebellar vermis was 12.7mm (SD, 1.6mm; 95% confidence interval, 12.7-12.8mm). The regression equation expressing the height of the CV as a function of the gestational age was: height (mm) = -4.85+0.78x gestational age. The correlation between dimension/ gestation was expressed by the coefficient r = 0.87. Conclusion This is the first prospective cross-sectional study on fetal cerebellar vermis biometry with such a large sample size reported in literature. It is a detailed statistical survey and contains new centile-based reference charts for fetal height of cerebellar vermis measurements.	[Cignini, Pietro; Giorlandino, Maurizio; Mangiafico, Lucia; Giorlandino, Claudio] ALTAMEDICA Fetal Maternal Med Ctr, Dept Prenatal Diag, Rome, Italy; [Brutti, Pierpaolo] Univ Roma La Sapienza, Dept Stat, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Aloisi, Alessia] Campus Biomedico Univ Rome, Dept Obstet & Gynecol, Rome, Italy	Sapienza University Rome; University Campus Bio-Medico - Rome Italy	Cignini, P (corresponding author), ALTAMEDICA Fetal Maternal Med Ctr, Dept Prenatal Diag, Rome, Italy.	info@pietrocignini.it	Aloisi, Alessia/AAM-7268-2020	aloisi, alessia/0000-0002-7008-097X				Achiron R, 2004, ULTRASOUND OBST GYN, V24, P506, DOI 10.1002/uog.1731; ALTMAN DG, 1994, BRIT J OBSTET GYNAEC, V101, P29, DOI 10.1111/j.1471-0528.1994.tb13006.x; American Institute of Ultrasound in Medicine, 2010, J Ultrasound Med, V29, P157; [Anonymous], 2005, METROPOLITAN ATLANTA; Babcook CJ, 1996, AM J ROENTGENOL, V166, P427, DOI 10.2214/ajr.166.2.8553961; Barkovic, 2000, PEDIAT NEUROIMAGING, P337; Basson MA, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00029; Blazer S, 1997, PRENATAL DIAG, V17, P907, DOI 10.1002/(SICI)1097-0223(199710)17:10<907::AID-PD172>3.0.CO;2-Q; Boddaert N, 2003, NEURORADIOLOGY, V45, P320, DOI 10.1007/s00234-003-0980-6; Boltshauser E, 2004, AM J MED GENET A, V126A, P376, DOI 10.1002/ajmg.a.20662; BROMLEY B, 1994, RADIOLOGY, V193, P761, DOI 10.1148/radiology.193.3.7972820; CHANG MC, 1994, RADIOLOGY, V193, P765, DOI 10.1148/radiology.193.3.7972821; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; COURCHESNE E, 1988, NEW ENGL J MED, V318, P1349, DOI 10.1056/NEJM198805263182102; Ecker JL, 2000, PRENATAL DIAG, V20, P328, DOI 10.1002/(SICI)1097-0223(200004)20:4<328::AID-PD806>3.0.CO;2-O; Forzano F, 2007, PRENATAL DIAG, V27, P495, DOI 10.1002/pd.1722; Ginath S, 2013, J MATERN-FETAL NEO M, V26, P757, DOI 10.3109/14767058.2012.755508; Has R, 2004, FETAL DIAGN THER, V19, P342, DOI 10.1159/000077963; HIRSCH JF, 1984, J NEUROSURG, V61, P515, DOI 10.3171/jns.1984.61.3.0515; Koenker R, 2005, ECONOMETRIC SOC MONO, P38; Koenker R., QUANTREG QUANTILE RE; Levine D, 2003, RADIOLOGY, V229, P51, DOI 10.1148/radiol.2291020770; Limperopoulos C, 2006, AM J OBSTET GYNECOL, V194, P1070, DOI 10.1016/j.ajog.2005.10.191; Malinger G, 2004, ULTRASOUND OBST GYN, V23, P333, DOI 10.1002/uog.1016; Malinger G, 2001, PRENATAL DIAG, V21, P687, DOI 10.1002/pd.137; Malinger G, 2009, PRENATAL DIAG, V29, P372, DOI 10.1002/pd.2196; Middleton FA, 2001, J NEUROSCI; Oh HS, 2011, J COMPUT GRAPH STAT, V20, P510, DOI 10.1198/jcgs.2010.10063; Paladini D, 2006, ULTRASOUND OBST GYN, V27, P482, DOI 10.1002/uog.2748; Parisi MA, 2003, MOL GENET METAB, V80, P36, DOI 10.1016/j.ymgme.2003.08.010; Pilu G, 2000, ULTRASOUND OBST GYN, V16, P115, DOI 10.1046/j.1469-0705.2000.00197.x; Pilu G, 2007, ULTRASOUND OBST GYN, V30, P233, DOI 10.1002/uog.4072; PILU G, 1992, ULTRASOUND OBST GYN, V2, P151, DOI 10.1046/j.1469-0705.1992.02030151.x; Pilu G, 1999, DIAGNOSIS FETAL ABNO, P5; Pya N., SCAM SHAPE CONSTRAIN; R Development Core Team, 2012, R LANG ENV STAT COMP; Rapoport M, 2000, J NEUROPSYCH CLIN N, V12, P193, DOI 10.1176/appi.neuropsych.12.2.193; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Rigby RA, 2006, STAT MODEL, V6, P209, DOI 10.1191/1471082X06st122oa; Robinson AJ, 2014, ULTRASOUND OBST GYN, V43, P123, DOI 10.1002/uog.13296; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; Royston P, 2000, STAT MED, V19, P2943, DOI 10.1002/1097-0258(20001115)19:21<2943::AID-SIM559>3.0.CO;2-5; Royston P, 1998, ULTRASOUND OBST GYN, V11, P30, DOI 10.1046/j.1469-0705.1998.11010030.x; Salomon LJ, 2005, ULTRASOUND OBST GYN, V25, P559, DOI 10.1002/uog.1901; Sgaier SK, 2005, NEURON, V45, P27, DOI 10.1016/S0896-6273(04)00802-5; Shevell MI, 1996, PEDIATR NEUROL, V15, P224, DOI 10.1016/S0887-8994(96)00220-2; Steinlin M, 1999, NEUROLOGY, V53, P966, DOI 10.1212/WNL.53.5.966; Tilea B, 2009, ULTRASOUND OBST GYN, V33, P173, DOI 10.1002/uog.6276; TimorTritsch IE, 1996, ULTRASOUND OBST GYN, V8, P42, DOI 10.1046/j.1469-0705.1996.08010042.x; van Buuren S, 2001, STAT MED, V20, P1259, DOI 10.1002/sim.746; van Buuren S, 2007, STAT MODEL, V7, P363, DOI 10.1177/1471082X0700700406; Vinals F, 2005, ULTRASOUND OBST GYN, V26, P622, DOI 10.1002/uog.2606; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zalel Y, 2002, ULTRASOUND OBST GYN, V19, P136, DOI 10.1046/j.0960-7692.2001.00621.x; Zhao D, 2013, PRENATAL DIAG, V33, P153, DOI 10.1002/pd.4027	55	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147528	10.1371/journal.pone.0147528	http://dx.doi.org/10.1371/journal.pone.0147528			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812238	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528000037
J	Kelly, SG; Plankey, M; Post, WS; Li, XH; Stall, R; Jacobson, LP; Witt, MD; Kingsley, L; Cox, C; Budoff, M; Palella, FJ				Kelly, Sean G.; Plankey, Michael; Post, Wendy S.; Li, Xiuhong; Stall, Ronald; Jacobson, Lisa P.; Witt, Mallory D.; Kingsley, Lawrence; Cox, Christopher; Budoff, Matthew; Palella, Frank J., Jr.			Associations between Tobacco, Alcohol, and Drug Use with Coronary Artery Plaque among HIV-Infected and Uninfected Men in the Multicenter AIDS Cohort Study	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CONTROLLED-TRIAL; HEART-DISEASE; SUBSTANCE USE; ANTIRETROVIRAL THERAPY; MYOCARDIAL-INFARCTION; COCAINE USERS; RISK; ATHEROSCLEROSIS	Background We characterized associations between smoking, alcohol, and recreational drug use and coronary plaque by HIV serostatus within the Multicenter AIDS Cohort Study (MACS). Methods MACS participants (N = 1005, 621 HIV+ and 384 HIV-) underwent non-contrast CT scanning to measure coronary artery calcium; 764 underwent coronary CT angiograms to evaluate plaque type and extent. Self-reported use of alcohol, tobacco, smoked/inhaled cocaine, methamphetamine, ecstasy, marijuana, inhaled nitrites, and erectile dysfunction drugs was obtained at semi-annual visits beginning 10 years prior to CT scanning. Multivariable logistic and linear regression models were performed, stratified by HIV serostatus. Results Among HIV+ men, current smoking, former smoking, and cumulative pack years of smoking were positively associated with multiple coronary plaque measures (coronary artery calcium presence and extent, total plaque presence and extent, calcified plaque presence, and stenosis >50%). Smoking was significantly associated with fewer plaque measures of comparable effect size among HIV-men; current smoking and calcified plaque extent was the only such association. Heavy alcohol use (>14 drinks/week) was associated with stenosis >50% among HIV+ men. Among HIV-men, low/moderate (1-14 drinks/week) and heavy alcohol use were inversely associated with coronary artery calcium and calcified plaque extent. Few significant associations between other recreational drug use and plaque measures were observed. Conclusion Smoking is strongly associated with coronary plaque among HIV+ men, underscoring the value of smoking cessation for HIV+ persons. Alcohol use may protect against coronary artery calcium and calcified plaque progression in HIV-(but not HIV+) men. Few positive associations were observed between recreational drug use and coronary plaque measures.	[Kelly, Sean G.; Palella, Frank J., Jr.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Plankey, Michael] Georgetown Univ, Washington, DC USA; [Post, Wendy S.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Post, Wendy S.; Li, Xiuhong; Jacobson, Lisa P.; Cox, Christopher] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Stall, Ronald; Kingsley, Lawrence] Univ Pittsburgh, Sch Publ Hlth, Pittsburgh, PA 15260 USA; [Witt, Mallory D.; Budoff, Matthew] Harbor UCLA Med Ctr, Torrance, CA 90509 USA	Northwestern University; Feinberg School of Medicine; Georgetown University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Kelly, SG (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.	Sean-Kelly@northwestern.edu	Budoff, Matthew/ABD-5175-2021	Budoff, Matthew/0000-0002-9616-1946; Kingsley, Lawrence/0000-0002-7000-8556; Jacobson, Lisa P./0000-0003-1722-6826	National heart, Lung and Blood Institute [RO1 HL095129]; National Institute of Allergy and Infectious Diseases; National Cancer Institute, The National Institute on Drug Abuse, The National Institute of Mental Health; National Center for Advancing Translational Sciences [UO1-AI-35042, UM1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041, Hopkins CRU UL1 TR 001079,, Harbor-UCLA UL1TR000124]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, UL1TR001079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI035043, U01AI035041, U01AI035040, U01AI035039, U01AI035042] Funding Source: NIH RePORTER	National heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, The National Institute on Drug Abuse, The National Institute of Mental Health; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by The National heart, Lung and Blood Institute (RO1 HL095129). The Multicenter AIDS Cohort Study is funded by The National Institute of Allergy and Infectious Diseases, with additional supplemental funding from The National Cancer Institute, The National Institute on Drug Abuse, The National Institute of Mental Health, and The National Center for Advancing Translational Sciences (UO1-AI-35042, UM1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041, Hopkins CRU UL1 TR 001079, and Harbor-UCLA UL1TR000124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi N, 2011, AM J CARDIOL, V107, P10, DOI 10.1016/j.amjcard.2010.08.034; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Austen W G, 1975, Circulation, V51, P5; Benzaquen BS, 2001, AM HEART J, V142, P402, DOI 10.1067/mhj.2001.117607; Bergersen BM, 2004, EUR J CLIN MICROBIOL, V23, P625, DOI 10.1007/s10096-004-1177-6; Brennan-Ing M, 2014, BEHAV MED, V40, P108, DOI 10.1080/08964289.2014.889069; Burkhalter JE, 2005, NICOTINE TOB RES, V7, P511, DOI 10.1080/14622200500186064; Chew D, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/237834; Cummins Denise, 2005, Nurs Stand, V20, P41; D'Abramo A, 2013, EARLY ATHEROSCLEROSI; DUDLEY J, 1995, AM J EPIDEMIOL, V142, P323, DOI 10.1093/oxfordjournals.aje.a117638; Ebersberger U, 2013, ATHEROSCLEROSIS, V229, P443, DOI 10.1016/j.atherosclerosis.2013.05.032; Farrugia PM, 2009, CARDIOL REV, V17, P211, DOI 10.1097/CRD.0b013e3181b151a3; Albuquerque VMG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-274; Gonzalez-Reimers E, 2014, WORLD J GASTROENTERO, V20, P14660, DOI 10.3748/wjg.v20.i40.14660; Hacioglu Y, 2013, ANATOL J CARDIOL, V13, P207, DOI 10.5152/akd.2013.065; Hakeem A, 2010, CURR ATHEROSCLER REP, V12, P119, DOI 10.1007/s11883-010-0089-4; Hultin LE, 2007, CYTOM PART B-CLIN CY, V72B, P249, DOI 10.1002/cyto.b.20176; Karch SB, 1999, J FORENSIC SCI, V44, P359; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Lai H, 2002, AM J CARDIOL, V90, P326, DOI 10.1016/S0002-9149(02)02475-X; Lai S, 2003, AIDS PATIENT CARE ST, V23, P815; Leone Aurelio, 2011, Recent Pat Cardiovasc Drug Discov, V6, P61, DOI 10.2174/157489011794578437; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Lloyd-Richardson EE, 2009, ADDICTION, V104, P1891, DOI 10.1111/j.1360-0443.2009.02623.x; Lo J, 2010, AIDS, V24, P243, DOI 10.1097/QAD.0b013e328333ea9e; Maggi P, 2009, AIDS PATIENT CARE ST, V23, P809, DOI 10.1089/apc.2009.0102; Matthews AK, 2013, AIDS PATIENT CARE ST, V27, P22, DOI 10.1089/apc.2012.0253; Meng QY, 2003, INT J CARDIOL, V88, P191, DOI 10.1016/S0167-5273(02)00394-7; Mittleman MA, 2001, CIRCULATION, V103, P2805; Moadel AB, 2012, JAIDS-J ACQ IMM DEF, V61, P208, DOI 10.1097/QAI.0b013e3182645679; Mosunjac MI, 2008, AM J FOREN MED PATH, V29, P9, DOI 10.1097/PAF.0b013e318165152f; Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044; Mukamal KJ, 2008, AM HEART J, V155, P465, DOI 10.1016/j.ahj.2007.10.049; Mukamal KJ, 2006, ARCH INTERN MED, V166, P2145, DOI 10.1001/archinte.166.19.2145; Mukamal KJ, 2004, ATHEROSCLEROSIS, V173, P79, DOI 10.1016/j.atherosclerosis.2003.10.011; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Mukamal KJ, 1987, J AM COLL CARDIOL, V2010, P1328, DOI DOI 10.1016/J.JACC.2009.10.056; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pletcher MJ, 2005, AM J EPIDEMIOL, V161, P423, DOI 10.1093/aje/kwi062; Post WS, 2014, ANN INTERN MED, V160, P458, DOI 10.7326/M13-1754; Robinson F Patrick, 2005, J Cardiovasc Nurs, V20, P149; Roussillon C, 2015, C RETR OPP INF FEBR; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Shrestha S, 2014, ARTERIOSCL THROM VAS, V34, P244, DOI 10.1161/ATVBAHA.113.302191; Sullivan PS, 1998, J ACQ IMMUN DEF SYND, V19, P266, DOI 10.1097/00042560-199811010-00009; Tai H, 2012, INT J CARDIOL, V161, P83, DOI 10.1016/j.ijcard.2011.04.034; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; Tolstrup J, 2006, BMJ-BRIT MED J, V332, P1244, DOI 10.1136/bmj.38831.503113.7C; Webb MS, 2007, J BEHAV MED, V30, P371, DOI 10.1007/s10865-007-9112-9; Yankelevitz DF, 2013, JACC-CARDIOVASC IMAG, V6, P651, DOI 10.1016/j.jcmg.2013.02.004; Zanni MV, 2014, AIDS, V28, P2061, DOI 10.1097/QAD.0000000000000360	52	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147822	10.1371/journal.pone.0147822	http://dx.doi.org/10.1371/journal.pone.0147822			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811937	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000369528000058
J	Kemppainen, E; George, J; Garipler, G; Tuomela, T; Kiviranta, E; Soga, T; Dunn, CD; Jacobs, HT				Kemppainen, Esko; George, Jack; Garipler, Gorkem; Tuomela, Tea; Kiviranta, Essi; Soga, Tomoyoshi; Dunn, Cory D.; Jacobs, Howard T.			Mitochondrial Dysfunction Plus High-Sugar Diet Provokes a Metabolic Crisis That Inhibits Growth	PLOS ONE			English	Article							MITORIBOSOMAL PROTEIN S12; DROSOPHILA-MELANOGASTER; ALTERNATIVE OXIDASE; ESCHERICHIA-COLI; PYRUVATE THERAPY; KETOGENIC DIET; DISEASE; TRANSLATION; EXPRESSION; MUTATION	The Drosophila mutant tko(25t) exhibits a deficiency ofmitochondrial protein synthesis, leading to a global insufficiency of respiration and oxidative phosphorylation. This entrains an organismal phenotype of developmental delay and sensitivity to seizures induced bymechanical stress. We found that the mutant phenotype is exacerbated in a dose-dependent fashion by high dietary sugar levels. tko(25t) larvae were found to exhibit severe metabolic abnormalities that were further accentuated by high-sugar diet. These include elevated pyruvate and lactate, decreased ATP and NADPH. Dietary pyruvate or lactate supplementation phenocopied the effects of high sugar. Based on tissue-specific rescue, the crucial tissue in which this metabolic crisis initiates is the gut. It is accompanied by down-regulation of the apparatus of cytosolic protein synthesis and secretion at both the RNA and post-translational levels, including a novel regulation of S6 kinase at the protein level.	[Kemppainen, Esko; George, Jack; Garipler, Gorkem; Tuomela, Tea; Kiviranta, Essi; Jacobs, Howard T.] Univ Tampere, BioMediTech & Tampere Univ Hosp, FI-33014 Tampere, Finland; [Garipler, Gorkem] Koc Univ, Dept Mol Biol & Genet, TR-34450 Istanbul, Turkey; [Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970035, Japan; [Jacobs, Howard T.] Univ Helsinki, Inst Biotechnol, FI-00014 Helsinki, Finland; [Garipler, Gorkem] NYU, Dept Biol, New York, NY 10003 USA	Tampere University; Tampere University Hospital; Koc University; Keio University; University of Helsinki; New York University	Jacobs, HT (corresponding author), Univ Tampere, BioMediTech & Tampere Univ Hosp, FI-33014 Tampere, Finland.; Jacobs, HT (corresponding author), Univ Helsinki, Inst Biotechnol, FI-00014 Helsinki, Finland.	howard.jacobs@helsinki.fi	Kemppainen, Esko/AAF-7618-2019	Jacobs, Howard/0000-0003-1895-6003; Morikka, Jack/0000-0002-0053-4171; Dunn, Cory/0000-0003-2393-5944	Academy of Finland [272376]; Tampere University Hospital Medical Research Fund; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Tampere University Hospital Medical Research Fund; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by funding from the Academy of Finland (CoE award 272376 to HTJ); Tampere University Hospital Medical Research Fund to HTJ; the Sigrid Juselius Foundation to HTJ and EMBO (Installation Grant 2010 to CDD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeva M, 2013, MITOCHONDRION, V13, P615, DOI 10.1016/j.mito.2013.08.011; Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Ahola-Erkkila S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076; Albert V, 2015, CURR OPIN CELL BIOL, V33, P55, DOI 10.1016/j.ceb.2014.12.001; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Calidas D, 2014, RNA, V20, P321, DOI 10.1261/rna.042432.113; Castillon GA, 2011, MOL BIOL CELL, V22, P2924, DOI 10.1091/mbc.E11-04-0294; CAVENER DR, 1983, P NATL ACAD SCI-BIOL, V80, P6286, DOI 10.1073/pnas.80.20.6286; CAVENER DR, 1986, GENETICS, V114, P111; Chen SJ, 2012, GENETICS, V192, P483, DOI 10.1534/genetics.112.143719; Clarke C, 2013, MOL GENET METAB, V110, P145, DOI 10.1016/j.ymgme.2013.07.011; Danhauser K, 2015, J INHERIT METAB DIS, V38, P467, DOI 10.1007/s10545-014-9796-2; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Fergestad Tim, 2006, Genetics, V173, P1357, DOI 10.1534/genetics.106.057463; Fernandez-Ayala DJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008549; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Ferri Stefano, 2011, J Diabetes Sci Technol, V5, P1068; Fujii T, 2014, MOL GENET METAB, V112, P133, DOI 10.1016/j.ymgme.2014.04.008; Fujita M, 2011, J CELL BIOL, V194, P61, DOI 10.1083/jcb.201012074; Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006; GRANDHEE SK, 1991, J BIOL CHEM, V266, P11649; Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Havula E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003438; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; HINMAN LM, 1981, J BIOL CHEM, V256, P6583; HODGE JE, 1953, J AGR FOOD CHEM, V1, P928, DOI 10.1021/jf60015a004; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jacobs HT, 2004, BBA-BIOENERGETICS, V1659, P190, DOI 10.1016/j.bbabio.2004.07.004; Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kemppainen E, 2009, MITOCHONDRION, V9, P353, DOI 10.1016/j.mito.2009.07.002; Kemppainen KK, 2014, G3-GENES GENOM GENET, V4, P2013, DOI 10.1534/g3.114.013946; Kemppainen KK, 2014, HUM MOL GENET, V23, P2078, DOI 10.1093/hmg/ddt601; Kerr DS, 2013, NEUROTHERAPEUTICS, V10, P307, DOI 10.1007/s13311-013-0176-7; Kojer K, 2014, BBA-PROTEINS PROTEOM, V1844, P1383, DOI 10.1016/j.bbapap.2014.02.004; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Merritt TJS, 2009, GENETICS, V182, P565, DOI 10.1534/genetics.109.100677; Merritt TJS, 2005, GENETICS, V171, P1707, DOI 10.1534/genetics.105.048249; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Nassel DR, 2015, GEN COMP ENDOCR, V221, P255, DOI 10.1016/j.ygcen.2014.11.021; Newsholme E, 2010, FUNCTIONAL BIOCH HLT; Pan DA, 2002, BIOCHEM J, V367, P179, DOI 10.1042/BJ20020703; Park S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004555; Park SY, 2014, GENETICS, V196, P539, DOI 10.1534/genetics.113.157602; Roy S, 1999, BIOESSAYS, V21, P486, DOI 10.1002/(SICI)1521-1878(199906)21:6&lt;486::AID-BIES5&gt;3.0.CO;2-M; ROYDEN CS, 1987, CELL, V51, P165, DOI 10.1016/0092-8674(87)90144-9; Ryoo HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075774; Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Sanz A, 2010, AGING-US, V2, P200, DOI 10.18632/aging.100137; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shah ZH, 1997, GENE, V204, P55, DOI 10.1016/S0378-1119(97)00521-0; Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385; Sun X, 2014, CELL REPORTS, V8, P1; Sunami T, 2010, J BIOL CHEM, V285, P4587, DOI 10.1074/jbc.M109.040667; Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7; Tan SX, 2009, MOL BIOL CELL, V20, P1493, DOI 10.1091/mbc.E08-07-0697; Tennessen JM, 2014, METHODS, V68, P105, DOI 10.1016/j.ymeth.2014.02.034; Terhzaz S, 2010, PHYSIOL GENOMICS, V579, P633; Toivonen JM, 1999, MOL MICROBIOL, V31, P1735, DOI 10.1046/j.1365-2958.1999.01307.x; Toivonen JM, 2001, GENETICS, V159, P241; Vartiainen S, 2014, DIS MODEL MECH, V7, P635, DOI 10.1242/dmm.016527; Zhang YQ, 1999, GENETICS, V153, P891; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	72	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0145836	10.1371/journal.pone.0145836	http://dx.doi.org/10.1371/journal.pone.0145836			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812173	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528000004
J	Komuro, H; Sato, N; Sasaki, A; Suzuki, N; Kano, M; Tanaka, Y; Yamaguchi-Kabata, Y; Kanazawa, M; Warita, H; Aoki, M; Fukudo, S				Komuro, Hazuki; Sato, Naoko; Sasaki, Ayaka; Suzuki, Naoki; Kano, Michiko; Tanaka, Yukari; Yamaguchi-Kabata, Yumi; Kanazawa, Motoyori; Warita, Hitoshi; Aoki, Masashi; Fukudo, Shin			Corticotropin-Releasing Hormone Receptor 2 Gene Variants in Irritable Bowel Syndrome	PLOS ONE			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; MAJOR DEPRESSIVE DISORDER; ADULT DEPRESSION; CHILDHOOD MALTREATMENT; RECTAL DISTENSION; PANIC DISORDER; MOTOR FUNCTION; STRESS; ASSOCIATION; EXPRESSION	Background Corticotropin-releasing hormone (CRH) plays an important role in the pathophysiology of irritable bowel syndrome (IBS) and regulates the stress response through two CRH receptors (R1 and R2). Previously, we reported that a CRHR1 gene polymorphism (rs110402, rs242924, and rs7209436) and haplotypes were associated with IBS. However, the association between the CRHR2 gene and IBS was not investigated. We tested the hypothesis that genetic polymorphisms and haplotypes of CRHR2 are associated with IBS pathophysiology and negative emotion in IBS patients. Methods A total of 142 IBS patients and 142 healthy controls participated in this study. Seven single nucleotide polymorphisms (SNPs) of the CRHR2 gene (rs4722999, rs3779250, rs2240403, rs2267710, rs2190242, rs2284217, and rs2284220) were genotyped. Subjects' psychological states were evaluated using the Perceived-Stress Scale, the State-Trait Anxiety Inventory, and the Self-Rating Depression Scale. Results We found that rs4722999 and rs3779250, located in intronic region, were associated with IBS in terms of genotype frequency (rs4722999: P = 0.037; rs3779250: P = 0.017) and that the distribution of the major allele was significantly different between patients and controls. There was a significant group effect (controls vs. IBS), and a CRHR2 genotype effect was observed for three psychological scores, but the interaction was not significant. We found a haplotype of four SNPs (rs4722999, rs3779250, rs2240403, and rs2267710) and two SNPs (rs2284217 and rs2284220) in strong linkage disequilibrium (D' > 0.90). We also found that haplotypes of the CRHR2 gene were significantly different between IBS patients and controls and that they were associated with negative emotion. Conclusion Our findings support the hypothesis that genetic polymorphisms and haplotypes of CRHR2 are related to IBS. In addition, we found associations between CRHR2 genotypes and haplotypes and negative emotion in IBS patients and controls. Further studies on IBS and the CRH system are warranted.	[Komuro, Hazuki; Sato, Naoko; Sasaki, Ayaka; Kano, Michiko; Tanaka, Yukari; Kanazawa, Motoyori; Fukudo, Shin] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan; [Suzuki, Naoki; Aoki, Masashi] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Kano, Michiko] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 980, Japan; [Tanaka, Yukari; Yamaguchi-Kabata, Yumi] Tohoku Univ, Tohoku Med Megabank Org, Dept Integrat Genom, Sendai, Miyagi 980, Japan; [Yamaguchi-Kabata, Yumi] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Fukudo, Shin] Tohoku Univ Hosp, Dept Psychosomat Med, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Fukudo, S (corresponding author), Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan.; Fukudo, S (corresponding author), Tohoku Univ Hosp, Dept Psychosomat Med, Sendai, Miyagi, Japan.	sfukudo@med.tohoku.ac.jp	Warita, Hitoshi/T-1970-2019; Suzuki, Naoki/J-6331-2019; Fukudo, Shin/J-4813-2014	Warita, Hitoshi/0000-0001-7934-3863; Suzuki, Naoki/0000-0001-8880-8554; xing zhi, shi zhi/0000-0003-3289-5681	Ministry of Education, Science, and Culture of Japan [15H04799, 15H15267]; Ministry of Health, Welfare, and Labor of Japan [26-4]	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare, and Labor of Japan(Ministry of Health, Labour and Welfare, Japan)	This research was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan, No. 15H04799, 15H15267 (http://www.mext.go.jp/english/), and Grant-in-Aid for Scientific Research from the Ministry of Health, Welfare, and Labor of Japan (26-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JL, 2007, DEPRESS ANXIETY, V24, P66, DOI 10.1002/da.20220; Aizawa E, 2012, GASTROENTEROLOGY, V143, P1188, DOI 10.1053/j.gastro.2012.07.104; Akiba Y, 2015, DIGEST DIS SCI, V60, P858, DOI 10.1007/s10620-015-3579-y; Anisman H, 2008, NEUROSCI BIOBEHAV R, V32, P1185, DOI 10.1016/j.neubiorev.2008.03.001; Bale TL, 2005, HORM BEHAV, V48, P1, DOI 10.1016/j.yhbeh.2005.01.009; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bouin M, 2002, GASTROENTEROLOGY, V122, P1771, DOI 10.1053/gast.2002.33601; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; CHALMERS DT, 1995, J NEUROSCI, V15, P6340; Chang J, 2011, AM J PHYSIOL-GASTR L, V300, pG884, DOI 10.1152/ajpgi.00319.2010; Chang L, 2006, GASTROENTEROLOGY, V130, P1435, DOI 10.1053/j.gastro.2005.09.071; DeYoung CG, 2011, J CHILD PSYCHOL PSYC, V52, P898, DOI 10.1111/j.1469-7610.2011.02404.x; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; DUNN AJ, 1990, BRAIN RES REV, V15, P71, DOI 10.1016/0165-0173(90)90012-D; Fukuda K, 1973, Seishin Shinkeigaku Zasshi, V75, P673; Fukudo S, 1998, GUT, V42, P845, DOI 10.1136/gut.42.6.845; FUKUDO S, 1993, J CLIN GASTROENTEROL, V17, P133, DOI 10.1097/00004836-199309000-00009; Fukudo S, 2007, J GASTROENTEROL, V42, P48, DOI 10.1007/s00535-006-1942-7; Grammatopoulos D, 1998, J CLIN ENDOCR METAB, V83, P2539, DOI 10.1210/jc.83.7.2539; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Guillaume S, 2013, J PSYCHIATR RES, V47, P259, DOI 10.1016/j.jpsychires.2012.10.014; Heim C, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.041.2009; Im E, 2010, GASTROENTEROLOGY, V138, P2457, DOI 10.1053/j.gastro.2010.02.055; Ishitobi Y, 2012, AM J MED GENET B, V159B, P429, DOI 10.1002/ajmg.b.32046; Iwahasi S, 2002, JPN J PSYCHOSOM MED, V42, P459; Kanazawa M, 2004, DIGEST DIS SCI, V49, P1046, DOI 10.1023/B:DDAS.0000034570.52305.10; Kanazawa M, 2008, AM J GASTROENTEROL, V103, P2550, DOI 10.1111/j.1572-0241.2008.02066.x; Kostich WA, 1998, MOL ENDOCRINOL, V12, P1077, DOI 10.1210/me.12.8.1077; Liu ZC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01548; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; LOVENBERG TW, 1995, ENDOCRINOLOGY, V136, P4139, DOI 10.1210/en.136.9.4139; Mahajan S, 2014, PEPTIDES, V54, P58, DOI 10.1016/j.peptides.2014.01.007; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; Mertz H, 2000, GASTROENTEROLOGY, V118, P842, DOI 10.1016/S0016-5085(00)70170-3; Mizuno T, 2006, J PSYCHOSOM RES, V60, P91, DOI 10.1016/j.jpsychores.2005.06.068; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; NAKAZATO K, 1989, PERCEPT MOTOR SKILL, V69, P611, DOI 10.2466/pms.1989.69.2.611; NAPPI RE, 1995, BIOL REPROD, V53, P1417, DOI 10.1095/biolreprod53.6.1417; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Polanczyk G, 2009, ARCH GEN PSYCHIAT, V66, P978, DOI 10.1001/archgenpsychiatry.2009.114; Poon AH, 2008, PHARMACOGENET GENOM, V18, P373, DOI 10.1097/FPC.0b013e3282fa760a; Ringel Y, 2013, AM J PHYSIOL-GASTR L, V305, pG529, DOI 10.1152/ajpgi.00207.2012; Sagami Y, 2004, GUT, V53, P958, DOI 10.1136/gut.2003.018911; Sato N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042450; Smith R, 1998, J CLIN ENDOCR METAB, V83, P2916, DOI 10.1210/jc.83.8.2916; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Sumner JA, 2014, PSYCHONEUROENDOCRINO, V43, P71, DOI 10.1016/j.psyneuen.2014.02.002; TACHE Y, 1993, ANN NY ACAD SCI, V697, P233, DOI 10.1111/j.1749-6632.1993.tb49936.x; Valdenaire O, 1997, BBA-GENE STRUCT EXPR, V1352, P129, DOI 10.1016/S0167-4781(97)00047-X; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Villafuerte SM, 2002, AM J MED GENET, V114, P222, DOI 10.1002/ajmg.10179; VITA N, 1993, FEBS LETT, V335, P1, DOI 10.1016/0014-5793(93)80427-V; Wang YZ, 2014, MED SCI MONITOR, V20, P1246, DOI 10.12659/MSM.890315; Watts AG, 2005, FRONT NEUROENDOCRIN, V26, P109, DOI 10.1016/j.yfrne.2005.09.001; Wolf EJ, 2013, DEPRESS ANXIETY, V30, P1161, DOI 10.1002/da.22176; Yu F, 2014, GENET MOL RES, V13, P10285, DOI 10.4238/2014.December.4.23; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	59	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147817	10.1371/journal.pone.0147817	http://dx.doi.org/10.1371/journal.pone.0147817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808377	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800216
J	Kumar, S; Wang, J; Rani, R; Gandhi, CR				Kumar, Sudhir; Wang, Jiang; Rani, Richa; Gandhi, Chandrashekhar R.			Hepatic Deficiency of Augmenter of Liver Regeneration Exacerbates Alcohol-Induced Liver Injury and Promotes Fibrosis in Mice	PLOS ONE			English	Article							SULFUR CLUSTER BIOGENESIS; FAT-STORING CELLS; IRON OVERLOAD; SULFHYDRYL OXIDASE; HEREDITARY HEMOCHROMATOSIS; LIPID-PEROXIDATION; FRIEDREICHS-ATAXIA; INSULIN-RESISTANCE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS	Why only a subpopulation (about 15%) of humans develops liver cirrhosis due to alcohol is a critical as yet unanswered question. Liver-specific depletion of augmenter of liver regeneration (ALR) protein in mice causes robust steatosis and hepatocyte apoptosis by 2 weeks; these pathologies regress subsequently with return of ALR expression even at lower than control levels, but the mice develop modest steatohepatitis by 8 weeks. We aimed to investigate whether chronic alcohol ingestion promotes excessive hepatic fibrosis in these ALR-deficient mice. Liver-specific ALR-deficient and wild type (WT) female mice (8-10 weeks old) were placed on 4% alcohol-supplemented or isocaloric diet for 4 weeks. Liver sections were examined for histopathology, and parameters of steatosis and fibrosis were quantified. The mRNA expression of alcohol dehydrogenase-1, acetaldehyde dehydrogenase-1 and cytochrome P450-2E1 increased in WT mice but decreased in ALR-deficient mice upon alcohol ingestion. While alcohol induced steatosis and mild inflammation in WT mice, ALR-deficient mice showed minimal steatosis, strong hepatocellular injury and inflammation, prominent ductular proliferation, and robust fibrosis. Compared to the WT mice, alcohol feeding of ALR-deficient mice resulted in significantly greater increase in hepatic TNF alpha and TGF beta, and oxidative stress; there was also hepatic iron accumulation, robust lipid peroxidation and mitochondrial DNA damage. Importantly, similar to ALR-deficient mice, lower hepatic ALR levels in human alcoholic liver cirrhosis were associated with increased iron content, reduced expression of alcohol dehydrogenase and acetaldehyde dehydrogenase, and elevated fibrogenic markers. We conclude that ALR deficiency or anomaly can play a critical role in alcohol-induced hepatic fibrosis/cirrhosis, mechanisms of which may involve dysregulation of alcohol metabolism and iron homeostasis, mitochondrial damage and oxidative injury.	[Kumar, Sudhir; Rani, Richa; Gandhi, Chandrashekhar R.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA; [Kumar, Sudhir; Rani, Richa; Gandhi, Chandrashekhar R.] Cincinnati VA Med Ctr, Cincinnati, OH USA; [Wang, Jiang] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH USA; [Gandhi, Chandrashekhar R.] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Gandhi, CR (corresponding author), Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA.	gandhicr@ucmail.uc.edu	Kumar, Sudhir/J-3844-2019		National Institutes of Health; US Department of Veterans Affairs; US Department of Defence; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs); US Department of Defence(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (CRG), US Department of Veterans Affairs (CRG), and US Department of Defence (CRG).	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Babady NE, 2007, MOL GENET METAB, V92, P23, DOI 10.1016/j.ymgme.2007.05.009; BACON BR, 1990, HEPATOLOGY, V11, P127, DOI 10.1002/hep.1840110122; Bailey SM, 1998, HEPATOLOGY, V28, P1318, DOI 10.1002/hep.510280521; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Bridle KR, 2006, ALCOHOL CLIN EXP RES, V30, P106, DOI 10.1111/j.1530-0277.2006.00002.x; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; CASINI A, 1991, HEPATOLOGY, V13, P758, DOI 10.1016/0270-9139(91)92576-T; CASTILLO T, 1992, HEPATOLOGY, V16, P992, DOI 10.1002/hep.1840160423; Cederbaum AI, 2001, FREE RADICAL BIO MED, V31, P1539, DOI 10.1016/S0891-5849(01)00743-2; Chen H, 2014, WORLD J GASTROENTERO, V20, P8681, DOI 10.3748/wjg.v20.i26.8681; Chu AS, 2011, HEPATOLOGY, V53, P1685, DOI 10.1002/hep.24206; CUNNINGHAM CC, 1986, BIOCHIM BIOPHYS ACTA, V885, P12, DOI 10.1016/0167-4889(86)90033-9; Deaciuc IV, 2005, HEPATOL RES, V31, P187, DOI 10.1016/j.hepres.2005.02.004; Dongiovanni P, 2011, J HEPATOL, V55, P920, DOI 10.1016/j.jhep.2011.05.008; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Fleming RE, 2005, SEMIN LIVER DIS, V25, P411, DOI 10.1055/s-2005-923313; Francavilla A, 1997, HEPATOLOGY, V25, P411; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gandhi CR, 2015, GASTROENTEROLOGY, V148, P379, DOI 10.1053/j.gastro.2014.10.008; Gandhi CR, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-10; Gandhi CR, 2010, J CELL PHYSIOL, V222, P365, DOI 10.1002/jcp.21957; Gandhi CR, 1999, HEPATOLOGY, V29, P1435, DOI 10.1002/hep.510290522; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; GORWITZ K, 1970, Q J STUD ALCOHOL, V31, P423; Grundy MA, 2004, J BIOCHEM BIOPH METH, V59, P195, DOI 10.1016/j.jbbm.2004.01.001; Harrison-Findik DD, 2006, J BIOL CHEM, V281, P22974, DOI 10.1074/jbc.M602098200; Hasegawa D, 2015, STELLATE CELLS IN HEALTH AND DISEASE, P41, DOI 10.1016/B978-0-12-800134-9.00004-X; HE FH, 1993, HEPATOLOGY, V17, P225, DOI 10.1016/0270-9139(93)90081-W; Kohgo Y, 2007, WORLD J GASTROENTERO, V13, P4699, DOI 10.3748/wjg.v13.i35.4699; Koyama Y, 2015, STELLATE CELLS IN HEALTH AND DISEASE, P87, DOI 10.1016/B978-0-12-800134-9.00006-3; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Le Guenno G, 2007, DIABETES RES CLIN PR, V77, P363, DOI 10.1016/j.diabres.2007.02.004; LELBACH WK, 1975, ALCOHOLIC LIVER PATH, P1; LIEBER CS, 1988, J PHARMACOL EXP THER, V247, P791; Lin RC, 1991, DRUG ALCOHOL ABUSE R, V2, P221; LUMENG L, 1992, MEASURING ALCOHOL CONSUMPTION, P161; MATTHEWSON K, 1986, GUT, V27, P756, DOI 10.1136/gut.27.7.756; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; MOSHAGE H, 1990, HEPATOLOGY, V12, P511, DOI 10.1002/hep.1840120311; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Niemela O, 1999, J LAB CLIN MED, V133, P451, DOI 10.1016/S0022-2143(99)90022-7; NUUTINEN H, 1983, ALCOHOL CLIN EXP RES, V7, P163, DOI 10.1111/j.1530-0277.1983.tb05432.x; Pietrangelo Antonello, 1998, Journal of Hepatology, V28, P8, DOI 10.1016/S0168-8278(98)80368-1; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; RAY MB, 1993, LIVER, V13, P36; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; SCHMIDT W, 1972, Q J STUD ALCOHOL, V33, P171; Scholten D, 2010, GASTROENTEROLOGY, V139, P987, DOI 10.1053/j.gastro.2010.05.005; SORRELL MF, 1987, ANN NY ACAD SCI, V492, P50, DOI 10.1111/j.1749-6632.1987.tb48652.x; TAKAHASHI T, 1993, HEPATOLOGY, V17, P236, DOI 10.1016/0270-9139(93)90083-Y; TAKASE S, 1989, HEPATOLOGY, V9, P704, DOI 10.1002/hep.1840090508; Thasler WE, 2005, HISTOPATHOLOGY, V47, P57, DOI 10.1111/j.1365-2559.2005.02172.x; Thirunavukkarasu C, 2004, GUT, V53, P1010, DOI 10.1136/gut.2003.026534; Thirunavukkarasu C, 2008, J HEPATOL, V48, P578, DOI 10.1016/j.jhep.2007.12.010; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Tsuchiya H, 2013, METABOLISM, V62, P62, DOI 10.1016/j.metabol.2012.06.008; TSUKAMOTO H, 1995, J CLIN INVEST, V96, P620, DOI 10.1172/JCI118077; TSUTSUMI M, 1989, HEPATOLOGY, V10, P437, DOI 10.1002/hep.1840100407; Tury A, 2005, BRAIN RES, V1048, P87, DOI 10.1016/j.brainres.2005.04.050; Wang G, 1999, J BIOL CHEM, V274, P11469, DOI 10.1074/jbc.274.17.11469; Wang HY, 2014, DIABETES, V63, P1506, DOI 10.2337/db13-1195; Wu DF, 2004, MOL PHARMACOL, V66, P749, DOI 10.1124/mol.104.002048; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200	68	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147864	10.1371/journal.pone.0147864	http://dx.doi.org/10.1371/journal.pone.0147864			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808690	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800234
J	Pang, JJ; Fuller, ND; Hu, N; Barton, LA; Henion, JM; Guo, R; Chen, YG; Ren, J				Pang, Jiaojiao; Fuller, Nathan D.; Hu, Nan; Barton, Linzi A.; Henion, Jeremy M.; Guo, Rui; Chen, Yuguo; Ren, Jun			Alcohol Dehydrogenase Protects against Endoplasmic Reticulum Stress-Induced Myocardial Contractile Dysfunction via Attenuation of Oxidative Stress and Autophagy: Role of PTEN-Akt-mTOR Signaling	PLOS ONE			English	Article							ER STRESS; CARDIAC OVEREXPRESSION; INSULIN-RESISTANCE; ALDEHYDE; DEFICIENCY; HYPERTROPHY; ALDH2; SURVIVAL; CANCER; LIVER	Background The endoplasmic reticulum (ER) plays an essential role in ensuring proper folding of the newly synthesized proteins. Aberrant ER homeostasis triggers ER stress and development of cardiovascular diseases. ADH is involved in catalyzing ethanol to acetaldehyde although its role in cardiovascular diseases other than ethanol metabolism still remains elusive. This study was designed to examine the impact of ADH on ER stress-induced cardiac anomalies and underlying mechanisms involved using cardiac-specific overexpression of alcohol dehydrogenase (ADH). Methods ADH and wild-type FVB mice were subjected to the ER stress inducer tunicamycin (1 mg/kg, i.p., for 48 hrs). Myocardial mechanical and intracellular Ca2+ properties, ER stress, autophagy and associated cell signaling molecules were evaluated. Results ER stress compromised cardiac contractile function (evidenced as reduced fractional shortening, peak shortening, maximal velocity of shortening/relengthening, prolonged relengthening duration and impaired intracellular Ca2+ homeostasis), oxidative stress and upregulated autophagy (increased LC3B, Atg5, Atg7 and p62), along with dephosphorylation of PTEN, Akt and mTOR, all of which were attenuated by ADH. In vitro study revealed that ER stress-induced cardiomyocyte anomaly was abrogated by ADH overexpression or autophagy inhibition using 3-MA. Interestingly, the beneficial effect of ADH was obliterated by autophagy induction, inhibition of Akt and mTOR. ER stress also promoted phosphorylation of the stress signaling ERK and JNK, the effect of which was unaffected by ADH transgene. Conclusions Taken together, these findings suggested that ADH protects against ER stress-induced cardiac anomalies possibly via attenuation of oxidative stress and PTEN/Akt/mTOR pathway-regulated autophagy.	[Pang, Jiaojiao; Chen, Yuguo] Shandong Univ, Qilu Hosp, Dept Emergency, Jinan 250100, Shandong, Peoples R China; [Pang, Jiaojiao; Fuller, Nathan D.; Hu, Nan; Barton, Linzi A.; Henion, Jeremy M.; Guo, Rui; Ren, Jun] Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA; [Ren, Jun] Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Shanghai 200433, Peoples R China	Shandong University; University of Wyoming; Fudan University	Chen, YG (corresponding author), Shandong Univ, Qilu Hosp, Dept Emergency, Jinan 250100, Shandong, Peoples R China.; Ren, J (corresponding author), Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.; Ren, J (corresponding author), Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Shanghai 200433, Peoples R China.	chen919085@126.com; jren@uwyo.edu	Ren, Jun/ACG-5366-2022; Guo, Rui/ACH-5568-2022	Ren, Jun/0000-0002-0275-0783; 	National Natural Science Foundation of China [81570401]; Taishan Scholar Program of Shandong Province [ts20130911]; Fundamental Research Funds of Shandong University [2014QLKY04]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Program of Shandong Province; Fundamental Research Funds of Shandong University; China Scholarship Council(China Scholarship Council)	The work was funded in part by grants from the National Natural Science Foundation of China (81570401), Taishan Scholar Program of Shandong Province (ts20130911), the Fundamental Research Funds of Shandong University (2014QLKY04) and China Scholarship Council.	Brennan P, 2004, AM J EPIDEMIOL, V159, P1, DOI 10.1093/aje/kwh003; Bull VH, 2012, ELECTROPHORESIS, V33, P1814, DOI 10.1002/elps.201100565; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Dickhout JG, 2011, CIRC RES, V108, P629, DOI 10.1161/CIRCRESAHA.110.226803; Doser TA, 2009, CIRCULATION, V119, P1941, DOI 10.1161/CIRCULATIONAHA.108.823799; Druesne-Pecollo N, 2009, LANCET ONCOL, V10, P173, DOI 10.1016/S1470-2045(09)70019-1; Duan JH, 2002, AM J PHYSIOL-HEART C, V282, pH1216, DOI 10.1152/ajpheart.00780.2001; Edenberg HJ, 2007, ALCOHOL RES HEALTH, V30, P5; Fang CX, 2005, DIABETOLOGIA, V48, P2412, DOI 10.1007/s00125-005-1940-y; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Goto M, 2015, GENES CELLS, V20, P464, DOI 10.1111/gtc.12237; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Groenendyk J, 2013, ANNU REV PHYSIOL, V75, P49, DOI 10.1146/annurev-physiol-030212-183707; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Guerrero-Hernandez A, 2014, CELL CALCIUM, V56, P311, DOI 10.1016/j.ceca.2014.08.006; Guo KK, 2006, AGING CELL, V5, P259, DOI 10.1111/j.1474-9726.2006.00215.x; Guo R, 2012, CARDIOVASC RES, V94, P480, DOI 10.1093/cvr/cvs127; Guo R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008757; Hsu HC, 2016, EUR J NUTR, V55, P2031, DOI 10.1007/s00394-015-1017-8; Hu N, 2015, PHARMACOL RES, V100, P175, DOI 10.1016/j.phrs.2015.08.005; Li Q, 2007, REJUV RES, V10, P501, DOI 10.1089/rej.2007.0552; Li SY, 2008, J MOL CELL CARDIOL, V44, P992, DOI 10.1016/j.yjmcc.2008.02.276; Liu GY, 2015, ACTA PHARMACOL SIN, V36, P1473, DOI 10.1038/aps.2015.101; Ma H, 2011, EUR HEART J, V32, P1025, DOI 10.1093/eurheartj/ehq253; Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; Mollereau B, 2014, J CELL COMMUN SIGNAL, V8, P311, DOI 10.1007/s12079-014-0251-9; Noda NN, 2015, ANNU REV BIOPHYS, V44, P101, DOI 10.1146/annurev-biophys-060414-034248; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Panzhinskiy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077228; Ramirez S, 2015, FEBS LETT, V589, P1678, DOI 10.1016/j.febslet.2015.04.025; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Ren J, 2008, CRIT CARE MED, V36, P2106, DOI 10.1097/CCM.0b013e31817bf925; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; SELLIN S, 1991, BIOCHEMISTRY-US, V30, P2514, DOI 10.1021/bi00223a031; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Svensson S, 1996, FEBS LETT, V394, P217, DOI 10.1016/0014-5793(96)00954-4; Turdi S, 2010, AGING CELL, V9, P592, DOI 10.1111/j.1474-9726.2010.00586.x; Winnier DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119941; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Xin Q, 2014, NEUROCHEM INT, V68, P18, DOI 10.1016/j.neuint.2014.02.001; Xu XH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000439; Yang LF, 2014, TOXICOL LETT, V225, P333, DOI 10.1016/j.toxlet.2013.12.024; Yuan RR, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-45; Zhang BF, 2013, BBA-MOL BASIS DIS, V1832, P574, DOI 10.1016/j.bbadis.2013.01.013; Zhang N, 2015, J PHYSIOL BIOCHEM, V71, P319, DOI 10.1007/s13105-015-0384-1; Zhang YM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-40; Zhang YM, 2011, FREE RADICAL BIO MED, V51, P2172, DOI 10.1016/j.freeradbiomed.2011.09.005; Zhang YM, 2011, ANTIOXID REDOX SIGN, V15, P2407, DOI 10.1089/ars.2010.3751; Zhang YM, 2011, PHARMACOL THERAPEUT, V132, P86, DOI 10.1016/j.pharmthera.2011.05.008; Zhou YY, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140141	50	18	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147322	10.1371/journal.pone.0147322	http://dx.doi.org/10.1371/journal.pone.0147322			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807981	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800073
J	Petrova, A; Moffett, DF				Petrova, Adelina; Moffett, David Franklin			Comprehensive Immunolocalization Studies of a Putative Serotonin Receptor from the Alimentary Canal of Aedes aegypti Larvae Suggest Its Diverse Roles in Digestion and Homeostasis	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; MALPIGHIAN TUBULES; NUCLEAR-LOCALIZATION; DIURETIC HORMONE; ION-TRANSPORT; MIDGUT; MECHANISMS; EXPRESSION; ANTERIOR; RHODNIUS	Serotonin regulates key processes including digestion and homeostasis in insects. Serotonin effects are mediated by serotonin receptors that transduce information through initiation of second messenger signaling pathways. Lack of information on serotonin receptors associated with the alimentary canal impedes the understanding of the serotonergic role in insect physiology. To address this void, the present study has cloned and identified a putative serotonin receptor (hereafter AaSeR-1) from the alimentary canal of Aedes aegypti (yellow fever mosquito) larvae. In addition to in-silico analyses of AaSeR-1 primary sequence, immunohistochemical investigations were carried out to elucidate receptor expression patterns. Specific AaSeR-1 immunofluorescence was detected in the caeca, the mid- and hind-gut, including the Malpighian tubules. These findings point out not only receptor ubiquitous nature but also its involvement in regulation of different stages of nutrient processing and homeostasis. Furthermore, AaSeR-1 may mediate an array of effects through its differential expression at various cell compartments. While AaSeR-1 specific immunofluorescence was depicted in the nucleus and nucleolus of principal cells of the anterior midgut, in the posterior, analyses suggest receptor association with the plasma membrane of both principal and regenerative cells. In addition, AaSeR-1 immunofluorescence was also found in some enteroendocrine cells and in both circular and longitudinal muscles that innervate the alimentary canal. Overall, immunohistochemical analyses of AaSeR-1 expression indicate that this receptor exercises multiple roles in digestion-and homeostasis-related mechanisms.	[Petrova, Adelina; Moffett, David Franklin] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	Washington State University	Petrova, A (corresponding author), Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.	adelina.petrova@wsu.edu			National Institutes of Health [1R01AI063463-01A2]; College of Arts and Sciences, Office of Commercialization at the WSU, Pullman, WA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Arts and Sciences, Office of Commercialization at the WSU, Pullman, WA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study has been funded by National Institutes of Health grant (1R01AI063463-01A2), College of Arts and Sciences, Office of Commercialization at the WSU, Pullman, WA and financial assistance from Prof Len Kirschner, Prof David Moffett and Dr. Petrova.	ALI DW, 1994, BIOGENIC AMINES, V10, P195; Anstey ML, 2009, SCIENCE, V323, P627, DOI 10.1126/science.1165939; AUDSLEY N, 1993, J EXP BIOL, V178, P231; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Beyenbach KW, 2003, J EXP BIOL, V206, P3845, DOI 10.1242/jeb.00639; Blenau W, 2011, ARTHROPOD STRUCT DEV, V40, P381, DOI 10.1016/j.asd.2011.01.004; Blundell JE, 1995, OBES RES, V3, pS471, DOI 10.1002/j.1550-8528.1995.tb00214.x; Boivin B, 2005, J MOL CELL CARDIOL, V38, P665, DOI 10.1016/j.yjmcc.2005.02.011; Boivin B, 2006, CARDIOVASC RES, V71, P69, DOI 10.1016/j.cardiores.2006.03.015; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Chapman R. F, 1998, INSECTS STRUCTURE FU, P38; Clark TM, 1999, J EXP BIOL, V202, P247; Clark TM, 1996, J INSECT PHYSIOL, V42, P593, DOI 10.1016/0022-1910(95)00124-7; Clements A.N., 1992, BIOL MOSQUITOES, V1, P231; Coast GM, 2009, J EXP BIOL, V212, P378, DOI 10.1242/jeb.024109; Cook JVF, 1997, ENDOCRINOLOGY, V138, P2800, DOI 10.1210/en.138.7.2800; Dierick HA, 2007, NAT GENET, V39, P678, DOI 10.1038/ng2029; Doufexis M, 2007, FASEB J, V21, P4095, DOI 10.1096/fj.06-7927com; Frazer A., 1999, BASIC NEUROCHEMISTRY; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gobeil F, 2002, CIRC RES, V90, P682, DOI 10.1161/01.RES.0000013303.17964.7A; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Jagadeshwaran U, 2010, J EXP BIOL, V213, P295, DOI 10.1242/jeb.037549; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Koladich PM, 2002, J EXP BIOL, V205, P3123; Kumar V, 2008, J BIOL CHEM, V283, P14072, DOI 10.1074/jbc.M708551200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LaJeunesse Dennis R., 2010, BMC Physiology, V10, P14, DOI 10.1186/1472-6793-10-14; Leary DJ, 2001, FEBS LETT, V509, P145, DOI 10.1016/S0014-5793(01)03143-X; MADDRELL SH, 1971, J EXP BIOL, V54, P779; MADDRELL SHP, 1991, J EXP BIOL, V156, P557; MADDRELL SHP, 1993, J EXP BIOL, V177, P273; Massfelder T, 1997, P NATL ACAD SCI USA, V94, P13630, DOI 10.1073/pnas.94.25.13630; Meethal SV, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-103; Moffett SB, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.20; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Nordquist N, 2010, UPSALA J MED SCI, V115, P2, DOI 10.3109/03009730903573246; OMARY MB, 1987, SCIENCE, V238, P1578, DOI 10.1126/science.2825352; Onken H, 2004, J EXP BIOL, V207, P3731, DOI 10.1242/jeb.01208; Onken H, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.4601; Onken H, 2009, J EXP BIOL, V212, P2571, DOI 10.1242/jeb.030221; Pietrantonio PV, 2001, INSECT MOL BIOL, V10, P357, DOI 10.1046/j.0962-1075.2001.00274.x; Portas CM, 2000, PROG NEUROBIOL, V60, P13, DOI 10.1016/S0301-0082(98)00097-5; Re M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011489; Re R, 1999, HYPERTENSION, V34, P534, DOI 10.1161/01.HYP.34.4.534; Rhee MH, 2000, FEBS LETT, V466, P300, DOI 10.1016/S0014-5793(00)01094-2; Robitaille M, 2010, CELL SIGNAL, V22, P1254, DOI 10.1016/j.cellsig.2010.04.005; Roser C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049459; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Sastri M, 2005, P NATL ACAD SCI USA, V102, P349, DOI 10.1073/pnas.0408608102; Sato M, 2011, J BIOL CHEM, V286, P17766, DOI 10.1074/jbc.M111.219816; Savard M, 2008, J CELL PHYSIOL, V216, P234, DOI 10.1002/jcp.21398; Schlenstedt J, 2006, J NEUROCHEM, V98, P1985, DOI 10.1111/j.1471-4159.2006.04012.x; Sehnal F., 1996, P55; Sepulveda VAT, 2002, ENDOCRINOLOGY, V143, P596, DOI 10.1210/en.143.2.596; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Terra W. R., 1996, P206; Thamm M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082407; Vleugels R, 2014, INSECT MOL BIOL, V23, P230, DOI 10.1111/imb.12076; Vleugels R., 2015, NEUROTRANSMITTER, V2, P314, DOI 10.14800/nt.314; VOLKMANN A, 1989, TISSUE CELL, V21, P243, DOI 10.1016/0040-8166(89)90069-4; Watson PH, 2000, J BONE MINER RES, V15, P1033, DOI 10.1359/jbmr.2000.15.6.1033; WITZ P, 1990, P NATL ACAD SCI USA, V87, P8940, DOI 10.1073/pnas.87.22.8940; Wright Geraldine A, 2011, Commun Integr Biol, V4, P318, DOI 10.4161/cib.4.3.14840; Zhang JH, 2001, J BIOL CHEM, V276, P10284, DOI 10.1074/jbc.M009247200; Zornik E, 1999, PEPTIDES, V20, P45, DOI 10.1016/S0196-9781(98)00151-X	67	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146587	10.1371/journal.pone.0146587	http://dx.doi.org/10.1371/journal.pone.0146587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808995	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800027
J	Skerry, C; Klinkenberg, LG; Page, KR; Karakousis, PC				Skerry, Ciaran; Klinkenberg, Lee G.; Page, Kathleen R.; Karakousis, Petros C.			TLR2-Modulating Lipoproteins of the Mycobacterium tuberculosis Complex Enhance the HIV Infectivity of CD4+T Cells	PLOS ONE			English	Article							SUSCEPTIBILITY; EXPRESSION; PREVENTION; VIRULENCE; RAKAI	Co-infection with Mycobacterium tuberculosis accelerates progression from HIV to AIDS. Our previous studies showed that M. tuberculosis complex, unlike M. smegmatis, enhances TLR2-dependent susceptibility of CD4+ T cells to HIV. The M. tuberculosis complex produces multiple TLR2-stimulating lipoproteins, which are absent in M. smegmatis. M. tuberculosis production of mature lipoproteins and TLR2 stimulation is dependent on cleavage by lipoprotein signal peptidase A (LspA). In order to determine the role of potential TLR2-stimulating lipoproteins on mycobacterial-mediated HIV infectivity of CD4+ T cells, we generated M. smegmatis recombinant strains overexpressing genes encoding various M. bovis BCG lipoproteins, as well as a Mycobacterium bovis BCG strain deficient in LspA (Delta/spA). Exposure of human peripheral blood mononuclear cells (PBMC) to M. smegmatis strains overexpressing the BCG lipoproteins, LprF (p<0.01), LprH (p<0.05), LprI (p<0.05), LprP (p<0.001), LprQ (p<0.005), MPT83 (p<0.005), or PhoS1 (p<0.05), resulted in increased HIV infectivity of CD4+ T cells isolated from these PBMC. Conversely, infection of PBMC with Delta/spA reduced HIV infectivity of CD4+ T cells by 40% relative to BCG-infected cells (p<0.05). These results may have important implications for TB vaccination programs in areas with high mother-to-child HIV transmission.	[Skerry, Ciaran; Klinkenberg, Lee G.; Page, Kathleen R.; Karakousis, Petros C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Karakousis, Petros C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Karakousis, PC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.; Karakousis, PC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.	petros@jhmi.edu	Skerry, Ciaran/AAX-8291-2020; Karakousis, Petros Constantine/AAR-7899-2020		Johns Hopkins University Center for AIDS Research, a National Institutes of Health-funded program [P30AI094189]; National Institutes of Health [K23HD056957]; NIH [K23HD056957]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD056957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Johns Hopkins University Center for AIDS Research, a National Institutes of Health-funded program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported in part by a developmental grant from the Johns Hopkins University Center for AIDS Research, a National Institutes of Health-funded program (P30AI094189) to LGK, and the National Institutes of Health under award number K23HD056957 to KRP. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funding sources had no role in the study design, data collection, data analysis, data interpretation, decision to publish, or writing of the manuscript.; Financial support: Research reported in this publication was supported in part by a developmental grant from the Johns Hopkins University Center for AIDS Research, an NIH-funded program (P30AI094189) to LGK, and the NIH under award number K23HD056957 to KRP. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banaiee N, 2007, J ANTIMICROB CHEMOTH, V60, P414, DOI 10.1093/jac/dkm223; Banaiee N, 2006, J IMMUNOL, V176, P3019, DOI 10.4049/jimmunol.176.5.3019; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; Drage MG, 2010, NAT STRUCT MOL BIOL, V17, P1088, DOI 10.1038/nsmb.1869; Gordhan B G, 2001, Methods Mol Med, V54, P77, DOI 10.1385/1-59259-147-7:077; Gray RH, 1999, AIDS, V13, P2113, DOI 10.1097/00002030-199910220-00015; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; HENG MCY, 1994, LANCET, V343, P255, DOI 10.1016/S0140-6736(94)91110-X; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Kalinkovich A, 2001, CLIN IMMUNOL, V100, P107, DOI 10.1006/clim.2001.5040; Kaul R, 2011, AM J REPROD IMMUNOL, V65, P317, DOI 10.1111/j.1600-0897.2010.00962.x; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; KREMER L, 1995, MOL MICROBIOL, V17, P913, DOI 10.1111/j.1365-2958.1995.mmi_17050913.x; Krishna S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028476; Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52; Lamichhane G, 2011, MBIO, V2, DOI 10.1128/mBio.00301-10; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; Mak TK, 2008, LANCET, V372, P786, DOI 10.1016/S0140-6736(08)61318-5; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Rodriguez ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080938; Sander P, 2004, MOL MICROBIOL, V52, P1543, DOI 10.1111/j.1365-2958.2004.04041.x; Sarkar D, 2011, J BACTERIOL, V193, P2336, DOI 10.1128/JB.00065-11; Thayil SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041093; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; UNAIDS, 2014 GLOB STAT; WHO, 2011, TB DAT 2011; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004	30	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147192	10.1371/journal.pone.0147192	http://dx.doi.org/10.1371/journal.pone.0147192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807859	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800058
J	Wang, C; Li, X; Zhang, YJ; Xu, Q; Huang, FF; Cao, K; Tao, LX; Guo, J; Gao, Q; Wang, W; Fang, LQ; Guo, XH				Wang, Chao; Li, Xia; Zhang, Yingjie; Xu, Qin; Huang, Fangfang; Cao, Kai; Tao, Lixin; Guo, Jin; Gao, Qi; Wang, Wei; Fang, Liqun; Guo, Xiuhua			Spatiotemporal Cluster Patterns of Hand, Foot, and Mouth Disease at the County Level in Mainland China, 2008-2012	PLOS ONE			English	Article							ASSOCIATION	Background Hand, foot, and mouth disease (HFMD) is known to be a highly contagious childhood illness. In recent years, the number of reported cases of HFMD has significantly increased in mainland China. This study aims at the epidemiological features, spatiotemporal patterns of HMFD at the county/district level in mainland China. Methods Data on reported HFMD cases for each county from 1 January 2008 to 31 December 2012 were obtained from the Chinese Center for Disease Control and Prevention. Cluster analysis, spatial autocorrelation, and retrospective scan methods were used to explore the spatiotemporal patterns of the disease. Results The annual incidences varied greatly among the counties, ranging from 0 to 74.31% with the median of 5.42%(interquartile range: 1.54%-13.55%) during 2008-2012 in mainland China. Counties close to provincial capital cities generally had higher incidences than rural counties. A seasonal distribution was observed between the northern and southern China, of which dual epidemic were shown in southern China and usually only one in northern China. Based on the global and local spatial autocorrelation analysis, we found that the spatial distribution of HFMD was presented a significant clustering pattern for each year (P<0.001), and hotspots of the disease were mostly distributed in coastal provinces of China. The retrospective scan statistic further identified the dynamics of spatiotemporal clustering areas of the disease, which were mainly distributed in the counties of eastern and southern China, as well as provincial capitals and their surrounding counties. Conclusions The spatiotemporal clustering areas of the disease identified in this way were relatively stable, and imminent public health planning and resource allocation should be focused within those areas.	[Wang, Chao; Li, Xia; Xu, Qin; Huang, Fangfang; Cao, Kai; Tao, Lixin; Guo, Jin; Gao, Qi; Wang, Wei; Guo, Xiuhua] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Wang, Chao; Li, Xia; Xu, Qin; Huang, Fangfang; Cao, Kai; Tao, Lixin; Guo, Jin; Gao, Qi; Wang, Wei; Guo, Xiuhua] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Li, Xia] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [Zhang, Yingjie] Chinese Ctr Dis Control & Prevent, Natl Ctr Publ Hlth, Surveillance & Informat Serv, Beijing, Peoples R China; [Wang, Wei] Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia; [Fang, Liqun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Capital Medical University; University of Limerick; Chinese Center for Disease Control & Prevention; Edith Cowan University; Beijing Institute of Microbiology & Epidemiology	Guo, XH (corresponding author), Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China.; Guo, XH (corresponding author), Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China.; Fang, LQ (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	fang_lq@163.com; guoxiuh@ccmu.edu.cn	Zhang, Yingjie/HHM-3016-2022; Gao, Qi/N-8721-2019; Ibrahim, Essam Hassan/G-1960-2018; Fang, Li-Qun/GWD-0296-2022; TAO, Li/HIR-4254-2022	Ibrahim, Essam Hassan/0000-0003-0130-2257; Wang, Chao/0000-0002-7172-8256; Gao, Qi/0000-0002-5370-5536	National Science and Technology Major Project [2012ZX10005009-003, 2014ZX10004005-001]; National 973 Project [2011CB505404]; National Natural Science Foundation of China [81302516]	National Science and Technology Major Project; National 973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	XG is supported by National Science and Technology Major Project (2012ZX10005009-003 and 2014ZX10004005-001, URL: http://www.nmp.gov.cn/) and National 973 Project(Serial Number: 2011CB505404, URL: http://www.973.gov.cn/). XL is supported by National Natural Science Foundation of China (serial no.: 81302516 URL: http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L., 1996, SPATIAL ANAL PERSPEC, P111, DOI [10.1201/9780203739051-8, DOI 10.1201/9780203739051-8]; Cao HaiLan, 2012, Modern Preventive Medicine, V39, P148; Chan Ta-Chien, 2010, INFECT DIS INFORM BI, P208; Chen YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126158; Chen YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068336; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; DUFF MF, 1968, BMJ-BRIT MED J, V2, P661, DOI 10.1136/bmj.2.5606.661; Higgs BW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001284; Hsu CH, 2011, J MICROBIOL IMMUNOL, V44, P265, DOI 10.1016/j.jmii.2011.01.029; Hu MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038978; Hu YueHua, 2014, Disease Surveillance, V29, P827; Huang Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-134; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Liu L, 2015, EPIDEMIOL INFECT, V143, P831, DOI 10.1017/S0950268814001587; Liu S, 2011, DIS SURVEILLANCE, V26, P499; Liu WD, 2012, ZHONGHUA LIU XING BI, V33, P813; Liu Yang, 2013, Biomed Res Int, V2013, P839683, DOI 10.1155/2013/839683; Ma E, 2010, JPN J INFECT DIS, V63, P422; Ma E, 2010, INT J INFECT DIS, V14, pE775, DOI 10.1016/j.ijid.2010.02.2265; Morrison AC, 1998, AM J TROP MED HYG, V58, P287, DOI 10.4269/ajtmh.1998.58.287; National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division Ministry of Health Labour and Welfare, 2012, IASR, V33, P55; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; Puenpa J, 2011, ARCH VIROL, V156, P2007, DOI 10.1007/s00705-011-1098-5; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; [唐咸艳 Tang Xianyan], 2011, [中华流行病学杂志, Chinese Journal of Epidemiology], V32, P274; The Ministry of Health of the People's Republic of China, 2008, CAP J PUBLIC HLTH, P146; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang H, 2015, INT J INFECT DIS, V34, P66, DOI 10.1016/j.ijid.2015.03.007; Wang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092745; Wang JF, 2013, GEOSPATIAL HEALTH, V7, P381, DOI 10.4081/gh.2013.95; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Xiao Ge-xin, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P808; Xie YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085440, 10.1371/journal.pone.0088065]; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005	39	20	31	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147532	10.1371/journal.pone.0147532	http://dx.doi.org/10.1371/journal.pone.0147532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809151	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800124
J	Heuser, S; Hufbauer, M; Steiger, J; Marshall, J; Sterner-Kock, A; Mauch, C; Zigrino, P; Akgul, B				Heuser, S.; Hufbauer, M.; Steiger, J.; Marshall, J.; Sterner-Kock, A.; Mauch, C.; Zigrino, P.; Akguel, B.			The fibronectin/alpha 3 beta 1 integrin axis serves as molecular basis for keratinocyte invasion induced by beta HPV	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN-PAPILLOMAVIRUS TYPE-8; SQUAMOUS-CELL CARCINOMA; SKIN TUMOR-FORMATION; TRANSGENIC MICE; E-CADHERIN; UP-REGULATION; STEM-CELLS; ORGANOTYPIC CULTURES; EARLY GENES	Organ-transplant-recipients exhibit cancerization of the skin from which multiple human papillomavirus (HPV)-positive squamous cell carcinomas (SCCs) arise. However, the molecular basis for HPV-induced invasion of skin keratinocytes is not known. We generated a transgenic mouse model expressing the E7 oncoprotein of HPV8 in the murine epidermis under the control of the keratin-14 promoter and showed that E7 is carcinogenic in mice. We further showed that both, the E7-expressing keratinocyte and mesenchymal components of the extracellular matrix as critical in eliciting the invasive behavior. E7 expression in basal keratinocytes, grown on fibronectin, led to epithelial-mesenchymal transition mediated by a cadherin switch. E7-positive keratinocytes displayed enhanced EDA-fibronectin expression and secretion and stimulated dermal fibroblasts to express EDA-fibronectin. Deposition of fibronectin was also detected in the peritumoral stroma of HPV8-positive skin SCC. When grown on fibronectin, E7-positive keratinocytes, in particular stem cell-like cells, exhibited increased cell surface levels of the alpha 3-integrin chain. Functional blocking confirmed alpha 3 as a critical molecule sufficient to induce E7-mediated invasion. This mechanistic link is further supported by expression of an E7-mutant, impaired in targeting alpha 3 to the cell surface. These findings highlight the importance of epithelial-extracellular matrix interaction required for keratinocyte invasion and provide further mechanistic evidence for a role of HPV in skin carcinogenesis.	[Heuser, S.; Hufbauer, M.; Akguel, B.] Univ Cologne, Inst Virol, Furst Puckler Str 56, D-50935 Cologne, Germany; [Steiger, J.; Mauch, C.; Zigrino, P.] Univ Cologne, Dept Dermatol & Venerol, Cologne, Germany; [Marshall, J.] Queen Mary Univ London, Barts Canc Inst, Ctr Tumour Biol, John Vane Sci Ctr, London, England; [Sterner-Kock, A.] Univ Cologne, Univ Hosp, Ctr Med Expt, Cologne, Germany	University of Cologne; University of Cologne; University of London; Queen Mary University London; University of Cologne	Akgul, B (corresponding author), Univ Cologne, Inst Virol, Furst Puckler Str 56, D-50935 Cologne, Germany.	baki.akguel@uk-koeln.de	Akgül, Baki/H-5629-2019; Hufbauer, Martin/AAZ-5473-2020	Akgül, Baki/0000-0002-6564-9412; Zigrino, Paola/0000-0002-7470-0064	Wilhelm-Sander-Stiftung, Germany [2012.105.1, 2012.105.2]; Deutsche Forschungsgemeinschaft [SFB 829]; Deutsche Krebshilfe [111087]	Wilhelm-Sander-Stiftung, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	We thank Herbert Pfister for helpful discussions, Esther Mahabir-Brenner (Animal Facility, Centre of Molecular Medicine Cologne (CMMC)) for generation of the K14-HPV8-E7 mice, John Doorbar for providing HPV8-E4 antibodies and Manuel Koch for collagen IV antibodies. This study was supported by the Wilhelm-Sander-Stiftung, Germany (grant no. 2012.105.1; 2012.105.2) to BA and by the Deutsche Forschungsgemeinschaft through SFB 829 (B4) to CM. MH was supported by the Deutsche Krebshilfe (no. 111087), which was granted to BA.	Aggarwal A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-459; Akgul B, 2007, EXP DERMATOL, V16, P590, DOI 10.1111/j.1600-0625.2007.00569.x; Akgul B, 2011, J GEN VIROL, V92, P395, DOI 10.1099/vir.0.025064-0; Akgul B, 2006, J PATHOL, V208, P165, DOI 10.1002/path.1893; Akgul B, 2005, CANCER RES, V65, P2216, DOI 10.1158/0008-5472.CAN-04-1952; Benton G, 2011, INT J CANCER, V128, P1751, DOI 10.1002/ijc.25781; Boxman ILA, 2001, J INVEST DERMATOL, V117, P1397, DOI 10.1046/j.0022-202x.2001.01602.x; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chen SH, 2010, ANTICANCER RES, V30, P4177; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; DiPersio CM, 1997, J CELL BIOL, V137, P729, DOI 10.1083/jcb.137.3.729; Euvrard S, 2012, NEW ENGL J MED, V367, P329, DOI 10.1056/NEJMoa1204166; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Hellner K, 2009, VIROLOGY, V391, P57, DOI 10.1016/j.virol.2009.05.036; Howley PM, 2015, VIROLOGY, V479, P290, DOI 10.1016/j.virol.2015.02.004; Hufbauer M, 2010, VIROLOGY, V403, P128, DOI 10.1016/j.virol.2010.04.013; Hufbauer M, 2013, J VIROL, V87, P12158, DOI 10.1128/JVI.01510-13; Hufbauer M, 2011, J DERMATOL SCI, V64, P7, DOI 10.1016/j.jdermsci.2011.06.008; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; Jones SM, 2006, NAT REV CANCER, V6, P175, DOI 10.1038/nrc1817; Kurtz KA, 2006, OTOLARYNG HEAD NECK, V134, P142, DOI 10.1016/j.otohns.2005.08.026; Lazic D, 2011, J DERMATOL SCI, V62, P84, DOI 10.1016/j.jdermsci.2011.02.006; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Leverrier S, 2007, APOPTOSIS, V12, P549, DOI 10.1007/s10495-006-0004-1; Lunt SJ, 2009, CLIN EXP METASTAS, V26, P19, DOI 10.1007/s10585-008-9182-2; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcuzzi GP, 2014, MED MICROBIOL IMMUN, V203, P155, DOI 10.1007/s00430-014-0327-4; Marcuzzi GP, 2009, J GEN VIROL, V90, P2855, DOI 10.1099/vir.0.012872-0; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Margulis A, 2006, INT J CANCER, V118, P821, DOI 10.1002/ijc.21409; Margulis A, 2005, CANCER RES, V65, P1783, DOI 10.1158/0008-5472.CAN-04-3399; Missan DS, 2014, J INVEST DERMATOL, V134, P2418, DOI 10.1038/jid.2014.166; Missan DS, 2012, CRIT REV EUKAR GENE, V22, P309, DOI 10.1615/CritRevEukarGeneExpr.v22.i4.50; Nystrom ML, 2005, J PATHOL, V205, P468, DOI 10.1002/path.1716; O'Shaughnessy RFL, 2007, CANCER RES, V67, P8207, DOI 10.1158/0008-5472.CAN-07-0755; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Peh WL, 2005, METH MOLEC MED, V119, P49; Pfefferle R, 2008, J INVEST DERMATOL, V128, P2310, DOI 10.1038/jid.2008.73; Quint KD, 2015, J PATHOL, V235, P342, DOI 10.1002/path.4425; Sachs N, 2012, P NATL ACAD SCI USA, V109, P21468, DOI 10.1073/pnas.1204614110; Schaper ID, 2005, CANCER RES, V65, P1394, DOI 10.1158/0008-5472.CAN-04-3263; Schmidt DS, 2004, EXP CELL RES, V297, P329, DOI 10.1016/j.yexcr.2004.02.023; Sun XJ, 2014, CARCINOGENESIS, V35, P184, DOI 10.1093/carcin/bgt276; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; van Roy F, 2014, NAT REV CANCER, V14, P121, DOI 10.1038/nrc3647; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vinzon SE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003924; Westphal K, 2009, CELL ONCOL, V31, P213, DOI 10.3233/CLO-2009-0476; Zhang WT, 2006, J CELL SCI, V119, P283, DOI 10.1242/jcs.02738	49	24	24	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	34					4529	4539		10.1038/onc.2015.512	http://dx.doi.org/10.1038/onc.2015.512			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU4AC	26804167				2022-12-26	WOS:000382153100010
J	Smoothey, AF; Gray, CA; Kennelly, SJ; Masens, OJ; Peddemors, VM; Robinson, WA				Smoothey, Amy F.; Gray, Charles A.; Kennelly, Steve J.; Masens, Oliver J.; Peddemors, Victor M.; Robinson, Wayne A.			Patterns of Occurrence of Sharks in Sydney Harbour, a Large Urbanised Estuary	PLOS ONE			English	Article							JUVENILE BULL SHARKS; NEW-SOUTH-WALES; CARCHARHINUS-LEUCAS; GALEOCERDO-CUVIER; MOVEMENT PATTERNS; TIGER SHARKS; HETERODONTUS-PORTUSJACKSONI; NOTORYNCHUS-CEPEDIANUS; REPRODUCTIVE-BIOLOGY; POPULATION-STRUCTURE	Information about spatial and temporal variability in the distribution and abundance of shark-populations are required for their conservation, management and to update measures designed to mitigate human-shark interactions. However, because some species of sharks are mobile, migratory and occur in relatively small numbers, estimating their patterns of distribution and abundance can be very difficult. In this study, we used a hierarchical sampling design to examine differences in the composition of species, size-and sex-structures of sharks sampled with bottom-set longlines in three different areas with increasing distance from the entrance of Sydney Harbour, a large urbanised estuary. During two years of sampling, we obtained data for four species of sharks (Port Jackson, Heterodontus portusjack-soni; wobbegong, Orectolobus maculatus; dusky whaler, Carcharhinus obscurus and bull shark, Carcharhinus leucas). Only a few O. maculatus and C. obscurus were caught, all in the area closest to the entrance of the Harbour. O. maculatus were caught in all seasons, except summer, while C. obscurus was only caught in summer. Heterodontus portusjack-soni were the most abundant species, caught in the entrance location mostly between July to November, when water temperature was below 21.5 degrees C. This pattern was consistent across both years. C. leucas, the second most abundant species, were captured in all areas of Sydney Harbour but only in summer and autumn when water temperatures were above 23 degrees C. This study quantified, for this first time, how different species utilise different areas of Sydney Harbour, at different times of the year. This information has implications for the management of human-shark interactions, by enabling creation of education programs to modify human behaviour in times of increased risk of potentially dangerous sharks.	[Smoothey, Amy F.; Masens, Oliver J.; Peddemors, Victor M.] Sydney Inst Marine Sci, NSW Dept Primary Ind, Mosman, NSW, Australia; [Gray, Charles A.] WildFish Res, Grays Point, NSW, Australia; [Kennelly, Steve J.] IC Independent Consulting, Cronulla, NSW, Australia; [Robinson, Wayne A.] Charles Sturt Univ, Sch Environm Sci, Thurgoona, NSW, Australia	NSW Department of Primary Industries; Sydney Institute of Marine Science; Charles Sturt University	Smoothey, AF (corresponding author), Sydney Inst Marine Sci, NSW Dept Primary Ind, Mosman, NSW, Australia.	amy.smoothey@dpi.nsw.gov.au	Peddemors, Victor M/Q-4281-2016	ROBINSON, WAYNE/0000-0002-8793-7466; Peddemors, Victor/0000-0002-8743-9782; Gray, Charles/0000-0001-9939-9995	NSW Department of Primary Industries	NSW Department of Primary Industries	This study was supported by funds from NSW Department of Primary Industries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors can confirm that SJK is now employed by IC Independent Consulting, NSW, Australia and CAG is now employed by WildFish Research, Grays Point, NSW, Australia. Both researchers were employed by NSW Department of Primary Industries when the study was designed, data collected, initially analysed and the decision made to publish. The funders (IC Independent Consulting and WildFish Research) provided support in the form of salaries for authors (SJK & CAG, respectively), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'authors contributions' section.	Afonso AS, 2014, J EXP MAR BIOL ECOL, V454, P55, DOI 10.1016/j.jembe.2014.02.008; Barnett A, 2010, J FISH BIOL, V77, P1688, DOI 10.1111/j.1095-8649.2010.02810.x; Barnett A, 2012, OIKOS, V121, P882, DOI 10.1111/j.1600-0706.2011.20000.x; Barnett A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015464; Barnett A, 2010, MAR ECOL PROG SER, V416, P189, DOI 10.3354/meps08778; Bernal D, 2012, CRC MAR BIOL SER, P211; Broadhurst MK, 2014, GLOB ECOL CONSERV, V2, P181, DOI 10.1016/j.gecco.2014.09.005; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carrier JC, 2004, CRC MAR BIOL SER, P269; Cavanaugh JE, 1997, STAT PROBABIL LETT, V33, P201, DOI 10.1016/S0167-7152(96)00128-9; Chapman MG, 2002, AUSTRAL ECOL, V27, P211, DOI 10.1046/j.1442-9993.2002.01172.x; Chin A, 2013, AQUAT CONSERV, V23, P468, DOI 10.1002/aqc.2349; Chin A, 2013, J FISH BIOL, V82, P1192, DOI 10.1111/jfb.12057; CLIFF G, 1991, S AFR J MARINE SCI, V10, P253; Clynick B, 2002, MAR FRESHWATER RES, V53, P669, DOI 10.1071/MF00147; Clynick BG, 2008, AUSTRAL ECOL, V33, P140, DOI 10.1111/j.1442-9993.2007.01802.x; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; Daly R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109357; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Froeschke JT, 2013, CAN J FISH AQUAT SCI, V70, P13, DOI 10.1139/cjfas-2012-0037; Gaston K.J., 1994, RARITY, P1; Gibbs L, 2015, MAR POLICY, V58, P116, DOI 10.1016/j.marpol.2015.04.014; Gibbs L, 2014, AUST GEOGR, V45, P101, DOI 10.1080/00049182.2014.899023; Grubbs RD, SHARK NURS GROUNDS G, P87; Hammerschlag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045958; Heithaus MR, 2008, J EXP MAR BIOL ECOL, V356, P43, DOI 10.1016/j.jembe.2007.12.013; Heithaus MR, 2007, CAN J FISH AQUAT SCI, V64, P1302, DOI 10.1139/F07-098; Heithaus MR, 2009, LIMNOL OCEANOGR, V54, P472, DOI 10.4319/lo.2009.54.2.0472; Heithaus MR, 2001, ENVIRON BIOL FISH, V61, P25, DOI 10.1023/A:1011021210685; Heupel MR, 2008, AQUAT BIOL, V1, P277, DOI 10.3354/ab00030; Heupel MR, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00012; Heupel MR, 2014, MAR ECOL PROG SER, V495, P291, DOI 10.3354/meps10597; Heupel MR, 2010, MAR FRESHWATER RES, V61, P1, DOI 10.1071/MF09019; Heupel MR, 2002, MAR FRESHWATER RES, V53, P543, DOI 10.1071/MF01132; Heupel MR, SHARK NURS GROUNDS G, P265; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Hutchings Pat A., 2013, Australian Zoologist, V36, P255, DOI 10.7882/AZ.2012.031; Huveneers C, 2009, AQUAT LIVING RESOUR, V22, P255, DOI 10.1051/alr/2009046; Johnston EL, 2015, MAR FRESHWATER RES, V66, P1073, DOI 10.1071/MF15159; Knip DM, 2011, MAR ECOL PROG SER, V425, P233, DOI 10.3354/meps09006; Kock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055048; KOLASA J, 1991, ECOLOGICAL HETEROGEN; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Lee KA, 2014, BIODIVERS CONSERV, V23, P2781, DOI 10.1007/s10531-014-0748-9; Macbeth W. G., 2009, OBSERVER BASED STUDY; Matich P, 2012, MAR ECOL PROG SER, V447, P165, DOI 10.3354/meps09497; Mayer-Pinto M, 2015, MAR FRESHWATER RES, V66, P1088, DOI 10.1071/MF15157; McCullagh P, 1989, GEN LINEAR MODELS; McPhee D, 2014, COAST MANAGE, V42, P478, DOI 10.1080/08920753.2014.942046; MORRISEY DJ, 1992, MAR ECOL PROG SER, V81, P197, DOI 10.3354/meps081197; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Neff C, 2012, COAST MANAGE, V40, P88, DOI 10.1080/08920753.2011.639867; Ortega LA, 2009, ENVIRON BIOL FISH, V84, P361, DOI 10.1007/s10641-009-9442-2; Powter DM, 2008, J FISH BIOL, V72, P2615, DOI 10.1111/j.1095-8649.2008.01878.x; Powter DM, 2008, MAR FRESHWATER RES, V59, P444, DOI 10.1071/MF07096; Pratt HL, 2001, ENVIRON BIOL FISH, V60, P157; Reid DD, 2011, MAR FRESHWATER RES, V62, P676, DOI 10.1071/MF10162; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Roy PS, 2001, ESTUAR COAST SHELF S, V53, P351, DOI 10.1006/ecss.2001.0796; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; Simpfendorfer CA, 2005, ESTUARIES, V28, P78, DOI 10.1007/BF02732755; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Sims DW, 2003, J FISH BIOL, V63, P53, DOI 10.1111/j.1095-8649.2003.00207.x; Smoothey AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061257; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Thompson RC, 1996, J EXP MAR BIOL ECOL, V202, P73, DOI 10.1016/0022-0981(96)00032-9; Tillett BJ, 2011, MAR FRESHWATER RES, V62, P850, DOI 10.1071/MF10271; Torres LG, 2006, HYDROBIOLOGIA, V569, P449, DOI 10.1007/s10750-006-0148-6; Underwood AJ, 1996, FRONTIERS OF POPULATION ECOLOGY, P369; Werry JM, 2011, MAR FRESHWATER RES, V62, P1421, DOI 10.1071/MF11136; Werry JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049796; West JG, 2011, MAR FRESHWATER RES, V62, P744, DOI 10.1071/MF10181; Williams GD, 2012, J FISH BIOL, V80, P1380, DOI 10.1111/j.1095-8649.2011.03179.x; Wirsing AJ, 2006, MAR BIOL, V149, P961, DOI 10.1007/s00227-006-0278-4; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034; Yates P.M., 2015, ESTUAR COAST, P1	77	20	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0146911	10.1371/journal.pone.0146911	http://dx.doi.org/10.1371/journal.pone.0146911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824349	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600011
J	Suzuki, N; Bassil, E; Hamilton, JS; Inupakutika, MA; Zandalinas, SI; Tripathy, D; Luo, YT; Dion, E; Fukui, G; Kumazaki, A; Nakano, R; Rivero, RM; Verbeck, GF; Azad, RK; Blumwald, E; Mittler, R				Suzuki, Nobuhiro; Bassil, Elias; Hamilton, Jason S.; Inupakutika, Madhuri A.; Zandalinas, Sara Izquierdo; Tripathy, Deesha; Luo, Yuting; Dion, Erin; Fukui, Ginga; Kumazaki, Ayana; Nakano, Ruka; Rivero, Rosa M.; Verbeck, Guido F.; Azad, Rajeev K.; Blumwald, Eduardo; Mittler, Ron			ABA Is Required for Plant Acclimation to a Combination of Salt and Heat Stress	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; GENE-EXPRESSION; REACTIVE OXYGEN; ABSCISIC-ACID; DROUGHT STRESS; SALICYLIC-ACID; ABIOTIC STRESS; HIGH-SALINITY; H+-ATPASE; RNA-SEQ	Abiotic stresses such as drought, heat or salinity are a major cause of yield loss worldwide. Recent studies revealed that the acclimation of plants to a combination of different environmental stresses is unique and cannot be directly deduced from studying the response of plants to each of the different stresses applied individually. Here we report on the response of Arabidopsis thaliana to a combination of salt and heat stress using transcriptome analysis, physiological measurements and mutants deficient in abscisic acid, salicylic acid, jasmonic acid or ethylene signaling. Arabidopsis plants were found to be more susceptible to a combination of salt and heat stress compared to each of the different stresses applied individually. The stress combination resulted in a higher ratio of Na+/K+ in leaves and caused the enhanced expression of 699 transcripts unique to the stress combination. Interestingly, many of the transcripts that specifically accumulated in plants in response to the salt and heat stress combination were associated with the plant hormone abscisic acid. In accordance with this finding, mutants deficient in abscisic acid metabolism and signaling were found to be more susceptible to a combination of salt and heat stress than wild type plants. Our study highlights the important role abscisic acid plays in the acclimation of plants to a combination of two different abiotic stresses.	[Suzuki, Nobuhiro; Fukui, Ginga; Kumazaki, Ayana; Nakano, Ruka] Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyoda Ku, 7-1 Kioi Cho, Tokyo 1028554, Japan; [Bassil, Elias; Blumwald, Eduardo] Univ Calif Davis, Dept Plant Sci, Mail Stop 5,1 Shields Ave, Davis, CA 95616 USA; [Hamilton, Jason S.; Inupakutika, Madhuri A.; Tripathy, Deesha; Luo, Yuting; Dion, Erin; Verbeck, Guido F.; Azad, Rajeev K.; Mittler, Ron] Univ N Texas, Coll Arts & Sci, Dept Biol Sci, 1155 Union Circle 305220, Denton, TX 76203 USA; [Zandalinas, Sara Izquierdo] Univ Jaume 1, Dept Ciencias Agrarias & Medio Nat, Campus Riu Sec, E-12071 Castellon de La Plana, Spain; [Rivero, Rosa M.] Campus Univ Espinardo, Ctr Edafol & Biol Aplicada Segura, Murcia 30100, Spain; [Azad, Rajeev K.] Univ N Texas, Dept Math, Denton, TX 76203 USA	Sophia University; University of California System; University of California Davis; University of North Texas System; University of North Texas Denton; Universitat Jaume I; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); University of Murcia; University of North Texas System; University of North Texas Denton	Suzuki, N (corresponding author), Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyoda Ku, 7-1 Kioi Cho, Tokyo 1028554, Japan.; Mittler, R (corresponding author), Univ N Texas, Coll Arts & Sci, Dept Biol Sci, 1155 Union Circle 305220, Denton, TX 76203 USA.	n-suzuki-cs6@sophia.ac.jp; ron.mittler@unt.edu	Bassil, Elias/F-1259-2011; Verbeck, Guido/AAF-3774-2019; Blumwald, Eduardo/Y-2751-2019; Mittler, Ron/ABE-6496-2020; Zandalinas, Sara I/AAH-1075-2019; Rivero, Rosa M/A-2761-2013; Suzuki, Nobuhiro/Y-2851-2019	Bassil, Elias/0000-0001-8109-5758; Verbeck, Guido/0000-0002-3317-9911; Zandalinas, Sara I/0000-0002-1256-9371; Rivero, Rosa M/0000-0003-3880-0241; Suzuki, Nobuhiro/0000-0002-0225-1597	National Science Foundation [NSF-0431327, IOS-0639964, IOS-0743954, IOS-0820188, IOS-1353886]; University of North Texas College of Arts and Sciences; Sophia University in Japan	National Science Foundation(National Science Foundation (NSF)); University of North Texas College of Arts and Sciences; Sophia University in Japan	This paper was supported by funding from the National Science Foundation (NSF-0431327, IOS-0639964, IOS-0743954, IOS-0820188 and IOS-1353886), the University of North Texas College of Arts and Sciences, and Sophia University in Japan.	Assmann SM, 2000, PLANT CELL ENVIRON, V23, P387, DOI 10.1046/j.1365-3040.2000.00551.x; Atkinson NJ, 2013, PLANT PHYSIOL, V162, P2028, DOI 10.1104/pp.113.222372; Blanco F, 2009, PLANT MOL BIOL, V70, P79, DOI 10.1007/s11103-009-9458-1; Caldelari D, 2011, PLANT MOL BIOL, V75, P25, DOI 10.1007/s11103-010-9701-9; Conde A, 2011, PLANT CELL PHYSIOL, V52, P1766, DOI 10.1093/pcp/pcr121; Consales F, 2012, J EXP BOT, V63, P727, DOI 10.1093/jxb/err308; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; De Boeck HJ, 2016, NEW PHYTOL, V209, P531, DOI 10.1111/nph.13601; Ding F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-431; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; Hamilton JS, 2015, J ANAL AT SPECTROM; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hu XL, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00298; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; Ishibashi Y, 2012, PLANT PHYSIOL, V158, P1705, DOI 10.1104/pp.111.192740; Janicka-Russak M, 2012, J PLANT PHYSIOL, V169, P1607, DOI 10.1016/j.jplph.2012.05.013; Keles Y, 2002, PLANT SCI, V163, P783, DOI 10.1016/S0168-9452(02)00213-3; Kim DH, 2013, PLANT CELL REP, V32, P1953, DOI 10.1007/s00299-013-1506-2; Kleine T, 2007, PLANT PHYSIOL, V144, P1391, DOI 10.1104/pp.107.098293; Koussevitzky S, 2008, J BIOL CHEM, V283, P34197, DOI 10.1074/jbc.M806337200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Li H, 2014, PLANT CELL ENVIRON, V37, P2768, DOI 10.1111/pce.12360; Liu ZS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0511-8; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mittler R, 2015, PLANT CELL, V27, P64, DOI 10.1105/tpc.114.133090; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Moeder Wolfgang, 2010, Plant Signal Behav, V5, P1231, DOI 10.4161/psb.5.10.12836; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Rasmussen S, 2013, PLANT PHYSIOL, V161, P1783, DOI 10.1104/pp.112.210773; Rivero RM, 2014, PLANT CELL ENVIRON, V37, P1059, DOI 10.1111/pce.12199; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Scarpeci TE, 2008, PLANT MOL BIOL, V66, P361, DOI 10.1007/s11103-007-9274-4; Sghaier DB, 2015, J PHOTOCH PHOTOBIO B, V149, P204, DOI 10.1016/j.jphotobiol.2015.06.003; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Shinde S, 2015, J EXP BOT, V66, P4001, DOI 10.1093/jxb/erv197; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Spalding EP, 1999, J GEN PHYSIOL, V113, P909, DOI 10.1085/jgp.113.6.909; Suzuki N, 2005, PLANT PHYSIOL, V139, P1313, DOI 10.1104/pp.105.070110; Suzuki N, 2008, J BIOL CHEM, V283, P9269, DOI 10.1074/jbc.M709187200; Suzuki N, 2014, NEW PHYTOL, V203, P32, DOI 10.1111/nph.12797; Suzuki N, 2013, PLANT CELL, V25, P3553, DOI 10.1105/tpc.113.114595; Suzuki N, 2013, J EXP BOT, V64, P253, DOI 10.1093/jxb/ers335; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-125; Tosti N, 2006, PLANT CELL ENVIRON, V29, P1686, DOI 10.1111/j.1365-3040.2006.01542.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; VAN DER STRAETEN D, 1993, PLANT PHYSIOL, V102, P401, DOI 10.1104/pp.102.2.401; Wen XG, 2005, PLANTA, V220, P486, DOI 10.1007/s00425-004-1382-7; YALOVSKY S, 1992, J BIOL CHEM, V267, P20689; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Yoon HS, 2013, J APPL GENET, V54, P129, DOI 10.1007/s13353-012-0117-x; Zhang JH, 2006, PLANT SCI, V170, P768, DOI 10.1016/j.plantsci.2005.11.009; Zhang YP, 2015, GENET MOL RES, V14, P3702, DOI 10.4238/2015.April.17.20; Zhu Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000844	63	152	165	12	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147625	10.1371/journal.pone.0147625	http://dx.doi.org/10.1371/journal.pone.0147625			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824246	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528600042
J	Margevicius, KJ; Generous, N; Abeyta, E; Althouse, B; Burkom, H; Castro, L; Daughton, A; Del Valle, SY; Fairchild, G; Hyman, JM; Kiang, R; Morse, AP; Pancerella, CM; Pullum, L; Ramanathan, A; Schlegelmilch, J; Scott, A; Taylor-McCabe, KJ; Vespignani, A; Deshpande, A				Margevicius, Kristen J.; Generous, Nicholas; Abeyta, Esteban; Althouse, Ben; Burkom, Howard; Castro, Lauren; Daughton, Ashlynn; Del Valle, Sara Y.; Fairchild, Geoffrey; Hyman, James M.; Kiang, Richard; Morse, Andrew P.; Pancerella, Carmen M.; Pullum, Laura; Ramanathan, Arvind; Schlegelmilch, Jeffrey; Scott, Aaron; Taylor-McCabe, Kirsten J.; Vespignani, Alessandro; Deshpande, Alina			The Biosurveillance Analytics Resource Directory (BARD): Facilitating the Use of Epidemiological Models for Infectious Disease Surveillance	PLOS ONE			English	Article							DECISION-MAKING; POLICY; REAL; TOOL	Epidemiological modeling for infectious disease is important for disease management and its routine implementation needs to be facilitated through better description of models in an operational context. A standardized model characterization process that allows selection or making manual comparisons of available models and their results is currently lacking. A key need is a universal framework to facilitate model description and understanding of its features. Los Alamos National Laboratory (LANL) has developed a comprehensive framework that can be used to characterize an infectious disease model in an operational context. The framework was developed through a consensus among a panel of subject matter experts. In this paper, we describe the framework, its application to model characterization, and the development of the Biosurveillance Analytics Resource Directory (BARD; http://brd.bsvgateway.org/brd/), to facilitate the rapid selection of operational models for specific infectious/communicable diseases. We offer this framework and associated database to stakeholders of the infectious disease modeling field as a tool for standardizing model description and facilitating the use of epidemiological models.	[Margevicius, Kristen J.; Generous, Nicholas; Abeyta, Esteban; Castro, Lauren; Daughton, Ashlynn; Del Valle, Sara Y.; Fairchild, Geoffrey; Taylor-McCabe, Kirsten J.; Deshpande, Alina] Los Alamos Natl Lab, Analyt Intelligence & Technol Div, Los Alamos, NM USA; [Althouse, Ben] Santa Fe Inst, Santa Fe, NM 87501 USA; [Burkom, Howard] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Hyman, James M.] Tulane Univ, Dept Math, New Orleans, LA 70118 USA; [Kiang, Richard] Natl Aeronaut & Space Adm, Greenbelt, MD USA; [Morse, Andrew P.] Univ Liverpool, Sch Environm Sci, Dept Geog & Planning, Liverpool L69 3BX, Merseyside, England; [Morse, Andrew P.] NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool, Merseyside, England; [Pancerella, Carmen M.] Sandia Natl Labs, Distributed Syst Res, Livermore, CA USA; [Pullum, Laura; Ramanathan, Arvind] Oak Ridge Natl Lab, Oak Ridge, TN USA; [Schlegelmilch, Jeffrey] Columbia Univ, Earth Inst, Natl Ctr Disaster Preparedness, New York, NY USA; [Scott, Aaron] USDA APHIS Vet Serv, Sci, Technol, Anal Serv, Ft Collins, CO USA; [Vespignani, Alessandro] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Tulane University; National Aeronautics & Space Administration (NASA); University of Liverpool; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Oak Ridge National Laboratory; Columbia University; United States Department of Agriculture (USDA); Northeastern University	Deshpande, A (corresponding author), Los Alamos Natl Lab, Analyt Intelligence & Technol Div, Los Alamos, NM USA.	Deshpande_a@lanl.gov	Del Valle, Sara/AAG-5148-2021; Hyman, James M/AAF-7389-2020	Del Valle, Sara/0000-0002-0159-1952; Hyman, James M/0000-0001-5247-5794; Ramanathan, Arvind/0000-0002-1622-5488; Morse, Andrew/0000-0002-0413-2065; burkom, howard/0000-0003-0667-9467; Deshpande, Alina/0000-0003-4541-4410; Margevicius, Kristen/0000-0002-4116-8307; Vespignani, Alessandro/0000-0003-3419-4205; Pullum, Laura/0000-0001-6045-7668; Abeyta, Esteban/0000-0001-5574-4822	Defense Threat Reductions Agency - Joint Science and Technology Office [CB10007, DTRA10027-10845]; Natural Environment Research Council [NE/H003525/1, NE/H003487/1] Funding Source: researchfish; NERC [NE/H003525/1, NE/H003487/1] Funding Source: UKRI	Defense Threat Reductions Agency - Joint Science and Technology Office; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by the Defense Threat Reductions Agency - Joint Science and Technology Office (Grant # CB10007, DTRA10027-10845).	Akselrod Hana, 2012, J Bus Contin Emer Plan, V6, P68; Althouse BM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002912; Althouse BM, 2010, P NATL ACAD SCI USA, V107, P1696, DOI 10.1073/pnas.0906078107; [Anonymous], GLOB EP MOB MOD; Barrett Christopher L., 2008, INT C HIGH PERF COMP; Chretien JP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0094130, 10.1371/currents.outbreaks.3408774290b1a0f2dd7cae877c8b8ff6]; Corley CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091989; Feighner BH, 2009, MIL MED, V174, P557, DOI 10.7205/MILMED-D-04-6108; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Frieden T.R, 2011, CDC FRAMEWORK PREVEN; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Harvey N, 2007, PREV VET MED, V82, P176, DOI 10.1016/j.prevetmed.2007.05.019; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Keeling MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1195, DOI 10.1098/rspb.2004.3046; Kite-Powell A, 2010, ESSENCE USER GUIDE; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Lagergren M, 1998, EUR J OPER RES, V105, P257, DOI 10.1016/S0377-2217(97)00233-6; Lenart B, 2013, HOMELAND SEC AFF, V9, P14; Louz D, 2010, CRIT REV MICROBIOL, V36, P195, DOI 10.3109/10408411003604619; Margevicius KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083730; McKenzie FE, 2004, AM J TROP MED HYG, V71, P94, DOI 10.4269/ajtmh.2004.71.94; Nsoesie EO, 2014, INFLUENZA OTHER RESP, V8, P309, DOI 10.1111/irv.12226; Pfeiffer D, 2004, VET J, V167, P123, DOI 10.1016/j.tvjl.2003.09.001; Sanson RL, 1999, REV SCI TECH OIE, V18, P593, DOI 10.20506/rst.18.3.1181; Schley D., ENHANCING CONFIDENCE; Sluka JP, 2014, BIOINFORMATICS, V30, P2367, DOI 10.1093/bioinformatics/btu210; Tildesley MJ, 2008, P ROY SOC B-BIOL SCI, V275, P1459, DOI 10.1098/rspb.2008.0006; Tizzoni M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-165	29	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0146600	10.1371/journal.pone.0146600	http://dx.doi.org/10.1371/journal.pone.0146600			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820405	gold, Green Submitted, Green Published			2022-12-26	WOS:000369528400008
J	Stauber, CE; Wedgworth, JC; Johnson, P; Olson, JB; Ayers, T; Elliott, M; Brown, J				Stauber, Christine E.; Wedgworth, Jessica C.; Johnson, Pauline; Olson, Julie B.; Ayers, Tracy; Elliott, Mark; Brown, Joe			Associations between Self-Reported Gastrointestinal Illness and Water System Characteristics in Community Water Supplies in Rural Alabama: A Cross-Sectional Study	PLOS ONE			English	Article							DRINKING-WATER; BOTTLED WATER; BLACK-BELT; RISK; INTERVENTION; QUALITY; HEALTH	Background Community water supplies in underserved areas of the United States may be associated with increased microbiological contamination and risk of gastrointestinal disease. Microbial and health risks affecting such systems have not been systematically characterized outside outbreak investigations. The objective of the study was to evaluate associations between self-reported gastrointestinal illnesses (GII) and household-level water supply characteristics. Methods We conducted a cross-sectional study of water quality, water supply characteristics, and GII in 906 households served by 14 small and medium-sized community water supplies in Alabama's underserved Black Belt region. Results We identified associations between respondent-reported water supply interruption and any symptoms of GII (adjusted odds ratio (aOR): 3.01, 95% confidence interval (CI) = 1.65-5.49), as well as low water pressure and any symptoms of GII (aOR: 4.51, 95% CI = 2.5-57.97). We also identified associations between measured water quality such as lack of total chlorine and any symptoms of GII (aOR: 5.73, 95% CI = 1.09-30.1), and detection of E. coli in water samples and increased reports of vomiting (aOR: 5.01, 95% CI = 1.62-15.52) or diarrhea (aOR: 7.75, 95% CI = 2.06-29.15). Conclusions Increased self-reported GII was associated with key water system characteristics as measured at the point of sampling in a cross-sectional study of small and medium water systems in rural Alabama in 2012 suggesting that these water supplies can contribute to endemic gastro-intestinal disease risks. Future studies should focus on further characterizing and managing microbial risks in systems facing similar challenges.	[Stauber, Christine E.; Ayers, Tracy] Georgia State Univ, Sch Publ Hlth, Div Environm Hlth, Atlanta, GA 30303 USA; [Wedgworth, Jessica C.; Olson, Julie B.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA; [Johnson, Pauline; Elliott, Mark] Univ Alabama, Dept Civil Construct & Environm Engn, Tuscaloosa, AL USA; [Brown, Joe] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA; [Wedgworth, Jessica C.] Univ West Alabama, Off Sponsored Programs, Livingston, AL USA	University System of Georgia; Georgia State University; University of Alabama System; University of Alabama Tuscaloosa; University of Alabama System; University of Alabama Tuscaloosa; University System of Georgia; Georgia Institute of Technology	Stauber, CE (corresponding author), Georgia State Univ, Sch Publ Hlth, Div Environm Hlth, Atlanta, GA 30303 USA.; Brown, J (corresponding author), Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA.	cstauber@gsu.edu; joe.brown@ce.gatech.edu	Elliott, Mark/N-1574-2019	Elliott, Mark/0000-0002-7835-0612; Ayers, Tracy/0000-0003-4140-3263	U.S. Environmental Protection Agency [R834866]	U.S. Environmental Protection Agency(United States Environmental Protection Agency)	This publication was developed under Assistance Agreement No. R834866 awarded by the U.S. Environmental Protection Agency to the University of Alabama (PJ JB). This paper has not been formally reviewed by EPA. The views expressed in this document are solely those of the authors and do not necessarily reflect those of the Agency. EPA does not endorse any products or commercial services mentioned in this publication.	Albuquerque Cd, 2011, REPORT SPECIAL RAPPO; Anadu EC, 2000, J AM WATER WORKS ASS, V92, P82, DOI 10.1002/j.1551-8833.2000.tb09051.x; [Anonymous], 2007, SELECTED HLTH STATUS; Arnold BF, 2013, AM J EPIDEMIOL, V177, P361, DOI 10.1093/aje/kws281; Colford John M. Jr., 2006, Journal of Water and Health, V4, P71, DOI 10.2166/wh.2006.018; Collier SA, 2012, EPIDEMIOL INFECT, V140, P2003, DOI 10.1017/S0950268811002858; Congressional Research Service, 2014, RUR WAT SUPPL SEW SY; Craun GF, 2010, CLIN MICROBIOL REV, V23, P507, DOI 10.1128/CMR.00077-09; DeFelice NB, 2015, ENV SCI TECHNOL; Doria Miguel F., 2006, Journal of Water and Health, V4, P271, DOI 10.2166/wh.2006.0023; Egorov A, 2002, INT J ENVIRON HEAL R, V12, P221, DOI 10.1080/09603/202/000000989; Ercumen A, 2014, ENVIRON HEALTH PERSP, V122, P651, DOI 10.1289/ehp.1306912; Gargano J. W., 2015, EPIDEMIOL INFECT FIR, P1; He JJ, 2011, ENVIRON ENG SCI, V28, P693, DOI 10.1089/ees.2011.0047; Hunter PR, 2005, CLIN INFECT DIS, V40, pE32, DOI 10.1086/427750; Izenberg M, 2013, ENV JUSTICE, V6; LeChevallier Mark W., 2003, Journal of Water and Health, V1, P3; Lichtenstein B, 2007, J RURAL HEALTH, V23, P68, DOI 10.1111/j.1748-0361.2007.00126.x; Liu AG, 2005, SCI TOTAL ENVIRON, V346, P112, DOI 10.1016/j.scitotenv.2004.11.019; MacDonald Gibson J, 2015, AM J PUBLIC HEALTH, pe1; Majowicz SE, 2008, EPIDEMIOL INFECT, V136, P886, DOI 10.1017/S0950268807009375; Messner Michael, 2006, Journal of Water and Health, V4, P201, DOI 10.2166/wh.2006.024; MMWR, 2013, MMWR-MORBID MORTAL W, V62, P6; Reynolds KA, 2008, REV ENVIRON CONTAM T, V192, P117, DOI 10.1007/978-0-387-71724-1_4; Rust K., 1985, J OFF STAT, V1, P381; Sanspree Mary Jean, 2008, Optometry, V79, P724, DOI 10.1016/j.optm.2008.09.011; Shortridge JE, 2014, WATER RES, V53, P26, DOI 10.1016/j.watres.2014.01.013; Sobsey Mark D., 2006, Journal of Water and Health, V4, P17; Tinker SC, 2010, J EXPO SCI ENV EPID, V20, P19, DOI 10.1038/jes.2008.68; U.S. Census, 2012, AL 2010 POP HOUS UN; Wedgworth JC, 2014, INT J ENV RES PUB HE, V11, P7376, DOI 10.3390/ijerph110707376; Wedgworth JC, 2013, WATER QUAL EXPOS HEA, V5, P69, DOI 10.1007/s12403-013-0088-0; Wimberley R. C., 2002, Southern Rural Sociology, V18, P294; World Health Organization (WHO), GUID DRINK WAT QUAL	34	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148102	10.1371/journal.pone.0148102	http://dx.doi.org/10.1371/journal.pone.0148102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820849	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528400066
J	Mutumi, GL; Jacobs, DS; Winker, H				Mutumi, Gregory L.; Jacobs, David S.; Winker, Henning			Sensory Drive Mediated by Climatic Gradients Partially Explains Divergence in Acoustic Signals in Two Horseshoe Bat Species, Rhinolophus swinnyi and Rhinolophus simulator	PLOS ONE			English	Article							ECHOLOCATION CALLS; GEOGRAPHIC-VARIATION; FREQUENCY; EVOLUTION; BIRDS; SEX	Geographic variation can be an indicator of still poorly understood evolutionary processes such as adaptation and drift. Sensory systems used in communication play a key role in mate choice and species recognition. Habitat-mediated (i.e. adaptive) differences in communication signals may therefore lead to diversification. We investigated geographic variation in echolocation calls of African horseshoe bats, Rhinolophus simulator and R. swinnyi in the context of two adaptive hypotheses: 1) James' Rule and 2) the Sensory Drive Hypothesis. According to James' Rule body-size should vary in response to relative humidity and temperature so that divergence in call frequency may therefore be the result of climate-mediated variation in body size because of the correlation between body size and call frequency. The Sensory Drive Hypothesis proposes that call frequency is a response to climate-induced differences in atmospheric attenuation and predicts that increases in atmospheric attenuation selects for calls of lower frequency. We measured the morphology and resting call frequency (RF) of 111 R. simulator and 126 R. swinnyi individuals across their distributional range to test the above hypotheses. Contrary to the prediction of James' Rule, divergence in body size could not explain the variation in RF. Instead, acoustic divergence in RF was best predicted by latitude, geography and climate-induced differences in atmospheric attenuation, as predicted by the Sensory Drive Hypothesis. Although variation in RF was strongly influenced by temperature and humidity, other climatic variables (associated with latitude and altitude) as well as drift (as suggested by a positive correlation between call variation and geographic distance, especially in R. simulator) may also play an important role.	[Mutumi, Gregory L.; Jacobs, David S.] Univ Cape Town, Dept Biol Sci, Anim Evolut & Systemat Grp AES, ZA-7701 Cape Town, South Africa; [Winker, Henning] SANBI, Ctr Stat Ecol Environm & Conservat SEEC, Cape Town, South Africa	University of Cape Town; South African National Biodiversity Institute	Mutumi, GL; Jacobs, DS (corresponding author), Univ Cape Town, Dept Biol Sci, Anim Evolut & Systemat Grp AES, ZA-7701 Cape Town, South Africa.	mtmgre001@myuct.ac.za; david.jacobs@uct.ac.za	Mutumi, Gregory/AAH-8447-2021; mutumi, gregory/GYD-4103-2022; Jacobs, David Steve/L-9118-2013	mutumi, gregory/0000-0003-1911-2232; Jacobs, David Steve/0000-0002-3243-8571	University of Cape Town; South African Research Chair Initiative of the Department of Science and Technology; National Research Foundation [GUN 64798]; University of Cape Town's Postgraduate Centre and Funding Office	University of Cape Town; South African Research Chair Initiative of the Department of Science and Technology; National Research Foundation; University of Cape Town's Postgraduate Centre and Funding Office	This research was supported by grants to DSJ from the University of Cape Town (www.uct.ac.za) and the South African Research Chair Initiative of the Department of Science and Technology (http://www.dst.gov.za), administered by the National Research Foundation (http://www.nrf.ac.za), grant number-GUN 64798. GLM also received funding (Research Associateship award) from the University of Cape Town's Postgraduate Centre and Funding Office (www.uct.ac.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter J, 2005, EXTENT FREQUENCY EUR; Andersson Malte, 1994; Anthony E.L.P., 1988, P47; BARCLAY RMR, 1982, BEHAV ECOL SOCIOBIOL, V10, P271, DOI 10.1007/BF00302816; Barnard G., 1963, J R STAT SOC B, V25, P294; BARTON NH, 1984, ANNU REV ECOL SYST, V15, P133, DOI 10.1146/annurev.es.15.110184.001025; Bastian A, 2015, ANIM BEHAV, V101, P141, DOI 10.1016/j.anbehav.2014.12.010; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; CLIFF AD, 1970, ECON GEOGR, V46, P269, DOI 10.2307/143144; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; DUELLMAN WE, 1983, COPEIA, P639, DOI 10.2307/1444328; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Ey E, 2009, BIOACOUSTICS, V19, P21, DOI 10.1080/09524622.2009.9753613; FENTON MB, 1995, PALEOBIOLOGY, V21, P229, DOI 10.1017/S0094837300013221; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gillam EH, 2009, BEHAV ECOL SOCIOBIOL, V64, P69, DOI 10.1007/s00265-009-0819-1; Gubitz T, 2005, P ROY SOC B-BIOL SCI, V272, P751, DOI 10.1098/rspb.2004.3018; Guillen A, 2000, J EVOLUTION BIOL, V13, P70; HELLER KG, 1989, OECOLOGIA, V80, P178, DOI 10.1007/BF00380148; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jacobs DS, 2007, OECOLOGIA, V152, P583, DOI 10.1007/s00442-007-0679-1; JAMES FC, 1970, ECOLOGY, V51, P365, DOI 10.2307/1935374; Jiang TL, 2015, INTEGR ZOOL, V10, P241, DOI 10.1111/1749-4877.12129; Jiang TL, 2010, J ACOUST SOC AM, V128, P2204, DOI 10.1121/1.3478855; Jiang TL, 2010, ETHOLOGY, V116, P691, DOI 10.1111/j.1439-0310.2010.01785.x; Jones G, 1999, J EXP BIOL, V202, P3359; Kazial KA, 2004, ANIM BEHAV, V67, P855, DOI 10.1016/j.anbehav.2003.04.016; Knornschild M, 2012, P ROY SOC B-BIOL SCI, V279, P4827, DOI 10.1098/rspb.2012.1995; Kormann U, 2015, DIVERS DISTRIB, P1; Kunz T.H., 2009, ECOLOGICAL BEHAV MET; LAWRENCE BD, 1982, J ACOUST SOC AM, V71, P585, DOI 10.1121/1.387529; Lomolino MV, 2006, J BIOGEOGR, V33, P1503, DOI 10.1111/j.1365-2699.2006.01593.x; Luo JH, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0961; Magurran AE, 1998, PHILOS T R SOC B, V353, P275, DOI 10.1098/rstb.1998.0209; Morrone JJ, 2009, EVOLUTIONARY BIOL IN; Odendaal LJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-60; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Podos J, 2007, ADV STUD BEHAV, V37, P403, DOI 10.1016/S0065-3454(07)37009-5; Puechmaille SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103452; RACEY PA, 1974, J ZOOL, V173, P264, DOI 10.1111/j.1469-7998.1974.tb03136.x; Schnitzler HU, 1987, RECENT ADV STUDY BAT; Schoeman MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003715; Schuchmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012842; Siemers BM, 2005, ACTA CHIROPTEROL, V7, P259, DOI 10.3161/1733-5329(2005)7[259:ISISAO]2.0.CO;2; Snell-Rood EC, 2012, J ACOUST SOC AM, V131, P1650, DOI 10.1121/1.3672695; Sternheim MM, 1986, GENERAL PHYSICS; Stilz WP, 2012, J ACOUST SOC AM, V132, P1765, DOI 10.1121/1.4733537; TAYLOR P. J., 2010, BATS SO CENTRAL AFRI; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Wilczynski W, 1999, GEOGRAPHIC VARIATION IN BEHAVIOR, P234; Zuckerwar A. J., 2002, HDB SPEED SOUND REAL; Zuur Alain F., 2009, P1	55	23	24	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0148053	10.1371/journal.pone.0148053	http://dx.doi.org/10.1371/journal.pone.0148053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815436	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528200070
J	Prado, JHF; Mattos, PH; Silva, KG; Secchi, ER				Prado, Jonatas H. F.; Mattos, Paulo H.; Silva, Kleber G.; Secchi, Eduardo R.			Long-Term Seasonal and Interannual Patterns of Marine Mammal Strandings in Subtropical Western South Atlantic	PLOS ONE			English	Article							AMERICAN SEA LION; WHALES MEGAPTERA-NOVAEANGLIAE; DOLPHIN PONTOPORIA-BLAINVILLEI; ANTARCTIC FUR-SEAL; GRANDE-DO-SUL; CETACEAN STRANDINGS; OTARIA-FLAVESCENS; GILLNET FISHERIES; BYCATCH; COAST	Understanding temporal patterns of marine mammal occurrence is useful for establishing conservation strategies. We used a 38 yr-long dataset spanning 1976 to 2013 to describe temporal patterns and trends in marine mammal strandings along a subtropical stretch of the east coast of South America. This region is influenced by a transitional zone between tropical and temperate waters and is considered an important fishing ground off Brazil. Generalized Additive Models were used to evaluate the temporal stranding patterns of the most frequently stranded species. Forty species were documented in 12,540 stranding events. Franciscana (n = 4,574), South American fur seal, (n = 3,419), South American sea lion (n = 2,049), bottlenose dolphins (n = 293) and subantarctic fur seal (n = 219) were the most frequently stranded marine mammals. The seasonality of strandings of franciscana and bottlenose dolphin coincided with periods of higher fishing effort and strandings of South American and subantarctic fur seals with post-reproductive dispersal. For South American sea lion the seasonality of strandings is associated with both fishing effort and post-reproductive dispersal. Some clear seasonal patterns were associated with occurrence of cold( e.g. subantarctic fur seal) and warm-water (e.g. rough-toothed dolphin) species in winter and summer, respectively. Inter-annual increases in stranding rate were observed for franciscana and South American fur seal and these are likely related to increased fishing effort and population growth, respectively. For subantarctic fur seal the stranding rate showed a slight decline while for bottlenose dolphin it remained steady. No significant year to year variation in stranding rate was observed for South American sea lion. The slight decrease in frequency of temperate/polar marine mammals and the increased occurrence of subtropical/tropical species since the late 1990s might be associated with environmental changes linked to climate change. This long-term study indicates that temporal stranding patterns of marine mammals might be explained by either fishing-related or environmental factors.	[Prado, Jonatas H. F.; Secchi, Eduardo R.] Univ Fed Rio Grande, Lab Ecol & Conservacao Megafauna Marinha, Inst Oceanog, Rio Grande, Brazil; [Mattos, Paulo H.] Univ Fed Rio Grande, Inst Oceanog, Lab Gerenciamento Costeiro, Rio Grande, Brazil; [Silva, Kleber G.] Nucl Educ & Monitoramento Ambiental, Rio Grande, Brazil	Universidade Federal do Rio Grande; Universidade Federal do Rio Grande	Prado, JHF (corresponding author), Univ Fed Rio Grande, Lab Ecol & Conservacao Megafauna Marinha, Inst Oceanog, Rio Grande, Brazil.	jonatashenriquef@gmail.com	Secchi, Eduardo R./ABF-1191-2020	Secchi, Eduardo R./0000-0001-9087-9909	Yaqu Pacha; Cetacean Society International; Fundacao O Boticario de Protecao a Natureza; Petrobras; Conselho Nacional para Desenvolvimento Cientifico e Tecnologico/CNPq; CNPq [140638/2012-1, PQ 307843/2014-0]; Yaqu Pacha (Germany); Fundacao O Boticario de Protecao a Natureza (Brazil); Conselho Nacional para Desenvolvimento Cientifico e Tecnologico/CNPq (Brazilian Government), Petrobras (Brazil); Cetacean Society International (USA)	Yaqu Pacha; Cetacean Society International; Fundacao O Boticario de Protecao a Natureza; Petrobras(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras); Conselho Nacional para Desenvolvimento Cientifico e Tecnologico/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Yaqu Pacha (Germany); Fundacao O Boticario de Protecao a Natureza (Brazil); Conselho Nacional para Desenvolvimento Cientifico e Tecnologico/CNPq (Brazilian Government), Petrobras (Brazil); Cetacean Society International (USA)	ES received support from Yaqu Pacha (http://www.yaqupacha.org/) and the Cetacean Society International (http://csiwhalesalive.org/). ES and KS received support from Fundacao O Boticario de Protecao a Natureza (http://www.fundacaogrupoboticario.org.br/pt/Pages/default.aspx). KS received support from Petrobras (http://sites.petrobras.com.br/ppa2010/home/). JP and ES received funding from Conselho Nacional para Desenvolvimento Cientifico e Tecnologico/CNPq (http://www.cnpq.br/). JP received a scholarship from CNPq (Process 140638/2012-1). CNPq also provided a Research Fellowship to ES(PQ 307843/2014-0). The funders had role in data collection providing financial support to carried out survey beach.; We are grateful to Dr. Maria Cristina Pinedo and Lic. Hugo P. Castello who initially implemented the Stranding Network in southern Brazil and to all researchers, students and volunteers from Laboratorio de Ecologia e Conservacao da Megafauna Marinha/EcoMega-FURG, Museu Oceanografico Prof. Eliezer C. Rios-FURG and Nucleo de Educacao e Monitoramento Ambiental/NEMA who participated in data collection over these 38 years. Financial support was provided by Yaqu Pacha (Germany), Fundacao O Boticario de Protecao a Natureza (Brazil), Conselho Nacional para Desenvolvimento Cientifico e Tecnologico/CNPq (Brazilian Government), Petrobras (Brazil) and Cetacean Society International (USA). Logistical support was provided by Universidade Federal de Rio Grande (FURG) and NEMA.). We also thank Luciano Dalla Rosa and Randall Reeves for kindly reviewing the manuscript. We are also grateful to Matthieu Authier and three anonymous referees provided useful suggestions to improved the manuscript. This study was part of the Prado's PhD thesis under the supervision of Secchi. Prado received a scholarship from CNPq (Process 140638/2012-1). CNPq also provided a Research Fellowship to E.R.Secchi (PQ 307843/2014-0). This is a contribution of the Research Group 'Ecologia e Conservacao da Megafauna Marinha-EcoMega/CNPq'.	[Anonymous], SCI REP WHALE RES I; Artico LO, 2010, BRAZ J MED BIOL RES, V43, P816, DOI 10.1590/S0100-879X2010007500074; Authier M, 2014, BIODIVERS CONSERV, V23, P2591, DOI 10.1007/s10531-014-0741-3; Bannister JL, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P80; Bastida R, 2007, MAMIFEROS ACUATICOS; Botta S, 2012, J MAR BIOL ASSOC UK, V92, P1689, DOI 10.1017/S0025315411000610; Bugoni Leandro, 2008, Endangered Species Research, V5, P137, DOI 10.3354/esr00115; Calliari L. J, 1998, ECOSISTEMAS COSTEIRO, P189; Castello H.P., 1977, Natureza em Revista, P40; Castello H.P., 1980, Boletim do Instituto Oceanografico, V29, P91; CASTELLO HP, 1979, J MAMMAL, V60, P429, DOI 10.2307/1379823; Castello HP, 1974, PHYSIS, V86, P371; Castello J.P., 1990, PUB ACIESP, V1-1, P112; Castello J. P, 1998, ECOSSISTEMAS COSTEIR, P189; CEPERG, DES PESC RIO GRAND 1; CIOTTI AM, 1995, CONT SHELF RES, V15, P1737, DOI 10.1016/0278-4343(94)00091-Z; Crespo E.A., 2012, CURRENT STATUS S AM; Dalla Rosa L, 2007, J MAR BIOL ASSOC UK, V87, P135, DOI 10.1017/S0025315407054306; Danilewicz D, 2009, J MAR BIOL ASSOC UK, V89, P943, DOI 10.1017/S002531540900054X; David JHM, 2003, AFR J MAR SCI, V25, P403, DOI 10.2989/18142320309504029; de Moura Jailson Fulgencio, 2012, Marine Biodiversity Records, V5, P1; de Souza RB, 2004, CONT SHELF RES, V24, P241, DOI 10.1016/j.csr.2003.10.001; Di Tullio JC, 2015, ENDANGER SPECIES RES, V29, P35, DOI 10.3354/esr00698; dos Santos RA, 2002, B MAR SCI, V71, P753; dos Santos RA, 2001, FISH RES, V52, P99; Epperly SP, 1996, B MAR SCI, V59, P289; Evans K, 2005, BIOL LETT-UK, V1, P147, DOI 10.1098/rsbl.2005.0313; FERREIRA EC, 2010, ATLANTICA, V32, P183, DOI DOI 10.5088/atl.2010.32.2.183; Ferreira JM, 2008, POLAR BIOL, V31, P303, DOI 10.1007/s00300-007-0358-z; Fire SE, 2011, HARMFUL ALGAE, V10, P330, DOI 10.1016/j.hal.2010.12.001; Fliedler PC, 2002, MAR ECOL PROG SER, V244, P265; Forcada J, 2006, GLOBAL CHANGE BIOL, V12, P411, DOI 10.1111/j.1365-2486.2006.01108.x; Forcada J, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P316; Fruet PF, 2012, J MAR BIOL ASSOC UK, V92, P1865, DOI 10.1017/S0025315410001888; Garrigue C, 1996, MAR MAMMAL SCI, V12, P624; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; Gianuca N.M., 1976, Scientific Rep Whales Res Inst Tokyo, VNo. 28, P119; GORDON AL, 1989, DEEP-SEA RES, V36, P359, DOI 10.1016/0198-0149(89)90042-3; Greig Antonio B., 2001, Journal of Cetacean Research and Management Special Issue, V2, P157; Gremillet D, 2008, J APPL ECOL, V45, P610, DOI 10.1111/j.1365-2664.2007.01447.x; Groch Karina R., 2005, Latin American Journal of Aquatic Mammals, V4, P41; HAIMOVICI M, 1994, MAR ECOL PROG SER, V108, P59, DOI 10.3354/meps108059; Haimovici M, 1998, ECOSISTEMAS COSTEIRO, P205; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; Hart KM, 2006, BIOL CONSERV, V129, P283, DOI 10.1016/j.biocon.2005.10.047; Harwood J, 1998, NATURE, V393, P17, DOI 10.1038/29877; Hassel Lucas B., 2003, Latin American Journal of Aquatic Mammals, V2, P47; Hofmeyr GJG, 2010, AFR ZOOL, V45, P144, DOI 10.3377/004.045.0112; KAWAMURA A, 1980, SCI REP WHALES RES, V32, P155; Kinas Paul G., 2005, Latin American Journal of Aquatic Mammals, V4, P7; Kinas PG, 2002, B MAR SCI, V70, P409; Lea MA, 2006, MAR ECOL PROG SER, V310, P77, DOI 10.3354/meps310077; Leeney RH, 2008, BIODIVERS CONSERV, V17, P2323, DOI 10.1007/s10531-008-9377-5; Lima ID, 1996, CONT SHELF RES, V16, P1307, DOI 10.1016/0278-4343(95)00066-6; Lodi Liliane, 1998, Bioikos, V12, P29; Lumpkin R, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006285; Machado Rodrigo, 2015, Neotropical Biology and Conservation, V10, P43, DOI 10.4013/nbc.2015.101.06; MacLeod Colin D., 2004, Journal of Cetacean Research and Management, V6, P79; Maldini Daniela, 2005, Pacific Science, V59, P55, DOI 10.1353/psc.2005.0009; Moller OO, 2008, CONT SHELF RES, V28, P1607, DOI 10.1016/j.csr.2008.03.012; Moura J.F., 2007, LATIN AM J AQUATIC M, V6, p103 , DOI DOI 10.5597/LAJAM00114; Muelbert JH, 2008, CONT SHELF RES, V28, P1662, DOI 10.1016/j.csr.2007.08.011; Oliveira L.R., 2004, THESIS U SAO PAULO; Oliveira LR, 1999, THESIS PONTIFICIA U; Paez E., 2006, BASES CONSERVACION M, P577; Paez E, 2013, EVALUACION RECURSOS, P65; Passadore C, 2015, ICES J MAR SCI, V72, P1637, DOI 10.1093/icesjms/fsu250; Passadore C, 2015, ICES J MAR SCI, V72, P1653, DOI 10.1093/icesjms/fsu251; Pavanato H, 2014, BRAZ J BIOL, V73, P855, DOI 10.1590/S1519-698420130004000023; Peltier H, 2012, ECOL INDIC, V18, P278, DOI 10.1016/j.ecolind.2011.11.014; Petry Maria V., 2002, Ornitologia Neotropical, V13, P137; Pinedo M. C., 2002, Journal of Cetacean Research and Management, V4, P323; Pinedo M. C., 1999, Journal of Cetacean Research and Management, V1, P179; Pinedo M. C., 1989, ATLANTICA, V11, P85; Pinedo MC, 1990, G ORLA SER ZOOL, V15, P37; Pinedo MC., 2001, ATLANTICA, V23, P67; PINEDO MC, 1987, SCI REP WHALE RES I, V38, P171; PINEDO MC, 1989, ATLANTICA, V11, P77; Piola AR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021638; Piola AR, 2000, J GEOPHYS RES-OCEANS, V105, P6565, DOI 10.1029/1999JC000300; Prado JHF, 2013, ECOL INDIC, V32, P35, DOI 10.1016/j.ecolind.2013.03.005; Pyenson ND, 2010, PALEOBIOLOGY, V36, P453, DOI 10.1666/09018.1; R Core Team, 2018, R LANG ENV STAT COMP; Reeves R. R., 2013, ENDANGER SPECIES RES, V20, P71; Reeves RR, 2008, IUCN 2015 IUCN RED L; Rosa FCW, 1989, ATLANTICA, V11, P109; ROSAS FCW, 1994, MAMMALIA, V58, P51, DOI 10.1515/mamm.1994.58.1.51; Secchi E. R., 2004, LAT AM J AQUAT MAMM, V3, P61, DOI DOI 10.5597/LAJAM00049; Secchi Eduardo R., 2001, Journal of Cetacean Research and Management, V3, P95; Secchi Eduardo R., 1998, Aquatic Mammals, V24, P117; Secchi Eduardo R., 1997, Report of the International Whaling Commission, V47, P653; Secchi ER, 2004, SC56SM20 INT WHAL CO; Seyboth E, 2015, MAR MAMMAL SCI, V31, P1521, DOI 10.1111/mms.12241; Sousa L, 2004, SERIE DOCUMENTOS REV; Szephegyi MN, 2010, 14 REUN TRAB EXP MAM; Toledo GAC, 2015, MAR BIODIVERS REC, V8, P1; Trathan PN, 2007, PHILOS T R SOC B, V362, P2351, DOI 10.1098/rstb.2006.1953; Tunez JI, 2008, HYDROBIOLOGIA, V598, P191, DOI 10.1007/s10750-007-9150-x; VOOREN CM, 1998, ECOSSISTEMAS COSTEIR, P157; Ward Eric, 2011, Journal of Cetacean Research and Management, P145; Wojtek B, 2010, SMITHSONIAN, V1000, P13; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295; Zerbini Alexandre N., 1997, Report of the International Whaling Commission, V47, P407; Zerbini Alexandre N., 2011, Journal of Cetacean Research and Management, P113; Zerbini Alexandre N., 1998, Report of the International Whaling Commission, V48, P519; Zerbini NA, 2004, SERIE DOCUMENTOS REV; Zuur A. F., 2014, BEGINNERS GUIDE GEN	108	44	45	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146339	10.1371/journal.pone.0146339	http://dx.doi.org/10.1371/journal.pone.0146339			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814667	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528200013
J	Gao, Y; Lu, YM; Yi, JM; Li, ZH; Gao, DW; Yu, ZL; Wu, TN; Zhang, CG				Gao, Yan; Lu, Yiming; Yi, Jianming; Li, Zhihui; Gao, Dawen; Yu, Zhoulong; Wu, Tongning; Zhang, Chenggang			A Genome-Wide mRNA Expression Profile in Caenorhabditis elegans under Prolonged Exposure to 1750MHz Radiofrequency Fields	PLOS ONE			English	Article							SHOCK GENE-EXPRESSION; LETHAL HEAT-STRESS; WAVES RF-EMW; ELECTROMAGNETIC-FIELDS; TRANSGENIC NEMATODES; SEMEN PARAMETERS; CELLULAR PHONES; MOBILE PHONE; IN-VITRO; CELLS	Objective C. elegans has been used as a biomonitor for microwave-induced stress. However, the RF (radiofrequency) fields that have been used in previous studies were weak (<= 1.8W/kg), and the bio-effects on C. elegans were mostly negative or ambiguous. Therefore, this study used more intense RF fields (SAR = 3W/kg) and longer time course of exposure (60h at 25 degrees C, L1 stage through adult stage) to investigate the biological consequences of 1750 MHz RF fields in wild-type worms. Methods The growth rates and lifespans of RF-exposure group and the control group were carefully recorded. RNA samples were collected at L4 (35h) and gravid adult (50h) stages for further high-throughput sequencing, focusing on differences between the RF-exposure and the sham control groups. Results The RF-exposed and sham control groups developed at almost the same rate and had similar longevity curves. In L4 stage worms, 94 up-regulated and 17 down-regulated genes were identified, while 186 up-regulated and 3 down-regulated genes were identified in adult stage worms. GO analysis showed that the differentially expressed genes at 35h were associated with growth, body morphogenesis and collagen and cuticle-based development. Genes that were linked to growth rate and reproductive development were differentially expressed at 50h. Some embryonic and larval development genes in the offspring were also differentially expressed at 50h. Ten genes were differentially expressed at both 35h and 50h, most of which were involved in both embryonic and larval developmental processes. Although prolonged RF fields did not induce significant temperature increase in RF exposure groups, the temperature inside worms during exposure was unknown. Conclusions No harmful effects were observed in prolonged exposure to 1750 MHz RF fields at SAR of 3W/kg on development and longevity of C. elegans. Although some differentially expressed genes were found after prolonged RF exposure, these differences were ascribed to oscillating gene expression patterns in L4 and gravid adult worms. It was also difficult to rule out a weak thermal effect caused by prolonged RF exposure inside the worms.	[Gao, Yan; Lu, Yiming; Yi, Jianming; Li, Zhihui; Gao, Dawen; Yu, Zhoulong; Zhang, Chenggang] Beijing Inst Radiat Med, Cognit & Mental Hlth Res Ctr, State Key Lab Prote, State Key Lab Millimeter Wave, Beijing 100850, Peoples R China; [Wu, Tongning] China Acad Telecommun Res, Minist Ind & Informat Technol, 52 Huayuanbei Rd, Beijing 100191, Peoples R China	Academy of Military Medical Sciences - China	Zhang, CG (corresponding author), Beijing Inst Radiat Med, Cognit & Mental Hlth Res Ctr, State Key Lab Prote, State Key Lab Millimeter Wave, Beijing 100850, Peoples R China.; Wu, TN (corresponding author), China Acad Telecommun Res, Minist Ind & Informat Technol, 52 Huayuanbei Rd, Beijing 100191, Peoples R China.	toniwoo@gmail.com; zhangcg@bmi.ac.cn	Wu, Tongning/J-7308-2019; Zhang, Chenggang/B-1480-2009	Zhang, Chenggang/0000-0002-4521-3304	General Program of the Natural Science Foundation of China [31101049, 31401141, 31300703, 81170558, 81573251]; Special Key Program for Science and Technology of China [2012ZX09102301-016, 2012ZX09J12107-03C, 2012AA022402]; General Program of the Key Laboratory of Tropical Marine Bio-resources and Ecology [LMB111001]; Program of the State Key Laboratory of Proteomics [SKLP-O201207-WTN, SKLP-Y201303-YML]	General Program of the Natural Science Foundation of China; Special Key Program for Science and Technology of China; General Program of the Key Laboratory of Tropical Marine Bio-resources and Ecology; Program of the State Key Laboratory of Proteomics	This work was supported by: 31101049 (YG), 31401141 (YML), 31300703 (YHW), 81170558 (HLL), 81573251 (CSC), the General Program of the Natural Science Foundation of China, http://www.nsfc.gov.cn/nsfc/cen/xxgk/slzz.html; 2012ZX09102301-016 (CGZ), 2012ZX09J12107-03C (ZWX), 2012AA022402 (CGZ), the Special Key Program for Science and Technology of China, http://www.most.gov.cn/; LMB111001 (CGZ), the General Program of the Key Laboratory of Tropical Marine Bio-resources and Ecology, http://www.scsio.cas.cn/jgsz/; SKLP-O201207-WTN, SKLP-Y201303-YML, the Program of the State Key Laboratory of Proteomics, http://bprc.biomart.cn/.	Agarwal A, 2009, FERTIL STERIL, V92, P1318, DOI 10.1016/j.fertnstert.2008.08.022; Ahlbom A, 2001, ENVIRON HEALTH PERSP, V109, P911, DOI 10.2307/3454653; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BERKS M, 1995, GENOME RES, V5, P99, DOI 10.1101/gr.5.2.99; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chege PM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00089; Cleary SF, 1997, BIOELECTROMAGNETICS, V18, P499, DOI 10.1002/(SICI)1521-186X(1997)18:7<499::AID-BEM5>3.0.CO;2-Y; COX GN, 1981, DEV BIOL, V86, P456, DOI 10.1016/0012-1606(81)90204-9; Daniells C, 1998, MUTAT RES-FUND MOL M, V399, P55, DOI 10.1016/S0027-5107(97)00266-2; David HE, 2003, ENVIRON TOXICOL CHEM, V22, P111, DOI [10.1897/1551-5028(2003)022&lt;0111:CAEOAT&gt;2.0.CO;2, 10.1002/etc.5620220114]; Dawe AS, 2008, BIOELECTROMAGNETICS, V29, P92, DOI 10.1002/bem.20366; Dawe AS, 2009, BIOELECTROMAGNETICS, V30, P602, DOI 10.1002/bem.20515; Dawe AS, 2006, BIOELECTROMAGNETICS, V27, P88, DOI 10.1002/bem.20192; Eichholz GG, 2002, HEALTH PHYS, V83, P920, DOI 10.1097/00004032-200212000-00021; Feijo C, 2011, HUM REPROD, V26, pI139; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Gurisik E, 2006, CELL BIOL INT, V30, P793, DOI 10.1016/j.cellbi.2006.06.001; Gutschi T, 2011, ANDROLOGIA, V43, P312, DOI 10.1111/j.1439-0272.2011.01075.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Humans IWGotEoCRt, 2013, IARC MONOGR EVAL CAR, V102, P1; Imai N, 2011, SYST BIOL REPROD MED, V57, P204, DOI 10.3109/19396368.2010.544839; JAUCHEM JR, 1994, J APPL PHYSIOL, V77, P434, DOI 10.1152/jappl.1994.77.1.434; Jauchem JR, 1997, J AUTON PHARMACOL, V17, P165, DOI 10.1046/j.1365-2680.1997.00453.x; Junkersdorf B, 2000, BIOELECTROMAGNETICS, V21, P100, DOI 10.1002/(SICI)1521-186X(200002)21:2<100::AID-BEM4>3.0.CO;2-U; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Laszlo A, 2005, RADIAT RES, V164, P163, DOI 10.1667/RR3406; Leszczynski D, 2002, DIFFERENTIATION, V70, P120, DOI 10.1046/j.1432-0436.2002.700207.x; Leszczynski D, 2012, PROTEOMICS, V12, P2493, DOI 10.1002/pmic.201200122; Lim HB, 2005, RADIAT RES, V163, P45, DOI 10.1667/RR3264; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Margaritis LH, 2014, ELECTROMAGN BIOL MED, V33, P165, DOI 10.3109/15368378.2013.800102; Miyakoshi J, 2005, BIOELECTROMAGNETICS, V26, P251, DOI 10.1002/bem.20077; Porta-de-la-Riva M, 2012, JOVE-J VIS EXP, DOI 10.3791/4019; Power RS, 1998, J BIOSCIENCES, V23, P513, DOI 10.1007/BF02936145; Prahlad V, 2009, TRENDS CELL BIOL, V19, P52, DOI 10.1016/j.tcb.2008.11.002; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Tas M, 2014, ELECTROMAGN BIOL MED, V33, P216, DOI 10.3109/15368378.2013.801850; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120	44	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147273	10.1371/journal.pone.0147273	http://dx.doi.org/10.1371/journal.pone.0147273			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811916	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528000026
J	White, J; Rehkopf, D; Mortensen, LH				White, James; Rehkopf, David; Mortensen, Laust Hvas			Trends in Socioeconomic Inequalities in Body Mass Index, Underweight and Obesity among English Children, 2007-2008 to 2011-2012	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; CHILDHOOD OBESITY; CARDIOVASCULAR-DISEASE; OVERWEIGHT PREVALENCE; ADOLESCENT HEALTH; RISK-FACTORS; MORTALITY; ADULTHOOD; COUNTRIES; THINNESS	Background Socioeconomic inequalities in childhood obesity have been reported in most developed countries, with obesity more common in deprived groups. Whether inequalities are found in the prevalence of underweight, the rest of the body mass index (BMI) distribution, or have changed across time is not clear. Methods and Findings The sample comprised 5,027,128 children on entry (4 to 5 years old) and leaving (10 to 11 years) state primary (elementary) school who participated in the National Child Measurement Programme (England, United Kingdom). We used area-level deprivation (Indices of Multiple Deprivation at the lower super output area) as a measure of socioeconomic deprivation. From 2007-2008 to 2011-2012 inequalities in obesity between the most compared to least deprived group increased (from 7.21% to 8.30%; p<0.001), whereas inequalities in the prevalence of underweight (1.50% to 1.21%; p = 0.15) were stable during this period. There were no differences by age group or by sex, but a three-way interaction suggested inequalities in obesity had increased at a faster rate for 10 to 11 year old girls, than 4 to 5 year old boys, (2.03% vs 0.07%; p<0.001 for interaction). Investigating inequalities across the distribution of zBMI showed increases in mean zBMI (0.18 to 0.23, p<0.001) could be attributed to increases in inequalities between the 50th and 75th centiles of BMI. Using the 2011 to 2012 population attributable risk estimates, if inequalities were halved, 14.04% (95% CI 14.00% to 14.07%) of childhood obesity could be avoided. Conclusions Socioeconomic inequalities in childhood obesity and zBMI increased in England between 2007-2008 and 2011-2012. Inequalities in the prevalence of underweight did not change. Traditional methods of examining inequalities only at the clinical thresholds of overweight and obesity may have led the magnitude of inequalities in childhood BMI to be underestimated.	[White, James] Cardiff Univ, SEWTU, Cardiff CF10 3AX, S Glam, Wales; [White, James] Cardiff Univ, Ctr Dev & Evaluat Complex Intervent Publ Hlth Imp, Cardiff CF10 3AX, S Glam, Wales; [Rehkopf, David] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Mortensen, Laust Hvas] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark	Cardiff University; Cardiff University; Stanford University; University of Copenhagen	White, J (corresponding author), Cardiff Univ, SEWTU, Cardiff CF10 3AX, S Glam, Wales.; White, J (corresponding author), Cardiff Univ, Ctr Dev & Evaluat Complex Intervent Publ Hlth Imp, Cardiff CF10 3AX, S Glam, Wales.	whitej11@cf.ac.uk		White, James/0000-0001-8371-8453; Rehkopf, David/0000-0002-7597-6513	Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a United Kingdom Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council [MR/KO232331/1]; Welsh Government; Wellcome Trust; NATIONAL INSTITUTE ON AGING [K01AG047280] Funding Source: NIH RePORTER; Medical Research Council [MR/K023233/1] Funding Source: researchfish; MRC [MR/K023233/1] Funding Source: UKRI	Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a United Kingdom Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welsh Government; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is undertaken with the support of The Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a United Kingdom Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence. Joint funding (MR/KO232331/1) from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the Welsh Government and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bambra CL, 2015, NIHR J LIB; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bjornelv S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-279; Bluher S, 2011, INT J PEDIATR OBES, V6, pE199, DOI 10.3109/17477166.2010.526305; CHARNEY E, 1976, NEW ENGL J MED, V295, P6, DOI 10.1056/NEJM197607012950102; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Dinsdale H, 2014504 PUBL HLTH EN; Dinsdale H, 2010, NATL CHILD MEASUREME; El-Sayed AM, 2012, OBESITY FACTS, V5, P671, DOI 10.1159/000343611; Elgar FJ, 2005, J ADOLESCENT HEALTH, V37, P371, DOI 10.1016/j.jadohealth.2004.07.014; Elgar FJ, 2015, LANCET, V385, P2088, DOI 10.1016/S0140-6736(14)61460-4; Ells LJ, 2015, ARCH DIS CHILD, V100, P631, DOI 10.1136/archdischild-2014-307036; Eriksson M, 2005, ACTA PAEDIATR, V94, P1558, DOI 10.1080/08035250500274926; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; Herouvi D, 2013, EUR J PEDIATR, V172, P721, DOI 10.1007/s00431-013-1932-8; Ice CL, 2011, INT J PEDIATR OBES, V6, P113, DOI 10.3109/17477161003792556; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Jantti M., 2006, AM EXCEPTIONALISM NE; Kannel WB, 1996, JAMA-J AM MED ASSOC, V275, P1571, DOI 10.1001/jama.275.20.1571; Kautiainen S, 2009, INT J PEDIATR OBES, V4, P360, DOI 10.3109/17477160902811173; Keane E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-974; Khang YH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-66; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Marmot M, 2010, FAIR SOC HLTH LIVES; MARMOT MG, 1986, LANCET, V2, P274; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Mendez MA, 1999, J NUTR, V129, P1555, DOI 10.1093/jn/129.8.1555; NHS Information Centre, 2009, NAT CHILD MEAS PROGR; O'Dea JA, 2010, INT J PUBLIC HEALTH, V55, P185, DOI 10.1007/s00038-009-0079-x; Program Operational Manual (POM), 2014, ON WASH NATL PROGR; Ridler C, 2009, NATL CHILD MEASUREME; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Salanave B, 2009, INT J PEDIATR OBES, V4, P66, DOI 10.1080/17477160902811207; Singh GK, 2002, INT J EPIDEMIOL, V31, P600, DOI 10.1093/ije/31.3.600; Sjoberg A, 2008, ACTA PAEDIATR, V97, P118, DOI 10.1111/j.1651-2227.2007.00613.x; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Stamatakis E, 2010, INT J OBESITY, V34, P41, DOI 10.1038/ijo.2009.217; Stamatakis E, 2010, J EPIDEMIOL COMMUN H, V64, P167, DOI 10.1136/jech.2009.098723; STUNKARD A, 1972, J AMER MED ASSOC, V221, P579, DOI 10.1001/jama.221.6.579; Sundblom E, 2008, INT J OBESITY, V32, P1525, DOI 10.1038/ijo.2008.104; The NHS Information Centre, 2011, NAT CHILD MEAS PROGR; The NHS Information Centre, 2012, NAT CHILD MEAS PROGR; The NHS Information Centre, 2010, NAT CHILD MEAS PROGR; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; World Health Organization (WHO), CRIT LINK INT PHYS G; Yang SM, 2008, AM J PUBLIC HEALTH, V98, P468, DOI 10.2105/AJPH.2007.111609	49	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147614	10.1371/journal.pone.0147614	http://dx.doi.org/10.1371/journal.pone.0147614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GB	26812152	Green Published, Green Accepted, gold			2022-12-26	WOS:000369528000044
J	Cobo, T; Viloria, CG; Solares, L; Fontanil, T; Gonzalez-Chamorro, E; De Carlos, F; Cobo, J; Cal, S; Obaya, AJ				Cobo, Teresa; Viloria, Cristina G.; Solares, Laura; Fontanil, Tania; Gonzalez-Chamorro, Elena; De Carlos, Felix; Cobo, Juan; Cal, Santiago; Obaya, Alvaro J.			Role of Periostin in Adhesion and Migration of Bone Remodeling Cells	PLOS ONE			English	Article							PERIODONTAL-LIGAMENT; OSTEOCLAST DIFFERENTIATION; MESENCHYMAL TRANSITION; EXTRACELLULAR-MATRIX; MC3T3-E1 CELLS; CANCER CELLS; EXPRESSION; PROLIFERATION; OSTEOBLAST; BREAST	Periostin is an extracellular matrix protein highly expressed in collagen-rich tissues subjected to continuous mechanical stress. Functionally, periostin is involved in tissue remodeling and its altered function is associated to numerous pathological processes. In orthodontics, periostin plays key roles in the maintenance of dental tissues and it is mainly expressed in those areas where tension or pressing forces are taking place. In this regard, high expression of periostin is essential to promote migration and proliferation of periodontal ligament fibroblasts. However little is known about the participation of periostin in migration and adhesion processes of bone remodeling cells. In this work we employ the mouse pre-osteoblastic MC3T3-E1 and the macrophage-like RAW 264.7 cell lines to overexpress periostin and perform different cell-based assays to study changes in cell behavior. Our data indicate that periostin overexpression not only increases adhesion capacity of MC3T3-E1 cells to different matrix proteins but also hampers their migratory capacity. Changes on RNA expression profile of MC3T3-E1 cells upon periostin overexpression have been also analyzed, highlighting the alteration of genes implicated in processes such as cell migration, adhesion or bone metabolism but not in bone differentiation. Overall, our work provides new evidence on the impact of periostin in osteoblasts physiology.	[Cobo, Teresa; Gonzalez-Chamorro, Elena; De Carlos, Felix; Cobo, Juan] Univ Oviedo, Fac Med, Dept Cirugia & Especialidades Med Quirurg, Asturias, Spain; [Viloria, Cristina G.; Solares, Laura; Obaya, Alvaro J.] Univ Oviedo, Fac Med, Dept Biol Func, Asturias, Spain; [Fontanil, Tania; Cal, Santiago] Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, Asturias, Spain; [Cal, Santiago; Obaya, Alvaro J.] Univ Oviedo, Fac Med, Inst Univ Oncol IUOPA, Asturias, Spain	University of Oviedo; University of Oviedo; University of Oviedo; University of Oviedo; Instituto Universitario de Oncologia de Asturias	Obaya, AJ (corresponding author), Univ Oviedo, Fac Med, Dept Biol Func, Asturias, Spain.; Obaya, AJ (corresponding author), Univ Oviedo, Fac Med, Inst Univ Oncol IUOPA, Asturias, Spain.	ajobaya@uniovi.es	COBO DIAZ, TERESA/GZG-8852-2022; Obaya, Alvaro J./AAQ-6115-2021; López, tania Fontanil/AAM-6512-2020	Obaya, Alvaro J./0000-0002-4163-2173; Fontanil, Tania/0000-0003-2261-7661	Fundacion Universidad de Oviedo; Instituto Asturiano de Odontologia; Beca de Colaboracion from Ministerio de Educacion, Cultura y Deporte of Spain; Instituto de Salud Carlos III (Spain) [FISS PI11/00371]; Fondos FEDER; Obra Social Cajastur	Fundacion Universidad de Oviedo; Instituto Asturiano de Odontologia; Beca de Colaboracion from Ministerio de Educacion, Cultura y Deporte of Spain; Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); Fondos FEDER(European Commission); Obra Social Cajastur	This work was supported by Fundacion Universidad de Oviedo and Instituto Asturiano de Odontologia. C.G.V. was financed by Fundacion Universidad de Oviedo and L.S. was a recipient of Beca de Colaboracion from Ministerio de Educacion, Cultura y Deporte of Spain. This work was also partially supported by a grant from the Instituto de Salud Carlos III (Spain) (FISS PI11/00371) and Fondos FEDER. The Instituto Universitario de Oncologia is supported by Obra Social Cajastur.	Baril P, 2007, ONCOGENE, V26, P2082, DOI 10.1038/sj.onc.1210009; Bonnet N, 2009, J BIOL CHEM, V284, P35939, DOI 10.1074/jbc.M109.060335; Brady RT, 2015, BIOCHEM BIOPH RES CO, V459, P118, DOI 10.1016/j.bbrc.2015.02.080; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Chen DH, 2012, NAT MED, V18, P1511, DOI 10.1038/nm.2940; Chen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104016; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; del Valle I, 2013, DEVELOPMENT, V140, P1684, DOI 10.1242/dev.088690; Dorval-Coiffec I, 2005, BIOL REPROD, V72, P602, DOI 10.1095/biolreprod.104.034892; Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Freitas F, 2002, BONE, V30, P99, DOI 10.1016/S8756-3282(01)00625-1; Gillan L, 2002, CANCER RES, V62, P5358; Gluhak-Heinrich J, 2003, J BONE MINER RES, V18, P807, DOI 10.1359/jbmr.2003.18.5.807; Gotz W, 2006, EUR J ORAL SCI, V114, P318; Hadjicharalambous C, 2015, J BIOMED MATER RES A, V103, P3834, DOI 10.1002/jbm.a.35527; Hakuno D, 2010, J CLIN INVEST, V120, P2292, DOI 10.1172/JCI40973; Henriquez M, 2011, J CELL SCI, V124, P1581, DOI 10.1242/jcs.073171; Hong LZ, 2010, MOL BIOL REP, V37, P2285, DOI 10.1007/s11033-009-9721-1; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Hu LF, 2015, CELL BIOL INT, V39, P364, DOI 10.1002/cbin.10391; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Jackson-Boeters L, 2009, J CELL COMMUN SIGNAL, V3, P125, DOI 10.1007/s12079-009-0057-3; Johansson MW, 2013, AM J RESP CELL MOL, V48, P503, DOI 10.1165/rcmb.2012-0150OC; Kanno A, 2008, INT J CANCER, V122, P2707, DOI 10.1002/ijc.23332; Kashimaa TG, 2009, HUM PATHOL, V40, P226, DOI 10.1016/j.humpath.2008.07.008; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kim CJ, 2011, INT J ONCOL, V38, P1759, DOI 10.3892/ijo.2011.997; Ko CH, 2015, CALCIFIED TISSUE INT, V96, P389, DOI 10.1007/s00223-015-9966-8; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Li GH, 2010, ATHEROSCLEROSIS, V208, P358, DOI 10.1016/j.atherosclerosis.2009.07.046; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; Lin W, 2015, J CELL BIOCHEM, DOI [10.1002/jcb.25310, DOI 10.1002/JCB]; Lindner V, 2005, ARTERIOSCL THROM VAS, V25, P77, DOI 10.1161/01.ATV.0000149141.81230.c6; Lu SH, 2015, J NAT PROD, V78, P61, DOI 10.1021/np500663y; Lv SY, 2014, J MOL HISTOL, V45, P303, DOI 10.1007/s10735-013-9548-x; Ma DD, 2011, J BIOL CHEM, V286, P4302, DOI 10.1074/jbc.M110.140202; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L; Moura AP, 2014, BONE, V69, P133, DOI 10.1016/j.bone.2014.09.019; Nakazawa T, 2004, J ORTHOP RES, V22, P520, DOI 10.1016/j.orthres.2003.10.007; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Ontsuka K, 2012, EXP DERMATOL, V21, P331, DOI 10.1111/j.1600-0625.2012.01454.x; Ouyang GL, 2009, CANCER LETT, V281, P213, DOI 10.1016/j.canlet.2009.02.030; Padial-Molina M, 2014, J PERIODONTAL RES, V49, P405, DOI 10.1111/jre.12120; Perrier A, 2010, BONE, V47, P23, DOI 10.1016/j.bone.2010.03.010; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Romanos GE, 2014, J CELL PHYSIOL, V229, P1, DOI 10.1002/jcp.24407; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Sanuki R, 2010, CONNECT TISSUE RES, V51, P150, DOI 10.3109/03008200903168484; Sasaki H, 2003, BREAST CANCER RES TR, V77, P245, DOI 10.1023/A:1021899904332; Satue M, 2013, BIOCHEM PHARMACOL, V86, P1476, DOI 10.1016/j.bcp.2013.09.009; Schneider MR, 2002, J ENDOCRINOL, V172, P423, DOI 10.1677/joe.0.1720423; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; Shen YF, 2010, CELL MOL NEUROBIOL, V30, P909, DOI 10.1007/s10571-010-9520-1; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Sureshbabu A, 2012, J CELL SCI, V125, P1693, DOI 10.1242/jcs.092882; Suzuki E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112566; Suzuki H, 2004, ANAT REC PART A, V281A, P1264, DOI 10.1002/ar.a.20080; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Tanabe H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012234; Uchida M, 2012, AM J RESP CELL MOL, V46, P677, DOI 10.1165/rcmb.2011-0115OC; Ventura RD, 2015, TISSUE ENG PT A, V21, P2649, DOI [10.1089/ten.TEA.2015.0024, 10.1089/ten.tea.2015.0024]; WARE CB, 1995, DEVELOPMENT, V121, P1283; Watanabe T, 2012, ARCH ORAL BIOL, V57, P52, DOI 10.1016/j.archoralbio.2011.07.010; Windischhofer W, 2012, BIOCHIMIE, V94, P1997, DOI 10.1016/j.biochi.2012.05.023; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Zhang Z, 2014, INT J MOL MED, V34, P253, DOI 10.3892/ijmm.2014.1760; Zhu SM, 2009, J CELL PHYSIOL, V218, P584, DOI 10.1002/jcp.21633	76	29	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147837	10.1371/journal.pone.0147837	http://dx.doi.org/10.1371/journal.pone.0147837			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809067	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800223
J	Doi, AM; Pignatari, ACC; Edmond, MB; Marra, AR; Camargo, LFA; Siqueira, RA; da Mota, VP; Colombo, AL				Doi, Andre Mario; Campos Pignatari, Antonio Carlos; Edmond, Michael B.; Marra, Alexandre Rodrigues; Aranha Camargo, Luis Fernando; Siqueira, Ricardo Andreotti; da Mota, Vivian Pereira; Colombo, Arnaldo Lopes			Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; HISTORICAL TRENDS; PARAPSILOSIS; MULTICENTER; FLUCONAZOLE; CANDIDIASIS; RESISTANCE; HOSPITALS; GLABRATA; YEAST	Candidemia is a growing problem in hospitals all over the world. Despite advances in the medical support of critically ill patients, candidiasis leads to prolonged hospitalization, and has a crude mortality rate around 50%. We conducted a multicenter surveillance study in 16 hospitals distributed across five regions of Brazil to assess the incidence, species distribution, antifungal susceptibility, and risk factors for bloodstream infections due to Candida species. From June 2007 to March 2010, we studied a total of 2,563 nosocomial bloodstream infection (nBSI) episodes. Candida spp. was the 7th most prevalent agent. Most of the patients were male, with a median age of 56 years. A total of 64 patients (46.7%) were in the ICU when candidemia occurred. Malignancies were the most common underlying condition (32%). The crude mortality rate of candidemia during the hospital admission was 72.2%. Non-albicans species of Candida accounted for 65.7% of the 137 yeast isolates. C. albicans (34.3%), Candida parapsilosis (24.1%), Candida tropicalis (15.3%) and Candida glabrata (10.2%) were the most prevalent species. Only 47 out of 137 Candida isolates were sent to the reference laboratory for antifungal susceptibility testing. All C. albicans, C. tropicalis and C. parapsilosis isolates were susceptible to the 5 antifungal drugs tested. Among 11 C. glabrata isolates, 36% were resistant to fluconazole, and 64% SDD. All of them were susceptible to anidulafungin and amphotericin B. We observed that C. glabrata is emerging as a major player among non-albicans Candida spp. and fluconazole resistance was primarily confined to C. glabrata and C. krusei strains. Candida resistance to echinocandins and amphotericin B remains rare in Brazil. Mortality rates remain increasingly higher than that observed in the Northern Hemisphere countries, emphasizing the need for improving local practices of clinical management of candidemia, including early diagnosis, source control and precise antifungal therapy.	[Doi, Andre Mario; Campos Pignatari, Antonio Carlos; Siqueira, Ricardo Andreotti; Colombo, Arnaldo Lopes] Univ Fed Sao Paulo, Dept Med, Div Infect Dis, Sao Paulo, SP, Brazil; [Marra, Alexandre Rodrigues] Hosp Israelita Albert Einstein, Div Med Practice, Sao Paulo, SP, Brazil; [Aranha Camargo, Luis Fernando] Hosp Israelita Albert Einstein, Inst Israelita Ensino & Pesquisa Albert Einstein, Sao Paulo, SP, Brazil; [Edmond, Michael B.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA USA; [da Mota, Vivian Pereira] Hosp Sao Paulo, Lab Cent, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein; University of Iowa	Colombo, AL (corresponding author), Univ Fed Sao Paulo, Dept Med, Div Infect Dis, Sao Paulo, SP, Brazil.	colomboal@terra.com.br	Colombo, Arnaldo Lopes/H-4397-2012; Colombo, Arnaldo Lopes/V-4417-2019; Pignatari, Antonio CC/C-8427-2012	Colombo, Arnaldo Lopes/0000-0003-0793-8491; Edmond, Michael/0000-0002-4144-8974; Camargo, Luis Fernando Aranha/0000-0002-3888-8661; Pignatari, Antonio/0000-0002-2146-8476	Pfizer, Inc.; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/13533-9]	Pfizer, Inc.(Pfizer); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The study was funded in part by an independent medical grant provided by Pfizer, Inc. Great part was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) 2010/13533-9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbiSaid D, 1997, CLIN INFECT DIS, V24, P1122, DOI 10.1086/513663; Ahmed A, 2014, INDIAN J CRIT CARE M, V18, P682, DOI 10.4103/0972-5229.142178; Arendrup MC, 2014, CURR OPIN INFECT DIS, V27, P484, DOI 10.1097/QCO.0000000000000111; Bassetti M, 2014, INTENS CARE MED, V40, P839, DOI 10.1007/s00134-014-3310-z; Bizerra FC, 2014, ANTIMICROB AGENTS CH, V58, P2438, DOI 10.1128/AAC.02189-13; Brito LR, 2006, MED MYCOL, V44, P261, DOI 10.1080/13693780500421476; Castanheira M, 2014, INT J ANTIMICROB AG, V44, P320, DOI 10.1016/j.ijantimicag.2014.06.007; Chen PY, 2014, J MICROBIOL IMMUNOL, V47, P95, DOI 10.1016/j.jmii.2012.08.025; Chowdhary A, 2014, EUR J CLIN MICROBIOL, V33, P919, DOI 10.1007/s10096-013-2027-1; Clinical and Laboratory Standards Institute, 2012, M27S4 CLSI, VM27-S4; CLSI, 1908, M27A3 CLSI; Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06; Colombo AL, 2014, INTENS CARE MED, V40, P1489, DOI 10.1007/s00134-014-3400-y; Colombo AL, 2013, MED MYCOL, V51, P38, DOI 10.3109/13693786.2012.698024; Cuenca-Estrella M, 2009, ANTIMICROB AGENTS CH, V53, P2192, DOI 10.1128/AAC.01543-08; Delaloye J, 2014, VIRULENCE, V5, P161, DOI 10.4161/viru.26187; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; Lortholary O, 2014, INTENS CARE MED, V40, P1303, DOI 10.1007/s00134-014-3408-3; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Marra AR, 2011, J CLIN MICROBIOL, V49, P1866, DOI 10.1128/JCM.00376-11; Nucci M, 2013, REV IBEROAM MICOL, V30, P179, DOI [10.1016/j.riam.2013.05.007, 10.1016/j.riam.2013.06.001]; Nucci M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059373; Nucci M, 2010, CLIN INFECT DIS, V51, P561, DOI 10.1086/655683; Pfaller MA, 2007, J CLIN MICROBIOL, V45, P1735, DOI 10.1128/JCM.00409-07; Pfaller MA, 2010, DIAGN MICROBIOL INFE, V68, P278, DOI DOI 10.1016/J.DIAGMICR0BI0.2010.06.015; Pfaller MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101510; Pfaller MA, 2011, J CLIN MICROBIOL, V49, P396, DOI 10.1128/JCM.01398-10; Souza ACR, 2015, ANTIMICROB AGENTS CH, V59, P6581, DOI 10.1128/AAC.01177-15; Wille MP, 2013, MEM I OSWALDO CRUZ, V108, P288, DOI 10.1590/S0074-02762013000300005; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wisplinghoff H, 2014, INT J ANTIMICROB AG, V43, P78, DOI 10.1016/j.ijantimicag.2013.09.005	31	114	121	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146909	10.1371/journal.pone.0146909	http://dx.doi.org/10.1371/journal.pone.0146909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808778	Green Submitted, gold, Green Published			2022-12-26	WOS:000369527800039
J	Hoeksema, L; Los, LI				Hoeksema, Lisette; Los, Leonoor I.			Vision-Related Quality of Life in Patients with Inactive HLA-B27-Associated-Spectrum Anterior Uveitis	PLOS ONE			English	Article							VISUAL FUNCTION QUESTIONNAIRE; STEROID TREATMENT TRIAL; ANKYLOSING-SPONDYLITIS; PSYCHOMETRIC EVALUATION; RHEUMATOID-ARTHRITIS; HEALTH-STATUS; DEPRESSION	We investigated the vision-related quality of life (VR-QOL) in patients with HLA-B27 associated anterior uveitis (AU). The study was conducted in 2012 at the ophthalmology department of the University Medical Center of Groningen. We included AU patients who were HLA-B27 positive and/or were diagnosed by a rheumatologist with an HLA-B27 associated systemic disease. Sixty-one of 123 (50%) adult patients participated. All patients filled-out the National Eye Institute Visual Functioning Questionnaire-25 (NEI VFQ-25), Beck Depression Inventory (BDI-II), social support lists and an additional questionnaire for gathering general information. Medical records were reviewed for clinical characteristics. Analyses were conducted on various patient and ocular characteristics. We compared our NEI VFQ-25 scores with those previously found in the literature. Our main outcome measures were VR-QOL scores and their associations with various general patient and ocular characteristics. We found that the NEI VFQ-25 mean overall composite score was 88.9 +/- 8.8, which is relatively high, but lower than that found in a normal working population. The mean general health score was 47.4 +/- 20.8, which is lower than in patients with other ocular diseases. Patients with a systemic disease scored significantly lower on general health and VR-QOL, compared to patients without a systemic disease. Patients with a depression (6/59 (10%)) frequently had ankylosing spondylitis (5/6 patients) and they scored significantly worse on VR-QOL. We concluded that patients with HLA-B27 associated AU have a relatively high VR-QOL. However, the presence of a systemic disease is associated with lower VR-QOL and general health scores. In addition, depression is associated with a lower VR-QOL.	[Hoeksema, Lisette; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Hoeksema, Lisette; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, WJ Kolff Inst, Groningen, Netherlands	University of Groningen; University of Groningen	Hoeksema, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.; Hoeksema, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, WJ Kolff Inst, Groningen, Netherlands.	l.hoeksema@umcg.nl			Stichting Nederlands Oogheelkundig Onderzoek; Stichting Blindenhulp	Stichting Nederlands Oogheelkundig Onderzoek; Stichting Blindenhulp	This work was supported by Professor Mulder Stichting, Stichting Nederlands Oogheelkundig Onderzoek, Stichting Blindenhulp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; Cahill MT, 2005, OPHTHALMOLOGY, V112, P152, DOI 10.1016/j.ophtha.2004.06.036; Chang JH, 2005, SURV OPHTHALMOL, V50, P364, DOI 10.1016/j.survophthal.2005.04.003; Dagfinrud H, 2004, ANN RHEUM DIS, V63, P1605, DOI 10.1136/ard.2003.019224; Davis JC, 2005, ARTHRIT RHEUM-ARTHR, V53, P494, DOI 10.1002/art.21330; Frick KD, 2012, INVEST OPHTH VIS SCI, V53, P1169, DOI 10.1167/iovs.11-8259; Hirneiss C, 2010, GRAEF ARCH CLIN EXP, V248, P85, DOI 10.1007/s00417-009-1186-3; Hoeksema L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085224; Hyphantis T, 2013, CLIN RHEUMATOL, V32, P635, DOI 10.1007/s10067-012-2162-6; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Jakob E, 2009, J RHEUMATOL, V36, P127, DOI 10.3899/jrheum.080102; Kempen JH, 2010, AM J OPHTHALMOL, V149, P550, DOI 10.1016/j.ajo.2009.11.019; Kuiper JJW, 2013, ACTA OPHTHALMOL, V91, pE329, DOI 10.1111/aos.12054; Li MY, 2012, INVEST OPHTH VIS SCI, V53, P5722, DOI 10.1167/iovs.11-9094; Maca SM, 2011, BRIT J OPHTHALMOL, V95, P699, DOI 10.1136/bjo.2009.174839; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P1496, DOI 10.1001/archopht.116.11.1496; Mangione CM, 2000, NEI VFQ SCORING ALGO; Naik RK, 2013, QUAL LIFE RES, V22, P2801, DOI 10.1007/s11136-013-0412-y; Ovayolu N, 2011, CLIN RHEUMATOL, V30, P655, DOI 10.1007/s10067-010-1604-2; Qian Y, 2012, AM J OPHTHALMOL, V153, P370, DOI 10.1016/j.ajo.2011.06.028; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Schiffman RM, 2001, ARCH OPHTHALMOL-CHIC, V119, P841	23	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146956	10.1371/journal.pone.0146956	http://dx.doi.org/10.1371/journal.pone.0146956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808922	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800040
J	Johnson, EJ; Zemanick, ET; Accurso, FJ; Wagner, BD; Robertson, CE; Harris, JK				Johnson, Emily J.; Zemanick, Edith T.; Accurso, Frank J.; Wagner, Brandie D.; Robertson, Charles E.; Harris, J. Kirk			Molecular Identification of Staphylococcus aureus in Airway Samples from Children with Cystic Fibrosis	PLOS ONE			English	Article							METHICILLIN-RESISTANT; GENE; FEMA; SENSITIVITY; MANAGEMENT; ALIGNMENT; SPUTUM; SILVA; MECA	Background Staphylococcus aureus is a common and significant pathogen in cystic fibrosis. We sought to determine if quantitative PCR (qPCR) and 16S rRNA gene sequencing could provide a rapid, culture-independent approach to the identification of S. aureus airway infections. Methods We examined the sensitivity and specificity of two qPCR assays, targeting the femA and 16S rRNA gene, using culture as the gold standard. In addition, 16S rRNA gene sequencing to identify S. aureus directly from airway samples was evaluated. DNA extraction was performed with and without prior enzymatic digestion. Results 87 samples [42 oropharyngeal (OP) and 45 expectorated sputum (ES)] were analyzed. 59 samples (68%) cultured positive for S. aureus. Using standard extraction techniques, sequencing had the highest sensitivity for S. aureus detection (85%), followed by FemA qPCR (52%) and 16SrRNA qPCR (34%). For all assays, sensitivity was higher from ES samples compared to OP swabs. Specificity of the qPCR assays was 100%, but 21.4% for sequencing due to detection of S. aureus in low relative abundance from culture negative samples. Enzymatic digestion increased the sensitivity of qPCR assays, particularly for OP swabs. Conclusion Sequencing had a high sensitivity for S. aureus, but low specificity. While femA qPCR had higher sensitivity than 16S qPCR for detection of S. aureus, neither assay was as sensitive as sequencing. The significance of S. aureus detection with low relative abundance by sequencing in culture-negative specimens is not clear.	[Johnson, Emily J.] Univ Colorado, Sch Med, Aurora, CO USA; [Zemanick, Edith T.; Accurso, Frank J.; Wagner, Brandie D.; Harris, J. Kirk] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Wagner, Brandie D.] Univ Colorado, Sch Med, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Robertson, Charles E.] Univ Colorado, Sch Med, Div Infect Dis, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Harris, JK (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA.	jonathan.harris@ucdenver.edu	Zemanick, Edith/D-5260-2017	Zemanick, Edith/0000-0002-7507-9337; Wagner, brandie/0000-0002-2745-0103; Harris, Jonathan/0000-0002-2378-4202; ROBERTSON, CHARLES/0000-0002-4136-4121	Cystic Fibrosis Foundation Therapeutics, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL114883] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation Therapeutics, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Cystic Fibrosis Foundation Therapeutics, Inc.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631; Caverly LJ, 2015, PEDIATR PULM, V50, pS31, DOI 10.1002/ppul.23243; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Deschaght P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-244; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Francois P, 2003, J CLIN MICROBIOL, V41, P254, DOI 10.1128/JCM.41.1.254-260.2003; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Hara N, 2012, J IMMUNOL, V189, P3805, DOI 10.4049/jimmunol.1201257; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; JOHNSON S, 1995, FEMS MICROBIOL LETT, V132, P221, DOI 10.1111/j.1574-6968.1995.tb07837.x; KOBAYASHI N, 1994, EPIDEMIOL INFECT, V113, P259, DOI 10.1017/S0950268800051682; Lynch SV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009738; Mahboubi MA, 2016, J CLIN MICROBIOL, V54, P613, DOI 10.1128/JCM.02299-15; MAIDHOF H, 1991, J BACTERIOL, V173, P3507, DOI 10.1128/jb.173.11.3507-3513.1991; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Robertson CE, 2013, BIOINFORMATICS; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Sibley CD, 2006, FUTURE MICROBIOL, V1, P53, DOI 10.2217/17460913.1.1.53; van Griethuysen A, 2005, J CLIN MICROBIOL, V43, P1361, DOI 10.1128/JCM.43.3.1361-1365.2005; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; Zemanick ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015101; Zhao JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033127	30	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147643	10.1371/journal.pone.0147643	http://dx.doi.org/10.1371/journal.pone.0147643			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808658	Green Submitted, gold, Green Published			2022-12-26	WOS:000369527800164
J	Kabore, J; Metzger, M; Helmer, C; Berr, C; Tzourio, C; Massy, ZA; Stengel, B				Kabore, Jean; Metzger, Marie; Helmer, Catherine; Berr, Claudine; Tzourio, Christophe; Massy, Ziad A.; Stengel, Benedicte			Kidney Function Decline and Apparent Treatment-Resistant Hypertension in the Elderly	PLOS ONE			English	Article							URINARY ALBUMIN EXCRETION; BLOOD-PRESSURE CONTROL; CLINICAL CHARACTERISTICS; RENAL-DISEASE; PREVALENCE; RISK; POPULATION; EQUATIONS; COMMITTEE; AWARENESS	Background Cross-sectional studies show a strong association between chronic kidney disease and apparent treatment-resistant hypertension, but the longitudinal association of the rate of kidney function decline with the risk of resistant hypertension is unknown. Methods The population-based Three-City included 8,695 participants older than 65 years, 4265 of them treated for hypertension. We estimated the odds ratios (OR) of new-onset apparent treatment-resistant hypertension, defined as blood pressure >= 140/90 mmHg despite use of 3 antihypertensive drug classes or >= 4 classes regardless of blood pressure, associated with the mean estimated glomerular filtration rate (eGFR) level and its rate of decline over 4 years, compared with both controlled hypertension and uncontrolled nonresistant hypertension with <= 2 drugs. GFR was estimated with three different equations. Results Baseline prevalence of apparent treatment-resistant hypertension and of controlled and uncontrolled nonresistant hypertension, were 6.5%, 62.3% and 31.2%, respectively. During follow-up, 162 participants developed apparent treatment-resistant hypertension. Mean eGFR decline with the MDRD equation was 1.5 +/- 2.9 mL/min/1.73m(2) per year: 27.7% of the participants had an eGFR >= 3 and 10.1% >= 5 mL/min/1.73m(2) per year. After adjusting for age, sex, obesity, diabetes, and cardiovascular history, the ORs for new-onset apparent treatment-resistant hypertension associated with a mean eGFR level, per 15 mL/min/1.73m(2) drop, were 1.23 [95% confidence interval 0.91-1.64] compared to controlled hypertension and 1.10 [0.83-1.45] compared to uncontrolled nonresistant hypertension; ORs associated with a decline rate >= 3 mL/min/1.73m(2) per year were 1.89 [1.09-3.29] and 1.99 [1.19-3.35], respectively. Similar results were obtained when we estimated GFR with the CKDEPI and the BIS1 equations. ORs tended to be higher for an eGFR decline rate >= 5 mL/min/1.73m(2) per year. Conclusion The speed of kidney function decline is associated more strongly than kidney function itself with the risk of apparent treatment-resistant hypertension in the elderly.	[Kabore, Jean; Metzger, Marie; Massy, Ziad A.; Stengel, Benedicte] INSERM, U1018, CESP, Villejuif, France; [Kabore, Jean; Metzger, Marie; Stengel, Benedicte] Univ Paris Saclay, Univ Paris Sud, Villejuif, France; [Kabore, Jean] IRSS Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Helmer, Catherine; Tzourio, Christophe] INSERM, Epidemiol Biostat U897, Bordeaux, France; [Helmer, Catherine; Tzourio, Christophe] Univ Bordeaux, Bordeaux, France; [Helmer, Catherine] Clin Invest Ctr Clin Epidemiol, Bordeaux, France; [Berr, Claudine] INSERM, U1061, Montpellier, France; [Berr, Claudine] Univ Montpellier I, Montpellier, France; [Massy, Ziad A.] Ambroise Pare Univ Hosp, Div Nephrol, Boulogne Billancourt, France; [Massy, Ziad A.] Univ Paris Ouest UVSQ, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre Muraz; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay	Kabore, J (corresponding author), INSERM, U1018, CESP, Villejuif, France.; Kabore, J (corresponding author), Univ Paris Saclay, Univ Paris Sud, Villejuif, France.; Kabore, J (corresponding author), IRSS Ctr Muraz, Bobo Dioulasso, Burkina Faso.	jean.kabore@inserm.fr	berr, Claudine/D-5238-2014; Tzourio, christophe/B-4015-2009; Tzourio, christophe/L-6344-2019; HELMER, Catherine/AAG-5126-2021; HELMER, Catherine/I-6581-2015; Stengel, Benedicte/G-5730-2015; Metzger, Marie/K-9772-2018	berr, Claudine/0000-0001-5254-7655; Tzourio, christophe/0000-0002-6517-2984; Tzourio, christophe/0000-0002-6517-2984; HELMER, Catherine/0000-0002-5169-7421; Stengel, Benedicte/0000-0001-9469-0804; Metzger, Marie/0000-0003-3597-5409; Kabore, Jean/0000-0002-4038-813X	Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; MGEN; Institut de la Longevite; Conseils Regionaux of Aquitaine and Bourgogne; Fondation de France; Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques"; Agence Nationale de la Recherche (ANR); French-speaking Society of Nephrology; French Ministry of Research	Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); MGEN; Institut de la Longevite; Conseils Regionaux of Aquitaine and Bourgogne(Region Bourgogne-Franche-ComteRegion Nouvelle-Aquitaine); Fondation de France(Fondation de France); Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques"; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); French-speaking Society of Nephrology; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	The Three-City Study was conducted under a partnership agreement between the Institut National de la Sante et de la Recherche Medicale (INSERM), the Victor Segalen-Bordeaux II University, and Sanofi-Aventis. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The Fondation Plan Alzheimer partly funded the follow-up of the study. The 3C Study was also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Conseils Regionaux of Aquitaine and Bourgogne, Fondation de France, and Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques". The study also received a grant from the Agence Nationale de la Recherche (ANR). The CKD ancillary study at the 4-year follow-up was granted by the French-speaking Society of Nephrology. Jean Kabore was supported by a research grant from the French Ministry of Research. No donors played a role in the design and the conduct of the study.; The Three-City Study is conducted under a partnership agreement between the Institut National de la Sante et de la Recherche Medicale (INSERM), the Victor Segalen-Bordeaux II University, and Sanofi-Aventis. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The Fondation Plan Alzheimer partly funded the follow-up of the study. The 3C Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Conseils Regionaux of Aquitaine and Bourgogne, Fondation de France, and Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques". The study also received a grant from the Agence Nationale de la Recherche (ANR). The CKD ancillary study at the 4-year follow-up was funded by the French-speaking Society of Nephrology. No donors played a role in the design and the conduct of the study. Jean Kabore is supported by a research grant from the French Ministry of Research. We thank Jo-Ann Cahn for editing the English version.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Brambilla G, 2013, J HYPERTENS, V31, P2018, DOI 10.1097/HJH.0b013e328363823f; Brantsma AH, 2006, J AM SOC NEPHROL, V17, P331, DOI 10.1681/ASN.2005111153; Briet M, 2011, J AM SOC NEPHROL, V22, P967, DOI 10.1681/ASN.2010080863; Brindel P, 2006, J HYPERTENS, V24, P51, DOI 10.1097/01.hjh.0000198028.84353.86; Cai GY, 2013, J AM GERIATR SOC, V61, P2160, DOI 10.1111/jgs.12551; Calhoun DA, 2008, CIRCULATION, V117, pE510, DOI 10.1161/CIRCULATIONAHA.108.189141; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Choi SW, 2014, J HUM HYPERTENS, V28, P201, DOI 10.1038/jhh.2013.76; Daugherty SL, 2012, CIRCULATION, V125, P1635, DOI 10.1161/CIRCULATIONAHA.111.068064; de la Sierra A, 2011, HYPERTENSION, V57, P898, DOI 10.1161/HYPERTENSIONAHA.110.168948; Egan BM, 2013, HYPERTENSION, V62, P691, DOI 10.1161/HYPERTENSIONAHA.113.01448; Egan BM, 2011, CIRCULATION, V124, P1046, DOI 10.1161/CIRCULATIONAHA.111.030189; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Galton F., 1886, J ANTHR I, V15, P246, DOI 10.2307%2F2841583; Gijon-Conde T, 2014, REV ESP CARDIOL, V67, P270, DOI 10.1016/j.rec.2013.09.027; Iyer AS, 2010, J AM SOC HYPERTENS, V4, P22, DOI 10.1016/j.jash.2010.02.002; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kestenbaum B, 2008, ANN INTERN MED, V148, P501, DOI 10.7326/0003-4819-148-7-200804010-00006; Koppe L, 2013, J NEPHROL, V26, P716, DOI 10.5301/jn.5000297; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, AM J KIDNEY DIS, V53, pS4, DOI 10.1053/j.ajkd.2008.07.048; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; McAdam-Marx C, 2009, CLIN THER, V31, P1116, DOI 10.1016/j.clinthera.2009.05.007; Muntner P, 2014, HYPERTENSION, V64, P1012, DOI 10.1161/HYPERTENSIONAHA.114.03850; Peralta CA, 2012, ARCH INTERN MED, V172, P41, DOI 10.1001/archinternmed.2011.619; Persell SD, 2011, HYPERTENSION, V57, P1076, DOI 10.1161/HYPERTENSIONAHA.111.170308; Plantinga LC, 2009, HYPERTENSION, V54, P47, DOI 10.1161/HYPERTENSIONAHA.109.129841; Roy L, 2013, KIDNEY INT, V84, P570, DOI 10.1038/ki.2013.103; Schaeffner ES, 2012, ANN INTERN MED, V157, P471, DOI 10.7326/0003-4819-157-7-201210020-00003; Sim JJ, 2013, MAYO CLIN PROC, V88, P1099, DOI 10.1016/j.mayocp.2013.06.017; Stengel B, 2011, NEPHROL DIAL TRANSPL, V26, P3286, DOI 10.1093/ndt/gfr323; Tanner RM, 2013, CLIN J AM SOC NEPHRO, V8, P1583, DOI 10.2215/CJN.00550113; Tonelli M, 2002, NEPHROL DIAL TRANSPL, V17, P1426, DOI 10.1093/ndt/17.8.1426; Viazzi F, 2014, NEPHROL DIAL TRANSPL, P1; Vidal-Petiot E, 2014, AM J KIDNEY DIS, V63, P865, DOI 10.1053/j.ajkd.2014.01.421; Weitzman D, 2014, HYPERTENSION, V64, P501, DOI 10.1161/HYPERTENSIONAHA.114.03718; Xu H, 2014, NEPHROL DIAL TRANSPL, V29, P1538, DOI 10.1093/ndt/gfu057	39	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146056	10.1371/journal.pone.0146056	http://dx.doi.org/10.1371/journal.pone.0146056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807712	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800015
J	Morganti, JM; Riparip, LK; Rosi, S				Morganti, Josh M.; Riparip, Lara-Kirstie; Rosi, Susanna			Call Off the Dog(ma): M1/M2 Polarization Is Concurrent following Traumatic Brain Injury	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; MACROPHAGE ACTIVATION; ALTERNATIVE ACTIVATION; CEREBRAL-CORTEX; WHITE-MATTER; SPINAL-CORD; MOUSE MODEL; IN-VIVO; INFLAMMATION; PARADIGM	Following the primary mechanical impact, traumatic brain injury (TBI) induces the simultaneous production of a variety of pro-and anti-inflammatory molecular mediators. Given the variety of cell types and their requisite expression of cognate receptors this creates a highly complex inflammatory milieu. Increasingly in neurotrauma research there has been an effort to define injury-induced inflammatory responses within the context of in vitro defined macrophage polarization phenotypes, known as "M1" and "M2". Herein, we expand upon our previous work in a rodent model of TBI to show that the categorization of inflammatory response cannot be so easily delineated using this nomenclature. Specifically, we show that TBI elicited a wide spectrum of concurrent expression responses within both pro-and anti-inflammatory arms. Moreover, we show that the cells principally responsible for the production of these inflammatory mediators, microglia/macrophages, simultaneously express both "M1" and "M2" phenotypic markers. Overall, these data align with recent reports suggesting thatmicroglia/macrophages cannot adequately switch to a polarized "M1-only" or "M2-only" phenotype, but display a mixed phenotype due to the complex signaling events surrounding them.	[Morganti, Josh M.; Riparip, Lara-Kirstie; Rosi, Susanna] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Morganti, Josh M.; Riparip, Lara-Kirstie; Rosi, Susanna] Univ Calif San Francisco, Dept Phys Therapy, San Francisco, CA 94143 USA; [Morganti, Josh M.; Riparip, Lara-Kirstie; Rosi, Susanna] Univ Calif San Francisco, Dept Rehabil Sci, San Francisco, CA 94143 USA; [Rosi, Susanna] Univ Calif San Francisco, Neurol Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rosi, S (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Dept Phys Therapy, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Dept Rehabil Sci, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Neurol Surg, San Francisco, CA 94143 USA.	susanna.rosi@ucsf.edu	Morganti, Josh/AAL-9727-2020	Morganti, Josh/0000-0002-4183-0049	National Institute Of Neurological Disorders And Stroke; National Institute on Aging of the National Institutes of Health [F32NS090805, R21NS087458, R21AG042016]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087458, F32NS090805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG042016] Funding Source: NIH RePORTER	National Institute Of Neurological Disorders And Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by National Institute Of Neurological Disorders And Stroke and National Institute on Aging of the National Institutes of Health under award numbers F32NS090805 (J.M.M.), R21NS087458 (S.R.); R21AG042016 (S.R.).	Belarbi K, 2013, CANCER RES, V73, P1201, DOI 10.1158/0008-5472.CAN-12-2989; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Josefowicz SZ, 2013, IMMUNOLOGY, V139, P299, DOI 10.1111/imm.12115; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morganti JM, 2012, J NEUROSCI, V32, P14592, DOI 10.1523/JNEUROSCI.0539-12.2012; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006	44	142	145	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0148001	10.1371/journal.pone.0148001	http://dx.doi.org/10.1371/journal.pone.0148001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808663	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800262
J	Munoz-Gutierrez, JF; Pierle, SA; Schneider, DA; Baszler, TV; Stanton, JB				Munoz-Gutierrez, Juan F.; Pierle, Sebastian Aguilar; Schneider, David A.; Baszler, Timothy V.; Stanton, James B.			Transcriptomic Determinants of Scrapie Prion Propagation in Cultured Ovine Microglia	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; NATURAL SCRAPIE; DENDRITIC CELLS; SELENOPROTEIN P; LYMPHOID-TISSUE; NEURONAL CELLS; MESSENGER-RNA; MOUSE MODELS; EXPRESSION; PROTEIN	Susceptibility to infection by prions is highly dependent on the amino acid sequence and host expression of the cellular prion protein (PrPC); however, cellular expression of a genetically susceptible PrPC is insufficient. As an example, it has been shown in cultured cells that permissive and resistant sublines derived from the same parental population often have similar expression levels of PrPC. Thus, additional cellular factors must influence susceptibility to prion infection. The aim of this study was to elucidate the factors associated with relative permissiveness and resistance to scrapie prions in cultured cells derived from a naturally affected species. Two closely related ovine microglia clones with different prion susceptibility, but no detectable differences in PrPC expression levels, were inoculated with either scrapie-positive or scrapie-negative sheep brainstem homogenates. Five passages post-inoculation, the transcriptional profiles of mock and infected clones were sequenced using Illumina technology. Comparative transcriptional analyses identified twenty-two differentially transcribed genes, most of which were upregulated in poorly permissive microglia. This included genes encoding for selenoprotein P, endolysosomal proteases, and proteins involved in extracellular matrix remodeling. Furthermore, in highly permissive microglia, transforming growth factor beta-induced, retinoic acid receptor response 1, and phosphoserine aminotranspherase 1 gene transcripts were upregulated. Gene Set Enrichment Analysis identified proteolysis, translation, and mitosis as the most affected pathways and supported the upregulation trend of several genes encoding for intracellular proteases and ribosomal proteins in poorly permissive microglia. This study identifies new genes potentially involved in scrapie prion propagation, corroborates results from other studies, and extends those results into another cell culture model.	[Munoz-Gutierrez, Juan F.; Pierle, Sebastian Aguilar; Schneider, David A.; Baszler, Timothy V.] Washington State Univ, Coll Vet Med, Dept Pathol & Microbiol, Pullman, WA 99164 USA; [Schneider, David A.] USDA, Agr Res Serv, Pullman, WA USA; [Stanton, James B.] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Munoz-Gutierrez, Juan F.] Univ Wyoming, Dept Vet Sci, Laramie, WY USA; [Pierle, Sebastian Aguilar] Inst Pasteur, Unite Plasticite Genome Bacterien, Dept Genomes & Genet, Paris, France	Washington State University; United States Department of Agriculture (USDA); University System of Georgia; University of Georgia; University of Wyoming; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Stanton, JB (corresponding author), Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA.; Munoz-Gutierrez, JF (corresponding author), Univ Wyoming, Dept Vet Sci, Laramie, WY USA.	juan.munoz@uwyo.edu; jbs@uga.edu	Stanton, James/A-5277-2011; Gutiérrez, Juan Muñoz/F-6626-2019; Schneider, David/A-2833-2010	Stanton, James/0000-0002-7661-2631; Schneider, David/0000-0001-9659-6731	United States Department of Agriculture, Agricultural Research Service [5348-32000-030-00D]	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the United States Department of Agriculture, Agricultural Research Service (5348-32000-030-00D).	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Baker CA, 2002, J VIROL, V76, P10905, DOI 10.1128/JVI.76.21.10905-10913.2002; Bellinger FP, 2008, J ALZHEIMERS DIS, V15, P465; Bosque PJ, 2000, J VIROL, V74, P4377, DOI 10.1128/JVI.74.9.4377-4386.2000; Brown CA, 2014, HUM MOL GENET, V23, P5102, DOI 10.1093/hmg/ddu233; Budhia S, 2006, J IMMUNOL METHODS, V309, P160, DOI 10.1016/j.jim.2005.12.006; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; Cappai R, 2005, J BIOL CHEM, V280, P13913, DOI 10.1074/jbc.M409179200; Carroll JA, 2015, J VIROL, V89, P2388, DOI 10.1128/JVI.02952-14; Casneuf T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-461; Du XB, 2014, INORG CHEM, V53, P11221, DOI 10.1021/ic501788v; El Kochairi I, 2006, MOL VIS, V12, P461; Erickson RR, 2005, BIOCHEM BIOPH RES CO, V332, P50, DOI 10.1016/j.bbrc.2005.04.090; Filali H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-59; Fonovic M, 2014, BBA-GEN SUBJECTS, V1840, P2560, DOI 10.1016/j.bbagen.2014.03.017; Goold R, 2013, J CELL SCI, V126, P3552, DOI 10.1242/jcs.120477; Gossner A, 2011, VET MICROBIOL, V153, P218, DOI 10.1016/j.vetmic.2011.05.036; Hamir AN, 2009, VET PATHOL, V46, P1205, DOI 10.1354/vp.08-VP-0258-H-FL; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Homma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04504; Huang FP, 2002, J GEN VIROL, V83, P267, DOI 10.1099/0022-1317-83-1-267; Huzarewich RLCH, 2011, J TOXICOL ENV HEAL A, V74, P1504, DOI 10.1080/15287394.2011.618979; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Luhr KM, 2004, NEUROREPORT, V15, P1663, DOI 10.1097/01.wnr.0000134931.81690.34; Luhr KM, 2004, J VIROL, V78, P4776, DOI 10.1128/JVI.78.9.4776-4782.2004; Marbiah MM, 2014, EMBO J, V33, P1527, DOI 10.15252/embj.201387150; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Munoz-Gutierrez JF, 2015, VIRUS RES, V198, P35, DOI 10.1016/j.virusres.2014.10.028; Nakanishi H, 2003, MOL NEUROBIOL, V27, P163, DOI 10.1385/MN:27:2:163; Nakano T, 2004, ACTA NEUROPATHOL, V107, P359, DOI 10.1007/s00401-004-0821-7; Nakaso K, 2004, BRAIN RES, V1012, P42, DOI 10.1016/j.brainres.2004.03.029; O'Rourke KI, 2000, J CLIN MICROBIOL, V38, P3254, DOI 10.1128/JCM.38.9.3254-3259.2000; Okoniewski MJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-276; Parakalan R, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-64; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pierle SA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-669; Pimpinelli F, 2005, EUR J NEUROSCI, V21, P2063, DOI 10.1111/j.1460-9568.2005.04049.x; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raymond GJ, 2006, J VIROL, V80, P596, DOI 10.1128/JVI.80.2.596-604.2006; Riemer C, 2004, BIOCHEM BIOPH RES CO, V323, P556, DOI 10.1016/j.bbrc.2004.08.124; Shibuya S, 1998, ANN NEUROL, V43, P826, DOI 10.1002/ana.410430618; Sorensen G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-114; Stanton JB, 2008, J VIROL, V82, P9839, DOI 10.1128/JVI.01137-08; Stanton JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051173; Stanton JB, 2009, BIOCHEM BIOPH RES CO, V386, P345, DOI 10.1016/j.bbrc.2009.06.030; Tanaka H, 2012, SCI REP, P2; Tiaden AN, 2012, J BIOL CHEM, V287, P21335, DOI 10.1074/jbc.M112.341032; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tseveleki V, 2010, GENOMICS, V96, P82, DOI 10.1016/j.ygeno.2010.04.004; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; WESTAWAY D, 1994, GENE DEV, V8, P959, DOI 10.1101/gad.8.8.959; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Yam GHF, 2012, INVEST OPHTH VIS SCI, V53, P5890, DOI 10.1167/iovs.11-9068; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhang J, 2015, EUR J HUM GENET, V23, P86, DOI 10.1038/ejhg.2014.52	63	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147727	10.1371/journal.pone.0147727	http://dx.doi.org/10.1371/journal.pone.0147727			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807844	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800198
J	Pirhonen, J; Arola, J; Sadevirta, S; Luukkonen, P; Karppinen, SM; Pihlajaniemi, T; Isomaki, A; Hukkanen, M; Yki-Jarvinen, H; Ikonen, E				Pirhonen, Juho; Arola, Johanna; Sadevirta, Sanja; Luukkonen, Panu; Karppinen, Sanna-Maria; Pihlajaniemi, Taina; Isomaki, Antti; Hukkanen, Mika; Yki-Jarvinen, Hannele; Ikonen, Elina			Continuous Grading of Early Fibrosis in NAFLD Using Label-Free Imaging: A Proof-of-Concept Study	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; MICROSCOPY; SYSTEMS	Background and Aims Early detection of fibrosis is important in identifying individuals at risk for advanced liver disease in non-alcoholic fatty liver disease (NAFLD). We tested whether second-harmonic generation (SHG) and coherent anti-Stokes Raman scattering (CARS) microscopy, detecting fibrillar collagen and fat in a label-free manner, might allow automated and sensitive quantification of early fibrosis in NAFLD. Methods We analyzed 32 surgical biopsies from patients covering histological fibrosis stages 0-4, using multimodal label-free microscopy. Native samples were visualized by SHG and CARS imaging for detecting fibrillar collagen and fat. Furthermore, we developed a method for quantitative assessment of early fibrosis using automated analysis of SHG signals. Results We found that the SHG mean signal intensity correlated well with fibrosis stage and the mean CARS signal intensity with liver fat. Little overlap in SHG signal intensities between fibrosis stages 0 and 1 was observed. A specific fibrillar SHG signal was detected in the liver parenchyma outside portal areas in all samples histologically classified as having no fibrosis. This signal correlated with immunohistochemical location of fibrillar collagens I and III. Conclusions This study demonstrates that label-free SHG imaging detects fibrillar collagen deposition in NAFLD more sensitively than routine histological staging and enables observer-independent quantification of early fibrosis in NAFLD with continuous grading.	[Pirhonen, Juho; Isomaki, Antti; Hukkanen, Mika; Ikonen, Elina] Univ Helsinki, Fac Med, Dept Anat, Helsinki, Finland; [Arola, Johanna] Univ Helsinki, Dept Pathol, Fac Med, Helsinki, Finland; [Sadevirta, Sanja; Luukkonen, Panu; Yki-Jarvinen, Hannele] Univ Helsinki, Dept Med, Fac Med, Helsinki, Finland; [Arola, Johanna] HUSLAB, Dept Pathol, Helsinki, Finland; [Pirhonen, Juho; Sadevirta, Sanja; Luukkonen, Panu; Yki-Jarvinen, Hannele; Ikonen, Elina] Minerva Fdn, Helsinki, Finland; [Karppinen, Sanna-Maria; Pihlajaniemi, Taina] Bioctr Oulu, Oulu Ctr Cell Matrix Res, Fac Biochem & Mol Med, Oulu, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Oulu	Pirhonen, J (corresponding author), Univ Helsinki, Fac Med, Dept Anat, Helsinki, Finland.; Pirhonen, J (corresponding author), Minerva Fdn, Helsinki, Finland.	juho.pirhonen@helsinki.fi		Ikonen, Elina/0000-0001-8382-1135; Karppinen, Sanna/0000-0001-6233-9075; Pihlajaniemi, Taina/0000-0002-1664-9045; Luukkonen, Panu/0000-0003-2085-679X; Isomaki, Antti/0000-0001-8059-0714	Academy of Finland [131489, 263841, 272130, 251314, 259872]; European Union/European Federation of Pharmaceutical Industries and Associations Innovative Medicines Initiative Joint Undertaking (European Medical Information Framework EMIF) [115372]; Sigrid Juselius; Special governmental subsidy for health sciences research (EVO, Helsinki University Central Hospital grant); Novo Nordisk Foundation	Academy of Finland(Academy of Finland); European Union/European Federation of Pharmaceutical Industries and Associations Innovative Medicines Initiative Joint Undertaking (European Medical Information Framework EMIF); Sigrid Juselius(Sigrid Juselius Foundation); Special governmental subsidy for health sciences research (EVO, Helsinki University Central Hospital grant); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was financially supported by the Academy of Finland (EI grants 131489, 263841, 272130; TP grant 251314; S-MK grant 259872, HYJ), European Union/European Federation of Pharmaceutical Industries and Associations Innovative Medicines Initiative Joint Undertaking (European Medical Information Framework EMIF grant no. 115372, HYJ), the Sigrid Juselius (EI, TP, HYJ), Special governmental subsidy for health sciences research (EVO, Helsinki University Central Hospital grant, HYJ) and the Novo Nordisk Foundation (HYJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arulanandan Ahilan, 2015, Curr Hepatol Rep, V14, P109; Bedossa P, 2014, HEPATOLOGY, V60, P565, DOI 10.1002/hep.27173; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; Cox G, 2003, J STRUCT BIOL, V141, P53, DOI 10.1016/S1047-8477(02)00576-2; DOYLE W, 1962, J ACM, V9, P259, DOI 10.1145/321119.321123; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gailhouste L, 2010, J HEPATOL, V52, P398, DOI 10.1016/j.jhep.2009.12.009; Galli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110295; Goodman ZD, 2007, J HEPATOL, V47, P598, DOI 10.1016/j.jhep.2007.07.006; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; Kleiner DE, 2012, SEMIN LIVER DIS, V32, P3, DOI 10.1055/s-0032-1306421; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1; Nakano M, 2005, HEPATOL RES, V33, P110, DOI 10.1016/j.hepres.2005.09.016; Pezacki JP, 2011, NAT CHEM BIOL, V7, P137, DOI 10.1038/NCHEMBIO.525; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Standish RA, 2006, GUT, V55, P569, DOI 10.1136/gut.2005.084475; Wells RG., 2007, TXB HEPATOLOGY, P264; Wieckowska A, 2007, HEPATOLOGY, V46, P582, DOI 10.1002/hep.21768; Xu SY, 2014, J HEPATOL, V61, P260, DOI 10.1016/j.jhep.2014.02.015; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268; Zumbusch A, 2013, PROG LIPID RES, V52, P615, DOI 10.1016/j.plipres.2013.07.003	25	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147804	10.1371/journal.pone.0147804	http://dx.doi.org/10.1371/journal.pone.0147804			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808140	gold, Green Published			2022-12-26	WOS:000369527800214
J	Rong, YJ; Lu, XJ; Chen, J				Rong, Ye-Jing; Lu, Xin-Jiang; Chen, Jiong			Molecular Characterization of E-Type Prostanoid Receptor 4 (EP4) from Ayu (Plecoglossus altivelis) and Its Functional Analysis in the Monocytes/Macrophages	PLOS ONE			English	Article							PROSTAGLANDIN E-2; PROINFLAMMATORY CYTOKINE; EXPRESSION ANALYSIS; RESPIRATORY BURST; IL-1-BETA GENE; SALMO-SALAR; CYCLIC-AMP; MACROPHAGES; ACTIVATION; MECHANISMS	Prostaglandin E2 (PGE2) plays an important role in a broad spectrum of physiological and pathological processes by interacting with E-type prostanoid receptors (EPs). EP4 is one of four EP subtypes known to mediate the immune response in mammalian monocytes/macrophages. However, the precise function and characteristics of EP4 in fish remain unclear. In this study, we characterized a novel EP4-like (PaEP4L) gene from ayu, Plecoglossus altivelis. The cDNA sequence of PaEP4L is 2781 nucleotides (nts) in length, encoding a polypeptide of 459 amino acid residues with a calculated molecular weight of 51.17 kDa. Sequence comparison and phylogenetic tree analysis showed that PaEP4L shared 76% amino acid identity with that of the Atlantic salmon (Salmo salar). PaEP4L mRNA was detected by real-time quantitative PCR (QPCR) in all tested tissues and head kidney-derived monocytes/macrophages (MO/M Phi). It varied greatly in liver, spleen and MO/M. upon Vibrio anguillarum infection. Western blot analysis revealed a significant increase of PaEP4L in cell homogenates from ayu MO/M Phi upon V. anguillarum infection. Moreover, anti-PaEP4L IgG reversed the down-regulation of interleukin 1 beta (IL-1 beta) and tumor necrosis factor alpha (TNF-alpha) mRNA expression as well as phagocytosis in ayu MO/M Phi caused by PGE2. There were no significant differences in the respiratory burst response between PGE2 treated and untreated cells. We further found that cAMP mediated PGE2/PaEP4L signal in ayu MO/M Phi. In conclusion, our results indicate that PaEP4L mediates PGE2 effects on ayu MO/M Phi function, revealing that EP4 also plays a role in the modulation of cells of the fish's innate immune system.	[Rong, Ye-Jing; Lu, Xin-Jiang; Chen, Jiong] Ningbo Univ, Sch Marine Sci, Lab Biochem & Mol Biol, Ningbo 315211, Zhejiang, Peoples R China; [Chen, Jiong] Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine Higheffici, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University; Ningbo University	Chen, J (corresponding author), Ningbo Univ, Sch Marine Sci, Lab Biochem & Mol Biol, Ningbo 315211, Zhejiang, Peoples R China.; Chen, J (corresponding author), Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine Higheffici, Ningbo 315211, Zhejiang, Peoples R China.	jchen1975@163.com		rong, yejing/0000-0002-9423-3002	Program for the National Natural Science Foundation of China [31372555, 31472300]; Zhejiang Provincial Natural Science Foundation of China [LZ13C190001]; Scientific Research Foundation of the Graduate School of Ningbo University [G15009]; KC Wong Magna Fund in Ningbo University	Program for the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Scientific Research Foundation of the Graduate School of Ningbo University; KC Wong Magna Fund in Ningbo University	This study was supported by the Program for the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (31372555, 31472300), Zhejiang Provincial Natural Science Foundation of China (http://www.zjnsf.gov.cn/) (LZ13C190001), the Scientific Research Foundation of the Graduate School of Ningbo University (http://www.nbu.edu.cn/) (G15009), and the KC Wong Magna Fund in Ningbo University (http://www.nbu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao JQ, 2008, MOL IMMUNOL, V45, P543, DOI 10.1016/j.molimm.2007.05.019; Beck-Speier I, 2001, ENVIRON HEALTH PERSP, V109, P613, DOI 10.2307/3454679; Bo YX, 2015, FISH SHELLFISH IMMUN, V46, P584, DOI 10.1016/j.fsi.2015.07.024; Cha YI, 2006, GENE DEV, V20, P77, DOI 10.1101/gad.1374506; Chadzinska M, 2014, DEV COMP IMMUNOL, V47, P68, DOI 10.1016/j.dci.2014.07.008; Cipollone F, 2005, ARTERIOSCL THROM VAS, V25, P1925, DOI 10.1161/01.ATV.0000177814.41505.41; de Pablo MA, 2000, IMMUNOL CELL BIOL, V78, P31, DOI 10.1046/j.1440-1711.2000.00875.x; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Gamil AAA, 2015, DEV COMP IMMUNOL, V48, P143, DOI 10.1016/j.dci.2014.09.013; Gonzalez-Stegmaier R, 2015, FISH SHELLFISH IMMUN, V47, P239, DOI 10.1016/j.fsi.2015.09.016; Guo TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120483; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; He YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076495; HUANG CF, 1995, BIOCHEM J, V307, P493, DOI 10.1042/bj3070493; HURME M, 1990, FEBS LETT, V263, P35, DOI 10.1016/0014-5793(90)80699-J; Jiang YS, 2015, MOL IMMUNOL, V66, P216, DOI 10.1016/j.molimm.2015.03.014; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Konya V, 2013, PHARMACOL THERAPEUT, V138, P485, DOI 10.1016/j.pharmthera.2013.03.006; KUNKEL SL, 1988, J BIOL CHEM, V263, P5380; Leong JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-279; Li Changhong, 2009, Weishengwu Xuebao, V49, P931; LIMAS C, 1984, ARCH BIOCHEM BIOPHYS, V233, P32, DOI 10.1016/0003-9861(84)90598-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu XJ, 2013, FISH SHELLFISH IMMUN, V34, P1253, DOI 10.1016/j.fsi.2013.02.009; Lu XJ, 2013, FISH SHELLFISH IMMUN, V34, P497, DOI 10.1016/j.fsi.2012.11.047; Lu XJ, 2013, J EXP MED, V210, P5, DOI 10.1084/jem.20121466; MacKenzie KF, 2013, J IMMUNOL, V190, P565, DOI 10.4049/jimmunol.1202462; McDonald PP, 1999, J IMMUNOL, V163, P6164; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nataraj C, 2001, J CLIN INVEST, V108, P1229, DOI 10.1172/JCI13640; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ottonello L, 1996, CLIN EXP IMMUNOL, V106, P97, DOI 10.1046/j.1365-2249.1996.d01-804.x; Qu FF, 2015, FISH SHELLFISH IMMUN, V42, P316, DOI 10.1016/j.fsi.2014.11.023; Rieger AM, 2011, DEV COMP IMMUNOL, V35, P1238, DOI 10.1016/j.dci.2011.03.009; Rodriguez M, 2014, MOL PHARMACOL, V85, P187, DOI 10.1124/mol.113.089573; Rogers LM, 2014, AM J REPROD IMMUNOL, V71, P34, DOI 10.1111/aji.12153; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SAVARESE TM, 1992, BIOCHEM J, V283, P1; SELDON PM, 1995, MOL PHARMACOL, V48, P747; Sokolowska M, 2015, J IMMUNOL, V194, P5472, DOI 10.4049/jimmunol.1401343; SOTTILE A, 1995, IMMUNOPHARM IMMUNOT, V17, P311, DOI 10.3109/08923979509019753; Stillman BA, 1998, EUR J PHARMACOL, V357, P73, DOI 10.1016/S0014-2999(98)00522-6; Takahashi HK, 2002, J IMMUNOL, V168, P4446, DOI 10.4049/jimmunol.168.9.4446; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang EHC, 2012, J CARDIOVASC PHARM, V59, P116, DOI 10.1097/FJC.0b013e3182244a12; Tsuge K, 2013, BIOCHEM BIOPH RES CO, V436, P685, DOI 10.1016/j.bbrc.2013.06.017; Wu Jun, 2015, Zoological Research, V36, P133; Yaqoob P, 2003, TRENDS IMMUNOL, V24, P639, DOI 10.1016/j.it.2003.10.002; Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195; Zhou QJ, 2014, J MICROBIOL METH, V104, P26, DOI 10.1016/j.mimet.2014.06.008	52	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147884	10.1371/journal.pone.0147884	http://dx.doi.org/10.1371/journal.pone.0147884			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809077	Green Submitted, gold, Green Published			2022-12-26	WOS:000369527800237
J	Wang, Z; Ji, L; Hou, XY; Schellenberg, MP				Wang, Zhen; Ji, Lei; Hou, Xiangyang; Schellenberg, Michael P.			Soil Respiration in Semiarid Temperate Grasslands under Various Land Management	PLOS ONE			English	Article							CARBON-DIOXIDE FLUXES; PRECIPITATION PULSES; CO2 EFFLUX; INTERANNUAL VARIABILITY; NITROGEN-FERTILIZATION; HABITAT FRAGMENTATION; TALLGRASS PRAIRIE; RESPONSES; TOPOGRAPHY; BIOMASS	Soil respiration, a major component of the global carbon cycle, is significantly influenced by land management practices. Grasslands are potentially a major sink for carbon, but can also be a source. Here, we investigated the potential effect of land management (grazing, clipping, and ungrazed enclosures) on soil respiration in the semiarid grassland of northern China. Our results showed the mean soil respiration was significantly higher under enclosures (2.17 mu mol.m(-2).s(-1)) and clipping (2.06 mu mol.m(-2).s(-1)) than under grazing (1.65 mu mol.m(-2).s(-1)) over the three growing seasons. The high rates of soil respiration under enclosure and clipping were associated with the higher belowground net primary productivity (BNPP). Our analyses indicated that soil respiration was primarily related to BNPP under grazing, to soil water content under clipping. Using structural equation models, we found that soil water content, aboveground net primary productivity (ANPP) and BNPP regulated soil respiration, with soil water content as the predominant factor. Our findings highlight that management-induced changes in abiotic (soil temperature and soil water content) and biotic (ANPP and BNPP) factors regulate soil respiration in the semiarid temperate grassland of northern China.	[Wang, Zhen; Ji, Lei; Hou, Xiangyang] Chinese Acad Agr Sci, Grassland Res Inst, Hohhot 010010, Peoples R China; [Schellenberg, Michael P.] AAFC AAC, SPARC, Box 1030, Swift Current, SK S9H 3X2, Canada	Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS	Hou, XY (corresponding author), Chinese Acad Agr Sci, Grassland Res Inst, Hohhot 010010, Peoples R China.	Houxy16@126.com			National Key Basic Research Development Program of China [2014CB138806]; International Science and Technology Cooperation Project of China [2013DFR30760]; Natural Science Foundation Committee of Inner Mongolia [ZD201502]; National Science Foundation for Young Scientists of China [41401264]; Natural Science Foundation of Inner Mongolia [2015BS0330]; National Natural Science Foundation of China [D010503]	National Key Basic Research Development Program of China(National Basic Research Program of China); International Science and Technology Cooperation Project of China; Natural Science Foundation Committee of Inner Mongolia; National Science Foundation for Young Scientists of China; Natural Science Foundation of Inner Mongolia; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Key Basic Research Development Program of China (2014CB138806), the International Science and Technology Cooperation Project of China (2013DFR30760), Natural Science Foundation Committee of Inner Mongolia (program no. ZD201502), National Science Foundation for Young Scientists of China (41401264), Natural Science Foundation of Inner Mongolia (2015BS0330), the Program of the National Natural Science Foundation of China (D010503).	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Bahn M, 2006, GLOBAL CHANGE BIOL, V12, P995, DOI 10.1111/j.1365-2486.2006.01144.x; Cao GM, 2004, SOIL BIOL BIOCHEM, V36, P237, DOI 10.1016/j.soilbio.2003.09.010; Carbone F, 2008, P NATL ACAD SCI USA, V105, P20161, DOI 10.1073/pnas.0811335106; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; Chen SP, 2009, GLOBAL CHANGE BIOL, V15, P2450, DOI 10.1111/j.1365-2486.2009.01879.x; Chen Z., 2000, TYPICAL STEPPE ECOSY; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Craine JM, 2002, BIOGEOCHEMISTRY, V59, P303, DOI 10.1023/A:1016019728665; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; Emmerich WE, 2003, AGR FOREST METEOROL, V116, P91, DOI 10.1016/S0168-1923(02)00231-9; Frank AB, 2002, SOIL BIOL BIOCHEM, V34, P1235, DOI 10.1016/S0038-0717(02)00062-7; Franzluebbers K, 2002, SOIL SCI SOC AM J, V66, P254, DOI 10.2136/sssaj2002.0254; Gallo ME, 2009, SOIL BIOL BIOCHEM, V41, P1433, DOI 10.1016/j.soilbio.2009.03.025; Gonzalez G, 2001, ECOLOGY, V82, P955, DOI 10.1890/0012-9658(2001)082[0955:SFAPLD]2.0.CO;2; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hoffmann C, 2008, J ARID ENVIRON, V72, P792, DOI 10.1016/j.jaridenv.2007.09.004; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; Huxman TE, 2004, OECOLOGIA, V141, P254, DOI 10.1007/s00442-004-1682-4; Inglima I, 2009, GLOBAL CHANGE BIOL, V15, P1289, DOI 10.1111/j.1365-2486.2008.01793.x; IUSS-Working-Group-WRB, 2006, WORLD REF BAS SOIL R; Jia BR, 2009, SOIL BIOL BIOCHEM, V41, P681, DOI 10.1016/j.soilbio.2008.12.030; Jia XX, 2012, AGR FOREST METEOROL, V166, P32, DOI 10.1016/j.agrformet.2012.05.022; Joshi J, 2006, OECOLOGIA, V148, P144, DOI 10.1007/s00442-005-0341-8; Knapp AK, 2008, GLOBAL CHANGE BIOL, V14, P615, DOI 10.1111/j.1365-2486.2007.01512.x; Lal R, 2001, POTENTIAL OF U.S. GRAZING LANDS TO SEQUESTER CARBON AND MITIGATE THE GREENHOUSE EFFECT, P249; LeCain DR, 2002, AGR ECOSYST ENVIRON, V93, P421, DOI 10.1016/S0167-8809(01)00290-0; Li GY, 2011, ECOL RES, V26, P497, DOI 10.1007/s11284-011-0806-7; Lin XW, 2011, AGR FOREST METEOROL, V151, P792, DOI 10.1016/j.agrformet.2011.01.009; Lin Y, 2010, AGR ECOSYST ENVIRON, V138, P282, DOI 10.1016/j.agee.2010.05.013; Liu WX, 2007, BIOL FERT SOILS, V44, P259, DOI 10.1007/s00374-007-0198-6; Liu XZ, 2002, PLANT SOIL, V240, P213, DOI 10.1023/A:1015744126533; Lu XT, 2015, PLANT SOIL, V387, P69, DOI 10.1007/s11104-014-2282-7; Lu XT, 2012, J ECOL, V100, P144, DOI 10.1111/j.1365-2745.2011.01881.x; Maestre FT, 2003, APPL SOIL ECOL, V23, P199, DOI 10.1016/S0929-1393(03)00050-7; Metcalfe DB, 2011, BIOGEOSCIENCES, V8, P2047, DOI 10.5194/bg-8-2047-2011; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Saiz G, 2006, GLOBAL CHANGE BIOL, V12, P1007, DOI 10.1111/j.1365-2486.2006.01145.x; Scholes RJ, 2009, TRENDS ECOL EVOL, V24, P427, DOI 10.1016/j.tree.2009.03.006; Steingrobe B, 2000, J PLANT NUTR SOIL SC, V163, P617, DOI 10.1002/1522-2624(200012)163:6<617::AID-JPLN617>3.0.CO;2-0; Thomas AD, 2011, GEODERMA, V167-68, P284, DOI 10.1016/j.geoderma.2011.07.034; Thomey ML, 2011, GLOBAL CHANGE BIOL, V17, P1505, DOI 10.1111/j.1365-2486.2010.02363.x; Wan SQ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001971; Wang CK, 2006, GLOBAL CHANGE BIOL, V12, P2103, DOI 10.1111/j.1365-2486.2006.01234.x; Wang W, 2009, GLOBAL PLANET CHANGE, V67, P20, DOI 10.1016/j.gloplacha.2008.12.011; Wilsey BJ, 2002, ECOL LETT, V5, P367, DOI 10.1046/j.1461-0248.2002.00322.x; Wu M.L, 2010, STRUCTURAL EQUATION; Xia J, 2009, BIOGEOSCIENCES, V6, P1361, DOI 10.5194/bg-6-1361-2009; Xu WH, 2008, SOIL BIOL BIOCHEM, V40, P679, DOI 10.1016/j.soilbio.2007.10.003; Xu X, 2015, GLOBAL CHANGE BIOL, V21, P3846, DOI 10.1111/gcb.12940; Xu X, 2012, GLOBAL CHANGE BIOL, V18, P1648, DOI 10.1111/j.1365-2486.2012.02651.x; Yan LM, 2011, GLOBAL CHANGE BIOL, V17, P1990, DOI 10.1111/j.1365-2486.2010.02365.x; Yang YS, 2007, PLANT ECOL, V193, P71, DOI 10.1007/s11258-006-9249-6; Yuste JC, 2004, GLOBAL CHANGE BIOL, V10, P161, DOI 10.1111/j.1529-8817.2003.00727.x; Zhou X, 2007, GLOBAL CHANGE BIOL, V13, P761, DOI 10.1111/j.1365-2486.2007.01333.x	55	18	21	6	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147987	10.1371/journal.pone.0147987	http://dx.doi.org/10.1371/journal.pone.0147987			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808376	Green Published, gold			2022-12-26	WOS:000369527800258
J	Meyer, CA; Singh, R; Jones, MT; Yu, CG; Power, RF; Geddes, JW				Meyer, Carolyn A.; Singh, Ranjana; Jones, Mackenzie T.; Yu, Chen-Guang; Power, Ronan F.; Geddes, James W.			Dietary Supplementation with Organoselenium Accelerates Recovery of Bladder Expression, but Does Not Improve Locomotor Function, following Spinal Cord Injury	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE; PARKINSONS-DISEASE; TISSUE RETENTION; OXIDATIVE DAMAGE; SELENOPROTEIN-P; RATING-SCALE; CELL-DEATH; IN-VITRO; SELENIUM; BRAIN	Selenium is an essential element required for activity of several antioxidant enzymes, including glutathione peroxidase. Because of the critical role of the antioxidant system in responding to traumatic events, we hypothesized that dietary selenium supplementation would enhance neuroprotection in a rodent model of spinal cord injury. Rats were maintained on either a control or selenium-enriched diet prior to, and following, injury. Dietary selenium supplementation, provided as selenized yeast added to normal rat chow, resulted in a doubling of selenium levels in the spinal cord. Dietary selenium reduced the time required for recovery of bladder function following thoracic spinal cord injury. However, this was not accompanied by improvement in locomotor function or tissue sparing.	[Meyer, Carolyn A.; Singh, Ranjana; Jones, Mackenzie T.; Yu, Chen-Guang; Geddes, James W.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Meyer, Carolyn A.; Singh, Ranjana; Geddes, James W.] Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY USA; [Power, Ronan F.] Alltech, Ctr Anim Nutrigen & Appl Anim Nutr, Nicholasville, KY USA	University of Kentucky; University of Kentucky	Geddes, JW (corresponding author), Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA.; Geddes, JW (corresponding author), Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY USA.	jgeddes@uky.edu		Jones, Mackenzie/0000-0001-9286-505X	NIH [T32 NS07789, P30 NS051220]; Kentucky Spinal Cord and Head Injury Research Trust; Admiral Sheeley Endowment for Spinal Cord and Brain Injury Research; Alltech Inc. (Nicholasville, KY); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS051220] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Spinal Cord and Head Injury Research Trust; Admiral Sheeley Endowment for Spinal Cord and Brain Injury Research; Alltech Inc. (Nicholasville, KY); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	CAM was supported by NIH T32 NS07789 and the research was supported by NIH P30 NS051220, the Kentucky Spinal Cord and Head Injury Research Trust, and the Admiral Sheeley Endowment for Spinal Cord and Brain Injury Research (JWG). Alltech Inc. (Nicholasville, KY) provided support in the form of salary for RFP and animal diets, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C.A.M. was supported by NIH T32 NS07789 and the research was supported by NIH P30 NS051220, the Kentucky Spinal Cord and Head Injury Research Trust, and the Admiral Sheeley Endowment for Spinal Cord and Brain Injury Research (J.W.G). We thank Dr. Richard Kryscio for assistance with the statistical analysis. Alltech Inc. (Nicholasville, KY) provided support in the form of salary for R.F.P and animal diets, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D K, 1985, Cent Nerv Syst Trauma, V2, P257; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BEHNE D, 1988, BIOCHIM BIOPHYS ACTA, V966, P12, DOI 10.1016/0304-4165(88)90123-7; Bellinger FP, 2012, J PARKINSON DIS, V2, P115, DOI 10.3233/JPD-2012-11052; Bierla K, 2012, TRAC-TREND ANAL CHEM, V41, P122, DOI 10.1016/j.trac.2012.08.006; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; BURK RF, 1972, J NUTR, V102, P1049, DOI 10.1093/jn/102.8.1049; Center N. S. C. I. S., 2013, SPIN CORD INJ FACTS; Chen XB, 2015, EUR REV MED PHARMACO, V19, P4434; DAWSON DA, 1995, NEUROSCI LETT, V185, P65, DOI 10.1016/0304-3940(94)11226-9; Ellwanger JH, 2015, NUTRITION, V31, P359, DOI 10.1016/j.nut.2014.07.004; Ferrero SL, 2015, J NEUROTRAUM, V32, P200, DOI 10.1089/neu.2013.3247; Griffiths JC, 2006, INT J TOXICOL, V25, P465, DOI 10.1080/10915810600959626; Grulova I, 2013, SPINE J, V13, P1881, DOI 10.1016/j.spinee.2013.06.073; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hill KE, 2007, J BIOL CHEM, V282, P10972, DOI 10.1074/jbc.M700436200; Kjell J, 2014, SPINAL CORD, V52, P186, DOI 10.1038/sc.2013.166; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627; Lovell MA, 2009, FREE RADICAL BIO MED, V46, P1527, DOI 10.1016/j.freeradbiomed.2009.03.008; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; Nuttall KL, 2006, ANN CLIN LAB SCI, V36, P409; Ogawa A, 1999, CEREBROVASC DIS, V9, P112, DOI 10.1159/000015908; Ozsoy O, 2012, RESTOR NEUROL NEUROS, V30, P363, DOI 10.3233/RNN-2012-110203; PARNHAM MJ, 1987, INT J TISSUE REACT, V9, P45; PROHASKA JR, 1977, BIOCHEM BIOPH RES CO, V76, P437, DOI 10.1016/0006-291X(77)90744-6; PROHASKA JR, 1976, J NEUROCHEM, V27, P1379, DOI 10.1111/j.1471-4159.1976.tb02619.x; Pruss H, 2011, BRAIN PATHOL, V21, P652, DOI 10.1111/j.1750-3639.2011.00488.x; Rabchevsky AG, 2002, J NEUROSCI RES, V68, P7, DOI 10.1002/jnr.10187; Rabchevsky AG, 2007, GLIA, V55, P831, DOI 10.1002/glia.20508; SALBE AD, 1990, J NUTR, V120, P207, DOI 10.1093/jn/120.2.207; Scheff SW, 2002, J NEUROTRAUM, V19, P1251, DOI 10.1089/08977150260338038; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Sharp KG, 2014, EXP NEUROL, V254, P1, DOI 10.1016/j.expneurol.2013.12.019; Song KD, 2013, ANIM SCI J, V84, P238, DOI [10.1111/j.1740-0929.2012.01060.x, 10.1111/j.17]; SPALLHOLZ JE, 1994, FREE RADICAL BIO MED, V17, P45, DOI 10.1016/0891-5849(94)90007-8; Spallholz JE, 1997, BIOMED ENVIRON SCI, V10, P260; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Vinceti M, 2013, NEUROTOXICOLOGY, V38, P25, DOI 10.1016/j.neuro.2013.05.016; Wrobel JK, 2013, NUTR CANCER, V65, P563, DOI 10.1080/01635581.2013.775315; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Yeo JE, 2008, CELL PHYSIOL BIOCHEM, V21, P225, DOI 10.1159/000113764; Yeo JE, 2007, BBA-MOL BASIS DIS, V1772, P1199, DOI 10.1016/j.bbadis.2007.09.004; Yip PK, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-6	46	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147716	10.1371/journal.pone.0147716	http://dx.doi.org/10.1371/journal.pone.0147716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824231	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528600050
J	Montes-Rodriguez, IM; Rivera, LE; Lopez-Garriga, J; Cadilla, CL				Montes-Rodriguez, Ingrid M.; Rivera, Linda E.; Lopez-Garriga, Juan; Cadilla, Carmen L.			Characterization and Expression of the Lucina pectinata Oxygen and Sulfide Binding Hemoglobin Genes	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS MITES; MULTIPLE SEQUENCE ALIGNMENT; NONVERTEBRATE GLOBIN GENES; MOLLUSK ANADARA-TRAPEZIA; AMINO-ACID-SEQUENCE; DEEP-SEA CLAM; MESSENGER-RNA; CODAKIA-ORBICULARIS; BACTERIA SYMBIOSIS; MAMMALIAN GENOMES	The clam Lucina pectinata lives in sulfide-rich muds and houses intracellular symbiotic bacteria that need to be supplied with hydrogen sulfide and oxygen. This clam possesses three hemoglobins: hemoglobin I (HbI), a sulfide-reactive protein, and hemoglobin II (HbII) and III (HbIII), which are oxygen-reactive. We characterized the complete gene sequence and promoter regions for the oxygen reactive hemoglobins and the partial structure and promoters of the HbI gene from Lucina pectinata. We show that HbI has two mRNA variants, where the 5' end had either a sequence of 96 bp (long variant) or 37 bp (short variant). The gene structure of the oxygen reactive Hbs is defined by having 4-exons/3-introns with conservation of intron location at B12.2 and G7.0 and the presence of pre-coding introns, while the partial gene structure of HbI has the same intron conservation but appears to have a 5-exon/4-intron structure. A search for putative transcription factor binding sites (TFBSs) was done with the promoters for HbII, HbIII, HbI short and HbI long. The HbII, HbIII and HbI long promoters showed similar predicted TFBSs. We also characterized MITE-like elements in the HbI and HbII gene promoters and intronic regions that are similar to sequences found in other mollusk genomes. The gene expression levels of the clam Hbs, from sulfide-rich and sulfide-poor environments showed a significant decrease of expression in the symbiont-containing tissue for those clams in a sulfide-poor environment, suggesting that the sulfide concentration may be involved in the regulation of these proteins. Gene expression evaluation of the two HbI mRNA variants indicated that the longer variant is expressed at higher levels than the shorter variant in both environments.	[Montes-Rodriguez, Ingrid M.; Lopez-Garriga, Juan] Univ Puerto Rico, Arts & Sci Fac, Dept Chem, Mayaguuez Campus,POB 9019, Mayaguez, PR 00681 USA; [Rivera, Linda E.; Cadilla, Carmen L.] Univ Puerto Rico, Sch Med, Dept Biochem, Med Sci Campus,POB 365067, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Mayaguez; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Cadilla, CL (corresponding author), Univ Puerto Rico, Sch Med, Dept Biochem, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.	carmen.cadilla@upr.edu			National Institute on Minority Health and Health Disparities RCMI grant [G12 MD007600]; National Institute of General Medical Sciences from the National Institutes of Health [P20GM103475, R25GM061838, R25 GM088023]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM088023, P20GM103475, R25GM061838] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007587, G12MD007600] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities RCMI grant; National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funds from National Institute on Minority Health and Health Disparities RCMI grant G12 MD007600, National Institute of General Medical Sciences - Awards Number P20GM103475 and R25GM061838 to CLC and R25 GM088023 to JLG from the National Institutes of Health supported this work. IMMR and LER received support from grants R25 GM088023 and R25GM061838, respectively.	ALLEN JA, 1958, PHILOS T R SOC B, V241, P421, DOI 10.1098/rstb.1958.0010; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antommattei-Perez FM, 1999, J PROTEIN CHEM, V18, P831, DOI 10.1023/A:1020623011363; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Bailey TL, 1994, C INT SYST MOL BIOL, P28; Bailly X, 2005, J INORG BIOCHEM, V99, P142, DOI 10.1016/j.jinorgbio.2004.10.012; Balkwill GD, 2009, BIOCHEMISTRY-US, V48, P11487, DOI 10.1021/bi901420k; Berezikov E, 2005, NUCLEIC ACIDS RES, V33, pW447, DOI 10.1093/nar/gki378; Berezikov Eugene, 2007, V395, P437; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; Brodie R, 2004, BIOINFORMATICS, V20, P279, DOI 10.1093/bioinformatics/btg406; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Cardazzo B, 2003, MOL BIOL EVOL, V20, P2034, DOI 10.1093/molbev/msg213; Caro A, 2009, APPL ENVIRON MICROB, V75, P3304, DOI 10.1128/AEM.02659-08; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Chen Jiongjiong, 2012, Mob Genet Elements, V2, P127; Childress JJ, 2011, J EXP BIOL, V214, P312, DOI 10.1242/jeb.049023; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; De Jesus-Bonilla W, 2006, J BIOL INORG CHEM, V11, P334, DOI 10.1007/s00775-006-0082-0; Dewilde S, 1998, J BIOL CHEM, V273, P13583, DOI 10.1074/jbc.273.22.13583; Duan ZJ, 2002, P NATL ACAD SCI USA, V99, P5509, DOI 10.1073/pnas.072084499; Duplessis MR, 2004, APPL ENVIRON MICROB, V70, P4144, DOI 10.1128/AEM.70.7.4144-4150.2004; Fattash I, 2013, GENOME, V56, P475, DOI 10.1139/gen-2012-0174; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Fossat N, 2014, EMBO REP, V15, P903, DOI 10.15252/embr.201438450; Gaffney PM, 2003, J MOL EVOL, V56, P308, DOI 10.1007/s00239-002-2402-5; Gavira JA, 2006, ACTA CRYSTALLOGR F, V62, P196, DOI 10.1107/S1744309106002648; Gavira JA, 2008, J BIOL CHEM, V283, P9414, DOI 10.1074/jbc.M705026200; GIBSON QH, 1989, J BIOL CHEM, V264, P100; GO M, 1981, NATURE, V291, P90, DOI 10.1038/291090a0; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hardison R, 1998, J EXP BIOL, V201, P1099; Hardison R, 2001, CLIN MANAGEMENT, P1; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Heyn P, 2015, BIOESSAYS, V37, P148, DOI 10.1002/bies.201400138; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kawano K, 2003, CELL MOL LIFE SCI, V60, P1952, DOI 10.1007/s00018-003-3184-7; KRAUS DW, 1990, J BIOL CHEM, V265, P16043; KRAUS DW, 1990, J BIOL CHEM, V265, P16054; KRAUS DW, 1995, AM ZOOL, V35, P112; Krebs S, 2009, ANAL BIOCHEM, V387, P136, DOI 10.1016/j.ab.2008.12.020; Laurent MCZ, 2009, MAR ENVIRON RES, V67, P83, DOI 10.1016/j.marenvres.2008.11.006; Lechaire JP, 2006, BIOL CELL, V98, P163, DOI 10.1042/BC20040502; LEWIN R, 1984, SCIENCE, V226, P328, DOI 10.1126/science.226.4672.328; Lu C, 2012, MOL BIOL EVOL, V29, P1005, DOI 10.1093/molbev/msr282; Mao L, 2000, GENOME RES, V10, P982, DOI 10.1101/gr.10.7.982; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; MCDONALD JF, 1993, CURR OPIN GENET DEV, V3, P855, DOI 10.1016/0959-437X(93)90005-A; MOENS L, 1992, FEBS LETT, V312, P105, DOI 10.1016/0014-5793(92)80915-4; Moucadel V, 2007, NUCLEIC ACIDS RES, V35, P1947, DOI 10.1093/nar/gkm062; Naito K, 2006, P NATL ACAD SCI USA, V103, P17620, DOI 10.1073/pnas.0605421103; NAITO Y, 1991, P NATL ACAD SCI USA, V88, P6672, DOI 10.1073/pnas.88.15.6672; Nassif NT, 1996, GENE, V183, P225, DOI 10.1016/S0378-1119(96)00564-1; Nicholas HB, 2002, BIOTECHNIQUES, V32, P572, DOI 10.2144/02323rv01; Nicholas KB, 1997, GENEDOC TOOL EDITING, P14; Oki N, 2008, GENES GENET SYST, V83, P321, DOI 10.1266/ggs.83.321; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Palavicini JP, 2012, J BIOL CHEM, V287, P17754, DOI 10.1074/jbc.M112.366005; Pietri R, 2005, BBA-PROTEINS PROTEOM, V1747, P195, DOI 10.1016/j.bbapap.2004.11.005; Pietri R, 2006, BBA-PROTEINS PROTEOM, V1764, P758, DOI 10.1016/j.bbapap.2005.11.006; Rivera L, 2008, GENE, V410, P122, DOI 10.1016/j.gene.2007.12.005; Rizzi M, 1996, J MOL BIOL, V258, P1, DOI 10.1006/jmbi.1996.0228; RIZZI M, 1994, J MOL BIOL, V244, P86, DOI 10.1006/jmbi.1994.1706; Rosenthal JJC, 2015, J EXP BIOL, V218, P1812, DOI 10.1242/jeb.119065; Ruiz-Martinez CR, 2009, ACTA CRYSTALLOGR F, V65, P25, DOI 10.1107/S1744309108038542; Satovic E, 2013, GENOME BIOL EVOL, V5, P2549, DOI 10.1093/gbe/evt202; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Shapiro JA, 2005, BIOL REV, V80, P227, DOI 10.1017/S1464793104006657; SHERMAN DR, 1992, P NATL ACAD SCI USA, V89, P11696, DOI 10.1073/pnas.89.24.11696; Silfa E, 1998, BIOSPECTROSCOPY, V4, P311, DOI 10.1002/(SICI)1520-6343(1998)4:5<311::AID-BSPY3>3.0.CO;2-T; Sobczak K, 2002, J BIOL CHEM, V277, P17349, DOI 10.1074/jbc.M109162200; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Suzuki T, 1998, CELL MOL LIFE SCI, V54, P979, DOI 10.1007/s000180050227; Suzuki T, 2000, INT J BIOCHEM CELL B, V32, P1205, DOI 10.1016/S1357-2725(00)00054-6; Taylor JD, 2000, GEOL SOC SPEC PUBL, V177, P207, DOI 10.1144/GSL.SP.2000.177.01.12; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; TITCHEN DA, 1991, BIOCHIM BIOPHYS ACTA, V1089, P61, DOI 10.1016/0167-4781(91)90085-Z; Torres-Mercado E, 2003, J PROTEIN CHEM, V22, P683, DOI 10.1023/B:JOPC.0000008734.44356.b7; Tsunoda T, 1999, BIOINFORMATICS, V15, P622, DOI 10.1093/bioinformatics/15.7.622; VETTER RD, 1985, MAR BIOL, V88, P33, DOI 10.1007/BF00393041; VINOGRADOV SN, 1992, COMP BIOCHEM PHYS B, V103, P759, DOI 10.1016/0305-0491(92)90193-U; Weber RE, 2001, PHYSIOL REV, V81, P569, DOI 10.1152/physrev.2001.81.2.569; Yang GJ, 2005, PLANT CELL, V17, P1559, DOI 10.1105/tpc.104.030528; Zhang Q, 2000, P NATL ACAD SCI USA, V97, P1160, DOI 10.1073/pnas.97.3.1160	89	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147977	10.1371/journal.pone.0147977	http://dx.doi.org/10.1371/journal.pone.0147977			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824233	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528600082
J	Whittle, S; Vijayakumar, N; Dennison, M; Schwartz, O; Simmons, JG; Sheeber, L; Allen, NB				Whittle, Sarah; Vijayakumar, Nandita; Dennison, Meg; Schwartz, Orli; Simmons, Julian G.; Sheeber, Lisa; Allen, Nicholas B.			Observed Measures of Negative Parenting Predict Brain Development during Adolescence	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; COGNITIVE-DEVELOPMENT; EXECUTIVE FUNCTIONS; EMOTION REGULATION; LATE CHILDHOOD; MATTER VOLUME; MATURATION; DISORDERS; CHILDREN; BEHAVIOR	Limited attention has been directed toward the influence of non-abusive parenting behaviour on brain structure in adolescents. It has been suggested that environmental influences during this period are likely to impact the way that the brain develops over time. The aim of this study was to investigate the association between aggressive and positive parenting behaviors on brain development from early to late adolescence, and in turn, psychological and academic functioning during late adolescence, using a multi-wave longitudinal design. Three hundred and sixty seven magnetic resonance imaging (MRI) scans were obtained over three time points from 166 adolescents (11-20 years). At the first time point, observed measures of maternal aggressive and positive behaviors were obtained. At the final time point, measures of psychological and academic functioning were obtained. Results indicated that a higher frequency of maternal aggressive behavior was associated with alterations in the development of right superior frontal and lateral parietal cortical thickness, and of nucleus accumbens volume, in males. Development of the superior frontal cortex in males mediated the relationship between maternal aggressive behaviour and measures of late adolescent functioning. We suggest that our results support an association between negative parenting and adolescent functioning, which may be mediated by immature or delayed brain maturation.	[Whittle, Sarah; Vijayakumar, Nandita; Dennison, Meg; Schwartz, Orli; Simmons, Julian G.; Allen, Nicholas B.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Whittle, Sarah; Simmons, Julian G.] Univ Melbourne, Melbourne Neuropsychiat Ctr, Dept Psychiat, Melbourne, Vic, Australia; [Whittle, Sarah; Dennison, Meg; Simmons, Julian G.] Melbourne Hlth, Melbourne, Vic, Australia; [Dennison, Meg] Univ Melbourne, Dept Psychiat, Australian Ctr Posttraumat Mental Hlth, Melbourne, Vic, Australia; [Sheeber, Lisa] Oregon Res Inst, Eugene, OR 97403 USA; [Allen, Nicholas B.] Univ Melbourne, Natl Ctr Excellence Youth Mental Hlth, Orygen, Melbourne, Vic, Australia; [Allen, Nicholas B.] Univ Oregon, Eugene, OR 97403 USA	University of Melbourne; University of Melbourne; University of Melbourne; Oregon Research Institute; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; University of Oregon	Whittle, S (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.; Whittle, S (corresponding author), Univ Melbourne, Melbourne Neuropsychiat Ctr, Dept Psychiat, Melbourne, Vic, Australia.; Whittle, S (corresponding author), Melbourne Hlth, Melbourne, Vic, Australia.	swhittle@unimelb.edu.au	Vijayakumar, Nandita/ABE-1215-2020; Schwartz, Orli/ABD-3996-2021; Whittle, Sarah/I-2200-2014	Vijayakumar, Nandita/0000-0002-5622-9547; Simmons, Julian G./0000-0002-7228-1847; Allen, Nicholas/0000-0002-1086-6639; Whittle, Sarah/0000-0003-3145-1528; Schwartz, Orli/0000-0001-7634-3737	National Health and Medical Research Council (NHMRC, Australia) [350241, 1007716]; Australian Research Council (ARC) [DP0878136]; Colonial Foundation	National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Colonial Foundation	This research was supported by grants from the Colonial Foundation, the National Health and Medical Research Council (NHMRC, Australia, Program Grant 350241; Career Development Fellowship ID: 1007716 to SW) and the Australian Research Council (ARC, Discovery Grant DP0878136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Belsky J, 2011, J CHILD PSYCHOL PSYC, V52, P409, DOI 10.1111/j.1469-7610.2010.02281.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Bernal-Rusiel JL, 2013, NEUROIMAGE, V66, P249, DOI 10.1016/j.neuroimage.2012.10.065; BRONFENBRENNER U, 1986, DEV PSYCHOL, V22, P723, DOI 10.1037/0012-1649.22.6.723; Capaldi DM., 1992, J EARLY ADOLESCENCE, V12, P153, DOI 10.1177/0272431692012002002; Cauffman E, 2005, CRIMINOLOGY, V43, P133, DOI 10.1111/j.0011-1348.2005.00005.x; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; Ducharme S, 2013, CEREB CORTEX; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Francis DD, 1999, CURR OPIN NEUROBIOL, V9, P128, DOI 10.1016/S0959-4388(99)80016-6; Frye RE, 2010, J INT NEUROPSYCH SOC, V16, P784, DOI 10.1017/S1355617710000585; Goto Y, 2008, TRENDS NEUROSCI, V31, P552, DOI 10.1016/j.tins.2008.08.002; Hart H, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00052; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Hops H., 1995, LIVING FAMILY ENV LI; Howell BR, 2014, DEV PSYCHOBIOL, V56, P1735, DOI 10.1002/dev.21237; Jones FL, 2001, WORK EMPLOY SOC, V15, P539, DOI 10.1177/09500170122119147; Kaufman J, 2000, BIOL PSYCHIAT, V48, P778, DOI 10.1016/S0006-3223(00)00998-7; Lee KH, 2014, SOCIAL COGNITIVE AFF; Luby JL, 2012, P NATL ACAD SCI USA, V109, P2854, DOI 10.1073/pnas.1118003109; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; McLaughlin KA, 2014, NEUROSCI BIOBEHAV R, V47, P578, DOI 10.1016/j.neubiorev.2014.10.012; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Moriceau S, 2006, NAT NEUROSCI, V9, P1004, DOI 10.1038/nn1733; Oldehinkel AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1757, DOI 10.1016/j.neubiorev.2010.10.013; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rao H, 2010, NEUROIMAGE, V49, P1144, DOI 10.1016/j.neuroimage.2009.07.003; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2011, NEUROIMAGE, V57, P19, DOI 10.1016/j.neuroimage.2011.02.076; ROTHBAUM F, 1994, PSYCHOL BULL, V116, P55, DOI 10.1037/0033-2909.116.1.55; Schaie KW, 1994, 3 DEV DESIGNS REVISI; Schneider S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.113; Schwartz OS, 2014, CLIN PSYCHOL SCI, V2, P272, DOI 10.1177/2167702613505531; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Shaw DS, 1997, PRECURSORS CORRELATE; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Sheeber LB, 2007, J ABNORM PSYCHOL, V116, P144, DOI 10.1037/0021-843X.116.1.144; Spera C, 2005, EDUC PSYCHOL REV, V17, P120, DOI 10.1007/s10648-005-3950-1; Tamnes CK, 2010, NEUROPSYCHOLOGIA, V48, P2496, DOI 10.1016/j.neuropsychologia.2010.04.024; Tomoda A, 2009, NEUROIMAGE, V47, pT66, DOI 10.1016/j.neuroimage.2009.03.005; Tupler LA, 2006, BIOL PSYCHIAT, V59, P523, DOI 10.1016/j.biopsych.2005.08.007; van Hasselt FN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037820; Vijayakumar N, 2014, DEV COGN NEUROS-NETH, V9, P30, DOI 10.1016/j.dcn.2013.12.002; Walsh ND, 2014, NEUROIMAGE-CLIN, V4, P308, DOI 10.1016/j.nicl.2014.01.001; Whittle S, 2009, SOCIAL COGNITIVE AFF; Whittle S, 2014, DEV COGN NEUROS-NETH, V8, P7, DOI 10.1016/j.dcn.2013.10.006; Yap MBH, 2007, CLIN CHILD FAM PSYCH, V10, P180, DOI 10.1007/s10567-006-0014-0; Yap MBH, 2011, DEV PSYCHOPATHOL, V23, P267, DOI 10.1017/S0954579410000787	53	63	63	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147774	10.1371/journal.pone.0147774	http://dx.doi.org/10.1371/journal.pone.0147774			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824348	Green Published, gold			2022-12-26	WOS:000369528600059
J	Choi, E; Choi, KH; Park, SM; Shin, D; Joh, HK; Cho, EY				Choi, Eunjoo; Choi, Kyung-Hyun; Park, Sang Min; Shin, Doosup; Joh, Hee-Kyung; Cho, Eunyoung			The Benefit of Bone Health by Drinking Coffee among Korean Postmenopausal Women: A Cross-Sectional Analysis of the Fourth & Fifth Korea National Health and Nutrition Examination Surveys	PLOS ONE			English	Article							MINERAL DENSITY; ESTROGENIC ACTIVITY; CALCIUM-METABOLISM; CAFFEINE INTAKE; ALCOHOL INTAKE; ELDERLY-WOMEN; RISK-FACTORS; CONSUMPTION; ASSOCIATION; FRACTURE	Purpose Although the concern about coffee-associated health problems is increasing, the effect of coffee on osteoporosis is still conflicting. This study aimed to determine the relationship between coffee consumption and bone health in Korean postmenopausal women. Methods A population-based, cross-sectional study was performed using a nationally representative sample of the Korean general population. All 4,066 postmenopausal women (mean age 62.6 years) from the fourth and fifth Korean National Health and Nutrition Examination Survey (2008-2011), who completed the questionnaire about coffee consumption and had data of dual-energy X-ray absorptiometry (DXA) examination. Bone mineral density (BMD) was measured using DXA at the femoral neck and lumbar spine and osteoporosis was defined by World Health Organization T-score criteria in addition to self-report of current anti-osteoporotic medication use. Results After adjusting for various demographic and lifestyle confounders (including hormonal factors), subjects in the highest quartile of coffee intake had 36% lower odds for osteoporosis compared to those in the lowest quartile (Adjusted odds ratio [aOR] = 0.64; 95% confidence interval [CI], 0.43-0.95; P for trend = 0.015). This trend was consistent in osteoporosis of lumbar spine and femoral neck (aOR = 0.65 and 0.55; P for trend = 0.026 and 0.003, respectively). In addition, age-and body mass index (BMI)-adjusted BMD of the femoral neck and lumbar spine increased with higher coffee intake (P for trend = 0.019 and 0.051, respectively). Conclusions Coffee consumption may have protective benefits on bone health in Korean postmenopausal women in moderate amount. Further, prospective studies are required to confirm this association.	[Choi, Eunjoo; Park, Sang Min] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Family Med, 101 Daehak Ro, Seoul 110744, South Korea; [Choi, Kyung-Hyun] Dongnam Inst Radiol & Med Sci, Ctr Hlth Promot & Canc Prevent, Jwadong Gil 40, Busan 619953, South Korea; [Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Biomed Sci, 28 Yunkeon Dong, Seoul 110744, South Korea; [Shin, Doosup] Seoul Natl Univ Hosp, Dept Educ & Res, 101 Daehak Ro, Seoul 110744, South Korea; [Joh, Hee-Kyung] Seoul Natl Univ, Coll Med, Dept Med, 28 Yunkeon Dong, Seoul 110744, South Korea; [Joh, Hee-Kyung] Seoul Natl Univ, Hlth Serv Ctr, Dept Family Med, Seoul 152742, South Korea; [Cho, Eunyoung] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Div Network Med, 181 Longwood Ave, Boston, MA 02115 USA; [Cho, Eunyoung] Brown Univ, Warren Alpert Med Sch, Dept Dermatol, 339 Eddy St, Providence, RI 02903 USA	Seoul National University (SNU); Seoul National University Hospital; Korea Institute of Radiological & Medical Sciences; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Brown University	Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Family Med, 101 Daehak Ro, Seoul 110744, South Korea.; Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, 28 Yunkeon Dong, Seoul 110744, South Korea.	smpark.snuh@gmail.com	Cho, Eunyoung/AAV-4469-2020; Park, Sang Min/V-9194-2019	Cho, Eunyoung/0000-0001-6594-2582; Joh, Hee-Kyung/0000-0003-3854-7012; Shin, Doosup/0000-0003-4960-5732				Allred KF, 2009, J NUTR, V139, P1833, DOI 10.3945/jn.109.108001; Arlot ME, 1997, J BONE MINER RES, V12, P683, DOI 10.1359/jbmr.1997.12.4.683; Atalar E, 2009, RHEUMATOL INT, V29, P1025, DOI 10.1007/s00296-008-0768-4; Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1; BARGERLUX MJ, 1995, J CLIN ENDOCR METAB, V80, P406, DOI 10.1210/jc.80.2.406; Carbone LD, 2003, J BONE MINER RES, V18, P1795, DOI 10.1359/jbmr.2003.18.10.1795; Cauley JA, 2005, OSTEOPOROSIS INT, V16, P1525, DOI 10.1007/s00198-005-1866-8; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Date C, 2005, J EPIDEMIOL, V15, pS9, DOI 10.2188/jea.15.S9; Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925; FELSON DT, 1995, AM J EPIDEMIOL, V142, P485, DOI 10.1093/oxfordjournals.aje.a117664; Forsmo S, 2001, OSTEOPOROSIS INT, V12, P222, DOI 10.1007/s001980170133; Gallus S, 2002, ANN EPIDEMIOL, V12, P202, DOI 10.1016/S1047-2797(01)00304-0; Ganry O, 2000, AM J EPIDEMIOL, V151, P773, DOI 10.1093/oxfordjournals.aje.a010277; Hallstrom H, 2006, OSTEOPOROSIS INT, V17, P1055, DOI 10.1007/s00198-006-0109-y; Halvorsen BL, 2006, AM J CLIN NUTR, V84, P95, DOI 10.1093/ajcn/84.1.95; Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710; HARRIS SS, 1994, AM J CLIN NUTR, V60, P573, DOI 10.1093/ajcn/60.4.573; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; HASLING C, 1992, J NUTR, V122, P1119, DOI 10.1093/jn/122.5.1119; Holvik K., 2003, NORSK EPIDEMIOLOGI, V13, P177; Je Y, 2014, ASIA PAC J CLIN NUTR, V23, P691, DOI 10.6133/apjcn.2014.23.4.11; Kim JY, 2006, BIOFACTORS, V26, P17, DOI 10.1002/biof.5520260103; KITTS DD, 1987, J TOXICOL ENV HEALTH, V20, P37, DOI 10.1080/15287398709530960; Lee DR, 2014, BONE, V63, P20, DOI 10.1016/j.bone.2014.02.007; Lee KW, 2013, NEUROTHERAPEUTICS, V10, P143, DOI 10.1007/s13311-012-0165-2; Lewiecki EM, 2008, BONE, V43, P1115, DOI 10.1016/j.bone.2008.08.106; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Lloyd T, 2000, J AM COLL NUTR, V19, P256, DOI 10.1080/07315724.2000.10718924; MASSEY LK, 1993, J NUTR, V123, P1611, DOI 10.1093/jn/123.9.1611; NILAS L, 1988, EUR J CLIN INVEST, V18, P529, DOI 10.1111/j.1365-2362.1988.tb01052.x; Ososki AL, 2003, PHYTOTHER RES, V17, P845, DOI 10.1002/ptr.1364; Rapuri PB, 2001, AM J CLIN NUTR, V74, P694; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674; Schliep KC, 2012, AM J CLIN NUTR, V95, P488, DOI 10.3945/ajcn.111.021287; Shin CS, 2010, BONE, V47, P378, DOI 10.1016/j.bone.2010.03.017; Stanford BD, 2010, J AM WATER WORKS ASS, V102, P55; Tang QY, 2006, HISTOCHEM CELL BIOL, V125, P215, DOI 10.1007/s00418-005-0062-4; United States Department of Agriculture, 2013, COFF WORLD MARK TRAD; Verhoef P, 2002, AM J CLIN NUTR, V76, P1244, DOI 10.1093/ajcn/76.6.1244; 박형무, 2010, Obstetrics & Gynecology Science, V53, P152	43	23	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147762	10.1371/journal.pone.0147762	http://dx.doi.org/10.1371/journal.pone.0147762			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816211	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528200048
J	Palmerini, CA; Mazzoni, M; Radicioni, G; Marzano, V; Granieri, L; Iavarone, F; Longhi, R; Messana, I; Cabras, T; Sanna, MT; Castagnola, M; Vitali, A				Palmerini, Carlo Alberto; Mazzoni, Michela; Radicioni, Giorgia; Marzano, Valeria; Granieri, Letizia; Iavarone, Federica; Longhi, Renato; Messana, Irene; Cabras, Tiziana; Sanna, Maria Teresa; Castagnola, Massimo; Vitali, Alberto			Antagonistic Effect of a Salivary Proline-Rich Peptide on the Cytosolic Ca2+ Mobilization Induced by Progesterone in Oral Squamous Cancer Cells	PLOS ONE			English	Article							MEMBRANE COMPONENT 1; HUMAN BREAST-CANCER; ALPHA MPR-ALPHA; PGRMC1 PROTEIN; SH3 DOMAIN; RECEPTOR; EXPRESSION; BINDING; IDENTIFICATION; FAMILY	A salivary proline-rich peptide of 1932 Da showed a dose-dependent antagonistic effect on the cytosolic Ca2+ mobilization induced by progesterone in a tongue squamous carcinoma cell line. Structure-activity studies showed that the activity of the peptide resides in the C-terminal region characterized by a proline stretch flanked by basic residues. Furthermore, lack of activity of the retro-inverso peptide analogue suggested the involvement of stereospecific recognition. Mass spectrometry-based shotgun analysis, combined with Western blotting tests and biochemical data obtained with the Progesterone Receptor Membrane Component 1 (PGRMC1) inhibitor AG205, showed strong evidence that p1932 performs its modulatory action through an interaction with the progesterone receptor PGRMC1, which is predominantly expressed in this cell line and, clearly, plays a role in progesterone induced Ca2+ response. Thus, our results point to p1932 as a modulator of the transduction signal pathway mediated by this protein and, given a well-established involvement of PGRMC1 in tumorigenesis, highlight a possible therapeutic potential of p1932 for the treatment of oral cancer.	[Palmerini, Carlo Alberto; Mazzoni, Michela; Granieri, Letizia] Dipartimento Sci Agr Alimentari & Ambiental, Unit Ric Biochim & Biol Mol, Perugia, Italy; [Radicioni, Giorgia; Marzano, Valeria; Iavarone, Federica; Castagnola, Massimo] Catholic Univ, Fac Med, Ist Biochim & Biochim Clin, Rome, Italy; [Longhi, Renato] Italian Natl Res Council, Ist Chim Riconoscimento Mol, Milan, Italy; [Messana, Irene; Cabras, Tiziana; Sanna, Maria Teresa] Cittadella Univ, Univ Cagliari, Dipartimento Sci Vita & Ambiente, Cagliari, Italy; [Castagnola, Massimo; Vitali, Alberto] Italian Natl Res Council, Ist Chim Riconoscimento Mol, Rome, Uos Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Vitali, A (corresponding author), Italian Natl Res Council, Ist Chim Riconoscimento Mol, Rome, Uos Rome, Italy.	alberto.vitali@icrm.cnr.it	Messana, Irene/L-2478-2019; Iavarone, Federica/K-6446-2016; Granieri, Letizia/AAC-2644-2019; Cabras, Tiziana/AAF-6231-2020; Vitali, Alberto/F-3667-2017; Castagnola, Massimo/AAB-2825-2019; Castagnola, Massimo/AAM-6355-2021; Marzano, Valeria/K-5770-2016	Messana, Irene/0000-0002-1436-6105; Iavarone, Federica/0000-0002-2074-5531; Vitali, Alberto/0000-0001-9828-4117; Castagnola, Massimo/0000-0002-0959-7259; Marzano, Valeria/0000-0001-6364-2121	Nando Peretti Foundation; Catholic University of Rome; Cagliari University; MIUR; FaReBio dQ CNR project; Regione Sardegna	Nando Peretti Foundation; Catholic University of Rome; Cagliari University; MIUR(Ministry of Education, Universities and Research (MIUR)); FaReBio dQ CNR project; Regione Sardegna(Regione Sardegna)	This work was supported by Nando Peretti Foundation, Catholic University of Rome, Cagliari University, MIUR and Regione Sardegna according to their programs of scientific diffusion. The work was also supported by FaReBio dQ 2012 CNR project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate C, 2015, EUR J PHARMACOL, V758, P16, DOI 10.1016/j.ejphar.2015.03.067; Ahmed IS, 2010, J PHARMACOL EXP THER, V333, P564, DOI 10.1124/jpet.109.164210; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Bandhakavi S, 2009, J PROTEOME RES, V8, P5590, DOI 10.1021/pr900675w; Baron AC, 1999, ORAL DIS, V5, P234, DOI 10.1111/j.1601-0825.1999.tb00307.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boonyaratanakornkit V, 2007, MOL ENDOCRINOL, V21, P359, DOI 10.1210/me.2006-0337; Cao R, 2012, J PROTEOME RES, V11, P829, DOI 10.1021/pr200677z; Castagnola M, 2011, TRENDS BIOTECHNOL, V29, P409, DOI 10.1016/j.tibtech.2011.04.002; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dressing GE, 2007, STEROIDS, V72, P111, DOI 10.1016/j.steroids.2006.10.006; Falkenstein E, 1999, ENDOCRINOLOGY, V140, P5999, DOI 10.1210/en.140.12.5999; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Fernandes MS, 2008, STEROIDS, V73, P942, DOI 10.1016/j.steroids.2007.12.004; Ferraro E, 2007, NUCLEIC ACIDS RES, V35, pW451, DOI 10.1093/nar/gkm296; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Franz M, 2006, HISTOCHEM CELL BIOL, V126, P125, DOI 10.1007/s00418-005-0126-5; Goobes R, 2007, BIOCHEMISTRY-US, V46, P4725, DOI 10.1021/bi602345a; Groschl M, 2008, CLIN CHEM, V54, P1759, DOI 10.1373/clinchem.2008.108910; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Helmerhorst EJ, 2007, J DENT RES, V86, P680, DOI 10.1177/154405910708600802; Helmerhorst EJ, 2008, J BIOL CHEM, V283, P19957, DOI 10.1074/jbc.M708282200; Huang YS, 2014, MED RES REV, V34, P532, DOI 10.1002/med.21297; Jang WS, 2010, MOL MICROBIOL, V77, P354, DOI 10.1111/j.1365-2958.2010.07210.x; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kimura I, 2012, CURR PROTEIN PEPT SC, V13, P687, DOI 10.2174/138920312804142110; Koulen P, 2008, CELL PHYSIOL BIOCHEM, V21, P161, DOI 10.1159/000113758; Kulasekara KK, 2009, ARCH ORAL BIOL, V54, P924, DOI 10.1016/j.archoralbio.2009.07.004; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Losel RM, 2008, FRONT NEUROENDOCRIN, V29, P258, DOI 10.1016/j.yfrne.2007.09.002; Lukits J, 2007, INT J ONCOL, V30, P155; Magister S, 2013, J CANCER, V4, P45, DOI 10.7150/jca.5044; Messana I, 2008, MOL CELL PROTEOMICS, V7, P911, DOI 10.1074/mcp.M700501-MCP200; Migliaccio A, 2012, STEROIDS, V77, P974, DOI 10.1016/j.steroids.2012.01.014; Musacchio A, 2003, ADV PROTEIN CHEM, V61, P211; Peluso JJ, 2011, STEROIDS, V76, P903, DOI 10.1016/j.steroids.2011.02.011; Petersen SL, 2013, J NEUROENDOCRINOL, V25, P991, DOI 10.1111/jne.12060; Radicioni G, 2015, BBA-BIOMEMBRANES, V1848, P2868, DOI 10.1016/j.bbamem.2015.08.019; Riva A, 2000, EUR J MORPHOL, V38, P219, DOI 10.1076/0924-3860(200010)38:4;1-O;FT219; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; Ruan X, 2012, CLIMACTERIC, V15, P467, DOI 10.3109/13697137.2011.648232; Sekine S, 2004, MICROBIOL-SGM, V150, P2373, DOI 10.1099/mic.0.27107-0; Smith JL, 2008, STEROIDS, V73, P1160, DOI 10.1016/j.steroids.2008.05.003; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tang YT, 2005, J MOL EVOL, V61, P372, DOI 10.1007/s00239-004-0375-2; Thomas P, 2008, FRONT NEUROENDOCRIN, V29, P292, DOI 10.1016/j.yfrne.2008.01.001; Thomas P, 2014, ENDOCRINOLOGY, V155, P1107, DOI 10.1210/en.2013-1991; van Waarde A, 2015, BBA-BIOMEMBRANES, V1848, P2703, DOI 10.1016/j.bbamem.2014.08.022; Vilner BJ, 2000, J PHARMACOL EXP THER, V292, P900; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100; Zhu Y, 2008, COMP BIOCHEM PHYS C, V148, P381, DOI 10.1016/j.cbpc.2008.05.019	54	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147925	10.1371/journal.pone.0147925	http://dx.doi.org/10.1371/journal.pone.0147925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814504	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528200064
J	Cools, P; Jespers, V; Hardy, L; Crucitti, T; Delany-Moretlwe, S; Mwaura, M; Ndayisaba, GF; van de Wijgert, JHHM; Vaneechoutte, M				Cools, Piet; Jespers, Vicky; Hardy, Liselotte; Crucitti, Tania; Delany-Moretlwe, Sinead; Mwaura, Mary; Ndayisaba, Gilles F.; van de Wijgert, Janneke H. H. M.; Vaneechoutte, Mario			A Multi-Country Cross-Sectional Study of Vaginal Carriage of Group B Streptococci (GBS) and Escherichia coli in Resource-Poor Settings: Prevalences and Risk Factors	PLOS ONE			English	Article							ONSET NEONATAL SEPSIS; MULTIPLEX PCR ASSAY; LOWER GENITAL-TRACT; PREGNANT-WOMEN; BACTERIAL VAGINOSIS; CERVICAL ECTOPY; AFRICAN WOMEN; ANTIMICROBIAL RESISTANCE; INTRAUTERINE-DEVICE; SAMPLING TECHNIQUES	Background One million neonates die each year in low- and middle-income countries because of neonatal sepsis; group B Streptococcus (GBS) and Escherichia coli are the leading causes. In sub-Saharan Africa, epidemiological data on vaginal GBS and E. coli carriage, a prerequisite for GBS and E. coli neonatal sepsis, respectively, are scarce but necessary to design and implement prevention strategies. Therefore, we assessed vaginal GBS and E. coli carriage rates and risk factors and the GBS serotype distribution in three sub-Saharan countries. Methods A total of 430 women from Kenya, Rwanda and South Africa were studied cross-sectionally. Vaginal carriage of GBS and E. coli, and GBS serotype were assessed using molecular techniques. Risk factors for carriage were identified using multivariable logistic regression analysis. Results Vaginal carriage rates in reference groups from Kenya and South Africa were 20.2% (95% CI, 13.7-28.7%) and 23.1%(95% CI, 16.2-31.9%), respectively for GBS; and 25.0% (95% CI, 17.8-33.9%) and 27.1%(95% CI, 19.6-36.2%), respectively for E. coli. GBS serotypes Ia (36.8%), V (26.3%) and III (14.0%) were most prevalent. Factors independently associated with GBS and E. coli carriage were Candida albicans, an intermediate vaginal microbiome, bacterial vaginosis, recent vaginal intercourse, vaginal washing, cervical ectopy and working as a sex worker. GBS and E. coli carriage were positively associated. Conclusions Reduced vaginal GBS carriage rates might be accomplished by advocating behavioral changes such as abstinence from sexual intercourse and by avoidance of vaginal washing during late pregnancy. It might be advisable to explore the inclusion of vaginal carriage of C. albicans, GBS, E. coli and of the presence of cervical ectopy in a risk- and/or screening-based administration of antibiotic prophylaxis. Current phase II GBS vaccines (a trivalent vaccine targeting serotypes Ia, Ib, and III, and a conjugate vaccine targeting serotype III) would not protect the majority of women against carriage in our study population.	[Cools, Piet; Vaneechoutte, Mario] Univ Ghent, Fac Med & Hlth Sci, Dept Microbiol Immunol & Clin Chem, Lab Bacteriol Res, B-9000 Ghent, Belgium; [Jespers, Vicky; Hardy, Liselotte] Inst Trop Med, Dept Publ Hlth, Unit Epidemiol & Control HIV STD, B-2000 Antwerp, Belgium; [Crucitti, Tania] Inst Trop Med, Dept Clin Sci, HIV STI Reference Lab, B-2000 Antwerp, Belgium; [Delany-Moretlwe, Sinead] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Mwaura, Mary] ICRH Kenya, Mombasa, Kenya; [Ndayisaba, Gilles F.] Rinda Ubuzima, Kigali, Rwanda; [van de Wijgert, Janneke H. H. M.] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England	Ghent University; Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); University of Witwatersrand; University of Liverpool	Vaneechoutte, M (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Microbiol Immunol & Clin Chem, Lab Bacteriol Res, B-9000 Ghent, Belgium.	mario.vaneechoutte@ugent.be	Crucitti, Tania/AAB-9967-2019; Hardy, Liselotte/AAF-3515-2019; Crucitti, Tania/AEQ-9792-2022; Crucitti, Tania/AAH-1902-2021; Vaneechoutte, Mario/A-6189-2009	Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038; Vaneechoutte, Mario/0000-0002-4586-203X; Cools, Piet/0000-0003-2980-5307; Hardy, Liselotte/0000-0002-8785-5081; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	European & Developing Countries Clinical Trials Partnership [IP_2007_33070_001]	European & Developing Countries Clinical Trials Partnership	The project was funded by the European & Developing Countries Clinical Trials Partnership (IP_2007_33070_001, http://www.edctp.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta CD, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001672; Afshar B, 2011, J CLIN MICROBIOL, V49, P1475, DOI 10.1128/JCM.02365-10; Anderson S, 2013, AM J OBSTET GYNECOL, V208, pS326, DOI 10.1016/j.ajog.2012.10.115; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; BAKER CJ, 1975, AM J OBSTET GYNECOL, V122, P820, DOI 10.1016/0002-9378(75)90721-8; BAKER CJ, 1977, J INFECT DIS, V135, P392, DOI 10.1093/infdis/135.3.392; Bayo M., 2002, International Microbiology, V5, P87, DOI 10.1007/s10123-002-0064-1; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Beigi RH, 2004, OBSTET GYNECOL, V104, P926, DOI 10.1097/01.AOG.0000140687.51048.73; Bergh K, 2004, INDIAN J MED RES, V119, P221; Brigtsen AK, 2015, J MICROBIOL METH, V108, P31, DOI 10.1016/j.mimet.2014.11.001; Capan M, 2012, WIEN KLIN WOCHENSCHR, V124, P14, DOI 10.1007/s00508-012-0239-5; Chase DJ, 2007, J CLIN MICROBIOL, V45, P1219, DOI 10.1128/JCM.02156-06; Chern EC, 2011, LETT APPL MICROBIOL, V52, P298, DOI 10.1111/j.1472-765X.2010.03001.x; Convert M, 2005, CLIN MICROBIOL INFEC, V11, P1022, DOI 10.1111/j.1469-0691.2005.01275.x; Cotch MF, 1998, AM J OBSTET GYNECOL, V178, P374, DOI 10.1016/S0002-9378(98)80028-8; Cutland CL, 2012, PEDIATRICS, V130, pE581, DOI 10.1542/peds.2011-1548; Cutland CL, 2009, LANCET, V374, P1909, DOI 10.1016/S0140-6736(09)61339-8; DAVIDPRINCE M, 1991, B SOC PATHOL EXOT, V84, P522; Davies HD, 2004, CLIN INFECT DIS, V39, P1129, DOI 10.1086/424518; DAWODU AH, 1983, TROP GEOGR MED, V35, P145; De Luca Brunori I., 1994, Clinical and Experimental Obstetrics and Gynecology, V21, P105; de Steenwinkel FDO, 2008, TROP MED INT HEALTH, V13, P427, DOI 10.1111/j.1365-3156.2008.02018.x; Dzowela T, 2005, MALAWI MED J, V17, P97, DOI 10.4314/mmj.v17i3.10888; Villar HE, 2013, J CHEMOTHERAPY, V25, P324, DOI 10.1179/1973947813Y.0000000081; EKWEMPU CC, 1981, J CLIN PATHOL, V34, P82, DOI 10.1136/jcp.34.1.82; El Aila NA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-285; El Aila NA, 2011, RES MICROBIOL, V162, P499, DOI 10.1016/j.resmic.2011.04.001; Eschenbach DA, 2001, J INFECT DIS, V183, P913, DOI 10.1086/319251; Foxman B, 2007, ANN EPIDEMIOL, V17, P854, DOI 10.1016/j.annepidem.2007.05.014; Foxman B, 2006, AM J EPIDEMIOL, V163, P544, DOI 10.1093/aje/kwj075; Foxman B, 2008, J INFECT DIS, V198, P1375, DOI 10.1086/592221; Gautam R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0831-1; Ghanem KG, 2005, SEX TRANSM INFECT, V81, P421, DOI 10.1136/sti.2004.013193; Ghartey JP, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.025; Gray KJ, 2011, EMERG INFECT DIS, V17, P1932, DOI 10.3201/eid1710.102008; Guiral E, 2011, FEMS MICROBIOL LETT, V314, P170, DOI 10.1111/j.1574-6968.2010.02160.x; Guiver M, 2001, J CLIN PATHOL, V54, P362, DOI 10.1136/jcp.54.5.362; Gupta C, 2004, J CLIN MICROBIOL, V42, P3975, DOI 10.1128/JCM.42.9.3975-3977.2004; Hadavand Shahrzad, 2015, Iran J Pathol, V10, P120; HASTINGS MJG, 1986, J INFECTION, V12, P23, DOI 10.1016/S0163-4453(86)94775-4; HILLIER SL, 1992, AM J OBSTET GYNECOL, V166, P938, DOI 10.1016/0002-9378(92)91368-K; Honig E, 2002, EUR J OBSTET GYN R B, V105, P177; Hornik CP, 2012, EARLY HUM DEV, V88, pS69, DOI 10.1016/S0378-3782(12)70019-1; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Iavazzo C, 2008, MED SCI MONITOR, V14, pCR228; Imperi M, 2010, J MICROBIOL METH, V80, P212, DOI 10.1016/j.mimet.2009.11.010; Ippolito DL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-336; Javanmanesh Forough, 2013, Med J Islam Repub Iran, V27, P7; Jespers V, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0825-z; Jespers V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109670; Joachim A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-437; Johri AK, 2006, NAT REV MICROBIOL, V4, P932, DOI 10.1038/nrmicro1552; Joubrel C, 2015, CLIN MICROBIOL INFEC, V21, P910, DOI 10.1016/j.cmi.2015.05.039; Kaliterna V, 2011, J OBSTET GYNAECOL RE, V37, P1035, DOI 10.1111/j.1447-0756.2010.01480.x; Karou Simplice D., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P294, DOI 10.1016/S2221-1691(12)60025-2; Kazi YF, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-22; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kim EJ, 2011, EPIDEMIOL HEALTH, V33, DOI 10.4178/epih/e2011010; Krohn MA, 1997, J INFECT DIS, V175, P606, DOI 10.1093/infdis/175.3.606; Kwatra G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098778; Kyongo JK, 2015, CLIN VACCINE IMMUNOL, V22, P526, DOI 10.1128/CVI.00762-14; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lee V, 2006, J FAM PLAN REPROD H, V32, P104, DOI 10.1783/147118906776276440; Lobos O, 2009, MICROBIOL-SGM, V155, P825, DOI 10.1099/mic.0.021733-0; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Macaluso M, 1999, CONTRACEPTION, V59, P195, DOI 10.1016/S0010-7824(99)00013-X; Madzivhandila M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017861; Mavenyengwa RT, 2010, ACTA OBSTET GYN SCAN, V89, P250, DOI 10.3109/00016340903398029; Melin P, 2013, VACCINE, V31, pD31, DOI 10.1016/j.vaccine.2013.05.012; Mitima KT, 2014, J INFECT DEV COUNTR, V8, P1195, DOI 10.3855/jidc.5030; Mobasheri M, 2014, TURK J MED SCI, V44, P232, DOI 10.3906/sag-1208-33; Moyo S. R., 2000, Central African Journal of Medicine, V46, P115; NATHOO KJ, 1990, CENT AFR J MED, V36, P150; Nikolaitchouk N, 2008, APMIS, V116, P263, DOI 10.1111/j.1600-0463.2008.00808.x; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Obata-Yasuoka M, 2002, MICROBIOL-SGM, V148, P2745, DOI 10.1099/00221287-148-9-2745; Ocak S, 2007, SAUDI MED J, V28, P727; Ohlsson A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007467.pub4; ONILE BA, 1980, T ROY SOC TROP MED H, V74, P367, DOI 10.1016/0035-9203(80)90102-9; PERCIVALSMITH R, 1983, CONTRACEPTION, V27, P497, DOI 10.1016/0010-7824(83)90046-X; Poyart C, 2007, J CLIN MICROBIOL, V45, P1985, DOI 10.1128/JCM.00159-07; Rabe LK, 2003, J CLIN MICROBIOL, V41, P3260, DOI 10.1128/JCM.41.7.3260-3264.2003; Rallu F, 2006, J CLIN MICROBIOL, V44, P725, DOI 10.1128/JCM.44.3.725-728.2006; Ravel J, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-29; Razzak MSA, 2011, N AM J MED SCI, V3, P185, DOI 10.4297/najms.2011.3185; Regan JA, 1996, AM J OBSTET GYNECOL, V174, P1354, DOI 10.1016/S0002-9378(96)70684-1; REGAN JA, 1991, OBSTET GYNECOL, V77, P604; Rocchetti TT, 2011, ARCH GYNECOL OBSTET, V283, P717, DOI 10.1007/s00404-010-1439-8; Rocha-Zavaleta L, 2004, INT J GYNECOL OBSTET, V85, P259, DOI 10.1016/j.ijgo.2003.10.002; Sagna T, 2010, Pak J Biol Sci, V13, P951, DOI 10.3923/pjbs.2010.951.955; Schellenberg JJ, 2011, APPL ENVIRON MICROB, V77, P4066, DOI 10.1128/AEM.02943-10; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Schwandt M, 2006, SEX TRANSM INFECT, V82, P392, DOI 10.1136/sti.2006.019794; Simonsen KA, 2014, CLIN MICROBIOL REV, V27, P21, DOI 10.1128/CMR.00031-13; Stokholm J, 2014, CLIN MICROBIOL INFEC, V20, P629, DOI 10.1111/1469-0691.12411; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Stoll BJ, 1998, PEDIATR INFECT DIS J, V17, P499, DOI 10.1097/00006454-199806000-00013; SUARA RO, 1994, J INFECT DIS, V170, P1316, DOI 10.1093/infdis/170.5.1316; Tameliene R, 2012, MEDICINA-LITHUANIA, V48, P71, DOI 10.3390/medicina48020013; Valkenburg-van den Berg AW, 2006, EUR J OBSTET GYN R B, V124, P178, DOI 10.1016/j.ejogrb.2005.06.007; van de Wijgert JHHM, 2000, J INFECT DIS, V181, P587, DOI 10.1086/315227; Veldhuijzen NJ, 2011, SEX HEALTH, V8, P251, DOI 10.1071/SH10047; Venkatesh KK, 2013, AM J REPROD IMMUNOL, V69, P68, DOI 10.1111/aji.12029; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Wakkee M, 2014, J INVEST DERMATOL, V134, DOI 10.1038/jid.2014.132; Yao KH, 2013, J CLIN MICROBIOL, V51, P503, DOI 10.1128/JCM.02417-12	109	46	51	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0148052	10.1371/journal.pone.0148052	http://dx.doi.org/10.1371/journal.pone.0148052			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811897	Green Published, gold			2022-12-26	WOS:000369528000074
J	Anan, M; Shinkoda, K; Suzuki, K; Yagi, M; Kito, N				Anan, Masaya; Shinkoda, Koichi; Suzuki, Kentaro; Yagi, Masahide; Kito, Nobuhiro			Dynamic Frequency Analyses of Lower Extremity Muscles during Sit-To-Stand Motion for the Patients with Knee Osteoarthritis	PLOS ONE			English	Article							QUADRICEPS STRENGTH; BIARTICULAR MUSCLES; FIBER TYPE; ELECTROMYOGRAM; WOMEN; STRATEGIES; MOVEMENT; SPECTRUM; FATIGUE; FORCE	Objective Muscle activities during the sit-to-stand motion (STS) are characterized by coordinated movements between hip extensors and knee extensors. However, previous reports regarding the STS and lower extremity muscle activities have focused on some quantitative assessment, but little qualitative research. This study aimed to examine the muscle activities of the lower extremity both quantitatively and qualitatively. Methods Study participants included 13 patients with knee osteoarthritis (knee OA) and 11 age-matched asymptomatic controls. The task was STS from a chair with a height-adjustable seat. EMG activities were acquired using surface electromyogram. The root mean square signals normalized as a percentage of maximum voluntary isometric contraction values (RMS% MVC) and the mean power frequency (MPF) were calculated. Results During STS, knee OA patients had increased RMS% MVC of the vastus medialis and raised MPF of the rectus femoris before buttocks-off. Conclusion These findings suggest that STS of knee OA patients not only increased relative muscle activity of the vastus medialis, but also enlisted the rectus femoris in knee extension to improve muscle contraction force by activating more type II fibers to accomplish buttocks-off.	[Anan, Masaya; Shinkoda, Koichi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biomech, Hiroshima Shi, Hiroshima, Japan; [Anan, Masaya; Shinkoda, Koichi] Hiroshima Univ, Ctr Adv Practice & Res Rehabil, Hiroshima Shi, Hiroshima, Japan; [Suzuki, Kentaro] Nagoya Univ Hosp, Nagoya Shi, Nagoya, Aichi, Japan; [Yagi, Masahide] Midorii Orthopaed Joint Reconstruct & Arthroscopy, Hiroshima Shi, Hiroshima, Japan; [Kito, Nobuhiro] Hiroshima Int Univ, Higashihiroshima, Hiroshima, Japan	Hiroshima University; Hiroshima University; Nagoya University	Anan, M (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biomech, Hiroshima Shi, Hiroshima, Japan.; Anan, M (corresponding author), Hiroshima Univ, Ctr Adv Practice & Res Rehabil, Hiroshima Shi, Hiroshima, Japan.	anan@hiroshima-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [21700532]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This is a part of the studies supported by grant-in-aid (21700532) by Japan Society for the Promotion of Science (JSPS). https://kaken.nii.ac.jp/d/p/21700532.en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN RD, 1987, J RHEUMATOL, V14, P3; Anan M, 2015, GAIT POSTURE, V41, P488, DOI 10.1016/j.gaitpost.2014.11.015; Andriacchi TP, 2009, J BONE JOINT SURG AM, V91A, P95, DOI 10.2106/JBJS.H.01408; BARRETT DS, 1991, J BONE JOINT SURG BR, V73, P53, DOI 10.1302/0301-620X.73B1.1991775; Bernardi M, 1997, Electromyogr Clin Neurophysiol, V37, P3; Bouchouras G, 2015, CLIN BIOMECH, V30, P599, DOI 10.1016/j.clinbiomech.2015.03.025; Cruz-Martinez A, 2000, EUR NEUROL, V43, P110, DOI 10.1159/000008145; GERDLE B, 1991, ACTA PHYSIOL SCAND, V142, P457, DOI 10.1111/j.1748-1716.1991.tb09180.x; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; Hislop H., 2013, DANIELS WORTHINGHAMS; HODGE E, 1989, TRANSPL P, V21, P1609; Hortobagyi T, 2000, J ELECTROMYOGR KINES, V10, P117, DOI 10.1016/S1050-6411(99)00026-7; Hortobagyi T, 2004, ARTHRITIS RHEUM, V51, P562, DOI [10.1002/art.20545, DOI 10.1002/ART.20545]; Hughes MA, 1996, J BIOMECH, V29, P1509, DOI 10.1016/0021-9290(96)00083-8; Hunter DJ, 2009, J BONE JOINT SURG AM, V91A, P85, DOI 10.2106/JBJS.H.01409; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Jones EJ, 2008, SPORTS MED, V38, P987, DOI 10.2165/00007256-200838120-00003; Kato H, 2009, MED BIOL, V152, P480; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; KOMI PV, 1979, EUR J APPL PHYSIOL, V42, P41, DOI 10.1007/BF00421103; KUMAMOTO M, 1994, HUM MOVEMENT SCI, V13, P611, DOI 10.1016/0167-9457(94)90009-4; KUPA EJ, 1995, J APPL PHYSIOL, V79, P23, DOI 10.1152/jappl.1995.79.1.23; LIPPOLD OCJ, 1952, J PHYSIOL-LONDON, V117, P492, DOI 10.1113/jphysiol.1952.sp004763; LUTZ GE, 1993, J BONE JOINT SURG AM, V75A, P732, DOI 10.2106/00004623-199305000-00014; McCartney N, 1986, HUMAN MUSCLE POWER; McHugh M, 2001, J ORTHOP SPORT PHYS, V31, P25, DOI 10.2519/jospt.2001.31.1.25; MILLINGTON PJ, 1992, ARCH PHYS MED REHAB, V73, P609; Miura H, 2009, KNEE, V16, P30, DOI 10.1016/j.knee.2008.09.003; MORITANI T, 1987, EUR J APPL PHYSIOL, V56, P260, DOI 10.1007/BF00690890; Muller W, 2012, SURG ARTHROSCOPY KNE, DOI [10.1007/978-3-642-72782-5, DOI 10.1007/978-3-642-72782-5]; NAGATA Akira, 1982, JAPANESE J ERGONOMIC, V18, P35, DOI [DOI 10.5100/JJE.18.35, 10.5100/jje.18.35]; OKADA Y, 1989, Hiroshima Journal of Medical Sciences, V38, P13; PAI YC, 1990, MED SCI SPORT EXER, V22, P378; Palmieri-Smith RM, 2010, AM J PHYS MED REHAB, V89, P541, DOI 10.1097/PHM.0b013e3181ddd5c3; Patsika G, 2011, J ELECTROMYOGR KINES, V21, P689, DOI 10.1016/j.jelekin.2011.05.006; Riley P O, 1997, IEEE Trans Rehabil Eng, V5, P353, DOI 10.1109/86.650289; Robertson GE., 2004, RES METHODS BIOMECHA; ROEBROECK ME, 1994, CLIN BIOMECH, V9, P235, DOI 10.1016/0268-0033(94)90004-3; SCHENAU GJV, 1990, NETH J ZOOL, V40, P521; Schenkman M, 1996, J AM GERIATR SOC, V44, P1441, DOI 10.1111/j.1532-5415.1996.tb04068.x; SCHENKMAN M, 1990, PHYS THER, V70, P638, DOI 10.1093/ptj/70.10.638; SENIAM, 2011, REC SENS LOC HIP UPP; Sharma L, 2003, ANN INTERN MED, V138, P613, DOI 10.7326/0003-4819-138-8-200304150-00006; SOLOMONOW M, 1990, J APPL PHYSIOL, V68, P1177, DOI 10.1152/jappl.1990.68.3.1177; Westbury J R, 1987, Electromyogr Clin Neurophysiol, V27, P427	45	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147496	10.1371/journal.pone.0147496	http://dx.doi.org/10.1371/journal.pone.0147496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807578	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800112
J	Broucqsault-Dedrie, C; De Jonckheere, J; Jeanne, M; Nseir, S				Broucqsault-Dedrie, Celine; De Jonckheere, Julien; Jeanne, Mathieu; Nseir, Saad			Measurement of Heart Rate Variability to Assess Pain in Sedated Critically Ill Patients: A Prospective Observational Study	PLOS ONE			English	Article							ANALGESIA-NOCICEPTION INDEX; POSTOPERATIVE PAIN; AGITATION	Introduction The analgesia nociception index (ANI) assesses the relative parasympathetic tone as a surrogate for antinociception/nociception balance in sedated patients. The aim of this study is to determine the effectiveness of ANI in detecting pain in deeply sedated critically ill patients. Methods This prospective observational study was performed in two medical ICUs. All patients receiving invasive mechanical ventilation and deep sedation were eligible. In all patients, heart rate and ANI were continuously recorded using the Physiodoloris (R) device during 5 minutes at rest (T1), during a painful stimulus (T2), and during 5 minutes after the end of the painful stimulus (T3). The chosen painful stimulus was patient turning for washstand. Pain was evaluated at T2, using the behavioral pain scale (BPS). The primary objective was to determine the effectiveness of ANI in detecting pain. Secondary objectives included the impact of norepinephrine on the effectiveness of ANI in detecting pain, and the correlation between ANI and BPS. Results Forty-one patients were included. ANI was significantly lower at T2 (Med (IQR) 69(55-78)) compared with T1 (85(67-96), p<0.0001), or T3 (81(63-89), p<0.0001). Similar results were found in the subgroups of patients with (n = 21) or without (n = 20) norepinephrine. ANI values were significantly higher in patients with norepinephrine compared with those without norepinephrine at T1, and T2. No significant correlation was found between ANI and BPS at T2. Conclusions ANI is effective in detecting pain in deeply sedated critically ill patients, including those patients treated with norepinephrine. No significant correlation was found between ANI and BPS.	[Broucqsault-Dedrie, Celine] Hop Victor Provo, Intens Care Unit, CS 60359, 35 Rue Barbieux, F-59056 Roubaix, France; [De Jonckheere, Julien; Jeanne, Mathieu] CHU Lille, Clin Invest Ctr Innovat Technol, INSERM CIC IT 1403, F-59000 Lille, France; [Jeanne, Mathieu] CHU Lille, Anesthesia & Surg Crit Care Dept, F-59000 Lille, France; [Nseir, Saad] CHU Lille, Crit Care Ctr, F-59000 Lille, France; [Nseir, Saad] Univ Lille, Sch Med, F-59000 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Franche-Comte; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Nseir, S (corresponding author), CHU Lille, Crit Care Ctr, F-59000 Lille, France.; Nseir, S (corresponding author), Univ Lille, Sch Med, F-59000 Lille, France.	s-nseir@chru-lille.fr		Nseir, Saad/0000-0002-7618-0357				Ahmad S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006642; Appelhans BM, 2008, BIOL PSYCHOL, V77, P174, DOI 10.1016/j.biopsycho.2007.10.004; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Benarroch EE, 2006, NEUROL SCI, V27, pS130, DOI 10.1007/s10072-006-0587-x; Benchetrit G, 2003, REV MAL RESPIR, V20, P978; Boselli E, 2013, BRIT J ANAESTH, V111, P453, DOI 10.1093/bja/aet110; Camm AJ, 1996, CIRCULATION, V93, P1043; Chanques G, 2014, CRIT CARE, V18, DOI 10.1186/cc14000; De Jonghe B, 2003, CRIT CARE MED, V31, P2344, DOI 10.1097/01.CCM.0000084850.16444.94; Demaree HA, 2004, BRAIN COGNITION, V56, P14, DOI 10.1016/j.bandc.2004.05.001; Greisen J, 2001, ANESTHESIOLOGY, V95, P578, DOI 10.1097/00000542-200109000-00007; Jaber S, 2005, CHEST, V128, P2749, DOI 10.1378/chest.128.4.2749; Jeanne M, 2012, J CLIN MONIT COMPUT, V26, P289, DOI 10.1007/s10877-012-9354-0; Jeanne M, 2014, CLIN J PAIN, V30, P1084, DOI 10.1097/AJP.0000000000000083; Jess G, 2016, EUR J ANAESTH, V33, P118, DOI 10.1097/EJA.0000000000000304; Le Guen M, 2012, INT J OBSTET ANESTH, V21, P146, DOI 10.1016/j.ijoa.2012.01.001; Logier R, 2004, P ANN INT IEEE EMBS, V26, P3937; Logier R, 2010, IEEE ENG MED BIO, P1194, DOI 10.1109/IEMBS.2010.5625971; Migeon A, 2013, PEDIATR ANESTH, V23, P1160, DOI 10.1111/pan.12243; Miu AC, 2009, AUTON NEUROSCI-BASIC, V145, P99, DOI 10.1016/j.autneu.2008.11.010; Page GG, 2001, PAIN, V90, P191, DOI 10.1016/S0304-3959(00)00403-6; Parati G, 2006, J APPL PHYSIOL, V101, P690, DOI 10.1152/japplphysiol.00584.2006; Payen JF, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0554-5; Payen JF, 2001, CRIT CARE MED, V29, P2258, DOI 10.1097/00003246-200112000-00004; Pumprla J, 2002, INT J CARDIOL, V84, P1, DOI 10.1016/S0167-5273(02)00057-8; Puntillo KA, 2014, AM J RESP CRIT CARE, V189, P39, DOI 10.1164/rccm.201306-1174OC; Robleda G, 2016, INTENS CARE MED, V42, P183, DOI 10.1007/s00134-015-4112-7; Robleda G, 2015, J ADV NURS, V71, P441, DOI 10.1111/jan.12513; Sabourdin N, 2013, PEDIATR ANESTH, V23, P149, DOI 10.1111/pan.12071; Skrobik Y, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-9	30	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147720	10.1371/journal.pone.0147720	http://dx.doi.org/10.1371/journal.pone.0147720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808971	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800194
J	Gong, Z; Tang, MM; Wu, XL; Phillips, N; Galkowski, D; Jarvis, GA; Fan, HZ				Gong, Zheng; Tang, M. Matt; Wu, Xueliang; Phillips, Nancy; Galkowski, Dariusz; Jarvis, Gary A.; Fan, Huizhou			Arginine- and Polyamine-Induced Lactic Acid Resistance in Neisseria gonorrhoeae	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; CHLAMYDIA-TRACHOMATIS; INFECTION; DISEASE; SEMEN; COLONIZATION; LACTOBACILLI; ASSOCIATION; PROTEINS; DIAMINES	Microbe-derived lactic acid protects women from pathogens in their genital tract. The purpose of this study was to determine lactic acid susceptibility of Neisseria gonorrhoeae, and identify potential acid resistance mechanisms present in this pathogen. Tested in vitro, lactic acid killed all 10 gonococcal strains analyzed in a low pH-dependent manner. Full inactivation occurred at pH 4.5. At low pH, lactic acid treatment resulted in the entry of the DNA-binding fluorochrome propidium iodide into the microbial cells, suggesting that hydrogen ions from lactic acid compromise the integrity of the bacterial cell wall/membrane. Most likely, hydrogen ions also inactivate intracellular proteins since arginine rendered significant protection against lactic acid presumably through action of the gonococcal arginine decarboxylase, an enzyme located in the bacterial cytoplasm. Surprisingly, arginine also lessened lactic acid-mediated cell wall/membrane disruption. This effect is probably mediated by agmatine, a triamine product of arginine decarboxylase, since agmatine demonstrated a stronger protective effect on GC than arginine at equal molar concentration. In addition to agmatine, diamines cadaverine and putrescine, which are generated by bacterial vaginosis-associated microbes, also induced significant resistance to lactic acid-mediated GC killing and cell wall/membrane disruption. These findings suggest that the arginine-rich semen protects gonococci through both neutralization-dependent and independent mechanisms, whereas polyamine-induced acid resistance contributes to the increased risk of gonorrhea in women with bacterial vaginosis.	[Gong, Zheng; Tang, M. Matt; Wu, Xueliang; Fan, Huizhou] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Wu, Xueliang] Hunan Univ Tradit Chinese Med, Affiliated Ningxiang Peoples Hosp, Dept Urol, Changsha, Hunan, Peoples R China; [Phillips, Nancy] Rutgers State Univ, Dept Obstet Gynecol & Reprod Sci, New Brunswick, NJ 08903 USA; [Phillips, Nancy] Rutgers State Univ, Womens Hlth Inst, New Brunswick, NJ 08903 USA; [Galkowski, Dariusz] New Jersey Dept Hlth, Publ Hlth & Environm Labs, Ewing, NJ USA; [Galkowski, Dariusz] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA; [Jarvis, Gary A.] Vet Affairs Med Ctr, Ctr Immunochem, San Francisco, CA 94121 USA; [Jarvis, Gary A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Hunan University of Chinese Medicine; Rutgers State University New Brunswick; Rutgers State University New Brunswick; New Jersey Department of Health & Senior Services; Rutgers State University New Brunswick; Rutgers State University Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Fan, HZ (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	fanhu@rwjms.rutgers.edu		FAN, HUIZHOU/0000-0002-4903-926X; Jarvis, Gary/0000-0002-7576-3702	National Institutes of Health grant [AI071954]; New Jersey Health Foundation Grant [PC7-13]; Hunan University of Traditional Chinese Medicine-affiliated Hospital; Hunan University of Traditional Chinese Medicine-affiliated Ningxiang People's Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071954, R33AI071954] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Health Foundation Grant; Hunan University of Traditional Chinese Medicine-affiliated Hospital; Hunan University of Traditional Chinese Medicine-affiliated Ningxiang People's Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health grant (grant number AI071954) and a New Jersey Health Foundation Grant (grant number PC7-13) to HF. XW was a recipient of an oversea research scholarship awarded by the Hunan University of Traditional Chinese Medicine-affiliated Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Ann E. Jerse for the kind supply of FA1090, Dr. Loren Runnels for giving us access to his fluorescence microscope equipped with an oil immersion objective, Drs. Theresa L. Chang, Gloria Bachmann and Lingli Tang for discussions and Mr. Malhar Desai for assistance in counting bacterial colonies. This work was supported by a National Institutes of Health grant (grant number AI071954) and a New Jersey Health Foundation Grant (grant number PC7-13) to HF. XW was a recipient of an oversea research scholarship awarded by the Hunan University of Traditional Chinese Medicine-affiliated Ningxiang People's Hospital.	Alakomi HL, 2000, APPL ENVIRON MICROB, V66, P2001, DOI 10.1128/AEM.66.5.2001-2005.2000; Aldunate M, 2013, J ANTIMICROB CHEMOTH, V68, P2015, DOI 10.1093/jac/dkt156; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; Center for Disease Control and Prevention, 2013, MMWR SURVEILL SUMM, V62, P424; Center for Disease Control and Prevention, 2014, CDC FACT SHEET; Centers For Disease Control and Prevention, 2015, SEX TRANSM DIS SURV; CHEN KCS, 1982, J INFECT DIS, V145, P337, DOI 10.1093/infdis/145.3.337; CHVAPIL M, 1978, OBSTET GYNECOL, V52, P88; Coconnier-Polter MH, 2005, APPL ENVIRON MICROB, V71, P6115, DOI 10.1128/AEM.71.10.6115-6120.2005; del Rio Carlos, 2012, Morbidity and Mortality Weekly Report, V61, P590; FAIR WR, 1972, FERTIL STERIL, V23, P38; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Gallo MF, 2012, ANN EPIDEMIOL, V22, P213, DOI 10.1016/j.annepidem.2011.11.005; Gong Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107758; Goytia M, 2010, INFECT IMMUN, V78, P3187, DOI 10.1128/IAI.01301-09; HILLIER SL, 1991, GENITOURIN MED, V67, P26; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; JERSE AE, 1994, J EXP MED, V179, P911, DOI 10.1084/jem.179.3.911; Kanjee U, 2013, ANNU REV MICROBIOL, V67, P65, DOI 10.1146/annurev-micro-092412-155708; Kieboom J, 2006, J BACTERIOL, V188, P5650, DOI 10.1128/JB.00323-06; Lefevre PLC, 2011, ENDOCR REV, V32, P694, DOI 10.1210/er.2011-0012; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; MARTIUS J, 1988, OBSTET GYNECOL, V71, P89; Mendonca K, 2015, NEW MICROBIOL, V38, P267; MIETTINEN A, 1990, SEX TRANSM DIS, V17, P10; Mitchell C, 2011, J CLIN MICROBIOL, V49, P735, DOI 10.1128/JCM.00991-10; Nelson TM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00253; O'Hanlon DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080074; Owen DH, 2005, J ANDROL, V26, P459, DOI 10.2164/jandrol.04104; Pettit RK, 1996, INFECT IMMUN, V64, P1039, DOI 10.1128/IAI.64.3.1039-1042.1996; Pettit RK, 2001, CAN J MICROBIOL, V47, P871, DOI 10.1139/cjm-47-9-871; Pettit RK, 1999, J MED MICROBIOL, V48, P149, DOI 10.1099/00222615-48-2-149; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; Richard HT, 2003, ADV APPL MICROBIOL, V52, P167, DOI 10.1016/S0065-2164(03)01007-4; Ronnqvist PDJ, 2006, ACTA OBSTET GYN SCAN, V85, P726, DOI 10.1080/00016340600578357; Schwebke JR, 2014, J INFECT DIS, V210, P338, DOI 10.1093/infdis/jiu089; Sewankambo N, 1997, LANCET, V350, P546, DOI 10.1016/S0140-6736(97)01063-5; Srinivasan S, 2015, MBIO, V6, DOI 10.1128/mBio.00204-15; STAMM WE, 1988, JAMA-J AM MED ASSOC, V260, P1429, DOI 10.1001/jama.260.10.1429; Tamrakar R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-128; Tsai MF, 2013, P NATL ACAD SCI USA, V110, P5893, DOI 10.1073/pnas.1301442110; WEIR SS, 1994, AIDS, V8, P1605, DOI 10.1097/00002030-199411000-00013; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; WILLIAMSON JD, 1984, NATURE, V310, P103, DOI 10.1038/310103a0; Zini A, 2001, UROLOGY, V58, P85, DOI 10.1016/S0090-4295(01)01001-9	47	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147637	10.1371/journal.pone.0147637	http://dx.doi.org/10.1371/journal.pone.0147637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808268	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800159
J	Wang, CC; Wang, YC; Wang, GJ; Shen, MY; Chang, YL; Liou, SY; Chen, HC; Chang, CT				Wang, Chun-Cheng; Wang, Yao-Chang; Wang, Guei-Jane; Shen, Ming-Yi; Chang, Yen-Lin; Liou, Show-Yih; Chen, Hung-Chih; Chang, Chiz-Tzung			Skin Autofluorescence Is Associated with Endothelial Dysfunction in Uremic Subjects on Hemodialysis	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; INTIMA-MEDIA THICKNESS; BRACHIAL-ARTERY; PENTOSIDINE; DISEASE; COMPLICATIONS; GLYCOXIDATION; ACCUMULATION; PRAVASTATIN; MORTALITY	Background Elevated levels of advanced glycation end products (AGEs) within tissues may contribute to endothelial dysfunction, an early indicator of atherosclerosis. We aimed to investigate whether levels of skin AGEs could be a useful marker to predict endothelial dysfunction in uremic subjects on hemodialysis. Methods and Results One hundred and nineteen uremic patients on hemodialysis and 57 control subjects with moderate-to-high cardiovascular risk factors and without chronic kidney disease (CKD) were enrolled. We used ultrasound tomeasure flow-mediated vasodilation (FMD). An AGE reader measured skin autoflurorescence (AF). We then compared differences in FMD and skin AF values between the two groups. The uremic subjects had significantly higher levels of skin AF (3.47 +/- 0.76 AU vs. 2.21 +/- 0.45 arbitrary units; P<0.01) and significantly lower levels of FMD (4.79%+/- 1.88% vs. 7.19%+/- 2.17%; P<0.01) than the non-CKD subjects. After adjusting for all potential covariates, we found that skin AF level independently predicted FMD in both the hemodialysis and the non-CKD groups. In the hemodialysis group, skin AF >= +/- 3.05 arbitrary units predicted abnormal FMD at a sensitivity of 87.9% and a specificity of 78.6%(P<0.01). Conclusions Skin AF could be a useful marker to predict endothelial dysfunction in uremic subjects on hemodialysis.	[Wang, Chun-Cheng; Wang, Guei-Jane; Shen, Ming-Yi] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Wang, Chun-Cheng] Buddhist Tzuchi Med Fdn, Taichung Tzuchi Hosp, Dept Internal Med, Div Cardiol, Taichung, Taiwan; [Wang, Yao-Chang] Chang Gung Mem Hosp, Keelung Branch, Div Cardiothorac Surg, Keelung, Taiwan; [Wang, Guei-Jane] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Wang, Guei-Jane] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Chang, Yen-Lin] Chung Yuan Christian Univ, Dept Biomed Engn, Taoyuan, Taiwan; [Liou, Show-Yih] Formosan Blood Purificat Fdn, Taipei, Taiwan; [Chen, Hung-Chih; Chang, Chiz-Tzung] China Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan; [Chang, Chiz-Tzung] China Med Univ, Coll Med, Taichung, Taiwan; [Wang, Chun-Cheng; Chang, Chiz-Tzung] China Med Univ Hosp, Cardiovas Res Lab, Taichung, Taiwan	China Medical University Taiwan; Chang Gung Memorial Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; Chung Yuan Christian University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chang, CT (corresponding author), China Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan.; Chang, CT (corresponding author), China Med Univ, Coll Med, Taichung, Taiwan.; Chang, CT (corresponding author), China Med Univ Hosp, Cardiovas Res Lab, Taichung, Taiwan.	d19863@mail.cmuh.org.tw	Shen, Ming-Yi/L-6861-2019	Shen, Ming-Yi/0000-0002-9351-1912; Chen, Hung-Chih/0000-0001-7666-9729	Tzu-chi General Hospital [TTCRD 103-16]; China Medical University Hospital [DMR-104-014]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]	Tzu-chi General Hospital; China Medical University Hospital; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study was supported by Taichung Tzu-chi General Hospital (grant number TTCRD 103-16), China Medical University Hospital (grant number DMR-104-014), Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019).	Brunet P, 2011, KIDNEY BLOOD PRESS R, V34, P284, DOI 10.1159/000327131; Contreras I, 1997, DIABETES CARE, V20, P832, DOI 10.2337/diacare.20.5.832; de Vos LC, 2013, ARTERIOSCL THROM VAS, V33, P131, DOI 10.1161/ATVBAHA.112.300016; Deng HF, 2005, ACTA PHARMACOL SIN, V26, P92, DOI 10.1111/j.1745-7254.2005.00013.x; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Iwamoto Y, 2012, ARTERIOSCL THROM VAS, V32, P2295, DOI 10.1161/ATVBAHA.112.249680; Jadoul M, 1999, KIDNEY INT, V55, P2487, DOI 10.1046/j.1523-1755.1999.00468.x; Kocak H, 2009, NEPHROLOGY, V14, P273, DOI 10.1111/j.1440-1797.2008.01062.x; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Miyata T, 2001, NEPHROL DIAL TRANSPL, V16, P8, DOI 10.1093/ndt/16.suppl_4.8; Miyazawa T, 2012, AMINO ACIDS, V42, P1163, DOI 10.1007/s00726-010-0772-3; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P567, DOI 10.1196/annals.1333.065; Monnier VM, 1999, DIABETES, V48, P870, DOI 10.2337/diabetes.48.4.870; Mulder DJ, 2009, NETH HEART J, V17, P162, DOI 10.1007/BF03086239; Mulder DJ, 2008, ATHEROSCLEROSIS, V197, P217, DOI 10.1016/j.atherosclerosis.2007.03.027; Nazratuna N, 2006, VASC MED, V11, P245, DOI 10.1177/1358863x06072202; Noordzij MJ, 2012, INT J CARDIOVAS IMAG, V28, P431, DOI 10.1007/s10554-011-9805-6; Parfrey PS, 1999, J AM SOC NEPHROL, V10, P1606; Raitakari OT, 2000, BRIT J CLIN PHARMACO, V50, P397, DOI 10.1046/j.1365-2125.2000.00277.x; Raj DSC, 2000, AM J KIDNEY DIS, V35, P365, DOI 10.1016/S0272-6386(00)70189-2; Sakata N, 2003, NEPHROL DIAL TRANSPL, V18, P1601, DOI 10.1093/ndt/gfg200; Schwedler SB, 2002, KIDNEY INT, V62, P301, DOI 10.1046/j.1523-1755.2002.00423.x; Shafi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126048; Shechter M, 2009, INT J CARDIOL, V134, P52, DOI 10.1016/j.ijcard.2008.01.021; Soro-Paavonen A, 2010, J HYPERTENS, V28, P780, DOI 10.1097/HJH.0b013e328335043e; Suliman ME, 2003, J AM SOC NEPHROL, V14, P1614, DOI 10.1097/01.ASN.0000067413.32377.CF; Tanaka K, 2012, DIABETIC MED, V29, P492, DOI 10.1111/j.1464-5491.2011.03448.x; Teragawa H, 2001, AM J CARDIOL, V88, P1147, DOI 10.1016/S0002-9149(01)02051-3; U. S. Renal Data system, 2015, USRDS 2013 ANN DAT R, V4, P2; Ueno H, 2008, METABOLISM, V57, P1452, DOI 10.1016/j.metabol.2008.05.016; Uydes-Dogan BS, 2005, LIFE SCI, V76, P1771, DOI 10.1016/j.lfs.2004.11.002; Wagner Z, 2006, AM J KIDNEY DIS, V47, P294, DOI 10.1053/j.ajkd.2005.10.010; Weiss MF, 2000, KIDNEY INT, V57, P2571, DOI 10.1046/j.1523-1755.2000.00117.x; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Zhou YL, 2010, ARTIF ORGANS, V34, P193, DOI 10.1111/j.1525-1594.2009.00801.x	37	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147771	10.1371/journal.pone.0147771	http://dx.doi.org/10.1371/journal.pone.0147771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809145	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800209
J	Workneh, MH; Bjune, GA; Yimer, SA				Workneh, Mahteme Haile; Bjune, Gunnar Aksel; Yimer, Solomon Abebe			Prevalence and Associated Factors of Diabetes Mellitus among Tuberculosis Patients in South-Eastern Amhara Region, Ethiopia: A Cross Sectional Study	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; CHALLENGES	Background The association between diabetes mellitus (DM) and tuberculosis (TB) is re-emerging worldwide. Recently, the prevalence of DM is increasing in resource poor countries where TB is of high burden. The objective of the current study was to determine the prevalence and analyze associated factors of TB and DM comorbidity in South-Eastern Amhara Region, Ethiopia. Methods This was a facility based cross-sectional study. All newly diagnosed TB patients attending selected health facilities in the study area were consecutively screened for DM. DM was diagnosed based on the World Health Organization diagnostic criteria. A pre-tested semi-structured questionnaire was used to collect socio-demographic, lifestyles and clinical data. Logistic regression analysis was performed to identify factors associated with TB and DM comorbidity. Result Among a total of 1314 patients who participated in the study, the prevalence of DM was estimated at 109 (8.3%). Being female [odds ratio (OR) 1.70; 95% confidence interval (CI) (1.10-2.62)], patients age [41-64 years (OR 3.35; 95% CI (2.01-5.57), 65-89 years (OR 3.18; 95% CI (1.52-6.64)], being a pulmonary TB case [(OR 1.69; 95% CI 1.09-2.63)] and having a family history of DM [(OR 4.54; 95% CI (2.36-8.73)] were associated factors identified with TB and DM comorbidity. Conclusion The prevalence of DM among TB patients in South-Eastern Amahra Region is high. Routine screening of TB patients for DM is recommended in the study area.	[Workneh, Mahteme Haile; Bjune, Gunnar Aksel; Yimer, Solomon Abebe] Univ Oslo, Inst Hlth & Soc, Fac Med, Oslo, Norway; [Workneh, Mahteme Haile; Yimer, Solomon Abebe] Amhara Reg State Hlth Bur, Bahir Dar, Ethiopia; [Yimer, Solomon Abebe] Oslo Univ Hosp, Dept Microbiol, Oslo, Norway; [Yimer, Solomon Abebe] Norwegian Inst Publ Hlth, Dept Bacteriol & Immunol, Oslo, Norway	University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH)	Workneh, MH (corresponding author), Univ Oslo, Inst Hlth & Soc, Fac Med, Oslo, Norway.; Workneh, MH (corresponding author), Amhara Reg State Hlth Bur, Bahir Dar, Ethiopia.	maykm24@yahoo.com			University of Oslo	University of Oslo	Funding support for the research was provided by the University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Achanta S, 2013, PUBLIC HEALTH ACTION, V3, pS43, DOI 10.5588/pha.13.0033; Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; Amare H, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-6; Amhara Regional State Health Bureau, 2007, ANN HLTH SERV REP; Amin S, 2011, GOMAL J MED SCI, V9, P163; [Anonymous], 2013, DIABETES ATLAS; Baghaei P, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-58; Balakrishnan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046502; Bukhary ZA, 2008, J TAIBAH UNIV MED SC, V3, P1; Castellanos-Joya M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106961; Chang JT, 2011, J FORMOS MED ASSOC, V110, P372, DOI 10.1016/S0929-6646(11)60055-7; Damtew E, 2014, WORLD J MED SCI, V11, P389; Dave P, 2013, PUBLIC HEALTH ACTION, V3, pS29, DOI 10.5588/pha.13.0027; Dyck RF, 2007, CAN J PUBLIC HEALTH, V98, P55, DOI 10.1007/BF03405386; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Federal Democratic Republic of Ethiopia, 2012, GUID CLIN PROGR MAN, P1; Getachew A., 2014, British Journal of Medicine and Medical Research, V4, P862; Guptan A, 2000, IND J TUB, V47, P1; Harries AD, 2013, PUBLIC HEALTH ACTION, V3, pS3, DOI 10.5588/pha.13.0024; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kalra S, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-2; Kapur A, 2009, EUREOPEAN ENDOCRINOL, V5, P10; Kibirige D, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-122; Kumar A, 2013, TROP MED INT HEALTH, V18, P636, DOI 10.1111/tmi.12084; Li L, 2012, TROP MED INT HEALTH, V17, P1294, DOI 10.1111/j.1365-3156.2012.03068.x; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; Martinez N, 2014, EUR J IMMUNOL, V44, P617, DOI 10.1002/eji.201344301; Naik B, 2013, PUBLIC HEALTH ACTION, V3, pS34, DOI 10.5588/pha.13.0022; Nair S, 2013, PUBLIC HEALTH ACTION, V3, pS38, DOI 10.5588/pha.13.0037; Nandakumar KV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076275; Ogbera Anthonia Okeoghene, 2014, Indian J Endocrinol Metab, V18, P475, DOI 10.4103/2230-8210.137488; Raghuraman S, 2014, N AM J MED SCI, V6, P30, DOI 10.4103/1947-2714.125863; Reid MJA, 2013, JEMDSA, V18, P135, DOI 10.1080/22201009.2013.10844551; Reis-Santos B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062604; Restrepo BI, 2007, EPIDEMIOL INFECT, V135, P483, DOI 10.1017/S0950268806006935; ReyPineda G.D, 2014, MYCOBACTERIAL DIS, V4, P2, DOI [10.4172/2161-1068.1000144, DOI 10.4172/2161-1068.1000144]; Rimpi Sangral, 2012, JK Science, V14, P177; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; Wang HT, 2014, THER CLIN RISK MANAG, V10, P45, DOI 10.2147/TCRM.S38872; Wang QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082660; World Health Organization, 2011, US GLYC HBA1C DIAGN, P1; World Health Organization, 2006, DEF DIAGN DIAB MELL; World Health Organization, 2014, GLOB TUB REP	43	38	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147621	10.1371/journal.pone.0147621	http://dx.doi.org/10.1371/journal.pone.0147621			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808967	Green Published, gold			2022-12-26	WOS:000369527800152
J	Paauwe, M; Heijkants, RC; Oudt, CH; van Pelt, GW; Cui, C; Theuer, CP; Hardwick, JCH; Sier, CFM; Hawinkels, LJAC				Paauwe, M.; Heijkants, R. C.; Oudt, C. H.; van Pelt, G. W.; Cui, C.; Theuer, C. P.; Hardwick, J. C. H.; Sier, C. F. M.; Hawinkels, L. J. A. C.			Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer	ONCOGENE			English	Article							TGF-BETA-RECEPTOR; MAMMARY-CARCINOMA; ENDOTHELIAL-CELLS; SOLID TUMORS; EXPRESSION; ANTIBODY; TRC105; BEVACIZUMAB; PROTEIN; NORMALIZATION	Endoglin, a transforming growth factor-beta co-receptor, is highly expressed on angiogenic endothelial cells in solid tumors. Therefore, targeting endoglin is currently being explored in clinical trials for anti-angiogenic therapy. In this project, the redundancy between endoglin and vascular endothelial growth factor (VEGF) signaling in angiogenesis and the effects of targeting both pathways on breast cancer metastasis were explored. In patient samples, increased endoglin signaling after VEGF inhibition was observed. In vitro TRC105, an endoglin-neutralizing antibody, increased VEGF signaling in endothelial cells. Moreover, combined targeting of the endoglin and VEGF pathway, with the VEGF receptor kinase inhibitor SU5416, increased antiangiogenic effects in vitro and in a zebrafish angiogenesis model. Next, in a mouse model for invasive lobular breast cancer, the effects of TRC105 and SU5416 on tumor growth and metastasis were explored. Although TRC105 and SU5416 decreased tumor vascular density, tumor volume was unaffected. Strikingly, in mice treated with TRC105, or TRC105 and SU5416 combined, a strong inhibition in the number of metastases was seen. Moreover, upon resection of the primary tumor, strong inhibition of metastatic spread by TRC105 was observed in an adjuvant setting. To confirm these data, we assessed the effects of endoglin-Fc (an endoglin ligand trap) on metastasis formation. Similar to treatment with TRC105 in the resection model, endoglin-Fc-expressing tumors showed strong inhibition of distant metastases. These results show, for the first time, that targeting endoglin, either with neutralizing antibodies or a ligand trap, strongly inhibits metastatic spread of breast cancer in vivo.	[Paauwe, M.; Heijkants, R. C.; Oudt, C. H.; Cui, C.; Hawinkels, L. J. A. C.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Paauwe, M.; Hardwick, J. C. H.; Sier, C. F. M.; Hawinkels, L. J. A. C.] Leiden Univ, Med Ctr, Dept Gastroenterol Hepatol, Leiden, Netherlands; [van Pelt, G. W.; Sier, C. F. M.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Theuer, C. P.] Tracon Pharmaceut, San Diego, CA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hawinkels, LJAC (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol & Gastroenterol Hepatol, Bldg 1,C4-P,POB 9600, NL-2300 RC Leiden, Netherlands.	L.J.A.C.Hawinkels@LUMC.nl	Hawinkels, Lukas/Q-5098-2019; Sier, Cornelis/A-7664-2008; Paauwe, Madelon/C-8244-2018; Hardwick, James/J-4862-2013	Hawinkels, Lukas/0000-0002-2274-9325; Sier, Cornelis/0000-0002-4337-2758; Hardwick, James/0000-0002-9575-5099	Alpe d'huZes/Bas Mulder award [UL2011-5051]; Tracon Pharmaceuticals	Alpe d'huZes/Bas Mulder award; Tracon Pharmaceuticals	We thank Jos Jonkers (Netherlands Cancer Institute, Amsterdam) for providing the KEP1-11 mouse breast cancer cells, Midory Thorikay for generating Fc and endoglin-Fc lentiviral expression constructs, Henry Cheung and Gabri van der Pluijm for practical help in establishing the in vivo model and Peter ten Dijke, Hans van Dam and Marie-Jose Goumans (Leiden University Medical Center) for valuable discussions. This work was supported by the Alpe d'huZes/Bas Mulder award 2011 (UL2011-5051) to LJACH and MP and by a sponsored research grant from Tracon Pharmaceuticals.	Anderberg C, 2013, J EXP MED, V210, P563, DOI 10.1084/jem.20120662; Aristorena M, 2014, J CELL SCI, V127, P2723, DOI 10.1242/jcs.143644; Arjaans M, 2013, CANCER RES, V73, P3347, DOI 10.1158/0008-5472.CAN-12-3518; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Buijs JT, 2015, J PATHOL, V235, P745, DOI 10.1002/path.4488; Burrows FJ, 1995, CLIN CANCER RES, V1, P1623; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Charpin-Taranger C, 2003, B ACAD NAT MED PARIS, V187, P1129, DOI 10.1016/S0001-4079(19)33943-3; de Kruijf EM, 2013, ANN ONCOL, V24, P384, DOI 10.1093/annonc/mds333; Dekker TJA, 2013, BREAST CANCER RES TR, V139, P371, DOI 10.1007/s10549-013-2571-5; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; FOLKMAN J, 1966, ANN SURG, V164, P491, DOI 10.1097/00000658-196609000-00012; Fonsatti E, 2000, CLIN CANCER RES, V6, P2037; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Gordon MS, 2014, CLIN CANCER RES, V20, P5918, DOI 10.1158/1078-0432.CCR-14-1143; Hawinkels L. J., 2015, CLIN CANC RES; Hawinkels LJAC, 2007, BRIT J CANCER, V97, P398, DOI 10.1038/sj.bjc.6603877; Hawinkels LJAC, 2014, ONCOGENE, V33, P97, DOI 10.1038/onc.2012.536; Hawinkels LJAC, 2008, EUR J CANCER, V44, P1904, DOI 10.1016/j.ejca.2008.06.031; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Henry LA, 2011, ONCOGENE, V30, P1046, DOI 10.1038/onc.2010.488; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Jerkic M, 2015, FASEB J, V29, P3678, DOI 10.1096/fj.14-269258; Karzai FH, 2015, BJU INT, V116, P546, DOI 10.1111/bju.12986; Khamis ZI, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/574025; LASTRES P, 1992, EUR J IMMUNOL, V22, P393, DOI 10.1002/eji.1830220216; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Liu YM, 2014, INVEST NEW DRUG, V32, P851, DOI 10.1007/s10637-014-0129-y; Liu YM, 2014, CANCER MED-US, V3, P580, DOI 10.1002/cam4.207; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Miller DW, 1999, INT J CANCER, V81, P568, DOI 10.1002/(SICI)1097-0215(19990517)81:4<568::AID-IJC11>3.3.CO;2-O; Nolan-Stevaux O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050920; Paauwe M, 2013, EXPERT OPIN THER TAR, V17, P421, DOI 10.1517/14728222.2013.758716; Pan CC, 2014, J BIOL CHEM, V289, P25486, DOI 10.1074/jbc.M114.578609; Perez-Gomez E, 2010, THESCIENTIFICWORLDJO, V10, P2367, DOI 10.1100/tsw.2010.230; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Romero D, 2011, CANCER RES, V71, P3482, DOI 10.1158/0008-5472.CAN-10-2665; Rosen LS, 2012, CLIN CANCER RES, V18, P4820, DOI 10.1158/1078-0432.CCR-12-0098; Seon BK, 2011, CURR DRUG DELIV, V8, P135; Sitohy B, 2012, CANCER RES, V72, P1909, DOI 10.1158/0008-5472.CAN-11-3406; Sounni NE, 2014, CELL METAB, V20, P280, DOI 10.1016/j.cmet.2014.05.022; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsujie M, 2008, INT J CANCER, V122, P2266, DOI 10.1002/ijc.23314; van Baardewijk LJ, 2013, INT ORTHOP, V37, P523, DOI 10.1007/s00264-012-1750-z; Zijlmans HJ, 2009, BRIT J CANCER, V100, P1617, DOI 10.1038/sj.bjc.6605009	48	44	48	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 4	2016	35	31					4069	4079		10.1038/onc.2015.509	http://dx.doi.org/10.1038/onc.2015.509			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8GG	26804178	Green Published			2022-12-26	WOS:000381020900005
J	Du, L; Ma, L; Qi, FF; Zheng, XL; Jiang, CY; Li, AL; Wan, XB; Liu, SJ; Li, SY				Du, Lei; Ma, Li; Qi, Feifei; Zheng, Xianliang; Jiang, Chengying; Li, Ailei; Wan, Xiaobo; Liu, Shuang-Jiang; Li, Shengying			Characterization of a Unique Pathway for 4-Cresol Catabolism Initiated by Phosphorylation in Corynebacterium glutamicum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biodegradation; cytochrome P450; gram-positive bacteria; microbiology; phosphorylation; 4-cresol; Corynebacterium glutamicum	P-CRESOL METHYLHYDROXYLASE; BETA-KETOADIPATE PATHWAY; PSEUDOMONAS-PUTIDA; TRANSCRIPTIONAL REGULATION; GENETIC-CHARACTERIZATION; ANAEROBIC DEGRADATION; AROMATIC-COMPOUNDS; PHENOL METABOLISM; STRAIN; ACID	4-Cresol is not only a significant synthetic intermediate for production of many aromatic chemicals, but also a priority environmental pollutant because of its toxicity to higher organisms. In our previous studies, a gene cluster implicated to be involved in 4-cresol catabolism, creCDEFGHIR, was identified in Corynebacterium glutamicum and partially characterized in vivo. In this work, we report on the discovery of a novel 4-cresol biodegradation pathway that employs phosphorylated intermediates. This unique pathway initiates with the phosphorylation of the hydroxyl group of 4-cresol, which is catalyzed by a novel 4-methylbenzyl phosphate synthase, CreHI. Next, a unique class I P450 system, CreJEF, specifically recognizes phosphorylated intermediates and successively oxidizes the aromatic methyl group into carboxylic acid functionality via alcohol and aldehyde intermediates. Moreover, CreD (phosphohydrolase), CreC (alcohol dehydrogenase), and CreG (aldehyde dehydrogenase) were also found to be required for efficient oxidative transformations in this pathway. Steady-state kinetic parameters (K-m and k(cat)) for each catabolic step were determined, and these results suggest that kinetic controls serve a key role in directing the metabolic flux to the most energy effective route.	[Du, Lei; Ma, Li; Qi, Feifei; Zheng, Xianliang; Li, Shengying] Chinese Acad Sci, CAS Key Lab Biofuels, Shandong Prov Key Lab Synthet Biol, Qingdao 266101, Shandong, Peoples R China; [Li, Ailei; Wan, Xiaobo] Chinese Acad Sci, CAS Key Lab Biobased Mat, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao 266101, Shandong, Peoples R China; [Du, Lei; Zheng, Xianliang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Jiang, Chengying; Liu, Shuang-Jiang] Chinese Acad Sci, State Key Lab Microbial Resources, Inst Microbiol, Beijing 100101, Peoples R China; [Jiang, Chengying; Liu, Shuang-Jiang] Chinese Acad Sci, Environm Microbiol & Biotechnol Res Ctr, Inst Microbiol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Li, SY (corresponding author), Chinese Acad Sci, CAS Key Lab Biofuels, Shandong Prov Key Lab Synthet Biol, Qingdao 266101, Shandong, Peoples R China.; Liu, SJ (corresponding author), Chinese Acad Sci, State Key Lab Microbial Resources, Inst Microbiol, Beijing 100101, Peoples R China.; Liu, SJ (corresponding author), Chinese Acad Sci, Environm Microbiol & Biotechnol Res Ctr, Inst Microbiol, Beijing 100101, Peoples R China.	liusj@im.ac.cn; lishengying@qibebt.ac.cn	Liu, Shuang-Jiang/E-5756-2013		National Natural Science Foundation of China [NSFC 31422002]; Shandong Provincial Natural Science Foundation [JQ201407]; Recruitment Program of Global Experts; 973 Project from Ministry of Science and Technology [2012CB7211-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Recruitment Program of Global Experts; 973 Project from Ministry of Science and Technology(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China under Grant NSFC 31422002 and Shandong Provincial Natural Science Foundation Grant JQ201407, and the funding from Recruitment Program of Global Experts (to S. L.) and 973 Project from Ministry of Science and Technology Grant 2012CB7211-04 (to S.-J. L.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 2008, TOX PROF CRES; Anzai Y, 2008, CHEM BIOL, V15, P950, DOI 10.1016/j.chembiol.2008.07.014; Ault A, 2004, J CHEM EDUC, V81, P347, DOI 10.1021/ed081p347; Back K. C., 1972, RECLASSIFICATION MAT; Becker J, 2011, METAB ENG, V13, P159, DOI 10.1016/j.ymben.2011.01.003; Bernhardt R, 2014, APPL MICROBIOL BIOT, V98, P6185, DOI 10.1007/s00253-014-5767-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breinig S, 2000, J BACTERIOL, V182, P5849, DOI 10.1128/JB.182.20.5849-5863.2000; Brinkrolf K, 2006, GENET MOL RES, V5, P773; Butler JE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-180; Carlson JC, 2011, NAT CHEM, V3, P628, DOI [10.1038/NCHEM.1087, 10.1038/nchem.1087]; Chaudhry MT, 2007, MICROBIOL-SGM, V153, P857, DOI 10.1099/mic.0.2006/002501-0; Chen YF, 2014, APPL MICROBIOL BIOT, V98, P1349, DOI 10.1007/s00253-013-5001-z; Cho AR, 2011, J MICROBIOL BIOTECHN, V21, P1179, DOI 10.4014/jmh.1104.04006; Cunane LM, 2000, J MOL BIOL, V295, P357, DOI 10.1006/jmbi.1999.3290; CURTIUS HC, 1976, J CHROMATOGR, V126, P569, DOI 10.1016/S0021-9673(01)84102-9; Di Gioia D, 2011, J BIOTECHNOL, V156, P309, DOI 10.1016/j.jbiotec.2011.08.014; Ding W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08044; Efimov I, 2004, BIOCHEMISTRY-US, V43, P6138, DOI 10.1021/bi035772x; Fiege H, 2000, ULLMANNS ENCY IND CH; Green MR, 2012, MOL CLONING LAB MANU, V1; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Hanukoglu I., 1996, ADV MOL CELL BIOL; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; HOPPER DJ, 1991, J BACTERIOL, V173, P1298, DOI 10.1128/JB.173.3.1298-1301.1991; Huang Y, 2008, APPL MICROBIOL BIOT, V78, P75, DOI 10.1007/s00253-007-1286-0; Huang Y, 2006, APPL ENVIRON MICROB, V72, P7238, DOI 10.1128/AEM.01494-06; Ikeda M, 2006, J IND MICROBIOL BIOT, V33, P610, DOI 10.1007/s10295-006-0104-5; Joesaar M, 2010, FEMS MICROBIOL ECOL, V72, P464, DOI 10.1111/j.1574-6941.2010.00858.x; Johannes J, 2008, J BACTERIOL, V190, P6493, DOI 10.1128/JB.00790-08; Jojima T, 2010, APPL MICROBIOL BIOT, V87, P159, DOI 10.1007/s00253-010-2493-7; JONES KH, 1993, APPL ENVIRON MICROB, V59, P1125, DOI 10.1128/AEM.59.4.1125-1130.1993; KEAT MJ, 1978, BIOCHEM J, V175, P649, DOI 10.1042/bj1750649; KENNER GW, 1955, J CHEM SOC, P522, DOI 10.1039/jr9550000522; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KIM JH, 1994, J BACTERIOL, V176, P6349, DOI 10.1128/jb.176.20.6349-6361.1994; Li SY, 2009, P NATL ACAD SCI USA, V106, P18463, DOI 10.1073/pnas.0907203106; Li T, 2014, J BIOTECHNOL, V192, P355, DOI 10.1016/j.jbiotec.2014.01.017; Liu Y, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-28; Londry KL, 1999, CAN J MICROBIOL, V45, P458, DOI 10.1139/cjm-45-6-458; MATHEWS FS, 1991, BIOCHEMISTRY-US, V30, P238, DOI 10.1021/bi00215a034; MCKENNA CE, 1977, TETRAHEDRON LETT, P155; Muller JA, 2001, J BACTERIOL, V183, P752, DOI 10.1128/JB.183.2.752-757.2001; OMURA T, 1964, J BIOL CHEM, V239, P2379; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Peters F, 2007, J BACTERIOL, V189, P4729, DOI 10.1128/JB.00260-07; Peters-Wendisch P, 2005, APPL ENVIRON MICROB, V71, P7139, DOI 10.1128/AEM.71.11.7139-7144.2005; POWLOWSKI JB, 1985, J BACTERIOL, V163, P1126, DOI 10.1128/JB.163.3.1126-1135.1985; Qi SW, 2007, PROTEOMICS, V7, P3775, DOI 10.1002/pmic.200700481; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Schmeling S, 2004, J BACTERIOL, V186, P8044, DOI 10.1128/JB.186.23.8044-8057.2004; Schuhle K, 2004, J BACTERIOL, V186, P4556, DOI 10.1128/JB.186.14.4556-4567.2004; Shen X.-H., 2005, MICROB ENV, V20, P160, DOI [10.1264/jsme2.20.160, DOI 10.1264/JSME2.20.160]; Shen XH, 2005, APPL ENVIRON MICROB, V71, P3442, DOI 10.1128/AEM.71.7.3442-3452.2005; Shen XH, 2012, APPL MICROBIOL BIOT, V95, P77, DOI 10.1007/s00253-012-4139-4; Sherman DH, 2006, J BIOL CHEM, V281, P26289, DOI 10.1074/jbc.M605478200; Stabler N, 2011, J BACTERIOL, V193, P1702, DOI 10.1128/JB.01295-10; Tallur PN, 2006, CURR MICROBIOL, V53, P529, DOI 10.1007/s00284-006-0309-x; Tallur PN, 2009, BIODEGRADATION, V20, P79, DOI 10.1007/s10532-008-9201-7; Tudzynski B, 2001, APPL ENVIRON MICROB, V67, P3514, DOI 10.1128/AEM.67.8.3514-3522.2001; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; YOKOYAMA MT, 1981, APPL ENVIRON MICROB, V41, P71, DOI 10.1128/AEM.41.1.71-76.1981; Yu L, 2006, BIOCHEMISTRY-US, V45, P9584, DOI 10.1021/bi060840b; Zhao KX, 2010, J BACTERIOL, V192, P1565, DOI 10.1128/JB.01338-09	64	29	33	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6583	6594		10.1074/jbc.M115.695320	http://dx.doi.org/10.1074/jbc.M115.695320			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26817843	Green Published, hybrid			2022-12-26	WOS:000372894200043
J	Brans, E; de Graaf, JS; Munzebrock, AVE; Bessem, B; Reininga, IHF				Brans, Erwin; de Graaf, Joost S.; Munzebrock, Arvid V. E.; Bessem, Bram; Reininga, Inge H. F.			Cross-Cultural Adaptation and Validation of the Dutch Version of the Hip and Groin Outcome Score (HAGOS-NL)	PLOS ONE			English	Article							FUNCTION ASSESSMENT QUESTIONNAIRE; CHRONIC PAIN; COPENHAGEN HIP; HERNIA REPAIR; CORE OUTCOMES; HEALTH SURVEY; QUALITY; RELIABILITY; AGREEMENT; VALIDITY	Background Valid and reliable questionnaires to assess hip and groin pain are lacking. The Hip and Groin Outcome Score (HAGOS) is a valid and reliable self-reported measure to assess symptoms, activity limitations, participation restrictions and quality of life of persons with hip and/or groin complaints. The purpose of this study was to translate and cross-culturally adapt the HAGOS into Dutch (HAGOS-NL), and to evaluate its internal consistency, validity and reliability. Methods Translation and cross-cultural adaption of the Dutch version of the HAGOS (HAGOS-NL) was performed according to international guidelines. The study population consisted of 178 adult patients who had undergone groin hernia repair surgery in the previous year. All respondents filled in the HAGOS-NL, the SF-36, and the SMFA-NL for determining construct validity of the HAGOS-NL. To determine reliability, 81 respondents filled in the HAGOS-NL after a time interval of two weeks. Results Factor analysis confirmed the original six-factor solution of the HAGOS. Internal consistency was good for all the subscales of the HAGOS-NL. High correlations were observed between the HAGOS-NL and the SF-36 and SMFA-NL, indicating good construct validity. The HAGOS-NL showed high reliability, except for the subscale Participation in Physical Activities which was moderate. Conclusions The HAGOS was successfully translated and cross-culturally adapted from English into Dutch (HAGOS-NL). This study shows that the HAGOS-NL is a valid and reliable instrument for the assessment of functional status and health-related quality of life in patients with groin complaints.	[Brans, Erwin; de Graaf, Joost S.; Munzebrock, Arvid V. E.] Med Ctr Leeuwarden, Dept Surg, Leeuwarden, Netherlands; [Munzebrock, Arvid V. E.; Reininga, Inge H. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Trauma Surg, NL-9713 AV Groningen, Netherlands; [Brans, Erwin; Bessem, Bram] Univ Groningen, Univ Med Ctr Groningen, Ctr Sports Med, NL-9713 AV Groningen, Netherlands	Medical Center Leeuwarden; University of Groningen; University of Groningen	Brans, E (corresponding author), Med Ctr Leeuwarden, Dept Surg, Leeuwarden, Netherlands.; Brans, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Sports Med, NL-9713 AV Groningen, Netherlands.	Erwin.brans@ZNB.nl	de Graaf, Joost/C-5364-2012; Reininga, Inge H.F./H-4250-2013	de Graaf, Joost/0000-0002-8781-7368; Reininga, Inge H.F./0000-0003-1341-845X				Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Bay-Nielsen M, 2001, ANN SURG, V233, P1, DOI 10.1097/00000658-200101000-00001; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bitzer EM, 2008, HERNIA, V12, P407, DOI 10.1007/s10029-008-0364-2; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bollen KA, 1989, STRUCTURAL EQUATIONS; Burney RE, 1997, J AM COLL SURGEONS, V185, P509, DOI 10.1016/S1072-7515(97)00108-7; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Clay L, 2012, LANGENBECK ARCH SURG, V397, P1219, DOI 10.1007/s00423-012-0932-x; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Jonge PVH, 2008, HERNIA, V12, P561, DOI 10.1007/s10029-008-0412-y; de Vet HCW, 2001, INT J TECHNOL ASSESS, V17, P479, DOI 10.1017/S0266462301107038; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Devlin N, GETTING MOST OUT PRO; Franneby U, 2008, BRIT J SURG, V95, P488, DOI 10.1002/bjs.6014; Loos M J A, 2007, Hernia, V11, P169, DOI 10.1007/s10029-007-0196-5; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-22; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Poobalan AS, 2003, CLIN J PAIN, V19, P48, DOI 10.1097/00002508-200301000-00006; Reininga IHF, 2012, INJURY, V43, P726, DOI 10.1016/j.injury.2011.07.013; Staerkle RF, 2011, BRIT J SURG, V98, P148, DOI 10.1002/bjs.7236; Swiontkowski MF, 1999, J BONE JOINT SURG AM, V81A, P1245, DOI 10.2106/00004623-199909000-00006; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Thomee R, 2014, KNEE SURG SPORT TR A, V22, P835, DOI 10.1007/s00167-013-2721-7; Thorborg K, 2011, BRIT J SPORT MED, V45, P478, DOI 10.1136/bjsm.2010.080937; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	28	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148119	10.1371/journal.pone.0148119	http://dx.doi.org/10.1371/journal.pone.0148119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GF	26821266	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528400069
J	Chang, EYC; Chang, YC; Shun, CT; Tien, YW; Tsai, SH; Hee, SW; Chen, IJ; Chuang, LM				Chang, Emily Yun-Chia; Chang, Yi-Cheng; Shun, Chia-Tung; Tien, Yu-Wen; Tsai, Shu-Huei; Hee, Siow-Wey; Chen, Ing-Jung; Chuang, Lee-Ming			Inhibition of Prostaglandin Reductase 2, a Putative Oncogene Overexpressed in Human Pancreatic Adenocarcinoma, Induces Oxidative Stress-Mediated Cell Death Involving xCT and CTH Gene Expressions through 15-Keto-PGE(2)	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; CANCER-CELLS; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; PPAR-GAMMA; UP-REGULATION; CYSTINE/GLUTAMATE ANTIPORTER; COLORECTAL-CANCER; CARCINOMA GROWTH; APOPTOSIS; PATHWAY	Prostaglandin reductase 2 (PTGR2) is the enzyme that catalyzes 15-keto-PGE(2), an endogenous PPAR gamma ligand, into 13,14-dihydro-15-keto-PGE(2). Previously, we have reported a novel oncogenic role of PTGR2 in gastric cancer, where PTGR2 was discovered to modulate ROS-mediated cell death and tumor transformation. In the present study, we demonstrated the oncogenic potency of PTGR2 in pancreatic cancer. First, we observed that the majority of the human pancreatic ductal adenocarcinoma tissues was stained positive for PTGR2 expression but not in the adjacent normal parts. In vitro analyses showed that silencing of PTGR2 expression enhanced ROS production, suppressed pancreatic cell proliferation, and promoted cell death through increasing 15-keto-PGE(2). Mechanistically, silencing of PTGR2 or addition of 15-keto-PGE(2) suppressed the expressions of solute carrier family 7 member 11 (xCT) and cystathionine gamma-lyase (CTH), two important providers of intracellular cysteine for the generation of glutathione (GSH), which is widely accepted as the first-line antioxidative defense. The oxidative stress-mediated cell death after silencing of PTGR2 or addition of 15-keto-PGE(2) was further abolished after restoring intracellular GSH concentrations and cysteine supply by N-acetyl-L-cysteine and 2-Mercaptomethanol. Our data highlight the therapeutic potential of targeting PTGR2/15-keto-PGE(2) for pancreatic cancer.	[Chang, Emily Yun-Chia; Chang, Yi-Cheng; Hee, Siow-Wey; Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chang, Yi-Cheng] Natl Taiwan Univ, Grad Inst Med Genom & Prote, Taipei 10764, Taiwan; [Chang, Yi-Cheng] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Chang, Yi-Cheng] Natl Taiwan Univ Hosp, Ctr Obes Life Style & Metab Surg, Taipei, Taiwan; [Shun, Chia-Tung] Natl Taiwan Univ Hosp, Dept Forens Med & Pathol, Taipei, Taiwan; [Tien, Yu-Wen] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Surg, Coll Med, Taipei 10764, Taiwan; [Tsai, Shu-Huei] BC Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada; [Chen, Ing-Jung; Chuang, Lee-Ming] Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei 10764, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ, Dept Med, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; British Columbia Cancer Agency; National Taiwan University; National Taiwan University	Chuang, LM (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.; Chuang, LM (corresponding author), Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei 10764, Taiwan.; Chuang, LM (corresponding author), Natl Taiwan Univ, Dept Med, Coll Med, Taipei 10764, Taiwan.	leeming@ntu.edu.tw	Chang, Yi-cheng/O-1334-2018; Chuang, Lee-Ming/AAF-3324-2019; Chen, Ing-Jung/AAX-7312-2020; Shun, Chia-Tung/M-1400-2019; Chen, Ing-Jung/AAX-7324-2020	Chang, Yi-cheng/0000-0002-8077-5011; Chen, Ing-Jung/0000-0003-3951-129X; Chen, Ing-Jung/0000-0003-3951-129X; TIEN, YU-WEN/0000-0002-9126-2705; CHUANG, LEE-MING/0000-0003-0978-2662; SHUN, CHIA-TUNG/0000-0002-0468-4468	National Science Council of Taiwan [NSC 100-2314-B-002 -068 -MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was done with a grant (NSC 100-2314-B-002 -068 -MY3) from the National Science Council of Taiwan (https://www.most.gov.tw/), and it did not require any external funding. LMC received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostoli AJ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0347-8; Chandel NS, 2014, BIOCH PHARM; Chang EYC, 2012, AM J PATHOL, V181, P1316, DOI 10.1016/j.ajpath.2012.07.006; Chen YX, 2003, WORLD J GASTROENTERO, V9, P2149; Chou WL, 2007, J BIOL CHEM, V282, P18162, DOI 10.1074/jbc.M702289200; Chu JS, 2003, MOL CANCER THER, V2, P1; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; Clay CE, 2002, J LIPID RES, V43, P1818, DOI 10.1194/jlr.M200224-JLR200; Dai L, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-30; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Ding YF, 2005, CARCINOGENESIS, V26, P65, DOI 10.1093/carcin/bgh277; Dong YW, 2009, WORLD J GASTROENTERO, V15, P441, DOI 10.3748/wjg.15.441; Eibl G, 2005, CANCER RES, V65, P982; Eibl G, 2008, PPAR RES, V2008, DOI 10.1155/2008/326915; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Frank B, 2011, CARCINOGENESIS, V32, P190, DOI 10.1093/carcin/bgq231; Fujiki K, 2014, ARCH TOXICOL, V88, P403, DOI 10.1007/s00204-013-1129-y; Fujiwara N, 2015, CANCER RES, V75, P3890, DOI 10.1158/0008-5472.CAN-15-0257; Fulzele SV, 2007, ANTI-CANCER DRUG, V18, P65, DOI 10.1097/CAD.0b013e3280101006; Genestra M, 2007, CELL SIGNAL, V19, P1807, DOI 10.1016/j.cellsig.2007.04.009; Glasauer A, 2014, J CLIN INVEST, V124, P117, DOI 10.1172/JCI71714; Goicoechea SM, 2013, ONCOGENE; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Guo WJ, 2011, CANCER LETT, V312, P55, DOI 10.1016/j.canlet.2011.07.024; Hourihan JM, 2013, ANTIOXID REDOX SIGN, V19, P465, DOI 10.1089/ars.2012.4944; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Konturek PC, 2004, J PHARMACOL SCI, V96, P134, DOI 10.1254/jphs.FPJ04016X; Kristiansen G, 2006, CLIN CANCER RES, V12, P6444, DOI 10.1158/1078-0432.CCR-06-0834; Lalier L, 2011, CELL DEATH DIFFER, V18, P528, DOI 10.1038/cdd.2010.128; Larsson K, 2015, P NATL ACAD SCI USA, V112, P8070, DOI 10.1073/pnas.1424355112; Lee ZW, 2014, BIOCHEM J, V460, P425, DOI 10.1042/BJ20131434; Leikam C, 2014, ONCOGENE, V33, P771, DOI 10.1038/onc.2012.641; Leikam C, 2013, ONCOGENE; Leung WK, 2004, GUT, V53, P331, DOI 10.1136/gut.2003.021105; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Li LY, 2001, J BIOL CHEM, V276, P38152; Lim JC, 2011, EXP EYE RES, V92, P162, DOI 10.1016/j.exer.2010.05.007; Linher-Melville K, 2015, MOL CELL BIOCHEM, V405, P205, DOI 10.1007/s11010-015-2412-4; Liu B, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0260-7; Lo M, 2008, BRIT J CANCER, V99, P464, DOI 10.1038/sj.bjc.6604485; Lo M, 2010, CURR ONCOL, V17, P9; Lu D, 2014, ONCOGENE, V33, P1101, DOI 10.1038/onc.2013.69; Lu DD, 2013, J BIOL CHEM, V288, P19484, DOI 10.1074/jbc.M113.453886; Luo S, 2015, BIOCHEM BIOPH RES CO, V462, P85, DOI 10.1016/j.bbrc.2015.04.023; Ma MZ, 2015, CANCER LETT, V368, P88, DOI 10.1016/j.canlet.2015.07.031; Ma XM, 2009, WORLD J GASTROENTERO, V15, P3874, DOI 10.3748/wjg.15.3874; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Min KW, 2012, TOXICOL APPL PHARM, V263, P225, DOI 10.1016/j.taap.2012.06.014; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Omura N, 2010, MOL CANCER RES, V8, P821, DOI 10.1158/1541-7786.MCR-09-0336; Pazienza V, 2012, PPAR RES, V2012, DOI 10.1155/2012/560846; Pazienza V, 2012, PPAR RES, V2012, DOI 10.1155/2012/461784; Pham H, 2010, PANCREAS, V39, P332, DOI 10.1097/MPA.0b013e3181baecbe; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Robert SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8103; Sabatino L, 2014, WORLD J GASTROENTERO, V20, P7137, DOI 10.3748/wjg.v20.i23.7137; Shiozaki A, 2014, J GASTROENTEROL, V49, P853, DOI 10.1007/s00535-013-0847-5; Simons AL, 2009, J ONCOL, V2009, DOI 10.1155/2009/519563; Srivastava N, 2014, CELL METAB, V20, P650, DOI 10.1016/j.cmet.2014.08.003; Stravodimou A, 2012, PPAR RES, V2012, DOI 10.1155/2012/367450; Takahashi N, 1999, FEBS LETT, V455, P135, DOI 10.1016/S0014-5793(99)00871-6; Thiel A, 2009, CLIN CANCER RES, V15, P4572, DOI 10.1158/1078-0432.CCR-08-2518; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tseng-Rogenski S, 2010, AM J PATHOL, V176, P1462, DOI 10.2353/ajpath.2010.090875; Tsujie M, 2003, EXP CELL RES, V289, P143, DOI 10.1016/S0014-4827(03)00263-5; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Wang MT, 2007, CANCER METAST REV, V26, P525, DOI 10.1007/s10555-007-9096-5; Wu YH, 2008, STRUCTURE, V16, P1714, DOI 10.1016/j.str.2008.09.007; Yamaue H, 2013, CANCER CHEMOTHER PHA; Yang Y, 2013, J RECEPT SIG TRANSD, V33, P14, DOI 10.3109/10799893.2012.752003; Ye P, 2014, MOL CELL BIOL, V34, P3421, DOI 10.1128/MCB.00221-14; Yin Peng, 2012, Cell Signal, V24, P1229, DOI 10.1016/j.cellsig.2012.02.003; Yip-Schneider MT, 2000, CARCINOGENESIS, V21, P139, DOI 10.1093/carcin/21.2.139; Zhang Y, 2015, INT J ONCOL, V46, P175, DOI 10.3892/ijo.2014.2709	76	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147390	10.1371/journal.pone.0147390	http://dx.doi.org/10.1371/journal.pone.0147390			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820738	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528400022
J	Cheng, TS; Loy, SL; Cheung, YB; Chan, JKY; Tint, MT; Godfrey, KM; Gluckman, PD; Kwek, K; Saw, SM; Chong, YS; Lee, YS; Yap, F; Lek, N				Cheng, Tuck Seng; Loy, See Ling; Cheung, Yin Bun; Chan, Jerry Kok Yen; Tint, Mya Thway; Godfrey, Keith M.; Gluckman, Peter D.; Kwek, Kenneth; Saw, Seang Mei; Chong, Yap-Seng; Lee, Yung Seng; Yap, Fabian; Lek, Ngee		Growing Singapore Towards Hlth Out	Singaporean Mothers' Perception of Their Three-year-old Child's Weight Status: A Cross-Sectional Study	PLOS ONE			English	Article							PARENTS PERCEPTIONS; OBESITY; OVERWEIGHT; CONSEQUENCES; PREVALENCE; DISEASE; RISKS	Objective Inaccurate parental perception of their child's weight status is commonly reported in Western countries. It is unclear whether similar misperception exists in Asian populations. This study aimed to evaluate the ability of Singaporean mothers to accurately describe their three-year-old child's weight status verbally and visually. Methods At three years post-delivery, weight and height of the children were measured. Body mass index (BMI) was calculated and converted into actual weight status using International Obesity Task Force criteria. The mothers were blinded to their child's measurements and asked to verbally and visually describe what they perceived was their child's actual weight status. Agreement between actual and described weight status was assessed using Cohen's Kappa statistic (kappa). Results Of 1237 recruited participants, 66.4% (n = 821) with complete data on mothers' verbal and visual perceptions and children's anthropometric measurements were analysed. Nearly thirty percent of the mothers were unable to describe their child's weight status accurately. In verbal description, 17.9% under-estimated and 11.8% over-estimated their child's weight status. In visual description, 10.4% under-estimated and 19.6% over-estimated their child's weight status. Many mothers of underweight children over-estimated (verbal 51.6%; visual 88.8%), and many mothers of overweight and obese children under-estimated (verbal 82.6%; visual 73.9%), their child's weight status. In contrast, significantly fewer mothers of normal-weight children were inaccurate (verbal 16.8%; visual 8.8%). Birth order (p< 0.001), maternal (p = 0.004) and child's weight status (p< 0.001) were associated with consistently inaccurate verbal and visual descriptions. Conclusions Singaporean mothers, especially those of underweight and overweight children, may not be able to perceive their young child's weight status accurately. To facilitate prevention of childhood obesity, educating parents and caregivers about their child's weight status is needed.	[Cheng, Tuck Seng; Yap, Fabian; Lek, Ngee] KK Womens & Childrens Hosp, Dept Paediat, Singapore, Singapore; [Loy, See Ling; Chan, Jerry Kok Yen] KK Womens & Childrens Hosp, KK Res Ctr, Singapore, Singapore; [Cheung, Yin Bun] Duke NUS Med Sch, Ctr Quantitat Med, Singapore, Singapore; [Cheung, Yin Bun] Univ Tampere, Dept Int Hlth, FIN-33101 Tampere, Finland; [Chan, Jerry Kok Yen; Yap, Fabian; Lek, Ngee] Duke NUS Med Sch, Singapore, Singapore; [Chan, Jerry Kok Yen] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore, Singapore; [Chan, Jerry Kok Yen; Chong, Yap-Seng] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 117548, Singapore; [Godfrey, Keith M.] Univ Southampton, MRC Life Course Epidemiol Unit, Southampton, Hants, England; [Godfrey, Keith M.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Godfrey, Keith M.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Gluckman, Peter D.; Chong, Yap-Seng; Lee, Yung Seng] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Kwek, Kenneth] KK Womens & Childrens Hosp, Dept Maternal Fetal Med, Singapore, Singapore; [Saw, Seang Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Yap, Fabian] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117548, Singapore	KK Women's & Children's Hospital; KK Women's & Children's Hospital; National University of Singapore; Tampere University; National University of Singapore; KK Women's & Children's Hospital; National University of Singapore; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Auckland; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); KK Women's & Children's Hospital; National University of Singapore; National University of Singapore	Lek, N (corresponding author), KK Womens & Childrens Hosp, Dept Paediat, Singapore, Singapore.; Lek, N (corresponding author), Duke NUS Med Sch, Singapore, Singapore.	lek.ngee@singhealth.com.sg	Henry, Christiani Jeyakumar/AHB-2632-2022; Tint, Mya-Thway/HGU-1202-2022; Lee, Yung Seng/F-2169-2014; Loy, SeeLing/AGW-6714-2022; Qiu, Anqi/H-2267-2011; Hsu, Chin-ying/E-7855-2016	Henry, Christiani Jeyakumar/0000-0002-1602-0140; Lee, Yung Seng/0000-0002-1253-0557; Qiu, Anqi/0000-0002-0215-6338; Amutha, Chinnaiah/0000-0003-1395-2089; TINT, Mya Thway/0000-0002-9548-7186; LAU, Ivy Yee-Man/0000-0003-0036-2477; Chong, Yap Seng/0000-0002-7232-8473; Shek, Lynette/0000-0001-9064-8983; Kapur, Jeevesh/0000-0002-5696-0233; Cheng, Tuck Seng/0000-0003-4442-7332; Richmond, Jenny/0000-0002-5808-4249; Godfrey, Keith/0000-0002-4643-0618; BISWAS, ARIJIT/0000-0002-3311-2135; Yap, Fabian/0000-0003-1083-7958; Hsu, Chin-ying/0000-0001-7367-3204; Tan, Kok Hian/0000-0003-1945-0266	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme; Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore; National Institute for Health Research through the NIHR Southampton Biomedical Research Centre; European Union's Seventh Framework Programme (FP7), project EarlyNutrition [289346]; Ministry of Health's National Medical Research Council, Singapore [NMRC/CSA/043/2012]; MRC [MC_U147585827, G0400491, MC_U147585819, MC_UU_12011/4, MC_UP_A620_1017] Funding Source: UKRI; British Heart Foundation [RG/07/009/23120] Funding Source: researchfish; Medical Research Council [MC_U147585819, MC_UP_A620_1014, U1475000001, MC_UU_12011/1, MC_U147585824, G0400491, MC_UU_12011/4, MC_U147585827, MC_UP_A620_1017] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082, NF-SI-0513-10085, NF-SI-0515-10042] Funding Source: researchfish	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme(National Research Foundation, Singapore); Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); National Institute for Health Research through the NIHR Southampton Biomedical Research Centre; European Union's Seventh Framework Programme (FP7), project EarlyNutrition; Ministry of Health's National Medical Research Council, Singapore(Ministry of Health-SingaporeNational Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC), Singapore- NMRC/TCR/004-NUS/2008; NMRC/TCR/012-NUHS/2014. Additional funding is provided by the Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore. KMG is supported by the National Institute for Health Research through the NIHR Southampton Biomedical Research Centre and by the European Union's Seventh Framework Programme (FP7/2007-2013), project EarlyNutrition under grant agreement no289346. JKYC received salary support from the Ministry of Health's National Medical Research Council, Singapore (NMRC/CSA/043/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binkin N, 2013, NUTR METAB CARDIOVAS, V23, P410, DOI 10.1016/j.numecd.2011.09.006; Chen S, 2014, ASIA PAC J CLIN NUTR, V23, P452, DOI 10.6133/apjcn.2014.23.3.14; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Eckstein KC, 2006, PEDIATRICS, V117, P681, DOI 10.1542/peds.2005-0910; Golan M, 2004, NUTR REV, V62, P39, DOI 10.1111/j.1753-4887.2004.tb00005.x; Hager ER, 2012, ARCH PEDIAT ADOL MED, V166, P417, DOI 10.1001/archpediatrics.2011.1900; Hager ER, 2010, OBESITY, V18, P397, DOI 10.1038/oby.2009.293; Lee YS, 2009, ANN ACAD MED SINGAP, V38, P75; Lundahl A, 2014, PEDIATRICS, V133, pE689, DOI 10.1542/peds.2013-2690; Mareno N, 2014, J ADV NURS, V70, P34, DOI 10.1111/jan.12143; McMullen S, 2014, P NUTR SOC, V73, P389, DOI 10.1017/S0029665114000111; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Pwint MK, 2013, ANN ACAD MED SINGAP, V42, P66; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Rietmeijer-Mentink M, 2013, MATERN CHILD NUTR, V9, P3, DOI 10.1111/j.1740-8709.2012.00462.x; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Soh SE, 2014, INT J EPIDEMIOL, V43, P1401, DOI 10.1093/ije/dyt125; Souto-Gallardo MC, 2011, ARCH LATINOAM NUTR, V61, P382; Thomsen M, 2014, JAMA INTERN MED, V174, P15, DOI 10.1001/jamainternmed.2013.10522; Warschburger P, 2009, PEDIATRICS, V124, pE60, DOI 10.1542/peds.2008-1845; Wen X, 2011, CHILD CARE HLTH DEV, V37, P343, DOI 10.1111/j.1365-2214.2010.01166.x; World Health Organization, 2008, WHO CHILD GROWTH STA; Yilmaz R, 2013, NUTR HOSP, V28, P741, DOI 10.3305/nh.2013.28.3.6358	26	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147563	10.1371/journal.pone.0147563	http://dx.doi.org/10.1371/journal.pone.0147563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820665	gold, Green Submitted, Green Published			2022-12-26	WOS:000369528400032
J	Zhang, JT; Weng, ZH; Tsang, KS; Tsang, LL; Chan, HC; Jiang, XH				Zhang, Jie Ting; Weng, Zhi Hui; Tsang, Kam Sze; Tsang, Lai Ling; Chan, Hsiao Chang; Jiang, Xiao Hua			MycN Is Critical for the Maintenance of Human Embryonic Stem Cell-Derived Neural Crest Stem Cells	PLOS ONE			English	Article							N-MYC; NEURONAL DIFFERENTIATION; TARGETED DISRUPTION; NERVOUS-SYSTEM; NEUROBLASTOMA; EXPRESSION; PHOX2B; GENE; TRANSCRIPTION; NEUROGENESIS	The biologic studies of human neural crest stem cells (hNCSCs) are extremely challenging due to the limited source of hNCSCs as well as ethical and technical issues surrounding isolation of early human embryonic tissues. On the other hand, vast majority of studies on MycN have been conducted in human tumor cells, thus, the role of MycN in normal human neural crest development is completely unknown. In the present study, we determined the role of MycN in hNCSCs isolated from in vitro-differentiating human embryonic stem cells (hESCs). For the first time, we show that suppression of MycN in hNCSCs inhibits cell growth and cell cycle progression. Knockdown of MycN in hNCSCs increases the expression of Cdkn1a, Cdkn2a and Cdkn2b, which encodes the cyclin-dependent kinases p21(CIP1), p16(INK4a) and p15(INK4b). In addition, MycN is involved in the regulation of human sympathetic neurogenesis, as knockdown of MycN enhances the expression of key transcription factors involved in sympathetic neuron differentiation, including Phox2a, Phox2b, Mash1, Hand2 and Gata3. We propose that unlimited source of hNCSCs provides an invaluable platform for the studies of human neural crest development and diseases.	[Zhang, Jie Ting; Weng, Zhi Hui; Tsang, Lai Ling; Chan, Hsiao Chang; Jiang, Xiao Hua] Chinese Univ Hong Kong, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Key Lab Regenerat Med,Minist Educ, Hong Kong, Hong Kong, Peoples R China; [Tsang, Kam Sze] Chinese Univ Hong Kong, Fac Med, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Chan, Hsiao Chang; Jiang, Xiao Hua] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Jiang, XH (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Key Lab Regenerat Med,Minist Educ, Hong Kong, Hong Kong, Peoples R China.; Jiang, XH (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.	xjiang@cuhk.edu.hk	Chan, Hsiao Chang/E-1507-2016; jiang, cynthia xiaohua/F-7580-2017	jiang, cynthia xiaohua/0000-0002-7372-4961	University Grants Committee [466710]; National Natural Science Foundation of China (NSFC) [81272548]; Health and Medical Research Fund (HMRF) [01120056]	University Grants Committee; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Health and Medical Research Fund (HMRF)	This research was supported by University Grants Committee (General Research Fund, No. 466710), National Natural Science Foundation of China (NSFC, No. 81272548) and Health and Medical Research Fund (HMRF, No. 01120056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam G, 2009, AM J PATHOL, V175, P856, DOI 10.2353/ajpath.2009.090019; Anderson DJ, 1997, COLD SPRING HARB SYM, V62, P493; Basch ML, 2006, NATURE, V441, P218, DOI 10.1038/nature04684; Basu S, 2009, P NATL ACAD SCI USA, V106, P1433, DOI 10.1073/pnas.0804863106; Benetatos L, 2014, CELL MOL LIFE SCI, V71, P257, DOI 10.1007/s00018-013-1426-x; CHARRON J, 1992, GENE DEV, V6, P2248, DOI 10.1101/gad.6.12a.2248; Corvetta D, 2013, J BIOL CHEM, V288, P8332, DOI 10.1074/jbc.M113.454280; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; Hatton BA, 2006, CANCER RES, V66, P8655, DOI 10.1158/0008-5472.CAN-06-1621; Herkert Barbara, 2010, Genes Cancer, V1, P580, DOI 10.1177/1947601910379012; Hurlin Peter J., 2005, Birth Defects Research, V75, P340, DOI 10.1002/bdrc.20059; Itahana Koji, 2010, Epigenomics, V2, P610; Jiang XH, 2009, STEM CELLS DEV, V18, P1059, DOI 10.1089/scd.2008.0362; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; O'Rahilly R, 1999, TERATOLOGY, V60, P39, DOI 10.1002/(SICI)1096-9926(199907)60:1<39::AID-TERA11>3.0.CO;2-I; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Pei DS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003533; Reiff T, 2011, DEVELOPMENT, V138, P4699, DOI 10.1242/dev.072157; Reiff T, 2010, J NEUROSCI, V30, P905, DOI 10.1523/JNEUROSCI.5368-09.2010; SAWAI S, 1993, DEVELOPMENT, V117, P1445; SAWAI S, 1990, MOL CELL BIOL, V10, P2017, DOI 10.1128/MCB.10.5.2017; SAWAI S, 1991, NEW BIOL, V3, P861; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Tiveron MC, 1996, J NEUROSCI, V16, P7649; van Bokhoven H, 2005, NAT GENET, V37, P465, DOI 10.1038/ng1546; von Levetzow C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019305; Wakamatsu Y, 1997, DEVELOPMENT, V124, P1953; Wakamatsu Y, 1997, DEVELOPMENT, V124, P3449; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Westermark UK, 2011, SEMIN CANCER BIOL, V21, P256, DOI 10.1016/j.semcancer.2011.08.001	36	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0148062	10.1371/journal.pone.0148062	http://dx.doi.org/10.1371/journal.pone.0148062			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815535	gold, Green Submitted, Green Published			2022-12-26	WOS:000369528200071
J	Lindensmith, CA; Rider, S; Bedrossian, M; Wallace, JK; Serabyn, E; Showalter, GM; Deming, JW; Nadeau, JL				Lindensmith, Christian A.; Rider, Stephanie; Bedrossian, Manuel; Wallace, J. Kent; Serabyn, Eugene; Showalter, G. Max; Deming, Jody W.; Nadeau, Jay L.			A Submersible, Off-Axis Holographic Microscope for Detection of Microbial Motility and Morphology in Aqueous and Icy Environments	PLOS ONE			English	Article							SEA-ICE; BACTERIAL MOTILITY; ARCTIC WINTER; PERMAFROST; GREENLAND; MICROORGANISMS; ECOLOGY; GLACIER; LIFE; BIODIVERSITY	Sea ice is an analog environment for several of astrobiology's near-term targets: Mars, Europa, Enceladus, and perhaps other Jovian or Saturnian moons. Microorganisms, both eukaryotic and prokaryotic, remain active within brine channels inside the ice, making it unnecessary to penetrate through to liquid water below in order to detect life. We have developed a submersible digital holographic microscope (DHM) that is capable of resolving individual bacterial cells, and demonstrated its utility for immediately imaging samples taken directly from sea ice at several locations near Nuuk, Greenland. In all samples, the appearance and motility of eukaryotes were conclusive signs of life. The appearance of prokaryotic cells alone was not sufficient to confirm life, but when prokaryotic motility occurred, it was rapid and conclusive. Warming the samples to above-freezing temperatures or supplementing with serine increased the number of motile cells and the speed of motility; supplementing with serine also stimulated chemotaxis. These results show that DHM is a useful technique for detection of active organisms in extreme environments, and that motility may be used as a biosignature in the liquid brines that persist in ice. These findings have important implications for the design of missions to icy environments and suggest ways in which DHM imaging may be integrated with chemical life-detection suites in order to create more conclusive life detection packages.	[Rider, Stephanie; Bedrossian, Manuel; Nadeau, Jay L.] CALTECH, Grad Aerosp Labs GALCIT, Pasadena, CA 91125 USA; [Lindensmith, Christian A.; Wallace, J. Kent; Serabyn, Eugene] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91125 USA; [Showalter, G. Max; Deming, Jody W.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	California Institute of Technology; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Washington; University of Washington Seattle	Nadeau, JL (corresponding author), CALTECH, Grad Aerosp Labs GALCIT, Pasadena, CA 91125 USA.	jnadeau@caltech.edu	Wallace, James/AAA-5741-2020	Nadeau, Jay/0000-0001-5258-0076	Gordon and Betty Moore Foundation (GBMF) [4037, 4038]	Gordon and Betty Moore Foundation (GBMF)(Gordon and Betty Moore Foundation)	This work was supported by the Gordon and Betty Moore Foundation (GBMF) grant numbers 4037 (McGill University, JN, subcontract to University of Washington, JWD, GMS) and 4038 (California Institute of Technology, CAL, SR, MB, JKW, ES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, SCIENCE, V347, P1294; Antkowiak M, 2008, OPT LETT, V33, P1626, DOI 10.1364/OL.33.001626; Bakermans C, 2011, ENVIRON MICROBIOL, V13, P2269, DOI 10.1111/j.1462-2920.2011.02485.x; Biele J, 2011, ADV SPACE RES, V48, P755, DOI 10.1016/j.asr.2010.02.029; Boetius A, 2015, NAT REV MICROBIOL, V13, P677, DOI 10.1038/nrmicro3522; Price PB, 2007, FEMS MICROBIOL ECOL, V59, P217, DOI 10.1111/j.1574-6941.2006.00234.x; Campen RK, 2003, GEOLOGY, V31, P231, DOI 10.1130/0091-7613(2003)031<0231:EOMCMW>2.0.CO;2; Colangelo-Lillis JR, 2016, FEMS MICROBIOLOGY EC; Collins RE, 2010, ENVIRON MICROBIOL, V12, P1828, DOI 10.1111/j.1462-2920.2010.02179.x; Colomb T, 2010, OPT LETT, V35, P1840, DOI 10.1364/OL.35.001840; Committee on an Astrobiology Strategy for the Exploration of Mars, 2007, ASTR STRAT EXPL MARS; Deming J, 2007, PLANETS LIFE EMERGIN, P292; Deming JW, 2016, SEA ICE INT IN PRESS; Ewert Marcela, 2013, Biology (Basel), V2, P603, DOI 10.3390/biology2020603; Ferraro P, 2005, OPT EXPRESS, V13, P6738, DOI 10.1364/OPEX.13.006738; Gilichinsky D, 2005, FEMS MICROBIOL ECOL, V53, P117, DOI 10.1016/j.femsec.2005.02.003; Gilichinsky D, 2003, ASTROBIOLOGY, V3, P331, DOI 10.1089/153110703769016424; Grossart HP, 2001, AQUAT MICROB ECOL, V25, P247, DOI 10.3354/ame025247; Hodson A, 2008, ECOL MONOGR, V78, P41, DOI 10.1890/07-0187.1; Huston AL, 2003, BACTERIAL ADAPTATI H; Ikavalko J, 1997, POLAR BIOL, V17, P473, DOI 10.1007/s003000050145; Jansson JK, 2014, NAT REV MICROBIOL, V12, P414, DOI 10.1038/nrmicro3262; Junge K, 2004, APPL ENVIRON MICROB, V70, P550, DOI 10.1128/AEM.70.1.550-557.2004; Junge K, 2001, ANN GLACIOL, V33, P304, DOI 10.3189/172756401781818275; Junge K., 2002, BACTERIAL ABUNDANCE; Krembs C, 2002, DEEP-SEA RES PT I, V49, P2163, DOI 10.1016/S0967-0637(02)00122-X; Krembs C, 2011, P NATL ACAD SCI USA, V108, P3653, DOI 10.1073/pnas.1100701108; Kuhn J, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4904449; Mader HM, 2006, GEOLOGY, V34, P169, DOI 10.1130/G22096.1; Margesin R, 2011, RES MICROBIOL, V162, P346, DOI 10.1016/j.resmic.2010.12.004; Martin-Torres FJ, 2015, TRANSIENT LIQUID WAT; McKay CP, 2013, ASTROBIOLOGY, V13, P334, DOI 10.1089/ast.2012.0878; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mikkelsen DM, 2008, MAR ECOL PROG SER, V368, P65, DOI 10.3354/meps07627; Mindl B, 2007, FEMS MICROBIOL ECOL, V59, P307, DOI 10.1111/j.1574-6941.2006.00262.x; Mitchell JG, 2006, FEMS MICROBIOL ECOL, V55, P3, DOI 10.1111/j.1574-6941.2005.00003.x; MITCHELL JG, 1995, APPL ENVIRON MICROB, V61, P877, DOI 10.1128/AEM.61.3.877-882.1995; Olson RJ, 2003, DEEP-SEA RES PT I, V50, P301, DOI 10.1016/S0967-0637(03)00003-7; Olson RJ, 2007, LIMNOL OCEANOGR-METH, V5, P195, DOI 10.4319/lom.2007.5.195; Pappalardo RT, 2013, ASTROBIOLOGY, V13, P740, DOI 10.1089/ast.2013.1003; Price PB, 2000, P NATL ACAD SCI USA, V97, P1247, DOI 10.1073/pnas.97.3.1247; Saur J, 2015, J GEOPHYS RES-SPACE, V120, P1715, DOI 10.1002/2014JA020778; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt JL, 1998, LIMNOL OCEANOGR, V43, P976, DOI 10.4319/lo.1998.43.5.0976; Shcherbakova VA, 2009, MICROBIOLOGY+, V78, P84, DOI 10.1134/S0026261709010111; Sheng J, 2007, P NATL ACAD SCI USA, V104, P17512, DOI 10.1073/pnas.0704658104; Sheridan PP, 2003, APPL ENVIRON MICROB, V69, P2153, DOI 10.1128/AEM.69.4.2153-2160.2003; Skidmore ML, 2000, APPL ENVIRON MICROB, V66, P3214, DOI 10.1128/AEM.66.8.3214-3220.2000; Sogaard DH, 2010, MAR ECOL PROG SER, V419, P31, DOI 10.3354/meps08845; Steven B, 2006, EXTREMOPHILES, V10, P259, DOI 10.1007/s00792-006-0506-3; Stibal M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00225; Stibal M, 2012, NAT GEOSCI, V5, P771, DOI 10.1038/ngeo1611; Tung HC, 2006, ASTROBIOLOGY, V6, P69, DOI 10.1089/ast.2006.6.69; von Quillfeldt CH, 2001, BOT MAR, V44, P375, DOI 10.1515/BOT.2001.048; Wallace JK, 2015, OPT EXPRESS, V23, P17367, DOI 10.1364/OE.23.017367	55	41	42	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147700	10.1371/journal.pone.0147700	http://dx.doi.org/10.1371/journal.pone.0147700			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812683	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000369528000049
J	Ramachandran, A; Radhapriya, P; Jayakumar, S; Dhanya, P; Geetha, R				Ramachandran, Andimuthu; Radhapriya, Parthasarathy; Jayakumar, Shanmuganathan; Dhanya, Praveen; Geetha, Rajadurai			Critical Analysis of Forest Degradation in the Southern Eastern Ghats of India: Comparison of Satellite Imagery and Soil Quality Index	PLOS ONE			English	Article							BIOCHEMICAL-PROPERTIES; MICROBIAL BIOMASS; TAMIL-NADU; INDICATORS; VEGETATION; ECOSYSTEM	India has one of the largest assemblages of tropical biodiversity, with its unique floristic composition of endemic species. However, current forest cover assessment is performed via satellite-based forest surveys, which havemany limitations. The present study, which was performed in the Eastern Ghats, analysed the satellite-based inventory provided by forest surveys and inferred from the results that this process no longer provides adequate information for quantifying forest degradation in an empirical manner. The study analysed 21 soil properties and generated a forest soil quality index of the Eastern Ghats, using principal component analysis. Using matrix modules and geospatial technology, we compared the forest degradation status calculated from satellite-based forest surveys with the degradation status calculated fromthe forest soil quality index. The Forest Survey of India classified about 1.8% of the Eastern Ghats' total area as degraded forests and the remainder (98.2%) as open, dense, and very dense forests, whereas the soil quality index results found that about 42.4% of the total area is degraded, with the remainder (57.6%) being non-degraded. Our ground truth verification analyses indicate that the forest soil quality index along with the forest cover density data from the Forest Survey of India are ideal tools for evaluating forest degradation.	[Ramachandran, Andimuthu; Radhapriya, Parthasarathy; Dhanya, Praveen; Geetha, Rajadurai] Anna Univ, Ctr Climate Change & Adaptat Res, Chennai 600025, Tamil Nadu, India; [Jayakumar, Shanmuganathan] Pondicherry Univ, Sch Life Sci, Dept Ecol & Environm Sci, Environm Informat & Spatial Modelling Lab, Pondicherry, India	Anna University; Anna University Chennai; Pondicherry University	Ramachandran, A; Radhapriya, P (corresponding author), Anna Univ, Ctr Climate Change & Adaptat Res, Chennai 600025, Tamil Nadu, India.	andimuthu.ramachandran@gmail.com; radhapriya.cc@gmail.com	/CAA-2711-2022; /AAP-2425-2020	/0000-0002-8157-3219; /0000-0002-8157-3219; Radhapriya, Parthasarathy/0000-0001-7568-0176; P, Dr. Dhanya/0000-0001-9957-8766; Dhanya, p/0000-0002-8443-269X	Anna University; Pondicherry University	Anna University; Pondicherry University(Pondicherry University)	This study received intramural funding from the Anna University and the Pondicherry University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton DF, 1993, PROGRAM ASSESS MONIT; Adolphus WHW, 1932, CONSOLIDATED WORKING; Anderson JM., 1993, TROPICAL SOIL BIOL F, V2nd, DOI DOI 10.1017/S0014479700024832; Andrews SS, 2003, GEODERMA, V114, P187, DOI 10.1016/S0016-7061(03)00041-7; Andrews SS, 2002, AGR ECOSYST ENVIRON, V90, P25, DOI 10.1016/S0167-8809(01)00174-8; Andrews SS, 2001, ECOL APPL, V11, P1573, DOI 10.1890/1051-0761(2001)011[1573:DASQAT]2.0.CO;2; Aziz SA, 2010, FRONT ECOL ENVIRON, V8, P178, DOI 10.1890/10.WB.014; Balaguru B, 2006, IDENTIFYING CONSERVA, P469; Bastida F, 2008, GEODERMA, V147, P159, DOI 10.1016/j.geoderma.2008.08.007; Bhardwaj AK, 2011, AGR ECOSYST ENVIRON, V140, P419, DOI 10.1016/j.agee.2011.01.005; Bhat D. M., 2001, Journal of Tropical Forest Science, V13, P601; Blake G.R., 1986, METHODS SOIL ANAL, V5, P363, DOI DOI 10.2136/SSSABOOKSER5.1.2ED.C13; Blecker SW, 2012, ECOL INDIC, V20, P65, DOI 10.1016/j.ecolind.2012.02.010; Brejda JJ, 2000, SOIL SCI SOC AM J, V64, P2115, DOI 10.2136/sssaj2000.6462115x; Chambers JQ, 2007, TRENDS ECOL EVOL, V22, P414, DOI 10.1016/j.tree.2007.05.001; Chen CR, 2003, FOREST ECOL MANAG, V186, P213, DOI 10.1016/S0378-1127(03)00275-5; Cleghorn H, 1861, FORESTS GARDENS S IN; Council of Europe, 1992, SOIL PROT REC COUNC; Doran J.W., 1996, METHODS ASSESSING SO, P25, DOI [10.2136/sssaspecpub49.c2, DOI 10.2136/SSSASPECPUB49.C2]; Erdas, 2011, ERD IM HEX G GEOSP I; Gil-Sotres F, 2005, SOIL BIOL BIOCHEM, V37, P877, DOI 10.1016/j.soilbio.2004.10.003; Goyal Neha, 2014, Environ Monit Assess, V186, P7941, DOI 10.1007/s10661-014-3978-0; Harikrishnan I., 1967, WORKING PLAN SALEM F; IBM Carp, 2013, IBM SPSS STAT WIND V; Jackson M.L, 1973, SOIL CHEM ANAL; Jayakumar S, 2007, KOREAN J REMOTE SENS, V23, P473; Jayakumar S, 2009, ENVIRON MANAGE, V43, P326, DOI 10.1007/s00267-008-9219-y; Joshi AA, 2015, TROP ECOL, V56, P233; Leiros MC, 2000, SOIL BIOL BIOCHEM, V32, P733, DOI 10.1016/S0038-0717(99)00195-9; Liebig MA, 2001, AGRON J, V93, P313, DOI 10.2134/agronj2001.932313x; Lilburne L, 2002, P SOIL QUAL SUST LAN, P47; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Masto RE, 2007, AGR ECOSYST ENVIRON, V118, P130, DOI 10.1016/j.agee.2006.05.008; Menon S, 1998, AMBIO, V27, P576; Ministry of Environment and Forests, 2003, FOR SURV IND STAT FO; Miralles I, 2007, BIOL FERT SOILS, V43, P721, DOI 10.1007/s00374-006-0155-9; Moffat AJ, 2003, FORESTRY, V76, P1, DOI DOI 10.1093/forestry/76.5.547; Ndiaye E. L., 2000, American Journal of Alternative Agriculture, V15, P26, DOI 10.1017/S0889189300008432; NRCS/USDA (Natural Resources Conservation Service/United States Department of Agriculture), 2022, SOIL TEXT CALC; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Owen JS, 2003, FOREST ECOL MANAG, V176, P519, DOI 10.1016/S0378-1127(02)00225-6; Pratt PF, 1956, METHODS SOIL ANAL 2, P1022; Puri GS, 1960, FOREST ECOLOGY; Puyravaud JP, 2010, CONSERV LETT, V3, P390, DOI 10.1111/j.1755-263X.2010.00141.x; Puyravaud JP, 2010, SCIENCE, V329, P32, DOI 10.1126/science.329.5987.32-b; Raizada P, 2006, CURR SCI, V94, P180; Ram Prasad, 2000, RAP Publication, P27; Ramachandran A., 2008, Indian Journal of Forestry, V31, P175; Ramachandran A., 2007, Indian Forester, V133, P25; Ramachandran A., 2005, Indian Forester, V131, P3; Ramachandran A, 2007, CURR SCI INDIA, V92, P323; Ramaswami G, 2014, J BIOSCIENCES, V39, P717, DOI 10.1007/s12038-014-9465-5; Ramaswami G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076995; Royal Commission on Environmental Pollution, 1996, 19 ROYAL COMM ENV PO; Sagar R, 2004, ENVIRON CONSERV, V31, P55, DOI 10.1017/S0376892904001031; Satyam Verma, 2012, Proceedings of the International Academy of Ecology and Environmental Sciences, V2, P168; Schoenholtz SH, 2000, FOREST ECOL MANAG, V138, P335, DOI 10.1016/S0378-1127(00)00423-0; STANFORD G, 1949, AGRON J, V41, P446, DOI 10.2134/agronj1949.00021962004100090012x; Stebbing EP, 1922, THE FORESTS OF INDIA, VI; Subbiah B, 1956, CURR SCI, V25, P8; Tan SY, 2014, ISPRST TECHN COMM 2, VXL-2; Tandon HLS, 1995, METHODS ANAL SOILS P; TESFAHUNEGN GB, 2014, APPL ENV SOIL SCI 20, P1, DOI DOI 10.1016/j.geoderma.2011.04.005; Thankam K., 1959, WORKING PLAN CHENGAL; TOTH SJ, 1949, SOIL SCI, V67, P439, DOI 10.1097/00010694-194906000-00003; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang DL, 1998, COMMUN SOIL SCI PLAN, V29, P15, DOI 10.1080/00103629809369925; Wang SQ, 2002, ENVIRON POLLUT, V116, pS157, DOI 10.1016/S0269-7491(01)00269-X	69	13	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147541	10.1371/journal.pone.0147541	http://dx.doi.org/10.1371/journal.pone.0147541			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812397	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528000038
J	Angers-Loustau, A; Petrillo, M; Paracchini, V; Kagkli, DM; Rischitor, PE; Gallardo, AP; Patak, A; Querci, M; Kreysa, J				Angers-Loustau, Alexandre; Petrillo, Mauro; Paracchini, Valentina; Kagkli, Dafni M.; Rischitor, Patricia E.; Gallardo, Antonio Puertas; Patak, Alex; Querci, Maddalena; Kreysa, Joachim			Towards Plant Species Identification in Complex Samples: A Bioinformatics Pipeline for the Identification of Novel Nuclear Barcode Candidates	PLOS ONE			English	Article							DNA BARCODE; GENES; QUANTIFICATION; VALIDATION; GENERATION; MARKERS; PROTEIN	Monitoring of the food chain to fight fraud and protect consumer health relies on the availability of methods to correctly identify the species present in samples, for which DNA barcoding is a promising candidate. The nuclear genome is a rich potential source of barcode targets, but has been relatively unexploited until now. Here, we show the development and use of a bioinformatics pipeline that processes available genome sequences to automatically screen large numbers of input candidates, identifies novel nuclear barcode targets and designs associated primer pairs, according to a specific set of requirements. We applied this pipeline to identify novel barcodes for plant species, a kingdom for which the currently available solutions are known to be insufficient. We tested one of the identified primer pairs and show its capability to correctly identify the plant species in simple and complex samples, validating the output of our approach.	[Angers-Loustau, Alexandre; Petrillo, Mauro; Paracchini, Valentina; Kagkli, Dafni M.; Rischitor, Patricia E.; Gallardo, Antonio Puertas; Patak, Alex; Querci, Maddalena; Kreysa, Joachim] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, Mol Biol & Genom Unit, I-21020 Ispra, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site	Angers-Loustau, A (corresponding author), Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, Mol Biol & Genom Unit, I-21020 Ispra, Italy.	alexandre.angers@ec.europa.eu	paracchini, valentina/AAG-6302-2021; Kagkli, Dafni-Maria/C-5987-2008; Petrillo, Mauro/AAL-6533-2021; Patak, Alex/L-2882-2015	Kagkli, Dafni-Maria/0000-0002-7351-135X; Petrillo, Mauro/0000-0002-6782-4704; Patak, Alex/0000-0002-9282-188X; Querci, Maddalena/0000-0002-0788-1627; Angers-Loustau, Alexandre/0000-0003-1425-4143; Puertas Gallardo, Antonio/0000-0003-3457-4777; Paracchini, Valentina/0000-0002-4847-9992				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bruno F, 2015, METHODS MOL BIOL, V1269, P257, DOI 10.1007/978-1-4939-2291-8_16; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coghlan Megan L, 2013, Investig Genet, V4, P27, DOI 10.1186/2041-2223-4-27; Coghlan ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/journal.pgen.1002657; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gordon A, 2010, FASTX TOOLKIT FASTQ; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; International Organization for Standardization Geneva Switzerland, 2005, 215712005 ISO ISOIEC; Jacchia S, 2015, J AGR FOOD CHEM, V63, P1711, DOI 10.1021/jf505516y; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kraaijeveld K, 2015, MOL ECOL RESOUR, V15, P8, DOI 10.1111/1755-0998.12288; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Li MG, 2008, CLADISTICS, V24, P727, DOI 10.1111/j.1096-0031.2008.00207.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Little DP, 2014, GENOME, V57, P513, DOI 10.1139/gen-2014-0130; Liu ZH, 2012, GENE, V499, P76, DOI 10.1016/j.gene.2012.02.016; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Naeem A, 2014, GENET MOL RES, V13, P10341, DOI 10.4238/2014.December.4.29; Pillon Y, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-35; Poczai P, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-6; Reneker J, 2012, P NATL ACAD SCI USA, V109, pE1183, DOI 10.1073/pnas.1121356109; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richardson RT, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400066; Salmela L, 2011, BIOINFORMATICS, V27, P1455, DOI 10.1093/bioinformatics/btr170; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Sonnante G, 2009, J AGR FOOD CHEM, V57, P10199, DOI 10.1021/jf902624z; Stoeckle MY, 2008, SCI AM, V299, P82	37	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147692	10.1371/journal.pone.0147692	http://dx.doi.org/10.1371/journal.pone.0147692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807711	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800183
J	Bello-Morales, R; Crespillo, AJ; Praena, B; Tabares, E; Revilla, Y; Garcia, E; Fraile-Ramos, A; Baron, W; Krummenacher, C; Lopez-Guerrero, JA				Bello-Morales, Raquel; Crespillo, Antonio Jesus; Praena, Beatriz; Tabares, Enrique; Revilla, Yolanda; Garcia, Elena; Fraile-Ramos, Alberto; Baron, Wia; Krummenacher, Claude; Lopez-Guerrero, Jose Antonio			Role of Proteolipid Protein in HSV-1 Entry in Oligodendrocytic Cells	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; CENTRAL-NERVOUS-SYSTEM; HEPARAN-SULFATE; LOW-PH; MYELIN; RECEPTOR; TYPE-1; HERPESVIRUSES; ENDOCYTOSIS; ADHESION	Herpes simplex virus type 1 (HSV-1) has the ability to enter many different hosts and cell types by several strategies. This highly prevalent alphaherpesvirus can enter target cells using different receptors and different pathways: fusion at a neutral pH, low-pH-dependent and low-pH-independent endocytosis. Several cell receptors for viral entry have been described, but several observations suggest that more receptors for HSV-1 might exist. In this work, we propose a novel role for the proteolipid protein (PLP) in HSV-1 entry into the human oligodendrocytic cell line HOG. Cells transfected with PLP-EGFP showed an increase in susceptibility to HSV-1. Furthermore, the infection of HOG and HOG-PLP transfected cells with the R120vGF virus-unable to replicate in ICP4-defficient cells-showed an increase in viral signal in HOG-PLP, suggesting a PLP involvement in viral entry. In addition, a mouse monoclonal antibody against PLP drastically inhibited HSV-1 entry into HOG cells. PLP and virions colocalized in confocal immunofluorescence images, and in electron microscopy images, which suggest that PLP acts at the site of entry into HOG cells. Taken together these results suggest that PLP may be involved in HSV-1 entry in human oligodendrocytic cells.	[Bello-Morales, Raquel; Crespillo, Antonio Jesus; Praena, Beatriz; Lopez-Guerrero, Jose Antonio] Univ Autonoma Madrid, Dept Biol Mol, Edificio Biol,Darwin 2, E-28049 Madrid, Spain; [Tabares, Enrique] Univ Autonoma Madrid, Fac Med, Arzobispo Morcillo 4, Madrid 28029, Spain; [Revilla, Yolanda; Garcia, Elena] CSIC UAM, Ctr Biol Mol Severo Ochoa, Nicolas Cabrera 5, Madrid 28049, Spain; [Bello-Morales, Raquel; Fraile-Ramos, Alberto] Univ Complutense Madrid, Fac Med, Plaza Ramon & Cajal,S-N Ciudad Univ, E-28040 Madrid, Spain; [Baron, Wia] Univ Groningen, Univ Med Ctr Groningen, Fac Med Sci, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands; [Krummenacher, Claude] Rowan Univ, Dept Biol Sci, Glassboro, NJ 08028 USA; [Krummenacher, Claude] Rowan Univ, Dept Biomed & Translat Sci, Glassboro, NJ 08028 USA	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Complutense University of Madrid; University of Groningen; Rowan University; Rowan University	Lopez-Guerrero, JA (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Edificio Biol,Darwin 2, E-28049 Madrid, Spain.	ja.lopez@uam.es	LÓPEZ-GUERRERO, JOSÉ ANTONIO/L-5667-2017; Bello-Morales, Raquel/AHD-5028-2022; Tabares, Enrique/AAA-4492-2019; Fraile-Ramos, Alberto/M-2072-2017	LÓPEZ-GUERRERO, JOSÉ ANTONIO/0000-0003-2817-5956; Fraile-Ramos, Alberto/0000-0002-0701-5454; Garcia Sanchez, Elena/0000-0003-2379-8126; Krummenacher, Claude/0000-0002-3492-4987; Yolanda, Revilla/0000-0001-6555-6331; Baron, Wia/0000-0002-6673-4766; Bello-Morales, Raquel/0000-0002-4415-6483; Praena, Beatriz/0000-0002-4628-7575; Bello-Morales, Raquel/0000-0002-8526-6590	Plan Nacional de I+D+I Subprograma de Proyectos de Investigacion Fundamental [SAF2012-40023]; Ministerio de Economia y Competitividad; Programa Estatal de Investigacion, Desarrollo e Innovacion Orientada a los Retos de la Sociedad [BIO2013-46605-R]; Ministerio de Economia y Competitividad [BFU2012-35067]	Plan Nacional de I+D+I Subprograma de Proyectos de Investigacion Fundamental; Ministerio de Economia y Competitividad(Spanish Government); Programa Estatal de Investigacion, Desarrollo e Innovacion Orientada a los Retos de la Sociedad; Ministerio de Economia y Competitividad(Spanish Government)	Financial support for the study was provided by Plan Nacional de I+D+I SAF2012-40023 Subprograma de Proyectos de Investigacion Fundamental, Ministerio de Economia y Competitividad and BIO2013-46605-R Programa Estatal de Investigacion, Desarrollo e Innovacion Orientada a los Retos de la Sociedad. A F-R and R B-M were supported by grant BFU2012-35067 (Ministerio de Economia y Competitividad). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420; Bello-Morales R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089141; Bello-Morales R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019388; Bello-Morales R, 2009, EXP CELL RES, V315, P3453, DOI 10.1016/j.yexcr.2009.08.003; BOISON D, 1995, J NEUROSCI, V15, P5502; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; DUNCAN ID, 1987, P NATL ACAD SCI USA, V84, P6287, DOI 10.1073/pnas.84.17.6287; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Gianni T, 2015, P NATL ACAD SCI USA, V112, pE3901, DOI 10.1073/pnas.1506846112; Greer JM, 2002, INT J BIOCHEM CELL B, V34, P211, DOI 10.1016/S1357-2725(01)00136-4; Held K, 2011, J NEUROVIROL, V17, P518, DOI 10.1007/s13365-011-0063-0; Jahn O, 2009, MOL NEUROBIOL, V40, P55, DOI 10.1007/s12035-009-8071-2; Karasneh GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-481; Knapp PE, 1996, DEV NEUROSCI-BASEL, V18, P297, DOI 10.1159/000111420; Krummenacher C, 2002, J VIROL, V76, P2424, DOI 10.1128/JVI.76.5.2424-2433.2002; Mateo M, 2015, J CELL SCI, V128, P431, DOI 10.1242/jcs.159400; Milne RSB, 2005, J VIROL, V79, P6655, DOI 10.1128/JVI.79.11.6655-6663.2005; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Mori Masahiro, 2014, Adv Neurobiol, V8, P91; Nicola AV, 2003, J VIROL, V77, P5324, DOI 10.1128/JVI.77.9.5324-5332.2003; POST GR, 1992, MOL CHEM NEUROPATHOL, V16, P303, DOI 10.1007/BF03159976; Reske A, 2007, REV MED VIROL, V17, P205, DOI 10.1002/rmv.531; Rikitake Y, 2012, J CELL SCI, V125, P3713, DOI 10.1242/jcs.099572; Roizman B, 2011, J NEUROVIROL, V17, P512, DOI 10.1007/s13365-011-0058-x; Sari TK, 2013, J VIROL, V87, P13922, DOI 10.1128/JVI.02500-13; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Schweighardt B, 2001, J NEUROVIROL, V7, P187; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Soldan MMP, 2012, SEMIN NEUROL, V32, P9, DOI 10.1055/s-0032-1306381; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; Stiles KM, 2010, J VIROL, V84, P11646, DOI 10.1128/JVI.01550-10; Suenaga T, 2010, P NATL ACAD SCI USA, V107, P866, DOI 10.1073/pnas.0913351107; Yool DA, 2000, HUM MOL GENET, V9, P987, DOI 10.1093/hmg/9.6.987	39	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147885	10.1371/journal.pone.0147885	http://dx.doi.org/10.1371/journal.pone.0147885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807581	Green Published, gold			2022-12-26	WOS:000369527800238
J	Felice, MR; Gulati, M; Giuffre, L; Giosa, D; Di Bella, LM; Criseo, G; Nobile, CJ; Romeo, O; Scordino, F				Felice, Maria Rosa; Gulati, Megha; Giuffre, Letterio; Giosa, Domenico; Di Bella, Luca Marco; Criseo, Giuseppe; Nobile, Clarissa J.; Romeo, Orazio; Scordino, Fabio			Molecular Characterization of the N-Acetylglucosamine Catabolic Genes in Candida africana, a Natural N-Acetylglucosamine Kinase (HXK1) Mutant	PLOS ONE			English	Article							ALBICANS; DUBLINIENSIS; PATHOGEN; IDENTIFICATION; PHYLOGENETICS; EPIDEMIOLOGY; INDUCTION; STRAINS; YEASTS	Background In this study we report the genetic characterization, including expression analysis, of the genes involved in the uptake (NGT1) and catabolism (HXK1/NAG5, DAC1/NAG2, NAG1) of the aminosugar N-acetylglucosamine (GlcNAc) in Candida africana, a pathogenic biovariant of Candida albicans that is naturally unable to assimilate the GlcNAc. Results DNA sequence analysis of these genes revealed a number of characteristic nucleotide substitutions including a unique and distinctive guanine insertion that shifts the reading frame and generates a premature stop codon (TGA) 154 bp downstream of the ATG start codon of the HXK1 gene encoding the GlcNAc-kinase, a key enzyme of the GlcNAc catabolic pathway. However, all examined genes produced transcripts even though different levels of expression were observed among the Candida isolates examined. In particular, we found an HXK1-idependent relationship of the NGT1 gene and a considerable influence of the GlcNAc-kinase functionality on the transcription of the DAC1 and NAG1 genes. Additional phenotypic analysis revealed that C. africana isolates are hyperfilamentous in the first 2448h of growth on filament-inducing media and revert to the yeast morphological form after 72h of incubation on these media. Conclusions Our results show that C. africana is a natural HXK1 mutant, displaying a number of phenotypic characteristics distinct from typical C. albicans isolates.	[Felice, Maria Rosa; Giuffre, Letterio; Giosa, Domenico; Di Bella, Luca Marco; Criseo, Giuseppe; Romeo, Orazio] Univ Messina, Dept Biol & Environm Sci, Messina, Italy; [Gulati, Megha; Nobile, Clarissa J.] Univ Calif Merced, Dept Mol & Cell Biol, Merced, CA USA; [Romeo, Orazio; Scordino, Fabio] Ctr Neurolesi Bonino Pulejo, Sci Inst Res Hospitalizat & Hlth Care IRCCS, Messina, Italy	University of Messina; University of California System; University of California Merced; IRCCS Bonino Pulejo	Romeo, O (corresponding author), Univ Messina, Dept Biol & Environm Sci, Messina, Italy.; Romeo, O (corresponding author), Ctr Neurolesi Bonino Pulejo, Sci Inst Res Hospitalizat & Hlth Care IRCCS, Messina, Italy.	oromeo@unime.it	Giosa, Domenico/B-8102-2017; SCORDINO, FABIO/K-1980-2016; Romeo, Orazio/A-6829-2010; Giosa, Domenico/X-8541-2019; Giuffre', Letterio/AAB-9254-2019; Nobile, Clarissa/C-2407-2015	Giosa, Domenico/0000-0002-3893-5296; SCORDINO, FABIO/0000-0002-7776-8515; Romeo, Orazio/0000-0001-5093-2525; Giosa, Domenico/0000-0002-3893-5296; Giuffre', Letterio/0000-0001-5091-3017; Nobile, Clarissa/0000-0003-0799-6499; Di Bella, Luca Marco/0000-0002-9834-8448; felice, maria rosa/0000-0002-4224-2345				Alonso-Vargas R, 2008, MED MYCOL, V46, P167, DOI 10.1080/13693780701633101; Alvarez FJ, 2007, MOL BIOL CELL, V18, P965, DOI 10.1091/mbc.E06-10-0931; Borman AM, 2013, J CLIN MICROBIOL, V51, P967, DOI 10.1128/JCM.02816-12; Ciardo DE, 2006, J CLIN MICROBIOL, V44, P77, DOI 10.1128/JCM.44.1.77-84.2006; Criseo G, 2015, J MICROBIOL METH, V111, P50, DOI 10.1016/j.mimet.2015.02.004; Dieng Y, 2012, J MYCOL MED, V22, P335, DOI 10.1016/j.mycmed.2012.07.052; Forche A, 1999, FUNGAL GENET BIOL, V28, P107, DOI 10.1006/fgbi.1999.1164; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Huang GH, 2012, VIRULENCE, V3, P251, DOI 10.4161/viru.20010; Huang GH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000806; Konopka JB, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/489208; Kurtzman C. P., 1998, YEASTS TAXONOMY STUD; Muller FMC, 1998, J CLIN MICROBIOL, V36, P1625; Naseem Shamoon, 2012, Commun Integr Biol, V5, P156, DOI 10.4161/cib.19034; Naseem S, 2011, J BIOL CHEM, V286, P28671, DOI 10.1074/jbc.M111.249854; Ngouana TK, 2015, MYCOSES, V58, P33, DOI 10.1111/myc.12266; Nnadi NE, 2012, MED MYCOL, V50, P765, DOI 10.3109/13693786.2012.662598; Nobile Clarissa J., 2009, V499, P175, DOI 10.1007/978-1-60327-151-6_17; O'Connor L, 2010, EUKARYOT CELL, V9, P1383, DOI 10.1128/EC.00042-10; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Odds FC, 2010, FUTURE MICROBIOL, V5, P67, DOI 10.2217/FMB.09.113; Pagniez F., 2015, J MYCOLOGIE M DICALE, V25, pe107, DOI DOI 10.1016/J.MYCMED.2015.02.028; Prediger E A, 2001, Methods Mol Biol, V160, P49; Rao KH, 2014, BIOCHEM BIOPH RES CO, V445, P138, DOI 10.1016/j.bbrc.2014.01.123; Rao KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053638; Romeo O, 2008, DIAGN MICR INFEC DIS, V62, P230, DOI 10.1016/j.diagmicrobio.2008.05.014; Romeo O, 2013, CURR FUNGAL INFECT R, V7, P192, DOI 10.1007/s12281-013-0142-1; Romeo O, 2011, MYCOSES, V54, P475, DOI 10.1111/j.1439-0507.2010.01939.x; Romeo O, 2011, MYCOSES, V54, pE57, DOI 10.1111/j.1439-0507.2009.01833.x; Romeo O, 2009, J CLIN MICROBIOL, V47, P212, DOI 10.1128/JCM.01540-08; Romeo O, 2009, MYCOSES, V52, P454, DOI 10.1111/j.1439-0507.2008.01630.x; Shan YY, 2014, MED MYCOL, V52, P636, DOI 10.1093/mmy/myu003; Sharma C, 2014, MYCOSES, V57, P544, DOI 10.1111/myc.12193; Singh P, 2001, INFECT IMMUN, V69, P7898, DOI 10.1128/IAI.69.12.7898-7903.2001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tietz HJ, 2001, MYCOSES, V44, P437, DOI 10.1046/j.1439-0507.2001.00707.x; TIETZ HJ, 1995, J CLIN MICROBIOL, V33, P2462, DOI 10.1128/JCM.33.9.2462-2465.1995; Wendland J, 2006, J BASIC MICROB, V46, P513, DOI 10.1002/jobm.200610167; Yazdanparast SA, 2015, MYCOPATHOLOGIA, V180, P317, DOI 10.1007/s11046-015-9924-z	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147902	10.1371/journal.pone.0147902	http://dx.doi.org/10.1371/journal.pone.0147902			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808192	Green Published, gold			2022-12-26	WOS:000369527800243
J	Vazquez-Guillen, JM; Palacios-Saucedo, GC; Rivera-Morales, LG; Garcia-Campos, J; Ortiz-Lopez, R; Noguera-Julian, M; Paredes, R; Vielma-Ramirez, HJ; Ramirez, TJ; Chavez-Garcia, M; Lopez-Guillen, P; Briones-Lara, E; Sanchez-Sanchez, LM; Vazquez-Martinez, CA; Rodriguez-Padilla, C				Manuel Vazquez-Guillen, Jose; Palacios-Saucedo, Gerardo C.; Rivera-Morales, Lydia G.; Garcia-Campos, Jorge; Ortiz-Lopez, Rocio; Noguera-Julian, Marc; Paredes, Roger; Vielma-Ramirez, Herlinda J.; Ramirez, Teresa J.; Chavez-Garcia, Marcelino; Lopez-Guillen, Paulo; Briones-Lara, Evangelina; Sanchez-Sanchez, Luz M.; Vazquez-Martinez, Carlos A.; Rodriguez-Padilla, Cristina			Mutations Related to Antiretroviral Resistance Identified by Ultra-Deep Sequencing in HIV-1 Infected Children under Structured Interruptions of HAART	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; HIV-1; VIRUS; PROTEASE; POPULATIONS; THERAPY; FAILURE; NAIVE	Although Structured Treatment Interruptions (STI) are currently not considered an alternative strategy for antiretroviral treatment, their true benefits and limitations have not been fully established. Some studies suggest the possibility of improving the quality of life of patients with this strategy; however, the information that has been obtained corresponds mostly to studies conducted in adults, with a lack of knowledge about its impact on children. Furthermore, mutations associated with antiretroviral resistance could be selected due to sub-therapeutic levels of HAART at each interruption period. Genotyping methods to determine the resistance profiles of the infecting viruses have become increasingly important for the management of patients under STI, thus low-abundance antiretroviral drug-resistant mutations (DRM's) at levels under limit of detection of conventional genotyping (< 20% of quasispecies) could increase the risk of virologic failure. In this work, we analyzed the protease and reverse transcriptase regions of the pol gene by ultra-deep sequencing in pediatric patients under STI with the aim of determining the presence of high-and low-abundance DRM's in the viral rebounds generated by the STI. High-abundance mutations in protease and high- and low-abundance mutations in reverse transcriptase were detected but no one of these are directly associated with resistance to antiretroviral drugs. The results could suggest that the evaluated STI program is virologically safe, but strict and carefully planned studies, with greater numbers of patients and interruption/ restart cycles, are still needed to evaluate the selection of DRM's during STI.	[Manuel Vazquez-Guillen, Jose; Rivera-Morales, Lydia G.; Vielma-Ramirez, Herlinda J.; Rodriguez-Padilla, Cristina] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Lab Inmunol & Virol, Monterrey, Nuevo Leon, Mexico; [Palacios-Saucedo, Gerardo C.; Garcia-Campos, Jorge; Chavez-Garcia, Marcelino; Briones-Lara, Evangelina; Sanchez-Sanchez, Luz M.; Vazquez-Martinez, Carlos A.] Hosp Especialidades 25, Unidad Med Alta Especialidad, Dept Pediat & Infectol Pediat, Inst Mexicano Seguro Social,Div Invest, Monterrey, Nuevo Leon, Mexico; [Ortiz-Lopez, Rocio] Univ Autonoma Nuevo Leon, Dept Bioquim & Med Mol, Fac Med, Monterrey, Nuevo Leon, Mexico; [Ortiz-Lopez, Rocio] Univ Autonoma Nuevo Leon, Ctr Invest Desarrollo Ciencias Salud, Monterrey, Nuevo Leon, Mexico; [Noguera-Julian, Marc; Paredes, Roger] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Inst Recerca SIDA, IrsiCaixa, Badalona, Spain; [Noguera-Julian, Marc; Paredes, Roger] Univ Vic, Catedra SIDA, Vic, Spain; [Ramirez, Teresa J.] Lab Estatal Salud Publ Estado Nuevo Leon, Secretaria Salud, Nuevo Leon, Mexico; [Lopez-Guillen, Paulo] Hosp Gen Reg 45, Inst Mexicano Seguro Social, Unidad Infectol Dr Juan I Menchaca, Jalisco, Mexico	Universidad Autonoma de Nuevo Leon; Instituto Mexicano del Seguro Social; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Instituto Mexicano del Seguro Social	Palacios-Saucedo, GC (corresponding author), Hosp Especialidades 25, Unidad Med Alta Especialidad, Dept Pediat & Infectol Pediat, Inst Mexicano Seguro Social,Div Invest, Monterrey, Nuevo Leon, Mexico.	palsaugc@gmail.com	Vazquez-Guillen, Jose Manuel/W-6886-2019; Ortiz-Lopez, Rocio/N-4827-2018; Noguera-Julian, Marc/F-8651-2016	Vazquez-Guillen, Jose Manuel/0000-0001-8256-4253; Ortiz-Lopez, Rocio/0000-0002-7783-026X; Noguera-Julian, Marc/0000-0002-6194-1395; Sanchez-Sanchez, Luz Maria/0000-0001-5973-3530; Rivera-Morales, Lydia Guadalupe/0000-0001-7329-0449	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico [44519]	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by the grant 44519 from the Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico. We thank to Ramses Medina-Gonzalez for his help and collaboration in the technical work of sequencing experiments, to the Laboratorio de Inmunologia y Virologia from Facultad de Ciencias Biologicas UANL for providing all the necessary facilities for the research, and to the Red Tematica de Inmunologia en Cancer y Enfermedades Infecciosas (INMUNOCANEI-CONACYT) for all its collaboration.	Alteri C, 2011, J ANTIMICROB CHEMOTH, V66, P2615, DOI 10.1093/jac/dkr354; [Anonymous], 1994, MMWR Recomm Rep, V43, P1; Borkowsky W, 2008, AIDS RES HUM RETROV, V24, P401, DOI 10.1089/aid.2007.0110; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; Ji HZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009263; Kalmar EMN, 2012, INT J STD AIDS, V23, P120, DOI 10.1258/ijsa.2011.011124; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Lori F, 2000, LANCET, V355, P287, DOI 10.1016/S0140-6736(99)03515-1; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Metzner KJ, 2003, J INFECT DIS, V188, P1433, DOI 10.1086/379215; Monpoux F, 2004, AIDS, V18, P2401; O'Meara D, 2001, J CLIN MICROBIOL, V39, P464, DOI 10.1128/JCM.39.2.464-473.2001; Palacios GC, 2010, INT J INFECT DIS, V14, pE34, DOI 10.1016/j.ijid.2009.03.003; Palacios-Saucedo GC, 2011, CURR HIV RES, V9, P154, DOI 10.2174/157016211795945250; Pennings PS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002527; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Saitoh A, 2008, PEDIATRICS, V121, pE513, DOI 10.1542/peds.2007-1086; Valle-Bahena OM, 2006, ARCH MED RES, V37, P1022, DOI 10.1016/j.arcmed.2006.05.014; Van Rompay KKA, 2006, J VIROL, V80, P6399, DOI 10.1128/JVI.02308-05; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642	24	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147591	10.1371/journal.pone.0147591	http://dx.doi.org/10.1371/journal.pone.0147591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807922	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800143
J	Pereira, RV; Lima, S; Siler, JD; Foditsch, C; Warnick, LD; Bicalho, RC				Pereira, Richard Van Vleck; Lima, Svetlana; Siler, Julie D.; Foditsch, Carla; Warnick, Lorin D.; Bicalho, Rodrigo Carvalho			Ingestion of Milk Containing Very Low Concentration of Antimicrobials: Longitudinal Effect on Fecal Microbiota Composition in Preweaned Calves	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; GUT MICROBIOTA; CHILDHOOD; INFECTION; RESIDUES; BACTERIA; RISK; EXTRACTION; STABILITY; EXPOSURE	Although antimicrobial drugs are central to combat disease in modern medicine, the use of these drugs can have undesired consequences for human and animal health. One consequence is the post-therapy excretion of pharmacological agents, such as the elimination of drug residues at very low concentrations in the milk of lactating mammals. Limited information is currently available on the impact from the exposure of the gut microbiota to drug residues using in vivo natural models. The objective of our study was to address this knowledge gap and evaluate the effect on the fecal microbiota composition from feeding preweaned dairy calves raw milk with residual concentrations of ampicillin, ceftiofur, penicillin, and oxytetracycline from birth to weaning. At birth, thirty calves were randomly assigned to a controlled feeding trial where: 15 calves were fed raw milk with no drug residues (NR), and 15 calves were fed raw milk with drug residues (DR) by adding ceftiofur, penicillin, ampicillin, and oxytetracycline at final concentrations in the milk of 0.1, 0.005, 0.01, and 0.3 mu g/ml, respectively. Fecal samples were rectally collected from each calf once a week starting at birth, prior to the first feeding in the trial (pretreatment), until 6 weeks of age. Sequencing of the microbial 16S rRNA genes was conducted using the Illumina MiSeq, which provides a high resolution of the microbiota down to the genus level. Discriminant analysis showed that, except for pretreatment samples, calves fed milk with drug residues and calves fed milk without drug residues easily discriminated at the genus level on their weekly microbial profile. However, analysis comparing the abundance of taxon between NR and DR showed significant differences only at the genus levels, and not at the phylum, class, order or family levels. These results suggest that although drug residues can result in clear discriminate gut microbial communities, they do not result in disruption of taxonomic levels above the genus.	[Pereira, Richard Van Vleck; Lima, Svetlana; Siler, Julie D.; Foditsch, Carla; Warnick, Lorin D.; Bicalho, Rodrigo Carvalho] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Pereira, Richard Van Vleck] Univ Calif Davis, Coll Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	Cornell University; University of California System; University of California Davis	Pereira, RV (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.; Pereira, RV (corresponding author), Univ Calif Davis, Coll Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	rvpereira@UCDavis.edu	Pereira, Richard/L-2684-2019	Pereira, Richard/0000-0003-2028-8761	National Institute of Food and Agriculture (NIFA), USDA, under HATCH award [NYC-478400]; National Center for Research Resources, a component of the National Institutes of Health (NIH) [T32ODO011000]	National Institute of Food and Agriculture (NIFA), USDA, under HATCH award; National Center for Research Resources, a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Research reported in this publication was supported by the National Institute of Food and Agriculture (NIFA), USDA, under HATCH award number NYC-478400. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Food and Agriculture (NIFA) or the USDA. Research reported in this publication was partially supported by National Center for Research Resources, a component of the National Institutes of Health (NIH), under Award Number T32ODO011000. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health.	Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Akiho Hirotada, 2010, World J Gastrointest Pathophysiol, V1, P97, DOI 10.4291/wjgp.v1.i3.97; Alexander TW, 2008, APPL ENVIRON MICROB, V74, P4405, DOI 10.1128/AEM.00489-08; Allen HK, 2011, MBIO, V2, DOI 10.1128/mBio.00260-11; Bendz D, 2005, J HAZARD MATER, V122, P195, DOI 10.1016/j.jhazmat.2005.03.012; Berendsen BJA, 2011, FOOD ADDIT CONTAM A, V28, P1657, DOI 10.1080/19440049.2011.604045; Berlin CM, 2005, SEMIN FETAL NEONAT M, V10, P149, DOI 10.1016/j.siny.2004.09.016; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bolder NM, 1999, POULTRY SCI, V78, P1681, DOI 10.1093/ps/78.12.1681; Candela M, 2008, INT J FOOD MICROBIOL, V125, P286, DOI 10.1016/j.ijfoodmicro.2008.04.012; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CDC, 2015, BRIDG RAC POP EST US, P1; CLSI, 2012, M100D22 CLSI; Dantas G, 2014, AM SCI, V102, P42, DOI 10.1511/2014.106.42; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Heinrichs A. J., 2005, Calf and heifer rearing: principles of rearing the modern dairy heifer from calf to calving. 60th University of Nottingham Easter School in Agricultural Science, Nottingham, UK. 23rd- 24th March, 2004, P53; Hernando MD, 2006, TALANTA, V69, P334, DOI 10.1016/j.talanta.2005.09.037; Johnson CC, 2005, J ALLERGY CLIN IMMUN, V115, P1218, DOI 10.1016/j.jaci.2005.04.020; Karageorgou EG, 2010, J SEP SCI, V33, P2862, DOI 10.1002/jssc.201000385; Kim BS, 2012, ANAEROBE, V18, P310, DOI 10.1016/j.anaerobe.2012.01.003; Klein-Jobstl D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00622; Kruger M, 2014, ANAEROBE, V27, P100, DOI 10.1016/j.anaerobe.2014.03.013; Kusel MMH, 2008, CLIN EXP ALLERGY, V38, P1921, DOI 10.1111/j.1365-2222.2008.03138.x; Langford FM, 2003, J DAIRY SCI, V86, P3963, DOI 10.3168/jds.S0022-0302(03)74006-5; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McManus PS, 2002, ANNU REV PHYTOPATHOL, V40, P443, DOI 10.1146/annurev.phyto.40.120301.093927; Niewold TA, 2007, POULTRY SCI, V86, P605, DOI 10.1093/ps/86.4.605; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Panda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095476; Pereira R. V., 2014, J DAIRY SCI; Pereira RV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115223; Rigsbee L, 2012, AM J GASTROENTEROL, V107, P1740, DOI 10.1038/ajg.2012.287; Riley Lee W, 2013, Front Public Health, V1, P69, DOI 10.3389/fpubh.2013.00069; Sandegren L, 2014, UPSALA J MED SCI, V119, P103, DOI 10.3109/03009734.2014.904457; Schenck FJ, 2000, FOOD ADDIT CONTAM, V17, P675, DOI 10.1080/02652030050083196; Schneider MJ, 2005, J AOAC INT, V88, P1160; Schriks M, 2010, WATER RES, V44, P461, DOI 10.1016/j.watres.2009.08.023; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Smaill FM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007482.pub3; Smith DR, 2012, VET CLIN N AM-FOOD A, V28, P465, DOI 10.1016/j.cvfa.2012.07.010; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; USDA, 2008, REF DAIR CATTL HLT 1; Webster G, 2007, DERMATOL CLIN, V25, P133, DOI 10.1016/j.det.2007.01.012; Wesolowska-Andersen A, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-19; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zwald AG, 2004, J DAIRY SCI, V87, P191, DOI 10.3168/jds.S0022-0302(04)73158-6	51	39	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147525	10.1371/journal.pone.0147525	http://dx.doi.org/10.1371/journal.pone.0147525			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808865	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800121
J	Schulte, EC; Altmaier, E; Berger, HS; Do, KT; Kastenmuller, G; Wahl, S; Adamski, J; Peters, A; Krumsiek, J; Suhre, K; Haslinger, B; Ceballos-Baumann, A; Gieger, C; Winkelmann, J				Schulte, Eva C.; Altmaier, Elisabeth; Berger, Hannah S.; Kieu Trinh Do; Kastenmueller, Gabi; Wahl, Simone; Adamski, Jerzy; Peters, Annette; Krumsiek, Jan; Suhre, Karsten; Haslinger, Bernhard; Ceballos-Baumann, Andres; Gieger, Christian; Winkelmann, Juliane			Alterations in Lipid and Inositol Metabolisms in Two Dopaminergic Disorders	PLOS ONE			English	Article							RESTLESS-LEGS-SYNDROME; POLYUNSATURATED FATTY-ACIDS; IDIOPATHIC PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; METABOLOMICS; POPULATION; BIOMARKERS; DIAGNOSIS	Background Serum metabolite profiling can be used to identify pathways involved in the pathogenesis of and potential biomarkers for a given disease. Both restless legs syndrome (RLS) and Parkinson's disease (PD) represent movement disorders for which currently no blood-based biomarkers are available and whose pathogenesis has not been uncovered conclusively. We performed unbiased serum metabolite profiling in search of signature metabolic changes for both diseases. Methods 456 metabolites were quantified in serum samples of 1272 general population controls belonging to the KORA cohort, 82 PD cases and 95 RLS cases by liquid-phase chromatography and gas chromatography separation coupled with tandem mass spectrometry. Genetically determined metabotypes were calculated using genome-wide genotyping data for the 1272 general population controls. Results After stringent quality control, we identified decreased levels of long-chain (polyunsaturated) fatty acids of individuals with PD compared to both RLS (PD vs. RLS: p = 0.0001 to 5.80x10(-9)) and general population controls (PD vs. KORA: p = 6.09x10(-5) to 3.45x10(-32)). In RLS, inositol metabolites were increased specifically (RLS vs. KORA: p = 1.35x10(-6) to 3.96x10(-7)). The impact of dopaminergic drugs was reflected in changes in the phenylalanine/tyrosine/dopamine metabolism observed in both individuals with RLS and PD. Conclusions A first discovery approach using serum metabolite profiling in two dopamine-related movement disorders compared to a large general population sample identified significant alterations in the polyunsaturated fatty acid metabolism in PD and implicated the inositol metabolism in RLS. These results provide a starting point for further studies investigating new perspectives on factors involved in the pathogenesis of the two diseases as well as possible points of therapeutic intervention.	[Schulte, Eva C.; Berger, Hannah S.; Haslinger, Bernhard; Ceballos-Baumann, Andres; Winkelmann, Juliane] Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, D-81675 Munich, Germany; [Schulte, Eva C.; Berger, Hannah S.; Winkelmann, Juliane] Helmholtz Zentrum Munchen, Inst Humangenet, D-85764 Neuherberg, Germany; [Altmaier, Elisabeth; Gieger, Christian] Helmholtz Zentrum Munchen, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Altmaier, Elisabeth; Wahl, Simone; Gieger, Christian] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Kieu Trinh Do; Krumsiek, Jan] Helmholtz Zentrum Munchen, Inst Computat Biol, D-85764 Neuherberg, Germany; [Kastenmueller, Gabi] Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, D-85764 Neuherberg, Germany; [Wahl, Simone; Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Adamski, Jerzy] Helmholtz Zentrum Munchen, Genome Anal Ctr, Inst Expt Genet, D-85764 Neuherberg, Germany; [Adamski, Jerzy] Tech Univ Munich, Lehrstuhl Expt Genet, Freising Weihenstephan, Germany; [Suhre, Karsten] Qatar Fdn Educ City, Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, POB 24144, Doha, Qatar; [Ceballos-Baumann, Andres] Schon Klin Munchen Schwabing, Munich, Germany; [Winkelmann, Juliane] Tech Univ Munich, Inst Humangenet, D-81675 Munich, Germany; [Winkelmann, Juliane] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Winkelmann, Juliane] Stanford Univ, Dept Neurol & Neurosci, Palo Alto, CA 94304 USA	Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Technical University of Munich; University of Munich; Stanford University	Winkelmann, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, D-81675 Munich, Germany.; Winkelmann, J (corresponding author), Helmholtz Zentrum Munchen, Inst Humangenet, D-85764 Neuherberg, Germany.; Winkelmann, J (corresponding author), Tech Univ Munich, Inst Humangenet, D-81675 Munich, Germany.; Winkelmann, J (corresponding author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.; Winkelmann, J (corresponding author), Stanford Univ, Dept Neurol & Neurosci, Palo Alto, CA 94304 USA.	winkelmann@lrz.tum.de	Kastenmüller, Gabi/ABF-5987-2020; Peters, Annette/A-6117-2011; Suhre, Karsten/AAF-1778-2020; Schulte, Eva C./AAT-2410-2021	Peters, Annette/0000-0001-6645-0985; Suhre, Karsten/0000-0001-9638-3912; Kastenmuller, Gabi/0000-0002-2368-7322; Adamski, Jerzy/0000-0001-9259-0199; Winkelmann, Juliane/0000-0003-2667-9691; Schulte, Eva Christina/0000-0003-3105-5672	Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH); German Federal Ministry of Education and Research (BMBF); State of Bavaria; European Union's Seventh Framework Programme (MIMOmics) [305280]; German Federal Ministry of Education and Research (BMBF) [01ZX1313C]; Kommission fur Klinische Forschung (KKF) des Klinikums rechts der Isar; Technische Universitat Munchen, Munich, Germany; Xenoport; UCB; Biomedical Research Program funds at Weill Cornell Medical College in Qatar; Qatar Foundation; Pfizer Worldwide Research and Development	Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH)(Helmholtz Association); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; European Union's Seventh Framework Programme (MIMOmics); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Kommission fur Klinische Forschung (KKF) des Klinikums rechts der Isar; Technische Universitat Munchen, Munich, Germany; Xenoport; UCB(UCB Pharma SA); Biomedical Research Program funds at Weill Cornell Medical College in Qatar(Qatar National Research Fund (QNRF)); Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); Pfizer Worldwide Research and Development	The KORA research platform is financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH), which is funded by the German Federal Ministry of Education and Research (BMBF; http://www.bmbf.de/) and by the State of Bavaria. EA was supported from the European Union's Seventh Framework Programme (FP7-Health-F5-2012) under grant agreement no 305280 (MIMOmics; http://www.mimomics.eu/). KTD was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:AtheroSysMed research and funding concept (grant no 01ZX1313C; http://www.sys-med.de/de/konsortien/eatherosysmed/). ECS and JW received funding from the Kommission fur Klinische Forschung (KKF) des Klinikums rechts der Isar, Technische Universitat Munchen, Munich, Germany (http://www.med.tum.de/en/node/427). JW received personal fees from Xenoport (http://www.xenoport.com/) and grant support from UCB (http://www.ucb.de/home) outside the submitted work. KS was supported in part by Biomedical Research Program funds at Weill Cornell Medical College in Qatar, a program funded by the Qatar Foundation (http://www.qf.org.qa/). Serum metabolic profiles of KORA controls were partly financed by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.; http://www.dzd-ev.de/) and from Pfizer Worldwide Research and Development (http://www.pfizer.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Altmaier E, 2008, ENDOCRINOLOGY, V149, P3478, DOI 10.1210/en.2007-1747; Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Berger K, 2004, ARCH INTERN MED, V164, P196, DOI 10.1001/archinte.164.2.196; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Bousquet M, 2011, J LIPID RES, V52, P263, DOI 10.1194/jlr.M011692; Bower JH, 1999, NEUROLOGY, V52, P1214, DOI 10.1212/WNL.52.6.1214; De Vito K, 2014, MOV DISORD; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fux M, 1996, AM J PSYCHIAT, V153, P1219; Gaut JP, 2014, CLIN CHEM, V60, P747, DOI 10.1373/clinchem.2013.212993; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Hu XW, 2013, ACTA NEUROL SCAND, V128, P73, DOI 10.1111/ane.12106; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Kamel F, 2014, PARKINSONISM RELAT D, V20, P82, DOI 10.1016/j.parkreldis.2013.09.023; Karube H, 2008, FEBS LETT, V582, P3693, DOI 10.1016/j.febslet.2008.10.001; Krumsiek J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003005; Krumsiek J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-21; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Meng QJ, 2010, EUR J PHARMACOL, V649, P127, DOI 10.1016/j.ejphar.2010.09.046; Menni C, 2013, INT J EPIDEMIOL, V42, P1111, DOI 10.1093/ije/dyt094; Quinones MP, 2009, NEUROBIOL DIS, V35, P165, DOI 10.1016/j.nbd.2009.02.019; Salloway S, 2011, NEUROLOGY, V77, P1253, DOI 10.1212/WNL.0b013e3182309fa5; Schormair B, 2008, NAT GENET, V40, P946, DOI 10.1038/ng.190; Schouwers S, 2012, CLIN CHIM ACTA, V413, P100, DOI 10.1016/j.cca.2011.08.037; Shchepinov MS, 2011, TOXICOL LETT, V207, P97, DOI 10.1016/j.toxlet.2011.07.020; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Trupp M, 2014, J PARKINSONS DIS; Whelan J, 2008, J NUTR, V138, P2521, DOI 10.3945/jn.108.095943; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099; Winkelmann J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002171; Yakunin E, 2012, BRAIN PATHOL, V22, P280, DOI 10.1111/j.1750-3639.2011.00530.x; Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x	40	23	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147129	10.1371/journal.pone.0147129	http://dx.doi.org/10.1371/journal.pone.0147129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808974	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800054
J	Sothilingam, V; Michalakis, S; Garrido, MG; Biel, M; Tanimoto, N; Seeliger, MW				Sothilingam, Vithiyanjali; Michalakis, Stylianos; Garrido, Marina Garcia; Biel, Martin; Tanimoto, Naoyuki; Seeliger, Mathias W.			HCN1 Channels Enhance Rod System Responsivity in the Retina under Conditions of Light Exposure	PLOS ONE			English	Article							CONE BIPOLAR CELLS; MOUSE RETINA; MAMMALIAN RETINA; GAP-JUNCTIONS; ION CHANNELS; PATHWAYS; MICE; MODULATION; VISION; INPUT	Purpose Vision originates in rods and cones at the outer retina. Already at these early stages, diverse processing schemes shape and enhance image information to permit perception over a wide range of lighting conditions. In this work, we address the role of hyperpolarization-activated and cyclic nucleotide-gated channels 1 (HCN1) in rod photoreceptors for the enhancement of rod system responsivity under conditions of light exposure. Methods To isolate HCN1 channel actions in rod system responses, we generated double mutant mice by crossbreeding Hcn1(-/-) mice with Cnga3(-/-) mice in which cones are non-functional. Retinal function in the resulting Hcn1(-/-) Cnga3(-/-) animals was followed by means of electroretinography (ERG) up to the age of four month. Retinal imaging via scanning laser ophthalmoscopy (SLO) and optical coherence tomography (OCT) was also performed to exclude potential morphological alterations. Results This study on Hcn1(-/-) Cnga3(-/-) mutant mice complements our previous work on HCN1 channel function in the retina. We show here in a functional rod-only setting that rod responses following bright light exposure terminate without the counteraction of HCN channels much later than normal. The resulting sustained signal elevation does saturate the retinal network due to an intensity-dependent reduction in the dynamic range. In addition, the lack of rapid adaptational feedback modulation of rod photoreceptor output via HCN1 in this double mutant limits the ability to follow repetitive (flicker) stimuli, particularly under mesopic conditions. Conclusions This work corroborates the hypothesis that, in the absence of HCN1-mediated feedback, the amplitude of rod signals remains at high levels for a prolonged period of time, leading to saturation of the retinal pathways. Our results demonstrate the importance of HCN1 channels for regular vision.	[Sothilingam, Vithiyanjali; Garrido, Marina Garcia; Tanimoto, Naoyuki; Seeliger, Mathias W.] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Div Ocular Neurodegenerat, Schleichstr 4-3, D-72076 Tubingen, Germany; [Michalakis, Stylianos; Biel, Martin] Univ Munich, Dept Pharm, Ctr Integrated Prot Sci Munich CIPSM, Ctr Drug Res, Butenandtstr 5-13, D-81377 Munich, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich	Sothilingam, V (corresponding author), Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Div Ocular Neurodegenerat, Schleichstr 4-3, D-72076 Tubingen, Germany.	Vithiyanjali.Sothilingam@med.uni-tuebingen.de	Michalakis, Stylianos/M-4677-2019; Biel, Martin/G-1175-2014; Michalakis, Stylianos/W-2094-2018	Michalakis, Stylianos/0000-0001-5092-9238; Biel, Martin/0000-0002-9974-3052; Michalakis, Stylianos/0000-0001-5092-9238	Deutsche Forschungsgemeinschaft (DFG) [Se837/4-1, Se837/5-2, Se837/6-2]; University of Tuebingen	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Tuebingen	This work was supported by the Deutsche Forschungsgemeinschaft (DFG), grants Se837/4-1, 5-2, and 6-2 and Open Access Publishing Fund of University of Tuebingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El-Barr MM, 2009, J NEUROPHYSIOL, V102, P1945, DOI 10.1152/jn.00142.2009; Barrow AJ, 2009, J NEUROSCI, V29, P5841, DOI 10.1523/JNEUROSCI.5746-08.2009; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Della Santina L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029812; Feigenspan A, 2004, J NEUROSCI, V24, P3325, DOI 10.1523/JNEUROSCI.5598-03.2004; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Haverkamp S, 2006, J NEUROSCI, V26, P5248, DOI 10.1523/JNEUROSCI.4483-05.2006; Ivanova E, 2006, VISUAL NEUROSCI, V23, P143, DOI 10.1017/S0952523806232048; Knop GC, 2008, EUR J NEUROSCI, V28, P2221, DOI 10.1111/j.1460-9568.2008.06512.x; KOLB H, 1977, J NEUROCYTOL, V6, P131, DOI 10.1007/BF01261502; Lee EJ, 2003, EUR J NEUROSCI, V18, P2925, DOI 10.1046/j.1460-9568.2003.03049.x; Muller F, 2003, EUR J NEUROSCI, V17, P2084, DOI 10.1046/j.1460-9568.2003.02634.x; NELSON R, 1977, J COMP NEUROL, V172, P109, DOI 10.1002/cne.901720106; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; RAVIOLA E, 1973, P NATL ACAD SCI USA, V70, P1677, DOI 10.1073/pnas.70.6.1677; Rieke F, 2009, NEURON, V64, P605, DOI 10.1016/j.neuron.2009.11.028; Seeliger MW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1540; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Sharpe LT, 1999, TRENDS NEUROSCI, V22, P497, DOI 10.1016/S0166-2236(99)01458-7; Tanimoto N, 2015, SCI REP-UK, V5, DOI 10.1038/srep10731; Tanimoto Naoyuki, 2013, Methods Mol Biol, V935, P69, DOI 10.1007/978-1-62703-080-9_4; Tanimoto N, 2012, J NEUROSCI, V32, P4861, DOI 10.1523/JNEUROSCI.4654-11.2012; Tanimoto N, 2009, FRONT BIOSCI-LANDMRK, V14, P2730, DOI 10.2741/3409; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497	25	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147728	10.1371/journal.pone.0147728	http://dx.doi.org/10.1371/journal.pone.0147728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807953	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800199
J	Tan, CT; Xuan, LL; Cao, SH; Yu, GG; Hou, Q; Wang, HY				Tan, Chunting; Xuan, Lingling; Cao, Shuhua; Yu, Ganggang; Hou, Qi; Wang, Haoyan			Decreased Histone Deacetylase 2 (HDAC2) in Peripheral Blood Monocytes (PBMCs) of COPD Patients	PLOS ONE			English	Article							NF-KAPPA-B; LUNG EPITHELIAL-CELLS; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; INFLAMMATION; SMOKING; TRANSCRIPTION; EPIGENETICS; EXPRESSION; RESPONSES	Background Histone deacetylase 2 (HDAC2) is a class I histone deacetylase family member that plays a critical role in suppressing inflammatory gene expression in the airways, lung parenchyma, and alveolar macrophages in patients with chronic obstructive pulmonary disease (COPD). However, the expression of HDAC2 in peripheral blood monocytes (PBMCs), nuclear factor kappa B (NF-kappa B) p65, and serum inflammatory cytokine levels in COPD patients, smokers, and non-smokers remains unclear. Methods PBMCs were obtained from COPD patients, healthy smokers, and healthy nonsmokers. The HDAC2 and NF-kappa B p65 expression were quantified byWestern Blot. HDAC activity was assessed by an HDAC fluorometric immunoprecipitation activity assay kit. Serum tumor necrosis factor-alpha (TNF-alpha) and interleukin-8 (IL-8) levels were measured by ELISA. Results HDAC2 expression and HDAC activity were decreased in PBMCs in COPD patients compared with smokers and non-smokers. Increased NF-kappa B p65 expression, serum TNF-alpha and IL-8 levels were observed in COPD patients compared with nonsmokers. The FEV1% pred was positively correlated with HDAC2 expression and HDAC activity in COPD patients. Smokers had decreased HDAC activity, increased NF-kappa B p65 expression and serum TNF-alpha compared with nonsmokers. Conclusions HDAC2 expression was decreased in PBMCs of COPD patients and was correlated with disease severity. The reduction of HDAC2 expression not only directly enhances the expression of inflammatory genes, but may account for the activation of NF-kappa B mediated inflammation. Decreased HDAC2 may serve as a potential biomarker of COPD and predict the decline of lung function.	[Tan, Chunting; Yu, Ganggang; Wang, Haoyan] Capital Med Univ, Beijing Friendship Hosp, Dept Resp Med, Beijing, Peoples R China; [Xuan, Lingling; Cao, Shuhua; Hou, Qi] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100730, Peoples R China; [Xuan, Lingling; Cao, Shuhua; Hou, Qi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xuan, Lingling] Chinese Acad Med Sci, Canc Inst Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China	Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Wang, HY (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Resp Med, Beijing, Peoples R China.	haoyanw@126.com	Tan, Chunting/AAC-5319-2019		Beijing Municipal Natural Science Foundation [7142046]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	Support was provided by the Beijing Municipal Natural Science Foundation (7142046).	Adcock Ian M, 2005, COPD, V2, P445; Adenuga D, 2009, AM J RESP CELL MOL, V40, P464, DOI 10.1165/rcmb.2008-0255OC; Andreoli C, 2015, CLIN CHEM LAB MED, V53, P57, DOI 10.1515/cclm-2013-0290; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Barnes Peter J, 2009, Ther Adv Respir Dis, V3, P235, DOI 10.1177/1753465809348648; Barnes PJ, 2009, ANNU REV PHYSIOL, V71, P451, DOI 10.1146/annurev.physiol.010908.163257; Barnes PJ, 2005, EUR RESPIR J, V25, P1084, DOI 10.1183/09031936.05.00139104; Caramori G, 2006, AM J RESP CRIT CARE, V174, P2, DOI 10.1164/rccm.2604001; Chen Y, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-10; Cosio BG, 2004, J EXP MED, V200, P689, DOI 10.1084/jem.20040416; Di Stefano A, 2002, EUR RESPIR J, V20, P556, DOI 10.1183/09031936.02.00272002; Faux SP, 2009, BIOMARKERS, V14, P90, DOI 10.1080/13547500902965047; Hacievliyagil SS, 2013, NIGER J CLIN PRACT, V16, P76, DOI 10.4103/1119-3077.106771; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Ito K., 2001, FASEB Journal, V15, P1110; Kersul AL, 2011, ARCH BRONCONEUMOL, V47, P176, DOI 10.1016/j.arbres.2010.12.003; Lakshmi SP, 2014, J BIOL CHEM, V289, P6383, DOI 10.1074/jbc.M113.536805; Lee KY, 2012, EUR RESPIR J, V40, P863, DOI 10.1183/09031936.00146811; Marwick JA, 2007, EXPERT OPIN THER TAR, V11, P745, DOI 10.1517/14728222.11.6.745; Marwick JA, 2010, DRUGS, V70, P929, DOI 10.2165/10898520-000000000-00000; Mittelstadt ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042152; Qu YQ, 2013, MOL BIOL REP, V40, P3995, DOI 10.1007/s11033-012-2477-z; Rahman I, 2002, BIOCHEM PHARMACOL, V64, P935, DOI 10.1016/S0006-2952(02)01153-X; Rajendrasozhan S, 2008, ANTIOXID REDOX SIGN, V10, P799, DOI 10.1089/ars.2007.1938; Rajendrasozhan S, 2009, COPD, V6, P291, DOI 10.1080/15412550903049132; Reddy NM, 2012, AM J PATHOL, V180, P562, DOI 10.1016/j.ajpath.2011.10.029; Schuliga M, 2015, BIOMOLECULES, V5, P1266, DOI 10.3390/biom5031266; Szulakowski P, 2006, AM J RESP CRIT CARE, V174, P41, DOI 10.1164/rccm.200505-725OC; Tatli U, 2013, IMPLANT DENT, V22, P519, DOI 10.1097/ID.0b013e31829a1718; Warburton David, 2006, Proc Am Thorac Soc, V3, P668, DOI 10.1513/pats.200605-122SF; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Yao HW, 2012, AM J PHYSIOL-LUNG C, V303, pL557, DOI 10.1152/ajplung.00175.2012	33	25	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147380	10.1371/journal.pone.0147380	http://dx.doi.org/10.1371/journal.pone.0147380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809128	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800083
J	Wells, JE; Howlett, M; Halse, HM; Heng, J; Ford, J; Cheung, LC; Samuels, AL; Crook, M; Charles, AK; Cole, CH; Kees, UR				Wells, J. E.; Howlett, M.; Halse, H. M.; Heng, J.; Ford, J.; Cheung, L. C.; Samuels, A. L.; Crook, M.; Charles, A. K.; Cole, C. H.; Kees, U. R.			High expression of connective tissue growth factor accelerates dissemination of leukaemia	ONCOGENE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MINIMAL RESIDUAL DISEASE; MARROW STROMAL CELLS; HUMAN-BONE-MARROW; EXTRACELLULAR-MATRIX; TUMOR-GROWTH; CLINICAL-SIGNIFICANCE; MOUSE MODEL; FACTOR CTGF; IN-VITRO	To improve treatment of acute lymphoblastic leukaemia (ALL), a better understanding of disease development is needed to tailor new therapies. Connective tissue growth factor (CTGF/CCN2) is highly expressed in leukaemia cells from the majority of paediatric patients with B-lineage ALL (pre-B ALL). CTGF is a matricellular protein and plays a role in aggressive cancers. Here we have genetically engineered leukaemia cells to modulate CTGF expression levels. Elevated CTGF levels accelerated disease dissemination and reduced survival in NOD/SCID mice. In vitro studies showed that CTGF protein induces stromal cell proliferation, promotes adhesion of leukaemia cells to stromal cells and leads to overexpression of genes associated with cell cycle and synthesis of extracellular matrix (ECM). Corresponding data from our leukaemia xenograft models demonstrated that CTGF leads to increased proliferation of non-leukaemia cells and deposition of ECM in the bone marrow. We document for the first time a functional role of CTGF in altering disease progression in a lymphoid malignancy. The findings provide support for targeting the bone marrow microenvironment in aggressive forms of leukaemia.	[Wells, J. E.; Howlett, M.; Halse, H. M.; Heng, J.; Ford, J.; Cheung, L. C.; Samuels, A. L.; Kees, U. R.] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Wells, J. E.; Cole, C. H.; Kees, U. R.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA, Australia; [Crook, M.; Charles, A. K.; Cole, C. H.] Princess Margaret Hosp Children, Perth, WA, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia	Kees, UR (corresponding author), Telethon Kids Inst, Head Childrens Leukaemia & Canc Div, POB 855,West Perth, Perth, WA 6872, Australia.	ursula.kees@telethonkids.org.au	Cheung, Laurence/R-9932-2017; Cheung, Laurence/HGU-5859-2022	Cheung, Laurence/0000-0001-6298-5288; Cheung, Laurence/0000-0001-6298-5288; Howlett, Meegan/0000-0003-4332-6572				Aikawa T, 2006, MOL CANCER THER, V5, P1108, DOI 10.1158/1535-7163.MCT-05-0516; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; BENTLEY SA, 1981, BRIT J HAEMATOL, V48, P287, DOI 10.1111/j.1365-2141.1981.tb08462.x; Biondi A, 2012, LANCET ONCOL, V13, P936, DOI 10.1016/S1470-2045(12)70377-7; Boag JM, 2006, LEUKEMIA, V20, P1731, DOI 10.1038/sj.leu.2404365; Boag JM, 2007, BRIT J HAEMATOL, V138, P740, DOI 10.1111/j.1365-2141.2007.06739.x; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Boyerinas B, 2013, BLOOD, V121, P4821, DOI 10.1182/blood-2012-12-475483; Capparelli C, 2012, CELL CYCLE, V11, P2272, DOI 10.4161/cc.20717; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; Cheung LC, 2014, HAEMATOLOGICA, V99, P1149, DOI 10.3324/haematol.2013.102327; Cichon MA, 2014, CELL ADHES MIGR, V8, P588, DOI 10.4161/19336918.2014.972788; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; Duan CW, 2014, CANCER CELL, V25, P778, DOI 10.1016/j.ccr.2014.04.015; Dworzak MN, 2002, BLOOD, V99, P1952, DOI 10.1182/blood.V99.6.1952; Finger EC, 2014, ONCOGENE, V33, P1093, DOI 10.1038/onc.2013.47; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Fujii M, 2012, CELL CYCLE, V11, P3373, DOI 10.4161/cc.21397; GORDON MY, 1988, BRIT J HAEMATOL, V70, P1, DOI 10.1111/j.1365-2141.1988.tb02425.x; Ijichi H, 2011, J CLIN INVEST, V121, P4106, DOI 10.1172/JCI42754; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kang HN, 2010, BLOOD, V115, P1394, DOI 10.1182/blood-2009-05-218560; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; KEES UR, 1987, LEUKEMIA RES, V11, P489, DOI 10.1016/0145-2126(87)90082-8; Khan RB, 2014, J CANCER SURVIV, V8, P688, DOI 10.1007/s11764-014-0375-1; Kim SK, 2014, MOL ONCOL, V8, P1653, DOI 10.1016/j.molonc.2014.06.016; Kuter DJ, 2007, BRIT J HAEMATOL, V139, P351, DOI 10.1111/j.1365-2141.2007.06807.x; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lu HB, 2014, ANN HEMATOL, V93, P485, DOI 10.1007/s00277-013-1939-2; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; MANABE A, 1994, BLOOD, V83, P758; Mayorca-Guiliani A, 2013, ONCOTARGETS THER, V6, P1729, DOI 10.2147/OTT.S38110; Neesse A, 2013, P NATL ACAD SCI USA, V110, P12325, DOI 10.1073/pnas.1300415110; Nishida T, 2000, J CELL PHYSIOL, V184, P197, DOI 10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R; Noren-Nystrom U, 2008, LEUKEMIA, V22, P504, DOI 10.1038/sj.leu.2405072; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Pui CH, 2014, LEUKEMIA, V28, P2336, DOI 10.1038/leu.2014.142; Safadi FF, 2003, J CELL PHYSIOL, V196, P51, DOI 10.1002/jcp.10319; Sala-Torra O, 2007, BLOOD, V109, P3080, DOI 10.1182/blood-2006-06-031096; SANERKIN NG, 1964, J CLIN PATHOL, V17, P541, DOI 10.1136/jcp.17.5.541; Schultz KR, 2009, J CLIN ONCOL, V27, P5175, DOI 10.1200/JCO.2008.21.2514; SHIMIZU Y, 1991, FASEB J, V5, P2292, DOI 10.1096/fasebj.5.9.1860621; Sison EAR, 2011, EXPERT REV HEMATOL, V4, P271, DOI [10.1586/ehm.11.30, 10.1586/EHM.11.30]; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793; Stow P, 2010, BLOOD, V115, P4657, DOI 10.1182/blood-2009-11-253435; Tesfai Y, 2012, LEUKEMIA RES, V36, P299, DOI 10.1016/j.leukres.2011.08.001; Vorwerk P, 2000, BRIT J CANCER, V83, P756, DOI 10.1054/bjoc.2000.1364; Welch MD, 2013, BRIT J HAEMATOL, V162, P537, DOI 10.1111/bjh.12417; Wells JE, 2015, INT J CANCER, V137, P504, DOI 10.1002/ijc.28972; WICKRAMASINGHE SN, 1991, CLIN LAB HAEMATOL, V13, P263; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zombori L, 2013, PEDIATR RHEUMATOL, V11, DOI 10.1186/1546-0096-11-20	55	5	6	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 1	2016	35	35					4591	4600		10.1038/onc.2015.525	http://dx.doi.org/10.1038/onc.2015.525			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU6PE	26804166				2022-12-26	WOS:000382336300005
J	Li, D; Yang, WP; Yang, F; Liu, HA; Zhu, ZX; Lian, KQ; Lei, CQ; Li, S; Liu, XT; Zheng, HX; Shu, HB				Li, Dan; Yang, Wenping; Yang, Fan; Liu, Huanan; Zhu, Zixiang; Lian, Kaiqi; Lei, Caoqi; Li, Shu; Liu, Xiangtao; Zheng, Haixue; Shu, Hongbing			The VP3 structural protein of foot-and-mouth disease virus inhibits the IFN-beta signaling pathway	FASEB JOURNAL			English	Article						Aphthovirus; innate immunity; pathogen	ADAPTER PROTEIN; INNATE IMMUNITY; KAPPA-B; ACTIVATION; RECOGNITION; IRF-3; MAVS; INVOLVEMENT; INFECTION; CLEAVAGE	Foot-and-mouth disease is a frequently occurring disease of cloven-hoofed animals that is caused by infection with the foot-and-mouth virus (FMDV). FMDV circumvents the type-I IFN response by expressing proteins that antagonize cellular innate immunity, such as leader protease and 3C protease. We identified the FMDV structural protein VP3 as a negative regulator of the virus-triggered IFN-beta signaling pathway. Expression of FMDV VP3 inhibited the Sendai virus-triggered activation of IFN regulatory factor-3 and the expression of retinoic acid-inducible gene-I/melanoma differentiation-associated protein-5. Transient transfection and coimmunoprecipitation confirmed that the structural protein VP3 interacts with virus-induced signaling adapter (VISA), which is dependent on the C-terminal aa 111-220 of VP3. In addition, we found that FMDV VP3 inhibits the expression of VISA by disrupting its mRNA. Taken together, our findings reveal a novel strategy used by the structural VP3 protein of FMDV to evade host innate immunity.-Li, D., Yang, W., Yang, F., Liu, H., Zhu, Z., Lian, K., Lei, C., Li, S., Liu, X., Zheng, H., Shu, H. The VP3 structural protein of foot-andmouth disease virus inhibits the IFN-beta signaling pathway.	[Li, Dan; Yang, Wenping; Yang, Fan; Liu, Huanan; Zhu, Zixiang; Lian, Kaiqi; Liu, Xiangtao; Zheng, Haixue] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Natl Foot & Mouth Dis Reference Lab, Lanzhou, Peoples R China; [Lei, Caoqi; Li, Shu; Shu, Hongbing] Wuhan Univ, Med Res Inst, Collaborat Innovat Ctr Viral Immunol, Wuhan 430072, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Med Res Inst, Collaborat Innovat Ctr Viral Immunol, Wuhan 430072, Peoples R China.; Zheng, HX (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Biotechnol, Lanzhou, Peoples R China.	haixuezheng@163.com; shuh@whu.edu.cn	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	National Natural Science Foundation of China [31402179, 31302118]; Gansu Science Foundation for Distinguished Young Scholars [145RJDA328]; National Science and Technology [2015BAD12B04]; Key Technologies Research and Development Program of Gansu Province [1302NKDA027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Gansu Science Foundation for Distinguished Young Scholars; National Science and Technology; Key Technologies Research and Development Program of Gansu Province	The authors thank other members of H.S.'s laboratory for stimulating discussions and technical help. This work was supported by National Natural Science Foundation of China (Grants 31402179 and 31302118), Gansu Science Foundation for Distinguished Young Scholars (Grant 145RJDA328), National Science and Technology (Support Project 2015BAD12B04), and Key Technologies Research and Development Program of Gansu Province (Grant 1302NKDA027). The authors declare no conflicts of interest.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BELSHAM GJ, 1993, PROG BIOPHYS MOL BIO, V60, P241, DOI 10.1016/0079-6107(93)90016-D; Borca MV, 2012, VIROLOGY, V422, P37, DOI 10.1016/j.virol.2011.09.031; Chinsangaram J, 1999, J VIROL, V73, P9891, DOI 10.1128/JVI.73.12.9891-9898.1999; de los Santos T, 2006, J VIROL, V80, P1906, DOI 10.1128/JVI.80.4.1906-1914.2006; de los Santos T, 2007, J VIROL, V81, P12803, DOI 10.1128/JVI.01467-07; DEVANEY MA, 1988, J VIROL, V62, P4407, DOI 10.1128/JVI.62.11.4407-4409.1988; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Domingo E, 2002, COMP IMMUNOL MICROB, V25, P297, DOI 10.1016/S0147-9571(02)00027-9; Du YJ, 2014, J VIROL, V88, P4908, DOI 10.1128/JVI.03668-13; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; JENSEN MJ, 1993, VIROLOGY, V193, P604, DOI 10.1006/viro.1993.1168; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; KITSON JDA, 1990, VIROLOGY, V179, P26, DOI 10.1016/0042-6822(90)90269-W; Kumar M, 2011, J VIROL, V85, P987, DOI 10.1128/JVI.01825-10; Lei CQ, 2010, IMMUNITY, V33, P878, DOI 10.1016/j.immuni.2010.11.021; Li XY, 2013, VET MICROBIOL, V166, P35, DOI 10.1016/j.vetmic.2013.04.028; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; MARQUARDT O, 1991, J VIROL METHODS, V33, P267, DOI 10.1016/0166-0934(91)90026-V; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Moniwa M, 2007, J VET DIAGN INVEST, V19, P9, DOI 10.1177/104063870701900103; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Nfon CK, 2008, VIRAL IMMUNOL, V21, P68, DOI 10.1089/vim.2007.0097; Ng MHJ, 2011, J IMMUNOL, V187, P6473, DOI 10.4049/jimmunol.1100719; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; SELLERS RF, 1968, ARCH GES VIRUSFORSCH, V23, P1, DOI 10.1007/BF01242108; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Wang B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003231; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang D, 2012, J VIROL, V86, P9311, DOI 10.1128/JVI.00722-12; Wang D, 2011, J VIROL, V85, P3758, DOI 10.1128/JVI.02589-10; Wang D, 2010, BIOCHEM BIOPH RES CO, V399, P72, DOI 10.1016/j.bbrc.2010.07.044; Wei CW, 2010, J IMMUNOL, V185, P1158, DOI 10.4049/jimmunol.0903874; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	45	46	56	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1757	1766		10.1096/fj.15-281410	http://dx.doi.org/10.1096/fj.15-281410			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26813975				2022-12-26	WOS:000374879400007
J	Beklemisheva, VR; Perelman, PL; Lemskaya, NA; Kulemzina, AI; Proskuryakova, AA; Burkanov, VN; Graphodatsky, AS				Beklemisheva, Violetta R.; Perelman, Polina L.; Lemskaya, Natalya A.; Kulemzina, Anastasia I.; Proskuryakova, Anastasia A.; Burkanov, Vladimir N.; Graphodatsky, Alexander S.			The Ancestral Carnivore Karyotype As Substantiated by Comparative Chromosome Painting of Three Pinnipeds, the Walrus, the Steller Sea Lion and the Baikal Seal (Pinnipedia, Carnivora)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; BANDING PATTERNS; EVOLUTION; INTERRELATIONSHIPS; HOMOPLASY; HEMIPLASY; ORIGIN; CAT; DOG; MAP	Karyotype evolution in Carnivora is thoroughly studied by classical and molecular cytogenetics and supplemented by reconstructions of Ancestral Carnivora Karyotype (ACK). However chromosome painting information from two pinniped families (Odobenidae and Otariidae) is noticeably missing. We report on the construction of the comparative chromosome map for species from each of the three pinniped families: the walrus (Odobenus rosmarus, Odobenidae-monotypic family), near threatened Steller sea lion (Eumetopias jubatus, Otariidae) and the endemic Baikal seal (Pusa sibirica, Phocidae) using combination of human, domestic dog and stone marten whole-chromosome painting probes. The earliest karyological studies of Pinnipedia showed that pinnipeds were characterized by a pronounced karyological conservatism that is confirmed here with species from Phocidae, Otariidae and Odobenidae sharing same low number of conserved human autosomal segments (32). Chromosome painting in Pinnipedia and comparison with non-pinniped carnivore karyotypes provide strong support for refined structure of ACK with 2n = 38. Constructed comparative chromosome maps show that pinniped karyotype evolution was characterized by few tandem fusions, seemingly absent inversions and slow rate of genome rearrangements (less then one rearrangement per 10 million years). Integrative comparative analyses with published chromosome painting of Phoca vitulina revealed common cytogenetic signature for Phoca/Pusa branch and supports Phocidae and Otaroidea (Otariidae/Odobenidae) as sister groups. We revealed rearrangements specific for walrus karyotype and found the chromosomal signature linking together families Otariidae and Odobenidae. The Steller sea lion karyotype is the most conserved among three studied species and differs from the ACK by single fusion. The study underlined the strikingly slow karyotype evolution of the Pinnipedia in general and the Otariidae in particular.	[Beklemisheva, Violetta R.; Perelman, Polina L.; Lemskaya, Natalya A.; Kulemzina, Anastasia I.; Proskuryakova, Anastasia A.; Graphodatsky, Alexander S.] Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Dept Comparat Genom, Novosibirsk, Russia; [Burkanov, Vladimir N.] Russian Acad Sci, Far East Branch, Pacific Geog Inst, Dept Higher Vertebrates Ecol,Kamchatka Branch, Petropavlovsk Kamchatski, Russia; [Burkanov, Vladimir N.] NOAA, Natl Marine Fisheries Serv, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA; [Perelman, Polina L.; Proskuryakova, Anastasia A.; Graphodatsky, Alexander S.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Russian Academy of Sciences; Pacific Geographical Institute of the Far Eastern Branch of the Russian Academy of Sciences; Russian Academy of Sciences; National Oceanic Atmospheric Admin (NOAA) - USA; Novosibirsk State University	Beklemisheva, VR (corresponding author), Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Dept Comparat Genom, Novosibirsk, Russia.	bekl@mcb.nsc.ru	Perelman, Polina/N-8088-2015; Kulemzina, Anastasia I/N-8554-2015; Proskuryakova, Anastasiya/N-8059-2015; Graphodatsky, Alexander/B-4922-2010; Perelman, Polina/AAD-9030-2019; Beklemisheva, Violetta R./N-9532-2015; Lemskaya, Natalya A./N-5609-2015; Burkanov, Vladimir/C-3116-2012	Perelman, Polina/0000-0002-0982-5100; Graphodatsky, Alexander/0000-0002-8282-1085; Perelman, Polina/0000-0002-0982-5100; Lemskaya, Natalya/0000-0002-3682-6125; Kulemzina, Anastasia/0000-0002-6791-5120; Burkanov, Vladimir/0000-0002-0129-7884	Russian Foundation for Basic Research [14-04-00467, 15-04-00962, 15-29-02384]; Molecular and Cell Biology of RAS	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Molecular and Cell Biology of RAS	This work was supported by Russian Foundation for Basic Research (https://kias.rfbr.ru): project 14-04-00467 to VRB; project 15-04-00962 to ASG; project 15-29-02384 to ASG and the Research grant of the Molecular and Cell Biology of RAS to ASG.	[Anonymous], 1999, WALKERS MAMMALS WORL; ARNASON U, 1970, HEREDITAS-GENETISK A, V64, P237; ARNASON U, 1972, HEREDITAS-GENETISK A, V70, P113; ARNASON U, 1974, HEREDITAS, V76, P179; ARNASON U, 1977, HEREDITAS, V87, P227; Arnason U, 2007, MOL PHYLOGENET EVOL, V45, P863, DOI 10.1016/j.ympev.2007.06.019; Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Bielec PE, 1998, CYTOGENET CELL GENET, V81, P18, DOI 10.1159/000015002; Bininda-Emonds ORP, 2000, EVOLUTION, V54, P1011; Breen M, 1999, GENOMICS, V61, P145, DOI 10.1006/geno.1999.5947; Cavagna P, 2000, MAMM GENOME, V11, P866, DOI 10.1007/s003350010172; DUTRILLAUX B, 1983, CYTOGENET CELL GENET, V35, P200, DOI 10.1159/000131867; FAY FH, 1967, CAN J ZOOLOG, V45, P773, DOI 10.1139/z67-088; Ferguson-Smith MA, 2007, NAT REV GENET, V8, P950, DOI 10.1038/nrg2199; Ferguson-Smith MA, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0125-8; FergusonSmith MA, 1997, EUR J HUM GENET, V5, P253, DOI 10.1159/000484775; Foote AD, 2015, NAT GENET, V47, P272, DOI 10.1038/ng.3198; Fronicke L, 1997, CHROMOSOMA, V106, P108; Graphodatsky A, 2001, CYTOGENET CELL GENET, V92, P243, DOI 10.1159/000056911; Graphodatsky A.S., 1989, P95; GRAPHODATSKY AS, 1987, GENETIKA+, V23, P93; Graphodatsky AS, 2000, CYTOGENET CELL GENET, V88, P296, DOI 10.1159/000015513; Hameister H, 1997, CHROMOSOME RES, V5, P5, DOI 10.1023/A:1018433200553; Jones KE, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0285-5; Kellogg ME, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-6; Kulemzina AI, 2009, CHROMOSOME RES, V17, P419, DOI 10.1007/s10577-009-9032-3; MITCHELL E, 1967, SYST ZOOL, V16, P350, DOI 10.2307/2412158; MURPHY WJ, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-6-REVIEWS0005; Nash WG, 1998, CYTOGENET CELL GENET, V83, P182, DOI 10.1159/000015176; Nash WG, 2001, CYTOGENET CELL GENET, V95, P210, DOI 10.1159/000059348; Nash WG, 2006, ATLAS MAMMALIAN CHRO, P537; Nash WG, 2006, ATLAS MAMMALIAN CHRO, P445; Nash WG, 2008, J HERED, V99, P241, DOI 10.1093/jhered/esm130; Nie W, 2012, HEREDITY, V108, P17, DOI 10.1038/hdy.2011.107; Nie WH, 2002, CHROMOSOME RES, V10, P209, DOI 10.1023/A:1015292005631; OBRIEN SJ, 1982, SCIENCE, V216, P257, DOI 10.1126/science.7063884; Perelman PL, 2012, CYTOGENET GENOME RES, V137, P174, DOI 10.1159/000341389; Perelman PL, 2008, CHROMOSOME RES, V16, P1215, DOI 10.1007/s10577-008-1270-2; Robinson TJ, 2008, P NATL ACAD SCI USA, V105, P14477, DOI 10.1073/pnas.0807433105; Robinson TJ, 2011, SYST BIOL, V60, P439, DOI 10.1093/sysbio/syr045; ROBINSON TJ, 1979, CYTOGENET CELL GENET, V23, P157, DOI 10.1159/000131321; Ruiz-Herrera A, 2012, HEREDITY, V108, P28, DOI 10.1038/hdy.2011.102; Sato JJ, 2006, ZOOL SCI, V23, P125, DOI 10.2108/zsj.23.125; SEABRIGH.M, 1971, LANCET, V2, P971; STANYON R, 1991, B ZOOL, V58, P81, DOI 10.1080/11250009109355732; Tian Y, 2004, CHROMOSOME RES, V12, P55, DOI 10.1023/B:CHRO.0000009299.59969.fa; Trifonov VA, 2012, CYTOGENET GENOME RES, V137, P208, DOI 10.1159/000339900; Vorontsov N, 1969, MAMMALS EVOLUTION KA, P23; Wilson D. E., 2005, MAMMAL SPECIES WORLD; WURSTERHILL DH, 1982, CYTOGENET CELL GENET, V34, P178, DOI 10.1159/000131806; WURSTERHILL DH, 1975, CYTOGENET CELL GENET, V15, P306, DOI 10.1159/000130528; WURSTERHILL DH, 1973, J MAMMAL, V54, P753, DOI 10.2307/1378975; Yang F, 1999, GENOMICS, V62, P189, DOI 10.1006/geno.1999.5989; Yang FT, 2004, CHROMOSOM T, V14, P215; Yu L, 2011, SYST BIOL, V60, P175, DOI 10.1093/sysbio/syq090	55	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147647	10.1371/journal.pone.0147647	http://dx.doi.org/10.1371/journal.pone.0147647			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821159	Green Published, gold			2022-12-26	WOS:000369528400036
J	Benedeti, PD; Paulino, PVR; Marcondes, MI; Maciel, IFS; da Silva, MC; Faciola, AP				Benedeti, Pedro Del Bianco; Rodrigues Paulino, Pedro Veiga; Marcondes, Marcos Inacio; Smith Maciel, Ivan Franca; da Silva, Matheus Custodio; Faciola, Antonio Pinheiro			Partial Replacement of Ground Corn with Glycerol in Beef Cattle Diets: Intake, Digestibility, Performance, and Carcass Characteristics	PLOS ONE			English	Article							CRUDE GLYCERIN; MEAT QUALITY; RUMINAL FERMENTATION; GROWTH-PERFORMANCE; RUMEN FERMENTATION; TRAITS; METABOLITES; ULTRASOUND; INCLUSION; BLOOD	The objective of this study was to evaluate the effects of replacing dry ground corn with crude glycerol on intake, apparent digestibility, performance, and carcass characteristics of finishing beef bulls. A completely randomized block design experiment with 25 d for adaptation and 100 d for data collection was conducted, in which 3,640 Nellore bulls (367 +/- 36.8 kg; 18 +/- 3 mo) were blocked by body weight and assigned to 20 pens. Bulls were randomly assigned to one of four treatments: 0, 5, 10, and 15% (dry matter basis) of crude glycerol in the diet. Initially, 20 bulls were slaughtered to serve as a reference to estimate initial empty body weight, which allowed for carcass gain calculation. Bulls were weighed at the beginning, at two-thirds, and at the end of the experiment for performance calculations. Carcass measurements were obtained by ultrasound. Fecal output was estimated using indigestible neutral detergent fiber as an internal marker. Data were analyzed using the mixed procedures in SAS 9.2 (SAS Institute Inc., Cary, NC). Intake of dry matter, organic matter, and neutral detergent fiber decreased linearly (P < 0.05) with crude glycerol inclusion. However, crude glycerol levels did not affect (P > 0.05) intakes of crude protein, non-fiber carbohydrates, and total digestible nutrients. Digestibility of dry matter, organic matter, neutral detergent fiber, and total digestible nutrients increased quadratically (P < 0.05) with the inclusion of crude glycerol in the diet. Crude glycerol inclusion did not change the intake of digestible dry matter, average daily gain, final body weight, carcass gain, carcass dressing, gain-to-feed ratio, Longissimus thoracis muscle area, and back and rump fat thicknesses (P > 0.05). These results suggest that crude glycerol may be included in finishing beef diets at levels up to 15% without impairing performance and carcass characteristics.	[Benedeti, Pedro Del Bianco; Marcondes, Marcos Inacio; Smith Maciel, Ivan Franca; da Silva, Matheus Custodio] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Rodrigues Paulino, Pedro Veiga] Cargill Anim Nutr Nutron, Campinas, SP, Brazil; [Faciola, Antonio Pinheiro] Univ Nevada, Dept Agr Nutr & Vet Sci, Reno, NV 89557 USA	Universidade Federal de Vicosa; Nevada System of Higher Education (NSHE); University of Nevada Reno	Faciola, AP (corresponding author), Univ Nevada, Dept Agr Nutr & Vet Sci, Reno, NV 89557 USA.	afaciola@cabnr.unr.edu	Del Bianco Benedeti, Pedro/C-3120-2016; Faciola, Antonio/U-4800-2018; Faciola, Antonio/AAF-3865-2019; Marcondes, Marcos/AAH-7553-2020	Del Bianco Benedeti, Pedro/0000-0003-2515-8974; Faciola, Antonio/0000-0003-0935-6233; Faciola, Antonio/0000-0003-0935-6233; Marcondes, Marcos/0000-0003-4843-2809	National Council for Scientific and Technological Development (CNPq); Granol Industria Comercio e Exportacao S.A.	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Granol Industria Comercio e Exportacao S.A.	The National Council for Scientific and Technological Development (CNPq) provided graduate scholarship to Pedro Del Bianco Benedeti. Granol Industria Comercio e Exportacao S.A. provided financial support to cover expenses related to animals, feed, and management. These funding organizations did not play a role in the study design, data collection and analysis, decision to publish, or manuscript preparation. At the time of this study Dr. Pedro Veiga Rodrigues Paulino held a faculty position at the Federal University of Vicosa, he is currently employed by Cargill Animal Nutrition / Nutron. Cargill Animal Nutrition / Nutron did not play a role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	Allen MS, 2000, J DAIRY SCI, V83, P1598, DOI 10.3168/jds.S0022-0302(00)75030-2; ANP, 2014, PROD NAC BIOD PURO B; AOAC, 2005, AOAC OFFICIAL METHOD, V18th ed.; Araujo FRC, 2003, THESIS U CALIFORNIA; Barton L, 2013, LIVEST SCI, V155, P53, DOI 10.1016/j.livsci.2013.04.010; Benedeti PD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143201; BERGMAN EN, 1968, AM J PHYSIOL, V215, P874; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; BERGNER H, 1995, ARCH ANIM NUTR, V48, P245, DOI 10.1080/17450399509381845; BRASIL, 1997, REG INSP IND SAN PRO; Brasil, 2004, SIST BRAS CLASS CARC; BRUNGARDT VH, 1963, J ANIM SCI, V22, P177, DOI 10.2527/jas1963.221177x; van Cleef EHCB, 2014, REV BRAS ZOOTECN, V43, P86, DOI 10.1590/S1516-35982014000200006; DeFrain JM, 2004, J DAIRY SCI, V87, P4195, DOI 10.3168/jds.S0022-0302(04)73564-X; Detmann E, 2010, ARQ BRAS MED VET ZOO, V62, P980, DOI 10.1590/S0102-09352010000400030; DiLorenzo N, 2010, J ANIM SCI, V88, pE123, DOI 10.2527/jas.2009-2362; DONKIN S., 2008, REV BRAS ZOOTECN, V37, P280, DOI DOI 10.1590/S1516-35982008001300032; Egea M, 2014, MEAT SCI, V98, P673, DOI 10.1016/j.meatsci.2014.06.034; Eiras CE, 2014, ANIM FEED SCI TECH, V197, P222, DOI 10.1016/j.anifeedsci.2014.07.004; Eiras CE, 2014, MEAT SCI, V96, P930, DOI 10.1016/j.meatsci.2013.10.002; Francozo MC, 2013, BRAZ ARCH BIOL TECHN, V56, P327, DOI 10.1590/S1516-89132013000200019; Greiner SP, 2003, J ANIM SCI, V81, P1736; Gunn P. J., 2011, Professional Animal Scientist, V27, P283; Hales KE, 2015, J ANIM SCI, V93, P348, DOI 10.2527/jas.2014-8075; Hales KE, 2013, J ANIM SCI, V91, P4277, DOI 10.2527/jas.2013-6341; Hales KE, 2013, J ANIM SCI, V91, P3875, DOI 10.2527/jas.2012-5944; Herring WO, 1998, J ANIM SCI, V76, P364; Hess B, 2009, J ANIM SCI S2, V86, P392; HUHTANEN P, 1994, ANIM FEED SCI TECH, V48, P211, DOI 10.1016/0377-8401(94)90173-2; Lage JF, 2014, MEAT SCI, V96, P1158, DOI 10.1016/j.meatsci.2013.10.027; Mach N, 2009, J ANIM SCI, V87, P632, DOI 10.2527/jas.2008-0987; Millen DD, 2009, J ANIM SCI, V87, P3427, DOI 10.2527/jas.2009-1880; Monnerat J. P. I. S., 2013, ENERGY PROTEIN METAB, V134, P97, DOI [10.3920/978-90-8686-781-3, DOI 10.3920/978-90-8686-781-3]; NRC (National Research Council), 2000, NUTR REQ BEEF CATTL, DOI DOI 10.17226/19014; Parsons GL, 2009, J ANIM SCI, V87, P653, DOI 10.2527/jas.2008-1053; Pyatt NA, 2007, J ANIM SCI, V85, P412; Ramos MH, 2012, J ANIM SCI, V90, P892, DOI 10.2527/jas.2011-4099; REMOND B, 1993, ANIM FEED SCI TECH, V41, P121, DOI 10.1016/0377-8401(93)90118-4; Robinson PH, 2006, ANIM FEED SCI TECH, V129, P1, DOI 10.1016/j.anifeedsci.2006.05.011; ROGER V, 1992, CURR MICROBIOL, V25, P197, DOI 10.1007/BF01570719; Schroder A., 1999, INT RAP C GOSF REG I, P241; Shin JH, 2012, J DAIRY SCI, V95, P4006, DOI 10.3168/jds.2011-5121; Trabue S, 2007, J AGR FOOD CHEM, V55, P7043, DOI 10.1021/jf071076i; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wang C, 2009, LIVEST SCI, V121, P15, DOI 10.1016/j.livsci.2008.05.010; Wilson D, 1998, BEEF RES REPORT	47	19	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148224	10.1371/journal.pone.0148224	http://dx.doi.org/10.1371/journal.pone.0148224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820725	gold, Green Submitted, Green Published			2022-12-26	WOS:000369528400077
J	Daut, EF; Lahodny, G; Peterson, MJ; Ivanek, R				Daut, Elizabeth F.; Lahodny, Glenn, Jr.; Peterson, Markus J.; Ivanek, Renata			Interacting Effects of Newcastle Disease Transmission and Illegal Trade on a Wild Population of White-Winged Parakeets in Peru: A Modeling Approach	PLOS ONE			English	Article							DOUBLE-CRESTED CORMORANTS; EXOTIC BIRDS; POSTFLEDGING SURVIVAL; INTERNATIONAL-TRADE; SOUTHERN-CALIFORNIA; INFECTIOUS-DISEASE; HEALTH EVALUATION; PSITTACINE BIRDS; RACING PIGEONS; HERD-IMMUNITY	Illegal wildlife-pet trade can threaten wildlife populations directly from overharvest, but also indirectly as a pathway for introduction of infectious diseases. This study evaluated consequences of a hypothetical introduction of Newcastle disease (ND) into a wild population of Peru's most trafficked psittacine, the white-winged parakeet (Brotogeris versicolurus), through release of infected confiscated individuals. We developed two mathematical models that describe ND transmission and the influence of illegal harvest in a homogeneous (model 1) and age-structured population of parakeets (model 2). Infection transmission dynamics and harvest were consistent for all individuals in model 1, which rendered it mathematically more tractable compared to the more complex, age-structured model 2 that separated the host population into juveniles and adults. We evaluated the interaction of ND transmission and harvest through changes in the basic reproduction number (R-0) and short-term host population dynamics. Our findings demonstrated that ND introduction would likely provoke considerable disease-related mortality, up to 24% population decline in two years, but high harvest rates would dampen the magnitude of the outbreak. Model 2 produced moderate differences in disease dynamics compared to model 1 (R-0 = 3.63 and 2.66, respectively), but highlighted the importance of adult disease dynamics in diminishing the epidemic potential. Therefore, we suggest that future studies should use a more realistic, age-structured model. Finally, for the presumptive risk that illegal trade of white-winged parakeets could introduce ND into wild populations, our results suggest that while high harvest rates may have a protective effect on the population by reducing virus transmission, the combined effects of high harvest and disease-induced mortality may threaten population survival. These results capture the complexity and consequences of the interaction between ND transmission and harvest in a wild parrot population and highlight the importance of preventing illegal trade.	[Daut, Elizabeth F.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, Schubot Exot Bird Hlth Ctr, College Stn, TX USA; [Lahodny, Glenn, Jr.] Texas A&M Univ, Dept Math, College Stn, TX 77843 USA; [Peterson, Markus J.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Lahodny, Glenn, Jr.; Ivanek, Renata] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX USA; [Daut, Elizabeth F.] Natl Socioenvironm Synth Ctr, Annapolis, MD USA; [Ivanek, Renata] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Texas System; University of Texas El Paso; Texas A&M University System; Texas A&M University College Station; Cornell University	Daut, EF (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, Schubot Exot Bird Hlth Ctr, College Stn, TX USA.; Daut, EF (corresponding author), Natl Socioenvironm Synth Ctr, Annapolis, MD USA.	edaut@sesync.org	Ivanek, Renata/B-9005-2009	Ivanek, Renata/0000-0001-6348-4709; Peterson, Markus/0000-0001-6145-0134	Applied Biodiversity Science NSF-IGERT 727 program; Department of Veterinary Pathobiology; Schubot Exotic Bird Health Center 728 at Texas AM University; Direct For Biological Sciences [1639145] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1052875] Funding Source: National Science Foundation	Applied Biodiversity Science NSF-IGERT 727 program; Department of Veterinary Pathobiology; Schubot Exotic Bird Health Center 728 at Texas AM University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	E. Daut is grateful 726 for the financial and academic support provided by Applied Biodiversity Science NSF-IGERT 727 program, the Department of Veterinary Pathobiology, and the Schubot Exotic Bird Health Center 728 at Texas A&M University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D. J., 2004, TECHNOLOGY REV NEWCA; Alexander Dennis J., 2009, P19, DOI 10.1007/978-88-470-0826-7_2; ALEXANDER DJ, 1986, VET REC, V118, P424, DOI 10.1136/vr.118.15.424; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON R M, 1991; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; Apanius V, 1980, AVIAN GROWTH DEV EVO, P203; AWAN MA, 1994, AVIAN PATHOL, V23, P405, DOI 10.1080/03079459408419012; Barman L. R., 2010, Bangladesh Veterinarian, V27, P56; Begazo AJ, 1989, THESIS U NACL AGRARI; Beissinger S.R., 1992, P73; Beissinger S.R., 2001, CONSERVATION EXPLOIT, P182; BEISSINGER SR, 1991, AUK, V108, P982; Bennett EL, 2011, ORYX, V45, P476, DOI 10.1017/S003060531000178X; Birdlife International, 2014, SPEC FACTSH BROT VER; BirdLife International, 2012, OV THREAT MAN LARG C; BirdLife International, 2014, COUNTR PROF; BirdLife International, 2015, BIRDLIFE DAT ZON; Brooks-Moizer F, 2009, AVIAN INFLUENZA H5N1; Brooks-Pollock E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008479; BRUNINGFANN C, 1992, J AM VET MED ASSOC, V201, P1709; Burger Joanna, 2003, Acta Ethologica, V6, P23; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butron O, 2010, J WILDLIFE DIS, V46, P718, DOI 10.7589/0090-3558-46.3.718; Cantu J. C. G., 2007, ILLEGAL PARROT TRADE; Carrasco AOT, 2009, TROP ANIM HEALTH PRO, V41, P1325, DOI 10.1007/s11250-009-9318-7; Chng SCL, 2015, MARKET EXTINCTION IN; Choisy M, 2006, P ROY SOC B-BIOL SCI, V273, P2025, DOI 10.1098/rspb.2006.3554; Chukwudi OE, 2012, PAK VET J, V32, P354; Clarke RV, 2013, J EXP CRIMINOL, V9, P333, DOI 10.1007/s11292-013-9177-0; Clubb SL, 1980, OUTBREAK VISCEROTROP, P105; Collar N. J., 2000, International Zoo Yearbook, V37, P21, DOI 10.1111/j.1748-1090.2000.tb00704.x; Cox WA, 2014, J WILDLIFE MANAGE, V78, P183, DOI 10.1002/jwmg.670; Alves RRD, 2010, HUM ECOL, V38, P147, DOI 10.1007/s10745-009-9295-5; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Daut EF, 2015, THESIS TEXAS A M U; Daut EF, 2015, J NAT CONSERV, V27, P44, DOI 10.1016/j.jnc.2015.06.005; Daut EF, 2015, J NAT CONSERV, V24, P72, DOI 10.1016/j.jnc.2014.10.005; Deem SL, 2005, J ZOO WILDLIFE MED, V36, P598, DOI 10.1638/04094.1; Denadai J., 2010, International Journal of Poultry Science, V9, P765; Diel DG, 2012, J CLIN MICROBIOL, V50, P378, DOI 10.1128/JCM.06018-11; Drews C, 2001, SOC ANIM, V9, P107, DOI 10.1163/156853001753639233; Dube C., 2007, C OIE, P13; Eniang EE, 2008, ETHIOPIAN J ENV STUD, V1, P68, DOI DOI 10.4314/EJESM.V1I2.41583; ERICKSON GA, 1980, AVIAN DIS, V24, P257, DOI 10.2307/1589785; ERICKSON GA, 1977, AVIAN DIS, V21, P642, DOI 10.2307/1589424; ERICKSON GA, 1978, AM J VET RES, V39, P105; Ferrer R, 2008, REV INVESTIG VET PER, V19, P67; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Forshaw JM, 1989, CANARY WINGED PARAKE, P528; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Galetti Mauro, 1997, Ararajuba, V5, P115; Gastanaga M, 2011, BIRD CONSERV INT, V21, P76, DOI 10.1017/S0959270910000249; GILARDI KVK, 1995, J WILDLIFE DIS, V31, P523, DOI 10.7589/0090-3558-31.4.523; Gilbert M, 2012, BIOL CONSERV, V153, P10, DOI 10.1016/j.biocon.2012.04.024; Godoy SN, 2010, J AVIAN MED SURG, V24, P199, DOI 10.1647/2009-029.1; Gomes GF, 2012, EFFORTS COMBAT WILDL, DOI [10.5772/48351, DOI 10.5772/48351]; Gonzalez JA, 2003, BIOL CONSERV, V114, P437, DOI 10.1016/S0006-3207(03)00071-5; Gonzalez Medina OE, 2004, ECOLOGIA AVES URBANA; GOODMAN BB, 1988, AVIAN DIS, V32, P713, DOI 10.2307/1590989; Grausgruber VW, 1972, WIENER TIERARZTLICHE, V59, P353; Haydon DT, 2004, NAT REV MICROBIOL, V2, P675, DOI 10.1038/nrmicro960; Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804; Heisey DM, 2006, ECOLOGY, V87, P2356, DOI 10.1890/0012-9658(2006)87[2356:TFOGFM]2.0.CO;2; Helton JC, 2003, RELIAB ENG SYST SAFE, V81, P23, DOI 10.1016/S0951-8320(03)00058-9; Herrera M, 2007, BIRD CONSERV INT, V17, P295, DOI 10.1017/S0959270907000858; Hess G, 1996, ECOLOGY, V77, P1617, DOI 10.2307/2265556; Hines Nichole L, 2012, Vet Med Int, V2012, P708216, DOI 10.1155/2012/708216; HIRAI K, 1981, JPN J VET SCI, V43, P557; Hochachka WM, 2000, P NATL ACAD SCI USA, V97, P5303, DOI 10.1073/pnas.080551197; Hoque MA, 2012, PREV VET MED, V103, P49, DOI 10.1016/j.prevetmed.2011.08.013; Hosseini PR, 2004, P ROY SOC B-BIOL SCI, V271, P2569, DOI 10.1098/rspb.2004.2938; Hudson P., 2002, ECOLOGY WILDLIFE DIS; HUGHJONES M, 1973, J HYG-CAMBRIDGE, V71, P325, DOI 10.1017/S0022172400022786; Ivanek R, 2009, APPL ENVIRON MICROB, V75, P5893, DOI 10.1128/AEM.02757-08; Jepson P, 2009, ORYX, V43, P364, DOI 10.1017/S0030605309990251; Jibril AH, 2014, ISRN EPIDEMIOLOGY, V2014, P1, DOI DOI 10.1155/2014/513961; JIMENEZ I, 2004, ORNITOLOGIA COLOMBIA, V2, P53; John TJ, 2000, EUR J EPIDEMIOL, V16, P601, DOI 10.1023/A:1007626510002; JOHNSON DC, 1986, AVIAN DIS, V30, P813, DOI 10.2307/1590590; Johnston J, 1992, COMPUTER MODELLING E, P46; Kaleta E. F., 1988, Newcastle disease., P197; Kapczynski DR, 2006, AVIAN DIS, V50, P336, DOI 10.1637/7479-112905R.1; Karesh W. B., 2012, Animal health and biodiversity: preparing for the future. Compendium of the OIE Global Conference on Wildlife, Paris, France, 23-25 February 2011, P51; KARESH WB, 1995, J ZOO WILDLIFE MED, V26, P2; Karesh WB, 1997, J ZOO WILDLIFE MED, V28, P368; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kinde H, 2005, AVIAN DIS, V49, P195, DOI 10.1637/7229-062704R; Kuiken T, 1998, J WILDLIFE DIS, V34, P457, DOI 10.7589/0090-3558-34.3.457; Kuiken T, 1998, AVIAN PATHOL, V27, P541, DOI 10.1080/03079459808419381; Kuiken T, 1999, WATERBIRDS, V22, P333, DOI 10.2307/1522109; Lande Russell, 2001, Conservation Biology Series (Cambridge), V6, P67; Leighton Frederick A., 2007, P3; Levinson M, 1987, INT WILDLIFE MAGAZIN, V17, P48; Li XX, 2009, VET MICROBIOL, V136, P226, DOI 10.1016/j.vetmic.2008.11.002; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; LINDSEY GD, 1994, J FIELD ORNITHOL, V65, P76; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; Lung NP, 1996, AM J VET RES, V57, P1162; Marini MA, 2005, CONSERV BIOL, V19, P665, DOI 10.1111/j.1523-1739.2005.00706.x; MAY RM, 1979, NATURE, V280, P455, DOI 10.1038/280455a0; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; Miller PJ, 2009, AVIAN DIS, V53, P39, DOI 10.1637/8407-071208-Reg.1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nekaris KAI, 2010, AM J PRIMATOL, V72, P877, DOI 10.1002/ajp.20842; Nijman V, 2012, HERPETOL J, V22, P83; Nilsson G, 1985, IMPORTATION BIRDS US, V2; Alves RRN, 2013, BIRD CONSERV INT, V23, P53, DOI 10.1017/S095927091200010X; OIE, 2015, WORLD AN HLTH INF DA; Oraby T, 2014, J THEOR BIOL, V340, P50, DOI 10.1016/j.jtbi.2013.09.003; Pain DJ, 2006, ANIM CONSERV, V9, P322, DOI 10.1111/j.1469-1795.2006.00040.x; PANIGRAHY B, 1993, AVIAN DIS, V37, P254, DOI 10.2307/1591484; PAREDE L, 1990, AVIAN DIS, V34, P803, DOI 10.2307/1591366; PEARSON GL, 1975, J AM VET MED ASSOC, V167, P610; Pearson GL, 1976, TECHNIQUES ISOLATION, P61; Powell LL, 2009, BIOTROPICA, V41, P279, DOI 10.1111/j.1744-7429.2009.00514.x; Ricklefs RE, 2000, CONDOR, V102, P9, DOI 10.1650/0010-5422(2000)102[0009:DDEOAT]2.0.CO;2; Rios L., 2008, REPORTE SITUACIONAL; RITCHIE BW, 1992, AM J VET RES, V53, P1512; Roldan-Clara B, 2014, ETHNOBIOL CONSERV, V3, DOI 10.15451/ec2014-10-3.5-1-18; Rosen GE, 2010, ECOHEALTH, V7, P24, DOI 10.1007/s10393-010-0317-y; ROWLEY I, 1983, AUST WILDLIFE RES, V10, P329; RSPCA, 2006, ITS TIM STOP WING IT; Rupiper DJ, 1998, J AVIAN MED SURG, V12, P70; Salinas-Melgoza A, 2007, J WILDLIFE MANAGE, V71, P43, DOI 10.2193/2005-646; Sandercock BK, 2002, J APPL STAT, V29, P589, DOI 10.1080/02664760120108818; Schat K. A., 2013, AVIAN IMMUNOLOGY, V2nd; Schulenberg T.S., 2007, BIRDS PERU REVISED U, P18; Shepherd Chris R., 2006, BirdingASIA, V5, P16; Shepherd CR, 2012, ENDANGER SPECIES RES, V11, P201; Shroads CV, 1974, STUDIES POPULATION C; Regueira RFS, 2012, BIOL CONSERV, V149, P16, DOI 10.1016/j.biocon.2012.02.009; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Spradbrow P, 2005, WORLD POULTRY SCI J, V61, P47, DOI 10.1079/WPS200441; Sung YH, 2013, CONSERV BIOL, V27, P1421, DOI 10.1111/cobi.12102; The Poultry Site, 2009, NEWC DIS BACK PER; Therneau T. M., 2014, PACKAGE RPART; Thomsen JB, 1992, PERCEPTIONS CONSERVA; Tieguhong JC, 2006, COMMODITY CHAIN ANAL; Tossas Adrianne G., 2012, Journal of Caribbean Ornithology, V25, P1; United States Department of Agriculture, 2014, NEWC DIS RESP PLAN R; van Boven M, 2008, AVIAN PATHOL, V37, P1, DOI 10.1080/03079450701772391; van den Berg T, 2009, REV SCI TECH OIE, V28, P93; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Vayssieres MP, 2000, J VEG SCI, V11, P679, DOI 10.2307/3236575; VICKERS ML, 1979, AVIAN DIS, V23, P70, DOI 10.2307/1589673; WALKER JW, 1973, AVIAN DIS, V17, P486, DOI 10.2307/1589147; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; Wobeser G, 2002, REV SCI TECH OIE, V21, P159, DOI 10.20506/rst.21.1.1326; Wonham MJ, 2004, P ROY SOC B-BIOL SCI, V271, P501, DOI 10.1098/rspb.2003.2608; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x; Woodroffe R, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P123; World Parrot Trust, 2004, DEADL NEWC DIS DISC; Wyatt KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003602; Young AM, 2012, ANIM CONSERV, V15, P28, DOI 10.1111/j.1469-1795.2011.00477.x; Zhang L, 2008, BIODIVERS CONSERV, V17, P1493, DOI 10.1007/s10531-008-9358-8	158	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147517	10.1371/journal.pone.0147517	http://dx.doi.org/10.1371/journal.pone.0147517			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816214	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528200036
J	Mata-Pinzon, Z; Valladares, AA; Valladares, RM; Valladares, A				Mata-Pinzon, Zaahel; Valladares, Ariel A.; Valladares, Renela M.; Valladares, Alexander			Superconductivity in Bismuth. A New Look at an Old Problem	PLOS ONE			English	Article							AB-INITIO; ELECTRONIC-PROPERTIES; AMORPHOUS BISMUTH; PHONON SPECTRUM; LOW TEMPERATURE; DENSITY; LIQUID; DIFFRACTION; SI; MOLECULES	To investigate the relationship between atomic topology, vibrational and electronic properties and superconductivity of bismuth, a 216-atom amorphous structure (a-Bi216) was computer-generated using our undermelt-quench approach. Its pair distribution function compares well with experiment. The calculated electronic and vibrational densities of states (eDOS and vDOS, respectively) show that the amorphous eDOS is about 4 times the crystalline at the Fermi energy, whereas for the vDOS the energy range of the amorphous is roughly the same as the crystalline but the shapes are quite different. A simple BCS estimate of the possible crystalline superconducting transition temperature gives an upper limit of 1.3 mK. The e-ph coupling is more preponderant in a-Bi than in crystalline bismuth (x-Bi) as indicated by the lambda obtained via McMillan's formula, lambda(c) = 0.24 and experiment lambda(a) = 2.46. Therefore with respect to x-Bi, superconductivity in a-Bi is enhanced by the higher values of. and of eDOS at the Fermi energy.	[Mata-Pinzon, Zaahel; Valladares, Ariel A.] Univ Nacl Autonoma Mexico, Inst Invest & Mat, Dept Mat Condensada & Criogenia, Mexico City 04510, DF, Mexico; [Valladares, Renela M.; Valladares, Alexander] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Fis, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Valladares, AA (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest & Mat, Dept Mat Condensada & Criogenia, Mexico City 04510, DF, Mexico.	valladar@unam.mx	VALLADARES, ARIEL A/G-1788-2017	Valladares, Ariel A./0000-0003-1505-2244; Mata-Pinzon, Zaahel/0000-0001-5307-5354	Direccion General de Asuntos del Personal Academico, UNAM; Proyecto "Simulando materiales metalicos amorfos. Su estructura y propiedades fisicas [IN110914]	Direccion General de Asuntos del Personal Academico, UNAM(Universidad Nacional Autonoma de Mexico); Proyecto "Simulando materiales metalicos amorfos. Su estructura y propiedades fisicas	This work was supported by Direccion General de Asuntos del Personal Academico, UNAM. Proyecto IN110914, "Simulando materiales metalicos amorfos. Su estructura y propiedades fisicas.	Alvarez F, 2002, J NON-CRYST SOLIDS, V299, P259, DOI 10.1016/S0022-3093(01)01005-5; [Anonymous], 2015, PHYSICA C, V514, piv, DOI [10.1016/S0921-4534(15)00168-9, DOI 10.1016/S0921-4534(15)00168-9]; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BARYAM Y, 1986, PHYS REV LETT, V56, P2203, DOI 10.1103/PhysRevLett.56.2203; BEEBY JL, 1989, J NON-CRYST SOLIDS, V114, P253, DOI 10.1016/0022-3093(89)90128-2; BEEBY JL, 1985, PHYS REV B, V32, P6464, DOI 10.1103/PhysRevB.32.6464; CHAMBERLAIN O, 1950, PHYS REV, V77, P305, DOI 10.1103/PhysRev.77.305; CHEN JT, 1967, PHYS LETT A, VA 25, P679, DOI 10.1016/0375-9601(67)90471-9; CHEN TT, 1969, PHYS REV LETT, V22, P526, DOI 10.1103/PhysRevLett.22.526; Delley B, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.155125; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; DESORBO W, 1958, J PHYS CHEM-US, V62, P965, DOI 10.1021/j150566a017; Dijk V, 1981, LANDOLT BORNSTEIN, P53; FUJIME S, 1966, JPN J APPL PHYS, V5, P764, DOI 10.1143/JJAP.5.764; Galvan-Colin J, 2013, MRS P, P1517; GONZE X, 1988, PHYS SCRIPTA, V37, P785, DOI 10.1088/0031-8949/37/5/022; GONZE X, 1990, PHYS REV B, V41, P11827, DOI 10.1103/PhysRevB.41.11827; Grimvall G., 1981, ELECT PHONON INTERAC; Grimvall G., 1999, THERMOPHYSICAL PROPE; HARRIS J, 1985, PHYS REV B, V31, P1770, DOI 10.1103/PhysRevB.31.1770; Herrera WT, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40337-3; Ishimaru M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.055502; Jezequel G, 1997, PHYS REV B, V56, P6620, DOI 10.1103/PhysRevB.56.6620; KAKIZAKI A, 1988, J PHYS F MET PHYS, V18, P2617, DOI 10.1088/0305-4608/18/12/012; LEY L, 1973, PHYS REV B, V8, P641, DOI 10.1103/PhysRevB.8.641; Lifshits I. M., 1988, INTRO THEORY DISORDE; LIN ZJ, 1993, J PHYS-CONDENS MAT, V5, P1055, DOI 10.1088/0953-8984/5/8/008; Madelung O., 1998, NONTETRAHEDRALLY BON, V41C; Mata-Pinzon Z, 2013, MRS P, P1520; MCMILLAN WL, 1965, PHYS REV LETT, V14, P108, DOI 10.1103/PhysRevLett.14.108; REYNOLDS JM, 1950, PHYS REV, V79, P405, DOI 10.1103/PhysRev.79.405; Richter H., 1969, J VAC SCI TECHNOL, P855; Romero C, 2010, MATERIALS, V3, P467, DOI 10.3390/ma3010467; Santiago-Cortes CU, 2011, THESIS U NACL AUTONO; TAKAGI M, 1956, J PHYS SOC JPN, V11, P396, DOI 10.1143/JPSJ.11.396; Tsuei CC, 2005, CONCISE ENCY MAGNETI, P43; Valladares A. A., 2008, ELECT VIBRATIONAL ST, P61; Valladares AA, 2001, EUR PHYS J B, V22, P443, DOI 10.1007/s100510170094; Valladares AA, 2011, MATERIALS, V4, P716, DOI 10.3390/ma4040716; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; Wyckoff R.W.G, 1963, CRYST STRUCT	43	21	21	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147645	10.1371/journal.pone.0147645	http://dx.doi.org/10.1371/journal.pone.0147645			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815431	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528200043
J	Seeger, B; Klawonn, F; Bekale, BN; Steinberg, P				Seeger, Bettina; Klawonn, Frank; Bekale, Boris Nguema; Steinberg, Pablo			Mixture Effects of Estrogenic Pesticides at the Human Estrogen Receptor alpha and beta	PLOS ONE			English	Article							IN-VITRO; XENOESTROGENS; DISRUPTION; ACTIVATION; MECHANISM; CHEMICALS; EXPOSURE; ASSAYS	Consumers of fruits and vegetables are frequently exposed to small amounts of hormonally active pesticides, some of them sharing a common mode of action such as the activation of the human estrogen receptor alpha (hER alpha) or beta (hER beta). Therefore, it is of particular importance to evaluate risks emanating from chemical mixtures, in which the individual pesticides are present at human-relevant concentrations, below their corresponding maximum residue levels. Binary and ternary iso-effective mixtures of estrogenic pesticides at effect concentrations eliciting a 1 or 10% effect in the presence or absence of 17 beta-estradiol were tested experimentally at the hER alpha in the yeast-based estrogen screen (YES) assay as well as in the human U2-OS cell-based ER alpha chemical-activated luciferase gene expression (ER alpha CALUX) assay and at the hER beta in the ER beta CALUX assay. The outcome was then compared to predictions calculated by means of concentration addition. In most cases, additive effects were observed with the tested combinations in all three test systems, an observation that supports the need to expand the risk assessment of pesticides and consider cumulative risk assessment. An additional testing of mixture effects at the hER beta showed that most test substances being active at the hER alpha could also elicit additive effects at the hER beta, but the hER beta was less sensitive. In conclusion, effects of the same ligands at the hER alpha and the hER beta could influence the estrogenic outcome under physiological conditions.	[Seeger, Bettina; Steinberg, Pablo] Univ Vet Med Hannover, Inst Food Toxicol & Analyt Chem, Bischofsholer Damm 15, D-30173 Hannover, Germany; [Klawonn, Frank] Helmholtz Ctr Infect Res, Biostat Grp, Inhoffenstr 7, D-38124 Braunschweig, Germany; [Klawonn, Frank; Bekale, Boris Nguema] Ostfalia Univ Appl Sci, Dept Comp Sci, Salzdahlumerstr 46-48, D-38302 Wolfenbuttel, Germany	University of Veterinary Medicine Hannover, Foundation; Helmholtz Association; Helmholtz-Center for Infection Research	Seeger, B (corresponding author), Univ Vet Med Hannover, Inst Food Toxicol & Analyt Chem, Bischofsholer Damm 15, D-30173 Hannover, Germany.	bettina.seeger@tiho-hannover.de	Seeger, Bettina/H-9072-2019; Klawonn, Frank/HFH-5887-2022	Seeger, Bettina/0000-0002-4653-2841; Klawonn, Frank/0000-0001-9613-182X	Federal Institute for Risk Assessment in Berlin, Germany [FK.3 1329-484 6433898]	Federal Institute for Risk Assessment in Berlin, Germany	This study was financially supported by the Federal Institute for Risk Assessment in Berlin, Germany (grant FK.3 1329-484 6433898). PS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HR, 2002, TOXICOL APPL PHARM, V179, P1, DOI 10.1006/taap.2001.9347; Auld DS, 2008, ACS CHEM BIOL, V3, P463, DOI 10.1021/cb8000793; Benford D, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3490; Bergman A, 2013, ENVIRON HEALTH PERSP, V121, pA104, DOI 10.1289/ehp.1205448; Bitsch Nikola, 2002, Umweltwissenschaften und Schadstoff-Forschung, V14, P76, DOI 10.1065/uwsf2002.04.016; Bottner M, 2014, J STEROID BIOCHEM, V139, P245, DOI 10.1016/j.jsbmb.2013.03.003; Bonefeld-Jorgensen EC, 2005, MOL CELL ENDOCRINOL, V244, P20, DOI 10.1016/j.mce.2005.01.017; Charles GD, 2002, TOXICOL SCI, V68, P349, DOI 10.1093/toxsci/68.2.349; European Food Safety Authority, 2014, EFSA J, V12, DOI [10.2903/j.efsa.2014.3694, 10.2903/j.efsa.2015.4038]; Gustafsson JA, 1999, J ENDOCRINOL, V163, P379, DOI 10.1677/joe.0.1630379; Hass U, 2007, ENVIRON HEALTH PERSP, V115, P122, DOI 10.1289/ehp.9360; Hass U, 2012, REPROD TOXICOL, V34, P261, DOI 10.1016/j.reprotox.2012.05.090; Kolle SN, 2010, TOXICOL IN VITRO, V24, P2030, DOI 10.1016/j.tiv.2010.08.008; Kortenkamp A, 1998, SCI TOTAL ENVIRON, V221, P59, DOI 10.1016/S0048-9697(98)00261-7; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P98, DOI 10.1289/ehp.9357; Kortenkamp A, 2014, REPRODUCTION, V147, P515, DOI 10.1530/REP-13-0440; Loewe S, 1926, N-S ARCH EX PATH PH, V114, P313; Medjakovic S, 2014, ENVIRON TOXICOL, V29, P1201, DOI 10.1002/tox.21852; Mertl J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100952; Montano M, 2010, TOXICOL SCI, V115, P462, DOI 10.1093/toxsci/kfq056; Niforou Katerina N., 2008, Cancer Genomics & Proteomics, V5, P63; OECD, 2015, TEST NO 455 DRAFT PE; Payne J, 2000, ENVIRON HEALTH PERSP, V108, P983, DOI 10.1289/ehp.00108983; Payne J, 2001, ENVIRON HEALTH PERSP, V109, P391, DOI 10.2307/3454899; Rajapakse N, 2002, ENVIRON HEALTH PERSP, V110, P917, DOI 10.1289/ehp.02110917; Rajapakse N, 2004, ENVIRON SCI TECHNOL, V38, P6343, DOI 10.1021/es049681e; Routledge EJ, 1996, ENVIRON TOXICOL CHEM, V15, P241, DOI 10.1002/etc.5620150303; Scholze M, 2001, ENVIRON TOXICOL CHEM, V20, P448, DOI 10.1002/etc.5620200228; Seeger B, 2016, TOXICOL LETT, V241, P193, DOI 10.1016/j.toxlet.2015.11.015; Silva E, 2002, ENVIRON SCI TECHNOL, V36, P1751, DOI 10.1021/es0101227; Sotoca AM, 2010, J STEROID BIOCHEM, V122, P204, DOI 10.1016/j.jsbmb.2010.06.010; Teng Y, 2013, TOXICOL SCI, V131, P71, DOI 10.1093/toxsci/kfs290; van der Burg B, 2010, REPROD TOXICOL, V30, P73, DOI 10.1016/j.reprotox.2010.04.007; Vinggaard AM, 1999, FOOD ADDIT CONTAM, V16, P533, DOI 10.1080/026520399283678	34	16	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147490	10.1371/journal.pone.0147490	http://dx.doi.org/10.1371/journal.pone.0147490			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812056	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528000035
J	Cattel, J; Kaur, R; Gibert, P; Martinez, J; Fraimout, A; Jiggins, F; Andrieux, T; Siozios, S; Anfora, G; Miller, W; Rota-Stabelli, O; Mouton, L				Cattel, Julien; Kaur, Rupinder; Gibert, Patricia; Martinez, Julien; Fraimout, Antoine; Jiggins, Francis; Andrieux, Thibault; Siozios, Stefanos; Anfora, Gianfranco; Miller, Wolfgang; Rota-Stabelli, Omar; Mouton, Laurence			Wolbachia in European Populations of the Invasive Pest Drosophila suzukii: Regional Variation in Infection Frequencies	PLOS ONE			English	Article							INDUCED CYTOPLASMIC INCOMPATIBILITY; MATSUMURA DIPTERA DROSOPHILIDAE; RHAGOLETIS-CERASI DIPTERA; SPOTTED WING DROSOPHILA; CHERRY FRUIT-FLY; DYNAMICS; TEMPERATURE; EXPRESSION; DENSITY; MUSCLE	The invasive pest Drosophila suzukii is characterized by a specific fresh-fruit targeting behavior and has quickly become a menace for the fruit economy of newly infested North American and European regions. D. suzukii carries a strain of the endosymbiotic bacterium Wolbachia, named wSuz, which has a low infection frequency and no reproductive manipulation capabilities in American populations of D. suzukii. To further understand the nature of wSuz biology and assess its utility as a tool for controlling this pest's populations, we investigated the prevalence of Wolbachia in 23 European D. suzukii populations, and compared our results with those available in American populations. Our data showed a highly variable infection frequency with a mean prevalence of 46%, which is significantly higher than the 17% found in American populations. Based on Multilocus Sequence Typing analysis, a single wSuz strain was diagnosed in all European populations of D. suzukii. In agreement with American data, we found no evidence of cytoplasmic incompatibility induced by wSuz. These findings raise two questions: a) why Wolbachia is maintained in field populations of D. suzukii and b) what are the selective forces responsible for the variation in prevalence within populations, particularly between European and American continents? Our results provide new insights into the D. suzukii-Wolbachia association and highlight regional variations that await further investigation and that should be taken into account for using Wolbachia-based pest management programs.	[Cattel, Julien; Gibert, Patricia; Andrieux, Thibault; Mouton, Laurence] Univ Lyon 1, Lab Biometrie & Biol Evolut, UMR CNRS 5558, 43 Bd 11 Novembre 1918, F-69622 Villeurbanne, France; [Kaur, Rupinder; Siozios, Stefanos; Anfora, Gianfranco; Rota-Stabelli, Omar] Fdn Edmund Mach, Dept Sustainable Agroecosyst & Bioresources, Chem Ecol Lab, San Michele All Adige, TN, Italy; [Kaur, Rupinder; Miller, Wolfgang] Med Univ Vienna, Ctr Anat & Cell Biol, Lab Genome Dynam, Dept Cell & Dev Biol, Vienna, Austria; [Martinez, Julien; Jiggins, Francis] Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England; [Fraimout, Antoine] Univ Paris 04, EPHE Museum Natl Hist Nat, Inst Systemat,Evolut,Biodiversite ISYEB, UMR CNRS 7205, 57 Rue Cuvier, Paris, France; [Siozios, Stefanos] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Fondazione Edmund Mach; Medical University of Vienna; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Liverpool	Cattel, J (corresponding author), Univ Lyon 1, Lab Biometrie & Biol Evolut, UMR CNRS 5558, 43 Bd 11 Novembre 1918, F-69622 Villeurbanne, France.; Kaur, R (corresponding author), Fdn Edmund Mach, Dept Sustainable Agroecosyst & Bioresources, Chem Ecol Lab, San Michele All Adige, TN, Italy.; Kaur, R (corresponding author), Med Univ Vienna, Ctr Anat & Cell Biol, Lab Genome Dynam, Dept Cell & Dev Biol, Vienna, Austria.	juliencattel@gmail.com; rupinderkaur@fmach.it	Miller, Wolfgang J/E-5716-2015; Martinez, Julien/AAW-6287-2020; Rota-Stabelli, Omar/G-8477-2011; Kaur, Rupinder/K-4709-2019	Miller, Wolfgang J/0000-0002-5044-6276; Martinez, Julien/0000-0001-8210-2921; Rota-Stabelli, Omar/0000-0002-0030-7788; Kaur, Rupinder/0000-0002-2132-8107; Gibert, Patricia/0000-0002-9461-6820; Mouton, Laurence/0000-0002-2718-9953; ANFORA, Gianfranco/0000-0003-2545-1409; Siozios, Stefanos/0000-0002-1104-7061; Jiggins, Francis Michael/0000-0001-7470-8157; Fraimout, Antoine/0000-0003-4552-3553	CNRS [IFR41-UMR5558]; Office National de l'Eau est des Milieux Aquatiques (ONEMA) (Ecophyto project) for France; FEM Accordo di Programma Provincia Autonoma di Trento and research funds for GrandiProgetti, Project LExEM (Laboratory of excellence for epidemiology and modeling), Italy; Rhone-Alpes region ("ARC Program" Grant); FIRS>T (FEM International Research School-Trentino) programme at Fondazione Edmund Mach, Italy	CNRS(Centre National de la Recherche Scientifique (CNRS)); Office National de l'Eau est des Milieux Aquatiques (ONEMA) (Ecophyto project) for France; FEM Accordo di Programma Provincia Autonoma di Trento and research funds for GrandiProgetti, Project LExEM (Laboratory of excellence for epidemiology and modeling), Italy; Rhone-Alpes region ("ARC Program" Grant)(Region Auvergne-Rhone-Alpes); FIRS>T (FEM International Research School-Trentino) programme at Fondazione Edmund Mach, Italy	This work was funded partly by CNRS (IFR41-UMR5558) and Office National de l'Eau est des Milieux Aquatiques (ONEMA) (Ecophyto project) for France, and FEM Accordo di Programma Provincia Autonoma di Trento and research funds for GrandiProgetti, Project LExEM (Laboratory of excellence for epidemiology and modeling, http://www.lexem.eu), Italy. Julien Cattel is the recipient of a PhD studentship from the Rhone-Alpes region ("ARC Program" Grant) and Rupinder Kaur has obtained a PhD fellowship from the FIRS>T (FEM International Research School-Trentino) programme at Fondazione Edmund Mach, Italy.	Atyame CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119288; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Ballard JWO, 2007, INSECT MOL BIOL, V16, P799, DOI 10.1111/j.1365-2583.2007.00760.x; BOLLER EF, 1976, ENTOMOL EXP APPL, V20, P237, DOI 10.1007/BF00573829; Bourtzis K, 2008, ADV EXP MED BIOL, V627, P104, DOI 10.1007/978-0-387-78225-6_9; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Calabria G, 2012, J APPL ENTOMOL, V136, P139, DOI 10.1111/j.1439-0418.2010.01583.x; CAMPBELL HD, 1993, P NATL ACAD SCI USA, V90, P11386, DOI 10.1073/pnas.90.23.11386; Chabert S, 2012, BIOL CONTROL, V63, P40, DOI 10.1016/j.biocontrol.2012.05.005; Chandler JA, 2014, PEERJ, V2, DOI 10.7717/peerj.474; Cini A, 2014, J PEST SCI, V87, P559, DOI 10.1007/s10340-014-0617-z; Cini A, 2012, B INSECTOL, V65, P149; Cordaux R, 2008, MOL BIOL EVOL, V25, P1889, DOI 10.1093/molbev/msn134; Cuthbertson Andrew G S, 2014, Insects, V5, P488, DOI 10.3390/insects5020488; Dobson SL, 2002, GENETICS, V160, P1087; Douglas AE, 2007, TRENDS BIOTECHNOL, V25, P338, DOI 10.1016/j.tibtech.2007.06.003; Dreves A, 2009, 899116 EM OR U, VEM 8991, P1; Dyck V.A., 2006, STERILE INSECT TECHN; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fast EM, 2011, SCIENCE, V334, P990, DOI 10.1126/science.1209609; Ferreira AG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004507; Fry AJ, 2002, EVOLUTION, V56, P1976, DOI 10.1111/j.0014-3820.2002.tb00123.x; Gargani E, 2013, REDIA, V96, P85; Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; Hamm CA, 2014, MOL ECOL, V23, P4871, DOI 10.1111/mec.12901; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hoffmann AA, 1998, GENETICS, V148, P221; Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84; Jaenike J, 2009, OIKOS, V118, P353, DOI 10.1111/j.1600-0706.2008.17110.x; Kanzawa T, 1936, REV APPL ENTOMOL, V24, P315; Lee JC, 2011, PEST MANAG SCI, V67, P1349, DOI 10.1002/ps.2271; Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369; Mazzetto F, 2015, B INSECTOL, V68, P153; Mitsui H, 2006, POPUL ECOL, V48, P233, DOI 10.1007/s10144-006-0260-5; Morrow JL, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0474-2; Mouton L, 2006, PARASITOLOGY, V132, P49, DOI 10.1017/S0031182005008723; O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797; Ometto L, 2013, GENOME BIOL EVOL, V5, P745, DOI 10.1093/gbe/evt034; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Pontier SM, 2015, CURR BIOL, V25, P2339, DOI 10.1016/j.cub.2015.07.052; Poyet M, 2013, PHYSIOL ENTOMOL, V38, P45, DOI 10.1111/phen.12002; R Core Team, 2021, R LANGUAGE ENV STAT; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; Riegler M, 2002, MOL ECOL, V11, P2425, DOI 10.1046/j.1365-294X.2002.01614.x; Rota-Stabelli O, 2013, CURR BIOL, V23, pR8, DOI 10.1016/j.cub.2012.11.021; Schneider D, 2012, FRONT MICROBIOL SER, P149; SIOZIOS S., 2013, GENOME ANNOUNCEMENTS, V1, P1, DOI DOI 10.1128/GEN0MEA.00032-13; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Tochen S, 2014, ENVIRON ENTOMOL, V43, P501, DOI 10.1603/EN13200; TURELLI M, 1995, GENETICS, V140, P1319; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Weinert LA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0249; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Woltz JM, 2015, J APPL ENTOMOL, V139, P759, DOI 10.1111/jen.12200; Yamada R, 2007, GENETICS, V177, P801, DOI 10.1534/genetics.106.068486; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zug R, 2015, BIOL REV, V90, P89, DOI 10.1111/brv.12098	63	24	26	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147766	10.1371/journal.pone.0147766	http://dx.doi.org/10.1371/journal.pone.0147766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809119	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800208
J	Quinonez-Calvache, EM; Rios-Chaparro, DI; Ramirez, JD; Soto-De Leon, SC; Camargo, M; Del Rio-Ospina, L; Sanchez, R; Patarroyo, ME; Patarroyo, MA				Margarita Quinonez-Calvache, Edith; Rios-Chaparro, Dora Ines; David Ramirez, Juan; Cecilia Soto-De Leon, Sara; Camargo, Milena; Del Rio-Ospina, Luisa; Sanchez, Ricardo; Elkin Patarroyo, Manuel; Alfonso Patarroyo, Manuel			Chlamydia trachomatis Frequency in a Cohort of HPV-Infected Colombian Women	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; HUMAN-PAPILLOMAVIRUS INFECTION; MOLECULAR-DETECTION; CANCER; PERSISTENCE; LESIONS; RISK; ASSOCIATION; COINFECTION	Background Chlamydia trachomatis (C. trachomatis), an obligate intracellular bacterium, is the commonest infectious bacterial agent of sexual transmission throughout the world. It has been shown that the presence of this bacteria in the cervix represents a risk regarding HPV persistence and, thereafter, in developing cervical cancer (CC). Prevalence rates may vary from 2% to 17% in asymptomatic females, depending on the population being analysed. This study reports the identification of C. trachomatis in a cohort of 219 HPV-infected Colombian females. Methods C. trachomatis infection frequency was determined during each of the study's follow-up visits; it was detected by amplifying the cryptic plasmid sequence by polymerase chain reaction (PCR) using two sets of primers: KL5/KL6 and KL1/KL2. Infection was defined as a positive PCR result using either set of primers at any time during the study. Cox proportional risk models were used for evaluating the association between the appearance of infection and a group of independent variables. Results Base line C. trachomatis infection frequency was 28% (n = 61). Most females infected by C. trachomatis were infected by multiple types of HPV (77.42%), greater prevalence occurring in females infected with HPV-16 (19.18%), followed by HPV-58 (17.81%). It was observed that females having had the most sexual partners (HR = 6.44: 1.59-26.05 95% CI) or infection with multiple types of HPV (HR = 2.85: 1.22-6.63 95% CI) had the greatest risk of developing C. trachomatis. Conclusions The study provides data regarding the epidemiology of C. trachomatis /HPV coinfection in different population groups of Colombian females and contributes towards understanding the natural history of C. trachomatis infection.	[Margarita Quinonez-Calvache, Edith; Cecilia Soto-De Leon, Sara; Camargo, Milena; Del Rio-Ospina, Luisa; Sanchez, Ricardo; Elkin Patarroyo, Manuel; Alfonso Patarroyo, Manuel] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia; [Margarita Quinonez-Calvache, Edith] Univ Nacl Colombia, Fac Sci, Inst Biotechnol, Bogota, Colombia; [Rios-Chaparro, Dora Ines; David Ramirez, Juan] Univ Rosario, Fac Nat & Math Sci, GIMUR, Bogota, Colombia; [Cecilia Soto-De Leon, Sara; Camargo, Milena; Alfonso Patarroyo, Manuel] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia; [Del Rio-Ospina, Luisa; Sanchez, Ricardo; Elkin Patarroyo, Manuel] Univ Nacl Colombia, Sch Med, Bogota, Colombia	Universidad Nacional de Colombia; Universidad del Rosario; Universidad del Rosario; Universidad Nacional de Colombia	Patarroyo, MA (corresponding author), Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia.; Patarroyo, MA (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia.	mapatarr.fidic@gmail.com	De León, Sara Cecilia Soto/AAF-6301-2021; Leon, Sara Cecilia Soto-De/ABD-3186-2020; Rios-Chaparro, Dora-Ines/G-4795-2016; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017; Patarroyo, Manuel A/I-8046-2016; Ramírez, Juan David/F-3524-2016; Sanchez, Ricardo/K-8254-2015	De León, Sara Cecilia Soto/0000-0003-4515-6749; Rios-Chaparro, Dora-Ines/0000-0002-7552-2677; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; Patarroyo, Manuel A/0000-0002-4751-2500; Ramírez, Juan David/0000-0002-1344-9312; Sanchez, Ricardo/0000-0002-7540-4734; Camargo, Milena/0000-0003-0246-0716				BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Bellaminutti S, 2014, J MED VIROL, V86, P1920, DOI 10.1002/jmv.24041; Calil LN, 2011, BRAZ J INFECT DIS, V15, P126, DOI [10.1590/S1413-86702011000200006, 10.1016/S1413-8670(11)70157-X]; Camargo M, 2011, ANN EPIDEMIOL, V21, P204, DOI 10.1016/j.annepidem.2010.11.003; Castellsague X, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0551-y; Cribb P, 2002, MEM I OSWALDO CRUZ, V97, P897, DOI 10.1590/S0074-02762002000600027; Deluca GD, 2011, BRAZ J INFECT DIS, V15, P567, DOI 10.1016/S1413-8670(11)70252-5; de Abreu ALP, 2012, AM J TROP MED HYG, V87, P1149, DOI 10.4269/ajtmh.2012.12-0287; de Vries HJC, 2015, CURR OPIN INFECT DIS, V28, P61, DOI 10.1097/QCO.0000000000000129; Deluca GD, 2005, EPIDEMIOLOGIA MOL CH; de Paula FDF, 2007, DIAGN CYTOPATHOL, V35, P198, DOI 10.1002/dc.20629; Finan R. R., 2002, Archives of Gynecology and Obstetrics, V266, P168, DOI 10.1007/s00404-001-0261-8; Fischer N, 2002, EUR J GYNAECOL ONCOL, V23, P247; Geisler WM, 2008, SEX TRANSM DIS, V35, P119, DOI 10.1097/OLQ.0b013e318151497d; Girgis S. A., 2015, International Journal of Current Microbiology and Applied Sciences, V4, P937; Golijow CD, 2005, GYNECOL ONCOL, V96, P181, DOI 10.1016/j.ygyno.2004.09.037; Gottlieb SL, 2010, J INFECT DIS, V201, pS156, DOI 10.1086/652396; Gravningen K, 2016, SEX TRANSM INFECT, V92, P97, DOI 10.1136/sextrans-2015-052152; Joyner JL, 2002, SEX TRANSM DIS, V29, P196, DOI 10.1097/00007435-200204000-00002; Kaushic C, 2000, INFECT IMMUN, V68, P4207, DOI 10.1128/IAI.68.7.4207-4216.2000; Kreader CA, 1996, APPL ENVIRON MICROB, V62, P1102, DOI 10.1128/AEM.62.3.1102-1106.1996; MAHONY JB, 1992, J CLIN MICROBIOL, V30, P2241, DOI 10.1128/JCM.30.9.2241-2245.1992; Tavares MCM, 2014, MOL BIOL REP, V41, P865, DOI 10.1007/s11033-013-2927-2; Ministerio-de-salud-Colombia, 2012, SIT INF TRANSM SEX D; Molano M, 2005, J INFECT DIS, V191, P907, DOI 10.1086/428287; Molano M, 2003, SEX TRANSM INFECT, V79, P474, DOI 10.1136/sti.79.6.474; Paba P, 2008, INTERVIROLOGY, V51, P230, DOI 10.1159/000156481; Peuchant O, 2015, DIAGN MICR INFEC DIS, V82, P14, DOI 10.1016/j.diagmicrobio.2015.01.014; Pinto VM, 2011, SEX TRANSM DIS, V38, P957, DOI 10.1097/OLQ.0b013e31822037fc; Santos Cristina, 2003, Braz J Infect Dis, V7, P91, DOI 10.1590/S1413-86702003000200001; Schachter J, 1997, IMMUNOL INVEST, V26, P157, DOI 10.3109/08820139709048923; Silins I, 2005, INT J CANCER, V116, P110, DOI 10.1002/ijc.20970; Silva J, 2014, ARCH GYNECOL OBSTET, V289, P715, DOI 10.1007/s00404-013-3122-3; Smith JS, 2004, INT J CANCER, V111, P431, DOI 10.1002/ijc.20257; Smith JS, 2002, J INFECT DIS, V185, P324, DOI 10.1086/338569; Soto-De Leon SC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-395; Wallin KL, 2002, INT J CANCER, V101, P371, DOI 10.1002/ijc.10639; World Health Organization, 2011, PREV INC SEL SEX TRA	38	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147504	10.1371/journal.pone.0147504	http://dx.doi.org/10.1371/journal.pone.0147504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807957	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800115
J	Fujiwara, S; Kawazoe, T; Ohnishi, K; Kitagawa, T; Popa, C; Valls, M; Genin, S; Nakamura, K; Kuramitsu, Y; Tanaka, N; Tabuchi, M				Fujiwara, Shoko; Kawazoe, Tomoki; Ohnishi, Kouhei; Kitagawa, Takao; Popa, Crina; Valls, Marc; Genin, Stephane; Nakamura, Kazuyuki; Kuramitsu, Yasuhiro; Tanaka, Naotaka; Tabuchi, Mitsuaki			RipAY, a Plant Pathogen Effector Protein, Exhibits Robust -Glutamyl Cyclotransferase Activity When Stimulated by Eukaryotic Thioredoxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plant defense; redox regulation; Saccharomyces cerevisiae; thioredoxin; type III secretion system (T3SS)	RALSTONIA-SOLANACEARUM; SACCHAROMYCES-CEREVISIAE; PSEUDOMONAS-AERUGINOSA; GLUTATHIONE; IDENTIFICATION; GENE; REPERTOIRE; ACTIVATION; EXPRESSION; SYSTEM	The plant pathogenic bacterium Ralstonia solanacearum injects more than 70 effector proteins (virulence factors) into the host plant cells via the needle-like structure of a type III secretion system. The type III secretion system effector proteins manipulate host regulatory networks to suppress defense responses with diverse molecular activities. Uncovering the molecular function of these effectors is essential for a mechanistic understanding of R. solanacearum pathogenicity. However, few of the effectors from R. solanacearum have been functionally characterized, and their plant targets remain largely unknown. Here, we show that the ChaC domain-containing effector RipAY/RSp1022 from R. solanacearum exhibits -glutamyl cyclotransferase (GGCT) activity to degrade the major intracellular redox buffer, glutathione. Heterologous expression of RipAY, but not other ChaC family proteins conserved in various organisms, caused growth inhibition of yeast Saccharomyces cerevisiae, and the intracellular glutathione level was decreased to approximate to 30% of the normal level following expression of RipAY in yeast. Although active site mutants of GGCT activity were non-toxic, the addition of glutathione did not reverse the toxicity, suggesting that the toxicity might be a consequence of activity against other -glutamyl compounds. Intriguingly, RipAY protein purified from a bacterial expression system did not exhibit any GGCT activity, whereas it exhibited robust GGCT activity upon its interaction with eukaryotic thioredoxins, which are important for intracellular redox homeostasis during bacterial infection in plants. Our results suggest that RipAY has evolved to sense the host intracellular redox environment, which triggers its enzymatic activity to create a favorable environment for R. solanacearum infection.	[Fujiwara, Shoko; Kawazoe, Tomoki; Tanaka, Naotaka; Tabuchi, Mitsuaki] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, 2393 Ikenobe Miki Cho, Kagawa 7610795, Japan; [Ohnishi, Kouhei] Kochi Univ, Res Inst Mol Genet, Nankoku, Kochi 7830093, Japan; [Kitagawa, Takao; Kuramitsu, Yasuhiro] Yamaguchi Univ, Grad Sch Med, Dept Biochem & Funct Prote, Ube, Yamaguchi 7558505, Japan; [Popa, Crina; Valls, Marc] Univ Barcelona, Dept Genet, Bellaterra, Catalonia, Spain; [Popa, Crina; Valls, Marc] Ctr Res Agr Genom, Bellaterra, Catalonia, Spain; [Genin, Stephane] INRA CNRS, Lab Interact Plantes Microoganismes, UMR441 2594, Castanet Tolosan, France; [Nakamura, Kazuyuki] Tokuyama Med Assoc Hosp, Ctr Clin Labs, Shunan 7450846, Japan	Kagawa University; Kochi University; Yamaguchi University; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Tabuchi, M (corresponding author), Kagawa Univ, Fac Agr, Dept Appl Biol Sci, 2393 Ikenobe Miki Cho, Kagawa 7610795, Japan.	mtabuchi@ag.kagawa-u.ac.jp	Valls, Marc/I-7285-2015; Ohnishi, Kouhei/AAN-9527-2020; Tabuchi, Mitsuaki/AAY-7378-2021; Tabuchi, Mitsuaki/E-9544-2010	Valls, Marc/0000-0003-2312-0091; Tabuchi, Mitsuaki/0000-0002-2042-691X; Tabuchi, Mitsuaki/0000-0002-2042-691X; Popa, Crina Mihaela/0000-0002-4294-9949; Genin, Stephane/0000-0003-2498-2400	Japan Society for the Promotion of Science [22580095, 25450104]; Institute of Fermentation, Osaka	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute of Fermentation, Osaka	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 22580095 and 25450104 and also, in part, by the General Research Grant of the Institute of Fermentation, Osaka. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson DM, 2011, MOL MICROBIOL, V82, P1454, DOI 10.1111/j.1365-2958.2011.07904.x; Angot A, 2006, P NATL ACAD SCI USA, V103, P14620, DOI 10.1073/pnas.0509393103; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bourbouloux A, 2000, J BIOL CHEM, V275, P13259, DOI 10.1074/jbc.275.18.13259; Chi ZK, 2014, CELL REP, V7, P681, DOI 10.1016/j.celrep.2014.03.048; Christen M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000430; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; Coll NS, 2013, MICROB BIOTECHNOL, V6, P614, DOI 10.1111/1751-7915.12056; Cunnac S, 2004, MOL MICROBIOL, V53, P115, DOI 10.1111/j.1365-2958.2004.04118.x; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Deslandes L, 2014, CURR OPIN PLANT BIOL, V20, P110, DOI 10.1016/j.pbi.2014.05.002; Deslandes L, 2012, TRENDS PLANT SCI, V17, P644, DOI 10.1016/j.tplants.2012.06.011; Dubreuil-Maurizi C, 2012, PLANT SIGNAL BEHAV, V7, P210, DOI 10.4161/psb.18831; FU H, 1993, P NATL ACAD SCI USA, V90, P2320, DOI 10.1073/pnas.90.6.2320; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gaspar AH, 2014, P NATL ACAD SCI USA, V111, P4560, DOI 10.1073/pnas.1316376111; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Genin S, 2012, ANNU REV PHYTOPATHOL, V50, P67, DOI 10.1146/annurev-phyto-081211-173000; Genin S, 2010, NEW PHYTOL, V187, P920, DOI 10.1111/j.1469-8137.2010.03397.x; Ghanta S, 2011, PLANTA, V233, P895, DOI 10.1007/s00425-011-1349-4; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; IVEY DM, 1993, J BIOL CHEM, V268, P11296; Kanda A, 2003, MOL PLANT MICROBE IN, V16, P447, DOI 10.1094/MPMI.2003.16.5.447; Kumar A, 2012, EMBO REP, V13, P1095, DOI 10.1038/embor.2012.156; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Kumar S, 2015, BIOCHEM J, V468, P73, DOI 10.1042/BJ20141154; Kuramitsu Y, 2009, PROTEOMICS, V9, P5078, DOI 10.1002/pmic.200800284; Laloi C, 2004, PLANT PHYSIOL, V134, P1006, DOI 10.1104/pp.103.035782; Le Roux C, 2015, CELL, V161, P1074, DOI 10.1016/j.cell.2015.04.025; Lesser CF, 2001, EMBO J, V20, P1840, DOI 10.1093/emboj/20.8.1840; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Mhamdi A, 2010, PLANT PHYSIOL, V153, P1144, DOI 10.1104/pp.110.153767; Mukaihara T, 2010, MOL PLANT MICROBE IN, V23, P251, DOI 10.1094/MPMI-23-3-0251; Oakley AJ, 2008, J BIOL CHEM, V283, P22031, DOI 10.1074/jbc.M803623200; Parisy V, 2007, PLANT J, V49, P159, DOI 10.1111/j.1365-313X.2006.02938.x; Peeters N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-859; Poueymiro M, 2014, MBIO, V5, DOI 10.1128/mBio.02065-14; Poueymiro M, 2009, CURR OPIN MICROBIOL, V12, P44, DOI 10.1016/j.mib.2008.11.008; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; Spoel SH, 2011, CURR OPIN PLANT BIOL, V14, P358, DOI 10.1016/j.pbi.2011.03.007; Tabuchi M, 2009, BIOSCI BIOTECH BIOCH, V73, P2261, DOI 10.1271/bbb.90360; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valdivia RH, 2004, EUKARYOT CELL, V3, P827, DOI 10.1128/EC.3.4.827-834.2004	47	33	33	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					6813	6830		10.1074/jbc.M115.678953	http://dx.doi.org/10.1074/jbc.M115.678953			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26823466	Green Published, hybrid			2022-12-26	WOS:000373299700021
J	Bowsher, AW; Ali, R; Harding, SA; Tsai, CJ; Donovan, LA				Bowsher, Alan W.; Ali, Rifhat; Harding, Scott A.; Tsai, Chung-Jui; Donovan, Lisa A.			Evolutionary Divergences in Root Exudate Composition among Ecologically-Contrasting Helianthus Species	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; AMINO-ACID-UPTAKE; ORGANIC-ACIDS; LUPINUS-ALBUS; MORPHOLOGICAL PLASTICITY; MECHANICAL IMPEDANCE; MISSING VALUES; RHIZOSPHERE; PLANT; SOIL	Plant roots exude numerous metabolites into the soil that influence nutrient availability. Although root exudate composition is hypothesized to be under selection in low fertility soils, few studies have tested this hypothesis in a phylogenetic framework. In this study, we examined root exudates of three pairs of Helianthus species chosen as phylogenetically-independent contrasts with respect to native soil nutrient availability. Under controlled environmental conditions, seedlings were grown to the three-leaf-pair stage, then transferred to either high or low nutrient treatments. After five days of nutrient treatments, we used gas chromatography-mass spectrometry for analysis of root exudates, and detected 37 metabolites across species. When compared in the high nutrient treatment, species native to low nutrient soils exhibited overall higher exudation than their sister species native to high nutrient soils in all three species pairs, providing support for repeated evolutionary shifts in response to native soil fertility. Species native to low nutrient soils and those native to high nutrient soils responded similarly to low nutrient treatments with increased exudation of organic acids (fumaric, citric, malic acids) and glucose, potentially as a mechanism to enhance nutrition acquisition. However, species native to low nutrient soils also responded to low nutrient treatments with a larger decrease in exudation of amino acids than species native to high nutrient soils in all three species pairs. This indicates that species native to low nutrient soils have evolved a unique sensitivity to changes in nutrient availability for some, but not all, root exudates. Overall, these repeated evolutionary divergences between species native to low nutrient soils and those native to high nutrient soils provide evidence for the adaptive value of root exudation, and its plasticity, in contrasting soil environments.	[Bowsher, Alan W.; Donovan, Lisa A.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Ali, Rifhat] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA; [Harding, Scott A.; Tsai, Chung-Jui] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Harding, Scott A.; Tsai, Chung-Jui] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bowsher, AW (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	bowsher@uga.edu	Donovan, Lisa A/H-4754-2016	Donovan, Lisa A/0000-0001-9814-0666	National Science Foundation [IOS-1122842]; Sigma Xi the Scientific Research Society; Georgia Research Alliance-Haynes Forest Biotechnology Endowment; Direct For Biological Sciences [1122842] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Sigma Xi the Scientific Research Society; Georgia Research Alliance-Haynes Forest Biotechnology Endowment; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by National Science Foundation IOS-1122842 to LAD (www.nsf.gov), a Grant-in-aid of Research from Sigma Xi the Scientific Research Society to AWB (https://www.sigmaxi.org), and the Georgia Research Alliance-Haynes Forest Biotechnology Endowment to CJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; [Anonymous], 2007, NUTR CYCLING TERREST; [Anonymous], 2005, MINERAL NUTR PLANTS; Aulakh MS, 2001, PLANT BIOLOGY, V3, P139, DOI 10.1055/s-2001-12905; Babushok VI, 2007, J CHROMATOGR A, V1157, P414, DOI 10.1016/j.chroma.2007.05.044; Badri DV, 2009, CURR OPIN BIOTECH, V20, P642, DOI 10.1016/j.copbio.2009.09.014; BARBER DA, 1974, NEW PHYTOL, V73, P39, DOI 10.1111/j.1469-8137.1974.tb04604.x; BOEUFTREMBLAY V, 1995, PLANT SOIL, V172, P279, DOI 10.1007/BF00011330; BOWEN GD, 1969, PLANT SOIL, V30, P139, DOI 10.1007/BF01885274; Bowsher AW, 2015, J PLANT NUTR SOIL SC, V178, P776, DOI 10.1002/jpln.201400521; Carvalhais LC, 2011, J PLANT NUTR SOIL SC, V174, P3, DOI 10.1002/jpln.201000085; Cesco S, 2010, PLANT SOIL, V329, P1, DOI 10.1007/s11104-009-0266-9; Condit R, 2013, P NATL ACAD SCI USA, V110, P5064, DOI 10.1073/pnas.1218042110; Coudun C, 2006, J BIOGEOGR, V33, P1750, DOI 10.1111/j.1365-2699.2005.01443.x; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Craine JM, 2013, FUNCT ECOL, V27, P833, DOI 10.1111/1365-2435.12081; Dakora FD, 2002, PLANT SOIL, V245, P35, DOI 10.1023/A:1020809400075; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; Denton MD, 2007, NEW PHYTOL, V173, P592, DOI 10.1111/j.1469-8137.2006.01956.x; Dijkstra FA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00216; DINKELAKER B, 1989, PLANT CELL ENVIRON, V12, P285, DOI 10.1111/j.1365-3040.1989.tb01942.x; Dodge Y., 1985, ANALYSIS OF EXPERIME; Dray S, 2015, PLANT ECOL, V216, P657, DOI 10.1007/s11258-014-0406-z; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fransen B, 1998, OECOLOGIA, V115, P351, DOI 10.1007/s004420050527; Frost CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044467; GARDNER WK, 1983, PLANT SOIL, V70, P107, DOI 10.1007/BF02374754; GERKE J, 1994, Z PFLANZ BODENKUNDE, V157, P289, DOI 10.1002/jpln.19941570408; Grayston SJ, 1997, APPL SOIL ECOL, V5, P29, DOI 10.1016/S0929-1393(96)00126-6; Grime J. P., 1979, Plant strategies and vegetation processes.; Grime J. P., 1994, EXPLOITATION ENV HET, P1; Groleau-Renaud V, 1998, PLANT SOIL, V201, P231, DOI 10.1023/A:1004316416034; Gromski PS, 2014, METABOLITES, V4, P433, DOI 10.3390/metabo4020433; Haase S, 2007, SOIL BIOL BIOCHEM, V39, P2208, DOI 10.1016/j.soilbio.2007.03.014; HARVEY PH, 1991, NATURE, V351, P619, DOI 10.1038/351619a0; HEISER C B JR, 1969, Memoirs of the Torrey Botanical Club, V22, P1; Henry S, 2008, ENVIRON MICROBIOL, V10, P3082, DOI 10.1111/j.1462-2920.2008.01599.x; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; Hirner A, 2006, PLANT CELL, V18, P1931, DOI 10.1105/tpc.106.041012; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Jeong ML, 2004, PLANT PHYSIOL, V136, P3364, DOI 10.1104/pp.104.044776; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Johnson JF, 1996, PLANT PHYSIOL, V112, P31, DOI 10.1104/pp.112.1.31; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; JONES DL, 1994, PLANT SOIL, V166, P247, DOI 10.1007/BF00008338; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; Kane NC, 2013, MOL ECOL RESOUR, V13, P10, DOI 10.1111/1755-0998.12023; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Kuzyakov Y, 2001, SOIL BIOL BIOCHEM, V33, P1915, DOI 10.1016/S0038-0717(01)00117-1; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Lambers H, 2013, AM J BOT, V100, P263, DOI 10.3732/ajb.1200474; Lesuffleur F, 2010, PLANT SOIL, V333, P191, DOI 10.1007/s11104-010-0334-1; Lopez-Raez JA, 2008, NEW PHYTOL, V178, P863, DOI 10.1111/j.1469-8137.2008.02406.x; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; MARSCHNER H, 1986, Z PFLANZ BODENKUNDE, V149, P441, DOI 10.1002/jpln.19861490408; Mason CM, 2015, EVOLUTION, V69, P2705, DOI 10.1111/evo.12768; Meier CL, 2009, J ECOL, V97, P941, DOI 10.1111/j.1365-2745.2009.01537.x; Moe LA, 2013, AM J BOT, V100, P1692, DOI 10.3732/ajb.1300033; MOGHIMI A, 1978, SOIL BIOL BIOCHEM, V10, P277, DOI 10.1016/0038-0717(78)90022-6; Neumann G, 1999, PLANT SOIL, V211, P121, DOI 10.1023/A:1004380832118; Neumann G, 2001, RHIZOSPHERE BIOCH OR, P23; Nicotra AB, 2002, OECOLOGIA, V130, P136, DOI 10.1007/s004420100788; Orwin KH, 2010, J ECOL, V98, P1074, DOI 10.1111/j.1365-2745.2010.01679.x; Pearse SJ, 2007, NEW PHYTOL, V173, P181, DOI 10.1111/j.1469-8137.2006.01897.x; Persson J, 2002, PLANTA, V215, P639, DOI 10.1007/s00425-002-0786-5; Pineda-Garcia F, 2011, PLANT CELL ENVIRON, V34, P1536, DOI 10.1111/j.1365-3040.2011.02351.x; Raupp FM, 2013, J AGR FOOD CHEM, V61, P10481, DOI 10.1021/jf402392e; Rengel Z, 2002, PLANT SOIL, V245, P59, DOI 10.1023/A:1020646011229; Roelofs RFR, 2001, PLANT CELL ENVIRON, V24, P891, DOI 10.1046/j.1365-3040.2001.00741.x; Shi SJ, 2011, FEMS MICROBIOL ECOL, V77, P600, DOI 10.1111/j.1574-6941.2011.01150.x; SHUM HY, 1995, IEEE T PATTERN ANAL, V17, P854, DOI 10.1109/34.406651; Stephens JD, 2015, AM J BOT, V102, P910, DOI 10.3732/ajb.1500031; Strom L, 1997, OIKOS, V80, P459, DOI 10.2307/3546618; TYLER G, 1995, ANN BOT-LONDON, V75, P75, DOI 10.1016/S0305-7364(05)80011-3; van der Krift TAJ, 2001, SOIL BIOL BIOCHEM, V33, P2115, DOI 10.1016/S0038-0717(01)00145-6; Veneklaas EJ, 2003, PLANT SOIL, V248, P187, DOI 10.1023/A:1022367312851; von Wiren N, 2000, PLANT J, V21, P167, DOI 10.1046/j.1365-313x.2000.00665.x; Wouterlood M, 2004, NEW PHYTOL, V162, P745, DOI 10.1111/j.1469-8137.2004.01070.x; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xue LJ, 2013, PLANT CELL, V25, P2714, DOI 10.1105/tpc.113.112839	80	26	27	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148280	10.1371/journal.pone.0148280	http://dx.doi.org/10.1371/journal.pone.0148280			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824236	gold, Green Submitted, Green Published			2022-12-26	WOS:000369528600114
J	Ochoa, E; Iriondo, M; Manzano, C; Fullaondo, A; Villar, I; Ruiz-Irastorza, G; Zubiaga, AM; Estonba, A				Ochoa, Eguzkine; Iriondo, Mikel; Manzano, Carmen; Fullaondo, Asier; Villar, Irama; Ruiz-Irastorza, Guillermo; Zubiaga, Ana M.; Estonba, Andone			LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CORONARY-ARTERY-DISEASE; AUTOIMMUNE-DISEASES; VALINE/LEUCINE(247) POLYMORPHISM; FAMILIAL HYPERCHOLESTEROLEMIA; RECEPTOR GENE; FACTOR-V; EXPRESSION; ATHEROSCLEROSIS; ANTICARDIOLIPIN	Introduction The identification of the genetic risk factors that could discriminate non-thrombotic from thrombotic antiphospholipid antibodies (aPLA) carriers will improve prognosis of these patients. Several human studies have shown the presence of aPLAs associated with atherosclerotic plaque, which is a known risk factor for thrombosis. Hence, in order to determine the implication of atherosclerosis in the risk of developing thrombosis in aPLA positive patients, we performed a genetic association study with 3 candidate genes, APOH, LDLR and PCSK9. Material & Methods For genetic association study we analyzed 190 aPLA carriers -100 with non-thrombotic events and 90 with thrombotic events-and 557 healthy controls. Analyses were performed by chi(2) test and were corrected by false discovery rate. To evaluate the functional implication of the newly established susceptibility loci, we performed expression analyses in 86 aPLA carrier individuals (43 with thrombotic manifestations and 43 without it) and in 45 healthy controls. Results Our results revealed significant associations after correction in SNPs located in LDLR gene with aPLA carriers and thrombotic aPLA carriers, when compared with healthy controls. The most significant association in LDLR gene was found between SNP rs129083082 and aPLA carriers in recessive model (adjusted P-value = 2.55 x 10(-3); OR = 2.18; 95% CI = 1.49-3.21). Furthermore, our work detected significant allelic association after correction between thrombotic aPLA carriers and healthy controls in SNP rs562556 located in PCSK9 gene (adjusted P-value = 1.03 x 10(-2); OR = 1.60; 95% CI = 1.24-2.06). Expression level study showed significantly decreased expression level of LDLR gene in aPLA carriers (P-value < 0.0001; 95% CI 0.16-2.10; SE 0.38-1.27) in comparison to the control group. Discussion Our work has identified LDLR gene as a new susceptibility gene associated with the development of thrombosis in aPLA carriers, describing for the first time the deregulation of LDLR expression in individuals with aPLAs. Besides, thrombotic aPLA carriers also showed significant association with PCSK9 gene, a regulator of LDLR plasma levels. These results highlight the importance of atherosclerotic processes in the development of thrombosis in patients with aPLA.	[Ochoa, Eguzkine; Iriondo, Mikel; Manzano, Carmen; Fullaondo, Asier; Zubiaga, Ana M.; Estonba, Andone] Univ Basque Country UPV EHU, Sch Sci & Technol, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Villar, Irama; Ruiz-Irastorza, Guillermo] Hosp Univ Cruces, BioCruces Hlth Res Inst, Serv Internal Med, Autoimmune Dis Res Unit, Baracaldo, Spain	University of Basque Country; Hospital Universitario Cruces	Zubiaga, AM; Estonba, A (corresponding author), Univ Basque Country UPV EHU, Sch Sci & Technol, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain.	ana.zubiaga@ehu.eus; andone.estonba@ehu.eus	Fullaondo, Asier/L-2848-2019; Iriondo, Mikel/AAA-7997-2019; zubiaga, ana/S-3457-2019; Ruiz-Irastorza, Guillermo/P-7058-2014; Fullaondo, Asier/G-7131-2019; Ochoa, Eguzkine/AAO-5639-2020	Fullaondo, Asier/0000-0001-5387-4762; Iriondo, Mikel/0000-0001-7835-0041; zubiaga, ana/0000-0002-2132-9708; Ruiz-Irastorza, Guillermo/0000-0001-7788-1043; Fullaondo, Asier/0000-0001-5387-4762; Ochoa, Eguzkine/0000-0002-1506-9065; Estonba, Andone/0000-0003-2851-5201; Manzano, Carmen/0000-0002-8261-0608	Basque Government [Etortek IE09-256, Saiotek S-PE10UN82, Plan +Euskadi 09UE09+/57, Saiotek-PE08UN73, Saiotek-PE09UN64]; University of the Basque Country [UFI 11/20]	Basque Government(Basque Government); University of the Basque Country	Support was provided by the Basque Government (www.euskadi.eus/) Etortek IE09-256, Saiotek S-PE10UN82, Plan +Euskadi 09UE09+/57, Saiotek-PE08UN73 and Saiotek-PE09UN64; and by the University of the Basque Country (www.ehu.eus/) UFI 11/20. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001043; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bernales I, 2008, GENES IMMUN, V9, P38, DOI 10.1038/sj.gene.6364443; Bertolaccini ML, 2001, THROMB HAEMOSTASIS, V85, P198, DOI 10.1055/s-0037-1615676; Biggioggero M, 2010, AUTOIMMUN REV, V9, pA299, DOI 10.1016/j.autrev.2009.11.013; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185; BROWN MS, 1979, P NATL ACAD SCI USA, V76, P3330, DOI 10.1073/pnas.76.7.3330; Cardenas-Roldan J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-73; Chamorro AJ, 2012, AUTOIMMUN REV, V11, P705, DOI 10.1016/j.autrev.2011.12.006; DelPapa N, 1997, ARTHRITIS RHEUM-US, V40, P551; Fischetti F, 2005, BLOOD, V106, P2340, DOI 10.1182/blood-2005-03-1319; Folsom AR, 2009, ATHEROSCLEROSIS, V202, P211, DOI 10.1016/j.atherosclerosis.2008.03.009; Full LE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2631; Galli M, 2000, BRIT J HAEMATOL, V108, P865, DOI 10.1046/j.1365-2141.2000.01964.x; George J, 1999, CIRCULATION, V99, P2227, DOI 10.1161/01.CIR.99.17.2227; GOLDSTEIN JL, 1979, ANNU REV GENET, V13, P259, DOI 10.1146/annurev.ge.13.120179.001355; Gregersen PK, 2006, NAT REV GENET, V7, P917, DOI 10.1038/nrg1944; Hamid C, 2007, ANN RHEUM DIS, V66, P1000, DOI 10.1136/ard.2006.063909; Harris EN, 2002, LUPUS, V11, P269, DOI 10.1191/0961203302lu202cr; Heit JA, 2008, ARTERIOSCL THROM VAS, V28, P370, DOI 10.1161/ATVBAHA.108.162545; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Hochberg Y. B. a. Y., 1995, J R STAT SOC B, V57, P12; Kenet G, 2000, STROKE, V31, P1283, DOI 10.1161/01.STR.31.6.1283; Levy Y, 2006, LUPUS, V15, P784, DOI 10.1177/0961203306071004; Levy Zohar, 2003, Eur J Intern Med, V14, P479, DOI 10.1016/j.ejim.2003.08.010; Linsel-Nitschke P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002986; Lopez-Pedrera C, 2006, ARTHRITIS RHEUM-US, V54, P301, DOI 10.1002/art.21549; Lopez-Pedrera C, 2008, ARTHRITIS RHEUM-US, V58, P2835, DOI 10.1002/art.23756; Martinelli N, 2010, BLOOD, V116, P5688, DOI 10.1182/blood-2010-03-277079; Matsuura Eiji, 2009, Curr Rheumatol Rep, V11, P61; Meroni PL, 2011, NAT REV RHEUMATOL, V7, P330, DOI 10.1038/nrrheum.2011.52; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Potti A, 2006, BLOOD, V107, P1391, DOI 10.1182/blood-2005-07-2669; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ruiz-Irastorza G, 2010, LANCET, V376, P1498, DOI 10.1016/S0140-6736(10)60709-X; Sebastiani GD, 2003, LUPUS, V12, P560, DOI 10.1191/0961203303lu402oa; Sene D, 2009, REV MED INTERNE, V30, P135, DOI 10.1016/j.revmed.2008.05.020; Sherer Y, 2006, NAT CLIN PRACT RHEUM, V2, P99, DOI 10.1038/ncprheum0092; Stanic AK, 2006, P NATL ACAD SCI USA, V103, P7018, DOI 10.1073/pnas.0602311103; Swadzba J, 2006, LUPUS, V15, P218, DOI 10.1191/0961203306lu2288oa; Tincani A, 2001, THROMB HAEMOSTASIS, V86, P575; Vazquez-Del Mercado M, 2007, SCAND J RHEUMATOL, V36, P206, DOI 10.1080/03009740601089648; Vega-Ostertag Mariano E, 2007, Curr Rheumatol Rep, V9, P190, DOI 10.1007/s11926-007-0031-0; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wisloff F, 2002, THROMB RES, V108, P263, DOI 10.1016/S0049-3848(02)00400-0; Wong RCW, 2004, THROMB RES, V114, P559, DOI 10.1016/j.thromres.2004.06.002; Yasuda S, 2005, ARTHRITIS RHEUM-US, V52, P212, DOI 10.1002/art.20741; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	50	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0146990	10.1371/journal.pone.0146990	http://dx.doi.org/10.1371/journal.pone.0146990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820623	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528400010
J	Gouse, H; Magidson, JF; Burnhams, W; Remmert, JE; Myers, B; Joska, JA; Carrico, AW				Gouse, Hetta; Magidson, Jessica F.; Burnhams, Warren; Remmert, Jocelyn E.; Myers, Bronwyn; Joska, John A.; Carrico, Adam W.			Implementation of Cognitive-Behavioral Substance Abuse Treatment in Sub-Saharan Africa: Treatment Engagement and Abstinence at Treatment Exit	PLOS ONE			English	Article							CONTINGENCY MANAGEMENT; ACCESS	Aims This study documented the treatment cascade for engagement in care and abstinence at treatment exit as well as examined correlates of these outcomes for the first certified Matrix Model (R) substance abuse treatment site in Sub-Saharan Africa. Design This retrospective chart review conducted at a resource-limited community clinic in Cape Town, South Africa, assessed treatment readiness and substance use severity at treatment entry as correlates of the number of sessions attended and biologically confirmed abstinence at treatment exit among 986 clients who initiated treatment from 2009-2014. Socio-demographic and clinical correlates of treatment outcomes were examined using logistic regression, modeling treatment completion and abstinence at treatment exit separately. Results Of the 2,233 clients who completed screening, approximately 44% (n = 986) initiated treatment. Among those who initiated treatment, 45% completed at least four group sessions, 30% completed early recovery skills training (i.e., at least eight group sessions), and 13% completed the full 16-week program. Approximately half (54%) of clients who provided a urine sample had negative urine toxicology results for any substance at treatment exit. Higher motivation at treatment entry was independently associated with greater odds of treatment completion and negative urine toxicology results at treatment exit. Conclusions Findings provide initial support for the successful implementation the Matrix Model in a resource-limited setting. Motivational enhancement interventions could support treatment initiation, promote sustained engagement in treatment, and achieve better treatment outcomes.	[Gouse, Hetta; Joska, John A.] HIV Mental Hlth Res Unit, Dept Psychiat & Mental Hlth, Cape Town, South Africa; [Magidson, Jessica F.; Remmert, Jocelyn E.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Magidson, Jessica F.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Burnhams, Warren] City Cape Town Hlth, Subst Abuse, Cape Town, South Africa; [Myers, Bronwyn] South African Med Res Council, Alcohol Tobacco & Other Drug Res Unit, Cape Town, South Africa; [Carrico, Adam W.] Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; South African Medical Research Council; University of California System; University of California San Francisco	Gouse, H (corresponding author), HIV Mental Hlth Res Unit, Dept Psychiat & Mental Hlth, Cape Town, South Africa.	hetta.gouse@uct.ac.za	Myers, Bronwyn/AAT-7788-2021; Gouse, Hetta/H-1461-2015	Myers, Bronwyn/0000-0003-0235-6716; Gouse, Hetta/0000-0001-7885-8363; Joska, John/0000-0003-4260-1181	NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH093310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA041901] Funding Source: NIH RePORTER; NIDA NIH HHS [K23 DA041901] Funding Source: Medline; NIMH NIH HHS [T32 MH093310] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ali R, 2002, ADDICTION, V97, P1183; [Anonymous], 1995, INTENSIVE OUTPATIENT; [Anonymous], 2015, WORLD DRUG REP 2015; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Carney T, 2012, SUBST ABUSE TREAT PR, V7, DOI 10.1186/1747-597X-7-25; City of Cape Town, 2010, TAFELSIG MATRIX TREA; Dada Sp, 2012, MONITORING ALCOHOL D, P1; Epstein DH, 2003, PSYCHOL ADDICT BEHAV, V17, P73, DOI 10.1037/0893-164X.17.1.73; Loveland D, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-41; Marinelli-Casey P, 2002, PSYCHIATR SERV, V53, P984, DOI 10.1176/appi.ps.53.8.984; Miller WR, 1996, PSYCHOL ADDICT BEHAV, V10, P81, DOI 10.1037/0893-164X.10.2.81; Myers B, 2008, TECHNICAL REPORT; Myers B, 2008, INT J SOC WELF, V17, P156, DOI 10.1111/j.1468-2397.2007.00546.x; Myers B, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-177; Myers B, 2012, SAMJ S AFR MED J, V102, P667, DOI 10.7196/SAMJ.5990; Myers BJ, 2010, SUBST ABUSE TREAT PR, V5, DOI 10.1186/1747-597X-5-28; Pasche S, 2015, INT J MENT HEALTH AD, V13, P322, DOI 10.1007/s11469-014-9537-7; Prendergast M, 2006, ADDICTION, V101, P1546, DOI 10.1111/j.1360-0443.2006.01581.x; Rawson RA, 2006, ADDICTION, V101, P267, DOI 10.1111/j.1360-0443.2006.01312.x; RAWSON RA, 1995, J SUBST ABUSE TREAT, V12, P117, DOI 10.1016/0740-5472(94)00080-B; Rawson RA, 2004, ADDICTION, V99, P708, DOI 10.1111/j.1360-0443.2004.00707.x; SHOPTAW S, 1994, J ADDICT DIS, V13, P129; Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, 2013, TREATM EP DAT SET TE	23	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147900	10.1371/journal.pone.0147900	http://dx.doi.org/10.1371/journal.pone.0147900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GD	26816208	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528200062
J	Chessa, D; Ganau, G; Spiga, L; Bulla, A; Mazzarello, V; Campus, GV; Rubino, S				Chessa, Daniela; Ganau, Giulia; Spiga, Luisella; Bulla, Antonio; Mazzarello, Vittorio; Campus, Gian Vittorio; Rubino, Salvatore			Staphylococcus aureus and Staphylococcus epidermidis Virulence Strains as Causative Agents of Persistent Infections in Breast Implants	PLOS ONE			English	Article							IN-VIVO; MEDICAL DEVICES; MOLECULAR-BASIS; BIOFILM; ADHESION; INSERTION; IS256	Staphylococcus epidermidis and Staphylococcus aureus are currently considered two of the most important pathogens in nosocomial infections associated with catheters and other medical implants and are also the main contaminants of medical instruments. However because these species of Staphylococcus are part of the normal bacterial flora of human skin and mucosal surfaces, it is difficult to discern when a microbial isolate is the cause of infection or is detected on samples as a consequence of contamination. Rapid identification of invasive strains of Staphylococcus infections is crucial for correctly diagnosing and treating infections. The aim of the present study was to identify specific genes to distinguish between invasive and contaminating S. epidermidis and S. aureus strains isolated on medical devices; the majority of our samples were collected from breast prostheses. As a first step, we compared the adhesion ability of these samples with their efficacy in forming biofilms; second, we explored whether it is possible to determine if isolated pathogens were more virulent compared with international controls. In addition, this work may provide additional information on these pathogens, which are traditionally considered harmful bacteria in humans, and may increase our knowledge of virulence factors for these types of infections.	[Chessa, Daniela; Ganau, Giulia; Spiga, Luisella; Mazzarello, Vittorio; Rubino, Salvatore] Univ Sassari, Dept Biomed Sci, Microbiol & Immunol Unit, I-07100 Sassari, Italy; [Bulla, Antonio; Campus, Gian Vittorio] Univ Sassari, Dept Surg Microsurg & Med Sci, Plast Surg Unit, I-07100 Sassari, Italy; [Rubino, Salvatore] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia	University of Sassari; University of Sassari; King Faisal Specialist Hospital & Research Center	Chessa, D (corresponding author), Univ Sassari, Dept Biomed Sci, Microbiol & Immunol Unit, I-07100 Sassari, Italy.	danielachessa@uniss.it	Barac, Aleksandra/W-9785-2019; Campus, Gian Vittorio/M-7428-2015; Rubino, Salvatore/AAC-5848-2022	Campus, Gian Vittorio/0000-0001-9448-3047; Mazzarello, Vittorio/0000-0002-9713-3306; Spiga, Luisella/0000-0002-4770-7156	Azienda Ospedaliera Univeritaria (AOU) Sassari, Italy	Azienda Ospedaliera Univeritaria (AOU) Sassari, Italy	The project was supported by Azienda Ospedaliera Univeritaria (AOU) Sassari, Italy and was founding by Fondazione Banco di Sardegna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenken KE, 2012, INFECT IMMUN, V80, P1634, DOI 10.1128/IAI.06134-11; Begun J, 2007, PLOS PATHOG, V3, P526, DOI 10.1371/journal.ppat.0030057; Beloin C, 2008, CURR TOP MICROBIOL, V322, P249; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089; Chen L, 2011, INT J ORAL SCI, V3, P66, DOI 10.4248/IJOS11022; Chessa D, 2009, MOL MICROBIOL, V71, P864, DOI 10.1111/j.1365-2958.2008.06566.x; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Galdbart JO, 2000, J INFECT DIS, V182, P351, DOI 10.1086/315660; Gu J, 2005, J HOSP INFECT, V61, P342, DOI 10.1016/j.jhin.2005.04.017; Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Joo HS, 2012, CHEM BIOL, V19, P1503, DOI 10.1016/j.chembiol.2012.10.022; Kim JH, 2008, J MICROBIOL BIOTECHN, V18, P28; Le KY, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00167; Leid JG, 2002, INFECT IMMUN, V70, P6339, DOI 10.1128/IAI.70.11.6339-6345.2002; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Rodrigues LR, 2011, ADV EXP MED BIOL, V715, P351, DOI 10.1007/978-94-007-0940-9_22; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Rubino C, 2014, J INFECT DEV COUNTR, V8, P1089, DOI 10.3855/jidc.3898; Taj Y, 2012, J INFECT DEV COUNTR, V6, P403, DOI 10.3855/jidc.1743; Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F; Vuong C, 2004, J INFECT DIS, V190, P1498, DOI 10.1086/424487; Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239; Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x	27	42	43	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146668	10.1371/journal.pone.0146668	http://dx.doi.org/10.1371/journal.pone.0146668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811915	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528000010
J	Archidona-Yuste, A; Navas-Cortes, JA; Cantalapiedra-Navarrete, C; Palomares-Rius, JE; Castillo, P				Archidona-Yuste, Antonio; Navas-Cortes, Juan A.; Cantalapiedra-Navarrete, Carolina; Palomares-Rius, Juan E.; Castillo, Pablo			Unravelling the Biodiversity and Molecular Phylogeny of Needle Nematodes of the Genus Longidorus (Nematoda: Longidoridae) in Olive and a Description of Six New Species	PLOS ONE			English	Article							N. SP NEMATODA; REVISED POLYTOMOUS KEY; HENANUS XU; XIPHINEMA; IDENTIFICATION; COMPLEX; REGION; DORYLAIMIDA; MICOLETZKY; DIVERSITY	The genus Longidorus includes a remarkable group of invertebrate animals of the phylum Nematoda comprising polyphagous root-ectoparasites of numerous plants including several agricultural crops and trees. Damage is caused by direct feeding on root cells as well as by transmitting nepoviruses that cause disease on those crops. Thus, correct identification of Longidorus species is essential to establish appropriate control measures. We provide the first detailed information on the diversity and distribution of Longidorus species infesting wild and cultivated olive soils in a wide-region in southern Spain that included 159 locations from which 449 sampling sites were analyzed. The present study doubles the known biodiversity of Longidorus species identified in olives by including six new species (Longidorus indalus sp. nov., Longidorus macrodorus sp. nov., Longidorus onubensis sp. nov., Longidorus silvestris sp. nov., Longidorus vallensis sp. nov., and Longidorus wicuolea sp. nov.), two new records for wild and cultivate olives (L. alvegus and L. vineacola), and two additional new records for wild olive (L. intermedius and L. lusitanicus). We also found evidence of some geographic species associations to western (viz. L. alvegus, L. intermedius, L. lusitanicus, L. onubensis sp. nov., L. vineacola, L. vinearum, L. wicuolea sp. nov.) and eastern distributions (viz. L. indalus sp. nov.), while only L. magnus was detected in both areas. We developed a comparative study by considering morphological and morphometrical features together with molecular data from nuclear ribosomal RNA genes (D2-D3 expansion segments of 28S, ITS1, and partial 18S). Results of molecular and phylogenetic analyses confirmed the morphological hypotheses and allowed the delimitation and discrimination of six new species of the genus described herein and four known species. Phylogenetic analyses of Longidorus spp. based on three molecular markers resulted in a general consensus of these species groups, since lineages were maintained for the majority of species. This study represents the most complete phylogenetic analysis for Longidorus species to date.	[Archidona-Yuste, Antonio; Navas-Cortes, Juan A.; Cantalapiedra-Navarrete, Carolina; Palomares-Rius, Juan E.; Castillo, Pablo] CSIC, IAS, Ave Menendez Pidal S-N, Cordoba 14004, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Castillo, P (corresponding author), CSIC, IAS, Ave Menendez Pidal S-N, Cordoba 14004, Spain.	p.castillo@csic.es	Castillo, Pablo/L-3397-2019; Navas-Cortes, Juan A./M-2060-2019; Palomares-Rius, Juan/K-8004-2015; Navas-Cortes, Juan A/H-3381-2014; Archidona-Yuste, Antonio/GRS-2729-2022; , Antonio/ABF-4935-2020; Archidona-Yuste, Antonio/C-2406-2018; Castillo, Pablo/A-1445-2011	Castillo, Pablo/0000-0001-6657-6385; Palomares-Rius, Juan/0000-0003-1776-8131; Navas-Cortes, Juan A/0000-0001-6480-1104; Archidona-Yuste, Antonio/0000-0003-4446-0642; , Antonio/0000-0003-4446-0642; Archidona-Yuste, Antonio/0000-0003-4446-0642; Castillo, Pablo/0000-0003-0256-876X	'Ministerio de Economia y Competitividad' of Spain [AGL-2012-37521]; 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia [P12-AGR-1486]; FEDER - European Union; Project PESTOLIVE 'Contribution of olive history for the management of soilborne parasites in the Mediterranean basin' from Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) [219262 ArimNET_ERANET]	'Ministerio de Economia y Competitividad' of Spain; 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia; FEDER - European Union(European Commission); Project PESTOLIVE 'Contribution of olive history for the management of soilborne parasites in the Mediterranean basin' from Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA))	Financial support was received by Projects AGL-2012-37521 from 'Ministerio de Economia y Competitividad' of Spain, Project P12-AGR-1486 from 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia, and FEDER financial support from the European Union is gratefully acknowledged. The grant 219262 ArimNET_ERANET FP7 2012-2015 Project PESTOLIVE 'Contribution of olive history for the management of soilborne parasites in the Mediterranean basin' from Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA), also provided partial financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD W., 1992, DORYLAIMIDA FREELIVI; Ali N, 2014, CR BIOL, V337, P423, DOI 10.1016/j.crvi.2014.05.006; Amrei SB, 2013, SYST PARASITOL, V85, P173, DOI 10.1007/s11230-013-9414-y; ARIAS M, 1986, Revue de Nematologie, V9, P101; Arias M, 1988, REV NEMATOL, V11, P415; Belaj A, 2007, ANN BOT-LONDON, V100, P449, DOI 10.1093/aob/mcm132; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Boucher G, 1995, CONSERV BIOL, V9, P1594, DOI 10.1046/j.1523-1739.1995.09061594.x; Bravo M. A., 1998, Agronomia Lusitana, V46, P101; BRAVO MA, 1995, FUND APPL NEMATOL, V18, P81; Brown D.J.F., 1994, Nematologia Mediterranea, V22, P253; Cantalapiedra-Navarrete C, 2013, ZOOL ANZ, V252, P246, DOI 10.1016/j.jcz.2012.08.002; CAP-JA, 2014, EST AGR; Castillo P, 2003, PHYTOPATHOLOGY, V93, P1093, DOI 10.1094/PHYTO.2003.93.9.1093; Castillo P, 2010, PLANT DIS, V94, P148, DOI 10.1094/PDIS-94-2-0148; Chen QW, 1997, FUND APPL NEMATOL, V20, P15; Cherry T, 1997, J NEMATOL, V29, P23; Cooler W.A., 1979, P317; Coomans A, 2000, NEMATOLOGY, V2, P3, DOI 10.1163/156854100508845; Coomans A, 2001, ANN SCI ZOOLOGIQUES, V287, P1; Coomans A, 2012, NEMATOLOGY, V14, P285, DOI 10.1163/156854111X594974; Coomans August, 1996, Russian Journal of Nematology, V4, P51; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Luca F, 2004, J NEMATOL, V36, P147; De Luca F, 2009, NEMATOLOGY, V11, P155, DOI 10.1163/156854108X398534; Decraemer W, 2007, J NEMATOL, V39, P295; Decraemer W, 2013, NEMATOLOGY, V15, P57, DOI 10.1163/156854112X645598; FLEGG JJM, 1967, ANN APPL BIOL, V60, P429, DOI 10.1111/j.1744-7348.1967.tb04497.x; Guo K, 2011, RUSS J NEMATOL, V19, P83; Gutierrez-Gutierrez C, 2013, ZOOL J LINN SOC-LOND, V167, P473, DOI 10.1111/zoj.12019; Gutierrez-Gutierrez C, 2012, EUR J PLANT PATHOL, V134, P561, DOI 10.1007/s10658-012-0039-9; Gutierrez-Gutierrez C, 2011, EUR J PLANT PATHOL, V129, P427, DOI 10.1007/s10658-010-9705-y; Gutierrez-Gutierrez C, 2010, ZOOL SCR, V39, P483, DOI 10.1111/j.1463-6409.2010.00437.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hashim Z., 1979, Nematologia Mediterranea, V7, P177; He Y, 2005, NEMATOLOGY, V7, P111, DOI 10.1163/1568541054192108; Hirata Kenji, 2002, Japanese Journal of Nematology, V32, P1, DOI 10.3725/jjn1993.32.1_1; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Hooper D. J., 1961, Nematologica, V6, P237; Ibrahim IKA, 2010, NEMATROPICA, V40, P239; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KOZLOWSKA J, 1979, NEMATOLOGICA, V25, P42, DOI 10.1163/187529279X00361; Krnjaic Dj., 2000, Nematologia Mediterranea, V28, P235; Lamberti F., 1996, Nematologia Mediterranea, V24, P79; Lamberti F., 1983, Nematologia Mediterranea, V11, P49; Lamberti F., 1982, Nematologia Mediterranea, V10, P183; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Loof PAA, 1999, NEMATOLOGY, V1, P55, DOI 10.1163/156854199507974; MACARA AM, 1985, NEMATOLOGICA, V31, P410; Macfarlane SA, 2003, MOL PLANT PATHOL, V4, P211, DOI 10.1046/j.1364-3703.2003.00164.x; MacFarlane SA, 2002, ADV BOT RES, V36, P169, DOI 10.1016/S0065-2296(02)36063-4; MAGRAMA, 2014, EST AGR; MICOLETZKY H., 1922, Arch. Naturgesch., V87, P1; Navas A., 1993, Nematologia Mediterranea, V21, P71; Navas A., 1990, Nematologia Mediterranea, V18, P103; Neilson R, 2004, HELMINTHOLOGIA, V41, P209; Niknam G, 2010, RUSS J NEMATOL, V18, P127; Nunn G.B., 1992, NEMATODE MOL EVOLUTI; Oliveira CMG, 2006, J NEMATOL, V38, P418; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palomares-Rius JE, 2008, NEMATOLOGY, V10, P87, DOI 10.1163/156854108783360186; Palomares-Rius JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116890; Palomares-Rius JE, 2014, NEMATOLOGY, V16, P1105, DOI 10.1163/15685411-00002831; Palomares-Rius JE, 2013, NEMATOLOGY, V15, P363, DOI 10.1163/15685411-00002680; Palomares-Rius JE, 2010, NEMATOLOGY, V12, P631, DOI 10.1163/138855410X12628646276041; Pearse A.S., 1942, INTRO PARASITOLOGY; Pedram M, 2008, SYST PARASITOL, V71, P199, DOI 10.1007/s11230-008-9148-4; Pena Santiago R, 2003, COLLECTION MONOGRAPH, V1; PENA-SANTIAGO R, 1990, Revue de Nematologie, V13, P113; Peneva VK, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.330.5750; Robbins Robert T., 1996, Russian Journal of Nematology, V4, P163; ROBBINS RT, 1995, SYST PARASITOL, V32, P33, DOI 10.1007/BF00009466; Roca F., 1989, Nematologia Mediterranea, V17, P1; Roca F., 1984, Nematologia Mediterranea, V12, P187; Romanenko ND, 1998, RUSS J NEMATOL, V6, P185; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SEINHORST J. W., 1962, NEMATOLOGICA, V8, P29; Siddiqi M. R., 2000, TYLENCHIDA PARASITES; SIDDIQI M. RAFIQ, 1962, NEMATOLOGICA, V8, P152; Sturhan D, 1954, NEMATOLOGICA, V10, P335; Subbotin SA, 2006, PLANT NEMATOLOGY, P33, DOI 10.1079/9781845930561.0033; Subbotin SA, 2014, EUR J PLANT PATHOL, V138, P377, DOI 10.1007/s10658-013-0338-9; Tarjan A. C., 1964, FAO PLANT PROTECTION, V12, P49; Taylor C.E., 1997, NEMATODE VECTORS PLA; THORNE GERALD, 1935, PROC HELMINTH SOC WASHINGTON, V2, P96; TOPHAM PB, 1985, J BIOGEOGR, V12, P165, DOI 10.2307/2844839; Tzortzakakis E. A., 2008, Nematologia Mediterranea, V36, P153; Tzortzakakis EA, 2014, EUR J PLANT PATHOL, V140, P563, DOI 10.1007/s10658-014-0488-4; VRAIN TC, 1992, FUND APPL NEMATOL, V15, P563; XU JH, 1992, FUND APPL NEMATOL, V15, P517; Ye WM, 2004, J NEMATOL, V36, P14; Zheng JW, 2001, NEMATOLOGY, V3, P219, DOI 10.1163/156854101750413298; ZOHARY D, 1975, SCIENCE, V187, P319, DOI 10.1126/science.187.4174.319	94	52	53	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147689	10.1371/journal.pone.0147689	http://dx.doi.org/10.1371/journal.pone.0147689			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808994	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800180
J	Campbell, J; Sharma, A				Campbell, Julia; Sharma, Anu			Visual Cross-Modal Re-Organization in Children with Cochlear Implants	PLOS ONE			English	Article							AUDITORY-EVOKED POTENTIALS; SPOKEN LANGUAGE-DEVELOPMENT; PRELINGUALLY DEAF-CHILDREN; EVENT-RELATED POTENTIALS; SPEECH-PERCEPTION; DEVELOPMENTAL-CHANGES; HEARING; PLASTICITY; MOTION; CORTEX	Background Visual cross-modal re-organization is a neurophysiological process that occurs in deafness. The intact sensory modality of vision recruits cortical areas from the deprived sensory modality of audition. Such compensatory plasticity is documented in deaf adults and animals, and is related to deficits in speech perception performance in cochlear-implanted adults. However, it is unclear whether visual cross-modal re-organization takes place in cochlear-implanted children and whether it may be a source of variability contributing to speech and language outcomes. Thus, the aim of this study was to determine if visual cross-modal re-organization occurs in cochlear-implanted children, and whether it is related to deficits in speech perception performance. Methods Visual evoked potentials (VEPs) were recorded via high-density EEG in 41 normal hearing children and 14 cochlear-implanted children, aged 5-15 years, in response to apparent motion and form change. Comparisons of VEP amplitude and latency, as well as source localization results, were conducted between the groups in order to view evidence of visual cross-modal re-organization. Finally, speech perception in background noise performance was correlated to the visual response in the implanted children. Results Distinct VEP morphological patterns were observed in both the normal hearing and cochlear-implanted children. However, the cochlear-implanted children demonstrated larger VEP amplitudes and earlier latency, concurrent with activation of right temporal cortex including auditory regions, suggestive of visual cross-modal re-organization. The VEP N1 latency was negatively related to speech perception in background noise for children with cochlear implants. Conclusion Our results are among the first to describe cross modal re-organization of auditory cortex by the visual modality in deaf children fitted with cochlear implants. Our findings suggest that, as a group, children with cochlear implants show evidence of visual cross-modal recruitment, which may be a contributing source of variability in speech perception outcomes with their implant.	[Campbell, Julia; Sharma, Anu] Univ Colorado, Brain & Behav Lab, 409 UCB,2501 Kittredge Loop Rd, Boulder, CO 80309 USA; [Campbell, Julia; Sharma, Anu] Univ Colorado, Inst Cognit Sci, 344 UCB, Boulder, CO 80309 USA; [Campbell, Julia; Sharma, Anu] Univ Colorado, Dept Speech Language & Hearing Sci, 409 UCB,2501 Kittredge Loop Rd, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Sharma, A (corresponding author), Univ Colorado, Brain & Behav Lab, 409 UCB,2501 Kittredge Loop Rd, Boulder, CO 80309 USA.; Sharma, A (corresponding author), Univ Colorado, Inst Cognit Sci, 344 UCB, Boulder, CO 80309 USA.; Sharma, A (corresponding author), Univ Colorado, Dept Speech Language & Hearing Sci, 409 UCB,2501 Kittredge Loop Rd, Boulder, CO 80309 USA.	anu.sharma@colorado.edu	Campbell, Julia/N-8425-2019	Campbell, Julia/0000-0003-3985-6204; SHARMA, ANU/0000-0001-8568-1420	National Institutes of Health National Institute on Deafness and Other Communication Disorders [F31DC011970]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC011970] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	JC was supported by National Institutes of Health National Institute on Deafness and Other Communication Disorders F31DC011970. http://www.nidcd.nih.gov/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavelier D, 2010, NAT NEUROSCI, V13, P1309, DOI 10.1038/nn1110-1309; Bench J, 1979, Br J Audiol, V13, P108, DOI 10.3109/03005367909078884; Bergeson TR, 2005, EAR HEARING, V26, P149, DOI 10.1097/00003446-200504000-00004; Bertrand JA, 2012, EXP BRAIN RES, V216, P145, DOI 10.1007/s00221-011-2920-8; Bucher K, 2006, NEUROIMAGE, V31, P1625, DOI 10.1016/j.neuroimage.2006.02.032; Buckley KA, 2011, EAR HEARING, V32, P2, DOI 10.1097/AUD.0b013e3181fa41bb; Caldwell A, 2013, J SPEECH LANG HEAR R, V56, P13, DOI 10.1044/1092-4388(2012/11-0338); Campbell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090594; Campbell J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00071; Chang DT, 2010, ARCH OTOLARYNGOL, V136, P648, DOI 10.1001/archoto.2010.90; Chen L, 2015, MED IMAGE ANAL, V23, P1, DOI 10.1016/j.media.2015.03.004; Chlubnova J, 2005, PHYSIOL RES, V54, P577, DOI 10.33549/physiolres.930649; Clayson PE, 2013, PSYCHOPHYSIOLOGY, V50, P174, DOI 10.1111/psyp.12001; Clemo HR, 2016, CEREB CORTEX, V26, P1365, DOI 10.1093/cercor/bhu225; De Raeve L, 2010, OTOL NEUROTOL, V31, P1261, DOI 10.1097/MAO.0b013e3181f1cde3; Debener S, 2008, PSYCHOPHYSIOLOGY, V45, P20, DOI 10.1111/j.1469-8986.2007.00610.x; Debener S, 2006, TRENDS COGN SCI, V10, P558, DOI 10.1016/j.tics.2006.09.010; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dettman S, 2013, OTOL NEUROTOL, V34, P451, DOI 10.1097/MAO.0b013e3182839650; Doucet ME, 2006, BRAIN, V129, P3376, DOI 10.1093/brain/awl264; Doucet ME, 2005, NEUROREPORT, V16, P1753, DOI 10.1097/01.wnr.0000185011.91197.58; Eggermont JJ, 1997, ACTA OTO-LARYNGOL, V117, P161, DOI 10.3109/00016489709117760; EGGERMONT JJ, 1988, ELECTROEN CLIN NEURO, V70, P293, DOI 10.1016/0013-4694(88)90048-X; Etymotic Research, 2005, BKB SIN SPEECH IN NO; Fine I, 2005, J COGNITIVE NEUROSCI, V17, P1621, DOI 10.1162/089892905774597173; Finney EM, 2003, NEUROREPORT, V14, P1425, DOI 10.1097/00001756-200308060-00004; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Geers AE, 2004, ARCH OTOLARYNGOL, V130, P634, DOI 10.1001/archotol.130.5.634; Geers Ann E, 2006, Adv Otorhinolaryngol, V64, P50, DOI 10.1159/000094644; Geers AE, 2009, J DEAF STUD DEAF EDU, V14, P371, DOI 10.1093/deafed/enn046; Gifford RH, 2011, J AM ACAD AUDIOL, V22, P623, DOI 10.3766/jaaa.22.9.7; Gilley PM, 2008, BRAIN RES, V1239, P56, DOI 10.1016/j.brainres.2008.08.026; Gilley PM, 2005, CLIN NEUROPHYSIOL, V116, P648, DOI 10.1016/j.clinph.2004.09.009; Giraud AL, 2007, RESTOR NEUROL NEUROS, V25, P381; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Harrison RV, 2005, DEV PSYCHOBIOL, V46, P252, DOI 10.1002/dev.20052; Hine J, 2007, CLIN NEUROPHYSIOL, V118, P1274, DOI 10.1016/j.clinph.2007.03.012; Holt RF, 2008, EAR HEARING, V29, P492, DOI 10.1097/AUD.0b013e31816c409f; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Klaver P, 2008, NEUROIMAGE, V39, P1815, DOI 10.1016/j.neuroimage.2007.11.009; Kok MA, 2014, J COMP NEUROL, V522, P654, DOI 10.1002/cne.23439; Kral A, 2007, BRAIN RES REV, V56, P259, DOI 10.1016/j.brainresrev.2007.07.021; Kral A, 2012, TRENDS NEUROSCI, V35, P111, DOI 10.1016/j.tins.2011.09.004; Kubova Z, 2014, DOC OPHTHALMOL, V128, P121, DOI 10.1007/s10633-014-9429-y; Lazard DS, 2014, HEARING RES, V307, P136, DOI 10.1016/j.heares.2013.08.006; Lazard DS, 2013, HUM BRAIN MAPP, V34, P1208, DOI 10.1002/hbm.21504; Le Grand R, 2003, NAT NEUROSCI, V6, P1108, DOI 10.1038/nn1121; Lee HJ, 2005, HEARING RES, V203, P2, DOI 10.1016/j.heares.2004.11.005; Lee HJ, 2007, CEREB CORTEX, V17, P909, DOI 10.1093/cercor/bhl001; Letourneau SM, 2011, PERCEPTION, V40, P563, DOI 10.1068/p6858; Lin FR, 2014, NEUROIMAGE, V90, P84, DOI 10.1016/j.neuroimage.2013.12.059; Lin FR, 2008, OTOL NEUROTOL, V29, P208, DOI 10.1097/MAO.0b013e31812f6fa6; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Meredith MA, 2011, P NATL ACAD SCI USA, V108, P8856, DOI 10.1073/pnas.1018519108; MOSKOWITZ A, 1983, ELECTROEN CLIN NEURO, V56, P1, DOI 10.1016/0013-4694(83)90002-0; NEVILLE HJ, 1987, BRAIN RES, V405, P268, DOI 10.1016/0006-8993(87)90296-4; NEVILLE HJ, 1983, BRAIN RES, V266, P127, DOI 10.1016/0006-8993(83)91314-8; Nicholas JG, 2007, J SPEECH LANG HEAR R, V50, P1048, DOI 10.1044/1092-4388(2007/073); Niparko JK, 2010, JAMA-J AM MED ASSOC, V303, P1498, DOI 10.1001/jama.2010.451; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Passarotti AM, 2003, DEVELOPMENTAL SCI, V6, P100, DOI 10.1111/1467-7687.00259; Peelle JE, 2011, J NEUROSCI, V31, P12638, DOI 10.1523/JNEUROSCI.2559-11.2011; Peterson NR, 2010, RESTOR NEUROL NEUROS, V28, P237, DOI 10.3233/RNN-2010-0535; Sandmann P, 2012, BRAIN, V135, P555, DOI 10.1093/brain/awr329; Sarant J, 2014, EAR HEARING, V35, P396, DOI 10.1097/AUD.0000000000000022; Sarant JZ, 2001, EAR HEARING, V22, P18, DOI 10.1097/00003446-200102000-00003; Scott GD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00177; Sharma A, 2002, ANN OTO RHINOL LARYN, V111, P38, DOI 10.1177/00034894021110S508; Sharma A, 2002, NEUROREPORT, V13, P1365, DOI 10.1097/00001756-200207190-00030; Sharma A, 2015, INT J PSYCHOPHYSIOL, V95, P135, DOI 10.1016/j.ijpsycho.2014.04.007; Sharma Anu, 2002, Ear and Hearing, V23, P532, DOI 10.1097/00003446-200212000-00004; Stothart G, 2014, CLIN NEUROPHYSIOL, V125, P1471, DOI 10.1016/j.clinph.2013.11.029; Strelnikov K, 2013, BRAIN, V136, P3682, DOI 10.1093/brain/awt274; Tobey EA, 2003, EAR HEARING, V24, p36S, DOI 10.1097/01.AUD.0000051688.48224.A6; Tyler RS, 1997, OTOLARYNG HEAD NECK, V117, P180, DOI 10.1016/S0194-5998(97)70172-4; Vachon P, 2013, NEUROSCIENCE, V245, P50, DOI 10.1016/j.neuroscience.2013.04.004; Wang NY, 2008, OTOL NEUROTOL, V29, P240, DOI 10.1097/MAO.0b013e3181627a37; Whittingstall K, 2007, HUM BRAIN MAPP, V28, P134, DOI 10.1002/hbm.20265; Wilke M, 2007, EXP BRAIN RES, V178, P296, DOI 10.1007/s00221-006-0732-z; Wilkinson F, 2000, CURR BIOL, V10, P1455, DOI 10.1016/S0960-9822(00)00800-9; Wilson RH, 2007, J SPEECH LANG HEAR R, V50, P844, DOI 10.1044/1092-4388(2007/059)	85	34	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147793	10.1371/journal.pone.0147793	http://dx.doi.org/10.1371/journal.pone.0147793			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807850	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800212
J	de Gardelle, V; Le Corre, F; Mamassian, P				de Gardelle, Vincent; Le Corre, Francois; Mamassian, Pascal			Confidence as a Common Currency between Vision and Audition	PLOS ONE			English	Article							MEMORY	The idea of a common currency underlying our choice behaviour has played an important role in sciences of behaviour, from neurobiology to psychology and economics. However, while it has been mainly investigated in terms of values, with a common scale on which goods would be evaluated and compared, the question of a common scale for subjective probabilities and confidence in particular has received only little empirical investigation so far. The present study extends previous work addressing this question, by showing that confidence can be compared across visual and auditory decisions, with the same precision as for the comparison of two trials within the same task. We discuss the possibility that confidence could serve as a common currency when describing our choices to ourselves and to others.	[de Gardelle, Vincent] CNRS, UMR 8174, Ctr Econ Sorbonne, Paris, France; [de Gardelle, Vincent] Paris Sch Econ, Paris, France; [Le Corre, Francois; Mamassian, Pascal] CNRS, UMR 8248, Lab Syst Perceptifs, Paris, France; [Le Corre, Francois; Mamassian, Pascal] PSL Res Univ, Ecole Normale Super, Inst Etude Cognit, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Paris School of Economics; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	de Gardelle, V (corresponding author), CNRS, UMR 8174, Ctr Econ Sorbonne, Paris, France.; de Gardelle, V (corresponding author), Paris Sch Econ, Paris, France.	vincent.gardelle@gmail.com	de Gardelle, Vincent/I-1226-2014; Mamassian, Pascal/F-4781-2012	de Gardelle, Vincent/0000-0001-5977-5597; Mamassian, Pascal/0000-0002-1605-4607	Agence Nationale de la Recherche [ANR-10-BLAN-1910]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by an Agence Nationale de la Recherche grant to PM[ANR-10-BLAN-1910 "Visual Confidence"]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrami B, 2010, SCIENCE, V329, P1081, DOI 10.1126/science.1185718; Baird B, 2013, J NEUROSCI, V33, P16657, DOI 10.1523/JNEUROSCI.0786-13.2013; Bornstein BH, 1999, J EXP PSYCHOL-APPL, V5, P76, DOI 10.1037/1076-898X.5.1.76; CABANAC M, 1992, J THEOR BIOL, V155, P173, DOI 10.1016/S0022-5193(05)80594-6; de Gardelle V, 2014, PSYCHOL SCI, V25, P1286, DOI 10.1177/0956797614528956; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Hunt AR, 2004, BRAIN COGNITION, V55, P325, DOI 10.1016/j.bandc.2004.02.072; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; Koriat A, 2012, SCIENCE, V336, P360, DOI 10.1126/science.1216549; Lebreton M, 2015, NAT NEUROSCI, V18, P1159, DOI 10.1038/nn.4064; Lebreton M, 2009, NEURON, V64, P431, DOI 10.1016/j.neuron.2009.09.040; Levy DJ, 2012, CURR OPIN NEUROBIOL, V22, P1027, DOI 10.1016/j.conb.2012.06.001; McCurdy LY, 2013, J NEUROSCI, V33, P1897, DOI 10.1523/JNEUROSCI.1890-12.2013; MCNAMARA JM, 1986, AM NAT, V127, P358, DOI 10.1086/284489; Morey RD, 2014, STAT PROBABIL LETT, V92, P121, DOI 10.1016/j.spl.2014.05.010; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rose AK, 2005, J ECON SURV, V19, P347, DOI 10.1111/j.0950-0804.2005.00251.x; Savage L.J., 1954, FDN STAT; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; West RF, 1997, PSYCHON B REV, V4, P387, DOI 10.3758/BF03210798; Zarnoth P, 1997, J EXP SOC PSYCHOL, V33, P345, DOI 10.1006/jesp.1997.1326; Zhang H, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00001	22	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147901	10.1371/journal.pone.0147901	http://dx.doi.org/10.1371/journal.pone.0147901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808061	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800242
J	Glenn, AE; Davis, CB; Gao, ML; Gold, SE; Mitchell, TR; Proctor, RH; Stewart, JE; Snook, ME				Glenn, Anthony E.; Davis, C. Britton; Gao, Minglu; Gold, Scott E.; Mitchell, Trevor R.; Proctor, Robert H.; Stewart, Jane E.; Snook, Maurice E.			Two Horizontally Transferred Xenobiotic Resistance Gene Clusters Associated with Detoxification of Benzoxazolinones by Fusarium Species	PLOS ONE			English	Article							ASPERGILLUS-KAWACHII; FUMONISIN PRODUCTION; FUNGAL ENDOPHYTES; BETA-LACTAMASES; VERTICILLIOIDES; ECOLOGY; BIOTRANSFORMATION; IDENTIFICATION; PHYTOALEXINS; DEGRADATION	Microbes encounter a broad spectrum of antimicrobial compounds in their environments and often possess metabolic strategies to detoxify such xenobiotics. We have previously shown that Fusarium verticillioides, a fungal pathogen of maize known for its production of fumonisin mycotoxins, possesses two unlinked loci, FDB1 and FDB2, necessary for detoxification of antimicrobial compounds produced by maize, including the gamma-lactam 2-benzoxazolinone ( BOA). In support of these earlier studies, microarray analysis of F. verticillioides exposed to BOA identified the induction of multiple genes at FDB1 and FDB2, indicating the loci consist of gene clusters. One of the FDB1 cluster genes encoded a protein having domain homology to the metallo-beta-lactamase (MBL) superfamily. Deletion of this gene ( MBL1) rendered F. verticillioides incapable of metabolizing BOA and thus unable to grow on BOA-amended media. Deletion of other FDB1 cluster genes, in particular AMD1 and DLH1, did not affect BOA degradation. Phylogenetic analyses and topology testing of the FDB1 and FDB2 cluster genes suggested two horizontal transfer events among fungi, one being transfer of FDB1 from Fusarium to Colletotrichum, and the second being transfer of the FDB2 cluster from Fusarium to Aspergillus. Together, the results suggest that plant-derived xenobiotics have exerted evolutionary pressure on these fungi, leading to horizontal transfer of genes that enhance fitness or virulence.	[Glenn, Anthony E.; Davis, C. Britton; Gold, Scott E.; Mitchell, Trevor R.; Snook, Maurice E.] USDA, ARS, Richard B Russell Res Ctr, Toxicol & Mycotoxin Res Unit, Athens, GA USA; [Gao, Minglu] Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA; [Proctor, Robert H.] USDA, ARS, Natl Ctr Agr Utilizat Res, Mycotoxin Prevent & Appl Microbiol Res Unit, Peoria, IL USA; [Stewart, Jane E.] Colorado State Univ, Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Davis, C. Britton] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	United States Department of Agriculture (USDA); University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); Colorado State University; University System of Georgia; University of Georgia	Glenn, AE (corresponding author), USDA, ARS, Richard B Russell Res Ctr, Toxicol & Mycotoxin Res Unit, Athens, GA USA.	anthony.glenn@ars.usda.gov		Glenn, Anthony/0000-0001-8329-1306				Abbas HK, 2009, TOXIN REV, V28, P142, DOI 10.1080/15569540903081590; Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; Baldwin TT, 2014, J AGR FOOD CHEM, V62, P2118, DOI 10.1021/jf5001106; Brown DW, 2012, FUNGAL GENET BIOL, V49, P521, DOI 10.1016/j.fgb.2012.05.010; Bulder AS, 2012, P 74 M JOINT FAOWHO, P325; Bush K, 2010, CRIT CARE, V14, DOI 10.1186/cc8892; Butchko RAE, 2012, FUNGAL GENET BIOL, V49, P602, DOI 10.1016/j.fgb.2012.06.003; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Futagami T, 2015, APPL ENVIRON MICROB, V81, P1353, DOI 10.1128/AEM.03483-14; Gardiner DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002952; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; Glenn AE, 2009, J APPL MICROBIOL, V107, P657, DOI 10.1111/j.1365-2672.2009.04246.x; Glenn AE, 2003, APPL ENVIRON MICROB, V69, P3165, DOI 10.1128/AEM.69.6.3165-3169.2003; Glenn AE, 2002, MOL PLANT MICROBE IN, V15, P91, DOI 10.1094/MPMI.2002.15.2.91; Glenn AE, 2001, APPL ENVIRON MICROB, V67, P2973, DOI 10.1128/AEM.67.7.2973-2981.2001; Glenn AE, 2008, MOL PLANT MICROBE IN, V21, P87, DOI 10.1094/MPMI-21-1-0087; Glenn AE, 2010, FEBS LETT, V584, P3158, DOI 10.1016/j.febslet.2010.05.063; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Karagianni EP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12900; Kettle AJ, 2015, MOL PLANT PATHOL, V16, P946, DOI 10.1111/mpp.12250; Kettle AJ, 2015, FUNGAL GENET BIOL, V83, P1, DOI 10.1016/j.fgb.2015.08.005; Leslie JF, 2006, FUSARIUM LAB MANUAL; Lim FY, 2012, APPL ENVIRON MICROB, V78, P4117, DOI 10.1128/AEM.07710-11; Marasas WFO, 2004, J NUTR, V134, P711, DOI 10.1093/jn/134.4.711; Morgavi DP, 2007, ANIM FEED SCI TECH, V137, P201, DOI 10.1016/j.anifeedsci.2007.06.002; Nesme J, 2015, ENVIRON MICROBIOL, V17, P913, DOI 10.1111/1462-2920.12631; NIEMEYER HM, 1988, PHYTOCHEMISTRY, V27, P3349, DOI 10.1016/0031-9422(88)80731-3; O'Donnell K, 2013, FUNGAL GENET BIOL, V52, P20, DOI 10.1016/j.fgb.2012.12.004; Saunders M, 2008, APPL ENVIRON MICROB, V74, P136, DOI 10.1128/AEM.01538-07; Saunders M, 2010, EVOL APPL, V3, P525, DOI 10.1111/j.1752-4571.2010.00141.x; Saunders M, 2009, NEW PHYTOL, V182, P229, DOI 10.1111/j.1469-8137.2008.02746.x; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Stone JK, 2000, BOOK SOIL P, P3; Sugimoto T, 2012, J IND MICROBIOL BIOT, V39, P605, DOI 10.1007/s10295-011-1053-1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vagena E, 2008, CURR DRUG METAB, V9, P628, DOI 10.2174/138920008785821729; VANETTEN HD, 1994, PLANT CELL, V6, P1191; Vilich V, 1999, MYCOL RES, V103, P1529, DOI 10.1017/S0953756299008862; Voss KA, 2007, ANIM FEED SCI TECH, V137, P299, DOI 10.1016/j.anifeedsci.2007.06.007; Williams LD, 2007, J AGR FOOD CHEM, V55, P2937, DOI 10.1021/jf0635614; Williams LD, 2006, J AGR FOOD CHEM, V54, P5694, DOI 10.1021/jf0610209; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	46	23	49	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147486	10.1371/journal.pone.0147486	http://dx.doi.org/10.1371/journal.pone.0147486			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808652	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800108
J	Huang, C; Sachse, FB; Hitchcock, RW; Kaza, AK				Huang, Chao; Sachse, Frank B.; Hitchcock, Robert W.; Kaza, Aditya K.			Sensitivity and Specificity of Cardiac Tissue Discrimination Using Fiber-Optics Confocal Microscopy	PLOS ONE			English	Article							CONGENITALLY CORRECTED TRANSPOSITION; FLUORESCEIN ANGIOGRAPHY; LASER ENDOMICROSCOPY; GREAT-ARTERIES; HEART-DISEASE; PROBE; IDENTIFICATION; JUNCTION; BLOCK; NODE	Disturbances of the cardiac conduction system constitute a major risk after surgical repair of complex cases of congenital heart disease. Intraoperative identification of the conduction system may reduce the incidence of these disturbances. We previously developed an approach to identify cardiac tissue types using fiber-optics confocal microscopy and extracellular fluorophores. Here, we applied this approach to investigate sensitivity and specificity of human and automated classification in discriminating images of atrial working myocardium and specialized tissue of the conduction system. Two-dimensional image sequences from atrial working myocardium and nodal tissue of isolated perfused rodent hearts were acquired using a fiber-optics confocal microscope (Leica FCM1000). We compared two methods for local application of extracellular fluorophores: topical via pipette and with a dye carrier. Eight blinded examiners evaluated 162 randomly selected images of atrial working myocardium (n = 81) and nodal tissue (n = 81). In addition, we evaluated the images using automated classification. Blinded examiners achieved a sensitivity and specificity of 99.2 +/- 0.3% and 98.0 +/- 0.7%, respectively, with the dye carrier method of dye application. Sensitivity and specificity was similar for dye application via a pipette (99.2 +/- 0.3% and 94.0 +/- 2.4%, respectively). Sensitivity and specificity for automated methods of tissue discrimination were similarly high. Human and automated classification achieved high sensitivity and specificity in discriminating atrial working myocardium and nodal tissue. We suggest that our findings facilitate clinical translation of fiber-optics confocal microscopy as an intraoperative imaging modality to reduce the incidence of conduction disturbances during surgical correction of congenital heart disease.	[Huang, Chao; Sachse, Frank B.; Hitchcock, Robert W.; Kaza, Aditya K.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Sachse, Frank B.] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Traininng I, Salt Lake City, UT USA; [Kaza, Aditya K.] Boston Childrens Hosp, Dept Cardiac Surg, Boston, MA USA; [Kaza, Aditya K.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Kaza, AK (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.; Kaza, AK (corresponding author), Boston Childrens Hosp, Dept Cardiac Surg, Boston, MA USA.; Kaza, AK (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	Aditya.Kaza@cardio.chboston.org	Kaza, Aditya/AAE-2116-2019	Kaza, Aditya/0000-0003-3450-4496; Sachse, Frank/0000-0003-4987-705X	US National Institutes of Health [R21 HL108099]; Nora Eccles Treadwell Foundation; Utah Science Technology and Research initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL108099] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nora Eccles Treadwell Foundation; Utah Science Technology and Research initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the US National Institutes of Health (R21 HL108099), the Nora Eccles Treadwell Foundation, and the Utah Science Technology and Research initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford R, 2009, MOL IMAGING, V8, P341, DOI 10.2310/7290.2009.00031; ANDERSON RH, 1983, THORAX, V38, P408, DOI 10.1136/thx.38.6.408; BHAVANANDAN VP, 1979, J BIOL CHEM, V254, P4000; Bogers AJJC, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-74; Bonatti V, 1998, Pediatr Med Chir, V20, P181; Camelliti P, 2005, MICROSC MICROANAL, V11, P249, DOI [10.1017/S1431927605050506, 10.1017/S143927605050506]; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Diaspro A, 2002, CONFOCAL 2 PHOTON MI; DICK M, 1979, CIRCULATION, V59, P150, DOI 10.1161/01.CIR.59.1.150; Fletcher RH, 2014, CLIN EPIDEMIOLOGY ES, V5; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Graham TP, 2000, J AM COLL CARDIOL, V36, P255, DOI 10.1016/S0735-1097(00)00682-3; Hong GS, 2012, NAT MED, V18, P1841, DOI 10.1038/nm.2995; Hoy CL, 2008, OPT EXPRESS, V16, P9996, DOI 10.1364/OE.16.009996; Huang C, 2014, FRONT PHYSIOL, V5; Huang C, 2013, CIRC-CARDIOVASC IMAG, V6, P739, DOI 10.1161/CIRCIMAGING.112.000121; Kwan ASL, 2006, CLIN EXP OPHTHALMOL, V34, P33, DOI 10.1111/j.1442-9071.2006.01136.x; KWITEROVICH KA, 1991, OPHTHALMOLOGY, V98, P1139; Lackey DP, 2011, ANN BIOMED ENG, V39, P2683, DOI 10.1007/s10439-011-0369-3; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; LILLEHEI CW, 1963, J THORAC CARDIOV SUR, V46, P436, DOI 10.1016/S0022-5223(19)33647-5; LINCOLN C, 1979, BRIT HEART J, V42, P339; Liu GJ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3555180; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; Sharma P, 2011, GASTROINTEST ENDOSC, V74, P465, DOI 10.1016/j.gie.2011.04.004; SODERSTROM KO, 1987, HISTOCHEMISTRY, V87, P557, DOI 10.1007/BF00492470; Thiberville L, 2009, EUR RESPIR J, V33, P974, DOI 10.1183/09031936.00083708; Wallace MB, 2010, ALIMENT PHARM THER, V31, P548, DOI 10.1111/j.1365-2036.2009.04207.x; Wallace SJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3027970; Weindling SN, 1998, AM J CARDIOL, V82, P525, DOI 10.1016/S0002-9149(98)00375-0; Wu K, 2011, UROLOGY, V78, P225, DOI 10.1016/j.urology.2011.02.057; Yicong W, 2010, ADV LASERS ELECTROOP; Yoo S, 2006, CIRCULATION, V114, P1360, DOI 10.1161/CIRCULATIONAHA.106.613182; Zhou H, 2010, STAT SCI, V25, P311, DOI 10.1214/10-STS336	34	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147667	10.1371/journal.pone.0147667	http://dx.doi.org/10.1371/journal.pone.0147667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808149	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800173
J	Schulte, EM; Tuttle, HM; Gearhardt, AN				Schulte, Erica M.; Tuttle, Hannah M.; Gearhardt, Ashley N.			Belief in Food Addiction and Obesity-Related Policy Support	PLOS ONE			English	Article							PUBLIC-OPINION; STIGMA; DYSFUNCTION; PREJUDICE; IMPACT; MODEL; SUGAR; SIDE	Objectives This study examines whether belief in the food addiction construct is associated with support for obesity-related policies (e. g., restrictions on foods served in schools and workplace cafeterias, subsidies on fruits and vegetables), while simultaneously examining other factors associated with policy support (e. g., political party affiliation). Design Cross-sectional. Setting Online Community. Participants 200 individuals were recruited through Amazon Mechanical Turk. Measurements Participants (n = 193) responded to three questions about belief in food addiction and a measure evaluating support for 13 obesity-related policy initiatives. Individuals also completed the modified Yale Food Addiction Scale (mYFAS), self-reported height and weight, and provided demographic information (age, gender, race, political party affiliation). Results Belief in food addiction was significantly associated with greater support for obesity-related initiatives, even when accounting for the significant associations of age, gender, and political party. Belief in food addiction and political party both had moderate effect sizes for predicting support for obesity-related policy. There was an interaction between age and belief in food addiction, with significant associations with policy support for both younger and older individuals, though the effect was larger for younger participants. Conclusion The current study provides evidence that belief in food addiction is associated with increased obesity-related policy support, comparable to the influence of one's political party. Growing evidence for the role of an addictive process in obesity may have important implications for public support of obesity-related policy initiatives.	[Schulte, Erica M.; Gearhardt, Ashley N.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Tuttle, Hannah M.] Univ N Carolina, Ctr Dev Sci, Chapel Hill, NC USA	University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill	Schulte, EM (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI USA.	eorenste@umich.edu		LaFata, Erica/0000-0002-8505-6366				Aiken L. S., 1991, MULTIPLE REGRESSION; Avena NM, 2008, PHYSIOL BEHAV, V94, P309, DOI 10.1016/j.physbeh.2008.01.008; Avena NM, 2012, NAT REV NEUROSCI, V13, DOI 10.1038/nrn3212-c1; Avena NM, 2009, J NUTR, V139, P623, DOI 10.3945/jn.108.097584; Barquera S, 2013, OBES REV, V14, P69, DOI 10.1111/obr.12096; Barry CL, 2013, AM J PREV MED, V44, P158, DOI 10.1016/j.amepre.2012.09.065; Boseley S, 2014, GUARDIAN, P16; Buchman D, 2009, AM J BIOETHICS, V9, P18, DOI 10.1080/15265160903090066; Cohen GL, 2003, J PERS SOC PSYCHOL, V85, P808, DOI 10.1037/0022-3514.85.5.808; Control CfD Prevention, 2010, TOB SMOK CAUS DIS BI; CRANDALL CS, 1994, J PERS SOC PSYCHOL, V66, P882, DOI 10.1037/0022-3514.66.5.882; Crandall CS, 2001, PERS SOC PSYCHOL B, V27, P30, DOI 10.1177/0146167201271003; Crocq Marc-Antoine, 2007, Dialogues Clin Neurosci, V9, P355; Cummings KM, 2002, ONCOGENE, V21, P7349, DOI 10.1038/sj.onc.1205810; Davis Caroline, 2013, ISRN Obes, V2013, P435027, DOI 10.1155/2013/435027; Dingel MJ, 2011, SOC SCI QUART, V92, P1363, DOI 10.1111/j.1540-6237.2011.00822.x; Elbel B, 2009, HEALTH AFFAIR, V28, pW1110, DOI 10.1377/hlthaff.28.6.w1110; Ellison B, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-21; Ennis S. R., 2011, HISPANIC POPULATION; Evans WD, 2005, AM J PREV MED, V28, P26, DOI 10.1016/j.amepre.2004.09.008; Flint AJ, 2014, AM J CLIN NUTR, V99, P578, DOI 10.3945/ajcn.113.068965; Freeman S, 2001, PHILOS PUBLIC AFF, V30, P105, DOI 10.1111/j.1088-4963.2001.00105.x; Gearhardt Ashley N, 2011, Curr Drug Abuse Rev, V4, P201; Gearhardt Ashley N, 2011, Curr Drug Abuse Rev, V4, P140; Gearhardt AN, 2009, J ADDICT MED, V3, P1, DOI 10.1097/ADM.0b013e318193c993; Gearhardt AN, 2009, APPETITE, V52, P430, DOI 10.1016/j.appet.2008.12.003; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Gonzalez JL, 2006, J NATL MED ASSOC, V98, P1483; Hardman CA, 2015, APPETITE, V91, P179, DOI 10.1016/j.appet.2015.04.052; Hinz A, 2007, GMS PSYCHOSOCIAL MED, V4; Howden L. M., 2010, AGE SEX COMPOSITION; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Koob GF, 2009, NEUROPHARMACOLOGY, V56, P18, DOI 10.1016/j.neuropharm.2008.07.043; Kvaale EP, 2013, CLIN PSYCHOL REV, V33, P782, DOI 10.1016/j.cpr.2013.06.002; Latner JD, 2014, APPETITE, V77, P77, DOI 10.1016/j.appet.2014.03.004; Lee NM, 2014, NUTRIENTS, V6, P5312, DOI 10.3390/nu6115312; Lee NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074836; Malika NM, 2015, EAT BEHAV, V18, P25, DOI 10.1016/j.eatbeh.2015.03.005; Meule A., 2014, CURR ADDICT REP, V1, P193, DOI [10.1007/s40429-014-0021-z, DOI 10.1007/S40429-014-0021-Z]; Oliver JE, 2005, J HEALTH POLIT POLIC, V30, P923, DOI 10.1215/03616878-30-5-923; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; Pescosolido BA, 2010, AM J PSYCHIAT, V167, P1321, DOI 10.1176/appi.ajp.2010.09121743; Rasmussen N, 2015, ADDICTION, V110, P217, DOI 10.1111/add.12774; Rastogi S., 2011, BLACK POPULATION 201; Schulte EM, 2015, FOODS MAY BE ADDICTI; Taber Katherine H, 2012, J Neuropsychiatry Clin Neurosci, V24, P1, DOI 10.1176/appi.neuropsych.24.1.1; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Volkow N D, 2012, Curr Top Behav Neurosci, V11, P1, DOI 10.1007/7854_2011_169; Warner KE, 2012, FOOD ADDICTION COMPR, P416; Ziauddeen H, 2013, OBES REV, V14, P19, DOI 10.1111/j.1467-789X.2012.01046.x	50	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147557	10.1371/journal.pone.0147557	http://dx.doi.org/10.1371/journal.pone.0147557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808427	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800133
J	Yagi, H; Asanoma, K; Ohgami, T; Ichinoe, A; Sonoda, K; Kato, K				Yagi, H.; Asanoma, K.; Ohgami, T.; Ichinoe, A.; Sonoda, K.; Kato, K.			GEP oncogene promotes cell proliferation through YAP activation in ovarian cancer	ONCOGENE			English	Article							PROTEIN-COUPLED RECEPTORS; HETEROTRIMERIC G-PROTEINS; HIPPO SIGNALING PATHWAY; YES-ASSOCIATED PROTEIN; ALPHA-SUBUNIT; SIZE-CONTROL; G12 FAMILY; ORGAN SIZE; IDENTIFICATION; ESTABLISHMENT	G-protein-coupled receptors (GPCRs) and their ligands function in the progression of human malignancies. G alpha(12) and G alpha(13), encoded by GNA12 and GNA13, respectively, are referred to as the GEP oncogene and are implicated in tumor progression. However, the molecular mechanisms by which G alpha(12/13) activation promotes cancer progression are not fully elucidated. Here, we demonstrate elevated expression of G alpha 12/13 in human ovarian cancer tissues. G alpha(12/13) activation did not promote cellular migration in the ovarian cancer cell lines examined. Rather, G alpha(12/13) activation promoted cell growth. We used a synthetic biology approach using chimeric G proteins and GPCRs activated solely by artificial ligands to selectively trigger signaling pathways downstream of specific G proteins. We found that G alpha(12/13) promotes proliferation of ovarian cancer cells by activating the transcriptional coactivator YAP, a critical component of the Hippo signaling pathway. Furthermore, we reveal that inhibition of YAP by short hairpin RNA or a specific inhibitor prevented the growth of ovarian cancer cells. Therefore, YAP may be a suitable therapeutic target in ovarian cancer.	[Yagi, H.; Asanoma, K.; Ohgami, T.; Ichinoe, A.; Sonoda, K.; Kato, K.] Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Fukuoka, Japan	Kyushu University	Yagi, H (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yagih@med.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24791709, 26861332]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We are grateful to Ms Emiko Hori, Ms Yoko Miyanari and Research Support Center, Graduate School of Medical Science, Kyushu University for technical supports. This study was supported in part by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#24791709 and #26861332).	Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; CHAN AML, 1993, MOL CELL BIOL, V13, P762, DOI 10.1128/MCB.13.2.762; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Gan CP, 2014, ONCOTARGET, V5, P9626, DOI 10.18632/oncotarget.2437; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Goldsmith Zachariah G, 2011, Genes Cancer, V2, P563, DOI 10.1177/1947601911419362; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; IMAI S, 1990, ONCOLOGY, V47, P177; Itamochi H, 2013, HUM CELL, V26, P121, DOI 10.1007/s13577-013-0062-y; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Muppidi JR, 2014, NATURE, V516, P254, DOI 10.1038/nature13765; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Sudol M, 2012, SEMIN CELL DEV BIOL, V23, P827, DOI 10.1016/j.semcdb.2012.05.002; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; XU NZ, 1994, BIOCHEM BIOPH RES CO, V201, P603, DOI 10.1006/bbrc.1994.1744; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221; Yang YM, 2015, ONCOGENE, V34, P2910, DOI 10.1038/onc.2014.218; Yotsumoto F, 2008, BIOCHEM BIOPH RES CO, V365, P555, DOI 10.1016/j.bbrc.2007.11.015; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	45	28	29	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	34					4471	4480		10.1038/onc.2015.505	http://dx.doi.org/10.1038/onc.2015.505			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU4AC	26804165				2022-12-26	WOS:000382153100005
J	Petrovich, E; Feigelson, SW; Stoler-Barak, L; Hatzav, M; Solomon, A; Bar-Shai, A; Ilan, N; Li, JP; Engelhardt, B; Vlodavsky, I; Alon, R				Petrovich, Ekaterina; Feigelson, Sara W.; Stoler-Barak, Liat; Hatzav, Miki; Solomon, Adam; Bar-Shai, Amir; Ilan, Neta; Li, Jin-Ping; Engelhardt, Britta; Vlodavsky, Israel; Alon, Ronen			Lung ICAM-1 and ICAM-2 support spontaneous intravascular effector lymphocyte entrapment but are not required for neutrophil entrapment or emigration inside endotoxin-inflamed lungs	FASEB JOURNAL			English	Article						beta(2) integrin; heparanase; heparan sulfate; inflammation	INTERCELLULAR-ADHESION MOLECULE-1; LEUKOCYTE SEQUESTRATION; T-CELLS; RECRUITMENT; HEPARANASE; ROLES; INTEGRINS; DEFORMABILITY; DIAPEDESIS; MIGRATION	The pulmonary vasculature constitutively expresses the integrin lymphocyte function-associated antigen-1 ligands intercellular adhesion molecule (ICAM)-1 and -2. In this study, effector T cells were temporarily entrapped by the lung vasculature on their way to inflamed lymph nodes, and this entrapment was strongly reduced in ICAM-1 and -2 double-deficient mice (79 and 86% reduction for CD8(+) and CD4(+) effectors, respectively, compared with wild-type mice). Although the pulmonary vasculature has been suggested to be masked by the heparan sulfate-containing glycocalyx, which is susceptible to heparanase-mediated shedding, lung and lymphocyte heparanase have been found to be unnecessary for this entrapment. Systemic LPS induced rapid neutrophil entrapment in the lung vasculature, but in contrast to T-cell entrapment, this sequestration was ICAM-1, ICAM-2, and heparanase independent. Furthermore, neutrophil migration into the bronchoalveolar space induced by LPS inhalation and LPS-induced leakage of red blood cells into this space were not dependent on lung ICAMs or heparanase activity. Nevertheless, heparanase was critical for neutrophil accumulation in smoke-exposed lungs. Our results indicate that, whereas T cells use ICAM-1 and -2 for temporary pulmonary entrapment, neutrophils get sequestered and extravasate into inflamed lungs independent of ICAMs. This is the first demonstration that the pulmonary vasculature is differentially recognized by T cells and neutrophils.-Petrovich, E., Feigelson, S. W., Stoler-Barak, L., Hatzav, M., Solomon, A., Bar-Shai, A., Ilan, N., Li, J.-P., Engelhardt, B., Vlodavsky, I., Alon, R. Lung ICAM-1 and ICAM-2 support spontaneous intravascular effector lymphocyte entrapment but are not required for neutrophil entrapment or emigration inside endotoxin-inflamed lungs.	[Petrovich, Ekaterina; Feigelson, Sara W.; Stoler-Barak, Liat; Hatzav, Miki; Solomon, Adam; Bar-Shai, Amir; Alon, Ronen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Ilan, Neta; Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, POB 9649, IL-31096 Haifa, Israel; [Li, Jin-Ping] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Engelhardt, Britta] Univ Bern, Theodor Kocher Inst, Bern, Switzerland	Weizmann Institute of Science; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Uppsala University; University of Bern	Alon, R (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ronen.alon@weizmann.ac.il	ALON, RONEN/GRX-6987-2022; Engelhardt, Britta/K-7267-2014	Engelhardt, Britta/0000-0003-3059-9846; Alon, Ronen/0000-0001-9161-6369; solomon, adam/0000-0003-1263-0707; Kopitman, Ekaterina/0000-0002-6050-6404	German-Israeli Foundation; Israel Science Foundation; U.S.-Israel Binational Science Foundation; Flight Attendant Medical Research Institute Foundation; Minerva Foundation, Germany; Swiss National Science Foundation	German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Flight Attendant Medical Research Institute Foundation; Minerva Foundation, Germany; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank Dr. U. Deutsch and Ms. C. Blatti (University of Bern) for expert technical support. R.A. is an incumbent of the Linda Jacobs Chair in Immune and Stem Cell Research, and his research is supported by the German-Israeli Foundation; the Israel Science Foundation; the U.S.-Israel Binational Science Foundation; the Flight Attendant Medical Research Institute Foundation; a research grant from Mr. and Mrs. W. Glied and the Minerva Foundation, Germany. B.E. is funded by the Swiss National Science Foundation. The authors declare no conflicts of interest.	Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Basit A, 2006, AM J PHYSIOL-LUNG C, V291, pL200, DOI 10.1152/ajplung.00346.2005; Boscacci RT, 2010, BLOOD, V116, P915, DOI 10.1182/blood-2009-11-254334; Burns AR, 2003, PHYSIOL REV, V83, P309, DOI 10.1152/physrev.00023.2002; Burns JA, 2001, AM J PATHOL, V158, P1809, DOI 10.1016/S0002-9440(10)64137-5; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Cohen SJ, 2013, BLOOD, V122, P2609, DOI 10.1182/blood-2013-04-495036; Doerschuk C M, 2000, Respir Res, V1, P136, DOI 10.1186/rr24; DOERSCHUK CM, 1992, AM J RESP CELL MOL, V7, P140, DOI 10.1165/ajrcmb/7.2.140; Doerschuk CM, 2001, MICROCIRCULATION, V8, P71, DOI 10.1038/sj.mn.7300151; Drost EM, 2002, EUR J IMMUNOL, V32, P393, DOI 10.1002/1521-4141(200202)32:2<393::AID-IMMU393>3.0.CO;2-5; Galkina E, 2005, J CLIN INVEST, V115, P3473, DOI 10.1172/JCI24482; Gao XP, 2001, J IMMUNOL, V167, P2895, DOI 10.4049/jimmunol.167.5.2895; GEBB SA, 1995, J APPL PHYSIOL, V79, P493, DOI 10.1152/jappl.1995.79.2.493; Gorina R, 2014, J IMMUNOL, V192, P324, DOI 10.4049/jimmunol.1300858; Hermano E, 2012, CELL MOL LIFE SCI, V69, P2501, DOI 10.1007/s00018-012-0930-8; Kadioglu A, 2011, J IMMUNOL, V186, P5907, DOI 10.4049/jimmunol.1001533; Kolarova H, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/694312; Kuebler WM, 1999, J VASC RES, V36, P282, DOI 10.1159/000025656; Kumasaka T, 1996, J CLIN INVEST, V97, P2362, DOI 10.1172/JCI118679; Lehmann JCU, 2003, J IMMUNOL, V171, P2588, DOI 10.4049/jimmunol.171.5.2588; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Mizgerd JP, 1997, J EXP MED, V186, P1357, DOI 10.1084/jem.186.8.1357; Moreland JG, 2002, AM J RESP CELL MOL, V27, P474, DOI 10.1165/rcmb.4694; Morris A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127032; Nakav S, 2012, AM J RESP CELL MOL, V46, P313, DOI 10.1165/rcmb.2011-0181OC; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Reutershan J, 2004, CRIT CARE, V8, P453, DOI 10.1186/cc2881; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173; Smits NC, 2010, ANAT REC, V293, P955, DOI 10.1002/ar.20895; Stoler-Barak L, 2015, FASEB J, V29, P2010, DOI 10.1096/fj.14-265447; Tanaka H, 2002, MICROVASC RES, V63, P81, DOI 10.1006/mvre.2001.2368; Vlodavsky I, 2013, MATRIX BIOL, V32, P220, DOI 10.1016/j.matbio.2013.03.001; Zcharia E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005181	39	11	11	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1767	1778		10.1096/fj.201500046	http://dx.doi.org/10.1096/fj.201500046			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26823454				2022-12-26	WOS:000374879400008
J	Young, SK; Palam, LR; Wu, C; Sachs, MS; Wek, RC				Young, Sara K.; Palam, Lakshmi Reddy; Wu, Cheng; Sachs, Matthew S.; Wek, Ronald C.			Ribosome Elongation Stall Directs Gene-specific Translation in the Integrated Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); eukaryotic initiation factor 2 (eIF2); stress response; translation control; translation initiation; CHOP; DDIT3; GADD153	UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA TRANSLATION; OPEN READING FRAME; ER-STRESS; ENDOPLASMIC-RETICULUM; NEUROSPORA-CRASSA; CELL-DEATH; CHOP; TRANSCRIPTION; PHOSPHORYLATION	Upon exposure to environmental stress, phosphorylation of the subunit of eIF2 (eIF2-P) represses global protein synthesis, coincident with preferential translation of gene transcripts that mitigate stress damage or alternatively trigger apoptosis. Because there are multiple mammalian eIF2 kinases, each responding to different stress arrangements, this translational control scheme is referred to as the integrated stress response (ISR). Included among the preferentially translated mRNAs induced by eIF2-P is that encoding the transcription factor CHOP (DDIT3/GADD153). Enhanced levels of CHOP promote cell death when ISR signaling is insufficient to restore cell homeostasis. Preferential translation of CHOP mRNA occurs by a mechanism involving ribosome bypass of an inhibitory upstream ORF (uORF) situated in the 5-leader of the CHOP mRNA. In this study, we used biochemical and genetic approaches to define the inhibitory features of the CHOP uORF and the biological consequences of loss of the CHOP uORF on CHOP expression during stress. We discovered that specific sequences within the CHOP uORF serve to stall elongating ribosomes and prevent ribosome reinitiation at the downstream CHOP coding sequence. As a consequence, deletion of the CHOP uORF substantially increases the levels and modifies the pattern of induction of CHOP expression in the ISR. Enhanced CHOP expression leads to increased expression of key CHOP target genes, culminating in increased cell death in response to stress.	[Young, Sara K.; Palam, Lakshmi Reddy; Wek, Ronald C.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA; [Wu, Cheng; Sachs, Matthew S.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Indiana University System; Indiana University Bloomington; Texas A&M University System; Texas A&M University College Station	Wek, RC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iu.edu		Young-Baird, Sara/0000-0002-8915-3139; Sachs, Matthew/0000-0001-9891-9223	National Institutes of Health [GM049164]; Ralph W. and Grace M. Showalter Research Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164, R29GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph W. and Grace M. Showalter Research Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM049164 (to R. C. W.) and the Ralph W. and Grace M. Showalter Research Trust Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baird TD, 2014, MOL BIOL CELL, V25, P1686, DOI 10.1091/mbc.E14-02-0704; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Fang P, 2004, P NATL ACAD SCI USA, V101, P4059, DOI 10.1073/pnas.0400554101; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Fawcett TW, 1996, J BIOL CHEM, V271, P14285, DOI 10.1074/jbc.271.24.14285; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jousse C, 2001, NUCLEIC ACIDS RES, V29, P4341, DOI 10.1093/nar/29.21.4341; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Oslowski Christine M, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P107, DOI 10.1097/MED.0b013e3283372843; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Teske BF, 2013, MOL BIOL CELL, V24, P2477, DOI 10.1091/mbc.E13-01-0067; Teske BF, 2011, METHOD ENZYMOL, V490, P333, DOI 10.1016/B978-0-12-385114-7.00019-2; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang Z, 1997, J BIOL CHEM, V272, P255; Wang Z, 1997, MOL CELL BIOL, V17, P4904, DOI 10.1128/MCB.17.9.4904; Young SK, 2015, J BIOL CHEM, V290, P28257, DOI 10.1074/jbc.M115.693184; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	31	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6546	6558		10.1074/jbc.M115.705640	http://dx.doi.org/10.1074/jbc.M115.705640			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26817837	hybrid, Green Published			2022-12-26	WOS:000372894200040
J	Elfving, K; Shakely, D; Andersson, M; Baltzell, K; Ali, AS; Bachelard, M; Falk, KI; Ljung, A; Msellem, MI; Omar, RS; Parola, P; Xu, WP; Petzold, M; Trollfors, B; Bjorkman, A; Lindh, M; Martensson, A				Elfving, Kristina; Shakely, Deler; Andersson, Maria; Baltzell, Kimberly; Ali, Abdullah S.; Bachelard, Marc; Falk, Kerstin I.; Ljung, Annika; Msellem, Mwinyi I.; Omar, Rahila S.; Parola, Philippe; Xu, Weiping; Petzold, Max; Trollfors, Birger; Bjorkman, Anders; Lindh, Magnus; Martensson, Andreas			Acute Uncomplicated Febrile Illness in Children Aged 2-59 months in Zanzibar - Aetiologies, Antibiotic Treatment and Outcome	PLOS ONE			English	Article							DIAGNOSTIC-TESTS; MALARIA; PNEUMONIA; BURDEN; MANAGEMENT; SYMPTOMS; VIRUSES; FEVER; KENYA	Background Despite the fact that a large proportion of children with fever in Africa present at primary health care facilities, few studies have been designed to specifically study the causes of uncomplicated childhood febrile illness at this level of care, especially in areas like Zanzibar that has recently undergone a dramatic change from high to low malaria transmission. Methods We prospectively studied the aetiology of febrile illness in 677 children aged 2-59 months with acute uncomplicated fever managed by IMCI (Integrated Management of Childhood Illness) guidelines in Zanzibar, using point-of-care tests, urine culture, blood-PCR, chest Xray (CXR) of IMCI-pneumonia classified patients, and multiple quantitative (q) PCR investigations of nasopharyngeal (NPH) (all patients) and rectal (GE) swabs (diarrhoea patients). For comparison, we also performed NPH and GE qPCR analyses in 167 healthy community controls. Final fever diagnoses were retrospectively established based on all clinical and laboratory data. Clinical outcome was assessed during a 14-day follow-up. The utility of IMCI for identifying infections presumed to require antibiotics was evaluated. Findings NPH-qPCR and GE-qPCR detected >= 1 pathogen in 657/672 (98%) and 153/164 (93%) of patients and 158/166 (95%) and 144/165 (87%) of controls, respectively. Overall, 57% (387/677) had IMCI-pneumonia, but only 12% (42/342) had CXR-confirmed pneumonia. Two patients were positive for Plasmodium falciparum. Respiratory syncytial virus (24.5%), influenza A/B (22.3%), rhinovirus (10.5%) and group-A streptococci (6.4%), CXR-confirmed pneumonia (6.2%), Shigella (4.3%) were the most common viral and bacterial fever diagnoses, respectively. Blood-PCR conducted in a sub-group of patients (n = 83) without defined fever diagnosis was negative for rickettsiae, chikungunya, dengue, Rift Valley fever and West Nile viruses. Antibiotics were prescribed to 500 (74%) patients, but only 152 (22%) had an infection retrospectively considered to require antibiotics. Clinical outcome was generally good. However, two children died. Only 68 (11%) patients remained febrile on day 3 and three of them had verified fever on day 14. An additional 29 (4.5%) children had fever relapse on day 14. Regression analysis determined C-reactive Protein (CRP) as the only independent variable significantly associated with CXR-confirmed pneumonia. Conclusions This is the first study on uncomplicated febrile illness in African children that both applied a comprehensive laboratory panel and a healthy control group. A majority of patients had viral respiratory tract infection. Pathogens were frequently detected by qPCR also in asymptomatic children, demonstrating the importance of incorporating controls in fever aetiology studies. The precision of IMCI for identifying infections requiring antibiotics was low.	[Elfving, Kristina; Andersson, Maria; Ljung, Annika; Lindh, Magnus] Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden; [Elfving, Kristina; Bachelard, Marc; Trollfors, Birger] Univ Gothenburg, Dept Paediat, Gothenburg, Sweden; [Shakely, Deler; Xu, Weiping; Bjorkman, Anders; Martensson, Andreas] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Malaria Res, Stockholm, Sweden; [Shakely, Deler] Kungalv Hosp, Dept Med, Kungalv, Sweden; [Baltzell, Kimberly] Univ Calif San Francisco, Dept Family Hlth Care Nursing, San Francisco, CA 94143 USA; [Ali, Abdullah S.; Msellem, Mwinyi I.; Omar, Rahila S.] Minist Hlth, Zanzibar Malaria Eliminat Programme, Zanzibar, Tanzania; [Falk, Kerstin I.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Parola, Philippe] Aix Marseille Univ, Fac Med, WHO Collaborat Ctr Rickettsioses & Other Arthropo, UM63, Marseille, France; [Petzold, Max] Univ Gothenburg, Akad Stat, Ctr Appl Biostat Occupat & Environm Med, Gothenburg, Sweden; [Martensson, Andreas] Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden; [Martensson, Andreas] Uppsala Univ, Dept Womens & Childrens Hlth, Int Maternal & Child Hlth Unit IMCH, Uppsala, Sweden	University of Gothenburg; University of Gothenburg; Karolinska Institutet; University of California System; University of California San Francisco; Karolinska Institutet; UDICE-French Research Universities; Aix-Marseille Universite; University of Gothenburg; Uppsala University; Uppsala University	Elfving, K (corresponding author), Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden.; Elfving, K (corresponding author), Univ Gothenburg, Dept Paediat, Gothenburg, Sweden.	kristina.elfving@vgregion.se	Parola, Philippe/AAY-4346-2021	Parola, Philippe/0000-0002-1061-1927; Elfving, Kristina/0000-0003-4477-8765	ACT Consortium through Bill and Melinda Gates Foundation	ACT Consortium through Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the ACT Consortium through an award from Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, POCKET BOOK HOSP CAR; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Castro AV, 2005, INDIAN PEDIATR, V42, P773; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Colvin JM, 2012, PEDIATRICS, V130, pE1455, DOI 10.1542/peds.2012-1391; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Elfving K, 2014, J CLIN MICROBIOL; English M, 2008, PLOS MED, V5, P1665, DOI 10.1371/journal.pmed.0050241; Feikin DR, 2013, PEDIATR INFECT DIS J, V32, pE14, DOI 10.1097/INF.0b013e31826fd39b; Fuller JA, 2013, J MED VIROL, V85, P924, DOI 10.1002/jmv.23455; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hazir T, 2006, BMJ-BRIT MED J, V333, P629, DOI 10.1136/bmj.38915.673322.80; Hazir T, 2011, CLIN INFECT DIS, V52, P293, DOI 10.1093/cid/ciq142; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Katz MA, 2012, J INFECT DIS, V206, pS53, DOI 10.1093/infdis/jis530; Kerkhof E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090847; Kotloff KL, 2013, LANCET; Laxminarayan R, 2015, LANCET; Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052; Liu J, 2014, LANCET INFECT DIS, V14, P716, DOI 10.1016/S1473-3099(14)70808-4; Mahende C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104197; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-290; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Puumalainen T, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-95; Senn N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090990; Shakely D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072912; Sokhna C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001999; Thriemer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030350; Van den Bruel A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3082; Waitumbi JN, 2010, AM J TROP MED HYG, V83, P1010, DOI 10.4269/ajtmh.2010.10-0174; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9	33	48	48	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0146054	10.1371/journal.pone.0146054	http://dx.doi.org/10.1371/journal.pone.0146054			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821179	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528400003
J	Rouch, JD; Scott, A; Lei, NY; Solorzano-Vargas, RS; Wang, JF; Hanson, EM; Kobayashi, M; Lewis, M; Stelzner, MG; Dunn, JCY; Eckmann, L; Martin, MG				Rouch, Joshua D.; Scott, Andrew; Lei, Nan Ye; Solorzano-Vargas, R. Sergio; Wang, Jiafang; Hanson, Elaine M.; Kobayashi, Masae; Lewis, Michael; Stelzner, Matthias G.; Dunn, James C. Y.; Eckmann, Lars; Martin, Martin G.			Development of Functional Microfold (M) Cells from Intestinal Stem Cells in Primary Human Enteroids	PLOS ONE			English	Article							EPITHELIAL M-CELLS; PATCH M-CELLS; NF-KAPPA-B; MESENCHYMAL TRANSITION; TRANSEPITHELIAL TRANSPORT; MOUSE INTESTINE; PEYERS-PATCHES; IN-VITRO; DIFFERENTIATION; EXPRESSION	Background & Aims Intestinal microfold (M) cells are specialized epithelial cells that act as gatekeepers of luminal antigens in the intestinal tract. They play a critical role in the intestinal mucosal immune response through transport of viruses, bacteria and other particles and antigens across the epithelium to immune cells within Peyer's patch regions and other mucosal sites. Recent studies in mice have demonstrated that M cells are generated from Lgr5+ intestinal stem cells (ISCs), and that infection with Salmonella enterica serovar Typhimurium increases M cell formation. However, it is not known whether and how these findings apply to primary human small intestinal epithelium propagated in an in vitro setting. Methods Human intestinal crypts were grown as monolayers with growth factors and treated with recombinant RANKL, and assessed for mRNA transcripts, immunofluorescence and uptake of microparticles and S. Typhimurium. Results Functional M cells were generated by short-term culture of freshly isolated human intestinal crypts in a dose-and time-dependent fashion. RANKL stimulation of the monolayer cultures caused dramatic induction of the M cell-specific markers, SPIB, and Glycoprotein-2 (GP2) in a process primed by canonical WNT signaling. Confocal microscopy demonstrated a pseudopod phenotype of GP2-positive M cells that preferentially take up microparticles. Furthermore, infection of the M cell-enriched cultures with the M cell-tropic enteric pathogen, S. Typhimurium, led to preferential association of the bacteria with M cells, particularly at lower inoculum sizes. Larger inocula caused rapid induction of M cells. Conclusions Human intestinal crypts containing ISCs can be cultured and differentiate into an epithelial layer with functional M cells with characteristic morphological and functional properties. This study is the first to demonstrate that M cells can be induced to form from primary human intestinal epithelium, and that S. Typhimurium preferentially infect these cells in an in vitro setting. We anticipate that this model can be used to generate large numbers of M cells for further functional studies of these key cells of intestinal immune induction and their impact on controlling enteric pathogens and the intestinal microbiome.	[Rouch, Joshua D.; Scott, Andrew; Dunn, James C. Y.] Univ Calif Los Angeles, Dept Surg, Div Pediat Surg, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Lei, Nan Ye; Kobayashi, Masae; Dunn, James C. Y.] Univ Calif Los Angeles, Dept Bioengn, Henry Samueli Sch Engn, Los Angeles, CA USA; [Solorzano-Vargas, R. Sergio; Wang, Jiafang; Martin, Martin G.] Univ Calif Los Angeles, Dept Pediat, Div Gastroenterol & Nutr, Mattel Childrens Hosp, Los Angeles, CA 90024 USA; [Solorzano-Vargas, R. Sergio; Wang, Jiafang; Martin, Martin G.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Hanson, Elaine M.; Eckmann, Lars] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lewis, Michael] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Pathol, Los Angeles, CA USA; [Stelzner, Matthias G.] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Surg, Los Angeles, CA USA; [Martin, Martin G.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles	Martin, MG (corresponding author), Univ Calif Los Angeles, Dept Pediat, Div Gastroenterol & Nutr, Mattel Childrens Hosp, Los Angeles, CA 90024 USA.; Martin, MG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.; Martin, MG (corresponding author), Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA.	mmartin@mednet.ucla.edu	Solorzano-Vargas, R Sergio/D-4869-2016; Martín, María/HDL-9512-2022	Dunn, James/0000-0002-6826-7065	Intestinal Stem Cell Consortium - National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases [DK085535]; NIDDK [DK083762, DK083319]; California Institute for Regenerative Medicine [RT2-01985]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085535, R01DK083762, P30DK041301] Funding Source: NIH RePORTER	Intestinal Stem Cell Consortium - National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intestinal Stem Cell Consortium (https://iscc.coh.org), a collaborative research project funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of Allergy and Infectious Diseases (DK085535); and other grants from NIDDK (DK083762, and DK083319), and the California Institute for Regenerative Medicine (RT2-01985).	AMERONGEN HM, 1992, ANN NY ACAD SCI, V664, P18, DOI 10.1111/j.1749-6632.1992.tb39745.x; AMERONGEN HM, 1991, J ACQ IMMUN DEF SYND, V4, P760; APTER FM, 1993, INFECT IMMUN, V61, P5279, DOI 10.1128/IAI.61.12.5279-5285.1993; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; de Lau W, 2012, MOL CELL BIOL, V32, P3639, DOI 10.1128/MCB.00434-12; de Lau WBM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-242; Desai MP, 1996, PHARMACEUT RES, V13, P1838, DOI 10.1023/A:1016085108889; Ermak TH, 1998, ADV DRUG DELIVER REV, V34, P261, DOI 10.1016/S0169-409X(98)00043-X; FANTINI J, 1991, P NATL ACAD SCI USA, V88, P9297, DOI 10.1073/pnas.88.20.9297; Fotopoulos G, 2002, P NATL ACAD SCI USA, V99, P9410, DOI 10.1073/pnas.142586899; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Gonzalez-Hernandez MB, 2014, J VIROL, V88, P6934, DOI 10.1128/JVI.00204-14; GRUTZKAU A, 1990, GUT, V31, P1011, DOI 10.1136/gut.31.9.1011; Jabaji Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107814; Jabaji Z, 2013, TISSUE ENG PART C-ME, V19, P961, DOI [10.1089/ten.tec.2012.0710, 10.1089/ten.TEC.2012.0710]; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kanaya T, 2012, NAT IMMUNOL, V13, P729, DOI 10.1038/ni.2352; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; Knoop KA, 2009, J IMMUNOL, V183, P5738, DOI 10.4049/jimmunol.0901563; Kobayashi A, 2013, MUCOSAL IMMUNOL, V6, P1027, DOI 10.1038/mi.2012.141; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Lahar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026898; Ma L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018083; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Odero-Marah VA, 2008, CELL RES, V18, P858, DOI 10.1038/cr.2008.84; PAPPO J, 1989, CLIN EXP IMMUNOL, V76, P144; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Tahoun A, 2012, CELL HOST MICROBE, V12, P645, DOI 10.1016/j.chom.2012.10.009; Terahara K, 2008, J IMMUNOL, V180, P7840, DOI 10.4049/jimmunol.180.12.7840; Vallin J, 2001, J BIOL CHEM, V276, P30350, DOI 10.1074/jbc.M103167200; WALKER RI, 1988, CAN J MICROBIOL, V34, P1142, DOI 10.1139/m88-201; Walter E, 2001, J CONTROL RELEASE, V76, P149, DOI 10.1016/S0168-3659(01)00413-8; Wang FC, 2013, GASTROENTEROLOGY, V145, P383, DOI 10.1053/j.gastro.2013.04.050; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	37	51	51	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148216	10.1371/journal.pone.0148216	http://dx.doi.org/10.1371/journal.pone.0148216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820624	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528400076
J	Stadlbauer, V; Haselgrubler, R; Lanzerstorfer, P; Plochberger, B; Borgmann, D; Jacak, J; Winkler, SM; Schroder, K; Hoglinger, O; Weghuber, J				Stadlbauer, Verena; Haselgruebler, Renate; Lanzerstorfer, Peter; Plochberger, Birgit; Borgmann, Daniela; Jacak, Jaroslaw; Winkler, Stephan M.; Schroeder, Klaus; Hoeglinger, Otmar; Weghuber, Julian			Biomolecular Characterization of Putative Antidiabetic Herbal Extracts	PLOS ONE			English	Article							PORTULACA-OLERACEA L.; HYPOGLYCEMIC ACTIVITY; GLUCOSE-UPTAKE; ADIPOCYTE DIFFERENTIATION; GLUT4 TRANSLOCATION; INSULIN-RESISTANCE; MEDICINAL-PLANTS; CELL-SURFACE; PURSLANE; OBESITY	Induction of GLUT4 translocation in the absence of insulin is considered a key concept to decrease elevated blood glucose levels in diabetics. Due to the lack of pharmaceuticals that specifically increase the uptake of glucose from the blood circuit, application of natural compounds might be an alternative strategy. However, the effects and mechanisms of action remain unknown for many of those substances. For this study we investigated extracts prepared from seven different plants, which have been reported to exhibit anti-diabetic effects, for their GLUT4 translocation inducing properties. Quantitation of GLUT4 translocation was determined by total internal reflection fluorescence (TIRF) microscopy in insulin sensitive CHO-K1 cells and adipocytes. Two extracts prepared from purslane (Portulaca oleracea) and tindora (Coccinia grandis) were found to induce GLUT4 translocation, accompanied by an increase of intracellular glucose concentrations. Our results indicate that the PI3K pathway is mainly responsible for the respective translocation process. Atomic force microscopy was used to prove complete plasma membrane insertion. Furthermore, this approach suggested a compound mediated distribution of GLUT4 molecules in the plasma membrane similar to insulin stimulated conditions. Utilizing a fluorescent actin marker, TIRF measurements indicated an impact of purslane and tindora on actin remodeling as observed in insulin treated cells. Finally, in-ovo experiments suggested a significant reduction of blood glucose levels under tindora and purslane treated conditions in a living organism. In conclusion, this study confirms the anti-diabetic properties of tindora and purslane, which stimulate GLUT4 translocation in an insulin-like manner.	[Stadlbauer, Verena; Haselgruebler, Renate; Lanzerstorfer, Peter; Hoeglinger, Otmar; Weghuber, Julian] Univ Appl Sci Upper Austria, Wels, Austria; [Plochberger, Birgit; Jacak, Jaroslaw] Univ Appl Sci Upper Austria, Linz, Austria; [Borgmann, Daniela; Winkler, Stephan M.] Univ Appl Sci Upper Austria, Hagenberg, Austria; [Schroeder, Klaus] BioMed Zet Life Sci GmbH, Linz, Austria; [Plochberger, Birgit] Vienna Univ Technol, A-1040 Vienna, Austria	Technische Universitat Wien	Weghuber, J (corresponding author), Univ Appl Sci Upper Austria, Wels, Austria.	julian.weghuber@fh-wels.at	Jacak, Jarosław/AAM-9987-2021	Jacak, Jarosław/0000-0002-4989-1276; Lanzerstorfer, Peter/0000-0003-4512-7964	Austrian Research Promotion Agency (FFG) [850681]; University of Applied Sciences Upper Austria Basic Funding initiative; federal state auf Upper Austria; BioMed zet Life Science GmbH	Austrian Research Promotion Agency (FFG); University of Applied Sciences Upper Austria Basic Funding initiative; federal state auf Upper Austria; BioMed zet Life Science GmbH	This work was funded by the Austrian Research Promotion Agency (FFG; project number 850681) and University of Applied Sciences Upper Austria Basic Funding initiative (project GlucoSTAR). BioMed zet Life Science GmbH is funded by the federal state auf Upper Austria. BioMed zet Life Science GmbH provided support in the form of salaries for author KS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	Almqvist N, 2004, BIOPHYS J, V86, P1753, DOI 10.1016/S0006-3495(04)74243-5; Bouderba S, 2014, J DIABETES, V6, P184, DOI 10.1111/1753-0407.12083; Bunkrongcheap R, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-88; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; de Souza CJ, 2001, DIABETES, V50, P1863, DOI 10.2337/diabetes.50.8.1863; El-Sayed MIK, 2011, J ETHNOPHARMACOL, V137, P643, DOI 10.1016/j.jep.2011.06.020; Esmaillzadeh A, 2015, J RES MED SCI, V20, P47; Gu JF, 2015, J ETHNOPHARMACOL, V161, P214, DOI 10.1016/j.jep.2014.12.002; He YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110711; Heyman L, 2014, J NUTR METAB, V2014, DOI 10.1155/2014/403041; Huyen VTT, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/765383; Jacak J, 2015, MICROSC MICROANAL, V21, P826, DOI 10.1017/S1431927615013513; Jiang ZY, 2002, J BIOL CHEM, V277, P509, DOI 10.1074/jbc.M108280200; Jung CH, 2015, NUTRIENTS, V7, P4851, DOI 10.3390/nu7064851; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Kar A, 2003, J ETHNOPHARMACOL, V84, P105, DOI 10.1016/S0378-8741(02)00144-7; Kroll DJ, 2007, INTEGR CANCER THER, V6, P110, DOI 10.1177/1534735407301825; Lanzerstorfer P, 2015, FEBS J, V282, P987, DOI 10.1111/febs.13213; Lanzerstorfer P, 2014, BRIT J PHARMACOL, V171, P5237, DOI 10.1111/bph.12845; Lee AS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/741824; Lee JO, 2015, J CELL BIOCHEM, V116, P1401, DOI 10.1002/jcb.25100; Li YM, 2012, PLANTA MED, V78, P1549, DOI 10.1055/s-0032-1315041; Lim Chun-Yan, 2014, Bioarchitecture, V4, P210, DOI 10.1080/19490992.2015.1031949; Liu LX, 2000, J CHROMATOGR A, V893, P207, DOI 10.1016/S0021-9673(00)00747-0; Lokman EF, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/120572; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Megalli S, 2006, J PHARM PHARM SCI, V9, P281; Mitsiades CS, 2004, CURR CANCER DRUG TAR, V4, P235, DOI 10.2174/1568009043333032; Mozaffari-Khosravi H, 2014, COMPLEMENT THER MED, V22, P9, DOI 10.1016/j.ctim.2013.12.017; Munasinghe MAAK, 2011, EXP DIABETES RES, DOI 10.1155/2011/978762; Naowaboot J, 2012, AM J CHINESE MED, V40, P163, DOI 10.1142/S0192415X12500139; Norberg A, 2004, J BIOL CHEM, V279, P41361, DOI 10.1074/jbc.M403435200; OMARAALWALA TR, 1991, J AM OIL CHEM SOC, V68, P198, DOI 10.1007/BF02657769; Patel D. K., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P320, DOI 10.1016/S2221-1691(12)60032-X; Prabhakar PK, 2011, THER ADV ENDOCRINOL, V2, P103, DOI 10.1177/2042018811411356; Purintrapiban J, 2006, BIOL PHARM BULL, V29, P1995, DOI 10.1248/bpb.29.1995; Qin ZY, 2012, J BIOENERG BIOMEMBR, V44, P579, DOI 10.1007/s10863-012-9460-1; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; SHIBIB BA, 1993, BIOCHEM J, V292, P267, DOI 10.1042/bj2920267; SIMOPOULOS AP, 1992, J AM COLL NUTR, V11, P374; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Stefanut MN, 2013, PLANT FOOD HUM NUTR, V68, P378, DOI 10.1007/s11130-013-0380-y; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Turmelle YP, 2006, FASEB J, V20, P2609, DOI 10.1096/fj.06-6511fje; Ueda M, 2010, FOOD FUNCT, V1, P167, DOI 10.1039/c0fo00105h; Vijayakumar MV, 2010, J BIOSCIENCES, V35, P525, DOI 10.1007/s12038-010-0060-0; Vijayakumar MV, 2005, BRIT J PHARMACOL, V146, P41, DOI 10.1038/sj.bjp.0706312; Weghuber J, 2011, BBA-BIOMEMBRANES, V1808, P2581, DOI 10.1016/j.bbamem.2011.06.007; Yoshiyama Y, 2005, BIOL PHARM BULL, V28, P1986, DOI 10.1248/bpb.28.1986; Zhan TZ, 2011, J CELL BIOCHEM, V112, P849, DOI 10.1002/jcb.22984; Zhang Z, 1993, J SHANXI U NATURAL S, V16, P307; Zidan Y, 2014, PHYTOMEDICINE, V21, P1504, DOI 10.1016/j.phymed.2014.07.010	55	14	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148109	10.1371/journal.pone.0148109	http://dx.doi.org/10.1371/journal.pone.0148109			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820984	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528400067
J	Winham, DM; Florian, TLA; Thompson, SV				Winham, Donna M.; Florian, Traci L. Armstrong; Thompson, Sharon V.			Low-Income US Women Under-informed of the Specific Health Benefits of Consuming Beans	PLOS ONE			English	Article							LEGUME CONSUMPTION; DIET QUALITY; GLYCEMIC RESPONSE; HEART-DISEASE; RISK; ACCULTURATION; BEHAVIORS; HISPANICS; ADHERENCE; RICE	Background Bean consumption can reduce chronic disease risk and improve nutrition status. Consumer knowledge of bean health benefits could lead to increased intakes. Low-income women have poorer health and nutrition, but their level of knowledge about bean health benefits is unknown. Beans are a familiar food of reasonable cost in most settings and are cultural staples for Hispanics and other ethnicities. Study objectives were to assess awareness of bean health benefits among low-income women, and to evaluate any differences by acculturation status for Hispanic women in the Southwestern United States. Methods A convenience sample of 406 primarily Mexican-origin (70%) low-income women completed a survey on knowledge of bean health benefits and general food behaviors. Principal components analysis of responses identified two summary scale constructs representing "bean health benefits" and "food behaviors." Acculturation level was the main independent variable in chi-square or ANOVA. Results survey completion rate was 86% (406/471). Most women agreed or strongly agreed that beans improved nutrition (65%) and were satiating (62%). Over 50% answered `neutral' to statements that beans could lower LDL cholesterol (52%), control blood glucose (56%) or reduce cancer risk (56%), indicating indifference or possible lack of knowledge about bean health benefits. There were significant differences by acculturation for beliefs that beans aid weight loss and intestinal health. Scores on the bean health benefits scale, but not the food behavior scale, also differed by acculturation. Conclusions Limited resource women have a favorable view of the nutrition value of beans, but the majority did not agree or disagreed with statements about bean health benefits. Greater efforts to educate low-income women about bean health benefits may increase consumption and improve nutrition.	[Winham, Donna M.] Iowa State Univ, Food Sci & Human Nutr, Ames, IA USA; [Florian, Traci L. Armstrong] Univ Arizona, Cooperat Extens Maricopa Cty, Phoenix, AZ USA; [Thompson, Sharon V.] Univ Illinois, Food Sci & Human Nutr, Urbana, IL USA	Iowa State University; University of Arizona; University of Illinois System; University of Illinois Urbana-Champaign	Winham, DM (corresponding author), Iowa State Univ, Food Sci & Human Nutr, Ames, IA USA.	dwinham@iastate.edu	Winham, Donna/B-2091-2014	Winham, Donna/0000-0003-3924-2560	United States Dry Bean Council, Nutrition Science [0020]	United States Dry Bean Council, Nutrition Science	This work was supported by the United States Dry Bean Council, Nutrition Science 0020, http://www.usdrybeans.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizona Department of Health Services, WIC NEEDS ASS; Bazzano LA, 2011, NUTR METAB CARDIOVAS, V21, P94, DOI 10.1016/j.numecd.2009.08.012; Bazzano LA, 2001, ARCH INTERN MED, V161, P2573, DOI 10.1001/archinte.161.21.2573; Beydoun MA, 2008, PREV MED, V46, P145, DOI 10.1016/j.ypmed.2007.06.016; CABAN A, 2008, DIABETES SPECTRUM, V21, P120, DOI DOI 10.2337/DIASPECT.21.2.120; Centers for Disease Control and Prevention, 2011, NAT DIAB FAT SHEET N; Darmadi-Blackberry I, 2004, ASIA PAC J CLIN NUTR, V13, P217; Desrochers N, 2001, CAN J DIET PRACT RES, V62, P193; Field AP, 2010, DISCOVERING STAT USI; Finley JW, 2007, J NUTR, V137, P2391, DOI 10.1093/jn/137.11.2391; Hiza HAB, 2013, J ACAD NUTR DIET, V113, P297, DOI 10.1016/j.jand.2012.08.011; Hutchins AM, 2012, BRIT J NUTR, V108, pS52, DOI 10.1017/S0007114512000761; Jimenez-Cruz A, 2006, NUTR HOSP, V21, P353; KEYS A, 1986, AM J EPIDEMIOL, V124, P903, DOI 10.1093/oxfordjournals.aje.a114480; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lanza E, 2006, J NUTR, V136, P1896, DOI 10.1093/jn/136.7.1896; Lichtenstein AH, 2002, J LIPID RES, V43, P264; Macartney Suzanne, 2013, AM COMMUNITY SURVEY; Marin G, 1996, HISPANIC J BEHAV SCI, V18, P297, DOI 10.1177/07399863960183002; Martinez AD, 2013, ETHNIC HEALTH, V18, P115, DOI 10.1080/13557858.2012.698254; Mattei J, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0109-9; Mattei J, 2014, HEALTH BEHAV POLICY, V1, P38, DOI 10.14485/HBPR.1.1.5; Mattei J, 2011, AM J CLIN NUTR, V94, P869, DOI 10.3945/ajcn.111.013219; Mitchell DC, 2009, J AM DIET ASSOC, V109, P909, DOI 10.1016/j.jada.2009.02.029; Purdue University, 2012, EXP FOOD NUTR ED PRO; Rodriguez CJ, 2014, CIRCULATION, V130, P593, DOI 10.1161/CIR.0000000000000071; Rose D, 2007, J NUTR EDUC BEHAV, V39, P226, DOI 10.1016/j.jneb.2007.04.180; Russell J., 2014, Journal of Nutrition & Intermediary Metabolism, V1, P18, DOI 10.1016/j.jnim.2014.10.059; Rustveld LO, 2009, PATIENT PREFER ADHER, V3, P123; Slawson DL, 2013, J ACAD NUTR DIET, V113, P972, DOI 10.1016/j.jand.2013.05.005; Smith WE, 2005, J AM DIET ASSOC, V105, P404, DOI 10.1016/j.jada.2004.12.005; Thompson SV, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-23; U.S. Department of Agriculture Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; United States Department of Agriculture, 2010, WIC FOOD PACK TIM CH; United States Department of Health and Human Services, 2011, 2011 HHS POV GUID, V72, P3147; [University of Arizona Maricopa County Cooperative Extension], 2011, MAR COUNT SUMM AD PA; *US DEP HHS USDA, 2005, DIET GUID AM; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM; Vijan S, 2005, DIABETIC MED, V22, P32, DOI 10.1111/j.1464-5491.2004.01342.x; Wiig K, 2009, PUBLIC HEALTH NUTR, V12, P1726, DOI 10.1017/S1368980008004102; Winham D., 2008, Nutrition Today, V43, P201, DOI 10.1097/01.NT.0000303354.21347.45; Winham DM, 2007, J AM COLL NUTR, V26, P243, DOI 10.1080/07315724.2007.10719607; Winham DM, 2010, J HUNGER ENVIRON NUT, V5, P498, DOI 10.1080/19320248.2010.527280; Winham DM, 2009, AM J LIFESTYLE MED, V3, p64S, DOI 10.1177/1559827609335552; Zambrana RE, 2001, J HEALTH CARE POOR U, V12, P20	45	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147592	10.1371/journal.pone.0147592	http://dx.doi.org/10.1371/journal.pone.0147592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820889	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528400034
J	Zhang, ML; Sun, YH; Chen, LQ; Cai, CF; Qiao, F; Du, ZY; Li, EC				Zhang, Meiling; Sun, Yuhong; Chen, Liqiao; Cai, Chunfang; Qiao, Fang; Du, Zhenyu; Li, Erchao			Symbiotic Bacteria in Gills and Guts of Chinese Mitten Crab (Eriocheir sinensis) Differ from the Free-Living Bacteria in Water	PLOS ONE			English	Article							SP NOV.; MICROBIOTA; COMMUNITIES; FISH; DIVERSITY; DECAPODA; PACIFIC; NUMBER	Aquatic animals have a close relationship with water, but differences in their symbiotic bacteria and the bacterial composition in water remains unclear. Wild or domestic Chinese mitten crabs (Eriocheir sinensis) and the water in which they live were collected from four sampling sites in Jiangsu and Shanghai, China. Bacterial composition in water, gills or guts of E. sinensis, were compared by high-throughput sequencing using 16S rRNA genes. Analysis of >660,000 sequences indicated that bacterial diversity was higher in water than in gills or guts. Tenericutes and Proteobacteria were dominant phyla in guts, while Actinobacteria, Proteobacteria and Bacteroidetes were dominant in gills and water. Non-metric multidimensional scaling analysis indicated that microbiota from gills, guts or water clearly separated into three groups, suggesting that crabs harbor a more specific microbial community than the water in which they live. The dominant OTUs in crab gut were related to Mycoplasmataceae, which were low in abundance in gills, showing that, like mammals, crabs have body-site specific microbiota. OTUs related to Ilumatobacter and Albimonas, which are commonly present in sediment and seawater, were dominant in gills but almost absent from the sampled water. Considering E. sinensis are bottom-dwelling crustacean and they mate in saline water or seawater, behavior and life cycle of crabs may play an important role in shaping the symbiotic bacterial pattern. This study revealed the relationship between the symbiotic bacteria of Chinese mitten crab and their habitat, affording information on the assembly factors of commensal bacteria in aquatic animals.	[Zhang, Meiling; Sun, Yuhong; Chen, Liqiao; Qiao, Fang; Du, Zhenyu; Li, Erchao] E China Normal Univ, Lab Aquaculture Nutr & Environm Hlth, Sch Life Sci, Shanghai 200241, Peoples R China; [Cai, Chunfang] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou 215123, Peoples R China	East China Normal University; Soochow University - China	Zhang, ML; Li, EC (corresponding author), E China Normal Univ, Lab Aquaculture Nutr & Environm Hlth, Sch Life Sci, Shanghai 200241, Peoples R China.	mlzhang@bio.ecnu.edu.cn; ecli@bio.ecnu.edu.cn	Zhang, Meiling/AEQ-4299-2022	Chen, Liqiao/0000-0003-0138-7828; LI, Erchao/0000-0001-8495-2241; Du, Zhen-Yu/0000-0001-6581-5313	Special Fund for Agro-scientific Research in the Public Interest [201003020, 201203065]; National Natural Science Foundation of China [31472291, 31172422]; National 'Twelfth Five-Year' Plan for Science & Technology Support [2012BAD25B03]; National Basic Research Program (973Program) [2014CB138803]; Shanghai Technology System for Chinese Mitten-handed Crab Industry; Shanghai University Knowledge Service Platform Shanghai Ocean University Aquatic Animal Breeding Center [ZF1206]	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 'Twelfth Five-Year' Plan for Science & Technology Support; National Basic Research Program (973Program)(National Basic Research Program of China); Shanghai Technology System for Chinese Mitten-handed Crab Industry; Shanghai University Knowledge Service Platform Shanghai Ocean University Aquatic Animal Breeding Center	This research was supported by grants from the Special Fund for Agro-scientific Research in the Public Interest (Nos. 201003020, 201203065), the National Natural Science Foundation of China (Nos. 31472291, 31172422), the National 'Twelfth Five-Year' Plan for Science & Technology Support (2012BAD25B03), the National Basic Research Program (973Program, No. 2014CB138803), Shanghai Technology System for Chinese Mitten-handed Crab Industry, and Shanghai University Knowledge Service Platform Shanghai Ocean University Aquatic Animal Breeding Center (ZF1206).	Bakke I, 2015, ENVIRON MICROBIOL, V17, P3914, DOI 10.1111/1462-2920.12888; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaiyapechara S, 2012, MICROB ECOL, V63, P938, DOI 10.1007/s00248-011-9936-2; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chen XB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123990; Dittel AI, 2009, J EXP MAR BIOL ECOL, V374, P79, DOI 10.1016/j.jembe.2009.04.012; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Goffredi SK, 2014, MOL ECOL, V23, P1457, DOI 10.1111/mec.12439; Kostic AD, 2013, GENE DEV, V27, P701, DOI 10.1101/gad.212522.112; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Larsen A, 2013, FEMS MICROBIOL ECOL, V85, P483, DOI 10.1111/1574-6941.12136; Leone FA, 2015, COMP BIOCHEM PHYS B, V186, P59, DOI 10.1016/j.cbpb.2015.04.010; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li GW, 2013, INT J SYST EVOL MICR, V63, P3597, DOI 10.1099/ijs.0.049742-0; Matsumoto A, 2013, INT J SYST EVOL MICR, V63, P3404, DOI 10.1099/ijs.0.047316-0; Meisterhans G, 2016, MICROB ECOL, V71, P194, DOI 10.1007/s00248-015-0662-z; Miyake S, 2015, MOL ECOL, V24, P656, DOI 10.1111/mec.13050; Mouchet MA, 2012, FEMS MICROBIOL ECOL, V79, P568, DOI 10.1111/j.1574-6941.2011.01241.x; O'Connor RM, 2014, P NATL ACAD SCI USA, V111, pE5096, DOI 10.1073/pnas.1413110111; Rudnick D, 2005, BIOL INVASIONS, V7, P333, DOI 10.1007/s10530-004-2286-y; Rungrassamee W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060802; Semova I, 2012, CELL HOST MICROBE, V12, P277, DOI 10.1016/j.chom.2012.08.003; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Simek K, 2010, APPL ENVIRON MICROB, V76, P631, DOI 10.1128/AEM.02203-09; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; Sun DL, 2013, APPL ENVIRON MICROB, V79, P5962, DOI 10.1128/AEM.01282-13; Tan SJ, 2015, FISH SHELLFISH IMMUN, V43, P264, DOI 10.1016/j.fsi.2014.12.034; Wei YM, 2015, ENVIRON SCI POLLUT R, V22, P12605, DOI 10.1007/s11356-015-4534-3; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; Ye L, 2014, ISME J, V8, P541, DOI 10.1038/ismej.2013.181; Zhang ML, 2014, AQUACULTURE, V434, P449, DOI 10.1016/j.aquaculture.2014.09.008	34	60	65	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148135	10.1371/journal.pone.0148135	http://dx.doi.org/10.1371/journal.pone.0148135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820139	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528400072
J	Davis, MA; Douglas, MR; Collyer, ML; Douglas, ME				Davis, Mark A.; Douglas, Marlis R.; Collyer, Michael L.; Douglas, Michael E.			Deconstructing a Species-Complex: Geometric Morphometric and Molecular Analyses Define Species in the Western Rattlesnake (Crotalus viridis)	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; CHARACTER DISPLACEMENT; NEOGENE VICARIANCE; SEXUAL-DIMORPHISM; MORPHOLOGY; SHAPE; DIVERGENCE; EVOLUTION; DIVERSIFICATION; VIPERIDAE	Morphological data are a conduit for the recognition and description of species, and their acquisition has recently been broadened by geometric morphometric (GM) approaches that co-join the collection of digital data with exploratory 'big data' analytics. We employed this approach to dissect the Western Rattlesnake (Crotalus viridis) species-complex in North America, currently partitioned by mitochondrial (mt) DNA analyses into eastern and western lineages (two and seven subspecies, respectively). The GM data (i.e., 33 dorsal and 50 lateral head landmarks) were gleaned from 2,824 individuals located in 10 museum collections. We also downloaded and concatenated sequences for six mtDNA genes from the NCBI GenBank database. GM analyses revealed significant head shape differences attributable to size and subspecies-designation (but not their interactions). Pairwise shape distances among subspecies were significantly greater than those derived from ancestral character states via squared-change parsimony, with the greatest differences separating those most closely related. This, in turn, suggests the potential for historic character displacement as a diversifying force in the complex. All subspecies, save one, were significantly differentiated in a Bayesian discriminant function analysis (DFA), regardless of whether our priors were uniform or informative (i.e., mtDNA data). Finally, shape differences among sister-clades were significantly greater than expected by chance alone under a Brownian model of evolution, promoting the hypothesis that selection rather than drift was the driving force in the evolution of the complex. Lastly, we combine head shape and mtDNA data so as to derived an integrative taxonomy that produced robust boundaries for six OTUs (operational taxonomic units) of the C. viridis complex. We suggest these boundaries are concomitant with species-status and subsequently provide a relevant nomenclature for its recognition and representation.	[Davis, Mark A.] Univ Illinois, Prairie Res Inst, Illinois Nat Hist Survey, Champaign, IL 61820 USA; [Douglas, Marlis R.; Douglas, Michael E.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Collyer, Michael L.] Western Kentucky Univ, Dept Biol, Bowling Green, KY 42101 USA	Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; University of Arkansas System; University of Arkansas Fayetteville; Western Kentucky University	Davis, MA (corresponding author), Univ Illinois, Prairie Res Inst, Illinois Nat Hist Survey, Champaign, IL 61820 USA.	davis63@illinois.edu	Douglas, Michael/T-1761-2019	Davis, Mark/0000-0001-9034-9430; Douglas, Michael/0000-0001-9670-7825				Adams DC, 1999, EVOL ECOL RES, V1, P959; Adams DC, 2015, EVOLUTION, V69, P823, DOI 10.1111/evo.12596; Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Anderson CG, 2012, HERPETOL MONOGR, V26, P19, DOI 10.1655/HERPMONOGRAPHS-D-11-00012.1; Ashton KG, 2001, MOL PHYLOGENET EVOL, V21, P176, DOI 10.1006/mpev.2001.1013; Avise J, 2004, MOL MARKERS NATURAL; Barlow KE, 1997, P ROY SOC B-BIOL SCI, V264, P1695, DOI 10.1098/rspb.1997.0235; Barraclough TG, 2001, TRENDS ECOL EVOL, V16, P391, DOI 10.1016/S0169-5347(01)02161-9; Bookstein FL, 1996, PROCEEDINGS OF THE IEEE WORKSHOP ON MATHEMATICAL METHODS IN BIOMEDICAL IMAGE ANALYSIS, P279, DOI 10.1109/MMBIA.1996.534080; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Bookstein FL, 2003, J HUM EVOL, V44, P167, DOI 10.1016/S0047-2484(02)00201-4; Bookstein FL, 1997, 1997 INTERNATIONAL CONFERENCE ON SHAPE MODELING AND APPLICATIONS, PROCEEDINGS, P110, DOI 10.1109/SMA.1997.634888; Bookstein FL, 1997, LECT NOTES COMPUTER, V1230, p[33, 15]; BRATTSTROM BH, 1967, COPEIA, P188; Bryson RW, 2012, MOL PHYLOGENET EVOL, V62, P447, DOI 10.1016/j.ympev.2011.10.014; Charlesworth D, 2010, HEREDITY, V105, P509, DOI 10.1038/hdy.2010.14; Collyer ML, 2015, HEREDITY, V115, P357, DOI 10.1038/hdy.2014.75; Corlett RT, 2015, TRENDS ECOL EVOL, V30, P36, DOI 10.1016/j.tree.2014.10.007; Coyne J.A., 2004, SPECIATION; Crother BI, 2012, HERPETOLOGICAL CIRCU, P1; Davis M, 2012, THESIS U ILLINOIS UR; Davis MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131067; Douglas ME, 2007, COPEIA, P920, DOI 10.1643/0045-8511(2007)7[920:GCBMAN]2.0.CO;2; Douglas ME, 2006, MOL ECOL, V15, P3353, DOI 10.1111/j.1365-294X.2006.03007.x; Douglas Michael E., 2002, P11; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ernst C.H., 2003, SNAKES US CANADA; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Giribet G, 2010, ACTA ZOOL-STOCKHOLM, V91, P11, DOI 10.1111/j.1463-6395.2009.00420.x; Grant P. R., 2008, WHY SPECIES MULTIPLY; Grismer L. Lee, 2001, Bulletin Southern California Academy of Sciences, V100, P12; Haig SM, 2006, CONSERV BIOL, V20, P1584, DOI 10.1111/j.1523-1739.2006.00530.x; Hampton PM, 2013, J MORPHOL, V247, P194, DOI [10.1002/jmor.20087, DOI 10.1002/JM0R.20087]; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Henderson RW, 2013, BIOL J LINN SOC, V109, P466, DOI 10.1111/bij.12052; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Holman, 2000, FOSSIL SNAKES N AM O; Holycross AT, 2007, BIOL CONSERV, V134, P142, DOI 10.1016/j.biocon.2006.07.020; Hopken MW, 2013, MOL ECOL, V22, P956, DOI 10.1111/mec.12156; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt G, 2007, P NATL ACAD SCI USA, V104, P18404, DOI 10.1073/pnas.0704088104; Jones MEH, 2008, J MORPHOL, V269, P945, DOI 10.1002/jmor.10634; Kaliontzopoulou A, 2008, BIOL J LINN SOC, V93, P111; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KLAUBER L. M., 1972, RATTLESNAKES THEIR H, V2nd; KLAUBER LAURENCE M., 1935, TRANS SUN DIEGO SOC NAT HIST, V8, P75; Klauber LM, 1949, T SAN DIEGO SOC NAT, V11, P161; Klauber LM, 1956, RATTLESNAKES THEIR H; Kozak KH, 2005, EVOLUTION, V59, P2000; Lamar W.W., 2004, VENOMOUS REPTILES W, VII; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Mallet J, 2001, J EVOLUTION BIOL, V14, P887, DOI 10.1046/j.1420-9101.2001.00342.x; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Margres MJ, 2015, MOL ECOL, V24, P3405, DOI 10.1111/mec.13240; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Martins EP, 1999, AM NAT, V153, P448, DOI 10.1086/303188; Meik JM, 2012, BIOL J LINN SOC, V106, P633, DOI 10.1111/j.1095-8312.2012.01881.x; Nenadic O, 2003, BARC INT C CORR AN R; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pante E, 2015, SYST BIOL, V64, P152, DOI 10.1093/sysbio/syu083; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PATTERSON C, 1993, ANNU REV ECOL SYST, V24, P153; Perkins SL, 2011, PARASITOLOGY, V138, P1664, DOI 10.1017/S0031182011000679; Pigot AL, 2013, ECOL LETT, V16, P330, DOI 10.1111/ele.12043; Pook CE, 2000, MOL PHYLOGENET EVOL, V15, P269, DOI 10.1006/mpev.1999.0756; Quinn HR, 1987, THESIS U HOUSTON; R Core Team, 2019, R LANG ENV STAT COMP; Reading CJ, 2010, BIOL LETTERS, V6, P777, DOI 10.1098/rsbl.2010.0373; Ricklefs RE, 2004, NATURE, V430, P338, DOI 10.1038/nature02700; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 1998, SYST BIOL, V47, P147, DOI 10.1080/106351598261094; Rohlf FJ., 2002, MORPHOLOGY SHAPE PHY; Rohlf FJ., 2006, TPSDIG VERSION 2 10; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruane S, 2015, ZOOL J LINN SOC-LOND, V174, P394, DOI 10.1111/zoj.12245; Runemark A, 2015, ECOLOGY, V96, P2077, DOI 10.1890/14-1996.1; Schluter D, 2000, AM NAT, V156, pS4, DOI 10.1086/303412; Schroer K, 2015, EVOLUTION, V69, P1630, DOI 10.1111/evo.12672; SHINE R, 1991, AM NAT, V138, P103, DOI 10.1086/285207; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Sites JW, 1997, CONSERV BIOL, V11, P1289, DOI 10.1046/j.1523-1739.1997.96254.x; Stebbins R.C., 1985, FIELD GUIDE W REPTIL, V2nd; Sullivan BK, 2014, COPEIA, P519, DOI 10.1643/CG-13-140; Thompson D. W., 1917, GROWTH FORM; Vincent SE, 2009, J EVOLUTION BIOL, V22, P1203, DOI 10.1111/j.1420-9101.2009.01739.x; Vincent SE, 2004, J ZOOL, V264, P53, DOI 10.1017/S0952836904005503; WILLIAMS BK, 1983, ECOLOGY, V64, P1283, DOI 10.2307/1937836; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	94	25	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146166	10.1371/journal.pone.0146166	http://dx.doi.org/10.1371/journal.pone.0146166			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816132	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528200009
J	Azevedo, LF; Perlingeiro, P; Hachul, DT; Gomes-Santos, IL; Tsutsui, JM; Negrao, CE; De Matos, LDNJ				Azevedo, Luciene Ferreira; Perlingeiro, Patricia; Hachul, Denise Tessariol; Gomes-Santos, Igor Lucas; Tsutsui, Jeane Mike; Negrao, Carlos Eduardo; De Matos, Luciana D. N. J.			Predominance of Intrinsic Mechanism of Resting Heart Rate Control and Preserved Baroreflex Sensitivity in Professional Cyclists after Competitive Training	PLOS ONE			English	Article							BLOOD-PRESSURE; SPECTRAL-ANALYSIS; VARIABILITY; BRADYCARDIA; DYSFUNCTION; EXERCISE; ADAPTATIONS; BLOCKADE; MARATHON; REFLEX	Different season trainings may influence autonomic and non-autonomic cardiac control of heart rate and provokes specific adaptations on heart's structure in athletes. We investigated the influence of transition training (TT) and competitive training (CT) on resting heart rate, its mechanisms of control, spontaneous baroreflex sensitivity (BRS) and relationships between heart rate mechanisms and cardiac structure in professional cyclists (N = 10). Heart rate (ECG) and arterial blood pressure (Pulse Tonometry) were recorded continuously. Autonomic blockade was performed (atropine-0.04 mg.kg(-1); esmolol-500 mu g.kg(-1) = 0.5 mg). Vagal effect, intrinsic heart rate, parasympathetic (n) and sympathetic (m) modulations, autonomic influence, autonomic balance and BRS were calculated. Plasma norepinephrine (high-pressure liquid chromatography) and cardiac structure (echocardiography) were evaluated. Resting heart rate was similar in TT and CT. However, vagal effect, intrinsic heart rate, autonomic influence and parasympathetic modulation (higher n value) decreased in CT (P <= 0.05). Sympathetic modulation was similar in both trainings. The autonomic balance increased in CT but still showed parasympathetic predominance. Cardiac diameter, septum and posterior wall thickness and left ventricular mass also increased in CT (P<0.05) as well as diastolic function. We observed an inverse correlation between left ventricular diastolic diameter, septum and posterior wall thickness and left ventricular mass with intrinsic heart rate. Blood pressure and BRS were similar in both trainings. Intrinsic heart rate mechanism is predominant over vagal effect during CT, despite similar resting heart rate. Preserved blood pressure levels and BRS during CT are probably due to similar sympathetic modulation in both trainings.	[Azevedo, Luciene Ferreira; Perlingeiro, Patricia; Gomes-Santos, Igor Lucas; Negrao, Carlos Eduardo; De Matos, Luciana D. N. J.] Univ Sao Paulo, Sch Med, Heart Inst InCor, Cardiovasc Rehabil & Exercise Physiol Unit, Sao Paulo, Brazil; [Hachul, Denise Tessariol] Univ Sao Paulo, Sch Med, Heart Inst InCor, Clin Arrhythmia Unit, Sao Paulo, Brazil; [Tsutsui, Jeane Mike] Univ Sao Paulo, Sch Med, Heart Inst InCor, Echocardiog Unit, Sao Paulo, Brazil; [Negrao, Carlos Eduardo] Univ Sao Paulo, Sch Phys Educ & Sport, Biodynam Movement Human Body, Sao Paulo, Brazil; [De Matos, Luciana D. N. J.] Hosp Israelita Albert Einstein, Rehabil Ctr, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Hospital Israelita Albert Einstein	Azevedo, LF (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor, Cardiovasc Rehabil & Exercise Physiol Unit, Sao Paulo, Brazil.	luciene.azevedo@usp.br	Negrao, Carlos E/C-4281-2012; Gomes dos Santos, Igor Lucas/H-3706-2013; De Matos, Luciana D.N.J/E-6723-2014; Azevedo, L F/A-9937-2010; Tsutsui, Jeane/C-6051-2013; Perlingeiro, Patricia/E-8646-2011	Gomes dos Santos, Igor Lucas/0000-0001-5946-8300; Diniz Nagem Janot de Matos, Luciana/0000-0002-9852-3293; Tessariol Hachul, Denise/0000-0001-5338-3242; Negrao, Carlos Eduardo/0000-0003-4652-1226	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/08912-3, 2006/56613-7]; CEN by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [301867/2010-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CEN by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	LFA and LDNJM were supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br/), # 2009/08912-3 and # 2006/56613-7, respectively), and CEN by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/), # 301867/2010-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo LF, 2014, INT J SPORTS MED, V35, P954, DOI 10.1055/s-0033-1364024; BERTINIERI G, 1988, AM J PHYSIOL, V254, pH377, DOI 10.1152/ajpheart.1988.254.2.H377; Bompa T., 2009, PERIODIZATION THEORY, V5th ed., P125; Bonaduce D, 1998, MED SCI SPORT EXER, V30, P691, DOI 10.1097/00005768-199805000-00008; Boyett MR, 2013, J APPL PHYSIOL, V114, P1351, DOI 10.1152/japplphysiol.01126.2012; Blasquez JCC, 2009, PSICOTHEMA, V21, P531; D'Souza A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4775; FURLAN R, 1993, CARDIOVASC RES, V27, P482, DOI 10.1093/cvr/27.3.482; Hug B, 2014, INT J SPORTS MED, V35, P676, DOI 10.1055/s-0033-1361184; Iellamo F, 2002, CIRCULATION, V105, P2719, DOI 10.1161/01.CIR.0000018124.01299.AE; Iellamo F, 1996, J HYPERTENS, V14, P1099; Iellamo F, 2001, J HYPERTENS, V19, P2231, DOI 10.1097/00004872-200112000-00017; JORDAN JL, 1978, CIRCULATION, V57, P217, DOI 10.1161/01.CIR.57.2.217; JOSE AD, 1969, J CLIN INVEST, V48, P2019, DOI 10.1172/JCI106167; JOSE AD, 1970, CARDIOVASC RES, V4, P160, DOI 10.1093/cvr/4.2.160; KATONA PG, 1982, J APPL PHYSIOL, V52, P1652, DOI 10.1152/jappl.1982.52.6.1652; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEHMANN M, 1993, MED SCI SPORT EXER, V25, P854, DOI 10.1249/00005768-199307000-00015; LEWIS SF, 1980, ACTA PHYSIOL SCAND, V109, P297, DOI 10.1111/j.1748-1716.1980.tb06600.x; Mitchell JH, 2005, J AM COLL CARDIOL, V45, P1364, DOI 10.1016/j.jacc.2005.02.015; Neilan TG, 2006, EUR HEART J, V27, P1079, DOI 10.1093/eurheartj/ehi813; Neilan TG, 2006, CIRCULATION, V114, P2325, DOI 10.1161/CIRCULATIONAHA.106.647461; Pagani M, 1997, CIRCULATION, V95, P1441; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; PARATI G, 1988, HYPERTENSION, V12, P214, DOI 10.1161/01.HYP.12.2.214; Porta A, 2000, AM J PHYSIOL-HEART C, V279, pH2558, DOI 10.1152/ajpheart.2000.279.5.H2558; Portier H, 2001, MED SCI SPORT EXER, V33, P1120; Raczak Grzegorz, 2006, Kardiol Pol, V64, P135; Rosenblueth A, 1934, AM J PHYSIOL, V110, P42, DOI 10.1152/ajplegacy.1934.110.1.42; Shin K, 1995, JPN J PHYSIOL, V45, P1053, DOI 10.2170/jjphysiol.45.1053; SMITH ML, 1989, MED SCI SPORT EXER, V21, P40, DOI 10.1249/00005768-198902000-00008; Stein R, 2000, EUR J APPL PHYSIOL, V82, P155, DOI 10.1007/s004210050666; Stein R, 2002, J AM COLL CARDIOL, V39, P1033, DOI 10.1016/S0735-1097(02)01722-9; VOLZZANG C, 1994, EUR J CLIN PHARMACOL, V46, P399; Zhang R, 2002, J PHYSIOL-LONDON, V543, P337, DOI 10.1113/jphysiol.2001.013398	35	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0148036	10.1371/journal.pone.0148036	http://dx.doi.org/10.1371/journal.pone.0148036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812615	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528000072
J	Park, J; Yun, C; Kang, S				Park, Jinhee; Yun, Chul; Kang, Seungcheol			Physical Condition Does Not Affect Gravity-Induced Loss of Consciousness during Human Centrifuge Training in Well-Experienced Young Aviators	PLOS ONE			English	Article							RESPIRATORY MUSCLE FATIGUE; VALSALVA MANEUVER; GZ ACCELERATION; STRAINING MANEUVERS; BLOOD-PRESSURE; G-TOLERANCE; PERFORMANCE; PROTECTION; AIRCREW	Background Consensus on whether physical condition affects the risk of gravity-induced loss of consciousness (G-LOC) has not been reached, and most previous studies about the issue did not include well-experienced aviators. We compared the physical conditions of well-experienced young aviators according to the occurrence of G-LOC during human centrifuge training. Methods Among 361 young male aviators on active flight duty with experience in high performance aircrafts for at least 2 years, 350 had full data available and were reviewed in this study. We divided the aviators into the G-LOC group and the non-G-LOC group according to their human centrifuge training results. We then compared their basic characteristics, body composition, physical fitness level, and pulmonary function. Results Twenty nine aviators (8.3%) who experienced G-LOC during human centrifuge training in their first trials were classified into the G-LOC group. There was no difference in physical condition of aviators between the two groups. Conclusions Young aviators with experience in G-LOC showed no difference in physical condition such as muscle mass, strength, and general endurance from the aviators with no such experience. Although more studies are needed, physical condition does not seem to be a significant determinant of G-LOC among the experienced aviators.	[Park, Jinhee] Seoul Natl Univ Hosp, 101 Daehak Ro, Seoul 110744, South Korea; [Yun, Chul] Republ Korea Air Force, Aerosp Med Ctr, POB 18, Cheongju, Chungcheongbuk, South Korea; [Kang, Seungcheol] Univ Ulsan, Coll Med, Asan Med Ctr Childrens Hosp, Dept Orthopaed Surg, 88,Olymp Ro,43 Gil, Seoul 05505, South Korea	Seoul National University (SNU); Seoul National University Hospital; University of Ulsan	Kang, S (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr Childrens Hosp, Dept Orthopaed Surg, 88,Olymp Ro,43 Gil, Seoul 05505, South Korea.	ziozio79@daum.net						Bain B, 1997, AVIAT SPACE ENVIR MD, V68, P118; Bateman WA, 2006, AVIAT SPACE ENVIR MD, V77, P573; Rocha JSB, 2012, REV BRAS GINECOL OBS, V34, P414, DOI 10.1590/S0100-72032012000900005; BUICK F, 1992, AVIAT SPACE ENVIR MD, V63, P670; BULBULIAN R, 1994, AVIAT SPACE ENVIR MD, V65, P1097; Burns JW, 2001, AVIAT SPACE ENVIR MD, V72, P413; BURTON RR, 1974, AEROSPACE MED, V45, P1115; BURTON RR, 1988, AVIAT SPACE ENVIR MD, V59, P2; Cao XS, 2012, MIL MED, V177, P163, DOI 10.7205/MILMED-D-11-00003; Choi HS, 2010, EUR J APPL PHYSIOL, V109, P625, DOI 10.1007/s00421-010-1401-2; Eiken O, 2003, AVIAT SPACE ENVIR MD, V74, P822; EPPERSON WL, 1985, AVIAT SPACE ENVIR MD, V56, P534; Green NDC, 2006, AVIAT SPACE ENVIR MD, V77, P619; Johnson BD, 1996, MED SCI SPORT EXER, V28, P1129, DOI 10.1097/00005768-199609000-00008; Roman PAL, 2012, NUTR HOSP, V27, P1236, DOI 10.3305/nh.2012.27.4.5743; Looga R, 2005, RESP PHYSIOL NEUROBI, V147, P39, DOI 10.1016/j.resp.2005.01.003; LYONS TJ, 1992, AVIAT SPACE ENVIR MD, V63, P60; MACDOUGALL JD, 1992, J APPL PHYSIOL, V73, P1590, DOI 10.1152/jappl.1992.73.4.1590; Mateika JH, 2002, CLIN AUTON RES, V12, P24, DOI 10.1007/s102860200007; Ogawa H, 2011, HEPATO-GASTROENTEROL, V58, P42; SHUBROOK.SJ, 1973, J APPL PHYSIOL, V34, P460, DOI 10.1152/jappl.1973.34.4.460; SHUBROOKS SJ, 1973, J APPL PHYSIOL, V35, P294, DOI 10.1152/jappl.1973.35.2.294; TESCH PA, 1983, AVIAT SPACE ENVIR MD, V54, P691; Werchan PM, 1996, AVIAT SPACE ENVIR MD, V67, P751; WHINNERY JE, 1990, ARCH NEUROL-CHICAGO, V47, P764, DOI 10.1001/archneur.1990.00530070058012; WOOD EH, 1987, AVIAT SPACE ENVIR MD, V58, P699; Yang P, 2007, AVIAT SPACE ENVIR MD, V78, P1035, DOI 10.3357/ASEM.2048.2007	27	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147921	10.1371/journal.pone.0147921	http://dx.doi.org/10.1371/journal.pone.0147921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812597	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528000063
J	He, MX; Lv, LY; Li, HY; Meng, WQ; Zhao, N				He, Mengxuan; Lv, Lingyue; Li, Hongyuan; Meng, Weiqing; Zhao, Na			Analysis on Soil Seed Bank Diversity Characteristics and Its Relation with Soil Physical and Chemical Properties after Substrate Addition	PLOS ONE			English	Article							CANONICAL CORRESPONDENCE-ANALYSIS; VEGETATION; RESTORATION; PLANTATIONS; SUITABILITY; DYNAMICS; WETLAND; GROWTH; PLANT	Aims Considered as an essential measure in the application of soil seed bank (SSB) projects, the mixing of substrate and surface soil can effectively improve soil condition. This research is aimed at exploring the diversity characteristics of SSBs and the relationships between SSBs and soil properties. Methods Canonical correspondence analysis (CCA) was adopted to describe the ordination of SSBs on soil properties' gradients; multiple linear regressions were adopted to analyze the relationship between average growth height and soil properties, density and soil properties. Results Experimental groups of mixed substrate (the mixture of organic and inorganic substrates) had high diversity indexes, especially the Shannon-Wiener Index compared with those of single substrate. Meanwhile, a higher number of species and increased density were also noted in those of mixed substrate. The best test group, No. 16, had the highest diversity indexes with a Shannon-Wiener of 1.898, Simpson of 0.633 and Pielou of 0.717, and also showed the highest density of 14000 germinants / m(2) and 21 species. In addition, an improvement of the soil's chemical and physical properties was noted when the substrates were mixed. The mixed substrate of turfy soil and perlite could effectively enhance the soil moisture content, whilst a mixed substrate of rice husk carbon and vermiculite could improve the content of available potassium (AK) and phosphorus (AP) and strengthen soil fertility. The germinated plants also reflected obvious regularities of ordination on soil factor gradients. Three distinct cluster groups were presented, of which the first cluster was distributed in an area with a relatively higher content of AK and AP; the second cluster was distributed at places with relatively higher soil moisture content; and the third cluster of plants didn't show any obvious relationship with soil physical and chemical properties. Through CCA analysis, AK and AP were considered the most important soil factors to influence the SSB, which was illustrated in regression analysis with a high correlation coefficient when dependent values were growth height and density respectively. The linear regression equations with: growth height = 142.728 - 1.514TC + 30.218AP - 5.083TN + 10.839AK + 1.234mc; density = -68.216 - 4.609TC + 9.566AP - 35.492TN + 19.779AK - 1.591mc. were established by multiple linear regression. Conclusions (1) The mixed substrates showed a greater advantage for SSBs than single substrates, both in improving the number of species, density and diversity indexes. (2) The germinated plants reflected an obvious preference to different soil conditions, which different mixed substrates could improve accordingly. (3) AK, AP were important soil factors to influence SSBs, especially in the growth of plants and density.	[He, Mengxuan; Lv, Lingyue; Li, Hongyuan; Zhao, Na] Nankai Univ, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China; [Meng, Weiqing] Tianjin Normal Univ, Coll Urban & Environm Sci, Tianjin, Peoples R China	Nankai University; Tianjin Normal University	Li, HY (corresponding author), Nankai Univ, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China.	eialee@nankai.edu.cn	Meng, Weiqing/H-6005-2018	Meng, Weiqing/0000-0003-2848-0475	National Natural Science Foundation of China [31370700, 41301096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Nos. 31370700 and 41301096).	Andreu MG, 2009, RESTOR ECOL, V17, P586, DOI 10.1111/j.1526-100X.2008.00457.x; Badwaik L. S., 2012, International Food Research Journal, V19, P341; [白文娟 Bai Wenjuan], 2012, [土壤, Soils], V44, P562; Bakker JP, 1996, ACTA BOT NEERL, V45, P461; Bhosale MD, 2015, CURR SCI INDIA, V108, P2257; Bodaghabadi MB, 2011, CATENA, V86, P66, DOI 10.1016/j.catena.2011.02.009; Borji H, 2012, RES CROP, V13, P258; Borowiak K, 2011, FRESEN ENVIRON BULL, V20, P2264; Cao Jing, 2015, Chinese Journal of Plant Ecology, V39, P167, DOI 10.17521/cjpe.2015.0016; Carlile W. R., 1999, Acta Horticulturae, P587; Carmona E, 2012, SPAN J AGRIC RES, V10, P482, DOI 10.5424/sjar/2012102-320-11; Caron J., 1999, Acta Horticulturae, P545; Davies RJP, 2013, BIOL CONSERV, V158, P287, DOI 10.1016/j.biocon.2012.08.013; Fisher JL, 2009, BIOL CONSERV, V142, P256, DOI 10.1016/j.biocon.2008.10.019; Gruda N, 2004, SCI HORTIC-AMSTERDAM, V100, P333, DOI 10.1016/j.scienta.2003.09.004; Hager HA, 2015, BIOL INVASIONS, V17, P1833, DOI 10.1007/s10530-014-0839-2; Hanin N, 2013, J ARID ENVIRON, V91, P151, DOI 10.1016/j.jaridenv.2013.01.004; [郝翠 HAO Cui], 2009, [湿地科学, Wetland Science], V7, P266; [贺梦璇 He Mengxuan], 2015, [水土保持通报, Bulletin of Soil and Water Conservation], V35, P325; He MX, 2015, THESIS; Heydari Mehdi, 2013, Forest Science and Practice, V15, P286, DOI 10.1007/s11632-013-0413-5; Hill M. O., 1974, Applied Statistics, V23, P340, DOI 10.2307/2347127; Hong JM, 2012, ECOL ENG, V42, P192, DOI 10.1016/j.ecoleng.2012.01.004; Hosogi D, 2006, J JAPANESE SOC REVEG, V31, P385; Islam S, 2002, J HORTIC SCI BIOTECH, V77, P143, DOI 10.1080/14620316.2002.11511470; Jimmon T, 2000, J JAPANESE SOC REVEG, V25, P397; Jin ZJ, 2015, ENVIRON EARTH SCI, V73, P267, DOI 10.1007/s12665-014-3421-4; [康红梅 Kang Hongmei], 2005, [土壤通报, Journal of Soil Science], V36, P124; KEDDY PA, 1982, AM J BOT, V69, P13, DOI 10.2307/2442827; Koh J, 2006, J JAPANESE SOC REVEG, V32, P62; Landman GB, 2007, WETLANDS, V27, P211, DOI 10.1672/0277-5212(2007)27[211:SSBAOP]2.0.CO;2; Li H-Y, 2007, J LIAONING TU, V26, P140; [李洪远 Li Hongyuan], 2009, [生态环境学报, Ecology and Environmental Sciences], V18, P731; [李洪远 LI Hongyuan], 2006, [生态环境, Ecology and Environment], V15, P791; Li SX, 2009, ADV AGRON, V102, P223, DOI 10.1016/S0065-2113(09)01007-4; Liang J, 2015, ECOL ENG, V77, P119, DOI 10.1016/j.ecoleng.2015.01.016; Liang Yao-yuan, 2009, Yingyong Shengtai Xuebao, V20, P2832; Lyaruu HVM, 1999, APPL VEG SCI, V2, P209, DOI 10.2307/1478984; Ma MJ, 2013, PLANT SOIL, V369, P283, DOI 10.1007/s11104-012-1560-5; Maranon T, 1998, J VEG SCI, V9, P371, DOI 10.2307/3237101; MARKS PL, 1985, B TORREY BOT CLUB, V112, P376, DOI 10.2307/2996038; Mo XQ, 2012, THESIS; Moreira DR, 1998, PESQUI AGROPECU BRAS, V33, P721; Nakamura K, 2006, J JAPANESE SOC REVEG, V32, P203; Nishihiro J., 2006, LANDSC ECOL ENG, V2, P171, DOI [10.1007/s11355-006-0005-9, DOI 10.1007/S11355-006-0005-9]; Page MJ, 2006, J ARID ENVIRON, V64, P323, DOI 10.1016/j.jaridenv.2005.05.003; Mesquita MLR, 2013, ACTA BOT BRAS, V27, P465, DOI 10.1590/S0102-33062013000300001; Shang ZH, 2013, PLANT SOIL, V364, P229, DOI 10.1007/s11104-012-1362-9; Shin JH, 2015, HORTIC ENVIRON BIOTE, V56, P178, DOI 10.1007/s13580-015-0154-6; Srivastava R, 2014, WEED BIOL MANAG, V14, P21, DOI 10.1111/wbm.12029; Sun ShouRu, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P41; Tai NH, 2010, KOREAN J HORTIC SCI, V28, P59; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Umehara T, 1997, JAPANESE J CONSERVAT, V2, P9; [王俊 WANG Jun], 2006, [生态环境, Ecology and Environment], V15, P1372; Whittle C. A., 1997, Environmental Reviews, V5, P79, DOI 10.1139/a97-003; Yamabe S, 2004, J JAPANESE SOC REVEG, V29, P393, DOI DOI 10.7211/JJSRT.29.393; Zhai FuQun, 2013, Research of Environmental Sciences, V26, P97; Zhang DJ, 2014, PLANT SOIL, V376, P307, DOI 10.1007/s11104-013-1954-z; Zhang ZM, 2014, REMOTE SENS-BASEL, V6, P1026, DOI 10.3390/rs6021026; Zhao ZH, 2014, ENVIRON SCI POLLUT R, V21, P3091, DOI 10.1007/s11356-013-2265-x	61	5	14	7	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147439	10.1371/journal.pone.0147439	http://dx.doi.org/10.1371/journal.pone.0147439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808785	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800095
J	Johnson, MJ; Allgar, V; Macleod, U; Jones, A; Oliver, S; Currow, D				Johnson, Miriam J.; Allgar, Victoria; Macleod, Una; Jones, Annie; Oliver, Steven; Currow, David			Family Caregivers Who Would Be Unwilling to Provide Care at the End of Life Again: Findings from the Health Survey for England Population Survey	PLOS ONE			English	Article							PALLIATIVE CARE; HEART-FAILURE; SERVICES; DEATH; PROFESSIONALS; MORTALITY; OUTCOMES; PEOPLE; TRENDS	Background Family caregivers provide significant care at the end of life. We aimed to describe caregiver characteristics, and of those unwilling to repeat this role under the same circumstances. Methods Observational study of adults in private households (Health Survey for England [HSE]). Caregiving questions included: whether someone close to them died within past 5 years; relationship to the deceased; provision, intensity and duration of care; supportive/palliative care services used; willingness to care again; able to carry on with life. Comparison between those willing to care again or not used univariable analyses and an exploratory multiple logistic regression. A descriptive comparison with Health Omnibus Survey (Australia) data was conducted. Findings HSE response was 64%. 2167/8861 (25%) respondents had someone close to them die in the previous 5 years. Some level of personal care was provided by 645/8861 (7.3%). 57/632 (9%) former caregivers would be unwilling to provide care again irrespective of time since the death, duration of care, education and income. Younger age (<= 65; odds ratio [OR] 2.79; 95% CI 136, 5.74) and use of palliative care services (odds ratio: 1.95, 95% CI: 1.09, 3.48) showed greater willingness to provide care again. Apart from use of palliative care services, findings were remarkably similar to the Australian data. Conclusions A significant group of caregivers would be unwilling to provide care again. Older people and those who had not used palliative care services were more likely to be unwilling to care again. Barriers preventing access for disadvantaged groups need to be overcome.	[Johnson, Miriam J.; Macleod, Una; Jones, Annie] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Allgar, Victoria; Oliver, Steven] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Currow, David] Flinders Univ S Australia, Discipline Palliat & Support Serv, Adelaide, SA 5001, Australia	University of Hull; University of York - UK; University of Hull; University of York - UK; Flinders University South Australia	Johnson, MJ (corresponding author), Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England.	miriam.johnson@hyms.ac.uk		Allgar, Victoria/0000-0002-5228-2623; Currow, David/0000-0003-1988-1250; Johnson, Miriam/0000-0001-6204-9158	North East Yorkshire, North Lincolnshire (NEYNL) Local Clinical Research Network	North East Yorkshire, North Lincolnshire (NEYNL) Local Clinical Research Network	The work was funded by palliative care speciality group lead (MJ) general support funding provided by the North East Yorkshire, North Lincolnshire (NEYNL) Local Clinical Research Network who were independent of the study and the funding unrelated to the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy A, 2009, PALLIATIVE MED, V23, P66, DOI 10.1177/0269216308098793; Abernethy AP, 2008, SUPPORT CARE CANCER, V16, P585, DOI 10.1007/s00520-007-0342-8; Ahmed N, 2004, PALLIATIVE MED, V18, P525, DOI 10.1191/0269216304pm921oa; [Anonymous], 2015, MDS FULL REP YEAR 20; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Boodhna G, 2014, METHODS DOCUMENTATIO, V2; Boyd KJ, 2009, PALLIATIVE MED, V23, P767, DOI 10.1177/0269216309346541; Buckner L, 2011, VALUING CARERS 2011; Burns CM, 2013, PALLIATIVE MED, V27, P608, DOI 10.1177/0269216313483664; Candy B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007617.pub2; Cantwell P, 2000, J PALLIATIVE CARE, V16, P23, DOI 10.1177/082585970001600105; Carers UK tvoc, 2012, FACTS CAR 2012; Christakis NA, 2003, SOC SCI MED, V57, P465, DOI 10.1016/S0277-9536(02)00370-2; Currow DC, 2011, J PAIN SYMPTOM MANAG, V41, P661, DOI 10.1016/j.jpainsymman.2010.06.017; Davidson PM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-342; Department of Health, 2008, CAR HEART 21 CENT FA; Funk L, 2010, PALLIATIVE MED, V24, P594, DOI 10.1177/0269216310371411; Gadoud A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113188; Gelfman LP, 2014, J PALLIAT MED, V17, P753, DOI 10.1089/jpm.2013.0675; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Gomes B, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007760.pub2, 10.1590/1516-3180.20161341T2]; Gomes B, 2012, PALLIATIVE MED, V26, P102, DOI 10.1177/0269216311432329; Grande G, 2009, PALLIATIVE MED, V23, P339, DOI 10.1177/0269216309104875; Grande G, 2008, PALLIATIVE MED, V22, P971, DOI 10.1177/0269216308098805; Grande GE, 2006, AGE AGEING, V35, P267, DOI 10.1093/ageing/afj071; Hauser JM, 2004, CLIN GERIATR MED, V20, P671, DOI 10.1016/j.cger.2004.07.003; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hudson PL, 2010, PALLIATIVE MED, V24, P656, DOI 10.1177/0269216310373167; Morris SM, 2015, PALLIATIVE MED, V29, P487, DOI 10.1177/0269216314565706; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; National Institute of Cancer Research, 2010, RAP REV RES SURV CAN; NHS The Information Centre for Health and Social Care, 2010, SURV CAR HOUSEH 2009; Office for National Statistics, 2014, STAT B; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pinnock Hilary, 2011, BMJ Support Palliat Care, V1, P174, DOI 10.1136/bmjspcare.d142rep; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Schulz R, 2008, GERIATRICS, V63, P20; Seaman JB, 2014, AM J HOSP PALLIAT CA; Simpson B, 2010, DOH CARERS PERSONALI; Stajduhar KI, 2010, PALLIATIVE MED, V24, P573, DOI 10.1177/0269216310371412; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476	41	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146960	10.1371/journal.pone.0146960	http://dx.doi.org/10.1371/journal.pone.0146960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809029	Green Published, gold, Green Accepted			2022-12-26	WOS:000369527800041
J	Sumida, K; Hoshino, J; Ueno, T; Mise, K; Hayami, N; Suwabe, T; Kawada, M; Imafuku, A; Hiramatsu, R; Hasegawa, E; Yamanouchi, M; Sawa, N; Fujii, T; Ohashi, K; Takaichi, K; Ubara, Y				Sumida, Keiichi; Hoshino, Junichi; Ueno, Toshiharu; Mise, Koki; Hayami, Noriko; Suwabe, Tatsuya; Kawada, Masahiro; Imafuku, Aya; Hiramatsu, Rikako; Hasegawa, Eiko; Yamanouchi, Masayuki; Sawa, Naoki; Fujii, Takeshi; Ohashi, Kenichi; Takaichi, Kenmei; Ubara, Yoshifumi			Effect of Proteinuria and Glomerular Filtration Rate on Renal Outcome in Patients with Biopsy-Proven Benign Nephrosclerosis	PLOS ONE			English	Article							CHRONIC HYPOXIA; KIDNEY-DISEASE; BLOOD-PRESSURE; HYPERTENSION; AUTOREGULATION; PROGRESSION; FIBROSIS	Background Reduced estimated glomerular filtration rate (eGFR) and proteinuria are risk factors for end-stage renal disease (ESRD), of which benign nephrosclerosis is a common cause. However, few biopsy-based studies have assessed these associations. Methods We performed retrospective cohort study of 182 Japanese patients who underwent renal biopsy from June 1985 through March 2014 and who were diagnosed with benign nephrosclerosis. Competing risk regression analyses were used to investigate the effect of eGFR and proteinuria levels at the time of renal biopsy on the risk for renal events (ESRD or a 50% decline in eGFR from baseline). Results During a median 5.8-year follow-up, 63 (34.6%) patients experienced renal events. The incidence of renal events increased with lower baseline eGFR and greater baseline proteinuria levels. After adjustment for baseline covariates, lower eGFR levels (subhazard ratios [SHRs], 1.30; 95% confidence interval [CI], 1.01-1.67, per 10 mL/min/1.73 m(2)) and higher proteinuria levels (SHR, 1.52; 95% CI, 1.23-1.87, per 1.0 g/day) at the time of renal biopsy were associated independently with higher risk for renal events. Lower levels of serum albumin (SHR, 2.07; 95% CI, 1.20-3.55 per 1.0 g/dL) were also associated with renal events. Patients with both eGFR <30 mL/min/1.73 m(2) and proteinuria >= 0.5 g/day had a 26.7-fold higher risk (95% CI, 3.97-179.4) of renal events than patients with both eGFR >= 60 mL/min/1.73 m(2) and proteinuria <0.5 g/day. Conclusions Reduced eGFR and increased proteinuria as well as lower serum albumin at the time of renal biopsy are independent risk factors for renal events among patients with biopsy-proven benign nephrosclerosis.	[Sumida, Keiichi; Hoshino, Junichi; Ueno, Toshiharu; Mise, Koki; Hayami, Noriko; Suwabe, Tatsuya; Takaichi, Kenmei; Ubara, Yoshifumi] Toranomon Hosp Kajigaya, Nephrol Ctr, Kanagawa, Japan; [Sumida, Keiichi; Hoshino, Junichi; Hayami, Noriko; Suwabe, Tatsuya; Kawada, Masahiro; Imafuku, Aya; Hiramatsu, Rikako; Hasegawa, Eiko; Yamanouchi, Masayuki; Sawa, Naoki; Takaichi, Kenmei; Ubara, Yoshifumi] Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan; [Fujii, Takeshi; Ohashi, Kenichi] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan; [Ohashi, Kenichi] Yokohama City Univ, Grad Sch Med, Dept Pathol, Kanagawa, Japan; [Takaichi, Kenmei; Ubara, Yoshifumi] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Tokyo, Japan	Toranomon Hospital; Toranomon Hospital; Yokohama City University; Toranomon Hospital	Sumida, K (corresponding author), Toranomon Hosp Kajigaya, Nephrol Ctr, Kanagawa, Japan.; Sumida, K (corresponding author), Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan.	k-sumida@umin.ac.jp	Fujii, Takeshi/D-5877-2014	Fujii, Takeshi/0000-0001-7237-1183; Mise, Koki/0000-0003-0296-7429	Okinaka Memorial Institute for Medical Research	Okinaka Memorial Institute for Medical Research	This study was funded by the Okinaka Memorial Institute for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy KM, 2013, KIDNEY INT, V84, P622, DOI 10.1038/ki.2013.243; Churg J, 1982, RENAL DIS CLASSIFICA, P211; Crimi E, 2007, FREE RADICAL RES, V41, P1364, DOI 10.1080/10715760701732830; D'Agati V, 2003, SEMIN NEPHROL, V23, P117, DOI 10.1053/snep.2003.50012; Dasgupta I, 2007, QJM-INT J MED, V100, P113, DOI 10.1093/qjmed/hcl139; EDDY AA, 1995, KIDNEY INT, V47, P1546, DOI 10.1038/ki.1995.218; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Griffin KA, 2008, AM J PHYSIOL-RENAL, V294, pF695, DOI 10.1152/ajprenal.00324.2007; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hill GS, 2006, KIDNEY INT, V69, P823, DOI 10.1038/sj.ki.5000163; Hill GS, 2003, KIDNEY INT, V63, P1027, DOI 10.1046/j.1523-1755.2003.00831.x; Kopp JB, 2013, CURR OPIN NEPHROL HY, V22, P266, DOI 10.1097/MNH.0b013e3283600f8c; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Marin Rafael, 2005, Kidney Int Suppl, pS52; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Meyrier A., 2014, NEPHROL DIAL TRANSPL; Nakai S, 2013, THER APHER DIAL, V17, P567, DOI 10.1111/1744-9987.12147; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Norman JT, 2000, KIDNEY INT, V58, P2351, DOI 10.1046/j.1523-1755.2000.00419.x; Norris KC, 2006, J AM SOC NEPHROL, V17, P2928, DOI 10.1681/ASN.2005101101; Olson JL, 2007, HEPTINSTALLS PATHOLO, P937; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Suzuki Hiromichi, 2015, Ther Adv Cardiovasc Dis, V9, P77, DOI 10.1177/1753944715578596; Takebayashi S, 2001, CLIN NEPHROL, V55, P349; TRACY RE, 1991, MODERN PATHOL, V4, P602; TRACY RE, 1992, VIRCHOWS ARCH A, V420, P479, DOI 10.1007/BF01600252; United States Renal Data System, 2014, 2014 ANN DAT REP EP; Veniant M, 1996, J CLIN INVEST, V98, P1966, DOI 10.1172/JCI119000; Vikse BE, 2003, NEPHROL DIAL TRANSPL, V18, P517, DOI 10.1093/ndt/18.3.517	30	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147690	10.1371/journal.pone.0147690	http://dx.doi.org/10.1371/journal.pone.0147690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809068	Green Submitted, gold, Green Published			2022-12-26	WOS:000369527800181
J	Viviani, L; van der Es, M; Irvine, L; Tam, CC; Rodrigues, LC; Jackson, KA; O'Brien, SJ; Hunter, PR				Viviani, Laura; van der Es, Mike; Irvine, Lisa; Tam, Clarence C.; Rodrigues, Laura C.; Jackson, Kathryn A.; O'Brien, Sarah J.; Hunter, Paul R.		IID2 Study Executive Comm	Estimating the Incidence of Acute Infectious Intestinal Disease in the Community in the UK: A Retrospective Telephone Survey	PLOS ONE			English	Article							ACUTE GASTROINTESTINAL ILLNESS; NATIONAL SURVEILLANCE; ACUTE GASTROENTERITIS; GENERAL-PRACTICE; UNITED-STATES; POPULATION; BURDEN; DIARRHEA; IRELAND; CANADA	Objectives To estimate the burden of intestinal infectious disease (IID) in the UK and determine whether disease burden estimations using a retrospective study design differ from those using a prospective study design. Design/Setting A retrospective telephone survey undertaken in each of the four countries comprising the United Kingdom. Participants were randomly asked about illness either in the past 7 or 28 days. Participants 14,813 individuals for all of whom we had a legible recording of their agreement to participate Outcomes Self-reported IID, defined as loose stools or clinically significant vomiting lasting less than two weeks, in the absence of a known non-infectious cause. Results The rate of self-reported IID varied substantially depending on whether asked for illness in the previous 7 or 28 days. After standardising for age and sex, and adjusting for the number of interviews completed each month and the relative size of each UK country, the estimated rate of IID in the 7-day recall group was 1,530 cases per 1,000 person-years (95% CI: 1135-2113), while in the 28-day recall group it was 533 cases per 1,000 person-years (95% CI: 377-778). There was no significant variation in rates between the four countries. Rates in this study were also higher than in a related prospective study undertaken at the same time. Conclusions The estimated burden of disease from IID varied dramatically depending on study design. Retrospective studies of IID give higher estimates of disease burden than prospective studies. Of retrospective studies longer recall periods give lower estimated rates than studies with short recall periods. Caution needs to be exercised when comparing studies of self-reported IID as small changes in study design or case definition can markedly affect estimated rates.	[Viviani, Laura; Tam, Clarence C.; Rodrigues, Laura C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [van der Es, Mike; Irvine, Lisa; Hunter, Paul R.] Univ E Anglia, Norwich Sch Med, Norwich NR4 7TJ, Norfolk, England; [Jackson, Kathryn A.; O'Brien, Sarah J.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	University of London; London School of Hygiene & Tropical Medicine; University of East Anglia; University of Liverpool	Hunter, PR (corresponding author), Univ E Anglia, Norwich Sch Med, Norwich NR4 7TJ, Norfolk, England.	Paul.Hunter@uea.ac.uk	Viviani, Laura/A-4787-2010; Hunter, Paul/A-7172-2008; RODRIGUES, LAURA CUNHA/AAO-4130-2021; Irvine, Lisa/ABH-5953-2020; Hunter, Paul/N-9021-2019	Viviani, Laura/0000-0003-2419-8472; Hunter, Paul/0000-0002-5608-6144; Hunter, Paul/0000-0002-5608-6144; O'Brien, Sarah Jane/0000-0003-2896-8999; Tam, Clarence/0000-0003-1697-286X; Irvine, Lisa/0000-0003-1936-3584	UK Food standards agency; Medical Research Council [MC_U122785837] Funding Source: researchfish	UK Food standards agency; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the UK Food standards agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, JACKKNIFE BOOTSTRAP; Baumann-Popczyk A, 2012, EPIDEMIOL INFECT, V140, P1173, DOI 10.1017/S0950268811001853; Boland M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-208; Cantwell LB, 2010, FOODBORNE PATHOG DIS, V7, P1225, DOI 10.1089/fpd.2010.0567; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; FOX JP, 1972, AM J EPIDEMIOL, V96, P270, DOI 10.1093/oxfordjournals.aje.a121458; Hauri AM, 2011, GESUNDHEITSWESEN, V73, P78, DOI 10.1055/s-0030-1270492; LITTLE RJA, 1993, J AM STAT ASSOC, V88, P1001, DOI 10.2307/2290792; Majowicz SE, 2008, EPIDEMIOL INFECT, V136, P886, DOI 10.1017/S0950268807009375; McNulty CAM, 2014, BRIT J GEN PRACT, V64, pE24, DOI 10.3399/bjgp14X676429; Muller L, 2012, EPIDEMIOL INFECT, V140, P290, DOI 10.1017/S0950268811000471; O'Brien SJ, 2012, CURR OPIN INFECT DIS, V25, P537, DOI 10.1097/QCO.0b013e328356aeba; O'Brien SJ, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-39; Roy Sharon L., 2006, Journal of Water and Health, V4, P31, DOI 10.2166/wh.2006.017; Scallan E, 2004, Commun Dis Public Health, V7, P61; Scallan E, 2005, INT J EPIDEMIOL, V34, P454, DOI 10.1093/ije/dyh413; Scavia G, 2012, EPIDEMIOL INFECT, V140, P1193, DOI 10.1017/S0950268811002020; Sethi D, 1999, Commun Dis Public Health, V2, P101; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Thomas MK, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-307; Van Cauteren D, 2012, EPIDEMIOL INFECT, V140, P697, DOI 10.1017/S0950268811000999; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046; World Health Organization, 2005, TREATM DIARRH MAN PH	23	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146171	10.1371/journal.pone.0146171	http://dx.doi.org/10.1371/journal.pone.0146171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807916	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800017
J	Zeestraten, EA; Benjamin, P; Lambert, C; Lawrence, AJ; Williams, OA; Morris, RG; Barrick, TR; Markus, HS				Zeestraten, Eva Anna; Benjamin, Philip; Lambert, Christian; Lawrence, Andrew John; Williams, Owen Alan; Morris, Robin Guy; Barrick, Thomas Richard; Markus, Hugh Stephen			Application of Diffusion Tensor Imaging Parameters to Detect Change in Longitudinal Studies in Cerebral Small Vessel Disease	PLOS ONE			English	Article							WHITE-MATTER; COGNITIVE IMPAIRMENT; SURROGATE MARKER; MRI; CADASIL; STROKE; BRAIN; ABNORMALITIES; LEUKOARAIOSIS; SEGMENTATION	Cerebral small vessel disease (SVD) is the major cause of vascular cognitive impairment, resulting in significant disability and reduced quality of life. Cognitive tests have been shown to be insensitive to change in longitudinal studies and, therefore, sensitive surrogate markers are needed to monitor disease progression and assess treatment effects in clinical trials. Diffusion tensor imaging (DTI) is thought to offer great potential in this regard. Sensitivity of the various parameters that can be derived from DTI is however unknown. We aimed to evaluate the differential sensitivity of DTI markers to detect SVD progression, and to estimate sample sizes required to assess therapeutic interventions aimed at halting decline based on DTI data. We investigated 99 patients with symptomatic SVD, defined as clinical lacunar syndrome with MRI confirmation of a corresponding infarct as well as confluent white matter hyperintensities over a 3 year follow-up period. We evaluated change in DTI histogram parameters using linear mixed effect models and calculated sample size estimates. Over a three-year follow-up period we observed a decline in fractional anisotropy and increase in diffusivity in white matter tissue and most parameters changed significantly. Mean diffusivity peak height was the most sensitive marker for SVD progression as it had the smallest sample size estimate. This suggests disease progression can be monitored sensitively using DTI histogram analysis and confirms DTI's potential as surrogate marker for SVD.	[Zeestraten, Eva Anna; Benjamin, Philip; Lambert, Christian; Williams, Owen Alan; Barrick, Thomas Richard] Univ London, Cardiovasc & Cell Sci Res Inst, Neurosci Res Ctr, London, England; [Benjamin, Philip] Imperial Coll NHS Trust, Dept Radiol, Charing Cross Hosp Campus, London, England; [Lawrence, Andrew John; Markus, Hugh Stephen] Univ Cambridge, Clin Neurosci, Stroke Res Grp, Cambridge, England; [Morris, Robin Guy] Kings Coll Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England	University of London; King's College London; Imperial College London; University of Cambridge	Zeestraten, EA (corresponding author), Univ London, Cardiovasc & Cell Sci Res Inst, Neurosci Res Ctr, London, England.	p1207006@sgul.ac.uk		Williams, Owen/0000-0001-8252-6521; Barrick, Thomas/0000-0003-1783-3650; Lambert, Christian/0000-0001-8281-4611; Lawrence, Andrew/0000-0002-1420-3381	Wellcome Trust [081589]; English National Institute for Health Research Senior Investigator award; Academy of Medical Sciences (GB) Clinical Lecturer Start-Up Grant; Alzheimer's Research UK [ARUK-PG2013-2]; English National Institute of Health Research (NIHR) Clinical Stroke Research Network; Academy of Medical Sciences (AMS) [AMS-SGCL8-Lambert] Funding Source: researchfish; Alzheimers Research UK [ARUK-PG2013-2] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10019, CL-2012-16-501] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); English National Institute for Health Research Senior Investigator award; Academy of Medical Sciences (GB) Clinical Lecturer Start-Up Grant; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); English National Institute of Health Research (NIHR) Clinical Stroke Research Network; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); National Institute for Health Research(National Institute for Health Research (NIHR))	The SCANS study was supported by a Wellcome Trust grant #081589, awarded to HSM (http://www.wellcome.ac.uk). HSM is supported by an English National Institute for Health Research Senior Investigator award (http://www.nihr.ac.uk). CL is supported by an Academy of Medical Sciences (GB) Clinical Lecturer Start-Up Grant (http://www.acmedsci.ac.uk). AJL is supported by a research grant from Alzheimer's Research UK: ARUK-PG2013-2 (http://www.alzheimersresearchuk.org). Recruitment was supported by the English National Institute of Health Research (NIHR) Clinical Stroke Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R, 2007, TR07JA2 FMRIB; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2011, NEUROIMAGE, V55, P954, DOI 10.1016/j.neuroimage.2010.12.049; BAMFORD J, 1987, STROKE, V18, P545, DOI 10.1161/01.STR.18.3.545; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Benjamin P, 2015, J CEREB BLOOD FLOW M, P1; Benjamin P, 2014, NEUROIMAGE-CLIN, V4, P828, DOI 10.1016/j.nicl.2014.05.009; Cercignani M, 2003, AM J NEURORADIOL, V24, P638; Chabriat H, 1999, STROKE, V30, P2637, DOI 10.1161/01.STR.30.12.2637; Charlton RA, 2010, J NEUROL NEUROSUR PS, V81, P13, DOI 10.1136/jnnp.2008.167288; Dunn JT, 2013, J CEREBR BLOOD F MET, V33, P1098, DOI 10.1038/jcbfm.2013.55; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fazekas F, 2002, J NEURAL TRANSM-SUPP, P61; Green HAL, 2002, STROKE, V33, P1517, DOI 10.1161/01.STR.0000016973.80180.7B; Gunda B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097173; Holtmannspotter M, 2005, STROKE, V36, P2559, DOI 10.1161/01.STR.0000189696.70989.a4; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kim SH, 2011, J NEUROIMAGING, V21, P317, DOI 10.1111/j.1552-6569.2010.00527.x; Lambert C, 2015, NEUROIMAGE-CLIN, V9, P194, DOI 10.1016/j.nicl.2015.07.002; Lambert C, 2013, NEUROIMAGE-CLIN, V2, P684, DOI 10.1016/j.nicl.2013.04.017; Lawrence AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135523; Lawrence AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061014; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Liem MK, 2009, NEUROLOGY, V72, P143, DOI 10.1212/01.wnl.0000339038.65508.96; Liu GH, 1997, BIOMETRICS, V53, P937, DOI 10.2307/2533554; Maillard P, 2011, STROKE, V42, P1917, DOI 10.1161/STROKEAHA.110.609768; NEEMAN M, 1991, MAGNET RESON MED, V21, P138, DOI 10.1002/mrm.1910210117; Nitkunan A, 2008, STROKE, V39, P1999, DOI 10.1161/STROKEAHA.107.507475; Nusbaum AO, 2001, AM J NEURORADIOL, V22, P136; O'Sullivan M, 2004, NEUROLOGY, V62, P702, DOI 10.1212/01.WNL.0000113760.72706.D2; O'Sullivan M, 2004, J NEUROL NEUROSUR PS, V75, P441, DOI 10.1136/jnnp.2003.014910; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; O'Sullivan M, 2001, NEUROLOGY, V57, P2307, DOI 10.1212/WNL.57.12.2307; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; Patel B, 2013, STROKE, V44, P356, DOI 10.1161/STROKEAHA.112.670216; Pearce LA, 2014, LANCET NEUROL, V13, P1177, DOI 10.1016/S1474-4422(14)70224-8; Rasbash J, 2009, MLWIN VERSION 21; Rovaris M, 1997, J NEUROL, V244, P266, DOI 10.1007/s004150050083; Schmidt R, 2012, STROKE, V43, P2643, DOI 10.1161/STROKEAHA.112.662593; Sexton CE, 2014, J NEUROSCI, V34, P15425, DOI 10.1523/JNEUROSCI.0203-14.2014; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; van Norden AGW, 2012, BBA-MOL BASIS DIS, V1822, P401, DOI 10.1016/j.bbadis.2011.04.008; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	46	35	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147836	10.1371/journal.pone.0147836	http://dx.doi.org/10.1371/journal.pone.0147836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808982	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000369527800222
J	Zhou, R; Curry, JM; Roy, LD; Grover, P; Haider, J; Moore, LJ; Wu, ST; Kamesh, A; Yazdanifar, M; Ahrens, WA; Leung, T; Mukherjee, P				Zhou, R.; Curry, J. M.; Roy, L. D.; Grover, P.; Haider, J.; Moore, L. J.; Wu, S-t; Kamesh, A.; Yazdanifar, M.; Ahrens, W. A.; Leung, T.; Mukherjee, P.			A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis	ONCOGENE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ADVANCED SOLID TUMORS; CANCER STEM-CELLS; TYROSINE KINASE; FACTOR RECEPTOR; IN-VITRO; EXPRESSION; PROGRESSION; MICE; TRANSDUCTION	We report that Mucin1 (MUC1), a transmembrane glycoprotein that is overexpressed in >80% of pancreatic ductal adenocarcinoma (PDA), induced a pro-angiogenic tumor microenvironment by increasing the levels of neuropilin-1 (NRP1, a co-receptor of vascular endothelial growth factor (VEGF)) and its ligand VEGF. Expression of tumor-associated MUC1 (tMUC1) positively correlated with NRP1 levels in human and mouse PDA. Further, tMUC1(hi) PDA cells secreted high levels of VEGF and expressed high levels of VEGF receptor 2 (VEGFR2) and its phosphorylated forms as compared with tMUC1(low/null) PDA. This enabled the tMUC1(hi)/NRP1(hi) PDA cells to (a) induce endothelial cell tube formation, (b) generate long ectopic blood vessels and (c) enhance distant metastasis in a zebrafish xenograft model. Concurrently, the proteins associated with epithelial-to-mesenchymal transition, N-cadherin and Vimentin, were highly induced in these tMUC1/NRP1(hi) PDA cells. Hence, blocking signaling via the NRP1-VEGF axis significantly reduced tube formation, new vessel generation and metastasis induced by tMUC1(hi) PDA cells. Finally, we show that blocking the interaction between VEGF(165) and NRP1 with a NRP1 antagonist significantly reduced VEGFR signaling and PDA tumor growth in vivo. Taken together, our data suggest a novel molecular mechanism by which tMUC1 may modulate NRP1-dependent VEGFR signaling in PDA cells.	[Zhou, R.; Curry, J. M.; Roy, L. D.; Grover, P.; Moore, L. J.; Wu, S-t; Kamesh, A.; Yazdanifar, M.; Mukherjee, P.] Univ N Carolina, Dept Biol Sci, 9201 Univ City Blvd, Charlotte, NC 28223 USA; [Haider, J.; Leung, T.] North Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Kannapolis, NC USA; [Ahrens, W. A.] Carolinas Med Ctr, Dept Surg, Sect Hepatobiliary & Pancreas Surg, Charlotte, NC 28203 USA	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; North Carolina Central University; Carolinas Medical Center	Mukherjee, P (corresponding author), Univ N Carolina, Dept Biol Sci, 9201 Univ City Blvd, Charlotte, NC 28223 USA.	pmukherj@uncc.edu			NIH [CA118944-01A1, CA173668-01]; Office of the Assistant Secretary of Defense for Health Affairs through the Pancreatic Cancer Research Program [W81XWH-12-1-0220]; NATIONAL CANCER INSTITUTE [R15CA173668, R03CA110832, R01CA118944] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Assistant Secretary of Defense for Health Affairs through the Pancreatic Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH CA118944-01A1 and NIH CA173668-01. This work was also supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Pancreatic Cancer Research Program under Award No. W81XWH-12-1-0220. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. We thank Dr Tim D Eubank (Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA) for the valuable support with angiogenesis study. We thank Dr Lloye Dillon (OncoTAB, Inc., Charlotte, NC, USA) for the critical review of the manuscript. We thank all the technicians in the animal facility for their assistance in maintaining our colonies.	Adham SAI, 2014, J HISTOCHEM CYTOCHEM, V62, P619, DOI 10.1369/0022155414538821; Bagri A, 2009, CLIN CANCER RES, V15, P1860, DOI 10.1158/1078-0432.CCR-08-0563; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Bernatchez PN, 1999, J BIOL CHEM, V274, P31047, DOI 10.1074/jbc.274.43.31047; Besmer DM, 2011, CANCER RES, V71, P4432, DOI 10.1158/0008-5472.CAN-10-4439; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; Binetruy-Tournaire R, 2000, EMBO J, V19, P1525, DOI 10.1093/emboj/19.7.1525; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Chang BW, 2010, J PANCREAS, V11, P313; Curry JM, 2013, J SURG ONCOL, V107, P713, DOI 10.1002/jso.23316; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Guidolin D, 2004, MICROVASC RES, V67, P117, DOI 10.1016/j.mvr.2003.11.002; Hamerlik P, 2012, J EXP MED, V209, P507, DOI 10.1084/jem.20111424; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hess-Stumpp H, 2005, CHEMBIOCHEM, V6, P550, DOI 10.1002/cbic.200400305; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; LAN MS, 1990, J BIOL CHEM, V265, P15294; Latil A, 2000, INT J CANCER, V89, P167, DOI 10.1002/(SICI)1097-0215(20000320)89:2<167::AID-IJC11>3.0.CO;2-9; Lau SK, 2004, AM J CLIN PATHOL, V122, P61, DOI 10.1309/9R6673QEC06D86Y4; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Miao HQ, 2000, FASEB J, V14, P2532, DOI 10.1096/fj.00-0250com; Moshal Karni S, 2011, Cancers (Basel), V3, P4102, DOI 10.3390/cancers3044102; Moshal KS, 2010, TRENDS CARDIOVAS MED, V20, P114, DOI 10.1016/j.tcm.2010.10.001; Nath S, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.16; PAJUSOLA K, 1992, CANCER RES, V52, P5738; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Parikh AA, 2003, CANCER, V98, P720, DOI 10.1002/cncr.11560; PARK JE, 1994, J BIOL CHEM, V269, P25646; Patnaik A, 2014, CANCER CHEMOTH PHARM, V73, P951, DOI 10.1007/s00280-014-2426-8; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Prud'homme GJ, 2012, ONCOTARGET, V3, P921, DOI 10.18632/oncotarget.626; Prud'homme GJ, 2012, CURR PHARM DESIGN, V18, P2838; Robinson CJ, 2001, J CELL SCI, V114, P853; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Sahraei M, 2012, ONCOGENE, V31, P4935, DOI 10.1038/onc.2011.651; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; SEETHARAM L, 1995, ONCOGENE, V10, P135; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Solorzano CC, 2001, CANCER BIOTHER RADIO, V16, P359, DOI 10.1089/108497801753354267; SPICER AP, 1995, J BIOL CHEM, V270, P30093; Starzec A, 2006, LIFE SCI, V79, P2370, DOI 10.1016/j.lfs.2006.08.005; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tinder TL, 2008, J IMMUNOL, V181, P3116, DOI 10.4049/jimmunol.181.5.3116; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Weekes CD, 2014, INVEST NEW DRUG, V32, P653, DOI 10.1007/s10637-014-0071-z; Whittle C, 1999, CLIN SCI, V97, P303, DOI 10.1042/CS19990016; Wild JRL, 2012, INT J EXP PATHOL, V93, P81, DOI 10.1111/j.1365-2613.2012.00810.x; Woo JK, 2012, ONCOGENE, V31, P2187, DOI 10.1038/onc.2011.410; Xin Y, 2012, CLIN CANCER RES, V18, P6040, DOI 10.1158/1078-0432.CCR-12-1652	53	41	44	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 27	2016	35	43					5608	5618		10.1038/onc.2015.516	http://dx.doi.org/10.1038/onc.2015.516			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XP	26804176	Green Accepted			2022-12-26	WOS:000386998300004
J	Muralidharan, SV; Bhadury, J; Nilsson, LM; Green, LC; McLure, KG; Nilsson, JA				Muralidharan, S. V.; Bhadury, J.; Nilsson, L. M.; Green, L. C.; McLure, K. G.; Nilsson, J. A.			BET bromodomain inhibitors synergize with ATR inhibitors to induce DNA damage, apoptosis, senescence-associated secretory pathway and ER stress in Myc-induced lymphoma cells	ONCOGENE			English	Article							NF-KAPPA-B; RNA-POLYMERASE-II; C-MYC; PROTEIN BRD4; CANCER-CELLS; P-TEFB; KINASE; CHROMATIN; TRANSCRIPTION; ELONGATION	Inhibiting the bromodomain and extra-terminal (BET) domain family of epigenetic reader proteins has been shown to have potent anti-tumoral activity, which is commonly attributed to suppression of transcription. In this study, we show that two structurally distinct BET inhibitors (BETi) interfere with replication and cell cycle progression of murine Myc-induced lymphoma cells at sublethal concentrations when the transcriptome remains largely unaltered. This inhibition of replication coincides with a DNA-damage response and enhanced sensitivity to inhibitors of the upstream replication stress sensor ATR in vitro and in mouse models of B-cell lymphoma. Mechanistically, ATR and BETi combination therapy cause robust transcriptional changes of genes involved in cell death, senescence-associated secretory pathway, NFkB signaling and ER stress. Our data reveal that BETi can potentiate the cell stress and death caused by ATR inhibitors. This suggests that ATRi can be used in combination therapies of lymphomas without the use of genotoxic drugs.	[Muralidharan, S. V.; Bhadury, J.; Nilsson, L. M.; Green, L. C.; Nilsson, J. A.] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Surg,Sahlgrenska Canc Ctr, Medicinaregatan 1G,Plan 6, SE-40530 Gothenburg, Sweden; [McLure, K. G.] Zenith Epigenet Corp, Calgary, AB, Canada; [McLure, K. G.] Ermaris Bio Corp, Calgary, AB, Canada	University of Gothenburg	Nilsson, JA (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Surg,Sahlgrenska Canc Ctr, Medicinaregatan 1G,Plan 6, SE-40530 Gothenburg, Sweden.	jonas.a.nilsson@surgery.gu.se	Bhadury, Joydeep/GPX-3446-2022; Bhadury, Joydeep/ABB-9252-2021; Bhadury, Joydeep/I-5059-2014	Bhadury, Joydeep/0000-0002-4333-9974; Bhadury, Joydeep/0000-0002-4333-9974; Nilsson, Jonas/0000-0003-0346-6837	Swedish Cancer Society; Swedish Research Council; Region Vastra Gataland (Sahlgrenska University Hospital, Gothenburg); Knut and Alice Wallenberg Foundation; Sahlgrenska Academy; BioCARE-a National Strategic Cancer Research Program at University of Gothenburg; Assar Gabrielsson Foundation; W&M Lundgren Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Region Vastra Gataland (Sahlgrenska University Hospital, Gothenburg); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Sahlgrenska Academy; BioCARE-a National Strategic Cancer Research Program at University of Gothenburg; Assar Gabrielsson Foundation; W&M Lundgren Foundation	We thank Sofia Nordstrand for animal care, and Eric Campeau and Zenith Epigenetics for RVX2135 and helpful discussions. This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council, the Region Vastra Gataland (Sahlgrenska University Hospital, Gothenburg), the Knut and Alice Wallenberg Foundation, the Sahlgrenska Academy and BioCARE-a National Strategic Cancer Research Program at University of Gothenburg (to JAN), and from the Assar Gabrielsson Foundation and the W&M Lundgren Foundation (to SVM, JB and LCG).	Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Bandopadhayay P, 2014, CLIN CANCER RES, V20, P912, DOI 10.1158/1078-0432.CCR-13-2281; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Bhadury J, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.8; Bhadury J, 2014, P NATL ACAD SCI USA, V111, pE2721, DOI 10.1073/pnas.1406722111; Boi M, 2015, CLIN CANCER RES, V21, P1628, DOI 10.1158/1078-0432.CCR-14-1561; Bolden JE, 2014, CELL REP, V8, P1919, DOI 10.1016/j.celrep.2014.08.025; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Ciceri P, 2014, NAT CHEM BIOL, V10, P305, DOI 10.1038/nchembio.1471; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Denis GV, 2006, J PROTEOME RES, V5, P502, DOI 10.1021/pr050430u; Denis GV, 2000, CELL GROWTH DIFFER, V11, P417; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Ember SWJ, 2014, ACS CHEM BIOL, V9, P1160, DOI 10.1021/cb500072z; Fang J, 2014, CELL REP, V8, P1328, DOI 10.1016/j.celrep.2014.07.062; Ferrao PT, 2012, ONCOGENE, V31, P1661, DOI 10.1038/onc.2011.358; Fiskus W, 2014, MOL CANCER THER, V13, P1142, DOI 10.1158/1535-7163.MCT-13-0770; Floyd SR, 2013, NATURE, V498, P246, DOI 10.1038/nature12147; Foote KM, 2013, J MED CHEM, V56, P2125, DOI 10.1021/jm301859s; Gao LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063563; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Hoglund A, 2011, CLIN CANCER RES, V17, P7067, DOI 10.1158/1078-0432.CCR-11-1198; Hoglund A, 2011, CELL CYCLE, V10, P3598, DOI 10.4161/cc.10.20.17887; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611; Josse R, 2014, CANCER RES, V74, P6968, DOI 10.1158/0008-5472.CAN-13-3369; Keene RG, 1999, NUCLEIC ACIDS RES, V27, P3173, DOI 10.1093/nar/27.15.3173; Keller U, 2005, ONCOGENE, V24, P6231, DOI 10.1038/sj.onc.1208779; Keller U, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-348; KERPPOLA TK, 1988, MOL CELL BIOL, V8, P4389, DOI 10.1128/MCB.8.10.4389; Klapproth K, 2009, BLOOD, V114, P2448, DOI 10.1182/blood-2008-09-181008; Lecona E, 2014, EXP CELL RES, V329, P26, DOI 10.1016/j.yexcr.2014.09.019; Loosveld M, 2014, ONCOTARGET, V5, P3168, DOI 10.18632/oncotarget.1873; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Murga M, 2011, NAT STRUCT MOL BIOL, V18, P1331, DOI 10.1038/nsmb.2189; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Pastori C, 2014, EPIGENETICS-US, V9, P611, DOI 10.4161/epi.27906; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Shortt J, 2013, BLOOD, V121, P2964, DOI 10.1182/blood-2012-08-446096; Sinha A, 2005, BIOCHEM J, V387, P257, DOI 10.1042/BJ20041793; Stanlie A, 2014, MOL CELL, V55, P97, DOI 10.1016/j.molcel.2014.05.018; Stratikopoulos EE, 2015, CANCER CELL, V27, P837, DOI 10.1016/j.ccell.2015.05.006; Tang C, 2014, CANCER IMMUNOL RES, V2, P831, DOI 10.1158/2326-6066.CIR-14-0069; Tolani B, 2014, ONCOGENE, V33, P2928, DOI 10.1038/onc.2013.242; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Venkataraman S, 2014, ONCOTARGET, V5, P2355; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zou Z, 2014, ONCOGENE, V33, P2395, DOI 10.1038/onc.2013.179	57	38	40	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 8	2016	35	36					4689	4697		10.1038/onc.2015.521	http://dx.doi.org/10.1038/onc.2015.521			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0IS	26804177				2022-12-26	WOS:000383324700002
J	Li, Y; Lauriola, M; Kim, D; Francesconi, M; D'Uva, G; Shibata, D; Malafa, MP; Yeatman, TJ; Coppola, D; Solmi, R; Cheng, JQ				Li, Y.; Lauriola, M.; Kim, D.; Francesconi, M.; D'Uva, G.; Shibata, D.; Malafa, M. P.; Yeatman, T. J.; Coppola, D.; Solmi, R.; Cheng, J. Q.			Adenomatous polyposis coli (APC) regulates miR17-92 cluster through beta-catenin pathway in colorectal cancer	ONCOGENE			English	Article							MIR-17-92 CLUSTER; TCF/BETA-CATENIN; CELL-MIGRATION; BREAST-CANCER; CYCLIN D1; EXPRESSION; MICRORNAS; ANGIOGENESIS; CARCINOMA; INVASION	Adenomatous polyposis coli (APC) mutation is the most common genetic change in sporadic colorectal cancer (CRC). Although deregulations of miRNAs have been frequently reported in this malignancy, APC-regulated miRNAs have not been extensively documented. Here, by using an APC-inducible cell line and array analysis, we identified a total of 26 deregulated miRNAs. Among them, members of miR-17-92 cluster were dramatically inhibited by APC and induced by enforced expression of beta-catenin. Furthermore, we demonstrate that activated beta-catenin resulted from APC loss binds to and activates the miR-17-92 promoter. Notably, enforced expression of miR-19a overrides APC tumor suppressor activity, and knockdown of miR-19a in cancer cells with compromised APC function reduced their aggressive features in vitro. Finally, we observed that expression of miR-19a significantly correlates with beta-catenin levels in colorectal cancer specimens, and it is associated to the aggressive stage of tumor progression. Thus, our study reveals that miR-17-92 cluster is directly regulated by APC/beta-catenin pathway and could be a potential therapeutic target in colon cancers with aberrant APC/beta-catenin signaling.	[Li, Y.; Lauriola, M.; Kim, D.; Cheng, J. Q.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr,SRB-3, Tampa, FL 33612 USA; [Lauriola, M.; D'Uva, G.; Solmi, R.] Univ Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, Via Massarenti 9, I-40138 Bologna, Italy; [Francesconi, M.] Ctr Genom Regulat CRG, EMBL CRG Syst Biol Unit, Barcelona, Spain; [Shibata, D.; Malafa, M. P.; Yeatman, T. J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL USA; [Coppola, D.] H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL USA; [Yeatman, T. J.] Gibbs Canc Ctr & Res Inst, Spartanburg, SC USA	H Lee Moffitt Cancer Center & Research Institute; University of Bologna; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Cheng, JQ (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr,SRB-3, Tampa, FL 33612 USA.; Solmi, R (corresponding author), Univ Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, Via Massarenti 9, I-40138 Bologna, Italy.; Coppola, D (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	domenico.coppola@moffitt.org; rossella.solmi@unibo.it; jin.cheng@moffitt.org	Kim, Donghwa/AAJ-8148-2021; francesconi, mirko/O-8080-2015; D'Uva, Gabriele/A-6252-2015	Kim, Donghwa/0000-0002-8994-8513; francesconi, mirko/0000-0002-8702-0877; D'Uva, Gabriele/0000-0001-9622-9288; lauriola, mattia/0000-0002-7966-0065	Moffitt Cancer Center Foundation; NCI Cancer Center Support Grant [P30 CA076292]; 'Fondazione del Monte di Bologna e di Ravenna' (Bologna, Italy);  [CA137041];  [CA160455]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA137041, R01CA160455] Funding Source: NIH RePORTER	Moffitt Cancer Center Foundation; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); 'Fondazione del Monte di Bologna e di Ravenna' (Bologna, Italy); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful for the Molecular Biology and Analytic Microscopy Core and Tissue Core facilities at H. Lee Moffitt Cancer Center. We also thank Dr Thomas Ried for providing NCI-H508 cell line. This work was supported in part by CA137041, CA160455 (JQC) and the Moffitt Cancer Center Foundation. The H. Lee Moffitt Cancer Center & Research Institute is supported in part by NCI Cancer Center Support Grant #P30 CA076292. ML was supported by 'Fondazione del Monte di Bologna e di Ravenna' (Bologna, Italy).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barth AIM, 2008, SEMIN CELL DEV BIOL, V19, P245, DOI 10.1016/j.semcdb.2008.02.003; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; D'Uva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080742; Diosdado B, 2009, BRIT J CANCER, V101, P707, DOI 10.1038/sj.bjc.6605037; Fish JE, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252pe1; Grillari J, 2010, BIOGERONTOLOGY, V11, P501, DOI 10.1007/s10522-010-9272-9; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Hong LX, 2010, CANCER RES, V70, P8547, DOI 10.1158/0008-5472.CAN-10-1938; Hulit J, 2004, MOL CELL BIOL, V24, P7598, DOI 10.1128/MCB.24.17.7598-7611.2004; Jiang H, 2014, AM J PATHOL, V184, P1355, DOI 10.1016/j.ajpath.2014.01.037; Koga Y, 2010, CANCER PREV RES, V3, P1435, DOI 10.1158/1940-6207.CAPR-10-0036; Kong W, 2014, ONCOGENE, V33, P679, DOI 10.1038/onc.2012.636; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kudo Y, 2004, CLIN CANCER RES, V10, P5455, DOI 10.1158/1078-0432.CCR-04-0372; Lanza G, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-54; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Lindow M, 2012, J CELL BIOL, V199, P407, DOI 10.1083/jcb.201208082; Luo XY, 2011, CANCER EPIDEM BIOMAR, V20, P1272, DOI 10.1158/1055-9965.EPI-11-0035; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Mimori-Kiyosue Y, 2007, GENES CELLS, V12, P219, DOI 10.1111/j.1365-2443.2007.01045.x; Miyazawa K, 2000, VIRCHOWS ARCH, V437, P508, DOI 10.1007/s004280000283; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Necela BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018501; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Pendas-Franco N, 2008, ONCOGENE, V27, P4467, DOI 10.1038/onc.2008.88; Phelps RA, 2009, CELL CYCLE, V8, P2549, DOI 10.4161/cc.8.16.9278; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Solmi R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-227; Song S, 2011, CANCER RES, V71, P7628, DOI 10.1158/0008-5472.CAN-11-2745; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Takahashi-Yanaga F, 2009, J PHARMACOL SCI, V109, P179, DOI 10.1254/jphs.08R28FM; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tysnes BB, 2010, NEOPLASIA, V12, P506, DOI 10.1593/neo.10290; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; van Haaften G, 2010, GENE DEV, V24, P1, DOI 10.1101/gad.1887110; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yu G, 2012, J SURG ONCOL, V106, P232, DOI 10.1002/jso.22138; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200; Zhou Jiao-Jiao, 2014, World J Biol Chem, V5, P301, DOI 10.4331/wjbc.v5.i3.301	50	35	35	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 1	2016	35	35					4558	4568		10.1038/onc.2015.522	http://dx.doi.org/10.1038/onc.2015.522			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU6PE	26804172	Green Accepted, Green Submitted			2022-12-26	WOS:000382336300002
J	Ichiki, T; Koga, T; Okuno, T; Saeki, K; Yamamoto, Y; Yamamoto, H; Sakaguchi, M; Yokomizo, T				Ichiki, Takako; Koga, Tomoaki; Okuno, Toshiaki; Saeki, Kazuko; Yamamoto, Yasuhiko; Yamamoto, Hiroshi; Sakaguchi, Masakiyo; Yokomizo, Takehiko			Modulation of leukotriene B4 receptor 1 signaling by receptor for advanced glycation end products (RAGE)	FASEB JOURNAL			English	Article						chemotaxis; GPCR; lipid mediator	PROTEIN-COUPLED RECEPTOR; INDUCED AIRWAY HYPERRESPONSIVENESS; NECROSIS-FACTOR-ALPHA; T-CELL RECRUITMENT; B-4 RECEPTOR; REGULATED KINASE; HUMAN NEUTROPHILS; KAPPA-B; EOSINOPHIL ACCUMULATION; HOST-DEFENSE	Leukotriene B-4 (LTB4) receptor 1 (BLT1), a high-affinity GPCR for LTB4, plays important roles in acute and chronic inflammatory diseases. Although the LTB4-BLT1 axis is known to promote inflammation, no studies have defined the binding proteins that modulate LTB4-BLT1 signaling. In this study, the receptor for advanced glycation end products (RAGE) interacted with BLT1 in human cervical epithelial HeLa cells. RAGE increased LTB4-BLT1-dependent ERK phosphorylation and inhibited LTB4-BLT1-dependent activation of NF-kB and up-regulation of proinflammatory cytokines and chemokines. RAGE-dependent inhibition of NF-kB was blunted by treatment with an MEK inhibitor, suggesting that RAGE suppresses LTB4-BLT1-dependent NF-kB signaling by enhancing the MEK-ERK pathway. Meanwhile, in a chemotaxis assay of mouse bone marrow-derived neutrophils, the velocity of LTB4-dependent neutrophil migration was attenuated by soluble RAGE, which is an inhibitory decoy protein for RAGE signaling, in a dose-dependent manner (0.2-5 mg/ml), or by RAGE deficiency. Furthermore, both LTB4-dependent ERK phosphorylation in neutrophils and LTB4-dependent neutrophil accumulation in a murine peritonitis model were significantly attenuated in RAGE-deficient mice compared with C57BL/6J wild-type mice, indicating that RAGE potentiates LTB4-dependent neutrophil migration by enhancing ERK phosphorylation. Our results demonstrate that RAGE interacts with BLT1 and modulates LTB4-BLT1 signaling through potentiation of the MEK-ERK pathway.	[Ichiki, Takako; Koga, Tomoaki; Okuno, Toshiaki; Saeki, Kazuko; Yokomizo, Takehiko] Juntendo Univ, Sch Med, Dept Biochem, Tokyo 1138421, Japan; [Yamamoto, Yasuhiko; Yamamoto, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Biochem & Mol Vasc Biol, Kanazawa, Ishikawa, Japan; [Sakaguchi, Masakiyo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Okayama 7008530, Japan	Juntendo University; Kanazawa University; Okayama University	Koga, T; Yokomizo, T (corresponding author), Juntendo Univ, Dept Biochem, Sch Med, Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan.	tkoga@juntendo.ac.jp; yokomizotky@umin.ac.jp	Sakaguchi, Masakiyo/B-2280-2011; Yokomizo, Takehiko/P-5673-2016	Yokomizo, Takehiko/0000-0002-5219-1553	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [22116001, 22116002, 15H05901, 15H05904, 15H04708, 25860223, 24590386, 15K08316, 24102522, 25460374]; Naito Foundation; Ono Medical Research Foundation; Uehara Memorial Foundation; Mitsubishi Foundation; Takeda Science Foundation; Foundation of Strategic Research Projects in Private Universities from MEXT [S1311011]; Institute for Environmental and Gender-Specific Medicine; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Ono Medical Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Foundation of Strategic Research Projects in Private Universities from MEXT; Institute for Environmental and Gender-Specific Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank J. Miyazaki (Osaka University, Osaka, Japan) for supplying the pCXN2 expression vector (26), J. Takasaki (Astellas Pharmaceuticals, Tokyo, Japan) for supplying YM-254890 (35), and the members of our laboratories for advice and helpful discussions. T.I. is a Research Fellow of the Japan Society for the Promotion of Science. This work was supported by Grants-in-Aid for Scientific Research 22116001, 22116002, 15H05901, 15H05904, and 15H04708 (to T.Y.); 25860223 (to T.K.); 24590386 and 15K08316 (to K.S.); and 24102522 and 25460374 (to T.O.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and by the Naito Foundation, the Ono Medical Research Foundation, the Uehara Memorial Foundation, the Mitsubishi Foundation, and the Takeda Science Foundation. This study was supported in part by Grant-in-Aid (S1311011) from the Foundation of Strategic Research Projects in Private Universities from MEXT and a grant from the Institute for Environmental and Gender-Specific Medicine. The authors declare no conflicts of interest.	Achouiti A, 2013, CRIT CARE, V17, DOI 10.1186/cc13162; Akirav EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095678; Back M, 2005, P NATL ACAD SCI USA, V102, P17501, DOI 10.1073/pnas.0505845102; Belcheva MM, 2002, NEUROSIGNALS, V11, P34, DOI 10.1159/000057320; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; Carter KB, 2000, J BIOL CHEM, V275, P27858; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Devchand PR, 2003, FASEB J, V17, P652, DOI 10.1096/fj.02-0770com; Dewas C, 2000, J IMMUNOL, V165, P5238, DOI 10.4049/jimmunol.165.9.5238; Forbes JM, 2004, DIABETES, V53, P1813, DOI 10.2337/diabetes.53.7.1813; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Fuhler GM, 2005, J LEUKOCYTE BIOL, V77, P257, DOI 10.1189/jlb.0504306; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Haribabu B, 2000, J EXP MED, V192, P433, DOI 10.1084/jem.192.3.433; Heller EA, 2005, CIRCULATION, V112, P578, DOI 10.1161/CIRCULATIONAHA.105.545616; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Kuniyeda K, 2007, J BIOL CHEM, V282, P3998, DOI 10.1074/jbc.M610540200; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lindsay MA, 1998, J LEUKOCYTE BIOL, V64, P555, DOI 10.1002/jlb.64.4.555; Masuda K, 1999, BIOCHEM J, V342, P79, DOI 10.1042/0264-6021:3420079; Miyahara N, 2005, AM J RESP CRIT CARE, V172, P161, DOI 10.1164/rccm.200502-205OC; Miyahara N, 2008, J IMMUNOL, V181, P1170, DOI 10.4049/jimmunol.181.2.1170; Moraes J, 2010, ATHEROSCLEROSIS, V212, P406, DOI 10.1016/j.atherosclerosis.2010.06.009; Myint KM, 2006, DIABETES, V55, P2510, DOI 10.2337/db06-0221; Nakamae-Akahori M, 2006, IMMUNOLOGY, V119, P393, DOI 10.1111/j.1365-2567.2006.02448.x; Nam YH, 2012, INFLAMM RES, V61, P97, DOI 10.1007/s00011-011-0425-3; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okamoto F, 2010, J BIOL CHEM, V285, P41113, DOI 10.1074/jbc.M110.175497; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Okuno T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117888; Patnode ML, 2014, J EXP MED, V211, P1281, DOI 10.1084/jem.20132336; Peters-Golden M, 1999, CLIN REV ALLERG IMMU, V17, P261, DOI 10.1007/BF02737609; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Sakaguchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023132; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Sasaki F, 2012, ANAL BIOCHEM, V425, P157, DOI 10.1016/j.ab.2012.03.014; Schiopu A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/828354; Serezani CH, 2011, J CLIN INVEST, V121, P671, DOI 10.1172/JCI43302; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Slowik A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-55; Soares EM, 2013, J IMMUNOL, V190, P1614, DOI 10.4049/jimmunol.1202932; Soro-Paavonen A, 2008, DIABETES, V57, P2461, DOI 10.2337/db07-1808; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tanaka N, 2000, J BIOL CHEM, V275, P25781, DOI 10.1074/jbc.M001235200; Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217; Toda A, 1999, BIOCHEM BIOPH RES CO, V262, P806, DOI 10.1006/bbrc.1999.1284; Ueno H, 2010, ATHEROSCLEROSIS, V211, P431, DOI 10.1016/j.atherosclerosis.2010.04.006; van den Berg JM, 2001, J LEUKOCYTE BIOL, V69, P467; Vincent AM, 2007, ENDOCRINOLOGY, V148, P548, DOI 10.1210/en.2006-0073; Woo CH, 2003, J IMMUNOL, V170, P6273, DOI 10.4049/jimmunol.170.12.6273; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Yamamoto Yasuhiko, 2013, Front Endocrinol (Lausanne), V4, P105, DOI 10.3389/fendo.2013.00105; Yamamoto Y, 2012, J DIABETES INVEST, V3, P107, DOI 10.1111/j.2040-1124.2011.00191.x; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Yeh PY, 2004, J BIOL CHEM, V279, P26143, DOI 10.1074/jbc.M402362200; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200	69	23	24	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					1811	1822		10.1096/fj.201500117	http://dx.doi.org/10.1096/fj.201500117			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26813973	Green Submitted			2022-12-26	WOS:000374879400012
J	Hanke-Gogokhia, C; Wu, ZJ; Gerstner, CD; Frederick, JM; Zhang, HB; Baehr, W				Hanke-Gogokhia, Christin; Wu, Zhijian; Gerstner, Cecilia D.; Frederick, Jeanne M.; Zhang, Houbin; Baehr, Wolfgang			Arf-like Protein 3 (ARL3) Regulates Protein Trafficking and Ciliogenesis in Mouse Photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; gene knock-out; lipid-binding protein; photoreceptor; protein trafficking (Golgi); retinal degeneration	CYCLIC-GMP PHOSPHODIESTERASE; ROD OUTER SEGMENTS; PDE-DELTA; CGMP PHOSPHODIESTERASE; RETINAL DEGENERATION; SMALL GTPASES; GENE; TRANSPORT; INPP5E; ARL13B	Arf-like protein 3 (ARL3) is a ubiquitous small GTPase expressed in ciliated cells of plants and animals. Germline deletion of Arl3 in mice causes multiorgan ciliopathy reminiscent of Bardet-Biedl or Joubert syndromes. As photoreceptors are elegantly compartmentalized and have cilia, we probed the function of ARL3 (ADP-ribosylation factor (Arf)-like 3 protein) by generating rod photoreceptor-specific (prefix (rod)) and retina-specific (prefix (ret)) Arl3 deletions. In predegenerate (rod)Arl3(-/-) mice, lipidated phototransduction proteins showed trafficking deficiencies, consistent with the role of ARL3 as a cargo displacement factor for lipid-binding proteins. By contrast, (ret)Arl3(-/-) rods and cones expressing Cre recombinase during embryonic development formed neither connecting cilia nor outer segments and degenerated rapidly. Absence of cilia infers participation of ARL3 in ciliogenesis and axoneme formation. Ciliogenesis was rescued, and degeneration was reversed in part by subretinal injection of adeno-associated virus particles expressing ARL3-EGFP. The conditional knock-out phenotypes permitted identification of two ARL3 functions, both in the GTP-bound form as follows: one as a regulator of intraflagellar transport participating in photoreceptor ciliogenesis and the other as a cargo displacement factor transporting lipidated protein to the outer segment. Surprisingly, a farnesylated inositol polyphosphate phosphatase only trafficked from the endoplasmic reticulum to the Golgi, thereby excluding it from a role in photoreceptor cilia physiology.	[Hanke-Gogokhia, Christin; Gerstner, Cecilia D.; Frederick, Jeanne M.; Baehr, Wolfgang] Univ Utah, Sch Med, John A Moran Eye Ctr, Dept Ophthalmol & Visual Sci, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Sch Med, Dept Neurobiol & Anat, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA; [Hanke-Gogokhia, Christin] Univ Potsdam, Dept Biol & Biochem, D-14476 Golm, Germany; [Wu, Zhijian] NEI, NIH, Bethesda, MD 20892 USA; [Zhang, Houbin] Hosp Univ Elect Sci & Technol China, Inst Lab Med, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu 610072, Sichuan, Peoples R China; [Zhang, Houbin] Sichuan Prov Peoples Hosp, Chengdu 610072, Sichuan, Peoples R China; [Zhang, Houbin] Univ Elect Sci & Technol China, Sch Med, Chengdu 610072, Sichuan, Peoples R China; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Potsdam; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Utah System of Higher Education; University of Utah	Zhang, HB (corresponding author), Hosp Univ Elect Sci & Technol China, Inst Lab Med, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu 610072, Sichuan, Peoples R China.; Zhang, HB (corresponding author), Sichuan Prov Peoples Hosp, Chengdu 610072, Sichuan, Peoples R China.; Baehr, W (corresponding author), Univ Utah, Moran Eye Ctr, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA.	houbin.zhang@gmail.com; wbaehr@hsc.utah.edu	wu, zhi/GXH-3041-2022; Zhang, Houbin/A-8887-2012	Zhang, Houbin/0000-0002-2968-7454	National Institutes of Health [EY08123, EY019298]; NEI Core [EY014800-039003]; Research to Prevent Blindness (New York); National Science Foundation of China [81371030]; Science and Technology Department of Sichuan [2014HH0009]; NATIONAL EYE INSTITUTE [ZIAEY000443, R01EY008123, P30EY014800, R01EY019298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI Core; Research to Prevent Blindness (New York)(Research to Prevent Blindness (RPB)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Sichuan; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grants EY08123 and EY019298 (to W. B.) and NEI Core Grant EY014800-039003, unrestricted grants to the University of Utah Department of Ophthalmology from Research to Prevent Blindness (New York), National Science Foundation of China Grant 81371030, and Science and Technology Department of Sichuan Grant 2014HH0009 (to H. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANANT JS, 1992, J BIOL CHEM, V267, P687; ANDERSON DH, 1978, INVEST OPHTH VIS SCI, V17, P117; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Avasthi P, 2012, DIFFERENTIATION, V83, pS30, DOI 10.1016/j.diff.2011.11.015; Avasthi P, 2009, J NEUROSCI, V29, P14287, DOI 10.1523/JNEUROSCI.3976-09.2009; BAEHR W, 1979, J BIOL CHEM, V254, P1669; BAEHR W, 1982, J BIOL CHEM, V257, P6452; Baehr W, 2014, INVEST OPHTH VIS SCI, V55, P8653, DOI 10.1167/iovs.14-16066; Barabas P, 2011, INVEST OPHTH VIS SCI, V52, P6766, DOI 10.1167/iovs.10-7147; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Bouabe H, 2013, METHODS MOL BIOL, V1064, P315, DOI 10.1007/978-1-62703-601-6_23; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; CAVENAGH MM, 1994, J BIOL CHEM, V269, P18937; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Conduit SE, 2012, FEBS LETT, V586, P2846, DOI 10.1016/j.febslet.2012.07.037; Cuvillier A, 2000, J CELL SCI, V113, P2065; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Friedel Roland H., 2007, Briefings in Functional Genomics & Proteomics, V6, P180, DOI 10.1093/bfgp/elm022; Friedel RH, 2011, METHODS MOL BIOL, V693, P205, DOI 10.1007/978-1-60761-974-1_12; FUNG BKK, 1983, J BIOL CHEM, V258, P495; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Gotthardt K, 2015, ELIFE, V4, DOI 10.7554/eLife.11859; Grayson C, 2002, HUM MOL GENET, V11, P3065, DOI 10.1093/hmg/11.24.3065; Grimm D, 2003, BLOOD, V102, P2412, DOI 10.1182/blood-2003-02-0495; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; INGLESE J, 1992, J BIOL CHEM, V267, P1422; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; Ishiba Y, 2007, EXP EYE RES, V84, P473, DOI 10.1016/j.exer.2006.10.016; Ismail SA, 2012, EMBO J, V31, P4085, DOI 10.1038/emboj.2012.257; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Jiang L, 2015, J BIOL CHEM, V290, P12765, DOI 10.1074/jbc.M115.638437; Kobayashi A, 2000, INVEST OPHTH VIS SCI, V41, P3268; Kobayashi A, 2003, FEBS LETT, V534, P26, DOI 10.1016/S0014-5793(02)03766-3; Kong AM, 2000, J BIOL CHEM, V275, P24052, DOI 10.1074/jbc.M000874200; LAI RK, 1990, P NATL ACAD SCI USA, V87, P7673, DOI 10.1073/pnas.87.19.7673; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; Lerea C L, 1987, Prog Clin Biol Res, V249, P31; Li LJ, 2013, INVEST OPHTH VIS SCI, V54, P4503, DOI 10.1167/iovs.13-12140; Li S, 2005, GENESIS, V41, P73, DOI 10.1002/gene.20097; Li YJ, 2010, J CELL BIOL, V189, P1039, DOI 10.1083/jcb.200912001; LIEBMAN PA, 1974, SCIENCE, V185, P457, DOI 10.1126/science.185.4149.457; Linari M, 1999, FEBS LETT, V458, P55, DOI 10.1016/S0014-5793(99)01117-5; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Nakatsu F, 2015, DEV CELL, V34, P379, DOI 10.1016/j.devcel.2015.08.008; PALCZEWSKI K, 1991, TRENDS BIOCHEM SCI, V16, P387, DOI 10.1016/0968-0004(91)90157-Q; QIN N, 1992, J BIOL CHEM, V267, P8458; Renault L, 2001, ACTA CRYSTALLOGR D, V57, P1167, DOI 10.1107/S0907444901009556; Schrick JJ, 2006, AM J PATHOL, V168, P1288, DOI 10.2353/ajpath.2006.050941; Schwarz N, 2012, VISION RES, V75, P2, DOI 10.1016/j.visres.2012.07.016; Su CY, 2012, DEVELOPMENT, V139, P4062, DOI 10.1242/dev.082321; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; Thomas S, 2014, HUM MUTAT, V35, P137, DOI 10.1002/humu.22470; Veltel S, 2008, FEBS LETT, V582, P2501, DOI 10.1016/j.febslet.2008.05.053; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; Wang J, 2007, MOL BIOL CELL, V18, P2646, DOI 10.1091/mbc.E06-10-0897; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111; YANG ZH, 1992, J BIOL CHEM, V267, P23197; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; Zhang HB, 2015, FASEB J, V29, P932, DOI 10.1096/fj.14-257915; Zhang HB, 2011, NAT NEUROSCI, V14, P874, DOI 10.1038/nn.2835; Zhang JM, 2008, INVEST OPHTH VIS SCI, V49, P5561, DOI 10.1167/iovs.08-2226; Zhang Q, 2013, EXP CELL RES, V319, P2316, DOI 10.1016/j.yexcr.2013.03.024	75	66	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7142	7155		10.1074/jbc.M115.710954	http://dx.doi.org/10.1074/jbc.M115.710954			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26814127	Green Published, hybrid			2022-12-26	WOS:000373299700047
J	Tsubota, T; Tomita, S; Uchino, K; Kimoto, M; Takiya, S; Kajiwara, H; Yamazaki, T; Sezutsu, H				Tsubota, Takuya; Tomita, Shuichiro; Uchino, Keiro; Kimoto, Mai; Takiya, Shigeharu; Kajiwara, Hideyuki; Yamazaki, Toshimasa; Sezutsu, Hideki			A Hox Gene, Antennapedia, Regulates Expression of Multiple Major Silk Protein Genes in the Silkworm Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bombyx mori; development; gene regulation; proteomics; silkworm; transcription regulation; transgenic; Antennapedia; Hox; silk gland	SERICIN-1 GENE; DROSOPHILA-MELANOGASTER; DOWNSTREAM GENES; LIM-HOMEODOMAIN; FIBROIN; GLAND; IDENTIFICATION; ULTRABITHORAX; PROMOTER; HALTERE	Hox genes play a pivotal role in the determination of anteroposterior axis specificity during bilaterian animal development. They do so by acting as a master control and regulating the expression of genes important for development. Recently, however, we showed that Hox genes can also function in terminally differentiated tissue of the lepidopteran Bombyx mori. In this species, Antennapedia (Antp) regulates expression of sericin-1, a major silk protein gene, in the silk gland. Here, we investigated whether Antp can regulate expression of multiple genes in this tissue. By means of proteomic, RT-PCR, and in situ hybridization analyses, we demonstrate that misexpression of Antp in the posterior silk gland induced ectopic expression of major silk protein genes such as sericin-3, fhxh4, and fhxh5. These genes are normally expressed specifically in the middle silk gland as is Antp. Therefore, the evidence strongly suggests that Antp activates these silk protein genes in the middle silk gland. The putative sericin-1 activator complex (middle silk gland-intermolt-specific complex) can bind to the upstream regions of these genes, suggesting that Antp directly activates their expression. We also found that the pattern of gene expression was well conserved between B. mori and the wild species Bombyx mandarina, indicating that the gene regulation mechanism identified here is an evolutionarily conserved mechanism and not an artifact of the domestication of B. mori. We suggest that Hox genes have a role as a master control in terminally differentiated tissues, possibly acting as a primary regulator for a range of physiological processes.	[Tsubota, Takuya; Tomita, Shuichiro; Uchino, Keiro; Sezutsu, Hideki] Natl Inst Agrobiol Sci, Transgen Silkworm Res Unit, 1-2 Owashi, Tsukuba, Ibaraki 3058634, Japan; [Kimoto, Mai; Takiya, Shigeharu] Hokkaido Univ, Fac Sci, Grad Sch Life Sci, Kita Ku, North 10,West 8, Sapporo, Hokkaido 0600810, Japan; [Takiya, Shigeharu] Hokkaido Univ, Fac Sci, Div Biol Sci, Kita Ku, North 10,West 8, Sapporo, Hokkaido 0600810, Japan; [Takiya, Shigeharu] Hokkaido Univ, Fac Sci, Ctr Genome Dynam, Kita Ku, North 10,West 8, Sapporo, Hokkaido 0600810, Japan; [Kajiwara, Hideyuki; Yamazaki, Toshimasa] Natl Inst Agrobiol Sci, Biomol Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan	National Institute of Agrobiological Sciences - Japan; Hokkaido University; Hokkaido University; Hokkaido University; National Institute of Agrobiological Sciences - Japan	Tsubota, T; Sezutsu, H (corresponding author), Natl Inst Agrobiol Sci, Transgen Silkworm Res Unit, 1-2 Owashi, Tsukuba, Ibaraki 3058634, Japan.	tsubota@affrc.go.jp; hsezutsu@affrc.go.jp		Uchino, Keiro/0000-0003-3650-7359; Sezutsu, Hideki/0000-0001-8886-1611; Tsubota, Takuya/0000-0002-5839-4570	National Institute of Agrobiological Sciences technical support system	National Institute of Agrobiological Sciences technical support system	We are grateful to Kaoru Nakamura, Koji Hashimoto, and Toshihiko Misawa for maintaining the silkworms and Dr. Natuo Komoto for providing B. mandarina. We also thank Satoko Kawamoto for technical assistances and Dr. Takao K. Suzuki for helpful discussion. This work was supported by the National Institute of Agrobiological Sciences technical support system.	Agrawal P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00205; BELLO B, 1994, B I PASTEUR, V92, P81; Crickmore MA, 2006, SCIENCE, V313, P63, DOI 10.1126/science.1128650; de Navas LF, 2006, DEVELOPMENT, V133, P4495, DOI 10.1242/dev.02609; Dhawan S, 2003, DEV GENES EVOL, V213, P523, DOI 10.1007/s00427-003-0357-1; FUKUTA M, 1993, J BIOL CHEM, V268, P19471; Hersh BM, 2007, DEV BIOL, V302, P717, DOI 10.1016/j.ydbio.2006.11.011; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Hueber SD, 2007, DEVELOPMENT, V134, P381, DOI 10.1242/dev.02746; Imamura M, 2003, GENETICS, V165, P1329; Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.ibmb.2004.10.002; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; Kajiwara H., 2009, J ELECTROPHOR, V53, P19; KAUFMAN TC, 1980, GENETICS, V94, P115; Kimoto M, 2015, INSECT BIOCHEM MOLEC, V56, P29, DOI 10.1016/j.ibmb.2014.11.003; Kimoto M, 2014, DEV BIOL, V386, P64, DOI 10.1016/j.ydbio.2013.12.002; Kimoto M, 2012, DEV GENES EVOL, V222, P351, DOI 10.1007/s00427-012-0418-4; Kobayashi I, 2011, ARCH INSECT BIOCHEM, V76, P195, DOI 10.1002/arch.20402; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MACH V, 1995, J BIOL CHEM, V270, P9340, DOI 10.1074/jbc.270.16.9340; Makhijani K, 2007, DEV BIOL, V302, P243, DOI 10.1016/j.ydbio.2006.09.029; Mohit P, 2003, DEVELOPMENT, V130, P1537, DOI 10.1242/dev.00393; Ohno K, 2013, J BIOL CHEM, V288, P31581, DOI 10.1074/jbc.M113.514471; Pallavi SK, 2006, DEV BIOL, V296, P340, DOI 10.1016/j.ydbio.2006.05.035; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Prochiantz A, 2015, NEURON, V85, P911, DOI 10.1016/j.neuron.2015.01.019; Robertson L.K., 2009, INSECT DEV, P1; Rohrschneider MR, 2007, DEV BIOL, V309, P358, DOI 10.1016/j.ydbio.2007.06.012; Schwab K, 2006, DEV BIOL, V293, P540, DOI 10.1016/j.ydbio.2006.02.023; Sezutsu Hideki, 2009, Journal of Insect Biotechnology and Sericology, V78, P1; Slattery M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014686; Takasu Y, 2007, INSECT BIOCHEM MOLEC, V37, P1234, DOI 10.1016/j.ibmb.2007.07.009; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P339, DOI 10.1016/j.ibmb.2010.02.010; Takiya S, 1997, BIOCHEM J, V321, P645, DOI 10.1042/bj3210645; Takiya S, 2011, INSECT BIOCHEM MOLEC, V41, P592, DOI 10.1016/j.ibmb.2011.03.011; Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0; Tatematsu K, 2010, TRANSGENIC RES, V19, P473, DOI 10.1007/s11248-009-9328-2; Tsubota T., 2016, INSECT SCI IN PRESS; Tsubota T, 2014, G3-GENES GENOM GENET, V4, P1347, DOI 10.1534/g3.114.011643; Uchino Keiro, 2006, Journal of Insect Biotechnology and Sericology, V75, P89; Uchino K, 2008, INSECT BIOCHEM MOLEC, V38, P1165, DOI 10.1016/j.ibmb.2008.09.009; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Zhang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123403	45	11	11	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2016	291	13					7087	7096		10.1074/jbc.M115.699819	http://dx.doi.org/10.1074/jbc.M115.699819			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DI2BC	26814126	Green Published, hybrid			2022-12-26	WOS:000373299700042
J	Webb, HE; Bugarel, M; den Bakker, HC; Nightingale, KK; Granier, SA; Scott, HM; Loneragan, GH				Webb, Hattie E.; Bugarel, Marie; den Bakker, Henk C.; Nightingale, Kendra K.; Granier, Sophie A.; Scott, H. Morgan; Loneragan, Guy H.			Carbapenem-Resistant Bacteria Recovered from Faeces of Dairy Cattle in the High Plains Region of the USA	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; ESCHERICHIA-COLI; ENTEROBACTERIACEAE; SPREAD; PRODUCERS; EVOLUTION; SEQUENCE; GENES	Objective A study was conducted to recover carbapenem-resistant bacteria from the faeces of dairy cattle and identify the underlying genetic mechanisms associated with reduced phenotypic susceptibility to carbapenems. Methods One hundred and fifty-nine faecal samples from dairy cattle were screened for carbapenem- resistant bacteria. Phenotypic screening was conducted on two media containing ertapenem. The isolates from the screening step were characterised via disk diffusion, Modified Hodge, and Carba NP assays. Carbapenem-resistant bacteria and carbapenemase-producing isolates were subjected to Gram staining and biochemical testing to include Gram-negative bacilli. Whole genome sequencing was performed on bacteria that exhibited either a carbapenemase-producing phenotype or were not susceptible to ertapenem and were presumptively Enterobacteriaceae. Results Of 323 isolates collected from the screening media, 28 were selected for WGS; 21 of which were based on a carbapenemase-producing phenotype and 7 were presumptively Enterobacteriaceae and not susceptible to ertapenem. Based on analysis of WGS data, isolates included: 3 Escherichia coli harbouring blaCMY-2 and truncated ompF genes; 8 Aeromonas harbouring blacphA-like genes; 1 Acinetobacter baumannii harbouring a novel blaOXA gene (blaOXA-497); and 6 Pseudomonas with conserved domains of various carbapenemase-producing genes. Conclusions Carbapenem resistant bacteria appear to be rare in cattle. Nonetheless, carbapenem-resistant bacteria were detected across various genera and were found to harbour a variety of mechanisms conferring reduced susceptibility. The development and dissemination of carbapenem-resistant bacteria in livestock would have grave implications for therapeutic treatment options in human medicine; thus, continued monitoring of carbapenem susceptibility among enteric bacteria of livestock is warranted.	[Webb, Hattie E.; Bugarel, Marie; den Bakker, Henk C.; Nightingale, Kendra K.; Loneragan, Guy H.] Texas Tech Univ, Dept Anim & Food Sci, Int Ctr Food Ind Excellence, Lubbock, TX 79409 USA; [Granier, Sophie A.] Paris Est Univ, ANSES, Lab Food Safety, Antimicrobial Resistance Unit, Maisons Alfort, France; [Scott, H. Morgan] Texas A&M Univ, Dept Vet Pathobiol, Coll Vet Med & Biomed Sci, College Stn, TX USA	Texas Tech University System; Texas Tech University; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Securite Aliments; Ecole Nationale Veterinaire d'Alfort (ENVA); Texas A&M University System; Texas A&M University College Station	Loneragan, GH (corresponding author), Texas Tech Univ, Dept Anim & Food Sci, Int Ctr Food Ind Excellence, Lubbock, TX 79409 USA.	guy.loneragan@ttu.edu	Scott, Harvey/ABC-9935-2020; Webb, Hattie/L-4072-2015; Granier, Sophie A./H-6796-2019; Bakker, Henk den/AAF-8282-2020	Scott, Harvey/0000-0002-0538-5961; Webb, Hattie/0000-0002-1190-7930; Granier, Sophie A./0000-0001-9676-2402; 	United States Department of Agriculture (USDA); National Institutes of Food and Agriculture; National Integrated Food Safety Initiative award [2011-51110-31081, 2010-51110-21083]; National Antimicrobial Resistance Monitoring System (USDA Agricultural Research Service project) [0204-41510-001-47G]; Texas Tech University; ANSES through the Chateaubriand Fellowship program; Houston Livestock Show and Rodeo	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); National Institutes of Food and Agriculture; National Integrated Food Safety Initiative award; National Antimicrobial Resistance Monitoring System (USDA Agricultural Research Service project); Texas Tech University; ANSES through the Chateaubriand Fellowship program; Houston Livestock Show and Rodeo	This work was supported in part by the United States Department of Agriculture (USDA), National Institutes of Food and Agriculture, National Integrated Food Safety Initiative award numbers 2011-51110-31081 and 2010-51110-21083, and the National Antimicrobial Resistance Monitoring System (USDA Agricultural Research Service project number 0204-41510-001-47G). In addition, we also thank the Embassy of France in the US for sponsoring research collaborations between Texas Tech University and ANSES through the Chateaubriand Fellowship program as well as the Houston Livestock Show and Rodeo for the graduate student assistantship.	Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Benedict MN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-8; Bush K, 2013, J INFECT CHEMOTHER, V19, P549, DOI 10.1007/s10156-013-0640-7; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; Centers for Disease Control and Prevention (CDC), ANT RES THREATS US A; Clinical and Laboratory Standards (CLSI), 2013, PERF STAND ANT SUSC; Clinical and Laboratory Standards Institute, 2010, METH ANT DIL DISK SU, V2rd; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dortet L, 2015, J ANTIMICROB CHEMOTH; *ECDC, ANT RES SURV EUR 201; EFSA, 2013, EFSA J, V11; European Commission, 2013, COMM IMPL DEC MON RE; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; Fischer J, 2013, J ANTIMICROB CHEMOTH, V68, P478, DOI 10.1093/jac/dks393; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Heritier C, 2005, ANTIMICROB AGENTS CH, V49, P3198, DOI 10.1128/AAC.49.8.3198-3202.2005; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Kochar S, 2009, INFECT CONT HOSP EP, V30, P447, DOI 10.1086/596734; Livermore D, 2007, J ANTIMICROB CHEMOTH, V60, pI59, DOI 10.1093/jac/dkm160; Livermore DM, 2001, ANTIMICROB AGENTS CH, V45, P1860, DOI 10.1128/AAC.45.6.1860-1867.2001; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Lou HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025825; Low AS, 2001, MOL MICROBIOL, V42, P619, DOI 10.1046/j.1365-2958.2001.02647.x; Lowrance TC, 2007, AM J VET RES, V68, P501, DOI 10.2460/ajvr.68.5.501; Nordmann P, 2014, CLIN MICROBIOL INFEC, V20, P821, DOI 10.1111/1469-0691.12719; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; Nordmann P, 2012, J CLIN MICROBIOL, V50, P2761, DOI 10.1128/JCM.06477-11; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; OIE, OIE LIST ANT AG VET; Poirel L, 2004, J CLIN MICROBIOL, V42, P3831, DOI 10.1128/JCM.42.8.3831-3833.2004; Poirel L, 2014, J ANTIMICROB CHEMOTH, V69, P2007, DOI [10.1093/jac/dku054, 10.1093/jac/dku323]; Poirel L, 2012, EMERG INFECT DIS, V18, P523, DOI 10.3201/eid1803.111330; Pournaras S, 2010, J ANTIMICROB CHEMOTH, V65, P1319, DOI 10.1093/jac/dkq124; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Ribeiro VB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/139305; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; ROSSOLINI GM, 1995, ANTIMICROB AGENTS CH, V39, P346, DOI 10.1128/AAC.39.2.346; Schwaber MJ, 2011, CLIN INFECT DIS, V52, P848, DOI 10.1093/cid/cir025; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Smet A, 2012, J ANTIMICROB CHEMOTH, V67, P3009, DOI 10.1093/jac/dks311; Tacao M, 2015, MICROB DRUG RESIST, V21, P497, DOI 10.1089/mdr.2015.0072; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; Wang T, 2012, EURASIP J WIREL COMM, P1, DOI 10.1186/1687-1499-2012-111; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang WJ, 2013, J ANTIMICROB CHEMOTH, V68, P1681, DOI 10.1093/jac/dkt066	50	45	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147363	10.1371/journal.pone.0147363	http://dx.doi.org/10.1371/journal.pone.0147363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824353	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528600027
J	Bai, Y; Chen, SL; Laurson, KR; Kim, YW; Saint-Maurice, PF; Welk, GJ				Bai, Yang; Chen, Senlin; Laurson, Kelly R.; Kim, Youngwon; Saint-Maurice, Pedro F.; Welk, Gregory J.			The Associations of Youth Physical Activity and Screen Time with Fatness and Fitness: The 2012 NHANES National Youth Fitness Survey	PLOS ONE			English	Article							CARDIOMETABOLIC RISK-FACTORS; SEDENTARY BEHAVIOR; CARDIORESPIRATORY FITNESS; HEALTH INDICATORS; CHILDREN; ADIPOSITY; MODERATE; OBESITY; INTENSITY; ADOLESCENTS	The purpose of the study is to examine the associations of youth physical activity and screen time with weight status and cardiorespiratory fitness in children and adolescents, separately, utilizing a nationally representative sample. A total of 1,113 participants (692 children aged 6-11 yrs; 422 adolescents aged 12-15 yrs) from the 2012 NHANES National Youth Fitness Survey. Participants completed physical activity and screen time questionnaires, and their body mass index and cardiorespiratory fitness (adolescents only) were assessed. Adolescents completed additional physical activity questions to estimate daily MET minutes. Children not meeting the screen time guideline had 1.69 times the odds of being overweight/obese compared to those meeting the screen time guideline, after adjusting for physical activity and other control variables. Among adolescent, screen time was significantly associated with being overweight/obese (odds ratio = 1.82, 95% confidence interval: 1.06-3.15), but the association attenuated toward the borderline of being significant after controlling for physical activity. Being physically active was positively associated with cardiorespiratory fitness, independent of screen time among adolescents. In joint association analysis, children who did not meet physical activity nor screen time guidelines had 2.52 times higher odds of being overweight/obese than children who met both guidelines. Adolescents who did not meet the screen time guideline had significantly higher odds ratio of being overweight/obese regardless of meeting the physical activity guideline. Meeting the physical activity guideline was also associated with cardiorespiratory fitness regardless of meeting the screen time guideline in adolescents. Screen time is a stronger factor than physical activity in predicting weight status in both children and adolescents, and only physical activity is strongly associated with cardiorespiratory fitness in adolescents.	[Bai, Yang; Chen, Senlin; Saint-Maurice, Pedro F.; Welk, Gregory J.] Iowa State Univ, Dept Kinesiol, Ames, IA USA; [Laurson, Kelly R.] Illinois State Univ, Sch Kinesiol & Recreat, Normal, IL 61761 USA; [Kim, Youngwon] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England	Iowa State University; Illinois State University; University of Cambridge	Bai, Y (corresponding author), Iowa State Univ, Dept Kinesiol, Ames, IA USA.	ybai@iastate.edu		Saint-Maurice, Pedro F./0000-0002-8752-2340	MRC [MC_U106179473, MC_UU_12015/3] Funding Source: UKRI; Medical Research Council [MC_UU_12015/3, MC_U106179473] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Borrud L, 2014, VITA HLTH STAT, V2; Chaput JP, 2012, PEDIATR OBES, V7, P251, DOI 10.1111/j.2047-6310.2011.00028.x; Chaput JP, 2013, APPL PHYSIOL NUTR ME, V38, P477, DOI 10.1139/apnm-2012-0382; Chinapaw MJM, 2011, OBES REV, V12, pE621, DOI 10.1111/j.1467-789X.2011.00865.x; Costigan SA, 2013, J ADOLESCENT HEALTH, V52, P382, DOI 10.1016/j.jadohealth.2012.07.018; Denton SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061073; Ekelund U, 2014, P NUTR SOC, V73, P319, DOI 10.1017/S0029665114000019; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Fulton JE, 2009, AM J PREV MED, V37, pS40, DOI 10.1016/j.amepre.2009.04.010; Hardy LL, 2009, AM J PREV MED, V36, P120, DOI 10.1016/j.amepre.2008.09.034; Hay J, 2012, ARCH PEDIAT ADOL MED, V166, P1022, DOI 10.1001/archpediatrics.2012.1028; Herman KM, 2014, PREV MED, V60, P115, DOI 10.1016/j.ypmed.2013.12.029; Herrick Kirsten A, 2014, NCHS Data Brief, P1; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Huang Jeannie S, 2011, BMC Res Notes, V4, P29, DOI 10.1186/1756-0500-4-29; Jago R, 2008, PREV MED, V47, P525, DOI 10.1016/j.ypmed.2008.07.016; Kriska A, 2013, PEDIATRICS, V131, pE850, DOI 10.1542/peds.2012-0620; Kuczmarski RJ, 2000, VITAL HLTH STAT, V11, P1; Kwon S, 2013, J PEDIATR-US, V162, P1169, DOI 10.1016/j.jpeds.2012.11.071; Laurson KR, 2008, J PEDIATR-US, V153, P209, DOI 10.1016/j.jpeds.2008.02.042; Liao Y, 2014, OBES REV, V15, P159, DOI 10.1111/obr.12112; Maher CA, 2013, OBESITY, V21, pE730, DOI 10.1002/oby.20430; Marques A, 2015, MED SCI SPORT EXER, V47, P575, DOI 10.1249/MSS.0000000000000426; Miller SA, 2008, INT J PEDIATR OBES, V3, P168, DOI 10.1080/17477160801915935; Mitchell JA, 2009, OBESITY, V17, P1596, DOI 10.1038/oby.2009.42; Moore JB, 2013, J SPORT SCI, V31, P1520, DOI 10.1080/02640414.2013.793378; Morrow JR, 2013, AM J PREV MED, V44, P439, DOI 10.1016/j.amepre.2013.01.008; Parikh T, 2011, SPORTS MED, V41, P477, DOI 10.2165/11588750-000000000-00000; Pate RR, 2013, OBES REV, V14, P645, DOI 10.1111/obr.12035; Ruiz JR, 2009, BRIT J SPORT MED, V43, P909, DOI 10.1136/bjsm.2008.056499; Rundle A, 2012, AM J EPIDEMIOL, V176, P986, DOI 10.1093/aje/kws187; Santos R, 2014, BRIT J SPORT MED, V48, P1508, DOI 10.1136/bjsports-2012-091610; Saunders TJ, 2014, CAN J DIABETES, V38, P53, DOI 10.1016/j.jcjd.2013.08.266; Steele RM, 2008, J APPL PHYSIOL, V105, P342, DOI 10.1152/japplphysiol.00072.2008; Steele RM, 2009, AM J CLIN NUTR, V90, P1185, DOI 10.3945/ajcn.2009.28153; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Trilk JL, 2013, MED SCI SPORT EXER, V45, P722, DOI 10.1249/MSS.0b013e31827aa875; Tucker JS, 2014, J PHYS ACT HEALTH, V11, P1006, DOI 10.1123/jpah.2011-0431; Welk GJ, 2011, AM J PREV MED, V41, pS111, DOI 10.1016/j.amepre.2011.07.007; Wiecha JL, 2006, ARCH PEDIAT ADOL MED, V160, P436, DOI 10.1001/archpedi.160.4.436	43	55	55	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148038	10.1371/journal.pone.0148038	http://dx.doi.org/10.1371/journal.pone.0148038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820144	gold, Green Submitted, Green Published			2022-12-26	WOS:000369528400061
J	Castejon, C; Barros-Zulaica, N; Nunez, A				Castejon, Carlos; Barros-Zulaica, Natali; Nunez, Angel			Control of Somatosensory Cortical Processing by Thalamic Posterior Medial Nucleus: A New Role of Thalamus in Cortical Function	PLOS ONE			English	Article							PYRAMIDAL NEURONS; BARREL CORTEX; LAYER-I; ELECTRICAL-STIMULATION; SENSORY INFORMATION; GABAERGIC NEURONS; PREFRONTAL CORTEX; CEREBRAL-CORTEX; TUFT DENDRITES; GABA RELEASE	Current knowledge of thalamocortical interaction comes mainly from studying lemniscal thalamic systems. Less is known about paralemniscal thalamic nuclei function. In the vibrissae system, the posterior medial nucleus (POm) is the corresponding paralemniscal nucleus. POm neurons project to L1 and L5A of the primary somatosensory cortex (S1) in the rat brain. It is known that L1 modifies sensory-evoked responses through control of intracortical excitability suggesting that L1 exerts an influence on whisker responses. Therefore, thalamocortical pathways targeting L1 could modulate cortical firing. Here, using a combination of electrophysiology and pharmacology in vivo, we have sought to determine how POm influences cortical processing. In our experiments, single unit recordings performed in urethane-anesthetized rats showed that POm imposes precise control on the magnitude and duration of supra-and infragranular barrel cortex whisker responses. Our findings demonstrated that L1 inputs from POm imposed a time and intensity dependent regulation on cortical sensory processing. Moreover, we found that blocking L1 GABAergic inhibition or blocking P/Q-type Ca2+ channels in L1 prevents POm adjustment of whisker responses in the barrel cortex. Additionally, we found that POm was also controlling the sensory processing in S2 and this regulation was modulated by corticofugal activity from L5 in S1. Taken together, our data demonstrate the determinant role exerted by the POm in the adjustment of somatosensory cortical processing and in the regulation of cortical processing between S1 and S2. We propose that this adjustment could be a thalamocortical gain regulation mechanism also present in the processing of information between cortical areas.	[Castejon, Carlos; Barros-Zulaica, Natali; Nunez, Angel] Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain	Autonomous University of Madrid	Nunez, A (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain.	angel.nunez@uam.es	Nuñez, Angel/Y-9137-2019	Nuñez, Angel/0000-0002-8013-4812	Ministerio de Economia y Competitividad [BFU2012-36107]	Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by a grant from Ministerio de Economia y Competitividad (BFU2012-36107).	Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Ahissar E, 2003, CEREB CORTEX, V13, P53, DOI 10.1093/cercor/13.1.53; Ahissar E, 2001, Prog Brain Res, V130, P75; Ahissar E, 2015, CEREB CORTEX, V25, P845, DOI 10.1093/cercor/bht296; [Anonymous], 2004, RAT NERVOUS SYSTEM; ARMSTRONGJAMES M, 1993, J NEUROSCI, V13, P2149; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Atencio CA, 2014, J NEUROPHYSIOL, V111, P1077, DOI 10.1152/jn.00749.2012; Barros-Zulaica N, 2014, NEUROSCIENCE, V281, P178, DOI 10.1016/j.neuroscience.2014.09.057; Beierlein M, 2002, J NEUROPHYSIOL, V88, P1924, DOI 10.1152/jn.2002.88.4.1924; Bokor H, 2008, J NEUROSCI, V28, P5169, DOI 10.1523/JNEUROSCI.0490-08.2008; Bragin A, 1997, J NEUROSCI, V17, P2567; BULLIER J, 1988, EXP BRAIN RES, V70, P90; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Castro-Alamancos MA, 2004, PROG NEUROBIOL, V74, P213, DOI 10.1016/j.pneurobio.2004.09.002; Castro-Alamancos MA, 2002, J NEUROPHYSIOL, V87, P946, DOI 10.1152/jn.00426.2001; Castro-Alamancos MA, 1999, J NEUROSCI, V19, part. no.; CastroAlamancos MA, 1997, PROG NEUROBIOL, V51, P581, DOI 10.1016/S0301-0082(97)00002-6; Chakrabarti S, 2008, J NEUROPHYSIOL, V100, P50, DOI 10.1152/jn.90327.2008; Christophe E, 2002, J NEUROPHYSIOL, V88, P1318, DOI 10.1152/jn.2002.88.3.1318; Chu ZG, 2003, J NEUROSCI, V23, P96; Clasca F, 2012, EUR J NEUROSCI, V35, P1524, DOI 10.1111/j.1460-9568.2012.08033.x; Cottam JCH, 2009, J NEUROPHYSIOL, V102, P9, DOI 10.1152/jn.00290.2009; Cruikshank SJ, 2012, J NEUROSCI, V32, P17813, DOI 10.1523/JNEUROSCI.3231-12.2012; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; DIAMOND ME, 1992, J COMP NEUROL, V318, P462, DOI 10.1002/cne.903180410; Dilgen J, 2013, J NEUROPHYSIOL, V110, P221, DOI 10.1152/jn.00531.2012; Feldmeyer D, 2013, PROG NEUROBIOL, V103, P3, DOI 10.1016/j.pneurobio.2012.11.002; Frangeul L, 2014, EUR J NEUROSCI, V39, P1455, DOI 10.1111/ejn.12524; Gambino F, 2014, NATURE, V515, P116, DOI 10.1038/nature13664; Girard P, 2001, J NEUROPHYSIOL, V85, P1328, DOI 10.1152/jn.2001.85.3.1328; Groh A, 2014, CEREB CORTEX, V24, P3167, DOI 10.1093/cercor/bht173; Guillery RW, 2011, BRAIN RES REV, V66, P205, DOI 10.1016/j.brainresrev.2010.08.001; Guillery RW, 2005, PROG BRAIN RES, V149, P235, DOI 10.1016/S0079-6123(05)49017-2; Haidarliu S, 2008, FRONT NEUROANAT, V2, DOI 10.3389/neuro.05.004.2008; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; HERKENHAM M, 1980, SCIENCE, V207, P532, DOI 10.1126/science.7352263; JACQUIN MF, 1989, J COMP NEUROL, V282, P24, DOI 10.1002/cne.902820104; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Jones E G, 1998, Adv Neurol, V77, P49; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; Killackey HP, 2003, J NEUROSCI, V23, P7381; Kubota Y, 2014, CURR OPIN NEUROBIOL, V26, P7, DOI 10.1016/j.conb.2013.10.003; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lee AJ, 2014, CEREB CORTEX; Letzkus JJ, 2006, J NEUROSCI, V26, P10420, DOI 10.1523/JNEUROSCI.2650-06.2006; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Masri R, 2008, J NEUROPHYSIOL, V100, P681, DOI 10.1152/jn.01322.2007; Masri R, 2012, ADV EXP MED BIOL, V760, P74; McCormick David A., 1994, Current Opinion in Neurobiology, V4, P550, DOI 10.1016/0959-4388(94)90056-6; Movshon JA, 1996, J NEUROSCI, V16, P7733; Nicolelis MAL, 2002, NAT NEUROSCI, V5, P517, DOI 10.1038/nn0602-517; Nunez A, 2012, J NEUROPHYSIOL, V108, P1656, DOI 10.1152/jn.00156.2012; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Ohno S, 2012, CEREB CORTEX, V22, P2840, DOI 10.1093/cercor/bhr356; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pezze M, 2014, J NEUROSCI, V34, P7931, DOI 10.1523/JNEUROSCI.3450-13.2014; Pierret T, 2000, J NEUROSCI, V20, P7455; Poulet JFA, 2012, NAT NEUROSCI, V15, P370, DOI 10.1038/nn.3035; PRIETO JJ, 1994, J COMP NEUROL, V344, P349, DOI 10.1002/cne.903440304; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Rose HJ, 2001, NEUROSCIENCE, V106, P331, DOI 10.1016/S0306-4522(01)00282-2; Rossignol E, 2013, ANN NEUROL, V74, P209, DOI 10.1002/ana.23913; Rubio-Garrido P, 2009, CEREB CORTEX, V19, P2380, DOI 10.1093/cercor/bhn259; Salling MC, 2014, J NEUROPHYSIOL, V112, P1169, DOI 10.1152/jn.00714.2013; Sewards TV, 2002, BRAIN RES BULL, V58, P243, DOI 10.1016/S0361-9230(02)00783-9; Sherman SM, 2012, CURR OPIN NEUROBIOL, V22, P575, DOI 10.1016/j.conb.2012.03.005; Sherman SM, 2011, J NEUROPHYSIOL, V106, P1068, DOI 10.1152/jn.00429.2011; Shlosberg D, 2006, J NEUROPHYSIOL, V96, P3170, DOI 10.1152/jn.00520.2006; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; Sitnikova E Yu, 2010, Neurosci Behav Physiol, V40, P325, DOI 10.1007/s11055-010-9259-7; Sosnik R, 2001, J NEUROPHYSIOL, V86, P339, DOI 10.1152/jn.2001.86.1.339; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; Steriade M, 1998, J NEUROPHYSIOL, V80, P1439, DOI 10.1152/jn.1998.80.3.1439; Swadlow HA, 1998, J NEUROSCI METH, V79, P131, DOI 10.1016/S0165-0270(97)00176-3; Theyel BB, 2010, NAT NEUROSCI, V13, P84, DOI 10.1038/nn.2449; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; Veinante P, 2000, J COMP NEUROL, V420, P233, DOI 10.1002/(SICI)1096-9861(20000501)420:2<233::AID-CNE6>3.0.CO;2-T; Veinante P, 1999, J NEUROSCI, V19, P5085; Viaene AN, 2011, P NATL ACAD SCI USA, V108, P18156, DOI 10.1073/pnas.1114828108; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068; WINER JA, 1989, NEUROSCIENCE, V33, P499, DOI 10.1016/0306-4522(89)90402-8; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Wozny C, 2011, CEREB CORTEX, V21, P1818, DOI 10.1093/cercor/bhq257; Wright N, 2010, J NEUROPHYSIOL, V103, P709, DOI 10.1152/jn.00560.2009; Yang JW, 2013, CEREB CORTEX, V23, P1299, DOI 10.1093/cercor/bhs103; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124; Zaitsev AV, 2007, J NEUROPHYSIOL, V97, P3567, DOI 10.1152/jn.01293.2006; Zhou FM, 1996, J NEUROPHYSIOL, V76, P651, DOI 10.1152/jn.1996.76.2.651; Zhu YH, 2004, J NEUROSCI, V24, P1272, DOI 10.1523/JNEUROSCI.4805-03.2004	95	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148169	10.1371/journal.pone.0148169	http://dx.doi.org/10.1371/journal.pone.0148169			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820514	Green Submitted, gold, Green Published			2022-12-26	WOS:000369528400075
J	Krueger, AS; Munck, C; Dantas, G; Church, GM; Galagan, J; Lehar, J; Sommer, MOA				Krueger, Andrew S.; Munck, Christian; Dantas, Gautam; Church, George M.; Galagan, James; Lehar, Joseph; Sommer, Morten O. A.			Simulating Serial-Target Antibacterial Drug Synergies Using Flux Balance Analysis	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; COMBINATION; CONSTRAINT; MODELS; METABOLISM; GROWTH; RECONSTRUCTION; RESISTANCE	Flux balance analysis (FBA) is an increasingly useful approach for modeling the behavior of metabolic systems. However, standard FBA modeling of genetic knockouts cannot predict drug combination synergies observed between serial metabolic targets, even though such synergies give rise to some of the most widely used antibiotic treatments. Here we extend FBA modeling to simulate responses to chemical inhibitors at varying concentrations, by diverting enzymatic flux to a waste reaction. This flux diversion yields very similar qualitative predictions to prior methods for single target activity. However, we find very different predictions for combinations, where flux diversion, which mimics the kinetics of competitive metabolic inhibitors, can explain serial target synergies between metabolic enzyme inhibitors that we confirmed in Escherichia coli cultures. FBA flux diversion opens the possibility for more accurate genome-scale predictions of drug synergies, which can be used to suggest treatments for infections and other diseases.	[Krueger, Andrew S.; Galagan, James; Lehar, Joseph] Boston Univ, 44 Cummington St, Boston, MA 02215 USA; [Munck, Christian; Sommer, Morten O. A.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark; [Dantas, Gautam] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO USA; [Dantas, Gautam] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Dantas, Gautam] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Galagan, James] Cambridge Ctr, Broad Inst, Cambridge, MA USA	Boston University; Technical University of Denmark; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Lehar, J (corresponding author), Boston Univ, 44 Cummington St, Boston, MA 02215 USA.; Sommer, MOA (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark.	jlehar@bu.edu; msom@bio.dtu.dk		church, george/0000-0001-6232-9969; Dantas, Gautam/0000-0003-0455-8370; Sommer, Morten Otto Alexander/0000-0003-4005-5674; Galagan, James/0000-0003-0542-3291	Lundbeck Foundation; EU FP7-Health Program Evotar [282004]; Lundbeck Foundation [R140-2013-13496, R77-2010-6772] Funding Source: researchfish; Novo Nordisk Fonden [NNF10CC1016517, NNF14OC0011335, NNF13SA0006019, NNF13SA0009311] Funding Source: researchfish; NNF Center for Biosustainability [Bacterial Synthetic Biology] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); EU FP7-Health Program Evotar; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	MOAS acknowledges funding from The Lundbeck Foundation (www.lundbeckfonden.com) and EU FP7-Health Program Evotar (282004) (www.cordis.europa.eu/fp7/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENBAUM MC, 1985, J THEOR BIOL, V114, P413, DOI 10.1016/S0022-5193(85)80176-4; Beste DJV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r89; Blazier AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00299; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Brandes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036947; Chang RL, 2013, SCIENCE, V340, P1220, DOI 10.1126/science.1234012; CHRISTOPHERSON RI, 1983, EUR J BIOCHEM, V134, P331, DOI 10.1111/j.1432-1033.1983.tb07571.x; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Cottarel G, 2007, TRENDS BIOTECHNOL, V25, P547, DOI 10.1016/j.tibtech.2007.09.004; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Edwards JS, 2000, BMC BIOINFORMATICS, V1, DOI 10.1186/1471-2105-1-1; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Federowicz S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004264; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fischbach MA, 2011, CURR OPIN MICROBIOL, V14, P519, DOI 10.1016/j.mib.2011.08.003; Gelius-Dietrich G, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-125; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hoppe A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-23; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Imielinski M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-40; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Lehar J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.51; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lerman JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1928; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; O'Brien EJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.52; Plata G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.60; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Suthers PF, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.56; Thiele I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045635; VARMA A, 1993, J THEOR BIOL, V165, P477, DOI 10.1006/jtbi.1993.1202; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994	45	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147651	10.1371/journal.pone.0147651	http://dx.doi.org/10.1371/journal.pone.0147651			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821252	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528400037
J	Singh, AR; Sivadas, A; Sabharwal, A; Vellarikal, SK; Jayarajan, R; Verma, A; Kapoor, S; Joshi, A; Scaria, V; Sivasubbu, S				Singh, Angom Ramcharan; Sivadas, Ambily; Sabharwal, Ankit; Vellarikal, Shamsudheen Karuthedath; Jayarajan, Rijith; Verma, Ankit; Kapoor, Shruti; Joshi, Adita; Scaria, Vinod; Sivasubbu, Sridhar			Chamber Specific Gene Expression Landscape of the Zebrafish Heart	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; IN-SITU HYBRIDIZATION; RNA-SEQ; CARDIAC DEVELOPMENT; NONCODING RNAS; MUTATIONS; REVEALS; CARDIOMYOPATHY; IDENTIFICATION; TRANSCRIPTOME	The organization of structure and function of cardiac chambers in vertebrates is defined by chamber-specific distinct gene expression. This peculiarity and uniqueness of the genetic signatures demonstrates functional resolution attributed to the different chambers of the heart. Altered expression of the cardiac chamber genes can lead to individual chamber related dysfunctions and disease patho-physiologies. Information on transcriptional repertoire of cardiac compartments is important to understand the spectrum of chamber specific anomalies. We have carried out a genome wide transcriptome profiling study of the three cardiac chambers in the zebrafish heart using RNA sequencing. We have captured the gene expression patterns of 13,396 protein coding genes in the three cardiac chambers-atrium, ventricle and bulbus arteriosus. Of these, 7,260 known protein coding genes are highly expressed (>= 10 FPKM) in the zebrafish heart. Thus, this study represents nearly an all-inclusive information on the zebrafish cardiac transcriptome. In this study, a total of 96 differentially expressed genes across the three cardiac chambers in zebrafish were identified. The atrium, ventricle and bulbus arteriosus displayed 20, 32 and 44 uniquely expressing genes respectively. We validated the expression of predicted chamber-restricted genes using independent semi-quantitative and qualitative experimental techniques. In addition, we identified 23 putative novel protein coding genes that are specifically restricted to the ventricle and not in the atrium or bulbus arteriosus. In our knowledge, these 23 novel genes have either not been investigated in detail or are sparsely studied. The transcriptome identified in this study includes 68 differentially expressing zebrafish cardiac chamber genes that have a human ortholog. We also carried out spatiotemporal gene expression profiling of the 96 differentially expressed genes throughout the three cardiac chambers in 11 developmental stages and 6 tissue types of zebrafish. We hypothesize that clustering the differentially expressed genes with both known and unknown functions will deliver detailed insights on fundamental gene networks that are important for the development and specification of the cardiac chambers. It is also postulated that this transcriptome atlas will help utilize zebrafish in a better way as a model for studying cardiac development and to explore functional role of gene networks in cardiac disease pathogenesis.	[Singh, Angom Ramcharan; Sabharwal, Ankit; Vellarikal, Shamsudheen Karuthedath; Jayarajan, Rijith; Verma, Ankit; Kapoor, Shruti; Joshi, Adita; Sivasubbu, Sridhar] CSIR Inst Genom & Integrat Biol, Genom & Mol Med, Mathura Rd, Delhi 110025, India; [Sivadas, Ambily; Scaria, Vinod] CSIR Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Mathura Rd, Delhi 110025, India; [Sivadas, Ambily; Sabharwal, Ankit; Vellarikal, Shamsudheen Karuthedath; Kapoor, Shruti; Scaria, Vinod; Sivasubbu, Sridhar] Acad Sci & Innovat Res, CSIR IGIB South Campus,Mathura Rd, Delhi 110025, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Academy of Scientific & Innovative Research (AcSIR)	Sivasubbu, S (corresponding author), CSIR Inst Genom & Integrat Biol, Genom & Mol Med, Mathura Rd, Delhi 110025, India.; Scaria, V (corresponding author), CSIR Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Mathura Rd, Delhi 110025, India.; Scaria, V; Sivasubbu, S (corresponding author), Acad Sci & Innovat Res, CSIR IGIB South Campus,Mathura Rd, Delhi 110025, India.	vinods@igib.res.in; s.sivasubbu@igib.res.in	Sabharwal, Ankit/AAH-4776-2019; Verma, Ankit/ABB-9786-2020; Karuthedath Vellarikkal, Shamsudheen/AAC-4142-2022; Scaria, Vinod/AAS-3151-2021; KAPOOR, SHRUTI/GLS-3871-2022	Sabharwal, Ankit/0000-0003-4355-0355; Verma, Ankit/0000-0002-9791-4997; Karuthedath Vellarikkal, Shamsudheen/0000-0002-6384-2948; Sivadas, Ambily/0000-0001-5694-3866; Scaria, Vinod/0000-0001-7644-7181; KAPOOR, SHRUTI/0000-0003-4216-8488	Indian Council of Medical Research (ICMR); Council of Scientific and Industrial Research (CSIR) India [BSC0122]	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR) India(Council of Scientific & Industrial Research (CSIR) - India)	ARS acknowledges a Senior Research Fellowship from the Indian Council of Medical Research (ICMR). Authors acknowledge funding from the Council of Scientific and Industrial Research (CSIR) India through Grant BSC0122. The funders had no role in preparation of the manuscript or decision to publish.	Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Bao ZZ, 1999, SCIENCE, V283, P1161, DOI 10.1126/science.283.5405.1161; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berdougo E, 2003, DEVELOPMENT, V130, P6121, DOI 10.1242/dev.00838; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bruneau BG, 2000, DEV BIOL, V217, P266, DOI 10.1006/dbio.1999.9548; Carniel E, 2005, CIRCULATION, V112, P54, DOI 10.1161/CIRCULATIONAHA.104.507699; Chen J, 2013, GENET MOL RES, V12, P4687, DOI 10.4238/2013.October.18.7; Chew GL, 2013, DEVELOPMENT, V140, P2828, DOI 10.1242/dev.098343; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Dang MQ, 2015, CELL PHYSIOL BIOCHEM, V35, P467, DOI 10.1159/000369712; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; EVERETT AW, 1986, FASEB J, V45, P2568; Franco D, 1998, CARDIOVASC RES, V38, P25, DOI 10.1016/S0008-6363(97)00321-0; Geng J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1127; Gong WM, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0460-0; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hoffmann B, 2001, Hum Mutat, V17, P524, DOI 10.1002/humu.1143; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Iruretagoyena JI, 2014, MOL HUM REPROD, V20, P690, DOI 10.1093/molehr/gau026; Ji Y, 2000, J BIOL CHEM, V275, P38073, DOI 10.1074/jbc.M004804200; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Kaushik K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083616; Kaynak B, 2003, CIRCULATION, V107, P2467, DOI 10.1161/01.CIR.0000066694.21510.E2; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KLEIN SC, 1991, J BIOL CHEM, V266, P18058; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leptidis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057800; Lescroart F, 2014, NAT CELL BIOL, V16, P829, DOI 10.1038/ncb3024; Li DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077938; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu HL, 2014, CELL BIOCHEM BIOPHYS, V70, P635, DOI 10.1007/s12013-014-9967-7; Liu H, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-10; Liu YC, 2015, GENOMICS, V105, P83, DOI 10.1016/j.ygeno.2014.12.002; Liu YB, 2014, GENE, V543, P15, DOI 10.1016/j.gene.2014.04.016; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Mayers CM, 2010, J BIOL CHEM, V285, P12344, DOI 10.1074/jbc.M110.106856; Mogensen J, 2004, J AM COLL CARDIOL, V44, P2315, DOI 10.1016/j.jacc.2004.05.088; Muthusamy S, 2014, J BIOL CHEM, V289, P29665, DOI 10.1074/jbc.M114.578682; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Nemtsas P, 2010, J MOL CELL CARDIOL, V48, P161, DOI 10.1016/j.yjmcc.2009.08.034; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; Osio A, 2007, CIRC RES, V100, P766, DOI 10.1161/01.RES.0000263008.66799.aa; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Patowary A, 2013, ZEBRAFISH, V10, P15, DOI 10.1089/zeb.2012.0848; Pattaro C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002584; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pipkin W, 2003, CIRCULATION, V107, P469, DOI 10.1161/01.CIR.0000044386.27444.5A; Posch MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028872; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodius S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-852; Ruzicka L, 2015, GENESIS, V53, P498, DOI 10.1002/dvg.22868; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sertie AL, 2000, HUM MOL GENET, V9, P2051, DOI 10.1093/hmg/9.13.2051; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Shih YH, 2015, CIRC-CARDIOVASC GENE, V8, P261, DOI 10.1161/CIRCGENETICS.114.000702; Sogah VM, 2010, DEV DYNAM, V239, P3115, DOI 10.1002/dvdy.22445; Somi S, 2003, ANAT REC PART A, V273A, P603, DOI 10.1002/ar.a.10070; Song GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077492; Sucov HM, 1998, ANNU REV PHYSIOL, V60, P287, DOI 10.1146/annurev.physiol.60.1.287; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tabibiazar R, 2003, CIRC RES, V93, P1193, DOI 10.1161/01.RES.0000103171.42654.DD; Tessier DJ, 2003, J SURG RES, V111, P152, DOI 10.1016/S0022-4804(03)00113-6; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Wooldridge AA, 2008, J BIOL CHEM, V283, P11850, DOI 10.1074/jbc.M708628200; Yamagishi H, 2001, DEV BIOL, V239, P190, DOI 10.1006/dbio.2001.0417; Yang KC, 2014, CIRCULATION, V129, P1009, DOI 10.1161/CIRCULATIONAHA.113.003863; Ying M, 2007, BBA-MOL CELL RES, V1773, P804, DOI 10.1016/j.bbamcr.2007.03.006; Zhang RL, 2009, DEV DYNAM, V238, P1564, DOI 10.1002/dvdy.21929; Zhao XS, 2002, PHYSIOL GENOMICS, V12, P53, DOI 10.1152/physiolgenomics.00086.2002; Zhou J, 2014, INT HEART J, V55, P71, DOI 10.1536/ihj.13-196; Zhuchenko O, 1996, GENOMICS, V37, P281, DOI 10.1006/geno.1996.0561	92	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147823	10.1371/journal.pone.0147823	http://dx.doi.org/10.1371/journal.pone.0147823			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815362	Green Published, gold, Green Submitted			2022-12-26	WOS:000369528200056
J	Do, TN; Seah, TET; Yu, HK; Phee, SJ				Thanh Nho Do; Seah, Tian En Timothy; Yu, Ho Khek; Phee, Soo Jay			Development and Testing of a Magnetically Actuated Capsule Endoscopy for Obesity Treatment	PLOS ONE			English	Article							BIOENTERICS INTRAGASTRIC BALLOON; SYSTEMS; SAFETY; TIME; DIET	Intra-gastric balloons (IGB) have become an efficient and less invasive method for obesity treatment. The use of traditional IGBs require complex insertion tools and flexible endoscopes to place and remove the balloon inside the patient's stomach, which may cause discomfort and complications to the patient. This paper introduces a new ingestible weightloss capsule with a magnetically remote-controlled inflatable and deflatable balloon. To inflate the balloon, biocompatible effervescent chemicals are used. As the source of the actuation is provided via external magnetic fields, the magnetic capsule size can be significantly reduced compared to current weight-loss capsules in the literature. In addition, there are no limitations on the power supply. To lose weight, the obese subject needs only to swallow the magnetic capsule with a glass of water. Once the magnetic capsule has reached the patient's stomach, the balloon will be wirelessly inflated to occupy gastric space and give the feeling of satiety. The balloon can be wirelessly deflated at any time to allow the magnetic capsule to travel down the intestine and exit the body via normal peristalsis. The optimal ratio between the acid and base to provide the desired gas volume is experimentally evaluated and presented. A prototype capsule (9.6mm x 27mm) is developed and experimentally validated in ex-vivo experiments. The unique ease of delivery and expulsion of the proposed magnetic capsule is slated to make this development a good treatment option for people seeking to lose excess weight.	[Thanh Nho Do; Seah, Tian En Timothy; Phee, Soo Jay] Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave, Singapore 639798, Singapore; [Yu, Ho Khek] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 119260, Singapore; [Yu, Ho Khek] Natl Univ Hlth Syst, Singapore 119260, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore	Do, TN (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave, Singapore 639798, Singapore.	thanh4@e.ntu.edu.sg	Nho, Thanh/M-7952-2013; Nho, Thanh/AAQ-1759-2021	Nho, Thanh/0000-0002-4980-5251; Nho, Thanh/0000-0002-4980-5251	STARTUP GRANT from Nanyang Technological University, Singapore [M4081419.050]	STARTUP GRANT from Nanyang Technological University, Singapore	This work was supported by the STARTUP GRANT, M4081419.050, from Nanyang Technological University, Singapore.	[Anonymous], CITR AC MON PROD INF; BURNMURDOCH R, 1980, J PHYSIOL-LONDON, V302, P395; Carbonelli MG, 2003, ACTA DIABETOL, V40, pS261, DOI 10.1007/s00592-003-0081-3; Chisaka H, 2006, DYSPHAGIA, V21, P275, DOI 10.1007/s00455-006-9054-3; Direct Food Substances Affirmed as Generally Recognized as Safe: U.S. Government Publishing Office, DIRECT FOOD SUBSTANC; Do TN, 2015, MECH MACH THEORY, V85, P14, DOI 10.1016/j.mechmachtheory.2014.11.003; Do T. N., 2014, Proceedings of the 11th International Conference on Informatics in Control, Automation and Robotics ICINCO 2014, P110; Dogan UB, 2013, OBES SURG, V23, P892, DOI 10.1007/s11695-013-0876-4; Dumonceau JM, 2008, OBES SURG, V18, P1611, DOI 10.1007/s11695-008-9593-9; Forestieri P, 2006, OBES SURG, V16, P635, DOI 10.1381/096089206776945156; Genco A, 2010, OBES SURG, V20, P1496, DOI 10.1007/s11695-010-0231-y; Giardiello C, 2012, OBES SURG, V22, P1916, DOI 10.1007/s11695-012-0786-x; Gorlewicz JL, 2013, IEEE T BIO-MED ENG, V60, P1225, DOI 10.1109/TBME.2012.2230631; Gou JH, 2014, CLIN ENDOSC, V47, P266, DOI 10.5946/ce.2014.47.3.266; Hu C, 2010, IEEE SENS J, V10, P903, DOI 10.1109/JSEN.2009.2035711; Imaz I, 2008, OBES SURG, V18, P841, DOI 10.1007/s11695-007-9331-8; Kannan RY, 2013, INT J SURG CASE REP, V4, P936, DOI 10.1016/j.ijscr.2013.07.025; Kencana AP, 2010, IEEE ENG MED BIO, P963, DOI 10.1109/IEMBS.2010.5627585; Kong K, 2012, J MED DEVICES, V6, DOI 10.1115/1.4007100; Lien GS, 2012, IEEE T BIO-MED ENG, V59, P2068, DOI 10.1109/TBME.2012.2198061; Lopez-Nava G, 2011, OBES SURG, V21, P5, DOI 10.1007/s11695-010-0093-3; Machytka E, 2011, OBES SURG, V21, P1499, DOI 10.1007/s11695-011-0424-z; Mahoney AW, 2013, IEEE INTERNATIONAL C; Manning EP, 2014, ANN EMERG MED, V64, P330, DOI 10.1016/j.annemergmed.2013.12.022; Martin Corby K, 2007, J Diabetes Sci Technol, V1, P574; Mathus-Vliegen EMH, 2005, GASTROINTEST ENDOSC, V61, P19, DOI 10.1016/S0016-5107(04)02406-X; Morita E, 2010, GASTROINTEST ENDOSC, V72, P836, DOI 10.1016/j.gie.2010.06.016; Munk JF, 1978, GASTROINTESTINAL MOT, P349; Neff KJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-8; NIEBEN OG, 1982, LANCET, V1, P198; Noori N, 2010, AM J KIDNEY DIS, V56, P338, DOI 10.1053/j.ajkd.2010.03.022; O'Donoghue K, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2014.2304271; Occupational Safety and Health Guideline for Acetic Acid: Centres for Disease Control and Prevention, OCC SAF HLTH GUID AC; Podczeck F, 2007, J PHARM PHARMACOL, V59, P23, DOI 10.1211/jpp.59.1.0004; Pryor R.W., 2011, MULTIPHYSICS MODELIN; SALESSIOTIS N, 1972, AM J SURG, V124, P331, DOI 10.1016/0002-9610(72)90036-0; Simi M, 2013, J MED DEVICES, V7, DOI 10.1115/1.4025185; Sioulas AD, 2012, OBESITY FACTS, V5, P436, DOI 10.1159/000341134; Solmaz A., 2015, Journal of Obesity & Weight Loss Therapy, V5, P265; Toennies JL, 2010, IEEE ENG MED BIO, P1946, DOI 10.1109/IEMBS.2010.5627793; Than TD, 2012, IEEE T BIO-MED ENG, V59, P2387, DOI 10.1109/TBME.2012.2201715; University CS, 2006, PATH DIG SYST 2006; Vasavid P, 2014, J NEUROGASTROENTEROL, V20, P371, DOI 10.5056/jnm13114; WADE JB, 1988, GROUP, V12, P172, DOI 10.1007/BF01456566; Wahlen CH, 2001, OBES SURG, V11, P524, DOI 10.1381/096089201321209468; Yan L, 2015, IEEE T IND ELECTRON, V62, P1125, DOI 10.1109/TIE.2014.2352216; Yim S, 2014, IEEE T BIO-MED ENG, V61, P513, DOI 10.1109/TBME.2013.2283369; Yim S, 2012, IEEE T ROBOT, V28, P1198, DOI 10.1109/TRO.2012.2197309	48	19	23	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0148035	10.1371/journal.pone.0148035	http://dx.doi.org/10.1371/journal.pone.0148035			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815309	Green Published, gold			2022-12-26	WOS:000369528200069
J	Wu, YJ; Chen, WS; Chen, HS; Zhang, LL; Chang, Y; Yan, SX; Dai, X; Ma, Y; Huang, Q; Wei, W				Wu, Yujing; Chen, Wensheng; Chen, Hengshi; Zhang, Lingling; Chang, Yan; Yan, Shangxue; Dai, Xing; Ma, Yang; Huang, Qiong; Wei, Wei			The Elevated Secreted Immunoglobulin D Enhanced the Activation of Peripheral Blood Mononuclear Cells in Rheumatoid Arthritis	PLOS ONE			English	Article							ADJUVANT-INDUCED ARTHRITIS; B-CELLS; T-CELLS; TACI-IG; EXPRESSION; RECEPTORS; LYMPHOCYTES; RESPONSES; SIGNALS; TARGETS	Immunoglobulin D (IgD) is a surface immunoglobulin that is expressed as either membrane IgD (mIgD) or secreted IgD (sIgD). Researchers have shown that sIgD is often elevated in patients with autoimmune diseases. The possible roles of sIgD on the function of peripheral blood mononuclear cells (PBMCs) in rheumatoid arthritis (RA) are still unclear. In this study, we compared the expression of sIgD, mIgD and IgD receptor (IgDR) in RA patients and healthy controls, and investigated the effect of sIgD on the function of PBMCs. We found that the levels of sIgD, mIgD and IgDR were significantly higher in RA patients compared with healthy controls. The concentrations of sIgD were positively correlated with soluble receptor activator of nuclear factor-kappa B ligand (sRANKL), rheumatoid factor (RF) and C-reactive protein (CRP) in RA patients. Strikingly, IgD could enhance the proliferation of PBMCs and induce IL-1 alpha, IL-1 beta, TNF-alpha, IL-6 and IL-10 production from PBMCs. Moreover, the percentage of activated T cell subsets (CD4(+) CD69(+), CD4(+) CD154(+)) and activated B cell subsets (CD19(+) CD23(+), CD19(+) CD21(+), CD19(+) IgD(+) and CD19(-)CD138(+)) were increased by IgD. The percentage of unactivated T cell subset (CD4(+) CD62L(+)) and immature B cell subset (CD19(+) IgM(+) IgD(-)) were decreased by IgD in PBMCs. Furthermore, the expressions of IgDR on T and B cells were significantly increased by treatment with IgD. Our results demonstrate that IgD enhanced the activation of PBMCs, which may contribute to RA pathogenesis. Therefore, IgD could be a potential novel immunotherapeutic target for the management of RA.	[Wu, Yujing; Chen, Wensheng; Chen, Hengshi; Zhang, Lingling; Chang, Yan; Yan, Shangxue; Dai, Xing; Ma, Yang; Huang, Qiong; Wei, Wei] Anhui Med Univ, Key Lab Antiinflammatory & Immune Med, Anhui Collaborat Innovat Ctr Antiinflammatory & I, Inst Clin Pharmacol,Minist Educ, Hefei 230032, Peoples R China	Anhui Medical University	Huang, Q; Wei, W (corresponding author), Anhui Med Univ, Key Lab Antiinflammatory & Immune Med, Anhui Collaborat Innovat Ctr Antiinflammatory & I, Inst Clin Pharmacol,Minist Educ, Hefei 230032, Peoples R China.	qionghuang@126.com; wwei@ahmu.edu.cn	wei, wei/HHR-8613-2022; Huang, Qiong/HGC-7895-2022; zhang, lingling/HDM-2189-2022	Huang, Qiong/0000-0002-0570-5961; 	National Natural Science Foundation of China [81173075, 81330081, 81202596, 81473223, 31200675]; Specialized Research Fund for the Doctoral Program of Higher Education [20113420120006, 20123420110003]; Anhui provincial Natural Science Foundation [1408085QH173]; Program for tackling key problems in science and technology by Anhui Province [1301042098]; China Postdoctoral Science Foundation [2013M540508, 2013M540509]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Anhui provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Program for tackling key problems in science and technology by Anhui Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was supported by the National Natural Science Foundation of China (No. 81173075; 81330081; 81202596; 81473223; 31200675), Specialized Research Fund for the Doctoral Program of Higher Education (No. 20113420120006; 20123420110003), Anhui provincial Natural Science Foundation (No. 1408085QH173), Program for tackling key problems in science and technology by Anhui Province (No. 1301042098) and China Postdoctoral Science Foundation (No. 2013M540508; 2013M540509).	Alghasham A, 2014, AUTOIMMUNITY, V47, P77, DOI 10.3109/08916934.2013.873413; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bluml S, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3906; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Chang Y, 2011, RHEUMATOLOGY, V50, P862, DOI 10.1093/rheumatology/keq404; Chen K, 2010, IMMUNOL REV, V237, P160, DOI 10.1111/j.1600-065X.2010.00929.x; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; COICO RF, 1988, IMMUNOL REV, V105, P45, DOI 10.1111/j.1600-065X.1988.tb00765.x; COICO RF, 1985, NATURE, V316, P744, DOI 10.1038/316744a0; COICO RF, 1990, J IMMUNOL, V145, P3556; Dai X, 2016, IMMUNOL RES, V64, P978, DOI 10.1007/s12026-015-8777-3; Enders A, 2014, P NATL ACAD SCI USA, V111, P4513, DOI 10.1073/pnas.1402739111; Furst DE, 2014, RHEUMATOLOGY, V53, P1560, DOI 10.1093/rheumatology/ket414; Gascoigne NRJ, 2011, CURR OPIN IMMUNOL, V23, P207, DOI 10.1016/j.coi.2010.12.017; Kim KW, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0563-z; Kloesch B, 2013, INT IMMUNOPHARMACOL, V15, P400, DOI 10.1016/j.intimp.2013.01.003; Nguyen TG, 2014, IMMUNOL LETT, V161, P157, DOI 10.1016/j.imlet.2014.06.007; Nguyen TG, 2010, J AUTOIMMUN, V35, P86, DOI 10.1016/j.jaut.2010.03.003; Norvell A, 1996, J IMMUNOL, V156, P1328; Raza K, 2006, BEST PRACT RES CL RH, V20, P849, DOI 10.1016/j.berh.2006.05.005; Rogers KA, 2006, IMMUNOLOGY, V118, P88, DOI 10.1111/j.1365-2567.2006.02345.x; ROSTENBERG I, 1978, CLIN CHIM ACTA, V85, P319, DOI 10.1016/0009-8981(78)90310-8; SCHMIDT K, 1973, Z IMMUNITATSFORSCH, V145, P385; SJOBERG O, 1980, SCAND J IMMUNOL, V11, P377, DOI 10.1111/j.1365-3083.1980.tb00003.x; Souto-Carneiro MM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2718; Tamma SML, 2001, CELL IMMUNOL, V207, P110, DOI 10.1006/cimm.2000.1747; Tanaka H, 2013, CLIN EXP IMMUNOL, V174, P364, DOI 10.1111/cei.12193; Trujillo MA, 2003, DNA CELL BIOL, V22, P525, DOI 10.1089/10445490360708937; VANVOLLENHOVEN RF, 1989, J AUTOIMMUN, V2, P259, DOI 10.1016/0896-8411(89)90268-0; Vazquez BN, 2009, J IMMUNOL, V183, P6513, DOI 10.4049/jimmunol.0900839; Wang D, 2013, J CELL MOL MED, V17, P1577, DOI 10.1111/jcmm.12128; Wang P, 2012, SCI CHINA LIFE SCI, V55, P219, DOI 10.1007/s11427-012-4301-3; Wu Y, 1999, CELL IMMUNOL, V192, P194, DOI 10.1006/cimm.1998.1453; Xie X, 2014, EXPERT OPIN BIOL TH, V14, P157, DOI 10.1517/14712598.2014.859672; Xu BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044719; Zhang LL, 2013, EUR J PHARMACOL, V708, P113, DOI 10.1016/j.ejphar.2013.02.025	36	16	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147788	10.1371/journal.pone.0147788	http://dx.doi.org/10.1371/journal.pone.0147788			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814717	gold, Green Published, Green Submitted			2022-12-26	WOS:000369528200052
J	Gutierrez-Zapata, DM; Galeano-Vasco, LF; Ceron-Munoz, MF				Maria Gutierrez-Zapata, Diana; Fernando Galeano-Vasco, Luis; Fernando Ceron-Munoz, Mario			Semiparametric Modeling of Daily Ammonia Levels in Naturally Ventilated Caged-Egg Facilities	PLOS ONE			English	Article							GENERALIZED ADDITIVE-MODELS; ATMOSPHERIC AMMONIA; AIR-POLLUTION; BROILER PRODUCTION; DAILY MORTALITY; EMISSIONS; PERFORMANCE; NITROGEN; GASES; DUST	Ammonia concentration (AMC) in poultry facilities varies depending on different environmental conditions and management; however, this is a relatively unexplored subject in Colombia (South America). The objective of this study was to model daily AMC variations in a naturally ventilated caged-egg facility using generalized additive models. Four sensor nodes were used to record AMC, temperature, relative humidity and wind speed on a daily basis, with 10 minute intervals for 12 weeks. The following variables were included in the model: Heat index, Wind, Hour, Location, Height of the sensor to the ground level, and Period of manure accumulation. All effects included in the model were highly significant (p<0.001). The AMC was higher during the night and early morning when the wind was not blowing (0.0 m/s) and the heat index was extreme. The average and maximum AMC were 5.94 +/- 3.83 and 31.70 ppm, respectively. Temperatures above 25 degrees C and humidity greater than 80% increased AMC levels. In naturally ventilated caged-egg facilities the daily variations observed in AMC primarily depend on cyclic variations of the environmental conditions and are also affected by litter handling (i.e., removal of the bedding material).	[Maria Gutierrez-Zapata, Diana] Univ Antioquia, Fac Ciencias Exactas & Nat, Medellin, Antioquia, Colombia; [Fernando Galeano-Vasco, Luis; Fernando Ceron-Munoz, Mario] Univ Antioquia, Fac Ciencias Agr, Medellin, Antioquia, Colombia; [Maria Gutierrez-Zapata, Diana; Fernando Galeano-Vasco, Luis; Fernando Ceron-Munoz, Mario] Univ Antioquia, Grp Invest Genet Mejoramiento & Modelac Anim GaMM, Medellin, Antioquia, Colombia	Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia	Gutierrez-Zapata, DM (corresponding author), Univ Antioquia, Fac Ciencias Exactas & Nat, Medellin, Antioquia, Colombia.; Gutierrez-Zapata, DM (corresponding author), Univ Antioquia, Grp Invest Genet Mejoramiento & Modelac Anim GaMM, Medellin, Antioquia, Colombia.	grupogamma@udea.edu.co	Cerón-Muñoz, Mario Fernando/AAD-9778-2020	Cerón-Muñoz, Mario Fernando/0000-0002-7233-6625	Comite para el Desarrollo de la Investigacion (Committee for Research Development) CODI of Universidad de Antioquia [E01533]; Estrategia de Sostenibilidad (Sustainability Strategy) CODI-UdeA projects	Comite para el Desarrollo de la Investigacion (Committee for Research Development) CODI of Universidad de Antioquia; Estrategia de Sostenibilidad (Sustainability Strategy) CODI-UdeA projects	The authors acknowledge the support of the Comite para el Desarrollo de la Investigacion (Committee for Research Development) CODI of Universidad de Antioquia through the E01533 "Design and validation of decision support systems for commercial-egg poultry farms" and the Estrategia de Sostenibilidad (Sustainability Strategy) CODI-UdeA 2016 projects granted to GaMMA research group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrin M, 2005, ATMOS ENVIRON, V39, P2145, DOI 10.1016/j.atmosenv.2004.12.020; Alencar M do CB de, 2004, Rev. Bras. Cienc. Avic., V6, P23, DOI 10.1590/S1516-635X2004000100004; Osorio JA, 2009, DYNA-COLOMBIA, V76, P89; Alloui N., 2013, J WORLDS POULT RES, V3, P54; ALMASHHADANI EH, 1985, POULTRY SCI, V64, P2056, DOI 10.3382/ps.0642056; ANDERSON DP, 1964, AVIAN DIS, V8, P369, DOI 10.2307/1587967; [Anonymous], 1992, OCCUPATIONAL SAFETY, P1; Atapattu NSBM, 2008, POULTRY SCI, V87, P2436, DOI 10.3382/ps.2007-00320; Beker A, 2004, J APPL POULTRY RES, V13, P5, DOI 10.1093/japr/13.1.5; Calvet S, 2011, POULTRY SCI, V90, P534, DOI 10.3382/ps.2010-01037; Carey JB, 2004, J APPL POULTRY RES, V13, P509, DOI 10.1093/japr/13.3.509; Carslaw DC, 2007, ATMOS ENVIRON, V41, P5289, DOI 10.1016/j.atmosenv.2007.02.032; Cheng WH, 2011, ENVIRON ENG SCI, V28, P283, DOI 10.1089/ees.2010.0205; Clark M., 2013, GEN ADDITIVE MODELS; DEATON JW, 1982, POULTRY SCI, V61, P1815, DOI 10.3382/ps.0611815; DEATON JW, 1984, POULTRY SCI, V63, P384, DOI 10.3382/ps.0630384; Diaz Z, 2013, MODELOS ADITIVOS GEN; Dominici F, 2002, AM J EPIDEMIOL, V156, P193, DOI 10.1093/aje/kwf062; Donham Kelley J, 2002, J Agromedicine, V8, P57, DOI 10.1300/J096v08n02_09; Estelles F, 2010, BIOSYST ENG, V107, P16, DOI 10.1016/j.biosystemseng.2010.06.007; Fairley D, 1999, ENVIRON HEALTH PERSP, V107, P637, DOI 10.2307/3434455; Fidanci UR, 2010, J ANIM VET ADV, V9, P346; Fiedler AM, 2011, METEOROL Z, V20, P59, DOI 10.1127/0941-2948/2011/0490; Fiedler M, 2014, ENVIRON ENG MANAG J, V13, P2193, DOI 10.30638/eemj.2014.244; Food and Agriculture Organization of the United Nations (FAO), 2011, RUR STRUCT TROP DES; Green AR, 2009, T ASABE, V52, P2027, DOI 10.13031/2013.29204; Green AR, 2009, J APPL POULTRY RES, V18, P605, DOI 10.3382/japr.2007-00086; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Gyldenkaerne S, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005459; Harper LA, 2010, POULTRY SCI, V89, P1802, DOI 10.3382/ps.2010-00718; Harper LA, 2005, AMMONIA MEASUREMENT; Hastie T., 1986, STAT SCI, V1, P297; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Heederik D, 2007, ENVIRON HEALTH PERSP, V115, P298, DOI 10.1289/ehp.8835; Kilic I, 2013, J ANIM VET ADV, V12, P42; Koerkamp PWGG, 1998, J AGR ENG RES, V70, P79, DOI 10.1006/jaer.1998.0275; Li LF, 2013, ENVIRON SCI TECHNOL, V47, P9291, DOI 10.1021/es401281r; Liang Y, 2004, 2004 ASAE CSAE ANN I; Mendes LB, 2015, BIOSYST ENG, V129, P360, DOI 10.1016/j.biosystemseng.2014.11.011; Miles DM, 2011, POULTRY SCI, V90, P1162, DOI 10.3382/ps.2010-01113; Miles DM, 2004, POULTRY SCI, V83, P1650, DOI 10.1093/ps/83.10.1650; National Research Council (NRC), 2003, AIR EM AN FEED OP CU, P225; Neijat M, 2011, POULTRY SCI, V90, P543, DOI 10.3382/ps.2010-01069; Nimmermark S, 2009, ANN AGR ENV MED, V16, P103; O'Shaughnessy P T, 2002, J Agric Saf Health, V8, P349; Patterson PH, 2005, J APPL POULTRY RES, V14, P638, DOI 10.1093/japr/14.3.638; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsay TO, 2003, EPIDEMIOLOGY, V14, P18, DOI 10.1097/00001648-200301000-00009; Reina Jhovana, 2012, Rev.EIA.Esc.Ing.Antioq, P19; Richards R, 2014, J COASTAL RES, V30, P1321, DOI 10.2112/JCOASTRES-D-12-00190.1; Ritz CW, 2004, J APPL POULTRY RES, V13, P684, DOI 10.1093/japr/13.4.684; Rumburg BP, 2006, DIFFERENTIAL OPTICAL; Schoen C, 2005, J APPL METEOROL, V44, P1413, DOI 10.1175/JAM2285.1; Schwartz J, 1996, J AIR WASTE MANAGE, V46, P927, DOI 10.1080/10473289.1996.10467528; Seedorf J, 1999, J AGR SCI, V133, P433, DOI 10.1017/S0021859699007170; Singh A, 2009, J APPL POULTRY RES, V18, P34, DOI 10.3382/japr.2008-00046; Staelens J, 2012, ATMOS ENVIRON, V49, P186, DOI 10.1016/j.atmosenv.2011.11.065; Terzi Y, 2009, SCI RES ESSAYS, V4, P867; The National Chicken Council (NCC), 2014, NAT CHICK COUNC AN W; Tinoco IFF, 2001, REV BRAS CIENC AVIC, V3; Tobias A., 2004, TIME SERIES REGRESSI; U. S. Department of Health and Human Services (DHHS), 2004, TOX PROF AMM; United Egg Producers (UEP), 2010, AN HUSB GUID US EGG; United States Environmental Protection Agency (EPA), 2004, NAT EM INV IN PRESS, P131; Venables WN, 2004, FISH RES, V70, P319, DOI 10.1016/j.fishres.2004.08.011; Wang YM, 2010, J ANIM VET ADV, V9, P2802, DOI 10.3923/javaa.2010.2802.2806; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Xin H, 2011, EMERGING ISSUES SOCI, P1; Xin H, 2004, P MIDW POULTR FED CO; Yahav S, 2004, ANIM RES, V53, P289, DOI 10.1051/animres:2004015; Yang P, 2000, T ASAE, V43, P1771, DOI 10.13031/2013.3080; Yang P, 2002, ASAE ANN M AM SOC AG; Zhang G, 2005, BIOSYST ENG, V92, P355, DOI 10.1016/j.biosystemseng.2005.08.002; Zhang K, 2010, ATMOS ENVIRON, V44, P1740, DOI 10.1016/j.atmosenv.2010.02.008; Zhao Y, 2015, POULTRY SCI, V94, P518, DOI 10.3382/ps/peu076; Zhao Y, 2013, T ASABE, V56, P1145; Zhu Z, 2011, T ASABE, V54, P1085, DOI 10.13031/2013.37100	77	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147135	10.1371/journal.pone.0147135	http://dx.doi.org/10.1371/journal.pone.0147135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812150	gold, Green Published			2022-12-26	WOS:000369528000020
J	Blanco-Heredia, J; Lecanda, A; Valenzuela-Ponce, H; Brander, C; Avila-Rios, S; Reyes-Teran, G				Blanco-Heredia, Juan; Lecanda, Aaron; Valenzuela-Ponce, Humberto; Brander, Christian; Avila-Rios, Santiago; Reyes-Teran, Gustavo			Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naive HIV-Infected Individuals	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RESTRICTED IMMUNE-RESPONSES; ORIGINAL ANTIGENIC SIN; I ALLELE PROMISCUITY; SELECTIVE PRESSURES; VARIANT EPITOPES; THERAPY; PERSISTENCE	Background Therapeutic HIV vaccines may prove helpful to intensify antiretroviral treatment (ART) efficacy and may be an integral part of future cure strategies. Methods We examined IFN-gamma ELISpot responses to a panel of 218 HIV clade B consensus-based HIV protease-reverse transcriptase peptides, designed to mimic previously described and predicted cytotoxic T lymphocyte epitopes overlapping drug resistance (DR) positions, that either included the consensus sequence or the DR variant sequence, in 49 ART-naive HIV-infected individuals. Next generation sequencing was used to assess the presence of minority DR variants in circulating viral populations. Results Although a wide spectrum of differential magnitudes of response to DR vs. WT peptide pairs was observed, responses to DR peptides were frequent and strong in the study cohort. No difference between the median magnitudes of response to DR vs. WT peptides was observed. Interestingly, of the 22 peptides that were recognized by > 15% of the participants, two-thirds (64%) corresponded to DR peptides. When analysing responses per peptide pair per individual, responses to only WT (median 4 pairs/individual) or DR (median 6 pairs/individual) were more common than responses to both WT and DR (median 2 pairs/individual; p< 0.001). While the presence of ELISpot responses to WT peptides was frequently associated with the presence of the corresponding peptide sequence in the patient's virus (mean 68% of cases), responses to DR peptides were generally not associated with the presence of DR mutations in the viral population, even at low frequencies (mean 1.4% of cases; p = 0.0002). Conclusions Our data suggests that DR peptides are frequently immunogenic and raises the potential benefit of broadening the antigens included in a therapeutic vaccine approach to immunogenic epitopes containing common DR sequences. Further studies are needed to assess the quality of responses elicited by DR peptides.	[Blanco-Heredia, Juan; Lecanda, Aaron; Valenzuela-Ponce, Humberto; Avila-Rios, Santiago; Reyes-Teran, Gustavo] Natl Inst Resp Dis, Ctr Infect Dis Res, Mexico City, DF, Mexico; [Lecanda, Aaron] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Brander, Christian] Hosp Badalona Germans Trias & Pujol, IrsiCaixa AIDS Res Inst HIVACAT, Badalona, Spain; [Brander, Christian] Inst Catalana Recerca & Estudis Avancats ICREA UA, Barcelona, Spain; [Brander, Christian] Univ Vic & Cent Catalonia, Vic, Spain	Max Planck Society; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; ICREA; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC)	Avila-Rios, S; Reyes-Teran, G (corresponding author), Natl Inst Resp Dis, Ctr Infect Dis Res, Mexico City, DF, Mexico.	santiago.avila@cieni.org.mx; gustavo.reyesteran@gmail.com	Avila-Rios, Santiago/AAB-4383-2020	Reyes-Teran, Gustavo/0000-0002-4115-4888	Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI); Mexican Government (Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana); CONACYT [SALUD-2013-01-202475]; National Council of Science and Technology (CONACyT) [229424]; National Autonomous University of Mexico (UNAM); ICREA Funding Source: Custom	Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI); Mexican Government (Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Autonomous University of Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); ICREA(ICREA)	This work was supported by grants by the Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI and Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana), CONACYT (SALUD-2013-01-202475). JBH received a scholarship by the National Council of Science and Technology (CONACyT; Scholarship No. 229424) and the National Autonomous University of Mexico (UNAM).	Archin NM, 2014, CURR OPIN INFECT DIS, V27, P29, DOI 10.1097/QCO.0000000000000026; Avila-Rios S, 2007, MED HYPOTHESES, V69, P422, DOI 10.1016/j.mehy.2006.12.012; Avila-Rios S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027812; Avila-Rios S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-72; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brumme ZL, 2011, JAIDS-J ACQ IMM DEF, V56, P100, DOI 10.1097/QAI.0b013e3181fe9450; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Chakradhar S, 2015, NAT MED, V21, P540, DOI 10.1038/nm0615-540; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Ensoli B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00417; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Harrer T, 2014, VACCINE, V32, P2657, DOI 10.1016/j.vaccine.2013.10.030; Hoof I, 2010, J IMMUNOL, V184, P5383, DOI 10.4049/jimmunol.0903516; Ji H, 2013, CAN J INFECT DIS MED; John M, 2005, ANTIVIR THER, V10, P551; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; LANL, 2015, LOS AL HIV IMM DAT; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Listgarten J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000016; Llano A, 2009, HIV MOL IMMUNOL, V2009, P3, DOI DOI 10.1016/J.M0LIMM.2008.12.019; Mothe B, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0392-5; Mueller SM, 2007, J VIROL, V81, P2887, DOI 10.1128/JVI.01547-06; Nixon DF, 1999, IMMUNOL LETT, V66, P219, DOI 10.1016/S0165-2478(98)00162-X; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Rao XY, 2011, IMMUNOGENETICS, V63, P691, DOI 10.1007/s00251-011-0552-6; Stnford University, 2015, HIV DRUG RES DAT; Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093; Yachi PP, 2006, IMMUNITY, V25, P203, DOI 10.1016/j.immuni.2006.05.015	30	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147571	10.1371/journal.pone.0147571	http://dx.doi.org/10.1371/journal.pone.0147571			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808823	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800137
J	Chiou, SY; Gottardi, SEA; Hodges, PW; Strutton, PH				Chiou, Shin-Yi; Gottardi, Sam E. A.; Hodges, Paul W.; Strutton, Paul H.			Corticospinal Excitability of Trunk Muscles during Different Postural Tasks	PLOS ONE			English	Article							LOW-BACK-PAIN; ERECTOR SPINAE MUSCLES; MOTOR-EVOKED-POTENTIALS; VOLUNTARY ARM MOVEMENTS; TRANSCRANIAL MAGNETIC STIMULATION; TRANSVERSUS ABDOMINIS; FLEXION MOVEMENTS; BALANCE-RECOVERY; CORTICAL CONTROL; REACTION-TIME	Evidence suggests that the primary motor cortex (M1) is involved in both voluntary, goal-directed movements and in postural control. Trunk muscles are involved in both tasks, however, the extent to which M1 controls these muscles in trunk flexion/extension (voluntary movement) and in rapid shoulder flexion (postural control) remains unclear. The purpose of this study was to investigate this question by examining excitability of corticospinal inputs to trunk muscles during voluntary and postural tasks. Twenty healthy adults participated. Transcranial magnetic stimulation was delivered to the M1 to examine motor evoked potentials (MEPs) in the trunk muscles (erector spinae (ES) and rectus abdominis (RA)) during dynamic shoulder flexion (DSF), static shoulder flexion (SSF), and static trunk extension (STE). The level of background muscle activity in the ES muscles was matched across tasks. MEP amplitudes in ES were significantly larger in DSF than in SSF or in STE; however, this was not observed for RA. Further, there were no differences in levels of muscle activity in RA between tasks. Our findings reveal that corticospinal excitability of the ES muscles appears greater during dynamic anticipatory posture-related adjustments than during static tasks requiring postural (SSF) and goal-directed voluntary (STE) activity. These results suggest that task-oriented rehabilitation of trunk muscles should be considered for optimal transfer of therapeutic effect to function.	[Chiou, Shin-Yi; Gottardi, Sam E. A.; Strutton, Paul H.] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Fac Med,Nick Davy Lab, Dept Surg & Canc,Div Surg,Human Performance Grp, London, England; [Hodges, Paul W.] Univ Queensland, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia	Imperial College London; University of Queensland	Strutton, PH (corresponding author), Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Fac Med,Nick Davy Lab, Dept Surg & Canc,Div Surg,Human Performance Grp, London, England.	p.strutton@imperial.ac.uk	Hodges, Paul W/B-6578-2008	Hodges, Paul W/0000-0002-1206-9107	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	PH is funded by a Senior Principal Research Fellowship from the National Health and Medical Research Council of Australia.	Aranyi Z, 1998, MUSCLE NERVE, V21, P1309, DOI 10.1002/(SICI)1097-4598(199810)21:10<1309::AID-MUS10>3.0.CO;2-X; Aruin AS, 1998, ELECTROMYOGR MOTOR C, V109, P350, DOI 10.1016/S0924-980X(98)00029-0; ARUIN AS, 1995, EXP BRAIN RES, V103, P323; Aruin AS, 1996, ELECTROMYOGR MOTOR C, V101, P497, DOI 10.1016/S0013-4694(96)95219-4; Ashe J, 1997, BEHAV BRAIN RES, V87, P255; Bard P, 1933, ARCH NEUROL PSYCHIAT, V30, P35; BELEN'KII V. E., 1967, BIOFIZIKA, V12, P135; Benvenuti F, 1997, BRAIN RES, V761, P59, DOI 10.1016/S0006-8993(97)00260-6; CHAN CWY, 1979, ELECTROEN CLIN NEURO, V46, P173, DOI 10.1016/0013-4694(79)90066-X; Chen R, 1999, CAN J NEUROL SCI, V26, P163, DOI 10.1017/S0317167100000196; Chiou SY, 2014, EUR J PAIN, V18, P794, DOI 10.1002/j.1532-2149.2013.00428.x; CLAUS D, 1990, MUSCLE NERVE, V13, P1125, DOI 10.1002/mus.880131207; CORDO PJ, 1982, J NEUROPHYSIOL, V47, P287, DOI 10.1152/jn.1982.47.2.287; COTTINGHAM SL, 1988, EXP BRAIN RES, V73, P198, DOI 10.1007/BF00279673; D'hooge R, 2013, J ELECTROMYOGR KINES, V23, P173, DOI 10.1016/j.jelekin.2012.09.003; Dault MC, 2001, GAIT POSTURE, V14, P110, DOI 10.1016/S0966-6362(01)00113-8; Davey NJ, 2002, SPINE, V27, P1355, DOI 10.1097/00007632-200206150-00019; Deliagina TG, 2008, BRAIN RES REV, V57, P212, DOI 10.1016/j.brainresrev.2007.06.017; Dettmers C, 1996, NEUROREPORT, V7, P2103, DOI 10.1097/00001756-199609020-00008; DIENER HC, 1988, J NEUROPHYSIOL, V59, P1888, DOI 10.1152/jn.1988.59.6.1888; Dum RP, 2002, PHYSIOL BEHAV, V77, P677, DOI 10.1016/S0031-9384(02)00929-0; FERBERT A, 1992, ELECTROEN CLIN NEURO, V85, P382, DOI 10.1016/0168-5597(92)90051-C; FRIEDLI WG, 1984, J NEUROL NEUROSUR PS, V47, P611, DOI 10.1136/jnnp.47.6.611; FRIEDLI WG, 1988, J NEUROL NEUROSUR PS, V51, P232, DOI 10.1136/jnnp.51.2.232; GAHERY Y, 1978, BRAIN RES, V149, P25, DOI 10.1016/0006-8993(78)90585-1; Galea MP, 2010, J NEUROSCI, V30, P858, DOI 10.1523/JNEUROSCI.4859-09.2010; Geurts ACH, 2005, GAIT POSTURE, V22, P267, DOI 10.1016/j.gaitpost.2004.10.002; Guye M, 2003, NEUROIMAGE, V19, P1349, DOI 10.1016/S1053-8119(03)00165-4; Guz A, 1997, RESP PHYSIOL, V109, P197, DOI 10.1016/S0034-5687(97)00050-9; HESS CW, 1987, J PHYSIOL-LONDON, V388, P397, DOI 10.1113/jphysiol.1987.sp016621; Hodges P, 1999, EXP BRAIN RES, V124, P69, DOI 10.1007/s002210050601; Hodges PW, 1997, EXP BRAIN RES, V114, P362, DOI 10.1007/PL00005644; Hodges PW, 1996, SPINE, V21, P2640, DOI 10.1097/00007632-199611150-00014; Hodges PW, 2001, EXP BRAIN RES, V138, P243, DOI 10.1007/s002210100693; Jacobs JV, 2010, CLIN NEUROPHYSIOL, V121, P431, DOI 10.1016/j.clinph.2009.11.076; Kouchtir-Devanne N, 2012, J NEUROPHYSIOL, V107, P1522, DOI 10.1152/jn.00786.2011; Kuppuswamy A, 2008, GAIT POSTURE, V27, P478, DOI 10.1016/j.gaitpost.2007.06.001; LEMON RN, 1976, PROC R SOC SER B-BIO, V194, P341, DOI 10.1098/rspb.1976.0083; Luu B, 2007, IBRO WORLD C NEUR SA; MacKinnon CD, 2000, J PHYSIOL-LONDON, V528, P633, DOI 10.1111/j.1469-7793.2000.00633.x; MacKinnon CD, 2007, J NEUROPHYSIOL, V97, P4368, DOI 10.1152/jn.01136.2006; Maier MA, 2002, CEREB CORTEX, V12, P281, DOI 10.1093/cercor/12.3.281; Maki BE, 2007, J NEURAL TRANSM, V114, P1279, DOI 10.1007/s00702-007-0764-y; MARSDEN CD, 1981, BRAIN, V104, P513, DOI 10.1093/brain/104.3.513; Masakado Y, 2008, Electromyogr Clin Neurophysiol, V48, P27; Masakado Yoshihisa, 2008, Keio Journal of Medicine, V57, P50, DOI 10.2302/kjm.57.50; Masse-Alarie H, 2012, EXP BRAIN RES, V218, P99, DOI 10.1007/s00221-012-3008-9; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; Metman Leo Verhagen, 1993, Brain Topography, V6, P13, DOI 10.1007/BF01234122; Mihara M, 2008, NEUROIMAGE, V43, P329, DOI 10.1016/j.neuroimage.2008.07.029; Nowicky AV, 2001, MOTOR CONTROL, V5, P270, DOI 10.1123/mcj.5.3.270; ODDSSON L, 1986, ACTA PHYSIOL SCAND, V128, P341, DOI 10.1111/j.1748-1716.1986.tb07987.x; Penfield W, 1937, BRAIN, V60, P55; Petersen TH, 2009, EXP BRAIN RES, V193, P161, DOI 10.1007/s00221-008-1603-6; Poortvliet PC, 2015, EXP BRAIN RES, V233, P3447, DOI 10.1007/s00221-015-4404-8; Quant S, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-18; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; Schieppati M, 1996, J PHYSIOL-LONDON, V491, P551, DOI 10.1113/jphysiol.1996.sp021239; Schneider C, 2004, J APPL PHYSIOL, V97, P2220, DOI 10.1152/japplphysiol.00542.2004; Soto O, 2006, J NEUROPHYSIOL, V96, P1711, DOI 10.1152/jn.00133.2006; Strutton PH, 2005, J SPINAL DISORD TECH, V18, P420, DOI 10.1097/01.bsd.0000169063.84628.fe; Tani T, 1997, ELECTROMYOGR MOTOR C, V105, P194, DOI 10.1016/S0924-980X(97)00017-9; Taniguchi S, 1999, SPINE, V24, P154, DOI 10.1097/00007632-199901150-00014; THORSTENSSON A, 1985, ACTA PHYSIOL SCAND, V125, P309, DOI 10.1111/j.1748-1716.1985.tb07721.x; TRAUB MM, 1980, BRAIN, V103, P393, DOI 10.1093/brain/103.2.393; Tsao H, 2011, NEUROSCIENCE, V181, P127, DOI 10.1016/j.neuroscience.2011.02.033; Tsao H, 2008, BRAIN, V131, P2161, DOI 10.1093/brain/awn154; Tsao H, 2011, SPINE, V36, P1721, DOI 10.1097/BRS.0b013e31821c4267; Tsao H, 2011, CLIN NEUROPHYSIOL, V122, P1580, DOI 10.1016/j.clinph.2011.01.048; Tunstill SA, 2001, EXP PHYSIOL, V86, P131, DOI 10.1113/eph8602071; van Hedel HJA, 2007, J NEUROL, V254, P1089, DOI 10.1007/s00415-006-0493-4; VIALLET F, 1992, EXP BRAIN RES, V88, P674; Zedka M, 1999, J PHYSIOL-LONDON, V520, P591, DOI 10.1111/j.1469-7793.1999.00591.x	73	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147650	10.1371/journal.pone.0147650	http://dx.doi.org/10.1371/journal.pone.0147650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807583	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800168
J	Hong, AR; Kim, JH; Song, YS; Lee, KE; Seo, SH; Seong, MW; Shin, CS; Kim, SW; Kim, SY				Hong, A. Ram; Kim, Jung Hee; Song, Young Shin; Lee, Kyu Eun; Seo, Soo Hyun; Seong, Moon-Woo; Shin, Chan Soo; Kim, Sang Wan; Kim, Seong Yeon			Genetics of Aldosterone-Producing Adenoma in Korean Patients	PLOS ONE			English	Article							K+ CHANNEL MUTATIONS; SOMATIC MUTATIONS; KCNJ5 MUTATIONS; HYPERTENSION; PREVALENCE; EXPRESSION; POTASSIUM; DIAGNOSIS; ATP1A1; ATP2B3	Objectives Recently, somatic mutations in KCNJ5, ATP1A1, ATP2B3, and CACNA1D genes were found to be associated with the pathogenesis of aldosterone-producing adenoma (APA). This study aimed to investigate the prevalence of somatic mutations in KCNJ5, ATP1A1, ATP2B3, and CACNA1D and examine the correlations between these mutations and the clinical and biochemical characteristics in Korean patients with APA. Methods We performed targeted gene sequencing in 66 patients with APA to detect somatic mutations in these genes. Results Somatic KCNJ5 mutations were found in 47 (71.2%) of the 66 patients with APA (31 cases of p. G151R and 16 cases of p. L168R); these two mutations were mutually exclusive. Somatic mutations in the ATP1A1, ATP2B3, and CACNA1D genes were not observed. Somatic KCNJ5 mutations were more prevalent in female patients (66% versus 36.8%, respectively; P = 0.030). Moreover, patients with KCNJ5 mutations comprised a significantly higher proportion of patients younger than 35 years of age (19.1% versus 0%, respectively; P = 0.040). There were no significant differences in pre-operative blood pressure, plasma aldosterone, serum potassium, lateralization index, and adenoma size according to mutational status. Patients with KCNJ5 mutations were less likely to need antihypertensive medications after adrenalectomy compared with those without mutation (36.2% versus 63.2%; P = 0.045). Conclusions The present study demonstrated the high prevalence of somatic KCNJ5 mutations in Korean patients with APA. Carriers of somatic KCNJ5 mutations were more likely to be female. Early diagnosis and better therapeutic outcomes were associated with somatic KCNJ5 mutations in APA.	[Hong, A. Ram; Kim, Jung Hee; Song, Young Shin; Shin, Chan Soo; Kim, Sang Wan; Kim, Seong Yeon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Lee, Kyu Eun] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Seo, Soo Hyun; Seong, Moon-Woo] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Kim, Sang Wan] Seoul Metropolitan Govt Boramae Med Ctr, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, SW; Kim, SY (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.; Kim, SW (corresponding author), Seoul Metropolitan Govt Boramae Med Ctr, Dept Internal Med, Seoul, South Korea.	seongyk@plaza.snu.ac.kr; swkimmd@snu.ac.kr	Kim, Jung Hee/AAG-1191-2019; Kim, Sang Wan/J-5399-2012	Kim, Jung Hee/0000-0003-1932-0234; Kim, Sang Wan/0000-0001-9561-9110; Seong, Moon-Woo/0000-0003-2954-3677	Seoul National University Hospital [3020140290]; Seoul Metropolitan Government Boramae Medical Center [26-2015-18]	Seoul National University Hospital; Seoul Metropolitan Government Boramae Medical Center	This study was supported by grant 3020140290 (2014-3283) to SYK from Seoul National University Hospital (http://www.snuh.org) and grant 26-2015-18 to SWK from Seoul Metropolitan Government Boramae Medical Center(http://www.brmh.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041926; Azizan EAB, 2012, J CLIN ENDOCR METAB, V97, pE819, DOI 10.1210/jc.2011-2965; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; Boulkroun S, 2012, HYPERTENSION, V59, P592, DOI 10.1161/HYPERTENSIONAHA.111.186478; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Fallo F, 2006, J CLIN ENDOCR METAB, V91, P454, DOI 10.1210/jc.2005-1733; Fernandes-Rosa FL, 2014, HYPERTENSION, V64, P354, DOI 10.1161/HYPERTENSIONAHA.114.03419; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Gomez-Sanchez CE, 2014, ENDOCRINOLOGY, V155, P47, DOI 10.1210/en.2013-1733; Han JY, 2014, LUNG CANCER, V85, P161, DOI 10.1016/j.lungcan.2014.04.009; Kitamoto T, 2015, J ATHEROSCLER THROMB, V22, P191, DOI 10.5551/jat.24455; Kuppusamy M, 2014, J CLIN ENDOCR METAB, V99, pE1765, DOI 10.1210/jc.2014-1927; Lenzini L, 2015, J CLIN ENDOCR METAB, V100, pE1089, DOI 10.1210/jc.2015-2149; Monticone S, 2012, J CLIN ENDOCR METAB, V97, pE1567, DOI 10.1210/jc.2011-3132; Mulatero P, 2013, NAT REV ENDOCRINOL, V9, P104, DOI 10.1038/nrendo.2012.230; Mulatero P, 2009, CURR HYPERTENS REP, V11, P217, DOI 10.1007/s11906-009-0038-1; Oki K, 2012, ENDOCRINOLOGY, V153, P1774, DOI 10.1210/en.2011-1733; Rossi GP, 2011, NAT REV ENDOCRINOL, V7, P485, DOI 10.1038/nrendo.2011.76; Seccia TM, 2012, J CLIN ENDOCR METAB, V97, pE2307, DOI 10.1210/jc.2012-2342; Taguchi R, 2012, J CLIN ENDOCR METAB, V97, P1311, DOI 10.1210/jc.2011-2885; Wang BJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000708; Williams TA, 2015, HYPERTENSION, V65, P507, DOI 10.1161/HYPERTENSIONAHA.114.04636; Williams TA, 2014, HYPERTENSION, V63, P188, DOI 10.1161/HYPERTENSIONAHA.113.01733; Wu VC, 2015, SCI REP-UK, V5, DOI 10.1038/srep11396; Zhang WQ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S11-S6; Zheng FF, 2015, HYPERTENSION, V65, P622, DOI 10.1161/HYPERTENSIONAHA.114.03346	26	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147590	10.1371/journal.pone.0147590	http://dx.doi.org/10.1371/journal.pone.0147590			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807823	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800142
J	Hong, T; Mitchell, P; Burlutsky, G; Liew, G; Wang, JJ				Hong, Thomas; Mitchell, Paul; Burlutsky, George; Liew, Gerald; Wang, Jie Jin			Visual Impairment, Hearing Loss and Cognitive Function in an Older Population: Longitudinal Findings from the Blue Mountains Eye Study	PLOS ONE			English	Article							MINI-MENTAL-STATE; VISION IMPAIRMENT; DECLINE; DEMENTIA; ADULTS; ACUITY; RISK; MMSE; AGE	The presence of visual impairment (VI) and hearing loss (HL) with may be a marker for subsequent cognitive decline over time in older people. A prospective, longitudinal population-based study of the 3654 participants of the Blue Mountains Eye Study were assessed for the associations between VI and HL and a decline in mini-mental state examination (MMSE) scores over a duration of 10 years from the 5-year (baseline of this report) to the 15-year follow-up visits. MMSE was assessed at the 5-, 10-and 15-year follow-up visits. A decline >= 3 scores from 5-year to 10- or 15-year visits indicated possible cognitive decline. VI was defined as best-corrected visual acuity <6/12 in the worse-eye, HL was defined as pure-tone average >40 decibels in the worse-ear and dual sensory impairment (DSI) was defined by the co-presence of VI and HL, detected at 5-year followup (baseline of this report). Participants with no VI and HL over the same 5- or 10-year corresponding period were controls. Associations of VI, HL and DSI with possible cognitive decline were assessed using logistic regression models adjusting for age and sex after excluding subjects with a stroke history. The presence of VI, HL or DSI was not associated with possible cognitive decline over 5 years (odds ratio (OR) 0.84, 95% confidence-intervals (CI) 0.40-1.79, OR 1.02, 95% CI 0.61-1.70 and 1.41, 95% CI 0.54-3.72, respectively) or 10 years (OR 1.09, 95% CI 0.52-2.30, OR 1.09, 95% CI 0.65-1.82 and 1.15, 95% CI 0.28-4.73, respectively). There were no changes to these findings after adjustment for other potential confounders. Age was significantly associated with possible cognitive decline (OR 1.07, 95% CI 1.04-1.10 for both periods). Neither visual impairment, hearing loss nor dual sensory impairment was independently associated with subsequent decline in cognition.	[Wang, Jie Jin] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW 2006, Australia; [Wang, Jie Jin] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research	Wang, JJ (corresponding author), Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW 2006, Australia.; Wang, JJ (corresponding author), Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia.	jiejin.wang@sydney.edu.au	Mitchell, Paul/P-1498-2014; Wang, Jie Jin/P-1499-2014; Liew, Gerald/AAB-6870-2022; wang, jie/GRS-0942-2022	Wang, Jie Jin/0000-0001-9491-4898; 	National Health and Medical Research Council, Australia [974159, 211069, 457349]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	PM was supported by National Health and Medical Research Council, Australia (grant nos. 974159, 211069, 457349) https://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attebo K, 1996, OPHTHALMOLOGY, V103, P357; Busse A, 2002, J CLIN EPIDEMIOL, V55, P909, DOI 10.1016/S0895-4356(02)00449-3; Clemons TE, 2006, ARCH OPHTHALMOL-CHIC, V124, P537; Diaz M, 2011, BRIT J OPHTHALMOL, V95, P24, DOI 10.1136/bjo.2010.183459; Dregan A, 2013, AGE AGEING, V42, P338, DOI 10.1093/ageing/afs166; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GENNIS V, 1991, ARCH INTERN MED, V151, P2259, DOI 10.1001/archinte.151.11.2259; Gopinath B, 2012, AGE AGEING, V41, P618, DOI 10.1093/ageing/afs058; Hensel A, 2007, J NEUROL NEUROSUR PS, V78, P1298, DOI 10.1136/jnnp.2006.109074; Hong T, 2013, OPHTHALMOLOGY, V120, P2091, DOI 10.1016/j.ophtha.2013.03.032; Jefferis JM, 2012, AGE AGEING, V41, P565, DOI 10.1093/ageing/afs042; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin MY, 2004, J AM GERIATR SOC, V52, P1996, DOI 10.1111/j.1532-5415.2004.52554.x; Lipnicki DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065841; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Ong SY, 2012, ARCH OPHTHALMOL; Rait G, 2005, AGE AGEING, V34, P242, DOI 10.1093/ageing/afi039; Reischies FM, 1997, BRIT J PSYCHIAT, V171, P449, DOI 10.1192/bjp.171.5.449; Reyes-Ortiz CA, 2005, J AM GERIATR SOC, V53, P681, DOI 10.1111/j.1532-5415.2005.53219.x; Sachdev PS, 2014, J NEUROL NEUROSUR PS, V63, P1618; Schultz-Larsen K, 2007, J CLIN EPIDEMIOL, V60, P268, DOI 10.1016/j.jclinepi.2006.06.007; Stein J, 2012, ACTA PSYCHIAT SCAND, V126, P208, DOI 10.1111/j.1600-0447.2012.01850.x; Sun JH, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.05; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; Tay T, 2006, GERONTOLOGY, V52, P386, DOI 10.1159/000095129; Valentijn SAM, 2005, J AM GERIATR SOC, V53, P374, DOI 10.1111/j.1532-5415.2005.53152.x; van Boxtel MPJ, 2000, J CLIN EXP NEUROPSYC, V22, P147, DOI 10.1076/1380-3395(200002)22:1;1-8;FT147	27	80	81	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147646	10.1371/journal.pone.0147646	http://dx.doi.org/10.1371/journal.pone.0147646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808979	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800166
J	Michael, BD; Griffiths, MJ; Granerod, J; Brown, D; Davies, NWS; Borrow, R; Solomon, T				Michael, Benedict D.; Griffiths, Michael J.; Granerod, Julia; Brown, David; Davies, Nicholas W. S.; Borrow, Ray; Solomon, Tom			Characteristic Cytokine and Chemokine Profiles in Encephalitis of Infectious, Immune-Mediated, and Unknown Aetiology	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; HERPES-SIMPLEX ENCEPHALITIS; ACUTE LIMBIC ENCEPHALITIS; CEREBROSPINAL-FLUID; MANIFESTATIONS; MACROPHAGES; MECHANISMS; EXPRESSION; CHILDREN; MARKERS	Background Encephalitis is parenchymal brain inflammation due to infectious or immune-mediated processes. However, in 15-60% the cause remains unknown. This study aimed to determine if the cytokine/chemokine-mediated host response can distinguish infectious from immune-mediated cases, and whether this may give a clue to aetiology in those of unknown cause. Methods We measured 38 mediators in serum and cerebrospinal fluid (CSF) of patients from the Health Protection Agency Encephalitis Study. Of serum from 78 patients, 38 had infectious, 20 immune-mediated, and 20 unknown aetiology. Of CSF from 37 patients, 20 had infectious, nine immune-mediated and eight unknown aetiology. Results Heat-map analysis of CSF mediator interactions was different for infectious and immune-mediated cases, and that of the unknown aetiology group was similar to the infectious pattern. Higher myeloperoxidase (MPO) concentrations were found in infectious than immune-mediated cases, in serum and CSF (p = 0.01 and p = 0.006). Serum MPO was also higher in unknown than immune-mediated cases (p = 0.03). Multivariate analysis selected serum MPO; classifying 31 (91%) as infectious (p = 0.008) and 17 (85%) as unknown (p = 0.009) as opposed to immune-mediated. CSF data also selected MPO classifying 11 (85%) as infectious as opposed to immune-mediated (p = 0.036). CSF neutrophils were detected in eight (62%) infective and one (14%) immune-mediated cases (p = 0.004); CSF MPO correlated with neutrophils (p < 0.0001). Conclusions Mediator profiles of infectious aetiology differed from immune-mediated encephalitis; and those of unknown cause were similar to infectious cases, raising the hypothesis of a possible undiagnosed infectious cause. Particularly, neutrophils and MPO merit further investigation.	[Michael, Benedict D.; Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England; [Michael, Benedict D.; Griffiths, Michael J.; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Michael, Benedict D.; Griffiths, Michael J.; Solomon, Tom] Univ Liverpool, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool L69 3BX, Merseyside, England; [Griffiths, Michael J.] Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England; [Granerod, Julia; Brown, David] Publ Hlth England, London, England; [Brown, David] Fiocruz MS, Influenza & Measles Lab, IOC, BR-21045900 Rio De Janeiro, Brazil; [Davies, Nicholas W. S.] Chelsea & Westminster NHS Fdn Trust, London, England; [Borrow, Ray] Publ Hlth England, Vaccine Evaluat Unit, Manchester, Lancs, England	Walton Centre; University of Liverpool; University of Liverpool; Alder Hey Children's NHS Foundation Trust; Public Health England; Fundacao Oswaldo Cruz; Imperial College London; Public Health England	Michael, BD (corresponding author), Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.; Michael, BD (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.; Michael, BD (corresponding author), Univ Liverpool, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool L69 3BX, Merseyside, England.	benmic@liv.ac.uk		Michael, Benedict/0000-0002-8693-8926; Solomon, Tom/0000-0001-7266-6547	NIHR Doctoral Research Fellowship [NIHR-DRF2010-03-97]; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections at Liverpool; MRC; Vaccine Evaluation Unit; Public Health England, Manchester, UK; MRC [G116/194] Funding Source: UKRI; Academy of Medical Sciences (AMS) [SGL015\\1016] Funding Source: researchfish; Medical Research Council [G116/194] Funding Source: researchfish; National Institute for Health Research [IS-HPU-1112-10117, CL-2014-07-002, 12/205/28, 3546, RP-PG-0108-10048, NF-SI-0514-10177, DRF-2010-03-97, ACF-2008-07-001] Funding Source: researchfish	NIHR Doctoral Research Fellowship; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections at Liverpool; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Vaccine Evaluation Unit; Public Health England, Manchester, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	BDM is an NIHR Academic Clinical Lecturer and this work received support as part of an NIHR Doctoral Research Fellowship (NIHR-DRF2010-03-97). TS received support from the NIHR Health Protection Research Unit in Emerging and Zoonotic Infections at Liverpool. TS was also supported by the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the laboratory team at the Vaccine Evaluation Unit, Public Health England, Manchester, UK. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England.	Ambrose HE, 2011, J CLIN MICROBIOL, V49, P3576, DOI 10.1128/JCM.00862-11; Armangue T, 2015, NEUROLOGY, V85, P1736, DOI 10.1212/WNL.0000000000002125; Asaoka K, 2004, INTERNAL MED, V43, P42, DOI 10.2169/internalmedicine.43.42; Baggiolini M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00285; Benjamin LA, 2011, EMERG INFECT DIS, V17, P1484, DOI 10.3201/eid1708.110165; Bien CG, 2012, BRAIN, V135, P1622, DOI 10.1093/brain/aws082; Boutin H, 2003, MOL NEUROBIOL, V27, P239, DOI 10.1385/MN:27:3:239; Burton JM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006921.pub3; Conrady CD, 2010, J NEUROIMMUNOL, V220, P1, DOI 10.1016/j.jneuroim.2009.09.013; Dalmau J, 2011, LANCET NEUROL, V10, P63, DOI 10.1016/S1474-4422(10)70253-2; Davies NWS, 2005, J NEUROL NEUROSUR PS, V76, P82, DOI 10.1136/jnnp.2004.045336; Ellermann-Eriksen S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-59; Emsley HCA, 2005, J NEUROL NEUROSUR PS, V76, P1366, DOI 10.1136/jnnp.2004.054882; Fraisier C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093637; Goenka A, 2014, CLIN INFECT DIS, V58, P775, DOI 10.1093/cid/cit922; Granerod J, 2010, NEUROLOGY, V75, P924, DOI 10.1212/WNL.0b013e3181f11d65; Granerod J, 2013, EMERG INFECT DIS, V19, P1455, DOI 10.3201/eid1909.130064; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Griffiths MJ, 2012, J INFECT DIS, V206, P881, DOI 10.1093/infdis/jis446; Hamed SA, 2009, NEUROPEDIATRICS, V40, P66, DOI 10.1055/s-0029-1231054; Hsu J, 2015, PHARM RES-DORDR, V32, P1264, DOI 10.1007/s11095-014-1531-z; Ichiyama T, 2008, CYTOKINE, V44, P149, DOI 10.1016/j.cyto.2008.07.002; Irani SR, 2014, ANN NEUROL, V76, P168, DOI 10.1002/ana.24200; Irani SR, 2010, BRAIN, V133, P1655, DOI 10.1093/brain/awq113; Kaluza J, 1997, FOLIA NEUROPATHOL, V35, P24; Kamei S, 2004, INTERNAL MED, V43, P796, DOI 10.2169/internalmedicine.43.796; Kamei S, 2009, CYTOKINE, V46, P187, DOI 10.1016/j.cyto.2009.01.004; Kang XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077427; Kaunisto A, 2015, MOL ONCOL, V9, P1140, DOI 10.1016/j.molonc.2015.02.004; Kimura A, 2015, J NEUROL SCI, V352, P79, DOI 10.1016/j.jns.2015.03.036; Kneen R, 2012, J INFECTION, V64, P449, DOI 10.1016/j.jinf.2011.11.013; Kothur K, 2015, CYTOKINE, pS1043; Leypoldt F, 2015, JAMA NEUROL, V72, P180, DOI 10.1001/jamaneurol.2014.2956; Liu WY, 2012, CNS NEUROSCI THER, V18, P609, DOI 10.1111/j.1755-5949.2012.00340.x; Love S, 2008, GREENFIELDS NEUROPAT, P1293; Majwala A, 2013, AM J TROP MED HYG, V88, P127, DOI 10.4269/ajtmh.2012.12-0447; Matsushita T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061835; McGlasson S, 2015, NAT REV NEUROL, V11, P515, DOI 10.1038/nrneurol.2015.143; Melchjorsen J, 2002, J VIROL, V76, P2780, DOI 10.1128/JVI.76.6.2780-2788.2002; Metzler KD, 2014, CELL REP, V8, P883, DOI 10.1016/j.celrep.2014.06.044; Michael BD, 2013, CYTOKINE, V64, P90, DOI 10.1016/j.cyto.2013.07.019; Minagawa K, 2014, J IMMUNOL, V192, P1512, DOI 10.4049/jimmunol.1301619; Moscato EH, 2010, EUR J NEUROSCI, V32, P298, DOI 10.1111/j.1460-9568.2010.07349.x; Palus M, 2015, J MED VIROL, V87, P885, DOI 10.1002/jmv.24140; Raschilas F, 2002, CLIN INFECT DIS, V35, P254, DOI 10.1086/341405; Schachtele SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036216; Schrier RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116526; Sili U, 2014, J CLIN VIROL, V60, P112, DOI 10.1016/j.jcv.2014.03.010; Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014; Szodoray P, 2007, RHEUMATOLOGY, V46, P417, DOI 10.1093/rheumatology/kel306; Tuzun E, 2009, ACTA NEUROPATHOL, V118, P737, DOI 10.1007/s00401-009-0582-4; Vilela MC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-19; Vincent A, 2004, BRAIN, V127, P701, DOI 10.1093/brain/awh077; WHITLEY RJ, 1987, INFECTION, V15, pS3, DOI 10.1007/BF01650104; Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328; Zou J, 2015, CLIN RHEUMATOL	56	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146288	10.1371/journal.pone.0146288	http://dx.doi.org/10.1371/journal.pone.0146288			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808276	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800020
J	Tiwary, S; Xu, L				Tiwary, Shweta; Xu, Lei			FRIZZLED7 Is Required for Tumor Inititation and Metastatic Growth of Melanoma Cells	PLOS ONE			English	Article							STEM-CELLS; WNT RECEPTOR; BRAF INHIBITORS; BETA-CATENIN; ACTIVATION; KINASE; RESISTANCE; GPR56; PROLIFERATION; MECHANISMS	Metastases are thought to arise from cancer stem cells and their tumor initiating abilities are required for the establishment of metastases. Nevertheless, in metastatic melanoma, the nature of cancer stem cells is under debate and their contribution to metastasis formation remains unknown. Using an experimental metastasis model, we discovered that high levels of the WNT receptor, FZD7, correlated with enhanced metastatic potentials of melanoma cell lines. Knocking down of FZD7 in a panel of four melanoma cell lines led to a significant reduction in lung metastases in animal models, arguing that FZD7 plays a causal role during metastasis formation. Notably, limiting dilution analyses revealed that FZD7 is essential for the tumor initiation of melanoma cells and FZD7 knockdown impeded the early expansion of metastatic melanoma cells shortly after seeding, in accordance with the view that tumor initiating ability of cancer cells is required for metastasis formation. FZD7 activated JNK in melanoma cell lines in vitro and the expression of a dominant negative JNK suppressed metastasis formation in vivo, suggesting that FZD7 may promote metastatic growth of melanoma cells via activation of JNK. Taken together, our findings uncovered a signaling pathway that regulates the tumor initiation of melanoma cells and contributes to metastasis formation in melanoma.	[Tiwary, Shweta; Xu, Lei] Univ Rochester, Med Ctr, Dept Biomed Genet, 601 Elmwood Ave, Rochester, NY 14642 USA; [Tiwary, Shweta] Univ Texas Houston, MD Anderson Canc Ctr, Dept Neurosurg, 1515 Holcombe Blvd, Houston, TX 77030 USA	University of Rochester; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Xu, L (corresponding author), Univ Rochester, Med Ctr, Dept Biomed Genet, 601 Elmwood Ave, Rochester, NY 14642 USA.	lei_xu@urmc.rochester.edu	Tiwary, Shweta/I-8076-2019	Tiwary, Shweta/0000-0002-2635-2560	James Wilmot Cancer Center Pilot Grant, University of Rochester Medical Center; IDEA Award from New York State Department of Health [N08G-480]; University of Rochester; JWCC/RPCI Collaborative Pilot Grant; NYSTEM IDEA AWARD [N08G-480]	James Wilmot Cancer Center Pilot Grant, University of Rochester Medical Center; IDEA Award from New York State Department of Health; University of Rochester; JWCC/RPCI Collaborative Pilot Grant; NYSTEM IDEA AWARD	This work was funded by the James Wilmot Cancer Center Pilot Grant, University of Rochester Medical Center, (to LX; https://www.urmc.rochester.edu/cancer-institute/researchers/fundingopportunities.aspx), and the IDEA Award for Stem Cell Research from the New York State Department of Health (#N08G-480, to LX; http://stemcell.ny.gov/grants-and-contracts-awarded). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Nancy Corson and Morgan Preziosi for technical assistance and Dr. Glynis Scott for reading the manuscript. This work was supported by the start-up fund from University of Rochester (L.X.), the JWCC/RPCI Collaborative Pilot Grant (L.X.) and the NYSTEM IDEA AWARD (#N08G-480; L.X.).	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Anastas JN, 2014, J CLIN INVEST, V124, P2877, DOI 10.1172/JCI70156; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bentzinger CF, 2014, J CELL BIOL, V205, P97, DOI 10.1083/jcb.201310035; Chalcrabarti R, 2014, NAT CELL BIOL, V16, P1004, DOI 10.1038/ncb3040; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Diehn M, 2009, SEMIN RADIAT ONCOL, V19, P78, DOI 10.1016/j.semradonc.2008.11.002; Fernandez A, 2014, P NATL ACAD SCI USA, V111, P1409, DOI 10.1073/pnas.1323697111; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Flanagan DJ, 2015, STEM CELL REP, V4, P759, DOI 10.1016/j.stemcr.2015.03.003; Gao L, 2006, CANCER RES, V66, P7880, DOI 10.1158/0008-5472.CAN-06-0254; Gao YJ, 2009, EXP NEUROL, V219, P146, DOI 10.1016/j.expneurol.2009.05.006; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; HERLYN M, 1985, J NATL CANCER I, V74, P283; Hersey P, 2010, PIGM CELL MELANOMA R, V24, pe1, DOI 10.1111/j.1755-148X.2010.00811.x; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Jorgensen K, 2006, MODERN PATHOL, V19, P1446, DOI 10.1038/modpathol.3800662; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; King TD, 2012, CELL SIGNAL, V24, P846, DOI 10.1016/j.cellsig.2011.12.009; Kleber M, 2004, CURR OPIN CELL BIOL, V16, P681, DOI 10.1016/j.ceb.2004.08.006; Klein CA, 2011, CURR OPIN GENET DEV, V21, P42, DOI 10.1016/j.gde.2010.10.011; Kolben T, 2012, BIOL CHEM, V393, P1433, DOI 10.1515/hsz-2012-0186; Labelle M, 2012, CANCER DISCOV, V2, P1091, DOI 10.1158/2159-8290.CD-12-0329; Lopez-Bergami P, 2011, PIGM CELL MELANOMA R, V24, P902, DOI 10.1111/j.1755-148X.2011.00908.x; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mei H, 2014, STEM CELLS, V32, P938, DOI 10.1002/stem.1582; Nishita M, 2010, MOL CELL BIOL, V30, P3610, DOI 10.1128/MCB.00177-10; O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x; Pode-Shakked N, 2011, ONCOGENE, V30, P1664, DOI 10.1038/onc.2010.549; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Sumanas S, 2000, DEVELOPMENT, V127, P1981; Tiwary S, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.23; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344; Xu L, 2007, CELL CYCLE, V6, P160, DOI 10.4161/cc.6.2.3760; Yang LQ, 2014, CANCER RES, V74, P1022, DOI 10.1158/0008-5472.CAN-13-1268; Yang LQ, 2011, CANCER RES, V71, P5558, DOI 10.1158/0008-5472.CAN-10-4543; Zabierowski SE, 2008, J CLIN ONCOL, V26, P2890, DOI 10.1200/JCO.2007.15.5465	53	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147638	10.1371/journal.pone.0147638	http://dx.doi.org/10.1371/journal.pone.0147638			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808375	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800160
J	Li, DL; Yang, XY; Zhang, Z; Wang, ZX; Qi, X; Ruan, YH; Zhou, YH; Li, CR; Luo, FJ; Lau, JTF				Li, Dongliang; Yang, Xueying; Zhang, Zheng; Wang, Zixin; Qi, Xiao; Ruan, Yuhua; Zhou, Yunhua; Li, Chunrong; Luo, Fengji; Lau, Joseph T. F.			Incidence of Co-Infections of HIV, Herpes Simplex Virus Type 2 and Syphilis in a Large Cohort of Men Who Have Sex with Men in Beijing, China	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; GENITAL ULCER DISEASE; VIRAL LOAD; CLINICAL-MANIFESTATIONS; RISK-FACTORS; IMMUNODEFICIENCY; INFECTION; PREVALENCE; CELL; ASSOCIATION	Background The HIV-epidemic among MSM in China has worsened. In this key population, prevalence of HSV-2 and syphilis infection and co-infection with HIV is high. Methods A longitudinal study was conducted (n = 962) in Beijing, China, with three overlapping cohorts (n = 857, 757 and 760) consisting of MSM that were free from pairs of infections of concern (i. e. HIV-HSV-2, HIV-syphilis, HSV-2-syphilis) at baseline to estimate incidence of HIV, HSV-2, syphilis, and those of co-infection. Results The incidence of HIV, HSV-2 and syphilis in the overall cohort was 3.90 (95% CI = 2.37, 5.43), 7.87 (95% CI = 5.74, 10.00) and 6.06 (95% CI = 4.18, 7.94) cases per 100 personyears (PYs), respectively. The incidence of HIV-HSV-2, HIV-Syphilis and HSV-2-Syphilis co-infections was 0.30 (95% CI = 0.29, 0.88), 1.02 (95% CI = 0.13, 2.17) and 1.41 (95% CI: 0.04, 2.78) cases per 100 PYs, respectively, in the three sub-cohorts constructed for this study. Conclusions The incidence of HIV, HSV-2 and syphilis was very high and those of their co-infections were relatively high. Such co-infections have negative impacts on the HIV/STI epidemics. Prevention practices need to take such co-infections into account.	[Li, Dongliang; Yang, Xueying; Zhang, Zheng; Qi, Xiao; Luo, Fengji] Chaoyang Ctr Dis Control & Prevent, Beijing, Peoples R China; [Yang, Xueying; Wang, Zixin; Li, Chunrong; Lau, Joseph T. F.] Chinese Univ Hong Kong SAR, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China; [Ruan, Yuhua] Chinese Ctr Dis Control & Prevent China CDC, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control SKLID, Beijing, Peoples R China; [Zhou, Yunhua] Soochow Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Suzhou, Jiangsu, Peoples R China	Chinese University of Hong Kong; Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Soochow University - China	Luo, FJ (corresponding author), Chaoyang Ctr Dis Control & Prevent, Beijing, Peoples R China.; Lau, JTF (corresponding author), Chinese Univ Hong Kong SAR, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China.	lfj67773666@126.com; jlau@cuhk.edu.hk	Wang, Zhiquan/HHS-6768-2022	Li, Chunrong/0000-0002-5128-0132	Ministry of Science and Technology of China [2012ZX10004-904]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	Funding for this study was provided by Ministry of Science and Technology of China (2012ZX10004-904).	Amaratunge BC, 2010, CLIN EXP OPHTHALMOL, V38, P68, DOI 10.1111/j.1442-9071.2010.02203.x; [Anonymous], 2008, DEP HLTH HUMAN SERVI, V1; Bergamini M, 2013, J Prev Med Hyg, V54, P114; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; Chesson HW, 2005, SEX TRANSM DIS, V32, P265, DOI 10.1097/01.olq.0000162359.75509.9c; Chow EPF, 2013, AIDS BEHAV, V17, P2387, DOI 10.1007/s10461-012-0300-4; Chow EPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022768; Chun Helen M, 2013, J Sex Transm Dis, V2013, P176459, DOI 10.1155/2013/176459; COREY L, 1983, ANN INTERN MED, V98, P958, DOI 10.7326/0003-4819-98-6-958; de Almeida SM, 2010, J NEUROVIROL, V16, P6, DOI 10.3109/13550280903514776; Diaz JJ, 1996, NATURE, V379, P273, DOI 10.1038/379273a0; Ding YY, 2016, SEX TRANSM INFECT, V92, P76, DOI 10.1136/sextrans-2014-051975; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Gao L, 2009, SEX TRANSM INFECT, V85, P354, DOI 10.1136/sti.2008.034702; Ghanem KG, 2008, CLIN INFECT DIS, V47, P258, DOI 10.1086/589295; Hao C, 2011, SEX TRANSM INFECT, V87, P199, DOI 10.1136/sti.2010.042903; Huang DY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/174870; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jarzebowski W, 2012, ARCH INTERN MED, V172, P1237, DOI 10.1001/archinternmed.2012.2706; Jiang J, 2006, SEX TRANSM DIS, V33, P118, DOI 10.1097/01.olq.0000199763.14766.2b; KUCERA LS, 1990, AIDS RES HUM RETROV, V6, P641, DOI 10.1089/aid.1990.6.641; Lama JR, 2006, J INFECT DIS, V194, P1459, DOI 10.1086/508548; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Lau JTF, 2013, AIDS BEHAV, V17, P1395, DOI 10.1007/s10461-012-0244-8; Li Chun-mei, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P126; Li DL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001829; Li HC, 2015, INT J STD AIDS, V26, P13, DOI 10.1177/0956462414528309; Meng XJ, 2013, SEX HEALTH, V10, P211, DOI 10.1071/SH12093; Moriuchi M, 2000, VIROLOGY, V278, P534, DOI 10.1006/viro.2000.0667; MUSHER DM, 1990, ANN INTERN MED, V113, P872, DOI 10.7326/0003-4819-113-11-872; Nasio JM, 1996, INT J STD AIDS, V7, P410, DOI 10.1258/0956462961918374; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Norman P., 1996, PREDICTING HLTH BEHA, P197; NORRIS SA, 1988, J INFECT DIS, V157, P209, DOI 10.1093/infdis/157.1.209; Palo G, 2001, Herpes, V8, P50; Prabhakar P, 2012, SEX TRANSM DIS, V39, P906, DOI 10.1097/OLQ.0b013e3182663e22; Renzi C, 2003, J INFECT DIS, V187, P19, DOI 10.1086/345867; Rodrigues J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-39; Rompalo AM, 2001, SEX TRANSM DIS, V28, P448, DOI 10.1097/00007435-200108000-00004; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; SAFRIN S, 1991, AIDS, V5, P1107, DOI 10.1097/00002030-199109000-00008; Schacker T, 1998, J INFECT DIS, V178, P1616, DOI 10.1086/314486; Sheth PM, 2008, J INFECT DIS, V197, P1394, DOI 10.1086/587697; SIEGAL FP, 1981, NEW ENGL J MED, V305, P1439, DOI 10.1056/NEJM198112103052403; Su YZ, 2011, THESIS; Tan Darrell H S, 2009, Can J Infect Dis Med Microbiol, V20, pe1; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Wu ZY, 2009, WHO M MSM GEN; Xu FJ, 2010, SEX TRANSM DIS, V37, P399, DOI 10.1097/OLQ.0b013e3181ce122b; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Yang HT, 2010, SEX TRANSM DIS, V37, P208, DOI 10.1097/OLQ.0b013e3181d13c59; Yin YP, 2012, SEX TRANSM DIS, V39, P354, DOI 10.1097/OLQ.0b013e318244aef0	54	11	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147422	10.1371/journal.pone.0147422	http://dx.doi.org/10.1371/journal.pone.0147422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820145	Green Published, Green Submitted, gold			2022-12-26	WOS:000369528400028
J	Kasai, T; Tokuda, T; Ohmichi, T; Ishii, R; Tatebe, H; Nakagawa, M; Mizuno, T				Kasai, Takashi; Tokuda, Takahiko; Ohmichi, Takuma; Ishii, Ryotaro; Tatebe, Harutsugu; Nakagawa, Masanori; Mizuno, Toshiki			Serum Levels of Coenzyme Q10 in Patients with Multiple System Atrophy	PLOS ONE			English	Article							Q(10); FIBROBLASTS; DEFICIENCY; UBIQUINONE; PHENOTYPE; DIAGNOSIS; SPECTRUM; MUSCLE	The COQ2 gene encodes an essential enzyme for biogenesis, coenzyme Q10 (CoQ10). Recessive mutations in this gene have recently been identified in families with multiple system atrophy (MSA). Moreover, specific heterozygous variants in the COQ2 gene have also been reported to confer susceptibility to sporadic MSA in Japanese cohorts. These findings have suggested the potential usefulness of CoQ10 as a blood-based biomarker for diagnosing MSA. This study measured serum levels of CoQ10 in 18 patients with MSA, 20 patients with Parkinson's disease and 18 control participants. Although differences in total CoQ10 (i.e., total levels of serum CoQ10 and its reduced form) among the three groups were not significant, total CoQ10 level corrected by serum cholesterol was significantly lower in the MSA group than in the Control group. Our findings suggest that serum CoQ10 can be used as a biomarker in the diagnosis of MSA and to provide supportive evidence for the hypothesis that decreased levels of CoQ10 in brain tissue lead to an increased risk of MSA.	[Kasai, Takashi; Tokuda, Takahiko; Ohmichi, Takuma; Ishii, Ryotaro; Tatebe, Harutsugu; Mizuno, Toshiki] Kyoto Prefectural Univ Med, Res Inst Geriatr, Dept Neurol, Kyoto 6020841, Japan; [Kasai, Takashi; Tokuda, Takahiko] Japan Agcy Med Res & Dev, AMED CREST, Kyoto 6020841, Japan; [Tokuda, Takahiko] Kyoto Prefectural Univ Med, Res Inst Geriatr, Dept Mol Pathobiol Brain Dis, Kyoto 6020841, Japan; [Tatebe, Harutsugu] Kyoto Prefectural Univ Med, Dept Zaitaku Homecare Med, Kyoto 6020841, Japan; [Nakagawa, Masanori] Kyoto Prefectural Univ Med, Med Ctr N, Kyoto 6292261, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Kasai, T (corresponding author), Kyoto Prefectural Univ Med, Res Inst Geriatr, Dept Neurol, Kyoto 6020841, Japan.; Kasai, T (corresponding author), Japan Agcy Med Res & Dev, AMED CREST, Kyoto 6020841, Japan.	kasaita@koto.kpu-m.ac.jp	Mizuno, Toshiki/AAH-7155-2020; Ishii, Ryotaro/K-4595-2019		AMED; AMED-CREST; Ministry of Education, Culture, Sports, Science and Technology of Japan [15K09319]	AMED; AMED-CREST; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by AMED, AMED-CREST and by a Grant-in-Aid (No. 15K09319) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhagavan HN, 2006, FREE RADICAL RES, V40, P445, DOI 10.1080/10715760600617843; Coppadoro A, 2013, J CRIT CARE, V28, P571, DOI 10.1016/j.jcrc.2013.02.009; Del Pozo-Cruz J, 2014, EXP GERONTOL, V52, P46, DOI 10.1016/j.exger.2014.01.026; FAUST JR, 1979, ARCH BIOCHEM BIOPHYS, V192, P86, DOI 10.1016/0003-9861(79)90074-2; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kaikkonen J, 1999, FEBS LETT, V443, P163, DOI 10.1016/S0014-5793(98)01712-8; LAAKSONEN R, 1995, J LAB CLIN MED, V125, P517; Mitsui J, 2013, NEW ENGL J MED, V369, P233, DOI 10.1056/NEJMoa1212115; Molina JA, 2000, J NEURAL TRANSM, V107, P1021, DOI 10.1007/s007020070050; Montero R, 2008, CLIN BIOCHEM, V41, P697, DOI 10.1016/j.clinbiochem.2008.03.007; Naini A, 2003, BIOFACTORS, V18, P145, DOI 10.1002/biof.5520180217; Ozawa T, 2004, BRAIN, V127, P2657, DOI 10.1093/brain/awh303; Ozawa T, 2010, J NEUROL NEUROSUR PS, V81, P1253, DOI 10.1136/jnnp.2009.182576; Steele Paul E, 2004, Am J Clin Pathol, V121 Suppl, pS113; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Yabe I, 2006, J NEUROL SCI, V249, P115, DOI 10.1016/j.jns.2006.05.064	16	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147574	10.1371/journal.pone.0147574	http://dx.doi.org/10.1371/journal.pone.0147574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812605	Green Published, gold			2022-12-26	WOS:000369528000040
J	Ouldamer, L; Goupille, C; Vilde, A; Arbion, F; Body, G; Chevalier, S; Cottier, JP; Bougnoux, P				Ouldamer, Lobna; Goupille, Caroline; Vilde, Anne; Arbion, Flavie; Body, Gilles; Chevalier, Stephan; Cottier, Jean Philippe; Bougnoux, Philippe			N-3 Polyunsaturated Fatty Acids of Marine Origin and Multifocality in Human Breast Cancer	PLOS ONE			English	Article							ADIPOSE-TISSUE; MAMMARY-TUMOR; EXPRESSION; RISK; OMEGA-3-FATTY-ACIDS; MULTICENTRICITY; INHIBITION; MODULATION; PREVENTION; GROWTH	Objective The microenvironment of breast epithelial tissue may contribute to the clinical expression of breast cancer. Breast epithelial tissue, whether healthy or tumoral, is directly in contact with fat cells, which in turn could influence tumor multifocality. In this pilot study we investigated whether the fatty acid composition of breast adipose tissue differed according to breast cancer focality. Methods Twenty-three consecutive women presenting with non-metastatic breast cancer underwent breast-imaging procedures including Magnetic Resonance Imaging prior to treatment. Breast adipose tissue specimens were collected during breast surgery. We established a biochemical profile of adipose tissue fatty acids by gas chromatography. We assessed whether there were differences according to breast cancer focality. Results We found that decreased levels in breast adipose tissue of docosahexaenoic and eicosapentaenoic acids, the two main polyunsaturated n-3 fatty acids of marine origin, were associated with multifocality. Discussion These differences in lipid content may contribute to mechanisms through which peritumoral adipose tissue fuels breast cancer multifocality.	[Ouldamer, Lobna; Body, Gilles] CHU Tours, Hop Bretonneau, Dept Gynecol, 2 Blvd Tonnelle, F-37044 Tours, France; [Ouldamer, Lobna; Goupille, Caroline; Chevalier, Stephan; Bougnoux, Philippe] INSERM, UMR1069, 10 Blvd Tonnelle, F-37044 Tours, France; [Ouldamer, Lobna; Goupille, Caroline; Body, Gilles; Chevalier, Stephan; Cottier, Jean Philippe; Bougnoux, Philippe] Univ Tours, 10 Blvd Tonnelle, F-37044 Tours, France; [Vilde, Anne; Cottier, Jean Philippe] Ctr Hosp Reg Univ Tours, Dept Radiol, Hop Bretonneau, 2 Blvd Tonnelle, F-37044 Tours, France; [Arbion, Flavie] Ctr Hosp Reg Univ Tours, Dept Pathol, Hop Bretonneau, 2 Blvd Tonnelle, F-37044 Tours, France; [Cottier, Jean Philippe] INSERM, UMR930, 10 Blvd Tonnelle, F-37044 Tours, France; [Bougnoux, Philippe] Ctr Hosp Reg Univ Tours, Dept Oncol, Hop Bretonneau, 2 Blvd Tonnelle, F-37044 Tours, France	CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours	Ouldamer, L (corresponding author), CHU Tours, Hop Bretonneau, Dept Gynecol, 2 Blvd Tonnelle, F-37044 Tours, France.; Ouldamer, L (corresponding author), INSERM, UMR1069, 10 Blvd Tonnelle, F-37044 Tours, France.; Ouldamer, L (corresponding author), Univ Tours, 10 Blvd Tonnelle, F-37044 Tours, France.	l.ouldamer@chu-tours.fr	Goupille, Caroline/AAC-3339-2022; Ouldamer, Lobna/I-2062-2016; Cottier, Jean-Philippe/AAZ-6005-2021	Goupille, Caroline/0000-0002-0177-0926; Chevalier, Stephan/0000-0001-5689-2034; Cottier, Jean-Philippe/0000-0001-9166-212X; Bougnoux, Philippe/0000-0002-8717-055X	Ligue nationale contre le cancer (Comite Departemental d'Indre et Loire)	Ligue nationale contre le cancer (Comite Departemental d'Indre et Loire)	We thank Dr Iris Kellal and Dr Aymeric Saint Hilaire for their contributions to the clinical study, Violetta Guerin for technical help and Region Centre (Lipid project of ARD 2020, biomedicaments) and the Ligue nationale contre le cancer (Comite Departemental d'Indre et Loire) for their support.	Aberg UWN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025720; Anderson BM, 2014, APPL PHYSIOL NUTR ME, V39, P699, DOI 10.1139/apnm-2013-0365; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; Barascu A, 2006, INT J BIOCHEM CELL B, V38, P196, DOI 10.1016/j.biocel.2005.08.015; BEYNEN AC, 1980, AM J CLIN NUTR, V33, P81, DOI 10.1093/ajcn/33.1.81; BOUGNOUX P, 1994, BRIT J CANCER, V70, P330, DOI 10.1038/bjc.1994.302; Chen Z, 2014, ONCOGENE, V33, P4548, DOI 10.1038/onc.2013.402; Chenais B, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/712536; Delort L, 2015, LIFE SCI; Djuric Z, 2012, BREAST, V21, P608, DOI 10.1016/j.breast.2012.02.003; Duraker N, 2014, BREAST J, V20, P61, DOI 10.1111/tbj.12205; Erickson KL, 2010, PROSTAG LEUKOTR ESS, V82, P237, DOI 10.1016/j.plefa.2010.02.019; Fabian CJ, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0571-6; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Jiang WQ, 2012, CANCER RES, V72, P3795, DOI 10.1158/0008-5472.CAN-12-1047; Kanumuri P, 2015, ANN SURG ONCOL, V22, P2475, DOI 10.1245/s10434-015-4430-6; LHUILLERY C, 1995, NUTR CANCER, V24, P299, DOI 10.1080/01635589509514419; Lynch SP, 2013, ONCOLOGIST, V18, P1167, DOI 10.1634/theoncologist.2013-0167; Merendino N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/310186; Nicol CJ, 2004, CARCINOGENESIS, V25, P1747, DOI 10.1093/carcin/bgh160; Panis C, 2012, BREAST CANCER RES TR, V133, P881, DOI 10.1007/s10549-011-1851-1; Senkus E, 2013, ANN ONCOL, V24, P7, DOI 10.1093/annonc/mdt284; Touvier M, 2012, AM J CLIN NUTR, V95, P944, DOI 10.3945/ajcn.111.027805; Vaughan VC, 2013, BRIT J CANCER, V108, P486, DOI 10.1038/bjc.2012.586; Vera-Badillo FE, 2014, BREAST CANCER RES TR, V146, P235, DOI 10.1007/s10549-014-3018-3; Wannous R, 2013, BBA-MOL CELL BIOL L, V1831, P1618, DOI 10.1016/j.bbalip.2013.07.010; Wei N, 2008, NUTR CANCER, V60, P810, DOI 10.1080/01635580802192858; Witte TR, 2015, LIPIDS, V50, P437, DOI 10.1007/s11745-015-4011-2; Wojcik C, 2014, J CELL MOL MED, V18, P590, DOI 10.1111/jcmm.12194; Yee LD, 2010, AM J CLIN NUTR, V91, P1185, DOI 10.3945/ajcn.2009.29036	31	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147148	10.1371/journal.pone.0147148	http://dx.doi.org/10.1371/journal.pone.0147148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812254	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528000021
J	Tomas-Gamisans, M; Ferrer, P; Albiol, J				Tomas-Gamisans, Marius; Ferrer, Pau; Albiol, Joan			Integration and Validation of the Genome-Scale Metabolic Models of Pichia pastoris: A Comprehensive Update of Protein Glycosylation Pathways, Lipid and Energy Metabolism	PLOS ONE			English	Article							CYANIDE-RESISTANT RESPIRATION; FATTY-ACID SYNTHESIS; YEAST SACCHAROMYCES-CEREVISIAE; N-LINKED OLIGOSACCHARIDES; ACYL-COA SYNTHETASE; METHYLOTROPHIC YEAST; KLUYVEROMYCES-LACTIS; FLUX ANALYSIS; HETEROLOGOUS PROTEINS; PRODUCTION HOST	Motivation Genome-scale metabolic models (GEMs) are tools that allow predicting a phenotype from a genotype under certain environmental conditions. GEMs have been developed in the last ten years for a broad range of organisms, and are used for multiple purposes such as discovering new properties of metabolic networks, predicting new targets for metabolic engineering, as well as optimizing the cultivation conditions for biochemicals or recombinant protein production. Pichia pastoris is one of the most widely used organisms for heterologous protein expression. There are different GEMs for this methylotrophic yeast of which the most relevant and complete in the published literature are iPP668, PpaMBEL1254 and iLC915. However, these three models differ regarding certain pathways, terminology for metabolites and reactions and annotations. Moreover, GEMs for some species are typically built based on the reconstructed models of related model organisms. In these cases, some organism-specific pathways could be missing or misrepresented. Results In order to provide an updated and more comprehensive GEM for P. pastoris, we have reconstructed and validated a consensus model integrating and merging all three existing models. In this step a comprehensive review and integration of the metabolic pathways included in each one of these three versions was performed. In addition, the resulting iMT1026 model includes a new description of some metabolic processes. Particularly new information described in recently published literature is included, mainly related to fatty acid and sphingolipid metabolism, glycosylation and cell energetics. Finally the reconstructed model was tested and validated, by comparing the results of the simulations with available empirical physiological datasets results obtained from a wide range of experimental conditions, such as different carbon sources, distinct oxygen availability conditions, as well as producing of two different recombinant proteins. In these simulations, the iMT1026 model has shown a better performance than the previous existing models.	[Tomas-Gamisans, Marius; Ferrer, Pau; Albiol, Joan] Univ Autonoma Barcelona, Dept Engn Quim Biol & Ambiental, E-08193 Barcelona, Spain	Autonomous University of Barcelona	Albiol, J (corresponding author), Univ Autonoma Barcelona, Dept Engn Quim Biol & Ambiental, E-08193 Barcelona, Spain.	joan.albiol@uab.cat	Tomàs-Gamisans, Màrius/B-4136-2016; Sala, Joan Albiol/A-8280-2008; Tomàs-Gamisans, Màrius/AAG-8539-2020; Ferrer, Pau/A-4147-2009; Albiol, Joan/Z-5173-2019	Tomàs-Gamisans, Màrius/0000-0002-6076-6716; Sala, Joan Albiol/0000-0001-5626-429X; Tomàs-Gamisans, Màrius/0000-0002-6076-6716; Ferrer, Pau/0000-0002-5287-4127; Albiol, Joan/0000-0001-5626-429X	Spanish Ministry of Economy and Competitiveness [CTQ2013-42391-R]; Spanish Ministry of Education, Culture and Sport [FPU12/06185]; ERA-IB IPCRES network (Integrated Process and Cell Refactoring Systems for Enhanced Industrial Biotechnology)	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Education, Culture and Sport(Spanish Government); ERA-IB IPCRES network (Integrated Process and Cell Refactoring Systems for Enhanced Industrial Biotechnology)	This work was supported by the project CTQ2013-42391-R of the Spanish Ministry of Economy and Competitiveness and the grant FPU12/06185 (M.T.) of the Spanish Ministry of Education, Culture and Sport. Also the authors would like to acknowledge partial support from the ERA-IB IPCRES network (Integrated Process and Cell Refactoring Systems for Enhanced Industrial Biotechnology - http://www.era-ib.net/ipcres). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002980; Aguilera-Romero A, 2014, BBA-MOL CELL BIOL L, V1841, P647, DOI 10.1016/j.bbalip.2013.10.014; Aung Hnin W, 2013, Ind Biotechnol (New Rochelle N Y), V9, P215; Balagurunathan B, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-27; Baumann K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-141; Bernard T, 2014, BRIEF BIOINFORM, V15, P123, DOI 10.1093/bib/bbs058; Borgel D, 2012, METAB ENG, V14, P412, DOI 10.1016/j.ymben.2012.03.003; Boghigian BA, 2010, METAB ENG, V12, P81, DOI 10.1016/j.ymben.2009.10.004; Bridges HR, 2010, MOL CELL PROTEOMICS, V9, P2318, DOI 10.1074/mcp.M110.001255; Bridges HR, 2009, BIOCHEM J, V422, P151, DOI 10.1042/BJ20090492; Buchel F, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-116; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Carnicer M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-83; Carnicer M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-65; Caspeta L, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-24; Caspeta L, 2013, BIOTECHNOL J, V8, P534, DOI 10.1002/biot.201200345; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Cereghino GPL, 2002, CURR OPIN BIOTECH, V13, P329, DOI 10.1016/S0958-1669(02)00330-0; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Chelliah V, 2015, NUCLEIC ACIDS RES, V43, pD542, DOI 10.1093/nar/gku1181; Chen Y, 2013, CURR OPIN BIOTECH, V24, P965, DOI 10.1016/j.copbio.2013.03.008; Cheng HR, 2014, APPL MICROBIOL BIOT, V98, P3539, DOI 10.1007/s00253-013-5501-x; Cheon SA, 2012, MOL MICROBIOL, V83, P728, DOI 10.1111/j.1365-2958.2011.07961.x; Cheung CYM, 2013, PLANT J, V75, P1050, DOI 10.1111/tpj.12252; Chung BKS, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-50; Chung BKS, 2013, APPL MICROBIOL BIOT, V97, P1865, DOI 10.1007/s00253-013-4702-7; Chung BK-S, 2012, THESIS NATL U SINGAP; Cos O, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-17; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Degtyarenko K, 2008, NUCLEIC ACIDS RES, V36, pD344, DOI 10.1093/nar/gkm791; Delic M, 2013, FEMS MICROBIOL REV, V37, P872, DOI 10.1111/1574-6976.12020; Dias O, 2014, BIOTECHNOL J, V9, P776, DOI 10.1002/biot.201300242; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dikicioglu D, 2014, TRENDS BIOTECHNOL, V32, P397, DOI 10.1016/j.tibtech.2014.05.003; Dobson PD, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-145; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Ejsing CS, 2006, J MASS SPECTROM, V41, P372, DOI 10.1002/jms.997; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Fonseca C, 2008, APPL ENVIRON MICROB, V74, P1845, DOI 10.1128/AEM.02453-07; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gasser B, 2006, BIOTECHNOL BIOENG, V94, P353, DOI 10.1002/bit.20851; Gasser B, 2013, FUTURE MICROBIOL, V8, P191, DOI [10.2217/fmb.12.133, 10.2217/FMB.12.133]; Goepfert S, 2007, CURR OPIN PLANT BIOL, V10, P245, DOI 10.1016/j.pbi.2007.04.007; Gonzalez-Barroso MM, 2006, YEAST, V23, P307, DOI 10.1002/yea.1355; Gopalakrishnan S, 2015, METAB ENG, V32, P12, DOI 10.1016/j.ymben.2015.08.006; Govindappa N, 2013, PROTEIN EXPRES PURIF, V88, P164, DOI 10.1016/j.pep.2012.12.009; Grillitsch K, 2014, BBA-BIOMEMBRANES, V1838, P1889, DOI 10.1016/j.bbamem.2014.03.012; GRINNA LS, 1989, YEAST, V5, P107, DOI 10.1002/yea.320050206; Guerra G, 2002, BIOCHEM MOL BIOL EDU, V30, P363, DOI 10.1002/bmb.2002.494030060133; Gurvitz A, 2001, J BIOL CHEM, V276, P895, DOI 10.1074/jbc.M003305200; Heavner BD, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat059; Heavner BD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-55; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Heyland J, 2010, BIOTECHNOL BIOENG, V107, P357, DOI 10.1002/bit.22836; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Hirose M, 2002, YEAST, V19, P1191, DOI 10.1002/yea.914; Gonzalez-Siso MI, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-46; Jahic M, 2006, BIOTECHNOL PROGR, V22, P1465, DOI 10.1021/bp060171t; Jorda J, 2014, NEW BIOTECHNOL, V31, P120, DOI 10.1016/j.nbt.2013.06.007; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kannan V, 2009, RAPID COMMUN MASS SP, V23, P1035, DOI 10.1002/rcm.3965; Kern A, 2007, MICROBIOL-SGM, V153, P1250, DOI 10.1099/mic.0.2006/001404-0; Kim TY, 2012, CURR OPIN BIOTECH, V23, P617, DOI 10.1016/j.copbio.2011.10.007; Klug L, 2014, BBA-MOL CELL BIOL L, V1841, P215, DOI 10.1016/j.bbalip.2013.11.005; Koivistoinen OM, 2012, GENE, V492, P177, DOI 10.1016/j.gene.2011.10.031; Koury MJ, 2003, TRENDS BIOTECHNOL, V21, P459, DOI 10.1016/j.tibtech.2003.09.005; Kuberl A, 2011, J BIOTECHNOL, V154, P312, DOI 10.1016/j.jbiotec.2011.04.014; Kursu VAS, 2013, MOL MICROBIOL, V90, P824, DOI 10.1111/mmi.12402; Kurtzman CP, 2009, J IND MICROBIOL BIOT, V36, P1435, DOI 10.1007/s10295-009-0638-4; Kurtzman CP, 2005, INT J SYST EVOL MICR, V55, P973, DOI 10.1099/ijs.0.63491-0; Lee SY, 2005, TRENDS BIOTECHNOL, V23, P349, DOI 10.1016/j.tibtech.2005.05.003; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Li PF, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0206-8; Lin-Cereghino Joan, 2007, V389, P11; Liu YF, 2015, APPL MICROBIOL BIOT, V99, P1109, DOI 10.1007/s00253-014-6298-y; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Corchero JL, 2013, BIOTECHNOL ADV, V31, P140, DOI 10.1016/j.biotechadv.2012.09.001; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Mattanovich D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-29; Mazat JP, 2013, IUBMB LIFE, V65, P171, DOI 10.1002/iub.1138; Minning S, 1998, J BIOTECHNOL, V66, P147, DOI 10.1016/S0168-1656(98)00142-4; Monk J, 2014, NAT BIOTECHNOL, V32, P447, DOI 10.1038/nbt.2870; Montesino R, 1998, PROTEIN EXPRES PURIF, V14, P197, DOI 10.1006/prep.1998.0933; Nakagawa T, 2000, J BIOL CHEM, V275, P3455, DOI 10.1074/jbc.275.5.3455; Naumov GI, 2013, ANTON LEEUW INT J G, V104, P339, DOI 10.1007/s10482-013-9956-7; Nett JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068325; Nicholls DG, 2003, BIOENERGETICS, P89, DOI [10.1016/B978-012518121-1/50007-5, DOI 10.1016/B978-012518121-1/50007-5]; Nocon J, 2014, METAB ENG, V24, P129, DOI 10.1016/j.ymben.2014.05.011; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Obermeyer T, 2007, J LIPID RES, V48, P2354, DOI 10.1194/jlr.M700300-JLR200; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Osterlund T, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-36; Osterlund T, 2012, BIOTECHNOL ADV, V30, P979, DOI 10.1016/j.biotechadv.2011.07.021; Petersen J, 2012, P NATL ACAD SCI USA, V109, P11150, DOI 10.1073/pnas.1202799109; PIRT SJ, 1982, ARCH MICROBIOL, V133, P300, DOI 10.1007/BF00521294; Pitkanen E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003465; Potvin G, 2012, BIOCHEM ENG J, V64, P91, DOI 10.1016/j.bej.2010.07.017; Prielhofer R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1393-8; Rebnegger C, 2014, BIOTECHNOL J, V9, P511, DOI 10.1002/biot.201300334; Rich JR, 2009, NAT CHEM BIOL, V5, P206, DOI 10.1038/nchembio.148; Roca C, 2012, PROCESS BIOCHEM, V47, P1670, DOI 10.1016/j.procbio.2012.04.004; Nicolas R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-79; Rottensteiner H, 2006, BBA-MOL CELL RES, V1763, P1527, DOI 10.1016/j.bbamcr.2006.08.012; Saha R, 2014, CURR OPIN BIOTECH, V29, P39, DOI 10.1016/j.copbio.2014.02.011; Sauls JT, 2014, BIOINFORMATICS, V30, P1036, DOI 10.1093/bioinformatics/btt747; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; SCORER CA, 1993, GENE, V136, P111, DOI 10.1016/0378-1119(93)90454-B; Sohn SB, 2010, BIOTECHNOL J, V5, P705, DOI 10.1002/biot.201000078; Sola A, 2004, EUR J BIOCHEM, V271, P2462, DOI 10.1111/j.1432-1033.2004.04176.x; Sola A, 2007, MICROBIOL-SGM, V153, P281, DOI 10.1099/mic.0.29263-0; Stadlmayr G, 2010, J BIOTECHNOL, V150, P519, DOI 10.1016/j.jbiotec.2010.09.957; Stephanopoulos G, 1998, REV CELLULAR METABOL, P21, DOI [10.1016/B978-012666260-3/50003-0, DOI 10.1016/B978-012666260-3/50003-0]; Takakuwa N, 2008, FEMS YEAST RES, V8, P839, DOI 10.1111/j.1567-1364.2008.00407.x; Tarrio N, 2006, FEMS YEAST RES, V6, P371, DOI 10.1111/j.1567-1364.2005.00021.x; Tarrio N, 2005, BBA-BIOENERGETICS, V1707, P199, DOI 10.1016/j.bbabio.2004.12.008; Tarrio N, 2006, BBA-BIOENERGETICS, V1757, P1476, DOI 10.1016/j.bbabio.2006.09.002; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Ternes P, 2006, J BIOL CHEM, V281, P5582, DOI 10.1074/jbc.M512864200; Ternes P, 2011, J BIOL CHEM, V286, P11401, DOI 10.1074/jbc.M110.193094; Theodoulou FL, 2006, FEBS LETT, V580, P1139, DOI 10.1016/j.febslet.2005.12.095; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; van Roermund CWT, 2012, J BIOL CHEM, V287, P20144, DOI 10.1074/jbc.M111.332833; van Roermund CWT, 2001, MOL CELL BIOL, V21, P4321, DOI 10.1128/MCB.21.13.4321-4329.2001; Veiga A, 2000, FEMS MICROBIOL LETT, V190, P93, DOI 10.1111/j.1574-6968.2000.tb09268.x; Veiga A, 2003, FEMS YEAST RES, V3, P141, DOI 10.1016/S1567-1356(02)00189-7; Veiga A, 2003, FEMS YEAST RES, V3, P239, DOI 10.1016/S1567-1356(03)00036-9; VERDUYN C, 1991, ANTON LEEUW INT J G, V60, P325, DOI 10.1007/BF00430373; VERDUYN C, 1991, ANTON LEEUW INT J G, V59, P49, DOI 10.1007/BF00582119; Vervecken W, 2004, APPL ENVIRON MICROB, V70, P2639, DOI 10.1128/AEM.70.5.2639-2646.2004; Visser WF, 2007, BIOCHEM J, V401, P365, DOI 10.1042/BJ20061352; Watanabe S, 2008, J BIOL CHEM, V283, P20372, DOI 10.1074/jbc.M801065200; Watkins PA, 1998, J BIOL CHEM, V273, P18210, DOI 10.1074/jbc.273.29.18210; Watkins PA, 2012, BBA-MOL BASIS DIS, V1822, P1411, DOI 10.1016/j.bbadis.2012.02.010; Weinhandl K, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-5; Wikstrom M, 2012, P NATL ACAD SCI USA, V109, P4431, DOI 10.1073/pnas.1120949109; WONG B, 1993, J BACTERIOL, V175, P6314, DOI 10.1128/JB.175.19.6314-6320.1993; Zou ZY, 2003, J BIOL CHEM, V278, P16414, DOI 10.1074/jbc.M210557200	148	36	36	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0148031	10.1371/journal.pone.0148031	http://dx.doi.org/10.1371/journal.pone.0148031			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812499	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528000071
J	Adler, PH; Kudelova, T; Kudela, M; Seitz, G; Ignjatovic-Cupina, A				Adler, Peter H.; Kudelova, Tatiana; Kudela, Matus; Seitz, Gunther; Ignjatovic-Cupina, Aleksandra			Cryptic Biodiversity and the Origins of Pest Status Revealed in the Macrogenome of Simulium colombaschense (Diptera: Simuliidae), History's Most Destructive Black Fly	PLOS ONE			English	Article							SPECIES GROUP DIPTERA; CYTOLOGICAL DESCRIPTION; FLIES DIPTERA; HABITAT; SYSTEMATICS; FEEDERS; LARVAE; GENES; RIVER	The European black fly Simulium (Simulium) colombaschense (Scopoli), once responsible for as many as 22,000 livestock deaths per year, is chromosomally mapped, permitting its evolutionary relationships and pest drivers to be inferred. The species is 12 fixed inversions removed from the standard sequence of the subgenus Simulium. Three of these fixed inversions, 38 autosomal polymorphisms, and a complex set of 12 X and 6 Y chromosomes in 29 zygotic combinations uniquely characterize S. colombaschense and reveal 5 cytoforms: 'A' in the Danube watershed, 'B' in Italy's Adige River, 'C' in the Aliakmonas River of Greece, 'D' in the Aoos drainage in Greece, and 'E' in the Bela River of Slovakia. 'C' and 'D' are reproductively isolated from one another, and 'B' is considered a cytotype of 'A,' the probable name bearer of colombaschense. The species status of 'E' cannot be determined without additional collections. Three derived polytene sequences, based on outgroup comparisons, place S. colombaschense in a clade of species composed of the S. jenningsi, S. malyschevi, and S. reptans species groups. Only cytoforms 'A' and 'B' are pests. Within the Simuliidae, pest status is reached through one of two principal pathways, both of which promote the production of large populations of blood-seeking flies: (1) colonization of the world's largest rivers (habitat specialization) or (2) colonization of multiple habitat types (habitat generalization). Evolutionary acquisition of the ability to colonize large rivers by an ancestor of the S. jenningsi-malyschevi-reptans clade set the scene for the pest status of S. colombaschense and other big-river members of the clade. In an ironic twist, the macrogenome of S. colombaschense reveals that the name associated with history's worst simuliid pest represents a complex of species, two or more of which are nonpests potentially vulnerable to loss of their limited habitat.	[Adler, Peter H.] Clemson Univ, Dept Agr & Environm Sci, Clemson, SC USA; [Kudelova, Tatiana; Kudela, Matus] Comenius Univ, Dept Zool, Bratislava, Slovakia; [Seitz, Gunther] Dist Govt Lower Bavaria, Landshut, Germany; [Ignjatovic-Cupina, Aleksandra] Univ Novi Sad, Fac Agr, Dept Environm & Plant Protect, Novi Sad 21000, Serbia	Clemson University; Comenius University Bratislava; University of Novi Sad	Adler, PH (corresponding author), Clemson Univ, Dept Agr & Environm Sci, Clemson, SC USA.	padler@clemson.edu		Ignjatovic Cupina, Aleksandra/0000-0001-7045-6896	National Science Foundation [DEB-0841636]; VEGA of the Ministry of Education of the Slovak Republic [1/0561/14]; Slovak Research and Development Agency [APVV-0436-12]; Ministry of Science, Education and Technological Development, Republic of Serbia [TR31084, III43007]; National Institute of Food and Agriculture/United States Department of Agriculture [SC-1700433]; EurNegVec COST Action [TD1303]; Clemson University Experiment Station [SC-1700433, 6348]	National Science Foundation(National Science Foundation (NSF)); VEGA of the Ministry of Education of the Slovak Republic; Slovak Research and Development Agency(Slovak Research and Development Agency); Ministry of Science, Education and Technological Development, Republic of Serbia; National Institute of Food and Agriculture/United States Department of Agriculture(United States Department of Agriculture (USDA)); EurNegVec COST Action(European Cooperation in Science and Technology (COST)); Clemson University Experiment Station	This work was funded, in part, by National Science Foundation (http://www.nsf.gov/) award DEB-0841636 to PHA under the American Recovery and Reinvestment Act of 2009; VEGA grant no. 1/0561/14 of the Ministry of Education of the Slovak Republic (http://www.minedu.sk/) to MK; Slovak Research and Development Agency (http://www.apvv.sk/) under contract No. APVV-0436-12 to MK; and the Ministry of Science, Education and Technological Development, Republic of Serbia (http://www.mpn.gov.rs/) under Project Nos. TR31084 and III43007 to AIC. The work of PHA also was supported in part by the National Institute of Food and Agriculture/United States Department of Agriculture (http://nifa.usda.gov/) linked to project number SC-1700433, and the work of AIC also was supported in part by EurNegVec COST Action TD1303 (http://www.cost.eu/COST_Actions/bmbs/TD1303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sasa Nestorovic, guardian of the Iron Gate National Park, for assistance in interpretation of the Serbian and Walachian legends of the Golubatz fly, including the tale of St. George and the dragon. We thank C. E. Beard for scanning the photographic negatives of the chromosomes and A. G. Wheeler for helpful comments on the manuscript. This is Technical Contribution No. 6348 of the Clemson University Experiment Station, linked to project number SC-1700433.	Adler P. H., 2015, WORLD BLACKFLIES DIP; Adler Peter H., 2005, P127; Adler PH, 2011, CAN ENTOMOL, V143, P612, DOI 10.4039/n11-035; Adler PH, 2010, INFECT GENET EVOL, V10, P846, DOI 10.1016/j.meegid.2010.07.003; Adler Peter H., 2009, P189; Adler PH, 2001, CAN J ZOOL, V79, P1972, DOI 10.1139/cjz-79-11-1972; Adler PH, 2004, BLACK FLIES SIMULIID; AMRINE JW, 1982, W V U AGR FOR EXP ST, V678, P1; ANDERSON JR, 1987, CAN ENTOMOL, V119, P29, DOI 10.4039/Ent11929-1; BEDO DG, 1975, CAN J ZOOL, V53, P1147, DOI 10.1139/z75-134; BOOBAR LR, 1980, ENVIRON ENTOMOL, V9, P412, DOI 10.1093/ee/9.4.412; Bruderova T, 2012, 5 INT SIM S 3 7 SEPT, P7; Bruderova Tatiana, 2012, Folia Faunistica Slovaca, V17, P133; Charalambous M, 1996, MED VET ENTOMOL, V10, P111, DOI 10.1111/j.1365-2915.1996.tb00716.x; Cheke RA, 2008, MED VET ENTOMOL, V22, P172, DOI 10.1111/j.1365-2915.2008.00725.x; CIADAMIDARO S, 2013, BR SIMULIID GROU JUL, P4; Cianchi R, 1986, Ann Ist Super Sanita, V22, P365; CIUREA T., 1924, Annals of Tropical Medicine and Parasitology, V18, P323; Conflitti IM, 2012, SYST ENTOMOL, V37, P571, DOI 10.1111/j.1365-3113.2012.00629.x; CROSSKEY R.W., 1990, NEW TAXONOMIC GEOGRA; Crosskey R.W., 1990, NATURAL HIST BLACKFL; FREDEEN F J H, 1985, Quaestiones Entomologicae, V21, P175; FREDEEN F J H, 1977, Quaestiones Entomologicae, V13, P219; FREDEEN F J H, 1969, Quaestiones Entomologicae, V5, P341; Fredeen F.J.H., 1958, P 10 INT C ENT MONTR, V3, P819; Garms R, 1988, BLACK FLIES ECOLOGY, P201; Hamada N, 1999, SYST ENTOMOL, V24, P273, DOI 10.1046/j.1365-3113.1999.00080.x; Hunter FF, 2000, J INSECT BEHAV, V13, P585, DOI 10.1023/A:1007871820796; Ignjatovic-Cupina A, 2010, BILJNI LEKAR NOVISAD, VXXXVIII, P208; Ignjatovic-Cupinai A., 2006, Acta Entomologica Serbica, P97; Jedlicka L., 1982, Acta Entomologica Bohemoslovaca, V79, P396; Jedlicka Ladislav, 2008, Lauterbornia, V62, P93; Karadzic VS, 1867, ZIVOT OBICAJI NARODA; Kirk H, 2013, EVOL APPL, V6, P842, DOI 10.1111/eva.12071; LANDAU R, 1962, CAN J ZOOLOG, V40, P921, DOI 10.1139/z62-082; Malmqvist B, 1999, AQUAT INSECT, V21, P89, DOI 10.1076/aqin.21.2.89.4534; Malmqvist B, 2004, P ROY SOC B-BIOL SCI, V271, pS152, DOI 10.1098/rsbl.2003.0120; Malmqvist B, 2001, OIKOS, V92, P35, DOI 10.1034/j.1600-0706.2001.920105.x; MASON GF, 1982, CAN J ZOOL, V60, P292, DOI 10.1139/z82-039; MULLA M S, 1976, Proceedings and Papers of the Annual Conference of the California Mosquito Control Association, V44, P130; Papanicolaou A, 2013, INSECT BIOCHEM MOLEC, V43, P1181, DOI 10.1016/j.ibmb.2013.09.008; PASTERNAK J, 1964, CAN J ZOOLOG, V42, P135, DOI 10.1139/z64-013; POST RJ, 1982, HEREDITY, V48, P85, DOI 10.1038/hdy.1982.9; Pramual P, 2015, J ASIA-PAC ENTOMOL, V18, P33, DOI 10.1016/j.aspen.2014.11.002; PROCUNIER WS, 1982, CAN J ZOOL, V60, P2852, DOI 10.1139/z82-364; RICHARDSON JS, 1991, OIKOS, V62, P370, DOI 10.2307/3545503; Rios-Velasquez C, 2002, INSECT SYST EVOL, V33, P113, DOI 10.1163/187631202X00082; Rivosecchi L, 1984, Ann Ist Super Sanita, V20, P377; Rivosecchi L., 1978, Fauna d'Italia, V13, P1; Rivosecchi L., 1965, Rivista di Parassitologia Roma, V26, P31; Rivosecchi L., 1961, Parassitologia, V3, P199; Rivosecchi L, 2007, QUAD MUS TRIDENTINO, V2, P1; Rivosecchi Leo, 2005, Annali dell'Istituto Superiore di Sanita, V41, P415; ROTHFELS K, 1989, GENOME, V32, P500, DOI 10.1139/g89-475; ROTHFELS K, 1978, CAN J ZOOL, V56, P1110, DOI 10.1139/z78-155; ROTHFELS K. H., 1953, CANADIAN JOUR ZOOL, V31, P226, DOI 10.1139/z53-020; Rothfels K.H., 1980, Symposia of the Royal Entomological Society of London, P207; Rothfels K.H., 1981, APPL GENETICS CYTOLO, P67; Rubtsov IA, 1956, FAUNA USSR NEW SERIE, V6; Ruiz-Arrondo I, 2014, SEA, V54, P193; Sariozkan Savas, 2014, Turkiye Parazitoloji Dergisi, V38, P116, DOI 10.5152/tpd.2014.3446; Schonbauer JA, 1795, GESCH SCHADLICHEN KO; Senatore GL, 2014, MOL PHYLOGENET EVOL, V75, P138, DOI 10.1016/j.ympev.2014.02.018; SHELLEY AJ, 2010, AQUATIC BIODIVERSITY, V6; Sherban EN, 1960, REV BIOL ACAD REPUB, V5, P145; Tangkawanit U, 2009, ZOOL J LINN SOC-LOND, V155, P289, DOI 10.1111/j.1096-3642.2008.00433.x; Thompson FC, 2001, ENTOMOL NEWS, V112, P125; Werner D, 2005, ABHANDLUNGEN BERICHT, V27, P205; Zanin E, 1983, ATTI SOC ITAL BUIATR, V15, P513; Zhang YX, 1996, BIOL J LINN SOC, V59, P261; Zhang YX, 1998, J APPL ECOL, V35, P673, DOI 10.1046/j.1365-2664.1998.355345.x; ZIVKOVIC V, 1975, Acta Veterinaria (Belgrade), V25, P279; Zivkovic V, 1955, ACAD SERBE SCI MONOG, V245, P1	73	24	24	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147673	10.1371/journal.pone.0147673	http://dx.doi.org/10.1371/journal.pone.0147673			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808274	Green Submitted, gold, Green Published			2022-12-26	WOS:000369527800174
J	Ahnaou, A; Biermans, R; Drinkenburg, WH				Ahnaou, Abdallah; Biermans, Ria; Drinkenburg, Wilhelmus H.			Modulation of mGlu2 Receptors, but Not PDE10A Inhibition Normalizes Pharmacologically-Induced Deviance in Auditory Evoked Potentials and Oscillations in Conscious Rats	PLOS ONE			English	Article							PHOSPHODIESTERASE 10A INHIBITORS; EVENT-RELATED POTENTIALS; PREPULSE INHIBITION; ACOUSTIC STARTLE; GATING DEFICITS; SCHIZOPHRENIA; P50; GLUTAMATE; DOPAMINE; AGONIST	Improvement of cognitive impairments represents a high medical need in the development of new antipsychotics. Aberrant EEG gamma oscillations and reductions in the P1/N1 complex peak amplitude of the auditory evoked potential (AEP) are neurophysiological biomarkers for schizophrenia that indicate disruption in sensory information processing. Inhibition of phosphodiesterase (i.e. PDE10A) and activation of metabotropic glutamate receptor (mGluR2) signaling are believed to provide antipsychotic efficacy in schizophrenia, but it is unclear whether this occurs with cognition-enhancing potential. The present study used the auditory paired click paradigm in passive awake Sprague Dawley rats to 1) model disruption of AEP waveforms and oscillations as observed in schizophrenia by peripheral administration of amphetamine and the N-methyl-D-aspartate (NMDA) antagonist phencyclidine (PCP); 2) confirm the potential of the antipsychotics risperidone and olanzapine to attenuate these disruptions; 3) evaluate the potential of mGluR2 agonist LY404039 and PDE10 inhibitor PQ-10 to improve AEP deficits in both the amphetamine and PCP models. PCP and amphetamine disrupted auditory information processing to the first click, associated with suppression of the P1/N1 complex peak amplitude, and increased cortical gamma oscillations. Risperidone and olanzapine normalized PCP and amphetamine-induced abnormalities in AEP waveforms and aberrant gamma/alpha oscillations, respectively. LY404039 increased P1/N1 complex peak amplitudes and potently attenuated the disruptive effects of both PCP and amphetamine on AEPs amplitudes and oscillations. However, PQ-10 failed to show such effect in either models. These outcomes indicate that modulation of the mGluR2 results in effective restoration of abnormalities in AEP components in two widely used animal models of psychosis, whereas PDE10A inhibition does not.	[Ahnaou, Abdallah; Biermans, Ria; Drinkenburg, Wilhelmus H.] Dept Neurosci Janssen Res & Dev, Div Janssen Pharmaceut NV A, Turnhoutseweg 30, B-2340 Beerse, Belgium	Johnson & Johnson; Janssen Pharmaceuticals	Ahnaou, A (corresponding author), Dept Neurosci Janssen Res & Dev, Div Janssen Pharmaceut NV A, Turnhoutseweg 30, B-2340 Beerse, Belgium.	aahnaou@its.jnj.com			Janssen Research Development	Janssen Research Development	The authors received no specific funding for this work. All authors are employed by Janssen Research & Development. Janssen Research & Development provided support in the form of salaries for authors [AA, RB and WD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ADLER LE, 1982, BIOL PSYCHIAT, V17, P639; ADLER LE, 1986, BIOL PSYCHIAT, V21, P787, DOI 10.1016/0006-3223(86)90244-1; Adler LE, 2004, AM J PSYCHIAT, V161, P1822, DOI 10.1176/appi.ajp.161.10.1822; Baldeweg T, 1998, LANCET, V352, P620, DOI 10.1016/S0140-6736(05)79575-1; Barch DM, 2012, TRENDS COGN SCI, V16, P27, DOI 10.1016/j.tics.2011.11.015; Blumenfeld LD, 2001, CLIN NEUROPHYSIOL, V112, P1650, DOI 10.1016/S1388-2457(01)00604-6; Boutros NN, 2009, SCHIZOPHR RES, V113, P339, DOI 10.1016/j.schres.2009.05.019; Boutros NN, 1999, BIOL PSYCHIAT, V45, P917, DOI 10.1016/S0006-3223(98)00253-4; Butler PD, 2005, CURR OPIN PSYCHIATR, V18, P151, DOI 10.1097/00001504-200503000-00008; Cadenhead KS, 2002, PSYCHIAT CLIN N AM, V25, P837, DOI 10.1016/S0193-953X(02)00021-7; Cadenhead KS, 2000, AM J PSYCHIAT, V157, P55, DOI 10.1176/ajp.157.1.55; Cartmell J, 1999, J PHARMACOL EXP THER, V291, P161; Cartmell J, 2000, PSYCHOPHARMACOLOGY, V148, P423, DOI 10.1007/s002130050072; Clementz BA, 2003, EUR J NEUROSCI, V18, P2853, DOI 10.1111/j.1460-9568.2003.03027.x; Clementz BA, 1997, BIOL PSYCHIAT, V41, P1035, DOI 10.1016/S0006-3223(96)00208-9; Connolly PM, 2003, BRAIN RES, V992, P85, DOI 10.1016/j.brainres.2003.08.035; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Cromwell HC, 2008, CLIN EEG NEUROSCI, V39, P69, DOI 10.1177/155005940803900209; CULLUM CM, 1993, SCHIZOPHR RES, V10, P131, DOI 10.1016/0920-9964(93)90048-N; DAVIS M, 1982, J NEUROSCI, V2, P791; de Bruin NMWJ, 1999, PSYCHOPHARMACOLOGY, V142, P9, DOI 10.1007/s002130050856; Dimpfel W, 2007, BRIT J PHARMACOL, V152, P538, DOI 10.1038/sj.bjp.0707427; DIMPFEL W, 1989, PSYCHOPHARMACOLOGY, V98, P297, DOI 10.1007/BF00451678; Ellenbroek BA, 2004, PSYCHOPHARMACOLOGY, V174, P65, DOI 10.1007/s00213-003-1684-7; Erwin RJ, 1998, SCHIZOPHR RES, V33, P157, DOI 10.1016/S0920-9964(98)00075-9; FREEDMAN R, 1983, BIOL PSYCHIAT, V18, P537; Galici R, 2005, J PHARMACOL EXP THER, V315, P1181, DOI 10.1124/jpet.105.091074; Gandal MJ, 2012, NEUROPHARMACOLOGY, V62, P1504, DOI 10.1016/j.neuropharm.2011.02.007; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; GRAHAM FK, 1975, PSYCHOPHYSIOLOGY, V12, P238, DOI 10.1111/j.1469-8986.1975.tb01284.x; Grauer SM, 2009, J PHARMACOL EXP THER, V331, P574, DOI 10.1124/jpet.109.155994; Gresack JE, 2014, PSYCHOPHARMACOLOGY, V231, P2189, DOI 10.1007/s00213-013-3371-7; Gruber T, 2005, CEREB CORTEX, V15, P109, DOI 10.1093/cercor/bhh113; Halene TB, 2008, J PHARMACOL EXP THER, V326, P230, DOI 10.1124/jpet.108.138586; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Hiyoshi T, 2014, J PHARMACOL EXP THER, V351, P642, DOI 10.1124/jpet.114.218651; Javitt DC, 2007, INT REV NEUROBIOL, V78, P69, DOI 10.1016/S0074-7742(06)78003-5; Javitt DC, 2000, ARCH GEN PSYCHIAT, V57, P1131, DOI 10.1001/archpsyc.57.12.1131; Johannesen JK, 2005, SCHIZOPHR RES, V78, P269, DOI 10.1016/j.schres.2005.05.022; JOHNSON MR, 1993, BIOL PSYCHIAT, V33, P380, DOI 10.1016/0006-3223(93)90328-B; Jones NC, 2012, INT J NEUROPSYCHOPH, V15, P657, DOI 10.1017/S1461145711000848; Joy B, 2004, PSYCHOPHARMACOLOGY, V174, P274, DOI 10.1007/s00213-003-1731-4; Kittelberger K, 2012, BRAIN STRUCT FUNCT, V217, P395, DOI 10.1007/s00429-011-0351-8; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Kocsis B, 2012, BIOL PSYCHIAT, V71, P987, DOI 10.1016/j.biopsych.2011.10.002; LACROIX D, 1995, PROG NEURO-PSYCHOPH, V19, P861, DOI 10.1016/0278-5846(95)00116-D; Lahti AC, 2001, NEUROPSYCHOPHARMACOL, V25, P455, DOI 10.1016/S0893-133X(01)00243-3; Laruelle M, 2003, ANN NY ACAD SCI, V1003, P138, DOI 10.1196/annals.1300.063; Lee KH, 2003, BRAIN RES REV, V41, P57, DOI 10.1016/S0165-0173(02)00220-5; Lewis DA, 2006, ARCH NEUROL-CHICAGO, V63, P1372, DOI 10.1001/archneur.63.10.1372; Light GA, 2000, BIOL PSYCHIAT, V47, P463, DOI 10.1016/S0006-3223(99)00280-2; Lijffijt M, 2009, PSYCHOPHYSIOLOGY, V46, P1059, DOI 10.1111/j.1469-8986.2009.00845.x; Ma JY, 2007, PSYCHOPHARMACOLOGY, V191, P961, DOI 10.1007/s00213-006-0667-x; Maxwell CR, 2004, NEUROPSYCHOPHARMACOL, V29, P739, DOI 10.1038/sj.npp.1300376; Maxwell CR, 2004, NEUROSCIENCE, V129, P101, DOI 10.1016/j.neuroscience.2004.07.038; Mazhari S, 2011, PSYCHIAT RES, V187, P317, DOI 10.1016/j.psychres.2011.01.003; Menniti FS, 2007, CURR OPIN INVESTIG D, V8, P54; Moreno JL, 2011, NEUROSCI LETT, V493, P76, DOI 10.1016/j.neulet.2011.01.046; Oranje B, 2006, PSYCHIAT RES, V143, P147, DOI 10.1016/j.psychres.2005.11.002; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Patterson JV, 2000, ARCH GEN PSYCHIAT, V57, P57, DOI 10.1001/archpsyc.57.1.57; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Phillips JM, 2007, NEUROSCIENCE, V144, P1314, DOI 10.1016/j.neuroscience.2006.11.003; Phillips WA, 2003, BEHAV BRAIN SCI, V26, P65, DOI 10.1017/S0140525X03000025; Pinault D, 2008, BIOL PSYCHIAT, V63, P730, DOI 10.1016/j.biopsych.2007.10.006; Reneerkens OAH, 2013, BEHAV BRAIN RES, V250, P251, DOI 10.1016/j.bbr.2013.05.014; Reneerkens OAH, 2013, BEHAV BRAIN RES, V236, P16, DOI 10.1016/j.bbr.2012.08.019; Rorick-Kehn LM, 2007, J PHARMACOL EXP THER, V321, P308, DOI 10.1124/jpet.106.110809; SALETU B, 1987, PHARMACOPSYCHIATRY, V20, P12, DOI 10.1055/s-2007-1017125; Schmidt CJ, 2008, J PHARMACOL EXP THER, V325, P681, DOI 10.1124/jpet.107.132910; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; SCHWARZKOPF SB, 1993, BIOL PSYCHIAT, V33, P815, DOI 10.1016/0006-3223(93)90023-7; Seeger TF, 2003, BRAIN RES, V985, P113, DOI 10.1016/S0006-8993(03)02754-9; Seeman P, 2013, NEUROPHARMACOLOGY, V66, P87, DOI 10.1016/j.neuropharm.2012.07.001; Siegel SJ, 2005, NEUROSCIENCE, V133, P729, DOI 10.1016/j.neuroscience.2005.03.027; Simosky JK, 2003, PSYCHOPHARMACOLOGY, V165, P386, DOI 10.1007/s00213-002-1285-x; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P386, DOI 10.1016/j.neuropharm.2006.04.013; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P374, DOI 10.1016/j.neuropharm.2006.01.012; Spencer KM, 2008, BIOL PSYCHIAT, V64, P369, DOI 10.1016/j.biopsych.2008.02.021; Spencer KM, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00190; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Stevens KE, 1997, PHARMACOL BIOCHEM BE, V57, P869, DOI 10.1016/S0091-3057(96)00466-2; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Tallon-Baudry C, 2004, TRENDS COGN SCI, V8, P523, DOI 10.1016/j.tics.2004.10.008; Tregellas JR, 2009, AM J PSYCHIAT, V166, P354, DOI 10.1176/appi.ajp.2008.08030411; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Umbricht D, 2004, BRAIN RES, V1019, P189, DOI 10.1016/j.brainres.2004.05.097; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Xie Z, 2006, NEUROSCIENCE, V139, P597, DOI 10.1016/j.neuroscience.2005.12.042	91	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147365	10.1371/journal.pone.0147365	http://dx.doi.org/10.1371/journal.pone.0147365			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808689	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800080
J	Boisrame-Helms, J; Meyer, G; Degirmenci, SE; Burban, M; Schini-Kerth, V; Cynober, L; De Bandt, JP; Hasselmann, M; Meziani, F				Boisrame-Helms, Julie; Meyer, Gregory; Degirmenci, Su Emmanuelle; Burban, Melanie; Schini-Kerth, Valerie; Cynober, Luc; De Bandt, Jean-Pascal; Hasselmann, Michel; Meziani, Ferhat			"Immunonutrition" Has Failed to Improve Peritonitis-Induced Septic Shock in Rodents	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; NITRIC-OXIDE PRODUCTION; CRITICALLY-ILL PATIENT; GAMMA-LINOLENIC ACID; CARE-UNIT PATIENTS; PARENTERAL-NUTRITION; SEVERE SEPSIS; L-ARGININE; FISH-OIL; OMEGA-3-FATTY-ACIDS IMPROVE	Background Immunonutrition in sepsis, including n-3 poly-unsaturated fatty acids (PUFAs) or L-arginine supplementation, is a controversial issue that has yielded a great number of studies for the last thirty-five years, and the conclusions regarding the quantity and quality of this support in patients are deceiving. The aim of the present experimental study is to investigate the effects of a pretreatment with enteral nutrition enriched with n-3 PUFAs or L-arginine on vascular dysfunctions, inflammation and oxidative stress during septic shock in rats. Design Rats were fed with enteral Peptamen (R) HN (HN group), Peptamen (R) AF containing n-3 PUFAs (AF group) or Peptamen (R) AF enriched with L-arginine (AFA group). On day 4, peritonitis by cecal ligation and puncture (CLP) was performed. Rats were resuscitated (H18) once septic shock was established. After a 4-hour resuscitation, vessels and organs were harvested to assess inflammation, superoxide anion, nitric oxide and prostacyclin levels. Ex-vivo vascular reactivity was also performed. Results Compared to CLP-AF or CLP-HN groups, 47.6% of CLP-AFA rats died before the beginning of hemodynamic measurements (vs. 8.0% and 20.0% respectively, p<0.05). AF and AFA rats required significantly increased norepinephrine infusion rates to reach the mean arterial pressure objective, compared to CLP-HN rats. Both CLP-AF and CLP-AFA reduced mesenteric resistance arterial contractility, decreased vascular oxidative stress, but increased NF-kappa B (0.40 +/- 0.15 in CLP-AF and 0.69 +/- 0.06 in CLP-AFA vs. 0.09 +/- 0.03 in SHAM rats and 0.30 +/- 0.06 in CLP-HN, beta-actin ratio, p<0.05) and pI kappa B expression (0.60 +/- 0.03 in CLP-AF and 0.94 +/- 0.15 in CLP-AFA vs. 0.04 +/- 0.01 in SHAM rats and 0.56 +/- 0.07 in CLP-HN, beta-actin ratio, p<0.05), nitric oxide and prostacyclin production in septic rats. Conclusions Although n-3 PUFAs or L-arginine supplementation exhibited an antioxidant effect, it worsened the septic shock-induced vascular dysfunction. Furthermore, mortality was higher after L-arginine supplementation.	[Boisrame-Helms, Julie; Meziani, Ferhat] Univ Strasbourg, Fac Med, FMTS, EA 7293, Strasbourg, France; [Boisrame-Helms, Julie; Hasselmann, Michel; Meziani, Ferhat] Hop Univ Strasbourg, Nouvel Hop Civil, Serv Reanimat Med, Strasbourg, France; [Meyer, Gregory] Univ Avignon, EA 4278, F-84000 Avignon, France; [Degirmenci, Su Emmanuelle; Burban, Melanie; Schini-Kerth, Valerie] Univ Strasbourg, Fac Pharm, CNRS, Lab Biophoton & Pharmacol,UMR 7213, Illkirch Graffenstaden, France; [Cynober, Luc; De Bandt, Jean-Pascal] Hop Cochin, AP HP, Hop Univ Paris Ctr, Dept Chim Clin, 27 Rue Faubourg St Jacques, F-75674 Paris, France; [Cynober, Luc; De Bandt, Jean-Pascal] Univ Paris 05, Sorbonne Paris Cite, Fac Pharm, Lab Biol Nutr,EA 4466, Paris, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Avignon Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Meziani, F (corresponding author), Univ Strasbourg, Fac Med, FMTS, EA 7293, Strasbourg, France.; Meziani, F (corresponding author), Hop Univ Strasbourg, Nouvel Hop Civil, Serv Reanimat Med, Strasbourg, France.	ferhat.meziani@chru-strasbourg.fr	De Bandt, Jean-Pascal/ABA-4382-2020; De BANDT, Jean Pascal/C-4822-2013; Cynober, Luc/ABB-2368-2020	Helms, Julie/0000-0003-0895-6800	Association for Research Development in Intensive Care (Association pour le Developpement de la Recherche En Reanimation, ADRER); Nestle; Alsacian Association for Respiratory Failure Help at Home (Association Des Insuffisants Respiratoires Alsace Lorraine, ADIRAL)	Association for Research Development in Intensive Care (Association pour le Developpement de la Recherche En Reanimation, ADRER); Nestle(Nestle SA); Alsacian Association for Respiratory Failure Help at Home (Association Des Insuffisants Respiratoires Alsace Lorraine, ADIRAL)	Funding source: this work has been in part supported by the Association for Research Development in Intensive Care (Association pour le Developpement de la Recherche En Reanimation, ADRER) and grant from Nestle. The authors also thank the Alsacian Association for Respiratory Failure Help at Home (Association Des Insuffisants Respiratoires Alsace Lorraine, ADIRAL) for its financial and material support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeywardena MY, 2001, CARDIOVASC RES, V52, P361, DOI 10.1016/S0008-6363(01)00406-0; Achard F, 1997, BIOCHEM BIOPH RES CO, V241, P513, DOI 10.1006/bbrc.1997.7848; Barbosa VM, 2010, CRIT CARE, V14, DOI 10.1186/cc8844; BARBUL A, 1984, J SURG RES, V36, P620, DOI 10.1016/0022-4804(84)90149-5; Barbul A, 2007, CRIT CARE MED, V35, pS564, DOI 10.1097/01.CCM.0000279188.97421.FE; Bertolini G, 2003, INTENS CARE MED, V29, P834, DOI 10.1007/s00134-003-1711-5; Boisrame-Helms J, 2015, PROG LIPID RES; Boisrame-Helms J, 2015, PROG LIPID RES, V60, P1, DOI 10.1016/j.plipres.2015.08.002; Boisrame-Helms J, 2014, SHOCK, V42, P548, DOI 10.1097/SHK.0000000000000255; Boisrame-Helms J, 2014, LIPIDS, V49, P1091, DOI 10.1007/s11745-014-3930-7; Boisrame-Helms J, 2014, THROMB HAEMOSTASIS, V111, P154, DOI 10.1160/TH13-04-0313; Boisrame-Helms J, 2013, CURR VASC PHARMACOL, V11, P150; Bruins MJ, 2002, CRIT CARE MED, V30, P508, DOI 10.1097/00003246-200203000-00003; Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Cynober L, 2012, CRIT CARE MED, V40, P2540, DOI 10.1097/CCM.0b013e318256b800; Das UN, 2013, CRIT CARE, V17, DOI 10.1186/cc12574; Davis JS, 2011, CRIT CARE MED, V39, P380, DOI 10.1097/CCM.0b013e3181ffd9f7; Desai SV, 2014, CHEST, V145, P1148, DOI 10.1378/chest.13-1158; Elwafi F, 2012, EUR J CLIN INVEST, V42, P282, DOI 10.1111/j.1365-2362.2011.02581.x; Fischer R, 2014, J LIPID RES, V55, P1150, DOI 10.1194/jlr.M047357; Fremont RD, 2015, NUTR CLIN PRACT, V30, P344, DOI 10.1177/0884533615578457; FREUND H, 1979, ANN SURG, V190, P571, DOI 10.1097/00000658-197911000-00003; Friesecke S, 2008, INTENS CARE MED, V34, P1411, DOI 10.1007/s00134-008-1072-1; Galban C, 2000, CRIT CARE MED, V28, P643, DOI 10.1097/00003246-200003000-00007; Goodfellow J, 2000, J AM COLL CARDIOL, V35, P265, DOI 10.1016/S0735-1097(99)00548-3; Gultekin G, 2014, PAK J MED SCI, V30, P299; Hamani D, 2007, INTENS CARE MED, V33, P1076, DOI 10.1007/s00134-007-0624-0; Hamani D, 2010, CLIN NUTR, V29, P654, DOI 10.1016/j.clnu.2010.02.011; Harvey SE, 2014, NEW ENGL J MED, V371, P1673, DOI 10.1056/NEJMoa1409860; Heller AR, 2006, CRIT CARE MED, V34, P972, DOI 10.1097/01.CCM.0000206309.83570.45; Heller AR, 2015, WORLD REV NUTR DIET, V112, P127, DOI 10.1159/000365607; Heyland DK, 2001, JPEN-PARENTER ENTER, V25, pS51, DOI 10.1177/014860710102500211; Iapichino G, 2010, MINERVA ANESTESIOL, V76, P325; Jain AP, 2015, EUR REV MED PHARMACO, V19, P441; Kalil AC, 2006, CRIT CARE MED, V34, P2719, DOI 10.1097/01.CCM.0000242757.26245.03; Kao CC, 2009, CLIN SCI, V117, P23, DOI 10.1042/CS20080444; Leclerc J, 2000, CRIT CARE MED, V28, P3672, DOI 10.1097/00003246-200011000-00023; Lorente JA, 1999, CRIT CARE MED, V27, P2474, DOI 10.1097/00003246-199911000-00025; Luiking YC, 2015, CLIN SCI, V128, P57, DOI 10.1042/CS20140343; Luiking YC, 2009, AM J CLIN NUTR, V89, P142, DOI 10.3945/ajcn.2007.25765; Meziani F, 2007, AM J PATHOL, V171, P1753, DOI 10.2353/ajpath.2007.070316; O'Dwyer MJ, 2006, CRIT CARE, V10, DOI 10.1186/cc5053; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; PARKER JL, 1993, CIRC RES, V72, P539, DOI 10.1161/01.RES.72.3.539; Pontes-Arruda A, 2006, CRIT CARE MED, V34, P2325, DOI 10.1097/01.CCM.0000234033.65657.B6; SEIFTER E, 1978, SURGERY, V84, P224; Simpson F, 2005, INTENS CARE MED, V31, P12, DOI 10.1007/s00134-004-2511-2; Singer P, 2011, INTENS CARE MED, V37, P601, DOI 10.1007/s00134-011-2146-z; SITREN HS, 1977, BRIT J NUTR, V37, P195, DOI 10.1079/BJN19770021; Stoclet JC, 1999, CIRCULATION, V100, P107, DOI 10.1161/01.CIR.100.2.107; Tadie JM, 2013, INTENS CARE MED, V39, P1663, DOI 10.1007/s00134-013-2984-y; UMANS JG, 1993, AM REV RESPIR DIS, V148, P1638, DOI 10.1164/ajrccm/148.6_Pt_1.1638; Villet S, 2005, CLIN NUTR, V24, P502, DOI 10.1016/j.clnu.2005.03.006; Visser M, 2011, BR J NUTR, P1; Wijnands KAP, 2015, NUTRIENTS, V7, P1426, DOI 10.3390/nu7031426	56	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147644	10.1371/journal.pone.0147644	http://dx.doi.org/10.1371/journal.pone.0147644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808822	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800165
J	Khalfaoui, S; Eichhorn, V; Karagiannidis, C; Bayh, I; Brockmann, M; Pieper, M; Windisch, W; Schildgen, O; Schildgen, V				Khalfaoui, Soumaya; Eichhorn, Vivien; Karagiannidis, Christian; Bayh, Inga; Brockmann, Michael; Pieper, Monika; Windisch, Wolfram; Schildgen, Oliver; Schildgen, Verena			Lung Infection by Human Bocavirus Induces the Release of Profibrotic Mediator Cytokines In Vivo and In Vitro	PLOS ONE			English	Article							HUMAN PARVOVIRUS B19; TNF-ALPHA; PULMONARY-FIBROSIS; LIVER FIBROSIS; POOR-PROGNOSIS; COMMON COLD; IFN-GAMMA; GM-CSF; CANCER; DNA	Human Bocavirus subtype 1 (HBoV1) is associated with respiratory diseases and may contribute to chronic lung diseases by persisting in the infected host. Here the question was addressed if HBoV infections could contribute to fibrogenesis processes as suggested by previously published clinical observations. Cytokine profiles induced by HBoV infection in CuFi-8 air-liquid interphase cell cultures and in bronchoalveolar lavage fluid (BALF) of 20 HBoV-positive and 12 HBoV-negative patients were analysed by semi-quantitative Western spot blot analyses. Although lots of cytokines were regulated independently of HBoV status, several cytokines associated with lung fibrosis and tumour development, e.g., EGF, VEGF, TARC (CCL17), TNF-alpha, TNF-beta, TIMP-1, were clearly upregulated in the HBoV-positive cohort. These findings suggest that the development of lung fibrosis might be triggered by HBoV induced cytokine expression.	[Khalfaoui, Soumaya; Eichhorn, Vivien; Brockmann, Michael; Pieper, Monika; Schildgen, Oliver; Schildgen, Verena] Kliniken Stadt Koln gGmbH, Univ Hosp Witten Herdecke, Inst Pathol, Ostmerheimer Str 200, D-51109 Cologne, Germany; [Karagiannidis, Christian; Windisch, Wolfram] Kliniken Stadt Koln gGmbH, Univ Hosp Witten Herdecke, Dept Pneumol & Crit Care Med, Ostmerheimer Str 200, D-51109 Cologne, Germany; [Bayh, Inga] Univ Witten Herdecke, Inst Med Biometry & Epidemiol, Fac Hlth, Alfred Herrhausen Str 50, Witten, Germany	University of Cologne; Witten Herdecke University	Schildgen, V (corresponding author), Kliniken Stadt Koln gGmbH, Univ Hosp Witten Herdecke, Inst Pathol, Ostmerheimer Str 200, D-51109 Cologne, Germany.	schildgenv@kliniken-koeln.de	Windisch, Wolfram/AFV-2171-2022; Windisch, Wolfram/ABI-7381-2020; Schildgen, Oliver/D-5327-2014	Schildgen, Oliver/0000-0003-4297-9627	Else Kroner-Fresenius Stiftung (Germany) [A100_2013]; Beatrix-Lichtken-Stifung (Germany); Private University of Witten/Herdecke	Else Kroner-Fresenius Stiftung (Germany); Beatrix-Lichtken-Stifung (Germany); Private University of Witten/Herdecke	This study was supported by research grants from the Else Kroner-Fresenius Stiftung (Germany) (grant number A100_2013 to VS), the Beatrix-Lichtken-Stifung (Germany) (grant for HBoV Research to OS), and the Private University of Witten/Herdecke (internal grant to VS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson LA, 2011, THYROID, V21, P411, DOI 10.1089/thy.2010.0307; Adamson-Small LA, 2014, ENDOCR PATHOL, V25, P339, DOI 10.1007/s12022-014-9305-z; Alevizakos M, 2013, CANCER CHEMOTH PHARM, V72, P1169, DOI 10.1007/s00280-013-2298-3; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2008, J CLIN VIROL, V41, P29, DOI 10.1016/j.jcv.2007.10.026; Avcuoglu S, 2011, AM J RESP CELL MOL, V45, P768, DOI 10.1165/rcmb.2010-0195OC; Bagnato G, 2015, EUR RESPIR REV, V24, P102, DOI 10.1183/09059180.00003214; Belperio JA, 2004, J IMMUNOL, V173, P4692, DOI 10.4049/jimmunol.173.7.4692; Besnard AG, 2013, J LEUKOCYTE BIOL, V94, P1317, DOI 10.1189/jlb.0313140; Chaudhary NI, 2007, EUR RESPIR J, V29, P976, DOI 10.1183/09031936.00152106; Cheadle EJ, 2007, CLIN CANCER RES, V13, P5719, DOI 10.1158/1078-0432.CCR-07-1145; CHEUNG AKM, 1980, J VIROL, V33, P739, DOI 10.1128/JVI.33.2.739-748.1980; Chou DHI, 1996, J IMMUNOL, V156, P4354; Coe BR, 2005, GENE CHROMOSOME CANC, V42, P308, DOI 10.1002/gcc.20137; Corsini J, 2001, VIROLOGY, V288, P154, DOI 10.1006/viro.2001.1076; De Vos N, 2009, EUR J CLIN MICROBIOL, V28, P1305, DOI 10.1007/s10096-009-0780-y; Di Stefano A, 2009, THORAX, V64, P968, DOI 10.1136/thx.2009.113647; Dijkman R, 2009, J VIROL, V83, P7739, DOI 10.1128/JVI.00614-09; Don M, 2011, J INFECT DIS, V203, P1031, DOI 10.1093/infdis/jiq157; Farkas L, 2009, J CLIN INVEST, V119, P1298, DOI 10.1172/JCI36136; Fisgin T, 2002, LEUKEMIA LYMPHOMA, V43, P2059, DOI 10.1080/1042819021000016168; Fuchs BC, 2014, HEPATOLOGY, V59, P1577, DOI 10.1002/hep.26898; Garcia-Garcia ML, 2010, PEDIATR PULM, V45, P585, DOI 10.1002/ppul.21225; Garnis C, 2005, ONCOGENE, V24, P4806, DOI 10.1038/sj.onc.1208643; GAULDIE J, 1993, THORAX, V48, P931, DOI 10.1136/thx.48.9.931; HART PH, 1989, IMMUNOLOGY, V66, P376; Hedman L, 2010, J CLIN VIROL, V48, P44, DOI 10.1016/j.jcv.2010.02.003; Henri S, 2002, J IMMUNOL, V169, P929, DOI 10.4049/jimmunol.169.2.929; Hobbs JA, 2015, SEMIN ONCOL, V42, P304, DOI 10.1053/j.seminoncol.2014.12.022; Huang QF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002899; Huaux F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064341; Huguenin A, 2012, J MED VIROL, V84, P979, DOI 10.1002/jmv.23272; Ibrahem WN, 2014, J PAK MED ASSOC, V64, P9; Isobe K, 2010, RESPIROLOGY, V15, P88, DOI 10.1111/j.1440-1843.2009.01666.x; Jartti Laura, 2011, Open Respir Med J, V5, P61, DOI 10.2174/1874306401105010061; Kantola K, 2011, J INFECT DIS, V204, P1403, DOI 10.1093/infdis/jir525; Kapoor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021362; Kaur J, 2014, FUTURE VIROL, V9, P715, DOI 10.2217/FVL.14.59; Keane MP, 2008, EUR RESPIR REV, V17, P151, DOI 10.1183/09059180.00010908; Kishi M, 2008, THORAX, V63, P810, DOI 10.1136/thx.2007.086074; Korppi M, 2010, PEDIATR INFECT DIS J, V29, P387, DOI 10.1097/INF.0b013e3181ce8e81; Kuusniemi AM, 2005, KIDNEY INT, V68, P121, DOI 10.1111/j.1523-1755.2005.00386.x; Lassauniere R, 2010, J VIROL METHODS, V165, P254, DOI 10.1016/j.jviromet.2010.02.005; Li YS, 2012, ONCOL LETT, V3, P635, DOI 10.3892/ol.2012.548; Lin HJ, 2015, J THORAC DIS, V7, P767, DOI 10.3978/j.issn.2072-1439.2015.04.17; Lloyd CM, 1997, J LEUKOCYTE BIOL, V62, P676, DOI 10.1002/jlb.62.5.676; Longtin J, 2010, J INFECT DIS, V202, P1617, DOI 10.1086/656786; Lusebrink J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019457; Mangieri D, 2012, NEPHROL DIAL TRANSPL, V27, P3875, DOI 10.1093/ndt/gfs408; Meldrum KK, 2007, AM J PHYSIOL-REG I, V292, pR1456, DOI 10.1152/ajpregu.00620.2005; Moore BB, 2000, J IMMUNOL, V165, P4032, DOI 10.4049/jimmunol.165.7.4032; Munthe-Kaas MC, 2015, J PEDIAT HEMATOL ONC, V37, pE67, DOI 10.1097/MPH.0000000000000093; Ohgino K, 2014, LUNG CANCER, V83, P90, DOI 10.1016/j.lungcan.2013.10.016; Okamura K, 2012, LUNG CANCER, V78, P100, DOI 10.1016/j.lungcan.2012.07.011; Parenti A, 1998, J BIOL CHEM, V273, P4220, DOI 10.1074/jbc.273.7.4220; Pesta M, 2011, ANTICANCER RES, V31, P4031; Pham NTK, 2010, J VIROL METHODS, V169, P193, DOI 10.1016/j.jviromet.2010.07.038; Ribeiro R, 2006, EUR J CANCER, V42, P1188, DOI 10.1016/j.ejca.2006.02.004; Ricci A, 2001, AM J RESP CELL MOL, V25, P439, DOI 10.1165/ajrcmb.25.4.4470; Ricci A, 2007, SARCOIDOSIS VASC DIF, V24, P13; Ruohola A, 2009, EMERG INFECT DIS, V15, P344, DOI 10.3201/eid1502.081468; Safranek J, 2009, ANTICANCER RES, V29, P2513; Saperstein S, 2009, J INTERF CYTOK RES, V29, P273, DOI 10.1089/jir.2008.0076; Saxena NK, 2002, HEPATOLOGY, V35, P762, DOI 10.1053/jhep.2002.32029; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; Schildgen V, 2014, MBIO, V5, DOI 10.1128/mBio.01186-14; Schildgen V, 2014, REV MED MICROBIOL, V25, P113, DOI 10.1097/MRM.0000000000000010; Schildgen V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068020; Seeger C., 2013, FIELDS VIROLOGY, V7th ed., P2185; Stoll P, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-116; Streiter M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-417; Uemura Y, 2006, INT J MOL MED, V18, P365; van Breugel PC, 2012, HEPATOLOGY, V56, P2116, DOI 10.1002/hep.25928; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Wang JH, 2008, BRIT J CANCER, V98, P611, DOI 10.1038/sj.bjc.6604196; Weigt SS, 2008, AM J TRANSPLANT, V8, P1512, DOI 10.1111/j.1600-6143.2008.02280.x; Weseslindtner L, 2011, AM J TRANSPLANT, V11, P542, DOI 10.1111/j.1600-6143.2010.03404.x; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Windisch W, 2013, J CLIN VIROL, V58, P325, DOI 10.1016/j.jcv.2013.05.020; Yoshiji H, 2000, HEPATOLOGY, V32, P1248, DOI 10.1053/jhep.2000.20521; Zeisel MB, 2015, GUT, V64, P1314, DOI 10.1136/gutjnl-2014-308943; Zhang K, 1997, J IMMUNOL, V158, P954; Zhao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048980	83	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147010	10.1371/journal.pone.0147010	http://dx.doi.org/10.1371/journal.pone.0147010			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807786	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800044
J	Kshatriya, GK; Acharya, SK				Kshatriya, Gautam K.; Acharya, Subhendu K.			Triple Burden of Obesity, Undernutrition, and Cardiovascular Disease Risk among Indian Tribes	PLOS ONE			English	Article							BODY-MASS-INDEX; SOCIOECONOMIC-STATUS; PRESCHOOL-CHILDREN; METABOLIC SYNDROME; DIETARY DIVERSITY; FAT PERCENTAGE; BLOOD-PRESSURE; HEIGHT RATIO; HEALTH-RISKS; HYPERTENSION	Background Socio-cultural transitions among individuals from vulnerable groups introduce epidemiological transition, with a concomitant increase in the prevalence of undernutrition, obesity, and cardiovascular disease risks. An accepted conventional wisdom exists for Indian tribes that they are undernourished and away from lifestyle-related diseases. However, the extent of this triple burden affecting them is unknown. In this study, we assessed this triple burden among the 9 major tribes of India. Methods and Findings During January 2011 to December 2013, we conducted a cross-sectional study among 1066 men and 1090 women constituting a total of 2156 adults belonging to the 9 major tribal groups: Santals, Oraons, and Koras (West Bengal); Santals, Bhumijs, and Bathudis (Odisha); and Dhodias, Kuknas, and Chaudharis (Gujarat) to estimate the prevalence of the triple burden (undernutrition, overweight or obesity, and hypertension). A high prevalence of undernutrition and hypertension was observed among the Koras (51.9% and 10.6%, respectively), Bathudis (51.3% and 12.1%, respectively), and Oraons (49.6% and 16.5%, respectively). However, the prevalence of overweight and hypertension among the Bhumijs (17.7% and 14.7%, respectively), Dhodias (23.8% and 12.9%, respectively), Kuknas (15.8% and 11.3%, respectively), and Santals of West Bengal (12.2% and 11.8%, respectively) and Odisha (15% and 9.6%, respectively) was most alarming. The prevalence of overweight or obesity among the women was 10.9% and 1.5%, respectively, with 14.0% hypertensive women. The prevalence of overweight and obesity among the men was 14.8% and 1.7%, respectively, with 9.2% hypertensive men. Undernutrition was highly prevalent among men and women. However, data from the past 30 years on systolic blood pressure (SBP) and body mass index (BMI) revealed that the studied tribes were at a higher risk than the general Indian population. In addition, a vast gender disparity with relation to the disease and risk prevalence was observed. Conclusion The alarming trend of an increasing prevalence of overweight/obesity, undernutrition, and hypertension is observed among indigenous populations of India, emphasizing the incorporation of a specific health management policy.	[Kshatriya, Gautam K.; Acharya, Subhendu K.] Univ Delhi, Dept Anthropol, Delhi 110007, India	University of Delhi	Kshatriya, GK (corresponding author), Univ Delhi, Dept Anthropol, Delhi 110007, India.	g26_51@yahoo.co.in			Indian Council of Medical Research (ICMR), Government of India [5/4/8-2/2010 NCD-II]	Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR))	This study was funded to GKK by the Indian Council of Medical Research (ICMR), Government of India, bearing project reference number 5/4/8-2/2010 NCD-II.	Allen LH, 2006, J PEDIATR GASTR NUTR, V43, pS8, DOI 10.1097/01.mpg.0000255845.99905.20; Anchala R, 2014, J HYPERTENS, V32, P1170, DOI 10.1097/HJH.0000000000000146; [Anonymous], 2010, STAT ED AM SCHED TRI; [Anonymous], 2010, STAT PROF SCHED TRIB; [Anonymous], 1998, WHONUTNCD981; Arnold F, 2009, NUTR INDIA NATL FAMI; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Ashwell M, 2009, OBESITY FACTS, V2, P97, DOI 10.1159/000203363; Azadbakht L, 2011, PUBLIC HEALTH NUTR, V14, P62, DOI 10.1017/S1368980010000522; Basu S., 1990, GENETIC SOCIOCULTURA; Benyshek DC, 2007, COLLEGIUM ANTROPOL, V31, P11; Bisai S, 2010, EJBS, V3, P43; Bisai S, 2014, INT J PEDIATR-MASSHA, V2, P347; Cassels S, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-10; Chandramouli C., 2011, RURAL URBAN DISTRIBU; Cheema A, 2014, J GLOB HEALTH, V4, DOI 10.7189/jogh.04.010404; Chow CK, 2008, ATHEROSCLEROSIS, V196, P943, DOI 10.1016/j.atherosclerosis.2007.02.027; Das S, 2013, HUM BIO REV, V2, P359; DAS S, 2012, ANTHROPOL NOTEB, V18, P5; Deurenberg P, 2001, EUR J CLIN NUTR, V55, P973, DOI 10.1038/sj.ejcn.1601254; Diaz ME, 2002, J HUM HYPERTENS, V16, pS18, DOI 10.1038/sj.jhh.1001335; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Galal OM, 2002, PUBLIC HEALTH NUTR, V5, P141, DOI 10.1079/PHN2001286; Gautam Mohan K., 1977, SEARCH IDENTITY CASE; Gautam RK, 2006, TRIBAL HLTH; Ghosh A, 2004, J R SOC PROMO HEALTH, V124, P86, DOI 10.1177/146642400412400213; Ghurye GS, 1963, ANATOMY RURAL URBAN; Gopalan C, 1992, 21 SEARO WHO REG OFF; Grijalva-Eternod CS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001320; Hackenberg R, 1983, HDB N AM INDIANS, V10; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HALL JE, 1994, HYPERTENSION, V23, P381, DOI 10.1161/01.HYP.23.3.381; Harris-Fry H, 2015, J HEALTH POPUL NUTR, V33, DOI 10.1186/s41043-015-0022-0; Hawkes C, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-4; HE J, 1994, AM J EPIDEMIOL, V139, P380, DOI 10.1093/oxfordjournals.aje.a117010; Height Haque M., 1990, CULTURAL ENV DIMENSI, P192; Henriksson KM, 2001, EUR J EPIDEMIOL, V17, P521, DOI 10.1023/A:1014508422504; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P702; Hsieh SD, 2000, INT J OBESITY, V24, P358, DOI 10.1038/sj.ijo.0801157; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; JONES DW, 1994, J HYPERTENS, V12, P1433, DOI 10.1097/00004872-199412000-00018; Kannel WB, 2000, AM J HYPERTENS, V13, p3S, DOI 10.1016/S0895-7061(99)00252-6; Kar GC, 2007, STUDY FOOD RELATED N; Kaur P, 2012, INT J PUBLIC HEALTH, V57, P87, DOI 10.1007/s00038-011-0303-3; Kesavachandran CN, 2012, INDIAN J MED RES, V135, P72, DOI 10.4103/0971-5916.93427; Kotchen TA, 2008, HYPERTENSION, V52, P801, DOI 10.1161/HYPERTENSIONAHA.108.120915; Kshatriya GK, 2008, ANTHROPOL ANZ, V66, P355, DOI 10.1127/aa/66/2008/355; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin WY, 2002, INT J OBESITY, V26, P1232, DOI 10.1038/sj.ijo.0802040; Lohman T. G., 1998, ANTROPOMETRIC STANDA; LUKASKI HC, 1985, AM J CLIN NUTR, V41, P810, DOI 10.1093/ajcn/41.4.810; Mahapatra D, 1990, CULTURAL ENV DIMENSI; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Misra A, 2007, INDIAN J MED RES, V125, P345; Misra R, 2011, INT J DIABETES DEV C, V31, P82, DOI 10.1007/s13410-011-0017-3; Mohan V, 2003, J Assoc Physicians India, V51, P771; Mohapatra G, 2012, TRANSCIENCE J GLOBAL, V3, P51; Muth ND., 2009, ACE BLOG        1202; [National Institute of Nutrition Indian Council of Medical Research], 2004, ANN REPORT; National Institute of Nutrition. Indian Council of Medical Research, 2000, SPEC REP ELD AD DIET; National Institute of Nutrition. Indian Council of Medical Research, 1971, ANN REPORT; National Institutes of Health, 1994, BIOEL IMP AN BOD COM, V12, P12; National Nutrition Monitoring Bureau, 2009, 25 NNMB NAT I NUTR I; Padhi S, 2011, 51 CRPC IIPA; Patel RC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001223; Peng Ya-guang, 2013, Zhonghua Xin Xue Guan Bing Za Zhi, V41, P607; Radhakrishna R, 2004, ECON POLIT WEEKLY, V39, P14; Ramachandran A, 2004, DIABETOLOGIA, V47, P860, DOI 10.1007/s00125-004-1387-6; Riha J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001683; Rizwan SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095896; Sawaya AL, 2005, MATERN CHILD NUTR, V1, P155, DOI 10.1111/j.1740-8709.2005.00033.x; Sayeed M A, 2003, Bangladesh Med Res Counc Bull, V29, P1; van der Sande MAB, 2001, AM J PUBLIC HEALTH, V91, P1641, DOI 10.2105/AJPH.91.10.1641; Wells JCK, 2011, EUR J CLIN NUTR, V65, P1173, DOI 10.1038/ejcn.2011.132; Welthungerhilfe IFPRI Concern Worldwide, 2014, GLOB HUNG IND CHALL; World Health Organization, 2000, INT ASS STUD OB INT; World Health Organization Western Pacific Region International Association for the Study of Obesity International Obesity Task Force, 2000, AS PAC PAC RED OB IT; Yajnik CS, 2004, P NUTR SOC, V63, P387, DOI 10.1079/PNS2004365	80	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147934	10.1371/journal.pone.0147934	http://dx.doi.org/10.1371/journal.pone.0147934			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808418	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800245
J	Lundeen, EA; Norris, SA; Martorell, R; Suchdev, PS; Mehta, NK; Richter, LM; Stein, AD				Lundeen, Elizabeth A.; Norris, Shane A.; Martorell, Reynaldo; Suchdev, Parminder S.; Mehta, Neil K.; Richter, Linda M.; Stein, Aryeh D.			Adolescent Pregnancy and Attained Height among Black South African Girls: Matched-Pair Prospective Study	PLOS ONE			English	Article							FINAL ADULT HEIGHT; MATERNAL GROWTH; NUTRITIONAL-STATUS; BIRTH-WEIGHT; OUTCOMES; AGE; CHILDREN; FATNESS; MOTHERS; SCHOOL	Importance The impact of adolescent pregnancy on offspring birth outcomes has been widely studied, but less is known about its impact on the growth of the young mother herself. Objective To determine the association between adolescent pregnancy and attained height. Design Prospective birth cohort study. Setting Cohort members followed from birth to age 20 y in Soweto, South Africa. Participant From among 840 Black females with sufficient data, we identified 54 matched pairs, in which a girl who became pregnant before the age of 17 years was matched with a girl who did not have a pregnancy by age 20 y. Pairs were matched on age at menarche and height-for-age z scores in the year before the case became pregnant (mean 15.0 y). Main Outcome Measures The two groups were compared with respect to attained height, measured at mean age 18.5 y. Results Mean age at conception was 15.9 years (range: 13.7 to 16.9 y). Mean height at matching was 159.4 cm in the adolescent pregnancy group and 159.3 cm in the comparison group (p = 0.3). Mean attained height was 160.4 cm in the adolescent pregnancy group and 160.3 cm in the comparison group (p = 0.7). Conclusions Among Black females in Soweto, South Africa, adolescent pregnancy was not associated with attained height.	[Lundeen, Elizabeth A.] Emory Univ, Laney Grad Sch, Div Biol & Biomed Sci, Nutr & Hlth Sci Program, Atlanta, GA 30322 USA; [Lundeen, Elizabeth A.; Norris, Shane A.; Richter, Linda M.; Stein, Aryeh D.] Univ Witwatersrand, MRC Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [Martorell, Reynaldo; Suchdev, Parminder S.; Mehta, Neil K.; Stein, Aryeh D.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Richter, Linda M.] Univ Witwatersrand, DST NRF Ctr Excellence Human Dev, Johannesburg, South Africa	Emory University; University of Witwatersrand; Emory University; Rollins School Public Health; University of Witwatersrand	Stein, AD (corresponding author), Univ Witwatersrand, MRC Dev Pathways Hlth Res Unit, Johannesburg, South Africa.; Stein, AD (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	aryeh.stein@emory.edu	Suchdev, Parmi S/K-4851-2012; Norris, Shane/C-4664-2014; Martorell, Reynaldo/I-2539-2012	Norris, Shane/0000-0001-7124-3788; Stein, Aryeh/0000-0003-1138-6458	Bill and Melinda Gates Foundation; Laney Graduate School at Emory University; Wellcome Trust (UK); Medical Research Council of South Africa; Anglo-American Chairman's Fund; University of the Witwatersrand; Human Sciences Research Council of South Africa; South African National Research Foundation; Medical Research Council [G1001333] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10012] Funding Source: researchfish; MRC [G1001333] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Laney Graduate School at Emory University; Wellcome Trust (UK)(Wellcome Trust); Medical Research Council of South Africa(South African Medical Research Council); Anglo-American Chairman's Fund; University of the Witwatersrand; Human Sciences Research Council of South Africa; South African National Research Foundation(National Research Foundation - South Africa); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this study was provided by the Bill and Melinda Gates Foundation and the Laney Graduate School at Emory University. The Birth-to-Twenty study has received financial and logistic support from the Wellcome Trust (UK), the Medical Research Council of South Africa, the Anglo-American Chairman's Fund, the University of the Witwatersrand, the Human Sciences Research Council of South Africa, and the South African National Research Foundation. The funders had no role in: the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication.	BACCI A, 1993, INT J GYNECOL OBSTET, V40, P19, DOI 10.1016/0020-7292(93)90767-Q; Biro FM, 2001, J PEDIATR-US, V138, P636, DOI 10.1067/mpd.2001.114476; Brennan L, 2005, J BIOSOC SCI, V37, P185, DOI 10.1017/S0021932003006515; Cameron N., 1984, MEASUREMENT HUMAN GR; Casanueva E, 2006, J NUTR, V136, P2498, DOI 10.1093/jn/136.10.2498; de Almeida MDC, 2011, CAD SAUDE PUBLICA, V27, P2386, DOI 10.1590/S0102-311X2011001200010; Conde-Agudelo A, 2005, AM J OBSTET GYNECOL, V192, P342, DOI 10.1016/j.ajog.2004.10.593; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; FRASER AM, 1995, NEW ENGL J MED, V332, P1113, DOI 10.1056/NEJM199504273321701; Frisancho AR, 1997, ANN NY ACAD SCI, V817, P272, DOI 10.1111/j.1749-6632.1997.tb48213.x; FRISCH RE, 1976, HUM BIOL, V48, P353; GARN SM, 1986, AM J CLIN NUTR, V43, P879, DOI 10.1093/ajcn/43.6.879; Gigante DP, 2005, J NUTR, V135, P74, DOI 10.1093/jn/135.1.74; Gilbert William, 2004, J Matern Fetal Neonatal Med, V16, P265, DOI 10.1080/14767050400018064; Gortzak-Uzan L, 2001, J Matern Fetal Med, V10, P393; Gunderson EP, 2009, ARCH PEDIAT ADOL MED, V163, P349, DOI 10.1001/archpediatrics.2009.9; Hediger ML, 1997, ANN NY ACAD SCI, V817, P281, DOI 10.1111/j.1749-6632.1997.tb48214.x; Igwegbe A O, 2001, J Obstet Gynaecol, V21, P478, DOI 10.1080/01443610120072027; Jolly MC, 2000, OBSTET GYNECOL, V96, P962, DOI 10.1016/S0029-7844(00)01075-9; Klein JD, 2005, PEDIATRICS, V116, P281, DOI 10.1542/peds.2005-0999; Koniak-Griffin D, 2001, J PERINAT NEONAT NUR, V15, P1; Lundeen EA, J NUTR IN PRESS; Medical Research Council OrcMacro, 2007, S AFR DEM HLTH SURV; Olausson PO, 1999, BRIT J OBSTET GYNAEC, V106, P116, DOI 10.1111/j.1471-0528.1999.tb08210.x; Pauli JM, 2013, ARCH GYNECOL OBSTET, V288, P679, DOI 10.1007/s00404-013-2781-4; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Rah JH, 2008, J NUTR, V138, P1505, DOI 10.1093/jn/138.8.1505; Richter L, 2007, INT J EPIDEMIOL, V36, P504, DOI 10.1093/ije/dym016; Roche, 1989, GROWTH GENETICS HORM, V5, P4; ROCHE AF, 1972, PEDIATRICS, V50, P874; SATIN AJ, 1994, AM J OBSTET GYNECOL, V171, P184, DOI 10.1016/0002-9378(94)90467-7; SCHOLL TO, 1990, AM J CLIN NUTR, V51, P790, DOI 10.1093/ajcn/51.5.790; SCHOLL TO, 1994, AM J CLIN NUTR, V60, P183, DOI 10.1093/ajcn/60.2.183; Uzun AK, 2013, J MATERN-FETAL NEO M, V26, P454, DOI 10.3109/14767058.2012.733748; WHO, 2006, WHO CHILD GROWTH STA	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147861	10.1371/journal.pone.0147861	http://dx.doi.org/10.1371/journal.pone.0147861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808552	Green Submitted, Green Published, gold			2022-12-26	WOS:000369527800233
J	Roura, E; Travier, N; Waterboer, T; de Sanjose, S; Bosch, FX; Pawlita, M; Pala, V; Weiderpass, E; Margall, N; Dillner, J; Gram, IT; Tjonneland, A; Munk, C; Palli, D; Khaw, KT; Overvad, K; Clavel-Chapelon, F; Mesrine, S; Fournier, A; Fortner, RT; Ose, J; Steffen, A; Trichopoulou, A; Lagiou, P; Orfanos, P; Masala, G; Tumino, R; Sacerdote, C; Polidoro, S; Mattiello, A; Lund, E; Peeters, PH; Bueno-de-Mesquita, HB; Quiros, JR; Sanchez, MJ; Navarro, C; Barricarte, A; Larranaga, N; Ekstrom, J; Lindquist, D; Idahl, A; Travis, RC; Merritt, MA; Gunter, MJ; Rinaldi, S; Tommasino, M; Franceschi, S; Riboli, E; Castellsague, X				Roura, Esther; Travier, Noemie; Waterboer, Tim; de Sanjose, Silvia; Bosch, F. Xavier; Pawlita, Michael; Pala, Valeria; Weiderpass, Elisabete; Margall, Nuria; Dillner, Joakim; Gram, Inger T.; Tjonneland, Anne; Munk, Christian; Palli, Domenico; Khaw, Kay-Tee; Overvad, Kim; Clavel-Chapelon, Franoise; Mesrine, Sylvie; Fournier, Agnes; Fortner, Renee T.; Ose, Jennifer; Steffen, Annika; Trichopoulou, Antonia; Lagiou, Pagona; Orfanos, Philippos; Masala, Giovanna; Tumino, Rosario; Sacerdote, Carlotta; Polidoro, Silvia; Mattiello, Amalia; Lund, Eiliv; Peeters, Petra H.; Bueno-de-Mesquita, H. B(as).; Quiros, J. Ramon; Sanchez, Maria-Jose; Navarro, Carmen; Barricarte, Aurelio; Larranaga, Nerea; Ekstrom, Johanna; Lindquist, David; Idahl, Annika; Travis, Ruth C.; Merritt, Melissa A.; Gunter, Marc J.; Rinaldi, Sabina; Tommasino, Massimo; Franceschi, Silvia; Riboli, Elio; Castellsague, Xavier			The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; ORAL-CONTRACEPTIVES; INTRAEPITHELIAL NEOPLASIA; REPRODUCTIVE FACTORS; REPLACEMENT THERAPY; WOMEN; HPV; SMOKING; PARITY; CARCINOGENESIS	Background In addition to HPV, high parity and hormonal contraceptives have been associated with cervical cancer (CC). However, most of the evidence comes from retrospective case-control studies. The aim of this study is to prospectively evaluate associations between hormonal factors and risk of developing cervical intraepithelial neoplasia grade 3 (CIN3)/carcinoma in situ (CIS) and invasive cervical cancer (ICC). Methods and Findings We followed a cohort of 308,036 women recruited in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. At enrollment, participants completed a questionnaire and provided serum. After a 9-year median follow-up, 261 ICC and 804 CIN3/CIS cases were reported. In a nested case-control study, the sera from 609 cases and 1,218 matched controls were tested for L1 antibodies against HPV types 11,16,18,31,33,35,45, 52,58, and antibodies against Chlamydia trachomatis and Human herpesvirus 2. Multivariate analyses were performed to estimate hazard ratios (HR), odds ratios (OR) and corresponding 95% confidence intervals (CI). The cohort analysis showed that number of fullterm pregnancies was positively associated with CIN3/CIS risk (p-trend = 0.03). Duration of oral contraceptives use was associated with a significantly increased risk of both CIN3/CIS and ICC (HR = 1.6 and HR = 1.8 respectively for >= 15 years versus never use). Ever use of menopausal hormone therapy was associated with a reduced risk of ICC (HR = 0.5, 95% CI: 0.4-0.8). A non-significant reduced risk of ICC with ever use of intrauterine devices (IUD) was found in the nested case-control analysis (OR = 0.6). Analyses restricted to all cases and HPV seropositive controls yielded similar results, revealing a significant inverse association with IUD for combined CIN3/CIS and ICC (OR = 0.7). Conclusions Even though HPV is the necessary cause of CC, our results suggest that several hormonal factors are risk factors for cervical carcinogenesis. Adherence to current cervical cancer screening guidelines should minimize the increased risk of CC associated with these hormonal risk factors.	[Roura, Esther; de Sanjose, Silvia; Bosch, F. Xavier; Castellsague, Xavier] Hosp Llobregat, Catalan Inst Oncol ICO IDIBELL, Canc Epidemiol Res Program, Unit Infect & Canc, Barcelona, Catalonia, Spain; [Roura, Esther; de Sanjose, Silvia; Sanchez, Maria-Jose; Navarro, Carmen; Barricarte, Aurelio; Larranaga, Nerea; Castellsague, Xavier] CIBERESP, Madrid, Spain; [Travier, Noemie] Hosp Llobregat, Catalan Inst Oncol ICO IDIBELL, Canc Epidemiol Res Program, Unit Nutr Environm & Canc, Barcelona, Catalonia, Spain; [Waterboer, Tim; Pawlita, Michael] German Canc Res Ctr, Res Program Infect Inflammat & Canc, Div Mol Diagnost Oncogen Infect F020, Heidelberg, Germany; [Pala, Valeria] Fdn IRCCS Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy; [Weiderpass, Elisabete; Dillner, Joakim] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiderpass, Elisabete; Gram, Inger T.; Lund, Eiliv] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Weiderpass, Elisabete] Canc Registry Norway, Dept Res, Oslo, Norway; [Weiderpass, Elisabete] Folkhalsan Res Ctr, Genet Epidemiol Grp, Helsinki, Finland; [Margall, Nuria] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Microbiol, E-08193 Barcelona, Catalonia, Spain; [Dillner, Joakim] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Tjonneland, Anne] Danish Canc Soc, Res Ctr, Diet Genes & Environm, Copenhagen, Denmark; [Munk, Christian] Danish Canc Soc, Res Ctr, Virus Lifestyle & Genes, Copenhagen, Denmark; [Palli, Domenico; Masala, Giovanna] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Khaw, Kay-Tee] Univ Cambridge, Sch Clin Med, Cambridge, England; [Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Clavel-Chapelon, Franoise; Mesrine, Sylvie; Fournier, Agnes] Nutr Hormones & Womens Hlth Team, Ctr Res Epidemiol & Populat Hlth CESP, INSERM, U318, F-94705 Villejuif, France; [Clavel-Chapelon, Franoise; Mesrine, Sylvie; Fournier, Agnes] Univ Paris Sud, UMRS 318, F-94705 Villejuif, France; [Clavel-Chapelon, Franoise; Mesrine, Sylvie; Fournier, Agnes] Inst Gustave Roussy, F-94705 Villejuif, France; [Fortner, Renee T.; Ose, Jennifer] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Steffen, Annika] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Trichopoulou, Antonia; Orfanos, Philippos] Hellen Hlth Fdn, Athens, Greece; [Lagiou, Pagona; Orfanos, Philippos] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Lagiou, Pagona] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA; [Tumino, Rosario] Civic MP Arezzo Hosp, Canc Registry & Histopathol Unit, Ragusa, Italy; [Sacerdote, Carlotta] Univ Turin, Canc Epidemiol Unit, Turin, Italy; [Sacerdote, Carlotta] Ctr Canc Epidemiol & Prevent CPO Piemonte, Turin, Italy; [Polidoro, Silvia] Human Genet Fdn HuGeF, Turin, Italy; [Mattiello, Amalia] Univ Naples Federico II, Dipartimento Med Clin & Chirurg, Naples, Italy; [Peeters, Petra H.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC PHE Ctr Environm & Hlth, London, England; [Peeters, Petra H.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [Bueno-de-Mesquita, H. B(as).] Natl Inst Publ Hlth & Environm RIVM, Dept Determinants Chron Dis DCD, Bilthoven, Netherlands; [Bueno-de-Mesquita, H. B(as).] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Bueno-de-Mesquita, H. B(as).; Merritt, Melissa A.; Gunter, Marc J.; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Bueno-de-Mesquita, H. B(as).] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Quiros, J. Ramon] Publ Hlth Directorate, Asturias, Spain; [Sanchez, Maria-Jose] Univ Granada, Hosp Univ Granada, Inst Invest Biosanitaria Ibs GRANADA, Escuela Andaluza Salud Publ, Granada, Spain; [Navarro, Carmen] IMIB Arrixaca, Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Navarro, Carmen] Univ Murcia, Dept Hlth & Social Sci, Murcia, Spain; [Barricarte, Aurelio] Navarra Publ Hlth Inst, Pamplona, Spain; [Barricarte, Aurelio] Navarra Inst Hlth Res IdiSNA, Pamplona, Spain; [Larranaga, Nerea] BIODonostia Res Inst, Basque Hlth Dept, Publ Hlth Div Gipuzkoa, Bilbao, Spain; [Ekstrom, Johanna] Lund Univ, BBMRI Se Serv Ctr Southern Sweden, Lund, Sweden; [Lindquist, David] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Idahl, Annika] Umea Univ, Dept Clin Sci Obstet & Gynecol, Umea, Sweden; [Travis, Ruth C.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England; [Rinaldi, Sabina; Tommasino, Massimo; Franceschi, Silvia] Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Helmholtz Association; German Cancer Research Center (DKFZ); Fondazione IRCCS Istituto Nazionale Tumori Milan; Karolinska Institutet; UiT The Arctic University of Tromso; University of Oslo; Folkhalsan Research Center; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Karolinska Institutet; Danish Cancer Society; Danish Cancer Society; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Cambridge; Aarhus University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Helmholtz Association; German Cancer Research Center (DKFZ); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Athens Medical School; National & Kapodistrian University of Athens; Harvard University; Harvard T.H. Chan School of Public Health; Civile M.P. Arezzo Hospital; University of Turin; University of Naples Federico II; Imperial College London; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Imperial College London; Universiti Malaya; Escuela Andaluza de Salud Publica; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Hospital Clinico Universitario Virgen de la Arrixaca; Murcia Regional Health Council; University of Murcia; Public Health Institute of Navarra; Lund University; Umea University; Umea University; University of Oxford; World Health Organization; International Agency for Research on Cancer (IARC)	Roura, E (corresponding author), Hosp Llobregat, Catalan Inst Oncol ICO IDIBELL, Canc Epidemiol Res Program, Unit Infect & Canc, Barcelona, Catalonia, Spain.; Roura, E (corresponding author), CIBERESP, Madrid, Spain.	eroura@iconcologia.net	Mattiello, Amalia AM/K-5112-2016; JOSÉ, FRANCESC XAVIER BOSCH/J-6339-2012; Weiderpass, Elisabete/AAP-2747-2021; Masala, Giovanna/AAC-5474-2022; de Sanjosé Llongueras, Silvia/H-6339-2014; Steffen, Annika/H-7709-2018; Polidoro, Silvia/GYJ-3517-2022; Waterboer, Tim/G-1252-2010; Khaw, Kay-Tee/AAZ-3209-2021; Pala, Valeria/K-4738-2016; Steffen, Annika/E-8540-2016; franceschi, silvia/M-2452-2014; Lindquist, David/AAM-3662-2020; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Gunter, Marc/AAP-8621-2020; Weiderpass, Elisabete/M-4029-2016; Fournier, Agnès/H-4615-2018; Sánchez, Maria-José/D-1087-2011; Pique, Xavier Castellsagué/N-5795-2014; Orfanos, Philippos/AAL-2606-2021	Mattiello, Amalia AM/0000-0003-3676-7353; JOSÉ, FRANCESC XAVIER BOSCH/0000-0002-7172-3412; Weiderpass, Elisabete/0000-0003-2237-0128; Masala, Giovanna/0000-0002-5758-9069; Steffen, Annika/0000-0003-4072-9245; Pala, Valeria/0000-0001-5438-970X; Steffen, Annika/0000-0003-4072-9245; franceschi, silvia/0000-0003-4181-8071; Lindquist, David/0000-0002-7507-937X; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Weiderpass, Elisabete/0000-0003-2237-0128; Fournier, Agnès/0000-0001-8380-3439; Sánchez, Maria-José/0000-0003-4817-0757; Pique, Xavier Castellsagué/0000-0002-0802-3595; Rasul, holem/0000-0003-0579-9029; Navarro, Carmen/0000-0001-8896-7483; Pawlita, Michael/0000-0002-4720-8306; Riboli, Elio/0000-0001-6795-6080; Polidoro, Silvia/0000-0003-2968-0575; Orfanos, Philippos/0000-0002-9949-3137; Sacerdote, Carlotta/0000-0002-8008-5096; tumino, rosario/0000-0003-2666-414X; Fortner, Renee/0000-0002-1426-8505; Larranaga, Nerea/0000-0002-9993-9880; Tjonneland, Anne/0000-0003-4385-2097; Gunter, Marc/0000-0001-5472-6761; Lund, Eiliv/0000-0002-8071-8711; Travier, Noemie/0000-0001-5228-7769; Tommasino, Massimo/0000-0002-0890-8596	Instituto de Salud Carlos III (Spanish Government) [FIS PI08/1308, PI13/00053, RCESP C03/09, RTICESP C03/10, RTIC RD06/0020/0095, RD12/0036/0056, RD12/0036/0018, CIBERESP]; Agencia de Gestio d'Ajuts Universitaris i de Recerca - Generalitat de Catalunya (Catalonian Government) [AGAUR 2005SGR00695, 2009SGR939, 2009SGR126, 2014SGR1077, 2014SGR2016]; European Commission (DG-SANCO); International Agency for Research on Cancer; Health Research Fund (FIS) of the Spanish Ministry of Health [P10710130]; Regional Governments of Andalucia, Asturias, Basque Country, Murcia [6236]; Navarra and the Catalan Institute of Oncology, La Caixa (Spain) [BM 06-130, RTICC-RD06/10091]; Danish Cancer Society (Denmark); Ligue contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); Hellenic Health Foundation (Greece); Italian Association for Research on Cancer (AIRC) and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF); Statistics Netherlands (The Netherlands); Swedish Cancer Society, Swedish Scientific Council and Regional Government of Skane and Vasterbotten (Sweden); Cancer Research UK, Medical Research Council (United Kingdom); Norwegian Research Council, Norwegian Cancer Society, University of Tromso (Norway); Cancer Research UK [16491, 14136] Funding Source: researchfish; Medical Research Council [G0401527, G1000143] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish	Instituto de Salud Carlos III (Spanish Government)(Instituto de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca - Generalitat de Catalunya (Catalonian Government); European Commission (DG-SANCO)(European CommissionEuropean Commission Joint Research Centre); International Agency for Research on Cancer; Health Research Fund (FIS) of the Spanish Ministry of Health(Instituto de Salud Carlos III); Regional Governments of Andalucia, Asturias, Basque Country, Murcia; Navarra and the Catalan Institute of Oncology, La Caixa (Spain); Danish Cancer Society (Denmark)(Danish Cancer Society); Ligue contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany)(Deutsche Krebshilfe); Hellenic Health Foundation (Greece); Italian Association for Research on Cancer (AIRC) and National Research Council (Italy)(Fondazione AIRC per la ricerca sul cancro); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland)(Netherlands Organization for Scientific Research (NWO)); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF)); Statistics Netherlands (The Netherlands)(Netherlands Government); Swedish Cancer Society, Swedish Scientific Council and Regional Government of Skane and Vasterbotten (Sweden)(Swedish Cancer Society); Cancer Research UK, Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Cancer Research UK); Norwegian Research Council, Norwegian Cancer Society, University of Tromso (Norway); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The work was partially supported by grants from the Instituto de Salud Carlos III (Spanish Government) (grants FIS PI08/1308, PI13/00053, RCESP C03/09, RTICESP C03/10, RTIC RD06/0020/0095, RD12/0036/0056, RD12/0036/0018, and CIBERESP) and from the Agencia de Gestio d'Ajuts Universitaris i de Recerca - Generalitat de Catalunya (Catalonian Government) (grants AGAUR 2005SGR00695, 2009SGR939 and 2009SGR126, 2014SGR1077, 2014SGR2016). The coordination of EPIC is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by the Health Research Fund (FIS) of the Spanish Ministry of Health (Exp P10710130), Regional Governments of Andalucia, Asturias, Basque Country, Murcia (no. 6236), Navarra and the Catalan Institute of Oncology, La Caixa (BM 06-130), RTICC-RD06/10091 (Spain); Danish Cancer Society (Denmark); Ligue contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); the Hellenic Health Foundation (Greece); Italian Association for Research on Cancer (AIRC) and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF) and Statistics Netherlands (The Netherlands); Swedish Cancer Society, Swedish Scientific Council and Regional Government of Skane and Vasterbotten (Sweden); Cancer Research UK, Medical Research Council (United Kingdom); Norwegian Research Council, Norwegian Cancer Society, University of Tromso (Norway). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI HO, 1989, INT J CANCER, V44, P833, DOI 10.1002/ijc.2910440515; Appleby P, 2006, INT J CANCER, V119, P1108, DOI 10.1002/ijc.21953; Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5; Baseman JG, 2005, J CLIN VIROL, V32, pS16, DOI 10.1016/j.jcv.2004.12.008; Berrington A, 2002, LANCET, V360, P410, DOI 10.1016/S0140-6736(02)09578-8; Castellsague X, 2006, JNCI-J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Castellsague X, 2014, INT J CANCER, V135, P440, DOI 10.1002/ijc.28665; Castellsague X, 2011, LANCET ONCOL, V12, P1023, DOI 10.1016/S1470-2045(11)70223-6; Castle PE, 2005, INT J CANCER, V117, P1007, DOI 10.1002/ijc.21279; Castle PE, 2002, JNCI-J NATL CANCER I, V94, P1406, DOI 10.1093/jnci/94.18.1406; Chung SH, 2010, TRENDS ENDOCRIN MET, V21, P504, DOI 10.1016/j.tem.2010.03.005; Clifford GM, 2007, CANCER EPIDEM BIOMAR, V16, P1874, DOI 10.1158/1055-9965.EPI-07-0349; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Daling JR, 1996, CANCER EPIDEM BIOMAR, V5, P541; de Gonzalez AB, 2007, INT J CANCER, V120, P885, DOI 10.1002/ijc.22357; Deacon JM, 2000, BRIT J CANCER, V83, P1565, DOI 10.1054/bjoc.2000.1523; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gadducci A, 2011, GYNECOL ENDOCRINOL, V27, P597, DOI 10.3109/09513590.2011.558953; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V91, P1; Jensen KE, 2013, BRIT J CANCER, V108, P234, DOI 10.1038/bjc.2012.513; Lacey JV, 2000, GYNECOL ONCOL, V77, P149, DOI 10.1006/gyno.2000.5731; LAVECCHIA C, 1993, INT J CANCER, V53, P215, DOI 10.1002/ijc.2910530207; Moodley M, 2003, INT J GYNECOL CANCER, V13, P103, DOI 10.1136/ijgc-00009577-200303000-00001; Moreno V, 2002, LANCET, V359, P1085, DOI 10.1016/S0140-6736(02)08150-3; Munoz N, 2002, LANCET, V359, P1093, DOI 10.1016/S0140-6736(02)08151-5; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Parazzini F, 1997, BRIT MED J, V315, P85, DOI 10.1136/bmj.315.7100.85; PARAZZINI F, 1989, BRIT J CANCER, V59, P805, DOI 10.1038/bjc.1989.168; Peters T, 2012, EUR J EPIDEMIOL, V27, P15, DOI 10.1007/s10654-011-9625-y; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rinaldi S, 2011, CANCER EPIDEM BIOMAR, V20, P2532, DOI 10.1158/1055-9965.EPI-11-0753; Roura E, 2014, INT J CANCER, V135, P453, DOI 10.1002/ijc.28666; Russo E, 2011, J LOW GENIT TRACT DI, V15, P195, DOI 10.1097/LGT.0b013e31820918ea; Schneider C, 2009, CLIMACTERIC, V12, P514, DOI 10.3109/13697130903075352; Sehr P, 2002, J VIROL METHODS, V106, P61, DOI 10.1016/S0166-0934(02)00134-9; Shields TS, 2004, CANCER EPIDEM BIOMAR, V13, P1574; Syrjanen K, 2006, ANTICANCER RES, V26, P4729; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Yoo YA, 2013, AM J PATHOL, V183, P1679, DOI 10.1016/j.ajpath.2013.07.026; Zondervan KT, 1996, BRIT J CANCER, V73, P1291, DOI 10.1038/bjc.1996.247	41	69	77	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147029	10.1371/journal.pone.0147029	http://dx.doi.org/10.1371/journal.pone.0147029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808155	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800047
J	Sharma, S; Sapkota, D; Xue, Y; Sun, Y; Finne-Wistrand, A; Bruland, O; Mustafa, K				Sharma, Sunita; Sapkota, Dipak; Xue, Ying; Sun, Yang; Finne-Wistrand, Anna; Bruland, Ove; Mustafa, Kamal			Adenoviral Mediated Expression of BMP2 by Bone Marrow Stromal Cells Cultured in 3D Copolymer Scaffolds Enhances Bone Formation	PLOS ONE			English	Article							BIODEGRADABLE POLYMER SCAFFOLDS; ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; MORPHOGENETIC PROTEIN-2; IN-VIVO; OSTEOGENIC DIFFERENTIATION; UP-REGULATION; GENE-THERAPY; II COLLAGEN; REGENERATION	Selection of appropriate osteoinductive growth factors, suitable delivery method and proper supportive scaffold are critical for a successful outcome in bone tissue engineering using bone marrow stromal cells (BMSC). This study examined the molecular and functional effect of a combination of adenoviral mediated expression of bone morphogenetic protein-2 (BMP2) in BMSC and recently developed and characterized, biodegradable Poly(L-lactideco-epsilon-caprolactone){poly(LLA-co-CL)} scaffolds in osteogenic molecular changes and ectopic bone formation by using in vitro and in vivo approaches. Pathway-focused custom PCR array, validation using TaqMan based quantitative RT-PCR (qRT-PCR) and ALP staining showed significant up-regulation of several osteogenic and angiogenic molecules, including ALPL and RUNX2 in ad-BMP2 BMSC group grown in poly(LLA-co-CL) scaffolds both at 3 and 14 days. Micro CT and histological analyses of the subcutaneously implanted scaffolds in NOD/SCID mice revealed significantly increased radiopaque areas, percentage bone volume and formation of vital bone in ad-BMP2 scaffolds as compared to the control groups both at 2 and 8 weeks. The increased bone formation in the ad-BMP2 group in vivo was paralleled at the molecular level with concomitant over-expression of a number of osteogenic and angiogenic genes including ALPL, RUNX2, SPP1, ANGPT1. The increased bone formation in ad-BMP2 explants was not found to be associated with enhanced endochondral activity as evidenced by qRT-PCR (SOX9 and FGF2) and Safranin O staining. Taken together, combination of adenoviral mediated BMP-2 expression in BMSC grown in the newly developed poly(LLA-co-CL) scaffolds induced expression of osteogenic markers and enhanced bone formation in vivo.	[Sharma, Sunita; Xue, Ying; Sun, Yang; Mustafa, Kamal] Univ Bergen, Fac Med & Dent, Dept Clin Dent, Bergen, Norway; [Sapkota, Dipak] Univ Bergen, Dept Clin Med, Gade Lab Pathol, Bergen, Norway; [Sun, Yang; Finne-Wistrand, Anna] Royal Inst Technol, Dept Fibre & Polymer Technol, Stockholm, Sweden; [Bruland, Ove] Haukeland Hosp, Dept Med Genet & Mol Med, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Royal Institute of Technology; University of Bergen; Haukeland University Hospital	Mustafa, K (corresponding author), Univ Bergen, Fac Med & Dent, Dept Clin Dent, Bergen, Norway.	kamal.mustafa@uib.no	Mustafa, Kamal/ABD-4458-2020	Sapkota, Dipak/0000-0003-0061-825X	Meltzer Research Fund; European Union FP7, VascuBone [242175]; European Union [242175]	Meltzer Research Fund; European Union FP7, VascuBone; European Union(European Commission)	We acknowledge the financial support by Meltzer Research Fund and The European Union FP7, VascuBone, (Project number 242175).; This work was supported by the European Union 7th Frame Program, VascuBone (Project number 242175) to KM, and the Meltzer Research Fund to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeel S, 2012, ARCH ORAL BIOL, V57, P445, DOI 10.1016/j.archoralbio.2011.10.002; Alonso N, 2010, TISSUE ENG PART C-ME, V16, P1183, DOI [10.1089/ten.tec.2009.0824, 10.1089/ten.TEC.2009.0824]; Calori GM, 2009, INJURY, V40, P67; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chang SCN, 2010, J BIOMED MATER RES A, V94A, P433, DOI 10.1002/jbm.a.32685; Chiu LH, 2014, BIOMATERIALS, V35, P2680, DOI 10.1016/j.biomaterials.2013.12.005; Danmark S, 2011, ACTA BIOMATER, V7, P2035, DOI 10.1016/j.actbio.2011.02.011; Danmark S, 2010, J BIOACT COMPAT POL, V25, P207, DOI 10.1177/0883911509358812; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; Edlund U, 2008, BIOMACROMOLECULES, V9, P901, DOI 10.1021/bm701267u; Farrell E, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-31; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Idris SB, 2010, J BIOACT COMPAT POL, V25, P567, DOI 10.1177/0883911510381368; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6; Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016; Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039; Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Mustafa K, 2000, CLIN ORAL IMPLAN RES, V11, P116, DOI 10.1034/j.1600-0501.2000.011002116.x; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Noel D, 2004, STEM CELLS, V22, P74, DOI 10.1634/stemcells.22-1-74; Odelius K, 2005, BIOMACROMOLECULES, V6, P2718, DOI 10.1021/bm050190b; Park J, 2007, BIOMATERIALS, V28, P2772, DOI 10.1016/j.biomaterials.2007.02.009; Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0; Sapkota D, 2011, EUR J CANCER, V47, P600, DOI 10.1016/j.ejca.2010.10.012; Suliman S, 2015, J CONTROL RELEASE, V197, P148, DOI 10.1016/j.jconrel.2014.11.003; Sun XQ, 2013, BIOMATERIALS, V34, P4971, DOI 10.1016/j.biomaterials.2013.03.015; Wong DA, 2008, SPINE J, V8, P1011, DOI 10.1016/j.spinee.2007.06.014; Xiao CW, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015013; Xing Z, 2013, TISSUE ENG PT A, V19, P1783, DOI [10.1089/ten.TEA.2012.0336, 10.1089/ten.tea.2012.0336]; Xing Z, 2011, J BIOMED MATER RES A, V96A, P349, DOI 10.1002/jbm.a.32989; Xue Y, 2010, J BIOMED MATER RES A, V95A, P1244, DOI 10.1002/jbm.a.32945; Yang L, 2010, J PERIODONTAL RES, V45, P532, DOI 10.1111/j.1600-0765.2009.01268.x; Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645; Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.tea.2010.0555, 10.1089/ten.TEA.2010.0555]; Zhao M, 2005, J CELL BIOCHEM, V95, P1, DOI 10.1002/jcb.20411	37	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147507	10.1371/journal.pone.0147507	http://dx.doi.org/10.1371/journal.pone.0147507			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808122	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800116
J	Shi, L; Li, NW; Wang, SQ; Zhou, YB; Huang, WJ; Yang, YC; Ma, YP; Zhou, RC				Shi, Lin; Li, Naiwei; Wang, Shuqiong; Zhou, Yubing; Huang, Weijie; Yang, Yuchen; Ma, Yongpeng; Zhou, Renchao			Molecular Evidence for the Hybrid Origin of Ilex dabieshanensis (Aquifoliaceae)	PLOS ONE			English	Article							SUNFLOWER HELIANTHUS-ANNUUS; SPECIES AQUIFOLIACEAE; ADAPTIVE INTROGRESSION; L. AQUIFOLIACEAE; SEQUENCE DATA; HYBRIDIZATION; HISTORY; BIOLOGY; MARKERS; TRAITS	Ilex, the largest genus of dioecious woody plants, is a good study system to assess the role of hybridization in speciation and evolution. Ilex dabieshanensis, a tree endemic to Dabieshan Mountains region, was initially described as a new species. Based on morphological intermediacy and sympatric distribution with its putative parental species, I. cornuta and I. latifolia, we proposed it as a natural hybrid between them. In this study, we sequenced one chloroplast intergenic spacer (trnH-psbA) and two nuclear genes (gapC and nepGS) in I. dabieshanensis and its putative parental species to test the hybrid origin hypothesis. Our results showed that there were one to two differentially fixed sequence differences between I. cornuta and I. latifolia at the two nuclear genes. Twelve of the 14 individuals of I. dabieshanensis exhibited additivity in chromatograms on these differentially fixed sites at both nuclear genes, and the remaining two exhibited additivity in chromatograms on the fixed site at only the nepGS gene. Except one haplotype of I. cornuta at the nepGS gene, all of the haplotypes of I. cornuta at the two nuclear genes were well separated from those of I. latifolia, and most haplotypes of I. dabieshanensis were shared with those of I. cornuta and I. latifolia. Phylogenetic analysis of these haplotypes was largely consistent with haplotype network analysis. I. cornuta and I. latifolia differed by two nucleotide substitutions in the chloroplast intergenic spacer, and 12 individuals of I. dabieshanensis had the same sequences as I. latifolia, while the remaining two were identical with I. cornuta. The molecular data provide convincing evidence for the hybrid origin of I. dabieshanensis and asymmetrical direction of hybridization. One haplotype of I. cornuta at the nepGS gene was nested with those of I. latifolia, indicating introgression to I. cornuta.	[Shi, Lin] Shunde Polytech, Foshan 528333, Peoples R China; [Li, Naiwei] Jiangsu Prov & Chinese Acad Sci, Inst Bot, Nanjing 210014, Jiangsu, Peoples R China; [Wang, Shuqiong; Zhou, Yubing; Huang, Weijie; Yang, Yuchen; Zhou, Renchao] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Shuqiong; Zhou, Yubing; Huang, Weijie; Yang, Yuchen; Zhou, Renchao] Sun Yat Sen Univ, Guangdong Prov Key Lab Plant Resources, Guangzhou 510275, Guangdong, Peoples R China; [Ma, Yongpeng] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming 650204, Peoples R China	Shunde Polytechnic; Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Zhou, RC (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.; Zhou, RC (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Plant Resources, Guangzhou 510275, Guangdong, Peoples R China.; Ma, YP (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming 650204, Peoples R China.	mayongpeng@mail.kib.ac.cn; zhrench@mail.sysu.edu.cn	Yang, Yuchen/GZK-6062-2022		National Natural Science Foundation of China [31170213, 91231106]; Fundamental Research Funds for the Central Universities [15lgjc23]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31170213 and 91231106) and the Fundamental Research Funds for the Central Universities (15lgjc23) to RZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Arnold Michael L., 2009, Journal of Biology (London), V8, P82, DOI 10.1186/jbiol176; BAAS P, 1978, BOT J LINN SOC, V77, P41, DOI 10.1111/j.1095-8339.1978.tb01371.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Chen S.K., 2008, FLORA CHINA, V11, P359; Chen S.-K., 1999, FLORA REIPUBLICAE PO, V45, P1; Cuenoud P, 2000, ANN BOT-LONDON, V85, P111, DOI 10.1006/anbo.1999.1003; Doyle J. J., 1987, PHYTOCHEM B, P11; Emshwiller E, 1999, MOL PHYLOGENET EVOL, V12, P310, DOI 10.1006/mpev.1999.0613; Galle F.C., 1997, HOLLIES GENUS ILEX; GARGIULLO MB, 1991, J CHEM ECOL, V17, P1091, DOI 10.1007/BF01402936; Gottlieb AM, 2005, AM J BOT, V92, P352, DOI 10.3732/ajb.92.2.352; Hamilton MB, 1999, MOL ECOL, V8, P521; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Lee NS, 2006, J PLANT BIOL, V49, P491, DOI 10.1007/BF03031131; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Loesener T., 1942, NATURLICHEN PFLANZ B, V20b, P36; Loizeau PA, 2004, FLOWERING PLANTS NEO, P26; Lu X, 2007, J JIANGSU FORESTRY S, V34, P32; Manen JF, 2010, MOL PHYLOGENET EVOL, V57, P961, DOI 10.1016/j.ympev.2010.09.006; Manen JF, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-46; Manen JF, 2002, PLANT SYST EVOL, V235, P79, DOI 10.1007/s00606-002-0225-x; Martinez MAD, 1997, BIOCHEM SYST ECOL, V25, P619, DOI 10.1016/S0305-1978(97)00054-9; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Powell M., 2000, KEW B, V55, P341; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Setoguchi H, 2000, AM J BOT, V87, P793, DOI 10.2307/2656887; Snow B. K., 1988, BIRDS BERRIES STUDY; Son SW, 2009, GENES GENOM, V31, P53, DOI 10.1007/BF03191138; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strand AE, 1997, MOL ECOL, V6, P113, DOI 10.1046/j.1365-294X.1997.00153.x; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsang ACW, 2005, CAN J BOT, V83, P1645, DOI 10.1139/b05-131; Whitney KD, 2006, AM NAT, V167, P794, DOI 10.1086/504606; Whitney KD, 2010, NEW PHYTOL, V187, P230, DOI 10.1111/j.1469-8137.2010.03234.x; Yao K., 1987, ACTA PHYTOTAXONOMICA, V25, P324	39	8	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147825	10.1371/journal.pone.0147825	http://dx.doi.org/10.1371/journal.pone.0147825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808531	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800218
J	Shokoohi, M; Karamouzian, M; Khajekazemi, R; Osooli, M; Sharifi, H; Haghdoost, AA; Kamali, K; Mirzazadeh, A				Shokoohi, Mostafa; Karamouzian, Mohammad; Khajekazemi, Razieh; Osooli, Mehdi; Sharifi, Hamid; Haghdoost, Ali Akbar; Kamali, Kianoush; Mirzazadeh, Ali			Correlates of HIV Testing among Female Sex Workers in Iran: Findings of a National Bio-Behavioural Surveillance Survey	PLOS ONE			English	Article							RISK BEHAVIORS; HIV/AIDS; PEOPLE	Introduction Female sex workers (FSWs) are the second most affected population by HIV in Iran. However, their HIV testing practices are poorly understood. The aim of this study was to investigate testing and its associated factors among HIV negative FSWs. Materials and Methods Using facility based sampling, 1005 FSWs were recruited in 14 cities of Iran in 2010. Biological and survey data were collected through dried blood spot testing and standardized risk assessment questionnaire, respectively. In this paper, the prevalence of HIV testing and its correlates were explored among 714 HIV-negative FSWs using descriptive statistics and logistic regression models. Results Overall 65.4% had not tested in the past year. Only 27.5% had tested in the past year and received their results. FSWs who perceived themselves at risk of HIV (Adjusted Odds Ratio (AOR) = 8.35, 95% CI: 1.46, 47.6), had received free condom during past year (AOR = 3.90, 95% CI: 1.67, 9.14), started sex work at an older age (AOR18-24 = 2.83, 95% CI: 1.14, 7.0; AOR (>24) = 2.76, 95% CI: 1.11, 6.84), and knew an HIV testing site (AOR = 5.67, 95% CI: 2.60, 12.4) had a significantly higher chance of having a recent HIV test result. Conclusions Less than one third of FSWs in Iran knew their recent HIV status. Interventions to help FSWs evaluate their potential risk for HIV and integrate HIV testing services in condom distribution programs, could be viable strategies in increasing HIV testing uptake among FSWs. Health policy makers should also try to de-stigmatize HIV testing, identify the barriers to HIV testing, and make HIV testing sites more visible to FSWs.	[Shokoohi, Mostafa; Karamouzian, Mohammad; Sharifi, Hamid; Mirzazadeh, Ali] Kerman Univ Med Sci, Reg Knowledge Hub, Kerman, Iran; [Shokoohi, Mostafa; Karamouzian, Mohammad; Sharifi, Hamid; Mirzazadeh, Ali] Kerman Univ Med Sci, WHO Collaborating Ctr HIV Surveillance, Inst Futures Studies Hlth, Kerman, Iran; [Khajekazemi, Razieh; Haghdoost, Ali Akbar] Kerman Univ Med Sci, Inst Futures Studies Hlth, Res Ctr Modeling Hlth, Kerman, Iran; [Osooli, Mehdi] Lund Univ, Dept Translat Med, Ctr Haemostasis & Thrombosis, Skane Univ Hosp, Lund, Sweden; [Kamali, Kianoush] Minist Hlth & Med Educ, Ctr Dis Control, Tehran, Iran; [Mirzazadeh, Ali] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization; Kerman University of Medical Sciences; Lund University; Skane University Hospital; Ministry of Health & Medical Education (MOHME); University of California System; University of California San Francisco	Karamouzian, M (corresponding author), Kerman Univ Med Sci, Reg Knowledge Hub, Kerman, Iran.; Karamouzian, M (corresponding author), Kerman Univ Med Sci, WHO Collaborating Ctr HIV Surveillance, Inst Futures Studies Hlth, Kerman, Iran.	Karamouzian.m@gmail.com	Karamouzian, Mohammad/C-9277-2018; Osooli, Mehdi/A-6457-2009; Mirzazadeh, Ali/AAJ-5907-2021; Haghdoost, Ali Akbar/C-2823-2009; Sharifi, Hamid/B-5493-2019	Karamouzian, Mohammad/0000-0002-5631-4469; Osooli, Mehdi/0000-0002-9862-3665; Haghdoost, Ali Akbar/0000-0003-4628-4849; Sharifi, Hamid/0000-0002-9008-7618	HIV/STI office at the Ministry of Health; Ministry of Health of Iran	HIV/STI office at the Ministry of Health; Ministry of Health of Iran	The authors are thankful to the HIV/STI office at the Ministry of Health for their technical and financial support of the study. We would also like to acknowledge the provincial university supervisors and staff who assisted us in data collection. Our gratitude also goes to the FSWs who took part in the study.; The survey was financially supported by the Ministry of Health of Iran in 2010. However, the authors received no funding for this specific paper.	[Anonymous], 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0120595, DOI 10.1371/JOURNAL.PONE.0120595]; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Chow EP, RISK BEHAV FEMALE SE; Deering KN, 2015, AIDS CARE, V27, P499, DOI 10.1080/09540121.2014.978730; Donoghoe M, 2009, WHO UNODC UNAIDS TEC; Dugas M, 2015, JAIDS-J ACQ IMM DEF, V68, pS198, DOI 10.1097/QAI.0000000000000463; Elhadi M, 2013, SEXUALLY TRANSMITTED; Fahimfar N, 2013, IRAN J PUBLIC HEALTH, V42, P98; Hong Y, 2012, AIDS BEHAV, V16, P44, DOI 10.1007/s10461-011-9960-8; Karamouzian M, 2015, J ASSOC NURSE AIDS C, V26, P46, DOI 10.1016/j.jana.2014.04.005; Karamouzian M, 2014, J ADOLESCENT HEALTH, V55, P149, DOI 10.1016/j.jadohealth.2014.04.009; Karamouzian M, 2014, INT J HEALTH POLICY, V2, P81, DOI 10.15171/ijhpm.2014.19; Kazerooni PA., 2014, J HLTH SCI SURVEILLA, V2, P99; Khajehkazemi R, 2014, SEX HEALTH, V11, P568, DOI 10.1071/SH14165; Kolahi A, 2012, QOM U MED SCI J, V6; Mirzazadeh A, 2014, AIDS BEHAV, V18, pS19, DOI 10.1007/s10461-013-0548-3; Mirzazadeh A, 2013, AIDS BEHAV, V17, P623, DOI 10.1007/s10461-012-0285-z; Mohebbi M, 2015, SEXUALLY TRANSMITTED, V81, P180; MOHME National AIDS Committee Secretariat, 2010, ISL REP IR AIDS PROG; Nasirian M, 2012, J RES HEALTH SCI, V12, P81; National ACS, 2015, ISLAMIC REPUBLIC IRA, P73; National AIDS Committee Secretariat Ministry of Health and Medical Education, 2015, ISL REP IR AIDS PROG; Parker SP, 1999, J CLIN PATHOL, V52, P633, DOI 10.1136/jcp.52.9.633; Rou KM, 2007, AIDS, V21, pS95, DOI 10.1097/01.aids.0000304703.77755.c7; Sajadi L, 2013, SEX TRANSM INFECT, V89, P37, DOI 10.1136/sextrans-2013-051028; Uddin SM, 2014, JPN J INFECT DIS, V67, P191, DOI 10.7883/yoken.67.191; UNAIDS, GLOB AIDS RESP PROGR; *UNAIDS, 2011, MIDDL E N AFR REG RE; UNAIDS, 2014, THE GAP REP; Valadez JJ, 2013, FILLING KNOWLEDGE GA; Xu JJ, 2011, SEX TRANSM DIS, V38, P89, DOI 10.1097/OLQ.0b013e3181f0bc5e	32	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147587	10.1371/journal.pone.0147587	http://dx.doi.org/10.1371/journal.pone.0147587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26807584	gold, Green Published, Green Submitted			2022-12-26	WOS:000369527800140
J	Simanski, M; Rademacher, F; Schroder, L; Glaser, R; Harder, J				Simanski, Maren; Rademacher, Franziska; Schroeder, Lena; Glaeser, Regine; Harder, Juergen			The Inflammasome and the Epidermal Growth Factor Receptor (EGFR) Are Involved in the Staphylococcus aureus-Mediated Induction of IL-1alpha and IL-1beta in Human Keratinocytes	PLOS ONE			English	Article							INTERLEUKIN-1-ALPHA SECRETION; HUMAN BETA-DEFENSIN-2; KAPPA-B; RNASE 7; SKIN; IL-1-BETA; ACTIVATION; EXPRESSION; PRECURSOR; ADAM17	Staphylococcus (S.) aureus is an important pathogen causing various infections including those of the skin. Keratinocytes are able to sense invading S. aureus and to initiate a fast defense reaction by the rapid release of innate defense mediators such as antimicrobial peptides and cytokines. There is increasing evidence that the cytokines IL-1alpha and IL-1beta, which both signal through the IL-1 receptor, play an important role in cutaneous defense against S. aureus. The aim of this study was to gain more insight into the underlying mechanisms leading to the S. aureus-induced IL-1alpha and IL-1beta expression in keratinocytes. Infection of human primary keratinocytes with S. aureus led to the induction of gene expression and protein secretion of IL-1alpha and IL-1beta. Full S. aureus-induced IL-1 protein release required the inflammasome components caspase-1 and ASC (apoptosis-associated speck-like protein containing a CARD) whereas gene induction of IL-1alpha and IL-1beta by S. aureus was not dependent on caspase-1 and ASC. Since patients receiving anti-cancer therapy by inhibition of the epidermal growth factor receptor (EGFR) often suffer from skin infections caused by S. aureus we additionally evaluated whether the EGFR pathway may be involved in the IL-1alpha and IL-1beta induction by S. aureus. Inactivation of the EGFR with a blocking antibody decreased the S. aureus-mediated IL-1alpha and IL-1beta induction in primary keratinocytes. Moreover, the use of siRNA experiments revealed that ADAM17 (A Disintegrin and A Metalloprotease 17), a metalloproteinase known to mediate the shedding and release of EGFR ligands, was required for full induction of IL-1alpha and IL-1beta in keratinocytes infected with S. aureus. A failure of keratinocytes to adequately upregulate IL-1alpha and IL-1beta may promote S. aureus skin infections.	[Simanski, Maren; Rademacher, Franziska; Schroeder, Lena; Glaeser, Regine; Harder, Juergen] Univ Kiel, Dept Dermatol, Schittenhelmstr 7, Kiel, Germany	University of Kiel	Harder, J (corresponding author), Univ Kiel, Dept Dermatol, Schittenhelmstr 7, Kiel, Germany.	jharder@dermatology.uni-kiel.de		Harder, Jurgen/0000-0002-4075-4603	German Research Foundation [HA 3386/5-1]	German Research Foundation(German Research Foundation (DFG))	This study was supported by a grant of the German Research Foundation given to JH (HA 3386/5-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Bartok E, 2013, NAT METHODS, V10, P147, DOI [10.1038/NMETH.2327, 10.1038/nmeth.2327]; Blaydon DC, 2011, NEW ENGL J MED, V365, P1502, DOI 10.1056/NEJMoa1100721; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Breshears LM, 2012, J BIOL CHEM, V287, P32578, DOI 10.1074/jbc.M112.352534; COOPER KD, 1990, J INVEST DERMATOL, V95, pS24, DOI 10.1111/1523-1747.ep12505698; Eilers RE, 2010, JNCI-J NATL CANCER I, V102, P47, DOI 10.1093/jnci/djp439; Erdag G, 2002, ANN SURG, V235, P113, DOI 10.1097/00000658-200201000-00015; Glaser R, 2014, J INVEST DERMATOL, V134, P2347, DOI 10.1038/jid.2014.176; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Grimstad O, 2013, J DERMATOL SCI, V72, P45, DOI 10.1016/j.jdermsci.2013.05.006; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Haugwitz U, 2006, CELL MICROBIOL, V8, P1591, DOI 10.1111/j.1462-5822.2006.00733.x; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Iwatsuki K, 2006, J DERMATOL SCI, V42, P203, DOI 10.1016/j.jdermsci.2006.03.011; Johnston A, 2011, J INVEST DERMATOL, V131, P329, DOI 10.1038/jid.2010.313; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kim B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00391; Kisich KO, 2007, J INVEST DERMATOL, V127, P2368, DOI 10.1038/sj.jid.5700861; Krishna S, 2012, SEMIN IMMUNOPATHOL, V34, P261, DOI 10.1007/s00281-011-0292-6; Lichtenberger BM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005886; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mempel M, 2003, J INVEST DERMATOL, V121, P1389, DOI 10.1111/j.1523-1747.2003.12630.x; Menzies BE, 2006, INFECT IMMUN, V74, P6847, DOI 10.1128/IAI.00389-06; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Miller LG, 2009, INFECT DIS CLIN N AM, V23, P35, DOI 10.1016/j.idc.2008.10.002; Milora KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6230; Mistry RD, 2013, PEDIATR CLIN N AM, V60, P1063, DOI 10.1016/j.pcl.2013.06.011; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Olaru F, 2010, J INVEST DERMATOL, V130, P1866, DOI 10.1038/jid.2010.37; Rose-John S, 2013, PHARMACOL RES, V71, P19, DOI 10.1016/j.phrs.2013.01.012; Roth SA, 2014, J INVEST DERMATOL, V134, P374, DOI 10.1038/jid.2013.313; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Simanski M, 2010, J INVEST DERMATOL, V130, P2836, DOI 10.1038/jid.2010.217; Sollberger G, 2012, J IMMUNOL, V188, P1992, DOI 10.4049/jimmunol.1101620; Soong G, 2012, J INFECT DIS, V205, P1571, DOI 10.1093/infdis/jis244; Wehkamp K, 2006, J INVEST DERMATOL, V126, P121, DOI 10.1038/sj.jid.5700020; Yazdi AS, 2013, ANN RHEUM DIS, V72, P96, DOI 10.1136/annrheumdis-2012-202252; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Yazdi AS, 2010, J INNATE IMMUN, V2, P228, DOI 10.1159/000283688; Zanger P, 2010, INFECT IMMUN, V78, P3112, DOI 10.1128/IAI.00078-10; Zanger P, 2009, J INFECT DIS, V200, P1907, DOI 10.1086/648408	47	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147118	10.1371/journal.pone.0147118	http://dx.doi.org/10.1371/journal.pone.0147118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808616	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800052
J	Ullrich, SR; Poehlein, A; Tischler, JS; Gonzalez, C; Ossandon, FJ; Daniel, R; Holmes, DS; Schlomann, M; Muhling, M				Ullrich, Sophie R.; Poehlein, Anja; Tischler, Judith S.; Gonzalez, Carolina; Ossandon, Francisco J.; Daniel, Rolf; Holmes, David S.; Schloemann, Michael; Muehling, Martin			Genome Analysis of the Biotechnologically Relevant Acidophilic Iron Oxidising Strain JA12 Indicates Phylogenetic and Metabolic Diversity within the Novel Genus "Ferrovum"	PLOS ONE			English	Article							PHOTOTROPHIC FE(II) OXIDATION; FORE-SUDETIC MONOCLINE; DNA-DNA HYBRIDIZATION; TRANSFER-RNA GENES; THIOBACILLUS-FERROOXIDANS; ACIDITHIOBACILLUS-FERROOXIDANS; RHODOBACTER-CAPSULATUS; MICROBIAL GENOMES; METAL RESISTANCE; DRAFT GENOME	Background Members of the genus "Ferrovum" are ubiquitously distributed in acid mine drainage (AMD) waters which are characterised by their high metal and sulfate loads. So far isolation and microbiological characterisation have only been successful for the designated type strain "Ferrovum myxofaciens" P3G. Thus, knowledge about physiological characteristics and the phylogeny of the genus "Ferrovum" is extremely scarce. Objective In order to access the wider genetic pool of the genus "Ferrovum" we sequenced the genome of a "Ferrovum"-containing mixed culture and successfully assembled the almost complete genome sequence of the novel "Ferrovum" strain JA12. Phylogeny and Lifestyle The genome-based phylogenetic analysis indicates that strain JA12 and the type strain represent two distinct "Ferrovum" species. "Ferrovum" strain JA12 is characterised by an unusually small genome in comparison to the type strain and other iron oxidising bacteria. The prediction of nutrient assimilation pathways suggests that "Ferrovum" strain JA12 maintains a chemolithoautotrophic lifestyle utilising carbon dioxide and bicarbonate, ammonium and urea, sulfate, phosphate and ferrous iron as carbon, nitrogen, sulfur, phosphorous and energy sources, respectively. Unique Metabolic Features The potential utilisation of urea by "Ferrovum" strain JA12 is moreover remarkable since it may furthermore represent a strategy among extreme acidophiles to cope with the acidic environment. Unlike other acidophilic chemolithoautotrophs "Ferrovum" strain JA12 exhibits a complete tricarboxylic acid cycle, a metabolic feature shared with the closer related neutrophilic iron oxidisers among the Betaproteobacteria including Sideroxydans lithotrophicus and Thiobacillus denitrificans. Furthermore, the absence of characteristic redox proteins involved in iron oxidation in the well-studied acidophiles Acidithiobacillus ferrooxidans (rusticyanin) and Acidithiobacillus ferrivorans (iron oxidase) indicates the existence of a modified pathway in "Ferrovum" strain JA12. Therefore, the results of the present study extend our understanding of the genus "Ferrovum" and provide a comprehensive framework for future comparative genome and metagenome studies.	[Ullrich, Sophie R.; Tischler, Judith S.; Schloemann, Michael; Muehling, Martin] TU Bergakad Freiberg, Inst Biol Sci, Leipziger Str 29, Freiberg, Germany; [Poehlein, Anja; Daniel, Rolf] Univ Gottingen, Genom & Appl Microbiol & Gottingen Genom Lab, Grisebachstr 8, D-37073 Gottingen, Germany; [Gonzalez, Carolina] Fraunhofer Chile Res Fdn, Ctr Syst Biotechnol, Biocomp Div, Ave Mariano Sanchez Fontecilla 310, Santiago, Chile; [Gonzalez, Carolina] Fraunhofer Chile Res Fdn, Appl Genet Div, Ave Mariano Sanchez Fontecilla 310, Santiago, Chile; [Gonzalez, Carolina; Ossandon, Francisco J.; Holmes, David S.] Fnd Ciencia & Vida, Ctr Bioinformat & Genome Biol, Zanartu 1482, Chile; [Gonzalez, Carolina; Ossandon, Francisco J.; Holmes, David S.] Univ Andres Bello, Fac Ciencias Biol, Ave Los Leones 745, Santiago, Chile	Technical University Freiberg; University of Gottingen; Universidad Andres Bello	Ullrich, SR; Muhling, M (corresponding author), TU Bergakad Freiberg, Inst Biol Sci, Leipziger Str 29, Freiberg, Germany.	sophie.ullrich@ioez.tu-freiberg.de; martin.muehling@ioez.tu-freiberg.de	Tischler, Judith/I-4433-2019; Daniel, Rolf/AAQ-5933-2021	Daniel, Rolf/0000-0002-8646-7925; Holmes, David/0000-0001-9555-138X; Poehlein, Anja/0000-0002-2473-6202; Gonzalez Rosales, Carolina/0000-0003-3566-4758	ESF junior research group GETGEOWEB [100101363]; German Federal Ministry of Education and Research (BMBF) through project SURFTRAP-II [03G0821B]; Basal Program of CONICYT [PFB16];  [FONDECYT 1130683];  [FONDECYT 3140005]	ESF junior research group GETGEOWEB; German Federal Ministry of Education and Research (BMBF) through project SURFTRAP-II(Federal Ministry of Education & Research (BMBF)); Basal Program of CONICYT; ; 	This project was funded by the ESF junior research group GETGEOWEB (project nr. 100101363) awarded to MS and MM, with additional support from the German Federal Ministry of Education and Research (BMBF) through project SURFTRAP-II (03G0821B) awarded to MS and through grants FONDECYT 1130683, FONDECYT 3140005, and the Basal Program of CONICYT PFB16 which were awarded to DSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Amouric A, 2011, MICROBIOL-SGM, V157, P111, DOI 10.1099/mic.0.044537-0; Andrews S., 2010, FASTQC QUALITY CONTR; Appia-Ayme C, 1999, APPL ENVIRON MICROB, V65, P4781; Appia-Ayme C, 2006, HYDROMETALLURGY, V83, P273, DOI 10.1016/j.hydromet.2006.03.029; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Baker-Austin C, 2007, TRENDS MICROBIOL, V15, P165, DOI 10.1016/j.tim.2007.02.005; Banks D, 1997, ENVIRON GEOL, V32, P157, DOI 10.1007/s002540050204; Barreto M, 2005, APPL ENVIRON MICROB, V71, P2902, DOI 10.1128/AEM.71.6.2902-2909.2005; Bathe S, 2007, APPL ENVIRON MICROB, V73, P2491, DOI 10.1128/AEM.02589-06; Beller HR, 2006, J BACTERIOL, V188, P1473, DOI 10.1128/JB.188.4.1473-1488.2006; BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994; Bertin PN, 2011, ISME J, V5, P1735, DOI 10.1038/ismej.2011.51; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonnefoy V, 2012, ENVIRON MICROBIOL, V14, P1597, DOI 10.1111/j.1462-2920.2011.02626.x; Boyd ES, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00349; Brown JF, 2011, APPL ENVIRON MICROB, V77, P545, DOI 10.1128/AEM.01550-10; Bruscella P, 2007, MICROBIOL-SGM, V153, P102, DOI 10.1099/mic.0.2006/000067-0; Butcher BG, 2000, APPL ENVIRON MICROB, V66, P1826, DOI 10.1128/AEM.66.5.1826-1833.2000; Butcher BG, 2002, MICROBIOL-SGM, V148, P3983, DOI 10.1099/00221287-148-12-3983; Byrne-Bailey KG, 2012, J BACTERIOL, V194, P2400, DOI 10.1128/JB.00214-12; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cannon GC, 2001, APPL ENVIRON MICROB, V67, P5351, DOI 10.1128/AEM.67.12.5351-5361.2001; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Chevreux B, 1999, GENOME RES, V14, P1147; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; Croal LR, 2007, J BACTERIOL, V189, P1774, DOI 10.1128/JB.01395-06; Darbari VC, 2015, ANNU REV BIOCHEM, V84, P603, DOI 10.1146/annurev-biochem-062911-102821; DINH T, 1994, J BACTERIOL, V176, P3825, DOI 10.1128/JB.176.13.3825-3831.1994; Dopson M, 2005, MICROBIOL-SGM, V151, P4127, DOI 10.1099/mic.0.28362-0; Dopson M, 2003, MICROBIOL-SGM, V149, P1959, DOI 10.1099/mic.0.26296-0; Dopson M, 2014, APPL MICROBIOL BIOT, V98, P8133, DOI 10.1007/s00253-014-5982-2; EATON KA, 1991, INFECT IMMUN, V59, P2470, DOI 10.1128/IAI.59.7.2470-2475.1991; Emerson D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00254; Esparza M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-229; Fabisch M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00390; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fujimura R, 2012, J BACTERIOL, V194, P4122, DOI 10.1128/JB.00696-12; Futterer O, 2004, P NATL ACAD SCI USA, V101, P9091, DOI 10.1073/pnas.0401356101; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Gonzalez-Toril E, 2003, APPL ENVIRON MICROB, V69, P4853, DOI 10.1128/AEM.69.8.4853-4865.2003; Gonzalez-Toril E, 2011, APPL ENVIRON MICROB, V77, P2685, DOI 10.1128/AEM.02459-10; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Grogan DW, 1997, MICROBIOL MOL BIOL R, V61, P429, DOI 10.1128/.61.4.429-441.1997; Hallberg KB, 2006, APPL ENVIRON MICROB, V72, P2022, DOI 10.1128/AEM.72.3.2022-2030.2006; HARRISON AP, 1980, J BACTERIOL, V143, P448, DOI 10.1128/JB.143.1.448-454.1980; Hayes ET, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-89; Hedrich S, 2012, BIORESOURCE TECHNOL, V106, P44, DOI 10.1016/j.biortech.2011.11.130; Hedrich S, 2011, ENVIRON SCI TECHNOL, V45, P7685, DOI 10.1021/es201564g; Hedrich S, 2011, MICROBIOL-SGM, V157, P1551, DOI 10.1099/mic.0.045344-0; Heijerick DG, 2002, COMP BIOCHEM PHYS C, V133, P207, DOI 10.1016/S1532-0456(02)00077-7; Heinzel E, 2009, ENVIRON SCI TECHNOL, V43, P6138, DOI 10.1021/es900067d; Heinzel E, 2009, APPL ENVIRON MICROB, V75, P858, DOI 10.1128/AEM.01045-08; Holmes D.S., 2007, BIOMINING, P281, DOI 10.1007/978-3-540-34911-2_14; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; Hua ZS, 2015, ISME J, V9, P1280, DOI 10.1038/ismej.2014.212; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ilbert M, 2013, BBA-BIOENERGETICS, V1827, P161, DOI 10.1016/j.bbabio.2012.10.001; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; INGLEDEW WJ, 1982, BIOCHIM BIOPHYS ACTA, V683, P89, DOI 10.1016/0304-4173(82)90007-6; Jendrossek D, 2014, ENVIRON MICROBIOL, V16, P2357, DOI 10.1111/1462-2920.12356; Jiao Y, 2007, J BACTERIOL, V189, P1765, DOI 10.1128/JB.00776-06; Johnson DB, 2014, APPL ENVIRON MICROB, V80, P672, DOI 10.1128/AEM.03230-13; JOHNSON DB, 1991, J MICROBIOL METH, V13, P113, DOI 10.1016/0167-7012(91)90011-E; JOHNSON DB, 1995, INT BIODETER BIODEGR, V35, P41, DOI 10.1016/0964-8305(95)00065-D; Johnson DB, 2005, SCI TOTAL ENVIRON, V338, P3, DOI 10.1016/j.scitotenv.2004.09.002; JOHNSON DB, 1995, J MICROBIOL METH, V23, P205, DOI 10.1016/0167-7012(95)00015-D; JOHNSON DB, 1983, J GEN MICROBIOL, V129, P2969; Jones DS, 2015, APPL ENVIRON MICROB, V81, P1242, DOI 10.1128/AEM.02919-14; Jones DS, 2012, ISME J, V6, P158, DOI 10.1038/ismej.2011.75; Jormakka M, 2003, CURR OPIN STRUC BIOL, V13, P418, DOI 10.1016/S0959-440X(03)00098-8; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kay CM, 2014, RES MICROBIOL, V165, P705, DOI 10.1016/j.resmic.2014.07.007; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; Kimura S, 2011, ENVIRON MICROBIOL, V13, P2092, DOI 10.1111/j.1462-2920.2011.02434.x; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Leplae R, 2010, NUCLEIC ACIDS RES, V38, pD57, DOI 10.1093/nar/gkp938; Liljeqvist M, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv011; Liljeqvist M, 2011, J BACTERIOL, V193, P4304, DOI 10.1128/JB.05373-11; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; Liu J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00037; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Maaty WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006964; Mangold S, 2013, EXTREMOPHILES, V17, P75, DOI 10.1007/s00792-012-0495-3; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Martinez-Cano DJ, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00742; Masepohl B, 2001, J BACTERIOL, V183, P637, DOI 10.1128/JB.183.2.637-643.2001; Matlakowska R, 2012, FEMS MICROBIOL ECOL, V81, P99, DOI 10.1111/j.1574-6941.2012.01326.x; Matlakowska R, 2011, CHEMOSPHERE, V83, P1255, DOI 10.1016/j.chemosphere.2011.03.003; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Meier-Kolthoff JP, 2014, INT J SYST EVOL MICR, V64, P352, DOI 10.1099/ijs.0.056994-0; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Mendez-Garcia C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00475; Merrick JM., 1978, PHOTOSYNTHETIC BACTE, P199; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Moriarty TF, 2006, LETT APPL MICROBIOL, V42, P617, DOI 10.1111/j.1472-765X.2006.01930.x; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Mosler S, 2013, ADV MATER RES-SWITZ, V825, P153, DOI 10.4028/www.scientific.net/AMR.825.153; Mossey P, 2010, J BACTERIOL, V192, P2830, DOI 10.1128/JB.01331-09; Moya-Beltran A, 2014, GENOME ANNOUNC, DOI [10.1128/genomeA.00834-14, DOI 10.1128/GEN0MEA.00834-14]; Mukhopadhyay R, 2002, ENVIRON HEALTH PERSP, V110, P745, DOI 10.1289/ehp.02110s5745; Nascimento Andrea M A, 2003, Genet Mol Res, V2, P92; Nicolle JLC, 2009, MICROBIOL-SGM, V155, P1302, DOI 10.1099/mic.0.023192-0; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Osorio H, 2013, APPL ENVIRON MICROB, V79, P2172, DOI 10.1128/AEM.03057-12; Cardenas JP, 2012, HYDROMETALLURGY, V127, P162, DOI 10.1016/j.hydromet.2012.07.014; Cardenas JP, 2010, APPL MICROBIOL BIOT, V88, P605, DOI 10.1007/s00253-010-2795-9; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Paytan A, 2007, CHEM REV, V107, P563, DOI 10.1021/cr0503613; Poynton RA, 2014, BBA-GEN SUBJECTS, V1840, P906, DOI 10.1016/j.bbagen.2013.08.001; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; Quatrini R, 2006, HYDROMETALLURGY, V83, P263, DOI 10.1016/j.hydromet.2006.03.030; Quatrini R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-394; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Riadi G, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/678761; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rowe OF, 2008, SYST APPL MICROBIOL, V31, P68, DOI 10.1016/j.syapm.2007.09.001; Santofimia E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066746; Schippers A., 2004, 379 GEOL SOC AM, V379, P49, DOI DOI 10.1130/0-8137-2379-5.49; Seufferheld MJ, 2008, APPL ENVIRON MICROB, V74, P5867, DOI 10.1128/AEM.00501-08; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Singer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025386; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; Soboh B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-173; Stolz JF, 2002, CHEMBIOCHEM, V3, P198, DOI 10.1002/1439-7633(20020301)3:2/3<198::AID-CBIC198>3.0.CO;2-C; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; The GAP Group, 2012, GAP GROUPS ALG PROGR; Tischler JS, 2014, WATER RES, V48, P345, DOI 10.1016/j.watres.2013.09.049; Tischler JS, 2013, J MICROBIOL METH, V95, P138, DOI 10.1016/j.mimet.2013.07.027; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Ullrich SR, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0040-y; Valdes J, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-51; Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597; Van Driessche G, 2003, J MOL EVOL, V57, P181, DOI 10.1007/s00239-003-2465-y; Viollier E, 2000, APPL GEOCHEM, V15, P785, DOI 10.1016/S0883-2927(99)00097-9; Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x; WALLING C, 1975, ACCOUNTS CHEM RES, V8, P125, DOI 10.1021/ar50088a003; WALTON KC, 1992, ENVIRON POLLUT, V76, P169, DOI 10.1016/0269-7491(92)90105-J; Wang Y, 2014, BIOSCI BIOTECH BIOCH, V78, P1274, DOI 10.1080/09168451.2014.915735; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wong KKY, 2001, J BACTERIOL, V183, P367, DOI 10.1128/JB.183.1.367-374.2001; Wood AP, 2004, FEMS MICROBIOL REV, V28, P335, DOI 10.1016/j.femsre.2003.12.001; You XY, 2011, J GENET GENOMICS, V38, P243, DOI 10.1016/j.jgg.2011.04.006; Young GM, 1996, J BACTERIOL, V178, P6487, DOI 10.1128/jb.178.22.6487-6495.1996; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	157	30	31	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146832	10.1371/journal.pone.0146832	http://dx.doi.org/10.1371/journal.pone.0146832			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808278	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800034
J	Verma, SK; Garikipati, VNS; Krishnamurthy, P; Khan, M; Thorne, T; Qin, GJ; Losordo, DW; Kishore, R				Verma, Suresh K.; Garikipati, Venkata Naga Srikanth; Krishnamurthy, Prasanna; Khan, Mohsin; Thorne, Tina; Qin, Gangjian; Losordo, Douglas W.; Kishore, Raj			IL-10 Accelerates Re-Endothelialization and Inhibits Post-Injury Intimal Hyperplasia following Carotid Artery Denudation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; DRUG-ELUTING STENT; MUSCLE-CELL-PROLIFERATION; VASCULAR INJURY; CYCLIN-A; TRANSCRIPTIONAL REPRESSION; INFLAMMATORY RESPONSE; NEOINTIMAL FORMATION; INTERLEUKIN-10; REENDOTHELIALIZATION	The role of inflammation on atherosclerosis and restenosis is well established. Restenosis is thought to be a complex response to injury, which includes early thrombus formation, acute inflammation and neo-intimal growth. Inflammatory cells are likely contributors in the host response to vascular injury, via cytokines and chemokines secretion, including TNFalpha (TNF). We have previously shown that IL-10 inhibits TNF and other inflammatory mediators produced in response to cardiovascular injuries. The specific effect of IL-10 on endothelial cell (ECs) biology is not well elucidated. Here we report that in a mouse model of carotid denudation, IL-10 knock-out mice (IL-10KO) displayed significantly delayed Re-endothelialization and enhanced neo-intimal growth compared to their WT counterparts. Exogenous recombinant IL-10 treatment dramatically blunted the neo-intimal thickening while significantly accelerating the recovery of the injured endothelium in WT mice. In vitro, IL-10 inhibited negative effects of TNF on ECs proliferation, ECs cell cycle, ECs-monocyte adhesion and ECs apoptosis. Furthermore, IL-10 treatment attenuated TNF-induced smooth muscle cells proliferation. Our data suggest that IL-10 differentially regulate endothelial and vascular smooth cells proliferation and function and thus inhibits neo-intimal hyperplasia. Thus, these results may provide insights necessary to develop new therapeutic strategies to limit vascular restenosis during percutaneous coronary intervention (PCI) in the clinics.	[Verma, Suresh K.; Garikipati, Venkata Naga Srikanth; Khan, Mohsin; Kishore, Raj] Temple Univ, Ctr Translat Med, Philadelphia, PA 19122 USA; [Kishore, Raj] Temple Univ, Dept Pharmacol, Philadelphia, PA 19122 USA; [Krishnamurthy, Prasanna] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX USA; [Thorne, Tina; Qin, Gangjian; Losordo, Douglas W.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; The Methodist Hospital System; The Methodist Hospital - Houston; Northwestern University; Feinberg School of Medicine	Kishore, R (corresponding author), Temple Univ, Ctr Translat Med, Philadelphia, PA 19122 USA.; Kishore, R (corresponding author), Temple Univ, Dept Pharmacol, Philadelphia, PA 19122 USA.	raj.kishore@temple.edu	Verma, Suresh/AAU-9979-2020	Verma, Suresh Kumar/0000-0002-0739-1302; KRISHNAMURTHY, PRASANNA/0000-0002-4842-6364; Losordo, Douglas/0000-0002-6857-7506	National Institutes of Health [HL091983, HL105597, HL126186, HL053354, HL108795]; American Heart Association-Scientist Development [14SDG20480104]; American Heart Association-Postdoctoral grant [15POST22720022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108795, R01HL091983, R01HL126186, R01HL116729, R01HL105597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association-Scientist Development(American Heart Association); American Heart Association-Postdoctoral grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All the work described in this manuscript was supported in part by National Institutes of Health grant numbers HL091983, HL105597, HL126186, HL053354, and HL108795 to R.K.; American Heart Association-Scientist Development Grant 14SDG20480104 to S.K.V.; American Heart Association-Postdoctoral grant 15POST22720022 to V.N.S.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Biswas R, 2003, J IMMUNOL, V170, P6202, DOI 10.4049/jimmunol.170.12.6202; Chaabane C, 2013, CARDIOVASC RES, V99, P353, DOI 10.1093/cvr/cvt115; Chen JP, 2008, SOUTH MED J, V101, P174, DOI 10.1097/01.smj.0000286752.67205.e0; Colombo A, 2004, J AM COLL CARDIOL, V43, P24, DOI 10.1016/j.jacc.2003.10.015; Curcio A, 2011, CIRC J, V75, P1287, DOI 10.1253/circj.CJ-11-0366; De Haro J, 2014, J VASC SURG; Donato AJ, 2015, J MOL CELL CARDIOL; Douglas G, 2013, EUR HEART J, V34, P3378, DOI 10.1093/eurheartj/ehs240; Feldman LJ, 2000, CIRCULATION, V101, P908, DOI 10.1161/01.CIR.101.8.908; Gasparyan AY, 2008, J AM COLL CARDIOL, V51, P1829, DOI 10.1016/j.jacc.2007.11.080; HANCOCK WW, 1994, AM J PATHOL, V145, P1008; HENGLEIN B, 1994, P NATL ACAD SCI USA, V91, P5490, DOI 10.1073/pnas.91.12.5490; Indolfi C, 2005, AM J CARDIOL, V95, P1146, DOI 10.1016/j.amjcard.2005.01.040; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Kibos A, 2007, Acute Card Care, V9, P111, DOI 10.1080/17482940701263285; Kishore R, 2005, J CLIN INVEST, V115, P1785, DOI 10.1172/JCI22849; Kishore R, 2003, CIRC RES, V93, P932, DOI 10.1161/01.RES.0000102400.22370.20; Kishore R, 1999, J IMMUNOL, V162, P2457; Kishore R, 2002, CIRC RES, V91, P307, DOI 10.1161/01.RES.0000031744.06353.D3; Krasinski K, 2001, CIRCULATION, V104, P1754, DOI 10.1161/hc4001.098046; Krishnamurthy P, 2010, FASEB J, V24, P2484, DOI 10.1096/fj.09-149815; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Luedemann C, 2005, ALCOHOL CLIN EXP RES, V29, P930, DOI 10.1097/01.ALC.0000171037.90100.6B; Maffia P, 2006, CIRCULATION, V114, P430, DOI 10.1161/CIRCULATIONAHA.105.602714; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; McDonald RA, 2015, J AM COLL CARDIOL, V65, P2314, DOI 10.1016/j.jacc.2015.03.549; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Murayama H, 2008, CARDIOVASC RES, V80, P175, DOI 10.1093/cvr/cvn250; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Roubille F, 2014, ATHEROSCLEROSIS, V236, P277, DOI 10.1016/j.atherosclerosis.2014.07.012; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Shah N, 2012, CURR ALLERGY ASTHM R, V12, P373, DOI 10.1007/s11882-012-0286-z; Slottow TLP, 2007, AM J CARDIOL, V100, p10M, DOI 10.1016/j.amjcard.2007.08.017; Verma SK, 2012, CIRCULATION, V126, P418, DOI 10.1161/CIRCULATIONAHA.112.112185; Yoneda S, 2013, CORONARY ARTERY DIS, V24, P368, DOI 10.1097/MCA.0b013e32836222ec; Zymek P, 2007, CARDIOVASC RES, V74, P313, DOI 10.1016/j.cardiores.2006.11.028	36	17	18	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147615	10.1371/journal.pone.0147615	http://dx.doi.org/10.1371/journal.pone.0147615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808574	Green Published, gold, Green Submitted			2022-12-26	WOS:000369527800149
J	Cho, Y; Chang, JS; Rha, KH; Hong, SJ; Choi, YD; Ham, WS; Kim, JW; Cho, J				Cho, Yeona; Chang, Jee Suk; Rha, Koon Ho; Hong, Sung Joon; Choi, Young Deuk; Ham, Won Sik; Kim, Jun Won; Cho, Jaeho			Does Radiotherapy for the Primary Tumor Benefit Prostate Cancer Patients with Distant Metastasis at Initial Diagnosis?	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; RADIATION-THERAPY; BREAST-CANCER; SURVIVAL; DISEASE; IMMUNOTHERAPY	Purpose/Objectives Treatment of the primary tumor reportedly improves survival in several types of metastatic cancer. We herein evaluated the efficacy and toxicity of radiotherapy for the primary tumor in prostate cancer with metastasis. Materials/Methods The study cohort included 140 men with metastatic prostate cancer at initial diagnosis. Metastatic sites were divided into 4 groups as follows: solitary bone, 2-4 bones, >= 5 bones, and visceral organs. Patient, tumor, and treatment characteristics, and clinical outcomes were compared between patients treated with (prostate radiotherapy [PRT] group) or without radiotherapy to the primary tumor. Results Patients in PRT group presented with a statistically significantly younger age (p = .02), whereas other characteristics showed no significant difference. Overall survival (OS) and biochemical failure-free survival (BCFFS) were improved in PRT patients (3-year OS: 69% vs. 43%, p = 0.004; 3-year BCFFS: 52% vs. 16%, p = 0.002). Multivariate analysis identified PRT as a significant predictor of both OS (hazard ratio [HR] = 0.43, p = 0.015). None of the 38 PRT patients experienced severe (grade >= 3) genitourinary or gastrointestinal toxicity. Conclusions Our data suggest that radiotherapy to the primary tumor was associated with improved OS and BCFFS in metastatic prostate cancer. The results of this study warrant prospective controlled clinical trials of this approach in stage IV prostate cancer patients with limited extent of bone metastasis and good performance status.	[Cho, Yeona; Chang, Jee Suk; Kim, Jun Won; Cho, Jaeho] Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul 120749, South Korea; [Rha, Koon Ho; Hong, Sung Joon; Choi, Young Deuk; Ham, Won Sik] Yonsei Univ, Coll Med, Dept Urol, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Cho, J (corresponding author), Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul 120749, South Korea.	jjhmd@yuhs.ac	Anshari, Dien/B-9544-2018; Cho, Yeona/AAT-3257-2021; Cho, Yoo Jin/I-8291-2018	Anshari, Dien/0000-0002-7984-0111; Cho, Yoo Jin/0000-0001-9590-9206; Borland, Ron/0000-0003-0059-178X; McKeever, Robert/0000-0002-5924-0514; Rha, Koon Ho/0000-0001-8588-7584; Ham, Won Sik/0000-0003-2246-8838; cho, Yeona/0000-0002-1202-0880; Hong, Sung Joon/0000-0001-9869-065X; Choi, Young Deuk/0000-0002-8545-5797; Chang, Jee Suk/0000-0001-7685-3382; Kim, Jun Won/0000-0003-1358-364X; Cho, Jaeho/0000-0001-9966-5157	Yonsei University College of Medicine [6-2014-0031]; NATIONAL CANCER INSTITUTE [R01CA167067] Funding Source: NIH RePORTER	Yonsei University College of Medicine(General Electric); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a faculty research grant from Yonsei University College of Medicine in 2014 (6-2014-0031).	Adli M, 2006, J NATL CANCER I, V98, P364, DOI 10.1093/jnci/djj077; Boehmer D, 2006, RADIOTHER ONCOL, V79, P259, DOI 10.1016/j.radonc.2006.05.012; Camphausen K, 2001, CANCER RES, V61, P2207; Coen JJ, 2002, J CLIN ONCOL, V20, P3199, DOI 10.1200/JCO.2002.01.086; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Demaria S, 2004, INT J RADIAT ONCOL, V58, P862, DOI 10.1016/j.ijrobp.2003.09.012; Engel J, 2010, EUR UROL, V57, P754, DOI 10.1016/j.eururo.2009.12.034; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; Gandaglia G, 2015, EUR UROL, V68, P325, DOI 10.1016/j.eururo.2014.07.020; Glass TR, 2003, J UROLOGY, V169, P164, DOI 10.1016/S0022-5347(05)64059-1; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Lam JS, 2006, J UROLOGY, V175, P27, DOI 10.1016/S0022-5347(05)00034-0; Lee IJ, 2009, INT J RADIAT ONCOL, V73, P1517, DOI 10.1016/j.ijrobp.2008.07.035; McGrath SD, 2010, BRACHYTHERAPY, V9, P137, DOI 10.1016/j.brachy.2009.07.005; Mickisch GHJ, 2001, LANCET, V358, P966, DOI 10.1016/S0140-6736(01)06103-7; Mohler JL, 2012, J NATL COMPR CANC NE, V10, P1081, DOI 10.6004/jnccn.2012.0114; Morgan SC, 2011, NAT REV CLIN ONCOL, V8, P504, DOI 10.1038/nrclinonc.2011.88; Nguyen DHA, 2012, ANN SURG ONCOL, V19, P3028, DOI 10.1245/s10434-012-2333-3; Nguyen DHA, 2012, INT J RADIAT ONCOL, V84, P39, DOI 10.1016/j.ijrobp.2011.11.046; Norgaard M, 2010, J UROLOGY, V184, P162, DOI 10.1016/j.juro.2010.03.034; Parker CC, 2013, BJU INT, V111, P697, DOI 10.1111/bju.12087; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Rapiti E, 2006, J CLIN ONCOL, V24, P2743, DOI 10.1200/JCO.2005.04.2226; Staehler MD, 2010, WORLD J UROL, V28, P543, DOI 10.1007/s00345-010-0560-4; Suzman DL, 2014, THER ADV MED ONCOL, V6, P167, DOI 10.1177/1758834014529176; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Temple LKF, 2004, J CLIN ONCOL, V22, P3475, DOI 10.1200/JCO.2004.10.218; Weckermann D, 2009, J CLIN ONCOL, V27, P1549, DOI 10.1200/JCO.2008.17.0563; Zelefsky MJ, 2008, INT J RADIAT ONCOL, V70, P1124, DOI 10.1016/j.ijrobp.2007.11.044; Zelefsky MJ, 2002, INT J RADIAT ONCOL, V53, P1111, DOI 10.1016/S0360-3016(02)02857-2	32	74	75	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147191	10.1371/journal.pone.0147191	http://dx.doi.org/10.1371/journal.pone.0147191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807740	Green Published, Green Submitted, gold			2022-12-26	WOS:000369527800057
J	Cho, YJ; Thrasher, JF; Swayampakala, K; Yong, HH; McKeever, R; Hammond, D; Anshari, D; Cummings, KM; Borland, R				Cho, Yoo Jin; Thrasher, James F.; Swayampakala, Kamala; Yong, Hua-Hie; McKeever, Robert; Hammond, David; Anshari, Dien; Cummings, K. Michael; Borland, Ron			Does Reactance against Cigarette Warning Labels Matter? Warning Label Responses and Downstream Smoking Cessation amongst Adult Smokers in Australia, Canada, Mexico and the United States	PLOS ONE			English	Article							PSYCHOLOGICAL REACTANCE; HEALTH WARNINGS; SENSATION SEEKING; TRAIT REACTANCE; IMPACT; MESSAGES	Objective Some researchers have raised concerns that pictorial health warning labels (HWLs) on cigarette packages may lead to message rejection and reduced effectiveness of HWL messages. This study aimed to determine how state reactance (i.e., negative affect due to perceived manipulation) in response to both pictorial and text-only HWLs is associated with other types of HWL responses and with subsequent cessation attempts. Methods Survey data were collected every 4 months between September 2013 and 2014 from online panels of adult smokers in Australia, Canada, Mexico, and the US were analyzed. Participants with at least one wave of follow-up were included in the analysis (n = 4,072 smokers; 7,459 observations). Surveys assessed psychological and behavioral responses to HWLs (i.e., attention to HWLs, cognitive elaboration of risks due to HWLs, avoiding HWLs, and forgoing cigarettes because of HWLs) and cessation attempts. Participants then viewed specific HWLs from their countries and were queried about affective state reactance. Logistic and linear Generalized Estimating Equation (GEE) models regressed each of the psychological and behavioral HWL responses on reactance, while controlling for socio-demographic and smoking-related variables. Logistic GEE models also regressed having attempted to quit by the subsequent survey on reactance, each of the psychological and behavioral HWL responses (analyzed separately), adjustment variables. Data from all countries were initially pooled, with interactions between country and reactance assessed; when interactions were statistically significant, country-stratified models were estimated. Results Interactions between country and reactance were found in all models that regressed psychological and behavioral HWL responses on study variables. In the US, stronger reactance was associated with more frequent reading of HWLs and thinking about health risks. Smokers from all four countries with stronger reactance reported greater likelihood of avoiding warnings and forgoing cigarettes due to warnings, although the association appeared stronger in the US. Both stronger HWLs responses and reactance were positively associated with subsequent cessation attempts, with no significant interaction between country and reactance. Conclusions Reactance towards HWLs does not appear to interfere with quitting, which is consistent with its being an indicator of concern, not a systematic effort to avoid HWL message engagement.	[Cho, Yoo Jin; Thrasher, James F.; Swayampakala, Kamala; Anshari, Dien] Univ South Carolina, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA; [Thrasher, James F.] Natl Inst Publ Hlth, Dept Tobacco Res, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico; [Yong, Hua-Hie; Borland, Ron] Canc Council Victoria, Melbourne, Vic, Australia; [McKeever, Robert] Univ South Carolina, Sch Journalism & Mass Commun, Columbia, SC 29208 USA; [Hammond, David] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada; [Anshari, Dien] Univ Indonesia, Fac Publ Hlth, Dept Hlth Educ & Behav Sci, Depok, Indonesia; [Cummings, K. Michael] Med Univ South Carolina, Dept Psychiat & Behav Sci, 171 Ashley Ave, Charleston, SC 29425 USA	University of South Carolina System; University of South Carolina Columbia; Instituto Nacional de Salud Publica; Cancer Council Victoria; University of South Carolina System; University of South Carolina Columbia; University of Waterloo; University of Indonesia; Medical University of South Carolina	Cho, YJ (corresponding author), Univ South Carolina, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA.	ycho@email.sc.edu	Anshari, Dien/B-9544-2018; Cho, Yeona/AAT-3257-2021; Cho, Yoo Jin/I-8291-2018	Anshari, Dien/0000-0002-7984-0111; Cho, Yoo Jin/0000-0001-9590-9206; Borland, Ron/0000-0003-0059-178X; McKeever, Robert/0000-0002-5924-0514; Rha, Koon Ho/0000-0001-8588-7584; Ham, Won Sik/0000-0003-2246-8838; cho, Yeona/0000-0002-1202-0880; Hong, Sung Joon/0000-0001-9869-065X; Choi, Young Deuk/0000-0002-8545-5797; Chang, Jee Suk/0000-0001-7685-3382; Kim, Jun Won/0000-0003-1358-364X; Cho, Jaeho/0000-0001-9966-5157	U.S. National Cancer Institute [R01 CA167067]; NATIONAL CANCER INSTITUTE [R01CA167067] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Data collection and analyses for the study were funded by a grant from the U.S. National Cancer Institute (R01 CA167067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanton H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096315; Borland R, 2009, TOB CONTROL, V18, P358, DOI 10.1136/tc.2008.028043; Borland R, 2014, UNDERSTANDING HARD T; Brehm SS, 1981, PSYCHOLOGICAL REACTA; Dillard JP, 2005, COMMUN MONOGR, V72, P144, DOI 10.1080/03637750500111815; Emery LF, 2014, NICOTINE TOB RES, V16, P263, DOI 10.1093/ntr/ntt124; Erceg-Hurn DM, 2011, J APPL SOC PSYCHOL, V41, P219, DOI 10.1111/j.1559-1816.2010.00710.x; Fathelrahman AI, 2013, TOB INDUC DIS, V11, DOI 10.1186/1617-9625-11-20; Gibson L, 2015, NICOTINE TOB RES, V17, P898, DOI 10.1093/ntr/ntv082; Grandpre J, 2003, HEALTH COMMUN, V15, P349, DOI 10.1207/S15327027HC1503_6; Hammond D, 2006, TOB CONTROL, V15, P19, DOI 10.1136/tc.2005.012294; Hammond D, 2004, AM J PUBLIC HEALTH, V94, P1442, DOI 10.2105/AJPH.94.8.1442; Hammond D, 2003, TOB CONTROL, V12, P391, DOI 10.1136/tc.12.4.391; Hammond D, 2007, AM J PREV MED, V32, P202, DOI 10.1016/j.amepre.2006.11.011; Hammond D, 2011, TOB CONTROL, V20, P327, DOI 10.1136/tc.2010.037630; HEATHERTON TF, 1989, BRIT J ADDICT, V84, P791; International Agency for Research on Cancer, 2008, METH EV TOB CONTR PO, V12; International Telecommunication Union, 2015, PERCENTAGE OF INDIVI; Kees J, 2006, J PUBLIC POLICY MARK, V25, P212, DOI 10.1509/jppm.25.2.212; Kees J, 2010, J PUBLIC POLICY MARK, V29, P265, DOI 10.1509/jppm.29.2.265; LaVoie NR, 2015, COMMUN RES; Maynard OM, 2014, DRUG ALCOHOL DEPEN, V136, P170, DOI 10.1016/j.drugalcdep.2014.01.001; Miller CH, 2010, HEALTH COMMUN, V25, P266, DOI 10.1080/10410231003698945; Noar SM, 2016, TOB CONTROL, V25, P341, DOI 10.1136/tobaccocontrol-2014-051978; O'Keefe DJ, 2003, COMMUN THEOR, V13, P251, DOI 10.1111/j.1468-2885.2003.tb00292.x; Peters E, 2007, NICOTINE TOB RES, V9, P473, DOI 10.1080/14622200701239639; Peters GJY, 2013, HEALTH PSYCHOL REV, V7, pS8, DOI 10.1080/17437199.2012.703527; Petty R. E., 1986, COMMUN PERSUATION; Quick BL, 2008, HUM COMMUN RES, V34, P448, DOI 10.1111/j.1468-2958.2008.00328.x; Quick BL, 2012, HEALTH COMMUN, V27, P1, DOI 10.1080/10410236.2011.567446; Quick BL, 2011, J HEALTH COMMUN, V16, P660, DOI 10.1080/10810730.2011.551989; Rains SA, 2007, HUM COMMUN RES, V33, P241, DOI 10.1111/j.1468-2958.2007.00298.x; Ruiter RAC, 2005, EUR J PUBLIC HEALTH, V15, P329, DOI 10.1093/eurpub/cki095; Shanahan P., 2001, EVALUATION OF THE HE; Slovic P, 2007, EUR J OPER RES, V177, P1333, DOI 10.1016/j.ejor.2005.04.006; Slovic P, 2006, CURR DIR PSYCHOL SCI, V15, P322, DOI 10.1111/j.1467-8721.2006.00461.x; Swayampakala K, 2015, HEALTH EDUC RES, V30, P35, DOI 10.1093/her/cyu022; Thrasher JF, 2015, NICOTINE TOB RES, V17, P870, DOI 10.1093/ntr/ntu246; Thrasher JF, 2010, SALUD PUBLICA MEXICO, V52, pS206, DOI 10.1590/S0036-36342010000800016; Thrasher JF, HLTH COMMUNICATION; Thrasher JF S K, CIGARETTE PACKAGE IN; WEGNER DM, 1994, PSYCHOL REV, V101, P34, DOI 10.1037/0033-295X.101.1.34; Wiium N, 2009, J APPL SOC PSYCHOL, V39, P1718, DOI 10.1111/j.1559-1816.2009.00501.x; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; WITTE K, 1994, COMMUN MONOGR, V61, P113, DOI 10.1080/03637759409376328; World Health Organization, 2008, THIRD SESSION OF THE; Xu J, 2015, PSYCHOL HEALTH, V30, P423, DOI 10.1080/08870446.2014.977280; Yong HH, 2014, HEALTH PSYCHOL, V33, P1410, DOI 10.1037/hea0000056	48	74	75	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159245	10.1371/journal.pone.0159245	http://dx.doi.org/10.1371/journal.pone.0159245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CP	26807740	Green Published, gold			2022-12-26	WOS:000379508300070
J	Snow, NJ; Mang, CS; Roig, M; McDonnell, MN; Campbell, KL; Boyd, LA				Snow, Nicholas J.; Mang, Cameron S.; Roig, Marc; McDonnell, Michelle N.; Campbell, Kristin L.; Boyd, Lara A.			The Effect of an Acute Bout of Moderate-Intensity Aerobic Exercise on Motor Learning of a Continuous Tracking Task	PLOS ONE			English	Article							PAIRED ASSOCIATIVE STIMULATION; SINGLE BOUT; CARDIOVASCULAR EXERCISE; MEMORY CONSOLIDATION; PERFORMANCE; ACCURACY; RELIABILITY; PLASTICITY; INCREASES; AROUSAL	Introduction There is evidence for beneficial effects of acute and long-term exercise interventions on several forms of memory, including procedural motor learning. In the present study we examined how performing a single bout of continuous moderate intensity aerobic exercise would impact motor skill acquisition and retention in young healthy adults, compared to a period of rest. We hypothesized that exercise would improve motor skill acquisition and retention, compared to motor practice alone. Materials and Methods Sixteen healthy adults completed sessions of aerobic exercise or seated rest that were immediately followed by practice of a novel motor task (practice). Exercise consisted of 30 minutes of continuous cycling at 60% peak O-2 uptake. Twenty-four hours after practice, we assessed motor learning with a no-exercise retention test (retention). We also quantified changes in offline motor memory consolidation, which occurred between practice and retention (offline). Tracking error was separated into indices of temporal precision and spatial accuracy. Results There were no differences between conditions in the timing of movements during practice (p = 0.066), at retention (p = 0.761), or offline (p = 0.966). However, the exercise condition enabled participants to maintain spatial accuracy during practice (p = 0.477); whereas, following rest performance diminished (p = 0.050). There were no significant differences between conditions at retention (p = 0.532) or offline (p = 0.246). Discussion An acute bout of moderate-intensity aerobic exercise facilitated the maintenance of motor performance during skill acquisition, but did not influence motor learning. Given past work showing that pairing high intensity exercise with skilled motor practice benefits learning, it seems plausible that intensity is a key modulator of the effects of acute aerobic exercise on changes in complex motor behavior. Further work is necessary to establish a dose-response relationship between aerobic exercise and motor learning.	[Snow, Nicholas J.; Mang, Cameron S.; Campbell, Kristin L.; Boyd, Lara A.] Univ British Columbia, Fac Med, Grad Program Rehabil Sci, Vancouver, BC, Canada; [Roig, Marc] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Roig, Marc] Montreal Ctr Interdisciplinary Res Rehabil CRIR, Memory & Motor Rehabil Lab MEMORY LAB, Feil & Oberfeld Res Ctr, Jewish Rehabil Hosp, Laval, PQ, Canada; [McDonnell, Michelle N.] Univ S Australia, Int Ctr Allied Hlth Evidence & Alliance Res Exerc, Sansom Inst Hlth Res, Sch Hlth Sci, Adelaide, SA 5001, Australia; [Boyd, Lara A.] Univ British Columbia, Fac Med, Grad Program Neurosci, Vancouver, BC, Canada	University of British Columbia; McGill University; McGill University; University of South Australia; University of British Columbia	Boyd, LA (corresponding author), Univ British Columbia, Fac Med, Grad Program Rehabil Sci, Vancouver, BC, Canada.; Boyd, LA (corresponding author), Univ British Columbia, Fac Med, Grad Program Neurosci, Vancouver, BC, Canada.	lara.boyd@ubc.ca	Campbell, Kristin L/A-5947-2009; Boyd, Lara/CAF-0372-2022; McDonnell, Michelle Nadine/B-9712-2009	McDonnell, Michelle Nadine/0000-0003-4445-0647; Snow, Nathan/0000-0002-5171-6493; Snow, Nicholas/0000-0003-0942-0688; Roig, Marc/0000-0002-1016-467X; Mang, Cameron/0000-0002-3376-5355	Natural Sciences and Engineering Research Council of Canada [RGPIN 401890-11]; Peter Wall Institute for Interdisciplinary Studies at the University of British Columbia; Natural Sciences and Engineering Research Council of Canada; University of British Columbia; Canada Research Chairs; Michael Smith Foundation for Health Research; Canada Foundation for Innovation; Reseau Provincial de Recherche en Adaptation-Readaptation (Recherche Clinique); Montreal Centre for Interdisciplinary Research in Rehabilitation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Peter Wall Institute for Interdisciplinary Studies at the University of British Columbia; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of British Columbia; Canada Research Chairs(Canada Research ChairsCGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Reseau Provincial de Recherche en Adaptation-Readaptation (Recherche Clinique); Montreal Centre for Interdisciplinary Research in Rehabilitation	This work was funded by awards from the Natural Sciences and Engineering Research Council of Canada (RGPIN 401890-11 to LAB; http://www.nserc-crsng.gc.ca/) and the Peter Wall Institute for Interdisciplinary Studies at the University of British Columbia (award to LAB; http://pwias.ubc.ca/). NJS and CSM are supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) and the University of British Columbia (https://www.ubc.ca/). LAB receives salary support from the Canada Research Chairs (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) and the Michael Smith Foundation for Health Research (http://www.msfhr.org/). MR was supported with funds from the Natural Sciences and Engineering Research Council of Canada (Discovery Grant; http://www.nserc-crsng.gc.ca/), Canada Foundation for Innovation (John R. Evans Leaders Fund; http://www.innovation.ca/), Reseau Provincial de Recherche en Adaptation-Readaptation (Recherche Clinique; http://www.repar.ca/FR/000/default.asp), and the Montreal Centre for Interdisciplinary Research in Rehabilitation (http:// www.crir.ca/?lang=EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine [ACSM], 2013, ACSMS GUIDELINES EXE; Audiffren M, 2008, ACTA PSYCHOL, V129, P410, DOI 10.1016/j.actpsy.2008.09.006; Bakken RC, 2001, PHYS THER, V81, P1870, DOI 10.1093/ptj/81.12.1870; Borg G, 1978, PSYCHOL RES PRACTICE, P333; Boyd LA, 2004, NEUROREHAB NEURAL RE, V18, P134, DOI 10.1177/0888439004269072; Boyd LA, 2004, LEARN MEMORY, V11, P388, DOI 10.1101/lm.80104; Boyd LA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-72; Cahill L, 2003, NEUROBIOL LEARN MEM, V79, P194, DOI 10.1016/S1074-7427(02)00036-9; Canadian Society for Exercise Physiology (CSEP), 2002, PHYS ACT READ QUEST; Cirillo J, 2009, J PHYSIOL-LONDON, V587, P5831, DOI 10.1113/jphysiol.2009.181834; Coco M, 2010, SOMATOSENS MOT RES, V27, P1, DOI 10.3109/08990220903471765; Cohen J.E., 1988, STAT POWER ANAL BEHA; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Crouter SE, 2006, EUR J APPL PHYSIOL, V98, P139, DOI 10.1007/s00421-006-0255-0; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Gold SM, 2003, J NEUROIMMUNOL, V138, P99, DOI 10.1016/S0165-5728(03)00121-8; Heyman E, 2012, PSYCHONEUROENDOCRINO, V37, P844, DOI 10.1016/j.psyneuen.2011.09.017; Hillman CH, 2003, INT J PSYCHOPHYSIOL, V48, P307, DOI 10.1016/S0167-8760(03)00080-1; Huang T, 2014, SCAND J MED SCI SPOR, V24, P1, DOI 10.1111/sms.12069; ISSEKUTZ B, 1962, J APPL PHYSIOL, V17, P47, DOI 10.1152/jappl.1962.17.1.47; Kamijo K, 2004, EUR J APPL PHYSIOL, V92, P305, DOI 10.1007/s00421-004-1097-2; Kantak SS, 2012, BEHAV BRAIN RES, V228, P219, DOI 10.1016/j.bbr.2011.11.028; Krakauer JW, 2006, CURR OPIN NEUROL, V19, P84, DOI 10.1097/01.wco.0000200544.29915.cc; Labban JD, 2011, RES Q EXERCISE SPORT, V82, P712, DOI 10.1080/02701367.2011.10599808; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Mang CS, 2014, J APPL PHYSIOL, V117, P1325, DOI 10.1152/japplphysiol.00498.2014; McClernon FJ, 2016, ADDICT BIOL, V21, P954, DOI 10.1111/adb.12253; McDonnell MN, 2013, J APPL PHYSIOL, V114, P1174, DOI 10.1152/japplphysiol.01378.2012; McDonnell MN, 2011, ARCH PHYS MED REHAB, V92, P1044, DOI 10.1016/j.apmr.2011.01.021; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McMorris T, 2012, BRAIN COGNITION, V80, P338, DOI 10.1016/j.bandc.2012.09.001; McMorris T, 2011, PHYSIOL BEHAV, V102, P421, DOI 10.1016/j.physbeh.2010.12.007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Potter D, 2005, J SPORT EXERCISE PSY, V27, P117, DOI 10.1123/jsep.27.1.117; Powers ME, 2015, J ATHL TRAINING, V50, P453, DOI 10.4085/1062-6050-50.1.07; Quaney BM, 2009, NEUROREHAB NEURAL RE, V23, P879, DOI 10.1177/1545968309338193; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Rhee J, 2016, PSYCHOL RES-PSYCH FO, V80, P518, DOI 10.1007/s00426-015-0682-9; Robertson EM, 2009, PLOS BIOL, V7, P11, DOI 10.1371/journal.pbio.1000019; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Roig M, 2014, NEUROBIOL AGING, V35, P1892, DOI 10.1016/j.neurobiolaging.2014.02.022; Roig M, 2013, NEUROSCI BIOBEHAV R, V37, P1645, DOI 10.1016/j.neubiorev.2013.06.012; Roig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044594; Saunders AC, 2005, J INHERIT METAB DIS, V28, P695, DOI 10.1007/s10545-005-0090-1; Segal SK, 2012, J ALZHEIMERS DIS, V32, P1011, DOI 10.3233/JAD-2012-121078; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Singh AM, 2016, BEHAV BRAIN RES, V301, P19, DOI 10.1016/j.bbr.2015.12.020; Singh AM, 2015, J MOTOR BEHAV, V47, P328, DOI 10.1080/00222895.2014.983450; Singh AM, 2014, EXP BRAIN RES, V232, P3675, DOI 10.1007/s00221-014-4049-z; Singh AM, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-23; Skriver K, 2014, NEUROBIOL LEARN MEM, V116, P46, DOI 10.1016/j.nlm.2014.08.004; Smith AE, 2014, EXP BRAIN RES, V232, P1875, DOI 10.1007/s00221-014-3879-z; SQUIRE LR, 1992, J COGNITIVE NEUROSCI, V4, P232, DOI 10.1162/jocn.1992.4.3.232; Statton MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141393; Taubert M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00692; Wadden K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00169; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003; Wulf G, 1997, J EXP PSYCHOL LEARN, V23, P987, DOI 10.1037/0278-7393.23.4.987	59	81	84	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150039	10.1371/journal.pone.0150039	http://dx.doi.org/10.1371/journal.pone.0150039			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26812148	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000371276100203
J	Wang, C; Lin, X; Li, L; Lin, SJ				Wang, Cong; Lin, Xin; Li, Ling; Lin, Senjie			Differential Growth Responses of Marine Phytoplankton to Herbicide Glyphosate	PLOS ONE			English	Article							DISSOLVED ORGANIC PHOSPHORUS; TRANSPORTER GENE PHND; FRESH-WATER POND; PSEUDOMONAS SP; ACUTE TOXICITY; ROUNDUP; LIMITATION; COMMUNITY; IMPACT; DEGRADATION	Glyphosate is a globally popular herbicide to kill weeds and its wide applications may lead to accumulation in coastal oceans as a source of phosphorus (P) nutrient or growth inhibitor of phytoplankton. We studied the physiological effects of glyphosate on fourteen species representing five major coastal phytoplankton phyla (haptophyta, bacillariophyta, dinoflagellata, raphidophyta, and chlorophyta). Based on growth responses to different concentrations of glyphosate under contrasting dissolved inorganic phosphorus (DIP) conditions, we found that phytoplankton species could be classified into five groups. Group I (Emiliania huxleyi, Skeletonema costatum, Phaeodactylum tricornutum) could utilize glyphosate as sole P-source to support growth in axenic culture, but in the presence of DIP, they were inhibited by both 36-mu M and 360-mu M glyphosate. Group II (Karenia mikimotoi, Prorocentrum minimum, Dunaliella tertiolecta, Symbiodinium sp., Heterosigma akashiwo and Alexandrium catenella) could not utilize glyphosate as sole P-source to support growth, and in the presence of DIP growth was not affected by 36-mu M but inhibited by 360-mu M glyphosate. Glyphosate consistently enhanced growth of Group III (Isochrysis galbana) and inhibited Group IV (Thalassiosira weissflogii, Thalassiosira pseudonana and Chattonella marina) regardless of DIP condition. Group V (Amphidinium carterae) exhibited no measurable response to glyphosate regardless of DIP condition. This grouping is not congruent with the phylogenetic relationships of the phytoplankton species suggesting functional differentiation driven by environmental pressure. We conclude that glyphosate could be used as P-source by some species while is toxic to some other species and yet has no effects on others. The observed differential effects suggest that the continued use of glyphosate and increasing concentration of this herbicide in the coastal waters will likely exert significant impact on coastal marine phytoplankton community structure.	[Wang, Cong; Lin, Xin; Li, Ling; Lin, Senjie] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; [Wang, Cong; Lin, Xin; Li, Ling; Lin, Senjie] Xiamen Univ, Coll Ocean & Marine Biodivers, Xiamen, Fujian, Peoples R China; [Wang, Cong; Lin, Xin; Li, Ling; Lin, Senjie] Xiamen Univ, Global Change Res Ctr, Xiamen, Fujian, Peoples R China; [Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	Xiamen University; Xiamen University; Xiamen University; University of Connecticut	Lin, SJ (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.; Lin, SJ (corresponding author), Xiamen Univ, Coll Ocean & Marine Biodivers, Xiamen, Fujian, Peoples R China.; Lin, SJ (corresponding author), Xiamen Univ, Global Change Res Ctr, Xiamen, Fujian, Peoples R China.; Lin, SJ (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	senjie.lin@uconn.edu	Lin, Senjie/A-7466-2011; Guo, chentao/G-7320-2016	CHEN, SHYR-CHYR/0000-0002-5858-3013; LIU, KAO-LANG/0000-0003-4100-8909; WANG, CHIH-HUNG/0000-0003-0802-7825; WU, YAO-MING/0000-0002-1720-7863; YANG, JUSTIN CHENG-TA/0000-0001-8256-2477; LIEN, WAN-CHING/0000-0001-9448-5093	National Natural Science Foundation of China (NSFC) [41176091, 41330959]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC), 41176091 and 41330959. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI A, 1978, CAN J BOT, V56, P2196, DOI 10.1139/b78-263; Annett R, 2014, J APPL TOXICOL, V34, P458, DOI 10.1002/jat.2997; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Arunakumara K. K. I. U., 2013, African Journal of Microbiology Research, V7, P4084; Baylis AD, 2000, PEST MANAG SCI, V56, P299, DOI 10.1002/(SICI)1526-4998(200004)56:4<299::AID-PS144>3.0.CO;2-K; BERNER T, 1989, J PHYCOL, V25, P70, DOI 10.1111/j.0022-3646.1989.00070.x; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; BOWMER KH, 1982, PESTIC SCI, V13, P623, DOI 10.1002/ps.2780130609; Busse MD, 2001, SOIL BIOL BIOCHEM, V33, P1777, DOI 10.1016/S0038-0717(01)00103-1; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; DICK RE, 1995, APPL MICROBIOL BIOT, V43, P545, DOI 10.1007/BF00218464; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Duke SO, 2011, J AGR FOOD CHEM, V59, P5835, DOI 10.1021/jf102704x; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Edge CB, 2013, SCI TOTAL ENVIRON, V444, P145, DOI 10.1016/j.scitotenv.2012.11.045; FENG JC, 1990, J AGR FOOD CHEM, V38, P1118, DOI 10.1021/jf00094a046; Fiori E, 2014, AQUAT TOXICOL, V147, P112, DOI 10.1016/j.aquatox.2013.12.014; FOLMAR LC, 1979, ARCH ENVIRON CON TOX, V8, P269, DOI 10.1007/BF01056243; Forlani G, 2008, PLANT CELL PHYSIOL, V49, P443, DOI 10.1093/pcp/pcn021; Forlani G, 2015, NEW PHYTOL, V205, P160, DOI 10.1111/nph.13022; Ge X, 2010, PEST MANAG SCI, V66, P345, DOI 10.1002/ps.1911; Giesy JP, 2000, REV ENVIRON CONTAM T, V167, P35; Gimsing AL, 2004, APPL SOIL ECOL, V27, P233, DOI 10.1016/j.apsoil.2004.05.007; GOLDSBOROUGH LG, 1989, ARCH ENVIRON CON TOX, V18, P537, DOI 10.1007/BF01055020; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; HERNANDO F, 1989, J PLANT PHYSIOL, V134, P26, DOI 10.1016/S0176-1617(89)80197-X; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Hove-Jensen B, 2014, MICROBIOL MOL BIOL R, V78, P176, DOI 10.1128/MMBR.00040-13; Ilikchyan IN, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00135; Ilikchyan IN, 2009, ENVIRON MICROBIOL, V11, P1314, DOI 10.1111/j.1462-2920.2009.01869.x; Kamlow M, 2013, THESIS NORWEGIAN U S; Karl DM, 2000, NATURE, V406, P31, DOI 10.1038/35017683; KARL DM, 1992, LIMNOL OCEANOGR, V37, P105, DOI 10.4319/lo.1992.37.1.0105; Kolowith LC, 2001, LIMNOL OCEANOGR, V46, P309, DOI 10.4319/lo.2001.46.2.0309; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; KREUTZWEISER DP, 1989, B ENVIRON CONTAM TOX, V42, P331, DOI 10.1007/BF01699957; Kryuchkova YV, 2014, MICROBIOL RES, V169, P99, DOI 10.1016/j.micres.2013.03.002; Krzysko-Lupicka T, 2008, CHEMOSPHERE, V71, P1386, DOI 10.1016/j.chemosphere.2007.11.006; Labry C, 2002, J PLANKTON RES, V24, P97, DOI 10.1093/plankt/24.2.97; Leggat W, 2007, J PHYCOL, V43, P1010, DOI 10.1111/j.1529-8817.2007.00387.x; LeGresley M, 2010, COUNTING CHAMBER MET; Lin X, 2011, J PHYCOL, V47, P1110, DOI 10.1111/j.1529-8817.2011.01038.x; Lipok J, 2010, ECOTOX ENVIRON SAFE, V73, P1681, DOI 10.1016/j.ecoenv.2010.08.017; LIU CM, 1991, APPL ENVIRON MICROB, V57, P1799, DOI 10.1128/AEM.57.6.1799-1804.1991; Ma J, 2003, B ENVIRON CONTAM TOX, V71, P594, DOI 10.1007/s00128-003-8521-x; MITCHELL DG, 1987, B ENVIRON CONTAM TOX, V39, P1028, DOI 10.1007/BF01689594; Modesto KA, 2010, CHEMOSPHERE, V81, P781, DOI 10.1016/j.chemosphere.2010.07.005; Mohr S, 2008, ENVIRON POLLUT, V152, P530, DOI 10.1016/j.envpol.2007.07.010; Mohr S, 2007, AQUAT TOXICOL, V82, P73, DOI 10.1016/j.aquatox.2007.02.001; MOORE JK, 1983, APPL ENVIRON MICROB, V46, P316, DOI 10.1128/AEM.46.2.316-320.1983; Nandula V. K., 2005, Outlooks on Pest Management, V16, P183, DOI 10.1564/16aug11; ORRETT K, 1987, LIMNOL OCEANOGR, V32, P383, DOI 10.4319/lo.1987.32.2.0383; Peck LS, 2011, MAR GENOM, V4, P237, DOI 10.1016/j.margen.2011.07.001; Perez GL, 2007, ECOL APPL, V17, P2310, DOI 10.1890/07-0499.1; Peruzzo PJ, 2008, ENVIRON POLLUT, V156, P61, DOI 10.1016/j.envpol.2008.01.015; PIPKE R, 1988, APPL ENVIRON MICROB, V54, P1293, DOI 10.1128/AEM.54.5.1293-1296.1988; PIPKE R, 1987, EUR J BIOCHEM, V165, P267, DOI 10.1111/j.1432-1033.1987.tb11437.x; QUINN JP, 1989, APPL MICROBIOL BIOT, V31, P283, DOI 10.1007/BF00258410; Relyea RA, 2005, ECOL APPL, V15, P1118, DOI 10.1890/04-1291; Sandrini JZ, 2013, AQUAT TOXICOL, V130, P171, DOI 10.1016/j.aquatox.2013.01.006; Saxton MA, 2011, J GREAT LAKES RES, V37, P683, DOI 10.1016/j.jglr.2011.07.004; Schaffer JD, 2004, B ENVIRON CONTAM TOX, V72, P1032, DOI 10.1007/s00128-004-0347-7; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; SCHULZ A, 1985, FEMS MICROBIOL LETT, V28, P297, DOI 10.1111/j.1574-6968.1985.tb00809.x; SERVIZI JA, 1987, B ENVIRON CONTAM TOX, V39, P15, DOI 10.1007/BF01691783; Shi XG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071232; Stachowski-Haberkorn S, 2008, AQUAT TOXICOL, V89, P232, DOI 10.1016/j.aquatox.2008.07.004; Stalikas CD, 2001, J CHROMATOGR A, V907, P1, DOI 10.1016/S0021-9673(00)01009-8; Sun YY, 2009, BIOTECHNOL BIOPROC E, V14, P225, DOI 10.1007/s12257-008-0013-8; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; Suzumura M, 1998, LIMNOL OCEANOGR, V43, P1553, DOI 10.4319/lo.1998.43.7.1553; TALBOT HW, 1984, CURR MICROBIOL, V10, P255, DOI 10.1007/BF01577137; Ternan NG, 1998, WORLD J MICROB BIOT, V14, P635, DOI 10.1023/A:1008848401799; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; VASSILIEV IR, 1995, PLANT PHYSIOL, V109, P963, DOI 10.1104/pp.109.3.963; Vendrell E, 2009, B ENVIRON CONTAM TOX, V82, P538, DOI 10.1007/s00128-009-9674-z; Vera MS, 2010, ECOTOXICOLOGY, V19, P710, DOI 10.1007/s10646-009-0446-7; Villarreal-Chiu JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00019; Webster TMU, 2014, ENVIRON SCI TECHNOL, V48, P1271, DOI 10.1021/es404258h; Winer BJ, 1971, STAT PRINCIPLES EXPT; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	84	118	126	9	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151633	10.1371/journal.pone.0151633	http://dx.doi.org/10.1371/journal.pone.0151633			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985828	Green Published, Green Submitted, gold			2022-12-26	WOS:000372580300099
J	Wang, CH; Wu, CY; Yang, JCT; Lien, WC; Wang, HP; Liu, KL; Wu, YM; Chen, SC				Wang, Chih-Hung; Wu, Cheng-Yi; Yang, Justin Cheng-Ta; Lien, Wan-Ching; Wang, Hsiu-Po; Liu, Kao-Lang; Wu, Yao-Ming; Chen, Shyr-Chyr			Long-Term Outcomes of Patients with Acute Cholecystitis after Successful Percutaneous Cholecystostomy Treatment and the Risk Factors for Recurrence: A Decade Experience at a Single Center	PLOS ONE			English	Article							LAPAROSCOPIC CHOLECYSTECTOMY; SURGICAL-PATIENTS; MANAGEMENT; DIAGNOSIS; BRIDGE; TRIAL; BILE	Background Percutaneous cholecystostomy tube (PCT) has been effectively used for the treatment of acute cholecystitis (AC) for patients unsuitable for early cholecystectomy. This retrospective study investigated the recurrence rate after successful PCT treatment and factors associated with recurrence. Methods We reviewed patients treated with PCT for AC from October 2004 through December 2013. Patients with successful PCT treatment were those who were free from persistent PCT drainage. We used multivariable logistic regression analysis sequentially to identify factors associated with each outcome. Results The study included 184 patients (mean age: 70.1 years). The average duration for parenteral antibiotics was 14.4 days and 20.0 days for PCT drainage. The one-year recurrence rate was 9.2% (17/184) with most recurrences occurring within two months (6.5%, 12/184) of the procedure. Complicated cholecystitis (odds ratio [OR]: 4.67; 95% confidence interval [CI]: 1.44-15.70; P = 0.01) and PCT drainage duration >32 days (OR: 4.92; 95% CI: 1.03-23.53; P = 0.05) positively correlated with one-year recurrence; parenteral antibiotics duration > 10 days (OR: 0.21; 95% CI: 0.05-0.68; P = 0.01) was inversely associated with one-year recurrence. Conclusions The recurrence rate was low for patients after successful PCT treatment. Predictors for recurrence included the severity of initial AC and subsequently provided treatments.	[Wang, Chih-Hung; Wu, Cheng-Yi; Chen, Shyr-Chyr] Natl Taiwan Univ, Dept Emergency Med, Taipei 10764, Taiwan; [Wang, Chih-Hung; Wu, Cheng-Yi; Yang, Justin Cheng-Ta; Wang, Hsiu-Po; Liu, Kao-Lang; Wu, Yao-Ming; Chen, Shyr-Chyr] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Yang, Justin Cheng-Ta; Liu, Kao-Lang] Natl Taiwan Univ, Dept Med Imaging, Taipei 10764, Taiwan; [Lien, Wan-Ching] Natl Taiwan Univ Hosp, Hsin Chu Branch, Hsinchu, Taiwan; [Lien, Wan-Ching] Natl Taiwan Univ, Hsinchu, Taiwan; [Wang, Hsiu-Po] Natl Taiwan Univ, Dept Internal Med, Taipei 10764, Taiwan; [Wu, Yao-Ming] Natl Taiwan Univ, Dept Surg, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University	Lien, WC (corresponding author), Natl Taiwan Univ Hosp, Hsin Chu Branch, Hsinchu, Taiwan.; Lien, WC (corresponding author), Natl Taiwan Univ, Hsinchu, Taiwan.	wanchinglien@ntu.edu.tw	Lin, Senjie/A-7466-2011; Guo, chentao/G-7320-2016	CHEN, SHYR-CHYR/0000-0002-5858-3013; LIU, KAO-LANG/0000-0003-4100-8909; WANG, CHIH-HUNG/0000-0003-0802-7825; WU, YAO-MING/0000-0002-1720-7863; YANG, JUSTIN CHENG-TA/0000-0001-8256-2477; LIEN, WAN-CHING/0000-0001-9448-5093				Browning P D, 1993, J Vasc Interv Radiol, V4, P531, DOI 10.1016/S1051-0443(93)71915-6; Chang YR, 2014, SURGERY, V155, P615, DOI 10.1016/j.surg.2013.12.026; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chok KSH, 2010, ANZ J SURG, V80, P280, DOI 10.1111/j.1445-2197.2009.05105.x; Crnich CJ, 2012, INFECT DIS CLIN N AM, V26, P143, DOI 10.1016/j.idc.2011.09.007; Davis CA, 1999, ARCH SURG-CHICAGO, V134, P727, DOI 10.1001/archsurg.134.7.727; de Mestral C, 2013, J TRAUMA ACUTE CARE, V74, P175, DOI 10.1097/TA.0b013e31827890e1; Decker G, 2001, ACTA CHIR BELG, V101, P294; Gomi H, 2013, J HEPATO-BIL-PAN SCI, V20, P60, DOI 10.1007/s00534-012-0572-0; Gurusamy K, 2010, BRIT J SURG, V97, P141, DOI 10.1002/bjs.6870; Hatjidakis AA, 1998, CARDIOVASC INTER RAD, V21, P36, DOI 10.1007/s002709900208; HOUGHTON PWJ, 1985, BRIT J SURG, V72, P220, DOI 10.1002/bjs.1800720327; HUBER DF, 1983, AM J SURG, V146, P719, DOI 10.1016/0002-9610(83)90326-4; Kiviniemi H, 1998, INT SURG, V83, P299; Kortram K, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-7; Leveau P, 2008, SCAND J GASTROENTERO, V43, P593, DOI 10.1080/00365520701851673; Li M, 2013, AM SURGEON, V79, P524; MARGIOTTA SJ, 1988, AM SURGEON, V54, P34; McGillicuddy EA, 2012, BRIT J SURG, V99, P1254, DOI 10.1002/bjs.8836; Miura F, 2013, J HEPATO-BIL-PAN SCI, V20, P47, DOI 10.1007/s00534-012-0563-1; MORRIS CR, 1952, SURGERY, V32, P673; Okamoto K, 2013, J HEPATO-BIL-PAN SCI, V20, P55, DOI 10.1007/s00534-012-0562-2; Pessaux P, 2001, SURG LAPARO ENDO PER, V11, P252, DOI 10.1097/00129689-200108000-00005; RADDER RW, 1980, DIAGN IMAGING, V49, P330; ROSLYN JJ, 1980, AM J SURG, V140, P126, DOI 10.1016/0002-9610(80)90428-6; Sanjay P, 2013, HPB, V15, P511, DOI 10.1111/j.1477-2574.2012.00610.x; Smith TJ, 2013, ANN SURG, V257, P1112, DOI 10.1097/SLA.0b013e318274779c; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; VANDERLINDEN W, 1970, AM J SURG, V120, P7, DOI 10.1016/S0002-9610(70)80133-7; Venara A, 2014, J VISC SURG, V151, P435, DOI 10.1016/j.jviscsurg.2014.06.003; Wang CH, 2014, WORLD J SURG, V38, P347, DOI 10.1007/s00268-013-2311-3; WERBEL GB, 1989, ARCH SURG-CHICAGO, V124, P782; Winbladh A, 2009, HPB, V11, P183, DOI 10.1111/j.1477-2574.2009.00052.x; Wise JN, 2005, AM J ROENTGENOL, V184, P1647, DOI 10.2214/ajr.184.5.01841647; Yokoe M, 2013, J HEPATO-BIL-PAN SCI, V20, P35, DOI 10.1007/s00534-012-0568-9; Zerem E, 2014, SURG LAPARO ENDO PER, V24, P187, DOI 10.1097/SLE.0b013e31828fa45e	36	118	126	9	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148017	10.1371/journal.pone.0148017	http://dx.doi.org/10.1371/journal.pone.0148017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26985828	Green Submitted, Green Published, gold			2022-12-26	WOS:000369528400058
J	Snow, NP; Halseth, JM; Lavelle, MJ; Hanson, TE; Blass, CR; Foster, JA; Humphrys, ST; Staples, LD; Hewitt, DG; VerCauteren, KC				Snow, Nathan P.; Halseth, Joseph M.; Lavelle, Michael J.; Hanson, Thomas E.; Blass, Chad R.; Foster, Justin A.; Humphrys, Simon T.; Staples, Linton D.; Hewitt, David G.; VerCauteren, Kurt C.			Bait Preference of Free-Ranging Feral Swine for Delivery of a Novel Toxicant	PLOS ONE			English	Article							BOAR SUS-SCROFA; BIRDS; PIGS; PHARMACEUTICALS; CONSUMPTION; BEHAVIOR; COLOR; HOGS	Invasive feral swine (Sus scrofa) cause extensive damage to agricultural and wildlife resources throughout the United States. Development of sodium nitrite as a new, orally delivered toxicant is underway to provide an additional tool to curtail growth and expansion of feral swine populations. A micro-encapsulation coating around sodium nitrite is used to minimize detection by feral swine and maximize stability for the reactive molecule. To maximize uptake of this toxicant by feral swine, development a bait matrix is needed to 1) protect the micro-encapsulation coating so that sodium nitrite remains undetectable to feral swine, 2) achieve a high degree of acceptance by feral swine, and 3) be minimally appealing to non-target species. With these purposes, a field evaluation at 88 sites in south-central Texas was conducted using remote cameras to evaluate preferences by feral swine for several oil-based bait matrices including uncolored peanut paste, black-colored peanut paste, and peanut-based slurry mixed onto whole-kernel corn. These placebo baits were compared to a reference food, whole-kernel corn, known to be readily taken by feral swine (i.e., control). The amount of bait consumed by feral swine was also estimated using remote cameras and grid boards at 5 additional sites. On initial exposure, feral swine showed reduced visitations to the uncolored peanut paste and peanut slurry treatments. This reduced visitation subsided by the end of the treatment period, suggesting that feral swine needed time to accept these bait types. The black-colored peanut paste was visited equally to the control throughout the study, and enough of this matrix was consumed to deliver lethal doses of micro-encapsulated sodium nitrite to most feral swine during 1-2 feeding events. None of the treatment matrices reduced visitations by nontarget species, but feral swine dominated visitations for all matrices. It was concluded that black-colored peanut paste achieved satisfactory preference and consumption by feral swine, and no discernable preference by non-target species, compared to the other treatments.	[Snow, Nathan P.; Hewitt, David G.] Texas A&M Univ, Caesar Kleberg Wildlife Res Inst, 700 Univ Blvd,MSC 218, Kingsville, TX 78363 USA; [Snow, Nathan P.; Halseth, Joseph M.; Lavelle, Michael J.; Hanson, Thomas E.; Blass, Chad R.; VerCauteren, Kurt C.] US Fish & Wildlife Serv, USDA, APHIS, Natl Wildlife Res Ctr, 4101 LaPorte Ave, Ft Collins, CO 80521 USA; [Foster, Justin A.] Texas Parks & Wildlife Dept, Kerr Wildlife Management Area, 2625 FM 1340, Hunt, TX 78024 USA; [Humphrys, Simon T.; Staples, Linton D.] Invas Anim CRC, 33 Flemington St, Glenside, SA 5062, Australia; [Staples, Linton D.] Anim Control Technol Australia Pty Ltd, 46-50 Freight Dr, Somerton, Vic 3062, Australia	Texas A&M University System; Texas A&M University Kingsville; United States Department of Agriculture (USDA); United States Department of the Interior; US Fish & Wildlife Service	Snow, NP (corresponding author), Texas A&M Univ, Caesar Kleberg Wildlife Res Inst, 700 Univ Blvd,MSC 218, Kingsville, TX 78363 USA.; Snow, NP (corresponding author), US Fish & Wildlife Serv, USDA, APHIS, Natl Wildlife Res Ctr, 4101 LaPorte Ave, Ft Collins, CO 80521 USA.	Nathan.P.Snow@aphis.usda.gov	Campbell, Kristin L/A-5947-2009; Boyd, Lara/CAF-0372-2022; McDonnell, Michelle Nadine/B-9712-2009	McDonnell, Michelle Nadine/0000-0003-4445-0647; Snow, Nathan/0000-0002-5171-6493; Snow, Nicholas/0000-0003-0942-0688; Roig, Marc/0000-0002-1016-467X; Mang, Cameron/0000-0002-3376-5355	USDA National Feral Swine Damage Management Program; Invasive Animals Cooperative Research Center	USDA National Feral Swine Damage Management Program; Invasive Animals Cooperative Research Center	Funding was provided by the USDA National Feral Swine Damage Management Program and the Invasive Animals Cooperative Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One author (LS) of this manuscript was commercially affiliated with Animal Control Technologies Australia Pty Ltd. This author played a role in the study by providing the test materials and preparation of the manuscript.	Adams CE., 2006, URBAN WILDLIFE MANAG; Bailey RG., 1980, DESCRIPTION ECOREGIO; Bailey RG, 1998, ECOREGIONS; Barrios-Garcia MN, 2012, BIOL INVASIONS, V14, P2283, DOI 10.1007/s10530-012-0229-6; Baubet E, 2003, WILDLIFE RES, V30, P179, DOI 10.1071/WR00113; Bevins SN, 2014, BIOSCIENCE, V64, P291, DOI 10.1093/biosci/biu015; BRYANT H, 1984, AUST WILDLIFE RES, V11, P509; CAITHNES.TA, 1971, NEW ZEAL J AGR, V122, P38; Campbell TA, 2012, P 25 VERT PEST C; Campbell TA, 2007, J WILDLIFE DIS, V43, P485, DOI 10.7589/0090-3558-43.3.485; Campbell TA, 2006, WILDLIFE SOC B, V34, P1184, DOI 10.2193/0091-7648(2006)34[1184:UBTDPT]2.0.CO;2; Campbell TA, 2013, INT J PEST MANAGE, V59, P197, DOI 10.1080/09670874.2013.815830; Campbell TA, 2011, PREV VET MED, V98, P243, DOI 10.1016/j.prevetmed.2010.11.018; Campbell TA, 2010, J WILDLIFE MANAGE, V74, P337, DOI 10.2193/2009-131; Campbell TA, 2009, J WILDLIFE MANAGE, V73, P615, DOI 10.2193/2008-326; Chapman J., 2003, WILD MAMMALS N AM, P1164; CHOQUENOT D, 1993, WILDLIFE RES, V20, P15, DOI 10.1071/WR9930015; COBLENTZ BE, 1987, J APPL ECOL, V24, P403, DOI 10.2307/2403883; Cowled BD, 2008, WILDLIFE RES, V35, P651, DOI 10.1071/WR07072; Cushman JH, 2004, ECOL APPL, V14, P1746, DOI 10.1890/03-5142; Day TD, 1999, NEW ZEAL J ECOL, V23, P261; Deligeorgis SG, 2006, APPL ANIM BEHAV SCI, V96, P233, DOI 10.1016/j.applanim.2005.06.006; DICKSON JG, 2001, WILDLIFE SO FORESTS, P191; Figueroa J, 2013, APPL ANIM BEHAV SCI, V148, P120, DOI 10.1016/j.applanim.2013.06.002; Fry J, 2011, PHOTOGRAMM ENG REMOT, V77, P858; Homer C, 2007, PHOTOGRAMM ENG REM S, V73, P337; Hone J, 2002, BIOL CONSERV, V105, P231, DOI 10.1016/S0006-3207(01)00185-9; ILSE LM, 1995, J MAMMAL, V76, P784, DOI 10.2307/1382747; Jolley DB, 2010, J MAMMAL, V91, P519, DOI 10.1644/09-MAMM-A-129.1; Kittawornrat Apisit, 2011, Animal Health Research Reviews, V12, P25, DOI 10.1017/S1466252310000174; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; Lapidge S, 2012, USDA NATL WILDLIFE C, P1158; Massei G, 2010, J WILDLIFE MANAGE, V74, P333, DOI 10.2193/2008-489; MAYER J, 2009, WILD PIGS BIOL DAMAG; Mayer J. J., 2014, SRNLSTI201400292; Newkirk ES, 2014, CPW PHOTO DATABASE; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pimentel David, 2007, P2; SMITH JE, 1966, AM J PHYSIOL, V210, P347, DOI 10.1152/ajplegacy.1966.210.2.347; Snow N, 2015, BAIT PREFERENCE FREE; Tanida H, 1996, APPL ANIM BEHAV SCI, V49, P173, DOI 10.1016/0168-1591(96)01039-8; Taylor RB, 1997, SOUTHWEST NAT, V42, P33; Theobald DM, 2007, ENVIRON MANAGE, V40, P134, DOI 10.1007/s00267-005-0199-x; van Riper C, 2001, STUD AVIAN BIOL-SER, P221; Weser C, 2013, NEW ZEAL J ZOOL, V40, P137, DOI 10.1080/03014223.2012.710639; West B.C., 2009, MANAGING WILD PIGS T; Williams BL, 2011, J WILDLIFE MANAGE, V75, P655, DOI 10.1002/jwmg.75; Zhang YW, 2013, STAT COMPUT, V23, P743, DOI 10.1007/s11222-012-9343-7	48	81	84	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146712	10.1371/journal.pone.0146712	http://dx.doi.org/10.1371/journal.pone.0146712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812148	gold, Green Published			2022-12-26	WOS:000369528000012
